PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sreekanth, CN; Bava, SV; Sreekumar, E; Anto, RJ				Sreekanth, C. N.; Bava, S. V.; Sreekumar, E.; Anto, R. J.			Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer	ONCOGENE			English	Article						chemical carcinogenesis; survival factors; xenograft tumors; natural products; chemosensitization; apoptosis	FACTOR-KAPPA-B; TAXOL-INDUCED APOPTOSIS; MULTIDRUG-RESISTANCE; TRANSCRIPTION FACTOR; OVARIAN-CANCER; DOWN-REGULATION; UTERINE CERVIX; P-GLYCOPROTEIN; BREAST-CANCER; CONSTITUTIVE ACTIVATION	The microtubule-targeting antineoplastic agent, paclitaxel, is highly efficacious against a wide spectrum of human cancers. However, dose-limiting toxicity and development of drug resistance limit its clinical application. Development of novel strategies that overcome chemoresistance and sensitize cancer cells to paclitaxel can enhance the therapeutic effect of this drug. We have previously shown that curcumin, a natural polyphenol, enhances paclitaxel-induced cytotoxicity in vitro through downregulation of nuclear factor (NF)-kappa B and Akt pathways. This study was undertaken to determine whether this synergism exists in vivo and to elucidate the underlying molecular mechanisms. Mouse cervical multistage squamous cell carcinoma model using 3-methylcholanthrene (3-MC) and a xenograft model of human cervical cancer in nonobese diabetic severe combined immunodeficient ( NOD-SCID) mice using HeLa cells were used to evaluate the synergism. We observed that the combined treatment of curcumin and paclitaxel induced a synergestic reduction in the tumor incidence as well as tumor volume of animals compared with the individual treatments of paclitaxel or curcumin, although curcumin alone could not induce any significant effect at the concentration used. The results suggest that a suboptimal concentration of curcumin augments the antitumor action of paclitaxel by down-regulating the activation and downstream signaling of antiapoptotic factors and survival signals such as NF-kappa B, Akt and mitogen-activated protein kinases that have significant roles in proliferation, survival, angiogenesis and metastasis. This study revealed for the first time that 3-MC-induced tumorigenesis in mice is associated with a strong constitutive activation of NF-kappa B activity. Furthermore, we also observed that pre-exposure of carcinoma cells isolated from 3-MC-induced tumors to curcumin potentiates paclitaxel-induced apoptosis. Overall, the findings of this preclinical study provide a strong rationale for the validation of this combination through clinical trials. As curcumin could effectively downregulate all these survival signals induced by paclitaxel, we suggest it as a potent chemosensitizer to improve the therapeutic index of paclitaxel. Oncogene (2011) 30, 3139-3152; doi:10.1038/onc.2011.23; published online 14 February 2011	[Sreekanth, C. N.; Bava, S. V.; Anto, R. J.] Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Integrated Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Sreekumar, E.] Rajiv Gandhi Ctr Biotechnol, Mol Virol Lab, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Anto, RJ (corresponding author), Rajiv Gandhi Ctr Biotechnol, Div Canc Res, Integrated Canc Res Program, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	rjanto@rgcb.res.in	Narayanapillai, Sreekanth Chanickal/AAQ-4442-2020		Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India. We thank Dr Marie Lue Antony, Dr TR Santhoshkumar and Arun Kumar T Thulasidasan for technical advice and help and Dr Thara Somanathan for verifying the histopathology data.	Aggarwal BB, 2005, CLIN CANCER RES, V11, P7490, DOI 10.1158/1078-0432.CCR-05-1192; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Aggarwal BB, 2007, MOL TARGETS THERAPEU; Aggarwal S, 2006, MOL PHARMACOL, V69, P195, DOI 10.1124/mol.105.017400; Ahn KS, 2007, CURR MOL MED, V7, P619, DOI 10.2174/156652407782564363; Ahn KS, 2008, BIOCHEM PHARMACOL, V75, P907, DOI 10.1016/j.bcp.2007.10.010; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Anto RJ, 2002, CARCINOGENESIS, V23, P143, DOI 10.1093/carcin/23.1.143; Anuchapreeda S, 2002, BIOCHEM PHARMACOL, V64, P573, DOI 10.1016/S0006-2952(02)01224-8; Banerjee S, 2002, CANCER RES, V62, P4945; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; BRADLEY G, 1994, CANCER METAST REV, V13, P223, DOI 10.1007/BF00689638; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chang YF, 1996, CANCER, V77, P14, DOI 10.1002/(SICI)1097-0142(19960101)77:1<14::AID-CNCR4>3.0.CO;2-N; Chaturvedi MM, 2000, METHOD ENZYMOL, V319, P585; CHHABRA SK, 1995, ONCOLOGY, V52, P32; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Gagnon V, 2008, APOPTOSIS, V13, P259, DOI 10.1007/s10495-007-0165-6; Ganta S, 2009, MOL PHARMACEUT, V6, P928, DOI 10.1021/mp800240j; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Hokeness K, 2005, ONCOL REP, V13, P965; Hou XL, 2008, INT J PHARM, V358, P224, DOI 10.1016/j.ijpharm.2008.03.010; HUSSAIN SP, 1991, CANCER LETT, V56, P231, DOI 10.1016/0304-3835(91)90007-5; Inoue M, 2008, INT J CANCER, V123, P2696, DOI 10.1002/ijc.23867; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Kuo HC, 2006, TOXICOL APPL PHARM, V210, P55, DOI 10.1016/j.taap.2005.06.020; KUTTAN R, 1985, CANCER LETT, V29, P197, DOI 10.1016/0304-3835(85)90159-4; Kutuk O, 2008, CANCER RES, V68, P7985, DOI 10.1158/0008-5472.CAN-08-1418; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Leland GD, 2002, CULTURE EPITHELIAL C, Vsecond, P277; Li L, 2005, CANCER-AM CANCER SOC, V104, P1322, DOI 10.1002/cncr.21300; Li L, 2007, MOL CANCER THER, V6, P1276, DOI 10.1158/1535-7163.MCT-06-0556; Liu B, 2001, BRIT J CANCER, V85, P303, DOI 10.1054/bjoc.2001.1910; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan RM, 2007, ORAL ONCOL, V43, P395, DOI 10.1016/j.oraloncology.2006.04.011; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Marupudi NI, 2007, EXPERT OPIN DRUG SAF, V6, P609, DOI 10.1517/14740338.6.5.609; MURPHY ED, 1961, JNCI-J NATL CANCER I, V27, P611; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Narayanan NK, 2009, INT J CANCER, V125, P1, DOI 10.1002/ijc.24336; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Reuter S, 2008, BIOCHEM PHARMACOL, V76, P1340, DOI 10.1016/j.bcp.2008.07.031; Sasaki N, 2001, CLIN CANCER RES, V7, P4136; Saunders DE, 1997, INT J CANCER, V70, P214, DOI 10.1002/(SICI)1097-0215(19970117)70:2<214::AID-IJC13>3.0.CO;2-I; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sumitomo M, 1999, J UROLOGY, V161, P674, DOI 10.1016/S0022-5347(01)61993-1; Sur I, 2008, INT REV IMMUNOL, V27, P205, DOI 10.1080/08830180802130319; Tai DI, 2000, CANCER, V89, P2274, DOI 10.1002/1097-0142(20001201)89:11<2274::AID-CNCR16>3.0.CO;2-2; Tang XM, 2006, CANCER, V107, P2637, DOI 10.1002/cncr.22315; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yagi H, 2009, INT J CANCER, V124, P1429, DOI 10.1002/ijc.24031; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zhang ZF, 2006, ANN THORAC SURG, V82, P243, DOI 10.1016/j.athoracsur.2006.01.049; Zhou G, 1997, J BIOL CHEM, V272, P15174, DOI 10.1074/jbc.272.24.15174	65	122	126	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	28					3139	3152		10.1038/onc.2011.23	http://dx.doi.org/10.1038/onc.2011.23			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	792FQ	21317920				2022-12-25	WOS:000292726300003
J	Polzien, L; Baljuls, A; Albrecht, M; Hekman, M; Rapp, UR				Polzien, Lisa; Baljuls, Angela; Albrecht, Marco; Hekman, Mirko; Rapp, Ulf R.			BAD Contributes to RAF-mediated Proliferation and Cooperates with B-RAF-V600E in Cancer Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 PROTEIN FAMILY; DEATH AGONIST BAD; B-RAF; CELL-DEATH; MITOCHONDRIAL LOCALIZATION; C-RAF; KINASE; PHOSPHORYLATION; BRAF; BINDING	BAD (Bcl-2 antagonist of cell death) belongs to the proapoptotic BH3-only subfamily of Bcl-2 proteins. Physiological activity of BAD is highly controlled by phosphorylation. To further analyze the regulation of BAD function, we investigated the role of recently identified phosphorylation sites on BAD-mediated apoptosis. We found that in contrast to the N-terminal phosphorylation sites, the serines 124 and 134 act in an antiapoptotic manner because the replacement by alanine led to enhanced cell death. Our results further indicate that RAF kinases represent, besides PAK1, BAD serine 134 phosphorylating kinases. Importantly, in the presence of wild type BAD, co-expression of survival kinases, such as RAF and PAK1, leads to a strongly increased proliferation, whereas substitution of serine 134 by alanine abolishes this process. Furthermore, we identified BAD serine 134 to be strongly involved in survival signaling of B-RAF-V600E-containing tumor cells and found that phosphorylation of BAD at this residue is critical for efficient proliferation in these cells. Collectively, our findings provide new insights into the regulation of BAD function by phosphorylation and its role in cancer signaling.	[Polzien, Lisa; Baljuls, Angela; Albrecht, Marco; Hekman, Mirko; Rapp, Ulf R.] Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Polzien, Lisa; Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, WG Kerckhoff Inst, D-61231 Bad Nauheim, Germany; [Rapp, Ulf R.] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Wurzburg; Max Planck Society; Max Planck Society	Polzien, L (corresponding author), Univ Wurzburg, Dept Microbiol, Bioctr, D-97074 Wurzburg, Germany.	lisa.polzien@uni-wuerzburg.de		Albrecht, Marco/0000-0002-1156-0623	Deutsche Forschungsgemeinschaft [SFB 487, C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 487 (Projects C3) and Graduate College 1141 Grant.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; BOS JL, 1989, CANCER RES, V49, P4682; Brose MS, 2002, CANCER RES, V62, P6997; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Eisenmann KM, 2003, CANCER RES, V63, P8330; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Gorden A, 2003, CANCER RES, V63, P3955; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kebache S, 2007, J BIOL CHEM, V282, P21873, DOI 10.1074/jbc.M611066200; Klumpp S, 2004, NEUROCHEM INT, V45, P747, DOI 10.1016/j.neuint.2004.02.006; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Macdonald A, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-1; Masters SC, 2001, MOL PHARMACOL, V60, P1325, DOI 10.1124/mol.60.6.1325; Panka DJ, 2006, CANCER RES, V66, P1611, DOI 10.1158/0008-5472.CAN-05-0808; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Polzien L, 2009, J BIOL CHEM, V284, P28004, DOI 10.1074/jbc.M109.010702; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rapp U. R., 2007, NAT PRECEDINGS  0823; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shimamura A, 2000, CURR BIOL, V10, P127, DOI 10.1016/S0960-9822(00)00310-9; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Subramanian RR, 2001, EXP CELL RES, V271, P142, DOI 10.1006/excr.2001.5376; Wang HG, 1996, CELL, V87, P629, DOI 10.1016/S0092-8674(00)81383-5; Weber C. K., 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang JY, 2005, CANCER RES, V65, P8372, DOI 10.1158/0008-5472.CAN-05-0576	56	14	14	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2011	286	20					17934	17944		10.1074/jbc.M110.177345	http://dx.doi.org/10.1074/jbc.M110.177345			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	763UM	21317286	Green Published, hybrid			2022-12-25	WOS:000290585200056
J	Puskar, NL; Xiu, XA; Lester, HA; Dougherty, DA				Puskar, Nyssa L.; Xiu, Xinan; Lester, Henry A.; Dougherty, Dennis A.			Two Neuronal Nicotinic Acetylcholine Receptors, alpha 4 beta 4 and alpha 7, Show Differential Agonist Binding Modes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-PI INTERACTIONS; UNNATURAL AMINO-ACIDS; IN-VIVO INCORPORATION; GATED ION CHANNELS; BUNGAROTOXIN; PROTEIN; RIC-3; SITE; EXPRESSION; SUBUNIT	Nicotinic acetylcholine receptors (nAChRs) are pentameric, neurotransmitter-gated ion channels responsible for rapid excitatory neurotransmission in the central and peripheral nervous systems, resulting in skeletal muscle tone and various cognitive effects in the brain. These complex proteins are activated by the endogenous neurotransmitter ACh as well as by nicotine and structurally related agonists. Activation and modulation of nAChRs has been implicated in the pathology of multiple neurological disorders, and as such, these proteins are established therapeutic targets. Here we use unnatural amino acid mutagenesis to examine the ligand binding mechanisms of two homologous neuronal nAChRs: the alpha 4 beta 4 and alpha 7 receptors. Despite sequence identity among the residues that form the core of the agonist-binding site, we find that the alpha 4 beta 4 and alpha 7 nAChRs employ different agonist-receptor binding interactions in this region. The alpha 4 beta 4 receptor utilizes a strong cation-pi interaction to a conserved tryptophan (TrpB) of the receptor for both ACh and nicotine, and nicotine participates in a strong hydrogen bond with a backbone carbonyl contributed by TrpB. Interestingly, we find that the alpha 7 receptor also employs a cation-pi interaction for ligand recognition, but the site has moved to a different aromatic amino acid of the agonist-binding site depending on the agonist. ACh participates in a cation-pi interaction with TyrA, whereas epibatidine participates in a cation-pi interaction with TyrC2.	[Puskar, Nyssa L.; Xiu, Xinan; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS 34407, NS 11756]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH086383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R37NS034407, R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS 34407 and NS 11756.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Arneric S, 1999, NEURONAL NICOTINIC R; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; BEERS WH, 1970, NATURE, V228, P917, DOI 10.1038/228917a0; Ben-Ami HC, 2005, J BIOL CHEM, V280, P28053, DOI 10.1074/jbc.M504369200; Blum AP, 2010, P NATL ACAD SCI USA, V107, P13206, DOI 10.1073/pnas.1007140107; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Castillo M, 2005, J BIOL CHEM, V280, P27062, DOI 10.1074/jbc.M503746200; Cheng AX, 2005, J BIOL CHEM, V280, P22502, DOI 10.1074/jbc.M414341200; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Court JA, 1997, DEV BRAIN RES, V101, P93, DOI 10.1016/S0165-3806(97)00052-7; Dart M J, 2000, Pharm Acta Helv, V74, P115, DOI 10.1016/S0031-6865(99)00023-0; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; Espinoza-Fonseca LM, 2006, BIOORG MED CHEM LETT, V16, P3519, DOI 10.1016/j.bmcl.2006.03.093; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Glennon R A, 2000, Pharm Acta Helv, V74, P103, DOI 10.1016/S0031-6865(99)00022-9; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; Grutter T, 2003, EMBO J, V22, P1990, DOI 10.1093/emboj/cdg197; Halevi S, 2002, EMBO J, V21, P1012, DOI 10.1093/emboj/21.5.1012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Lummis SCR, 2005, CHEM BIOL, V12, P993, DOI 10.1016/j.chembiol.2005.06.012; Martin LF, 2004, PSYCHOPHARMACOLOGY, V174, P54, DOI 10.1007/s00213-003-1750-1; Moroni M, 2006, MOL PHARMACOL, V70, P755, DOI 10.1124/mol.106.023044; Mu TW, 2003, J AM CHEM SOC, V125, P6850, DOI 10.1021/ja0348086; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; O'Neill MJ, 2002, CNS NEUROL DISORD-DR, V1, P399, DOI 10.2174/1568007023339166; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Parker MJ, 1998, MOL PHARMACOL, V54, P1132, DOI 10.1124/mol.54.6.1132; Placzek AN, 2005, MOL PHARMACOL, V68, P1863, DOI 10.1124/mol.105.016402; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sixma TK, 2003, ANNU REV BIOPH BIOM, V32, P311, DOI 10.1146/annurev.biophys.32.110601.142536; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Wu J, 2006, J PHYSIOL-LONDON, V576, P103, DOI 10.1113/jphysiol.2006.114645; XIU X, 2007, STRUCTURE FUNCTION S, P67; Xiu XA, 2009, NATURE, V458, P534, DOI 10.1038/nature07768; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	52	45	46	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14618	14627		10.1074/jbc.M110.206565	http://dx.doi.org/10.1074/jbc.M110.206565			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343288	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000289556200081
J	Shen, N; Yu, XA; Pan, FY; Gao, XA; Xue, B; Li, CJ				Shen, Ning; Yu, Xiao; Pan, Fei-Yan; Gao, Xiang; Xue, Bin; Li, Chao-Jun			An Early Response Transcription Factor, Egr-1, Enhances Insulin Resistance in Type 2 Diabetes with Chronic Hyperinsulinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; RECEPTOR SUBSTRATE-1; C-JUN; TYROSINE PHOSPHORYLATION; CELL-GROWTH; ADIPOCYTES; EXPRESSION; IRS-1; PATHWAYS	One of the most important characteristics of type 2 diabetes is insulin resistance, during which the patients normally experienced hyperinsulinism stress that would alter insulin signal transduction in insulin target tissues. We have previously found that early growth responsive gene-1 (Egr-1), a zinc finger transcription factor, is highly expressed in db/db mice and in the fat tissue of individuals with type 2 diabetes. In this report, we found that chronic exposure to hyperinsulinism caused persistent Erk/MAPK activity in adipocytes and enhanced insulin resistance in an Egr-1-dependent manner. An elevation in Egr-1 augmented Erk1/2 activation via geranylgeranyl diphosphate synthase (GGPPS). Egr-1-promoted GGPPS transcription increased Ras prenylation and caused Erk1/2 activation. The sustained activation of Erk1/2 resulted in the phosphorylation of insulin receptor substrate-1 at Serine 612. Phosphorylation at this site impaired insulin signaling in adipocytes and reduced glucose uptake. The loss of Egr-1 function, knockdown of GGPPS, or inhibition of Erk1/2 activity in insulin-resistant adipocytes restored insulin receptor substrate-1 tyrosine phosphorylation and increased insulin sensitivity. Our results suggest a new mechanism by which the Egr-1/GGPPS/Erk1/2 pathway is responsible for insulin resistance during hyperinsulinism. This pathway provides a new therapeutic target for increasing insulin sensitivity: inhibiting the function of Egr-1.	[Shen, Ning; Gao, Xiang; Xue, Bin; Li, Chao-Jun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Model Anim Res Ctr, Minist Educ,Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Shen, Ning; Gao, Xiang; Xue, Bin; Li, Chao-Jun] Nanjing Univ, Natl Resource Ctr Mutant Mice, Sch Med, Nanjing 210061, Peoples R China; [Yu, Xiao; Pan, Fei-Yan] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing 210046, Peoples R China	Nanjing University; Nanjing University; Nanjing Normal University	Xue, B (corresponding author), Nanjing Univ, Model Anim Res Ctr, Nanjing 210093, Peoples R China.	xuebin@nju.edu.cn; licj@nju.edu.cn		Li, Chaojun/0000-0001-9474-7321; Yu, Xiao/0000-0001-9441-1705	National Basic Research Program of China [2009CB918703, 2006CB943500]; National Natural Science Foundation of China [30671086, 30700394]; Natural Science Foundation of Jiangsu Province of China [BK2007598]; Foundation of the Jiangsu Key Laboratory for Molecular and Medical Biotechnology [NMB09KF03]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Foundation of the Jiangsu Key Laboratory for Molecular and Medical Biotechnology	This work was supported by National Basic Research Program of China Grants 2009CB918703 and 2006CB943500 and National Natural Science Foundation of China Grant 30671086 awarded (to C.-J. L.). This work was also supported by National Natural Science Foundation of China Grant 30700394, Natural Science Foundation of Jiangsu Province of China Grant BK2007598, and Foundation of the Jiangsu Key Laboratory for Molecular and Medical Biotechnology Grant NMB09KF03 (to B. X.).	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bard-Chapeau EA, 2005, NAT MED, V11, P567, DOI 10.1038/nm1227; Baron V, 2003, ANN NY ACAD SCI, V1002, P197, DOI 10.1196/annals.1281.024; Begum N, 1998, AM J PHYSIOL-CELL PH, V275, pC42, DOI 10.1152/ajpcell.1998.275.1.C42; Benz AH, 2010, BRIT J PHARMACOL, V160, P1621, DOI 10.1111/j.1476-5381.2010.00812.x; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; Emanuelli B, 2008, P NATL ACAD SCI USA, V105, P3545, DOI 10.1073/pnas.0712275105; Eringa EC, 2004, AM J PHYSIOL-HEART C, V287, pH2043, DOI 10.1152/ajpheart.00067.2004; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; Fujishiro M, 2003, MOL ENDOCRINOL, V17, P487, DOI 10.1210/me.2002-0131; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; Goalstone ML, 1999, J BIOL CHEM, V274, P2880, DOI 10.1074/jbc.274.5.2880; Greene MW, 2003, J BIOL CHEM, V278, P8199, DOI 10.1074/jbc.M209153200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327; Kainou T, 1999, BBA-MOL CELL BIOL L, V1437, P333, DOI 10.1016/S1388-1981(99)00028-1; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Kim S, 2002, J NUTR, V132, P1135, DOI 10.1093/jn/132.6.1135; Levkovitz Y, 2001, J NEUROSCI, V21, P5893, DOI 10.1523/JNEUROSCI.21-16-05893.2001; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Moeschel K, 2004, J BIOL CHEM, V279, P25157, DOI 10.1074/jbc.M402477200; Mostecki J, 2005, J BIOL CHEM, V280, P2596, DOI 10.1074/jbc.M408938200; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Sambrook J, 2001, MOL CLONING LAB MANU; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Sartipy P, 2003, J BIOL CHEM, V278, P52298, DOI 10.1074/jbc.M306922200; Seboek D, 2004, J CLIN ENDOCR METAB, V89, P4833, DOI 10.1210/jc.2004-0271; Silverman ES, 1999, AM J PATHOL, V154, P665, DOI 10.1016/S0002-9440(10)65312-6; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang ZC, 2006, BIOCHEM BIOPH RES CO, V345, P976, DOI 10.1016/j.bbrc.2006.04.173; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Wick KR, 2003, J BIOL CHEM, V278, P8460, DOI 10.1074/jbc.M208518200; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	46	60	70	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14508	14515		10.1074/jbc.M110.190165	http://dx.doi.org/10.1074/jbc.M110.190165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21321112	hybrid, Green Published			2022-12-25	WOS:000289556200071
J	Ghosh, M; Schonbrunn, A				Ghosh, Madhumita; Schonbrunn, Agnes			Differential Temporal and Spatial Regulation of Somatostatin Receptor Phosphorylation and Dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; MEDIATED ENDOCYTOSIS; PROTEIN-KINASE; SST2A; INTERNALIZATION; SEQUESTRATION; SPECIFICITY; TRAFFICKING; ARRESTINS; RHODOPSIN	The G(i)-coupled somatostatin 2A receptor (sst2A) mediates many of the neuromodulatory and neuroendocrine actions of somatostatin (SS) and is targeted by the SS analogs used to treat neuroendocrine tumors. As for other G protein-coupled receptors, agonists stimulate sst2A receptor phosphorylation on multiple residues, and phosphorylation at different sites has distinct effects on receptor internalization and uncoupling. To elucidate the spatial and temporal regulation of sst2A receptor phosphorylation, we examined agonist-stimulated phosphorylation of multiple receptor GPCR kinase sites using phospho-site-specific antibodies. SS increased receptor phosphorylation sequentially, first on Ser-341/343 and then on Thr-353/354, followed by receptor internalization. Reversal of receptor phosphorylation was determined by the duration of prior agonist exposure. In acutely stimulated cells, in which most receptors remained on the cell surface, dephosphorylation occurred only on Thr-353/354. In contrast, both Ser-341/343 and Thr-353/354 were rapidly dephosphorylated when cells were stimulated long enough to allow receptor internalization before agonist removal. Consistent with these observations, dephosphorylation of Thr-353/354 was not affected by either hypertonic sucrose or dynasore, which prevent receptor internalization, whereas dephosphorylation of Ser-341/343 was completely blocked. An okadaic acid- and fostriecin-sensitive phosphatase catalyzed the dephosphorylation of Thr-353/354 both intracellularly and at the cell surface. In contrast, dephosphorylation of Ser-3411343 was insensitive to these inhibitors. Our results show that the phosphorylation and dephosphorylation of neighboring GPCR kinase sites in the sst2A receptor are subject to differential spatial and temporal regulation. Thus, the pattern of receptor phosphorylation is determined by the duration of agonist stimulation and compartment-specific enzymatic activity.	[Ghosh, Madhumita; Schonbrunn, Agnes] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Schonbrunn, A (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77225 USA.	agnes.schonbrunn@uth.tmc.edu			National Institutes of Health [DK032234]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032234, R01DK032234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK032234 (to A. S.).	Brown BM, 2002, BIOCHEMISTRY-US, V41, P13526, DOI 10.1021/bi0204490; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Celver J, 2004, MOL PHARMACOL, V65, P528, DOI 10.1124/mol.65.3.528; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Elberg G, 2002, MOL ENDOCRINOL, V16, P2502, DOI 10.1210/me.2002-0207; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Gu YZ, 1997, MOL ENDOCRINOL, V11, P527, DOI 10.1210/me.11.5.527; Gurevich V. V., 2008, V186, P15, DOI 10.1007/978-3-540-72843-6_2; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hipkin RW, 2000, J BIOL CHEM, V275, P5591, DOI 10.1074/jbc.275.8.5591; Hipkin RW, 1997, J BIOL CHEM, V272, P13869, DOI 10.1074/jbc.272.21.13869; Horie K, 2000, J BIOL CHEM, V275, P29433, DOI 10.1074/jbc.M003413200; Iyer V, 2006, BRIT J PHARMACOL, V147, P249, DOI 10.1038/sj.bjp.0706551; Jones BW, 2007, J BIOL CHEM, V282, P12893, DOI 10.1074/jbc.M610854200; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Krueger KM, 1997, J BIOL CHEM, V272, P5; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Liu Q, 2008, MOL PHARMACOL, V73, P292, DOI 10.1124/mol.107.038570; Liu QS, 2009, MOL PHARMACOL, V76, P68, DOI 10.1124/mol.108.054262; Liu QS, 2005, MOL PHARMACOL, V68, P90, DOI 10.1124/mol.105.011767; Liu QS, 2003, J CLIN ENDOCR METAB, V88, P6073, DOI 10.1210/jc.2003-030986; Liu QS, 2001, J BIOL CHEM, V276, P3709, DOI 10.1074/jbc.M008873200; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; Olias G, 2004, J NEUROCHEM, V89, P1057, DOI 10.1111/j.1471-4159.2004.02402.x; Park PSH, 2008, ANNU REV PHARMACOL, V48, P107, DOI 10.1146/annurev.pharmtox.48.113006.094630; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Pollok-Kopp B, 2003, J BIOL CHEM, V278, P2190, DOI 10.1074/jbc.M209844200; Rajeswaran WG, 2001, J MED CHEM, V44, P1305, DOI 10.1021/jm0005048; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Salazar C, 2009, FEBS J, V276, P3177, DOI 10.1111/j.1742-4658.2009.07027.x; SCHONBRUNN A, 2004, ENCY BIOL CHEM, P55; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Swingle Mark, 2007, V365, P23; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tran TM, 2007, MOL PHARMACOL, V71, P47, DOI 10.1124/mol.106.028456; Trester-Zedlitz M, 2005, BIOCHEMISTRY-US, V44, P6133, DOI 10.1021/bi0475469; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; WEISER DC, 2003, CURR PROTOC MOL BIOL, V18; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	53	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13561	13573		10.1074/jbc.M110.215723	http://dx.doi.org/10.1074/jbc.M110.215723			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343287	hybrid, Green Published			2022-12-25	WOS:000289282200076
J	Matsuo, Y; Kishimoto, H; Tanae, K; Kitamura, K; Katayama, S; Kawamukai, M				Matsuo, Yuzy; Kishimoto, Hayafumi; Tanae, Katsuhiro; Kitamura, Kenji; Katayama, Satoshi; Kawamukai, Makoto			Nuclear Protein Quality Is Regulated by the Ubiquitin-Proteasome System through the Activity of Ubc4 and San1 in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; SCHIZOSACCHAROMYCES-POMBE; MITOCHONDRIAL MAINTENANCE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; CONJUGATING ENZYMES; 26S PROTEASOME; DEGRADATION; LOCALIZATION; GENE	Eukaryotic cells monitor and maintain protein quality through a set of protein quality control (PQC) systems whose role is to minimize the harmful effects of the accumulation of aberrant proteins. Although these PQC systems have been extensively studied in the cytoplasm, nuclear PQC systems are not well understood. The present work shows the existence of a nuclear PQC system mediated by the ubiquitin-proteasome system in the fission yeast Schizosaccharomyces pombe. Asf1-30, a mutant form of the histone chaperone Asf1, was used as a model substrate for the study of the nuclear PQC. A temperature-sensitive Asf1-30 protein localized to the nucleus was selectively degraded by the ubiquitin-proteasome system. The Asf1-30 mutant protein was highly ubiquitinated at higher temperatures, and it remained stable in an mts2-1 mutant, which lacks proteasome activity. The E2 enzyme Ubc4 was identified among 11 candidate proteins as the ubiquitin-conjugating enzyme in this system, and San1 was selected among 100 candidates as the ubiquitin ligase (E3) targeting Asf1-30 for degradation. San1, but not other nuclear E3s, showed specificity for the mutant nuclear Asf1-30, but did not show activity against wild-type Asf1. These data clearly showed that the aberrant nuclear protein was degraded by a defined set of E1-E2-E3 enzymes through the ubiquitin-proteasome system. The data also show, for the first time, the presence of a nuclear PQC system in fission yeast.	[Matsuo, Yuzy; Kishimoto, Hayafumi; Tanae, Katsuhiro; Katayama, Satoshi; Kawamukai, Makoto] Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, Matsue, Shimane 6908504, Japan; [Kitamura, Kenji] Hiroshima Univ, Ctr Gene Sci, Higashihiroshima 7398527, Japan	Shimane University; Hiroshima University	Kawamukai, M (corresponding author), Shimane Univ, Fac Life & Environm Sci, Dept Life Sci & Biotechnol, 1060 Nishikawatsu, Matsue, Shimane 6908504, Japan.	kawamuka@life.shimane-u.ac.jp	Kawamukai, Makoto/AET-1038-2022; Kitamura, Kenji/C-4173-2018	Kawamukai, Makoto/0000-0003-2929-8798; Kitamura, Kenji/0000-0003-1046-7133	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science research fellowships for young scientists.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Goshima G, 2003, EMBO J, V22, P2752, DOI 10.1093/emboj/cdg266; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Kato H, 2008, CELL CYCLE, V7, P1085; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Kitamura K, 2001, DEV CELL, V1, P389, DOI 10.1016/S1534-5807(01)00037-5; Laporte D, 2008, J CELL BIOL, V181, P737, DOI 10.1083/jcb.200711154; Le SY, 1997, YEAST, V13, P1029, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1029::AID-YEA160>3.0.CO;2-1; Lehmann A, 2004, GENES CELLS, V9, P367, DOI 10.1111/j.1356-9597.2004.00730.x; MATSUMOTO T, 1993, MOL BIOL CELL, V4, P337, DOI 10.1091/mbc.4.3.337; Matsuo Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1992, DOI 10.1271/bbb.60087; Matsuo Y, 2010, BIOSCI BIOTECH BIOCH, V74, P685, DOI 10.1271/bbb.90967; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Munakata T, 2000, GENES CELLS, V5, P221, DOI 10.1046/j.1365-2443.2000.00319.x; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Oowatari Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1591, DOI 10.1271/bbb.90103; Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388; Ozoe F, 2002, MOL CELL BIOL, V22, P7105, DOI 10.1128/MCB.22.20.7105-7119.2002; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Sambrook J, 1989, J SAMBROOK MOL CLONI; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SCHNELL R, 1989, GENETICS, V122, P29; Seino H, 2003, MOL CELL BIOL, V23, P3497, DOI 10.1128/MCB.23.10.3497-3505.2003; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Shiozaki K, 1997, METHOD ENZYMOL, V283, P506; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Tanabe K, 2003, EUKARYOT CELL, V2, P1274, DOI 10.1128/EC.2.6.1274-1287.2003; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Umehara T, 2002, GENES CELLS, V7, P59, DOI 10.1046/j.1356-9597.2001.00493.x; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1	55	21	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13775	13790		10.1074/jbc.M110.169953	http://dx.doi.org/10.1074/jbc.M110.169953			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324894	Green Published, hybrid			2022-12-25	WOS:000289282200095
J	Moretti, R; Chang, A; Peltier-Pain, P; Bingman, CA; Phillips, GN; Thorson, JS				Moretti, Rocco; Chang, Aram; Peltier-Pain, Pauline; Bingman, Craig A.; Phillips, George N., Jr.; Thorson, Jon S.			Expanding the Nucleotide and Sugar 1-Phosphate Promiscuity of Nucleotidyltransferase RmlA via Directed Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-PRODUCT GLYCOSYLTRANSFERASE; RANDOM MUTAGENESIS LIBRARIES; ENZYME-CATALYZED SYNTHESIS; ESCHERICHIA-COLI; MEGAPRIMER PCR; TOOLS; REVERSIBILITY	Directed evolution is a valuable technique to improve enzyme activity in the absence of a priori structural knowledge, which can be typically enhanced via structure-guided strategies. In this study, a combination of both whole-gene error-prone polymerase chain reaction and site-saturation mutagenesis enabled the rapid identification of mutations that improved RmlA activity toward non-native substrates. These mutations have been shown to improve activities over 10-fold for several targeted substrates, including non-native pyrimidine- and purine-based NTPs as well as non-native D- and L-sugars (both alpha- and beta-isomers). This study highlights the first broadly applicable high throughput sugar-1-phosphate nucleotidyltransferase screen and the first proof of concept for the directed evolution of this enzyme class toward the identification of uniquely permissive RmlA variants.	[Moretti, Rocco; Chang, Aram; Phillips, George N., Jr.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Chang, Aram; Bingman, Craig A.; Phillips, George N., Jr.] Univ Wisconsin, Ctr Eukaryot Struct Genom, Madison, WI 53706 USA; [Moretti, Rocco; Peltier-Pain, Pauline; Thorson, Jon S.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA; [Moretti, Rocco; Peltier-Pain, Pauline; Thorson, Jon S.] Univ Wisconsin, Wisconsin Ctr Nat Prod, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Phillips, GN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	Phillips@biochem.wisc.edu; jsthorson@pharmacy.wisc.edu	Thorson, Jon S/L-3696-2013	Thorson, Jon S/0000-0002-7148-0721	National Institutes of Health (NIH) [GM07215, AI552218, U54 GM074901, GM08293]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-102-ENG-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052218] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008293, T32GM007215, U54GM074901] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Molecular Bioscience Training Grant GM07215 (to R. M., trainee) and NIH Grant AI552218 (to J. S. T. in support of R. M.), NIH Grant U54 GM074901 (to John L. Markley, Principal Investigator, for G. N. P., C. A. B., and A. C.), and NIH Molecular Biophysics Training Grant GM08293 (to A. C., trainee). The Life Sciences Collaborative Access Team was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contact W-31-102-ENG-38. J. S. T. is a co-founder of Centrose (Madison, WI).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bae J, 2005, CHEMBIOCHEM, V6, P1963, DOI 10.1002/cbic.200500183; Barton WA, 2002, P NATL ACAD SCI USA, V99, P13397, DOI 10.1073/pnas.192468299; Beaton SA, 2009, CHEM COMMUN, P238, DOI 10.1039/b808078j; Bloom JD, 2005, CURR OPIN STRUC BIOL, V15, P447, DOI 10.1016/j.sbi.2005.06.004; Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/nchem.399, 10.1038/NCHEM.399]; Bulter T, 1999, GLYCOCONJUGATE J, V16, P147, DOI 10.1023/A:1026444726698; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu X, 2005, ORG LETT, V7, P1513, DOI 10.1021/ol0501626; Gantt RW, 2008, ANGEW CHEM INT EDIT, V47, P8889, DOI 10.1002/anie.200803508; Hoffmeister D, 2003, P NATL ACAD SCI USA, V100, P13184, DOI 10.1073/pnas.2235011100; Huestis MP, 2008, ORG BIOMOL CHEM, V6, P477, DOI 10.1039/b716955h; Jakeman DL, 2008, BIOCHEMISTRY-US, V47, P8719, DOI 10.1021/bi800978u; Jiang JQ, 2003, CHEMBIOCHEM, V4, P443, DOI 10.1002/cbic.200200566; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kiessling LL, 2010, ANNU REV BIOCHEM, V79, P619, DOI 10.1146/annurev.biochem.77.070606.100917; Kittl R, 2010, CARBOHYD RES, V345, P1272, DOI 10.1016/j.carres.2010.04.002; Ko KS, 2004, J AM CHEM SOC, V126, P13188, DOI 10.1021/ja045522j; Kren V, 2008, FEMS MICROBIOL REV, V32, P858, DOI 10.1111/j.1574-6976.2008.00124.x; Langenhan JM, 2005, J NAT PROD, V68, P1696, DOI 10.1021/np0502084; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lepenies B, 2010, CURR OPIN CHEM BIOL, V14, P404, DOI 10.1016/j.cbpa.2010.02.016; LEVER M, 1973, J LAB CLIN MED, V82, P649; Lutz S, 2004, CURR OPIN BIOTECH, V15, P291, DOI 10.1016/j.copbio.2004.05.004; Luzhetskyy A, 2008, CURR TOP MED CHEM, V8, P680, DOI 10.2174/156802608784221514; Miyazaki K, 1999, J MOL EVOL, V49, P716, DOI 10.1007/PL00006593; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Miyazaki Kentaro, 2003, Methods Mol Biol, V231, P23; Moretti R, 2008, ANAL BIOCHEM, V377, P251, DOI 10.1016/j.ab.2008.03.018; Moretti R, 2007, J BIOL CHEM, V282, P16942, DOI 10.1074/jbc.M701951200; Morley KL, 2005, TRENDS BIOTECHNOL, V23, P231, DOI 10.1016/j.tibtech.2005.03.005; Nahalka J, 2003, CHEM-EUR J, V9, P373, DOI 10.1002/chem.200390038; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rupprath C, 2005, CURR MED CHEM, V12, P1637, DOI 10.2174/0929867054367167; Salamone PR, 2002, P NATL ACAD SCI USA, V99, P1070, DOI 10.1073/pnas.012603799; Thibodeaux CJ, 2008, ANGEW CHEM INT EDIT, V47, P9814, DOI 10.1002/anie.200801204; THORSON JS, 1994, J BACTERIOL, V176, P1840, DOI 10.1128/jb.176.7.1840-1849.1994; Timmons SC, 2008, ORG LETT, V10, P161, DOI 10.1021/ol7023949; Timmons SC, 2007, ORG LETT, V9, P857, DOI 10.1021/ol0630853; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Voigt CA, 2001, J CELL BIOCHEM, V84, P58, DOI 10.1002/jcb.10066; Wagner GK, 2009, NAT PROD REP, V26, P1172, DOI 10.1039/b909621n; Weijers CAGM, 2008, BIOTECHNOL ADV, V26, P436, DOI 10.1016/j.biotechadv.2008.05.001; White-Phillip J, 2009, METHOD ENZYMOL, V459, P521, DOI 10.1016/S0076-6879(09)04621-7; Williams GJ, 2007, NAT CHEM BIOL, V3, P657, DOI 10.1038/nchembio.2007.28; Williams GJ, 2011, ACS CHEM BIOL, V6, P95, DOI 10.1021/cb100267k; Williams GJ, 2008, CURR OPIN CHEM BIOL, V12, P556, DOI 10.1016/j.cbpa.2008.07.013; Yang J, 2005, CHEM BIOL, V12, P657, DOI 10.1016/j.chembiol.2005.04.009; Zhang CS, 2006, J AM CHEM SOC, V128, P16420, DOI 10.1021/ja065950k; Zhang CS, 2006, SCIENCE, V313, P1291, DOI 10.1126/science.1130028	58	32	31	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13235	13243		10.1074/jbc.M110.206433	http://dx.doi.org/10.1074/jbc.M110.206433			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317292	hybrid, Green Published			2022-12-25	WOS:000289282200044
J	Quack, I; Woznowski, M; Potthoff, SA; Palmer, R; Konigshausen, E; Sivritas, S; Schiffer, M; Stegbauer, J; Vonend, O; Rump, LC; Sellin, L				Quack, Ivo; Woznowski, Magdalena; Potthoff, Sebastian A.; Palmer, Romy; Koenigshausen, Eva; Sivritas, Sema; Schiffer, Mario; Stegbauer, Johannes; Vonend, Oliver; Rump, Lars Christian; Sellin, Lorenz			PKC alpha Mediates beta-Arrestin2-dependent Nephrin Endocytosis in Hyperglycemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; EXPERIMENTAL DIABETIC-NEPHROPATHY; BETA-ARRESTINS; SLIT DIAPHRAGM; RECEPTOR; EXPRESSION; MECHANISMS; PODOCYTES; PICK1	Nephrin, the key molecule of the glomerular slit diaphragm, is expressed on the surface of podocytes and is critical in preventing albuminuria. In diabetes, hyperglycemia leads to the loss of surface expression of nephrin and causes albuminuria. Here, we report a mechanism that can explain this phenomenon: hyperglycemia directly enhances the rate of nephrin endocytosis via regulation of the beta-arrestin2-nephrin interaction by PKC alpha. We identified PKC alpha and protein interacting with c kinase-1 (PICK1) as nephrin-binding proteins. Hyperglycemia induced up-regulation of PKC alpha and led to the formation of a complex of nephrin, PKC alpha, PICK1, and beta-arrestin2 in vitro and in vivo. Binding of beta-arrestin2 to the nephrin intracellular domain depended on phosphorylation of nephrin threonine residues 1120 and 1125 by PKC alpha. Further, cellular knockdown of PKC alpha and/or PICK1 attenuated the nephrin beta-arrestin2 interaction and abrogated the amplifying effect of high blood glucose on nephrin endocytosis. In C57BL/6 mice, hyperglycemia over 24 h caused a significant increase in urinary albumin excretion, supporting the concept of the rapid impact of hyperglycemia on glomerular permselectivity. In summary, we have provided a molecular model of hyperglycemia-induced nephrin endocytosis and subsequent proteinuria and highlighted PKC alpha and PICK1 as promising therapeutic targets for diabetic nephropathy.	[Quack, Ivo; Woznowski, Magdalena; Potthoff, Sebastian A.; Palmer, Romy; Koenigshausen, Eva; Sivritas, Sema; Stegbauer, Johannes; Vonend, Oliver; Rump, Lars Christian; Sellin, Lorenz] Univ Dusseldorf, Dept Nephrol, D-40225 Dusseldorf, Germany; [Stegbauer, Johannes] Duke Univ, Div Nephrol, Durham, NC 27710 USA; [Schiffer, Mario] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany	Heinrich Heine University Dusseldorf; Duke University; Hannover Medical School	Quack, I (corresponding author), Univ Dusseldorf, Univ Hosp, Dept Nephrol, Moorenstr 5, D-40225 Dusseldorf, Germany.	ivo.quack@med.uni-duesseldorf.de	Schiffer, Mario/U-7050-2019; Stegbauer, Johannes/L-7461-2013	Schiffer, Mario/0000-0002-8414-1470; 	Deutsche Forschungsgemeinschaft [QU280/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Grant QU280/3-1 (to I. Q.).	Aaltonen P, 2001, LAB INVEST, V81, P1185, DOI 10.1038/labinvest.3780332; Axelsson J, 2010, AM J PHYSIOL-RENAL, V298, pF1306, DOI 10.1152/ajprenal.00710.2009; Boleti H, 1999, J CELL SCI, V112, P1487; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kalaitzidis R, 2009, J CLIN HYPERTENS, V11, P636, DOI 10.1111/j.1751-7176.2009.00184.x; Kim JH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/11/115609; Koop K, 2003, J AM SOC NEPHROL, V14, P2063, DOI 10.1097/01.ASN.0000078803.53165.C9; Lorenz S, 2007, ENDOCRINOLOGY, V148, P2398, DOI 10.1210/en.2006-1035; Meier M, 2009, DIABETOLOGIA, V52, P765, DOI 10.1007/s00125-009-1278-y; Menne J, 2006, KIDNEY INT, V70, P1456, DOI 10.1038/sj.ki.5001830; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Rossing Peter, 2006, Curr Diab Rep, V6, P479, DOI 10.1007/s11892-006-0083-y; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sitek B, 2006, PROTEOMICS, V6, P4337, DOI 10.1002/pmic.200500739; Tossidou I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010185; Tossidou I, 2009, CELL PHYSIOL BIOCHEM, V24, P627, DOI 10.1159/000257518; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Williams ME, 2003, J NEUROSCI, V23, P11279; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Xiang B, 2001, J BIOL CHEM, V276, P4709, DOI 10.1074/jbc.M006187200; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482; Ziyadeh FN, 2008, CURR DIABETES REV, V4, P39, DOI 10.2174/157339908783502370	34	71	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12959	12970		10.1074/jbc.M110.204024	http://dx.doi.org/10.1074/jbc.M110.204024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321125	Green Published, hybrid			2022-12-25	WOS:000289282200016
J	Zhang, YT; Conrad, AH; Conrad, GW				Zhang, Yuntao; Conrad, Abigail H.; Conrad, Gary W.			Effects of Ultraviolet-A and Riboflavin on the Interaction of Collagen and Proteoglycans during Corneal Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATAN SULFATE PROTEOGLYCAN; RELATIVE TISSUE EXPRESSION; CHONDROITIN SULFATE; MOLECULAR-CLONING; KERATOCAN; LUMICAN; GLYCOSAMINOGLYCAN; DIAMETER; DECORIN; MIMECAN	Corneal cross-linking using riboflavin and ultraviolet-A (RFUVA) is a clinical treatment targeting the stroma in progressive keratoconus. The stroma contains keratocan, lumican, mimecan, and decorin, core proteins of major proteoglycans (PGs) that bind collagen fibrils, playing important roles in stromal transparency. Here, a model reaction system using purified, non-glycosylated PG core proteins in solution in vitro has been compared with reactions inside an intact cornea, ex vivo, revealing effects of RFUVA on interactions between PGs and collagen cross-linking. Irradiation with UVA and riboflavin cross-links collagen alpha and beta chains into larger polymers. In addition, RFUVA cross-links PG core proteins, forming higher molecular weight polymers. When collagen type I is mixed with individual purified, non-glycosylated PG core proteins in solution in vitro and subjected to RFUVA, both keratocan and lumican strongly inhibit collagen cross-linking. However, mimecan and decorin do not inhibit but instead form cross-links with collagen, forming new high molecular weight polymers. In contrast, corneal glycosaminoglycans, keratan sulfate and chondroitin sulfate, in isolation from their core proteins, are not cross-linked by RFUVA and do not form cross-links with collagen. Significantly, when RFUVA is conducted on intact corneas e,x vivo, both keratocan and lumican, in their natively glycosylated form, do form cross-links with collagen. Thus, RFUVA causes cross-linking of collagen molecules among themselves and PG core proteins among themselves, together with limited linkages between collagen and keratocan, lumican, mimecan, and decorin. RFUVA as a diagnostic tool reveals that keratocan and lumican core proteins interact with collagen very differently than do mimecan and decorin.	[Zhang, Yuntao; Conrad, Abigail H.; Conrad, Gary W.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Zhang, YT (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	ytz@ksu.edu			National Institutes of Health [R01EY000952]; Research Career Development Core (Brychta) in the Division of Biology at Kansas State University [GOBO000657]; National Science Foundation [0521 587]; Terry C. Johnson Center for Basal Cancer Research at Kansas State University; NATIONAL EYE INSTITUTE [R01EY000952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Career Development Core (Brychta) in the Division of Biology at Kansas State University; National Science Foundation(National Science Foundation (NSF)); Terry C. Johnson Center for Basal Cancer Research at Kansas State University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01EY000952 (to G. W. C.). This work was also supported by the Research Career Development Core (Brychta) in the Division of Biology at Kansas State University GOBO000657 (to G. W. C.), by National Science Foundation Major Research Instrumentation Program Grant 0521 587 (to Kansas State University), and by the Terry C. Johnson Center for Basal Cancer Research at Kansas State University.	Al-Aqaba MA, 2010, BRIT J OPHTHALMOL, V94, P784, DOI 10.1136/bjo.2009.173799; BEUERMAN RNV, 1996, Microsc Res Tech, V33, P335; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Conrad AH, 2010, INVEST OPHTH VIS SCI, V51, P4500, DOI 10.1167/iovs.09-4914; CONRAD GW, 1982, J BIOL CHEM, V257, P464; Corpuz LM, 1996, J BIOL CHEM, V271, P9759, DOI 10.1074/jbc.271.16.9759; Corpuz LM, 2000, MATRIX BIOL, V19, P699, DOI 10.1016/S0945-053X(00)00117-7; Corpuz LM, 2000, MATRIX BIOL, V19, P693, DOI 10.1016/S0945-053X(00)00116-5; de La Rochette A, 2003, BBA-GEN SUBJECTS, V1621, P235, DOI 10.1016/S0304-4165(03)00072-2; Dhaliwal JS, 2009, CORNEA, V28, P62, DOI 10.1097/ICO.0b013e31818225c3; Dunlevy JR, 1998, J BIOL CHEM, V273, P9615, DOI 10.1074/jbc.273.16.9615; Edrington T B, 1995, Optom Clin, V4, P65; EPSTEIN EH, 1971, J BIOL CHEM, V246, P1718; Ertan A, 2007, J CATARACT REFR SURG, V33, P1303, DOI 10.1016/j.jcrs.2007.02.048; Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951; FUNDERBURGH JL, 1991, BIOCHEM SOC T, V19, P871, DOI 10.1042/bst0190871; FUNDERBURGH JL, 1993, J BIOL CHEM, V268, P11874; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Garcia-Lledo Magdalena, 2006, Compr Ophthalmol Update, V7, P47; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; HAY ED, 1985, J CELL BIOCHEM, V27, P143, DOI 10.1002/jcb.240270208; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; ISEMURA M, 1975, BIOCHIM BIOPHYS ACTA, V411, P11, DOI 10.1016/0304-4165(75)90280-9; Kampik D, 2010, INVEST OPHTH VIS SCI, V51, P3929, DOI 10.1167/iovs.09-4524; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Kao WWY, 2002, GLYCOCONJUGATE J, V19, P275, DOI 10.1023/A:1025396316169; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; KOHLHAAS M, 2004, J CATARACT REFR SURG, V32, P279; KRISHNA CM, 1991, PHOTOCHEM PHOTOBIOL, V54, P51, DOI 10.1111/j.1751-1097.1991.tb01984.x; LI W, 1992, ARCH BIOCHEM BIOPHYS, V296, P190, DOI 10.1016/0003-9861(92)90562-B; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Meek KM, 2003, MATRIX BIOL, V22, P467, DOI 10.1016/S0945-053X(03)00081-7; Mencucci R, 2010, CLIN EXP OPHTHALMOL, V38, P49, DOI 10.1111/j.1442-9071.2010.02207.x; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; NEWSOME DA, 1982, INVEST OPHTH VIS SCI, V22, P376; PARRY DAD, 1988, BIOPHYS CHEM, V29, P195, DOI 10.1016/0301-4622(88)87039-X; Pramanik S, 2006, OPHTHALMOLOGY, V113, P1633, DOI 10.1016/j.ophtha.2006.02.058; Robert L, 2001, PATHOL BIOL, V49, P353, DOI 10.1016/S0369-8114(01)00144-4; Romero-Jimenez M, 2010, CONTACT LENS ANTERIO, V33, P157, DOI 10.1016/j.clae.2010.04.006; RUOSLAHTI E, 1980, BIOCHIM BIOPHYS ACTA, V631, P350, DOI 10.1016/0304-4165(80)90308-6; Schilde T, 2008, OPHTHALMOLOGE, V105, P165, DOI 10.1007/s00347-007-1587-9; SCOTT JE, 1991, BIOCHEM SOC T, V19, P877, DOI 10.1042/bst0190877; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; Snibson GR, 2010, CLIN EXP OPHTHALMOL, V38, P141, DOI 10.1111/j.1442-9071.2010.02228.x; SPIRO RC, 1991, J CELL BIOL, V115, P1463, DOI 10.1083/jcb.115.5.1463; Spoerl E, 2004, CURR EYE RES, V29, P35, DOI 10.1080/02713680490513182; Spoerl E, 2004, OPHTHALMOLOGICA, V218, P136, DOI 10.1159/000076150; Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346; Tan DT, 2007, CURR OPIN OPHTHALMOL, V18, P284; Wollensak G, 2004, J CATARACT REFR SURG, V30, P689, DOI 10.1016/j.jcrs.2003.11.032; Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f; Wollensak G, 2003, OPHTHALMIC RES, V35, P324, DOI 10.1159/000074071; Wollensak G, 2003, OPHTHALMOLOGE, V100, P44, DOI 10.1007/s00347-002-0700-3; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1; Wollensak G, 2009, J CATARACT REFR SURG, V35, P540, DOI 10.1016/j.jcrs.2008.11.036; WORTHINGTON CR, 1984, Q REV BIOPHYS, V17, P423, DOI 10.1017/S003358350000487X; Zhang Y, 2005, ANAL CHEM, V77, P902, DOI 10.1021/ac040074j; Zhang YT, 2005, INVEST OPHTH VIS SCI, V46, P1604, DOI 10.1167/iovs.04-1453	65	125	141	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13011	13022		10.1074/jbc.M110.169813	http://dx.doi.org/10.1074/jbc.M110.169813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335557	hybrid, Green Published			2022-12-25	WOS:000289282200021
J	Qian, YJ; Jung, YS; Chen, XB				Qian, Yingjuan; Jung, Yong-Sam; Chen, Xinbin			Delta Np63, a Target of DEC1 and Histone Deacetylase 2, Modulates the Efficacy of Histone Deacetylase Inhibitors in Growth Suppression and Keratinocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; P53 FAMILY; TRANSCRIPTION FACTOR; PROXIMAL PROMOTER; CANCER CELLS; C-TERMINUS; E-BOX; P63; EXPRESSION; STRA13	The p63 gene, a member of the p53 family, is expressed as TA and Delta N isoforms. Delta Np63 is the predominant isoform expressed in cells of epithelial origin and frequently overexpressed in cancers. However, what regulates p63 expression is uncertain. Here, we showed that Delta Np63 is regulated by the transcription factor DEC1, a p53 family target. We also showed that the ability of DEC1 to regulate Delta Np63 is enhanced by histone deacetylase (HDAC) inhibitors or knockdown of histone deacetylase 2 (HDAC2). Consistent with this, we found that DEC1 and HDAC2 physically interact and knockdown of HDAC2 leads to increased binding of DEC1 to the Delta Np63 promoter. Interestingly, we found that growth suppression induced by HDAC inhibitors is attenuated by ectopic expression of DEC1 in a Delta Np63-dependent manner. In addition, we showed that ectopic expression of DEC1 inhibits, whereas knockdown of DEC1 promotes, keratinocyte differentiation via modulating Delta Np63 expression. Finally, we showed that DEC1 cooperates with HDAC inhibitors to further decrease keratinocyte differentiation. Together, we conclude that Delta Np63 is a novel target of DEC1 and HDAC2 and modulates the efficacy of HDAC inhibitors in growth suppression and keratinocyte differentiation.	[Qian, Yingjuan; Jung, Yong-Sam; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA102188]; NATIONAL CANCER INSTITUTE [R01CA102188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA102188.	Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hagiwara K, 1999, CANCER RES, V59, P4165; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Harms KL, 2005, MOL CELL BIOL, V25, P2014, DOI 10.1128/MCB.25.5.2014-2030.2005; Helton ES, 2006, J BIOL CHEM, V281, P2533, DOI 10.1074/jbc.M507964200; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Ivanova AV, 2001, J BIOL CHEM, V276, P15306, DOI 10.1074/jbc.M010516200; King KE, 2003, ONCOGENE, V22, P3635, DOI 10.1038/sj.onc.1206536; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Ladd PA, 2003, J BIOL CHEM, V278, P35184, DOI 10.1074/jbc.M301666200; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Mangiulli M, 2009, NUCLEIC ACIDS RES, V37, P6092, DOI 10.1093/nar/gkp674; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Muscolini M, 2008, MOL CANCER THER, V7, P1410, DOI 10.1158/1535-7163.MCT-08-0299; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; PILLAI S, 1992, J CELL PHYSIOL, V151, P623, DOI 10.1002/jcp.1041510323; Qian YJ, 2008, J BIOL CHEM, V283, P22410, DOI 10.1074/jbc.M800643200; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Sabbisetti V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005877; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shen M, 2002, J BIOL CHEM, V277, P50112, DOI 10.1074/jbc.M206771200; St-Pierre B, 2004, DEV DYNAM, V230, P124, DOI 10.1002/dvdy.20013; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Sun H, 2000, P NATL ACAD SCI USA, V97, P4058, DOI 10.1073/pnas.070526297; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Turley H, 2004, J PATHOL, V203, P808, DOI 10.1002/path.1585; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999; Zhang J, 2010, P NATL ACAD SCI USA, V107, P9614, DOI 10.1073/pnas.0912594107	52	22	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.207241	http://dx.doi.org/10.1074/jbc.M110.207241			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317427	hybrid, Green Published			2022-12-25	WOS:000289077500017
J	Jers, C; Kobir, A; Sondergaard, EO; Jensen, PR; Mijakovic, I				Jers, Carsten; Kobir, Ahasanul; Sondergaard, Elsebeth Oline; Jensen, Peter Ruhdal; Mijakovic, Ivan			Bacillus subtilis Two-Component System Sensory Kinase DegS Is Regulated by Serine Phosphorylation in Its Input Domain	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; TYROSINE KINASE; PROTEIN-KINASES; SER/THR KINASE; DNA; COMPETENCE; BACTERIA; TRANSFORMATION	Bacillus subtilis two-component system DegS/U is well known for the complexity of its regulation. The cytosolic sensory kinase DegS does not receive a single predominant input signal like most two-component kinases, instead it integrates a wide array of metabolic inputs that modulate its activity. The phosphorylation state of the response regulator DegU also does not confer a straightforward "on/off" response; it is fine-tuned and at different levels triggers different sub-regulons. Here we describe serine phosphorylation of the DegS sensing domain, which stimulates its kinase activity. We demonstrate that DegS phosphorylation can be carried out by at least two B. subtilis Hanks-type kinases in vitro, and this stimulates the phosphate transfer towards DegU. The consequences of this process were studied in vivo, using phosphomimetic (Ser76Asp) and non-phosphorylatable (Ser76Ala) mutants of DegS. In a number of physiological assays focused on different processes regulated by DegU, DegS S76D phosphomimetic mutant behaved like a strain with intermediate levels of DegU phosphorylation, whereas DegS S76A behaved like a strain with lower levels of DegU phophorylation. These findings suggest a link between DegS phosphorylation at serine 76 and the level of DegU phosphorylation, establishing this post-translational modification as an additional trigger for this two-component system.	[Jers, Carsten; Sondergaard, Elsebeth Oline; Jensen, Peter Ruhdal] Tech Univ Denmark, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark; [Kobir, Ahasanul; Mijakovic, Ivan] AgroParisTech Inst Natl Rech Agron, Micalis, Jouy En Josas, France	Technical University of Denmark; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jers, C (corresponding author), Tech Univ Denmark, Ctr Syst Microbiol, DK-2800 Lyngby, Denmark.	Ivan.Mijakovic@grignon.inra.fr	Mijakovic, Ivan/Q-5583-2016; jensen, Peter Ruhdal/AAC-4891-2019	Mijakovic, Ivan/0000-0002-8860-6853; Jensen, Peter Ruhdal/0000-0003-2080-2070	Danish National Research Council (FNU) [272-07-0129]; Lundbeckfonden [R17-A1535]; Institut National de Recherche Agronomique (INRA); Technical University of Denmark (DTU)	Danish National Research Council (FNU)(Danmarks GrundforskningsfondDanish Natural Science Research Council); Lundbeckfonden(Lundbeckfonden); Institut National de Recherche Agronomique (INRA); Technical University of Denmark (DTU)	This work was supported by grants from the Danish National Research Council (FNU) 272-07-0129, the Lundbeckfonden R17-A1535 and the Institut National de Recherche Agronomique (INRA) installation package to IM and a PhD stipend from the Technical University of Denmark (DTU) to CJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati G, 2004, J BACTERIOL, V186, P6003, DOI 10.1128/jb.186.18.6003-6014.2004; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; CHANG S, 1979, MOL GEN GENET, V168, P111, DOI 10.1007/BF00267940; Christiansen LC, 1997, J BACTERIOL, V179, P2540, DOI 10.1128/jb.179.8.2540-2550.1997; Dervyn E, 2004, MOL MICROBIOL, V51, P1629, DOI 10.1111/j.1365-2958.2003.03951.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Jarmer H, 2002, FEMS MICROBIOL LETT, V206, P197, DOI 10.1016/S0378-1097(01)00525-0; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Kobayashi K, 2007, MOL MICROBIOL, V66, P395, DOI 10.1111/j.1365-2958.2007.05923.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Lin WJ, 2009, MOL MICROBIOL, V71, P1477, DOI 10.1111/j.1365-2958.2009.06616.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5; Mader U, 2002, MOL GENET GENOMICS, V268, P455, DOI 10.1007/s00438-002-0774-2; Maguin E, 1996, J BACTERIOL, V178, P931, DOI 10.1128/jb.178.3.931-935.1996; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; MSADEK T, 1990, J BACTERIOL, V172, P824, DOI 10.1128/jb.172.2.824-834.1990; MUKAI K, 1992, J BACTERIOL, V174, P7954, DOI 10.1128/JB.174.24.7954-7962.1992; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ogura M, 2003, MOL MICROBIOL, V49, P1685, DOI 10.1046/j.1365-2958.2003.03665.x; Ogura M, 1997, MOL GEN GENET, V254, P157, DOI 10.1007/s004380050403; Ogura M, 2001, NUCLEIC ACIDS RES, V29, P3804, DOI 10.1093/nar/29.18.3804; Ogura M, 2010, MOL MICROBIOL, V75, P1244, DOI 10.1111/j.1365-2958.2010.07047.x; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Petranovic D, 2009, J MOL MICROB BIOTECH, V17, P83, DOI 10.1159/000206635; Phalip V, 2001, BIOCHEM J, V360, P639, DOI 10.1042/0264-6021:3600639; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Steil L, 2005, MICROBIOL-SGM, V151, P399, DOI 10.1099/mic.0.27493-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Verhamme DT, 2007, MOL MICROBIOL, V65, P554, DOI 10.1111/j.1365-2958.2007.05810.x; Wang ST, 2006, J MOL BIOL, V358, P16, DOI 10.1016/j.jmb.2006.01.059; WITTEKIND M, 1989, BIOCHEMISTRY-US, V28, P9908, DOI 10.1021/bi00452a005; YASBIN RE, 1975, J BACTERIOL, V121, P296, DOI 10.1128/JB.121.1.296-304.1975; Yasumura A, 2008, J BACTERIOL, V190, P5162, DOI 10.1128/JB.00368-08	45	38	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14653	10.1371/journal.pone.0014653	http://dx.doi.org/10.1371/journal.pone.0014653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304896	Green Published, Green Submitted, gold			2022-12-25	WOS:000287036600005
J	Corbett, JE; Fischer, J; Whitney, D				Corbett, Jennifer E.; Fischer, Jason; Whitney, David			Facilitating Stable Representations: Serial Dependence in Vision	PLOS ONE			English	Article							MEMORY; PERCEPTION; NUMBER	We tested whether the intervening time between multiple glances influences the independence of the resulting visual percepts. Observers estimated how many dots were present in brief displays that repeated one, two, three, four, or a random number of trials later. Estimates made farther apart in time were more independent, and thus carried more information about the stimulus when combined. In addition, estimates from different visual field locations were more independent than estimates from the same location. Our results reveal a retinotopic serial dependence in visual numerosity estimates, which may be a mechanism for maintaining the continuity of visual perception in a noisy environment.	[Corbett, Jennifer E.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Fischer, Jason; Whitney, David] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	Brown University; University of California System; University of California Berkeley	Corbett, JE (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.	jennifer.e.corbett@gmail.com			National Science Foundation [0748689]; National Institutes of Health [EY018216]; NATIONAL EYE INSTITUTE [R01EY018216] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by the National Science Foundation (0748689) and the National Institutes of Health (EY018216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADSHAW JL, 1978, TRENDS NEUROSCI, V1, P113, DOI 10.1016/0166-2236(78)90080-2; Brascamp JW, 2007, J VISION, V7, DOI 10.1167/7.12.12; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; Butterworth B, 2008, CURR BIOL, V18, pR388, DOI 10.1016/j.cub.2008.03.014; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; PHILLIPS WA, 1974, PERCEPT PSYCHOPHYS, V16, P283, DOI 10.3758/BF03203943; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rensink RA, 2000, VIS COGN, V7, P127, DOI 10.1080/135062800394720; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Vul E, 2008, PSYCHOL SCI, V19, P645, DOI 10.1111/j.1467-9280.2008.02136.x; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601	18	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16701	10.1371/journal.pone.0016701	http://dx.doi.org/10.1371/journal.pone.0016701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21304953	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300124
J	Cutfield, WS; Derraik, JGB; Gunn, AJ; Reid, K; Delany, T; Robinson, E; Hofman, PL				Cutfield, Wayne S.; Derraik, Jose G. B.; Gunn, Alistair J.; Reid, Kyle; Delany, Theresa; Robinson, Elizabeth; Hofman, Paul L.			Non-Compliance with Growth Hormone Treatment in Children Is Common and Impairs Linear Growth	PLOS ONE			English	Article							PATIENT COMPLIANCE; THERAPY	Background: GH therapy requires daily injections over many years and compliance can be difficult to sustain. As growth hormone (GH) is expensive, non-compliance is likely to lead to suboptimal growth, at considerable cost. Thus, we aimed to assess the compliance rate of children and adolescents with GH treatment in New Zealand. Methods: This was a national survey of GH compliance, in which all children receiving government-funded GH for a four-month interval were included. Compliance was defined as >= 85% adherence (no more than one missed dose a week on average) to prescribed treatment. Compliance was determined based on two parameters: either the number of GH vials requested (GHreq) by the family or the number of empty GH vials returned (GHret). Data are presented as mean +/- SEM. Findings: 177 patients were receiving GH in the study period, aged 12.1 +/- 0.6 years. The rate of returned vials, but not number of vials requested, was positively associated with HVSDS (p<0.05), such that patients with good compliance had significantly greater linear growth over the study period (p<0.05). GHret was therefore used for subsequent analyses. 66% of patients were non-compliant, and this outcome was not affected by sex, age or clinical diagnosis. However, Maori ethnicity was associated with a lower rate of compliance. Interpretation: An objective assessment of compliance such as returned vials is much more reliable than compliance based on parental or patient based information. Non-compliance with GH treatment is common, and associated with reduced linear growth. Non-compliance should be considered in all patients with apparently suboptimal response to GH treatment.	[Cutfield, Wayne S.; Derraik, Jose G. B.; Delany, Theresa; Hofman, Paul L.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Cutfield, Wayne S.; Hofman, Paul L.] Univ Auckland, Natl Res Ctr Growth & Dev, Auckland 1, New Zealand; [Gunn, Alistair J.] Univ Auckland, Dept Physiol, Auckland 1, New Zealand; [Gunn, Alistair J.] Univ Auckland, Dept Paediat, Auckland 1, New Zealand; [Reid, Kyle] Pharmaceut Management Agcy New Zealand PHARMAC, Wellington, New Zealand; [Robinson, Elizabeth] Univ Auckland, Dept Epidemiol & Biostat, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland; University of Auckland	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Gunn, Alistair/0000-0003-0656-7035	PHARMAC (the pharmaceutical purchasing division of New Zealand's Ministry of Health)	PHARMAC (the pharmaceutical purchasing division of New Zealand's Ministry of Health)	This study was funded by PHARMAC (the pharmaceutical purchasing division of New Zealand's Ministry of Health) who assisted with data collection. However, PHARMAC had no role on the analysis, decision to publish, or preparation of the manuscript. Note that, as a government agency, PHARMAC is completely independent of the pharmaceutical industry.	Allen DB, 2006, PEDIATRICS, V118, P343, DOI 10.1542/peds.2006-0329; Barclay E, 2009, LANCET, V373, P15, DOI 10.1016/S0140-6736(08)61938-8; Carter PJ, 2008, DIABETOLOGIA, V51, P1835, DOI 10.1007/s00125-008-1106-9; CHRISTENSEN DB, 1978, HEALTH SERV RES, V13, P171; CROMER BA, 1989, J DEV BEHAV PEDIATR, V10, P207; Desrosiers Paul, 2005, Pediatr Endocrinol Rev, V2 Suppl 3, P327; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; GABRIEL M, 1977, AM J PUBLIC HEALTH, V67, P968, DOI 10.2105/AJPH.67.10.968; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Haverkamp F, 2008, CLIN THER, V30, P307, DOI 10.1016/j.clinthera.2008.02.017; Hunter I, 2000, ARCH DIS CHILDHOOD, V82, pA8, DOI [10.1136/adc.47.255.839-c, DOI 10.1136/ADC.47.255.839-C]; Kapoor RR, 2008, ARCH DIS CHILD, V93, P147, DOI 10.1136/adc.2006.114249; Kardas P, 2002, J ANTIMICROB CHEMOTH, V49, P897, DOI 10.1093/jac/dkf046; MAIN KM, 1995, ACTA PAEDIATR, V84, P331, DOI 10.1111/j.1651-2227.1995.tb13638.x; Marcus S F, 2001, Hum Fertil (Camb), V4, P85, DOI 10.1080/1464727012000199351; McCreanor Timothy, 2002, N Z Med J, V115, pU272; Oyarzabal M, 1998, ACTA PAEDIATR, V87, P387, DOI 10.1080/08035259850156959; Rosenfeld Ron G, 2008, Endocr Pract, V14, P143; SMITH SL, 1993, ARCH DIS CHILD, V68, P91, DOI 10.1136/adc.68.1.91; SMYTH AR, 1993, ARCH DIS CHILD, V68, P235, DOI 10.1136/adc.68.2.235; *US OFF INSP GEN, 1990, OEI048989121 US OFF	21	150	168	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16223	10.1371/journal.pone.0016223	http://dx.doi.org/10.1371/journal.pone.0016223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305004	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300042
J	Jain, S; Moscicka, KB; Bos, MP; Pachulec, E; Stuart, MCA; Keegstra, W; Boekema, EJ; van der Does, C				Jain, Samta; Moscicka, Katarzyna B.; Bos, Martine P.; Pachulec, Emilia; Stuart, Marc C. A.; Keegstra, Wilko; Boekema, Egbert J.; van der Does, Chris			Structural Characterization of Outer Membrane Components of the Type IV Pili System in Pathogenic Neisseria	PLOS ONE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; SECRETIN PULD; CRYOELECTRON MICROSCOPY; TWITCHING MOTILITY; BIOFILM FORMATION; PHASE VARIATION; DNA TRANSFER; GONORRHOEAE	Structures of the type IV pili secretin complexes from Neisseria gonorrhoeae and Neisseria meningitidis, embedded in outer membranes were investigated by transmission electron microscopy. Single particle averaging revealed additional domains not observed previously. Secretin complexes of N. gonorrhoeae showed a double ring structure with a 14-15-fold symmetry in the central ring, and a 14-fold symmetry of the peripheral ring with 7 spikes protruding. In secretin complexes of N. meningitidis, the spikes were absent and the peripheral ring was partly or completely lacking. When present, it had a 19-fold symmetry. The structures of the complexes in several pil mutants were determined. Structures obtained from the pilC1/C2 adhesin and the pilW minor pilin deletion strains were similar to wild-type, whereas deletion of the homologue of N. meningitidis PilW resulted in the absence of secretin structures. Remarkably, the pilE pilin subunit and pilP lipoprotein deletion mutants showed a change in the symmetry of the peripheral ring from 14 to 19 and loss of spikes. The pilF ATPase mutant also lost the spikes, but maintained 14-fold symmetry. These results show that secretin complexes contain previously unidentified large and flexible extra domains with a probable role in stabilization or assembly of type IV pili.	[Jain, Samta; Pachulec, Emilia; van der Does, Chris] Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands; [Jain, Samta; Pachulec, Emilia; van der Does, Chris] Univ Groningen, Zernike Inst Adv Mat, Haren, Netherlands; [Moscicka, Katarzyna B.; Stuart, Marc C. A.; Keegstra, Wilko; Boekema, Egbert J.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Bos, Martine P.] Univ Utrecht, Dept Mol Microbiol, Fac Sci, Utrecht, Netherlands; [Jain, Samta; van der Does, Chris] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Max Planck Society	Jain, S (corresponding author), Univ Groningen, Dept Mol Microbiol, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands.	does@mpi-marburg.mpg.de	Institute, Zernike/W-7033-2019; Stuart, Marc/B-6274-2008	Stuart, Marc/0000-0003-0667-6338				Aho EL, 1997, INFECT IMMUN, V65, P2613, DOI 10.1128/IAI.65.7.2613-2620.1997; Balasingham SV, 2007, J BACTERIOL, V189, P5716, DOI 10.1128/JB.00060-07; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; BLACK WJ, 1984, INFECT IMMUN, V45, P453, DOI 10.1128/IAI.45.2.453-457.1984; Bos MP, 2005, INFECT IMMUN, V73, P6194, DOI 10.1128/IAI.73.9.6194-6197.2005; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x; Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chen I, 2003, FRONT BIOSCI, V8, pS544; Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x; Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003; Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Drake SL, 1997, MOL MICROBIOL, V23, P657, DOI 10.1046/j.1365-2958.1997.2511618.x; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; FROHOLM LO, 1973, ACTA PATH MICRO IM B, VB 81, P525; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; Greiner LL, 2005, INFECT IMMUN, V73, P1964, DOI 10.1128/IAI.73.4.1964-1970.2005; Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamilton HL, 2001, J BACTERIOL, V183, P4718, DOI 10.1128/JB.183.16.4718-4726.2001; HANCOCK REW, 1978, J BACTERIOL, V136, P381, DOI 10.1128/JB.136.1.381-390.1978; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; Hazes B, 2008, BBA-BIOMEMBRANES, V1778, P1839, DOI 10.1016/j.bbamem.2008.03.011; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Kereiche S, 2008, FEBS LETT, V582, P3650, DOI 10.1016/j.febslet.2008.09.050; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Kouril R, 2005, FEBS LETT, V579, P3253, DOI 10.1016/j.febslet.2005.03.051; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; NEWHALL WJ, 1980, INFECT IMMUN, V27, P475, DOI 10.1128/IAI.27.2.475-482.1980; NICOLSON IJ, 1987, J GEN MICROBIOL, V133, P553; Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Okon M, 2008, STRUCTURE, V16, P1544, DOI 10.1016/j.str.2008.08.006; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; REICHOW SL, 2010, NAT STRUCT MOL BIOL; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Schuch R, 2001, J BACTERIOL, V183, P6991, DOI 10.1128/JB.183.24.6991-6998.2001; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; SWANSON J, 1971, J EXP MED, V134, P886, DOI 10.1084/jem.134.4.886; Tonjum T, 1998, MOL MICROBIOL, V29, P111, DOI 10.1046/j.1365-2958.1998.00910.x; Trindade MB, 2008, J MOL BIOL, V378, P1031, DOI 10.1016/j.jmb.2008.03.028; TSAI CM, 1980, J BACTERIOL, V141, P169, DOI 10.1128/JB.141.1.169-176.1980; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Yeremenko N, 2004, BIOCHEMISTRY-US, V43, P10308, DOI 10.1021/bi048772l	69	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16624	10.1371/journal.pone.0016624	http://dx.doi.org/10.1371/journal.pone.0016624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304951	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300101
J	Sela, I; Krentsis, IM; Shlomai, Z; Sadeh, M; Dabby, R; Argov, Z; Ben-Bassat, H; Mitrani-Rosenbaum, S				Sela, Ilan; Krentsis, Irit Milman; Shlomai, Zipora; Sadeh, Menachem; Dabby, Ron; Argov, Zohar; Ben-Bassat, Hannah; Mitrani-Rosenbaum, Stella			The Proteomic Profile of Hereditary Inclusion Body Myopathy	PLOS ONE			English	Article							DISTAL MYOPATHY; SIALIC ACIDS; MUSCLE; PROTEINS; MUTATION; GENE; QUADRICEPS; EXPRESSION; MYOBLASTS; MYOSITIS	Hereditary inclusion body myopathy (HIBM) is an adult onset, slowly progressive distal and proximal myopathy. Although the causing gene, GNE, encodes for a key enzyme in the biosynthesis of sialic acid, its primary function in HIBM remains unknown. The goal of this study was to unravel new clues on the biological pathways leading to HIBM by proteomic comparison. Muscle cultures and biopsies were analyzed by two dimensional gel electrophoresis (2-DE) and the same biopsy extracts by isobaric tag for relative and absolute quantitation (iTRAQ). Proteins that were differentially expressed in all HIBM specimens versus all controls in each analysis were identified by mass spectrometry. The muscle cultures 2-DE analysis yielded 41 such proteins, while the biopsies 2-DE analysis showed 26 differentially expressed proteins. Out of the 400 proteins identified in biopsies by iTRAQ, 41 showed altered expression. In spite of the different nature of specimens (muscle primary cultures versus muscle biopsies) and of the different methods applied (2D gels versus iTRAQ) the differentially expressed proteins identified in each of the three analyses where related mainly to the same pathways, ubiquitination, stress response and mitochondrial processes, but the most robust cluster (30%) was assigned to cytoskeleton and sarcomere organization. Taken together, these findings indicate a possible novel function of GNE in the muscle filamentous apparatus that could be involved in the pathogenesis of HIBM.	[Sela, Ilan; Krentsis, Irit Milman; Mitrani-Rosenbaum, Stella] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Shlomai, Zipora; Ben-Bassat, Hannah] Hadassah Hebrew Univ Med Ctr, Expt Surg Lab, Jerusalem, Israel; [Sadeh, Menachem; Dabby, Ron] Wolfson Med Ctr, Dept Neurol, Holon, Israel; [Argov, Zohar] Hadassah Hebrew Univ Med Ctr, Dept Neurol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Sela, I (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	stella@cc.huji.ac.il		Mitrani-Rosenbaum, Stella/0000-0001-5335-8709	German Israeli Foundation [I-9191-142.3/2006]; Israel Science Foundation [671/07]; Neuromuscular Disease Foundation	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Neuromuscular Disease Foundation	The work was supported in part by the German Israeli Foundation (www.gif.org.il) (I-9191-142.3/2006), by the Israel Science Foundation (www.isf.org.il) (671/07) and by the Neuromuscular Disease Foundation (www.neuromuscdisease.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsili S, 2007, CELL DEATH DIFFER, V14, P1916, DOI 10.1038/sj.cdd.4402208; Amsili S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002477; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; Arnardottir S, 2004, J NEUROL NEUROSUR PS, V75, P917, DOI 10.1136/jnnp.2003.018994; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; ASKANAS V, 1998, INCLUSION BODY MYOSI, P3; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; De Palma S, 2006, PROTEOMICS, V6, P379, DOI 10.1002/pmic.200500098; Doran P, 2004, EUR J BIOCHEM, V271, P3943, DOI 10.1111/j.1432-1033.2004.04332.x; Doran P, 2009, PROTEOMICS, V9, P989, DOI 10.1002/pmic.200800365; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg I, 2008, HUM MOL GENET, V17, P3663, DOI 10.1093/hmg/ddn261; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gelfi C, 2006, J PROTEOME RES, V5, P1344, DOI 10.1021/pr050414x; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Krause S, 2003, NEUROMUSCULAR DISORD, V13, P830, DOI 10.1016/S0960-8966(03)00140-8; Kruger J, 2008, NEUROMUSCULAR DISORD, V18, P501, DOI 10.1016/j.nmd.2008.04.003; Li J, 2006, J NEUROPATH EXP NEUR, V65, P826, DOI 10.1097/01.jnen.0000228204.19915.69; LINDBERG C, 1991, J NEUROL SCI, V103, P76, DOI 10.1016/0022-510X(91)90287-H; Mahjneh I, 2003, NEUROLOGY, V61, P87, DOI 10.1212/01.WNL.0000073618.91577.E8; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Nonaka Ikuya, 2005, Curr Neurol Neurosci Rep, V5, P61, DOI 10.1007/s11910-005-0025-0; O'Connell K, 2009, PROTEOMICS, V9, P5509, DOI 10.1002/pmic.200900472; Ohlendieck K, 2010, EXPERT REV PROTEOMIC, V7, P283, DOI 10.1586/EPR.10.2; Parker KC, 2009, MUSCLE NERVE, V39, P739, DOI 10.1002/mus.21230; Reuter G, 1996, BIOL CHEM H-S, V377, P325; Rosen R, 2004, PROTEOMICS, V4, P1061, DOI 10.1002/pmic.200300640; Rosen R, 2001, FEMS MICROBIOL ECOL, V35, P277, DOI 10.1111/j.1574-6941.2001.tb00813.x; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Varki A, 1997, FASEB J, V11, P248, DOI 10.1096/fasebj.11.4.9068613; WHEELER SD, 1982, PHYS THER, V62, P1809, DOI 10.1093/ptj/62.12.1809	39	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16334	10.1371/journal.pone.0016334	http://dx.doi.org/10.1371/journal.pone.0016334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305017	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300051
J	Bichsel, C; Neeld, DK; Hamazaki, T; Wu, DH; Chang, LJ; Yang, LJ; Terada, N; Jin, SG				Bichsel, Candace; Neeld, Dennis K.; Hamazaki, Takashi; Wu, Donghai; Chang, Lung-Ji; Yang, Lijun; Terada, Naohiro; Jin, Shouguang			Bacterial Delivery of Nuclear Proteins into Pluripotent and Differentiated Cells	PLOS ONE			English	Article							III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; LENTIVIRAL VECTOR; CRE RECOMBINASE; STEM-CELLS; INDUCTION; FIBROBLASTS; EXCISION	Numerous Gram negative pathogens possess a type III secretion system (T3SS) which allows them to inject virulent proteins directly into the eukaryotic cell cytoplasm. Injection of these proteins is dependent on a variable secretion signal sequence. In this study, we utilized the N-terminal secretion signal sequence of Pseudomonas aeruginosa exotoxin ExoS to translocate Cre recombinase containing a nuclear localization sequence (Cre-NLS). Transient exposure of human sarcoma cell line, containing Cre-dependent lacZ reporter, resulted in efficient recombination in the host chromosome, indicating that the bacterially delivered protein was not only efficiently localized to the nucleus but also retained its biological function. Using this system, we also illustrate the ability of P. aeruginosa to infect mouse embryonic stem cells (mESC) and the susceptibility of these cells to bacterially delivered Cre-NLS. A single two-hour infection caused as high as 30% of the mESC reporter cells to undergo loxP mediated chromosomal DNA recombination. A simple antibiotic treatment completely eliminated the bacterial cells following the delivery, while the use of an engineered mutant strain greatly reduced cytotoxicity. Utility of the system was demonstrated by delivery of the Cre-NLS to induced pluripotent stem cells to excise the floxed oncogenic nuclear reprogramming cassette. These results validate the use of T3SS for the delivery of transcription factors for the purpose of cellular reprogramming.	[Bichsel, Candace; Neeld, Dennis K.; Chang, Lung-Ji; Jin, Shouguang] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Hamazaki, Takashi; Yang, Lijun; Terada, Naohiro] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Bichsel, C (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	sjin@mgm.ufl.edu	Jin, Shouguang/N-5548-2016		National Institutes of Health [RC1GM091238]; UF Opportunity Fund [UF-RGP80830]; Bankhead-Coley Cancer Research Program [FLDH 09BW-12]; National Basic Research Program of China (973 Program) [2011CB504004, 2010CB945500]; National Natural Science Foundation of China [90813033]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UF Opportunity Fund; Bankhead-Coley Cancer Research Program; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (RC1GM091238), UF Opportunity Fund (UF-RGP80830), Bankhead-Coley Cancer Research Program (FLDH 09BW-12), National Basic Research Program of China (973 Program) (2011CB504004 and 2010CB945500) and the National Natural Science Foundation of China (90813033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; Epaulard O, 2006, MOL THER, V14, P656, DOI 10.1016/j.ymthe.2006.06.011; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Ha U, 2001, INFECT IMMUN, V69, P4398, DOI 10.1128/IAI.69.7.4398-4406.2001; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim J, 2005, MICROBIOL-SGM, V151, P3575, DOI 10.1099/mic.0.28277-0; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Marx Christopher J, 2008, BMC Res Notes, V1, P1, DOI 10.1186/1756-0500-1-1; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Oka Masahiro, 2006, V329, P273; Polack B, 2000, BIOCHEM BIOPH RES CO, V275, P854, DOI 10.1006/bbrc.2000.3399; Rabin SDP, 2005, INFECT IMMUN, V73, P573, DOI 10.1128/IAI.73.1.573-582.2005; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yu J, 2009, INFECT IMMUN, V77, P585, DOI 10.1128/IAI.01003-08; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaiss AK, 2002, J VIROL, V76, P7209, DOI 10.1128/JVI.76.14.7209-7219.2002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	35	29	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16465	10.1371/journal.pone.0016465	http://dx.doi.org/10.1371/journal.pone.0016465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304583	gold, Green Published			2022-12-25	WOS:000286663900053
J	Kawanishi, T; Shiraishi, T; Okano, Y; Sugawara, K; Hashimoto, M; Maejima, K; Komatsu, K; Kakizawa, S; Yamaji, Y; Hamamoto, H; Oshima, K; Namba, S				Kawanishi, Takeshi; Shiraishi, Takuya; Okano, Yukari; Sugawara, Kyoko; Hashimoto, Masayoshi; Maejima, Kensaku; Komatsu, Ken; Kakizawa, Shigeyuki; Yamaji, Yasuyuki; Hamamoto, Hiroshi; Oshima, Kenro; Namba, Shigetou			New Detection Systems of Bacteria Using Highly Selective Media Designed by SMART: Selective Medium-Design Algorithm Restricted by Two Constraints	PLOS ONE			English	Article							OCEAN SAMPLING EXPEDITION; CAMPESTRIS PV. MUSACEARUM; SEQUENCING TECHNOLOGIES; SEMISELECTIVE MEDIUM; SOIL; MICROORGANISMS; DIVERSITY; GENOMES; GENES; ELISA	Culturing is an indispensable technique in microbiological research, and culturing with selective media has played a crucial role in the detection of pathogenic microorganisms and the isolation of commercially useful microorganisms from environmental samples. Although numerous selective media have been developed in empirical studies, unintended microorganisms often grow on such media probably due to the enormous numbers of microorganisms in the environment. Here, we present a novel strategy for designing highly selective media based on two selective agents, a carbon source and antimicrobials. We named our strategy SMART for highly Selective Medium-design Algorithm Restricted by Two constraints. To test whether the SMART method is applicable to a wide range of microorganisms, we developed selective media for Burkholderia glumae, Acidovorax avenae, Pectobacterium carotovorum, Ralstonia solanacearum, and Xanthomonas campestris. The series of media developed by SMART specifically allowed growth of the targeted bacteria. Because these selective media exhibited high specificity for growth of the target bacteria compared to established selective media, we applied three notable detection technologies: paper-based, flow cytometry-based, and color change-based detection systems for target bacteria species. SMART facilitates not only the development of novel techniques for detecting specific bacteria, but also our understanding of the ecology and epidemiology of the targeted bacteria.	[Kawanishi, Takeshi; Shiraishi, Takuya; Okano, Yukari; Sugawara, Kyoko; Hashimoto, Masayoshi; Maejima, Kensaku; Komatsu, Ken; Kakizawa, Shigeyuki; Yamaji, Yasuyuki; Hamamoto, Hiroshi; Oshima, Kenro; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan	University of Tokyo	Kawanishi, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Agr & Environm Biol, Tokyo, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Komatsu, Ken/B-3244-2015; kakizawa, shigeyuki/L-8901-2018; Yamazaki, Kyoko/O-4931-2014	Komatsu, Ken/0000-0003-3323-7314; kakizawa, shigeyuki/0000-0003-3885-4434; Oshima, Kenro/0000-0001-7327-4481	Grants-in-Aid for Scientific Research [21248004] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; CHUN WWC, 1983, PLANT DIS, V67, P632; Connon SA, 2002, APPL ENVIRON MICROB, V68, P3878, DOI 10.1128/AEM.68.8.3878-3885.2002; Cordwell SJ, 1999, ARCH MICROBIOL, V172, P269, DOI 10.1007/s002030050780; Courvalin P, 2001, CLIN INFECT DIS, V33, pS138, DOI 10.1086/321840; CUPPELS D, 1974, PHYTOPATHOLOGY, V64, P468, DOI 10.1094/Phyto-64-468; Fournier PE, 2007, LANCET INFECT DIS, V7, P711, DOI 10.1016/S1473-3099(07)70260-8; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Giovannoni S, 2007, NAT REV MICROBIOL, V5, P820, DOI 10.1038/nrmicro1752; GRANADA GA, 1983, CAN J MICROBIOL, V29, P433, DOI 10.1139/m83-070; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; Jin M, 2005, APPL MICROBIOL BIOT, V69, P229, DOI 10.1007/s00253-005-0108-5; Jones JB, 1997, J APPL MICROBIOL, V83, P397, DOI 10.1046/j.1365-2672.1997.00251.x; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kawaradani Mitsuo, 2000, Journal of General Plant Pathology, V66, P234, DOI 10.1007/PL00012951; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Martinez JL, 2007, NAT REV MICROBIOL, V5, P958, DOI 10.1038/nrmicro1796; Mwangi M, 2007, PLANT PATHOL, V56, P383, DOI 10.1111/j.1365-3059.2007.01564.x; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Roy D, 2001, INT J FOOD MICROBIOL, V69, P167, DOI 10.1016/S0168-1605(01)00496-2; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; SCHLEGEL HG, 1967, ANNU REV MICROBIOL, V21, P49, DOI 10.1146/annurev.mi.21.100167.000405; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; SHIRAKAWA T, 2000, ANN PHYTOPATHOL SOC, V66, P132; Sundsfjord A, 2004, APMIS, V112, P815, DOI 10.1111/j.1600-0463.2004.apm11211-1208.x; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tripathi L, 2007, EUR J PLANT PATHOL, V117, P177, DOI 10.1007/s10658-006-9083-7; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang ZK, 1999, PLANT PATHOL, V48, P245, DOI 10.1046/j.1365-3059.1999.00332.x; Williams P. H., 1980, Plant Disease, V64, P736, DOI 10.1094/PD-64-736; Yooseph S, 2007, PLOS BIOL, V5, pe16, DOI DOI 10.1371/journal.pbio.0050016; Zengler K, 2002, P NATL ACAD SCI USA, V99, P15681, DOI 10.1073/pnas.252630999	44	25	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16512	10.1371/journal.pone.0016512	http://dx.doi.org/10.1371/journal.pone.0016512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304596	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900059
J	Jo, Y; Sguigna, PV; Debose-Boyd, RA				Jo, Youngah; Sguigna, Peter V.; Debose-Boyd, Russell A.			Membrane-associated Ubiquitin Ligase Complex Containing gp78 Mediates Sterol-accelerated Degradation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; HMG COA REDUCTASE; COENZYME-A REDUCTASE; AAA ATPASE CDC48/P97; MESSENGER-RNA; FEEDBACK-REGULATION; INSIG-1; PROTEIN; DOMAIN; ER	The endoplasmic reticulum (ER)-associated degradation (ERAD) pathway in the yeast Saccharomyces cerevisiae is mediated by two membrane-bound ubiquitin ligases, Doa10 and Hrd1. These enzymes are found in distinct multiprotein complexes that allow them to recognize and target a variety of substrates for proteasomal degradation. Although multiprotein complexes containing mammalian ERAD ubiquitin ligases likely exist, they have yet to be identified and characterized in detail. Here, we identify two ER membrane proteins, SPFH2 and TMUB1, as associated proteins of mammalian gp78, a membrane-bound ubiquitin ligase that bears significant sequence homology with mammalian Hrd1 and mediates sterol-accelerated ERAD of the cholesterol biosynthetic enzyme HMG-CoA reductase. Co-immunoprecipitation studies indicate that TMUB1 bridges SPFH2 to gp78 in ER membranes. The functional significance of these interactions is revealed by the observation that RNA interference (RNAi)-mediated knockdown of SPFH2 and TMUB1 blunts both the sterol-induced ubiquitination and degradation of endogenous reductase in HEK-293 cells. These studies mark the initial steps in the characterization of the mammalian gp78 ubiquitin ligase complex, the further elucidation of which may yield important insights into mechanisms underlying gp78-mediated ERAD.	[Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Jo, Youngah; Sguigna, Peter V.; Debose-Boyd, Russell A.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Debose-Boyd, RA (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Russell.DeBose-Boyd@utsouthwestern.edu			National Institutes of Health [HL20948, GM090216]; Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perot Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL20948 and GM090216. This work was also supported by the Perot Family Foundation.	Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; BROWN MS, 1980, J LIPID RES, V21, P505; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Jarosch E, 2003, INT REV CYTOL, V223, P39; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; LISCUM L, 1983, J BIOL CHEM, V258, P8450; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; NAKANISHI M, 1988, J BIOL CHEM, V263, P8929; Pearce MMP, 2007, J BIOL CHEM, V282, P20104, DOI 10.1074/jbc.M701862200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2008, J CELL MOL MED, V12, P2511, DOI 10.1111/j.1582-4934.2008.00462.x; Wang Y, 2009, BBA-MOL CELL RES, V1793, P1710, DOI 10.1016/j.bbamcr.2009.09.004; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yang HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002809; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	33	65	68	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15022	15031		10.1074/jbc.M110.211326	http://dx.doi.org/10.1074/jbc.M110.211326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343306	hybrid, Green Published			2022-12-25	WOS:000289788300032
J	Grimm, MOW; Kuchenbecker, J; Grosgen, S; Burg, VK; Hundsdorfer, B; Rothhaar, TL; Friess, P; de Wilde, MC; Broersen, LM; Penke, B; Peter, M; Vigh, L; Grimm, HS; Hartmann, T				Grimm, Marcus O. W.; Kuchenbecker, Johanna; Groesgen, Sven; Burg, Verena K.; Hundsdoerfer, Benjamin; Rothhaar, Tatjana L.; Friess, Petra; de Wilde, Martijn C.; Broersen, Laus M.; Penke, Botond; Peter, Maria; Vigh, Laszlo; Grimm, Heike S.; Hartmann, Tobias			Docosahexaenoic Acid Reduces Amyloid beta Production via Multiple Pleiotropic Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODERATE ALZHEIMER-DISEASE; ALPHA-SECRETASE CLEAVAGE; DOUBLE-BLIND TRIAL; N-3 FATTY-ACIDS; PRECURSOR PROTEIN; GAMMA-SECRETASE; LIPID RAFTS; A-BETA; TRANSGENIC MICE; HUMAN BRAIN	Alzheimer disease is characterized by accumulation of the beta-amyloid peptide (A beta) generated by beta- and gamma-secretase processing of the amyloid precursor protein (APP). The intake of the polyunsaturated fatty acid docosahexaenoic acid (DHA) has been associated with decreased amyloid deposition and a reduced risk in Alzheimer disease in several epidemiological trials; however, the exact underlying molecular mechanism remains to be elucidated. Here, we systematically investigate the effect of DHA on amyloidogenic and nonamyloidogenic APP processing and the potential cross-links to cholesterol metabolism in vivo and in vitro. DHA reduces amyloidogenic processing by decreasing beta- and gamma-secretase activity, whereas the expression and protein levels of BACE1 and presenilin1 remain unchanged. In addition, DHA increases protein stability of alpha-secretase resulting in increased nonamyloidogenic processing. Besides the known effect of DHA to decrease cholesterol de novo synthesis, we found cholesterol distribution in plasma membrane to be altered. In the presence of DHA, cholesterol shifts from raft to non-raft domains, and this is accompanied by a shift in gamma-secretase activity and presenilin1 protein levels. Taken together, DHA directs amyloidogenic processing of APP toward nonamyloidogenic processing, effectively reducing A beta release. DHA has a typical pleiotropic effect; DHA-mediated A beta reduction is not the consequence of a single major mechanism but is the result of combined multiple effects.	[Grimm, Marcus O. W.; Kuchenbecker, Johanna; Groesgen, Sven; Burg, Verena K.; Hundsdoerfer, Benjamin; Rothhaar, Tatjana L.; Friess, Petra; Grimm, Heike S.; Hartmann, Tobias] Univ Saarland, Dept Neurodegenerat & Neurobiol, Deutsch Inst DemenzPravent, D-66421 Homburg, Germany; [de Wilde, Martijn C.; Broersen, Laus M.] Danone Res, Nutricia Adv Med Nutr, Ctr Specialised Nutr, NL-6700 CA Wageningen, Netherlands; [Penke, Botond] Hungarian Acad Sci, Supramol & Nanostruct Mat Res Grp, H-6723 Szeged, Hungary; [Penke, Botond] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Peter, Maria; Vigh, Laszlo] Hungarian Acad Sci, Inst Biochem, Biol Res Ctr, H-6723 Szeged, Hungary	Saarland University; Danone Nutricia; Hungarian Academy of Sciences; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Grimm, MOW (corresponding author), Kirrberger Str 1, D-66421 Homburg, Germany.	marcus.grimm@uks.eu; Tobias.Hartmann@uniklinikum-saarland.de	de Wilde, Martijn/A-3855-2012; Hartmann, Tobias/AAB-8297-2022; soler, martha maricel m gomez/L-6025-2014; Grimm, Marcus O. W./F-8134-2011	soler, martha maricel m gomez/0000-0002-4412-8108; Grimm, Marcus O. W./0000-0002-4160-6506; Hartmann, Tobias/0000-0001-7481-6430	European Union [211696]; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Forschung, Wissenschaft, und Technologie; Kompetenznetz Degenerative Demenzen; Saarland University	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Forschung, Wissenschaft, und Technologie(Federal Ministry of Education & Research (BMBF)); Kompetenznetz Degenerative Demenzen; Saarland University	This work was supported by European Union FP7 Project LipiDiDiet Grant 211696 (to T.H.), Deutsche Forschungsgemeinschaft, Bundesministerium fur Bildung, Forschung, Wissenschaft, und Technologie via NGFNplus (to T. H.), and Kompetenznetz Degenerative Demenzen (KNDD) (to T.H.), HOMFOR 2008 and HOMFOR 2009 Saarland University Research Grants (to M.O.W.G. and T.H.).	Abad-Rodriguez J, 2004, J CELL BIOL, V167, P953, DOI 10.1083/jcb.200404149; Albanese E, 2009, AM J CLIN NUTR, V90, P392, DOI 10.3945/ajcn.2009.27580; Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; ANSARI KA, 1990, NEUROCHEM RES, V15, P7, DOI 10.1007/BF00969177; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; BAZAN NG, 1990, UPSALA J MED SCI, P97; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; CLADERA JL, 1985, DEV GENET, V6, P27, DOI 10.1002/dvg.1020060103; Cole GM, 2009, PROSTAG LEUKOTR ESS, V81, P213, DOI 10.1016/j.plefa.2009.05.015; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Frears ER, 1999, NEUROREPORT, V10, P1699, DOI 10.1097/00001756-199906030-00014; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Hunt CE, 2009, FEBS J, V276, P1845, DOI 10.1111/j.1742-4658.2009.06929.x; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kamphuis PJGH, 2010, J ALZHEIMERS DIS, V20, P765, DOI 10.3233/JAD-2010-091558; KANG J, 1990, BIOCHEM BIOPH RES CO, V166, P1192, DOI 10.1016/0006-291X(90)90992-V; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim SH, 2003, J BIOL CHEM, V278, P33992, DOI 10.1074/jbc.M305834200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Langelier B, 2010, J CELL BIOCHEM, V110, P1356, DOI 10.1002/jcb.22652; Lien EL, 2009, PROSTAG LEUKOTR ESS, V81, P125, DOI 10.1016/j.plefa.2009.05.004; Liu WW, 2009, J NEUROCHEM, V108, P341, DOI 10.1111/j.1471-4159.2008.05753.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu F, 2010, CHINESE MED J-PEKING, V123, P1864, DOI 10.3760/cma.j.issn.0366-6999.2010.14.007; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Marquer C, 2011, FASEB J, V25, P1295, DOI 10.1096/fj.10-168633; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Prince M, 2009, ALZHEIMERS DIS INT W, P1; Rapoport SI, 2007, PROSTAG LEUKOTR ESS, V77, P251, DOI 10.1016/j.plefa.2007.10.023; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Schneider A, 2006, NEUROBIOL DIS, V23, P573, DOI 10.1016/j.nbd.2006.04.015; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaikh SR, 2010, PROSTAG LEUKOTR ESS, V82, P159, DOI 10.1016/j.plefa.2010.02.026; Shaikh SR, 2009, BBA-BIOMEMBRANES, V1788, P2421, DOI 10.1016/j.bbamem.2009.08.019; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Shie FS, 2002, NEUROREPORT, V13, P455, DOI 10.1097/00001756-200203250-00019; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SODERBERG M, 1991, LIPIDS, V26, P421, DOI 10.1007/BF02536067; Solomon A, 2010, NEURODEGENER DIS, V7, P180, DOI 10.1159/000295659; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; TATE BA, 2006, SCI AGING KNOWLEDGE, pRE2; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Tun H, 2002, J MOL NEUROSCI, V19, P31, DOI 10.1007/s12031-002-0007-5; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Woods AJ, 2004, EMBO J, V23, P2531, DOI 10.1038/sj.emboj.7600267	82	160	164	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14028	14039		10.1074/jbc.M110.182329	http://dx.doi.org/10.1074/jbc.M110.182329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324907	Green Published, hybrid			2022-12-25	WOS:000289556200025
J	Gentle, IE; Wong, WWL; Evans, JM; Bankovacki, A; Cook, WD; Khan, NR; Nachbur, U; Rickard, J; Anderton, H; Moulin, M; Lluis, JM; Moujalled, DM; Silke, J; Vaux, DL				Gentle, Ian E.; Wong, W. Wei-Lynn; Evans, Joseph M.; Bankovacki, Alexandra; Cook, Wendy D.; Khan, Nufail R.; Nachbur, Ulrich; Rickard, James; Anderton, Holly; Moulin, Maryline; Lluis, Josep Maria; Moujalled, Donia M.; Silke, John; Vaux, David L.			In TNF-stimulated Cells, RIPK1 Promotes Cell Survival by Stabilizing TRAF2 and cIAP1, which Limits Induction of Non-canonical NF-kappa B and Activation of Caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEATH DOMAIN KINASE; NECROSIS-FACTOR TNF; ALPHA-DEPENDENT APOPTOSIS; WEAK INDUCER; C-FLIP; UBIQUITINATION; DEGRADATION; COMPLEX; INHIBITOR; PROTEIN	RIPK1 is involved in signaling from TNF and TLR family receptors. After receptor ligation, RIPK1 not only modulates activation of both canonical and NIK-dependent NF-kappa B, but also regulates caspase-8 activation and cell death. Although overexpression of RIPK1 can cause caspase-8-dependent cell death, when RIPK1(-/-) cells are exposed to TNF and low doses of cycloheximide, they die more readily than wild-type cells, indicating RIPK1 has pro-survival as well as pro-apoptotic activities (1, 2). To determine how RIPK1 promotes cell survival, we compared wild-type and RIPK1(-/-) cells treated with TNF. Although TRAF2 levels remained constant in TNF-treated wild-type cells, TNF stimulation of RIPK1(-/-) cells caused TRAF2 and cIAP1 to be rapidly degraded by the proteasome, which led to an increase in NIK levels. This resulted in processing of p100 NF-kappa B2 to p52, a decrease in levels of cFLIP(L), and activation of caspase-8, culminating in cell death. Therefore, the pro-survival effect of RIPK1 is mediated by stabilization of TRAF2 and cIAP1.	[Vaux, David L.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia; La Trobe Univ, La Trobe Inst Mol Sci, Bundoora, Vic 3086, Australia	La Trobe University; La Trobe University	Vaux, DL (corresponding author), La Trobe Univ, Dept Biochem, Kingsbury Dr, Bundoora, Vic 3086, Australia.	d.vaux@latrobe.edu.au	Gentle, Ian/X-2888-2019; Cook, Wendy/N-7506-2019; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015; Vaux, David L/C-7249-2013	Gentle, Ian/0000-0002-6707-7809; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Vaux, David L/0000-0003-2703-1651; Anderton, Holly/0000-0003-3913-9686; Nachbur, Ueli/0000-0001-5968-2235; Moulin, Maryline/0000-0002-1851-8727	NHMRC [433013, 541901, 541902, 461221]; Leukemia and Lymphoma Society Center; NHMRC Australian [487348]; Swiss National Science Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society Center(Leukemia and Lymphoma Society); NHMRC Australian(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported in part by the NHMRC (433013, 541901, and 541902) (to J. S.), a Leukemia and Lymphoma Society Center Grant and the NHMRC (461221) (to D. L V.), an NHMRC Australian Postdoctoral Training Fellowship (487348) (to I. E. G.), and the Swiss National Science Foundation (to U. N.).	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Blonska M, 2005, J BIOL CHEM, V280, P43056, DOI 10.1074/jbc.M507807200; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Feltham R, 2010, J BIOL CHEM, V285, P17525, DOI 10.1074/jbc.M109.087635; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rauert H, 2010, J BIOL CHEM, V285, P7394, DOI 10.1074/jbc.M109.037341; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; STANGER BZ, 1995, CELL, V81, P513, DOI 10.1016/0092-8674(95)90072-1; Tada K, 2001, J BIOL CHEM, V276, P36530, DOI 10.1074/jbc.M104837200; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wicovsky A, 2009, CELL DEATH DIFFER, V16, P1445, DOI 10.1038/cdd.2009.80; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang LQ, 2010, J MOL BIOL, V396, P528, DOI 10.1016/j.jmb.2010.01.008	40	76	79	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13282	13291		10.1074/jbc.M110.216226	http://dx.doi.org/10.1074/jbc.M110.216226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339290	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000289282200049
J	Keck, M; Gisch, N; Moll, H; Vorholter, FJ; Gerth, K; Kahmann, U; Lissel, M; Lindner, B; Niehaus, K; Hoist, O				Keck, Matthias; Gisch, Nicolas; Moll, Hermann; Vorhoelter, Frank-Joerg; Gerth, Klaus; Kahmann, Uwe; Lissel, Manfred; Lindner, Buko; Niehaus, Karsten; Hoist, Otto			Unusual Outer Membrane Lipid Composition of the Gram-negative, Lipopolysaccharide-lacking Myxobacterium Sorangium cellulosum So ce56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SER/THR KINASE CASCADE; ABSOLUTE-CONFIGURATION; GLYCOSPHINGOLIPIDS; IDENTIFICATION; SPHINGOLIPIDS; PHOSPHOLIPIDS; BIOSYNTHESIS; CYSTOBACTER; BACTERIA	The Gram-negative myxobacterium Sorangium cellulosum So ce56 bears the largest bacterial genome published so far, coding for nearly 10,000 genes. Careful analysis of this genome data revealed that part of the genes coding for the very well conserved biosynthesis of lipopolysaccharides (LPS) are missing in this microbe. Biochemical analysis gave no evidence for the presence of LPS in the membranes of So ce56. By analyzing the lipid composition of its outer membrane sphingolipids were identified as the major lipid class, together with ornithine-containing lipids (OL) and ether lipids. A detailed analysis of these lipids resulted in the identification of more than 50 structural variants within these three classes, which possessed several interesting properties regarding to LPS replacement, mediators in myxobacterial differentiation, as well as potential bioactive properties. The sphingolipids with the basic structure C9-methyl-C-20-sphingosine possessed as an unusual trait C9-methylation, which is common to fungi but highly uncommon to bacteria. Such sphingolipids have not been found in bacteria before, and they may have a function in myxobacterial development. The OL, also identified in myxobacteria for the first time, contained acyloxyacyl groups, which are also characteristic for LPS and might replace those in certain functions. Finally, the ether lipids may serve as biomarkers in myxobacterial development.	[Keck, Matthias; Vorhoelter, Frank-Joerg; Lissel, Manfred; Niehaus, Karsten] Univ Bielefeld, Dept Proteome & Metabolome Res, Fac Biol, D-33615 Bielefeld, Germany; [Kahmann, Uwe] Univ Bielefeld, IIT GmbH, ZUD, D-33615 Bielefeld, Germany; [Gisch, Nicolas; Moll, Hermann; Lindner, Buko] Leibniz Ctr Med & Biosci, Div Immunochem, D-23845 Borstel, Germany; [Hoist, Otto] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, D-23845 Borstel, Germany; [Gerth, Klaus] Helmholtz Ctr Infect Res, Res Grp Microbial Drugs, D-38124 Braunschweig, Germany	University of Bielefeld; University of Bielefeld; Forschungszentrum Borstel; Helmholtz Association; Helmholtz-Center for Infection Research	Niehaus, K (corresponding author), Univ Bielefeld, Dept Proteome & Metabolome Res, Fac Biol, POB 100131, D-33615 Bielefeld, Germany.	kniehaus@cebitec.uni-bielefeld.de	Niehaus, Karsten/A-3966-2010; Lindner, Buko/G-9731-2014	Gisch, Nicolas/0000-0003-3260-5269	German Federal Ministry of Education and Research (BMBF) [32106669]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was funded by Grant 32106669 from the German Federal Ministry of Education and Research (BMBF) (GenoMik and GenoMikPlus).	Adosraku RK, 1996, BBA-LIPID LIPID MET, V1299, P167, DOI 10.1016/0005-2760(95)00181-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CAILLON E, 1983, J BACTERIOL, V153, P1348, DOI 10.1128/JB.153.3.1348-1351.1983; ECKAU H, 1984, Z NATURFORSCH C, V39, P1; Engels A, 1997, BBA-PROTEIN STRUCT M, V1340, P33, DOI 10.1016/S0167-4838(97)00025-3; Gao JM, 2001, LIPIDS, V36, P175, DOI 10.1007/s11745-001-0704-x; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; Gerth K, 1996, J ANTIBIOT, V49, P560, DOI 10.7164/antibiotics.49.560; Gerth K, 2003, J BIOTECHNOL, V106, P233, DOI 10.1016/j.jbiotec.2003.07.015; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; HARDY PH, 1983, P SOC EXP BIOL MED, V174, P47; HARVEY DJ, 1984, J CHROMATOGR, V301, P173, DOI 10.1016/S0021-9673(01)89187-1; Hubner G, 2009, J MASS SPECTROM, V44, P1676, DOI 10.1002/jms.1673; Jayasimhulu K, 2007, J AM SOC MASS SPECTR, V18, P394, DOI 10.1016/j.jasms.2006.10.014; JIN WZ, 1994, J ORG CHEM, V59, P144, DOI 10.1021/jo00080a023; KAWAHARA K, 1991, FEBS LETT, V292, P107, DOI 10.1016/0014-5793(91)80845-T; Kawahara K, 2000, EUR J BIOCHEM, V267, P1837, DOI 10.1046/j.1432-1327.2000.01189.x; KAWAI G, 1982, BIOCHIM BIOPHYS ACTA, V719, P612, DOI 10.1016/0304-4165(82)90252-5; KAWASAKI S, 1994, J BACTERIOL, V176, P284, DOI 10.1128/JB.176.2.284-290.1994; LAMKY JR, 1976, J BACTERIOL, V126, P1278; Leone S, 2006, GLYCOBIOLOGY, V16, P766, DOI 10.1093/glycob/cwj120; Li SR, 1999, J LIPID RES, V40, P764; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; MASON WT, 1972, BIOCHIM BIOPHYS ACTA, V280, P538, DOI 10.1016/0005-2760(72)90133-6; MCBROOM AJ, 2005, OUTER MEMBRANE VESIC; Metcalf WW, 2009, ANNU REV BIOCHEM, V78, P65, DOI 10.1146/annurev.biochem.78.091707.100215; Muller R, 2006, J BIOTECHNOL, V121, P192, DOI 10.1016/j.jbiotec.2005.10.012; Nariya H, 2005, MOL MICROBIOL, V58, P367, DOI 10.1111/j.1365-2958.2005.04826.x; Nariya H, 2006, MOL MICROBIOL, V60, P1205, DOI 10.1111/j.1365-2958.2006.05178.x; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Pradella S, 2002, ARCH MICROBIOL, V178, P484, DOI 10.1007/s00203-002-0479-2; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; RIETSCHEL ET, 1976, EUR J BIOCHEM, V64, P423, DOI 10.1111/j.1432-1033.1976.tb10318.x; Ring MW, 2006, J BIOL CHEM, V281, P36691, DOI 10.1074/jbc.M607616200; ROSENFELDER G, 1974, EUR J BIOCHEM, V44, P411, DOI 10.1111/j.1432-1033.1974.tb03499.x; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; STEINER S, 1973, J BACTERIOL, V116, P1199, DOI 10.1128/JB.116.3.1199-1211.1973; SUTHERLAND IW, 1979, J GEN MICROBIOL, V111, P211, DOI 10.1099/00221287-111-1-211; SUTHERLAND IW, 1973, J GEN MICROBIOL, V74, P259, DOI 10.1099/00221287-74-2-259; TAKAYAMA K, 1987, INFECT IMMUN, V55, P2311, DOI 10.1128/IAI.55.9.2311-2313.1987; WAI SN, 1995, MICROBIOL IMMUNOL, V39, P451, DOI 10.1111/j.1348-0421.1995.tb02228.x; Wenzel SC, 2007, NAT PROD REP, V24, P1211, DOI 10.1039/b706416k; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Yang YL, 2010, ORG BIOMOL CHEM, V8, P4252, DOI 10.1039/c0ob00169d; Zhang Y, 2007, LIPIDS, V42, P759, DOI 10.1007/s11745-007-3079-8	51	21	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12850	12859		10.1074/jbc.M110.194209	http://dx.doi.org/10.1074/jbc.M110.194209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321121	Green Published, hybrid			2022-12-25	WOS:000289282200005
J	Zhu, H; Lin, PH; De, GJ; Choi, KH; Takeshima, H; Weisleder, N; Ma, JJ				Zhu, Hua; Lin, Peihui; De, Gejing; Choi, Kyoung-han; Takeshima, Hiroshi; Weisleder, Noah; Ma, Jianjie			Polymerase Transcriptase Release Factor (PTRF) Anchors MG53 Protein to Cell Injury Site for Initiation of Membrane Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL GENERALIZED LIPODYSTROPHY; MUSCULAR-DYSTROPHY; DYSFERLIN; CAVEOLIN-3; MUTATIONS; MUSCLE; SURFACE; CLONING; TYPE-4; CAVIN	Plasma membrane repair is an essential process for maintenance of homeostasis at the cellular and tissue levels, whereas compromised repair capacity contributes to degenerative human diseases. Our recent studies show that MG53 is essential for muscle membrane repair, and defects in MG53 function are linked to muscular dystrophy and cardiac dysfunction. Here we report that polymerase I and transcript release factor (PTRF), a gene known to regulate caveolae membrane structure, is an indispensable component of the membrane repair machinery. PTRF acts as a docking protein for MG53 during membrane repair potentially by binding exposed membrane cholesterol at the injury site. Cells lacking expression of endogenous PTRF show defective trafficking of MG53 to membrane injury sites. A mutation in PTRF associated with human disease results in aberrant nuclear localization of PTRF and disrupts MG53 function in membrane resealing. Although RNAi silencing of PTRF leads to defective muscle membrane repair, overexpression of PTRF can rescue membrane repair defects in dystrophic muscle. Our data suggest that membrane-delimited interaction between MG53 and PTRF contributes to initiation of cell membrane repair, which can be an attractive target for treatment or prevention of tissue injury in human diseases.	[Zhu, Hua; Lin, Peihui; De, Gejing; Choi, Kyoung-han; Weisleder, Noah; Ma, Jianjie] Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Takeshima, Hiroshi] Kyoto Univ, Dept Biol Chem, Grad Sch Pharmaceut Sci, Kyoto 6068501, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Kyoto University	Ma, JJ (corresponding author), Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	Weisleder, Noah L/A-7098-2013; Zhu, Hua/G-4409-2010; Lin, Pei-Hui/I-3011-2015	Weisleder, Noah L/0000-0002-2619-8022; Lin, Pei-Hui/0000-0002-3894-5099; Weisleder, Noah/0000-0003-2710-3088; Zhu, Hua/0000-0001-7136-7326; Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health grants (to J. M., N. W., and H. T.). J. M. and N. W. are co-founders of TRIM-edicine, Inc., a university spin-off biotechnology company that is developing recombinant MG53 protein as a therapeutic agent for treatment of tissue injuries.	Aboulaich N, 2004, BIOCHEM J, V383, P237, DOI 10.1042/BJ20040647; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Doherty KR, 2003, TRENDS MOL MED, V9, P327, DOI 10.1016/S1471-4914(03)00136-9; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; McNeil PL, 2003, P NATL ACAD SCI USA, V100, P4592, DOI 10.1073/pnas.0736739100; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000874; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Wang XL, 2010, J APPL PHYS, V107, DOI 10.1063/1.3358007	29	79	89	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12820	12824		10.1074/jbc.C111.221440	http://dx.doi.org/10.1074/jbc.C111.221440			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343302	Green Published, hybrid			2022-12-25	WOS:000289282200002
J	Ratovitski, T; Chighladze, E; Waldron, E; Hirschhorn, RR; Ross, CA				Ratovitski, Tamara; Chighladze, Ekaterine; Waldron, Elaine; Hirschhorn, Ricky R.; Ross, Christopher A.			Cysteine Proteases Bleomycin Hydrolase and Cathepsin Z Mediate N-terminal Proteolysis and Toxicity of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PC12 CELL MODEL; WILD-TYPE; INTRANUCLEAR INCLUSIONS; PALLIDOLUYSIAN ATROPHY; DEPENDENT PROTEOLYSIS; MEMBRANE ASSOCIATION; CASPASE CLEAVAGE; REDUCES TOXICITY; TRANSGENIC MICE; REPEAT LENGTH	N-terminal proteolysis of huntingtin is thought to be an important mediator of HD pathogenesis. The formation of short N-terminal fragments of huntingtin (cp-1/cp-2, cp-A/cp-B) has been demonstrated in cells and in vivo. We previously mapped the cp-2 cleavage site by mass spectrometry to position Arg(167) of huntingtin. The proteolytic enzymes generating short N-terminal fragments of huntingtin remain unknown. To search for such proteases, we conducted a genome-wide screen using an RNA-silencing approach and an assay for huntingtin proteolysis based on the detection of cp-1 and cp-2 fragments by Western blotting. The primary screen was carried out in HEK293 cells, and the secondary screen was carried out in neuronal HT22 cells, transfected in both cases with a construct encoding the N-terminal 511 amino acids of mutant huntingtin. For additional validation of the hits, we employed a complementary assay for proteolysis of huntingtin involving overexpression of individual proteases with huntingtin in two cell lines. The screen identified 11 enzymes, with two major candidates to carry out the cp-2 cleavage, bleomycin hydrolase (BLMH) and cathepsin Z, which are both cysteine proteases of a papain-like structure. Knockdown of either protease reduced cp-2 cleavage, and ameliorated mutant huntingtin induced toxicity, whereas their overexpression increased the cp-2 cleavage. Both proteases partially co-localized with Htt in the cytoplasm and within or in association with early and late endosomes, with some nuclear co-localization observed for cathepsin Z. BLMH and cathepsin Z are expressed in the brain and have been associated previously with neurodegeneration. Our findings further validate the cysteine protease family, and BLMH and cathepsin Z in particular, as potential novel targets for HD therapeutics.	[Ratovitski, Tamara; Chighladze, Ekaterine; Waldron, Elaine; Hirschhorn, Ricky R.; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Program Cellular & Mol Med, Baltimore, MD 21287 USA; [Hirschhorn, Ricky R.] Hood Coll, Dept Biol, Frederick, MD 21701 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ratovitski, T (corresponding author), CMSC 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	tratovi1@jhmi.edu; caross@jhu.edu			NINDS, National Institutes of Health [16375]; HDSA Coalition for the Cure; High Q Foundation CHDI	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HDSA Coalition for the Cure; High Q Foundation CHDI	This work was supported, in whole or in part, by NINDS, National Institutes of Health, Grant 16375. This work was also supported by HDSA Coalition for the Cure and the High Q Foundation CHDI.	AKIYAMA S, 1981, BIOCHEM BIOPH RES CO, V101, P55, DOI 10.1016/S0006-291X(81)80009-5; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Bizat N, 2003, J NEUROSCI, V23, P5020; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cooper JK, 1998, HUM MOL GENET, V7, P783, DOI 10.1093/hmg/7.5.783; Deussing J, 2000, BBA-GENE STRUCT EXPR, V1491, P93, DOI 10.1016/S0167-4781(00)00021-X; Devanathan G, 2005, BIOCHEM BIOPH RES CO, V329, P445, DOI 10.1016/j.bbrc.2005.01.150; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Igarashi S, 2003, NEUROREPORT, V14, P565, DOI 10.1097/00001756-200303240-00007; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kamata Y, 2007, J BIOCHEM, V141, P69, DOI 10.1093/jb/mvm005; Kegel KB, 2000, J NEUROSCI, V20, P7268, DOI 10.1523/jneurosci.20-19-07268.2000; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kim M, 1999, J NEUROSCI, V19, P964; Kim MH, 2003, EXP NEUROL, V183, P109, DOI 10.1016/S0014-4886(03)00132-8; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Koldamova RP, 1998, BIOCHEMISTRY-US, V37, P2282, DOI 10.1021/bi9722204; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Li X, 2008, NEUROREPORT, V19, P1643, DOI 10.1097/WNR.0b013e328315cd4c; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Lunkes A, 1998, HUM MOL GENET, V7, P1355, DOI 10.1093/hmg/7.9.1355; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Montoya SE, 2007, NEUROSCIENCE, V146, P890, DOI 10.1016/j.neuroscience.2007.02.027; Nagler DK, 1998, FEBS LETT, V434, P135, DOI 10.1016/S0014-5793(98)00964-8; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P12648, DOI 10.1021/bi991371z; Namba Y, 1999, BRAIN RES, V830, P200, DOI 10.1016/S0006-8993(99)01435-3; O'Farrell PA, 1999, STRUCT FOLD DES, V7, P619, DOI 10.1016/S0969-2126(99)80083-5; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Peters MF, 2001, J BIOL CHEM, V276, P3188, DOI 10.1074/jbc.M008099200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Truant R, 2006, BIOCHEM CELL BIOL, V84, P912, DOI 10.1139/O06-181; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P55, DOI 10.1007/s00401-007-0306-6; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wendt W, 2007, EXP NEUROL, V204, P525, DOI 10.1016/j.expneurol.2007.01.007; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Zheng WJ, 1998, CELL, V93, P103, DOI 10.1016/S0092-8674(00)81150-2; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	67	33	33	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.185348	http://dx.doi.org/10.1074/jbc.M110.185348			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310951	hybrid, Green Published			2022-12-25	WOS:000289077500070
J	Zbidi, H; Jardin, I; Woodard, GE; Lopez, JJ; Berna-Erro, A; Salido, GM; Rosado, JA				Zbidi, Hanene; Jardin, Isaac; Woodard, Geoffrey E.; Lopez, Jose J.; Berna-Erro, Alejandro; Salido, Gines M.; Rosado, Juan A.			STIM1 and STIM2 Are Located in the Acidic Ca2+ Stores and Associates with Orai1 upon Depletion of the Acidic Stores in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; VACUOLAR H+-ATPASES; CALCIUM-ENTRY; TRPC CHANNELS; DIFFERENTIAL SENSITIVITY; OPERATED CHANNELS; MEMBRANE-VESICLES; MAMMALIAN-CELLS; RELEASE; PROTEIN	Mammalian cells accumulate Ca2+ into agonist-sensitive acidic organelles, vesicles that possess a vacuolar proton-ATPase. Acidic Ca2+ stores include secretory granules and lysosome-related organelles. Current evidence clearly indicates that acidic Ca2+ stores participate in cell signaling and function, including the activation of store-operated Ca2+ entry in human platelets upon depletion of the acidic stores, although the mechanism underlying the activation of store-operated Ca2+ entry controlled by the acidic stores remains unclear. STIM1 has been presented as the endoplasmic reticulum Ca2+ sensor, but its role sensing intraluminal Ca2+ concentration in the acidic stores has not been investigated. Here we report that STIM1 and STIM2 are expressed in the lysosome-related organelles and dense granules in human platelets isolated by immunomagnetic sorting. Depletion of the acidic Ca2+ stores using the specific vacuolar proton-ATPase inhibitor, bafilomycin A1, enhanced the association between STIM1 and STIM2 as well as between these proteins and the plasma membrane channel Orai1. Depletion of the acidic Ca2+ stores also induces time-dependent co-immunoprecipitation of STIM1 with the TRPC proteins hTRPC1 and hTRPC6, as well as between Orai1 and both TRPC proteins. In addition, bafilomycin A1 enhanced the association between STIM2 and SERCA3. These findings demonstrate the location of STIM1 and STIM2 in the acidic Ca2+ stores and their association with Ca2+ channels and ATPases upon acidic stores discharge.	[Zbidi, Hanene; Jardin, Isaac; Berna-Erro, Alejandro; Salido, Gines M.; Rosado, Juan A.] Univ Extremadura, Cell Physiol Res Grp, Dept Physiol, Caceres 10003, Spain; [Woodard, Geoffrey E.] NIDDK, NIH, Bethesda, MD 20892 USA; [Lopez, Jose J.] INSERM, Hemostase & Dynam Cellulaire Vasc U770, F-94276 Le Kremlin Bicetre, France	Universidad de Extremadura; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Institut National de la Sante et de la Recherche Medicale (Inserm)	Rosado, JA (corresponding author), Univ Extremadura, Dept Physiol, Caceres 10071, Spain.	jarosado@unex.es	Erro, Alejandro Berna/S-5909-2019; Salido, Gines M/A-4292-2009; Lopez, Jose J/F-4602-2016; Jardin, Isaac/E-8310-2016; Rosado, Juan A/H-3488-2015	Erro, Alejandro Berna/0000-0003-1459-6418; Salido, Gines M/0000-0002-8687-2445; Lopez, Jose J/0000-0002-5234-1478; Jardin, Isaac/0000-0003-4575-8264; Rosado, Juan A/0000-0002-9749-2325	Ministerio de Ciencia e Innovacion [BFU2010-21043-C02-01, BES-2008-002875]; Ministerio de Asuntos Exteriores y de Cooperacion Proyecto Conjunto de Investigacion [A/023417/09]; Junta de Extremadura-Fondo Europeo de Desarrollo Regional [GR10010]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Asuntos Exteriores y de Cooperacion Proyecto Conjunto de Investigacion; Junta de Extremadura-Fondo Europeo de Desarrollo Regional	This work was supported by Ministerio de Ciencia e Innovacion Grant BFU2010-21043-C02-01, Ministerio de Asuntos Exteriores y de Cooperacion Proyecto Conjunto de Investigacion Grant A/023417/09, and Junta de Extremadura-Fondo Europeo de Desarrollo Regional Grant GR10010.; Supported by Ministerio de Ciencia e Innovacion Fellowship BES-2008-002875.	ADUNYAH SE, 1986, J BIOL CHEM, V261, P3122; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; BOBE R, 1994, J BIOL CHEM, V269, P1417; Bode HP, 1996, PFLUG ARCH EUR J PHY, V432, P97, DOI 10.1007/s004240050110; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Camello C, 2000, CURR BIOL, V10, P161, DOI 10.1016/S0960-9822(00)00313-4; Camello-Almaraz C, 2000, BIOCHEM BIOPH RES CO, V271, P311, DOI 10.1006/bbrc.2000.2633; Cancela JM, 2003, PFLUG ARCH EUR J PHY, V446, P322, DOI 10.1007/s00424-003-1035-x; Cancela JM, 2001, ANNU REV PHYSIOL, V63, P99, DOI 10.1146/annurev.physiol.63.1.99; CAVALLINI L, 1995, BIOCHEM J, V310, P449, DOI 10.1042/bj3100449; CHAKRABARTI R, 1989, J BIOL CHEM, V264, P15494; Christensen KA, 2002, J CELL SCI, V115, P599; DHAR A, 1994, J BIOL CHEM, V269, P9123; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; GEAR ARL, 1994, CAN J PHYSIOL PHARM, V72, P285, DOI 10.1139/y94-044; Gerasimenko O, 2010, METHODS MOL BIOL, V591, P201, DOI 10.1007/978-1-60761-404-3_12; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Jardin I, 2008, J BIOL CHEM, V283, P25296, DOI 10.1074/jbc.M802904200; Jardin I, 2008, CELL SIGNAL, V20, P737, DOI 10.1016/j.cellsig.2007.12.010; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Jardin I, 2009, BBA-MOL CELL RES, V1793, P1614, DOI 10.1016/j.bbamcr.2009.07.003; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Kovacs T, 1997, BRIT J HAEMATOL, V97, P192, DOI 10.1046/j.1365-2141.1997.9982639.x; KRIEGERBRAUER HI, 1983, J NEUROCHEM, V41, P1269, DOI 10.1111/j.1471-4159.1983.tb00821.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168; Lopez JJ, 2006, J BIOL CHEM, V281, P28254, DOI 10.1074/jbc.M604272200; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; McGuinness L, 2007, NEUROPHARMACOLOGY, V52, P126, DOI 10.1016/j.neuropharm.2006.07.029; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; NIESSEN J, 2010, CURR PROTOC CELL BIO, V46; Nissen J, 2007, J IMMUNOL METHODS, V328, P89, DOI 10.1016/j.jim.2007.08.010; PAPP B, 1992, BIOCHEM J, V288, P297, DOI 10.1042/bj2880297; PAPP B, 1991, J BIOL CHEM, V266, P14593; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Redondo PC, 2008, BBA-MOL CELL RES, V1783, P1163, DOI 10.1016/j.bbamcr.2007.12.008; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Rosado JA, 2004, J BIOL CHEM, V279, P29231, DOI 10.1074/jbc.M403509200; Rosado JA, 2002, J BIOL CHEM, V277, P42157, DOI 10.1074/jbc.M207320200; Rosado JA, 2010, ARTERIOSCL THROM VAS, V30, P419, DOI 10.1161/ATVBAHA.109.194530; Salido GM, 2009, CELL SIGNAL, V21, P457, DOI 10.1016/j.cellsig.2008.11.005; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; Schindl R, 2009, CELL CALCIUM, V46, P227, DOI 10.1016/j.ceca.2009.08.003; Sehgal S, 2007, J THROMB HAEMOST, V5, P2009, DOI 10.1111/j.1538-7836.2007.02698.x; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; WUYTACK F, 1994, J BIOL CHEM, V269, P1410; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhu Michael X., 2010, Communicative & Integrative Biology, V3, P12	64	60	60	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.190694	http://dx.doi.org/10.1074/jbc.M110.190694			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321120	Green Published, hybrid			2022-12-25	WOS:000289077500040
J	Yang, HC; Gu, JX; Zheng, QP; Li, M; Lian, XN; Miao, JC; Jiang, JT; Wei, WX				Yang, Huicui; Gu, Junxia; Zheng, Qiping; Li, Min; Lian, Xiaoning; Miao, Jingcheng; Jiang, Jingting; Wei, Wenxiang			RPB5-mediating Protein Is Required for the Proliferation of Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; VIRUS X-PROTEIN; CYCLIN B1; TRANSCRIPTION; SUBUNIT; RPB5; TRANSACTIVATION; ORGANIZATION; CHECKPOINT; EXPRESSION	RPB5-mediating protein (RMP) is associated with the RNA polymerase II subunit RPB5. RMP functionally counteracts the transcriptional activation of hepatitis B virus X protein that has been shown to play a role in the development of hepatocellular carcinoma (HCC). However, the effect of RMP on the growth of HCC remains unclear. In this study, we characterized the potential role of RMP in the proliferation of human HCC cells using two cell lines, SMMC-7721 and HepG2. We found that RMP expression increased when HCC cells were treated with Co-60 gamma-irradiation. Cell growth and colony formation assays suggest that RMP plays an antiapoptotic role in the proliferation and growth of HCC cells. We also show that RMP depletion induced the G(2) arrest of HCC cells characterized by the decreased expression of Cdk1 and Cyclin B. Tumor formation assays further confirmed the in vivo requirement of RMP during HCC growth. In conclusion, our results demonstrate that RMP is a radiation-sensitive factor, and it may play essential roles in HCC growth by affecting the proliferation and apoptosis of HCC cells.	[Jiang, Jingting] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biotherapy, Changzhou 213003, Peoples R China; [Yang, Huicui; Li, Min; Lian, Xiaoning; Miao, Jingcheng; Wei, Wenxiang] Soochow Univ, Sch Med, Dept Cell Biol, Suzhou 215123, Peoples R China; [Gu, Junxia] Jiangsu Univ, Sch Med Sci & Lab Med, Dept Hematol & Hematol Lab Sci, Zhenjiang 212013, Peoples R China; [Zheng, Qiping] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA	Soochow University - China; Soochow University - China; Jiangsu University; Rush University	Jiang, JT (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Tumor Biotherapy, Changzhou 213003, Peoples R China.	jjtnew@163.com; wenxiangw@suda.edu.cn			Natural Science Foundation of Jiangsu Province [BK2005028, BK2009121]; Suzhou Foundation for Science and Technology [SYS201008]; National 973 Programs of China [2007CB947002, 2010CB945600]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Suzhou Foundation for Science and Technology; National 973 Programs of China(National Basic Research Program of China)	This work was supported in part by Natural Science Foundation of Jiangsu Province Grants BK2005028 and BK2009121, Suzhou Foundation for Science and Technology Grant SYS201008, and National 973 Programs of China Grants 2007CB947002 and 2010CB945600.	CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Dong YY, 2002, CANCER LETT, V177, P13, DOI 10.1016/S0304-3835(01)00770-4; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Golfier S, 2009, RADIAT PROT DOSIM, V134, P55, DOI 10.1093/rpd/ncp061; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Gu JX, 2009, ACTA BIOCH BIOPH SIN, V41, P831, DOI 10.1093/abbs/gmp072; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Li JQ, 2003, INT J ONCOL, V22, P1101; Li XH, 2008, CARCINOGENESIS, V29, P1587, DOI 10.1093/carcin/bgn052; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Sakurai H, 2001, GENES CELLS, V6, P25, DOI 10.1046/j.1365-2443.2001.00394.x; Seo HR, 2006, CELL DEATH DIFFER, V13, P1475, DOI 10.1038/sj.cdd.4401822; SIMS RJ, 2004, GENE DEV, V18, P2437, DOI DOI 10.1101/GAD.1235904; Stark George R, 2004, Methods Mol Biol, V280, P51; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Takeno S, 2002, CANCER, V94, P2874, DOI 10.1002/cncr.10542; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; Todone F, 2000, P NATL ACAD SCI USA, V97, P6306, DOI 10.1073/pnas.97.12.6306; Turner J, 2005, BLOOD, V106, P3191, DOI 10.1182/blood-2005-03-1263; Van Leuven F, 1998, GENOMICS, V54, P511, DOI 10.1006/geno.1998.5609; Venters BJ, 2009, CRIT REV BIOCHEM MOL, V44, P117, DOI 10.1080/10409230902858785; Wei WX, 2003, CELL RES, V13, P111, DOI 10.1038/sj.cr.7290155; Wei WX, 2001, J BIOL CHEM, V276, P12266, DOI 10.1074/jbc.M009634200; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zaros C, 2007, NUCLEIC ACIDS RES, V35, P634, DOI 10.1093/nar/gkl686	29	29	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11865	11874		10.1074/jbc.M110.136929	http://dx.doi.org/10.1074/jbc.M110.136929			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310960	hybrid, Green Published			2022-12-25	WOS:000288797100093
J	Kwee, RM; Hofman, PAM; Gronenschild, EHBM; van Oostenbrugge, RJ; Mess, WH; ter Berg, JWM; Franke, CL; Korten, AGGC; Meems, BJ; van Engelshoven, JMA; Wildberger, JE; Kooi, ME				Kwee, Robert M.; Hofman, Paul A. M.; Gronenschild, Ed H. B. M.; van Oostenbrugge, Robert J.; Mess, Werner H.; ter Berg, Johannes W. M.; Franke, Cees L.; Korten, Arthur G. G. C.; Meems, Be J.; van Engelshoven, Jos M. A.; Wildberger, Joachim E.; Kooi, M. Eline			Association between Carotid Plaque Characteristics and Cerebral White Matter Lesions: One-Year Follow-Up Study by MRI	PLOS ONE			English	Article							ELDERLY-PEOPLE; HYPERINTENSITIES; POPULATION; STROKE; RISK; ATHEROSCLEROSIS; ENDARTERECTOMY; LEUKOARAIOSIS; PROGRESSION; INFARCTS	Objective: To prospectively assess the relation between carotid plaque characteristics and the development of new cerebral white matter lesions (WMLs) at MRI. Methods: Fifty TIA/stroke patients with ipsilateral 30-69% carotid stenosis underwent MRI of the plaque at baseline. Total plaque volume and markers of vulnerability to thromboembolism (lipid-rich necrotic core [LRNC] volume, fibrous cap [FC] status, and presence of intraplaque hemorrhage [IPH]) were assessed. All patients also underwent brain MRI at baseline and after one year. Ipsilateral cerebral WMLs were quantified with a semiautomatic method. Results: Mean WML volume significantly increased over a one-year period (6.52 vs. 6.97 mm(3), P = 0.005). WML volume at baseline and WML progression did not significantly differ (P>0.05) between patients with 30-49% and patients with 50-69% stenosis. There was a significant correlation between total plaque volume and baseline ipsilateral WML volume (Spearman rho = 0.393, P = 0.005). There was no significant correlation between total plaque volume and ipsilateral WML progression. There were no significant associations between LRNC volume and WML volume at baseline and WML progression. WML volume at baseline and WML progression did not significantly differ between patients with a thick and intact FC and patients with a thin and/or ruptured FC. WML volume at baseline and WML progression also did not significantly differ between patients with and without IPH. Conclusion: The results of this study indicate that carotid plaque burden is significantly associated with WML severity, but that there is no causal relationship between carotid plaque vulnerability and the occurrence of WMLs.	[Kwee, Robert M.; Hofman, Paul A. M.; van Engelshoven, Jos M. A.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands; [Kwee, Robert M.; van Oostenbrugge, Robert J.; Mess, Werner H.; van Engelshoven, Jos M. A.; Wildberger, Joachim E.; Kooi, M. Eline] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Gronenschild, Ed H. B. M.] Maastricht Univ Med Ctr, Dept Psychiat, Maastricht, Netherlands; [Gronenschild, Ed H. B. M.] Maastricht Univ Med Ctr, Dept Neuropsychol, Maastricht, Netherlands; [van Oostenbrugge, Robert J.] Maastricht Univ Med Ctr, Dept Neurol, Maastricht, Netherlands; [Mess, Werner H.] Maastricht Univ Med Ctr, Dept Clin Neurophysiol, Maastricht, Netherlands; [ter Berg, Johannes W. M.] Orbis Med Ctr, Dept Neurol, Sittard, Netherlands; [Franke, Cees L.] Atrium Med Ctr, Dept Neurol, Heerlen, Netherlands; [Korten, Arthur G. G. C.] Laurentius Hosp, Dept Neurol, Roermond, Netherlands; [Meems, Be J.] Vie Curi Med Ctr, Dept Neurol, Venlo, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Orbis Medical Center; Atrium Medical Center; VieCuri Medical Center	Kwee, RM (corresponding author), Maastricht Univ Med Ctr, Dept Radiol, Maastricht, Netherlands.	eline.kooi@mumc.nl	Mess, Werner/AAB-9527-2020; Kooi, M. Eline/D-3848-2016	Kooi, M. Eline/0000-0001-7562-5724; Wildberger, Joachim/0000-0002-4810-6854	Dutch Heart Foundation [2006B061]	Dutch Heart Foundation(Netherlands Heart Foundation)	This study was supported by Dutch Heart Foundation grant 2006B061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaf N, 2008, RADIOLOGY, V248, P202, DOI 10.1148/radiol.2481070300; [Anonymous], DEF DIAGN DIAB MELL; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Groot JC, 2001, NEUROLOGY, V56, P1539, DOI 10.1212/WNL.56.11.1539; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; de Leeuw FE, 2000, J NEUROL, V247, P291, DOI 10.1007/s004150050586; Fujita S, 2005, INT PSYCHOGERIATR, V17, P689, DOI 10.1017/S104161020500164X; Gouw AA, 2008, STROKE, V39, P1414, DOI 10.1161/STROKEAHA.107.498535; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Henskens LH, 2009, J HYPERTENS, V27, P1446, DOI 10.1097/HJH.0b013e32832b5204; Inzitari Domenico, 2009, BMJ, V339, pb2477, DOI 10.1136/bmj.b2477; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Kwee RM, 2010, STROKE, V41, P1389, DOI 10.1161/STROKEAHA.109.575670; Kwee RM, 2009, STROKE, V40, P3718, DOI 10.1161/STROKEAHA.109.564088; Kwee RM, 2009, STROKE, V40, P3017, DOI 10.1161/STROKEAHA.109.555052; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Moustafa RR, 2010, STROKE, V41, P1410, DOI 10.1161/STROKEAHA.110.580415; Ouhlous M, 2005, AM J NEURORADIOL, V26, P1044; Pantoni L, 2002, CEREBROVASC DIS, V13, P7, DOI 10.1159/000049143; Patterson AJ, 2009, EUR J VASC ENDOVASC, V38, P149, DOI 10.1016/j.ejvs.2009.04.005; Pico F, 2002, CEREBROVASC DIS, V14, P109, DOI 10.1159/000064741; Prins ND, 2004, ARCH NEUROL-CHICAGO, V61, P1531, DOI 10.1001/archneur.61.10.1531; Rothwell PM, 2003, LANCET, V361, P107, DOI 10.1016/S0140-6736(03)12228-3; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Vermeer SE, 2003, STROKE, V34, P1126, DOI 10.1161/01.STR.0000068408.82115.D2	28	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17070	10.1371/journal.pone.0017070	http://dx.doi.org/10.1371/journal.pone.0017070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347225	Green Submitted, Green Published, gold			2022-12-25	WOS:000287369200017
J	Young, RP; Hopkins, RJ; Whittington, CF; Hay, BA; Epton, MJ; Gamble, GD				Young, Robert P.; Hopkins, Raewyn J.; Whittington, Chris F.; Hay, Bryan A.; Epton, Michael J.; Gamble, Gregory D.			Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENOME-WIDE ASSOCIATION; C-REACTIVE PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; NUTRITION EXAMINATION SURVEY; GLYCATION END-PRODUCTS; FLOATING ABSOLUTE RISK; AIR-FLOW OBSTRUCTION; GENETIC SUSCEPTIBILITY; NICOTINE DEPENDENCE	Epidemiological studies show that approximately 20-30% of chronic smokers develop chronic obstructive pulmonary disease (COPD) while 10-15% develop lung cancer. COPD pre-exists lung cancer in 50-90% of cases and has a heritability of 40-77%, much greater than for lung cancer with heritability of 15-25%. These data suggest that smokers susceptible to COPD may also be susceptible to lung cancer. This study examines the association of several overlapping chromosomal loci, recently implicated by GWA studies in COPD, lung function and lung cancer, in (n = 1400) subjects sub-phenotyped for the presence of COPD and matched for smoking exposure. Using this approach we show; the 15q25 locus confers susceptibility to lung cancer and COPD, the 4q31 and 4q22 loci both confer a reduced risk to both COPD and lung cancer, the 6p21 locus confers susceptibility to lung cancer in smokers with pre-existing COPD, the 5p15 and 1q23 loci both confer susceptibility to lung cancer in those with no pre-existing COPD. We also show the 5q33 locus, previously associated with reduced FEV1, appears to confer susceptibility to both COPD and lung cancer. The 6p21 locus previously linked to reduced FEV1 is associated with COPD only. Larger studies will be needed to distinguish whether these COPD-related effects may reflect, in part, associations specific to different lung cancer histology. We demonstrate that when the "risk genotypes" derived from the univariate analysis are incorporated into an algorithm with clinical variables, independently associated with lung cancer in multivariate analysis, modest discrimination is possible on receiver operator curve analysis (AUC = 0.70). We suggest that genetic susceptibility to lung cancer includes genes conferring susceptibility to COPD and that sub-phenotyping with spirometry is critical to identifying genes underlying the development of lung cancer.	[Young, Robert P.; Hopkins, Raewyn J.; Whittington, Chris F.; Hay, Bryan A.; Gamble, Gregory D.] Auckland Hosp, Dept Med, Auckland, New Zealand; [Epton, Michael J.] Univ Otago, Dept Med, Christchurch, New Zealand; [Young, Robert P.] Synergenz Biosci Ltd, Auckland, New Zealand	Auckland City Hospital; University of Otago	Young, RP (corresponding author), Auckland Hosp, Dept Med, Auckland, New Zealand.	roberty@adhb.govt.nz		Gamble, Greg/0000-0003-0412-3203; Hopkins, Raewyn/0000-0003-2168-6235; Epton, Michael/0000-0003-4644-366X	HRC grant; Synergenz BioScience Ltd.	HRC grant; Synergenz BioScience Ltd.	This project was jointly funded by an HRC grant and Synergenz BioScience Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Brown V, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-24; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Dasari V, 2006, AM J RESP CELL MOL, V35, P3, DOI 10.1165/rcmb.2006-0051SF; de Torres JP, 2007, CHEST, V132, P1932, DOI 10.1378/chest.07-1490; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dijkstra A, 2009, VIRCHOWS ARCH, V454, P441, DOI 10.1007/s00428-009-0748-4; DOCKERY DW, 1988, AM REV RESPIR DIS, V137, P286, DOI 10.1164/ajrccm/137.2.286; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gwilt CR, 2007, PHARMACOL THERAPEUT, V115, P208, DOI 10.1016/j.pharmthera.2007.05.007; Hancock DB, 2009, NAT GENET, V42, P45; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Jin GF, 2009, CARCINOGENESIS, V30, P987, DOI 10.1093/carcin/bgp090; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; Lee G, 2009, CURR OPIN PULM MED, V15, P303, DOI 10.1097/MCP.0b013e32832c975a; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Mannino DM, 2003, ARCH INTERN MED, V163, P1475, DOI 10.1001/archinte.163.12.1475; MATTSON ME, 1987, AM J PUBLIC HEALTH, V77, P425, DOI 10.2105/AJPH.77.4.425; Minetti M, 2008, ANTIOXID REDOX SIGN, V10, P829, DOI 10.1089/ars.2007.1864; Molfino NA, 2004, CHEST, V125, P1929, DOI 10.1378/chest.125.5.1929; Mortensen EM, 2010, AM J MED, V123, P66, DOI 10.1016/j.amjmed.2009.08.009; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Petty TL, 2005, CHEST, V128, P1895, DOI 10.1378/chest.128.4.1895; Piitulainen E, 1999, EUR RESPIR J, V13, P247, DOI 10.1183/09031936.99.13224799; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Pritchard JK, 2000, GENETICS, V155, P945; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Qi B, 2009, CURR PHARM DESIGN, V15, P2336, DOI 10.2174/138161209788682352; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; REDLINE S, 1989, AM J EPIDEMIOL, V129, P827, DOI 10.1093/oxfordjournals.aje.a115197; Repapi E, 2009, NAT GENET, V42, P36; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Schwartz AG, 2006, AM J RESP CRIT CARE, V173, P16, DOI 10.1164/rccm.200502-235PP; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Sohal SS, 2009, SMOKING HAS POTENTIA; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; Stav D, 2007, ISR MED ASSOC J, V9, P800; Thakkinstian A, 2009, J APPL STAT, V36, P633, DOI 10.1080/02664760802484990; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; TOCKMAN MS, 1987, ANN INTERN MED, V106, P512, DOI 10.7326/0003-4819-106-4-512; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Wilson DO, 2008, AM J RESP CRIT CARE, V178, P738, DOI 10.1164/rccm.200803-435OC; Wright CF, 2010, HUM GENET, V127, P125, DOI 10.1007/s00439-009-0767-x; Xu HY, 2005, HUM GENET, V116, P121, DOI 10.1007/s00439-004-1212-9; Yang P, 2005, CHEST, V128, P452, DOI 10.1378/chest.128.1.452; Yang P, 2010, CANCER EPIDEM BIOMAR, V19, P240, DOI 10.1158/1055-9965.EPI-09-0710; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Young RP, 2010, EUR RESPIR J, V36, P1375, DOI 10.1183/09031936.00033310; Young RP, 2009, EUR RESPIR REV, V18, P222, DOI 10.1183/09059180.00005309; Young RP, 2009, POSTGRAD MED J, V85, P515, DOI 10.1136/pgmj.2008.077107; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Young RP, 2011, APPL CLIN GENET, V4, P1, DOI 10.2147/TACG.S15758; Young RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005302; Young RP, 2008, EUR RESPIR J, V32, P1; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	84	82	84	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16476	10.1371/journal.pone.0016476	http://dx.doi.org/10.1371/journal.pone.0016476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304900	gold, Green Submitted, Green Published			2022-12-25	WOS:000287036600008
J	Biedasek, K; Andres, J; Mai, K; Adams, S; Spuler, S; Fielitz, J; Spranger, J				Biedasek, Katrin; Andres, Janin; Mai, Knut; Adams, Stephanie; Spuler, Simone; Fielitz, Jens; Spranger, Joachim			Skeletal Muscle 11beta-HSD1 Controls Glucocorticoid-Induced Proteolysis and Expression of E3 Ubiquitin Ligases Atrogin-1 and MuRF-1	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; FOXO TRANSCRIPTION FACTORS; C2C12 MYOTUBES; ADIPOSE-TISSUE; PROTEIN BREAKDOWN; ATROPHY; OBESITY; RESPONSES; PATHWAY; L6	Recent studies demonstrated expression and activity of the intracellular cortisone-cortisol shuttle 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) in skeletal muscle and inhibition of 11beta-HSD1 in muscle cells improved insulin sensitivity. Glucocorticoids induce muscle atrophy via increased expression of the E3 ubiquitin ligases Atrogin-1 (Muscle Atrophy F-box (MAFbx)) and MuRF-1 (Muscle RING-Finger-1). We hypothesized that 11beta-HSD1 controls glucocorticoid-induced expression of atrophy E3 ubiquitin ligases in skeletal muscle. Primary human myoblasts were generated from healthy volunteers. 11beta-HSD1-dependent protein degradation was analyzed by [H-3]-tyrosine release assay. RT-PCR was used to determine mRNA expression of E3 ubiquitin ligases and 11beta-HSD1 activity was measured by conversion of radioactively labeled [H-3]-cortisone to [H-3]-cortisol separated by thin-layer chromatography. We here demonstrate that 11beta-HSD1 is expressed and biologically active in interconverting cortisone to active cortisol in murine skeletal muscle cells (C2C12) as well as in primary human myotubes. 11beta-HSD1 expression increased during differentiation from myoblasts to mature myotubes (p<0.01), suggesting a role of 11beta-HSD1 in skeletal muscle growth and differentiation. Treatment with cortisone increased protein degradation by about 20% (p<0.001), which was paralleled by an elevation of Atrogin-1 and MuRF-1 mRNA expression (p<0.01, respectively). Notably, pre-treatment with the 11beta-HSD1 inhibitor carbenoxolone (Cbx) completely abolished the effect of cortisone on protein degradation as well as on Atrogin-1 and MuRF-1 expression. In summary, our data suggest that 11beta-HSD1 controls glucocorticoid-induced protein degradation in human and murine skeletal muscle via regulation of the E3 ubiquitin ligases Atrogin-1 and MuRF-1.	[Biedasek, Katrin; Andres, Janin; Mai, Knut; Spranger, Joachim] Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany; [Adams, Stephanie; Spuler, Simone] Charite, Muscle Res Unit, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Fielitz, Jens] Charite, Dept Cardiol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Biedasek, K (corresponding author), Charite, Dept Endocrinol Diabet & Nutr, D-13353 Berlin, Germany.	joachim.spranger@charite.de	Mai, Knut/W-9904-2019; Fielitz, Jens/AAF-4178-2020	Mai, Knut/0000-0003-0126-3155; Fielitz, Jens/0000-0001-8522-1045; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Spuler, Simone/0000-0002-0155-1117	German Research Foundation (DFG) [DFG GK 1208, GK 1631, KFO218/1, FI 965/2-1]; research group (Molecular Nutrition) of the Bundesministerium fur Bildung und Forschung (BMBF); Deutsche Forschungsgemeinschaft [DFG SP716/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); research group (Molecular Nutrition) of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG GK 1208, GK 1631, KFO218/1 and FI 965/2-1). JS was supported by a research group (Molecular Nutrition) of the Bundesministerium fur Bildung und Forschung (BMBF) and a Heisenberg-Professorship of the Deutsche Forschungsgemeinschaft (DFG SP716/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2005, EUR J CLIN INVEST, V35, P627, DOI 10.1111/j.1365-2362.2005.01552.x; Aubry EM, 2009, ENDOCRINOLOGY, V150, P2700, DOI 10.1210/en.2008-1618; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CHO YS, 2009, ANAL BIOCH; Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Jang C, 2007, J CLIN ENDOCR METAB, V92, P3314, DOI 10.1210/jc.2006-2729; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lindsay RS, 2003, J CLIN ENDOCR METAB, V88, P2738, DOI 10.1210/jc.2002-030017; Lofberg E, 2002, EUR J CLIN INVEST, V32, P345, DOI 10.1046/j.1365-2362.2002.00993.x; Mai K, 2007, CLIN ENDOCRINOL, V67, P419, DOI 10.1111/j.1365-2265.2007.02903.x; Mariniello B, 2006, EUR J ENDOCRINOL, V155, P435, DOI 10.1530/eje.1.02228; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sultan KR, 2006, AM J PHYSIOL-CELL PH, V290, pC650, DOI 10.1152/ajpcell.00163.2005; TOMAS FM, 1979, BIOCHEM J, V178, P139, DOI 10.1042/bj1780139; Zhang M, 2009, MOL CELL BIOCHEM, V324, P147, DOI 10.1007/s11010-008-9993-0	23	28	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16674	10.1371/journal.pone.0016674	http://dx.doi.org/10.1371/journal.pone.0016674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304964	Green Accepted, gold, Green Published			2022-12-25	WOS:000286834300118
J	Chakraborty, C; Roy, SS; Hsu, MJ; Agoramoorthy, G				Chakraborty, Chiranjib; Roy, Sanjiban S.; Hsu, Minna J.; Agoramoorthy, Govindasamy			Landscape Mapping of Functional Proteins in Insulin Signal Transduction and Insulin Resistance: A Network-Based Protein-Protein Interaction Analysis	PLOS ONE			English	Article							DATABASE; 3-KINASE; MATRIX	The type 2 diabetes has increased rapidly in recent years throughout the world. The insulin signal transduction mechanism gets disrupted sometimes and it's known as insulin-resistance. It is one of the primary causes associated with type-2 diabetes. The signaling mechanisms involved several proteins that include 7 major functional proteins such as INS, INSR, IRS1, IRS2, PIK3CA, Akt2, and GLUT4. Using these 7 principal proteins, multiple sequences alignment has been created. The scores between sequences also have been developed. We have constructed a phylogenetic tree and modified it with node and distance. Besides, we have generated sequence logos and ultimately developed the protein-protein interaction network. The small insulin signal transduction protein arrangement shows complex network between the functional proteins.	[Hsu, Minna J.] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan; [Chakraborty, Chiranjib] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India; [Roy, Sanjiban S.] VIT Univ, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India; [Agoramoorthy, Govindasamy] Tajen Univ, Coll Environm & Hlth Sci, Yanpu, Taiwan	National Sun Yat Sen University; Vellore Institute of Technology; Vellore Institute of Technology	Hsu, MJ (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan.	hsumin@mail.nsysu.edu.tw; agoram@mail.tajen.edu.tw	Roy, Sanjiban Sekhar/T-4266-2019; Chakraborty, Chiranjib/J-4847-2013	Roy, Sanjiban Sekhar/0000-0003-2003-7882; Chakraborty, Chiranjib/0000-0002-3958-239X; Hsu, Minna J/0000-0001-7681-3532; Agoramoorthy, Govindasamy/0000-0002-8936-6978				Chakraborty C, 2006, CURR PROTEIN PEPT SC, V7, P113, DOI 10.2174/138920306776359759; Cho I, 2007, ACTA APPL MATH, V95, P95, DOI 10.1007/s10440-006-9081-y; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Del Aguila LF, 2000, AM J PHYSIOL-ENDOC M, V279, pE206, DOI 10.1152/ajpendo.2000.279.1.E206; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; Ginter E, 2010, BRATISL MED J, V111, P134; Hu ZJ, 2005, NUCLEIC ACIDS RES, V33, pW352, DOI 10.1093/nar/gki431; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufman FR, 2002, J PEDIATR ENDOCR MET, V15, P737; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Liu Y, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-158; NEOGI S, 2007, HINDUSTAN TIMES 0903; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taylor Simeon I., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P419; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303	23	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16388	10.1371/journal.pone.0016388	http://dx.doi.org/10.1371/journal.pone.0016388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305025	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300059
J	Guerra, F; Mancinelli, L; Angelini, L; Fortunati, M; Rappelli, A; Dessi-Fulgheri, P; Sarzani, R				Guerra, Federico; Mancinelli, Lucia; Angelini, Luca; Fortunati, Marco; Rappelli, Alessandro; Dessi-Fulgheri, Paolo; Sarzani, Riccardo			The Association of Left Ventricular Hypertrophy with Metabolic Syndrome is Dependent on Body Mass Index in Hypertensive Overweight or Obese Patients	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; GENDER-DIFFERENCES; RISK-FACTOR; MORTALITY; GEOMETRY; IMPACT; ADULTS; POPULATION; PREVALENCE; NUTRITION	Background: Overweight (Ow) and obesity (Ob) influence blood pressure (BP) and left ventricular hypertrophy (LVH). It is unclear whether the presence of metabolic syndrome (MetS) independently affects echocardiographic parameters in hypertension. Methods: 380 Ow/Ob essential hypertensive patients (age <= 65 years) presenting for referred BP control-related problems. MetS was defined according to NCEP III/ATP with AHA modifications and LVH as LVM/h(2.7) >= 49.2 g/m(2.7) in males and >= 46.7 g/m(2.7) in females. Treatment intensity score (TIS) was used to control for BP treatment as previously reported. Results: Hypertensive patients with MetS had significantly higher BMI, systolic and mean BP, interventricular septum and relative wall thickness and lower ejection fraction than those without MetS. LVM/h(2.7) was significantly higher in MetS patients (59.14 +/- 14.97 vs. 55.33 +/- 14.69 g/m(2.7); p = 0.022). Hypertensive patients with MetS had a 2.3-fold higher risk to have LVH/h(2.7) after adjustment for age, SBP and TIS (OR 2.34; 95% CI 1.40-3.92; p = 0.001), but MetS lost its independent relationship with LVH when BMI was included in the model. Conclusions: In Ow/Ob hypertensive patients MetS maintains its role of risk factor for LVH independently of age, SBP, and TIS, resulting in a useful predictor of target organ damage in clinical practice. However, MetS loses its independent relationship when BMI is taken into account, suggesting that the effects on MetS on LV parameters are mainly driven by the degree of adiposity.	[Guerra, Federico; Mancinelli, Lucia; Angelini, Luca; Fortunati, Marco; Rappelli, Alessandro; Dessi-Fulgheri, Paolo; Sarzani, Riccardo] Univ Politecn Marche, Univ Hosp Osped Riuniti, Dept Internal Med & Cardiovasc Dis, Hypertens Excellence Ctr,European Soc Hypertens, Ancona, Italy	Marche Polytechnic University	Guerra, F (corresponding author), Univ Politecn Marche, Univ Hosp Osped Riuniti, Dept Internal Med & Cardiovasc Dis, Hypertens Excellence Ctr,European Soc Hypertens, Ancona, Italy.	r.sarzani@univpm.it	Guerra, Federico/P-6635-2017; Sarzani, Riccardo/AAB-3110-2021; Mancinelli, Lucia LM/K-4136-2018	Guerra, Federico/0000-0001-5394-1312; Sarzani, Riccardo/0000-0002-5159-0181; Mancinelli, Lucia LM/0000-0003-3783-4482				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Bailey KR, 2008, HYPERTENSION, V51, P841, DOI 10.1161/HYPERTENSIONAHA.107.101659; Chumlea WC, 2009, J NUTR HEALTH AGING, V13, P821, DOI 10.1007/s12603-009-0219-2; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DEVEREUX RB, 1984, J AM COLL CARDIOL, V4, P1222, DOI 10.1016/S0735-1097(84)80141-2; Foppa Murilo, 2005, Cardiovasc Ultrasound, V3, P17, DOI 10.1186/1476-7120-3-17; Gerdts E, 2008, HYPERTENSION, V51, P1109, DOI 10.1161/HYPERTENSIONAHA.107.107474; Hallan S, 2004, AM J KIDNEY DIS, V44, P84, DOI 10.1053/j.ajkd.2004.03.027; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Krauser DG, 2006, HERZ, V31, P305, DOI 10.1007/s00059-006-2819-5; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; MacMahon S, 2008, LANCET, V371, P1480, DOI 10.1016/S0140-6736(08)60632-7; Mancia G, 2005, J HYPERTENS, V23, pS17; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; MULE G, 1987, INT J CARDIOL, V121, P267; Mule G, 2008, AM J HYPERTENS, V21, P1055, DOI 10.1038/ajh.2008.225; Papademetriou V, 2001, AM J HYPERTENS, V14, P768, DOI 10.1016/S0895-7061(01)01292-4; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Patel DA, 2009, AM J CARDIOL, V104, P69, DOI 10.1016/j.amjcard.2009.02.063; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Reaven GM, 2005, CLIN CHEM, V51, P931, DOI 10.1373/clinchem.2005.048611; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sarzani R, 2008, J HYPERTENS, V26, P831, DOI 10.1097/HJH.0b013e3282f624a0; SAVAGE DD, 1987, CIRCULATION, V75, P26; Schillaci G, 2006, HYPERTENSION, V47, P881, DOI 10.1161/01.HYP.0000216778.83626.39; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Schmieder RE, 2005, NEPHROL DIAL TRANSPL, V20, P2610, DOI 10.1093/ndt/gfi190; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tsioufis C, 2008, J HYPERTENS, V26, P773, DOI 10.1097/HJH.0b013e3282f430b0	37	37	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16630	10.1371/journal.pone.0016630	http://dx.doi.org/10.1371/journal.pone.0016630			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304952	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300102
J	Hunt, PW; Landay, AL; Sinclair, E; Martinson, JA; Hatano, H; Emu, B; Norris, PJ; Busch, MP; Martin, JN; Brooks, C; McCune, JM; Deeks, SG				Hunt, Peter W.; Landay, Alan L.; Sinclair, Elizabeth; Martinson, Jeffrey A.; Hatano, Hiroyu; Emu, Brinda; Norris, Philip J.; Busch, Michael P.; Martin, Jeffrey N.; Brooks, Cicely; McCune, Joseph M.; Deeks, Steven G.			A Low T Regulatory Cell Response May Contribute to Both Viral Control and Generalized Immune Activation in HIV Controllers	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-LEVEL VIREMIA; HLA-B-ASTERISK-57(+) ELITE SUPPRESSORS; BLOOD-BANK COHORT; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; LYMPHOCYTE ACTIVATION; INFECTED INDIVIDUALS; PERIPHERAL-BLOOD; TYPE-1 INFECTION	HIV-infected individuals maintaining undetectable viremia in the absence of therapy (HIV controllers) often maintain high HIV-specific T cell responses, which has spurred the development of vaccines eliciting HIV-specific T cell responses. However, controllers also often have abnormally high T cell activation levels, potentially contributing to T cell dysfunction, CD4+ T cell depletion, and non-AIDS morbidity. We hypothesized that a weak T regulatory cell (Treg) response might contribute to the control of viral replication in HIV controllers, but might also contribute to generalized immune activation, contributing to CD4+ T cell loss. To address these hypotheses, we measured frequencies of activated (CD38+ HLA-DR+), regulatory (CD4+CD25+CD127(dim)), HIV-specific, and CMV-specific T cells among HIV controllers and 3 control populations: HIV-infected individuals with treatment-mediated viral suppression (ART-suppressed), untreated HIV-infected "non-controllers'' with high levels of viremia, and HIV-uninfected individuals. Despite abnormally high T cell activation levels, controllers had lower Treg frequencies than HIV-uninfected controls (P = 0.014). Supporting the propensity for an unusually low Treg response to viral infection in HIV controllers, we observed unusually high CMV-specific CD4+ T cell frequencies and a strong correlation between HIV-specific CD4+ T cell responses and generalized CD8+ T cell activation levels in HIV controllers (P <= 0.001). These data support a model in which low frequencies of Tregs in HIV controllers may contribute to an effective adaptive immune response, but may also contribute to generalized immune activation, potentially contributing to CD4 depletion.	[Hunt, Peter W.; Sinclair, Elizabeth; Hatano, Hiroyu; Emu, Brinda; Norris, Philip J.; Busch, Michael P.; Martin, Jeffrey N.; McCune, Joseph M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Hunt, Peter W.; Sinclair, Elizabeth; Hatano, Hiroyu; Emu, Brinda; Norris, Philip J.; Busch, Michael P.; Martin, Jeffrey N.; McCune, Joseph M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Landay, Alan L.; Martinson, Jeffrey A.; Brooks, Cicely] Rush Univ, Med Ctr, Dept Microbiol Immunol, Chicago, IL 60612 USA; [Norris, Philip J.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rush University; Vitalant; Vitalant Research Institute	Hunt, PW (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	phunt@php.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870	UCSF/Gladstone Center for AIDS Research [P30 AI27763, P30 MH59037]; NIAID [AI065244, AI055273, AI44595, AI067854, AI076981, AI-76174]; Center for AIDS Prevention Studies [P30 MH62246]; UCSF Clinical and Translational Science Institute [UL1 RR024131-01]; CFAR Network of Integrated Clinical Sciences [5R24AI067039]; Ragon Institute of MGH; American Foundation for AIDS Research [106710-40-RGRL]; NIH Roadmap for Medical Research [DPI OD00329]; Ragon Institute of MIT; Ragon Institute of Harvard; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, R01AI044595, U19AI076981, U19AI067854, P01AI076174, P30AI027763, K23AI065244, R24AI067039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037, P30MH062246] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	UCSF/Gladstone Center for AIDS Research; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Prevention Studies; UCSF Clinical and Translational Science Institute; CFAR Network of Integrated Clinical Sciences; Ragon Institute of MGH; American Foundation for AIDS Research; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MIT; Ragon Institute of Harvard; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the UCSF/Gladstone Center for AIDS Research (P30 AI27763, P30 MH59037); NIAID (AI065244, AI055273, AI44595, AI067854, AI076981, and AI-76174); the Center for AIDS Prevention Studies (P30 MH62246); the UCSF Clinical and Translational Science Institute (UL1 RR024131-01); the CFAR Network of Integrated Clinical Sciences (5R24AI067039); the Ragon Institute of MGH, MIT, and Harvard; and American Foundation for AIDS Research (106710-40-RGRL). JMM is a recipient of a grant (DPI OD00329) from the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bailey JR, 2009, J VIROL, V83, P88, DOI 10.1128/JVI.01958-08; Begaud E, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-35; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Davidson R, 1993, ESTIMATION INFERENCE; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Giorgi JV, 2002, J ACQ IMMUN DEF SYND, V29, P346, DOI 10.1097/00126334-200204010-00004; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goudsmit J, 2002, AIDS, V16, P791, DOI 10.1097/00002030-200203290-00016; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; Harari A, 2004, BLOOD, V103, P966, DOI 10.1182/blood-2003-04-1203; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; HO HN, 1993, J IMMUNOL, V150, P3070; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hubert JB, 2000, AIDS, V14, P123, DOI 10.1097/00002030-200001280-00007; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; JAGANNATHAN P, 2009, J VIROL; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Jennes W, 2006, CLIN EXP IMMUNOL, V143, P435, DOI 10.1111/j.1365-2249.2006.03017.x; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Kannanganat S, 2007, J VIROL, V81, P12071, DOI 10.1128/JVI.01261-07; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2004, J VIROL, V78, P4463, DOI 10.1128/JVI.78.9.4463-4477.2004; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Loeuillet C, 2008, PLOS BIOL, V6, P319, DOI 10.1371/journal.pbio.0060032; Madec Y, 2005, AIDS, V19, P2001, DOI 10.1097/01.aids.0000194134.28135.cd; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MDEL MD, J INFECT DIS, V201, P331; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Morgan ME, 2005, HUM IMMUNOL, V66, P13, DOI 10.1016/j.humimm.2004.05.016; NAEGER DM, PLOS ONE, V5, pE8886; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Para MF, 2001, J ACQ IMMUN DEF SYND, V26, P320, DOI 10.1097/00126334-200104010-00004; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Roland ME, 2005, CLIN INFECT DIS, V41, P1507, DOI 10.1086/497268; Roncador G, 2005, EUR J IMMUNOL, V35, P1681, DOI 10.1002/eji.200526189; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Sajadi MM, 2010, AIDS, V24, P1689, DOI 10.1097/QAD.0b013e32833a2a32; Salkowitz JR, 2001, CLIN IMMUNOL, V98, P200, DOI 10.1006/clim.2000.4969; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; van Manen D, 2009, AIDS, V23, P19, DOI 10.1097/QAD.0b013e32831db247; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Zaunders JJ, 1999, J INFECT DIS, V180, P320, DOI 10.1086/314880; Zaunders JJ, 2004, BLOOD, V103, P2238, DOI 10.1182/blood-2003-08-2765	86	108	112	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15924	10.1371/journal.pone.0015924	http://dx.doi.org/10.1371/journal.pone.0015924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305005	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300029
J	Makarova, AV; Grabow, C; Gening, LV; Tarantul, VZ; Tahirov, TH; Bessho, T; Pavlov, YI				Makarova, Alena V.; Grabow, Corinn; Gening, Leonid V.; Tarantul, Vyacheslav Z.; Tahirov, Tahir H.; Bessho, Tadayoshi; Pavlov, Youri I.			Inaccurate DNA Synthesis in Cell Extracts of Yeast Producing Active Human DNA Polymerase Iota	PLOS ONE			English	Article							SEQUENTIAL ACTION; REPLICATION; FIDELITY; VARIANT; ETA; EXPRESSION; BYPASS; BASE; OVEREXPRESSION; INVOLVEMENT	Mammalian Pol i has an unusual combination of properties: it is stimulated by Mn2+ ions, can bypass some DNA lesions and misincorporates "G" opposite template "T" more frequently than incorporates the correct "A." We recently proposed a method of detection of Pol i activity in animal cell extracts, based on primer extension opposite the template T with a high concentration of only two nucleotides, dGTP and dATP (incorporation of "G" versus "A" method of Gening, abbreviated as "misGvA"). We provide unambiguous proof of the "misGvA" approach concept and extend the applicability of the method for the studies of variants of Pol i in the yeast model system with different cation cofactors. We produced human Pol i in baker's yeast, which do not have a POLI ortholog. The "misGvA" activity is absent in cell extracts containing an empty vector, or producing catalytically dead Pol i, or Pol i lacking exon 2, but is robust in the strain producing wild-type Pol i or its catalytic core, or protein with the active center L62I mutant. The signature pattern of primer extension products resulting from inaccurate DNA synthesis by extracts of cells producing either Pol i or human Pol g is different. The DNA sequence of the template is critical for the detection of the infidelity of DNA synthesis attributed to DNA Pol i. The primer/template and composition of the exogenous DNA precursor pool can be adapted to monitor replication fidelity in cell extracts expressing various error-prone Pols or mutator variants of accurate Pols. Finally, we demonstrate that the mutation rates in yeast strains producing human DNA Pols i and g are not elevated over the control strain, despite highly inaccurate DNA synthesis by their extracts.	[Makarova, Alena V.; Gening, Leonid V.; Tarantul, Vyacheslav Z.] Russian Acad Sci, Inst Mol Genet, Moscow, Russia; [Makarova, Alena V.; Grabow, Corinn; Tahirov, Tahir H.; Bessho, Tadayoshi; Pavlov, Youri I.] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE USA	Russian Academy of Sciences; University of Nebraska System; University of Nebraska Medical Center	Makarova, AV (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow, Russia.	ypavlov@unmc.edu	Makarova, Alena Vladimirovna/I-1338-2014; Pavlov, Youri/T-7532-2017	Tahirov, Tahir/0000-0002-1238-0069; Pavlov, Youri/0000-0003-1179-5796	Nebraska Department of Health and Human Services [2011-27]; National Cancer Institute [CA129925]; RFFI [10-04-01434-a]; National Institute of General Medical Sciences [R01GM082923]; NATIONAL CANCER INSTITUTE [R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923] Funding Source: NIH RePORTER	Nebraska Department of Health and Human Services; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RFFI(Russian Foundation for Basic Research (RFBR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work has been supported by Nebraska Department of Health and Human Services grant 2011-27 to YIP and, in part, by National Cancer Institute grant CA129925 to YIP; by RFFI grant 10-04-01434-a to LVG and LVZ; and by National Institute of General Medical Sciences grant R01GM082923 to THT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bebenek K, 2000, COLD SPRING HARB SYM, V65, P81, DOI 10.1101/sqb.2000.65.81; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Dumstorf CA, 2006, P NATL ACAD SCI USA, V103, P18083, DOI 10.1073/pnas.0605247103; Faili A, 2002, NATURE, V419, P944, DOI 10.1038/nature01117; Fortune JM, 2006, NUCLEIC ACIDS RES, V34, P4335, DOI 10.1093/nar/gkl403; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Gening LV, 2006, IMMUNOL LETT, V106, P198, DOI 10.1016/j.imlet.2006.05.002; Gening LV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P155, DOI 10.1134/S0006297906020064; Gening LV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P435, DOI 10.1023/B:BIRY.0000026201.71587.a2; Ho V, 2010, ENVIRON MOL MUTAGEN, V51, P552, DOI 10.1002/em.20573; Ito A, 2006, BIOCHEM BIOPH RES CO, V351, P306, DOI 10.1016/j.bbrc.2006.10.048; Jain R, 2009, STRUCTURE, V17, P974, DOI 10.1016/j.str.2009.04.011; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; [Казаков А.А. Kazakov A.A.], 2008, [Медицинская генетика, Meditsinskaya genetika], V7, P32; Kazakov AA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P905, DOI 10.1134/S0006297910070138; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Lee GH, 2005, CANCER SCI, V96, P256, DOI 10.1111/j.1349-7006.2005.00042.x; Makarova AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P346, DOI 10.1134/S0006297908030176; Makarova A V, 2008, Ontogenez, V39, P367; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; McDonald JP, 2001, PHILOS T R SOC B, V356, P53, DOI 10.1098/rstb.2000.0748; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohkumo T, 2006, MOL CELL BIOL, V26, P7696, DOI 10.1128/MCB.01076-06; Pavlov YI, 2002, MOL CELL, V10, P207, DOI 10.1016/S1097-2765(02)00567-1; Pavlov YI, 2001, MUTAT RES-FUND MOL M, V478, P129, DOI 10.1016/S0027-5107(01)00131-2; Pavlov YI, 2006, INT REV CYTOL, V255, P41, DOI 10.1016/S0074-7696(06)55002-8; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Poltoratsky V, 2000, J EXP MED, V192, pF27, DOI 10.1084/jem.192.10.F27; Prasad R, 2003, J BIOL CHEM, V278, P29649, DOI 10.1074/jbc.M305399200; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sakiyama T, 2005, INT J CANCER, V114, P730, DOI 10.1002/ijc.20790; Stallons LJ, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/643857; Tissier A, 2000, GENE DEV, V14, P1642; Vaisman A, 2006, DNA REPAIR, V5, P210, DOI 10.1016/j.dnarep.2005.09.011; Vidal AE, 2009, DNA REPAIR, V8, P420, DOI 10.1016/j.dnarep.2008.12.007; Wang HB, 2010, NEURO-ONCOLOGY, V12, P679, DOI 10.1093/neuonc/nop074; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Washington MT, 2004, MOL CELL BIOL, V24, P5687, DOI 10.1128/MCB.24.13.5687-5693.2004; Wolfle WT, 2006, MOL CELL BIOL, V26, P381, DOI 10.1128/MCB.26.1.381-386.2006; Yagi Y, 2005, DNA REPAIR, V4, P1252, DOI 10.1016/j.dnarep.2005.06.010; Yang J, 2004, CANCER RES, V64, P5597, DOI 10.1158/0008-5472.CAN-04-0603; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	52	22	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16612	10.1371/journal.pone.0016612	http://dx.doi.org/10.1371/journal.pone.0016612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304950	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300099
J	Pacifici, PG; Peter, C; Yampolsky, P; Koenen, M; McArdle, JJ; Witzemann, V				Pacifici, Pier Giorgio; Peter, Christoph; Yampolsky, Pessah; Koenen, Michael; McArdle, Joseph J.; Witzemann, Veit			Novel Mouse Model Reveals Distinct Activity-Dependent and -Independent Contributions to Synapse Development	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; CONGENITAL MYASTHENIC SYNDROME; MUSCLE ACETYLCHOLINE-RECEPTOR; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; SKELETAL-MUSCLE; EPSILON-SUBUNIT; DEFICIENT MICE; GAMMA-SUBUNIT; AGRIN	The balanced action of both pre- and postsynaptic organizers regulates the formation of neuromuscular junctions (NMJ). The precise mechanisms that control the regional specialization of acetylcholine receptor (AChR) aggregation, guide ingrowing axons and contribute to correct synaptic patterning are unknown. Synaptic activity is of central importance and to understand synaptogenesis, it is necessary to distinguish between activity-dependent and activity-independent processes. By engineering a mutated fetal AChR subunit, we used homologous recombination to develop a mouse line that expresses AChR with massively reduced open probability during embryonic development. Through histological and immunochemical methods as well as electrophysiological techniques, we observed that endplate anatomy and distribution are severely aberrant and innervation patterns are completely disrupted. Nonetheless, in the absence of activity AChRs form postsynaptic specializations attracting motor axons and permitting generation of multiple nerve/muscle contacts on individual fibers. This process is not restricted to a specialized central zone of the diaphragm and proceeds throughout embryonic development. Phenotypes can be attributed to separate activity-dependent and -independent pathways. The correct patterning of synaptic connections, prevention of multiple contacts and control of nerve growth require AChR-mediated activity. In contrast, myotube survival and acetylcholine-mediated dispersal of AChRs are maintained even in the absence of AChR-mediated activity. Because mouse models in which acetylcholine is entirely absent do not display similar effects, we conclude that acetylcholine binding to the AChR initiates activity-dependent and activity-independent pathways whereby the AChR modulates formation of the NMJ.	[Pacifici, Pier Giorgio; Peter, Christoph; Yampolsky, Pessah; Koenen, Michael; Witzemann, Veit] Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany; [McArdle, Joseph J.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Max Planck Society; Rutgers State University New Brunswick; Rutgers State University Medical Center	Pacifici, PG (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Heidelberg, Germany.	Veit.Witzemann@mpimf-heidelberg.mpg.de			Deutsche Forschungsgemeinschaft [SFB 488]; Ruprecht-Karls Universitat Heidelberg [Graduiertenkolleg 791/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls Universitat Heidelberg	This work was supported by Deutsche Forschungsgemeinschaft SFB 488 and by the Graduiertenkolleg 791/2 of the Ruprecht-Karls Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Christoph P, 2005, PFLUG ARCH EUR J PHY, V450, P178, DOI 10.1007/s00424-005-1387-5; de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, J NEUROCYTOL, V32, P1017, DOI 10.1023/B:NEUR.0000020639.22895.28; ENTWISTLE A, 1988, J CELL BIOL, V106, P1703, DOI 10.1083/jcb.106.5.1703; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Herlitze S, 1996, J PHYSIOL-LONDON, V492, P775, DOI 10.1113/jphysiol.1996.sp021345; Jing LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008843; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429; Krause RM, 1995, J PHYSIOL-LONDON, V489, P779, DOI 10.1113/jphysiol.1995.sp021091; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115; Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Liu Y, 2008, DEVELOPMENT, V135, P1957, DOI 10.1242/dev.018119; Lomo T, 2003, J NEUROCYTOL, V32, P835, DOI 10.1023/B:NEUR.0000020627.18156.b1; LOMO T, 1972, J PHYSIOL-LONDON, V221, P493, DOI 10.1113/jphysiol.1972.sp009764; McArdle JJ, 2005, NEUROPHARMACOLOGY, V49, P1132, DOI 10.1016/j.neuropharm.2005.06.011; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Mitra A, 2005, P NATL ACAD SCI USA, V102, P15069, DOI 10.1073/pnas.0505090102; Muller JS, 2006, BRAIN, V129, P2784, DOI 10.1093/brain/awl188; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Vock VM, 2008, J NEUROSCI, V28, P3123, DOI 10.1523/JNEUROSCI.5080-07.2008; Yampolsky P, 2008, MOL CELL NEUROSCI, V37, P634, DOI 10.1016/j.mcn.2007.12.014; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16469	10.1371/journal.pone.0016469	http://dx.doi.org/10.1371/journal.pone.0016469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305030	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300067
J	Voisin, SN; Krakovska, O; Matta, A; DeSouza, LV; Romaschin, AD; Colgan, TJ; Siu, KWM				Voisin, Sebastien N.; Krakovska, Olga; Matta, Ajay; DeSouza, Leroi V.; Romaschin, Alexander D.; Colgan, Terence J.; Siu, K. W. Michael			Identification of Novel Molecular Targets for Endometrial Cancer Using a Drill-Down LC-MS/MS Approach with iTRAQ	PLOS ONE			English	Article							MULTIDIMENSIONAL LIQUID-CHROMATOGRAPHY; PYRUVATE-KINASE M2; MASS-SPECTROMETRY; BIOMARKER DISCOVERY; OXIDATIVE STRESS; S100 PROTEINS; CATHEPSIN-B; PROTEOMICS; SURVIVAL; ROLES	Background: The number of patients with endometrial carcinoma (EmCa) with advanced stage or high histological grade is increasing and prognosis has not improved for over the last decade. There is an urgent need for the discovery of novel molecular targets for diagnosis, prognosis and treatment of EmCa, which will have the potential to improve the clinical strategy and outcome of this disease. Methodology and Results: We used a "drill-down'' proteomics approach to facilitate the identification of novel molecular targets for diagnosis, prognosis and/or therapeutic intervention for EmCa. Based on peptide ions identified and their retention times in the first LC-MS/MS analysis, an exclusion list was generated for subsequent iterations. A total of 1529 proteins have been identified below the Proteinpilot (R) 5% error threshold from the seven sets of iTRAQ experiments performed. On average, the second iteration added 78% new peptides to those identified after the first run, while the third iteration added 36% additional peptides. Of the 1529 proteins identified, only 40 satisfied our criteria for significant differential expression in EmCa in comparison to normal proliferative tissues. These proteins included metabolic enzymes (pyruvate kinase M2 and lactate dehydrogenase A); calcium binding proteins (S100A6, calcyphosine and calumenin), and proteins involved in regulating inflammation, proliferation and invasion (annexin A1, interleukin enhancer-binding factor 3, alpha-1-antitrypsin, macrophage capping protein and cathepsin B). Network analyses revealed regulation of these molecular targets by c-myc, Her2/neu and TNF alpha, suggesting intervention with these pathways may be a promising strategy for the development of novel molecular targeted therapies for EmCa. Conclusions: Our analyses revealed the significance of drill-down proteomics approach in combination with iTRAQ to overcome some of the limitations of current proteomics strategies. This study led to the identification of a number of novel molecular targets having therapeutic potential for targeted molecular therapies for endometrial carcinoma.	[Voisin, Sebastien N.; Krakovska, Olga; Matta, Ajay; DeSouza, Leroi V.; Siu, K. W. Michael] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Voisin, Sebastien N.; Krakovska, Olga; Matta, Ajay; DeSouza, Leroi V.] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Romaschin, Alexander D.] St Michaels Hosp, Div Clin Biochem, Toronto, ON M5B 1W8, Canada; [Romaschin, Alexander D.; Colgan, Terence J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Colgan, Terence J.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	York University - Canada; York University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Voisin, SN (corresponding author), York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada.	kwmsiu@yorku.ca	Colgan, Terence J/J-2339-2016; MATTA, AJAY/AFT-2977-2022; DeSouza, Leroi V/H-3831-2013	Voisin, Sebastien/0000-0001-5897-333X	Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada); MITACS, Ontario, Canada	Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada); MITACS, Ontario, Canada	The support of the Canadian Cancer Society Research Institute (formerly the National Cancer Institute of Canada) is gratefully acknowledged. AB SCIEX provided infrastructural and reagent support of this research; Ajay Matta is the recipient of a MITACS Accelerate Fellowship, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chen HS, 2005, ANAL CHEM, V77, P7816, DOI 10.1021/ac050956y; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Clarke BA, 2010, J CLIN PATHOL, V63, P410, DOI 10.1136/jcp.2009.071225; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; De Petris L, 2009, LUNG CANCER, V63, P410, DOI 10.1016/j.lungcan.2008.06.003; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; DeSouza LV, 2007, MOL CELL PROTEOMICS, V6, P1170, DOI 10.1074/mcp.M600378-MCP200; DeSouza LV, 2009, ANAL CHEM, V81, P3462, DOI 10.1021/ac802726a; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; Diamandis EP, 2004, MOL CELL PROTEOMICS, V3, P367, DOI 10.1074/mcp.R400007-MCP200; Dizon DS, 2010, GYNECOL ONCOL, V117, P373, DOI 10.1016/j.ygyno.2010.02.007; Dube V, 2007, J PROTEOME RES, V6, P2648, DOI 10.1021/pr070087o; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emberley ED, 2004, BIOCHEM CELL BIOL, V82, P508, DOI 10.1139/O04-052; Fais S, 2004, TRENDS MOL MED, V10, P249, DOI 10.1016/j.molmed.2004.04.005; Ferguson EC, 2008, TRENDS BIOCHEM SCI, V33, P359, DOI 10.1016/j.tibs.2008.05.006; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Guo WH, 2011, J CANCER RES CLIN, V137, P65, DOI 10.1007/s00432-010-0860-5; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hung KE, 2010, GASTROENTEROLOGY, V138, P46, DOI 10.1053/j.gastro.2009.11.020; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kaiserman Dion, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000184; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lesniak W, 2009, BIOCHEM BIOPH RES CO, V390, P1087, DOI 10.1016/j.bbrc.2009.10.150; Li ZY, 2008, INT J CANCER, V123, P2377, DOI 10.1002/ijc.23808; Li ZY, 2010, INT J GYNECOL CANCER, V20, P9, DOI 10.1111/IGC.0b013e3181a9026d; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Makawita S, 2010, CLIN CHEM, V56, P212, DOI 10.1373/clinchem.2009.127019; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Negishi A, 2009, CANCER SCI, V100, P514, DOI 10.1111/j.1349-7006.2008.01055.x; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Ralhan R, 2009, J PROTEOME RES, V8, P300, DOI 10.1021/pr800501j; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Scherl A, 2004, PROTEOMICS, V4, P917, DOI 10.1002/pmic.200300673; Shi HS, 2010, CANCER SCI, V101, P1447, DOI 10.1111/j.1349-7006.2010.01562.x; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simpson RJ, 2008, CURR OPIN CHEM BIOL, V12, P72, DOI 10.1016/j.cbpa.2008.02.010; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Street JM, 2010, BRIT J CLIN PHARMACO, V69, P367, DOI 10.1111/j.1365-2125.2009.03610.x; Tomoo K, 2010, CURR TOP MED CHEM, V10, P696, DOI 10.2174/156802610791113441; van der Merwe DE, 2007, ADV CANCER RES, V96, P23, DOI 10.1016/S0065-230X(06)96002-3; Vander Heiden MG, 2010, BIOCHEM PHARMACOL, V79, P1118, DOI 10.1016/j.bcp.2009.12.003; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wang N, 2008, ANAL CHEM, V80, P4696, DOI 10.1021/ac800260w; Wang XH, 2010, AM J PATHOL, V177, P586, DOI 10.2353/ajpath.2010.091217	50	37	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16352	10.1371/journal.pone.0016352	http://dx.doi.org/10.1371/journal.pone.0016352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305022	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300054
J	Whittington, RA; Virag, L; Marcouiller, F; Papon, MA; El Khoury, NB; Julien, C; Morin, F; Emala, CW; Planel, E				Whittington, Robert A.; Virag, Laszlo; Marcouiller, Francois; Papon, Marie-Amelie; El Khoury, Noura B.; Julien, Carl; Morin, Francoise; Emala, Charles W.; Planel, Emmanuel			Propofol Directly Increases Tau Phosphorylation	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; PROTEIN PHOSPHATASE 2A; ALZHEIMERS-DISEASE; IN-VIVO; KINASE; HYPERPHOSPHORYLATION; ANESTHESIA; INHIBITION; PATHOLOGY; HYPOTHERMIA	In Alzheimer's disease (AD) and other tauopathies, the microtubule-associated protein tau can undergo aberrant hyperphosphorylation potentially leading to the development of neurofibrillary pathology. Anesthetics have been previously shown to induce tau hyperphosphorylation through a mechanism involving hypothermia-induced inhibition of protein phosphatase 2A (PP2A) activity. However, the effects of propofol, a common clinically used intravenous anesthetic, on tau phosphorylation under normothermic conditions are unknown. We investigated the effects of a general anesthetic dose of propofol on levels of phosphorylated tau in the mouse hippocampus and cortex under normothermic conditions. Thirty min following the administration of propofol 250 mg/kg i.p., significant increases in tau phosphorylation were observed at the AT8, CP13, and PHF-1 phosphoepitopes in the hippocampus, as well as at AT8, PHF-1, MC6, pS262, and pS422 epitopes in the cortex. However, we did not detect somatodendritic relocalization of tau. In both brain regions, tau hyperphosphorylation persisted at the AT8 epitope 2 h following propofol, although the sedative effects of the drug were no longer evident at this time point. By 6 h following propofol, levels of phosphorylated tau at AT8 returned to control levels. An initial decrease in the activity and expression of PP2A were observed, suggesting that PP2A inhibition is at least partly responsible for the hyperphosphorylation of tau at multiple sites following 30 min of propofol exposure. We also examined tau phosphorylation in SH-SY5Y cells transfected to overexpress human tau. A 1 h exposure to a clinically relevant concentration of propofol in vitro was also associated with tau hyperphosphorylation. These findings suggest that propofol increases tau phosphorylation both in vivo and in vitro under normothermic conditions, and further studies are warranted to determine the impact of this anesthetic on the acceleration of neurofibrillary pathology.	[Whittington, Robert A.; Virag, Laszlo; Emala, Charles W.] Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, New York, NY 10027 USA; [Marcouiller, Francois; Papon, Marie-Amelie; El Khoury, Noura B.; Julien, Carl; Morin, Francoise; Planel, Emmanuel] CHU Laval, Quebec City, PQ G1V 4G2, Canada	Columbia University; Laval University	Whittington, RA (corresponding author), Columbia Univ, Dept Anesthesiol, Coll Phys & Surg, New York, NY 10027 USA.	raw9@columbia.edu; emmanuel@planel.org	Julien, Carl/AAU-5309-2021	Planel, Emmanuel/0000-0001-5128-0565	Columbia University Department of Anesthesiology; CIHR [MOP-106423, PCN-102993]; NSERC [354722]; FRSQ [16205, 20048]	Columbia University Department of Anesthesiology; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Columbia University Department of Anesthesiology Research Allocation Panel Fund to RAW, and from the CIHR (MOP-106423, PCN-102993), the NSERC (354722), and the FRSQ (16205, 20048) to EP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Bennecib M, 2000, FEBS LETT, V485, P87, DOI 10.1016/S0014-5793(00)02203-1; Bianchi SL, 2008, NEUROBIOL AGING, V29, P1002, DOI 10.1016/j.neurobiolaging.2007.02.009; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; DEGARCINI EM, 1986, BIOCHEM BIOPH RES CO, V141, P790, DOI 10.1016/S0006-291X(86)80242-X; Delobel P, 2002, J NEUROCHEM, V83, P412, DOI 10.1046/j.1471-4159.2002.01143.x; Eckenhoff RG, 2004, ANESTHESIOLOGY, V101, P703, DOI 10.1097/00000542-200409000-00019; ECKENHOFF RG, 2007, CELLSCIENCE REV, P78; Ehlenbach WJ, 2010, JAMA-J AM MED ASSOC, V303, P763, DOI 10.1001/jama.2010.167; Engdahl O, 1998, BRIT J ANAESTH, V81, P957, DOI 10.1093/bja/81.6.957; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, FEBS LETT, V312, P95, DOI 10.1016/0014-5793(92)81418-L; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Maccioni RB, 2001, EUR J BIOCHEM, V268, P1518, DOI 10.1046/j.1432-1327.2001.02024.x; Mailliot C, 2000, ANN NY ACAD SCI, V920, P107; Oscarsson A, 2007, ACTA ANAESTH SCAND, V51, P1184, DOI 10.1111/j.1399-6576.2007.01388.x; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PAPON MA, 2011, FRONTIERS N IN PRESS; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Planel E, 2002, DRUG DEVELOP RES, V56, P491, DOI 10.1002/ddr.10100; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Planel E, 2004, J NEUROSCI, V24, P2401, DOI 10.1523/JNEUROSCI.5561-03.2004; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Planel E, 2009, FASEB J, V23, P2595, DOI 10.1096/fj.08-122424; Planel E, 2008, J NEUROSCI, V28, P12798, DOI 10.1523/JNEUROSCI.4101-08.2008; RUN X, 2010, J ALZHEIMERS DIS; Run XQ, 2009, J ALZHEIMERS DIS, V16, P619, DOI 10.3233/JAD-2009-1003; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; SINGH TJ, 1994, MOL CELL BIOCHEM, V131, P181; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SU JH, 1994, NEUROREPORT, V5, P2358, DOI 10.1097/00001756-199411000-00037; Tian Q, 2002, NEUROSIGNALS, V11, P262, DOI 10.1159/000067425; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wunsch H, 2009, CRIT CARE MED, V37, P3031, DOI 10.1097/CCM.0b013e3181b02eff; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2007, J NEUROSCI, V27, P1247, DOI 10.1523/JNEUROSCI.5320-06.2007; Zhu XW, 2002, NEUROSIGNALS, V11, P270, DOI 10.1159/000067426	48	105	109	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16648	10.1371/journal.pone.0016648	http://dx.doi.org/10.1371/journal.pone.0016648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304998	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300108
J	Sfeir, C; Lee, D; Li, JH; Zhang, XY; Boskey, AL; Kumta, PN				Sfeir, Charles; Lee, Donghyun; Li, Jinhua; Zhang, Xiaoyuan; Boskey, Adele L.; Kumta, Prashant N.			Expression of Phosphophoryn Is Sufficient for the Induction of Matrix Mineralization by Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST-LIKE CELLS; RAT INCISOR DENTIN; BONE SIALOPROTEIN; CASEIN KINASE; HYDROXYAPATITE FORMATION; BIOMINERALIZATION; OSTEOPONTIN; PHOSPHORYLATION; PROTEINS; BINDING	Mineralized tissues such as dentin and bone assemble extracellular matrices uniquely rich in a variety of acidic phosphoproteins. Although these proteins are presumed to play a role in the process of biomineralization, key questions regarding the nature of their contributions remain unanswered. First, it is not known whether highly phosphorylated proteins alone can induce matrix mineralization, or whether this activity requires the involvement of other bone/dentin non-collagenous proteins. Second, it remains to be established whether the protein kinases that phosphorylate these acidic proteins are unique to cells responsible for producing mineralized tissues. To begin to address these questions, we consider the case of phosphophoryn (PP), due to its high content of phosphate, high affinity for Ca2+, and its potential role in hydroxyapatite nucleation. We have created a model system of biomineralization in a cellular environment by expressing PP in NIH3T3 fibroblasts (which do not produce a mineralized matrix); as a positive control, PP was expressed in MC3T3-E1 osteoblastic cells, which normally mineralize their matrices. We show that expression of PP in NIH3T3 cells is sufficient for the induction of matrix mineralization. In addition, assessment of the phosphorylation status of PP in these cells reveals that the transfected NIH3T3 cells are able to phosphorylate PP. We suggest that the phosphorylation of PP is essential for mineral formation. The principle goal of this study is to enrich the current knowledge of mineralized tissue phosphorylation events by analyzing them in the context of a complete cellular environment.	[Sfeir, Charles; Li, Jinhua; Zhang, Xiaoyuan] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Sfeir, Charles; Li, Jinhua; Zhang, Xiaoyuan] Univ Pittsburgh, Ctr Craniofacial Regenerat, Pittsburgh, PA 15260 USA; [Lee, Donghyun; Kumta, Prashant N.] Univ Pittsburgh, Dept Bioengn Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Boskey, Adele L.] Hosp Special Surg, Musculoskeletal Integr Program, New York, NY 10021 USA; [Lee, Donghyun] Chung Ang Univ, Dept Biomed Engn, Seoul 156756, South Korea	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chung Ang University	Sfeir, C (corresponding author), 552 Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	csfeir@pitt.edu		Boskey, Adele/0000-0002-6181-2219	National Institutes of Health [DE016123, DE04141]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE004141, R01DE016123, R37DE004141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE016123 (to C.S.) and DE04141 (to A.L.B.).	BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BOSKEY AL, 1989, J PHYS CHEM-US, V93, P1628, DOI 10.1021/j100341a086; Boskey AL, 2003, CONNECT TISSUE RES, V44, P5, DOI 10.1080/03008200390152007; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; DIMUZIO MT, 1978, CALC TISS RES, V25, P169, DOI 10.1007/BF02010765; FISHER LW, 1983, J BIOL CHEM, V258, P2723; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Gorski JP, 1998, CRIT REV ORAL BIOL M, V9, P201, DOI 10.1177/10454411980090020401; Harris NL, 2000, BONE, V27, P795, DOI 10.1016/S8756-3282(00)00392-6; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; Magne D, 2004, CONNECT TISSUE RES, V45, P101, DOI 10.1080/03008200490464839; MARK MP, 1988, CELL TISSUE RES, V251, P23, DOI 10.1007/BF00215443; Morais S, 1998, BIOMATERIALS, V19, P13, DOI 10.1016/S0142-9612(97)00149-X; NIEMANN A, 1990, BIOCHEM BIOPH RES CO, V170, P1216, DOI 10.1016/0006-291X(90)90523-P; NOMURA S, 1988, J CELL BIOL, V106, P441, DOI 10.1083/jcb.106.2.441; Pourmand EP, 2007, J CELL BIOCHEM, V100, P43, DOI 10.1002/jcb.20977; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; Salih E, 1996, J BIOL CHEM, V271, P16897, DOI 10.1074/jbc.271.28.16897; Sfeir C, 1996, CONNECT TISSUE RES, V35, P215, DOI 10.3109/03008209609029194; SFEIR C, 1995, J BONE MINER RES, V10, P607; Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y; STETLERSTEVENSON WG, 1987, CALCIFIED TISSUE INT, V40, P97, DOI 10.1007/BF02555712; Stubbs JT, 1997, J BONE MINER RES, V12, P1210, DOI 10.1359/jbmr.1997.12.8.1210; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; TRAUB W, 1992, MATRIX, V12, P197, DOI 10.1016/S0934-8832(11)80062-4; Ueno A, 2006, J CELL PHYSIOL, V209, P322, DOI 10.1002/jcp.20735; Veis A, 2005, SCIENCE, V307, P1419, DOI 10.1126/science.1109440; Veis A, 1998, EUR J ORAL SCI, V106, P234, DOI 10.1111/j.1600-0722.1998.tb02181.x; VEIS A, 1977, CALCIUM BINDING PROT, P409; WILLIS JB, 1960, SPECTROCHIM ACTA, V16, P259, DOI 10.1016/0371-1951(60)80089-6; WU CB, 1992, J BIOL CHEM, V267, P16588; Wu CB, 1996, CONNECT TISSUE RES, V34, P23, DOI 10.3109/03008209609028890	37	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20228	20238		10.1074/jbc.M110.209528	http://dx.doi.org/10.1074/jbc.M110.209528			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21343307	Green Published, hybrid			2022-12-25	WOS:000291267600010
J	Regner, KR; Nozu, K; Lanier, SM; Blumer, JB; Avner, ED; Sweeney, WE; Park, F				Regner, Kevin R.; Nozu, Kandai; Lanier, Stephen M.; Blumer, Joe B.; Avner, Ellis D.; Sweeney, William E., Jr.; Park, Frank			Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents	FASEB JOURNAL			English	Article						accessory proteins; renal epithelial cells; signal transduction	RECEPTOR-INDEPENDENT ACTIVATORS; GUANINE-NUCLEOTIDE EXCHANGE; ADENYLYL-CYCLASE; EPITHELIAL-CELLS; BETA-GAMMA; ISCHEMIA-REPERFUSION; POSTISCHEMIC KIDNEY; AGS3; BINDING; FAILURE	The intracellular mechanisms underlying renal tubular epithelial cell proliferation and tubular repair following ischemia-reperfusion injury (IRI) remain poorly understood. In this report, we demonstrate that activator of G-protein signaling 3 (AGS3), an unconventional receptor-independent regulator of heterotrimeric G-protein function, influences renal tubular regeneration following IRI. In rat kidneys exposed to IRI, there was a temporal induction in renal AGS3 protein expression that peaked 72 h after reperfusion and corresponded to the repair and recovery phase following ischemic injury. Renal AGS3 expression was localized predominantly to the recovering outer medullary proximal tubular cells and was highly coexpressed with Ki-67, a marker of cell proliferation. Kidneys from mice deficient in the expression of AGS3 exhibited impaired renal tubular recovery 7 d following IRI compared to wild-type AGS3-expressing mice. Mechanistically, genetic knockdown of endogenous AGS3 mRNA and protein in renal tubular epithelial cells reduced cell proliferation in vitro. Similar reductions in renal tubular epithelial cell proliferation were observed following incubation with gallein, a selective inhibitor of G beta gamma subunit activity, and lentiviral overexpression of the carboxyl-terminus of G-protein-coupled receptor kinase 2 (GRK2ct), a scavenger of G beta gamma subunits. In summary, these data suggest that AGS3 acts through a novel receptor-independent mechanism to facilitate renal tubular epithelial cell proliferation and renal tubular regeneration.-Regner, K. R., Nozu, K., Lanier, S. M., Blumer, J. B., Avner, E. D., Sweeney, Jr., W. E., Park, F. Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents. FASEB J. 25, 1844-1855 (2011). www.fasebj.org	[Park, Frank] Med Coll Wisconsin, Dept Med, Kidney Dis Ctr, Div Nephrol, Milwaukee, WI 53226 USA; [Nozu, Kandai; Avner, Ellis D.; Sweeney, William E., Jr.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Avner, Ellis D.; Park, Frank] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Lanier, Stephen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical University of South Carolina	Park, F (corresponding author), Med Coll Wisconsin, Dept Med, Kidney Dis Ctr, Div Nephrol, 8701 Watertown Plank Rd,HRC 4100, Milwaukee, WI 53226 USA.	fpark@mcw.edu	Nozu, Kandai/Q-9383-2019; Regner, Kevin/AAQ-1073-2020; Park, Frank/I-4590-2019	Park, Frank/0000-0003-2324-2937; Lanier, Stephen/0000-0002-2740-7607; Blumer, Joe/0000-0002-0020-3815	U.S. National Institutes of Health [P50DK079306, NS24821, DA025896, GM086510]; Advancing a Healthier Wisconsin; PKD Foundation; Clinical Translational Science Institute; Research Affairs Committee; Medical College of Wisconsin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK079306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH065092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024821, R29NS024821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Advancing a Healthier Wisconsin; PKD Foundation; Clinical Translational Science Institute; Research Affairs Committee; Medical College of Wisconsin(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Dr. J. L. Benovic (Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA) for the pcDNA3-GRK2ct plasmid, Ms. Christine Naughton for her help with the immunohistochemistry, Mr. G. Jia for his expertise in generating the lentiviral vectors, Ms. M. Kwon for her molecular biological expertise, Ms. S. White for her technical assistance with the rodent surgeries, and Mr. N. Kampa for his help with the maintenance of the AGS3 mice. This work was supported, in part, by departmental funding (F.P., K.R.R.); U.S. National Institutes of Health grants P50DK079306 (E.D.A.), NS24821 (S.M.L.), DA025896 (S.M.L.), and GM086510 (J.B.B.); Advancing a Healthier Wisconsin (F.P.); the PKD Foundation (F.P.); and the Clinical Translational Science Institute (K.R.R.) and Research Affairs Committee (K.R.R.) at the Medical College of Wisconsin.	Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Calvet JP, 2008, CLIN J AM SOC NEPHRO, V3, P1205, DOI 10.2215/CJN.05651207; Chabardes D, 1999, CELL SIGNAL, V11, P651, DOI 10.1016/S0898-6568(99)00031-5; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; De Deyn PP, 2001, KIDNEY INT, V59, pS77, DOI 10.1046/j.1523-1755.2001.59780077.x; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; KATSETOS CD, 1994, ARCH PATHOL LAB MED, V118, P633; Kim J, 2010, AM J PHYSIOL-RENAL, V298, pF1118, DOI 10.1152/ajprenal.00701.2009; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lameire N, 2006, NAT CLIN PRACT NEPHR, V2, P364, DOI 10.1038/ncpneph0218; Liang HL, 2009, AM J PHYSIOL-RENAL, V296, pF266, DOI 10.1152/ajprenal.90533.2008; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Nony PA, 2003, J PHARMACOL EXP THER, V304, P905, DOI 10.1124/jpet.102.035022; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Park F, 2000, NAT GENET, V24, P49, DOI 10.1038/71673; Park F, 2009, AM J PHYSIOL-RENAL, V296, pF575, DOI 10.1152/ajprenal.90705.2008; Peterson YK, 2002, J BIOL CHEM, V277, P6767, DOI 10.1074/jbc.C100699200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Qian Z, 2006, MOL THER, V13, P694, DOI 10.1016/j.ymthe.2005.11.016; Regner KR, 2009, KIDNEY INT, V75, P511, DOI 10.1038/ki.2008.600; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato Motohiko, 2010, Pathophysiology, V17, P89, DOI 10.1016/j.pathophys.2009.03.011; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwindinger WF, 2001, ONCOGENE, V20, P1653, DOI 10.1038/sj.onc.1204181; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; SILVA FG, 1993, ARCH PATHOL LAB MED, V117, P1233; Sweeney WE, 2003, KIDNEY INT, V64, P1310, DOI 10.1046/j.1523-1755.2003.00232.x; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; WATANABE M, 1981, J HISTOCHEM CYTOCHEM, V29, P779, DOI 10.1177/29.7.7053086; Westhoff JH, 2010, J AM SOC NEPHROL, V21, P327, DOI 10.1681/ASN.2009010072; WITZGALL R, 1994, J CLIN INVEST, V93, P2175, DOI 10.1172/JCI117214	52	30	30	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1844	1855		10.1096/fj.10-169797	http://dx.doi.org/10.1096/fj.10-169797			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21343176	Green Published			2022-12-25	WOS:000291023800008
J	Yin, K; Deng, XA; Mo, ZC; Zhao, GJ; Jiang, J; Cui, LB; Tan, CZ; Wen, GB; Fu, YC; Tang, CK				Yin, Kai; Deng, Xiang; Mo, Zhong-Cheng; Zhao, Guo-Jun; Jiang, Jin; Cui, Li-Bao; Tan, Chun-Zhi; Wen, Ge-Bo; Fu, Yuchang; Tang, Chao-Ke			Tristetraprolin-dependent Post-transcriptional Regulation of Inflammatory Cytokine mRNA Expression by Apolipoprotein A-I ROLE OF ATP-BINDING MEMBRANE CASSETTE TRANSPORTER A1 AND SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; REVERSE CHOLESTEROL TRANSPORT; FACTOR-KAPPA-B; FACTOR-ALPHA; GENE-EXPRESSION; TNF-ALPHA; P38 MAPK; CARDIOVASCULAR EVENTS; APOA-I	Atherosclerosis is an inflammatory disease characterized by the accumulation of macrophages in the arterial intima. The activated macrophages secreted more pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-alpha, which promote the development of the disease. Apolipoprotein A-I (apoA-I), the major component of high density lipoprotein, is involved in reverse cholesterol transport of lipid metabolism. Recently, it has been found that apoA-I suppresses inflammation via repression of inflammatory cytokine expression; the mechanisms of the apoA-I-suppressive action, however, are not yet well characterized. In this study, we have for the first time found that apoA-I suppresses the expression of some inflammatory cytokines induced by lipopolysaccharide via a specific post-transcriptional regulation process, namely mRNA destabilization, in macrophages. Our further studies have also shown that AU-rich elements in the 3'-untranslated region of TNF-alpha mRNA are responsive to the apoA-I-mediated mRNA destabilization. The apoA-I-induced inflammatory cytokine mRNA destabilization was associated with increased expression of mRNA-destabilizing protein tristetraprolin through a JAK2/STAT3 signaling pathway-dependent manner. When blocking interaction of apoA-I with ATP-binding membrane cassette transporter A1 (ABCA1), a major receptor for apoA-I in macrophages, it would almost totally abolish the effect of apoA-I on tristetraprolin expression. These results present not only a novel mechanism for the apoA-I-mediated inflammation suppression in macrophages but also provide new insights for developing strategies for modulating vascular inflammation and atherosclerosis.	[Yin, Kai; Mo, Zhong-Cheng; Zhao, Guo-Jun; Jiang, Jin; Cui, Li-Bao; Tan, Chun-Zhi; Wen, Ge-Bo; Tang, Chao-Ke] Univ S China, Affiliated Hosp 1, Key Lab Atherosclerol Hunan Prov, Life Sci Res Ctr,Inst Cardiovasc Res, Hengyang 421001, Peoples R China; [Yin, Kai; Wen, Ge-Bo] Univ S China, Affiliated Hosp 1, Dept Diagnost, Coll Med, Hengyang 421001, Peoples R China; [Deng, Xiang; Wen, Ge-Bo] Univ S China, Affiliated Hosp 1, Dept Endocrinol & Metab, Hengyang 421001, Peoples R China; [Fu, Yuchang] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA	University of South China; University of South China; University of South China; University of Alabama System; University of Alabama Birmingham	Tang, CK (corresponding author), Univ S China, Affiliated Hosp 1, Key Lab Atherosclerol Hunan Prov, Life Sci Res Ctr,Inst Cardiovasc Res, Hengyang 421001, Peoples R China.	tchaoke@yahoo.com.cn	莫, 中成/AAY-8561-2020		National Natural Sciences Foundation of China [30470720, 81070220]; Post-doctoral Sciences Foundation of China [2005037157]; Hunan Provincial Natural Sciences Foundation of China [10JJ9019, 06jj5058]; Hunan Post-graduate Innovative Project [CX2010B379]; Science and Technology Department Funds of Heng Yang of Hunan Province [2010kj17]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Post-doctoral Sciences Foundation of China(China Postdoctoral Science Foundation); Hunan Provincial Natural Sciences Foundation of China; Hunan Post-graduate Innovative Project; Science and Technology Department Funds of Heng Yang of Hunan Province	This work was supported by National Natural Sciences Foundation of China Grants 30470720 and 81070220, Post-doctoral Sciences Foundation of China Grant 2005037157, Heng Yang Joint Funds of Hunan Provincial Natural Sciences Foundation of China Grant 10JJ9019, Hunan Post-graduate Innovative Project Grant CX2010B379, Hunan Provincial Natural Sciences Foundation of China Grant 06jj5058, and Science and Technology Department Funds of Heng Yang of Hunan Province Grant 2010kj17.	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Asztalos BF, 2005, ARTERIOSCL THROM VAS, V25, P2185, DOI 10.1161/01.ATV.0000183727.90611.4f; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Cheneval D, 2010, J BIOMOL SCREEN, V15, P609, DOI 10.1177/1087057110365897; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Drouineaud V, 2007, MOL HUM REPROD, V13, P373, DOI 10.1093/molehr/gam019; Eberhardt W, 2007, PHARMACOL THERAPEUT, V114, P56, DOI 10.1016/j.pharmthera.2007.01.002; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; GEISTERFER M, 1993, CYTOKINE, V5, P1, DOI 10.1016/1043-4666(93)90017-Y; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hao XR, 2009, ATHEROSCLEROSIS, V203, P417, DOI 10.1016/j.atherosclerosis.2008.07.029; Hu Yan-Wei, 2009, Atherosclerosis, V204, pe35, DOI 10.1016/j.atherosclerosis.2008.11.003; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Ivashkiv LB, 2004, ARTHRITIS RES THER, V6, P159, DOI 10.1186/ar1197; JACOB CO, 1993, NUCLEIC ACIDS RES, V21, P2761, DOI 10.1093/nar/21.11.2761; Karwatsky J, 2010, J LIPID RES, V51, P1144, DOI 10.1194/jlr.M003145; Khabar KSA, 2007, J LEUKOCYTE BIOL, V81, P1335, DOI 10.1189/jlb.0207109; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; King EM, 2009, J PHARMACOL EXP THER, V330, P575, DOI 10.1124/jpet.109.151423; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; Liu XH, 2010, J CARDIOVASC PHARM, V56, P309, DOI 10.1097/FJC.0b013e3181edaf69; Luo NL, 2010, DIABETES, V59, P791, DOI 10.2337/db09-1338; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Ma PL, 2004, J LEUKOCYTE BIOL, V76, P278, DOI 10.1189/jlb.1203653; Mahtani KR, 2001, MOL CELL BIOL, V21, P6461, DOI 10.1128/MCB.21.9.6461-6469.2001; Maitra S, 2008, RNA, V14, P950, DOI 10.1261/rna.983708; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Patel S, 2009, J AM COLL CARDIOL, V53, P962, DOI 10.1016/j.jacc.2008.12.008; Patino WD, 2006, CIRC RES, V98, P1282, DOI 10.1161/01.RES.0000222284.48288.28; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Ramsamy TA, 2003, J LIPID RES, V44, P733, DOI 10.1194/jlr.M200339-JLR200; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Ronkina N, 2007, MOL CELL BIOL, V27, P170, DOI 10.1128/MCB.01456-06; Rye KA, 2008, ARTERIOSCL THROM VAS, V28, P1890, DOI 10.1161/ATVBAHA.108.173575; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Serio KJ, 2000, AM J RESP CELL MOL, V23, P234, DOI 10.1165/ajrcmb.23.2.4042; Skoog T, 1999, HUM MOL GENET, V8, P1443, DOI 10.1093/hmg/8.8.1443; Smoak KA, 2010, CELL METAB, V11, P493, DOI 10.1016/j.cmet.2010.04.006; Suzuki K, 2003, J EXP MED, V198, P1717, DOI 10.1084/jem.20031701; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tang CK, 2004, ACTA BIOCH BIOPH SIN, V36, P218, DOI 10.1093/abbs/36.3.218; Tellier E, 2008, J CELL PHYSIOL, V214, P687, DOI 10.1002/jcp.21265; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Yin K, 2010, MOL MED, V16, P438, DOI 10.2119/molmed.2010.00004; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zabalawi M, 2007, J LIPID RES, V48, P52, DOI 10.1194/jlr.M600370-JLR200; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	63	55	62	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13834	13845		10.1074/jbc.M110.202275	http://dx.doi.org/10.1074/jbc.M110.202275			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21339300	hybrid, Green Published			2022-12-25	WOS:000289556200006
J	Basford, JE; Wancata, L; Hofmann, SM; Silva, RAGD; Davidson, WS; Howles, PN; Hui, DY				Basford, Joshua E.; Wancata, Lauren; Hofmann, Susanna M.; Silva, R. A. Gangani D.; Davidson, W. Sean; Howles, Philip N.; Hui, David Y.			Hepatic Deficiency of Low Density Lipoprotein Receptor-related Protein-1 Reduces High Density Lipoprotein Secretion and Plasma Levels in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; SELECTIVE UPTAKE; ENDOTHELIAL LIPASE; IN-VIVO; APOA-I; TARGETED INACTIVATION; CHYLOMICRON REMNANTS; CHOLESTERYL ESTERS; LYSOSOMAL-ENZYMES; CATHEPSIN-D	The low density lipoprotein receptor-related protein-1 (LRP1) is known to serve as a chylomicron remnant receptor in the liver responsible for the binding and plasma clearance of apolipoprotein E-containing lipoproteins. Previous in vitro studies have provided evidence to suggest that LRP1 expression may also influence high density lipoprotein (HDL) metabolism. The current study showed that liver-specific LRP1 knock-out (hLrp1(-/-)) mice displayed lower fasting plasma HDL cholesterol levels when compared with hLrp1(+/+) mice. Lecithin:cholesterol acyl transferase and hepatic lipase activities in plasma of hLrp1(-/-) mice were comparable with those observed in hLrp1(+/+) mice, indicating that hepatic LRP1 inactivation does not influence plasma HDL remodeling. Plasma clearance of HDL particles and HDL-associated cholesteryl esters was also similar between hLrp1(+/+) and hLrp1(-/-) mice. In contrast, HDL secretion from primary hepatocytes isolated from hLrp1(-/-) mice was significantly reduced when compared with that observed with hLrp1(+/+) hepatocytes. Biotinylation of cell surface proteins revealed decreased surface localization of the ATP-binding cassette, subfamily A, member 1 (ABCA1) protein, but total cellular ABCA1 level was not changed in hLrp1(-/-) hepatocytes. Finally, hLrp1(-/-) hepatocytes displayed reduced binding capacity for extracellular cathepsin D, resulting in lower intracellular cathepsin D content and impairment of prosaposin activation, a process that is required for membrane translocation of ABCA1 to facilitate cholesterol efflux and HDL secretion. Taken together, these results documented that hepatic LRP1 participates in cellular activation of lysosomal enzymes and through this mechanism, indirectly modulates the production and plasma levels of HDL.	[Basford, Joshua E.; Wancata, Lauren; Hofmann, Susanna M.; Silva, R. A. Gangani D.; Davidson, W. Sean; Howles, Philip N.; Hui, David Y.] Univ Cincinnati, Coll Med, Metab Dis Inst, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Coll Med, Metab Dis Inst, Dept Pathol, ML 0507,2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Hofmann, Susanna/F-2654-2014	Hofmann, Susanna/0000-0001-7682-5840; Davidson, William/0000-0003-2756-2989	National Institutes of Health [DK74932, HL62542]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK060444, R01DK074932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK74932 (to D. Y. H.) and HL62542 (to W. S. D.).	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Badellino KO, 2004, CURR OPIN CARDIOL, V19, P392, DOI 10.1097/01.hco.0000130161.89169.02; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Chisholm JW, 2002, J LIPID RES, V43, P36; Dittmer F, 1999, J CELL SCI, V112, P1591; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Fazio S, 2000, TRENDS CARDIOVAS MED, V10, P23, DOI 10.1016/S1050-1738(00)00033-5; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gilham D, 2005, METHODS, V36, P139, DOI 10.1016/j.ymeth.2004.11.003; Gopalakrishnan MM, 2004, BIOCHEM J, V383, P507, DOI 10.1042/BJ20040175; Haidar B, 2006, J BIOL CHEM, V281, P39971, DOI 10.1074/jbc.M605095200; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2009, J LIPID RES, V50, pS287, DOI 10.1194/jlr.R800077-JLR200; Hiesberger T, 1998, EMBO J, V17, P4617, DOI 10.1093/emboj/17.16.4617; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; HOMANICS GE, 1995, J BIOL CHEM, V270, P2974, DOI 10.1074/jbc.270.7.2974; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Jin WJ, 2003, J CLIN INVEST, V111, P357, DOI [10.1172/JCI16146, 10.1172/JCI200316146]; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Kiss RS, 2006, J BIOL CHEM, V281, P12081, DOI 10.1074/jbc.M600621200; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Krimbou L, 2001, J BIOL CHEM, V276, P33241, DOI 10.1074/jbc.M100326200; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; LUDWIG T, 1995, TRENDS CELL BIOL, V5, P202, DOI 10.1016/S0962-8924(00)89000-5; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Santo SMSE, 2004, BLOOD, V103, P3777, DOI 10.1182/blood-2003-11-4051; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Vassiliou G, 2004, ARTERIOSCL THROM VAS, V24, P1669, DOI 10.1161/01.ATV.0000134295.09932.60; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; Verges M, 2004, J BIOL CHEM, V279, P9030, DOI 10.1074/jbc.M312908200; Wang MD, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M700326200; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; Yu KCW, 2001, J CLIN INVEST, V107, P1387, DOI 10.1172/JCI11750; Zhou L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006853	51	36	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13079	13087		10.1074/jbc.M111.229369	http://dx.doi.org/10.1074/jbc.M111.229369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343303	Green Published, hybrid			2022-12-25	WOS:000289282200028
J	Helbig, L; Damrot, J; Hulsenbeck, J; Koberle, B; Brozovic, A; Osmak, M; Fiket, Z; Kaina, B; Fritz, G				Helbig, Lars; Damrot, Julia; Huelsenbeck, Johannes; Koeberle, Beate; Brozovic, Anamaria; Osmak, Maja; Fiket, Zeljka; Kaina, Bernd; Fritz, Gerhard			Late Activation of Stress-activated Protein Kinases/c-Jun N-terminal Kinases Triggered by Cisplatin-induced DNA Damage in Repair-defective Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ABL TYROSINE KINASE; ENDOPLASMIC-RETICULUM STRESS; DOUBLE-STRANDED BREAKS; C-ABL; IONIZING-RADIATION; GROWTH-FACTOR; UV-LIGHT; SIGNAL-TRANSDUCTION; ULTRAVIOLET-LIGHT	Although stress-activated protein kinases/c-Jun N-terminal kinases (SAPK/JNK) are rapidly activated by genotoxins, the role of DNA damage in this response is not well defined. Here we show that the SEK1/MKK4-mediated dual phosphorylation of SAPK/JNK (Thr-183/Tyr-185) correlates with the level of cis-platin-DNA adducts at late times (16-24 h) after drug treatment in both human and mouse cells, Transfection of platinated plasmid DNA also caused SAPK/JNK activation. A defect in transcription-coupled nucleotide excision repair resting on a mutation in Cockayne syndrome group B protein promoted the late SAPK/JNK activation following cisplatin exposure. Signaling to SAPK/JNK was accompanied by activation of Ataxia telangiectasia mutated- and Rad3-related kinase, replication protein A, and checkpoint kinases as well as by the formation of DNA double strand breaks (DSBs). Ionizing radiation-induced DSBs did not provoke SAP K/JNK activation, and inhibition of transcription also failed to provoke this response. Late activation of SAPK/JNK stimulated by cisplatin-induced DNA lesions was reduced in the absence of specific DNA repair proteins, such as xeroderma pigmentosum protein C, pointing to an essential function of individual repair factors in DNA damage signaling to SAPK/JNK. Collectively, the data indicate that late SAPK/JNK activation is triggered by non-repaired cisplatin adducts in transcribed genes and involves replication-associated events, DSBs, tyrosine kinases, Rho GTPases, and specific repair factors.	[Helbig, Lars; Damrot, Julia; Huelsenbeck, Johannes; Koeberle, Beate; Kaina, Bernd; Fritz, Gerhard] Johannes Gutenberg Univ Mainz, Dept Toxicol, Univ Med Ctr, D-55131 Mainz, Germany; [Brozovic, Anamaria; Osmak, Maja] Rudjer Boskovic Inst, Div Mol Biol, Zagreb 10000, Croatia; [Fiket, Zeljka] Rudjer Boskovic Inst, Div Marine & Environm Res, Zagreb 10000, Croatia	Johannes Gutenberg University of Mainz; Rudjer Boskovic Institute; Rudjer Boskovic Institute	Fritz, G (corresponding author), Univ Dusseldorf, Inst Toxicol, Univ Str 1, D-40225 Dusseldorf, Germany.	fritz@uni-duesseldorf.de	Brozovic, Anamaria/D-5270-2016; Kaina, Bernd/AAE-4692-2020; Fiket, Zeljka/J-4985-2019	Brozovic, Anamaria/0000-0002-6820-2173; Fiket, Zeljka/0000-0002-7628-9045	Deutsche Forschungsgemeinschaft [Fr 1541/5-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fr 1541/5-3.	Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Bogliolo M, 2007, EMBO J, V26, P1340, DOI 10.1038/sj.emboj.7601574; Brozovic A, 2004, INT J CANCER, V112, P974, DOI 10.1002/ijc.20522; Canman CE, 1996, NATURE, V384, P213, DOI 10.1038/384213a0; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; COFFER PJ, 1995, ONCOGENE, V11, P561; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; D'Andrea A, 2003, CURR BIOL, V13, pR546, DOI 10.1016/S0960-9822(03)00467-6; Damrot J, 2009, J MOL BIOL, V385, P1409, DOI 10.1016/j.jmb.2008.12.015; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; Dhar V, 1996, CELL GROWTH DIFFER, V7, P841; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES, P25; Fritz G, 2006, MOL BIOL CELL, V17, P851, DOI 10.1091/mbc.E05-07-0606; Furuta T, 2002, CANCER RES, V62, P4899; Gnad R, 2000, MOL PHARMACOL, V58, P1389, DOI 10.1124/mol.58.6.1389; Gross S, 1999, J BIOL CHEM, V274, P26378, DOI 10.1074/jbc.274.37.26378; Hamdi M, 2005, ONCOGENE, V24, P7135, DOI 10.1038/sj.onc.1208875; HANSSON J, 1989, NUCLEIC ACIDS RES, V17, P8073, DOI 10.1093/nar/17.20.8073; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kaina B, 1997, CANCER RES, V57, P2721; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Kharbanda S, 2000, MOL CELL BIOL, V20, P4979, DOI 10.1128/MCB.20.14.4979-4989.2000; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kolbus A, 2000, MOL CELL BIOL, V20, P575, DOI 10.1128/MCB.20.2.575-582.2000; KRAMER M, 1993, J BIOL CHEM, V268, P6734; Lackinger D, 2000, MUTAT RES-FUND MOL M, V457, P113, DOI 10.1016/S0027-5107(00)00133-0; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Liedert B, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl051; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Ljungman M, 2005, MUTAT RES-FUND MOL M, V577, P203, DOI 10.1016/j.mrfmmm.2005.02.014; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ljungman M, 1999, ONCOGENE, V18, P583, DOI 10.1038/sj.onc.1202356; Ljungman M, 2007, CELL CYCLE, V6, P2252, DOI 10.4161/cc.6.18.4751; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Malinge JM, 1999, J INORG BIOCHEM, V77, P23, DOI 10.1016/S0162-0134(99)00148-8; Mandic A, 2003, J BIOL CHEM, V278, P9100, DOI 10.1074/jbc.M210284200; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; Nehme A, 1999, BRIT J CANCER, V79, P1104, DOI 10.1038/sj.bjc.6690176; Nehme A, 1997, CANCER RES, V57, P3253; Ochs K, 2000, CANCER RES, V60, P5815; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Radi M, 2008, BIOORG MED CHEM LETT, V18, P1207, DOI 10.1016/j.bmcl.2007.11.112; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Rebillard A, 2008, CURR MED CHEM, V15, P2656, DOI 10.2174/092986708786242903; Rodemann HP, 2007, INT J RADIAT BIOL, V83, P781, DOI 10.1080/09553000701769970; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Shangary S, 2000, J BIOL CHEM, V275, P30163, DOI 10.1074/jbc.M004302200; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wang HC, 2001, CANCER RES, V61, P270; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yoshizumi M, 2008, CELL BIOL INT, V32, P1405, DOI 10.1016/j.cellbi.2008.08.011; ZAMBLE DB, 1995, TRENDS BIOCHEM SCI, V20, P435, DOI 10.1016/S0968-0004(00)89095-7	91	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12991	13001		10.1074/jbc.M110.190645	http://dx.doi.org/10.1074/jbc.M110.190645			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324906	hybrid, Green Published			2022-12-25	WOS:000289282200019
J	Ma, XX; Guo, PC; Shi, WW; Luo, M; Tan, XF; Chen, YX; Zhou, CZ				Ma, Xiao-Xiao; Guo, Peng-Chao; Shi, Wei-Wei; Luo, Ming; Tan, Xiao-Feng; Chen, Yuxing; Zhou, Cong-Zhao			Structural Plasticity of the Thioredoxin Recognition Site of Yeast Methionine S-Sulfoxide Reductase Mxr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ENZYMATIC REDUCTION; CATALYTIC MECHANISM; BACKBONE DYNAMICS; REDUCED FORM; LIFE-SPAN; PROTEIN; DISULFIDE; COMPLEX; DSBD	The methionine S-sulfoxide reductase MsrA catalyzes the reduction of methionine sulfoxide, a ubiquitous reaction depending on the thioredoxin system. To investigate interactions between MsrA and thioredoxin (Trx), we determined the crystal structures of yeast MsrA/Mxr1 in their reduced, oxidized, and Trx2-complexed forms, at 2.03, 1.90, and 2.70 angstrom, respectively. Comparative structure analysis revealed significant conformational changes of the three loops, which form a plastic "cushion" to harbor the electron donor Trx2. The flexible C-terminal loop enabled Mxr1 to access the methionine sulfoxide on various protein substrates. Moreover, the plasticity of the Trx binding site on Mxr1 provides structural insights into the recognition of diverse substrates by a universal catalytic motif of Trx.	[Ma, Xiao-Xiao; Guo, Peng-Chao; Shi, Wei-Wei; Luo, Ming; Tan, Xiao-Feng; Chen, Yuxing; Zhou, Cong-Zhao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, CZ (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zcz@ustc.edu.cn	Chen, Yuxing/P-4156-2014; guo, peng/AAG-4052-2019; Zhou, Cong-Zhao/E-9174-2011; tan, xiao/GZL-0264-2022; Guo, Peng/GWC-0572-2022	Chen, Yuxing/0000-0002-7560-1922; Zhou, Cong-Zhao/0000-0002-6881-7151; 	National Natural Science Foundation of China [30870490]; Ministry of Science and Technology of China [2006CB910202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Program 30870490) and the Ministry of Science and Technology of China (Project 2006CB910202).	ABRAMS WR, 1981, P NATL ACAD SCI-BIOL, V78, P7483, DOI 10.1073/pnas.78.12.7483; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao R, 2007, PROTEINS, V66, P246, DOI 10.1002/prot.21194; Boschi-Muller S, 2008, ARCH BIOCHEM BIOPHYS, V474, P266, DOI 10.1016/j.abb.2008.02.007; BROT N, 1981, P NATL ACAD SCI-BIOL, V78, P2155, DOI 10.1073/pnas.78.4.2155; Chartron J, 2007, BIOCHEMISTRY-US, V46, P3942, DOI 10.1021/bi700130e; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coudevylle N, 2007, J MOL BIOL, V366, P193, DOI 10.1016/j.jmb.2006.11.042; Dai SD, 2007, NATURE, V448, P92, DOI 10.1038/nature05937; Davis DA, 2000, BIOCHEM J, V346, P305, DOI 10.1042/0264-6021:3460305; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; KALLIS GB, 1980, J BIOL CHEM, V255, P261; Kim YK, 2009, MOL MICROBIOL, V72, P699, DOI 10.1111/j.1365-2958.2009.06680.x; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Li Y, 2007, J BIOL CHEM, V282, P11078, DOI 10.1074/jbc.M700970200; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2000, BIOCHEMISTRY-US, V39, P13307, DOI 10.1021/bi0020269; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Maeda K, 2006, STRUCTURE, V14, P1701, DOI 10.1016/j.str.2006.09.012; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Moskovitz J, 1996, P NATL ACAD SCI USA, V93, P2095, DOI 10.1073/pnas.93.5.2095; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Quinternet M, 2009, STRUCTURE, V17, P1024, DOI 10.1016/j.str.2009.05.011; Quinternet M, 2008, BIOCHEMISTRY-US, V47, P12710, DOI 10.1021/bi801343c; Ranaivoson FM, 2008, J MOL BIOL, V377, P268, DOI 10.1016/j.jmb.2008.01.021; Ranaivoson FM, 2009, J MOL BIOL, V394, P83, DOI 10.1016/j.jmb.2009.08.073; Rouhier N, 2007, J BIOL CHEM, V282, P3367, DOI 10.1074/jbc.M605007200; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Saghert D, 2006, P NATL ACAD SCI USA, V103, P8656, DOI 10.1073/pnas.0602826103; Savage H, 1997, STRUCTURE, V5, P895, DOI 10.1016/S0969-2126(97)00244-X; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Taylor AB, 2003, J BACTERIOL, V185, P4119, DOI 10.1128/JB.185.14.4119-4126.2003; Tete-Favier F, 2000, STRUCTURE, V8, P1167, DOI 10.1016/S0969-2126(00)00526-8; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; Weissbach H, 2002, ARCH BIOCHEM BIOPHYS, V397, P172, DOI 10.1006/abbi.2001.2664; Zhang XH, 2008, BIOL REV, V83, P249, DOI 10.1111/j.1469-185X.2008.00042.x	47	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13430	13437		10.1074/jbc.M110.205161	http://dx.doi.org/10.1074/jbc.M110.205161			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345799	Green Published, hybrid			2022-12-25	WOS:000289282200063
J	Wu, D; Ahrens, R; Osterfeld, H; Noah, TK; Groschwitz, K; Foster, PS; Steinbrecher, KA; Rothenberg, ME; Shroyer, NF; Matthaei, KI; Finkelman, FD; Hogan, SP				Wu, David; Ahrens, Richard; Osterfeld, Heather; Noah, Taeko K.; Groschwitz, Katherine; Foster, Paul S.; Steinbrecher, Kris A.; Rothenberg, Marc E.; Shroyer, Noah F.; Matthaei, Klaus I.; Finkelman, Fred D.; Hogan, Simon P.			Interleukin-13 (IL-13)/IL-13 Receptor alpha 1 (IL-13R alpha 1) Signaling Regulates Intestinal Epithelial Cystic Fibrosis Transmembrane Conductance Regulator Channel-dependent Cl- Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-13 RECEPTOR; ULCERATIVE-COLITIS; CHLORIDE CHANNELS; APICAL MEMBRANE; TH2 CYTOKINE; MAST-CELLS; EXPRESSION; ACTIVATION; TRANSPORT; AIRWAY	Interleukin-13 (IL-13) has been linked to the pathogenesis of inflammatory diseases of the gastrointestinal tract. It is postulated that IL-13 drives inflammatory lesions through the modulation of both hematopoietic and nonhematopoietic cell function in the intestine. To delineate the relevant contribution of elevated levels of intestinal IL-13 to intestinal structure and function, we generated an intestinal IL-13 transgenic mouse (iIL-13Tg). We show that constitutive overexpression of IL-13 in the small bowel induces modification of intestinal epithelial architecture (villus blunting, goblet cell hyperplasia, and increased epithelial proliferation) and epithelial function (altered basolateral -> apical Cl- ion conductance). Pharmacological analyses in vitro and in vivo determined that elevated Cl- conductance is mediated by altered cystic fibrosis transmembrane conductance regulator expression and activity. Generation of iIL-13Tg/Il13r alpha 1(-/-), iIL-13Tg/Il13r alpha 2(-/-), and iIL-13Tg/Stat6(-/-) mice revealed that IL-13-mediated dysregulation of epithelial architecture and Cl- conductance is dependent on IL-13R alpha 1 and STAT-6. These observations demonstrate a central role for the IL-13/IL-13R alpha 1 pathway in the regulation of intestinal epithelial cell Cl- secretion via up-regulation of cystic fibrosis transmembrane conductance regulator, suggesting an important role for this pathway in secretory diarrhea.	[Wu, David; Ahrens, Richard; Osterfeld, Heather; Groschwitz, Katherine; Rothenberg, Marc E.; Hogan, Simon P.] Univ Cincinnati, Div Allergy & Immunol, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, Cincinnati, OH 45229 USA; [Noah, Taeko K.; Steinbrecher, Kris A.; Shroyer, Noah F.] Univ Cincinnati, Div Gastroenterol Hepatol & Nutr, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, Cincinnati, OH 45229 USA; [Foster, Paul S.] Univ Newcastle, Sch Biomed Sci, Asthma Allergy & Inflammat Res Ctr, Newcastle, NSW 2300, Australia; [Matthaei, Klaus I.] Australian Natl Univ, John Curtin Sch Med Res, Dept Biol Struct, Stem Cell & Gene Targeting Lab, Canberra, ACT 2601, Australia; [Matthaei, Klaus I.] King Saud Univ, Dept Anat, Stem Cell Unit, Riyadh 11745, Saudi Arabia; [Finkelman, Fred D.] Univ Cincinnati, Div Immunobiol, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, Cincinnati, OH 45229 USA; [Finkelman, Fred D.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Newcastle; Australian National University; John Curtin School of Medical Research; King Saud University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Hogan, SP (corresponding author), Univ Cincinnati, Div Allergy & Immunol, Cincinnati Childrens Hosp, Med Ctr,Coll Med,Dept Pediat, 3333 Burnet Ave,ML7028, Cincinnati, OH 45229 USA.	simon.hogan@cchmc.org	Klaus, Matthaei/D-8691-2011; Foster, Paul/G-5057-2013	Shroyer, Noah/0000-0002-5934-2852	National Institutes of Health [R01AI073553-01]; Department of Veterans Affairs; American Heart Foundation Midwest Affiliate and Food Allergy and Anaphylaxis Network; NATIONAL CANCER INSTITUTE [R01CA142826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK084167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Foundation Midwest Affiliate and Food Allergy and Anaphylaxis Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI073553-01 (to S. P. H.). This work was also supported by a Department of Veterans Affairs merit award (to F. D. F.) and the American Heart Foundation Midwest Affiliate and Food Allergy and Anaphylaxis Network (to S. P. H.).	Akiho H, 2005, GASTROENTEROLOGY, V129, P131, DOI 10.1053/j.gastro.2005.03.049; Akiho H, 2002, AM J PHYSIOL-GASTR L, V282, pG226, DOI 10.1152/ajpgi.2002.282.2.G226; Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; Anthony RM, 2006, NAT MED, V12, P955, DOI 10.1038/nm1451; Bhuiyan TR, 2009, INFECT IMMUN, V77, P1888, DOI 10.1128/IAI.01101-08; Brandt EB, 2009, J ALLERGY CLIN IMMUN, V123, P53, DOI 10.1016/j.jaci.2008.10.001; Ceponis PJM, 2000, J BIOL CHEM, V275, P29132, DOI 10.1074/jbc.M003516200; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Chiaramonte MG, 2003, J EXP MED, V197, P687, DOI 10.1084/jem.20020903; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Crutchley RD, 2010, ANN PHARMACOTHER, V44, P878, DOI 10.1345/aph.1M658; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Escaffit F, 2005, J CELL PHYSIOL, V203, P15, DOI 10.1002/jcp.20189; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Forbes EE, 2008, J EXP MED, V205, P897, DOI 10.1084/jem.20071046; Fulkerson PC, 2006, AM J RESP CELL MOL, V35, P337, DOI 10.1165/rcmb.2005-0474OC; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; GAZITUA S, 1982, PFLUG ARCH EUR J PHY, V394, P32, DOI 10.1007/BF01108305; GRASSET E, 1984, AM J PHYSIOL, V247, pC260, DOI 10.1152/ajpcell.1984.247.3.C260; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; Groschwitz KR, 2009, P NATL ACAD SCI USA, V106, P22381, DOI 10.1073/pnas.0906372106; GRUBB BR, 1995, AM J PHYSIOL-GASTR L, V268, pG505, DOI 10.1152/ajpgi.1995.268.3.G505; Gyomorey K, 2001, PFLUG ARCH EUR J PHY, V443, pS103, DOI 10.1007/s004240100654; HAWKER PC, 1980, GASTROENTEROLOGY, V79, P508; Heller F, 2008, MUCOSAL IMMUNOL, V1, pS58, DOI 10.1038/mi.2008.46; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hershey GKK, 2003, J ALLERGY CLIN IMMUN, V111, P677, DOI 10.1067/mai.2003.1333; Horsnell WGC, 2007, PLOS PATHOG, V3, P46, DOI 10.1371/journal.ppat.0030001; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kellner J, 2007, INT ARCH ALLERGY IMM, V142, P199, DOI 10.1159/000097022; Khodoun M, 2007, J IMMUNOL, V179, P6429, DOI 10.4049/jimmunol.179.10.6429; Kirkpatrick BD, 2002, J INFECT DIS, V186, P94, DOI 10.1086/341296; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Madden KB, 2002, J IMMUNOL, V169, P4417, DOI 10.4049/jimmunol.169.8.4417; Mentink-Kane MM, 2004, IMMUNOL REV, V202, P191, DOI 10.1111/j.0105-2896.2004.00210.x; Moyer BD, 1999, J CLIN INVEST, V104, P1353, DOI 10.1172/JCI7453; Murata T, 1998, INT IMMUNOL, V10, P1103, DOI 10.1093/intimm/10.8.1103; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; SANDLE GI, 1986, GUT, V27, P309, DOI 10.1136/gut.27.3.309; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Skowron-Zwarg M, 2007, EXP CELL RES, V313, P2695, DOI 10.1016/j.yexcr.2007.02.035; Strait RT, 2003, J IMMUNOL, V170, P3835, DOI 10.4049/jimmunol.170.7.3835; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Surawicz Christina M, 2010, Curr Gastroenterol Rep, V12, P236, DOI 10.1007/s11894-010-0113-4; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, pC358; Weber CR, 2010, J BIOL CHEM, V285, P12037, DOI 10.1074/jbc.M109.064808; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zhao AP, 2008, GASTROENTEROLOGY, V135, P217, DOI 10.1053/j.gastro.2008.03.077; Zhao AP, 2003, J IMMUNOL, V171, P948, DOI 10.4049/jimmunol.171.2.948; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458; Zheng T, 2003, J ALLERGY CLIN IMMUN, V111, P720, DOI 10.1067/mai.2003.1383; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zund G, 1996, J BIOL CHEM, V271, P7460; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	68	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13357	13369		10.1074/jbc.M110.214965	http://dx.doi.org/10.1074/jbc.M110.214965			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21303908	Green Submitted, hybrid, Green Published			2022-12-25	WOS:000289282200056
J	Brunel, A; Wilson, A; Henry, L; Dorlet, P; Santolini, J				Brunel, Albane; Wilson, Adjele; Henry, Laura; Dorlet, Pierre; Santolini, Jerome			The Proximal Hydrogen Bond Network Modulates Bacillus subtilis Nitric-oxide Synthase Electronic and Structural Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; DEINOCOCCUS-RADIODURANS; STAPHYLOCOCCUS-AUREUS; NO SYNTHASE; L-ARGININE; CATALYTIC PROFILES; HEME COORDINATION; BINDING-SITES; PROTEIN; COMPLEXES	Bacterial nitric-oxide synthase (NOS)-like proteins are believed to be genuine NOSs. As for cytochromes P450 (CYPs), NOS-proximal ligand is a thiolate that exerts a push effect crucial for the process of dioxygen activation. Unlike CYPs, this catalytic electron donation seems controlled by a hydrogen bond (H-bond) interaction between the thiolate ligand and a vicinal tryptophan. Variations of the strength of this H-bond could provide a direct way to tune the stability along with the electronic and structural properties of NOS. We generated five different mutations of bsNOS Trp(66), which can modulate this proximal H-bond. We investigated the effects of these mutations on different NOS complexes (Fe-III, (FeCO)-C-II, and (FeNO)-N-II), using a combination of UV-visible absorption, EPR, FTIR, and resonance Raman spectroscopies. Our results indicate that (i) the proximal H-bond modulation can selectively decrease or increase the electron donating properties of the proximal thiolate, (ii) this modulation controls the sigma-competition between distal and proximal ligands, (iii) this H-bond controls the stability of various NOS intermediates, and (iv) a fine tuning of the electron donation by the proximal ligand is required to allow at the same time oxygen activation and to prevent uncoupling reactions.	CEA, iBiTec S, SB2SM, F-91191 Gif Sur Yvette, France; CNRS, Lab Stress Oxydant & Detoxicat, URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Santolini, J (corresponding author), CEA Saclay, F-91191 Gif Sur Yvette, France.	jerome.santolini@cea.fr		Dorlet, Pierre/0000-0001-7394-3374; Wilson, Adjele Flore/0000-0003-2622-3600; Santolini, Jerome/0000-0001-8919-112X				Abu-Soud HM, 1998, BIOCHEMISTRY-US, V37, P3777, DOI 10.1021/bi972398q; Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; Berka V, 2000, BIOCHEMISTRY-US, V39, P9373, DOI 10.1021/bi992769y; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bredt DS, 2003, J CELL SCI, V116, P9, DOI 10.1242/jcs.00183; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; Chabin RM, 1996, BIOCHEMISTRY-US, V35, P9567, DOI 10.1021/bi960476o; Chartier FJM, 2006, J BIOL CHEM, V281, P9953, DOI 10.1074/jbc.M513893200; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; Chartier FJM, 2007, BIOCHEM J, V401, P235, DOI 10.1042/BJ20060913; Couture M, 2001, J BIOL CHEM, V276, P38280; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Doukov T, 2009, BIOCHEMISTRY-US, V48, P10246, DOI 10.1021/bi9009743; Fan BC, 1997, BIOCHEMISTRY-US, V36, P12660, DOI 10.1021/bi9715369; Ghosh DK, 2003, FRONT BIOSCI-LANDMRK, V8, pD193, DOI 10.2741/959; Giroud C, 2010, J BIOL CHEM, V285, P7233, DOI 10.1074/jbc.M109.038240; Gorren ACF, 2002, BIOCHEMISTRY-US, V41, P7819, DOI 10.1021/bi025675o; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Hughes MN, 2008, METHOD ENZYMOL, V436, P3, DOI 10.1016/S0076-6879(08)36001-7; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Li D, 2007, J AM CHEM SOC, V129, P6943, DOI 10.1021/ja070683j; Li HY, 2006, J BIOL INORG CHEM, V11, P753, DOI 10.1007/s00775-006-0123-8; Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1242/jcs.01166; Marechal A, 2010, FEBS J, V277, P3963, DOI 10.1111/j.1742-4658.2010.07786.x; Martinis SA, 1996, BIOCHEMISTRY-US, V35, P14530, DOI 10.1021/bi961511u; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Migita CT, 1997, BIOCHEMISTRY-US, V36, P10987, DOI 10.1021/bi970823+; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Mungrue IN, 2004, J CELL SCI, V117, P2627, DOI 10.1242/jcs.01187; Ogliaro F, 2002, J INORG BIOCHEM, V91, P554, DOI 10.1016/S0162-0134(02)00437-3; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Patel BA, 2009, P NATL ACAD SCI USA, V106, P18183, DOI 10.1073/pnas.0907262106; Poulos TL, 2007, DRUG METAB REV, V39, P557, DOI 10.1080/03602530701498240; Poulos TL, 1996, J BIOL INORG CHEM, V1, P356, DOI 10.1007/s007750050064; Poulos TL, 2005, DRUG METAB DISPOS, V33, P10, DOI 10.1124/dmd.104.002071; Presta A, 1998, BIOCHEMISTRY-US, V37, P298, DOI 10.1021/bi971944c; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; Reece SY, 2009, BIOCHEMISTRY-US, V48, P5483, DOI 10.1021/bi900385g; Rousseau DL, 2005, J INORG BIOCHEM, V99, P306, DOI 10.1016/j.jinorgbio.2004.11.007; Salard I, 2006, J INORG BIOCHEM, V100, P2024, DOI 10.1016/j.jinorgbio.2006.09.017; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Sessa WC, 2004, J CELL SCI, V117, P2427, DOI 10.1242/jcs.01165; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stuehr DJ, 2004, J BIOL CHEM, V279, P36167, DOI 10.1074/jbc.R400017200; Sudhamsu J, 2006, J BIOL CHEM, V281, P9623, DOI 10.1074/jbc.M510062200; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Voegtle HL, 2003, BIOCHEMISTRY-US, V42, P2475, DOI 10.1021/bi0271502; WANG JL, 1993, J BIOL CHEM, V268, P22255; WANG JL, 1994, P NATL ACAD SCI USA, V91, P10512, DOI 10.1073/pnas.91.22.10512; WANG JL, 1995, BIOCHEMISTRY-US, V34, P7080, DOI 10.1021/bi00021a020; Wang JL, 1997, BIOCHEMISTRY-US, V36, P4595, DOI 10.1021/bi962309u; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2010, J INORG BIOCHEM, V104, P349, DOI 10.1016/j.jinorgbio.2009.11.006; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008	74	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.195446	http://dx.doi.org/10.1074/jbc.M110.195446			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310962	Green Published, hybrid			2022-12-25	WOS:000289077500013
J	Shanware, NP; Hutchinson, JA; Kim, SH; Zhan, LH; Bowler, MJ; Tibbetts, RS				Shanware, Naval P.; Hutchinson, John A.; Kim, Sang Hwa; Zhan, Lihong; Bowler, Michael J.; Tibbetts, Randal S.			Casein Kinase 1-dependent Phosphorylation of Familial Advanced Sleep Phase Syndrome-associated Residues Controls PERIOD 2 Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; CKI-EPSILON; PROTEIN; MUTATION; DROSOPHILA; RHYTHM; DEGRADATION; CK1-EPSILON; GROWTH; PLAYS	The mammalian circadian clock component PERIOD2 (PER2) plays a critical role in circadian rhythm entrainment. Recently, a missense mutation at a putative phosphorylation site in hPER2, Ser-662, was identified in patients that suffer from familial advanced sleep phase syndrome (FASPS). Patients with FASPS display abnormal sleep-wake patterns characterized by a lifelong pattern of sleep onset in the early evening and offset in the early morning. Although the phosphorylation of PER2 is strongly implied from functional studies, it has not been possible to study the site-specific phosphorylation of PER2 on Ser-662, and the biochemical functions of this residue are unclear. Here, we used phospho-specific antibodies to show that PER2 is phosphorylated on Ser-662 and flanking casein kinase (CK) sites in vivo. The phosphorylation of PER2 was carried out by the combined activities of casein kinase 1 delta (CK1 delta) and casein kinase 1 epsilon (CK1 epsilon) and was antagonized by protein phosphatase 1. PER2 phosphorylation was rapidly induced in response to circadian entrainment of mammalian cell lines and occurred in both cytosolic and nuclear compartments. Importantly, we found that the pool of Ser-662-phosphorylated PER2 proteins was more stable than the pool of total PER2 molecules, implying that the FASPS phosphorylation cluster antagonizes PER2 degradation. Consistent with this idea, a Ser-662 -> Ala mutation that abrogated PER2 phosphorylation significantly reduced its half-life, whereas a phosphomimetic Ser-662 -> Asp substitution led to an elevation in half-life. Our combined findings provide new insights into PER2 regulation and the biochemical basis of FASPS.	[Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53705 USA; Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53705 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722, T32ES007015]; American Cancer Society [RSG-06-113-01]; Greater Milwaukee Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124722 (to R. S. T.) and T32ES007015 (to J. A. H.). This work was also supported by American Cancer Society Grant RSG-06-113-01 and a Shaw scientist award (to R. S. T.) from the Greater Milwaukee Foundation.; Supported by an American Heart Association Predoctoral Fellowship.	Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Arjona A, 2006, J INTERF CYTOK RES, V26, P645, DOI 10.1089/jir.2006.26.645; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Connor JH, 1998, J BIOL CHEM, V273, P27716, DOI 10.1074/jbc.273.42.27716; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2001, CHRONOBIOL INT, V18, P389, DOI 10.1081/CBI-100103963; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gallego M, 2006, BIOCHEM J, V399, P169, DOI 10.1042/BJ20060678; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Kondratov RV, 2007, TRENDS CELL BIOL, V17, P311, DOI 10.1016/j.tcb.2007.07.001; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Mackey SR, 2007, COLD SPRING HARB SYM, V72, P7, DOI 10.1101/sqb.2007.72.060; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Preuss F, 2004, MOL CELL BIOL, V24, P886, DOI 10.1128/MCB.24.2.886-898.2004; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rosbash M, 2007, COLD SPRING HARB SYM, V72, P75, DOI 10.1101/sqb.2007.72.062; Sathyanarayanan S, 2004, CELL, V116, P603, DOI 10.1016/S0092-8674(04)00128-X; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; Suri V, 2000, J NEUROSCI, V20, P7547; Swingle Mark, 2007, V365, P23; Takano A, 2006, BIOCHEM BIOPH RES CO, V346, P95, DOI 10.1016/j.bbrc.2006.05.082; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Udho E, 2002, BIOCHEM BIOPH RES CO, V297, P463, DOI 10.1016/S0006-291X(02)02236-2; Vanselow K, 2007, COLD SPRING HARB SYM, V72, P167, DOI 10.1101/sqb.2007.72.036; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453	37	50	53	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M111.224014	http://dx.doi.org/10.1074/jbc.M111.224014			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324900	Green Published, hybrid			2022-12-25	WOS:000289077500087
J	Volkmann, K; Lucas, JL; Vuga, D; Wang, XP; Brumm, D; Stiles, C; Kriebel, D; Der-Sarkissian, A; Krishnan, K; Schweitzer, C; Liu, Z; Malyankar, UM; Chiovitti, D; Canny, M; Durocher, D; Sicheri, F; Patterson, JB				Volkmann, Kori; Lucas, Julie L.; Vuga, Danka; Wang, Xiaoping; Brumm, Duane; Stiles, Caryn; Kriebel, David; Der-Sarkissian, Ani; Krishnan, Kris; Schweitzer, Colleen; Liu, Zheng; Malyankar, Uriel M.; Chiovitti, David; Canny, Marella; Durocher, Dan; Sicheri, Frank; Patterson, John B.			Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTOR; ER STRESS; PYRIDOXAL-PHOSPHATE; MAMMALIAN-CELLS; KINASE-ACTIVITY; RIBONUCLEASE-A	Inositol-requiring enzyme 1 (IRE1) is the most highly conserved signaling node of the unfolded protein response (UPR) and represents a potential therapeutic target for a number of diseases associated with endoplasmic reticulum stress. IRE1 activates the XBP-1 transcription factor by site-specific cleavage of two hairpin loops within its mRNA to facilitate its nonconventional splicing and alternative translation. We screened for inhibitors using a construct containing the unique cytosolic kinase and endoribonuclease domains of human IRE1 alpha (hIRE1 alpha-cyto) and a mini-XBP-1 stem-loop RNA as the substrate. One class compounds was salicylaldehyde analogs from the hydrolyzed product of salicylaldimines in the library. Salicylaldehyde analogs were active in inhibiting the site-specific cleavage of several mini-XBP-1 stem-loop RNAs in a dose-dependent manner. Salicyaldehyde analogs were also active in inhibiting yeast Ire1 but had little activity inhibiting RNase L or the unrelated RNases A and T-1. Kinetic analysis revealed that one potent salicylaldehyde analog, 3-ethoxy-5,6-dibromosalicylaldehyde, is a non-competitive inhibitor with respect to the XBP-1 RNA substrate. Surface plasmon resonance studies confirmed this compound bound to IRE1 in a specific, reversible and dose-dependent manner. Salicylaldehydes inhibited XBP-1 splicing induced pharmacologically in human cells. These compounds also blocked transcriptional up-regulation of known XBP-1 targets as well as mRNAs targeted for degradation by IRE1. Finally, the salicylaldehyde analog 3-methoxy-6-bromosalicylaldehyde strongly inhibited XBP-1 splicing in an in vivo model of acute endoplasmic reticulum stress. To our knowledge, salicylaldehyde analogs are the first reported specific IRE1 endoribonuclease inhibitors.	[Volkmann, Kori; Lucas, Julie L.; Vuga, Danka; Wang, Xiaoping; Brumm, Duane; Stiles, Caryn; Kriebel, David; Der-Sarkissian, Ani; Krishnan, Kris; Schweitzer, Colleen; Liu, Zheng; Malyankar, Uriel M.; Patterson, John B.] MannKind Corp, Valencia, CA 91355 USA; [Chiovitti, David; Canny, Marella; Durocher, Dan; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Syst Biol, Toronto, ON M5G 1X5, Canada; [Durocher, Dan; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Patterson, JB (corresponding author), 28903 N Ave Paine, Valencia, CA 91355 USA.	jpatterson@mannkindcorp.com	Sicheri, Frank/F-8856-2013; Durocher, Daniel/A-7733-2010	Durocher, Daniel/0000-0003-3863-8635; Lucas, Julie/0000-0001-6094-1740	Multiple Myeloma Research Foundation	Multiple Myeloma Research Foundation	This work was supported in part by a Biotech Investment Award from the Multiple Myeloma Research Foundation.	Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Carroll SS, 1996, J BIOL CHEM, V271, P4988; Copeland R. A., 2005, EVALUATION ENZYME IN; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Dong BH, 2001, RNA, V7, P361, DOI 10.1017/S1355838201002230; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; GEORGALIS Y, 1991, BIOCHIM BIOPHYS ACTA, V1118, P1, DOI 10.1016/0167-4838(91)90434-2; Gonzalez TN, 1999, EMBO J, V18, P3119, DOI 10.1093/emboj/18.11.3119; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kao RYT, 2002, P NATL ACAD SCI USA, V99, P10066, DOI 10.1073/pnas.152342999; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lee AS, 2006, CANCER BIOL THER, V5, P721, DOI 10.4161/cbt.5.7.3120; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; MORI K, 1993, CELL, V74, P743; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; Oikawa D, 2007, BIOCHEM BIOPH RES CO, V360, P122, DOI 10.1016/j.bbrc.2007.06.020; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Qiu YF, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000514; RAETZ CRH, 1972, BIOCHEMISTRY-US, V11, P2229, DOI 10.1021/bi00762a004; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RIQUELME P, 1975, INT J PEPT PROT RES, V7, P379; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Smith M.B., 2007, ADV ORGANIC CHEM REA, V6th ed, DOI 10.1002/9780470084960.ch15; Spiotto MT, 2010, CANCER RES, V70, P78, DOI 10.1158/0008-5472.CAN-09-2747; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Thakur CS, 2007, P NATL ACAD SCI USA, V104, P9585, DOI 10.1073/pnas.0700590104; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Ueno Y, 2003, BIOORGAN MED CHEM, V11, P5069, DOI 10.1016/j.bmc.2003.08.025; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2009, CELL STRUCT FUNCT, V34, P1, DOI 10.1247/csf.06028; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	55	164	182	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.199737	http://dx.doi.org/10.1074/jbc.M110.199737			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21303903	hybrid, Green Published			2022-12-25	WOS:000289077500085
J	Long, JY; Wang, Y; Wang, WJ; Chang, BHJ; Danesh, FR				Long, Jianyin; Wang, Yin; Wang, Wenjian; Chang, Benny H. J.; Danesh, Farhad R.			MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-KINASE INHIBITOR; KIDNEY GLOMERULI; GENE-EXPRESSION; GROWTH-FACTOR; PROTEIN; REGULATOR; APOPTOSIS; CANCER; MIR-29; DIFFERENTIATION	Although several recent publications have suggested that microRNAs contribute to the pathogenesis of diabetic nephropathy, the role of miRNAs in vivo still remains poorly understood. Using an integrated in vitro and in vivo comparative miRNA expression array, we identified miR-29c as a signature miRNA in the diabetic environment. We validated our profiling array data by examining miR-29c expression in the kidney glomeruli obtained from db/db mice in vivo and in kidney microvascular endothelial cells and podocytes treated with high glucose in vitro. Functionally, we found that miR-29c induces cell apoptosis and increases extracellular matrix protein accumulation. Indeed, forced expression of miR-29c strongly induced podocyte apoptosis. Conversely, knockdown of miR-29c prevented high glucose-induced cell apoptosis. We also identified Sprouty homolog 1 (Spry1) as a direct target of miR-29c with a nearly perfect complementarity between miR-29c and the 3'-untranslated region (UTR) of mouse Spry1. Expression of miR-29c decreased the luciferase activity of Spry1 when co-transfected with the mouse Spry1 3'-UTR reporter construct. Overexpression of miR-29c decreased the levels of Spry1 protein and promoted activation of Rho kinase. Importantly, knockdown of miR-29c by a specific antisense oligonucleotide significantly reduced albuminuria and kidney mesangial matrix accumulation in the db/db mice model in vivo. These findings identify miR-29c as a novel target in diabetic nephropathy and provide new insights into the role of miR-29c in a previously unrecognized signaling cascade involving Spry1 and Rho kinase activation.	[Long, Jianyin; Wang, Yin; Wang, Wenjian; Danesh, Farhad R.] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Chang, Benny H. J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Danesh, Farhad R.] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Danesh, FR (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, 1 Baylor Plaza, Houston, TX 77030 USA.	danesh@bcm.edu	Long, Jianyin/H-8261-2013	Danesh, Farhad/0000-0001-6849-5239	National Institutes of Health through the NIDDK [RO1DK067604, RO1DK078900]; Diabetes and Endocrinology Research Center at the Baylor College of Medicine [DK079638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638, R01DK067604, R01DK078900] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; Diabetes and Endocrinology Research Center at the Baylor College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK067604 and RO1DK078900 through the NIDDK (to F. R. D.). This work was also partly supported by the Diabetes and Endocrinology Research Center (Grant DK079638) at the Baylor College of Medicine.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Danesh FR, 2002, P NATL ACAD SCI USA, V99, P8301, DOI 10.1073/pnas.122228799; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Du M, 2006, FEBS J, V273, P732, DOI 10.1111/j.1742-4658.2006.05106.x; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Garofalo M, 2011, ANNU REV PHARMACOL, V51, P25, DOI 10.1146/annurev-pharmtox-010510-100517; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Hartshorne DJ, 1999, MOL CELL BIOCHEM, V190, P79, DOI 10.1023/A:1006917032557; Horwich MD, 2008, NAT PROTOC, V3, P1537, DOI 10.1038/nprot.2008.145; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kikuchi Y, 2007, J ENDOCRINOL, V192, P595, DOI 10.1677/JOE-06-0045; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Langley RR, 2003, CANCER RES, V63, P2971; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lewko B, 2009, J CELL PHYSIOL, V221, P288, DOI 10.1002/jcp.21856; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nagpal JK, 2010, CURR MOL MED, V10, P503, DOI 10.2174/156652410791608216; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peng FF, 2008, DIABETES, V57, P1683, DOI 10.2337/db07-1149; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sabatel C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-231; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Varallyay E, 2008, NAT PROTOC, V3, P190, DOI 10.1038/nprot.2007.528; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang Y, 2008, GENE DEV, V22, P878, DOI 10.1101/gad.452908; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Xiong YJ, 2010, HEPATOLOGY, V51, P836, DOI 10.1002/hep.23380; Yoneda A, 2007, MOL BIOL CELL, V18, P66, DOI 10.1091/mbc.E06-08-0684; Zeng LX, 2005, FASEB J, V19, P1845, DOI 10.1096/fj.05-4240fje; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147	70	213	240	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11837	11848		10.1074/jbc.M110.194969	http://dx.doi.org/10.1074/jbc.M110.194969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310958	Green Published, hybrid			2022-12-25	WOS:000288797100090
J	Kostic, C; Crippa, SV; Pignat, V; Bemelmans, AP; Samardzija, M; Grimm, C; Wenzel, A; Arsenijevic, Y				Kostic, Corinne; Crippa, Sylvain Vincent; Pignat, Verene; Bemelmans, Alexis-Pierre; Samardzija, Marijana; Grimm, Christian; Wenzel, Andreas; Arsenijevic, Yvan			Gene Therapy Regenerates Protein Expression in Cone Photoreceptors in Rpe65R91W1aR91W Mice	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; PUPILLARY LIGHT REFLEX; RPE65 MUTATIONS; RETINAL DYSTROPHY; RESTORES VISION; VISUAL FUNCTION; CANINE MODEL; MOUSE MODEL; TRANSLOCATION; DEGENERATION	Cone photoreceptors mediate visual acuity under daylight conditions, so loss of cone-mediated central vision of course dramatically affects the quality of life of patients suffering from retinal degeneration. Therefore, promoting cone survival has become the goal of many ocular therapies and defining the stage of degeneration that still allows cell rescue is of prime importance. Using the Rpe65(R91W/R91W) mouse, which carries a mutation in the Rpe65 gene leading to progressive photoreceptor degeneration in both patients and mice, we defined stages of retinal degeneration that still allow cone rescue. We evaluated the therapeutic window within which cones can be rescued, using a subretinal injection of a lentiviral vector driving expression of RPE65 in the Rpe65(R91W/R91W) mice. Surprisingly, when applied to adult mice (1 month) this treatment not only stalls or slows cone degeneration but, actually, induces cone-specific protein expression that was previously absent. Before the intervention only part of the cones (40% of the number found in wild-type animals) in the Rpe65(R91W/R91W) mice expressed cone transducin (GNAT2); this fraction increased to 64% after treatment. Correct S-opsin localization is also recovered in the transduced region. In consequence these results represent an extended therapeutic window compared to the Rpe65(-/-) mice, implying that patients suffering from missense mutations might also benefit from a prolonged therapeutic window. Moreover, cones are not only rescued during the course of the degeneration, but can actually recover their initial status, meaning that a proportion of altered cones in chromophore deficiency-related disease can be rehabilitated even though they are severely affected.	[Kostic, Corinne; Crippa, Sylvain Vincent; Pignat, Verene; Bemelmans, Alexis-Pierre; Arsenijevic, Yvan] Univ Lausanne, Unit Gene Therapy & Stem Cell Biol, Jules Gonin Eye Hosp, Lausanne, Switzerland; [Samardzija, Marijana; Grimm, Christian; Wenzel, Andreas] Univ Zurich, Lab Retinal Cell Biol, Dept Ophthalmol, Zurich, Switzerland	University of Lausanne; University of Zurich	Kostic, C (corresponding author), Univ Lausanne, Unit Gene Therapy & Stem Cell Biol, Jules Gonin Eye Hosp, Lausanne, Switzerland.	corinne.kostic@fa2.ch	Bemelmans, Alexis-Pierre/H-4476-2019; Samardzija, Marijana/B-9245-2008	Bemelmans, Alexis-Pierre/0000-0001-7605-5225; Samardzija, Marijana/0000-0003-0991-4653; Kostic, Corinne/0000-0003-1006-9733; Grimm, Christian/0000-0001-9318-4352; Crippa, Sylvain Vincent/0000-0002-4677-2642; Arsenijevic, Yvan/0000-0001-6960-1291	Provisu foundation; Novartis foundation	Provisu foundation; Novartis foundation(Novartis)	This work was supported by the Provisu foundation (www.provisu.ch) and the Novartis foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Aleman TS, 2004, INVEST OPHTH VIS SCI, V45, P1259, DOI 10.1167/iovs.03-1230; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bemelmans AP, 2006, PLOS MED, V3, P1892, DOI 10.1371/journal.pmed.0030347; Cachafeiro M, 2010, INVEST OPHTHALMOL VI; Caruso RC, 2010, INVEST OPHTHALMOL VI; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Cideciyan AV, 2010, PROG RETIN EYE RES, V29, P398, DOI 10.1016/j.preteyeres.2010.04.002; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coleman JE, 2005, INVEST OPHTH VIS SCI, V46, P12, DOI 10.1167/iovs.04-0691; Dejneka NS, 2004, MOL THER, V9, P182, DOI 10.1016/j.ymthe.2003.11.013; Dinculescu A, 2005, HUM GENE THER, V16, P649, DOI 10.1089/hum.2005.16.649; El Matri L, 2006, GRAEF ARCH CLIN EXP, V244, P1104, DOI 10.1007/s00417-005-0096-2; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2008, INVEST OPHTH VIS SCI, V49, P4573, DOI 10.1167/iovs.08-2121; Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104; Jacobson SG, 2005, P NATL ACAD SCI USA, V102, P6177, DOI 10.1073/pnas.0500646102; Jin MH, 2009, J NEUROSCI, V29, P1486, DOI 10.1523/JNEUROSCI.3882-08.2009; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Lai Chooi-May, 2004, Genet Vaccines Ther, V2, P3, DOI 10.1186/1479-0556-2-3; Le Meur G, 2007, GENE THER, V14, P292, DOI 10.1038/sj.gt.3302861; Lorenz B, 2008, INVEST OPHTH VIS SCI, V49, P5235, DOI 10.1167/iovs.07-1671; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Mendez A, 2003, J NEUROSCI, V23, P3124; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Narfstrom K, 2003, INVEST OPHTH VIS SCI, V44, P1663, DOI 10.1167/iovs.02-0595; NEGOESCU A, 1994, J HISTOCHEM CYTOCHEM, V42, P433, DOI 10.1177/42.3.7508473; Nusinowitz S, 2006, VISION RES, V46, P3926, DOI 10.1016/j.visres.2006.05.010; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Paunescu K, 2005, GRAEF ARCH CLIN EXP, V243, P417, DOI 10.1007/s00417-004-1020-x; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Salmon P, 2000, MOL THER, V2, P404, DOI 10.1006/mthe.2000.0141; Samardzija M, 2008, HUM MOL GENET, V17, P281, DOI 10.1093/hmg/ddm304; Samardzija M, 2009, HUM MOL GENET, V18, P1266, DOI 10.1093/hmg/ddp026; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Yanez-Munoz RJ, 2006, NAT MED, V12, P348, DOI 10.1038/nm1365; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zernant J, 2005, INVEST OPHTH VIS SCI, V46, P3052, DOI 10.1167/iovs.05-0111; Zhang HB, 2003, MOL VIS, V9, P231; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	58	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16588	10.1371/journal.pone.0016588	http://dx.doi.org/10.1371/journal.pone.0016588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304899	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600010
J	Chiu, WC; Lai, YP; Chou, MY				Chiu, Wei-Chun; Lai, Ya-Ping; Chou, Min-Yuan			Humanization and Characterization of an Anti-Human TNF-alpha Murine Monoclonal Antibody	PLOS ONE			English	Article							FRAMEWORK RESIDUES; VARIABLE DOMAINS; ARTHRITIS; THERAPY; IMMUNOGENICITY; MECHANISMS; CELLS; BINDS	A murine monoclonal antibody, m357, showing the highly neutralizing activities for human tumor necrosis factor (TNF-alpha) was chosen to be humanized by a variable domain resurfacing approach. The non-conserved surface residues in the framework regions of both the heavy and light chain variable regions were identified via a molecular modeling of m357 built by computer-assisted homology modeling. By replacing these critical surface residues with the human counterparts, a humanized version, h357, was generated. The humanized h357 IgG(1) was then stably expressed in a mammalian cell line and the purified antibody maintained the high antigen binding affinity as compared with the parental m357 based on a soluble TNF-alpha neutralization bioassay. Furthermore, h357 IgG(1) possesses the ability to mediate antibody-dependent cell-mediated cytotoxicity and complement dependent cytotoxicity upon binding to cells bearing the transmembrane form of TNF-alpha. In a mouse model of collagen antibody-induced arthritis, h357 IgG significantly inhibited disease progression by intra-peritoneal injection of 50 mu g/mouse once-daily for 9 consecutive days. These results provided a basis for the development of h357 IgG as therapeutic use.	[Chiu, Wei-Chun; Lai, Ya-Ping; Chou, Min-Yuan] Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan	Industrial Technology Research Institute - Taiwan	Chiu, WC (corresponding author), Ind Technol Res Inst, Biomed Technol & Device Res Labs, Hsinchu, Taiwan.	minyuanc@itri.org.tw			Ministry of Economic Affairs [9356E71100]	Ministry of Economic Affairs	This work was funded by the Ministry of Economic Affairs, grant number 9356E71100 (http://www.moeaidb.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aringer M, 2008, EXPERT OPIN DRUG SAF, V7, P411, DOI [10.1517/14740338.7.4.411, 10.1517/14740338.7.4.411 ]; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Beenhouwer D, 2004, J RHEUMATOL, V31, P1888; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUGGEMANN M, 1989, J EXP MED, V170, P2153, DOI 10.1084/jem.170.6.2153; Caron G, 1999, EUR J IMMUNOL, V29, P3588, DOI 10.1002/(SICI)1521-4141(199911)29:11<3588::AID-IMMU3588>3.0.CO;2-O; Dokurno P, 1998, J MOL BIOL, V284, P713, DOI 10.1006/jmbi.1998.2209; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Feldmann M, 2001, NAT IMMUNOL, V2, P771, DOI 10.1038/ni0901-771; Fontayne A, 2006, THROMB HAEMOSTASIS, V96, P671, DOI 10.1160/TH06-06-0297; Kabat E.A., 1991, SEQUENCES IMMUNOLOGI; Khachigian LM, 2006, NAT PROTOC, V1, P2512, DOI 10.1038/nprot.2006.393; MATTHEWS N, 1987, LYMPHOKINES INTERFER, P221; MEAGER A, 1987, HYBRIDOMA, V6, P305, DOI 10.1089/hyb.1987.6.305; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; MORRISON SL, 1984, P NATL ACAD SCI-BIOL, V81, P6851, DOI 10.1073/pnas.81.21.6851; Murali R, 1998, PROTEIN ENG, V11, P79, DOI 10.1093/protein/11.2.79; O'Connor SJ, 1998, PROTEIN ENG, V11, P321, DOI 10.1093/protein/11.4.321; OWENS RJ, 1994, J IMMUNOL METHODS, V168, P149, DOI 10.1016/0022-1759(94)90051-5; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; PEREZ C, 1990, CELL, V63, P251, DOI 10.1016/0092-8674(90)90158-B; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; SANDHU JS, 1992, CRIT REV BIOTECHNOL, V12, P437, DOI 10.3109/07388559209114235; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; SCHROFF RW, 1985, CANCER RES, V45, P879; Staelens S, 2006, MOL IMMUNOL, V43, P1243, DOI 10.1016/j.molimm.2005.07.018; Taylor PC, 2010, CURR OPIN PHARMACOL, V10, P1; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Zhang W, 2005, MOL IMMUNOL, V42, P1445, DOI 10.1016/j.molimm.2005.01.015	33	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16373	10.1371/journal.pone.0016373	http://dx.doi.org/10.1371/journal.pone.0016373			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305012	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300056
J	Ribeiro, CMS; Bird, S; Raes, G; Ghassabeh, GH; Schijns, VEJC; Pontes, MJSL; Savelkoul, HFJ; Wiegertjes, GF				Ribeiro, Carla M. S.; Bird, Steve; Raes, Geert; Ghassabeh, Gholamreza H.; Schijns, Virgil E. J. C.; Pontes, Maria J. S. L.; Savelkoul, Huub F. J.; Wiegertjes, Geert F.			A Novel Soluble Immune-Type Receptor (SITR) in Teleost Fish: Carp SITR Is Involved in the Nitric Oxide-Mediated Response to a Protozoan Parasite	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE TRANSCRIPTS; IG-LIKE DOMAINS; TRYPANOPLASMA-BORRELI; GENE-CLUSTER; EVOLUTION; MOLECULES; RECOGNITION; FAMILY; MEMBER; CELLS	Background: The innate immune system relies upon a wide range of germ-line encoded receptors including a large number of immunoglobulin superfamily (IgSF) receptors. Different Ig-like immune receptor families have been reported in mammals, birds, amphibians and fish. Most innate immune receptors of the IgSF are type I transmembrane proteins containing one or more extracellular Ig-like domains and their regulation of effector functions is mediated intracellularly by distinct stimulatory or inhibitory pathways. Methodology/Principal Findings: Carp SITR was found in a substracted cDNA repertoire from carp macrophages, enriched for genes up-regulated in response to the protozoan parasite Trypanoplasma borreli. Carp SITR is a type I protein with two extracellular Ig domains in a unique organisation of a N-proximal V/C2 (or I-) type and a C-proximal V-type Ig domain, devoid of a transmembrane domain or any intracytoplasmic signalling motif. The carp SITR C-proximal V-type Ig domain, in particular, has a close sequence similarity and conserved structural characteristics to the mammalian CD300 molecules. By generating an anti-SITR antibody we could show that SITR protein expression was restricted to cells of the myeloid lineage. Carp SITR is abundantly expressed in macrophages and is secreted upon in vitro stimulation with the protozoan parasite T. borreli. Secretion of SITR protein during in vivo T. borreli infection suggests a role for this IgSF receptor in the host response to this protozoan parasite. Overexpression of carp SITR in mouse macrophages and knock-down of SITR protein expression in carp macrophages, using morpholino antisense technology, provided evidence for the involvement of carp SITR in the parasite-induced NO production. Conclusion/Significance: We report the structural and functional characterization of a novel soluble immune-type receptor (SITR) in a teleost fish and propose a role for carp SITR in the NO-mediated response to a protozoan parasite.	[Ribeiro, Carla M. S.; Schijns, Virgil E. J. C.; Pontes, Maria J. S. L.; Savelkoul, Huub F. J.; Wiegertjes, Geert F.] Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Bird, Steve] Univ Aberdeen, Scottish Fish Immunol Res Ctr, Sch Biol Sci, Aberdeen, Scotland; [Raes, Geert; Ghassabeh, Gholamreza H.] Vrije Univ Brussel, Cellular & Mol Immunol Lab, Brussels, Belgium; [Raes, Geert; Ghassabeh, Gholamreza H.] Vrije Univ Brussel, Dept Mol & Cellular Interact, Brussels, Belgium	Wageningen University & Research; University of Aberdeen; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Ribeiro, CMS (corresponding author), Wageningen Univ, Dept Anim Sci, Cell Biol & Immunol Grp, Wageningen, Netherlands.	geert.wiegertjes@wur.nl	Bird, Steve/K-4822-2014; Raes, Geert M/H-5185-2013; Wiegertjes, Geert F/E-3330-2012; Savelkoul, Huub FJ/F-6026-2012; Pontes, Maria Jose/GQB-0171-2022	Bird, Steve/0000-0003-2937-8579; Raes, Geert M/0000-0002-9065-1549; wiegertjes, geert/0000-0001-9265-3436; Ribeiro, Carla/0000-0002-5682-4143	Portuguese foundation Fundacao para a Ciencia e Tecnologia [SFRH/BD/21522/2005]	Portuguese foundation Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This study was supported by the Portuguese foundation Fundacao para a Ciencia e Tecnologia under grant agreement number SFRH/BD/21522/2005 (http://alfa.fct.mctes.pt/contactos.phtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar H, 2004, J IMMUNOL, V173, P6703, DOI 10.4049/jimmunol.173.11.6703; Allcock RJN, 2003, EUR J IMMUNOL, V33, P567, DOI 10.1002/immu.200310033; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barclay AN, 1999, P NATL ACAD SCI USA, V96, P14672, DOI 10.1073/pnas.96.26.14672; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boyington JC, 2001, IMMUNOL REV, V181, P66, DOI 10.1034/j.1600-065X.2001.1810105.x; Buljan M, 2009, BIOCHEM SOC T, V37, P751, DOI 10.1042/BST0370751; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Cannon JP, 2006, IMMUNOGENETICS, V58, P362, DOI 10.1007/s00251-006-0112-7; Cannon JP, 2010, SEMIN IMMUNOL, V22, P17, DOI 10.1016/j.smim.2009.11.006; Clark GJ, 2009, IMMUNOBIOLOGY, V214, P730, DOI 10.1016/j.imbio.2009.06.004; Clark GJ, 2009, TRENDS IMMUNOL, V30, P209, DOI 10.1016/j.it.2009.02.003; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Clark GJ, 2001, TISSUE ANTIGENS, V57, P415, DOI 10.1034/j.1399-0039.2001.057005415.x; Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019; Dahm R, 2006, MAR BIOTECHNOL, V8, P329, DOI 10.1007/s10126-006-5139-0; Diefenbach A, 2003, CURR OPIN IMMUNOL, V15, P37, DOI 10.1016/S0952-7915(02)00007-9; Du Pasquier L, 2004, IMMUNOL LETT, V92, P3, DOI 10.1016/j.imlet.2003.10.012; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Forlenza M, 2008, MOL IMMUNOL, V45, P3178, DOI 10.1016/j.molimm.2008.02.025; GAMULIN V, 1994, BIOL CHEM H-S, V375, P583; Gattis JL, 2006, J BIOL CHEM, V281, P13396, DOI 10.1074/jbc.M600489200; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847; IRNAZAROW I, 1995, AQUACULTURE, V129, P215, DOI 10.1016/0044-8486(95)91961-T; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Joerink M, 2006, J IMMUNOL, V177, P61, DOI 10.4049/jimmunol.177.1.61; Joerink M, 2006, FISH SHELLFISH IMMUN, V21, P561, DOI 10.1016/j.fsi.2006.03.006; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; KOUMANSVANDIEPEN JCE, 1995, DEV COMP IMMUNOL, V19, P97, DOI 10.1016/0145-305X(94)00061-J; Lebbink RJ, 2004, J IMMUNOL, V172, P5535, DOI 10.4049/jimmunol.172.9.5535; Lebbink RJ, 2008, J IMMUNOL, V180, P1662, DOI 10.4049/jimmunol.180.3.1662; Levine SJ, 2004, J IMMUNOL, V173, P5343, DOI 10.4049/jimmunol.173.9.5343; Litman GW, 2001, IMMUNOL REV, V181, P250, DOI 10.1034/j.1600-065X.2001.1810121.x; Long M, 2001, CURR OPIN GENET DEV, V11, P673, DOI 10.1016/S0959-437X(00)00252-5; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; Martinez-Barriocanal A, 2006, J IMMUNOL, V177, P2819, DOI 10.4049/jimmunol.177.5.2819; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nakayasu C, 1998, FISH SHELLFISH IMMUN, V8, P91, DOI 10.1006/fsim.1997.0125; Nikolaidis N, 2005, IMMUNOGENETICS, V57, P151, DOI 10.1007/s00251-004-0764-0; Ostergaard AE, 2009, DEV COMP IMMUNOL, V33, P525, DOI 10.1016/j.dci.2008.10.002; Overath P, 1998, PARASITOL RES, V84, P343, DOI 10.1007/s004360050408; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patthy L, 1999, GENE, V238, P103, DOI 10.1016/S0378-1119(99)00228-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Ribeiro CMS, 2010, J IMMUNOL, V184, P2355, DOI 10.4049/jimmunol.0900990; RIBEIRO CM, 2002, J IMMUNOL, V184, P2355; Rombout JHWM, 1996, J FISH BIOL, V49, P521, DOI 10.1111/j.1095-8649.1996.tb00047.x; Saeij JPJ, 2003, DEV COMP IMMUNOL, V27, P859, DOI 10.1016/S0145-305X(03)00083-1; Saeij JPJ, 2002, PARASITOLOGY, V124, P77, DOI 10.1017/S0031182001008915; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; SECOMBES CJ, 1983, IMMUNOLOGY, V48, P165; STEINHAGEN D, 1989, J PARASITOL, V75, P685, DOI 10.2307/3283050; Steinhagen D, 2000, DIS AQUAT ORGAN, V41, P195, DOI 10.3354/dao041195; Stet RJM, 2005, IMMUNOGENETICS, V57, P77, DOI 10.1007/s00251-005-0771-9; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Torkar M, 2000, EUR J IMMUNOL, V30, P3655, DOI 10.1002/1521-4141(200012)30:12<3655::AID-IMMU3655>3.0.CO;2-Y; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Volz A, 2001, IMMUNOL REV, V181, P39, DOI 10.1034/j.1600-065X.2001.1810103.x; Weyts FAA, 1997, FISH SHELLFISH IMMUN, V7, P123, DOI 10.1006/fsim.1996.0069; Wines BD, 1999, J IMMUNOL, V162, P2146; Yoder JA, 2004, P NATL ACAD SCI USA, V101, P15706, DOI 10.1073/pnas.0405242101; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004	73	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15986	10.1371/journal.pone.0015986	http://dx.doi.org/10.1371/journal.pone.0015986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305002	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300031
J	Shvadchak, VV; Falomir-Lockhart, LJ; Yushchenko, DA; Jovin, TM				Shvadchak, Volodymyr V.; Falomir-Lockhart, Lisandro J.; Yushchenko, Dmytro A.; Jovin, Thomas M.			Specificity and Kinetics of alpha-Synuclein Binding to Model Membranes Determined with Fluorescent Excited State Intramolecular Proton Transfer (ESIPT) Probe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-MEMBRANES; DISEASE; AGGREGATION; VESICLE; NMR; EPR; AFFINITY; BILAYERS; RELEASE; PACKING	Parkinson disease is characterized cytopathologically by the deposition in the midbrain of aggregates composed primarily of the presynaptic neuronal protein a-synuclein (AS). Neurotoxicity is currently attributed to oligomeric microaggregates subjected to oxidative modification and promoting mitochondrial and proteasomal dysfunction. Unphysiological binding to membranes of these and other organelles is presumably involved. In this study, we performed a systematic determination of the influence of charge, phase, curvature, defects, and lipid unsaturation on AS binding to model membranes using a new sensitive solvatochromic fluorescent probe. The interaction of AS with vesicular membranes is fast and reversible. The protein dissociates from neutral membranes upon thermal transition to the liquid disordered phase and transfers to vesicles with higher affinity. The binding of AS to neutral and negatively charged membranes occurs by apparently different mechanisms. Interaction with neutral bilayers requires the presence of membrane defects; binding increases with membrane curvature and rigidity and decreases in the presence of cholesterol. The association with negatively charged membranes is much stronger and much less sensitive to membrane curvature, phase, and cholesterol content. The presence of unsaturated lipids increases binding in all cases. These findings provide insight into the relation between membrane physical properties and AS binding affinity and dynamics that presumably define protein localization in vivo and, thereby, the role of AS in the physiopathology of Parkinson disease.	[Shvadchak, Volodymyr V.; Falomir-Lockhart, Lisandro J.; Yushchenko, Dmytro A.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany	Max Planck Society	Jovin, TM (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, Fassberg 11, D-37077 Gottingen, Germany.	tjovin@gwdg.de	Yushchenko, Dmytro/J-1020-2017; Shvadchak, Volodymyr/E-1475-2017; Falomir Lockhart, Lisandro Jorge/V-7730-2019	Yushchenko, Dmytro/0000-0003-0355-6197; Shvadchak, Volodymyr/0000-0001-8302-8073; Falomir Lockhart, Lisandro Jorge/0000-0003-4815-5768	Max Planck Society; Deutsche Forschungsgemeinschaft Center for the Molecular Physiology of the Brain [EXC 171-FZT103]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft Center for the Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was funded by the Max Planck Society, the Toxic Proteins Project (Innovation Fund of the Max Planck Society), and Excellence Cluster EXC 171-FZT103 "Microscopy at the Nanometer Range" associated with the Deutsche Forschungsgemeinschaft Center for the Molecular Physiology of the Brain.	Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bisaglia M, 2009, FASEB J, V23, P329, DOI 10.1096/fj.08-119784; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Bortolus M, 2008, J AM CHEM SOC, V130, P6690, DOI 10.1021/ja8010429; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; CHOU PT, 1993, J PHYS CHEM-US, V97, P2618, DOI 10.1021/j100113a024; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Demchenko AP, 2009, BIOPHYS J, V96, P3461, DOI 10.1016/j.bpj.2009.02.012; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2008, J AM CHEM SOC, V130, P7796, DOI 10.1021/ja801594s; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Golovko MY, 2009, MOL CELL BIOCHEM, V326, P55, DOI 10.1007/s11010-008-0008-y; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Kamp F, 2006, J BIOL CHEM, V281, P9251, DOI 10.1074/jbc.M512292200; Kim HP, 2009, J ENG GAS TURB POWER, V131, DOI 10.1115/1.3095808; Kjaer L, 2009, BIOPHYS J, V96, P2857, DOI 10.1016/j.bpj.2008.12.3940; Klymchenko AS, 2004, BBA-BIOMEMBRANES, V1665, P6, DOI 10.1016/j.bbamem.2004.06.004; Klymchenko AS, 2004, NEW J CHEM, V28, P687, DOI 10.1039/b316149h; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li CG, 2009, BIOCHEMISTRY-US, V48, P8578, DOI 10.1021/bi900872p; Liu JP, 2010, MOL CELL NEUROSCI, V43, P33, DOI 10.1016/j.mcn.2009.07.013; Maguire-Zeiss KA, 2008, PHARMACOL RES, V58, P271, DOI 10.1016/j.phrs.2008.09.006; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Necula M, 2003, J BIOL CHEM, V278, P46674, DOI 10.1074/jbc.M308231200; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nuscher B, 2004, J BIOL CHEM, V279, P21966, DOI 10.1074/jbc.M401076200; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Oncul S, 2010, BBA-BIOMEMBRANES, V1798, P1436, DOI 10.1016/j.bbamem.2010.01.013; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Postupalenko VY, 2011, BBA-BIOMEMBRANES, V1808, P424, DOI 10.1016/j.bbamem.2010.09.013; Rao JN, 2010, J AM CHEM SOC, V132, P8657, DOI 10.1021/ja100646t; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Shynkar VV, 2007, J AM CHEM SOC, V129, P2187, DOI 10.1021/ja068008h; Stockl M, 2008, J MOL BIOL, V375, P1394, DOI 10.1016/j.jmb.2007.11.051; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; van Rooijen BD, 2009, BBA-BIOMEMBRANES, V1788, P1271, DOI 10.1016/j.bbamem.2009.03.010; Wang GF, 2010, PROTEIN SCI, V19, P1686, DOI 10.1002/pro.449; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yushchenko DA, 2010, J AM CHEM SOC, V132, P7860, DOI 10.1021/ja102838n; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	64	79	80	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13023	13032		10.1074/jbc.M110.204776	http://dx.doi.org/10.1074/jbc.M110.204776			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330368	Green Published, hybrid			2022-12-25	WOS:000289282200022
J	Zeng, WG; Horrocks, KJ; Robevska, G; Wong, CY; Azzopardi, K; Tauschek, M; Robins-Browne, RM; Jackson, DC				Zeng, Weiguang; Horrocks, Kylie J.; Robevska, Gorjana; Wong, Chinn Yi; Azzopardi, Kristy; Tauschek, Marija; Robins-Browne, Roy M.; Jackson, David C.			A Modular Approach to Assembly of Totally Synthetic Self-adjuvanting Lipopeptide-based Vaccines Allows Conformational Epitope Building	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROTOXIGENIC ESCHERICHIA-COLI; DISULFIDE BOND FORMATION; HEAT-STABLE ENTEROTOXIN; CD8(+) T-CELLS; IMMUNOCONTRACEPTIVE VACCINES; IMMUNE-RESPONSE; INFLUENZA-VIRUS; PEPTIDE; CHALLENGE; ANTIBODY	The technology described here allows the chemical synthesis of vaccines requiring correctly folded epitopes and that contain difficult or long peptide sequences. The final self-adjuvanting product promotes strong humoral and/or cell-mediated immunity. A module containing common components of the vaccine (T helper cell epitope and the adjuvanting lipid moiety S-[2,3-bis(palmitoyloxy)propyl] cysteine) was assembled to enable a plug and play approach to vaccine assembly. The inclusion within the module of a chemical group with chemical properties complementary and orthogonal to a chemical group present in the target epitope allowed chemoselective ligation of the two vaccine components. The heat-stable enterotoxin of enterotoxigenic Escherichia coli that requires strict conformational integrity for biological activity and the reproductive hormone luteinizing hormone-releasing hormone were used as the target epitopes for the antibody vaccines. An epitope from the acid polymerase of influenza virus was used to assemble a CD8(+) T cell vaccine. Evaluation of each vaccine candidate in animals demonstrated the feasibility of the approach and that the type of immune response required, viz, antibody or cytotoxic T lymphocyte, dictates the nature of the chemical linkage between the module and target epitope. The use of a thioether bond between the module and target epitope had little or no adverse effect on antibody responses, whereas the use of a disulfide bond between the module and target epitope almost completely abrogated the antibody response. In contrast, better cytotoxic T lymphocyte responses were obtained when a disulfide bond was used.	[Zeng, Weiguang; Horrocks, Kylie J.; Robevska, Gorjana; Wong, Chinn Yi; Azzopardi, Kristy; Tauschek, Marija; Robins-Browne, Roy M.; Jackson, David C.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	University of Melbourne	Jackson, DC (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	davidcj@unimelb.edu.au	Robinsbrowne, Roy/ABF-8434-2020	Robinsbrowne, Roy/0000-0001-9179-7884; Jackson, David/0000-0001-7255-270X	National Health and Medical Research Council of Australia; Australian Research Council; Bill and Melinda Gates Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the National Health and Medical Research Council of Australia, the Australian Research Council and the Bill and Melinda Gates Foundation.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Batzloff MR, 2006, J INFECT DIS, V194, P325, DOI 10.1086/505146; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO;2-C; BROWN LE, 1988, J VIROL, V62, P1746, DOI 10.1128/JVI.62.5.1746-1752.1988; Brown Lorena E., 2005, Current Drug Delivery, V2, P383, DOI 10.2174/156720105774370258; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; Day EB, 2007, J IMMUNOL, V179, P2187, DOI 10.4049/jimmunol.179.4.2187; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Fitzmaurice CJ, 2000, INT IMMUNOL, V12, P527, DOI 10.1093/intimm/12.4.527; Gali H, 2002, BIOCONJUGATE CHEM, V13, P224, DOI 10.1021/bc010062u; Ghosh S, 2001, IMMUNOLOGY, V104, P58, DOI 10.1046/j.0019-2805.2001.01271.x; Jackson DC, 2002, CURR DRUG TARGETS, V3, P175, DOI 10.2174/1389450024605436; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; JACKSON DC, 1994, VIROLOGY, V198, P613, DOI 10.1006/viro.1994.1073; Lau YF, 2006, INT IMMUNOL, V18, P1801, DOI 10.1093/intimm/dxl114; Ng WC, 2009, INFLUENZA OTHER RESP, V3, P177, DOI 10.1111/j.1750-2659.2009.00087.x; Pejoski D, 2010, IMMUNOL CELL BIOL, V88, P605, DOI 10.1038/icb.2010.15; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; ROBINSBROWNE RM, 1981, GASTROENTEROLOGY, V80, P321; Rose K, 1996, BIOCONJUGATE CHEM, V7, P552, DOI 10.1021/bc960039m; SHIMONISHI Y, 1987, FEBS LETT, V215, P165, DOI 10.1016/0014-5793(87)80134-5; Taxt A, 2010, INFECT IMMUN, V78, P1824, DOI 10.1128/IAI.01397-09; Walker J, 2007, VACCINE, V25, P7111, DOI 10.1016/j.vaccine.2007.07.047; Zeng WG, 2007, MOL IMMUNOL, V44, P3724, DOI 10.1016/j.molimm.2007.04.004; Zeng WG, 2011, MOL IMMUNOL, V48, P490, DOI 10.1016/j.molimm.2010.10.003; Zeng WG, 2005, VACCINE, V23, P4427, DOI 10.1016/j.vaccine.2005.04.015; Zeng WG, 2002, J IMMUNOL, V169, P4905, DOI 10.4049/jimmunol.169.9.4905; Zeng WG, 2001, VACCINE, V19, P3843, DOI 10.1016/S0264-410X(01)00152-9	31	26	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12944	12951		10.1074/jbc.M111.227744	http://dx.doi.org/10.1074/jbc.M111.227744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321114	hybrid, Green Published			2022-12-25	WOS:000289282200014
J	Nishie, M; Sasaki, M; Nagao, J; Zendo, T; Nakayama, J; Sonomoto, K				Nishie, Mami; Sasaki, Makoto; Nagao, Jun-ichi; Zendo, Takeshi; Nakayama, Jiro; Sonomoto, Kenji			Lantibiotic Transporter Requires Cooperative Functioning of the Peptidase Domain and the ATP Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING PATHWAY; FERMENTED RICE BRAN; CASSETTE TRANSPORTER; ESCHERICHIA-COLI; NUKACIN ISK-1; LACTOCOCCUS-LACTIS; ABC TRANSPORTER; GENE-CLUSTER; BIOSYNTHESIS; BACTERIOCIN	Lantibiotics are ribosomally synthesized and post-translationally modified peptide antibiotics that contain unusual amino acids such as dehydro and lanthionine residues. Nukacin ISK-1 is a class II lantibiotic, whose precursor peptide (NukA) is modified by NukM to form modified NukA. ATP-binding cassette (ABC) transporter NukT is predicted to cleave off the N-terminal leader peptide of modified NukA and secrete the mature peptide. Multiple sequence alignments revealed that NukT has an N-terminal peptidase domain (PEP) and a C-terminal ATP binding domain (ABD). Previously, in vitro reconstitution of NukT has revealed that NukT peptidase activity depends on ATP hydrolysis. Here, we constructed a series of NukT mutants and investigated their transport activity in vivo and peptidase activity in vitro. Most of the mutations of the conserved residues of PEP or ABD resulted in failure of nukacin ISK-1 production and accumulation of modified NukA inside the cells. NukT(N106D) was found to be the only mutant capable of producing nukacin ISK-1. Asn(106) is conserved as Asp in other related ABC transporters. Additionally, an in vitro peptidase assay of NukT mutants demonstrated that PEP is on the cytosolic side and all of the ABD mutants as well as PEP (with the exception of NukT(N106D)) did not have peptidase activity in vitro. Taken together, these observations suggest that the leader peptide is cleaved off inside the cells before peptide secretion; both PEP and ABD are important for NukT peptidase activity, and cooperation between these two domains inside the cells is indispensable for proper functioning of NukT.	[Nishie, Mami; Sasaki, Makoto; Zendo, Takeshi; Nakayama, Jiro; Sonomoto, Kenji] Kyushu Univ, Lab Microbial Technol, Div Appl Mol Microbiol & Biomass Chem, Dept Biosci & Biotechnol,Fac Agr,Grad Sch, Fukuoka 8128581, Japan; [Nagao, Jun-ichi] Fukuoka Dent Coll, Sect Infect Biol, Dept Funct Biosci, Fukuoka 8140193, Japan; [Sonomoto, Kenji] Kyushu Univ, Lab Funct Food Design, Dept Funct Metab Design, Bioarchitecture Ctr, Fukuoka 8128581, Japan	Kyushu University; Fukuoka Dental College (FDC); Kyushu University	Sonomoto, K (corresponding author), 6-10-1 Hakozaki,Higashi Ku, Fukuoka 8128581, Japan.	sonomoto@agr.kyushu-u.ac.jp		Zendo, Takeshi/0000-0001-5147-7026; Nagao, Jun-ichi/0000-0003-1489-4140	Japan Society for the Promotion of Science; Japan Science Society; Novartis Foundation (Japan) for the Promotion of Science; Nagase Science and Technology Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society; Novartis Foundation (Japan) for the Promotion of Science(Novartis); Nagase Science and Technology Foundation	This study was supported in part by grants from the Japan Society for the Promotion of Science, the Japan Science Society, the Novartis Foundation (Japan) for the Promotion of Science, Novozymes Japan Research Fund, and the Nagase Science and Technology Foundation.	ALTENDORF KH, 1974, J BACTERIOL, V117, P888, DOI 10.1128/JB.117.2.888-899.1974; Asaduzzaman SM, 2006, APPL ENVIRON MICROB, V72, P6012, DOI 10.1128/AEM.00678-06; Asaduzzaman SM, 2009, J BIOSCI BIOENG, V107, P475, DOI 10.1016/j.jbiosc.2009.01.003; Aso Y, 2004, J BIOSCI BIOENG, V98, P429, DOI 10.1263/jbb.98.429; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V54, P203; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; DRENTH J, 1976, BIOCHEMISTRY-US, V15, P3731, DOI 10.1021/bi00662a014; Franke CM, 1999, J BIOL CHEM, V274, P8484, DOI 10.1074/jbc.274.13.8484; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; Holo H, 1995, Methods Mol Biol, V47, P195; Hunke S, 2000, J BACTERIOL, V182, P1432, DOI 10.1128/JB.182.5.1432-1436.2000; Ihnken LAF, 2008, BIOCHEMISTRY-US, V47, P7352, DOI 10.1021/bi800278n; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; Ishii S, 2010, J BIOL CHEM, V285, P10777, DOI 10.1074/jbc.M109.093781; JENSEN PR, 1993, APPL ENVIRON MICROB, V59, P4363, DOI 10.1128/AEM.59.12.4363-4366.1993; KABACK HR, 1972, BIOCHIM BIOPHYS ACTA, V265, P367, DOI 10.1016/0304-4157(72)90014-7; Kimura H, 1997, BIOSCI BIOTECH BIOCH, V61, P1049, DOI 10.1271/bbb.61.1049; Kimura H, 1998, ANN NY ACAD SCI, V864, P345, DOI 10.1111/j.1749-6632.1998.tb10336.x; Kotake Y, 2008, BIOCHEMISTRY-US, V47, P2531, DOI 10.1021/bi702253n; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Matsushita K, 2005, J BACTERIOL, V187, P4346, DOI 10.1128/JB.187.13.4346-4352.2005; Nagao J, 2005, BIOCHEM BIOPH RES CO, V336, P507, DOI 10.1016/j.bbrc.2005.08.125; Nagao JI, 2007, J MOL MICROB BIOTECH, V13, P235, DOI 10.1159/000104749; Nagao JI, 2006, J BIOSCI BIOENG, V102, P139, DOI 10.1263/jbb.102.139; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nishie M, 2009, J BIOSCI BIOENG, V108, P460, DOI 10.1016/j.jbiosc.2009.06.002; Pag U, 2002, CURR PHARM DESIGN, V8, P815, DOI 10.2174/1381612023395439; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Sambrook J., 2002, MOL CLONING LAB MANU; SIZEMORE C, 1991, MOL GEN GENET, V227, P377, DOI 10.1007/BF00273926; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; Xie LL, 2004, CURR OPIN CHEM BIOL, V8, P498, DOI 10.1016/j.cbpa.2004.08.005; Zhong XT, 1996, J BIOL CHEM, V271, P28057, DOI 10.1074/jbc.271.45.28057	37	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11163	11169		10.1074/jbc.M110.212704	http://dx.doi.org/10.1074/jbc.M110.212704			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21303905	Green Published, hybrid			2022-12-25	WOS:000288797100026
J	Paximadis, M; Minevich, G; Winchester, R; Schramm, DB; Gray, GE; Sherman, GG; Coovadia, AH; Kuhn, L; Tiemessen, CT				Paximadis, Maria; Minevich, Gregory; Winchester, Robert; Schramm, Diana B.; Gray, Glenda E.; Sherman, Gayle G.; Coovadia, Ashraf H.; Kuhn, Louise; Tiemessen, Caroline T.			KIR-HLA and Maternal-Infant HIV-1 Transmission in Sub-Saharan Africa	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INHIBITORY RECEPTOR GENES; VIRUS TYPE-1 INFECTION; CLASS-I; DISEASE PROGRESSION; ALLELES; KIR3DL1; RESPONSES; ABSENCE; PROPORTION	Numerous studies have suggested a role for natural killer (NK) cells in attenuation of HIV-1 disease progression via recognition by killer-cell immunoglobulin-like receptors (KIRs) of specific HLA class I molecules. The role of KIR and HLA class I has not been addressed in the context of maternal-infant HIV-1 transmission. KIR and HLA class I B and C genes from 224 HIV-1-infected mothers and 222 infants (72 infected and 150 uninfected) from South Africa were characterized. Although a number of significant associations were determined in both the total group and in the nevirapine (NVP) exposed group, the most significant findings involved KIR2DL2 and KIR2DL3 and HLA-C. KIR2DL2/KIR2DL3 was underrepresented in intrapartum (IP)-transmitting mothers compared to non-transmitting (NT) mothers (P = 0.008) and remained significant (P = 0.036) after correction for maternal viral load (MVL). Homozygosity for KIR2DL3 alone and in combination with HLA-C allotype heterozygosity (C1C2) was elevated in IP-transmitting mothers compared to NT mothers (P = 0.034 and P = 0.01 respectively), and after MVL correction (P = 0.033 and P = 0.027, respectively). In infants, KIR2DL3 in combination with its HLA-C1 ligand (C1) as well as homozygosity for KIR2DL3 with C1C2, were both found to be underrepresented in infected infants compared to exposed uninfected infants in the total group (P = 0.06 and P = 0.038, respectively) and in the sub-group of infants whose mothers received NVP (P = 0.007 and P = 0.03, respectively). These associations were stronger post MVL adjustment (total group: P = 0.02 and P = 0.009, respectively; NVP group: P = 0.004 and P = 0.02, respectively). Upon stratification according to low and high MVL, all significant associations fell within the low MVL group, suggesting that with low viral load, the effects of genotype can be more easily detected. In conclusion this study has identified a number of significant associations that suggest an important role for NK cells in maternal-to-infant HIV-1 transmission.	[Paximadis, Maria; Schramm, Diana B.; Tiemessen, Caroline T.] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa; [Minevich, Gregory; Winchester, Robert] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Gray, Glenda E.] Chris Hani Baragwanath Hosp, Perinatal HIV Res Unit, Soweto, South Africa; [Sherman, Gayle G.] Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, Johannesburg, South Africa; [Sherman, Gayle G.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Coovadia, Ashraf H.] Univ Witwatersrand, Empilweni Clin, Coronat Women & Children Hosp, Enhancing Childhood HIV Outcomes ECHO, Johannesburg, South Africa; [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA; [Kuhn, Louise] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Tiemessen, Caroline T.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); Columbia University; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; Columbia University; Columbia University; University of Witwatersrand	Paximadis, M (corresponding author), Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa.	paxim@nicd.ac.za		Minevich, Gregory/0000-0002-7115-4416; Tiemessen, Caroline/0000-0002-0991-1690	NICHD [42402]; Wellcome Trust; Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042402] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); Elizabeth Glaser Pediatric AIDS Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from NICHD 42402, the Wellcome Trust and Elizabeth Glaser Pediatric AIDS Foundation. Caroline T. Tiemessen is a Wellcome Trust International Senior Research Fellow (076352/Z/05/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Ballan WM, 2007, J IMMUNOL, V179, P3362, DOI 10.4049/jimmunol.179.5.3362; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Boulet S, 2008, AIDS, V22, P1487, DOI 10.1097/QAD.0b013e3282ffde7e; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; CEREB N, 1995, TISSUE ANTIGENS, V45, P1, DOI 10.1111/j.1399-0039.1995.tb02408.x; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gumperz JE, 1997, J IMMUNOL, V158, P5237; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Mackelprang RD, 2008, J INFECT DIS, V197, P1156, DOI 10.1086/529528; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; MIDDLETON D, TISSUE ANTIGENS, V61, P403; Moretta A, 1996, ANNU REV IMMUNOL, V14, P619, DOI 10.1146/annurev.immunol.14.1.619; MULLER CA, 1989, IMMUNOGENETICS, V30, P200, DOI 10.1007/BF02421207; Schramm DB, 2006, JAIDS-J ACQ IMM DEF, V42, P545, DOI 10.1097/01.qai.0000225009.30698.ce; Stratov I, 2008, J VIROL, V82, P5450, DOI 10.1128/JVI.01952-07; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Thobakgale CF, 2009, J VIROL, V83, P10234, DOI 10.1128/JVI.00921-09; Tiemessen CT, 2010, J INFECT DIS, V202, P1444, DOI 10.1086/656535; Tiemessen CT, 2009, J IMMUNOL, V182, P5914, DOI 10.4049/jimmunol.0900419; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; UITENBROEK DG, 1997, SISA BINOMIAL SOUTHA; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597	34	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16541	10.1371/journal.pone.0016541	http://dx.doi.org/10.1371/journal.pone.0016541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346814	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600009
J	Zaher, H; Pol, D; Carvalho, AB; Nascimento, PM; Riccomini, C; Larson, P; Juarez-Valieri, R; Pires-Domingues, R; da Silva, NJ; Campos, DD				Zaher, Hussam; Pol, Diego; Carvalho, Alberto B.; Nascimento, Paulo M.; Riccomini, Claudio; Larson, Peter; Juarez-Valieri, Ruben; Pires-Domingues, Ricardo; da Silva, Nelson Jorge, Jr.; Campos, Diogenes de Almeida			A Complete Skull of an Early Cretaceous Sauropod and the Evolution of Advanced Titanosaurians	PLOS ONE			English	Article							DINOSAURS; REDESCRIPTION; DIVERSITY; LAMINAE; LINK	Advanced titanosaurian sauropods, such as nemegtosaurids and saltasaurids, were diverse and one of the most important groups of herbivores in the terrestrial biotas of the Late Cretaceous. However, little is known about their rise and diversification prior to the Late Cretaceous. Furthermore, the evolution of their highly-modified skull anatomy has been largely hindered by the scarcity of well-preserved cranial remains. A new sauropod dinosaur from the Early Cretaceous of Brazil represents the earliest advanced titanosaurian known to date, demonstrating that the initial diversification of advanced titanosaurians was well under way at least 30 million years before their known radiation in the latest Cretaceous. The new taxon also preserves the most complete skull among titanosaurians, further revealing that their low and elongated diplodocid-like skull morphology appeared much earlier than previously thought.	[Zaher, Hussam; Carvalho, Alberto B.; Nascimento, Paulo M.; Pires-Domingues, Ricardo] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Pol, Diego] Consejo Nacl Invest Cient & Tecn, Museo Paleontol Egidio Feruglio, Trelew, Chubut, Argentina; [Riccomini, Claudio; Pires-Domingues, Ricardo] Univ Sao Paulo, Inst Geosci, Sao Paulo, Brazil; [Larson, Peter] Black Hills Inst Geol Res, Hill City, SD USA; [Larson, Peter] Univ Manchester, Manchester, Lancs, England; [Juarez-Valieri, Ruben] Museo Patagon Ciencias Nat, Gen Roca, Rio Negro, Argentina; [da Silva, Nelson Jorge, Jr.] Pontificia Univ Catolica Goias, Dept Biol, Goiania, Go, Brazil; [Campos, Diogenes de Almeida] Museu Ciencias Terra, Dept Nacl Prod Mineral, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidade de Sao Paulo; University of Manchester; Pontificia Universidade Catolica de Goias	Zaher, H (corresponding author), Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil.	hzaher@usp.br	da Silva, Nelson Jorge/AAV-1811-2021; Zaher, Hussam/D-4000-2012; Riccomini, Claudio/G-1764-2010; Pol, Diego/A-8007-2008; Silva, Nelson Jorge/Z-3842-2019; Zaher, Hussam/ABC-1701-2021	Zaher, Hussam/0000-0002-6994-489X; Riccomini, Claudio/0000-0002-7249-5706; Pol, Diego/0000-0002-9690-7517; Silva, Nelson Jorge/0000-0001-5517-3791; Zaher, Hussam/0000-0002-6994-489X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo BIOTA/FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo BIOTA/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by a grant from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo BIOTA/FAPESP to H. Zaher (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apesteguia S, 2004, NATURWISSENSCHAFTEN, V91, P493, DOI 10.1007/s00114-004-0560-6; Apesteguia S, 2007, GONDWANA RES, V12, P533, DOI 10.1016/j.gr.2007.04.007; Arai M., 1995, ATAS 14 CONGRESSO BR, P2; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; Barrett PM, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P125; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Campos J.E.G., REV BRAS GEOCIENC, V27, P269, DOI [10.25249/0375-7536.1997269282, DOI 10.25249/0375-7536.1997269282]; Carvalho I.S., 1994, STRATIGRAPHIC RANGE; CODDINGTON J, 1994, CLADISTICS, V10, P415; do Carmo D.A., 2004, RBP, V7, P139; Goloboff P.A., 2008, TNT TREE ANAL USING; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hocknull SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006190; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Riccomini C., 2005, MESOZOIC CENOZOIC AL, P31, DOI [10.2138/am.2007.485, DOI 10.2138/AM.2007.485]; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Salgado Leonardo, 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P69; Salgado Leonardo, 1997, Ameghiniana, V34, P3; SANTOS VF, 1994, GAIA, V10, P5; Sereno PC, 2004, P ROY SOC B-BIOL SCI, V271, P1325, DOI 10.1098/rspb.2004.2692; Suteethorn S, 2009, GEOL SOC SPEC PUBL, V315, P189, DOI 10.1144/SP315.14; TURNER S, 1994, EARTH PLANET SC LETT, V121, P333, DOI 10.1016/0012-821X(94)90076-0; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; Upchurch P, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P104; Upchurch P, 2004, DINOSAURIA, 2ND EDITION, P259; Wilkinson M, 2000, SYST BIOL, V49, P754, DOI 10.1080/106351500750049815; WILSON J., 2006, ACT 3 JORN DIN ENT B, P169; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; Wilson JA, 2005, J SYST PALAEONTOL, V3, P283, DOI 10.1017/S1477201905001628; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691	34	104	107	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16663	10.1371/journal.pone.0016663	http://dx.doi.org/10.1371/journal.pone.0016663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326881	gold, Green Published, Green Submitted			2022-12-25	WOS:000287037100011
J	Grantham, HS; Game, ET; Lombard, AT; Hobday, AJ; Richardson, AJ; Beckley, LE; Pressey, RL; Huggett, JA; Coetzee, JC; van der Lingen, CD; Petersen, SL; Merkle, D; Possingham, HP				Grantham, Hedley S.; Game, Edward T.; Lombard, Amanda T.; Hobday, Alistair J.; Richardson, Anthony J.; Beckley, Lynnath E.; Pressey, Robert L.; Huggett, Jenny A.; Coetzee, Janet C.; van der Lingen, Carl D.; Petersen, Samantha L.; Merkle, Dagmar; Possingham, Hugh P.			Accommodating Dynamic Oceanographic Processes and Pelagic Biodiversity in Marine Conservation Planning	PLOS ONE			English	Article							PENGUINS SPHENISCUS-DEMERSUS; SEA-SURFACE TEMPERATURE; GANNETS MORUS-CAPENSIS; FOOD AVAILABILITY; SOUTH-AFRICA; POSSIBLE MECHANISMS; ECOSYSTEM APPROACH; TROPHIC CASCADES; PROTECTED AREAS; REGIME SHIFTS	Pelagic ecosystems support a significant and vital component of the ocean's productivity and biodiversity. They are also heavily exploited and, as a result, are the focus of numerous spatial planning initiatives. Over the past decade, there has been increasing enthusiasm for protected areas as a tool for pelagic conservation, however, few have been implemented. Here we demonstrate an approach to plan protected areas that address the physical and biological dynamics typical of the pelagic realm. Specifically, we provide an example of an approach to planning protected areas that integrates pelagic and benthic conservation in the southern Benguela and Agulhas Bank ecosystems off South Africa. Our aim was to represent species of importance to fisheries and species of conservation concern within protected areas. In addition to representation, we ensured that protected areas were designed to consider pelagic dynamics, characterized from time-series data on key oceanographic processes, together with data on the abundance of small pelagic fishes. We found that, to have the highest likelihood of reaching conservation targets, protected area selection should be based on time-specific data rather than data averaged across time. More generally, we argue that innovative methods are needed to conserve ephemeral and dynamic pelagic biodiversity.	[Grantham, Hedley S.; Richardson, Anthony J.; Pressey, Robert L.; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia; [Lombard, Amanda T.] Nelson Mandela Metropolitan Univ, Dept Bot, George, South Africa; [Hobday, Alistair J.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Richardson, Anthony J.] CSIRO Marine & Atmospher Res, Cleveland, Qld, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math CARM, Sch Math & Phys, St Lucia, Qld, Australia; [Beckley, Lynnath E.] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia; [Huggett, Jenny A.; Coetzee, Janet C.; van der Lingen, Carl D.; Merkle, Dagmar] Dept Environm Affairs & Tourism, Cape Town, South Africa; [Huggett, Jenny A.; van der Lingen, Carl D.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, South Africa; [Petersen, Samantha L.] WWF S Africa, WWF Responsible Fisheries Programme, Cape Town, South Africa; [Grantham, Hedley S.; Richardson, Anthony J.; Pressey, Robert L.; Possingham, Hugh P.] Univ Queensland, Ctr Appl Environm Decis Anal, St Lucia, Qld, Australia	University of Queensland; Nelson Mandela University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Murdoch University; University of Cape Town; World Wildlife Fund; University of Queensland	Grantham, HS (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia.	h.grantham@uq.edu.au	Pressey, Bob/C-8370-2013; Possingham, Hugh/B-1337-2008; Richardson, Anthony J/B-3649-2010; Game, Edward/AAD-2289-2020; Lombard, Mandy/AAE-4649-2019; POSSINGHAM, HUGH/R-8310-2019; Hobday, Alistair/A-1460-2012	Pressey, Bob/0000-0003-2740-0330; Possingham, Hugh/0000-0001-7755-996X; Richardson, Anthony J/0000-0002-9289-7366; Game, Edward/0000-0003-4707-9281; Lombard, Mandy/0000-0002-4323-1170; POSSINGHAM, HUGH/0000-0001-7755-996X; Hobday, Alistair/0000-0002-3194-8326; Huggett, Jenny/0000-0001-9315-8672; Coetzee, Janet/0000-0002-2382-7815	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative; African Coelacanth Ecosystem Programme; National Research Foundation of South African; Australian Research Council	Commonwealth Environment Research Facilities (CERF) program; Australian Government initiative(Australian Government); African Coelacanth Ecosystem Programme; National Research Foundation of South African; Australian Research Council(Australian Research Council)	This work was supported by the Applied Environmental Decision Analysis research hub funded by the Commonwealth Environment Research Facilities (CERF) program, an Australian Government initiative, African Coelacanth Ecosystem Programme, National Research Foundation of South African, Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbag JJ, 2003, PROG OCEANOGR, V59, P275, DOI 10.1016/j.pocean.2003.07.004; Airame S, 2003, ECOL APPL, V13, pS170; Alpine JE, 2007, MAR FRESHWATER RES, V58, P558, DOI 10.1071/MF06214; Apostolaki P, 2002, CAN J FISH AQUAT SCI, V59, P405, DOI 10.1139/F02-018; Ardron J, 2008, MAR POLICY, V32, P832, DOI 10.1016/j.marpol.2008.03.018; Bakun A., 1996, OCEAN PROCESSES MARI; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Barange M, 1999, S AFR J MARINE SCI, V21, P367; Beckley LE, 1999, MAR FRESHWATER RES, V50, P955, DOI 10.1071/MF99068; BECKLEY LE, 1994, S AFR J MARINE SCI, V14, P205; BECKLEY LE, 1986, S AFR J ZOOL, V21, P244; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Campbell RA, 2003, SWORDFISH ENV SEAMOU; Camphuysen KCJ, 2007, J ORNITHOL, V148, P333, DOI 10.1007/s10336-007-0135-3; Coetzee J, 2010, BIOL LETT; Coetzee JC, 2008, AFR J MAR SCI, V30, P205, DOI 10.2989/AJMS.2008.30.2.1.551; Coetzee JC, 2008, ICES J MAR SCI, V65, P1676, DOI 10.1093/icesjms/fsn184; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Crawford RJM, 2007, FINAL REPORT BCLME P; Crawford RJM, 2007, J ORNITHOL, V148, pS253, DOI 10.1007/s10336-007-0228-z; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; Cury PM, 2005, ICES J MAR SCI, V62, P430, DOI 10.1016/j.icesjms.2004.12.006; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Dingle RV, 1987, ANN S AFRICAN MUSEUM, P98; Dreyfus-Leon M, 2001, ECOL MODEL, V146, P47, DOI 10.1016/S0304-3800(01)00295-2; Driver A., 2005, NATL SPATIAL BIODIVE; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Etnoyer P, 2006, DEEP-SEA RES PT II, V53, P340, DOI 10.1016/j.dsr2.2006.01.010; Etnoyer Peter, 2004, Oceanography, V17, P90; Field JC, 2006, FISH FISH, V7, P284, DOI 10.1111/j.1467-2979.2006.00226.x; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Game ET, 2010, TRENDS ECOL EVOL, V25, P63, DOI 10.1016/j.tree.2009.09.002; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Game ET, 2008, MARXAN USER MANUAL M; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Gilman E, 2008, MAR POLICY, V32, P1, DOI 10.1016/j.marpol.2007.05.001; Grantham Hedley S., 2008, Endangered Species Research, V5, P291, DOI 10.3354/esr00159; Gremillet D., 2008, P ROY SOC LOND B BIO, V18, P1; Gremillet D, 2008, J APPL ECOL, V45, P610, DOI 10.1111/j.1365-2664.2007.01447.x; Griffiths CL, 1997, T ROY SOC S AFR, V52, P121, DOI 10.1080/00359199709520619; Hall SJ, 2004, FISH FISH, V5, P1, DOI 10.1111/j.1467-2960.2004.00133.x; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hobday AJ, 2006, FISHERIES MANAG ECOL, V13, P365, DOI 10.1111/j.1365-2400.2006.00515.x; Hobday AJ, INFLUENCE TOPOGRAPHY; Howell Evan A., 2008, Endangered Species Research, V5, P267, DOI 10.3354/esr00096; Huggett J, 2009, PROG OCEANOGR, V83, P197, DOI 10.1016/j.pocean.2009.07.048; Hunt BPV, 2003, J PLANKTON RES, V25, P885, DOI 10.1093/plankt/25.8.885; Hutchings L, 2002, MAR FRESHWATER RES, V53, P307, DOI 10.1071/MF01147; Hutchings L, 2006, BENGUELA PREDICTING; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Jonker FC, 1998, ANTARCT SCI, V10, P21, DOI 10.1017/S0954102098000042; Kemper J, 2007, FINAL REPORT BCLME P; Keough HL, 2006, CONSERV BIOL, V20, P1373, DOI 10.1111/j.1523-1739.2006.00445.x; Klages NTW, 1998, MAR BIOL, V131, P559, DOI 10.1007/s002270050348; Knight AT, 2006, CONSERV BIOL, V20, P408, DOI 10.1111/j.1523-1739.2006.00305.x; Leslie HM, 2005, CONSERV BIOL, V19, P1701, DOI 10.1111/j.1523-1739.2005.00268.x; Lett C, 2006, FISH OCEANOGR, V15, P363, DOI 10.1111/j.1365-2419.2005.00392.x; Lombard AT, 2007, ANTARCT SCI, V19, P39, DOI 10.1017/S0954102007000077; Lombard AT, 2005, NATL SPATIAL BIODIVE, VVol 4; Lundquist CJ, 2005, CONSERV BIOL, V19, P1771, DOI 10.1111/j.1523-1739.2005.00279.x; Martell SJD, 2005, CAN J FISH AQUAT SCI, V62, P1320, DOI 10.1139/F05-114; Moilanen A., 2009, SPATIAL CONSERVATION; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nel DC, 2001, MAR ECOL PROG SER, V217, P15, DOI 10.3354/meps217015; Nielsen KN, 2007, MAR POLICY, V31, P669, DOI 10.1016/j.marpol.2007.03.014; Omardien A., 2007, WWF REPORT SERIES; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Pakhomov EA, 2000, POLAR BIOL, V23, P410, DOI 10.1007/s003000050462; Paterson HL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004707; Pecquerie L, 2004, AFR J MAR SCI, V26, P115, DOI 10.2989/18142320409504053; Penven P, 2001, S AFR J SCI, V97, P472; Petersen S., 2008, WWF S AFRICA REPORT; Petersen SL, 2006, IBIS, V148, P14, DOI 10.1111/j.1474-919X.2006.00459.x; Pichegru L, 2007, MAR ECOL PROG SER, V350, P127, DOI 10.3354/meps07128; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher GC, 1996, J PLANKTON RES, V18, P643, DOI 10.1093/plankt/18.5.643; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Richardson AJ, 2003, MAR ECOL PROG SER, V254, P239, DOI 10.3354/meps254239; Richardson AJ, 1998, S AFR J MARINE SCI, V19, P275; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roughan M, 2002, CONTINENTAL SHELF RE, P22; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shannon LJ, 2006, AFR J MAR SCI, V28, P115, DOI 10.2989/18142320609504139; Sink E, 2007, DRAFT GUIDELINES EST; Thibault-Botha D, 2004, J PLANKTON RES, V26, P1115, DOI 10.1093/plankt/fbh104; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; van der Lingen CD, 2006, LAR MAR ECOSYST, V14, P309; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Verity PG, 2002, ENVIRON CONSERV, V29, P207, DOI 10.1017/S0376892902000139; Walmsley SA, 2007, ICES J MAR SCI, V64, P405, DOI 10.1093/icesjms/fsl022; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2	98	56	56	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16552	10.1371/journal.pone.0016552	http://dx.doi.org/10.1371/journal.pone.0016552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311757	gold, Green Published, Green Accepted			2022-12-25	WOS:000287036200020
J	Robert, EMR; Schmitz, N; Boeren, I; Driessens, T; Herremans, K; De Mey, J; Van de Casteele, E; Beeckman, H; Koedam, N				Robert, Elisabeth M. R.; Schmitz, Nele; Boeren, Ilse; Driessens, Tess; Herremans, Kristof; De Mey, Johan; Van de Casteele, Elke; Beeckman, Hans; Koedam, Nico			Successive Cambia: A Developmental Oddity or an Adaptive Structure?	PLOS ONE			English	Article							SECONDARY GROWTH; FUNCTIONAL-SIGNIFICANCE; AVICENNIA-MARINA; STEM; PHLOEM; WOOD; TISSUES; VARIANT; XYLEM; DIFFERENTIATION	Background: Secondary growth by successive cambia is a rare phenomenon in woody plant species. Only few plant species, within different phylogenetic clades, have secondary growth by more than one vascular cambium. Often, these successive cambia are organised concentrically. In the mangrove genus Avicennia however, the successive cambia seem to have a more complex organisation. This study aimed (i) at understanding the development of successive cambia by giving a three-dimensional description of the hydraulic architecture of Avicennia and (ii) at unveiling the possible adaptive nature of growth by successive cambia through a study of the ecological distribution of plant species with concentric internal phloem. Results: Avicennia had a complex network of non-cylindrical wood patches, the complexity of which increased with more stressful ecological conditions. As internal phloem has been suggested to play a role in water storage and embolism repair, the spatial organisation of Avicennia wood could provide advantages in the ecologically stressful conditions species of this mangrove genus are growing in. Furthermore, we could observe that 84.9% of the woody shrub and tree species with concentric internal phloem occurred in either dry or saline environments strengthening the hypothesis that successive cambia provide the necessary advantages for survival in harsh environmental conditions. Conclusions: Successive cambia are an ecologically important characteristic, which seems strongly related with water-limited environments.	[Robert, Elisabeth M. R.; Schmitz, Nele; Driessens, Tess; Herremans, Kristof; Koedam, Nico] Vrije Univ Brussel VUB, Lab Plant Biol & Nat Management APNA, Brussels, Belgium; [Robert, Elisabeth M. R.; Schmitz, Nele; Boeren, Ilse; Beeckman, Hans] Royal Museum Cent Africa RMCA, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Boeren, Ilse] Univ Stuttgart Hohenheim, Inst Bot 210, D-70599 Stuttgart, Germany; [De Mey, Johan] Univ Ziekenhuis Brussel, Brussels, Belgium; [Van de Casteele, Elke] SkyScan NV, Kontich, Belgium; [Van de Casteele, Elke] Univ Antwerpen UA, Vis Lab, Antwerp, Belgium	Vrije Universiteit Brussel; Royal Museum for Central Africa; University Hohenheim; University Hospital Brussels; Vrije Universiteit Brussel; University of Antwerp	Robert, EMR (corresponding author), Vrije Univ Brussel VUB, Lab Plant Biol & Nat Management APNA, Brussels, Belgium.	erobert@vub.ac.be	Robert, Elisabeth/A-8524-2018; Beeckman, Hans/I-7653-2019; de Mey, Johan/AAL-9312-2021; Robert, Elisabeth/AAJ-4984-2021; de Mey, Johan/F-3602-2011	Robert, Elisabeth/0000-0002-3611-7265; Beeckman, Hans/0000-0001-8954-6277; Robert, Elisabeth/0000-0002-3611-7265; Van de Casteele, Elke/0000-0003-0395-3002; de Mey, Johan/0000-0002-3601-3212	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); National Fund for Scientific Research (FWO, Belgium); King Leopold III Fund for Nature Exploration and Conservation, Belgium; Royal Museum for Central Africa (RMCA), Tervuren	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); National Fund for Scientific Research (FWO, Belgium)(FWO); King Leopold III Fund for Nature Exploration and Conservation, Belgium; Royal Museum for Central Africa (RMCA), Tervuren	The study was financially supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen), the National Fund for Scientific Research (FWO, Belgium), the King Leopold III Fund for Nature Exploration and Conservation, Belgium, and the AFRODENDRO project of the Royal Museum for Central Africa (RMCA), Tervuren. The funders had no role in study design, content of the study, decision to publish or determination of the conclusions.	Araujo GUC, 2006, IAWA J, V27, P269, DOI 10.1163/22941932-90000154; BAKER RT, 1915, J P ROY SOC NS WALES, V49, P257; BHAMBIE S, 1985, P INDIAN AS-PLANT SC, V95, P295; BHAMBIE S, 1972, P INDIAN ACAD SCI B, V75, P246; Breckle S.W, 2002, WALTERS VEGETATION E; Carlquist S., 2001, COMP WOOD ANATOMY; Carlquist S, 2007, J TORREY BOT SOC, V134, P301, DOI 10.3159/1095-5674(2007)134[301:SCROHD]2.0.CO;2; Carlquist S, 2007, BOT J LINN SOC, V153, P141, DOI 10.1111/j.1095-8339.2007.00593.x; Chapman V. J., 1947, Proc. Linn. Soc. Lond. 1945-46, V158, P2; DENOUTER RW, 1995, IAWA J, V16, P151, DOI 10.1163/22941932-90001401; DOBBINS DR, 1986, BOT GAZ, V147, P278, DOI 10.1086/337595; Dunisch O, 2003, HOLZFORSCHUNG, V57, P196, DOI 10.1515/HF.2003.029; FAHN A, 1967, PHYTOMORPHOLOGY, V17, P147; FAHN A, 1982, BOT GAZ, V143, P353, DOI 10.1086/337309; FELDKAMP LA, 1997, J MICROSC-OXFORD, V185, P67; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; GILL AM, 1971, FOREST SCI, V17, P462; KITIN P, 2007, INT C PLANT VASC BIO; Kitin P, 2009, ANN BOT-LONDON, V103, P1145, DOI 10.1093/aob/mcp050; KRISHNAMURTHY K V, 1984, Indian Journal of Botany, V7, P183; Mauseth JD, 1997, AM J BOT, V84, P815, DOI 10.2307/2445817; MCDONALD JA, 1992, B TORREY BOT CLUB, V119, P262, DOI 10.2307/2996757; Murakami Y, 1999, ANN BOT-LONDON, V84, P429, DOI 10.1006/anbo.1999.0931; NAIR MNB, 1993, IAWA J, V14, P191, DOI 10.1163/22941932-90001317; NAIR MNB, 1990, IAWA BULL, V11, P379, DOI 10.1163/22941932-90000526; PHILIPSON WR, 1971, VASCULAR CAMBIUM DEV; Rajput KS, 2006, FLORA, V201, P65, DOI 10.1016/j.flora.2005.04.004; Rajput KS, 2000, IAWA J, V21, P417, DOI 10.1163/22941932-90000257; Robert EMR, 2009, FUNCT ECOL, V23, P649, DOI 10.1111/j.1365-2435.2009.01551.x; Salleo S, 2004, PLANT CELL ENVIRON, V27, P1065, DOI 10.1111/j.1365-3040.2004.01211.x; Salleo S, 2006, FUNCT PLANT BIOL, V33, P1063, DOI 10.1071/FP06149; Salleo S, 2009, FUNCT PLANT BIOL, V36, P815, DOI 10.1071/FP09103; Schmitz Nele, 2007, Dendrochronologia, V25, P87, DOI 10.1016/j.dendro.2006.08.001; Schmitz N, 2008, ANN BOT-LONDON, V101, P49, DOI 10.1093/aob/mcm280; Scholz FG, 2007, PLANT CELL ENVIRON, V30, P236, DOI 10.1111/j.1365-3040.2006.01623.x; STUDHOLME W. P., 1966, N Z J BOT, V4, P355; TERRAZAS T, 1991, AM J BOT, V78, P1335, DOI 10.2307/2445272; Tomlinson PB, 1994, BOT MANGROVES; WHEAT D, 1977, AM J BOT, V64, P1209, DOI 10.2307/2442483; ZAMSKI E, 1981, ISRAEL J BOT, V30, P57; ZAMSKI E, 1980, ANN BOT-LONDON, V45, P561, DOI 10.1093/oxfordjournals.aob.a085861; ZAMSKI E, 1979, BOT GAZ, V140, P67, DOI 10.1086/337058; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	43	52	56	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16558	10.1371/journal.pone.0016558	http://dx.doi.org/10.1371/journal.pone.0016558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304983	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300086
J	Sheppard, JP; Wang, JP; Wong, PCM				Sheppard, John P.; Wang, Ji-Ping; Wong, Patrick C. M.			Large-Scale Cortical Functional Organization and Speech Perception across the Lifespan	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; SMALL-WORLD; PREFRONTAL CORTEX; BRAIN NETWORKS; INDIVIDUAL-DIFFERENCES; LOW-FREQUENCY; DEFAULT MODE; CONNECTIVITY	Aging is accompanied by substantial changes in brain function, including functional reorganization of large-scale brain networks. Such differences in network architecture have been reported both at rest and during cognitive task performance, but an open question is whether these age-related differences show task-dependent effects or represent only task-independent changes attributable to a common factor (i.e., underlying physiological decline). To address this question, we used graph theoretic analysis to construct weighted cortical functional networks from hemodynamic (functional MRI) responses in 12 younger and 12 older adults during a speech perception task performed in both quiet and noisy listening conditions. Functional networks were constructed for each subject and listening condition based on inter-regional correlations of the fMRI signal among 66 cortical regions, and network measures of global and local efficiency were computed. Across listening conditions, older adult networks showed significantly decreased global (but not local) efficiency relative to younger adults after normalizing measures to surrogate random networks. Although listening condition produced no main effects on whole-cortex network organization, a significant age group x listening condition interaction was observed. Additionally, an exploratory analysis of regional effects uncovered age-related declines in both global and local efficiency concentrated exclusively in auditory areas (bilateral superior and middle temporal cortex), further suggestive of specificity to the speech perception tasks. Global efficiency also correlated positively with mean cortical thickness across all subjects, establishing gross cortical atrophy as a task-independent contributor to age-related differences in functional organization. Together, our findings provide evidence of age-related disruptions in cortical functional network organization during speech perception tasks, and suggest that although task-independent effects such as cortical atrophy clearly underlie age-related changes in cortical functional organization, age-related differences also demonstrate sensitivity to task domains.	[Sheppard, John P.; Wong, Patrick C. M.] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL USA; [Sheppard, John P.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Wang, Ji-Ping] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [Wong, Patrick C. M.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Sheppard, JP (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	pwong@northwestern.edu	Wong, Patrick/A-8102-2012	Wong, Patrick/0000-0002-6105-5027; Sheppard, John/0000-0002-8040-8481	National Science Foundation [BCS-0719666]; National Institutes of Health [R01DC008333, R21DC009652]; Northwestern University Office of the Provost; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009652, R01DC008333] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Office of the Provost; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Science Foundation (grants BCS-0719666 to P. W.), the National Institutes of Health (grants R01DC008333 and R21DC009652 to P.W.) and grants administered through the Northwestern University Office of the Provost to J.S. The funders' websites are available at www.nsf.gov, www.nih.gov, and www.northwestern.edu/provost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Belin P, 1999, NEUROIMAGE, V10, P417, DOI 10.1006/nimg.1999.0480; BILGER RC, 1984, J SPEECH HEAR RES, V27, P32, DOI 10.1044/jshr.2701.32; Blumenfeld RS, 2007, NEUROSCIENTIST, V13, P280, DOI 10.1177/1073858407299290; BRESSLER SL, 1995, BRAIN RES REV, V20, P288, DOI 10.1016/0165-0173(94)00016-I; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 1997, J NEUROSCI, V17, P391; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frisina DR, 1997, HEARING RES, V106, P95, DOI 10.1016/S0378-5955(97)00006-3; FRISINA DR, 2001, FUNCTIONAL NEUROBIOL, P565; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; GordonSalant S, 2010, SPRINGER HANDB AUDIT, V34, P1; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Grady CL, 2003, HIPPOCAMPUS, V13, P572, DOI 10.1002/hipo.10114; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunning-Dixon FM, 2003, NEUROBIOL AGING, V24, P285, DOI 10.1016/S0197-4580(02)00099-4; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humes LE, 2007, J AM ACAD AUDIOL, V18, P590, DOI 10.3766/jaaa.18.7.6; HUMES LE, 1991, J SPEECH HEAR RES, V34, P686, DOI 10.1044/jshr.3403.686; HUMES LE, 1994, J SPEECH HEAR RES, V37, P465, DOI 10.1044/jshr.3702.465; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Polli FE, 2005, P NATL ACAD SCI USA, V102, P15700, DOI 10.1073/pnas.0503657102; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAYMER AM, 1990, FLORIDA SEMATI UNPUB; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Resnick SM, 2003, J NEUROSCI, V23, P3295; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Saad ZS, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P1510; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Schneider B.A., 2000, HDB AGING COGNITION, P155; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Stelmach G., 1993, SENSORIMOTOR IMPAIRM, DOI [10.1007/978-94-011-1976-4, DOI 10.1007/978-94-011-1976-4]; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wong PCM, 2008, J SPEECH LANG HEAR R, V51, P1026, DOI 10.1044/1092-4388(2008/075); Wong PCM, 2010, EAR HEARING, V31, P471, DOI 10.1097/AUD.0b013e3181d709c2; Wong PCM, 2009, NEUROPSYCHOLOGIA, V47, P693, DOI 10.1016/j.neuropsychologia.2008.11.032; Wong PCM, 2004, J NEUROSCI, V24, P9153, DOI 10.1523/JNEUROSCI.2225-04.2004; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	83	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16510	10.1371/journal.pone.0016510	http://dx.doi.org/10.1371/journal.pone.0016510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304991	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000286834300073
J	Frydman-Marom, A; Levin, A; Farfara, D; Benromano, T; Scherzer-Attali, R; Peled, S; Vassar, R; Segal, D; Gazit, E; Frenkel, D; Ovadia, M				Frydman-Marom, Anat; Levin, Aviad; Farfara, Dorit; Benromano, Tali; Scherzer-Attali, Roni; Peled, Sivan; Vassar, Robert; Segal, Daniel; Gazit, Ehud; Frenkel, Dan; Ovadia, Michael			Orally Administrated Cinnamon Extract Reduces beta-Amyloid Oligomerization and Corrects Cognitive Impairment in Alzheimer's Disease Animal Models	PLOS ONE			English	Article							A-BETA; TRANSGENIC MICE; PROTEIN; POLYPHENOLS; NEURODEGENERATION; AGGREGATION; INHIBITORS; GLUCOSE; COMMON; BRAIN	An increasing body of evidence indicates that accumulation of soluble oligomeric assemblies of beta-amyloid polypeptide (A beta) play a key role in Alzheimer's disease (AD) pathology. Specifically, 56 kDa oligomeric species were shown to be correlated with impaired cognitive function in AD model mice. Several reports have documented the inhibition of A beta plaque formation by compounds from natural sources. Yet, evidence for the ability of common edible elements to modulate A beta oligomerization remains an unmet challenge. Here we identify a natural substance, based on cinnamon extract (CEppt), which markedly inhibits the formation of toxic A beta oligomers and prevents the toxicity of A beta on neuronal PC12 cells. When administered to an AD fly model, CEppt rectified their reduced longevity, fully recovered their locomotion defects and totally abolished tetrameric species of A beta in their brain. Furthermore, oral administration of CEppt to an aggressive AD transgenic mice model led to marked decrease in 56 kDa A beta oligomers, reduction of plaques and improvement in cognitive behavior. Our results present a novel prophylactic approach for inhibition of toxic oligomeric A beta species formation in AD through the utilization of a compound that is currently in use in human diet.	[Frydman-Marom, Anat; Scherzer-Attali, Roni; Peled, Sivan; Segal, Daniel; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Levin, Aviad; Ovadia, Michael] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Farfara, Dorit; Benromano, Tali; Frenkel, Dan] Tel Aviv Univ, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Vassar, Robert] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; Northwestern University	Frydman-Marom, A (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	ehudg@post.tau.ac.il; dfrenkel@post.tau.ac.il; MichaelO@tauex.tau.ac.il	Gazit, Ehud/M-8026-2019; Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X; Farfara, Dorit/0000-0001-7515-5769				Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bastianetto S, 2008, MINI-REV MED CHEM, V8, P429, DOI 10.2174/138955708784223512; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; De Felice FG, 2004, FASEB J, V18, P1366, DOI 10.1096/fj.04-1764com; Dugoua JJ, 2007, CAN J PHYSIOL PHARM, V85, P837, DOI 10.1139/Y07-080; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Frenkel D, 2008, ANN NEUROL, V63, P591, DOI 10.1002/ana.21340; Frydman-Marom A, 2009, ANGEW CHEM INT EDIT, V48, P1981, DOI 10.1002/anie.200802123; Gazit E, 2004, DRUG FUTURE, V29, P613, DOI 10.1358/dof.2004.029.06.853453; GRAVINA SA, 1995, J BIOL CHEM, V270, P7013, DOI 10.1074/jbc.270.13.7013; HAMAGUCHI T, 2010, CNS NEUROSCI THER; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; JARRETT JT, 1993, ANN NY ACAD SCI, V24, P144; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Kim DSHL, 2007, J ALTERN COMPLEM MED, V13, P333, DOI 10.1089/acm.2006.6107; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Moloney A, 2010, TRENDS BIOCHEM SCI, V35, P228, DOI 10.1016/j.tibs.2009.11.004; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Paiva SAR, 1999, J AM COLL NUTR, V18, P426, DOI 10.1080/07315724.1999.10718880; Panickar KS, 2009, EXP NEUROL, V216, P420, DOI 10.1016/j.expneurol.2008.12.024; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Prins ND, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt28; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; SEVILLIA G, 2007, CINNAMON EXTRACT INH, P467; Shoval H, 2008, BBA-PROTEINS PROTEOM, V1784, P1570, DOI 10.1016/j.bbapap.2008.08.007; Spires Tara L, 2005, NeuroRx, V2, P423, DOI 10.1602/neurorx.2.3.423; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; YOUNG HM, 2008, J NUTR BIOCH, V19, P448	43	137	141	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16564	10.1371/journal.pone.0016564	http://dx.doi.org/10.1371/journal.pone.0016564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305046	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100044
J	Zhang, LH; Wang, MN; Bisogno, T; Di Marzo, V; Alger, BE				Zhang, Longhua; Wang, Meina; Bisogno, Tiziana; Di Marzo, Vincenzo; Alger, Bradley E.			Endocannabinoids Generated by Ca2+ or by Metabotropic Glutamate Receptors Appear to Arise from Different Pools of Diacylglycerol Lipase	PLOS ONE			English	Article							ENDOGENOUS CANNABINOIDS; RETROGRADE; INHIBITION; SUPPRESSION; SYNAPSES; BLOCKADE; SYSTEM; ALPHA; BINDS	The identity and subcellular sources of endocannabinoids (eCBs) will shape their ability to affect synaptic transmission and, ultimately, behavior. Recent discoveries support the conclusion that 2-arachidonoyl glycerol, 2-AG, is the major signaling eCB, however, some important issues remain open. 2-AG can be synthesized by a mechanism that is strictly Ca2+-dependent, and another that is initiated by G-protein coupled receptors (GPCRs) and facilitated by Ca2+. An important question is whether or not the 2-AG in these cases is synthesized by the same pool of diacylglycerol lipase alpha (DAGL alpha). Using whole-cell voltage-clamp techniques in CA1 pyramidal cells in acute in vitro rat hippocampal slices, we investigated two mechanistically distinct eCB-mediated responses to address this issue. We now report that pharmacological inhibitors of DGL alpha have quantitatively different effects on eCB-mediated responses triggered by different stimuli, suggesting that functional, and perhaps physical, distinctions among pools of DAGL alpha exist.	[Zhang, Longhua; Wang, Meina; Alger, Bradley E.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; [Alger, Bradley E.] Univ Maryland, Sch Med, Neurosci Program, Baltimore, MD 21201 USA; [Bisogno, Tiziana; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, ECB Res Grp, Pozzuoli, Italy	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Consiglio Nazionale delle Ricerche (CNR)	Zhang, LH (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	balgerlab@gmail.com	Bisogno, Tiziana/B-7891-2015; Di Marzo, Vincenzo/AAD-7742-2019; Zhang, Longhua/P-1417-2014	Di Marzo, Vincenzo/0000-0002-1490-3070; 	NIH [RO1 MH077277, RO1 DA014625]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH RO1 MH077277 and RO1 DA014625 to B. E. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adermark L, 2007, P NATL ACAD SCI USA, V104, P20564, DOI 10.1073/pnas.0706873104; ALGER BE, 2010, TRENDS NEUR IN PRESS; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Edwards DA, 2008, P NATL ACAD SCI USA, V105, P8142, DOI 10.1073/pnas.0803558105; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Min R, 2010, NEUROSCIENTIST, V16, P608, DOI 10.1177/1073858410373281; Min R, 2010, J NEUROSCI, V30, P2710, DOI 10.1523/JNEUROSCI.BC-3622-09.2010; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Ortar G, 2008, J MED CHEM, V51, P6970, DOI 10.1021/jm800978m; Pan B, 2009, J PHARMACOL EXP THER, V331, P591, DOI 10.1124/jpet.109.158162; Ronesi J, 2004, J NEUROSCI, V24, P1673, DOI 10.1523/JNEUROSCI.5214-03.2004; Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Uchigashima M, 2007, J NEUROSCI, V27, P3663, DOI 10.1523/JNEUROSCI.0448-07.2007; Varma N, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-24-j0003.2001; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	32	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16305	10.1371/journal.pone.0016305	http://dx.doi.org/10.1371/journal.pone.0016305			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305054	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100021
J	Brunnschweiler, JM; Baensch, H				Brunnschweiler, Juerg M.; Baensch, Harald			Seasonal and Long-Term Changes in Relative Abundance of Bull Sharks from a Tourist Shark Feeding Site in Fiji	PLOS ONE			English	Article							UNDERWATER VISUAL CENSUS; SICKLEFIN LEMON SHARKS; REEF-MARINE-RESERVE; CARCHARHINUS-LEUCAS; CARCHARODON-CARCHARIAS; NEGAPRION-ACUTIDENS; MOVEMENT PATTERNS; FRENCH-POLYNESIA; SOUTH-PACIFIC; BEHAVIOR	Shark tourism has become increasingly popular, but remains controversial because of major concerns originating from the need of tour operators to use bait or chum to reliably attract sharks. We used direct underwater sampling to document changes in bull shark Carcharhinus leucas relative abundance at the Shark Reef Marine Reserve, a shark feeding site in Fiji, and the reproductive cycle of the species in Fijian waters. Between 2003 and 2009, the total number of C. leucas counted on each day ranged from 0 to 40. Whereas the number of C. leucas counted at the feeding site increased over the years, shark numbers decreased over the course of a calendar year with fewest animals counted in November. Externally visible reproductive status information indicates that the species' seasonal departure from the feeding site may be related to reproductive activity.	[Brunnschweiler, Juerg M.] Swiss Fed Inst Technol, Zurich, Switzerland; [Baensch, Harald] Univ Nebraska Kearney, Dept Biol, Kearney, NE USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Nebraska System	Brunnschweiler, JM (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	juerg@gluecklich.net	Brunnschweiler, Juerg/A-2110-2008	Brunnschweiler, Juerg/0000-0002-9901-3279	Save Our Seas Foundation; Shark Foundation Switzerland	Save Our Seas Foundation; Shark Foundation Switzerland	This work was funded through grants to JMB from the Save Our Seas Foundation (http://saveourseas.com/) and the Shark Foundation Switzerland (http://www.shark.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2006, CYBIUM, V30, P133; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Buray N, 2009, CYBIUM, V33, P21; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Carrier JC, 2004, CRC MAR BIOL SER, P269; Castro ALF, 2005, ENVIRON BIOL FISH, V72, P213, DOI 10.1007/s10641-004-1479-7; Cater C., 2008, NEW FRONTIERS MARINE, DOI 10.1016/B978-0-08-045357-6.50006-1; Catlin J, 2010, INT J TOUR RES, V12, P134, DOI 10.1002/jtr.742; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Colonello JH, 2007, ICES J MAR SCI, V64, P131, DOI 10.1093/icesjms/fsl004; Cruz-Martinez A., 2005, Journal of Northwest Atlantic Fishery Science, V35, P367; Dicken ML, 2006, AFR J MAR SCI, V28, P603, DOI 10.2989/18142320609504210; Dicken ML, 2009, AFR J MAR SCI, V31, P227, DOI 10.2989/AJMS.2009.31.2.10.882; Dobson J., 2006, Tourism in Marine Environments, V3, P15, DOI 10.3727/154427306779380275; Dobson J, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P49, DOI 10.1079/9781845933456.0049; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; DURBIN J, 1951, BIOMETRIKA, V38, P159, DOI 10.1093/biomet/38.1-2.159; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; KOHLER N. E., 1998, MAR FISH REV, V60, P1, DOI DOI 10.7755/MFR.81.2.1; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; MYRBERG AA, 1974, COPEIA, P358; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Porcher IF, 2005, MAR BIOL, V146, P1207, DOI 10.1007/s00227-004-1518-0; Rasalato E, 2010, ENVIRON CONSERV, V37, P90, DOI 10.1017/S0376892910000317; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; SNELSON FF, 1984, B MAR SCI, V34, P71; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181	36	48	49	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16597	10.1371/journal.pone.0016597	http://dx.doi.org/10.1371/journal.pone.0016597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21346792	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900079
J	Zhang, X; George, J; Deb, S; Degoutin, JL; Takano, EA; Fox, SB; Bowtell, DDL; Harvey, KF				Zhang, X.; George, J.; Deb, S.; Degoutin, J. L.; Takano, E. A.; Fox, S. B.; Bowtell, D. D. L.; Harvey, K. F.		AOCS Study Grp	The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene	ONCOGENE			English	Article						ovarian cancer; Hippo pathway; YAP; oncogenic transformation; clear cell cancer	YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR GENE; CELL CONTACT INHIBITION; SIZE-CONTROL; PROMOTES APOPTOSIS; CYCLE EXIT; ORGAN SIZE; PROLIFERATION; DROSOPHILA; SALVADOR	The Salvador-Warts-Hippo (SWH) pathway was first discovered in Drosophila melanogaster as a potent inhibitor of tissue growth. The SWH pathway is highly conserved between D. melanogaster and mammals, both in function and in the mechanism of signal transduction. The mammalian SWH pathway limits tissue growth by inhibiting the nuclear access and expression of the transcriptional co-activator, Yes-associated protein (YAP). Mutation and altered expression of SWH pathway proteins has been observed in several types of human cancer, but the contribution of these events to tumorigenesis has been unclear. Here we show that YAP can enhance the transformed phenotype of ovarian cancer cell lines and that YAP confers resistance to chemotherapeutic agents that are commonly used to treat ovarian cancer. We find that high nuclear YAP expression correlates with poor patient prognosis in a cohort of 268 invasive epithelial ovarian cancer samples. Segregation by histo-type shows that the correlation between nuclear YAP and poor survival is predominantly associated with clear cell tumors, independent of stage. Collectively our findings suggest that YAP derepression contributes to the genesis of ovarian clear cell carcinoma and that the SWH pathway is an attractive therapeutic target. Oncogene (2011) 30, 2810-2822; doi: 10.1038/onc.2011.8; published online 14 February 2011	[Zhang, X.; George, J.; Deb, S.; Degoutin, J. L.; Takano, E. A.; Fox, S. B.; Bowtell, D. D. L.; Harvey, K. F.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Zhang, X.; George, J.; Degoutin, J. L.; Bowtell, D. D. L.; Harvey, K. F.] Univ Melbourne, Melbourne, Vic, Australia; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [AOCS Study Grp] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Sydney, NSW 2006, Australia	Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; University of Sydney; Westmead Institute for Medical Research	Harvey, KF (corresponding author), Peter MacCallum Canc Ctr, 7 St Andrews Pl, Melbourne, Vic 3072, Australia.	kieran.harvey@petermac.org	George, Joshy/K-4841-2019; Bowtell, David/H-1007-2016; Harvey, Kieran/AAD-5268-2022; Fox, Stephen/G-9719-2016	Bowtell, David/0000-0001-9089-7525; Fox, Stephen/0000-0002-7648-8896; Harvey, Kieran/0000-0001-7845-369X	US Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania; National Health and Medical Research Council of Australia (NHMRC); International Human Frontier Science Program Organization; NHMRC of Australia; Victorian Breast Cancer Research Consortium	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); International Human Frontier Science Program Organization(Human Frontier Science Program); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Breast Cancer Research Consortium	We thank the study nurses and research assistants for their contribution to AOCS (http://www.aocstudy.org/) and thank all the women who participated in the study. AOCS was approved by the Human Research Ethics Committees at the Peter Mac, QIMR and participating hospitals. The study was supported by the US Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the National Health and Medical Research Council of Australia (NHMRC). We thank D Thomas for comments, D Haber for pBABE-YAP2L and the Peter Mac, Pfizer Incorporated TORCH program for ovarian cancer cell lines. KFH is a Sylvia and Charles Viertel Senior Medical Research Fellow. This work was supported by a Career Development Award from the International Human Frontier Science Program Organization and a Project Grant from the NHMRC of Australia to KFH and the Victorian Breast Cancer Research Consortium to SBF.	Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Chosdol K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-5; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Stewart B.W., 2003, WORLD CANC REPORT; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tan DSP, 2007, J CLIN PATHOL, V60, P355, DOI 10.1136/jcp.2006.040030; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zhang XM, 2006, INT J CANCER, V118, P2072, DOI 10.1002/ijc.21592; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zorn KK, 2005, CLIN CANCER RES, V11, P6422, DOI 10.1158/1078-0432.CCR-05-0508	48	232	249	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	25					2810	2822		10.1038/onc.2011.8	http://dx.doi.org/10.1038/onc.2011.8			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21317925				2022-12-25	WOS:000291977800002
J	Xia, CW; Hamdane, D; Shen, AL; Choi, V; Kasper, CB; Pearl, NM; Zhang, HM; Im, SC; Waskell, L; Kim, JJP				Xia, Chuanwu; Hamdane, Djemel; Shen, Anna L.; Choi, Vivian; Kasper, Charles B.; Pearl, Naw May; Zhang, Haoming; Im, Sang-Choul; Waskell, Lucy; Kim, Jung-Ja P.			Conformational Changes of NADPH-Cytochrome P450 Oxidoreductase Are Essential for Catalysis and Cofactor Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER; DISULFIDE BOND; OXIDATION-REDUCTION; P-450 REDUCTASE; PROTEIN; FMN; STABILIZATION; MECHANISM; SITE; FAD	The crystal structure of NADPH-cytochrome P450 reductase (CYPOR) implies that a large domain movement is essential for electron transfer from NADPH via FAD and FMN to its redox partners. To test this hypothesis, a disulfide bond was engineered betweenresiduesAsp(147) and Arg(514) in the FMN and FAD domains, respectively. The cross-linked form of this mutant protein, designated 147CC514, exhibited a significant decrease in the rate of interflavin electron transfer and large (>= 90%) decreases in rates of electron transfer to its redox partners, cytochrome c and cytochrome P450 2B4. Reduction of the disulfide bond restored the ability of the mutant to reduce its redox partners, demonstrating that a conformational change is essential for CYPOR function. The crystal structures of the mutant without and with NADP(+) revealed that the two flavin domains are joined by a disulfide linkage and that the relative orientations of the two flavin rings are twisted similar to 20 degrees compared with the wild type, decreasing the surface contact area between the two flavin rings. Comparison of the structures without and with NADP(+) shows movement of the Gly(631)-Asn(635) loop. IntheNADP(+) -free structure, the loop adopts a conformation that sterically hinders NADP( H) binding. The structure with NADP(+) shows movement of the Gly(631)-Asn(635) loop to a position that permits NADP(H) binding. Furthermore, comparison of these mutant and wild type structures strongly suggests that the Gly(631)-Asn(635) loop movement controls NADPH binding and NADP(+) release; this loop movement in turn facilitates the flavin domain movement, allowing electron transfer from FMN to the CYPOR redox partners.	[Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Hamdane, Djemel; Pearl, Naw May; Zhang, Haoming; Im, Sang-Choul; Waskell, Lucy] Vet Affairs Med Res Ctr, Ann Arbor, MI 48105 USA; [Xia, Chuanwu; Kim, Jung-Ja P.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Shen, Anna L.; Choi, Vivian; Kasper, Charles B.] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Michigan System; University of Michigan; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	Waskell, L (corresponding author), Univ Michigan, Dept Anesthesiol, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	waskell@umich.edu; jjkim@mcw.edu	Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394; Choi, Vivian/0000-0003-4787-0735	National Institutes of Health [CA22484, GM35533, GM52682]; Veterans Affairs; NATIONAL CANCER INSTITUTE [P01CA022484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052682, R01GM035533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA22484 (to A. L. S. and C. B. K.), GM35533 (to L. W.), and GM52682 (to J.-J. P. K.). This work was also supported by a Veterans Affairs merit review grant (to L. W.).	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; DAGGETT V, 1993, ANNU REV BIOPH BIOM, V22, P353, DOI 10.1146/annurev.bb.22.060193.002033; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; GUSEV NB, 1991, J BIOL CHEM, V266, P16622; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hay S, 2010, J AM CHEM SOC, V132, P9738, DOI 10.1021/ja1016206; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; IYANAGI T, 1974, BIOCHEMISTRY-US, V13, P1701, DOI 10.1021/bi00705a023; JENG MF, 1995, BIOCHEMISTRY-US, V34, P611, DOI 10.1021/bi00002a028; KANAYA S, 1991, J BIOL CHEM, V266, P6038; KUTHAN H, 1982, BIOCHEM J, V203, P551, DOI 10.1042/bj2030551; Lamb DC, 2006, STRUCTURE, V14, P51, DOI 10.1016/j.str.2005.09.015; MASTERS BSS, 1965, J BIOL CHEM, V240, P921; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; MATTHEWS RG, 1991, FLAVINS AND FLAVOPROTEINS 1990, P593; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1999, CRYSTALLIZATION BIOL; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; NISIMOTO Y, 1986, J BIOL CHEM, V261, P14232; OMURA T, 1964, J BIOL CHEM, V239, P2379; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; SEM DS, 1994, BIOCHEMISTRY-US, V33, P12012, DOI 10.1021/bi00206a002; SHEN AL, 1991, J BIOL CHEM, V266, P19976; SHEN AL, 1989, J BIOL CHEM, V264, P7584; SHEN AL, 1995, J BIOL CHEM, V270, P27475, DOI 10.1074/jbc.270.46.27475; Shen AL, 1999, J BIOL CHEM, V274, P5391, DOI 10.1074/jbc.274.9.5391; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; VERMILION JL, 1981, J BIOL CHEM, V256, P266; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411	52	79	83	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M111.230532	http://dx.doi.org/10.1074/jbc.M111.230532			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21345800	hybrid, Green Published			2022-12-25	WOS:000290022800064
J	Banerjee, NS; Wang, HK; Broker, TR; Chow, LT				Banerjee, N. Sanjib; Wang, Hsu-Kun; Broker, Thomas R.; Chow, Louise T.			Human Papillomavirus (HPV) E7 Induces Prolonged G(2) following S Phase Reentry in Differentiated Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; 14-3-3 PROTEIN-BINDING; DNA-DAMAGE CHECKPOINT; LARGE T-ANTIGEN; HUMAN CDC25C; HUMAN MYT1; PHOSPHORYLATES CDC2; INHIBITORY KINASE; LIFE-CYCLE; HIGH-RISK	The productive program of human papillomaviruses occurs in differentiated squamous keratinocytes. We have previously shown that HPV-18 DNA amplification initiates in spinous cells in organotypic cultures of primary human keratinocytes during prolonged G(2) phase, as signified by abundant cytoplasmic cyclin B1 (Wang, H. K., Duffy, A. A., Broker, T. R., and Chow, L. T. (2009) Genes Dev. 23, 181-194). In this study, we demonstrated that the E7 protein, which induces S phase reentry in suprabasal cells by destabilizing the p130 pocket protein (Genovese, N. J., Banerjee, N. S., Broker, T. R., and Chow, L. T. (2008) J. Virol. 82, 4862-4873), also elicited extensive G(2) responses. Western blots and indirect immunofluorescence assays were used to probe for host proteins known to control G(2)/M progression. E7 expression induced cytoplasmic accumulation of cyclin B1 and cdc2 in the suprabasal cells. The elevated cdc2 had inactivating phosphorylation on Thr(14) or Tyr(15), and possibly both, due to an increase in the responsible Wee1 and Myt1 kinases. In cells that harbored cytoplasmic cyclin B1 or cdc2, there was also an accumulation of the phosphatase-inactive cdc25C phosphorylated on Ser(216), unable to activate cdc2. Moreover, E7 expression induced elevated expression of phosphorylated ATM (Ser(1981)) and the downstream phosphorylated Chk1, Chk2, and JNKs, kinases known to inactivate cdc25C. Similar results were observed in primary human keratinocyte raft cultures in which the productive program of HPV-18 took place. Collectively, this study has revealed the mechanisms by which E7 induces prolonged G(2) phase in the differentiated cells following S phase induction.	[Banerjee, N. Sanjib; Wang, Hsu-Kun; Broker, Thomas R.; Chow, Louise T.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Chow, LT (corresponding author), 501 MCLM Bldg,1918 Univ Blvd, Birmingham, AL 35294 USA.	LTChow@uab.edu			National Institutes of Health [CA83679]; NATIONAL CANCER INSTITUTE [R01CA083679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA83679.	ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05; Banerjee NS, 2005, METH MOLEC MED, V119, P187; Boichuk S, 2010, J VIROL, V84, P8007, DOI 10.1128/JVI.00334-10; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335; Chien WM, 2000, CELL GROWTH DIFFER, V11, P425; Chien WM, 2002, J VIROL, V76, P2964, DOI 10.1128/JVI.76.6.2964-2972.2002; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; Chow LT, 2009, CELL CYCLE, V8, P1319, DOI 10.4161/cc.8.9.8242; COLEMAN TR, 1994, CURR OPIN CELL BIOL, V6, P877, DOI 10.1016/0955-0674(94)90060-4; Dahl J, 2005, J VIROL, V79, P13007, DOI 10.1128/JVI.79.20.13007-13017.2005; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Datta A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-49; Davy C, 2007, VIROLOGY, V368, P219, DOI 10.1016/j.virol.2007.05.043; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Doorbar J, 1997, VIROLOGY, V238, P40, DOI 10.1006/viro.1997.8768; DUNPHY WG, 1991, CELL, V67, P189, DOI 10.1016/0092-8674(91)90582-J; Gabrielli BG, 1997, ONCOGENE, V15, P749, DOI 10.1038/sj.onc.1201254; Garner-Hamrick PA, 2004, J VIROL, V78, P9041, DOI 10.1128/JVI.78.17.9041-9050.2004; Genovese NJ, 2008, J VIROL, V82, P4862, DOI 10.1128/JVI.01202-07; Gutierrez GJ, 2010, J BIOL CHEM, V285, P14217, DOI 10.1074/jbc.M110.121848; Hardouin N, 2000, GENESIS, V26, P245, DOI 10.1002/(SICI)1526-968X(200004)26:4<245::AID-GENE50>3.0.CO;2-9; Hein J, 2009, J VIROL, V83, P117, DOI 10.1128/JVI.01515-08; HERZINGER T, 1995, ONCOGENE, V11, P2151; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kino T, 2005, J VIROL, V79, P2780, DOI 10.1128/JVI.79.5.2780-2787.2005; Knight GL, 2011, VIROLOGY, V412, P196, DOI 10.1016/j.virol.2011.01.007; KORNBLUTH S, 1994, MOL BIOL CELL, V5, P273, DOI 10.1091/mbc.5.3.273; Kudoh A, 2004, J VIROL, V78, P104, DOI 10.1128/JVI.78.1.104-115.2004; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Liu F, 1999, MOL CELL BIOL, V19, P5113; Liu F, 1997, MOL CELL BIOL, V17, P571, DOI 10.1128/MCB.17.2.571; Luo Y, 2011, J VIROL, V85, P133, DOI 10.1128/JVI.01534-10; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Noya F, 2001, J VIROL, V75, P6121, DOI 10.1128/JVI.75.13.6121-6134.2001; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1998, CELL GROWTH DIFFER, V9, P197; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Rogoff HA, 2004, MOL CELL BIOL, V24, P2968, DOI 10.1128/MCB.24.7.2968-2977.2004; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Shirata N, 2005, J BIOL CHEM, V280, P30336, DOI 10.1074/jbc.M500976200; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STRAUSFELD U, 1994, J BIOL CHEM, V269, P5989; Taylor WR, 1999, MOL BIOL CELL, V10, P3607, DOI 10.1091/mbc.10.11.3607; Toyoshima F, 1998, EMBO J, V17, P2728, DOI 10.1093/emboj/17.10.2728; Van Tine Brian A, 2005, Methods Mol Biol, V292, P215; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang ZQ, 2009, J CELL PHYSIOL, V221, P213, DOI 10.1002/jcp.21844; WILSON JL, 1992, CELL GROWTH DIFFER, V3, P471; Yoshizuka N, 2005, J VIROL, V79, P11366, DOI 10.1128/JVI.79.17.11366-11381.2005; Zhang BY, 2006, P NATL ACAD SCI USA, V103, P437, DOI 10.1073/pnas.0510012103; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	60	80	83	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15473	15482		10.1074/jbc.M110.197574	http://dx.doi.org/10.1074/jbc.M110.197574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21321122	Green Published, hybrid			2022-12-25	WOS:000289788300075
J	Hulikova, A; Vaughan-Jones, RD; Swietach, P				Hulikova, Alzbeta; Vaughan-Jones, Richard D.; Swietach, Pawel			Dual Role of CO2/HCO3- Buffer in the Regulation of Intracellular pH of Three-dimensional Tumor Growths	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBONIC-ANHYDRASE-IX; VENTRICULAR MYOCYTE; NA+/H+ EXCHANGER; EXTRACELLULAR PH; CDNA CLONING; GENE FAMILY; DNA-BINDING; CELLS; EXPRESSION; HYPOXIA	Intracellular pH (pH(i)), a major modulator of cell function, is regulated by acid/base transport across membranes. Excess intracellular H+ ions (e.g. produced by respiration) are extruded by transporters such as Na+/H+ exchange, or neutralized by HCO3- taken up by carriers such as Na+-HCO3- cotransport. Using fluorescence pH(i) imaging, we show that cancer-derived cell lines (colorectal HCT116 and HT29, breast MDA-MB-468, pancreatic MiaPaca2, and cervical HeLa) extrude acid by H+ efflux and HCO3- influx, largely sensitive to dimethylamiloride and 4,4'-diisothiocyanatostilbene-2,2'-disulfonate (DIDS), respectively. The magnitude of HCO3- influx was comparable among the cell lines and may represent a constitutive element of tumor pH(i) regulation. In contrast, H+ efflux varied considerably (MDA-MB-468 > HCT116 > HT29 > MiaPaca2 > HeLa). When HCO3- flux was pharmacologically inhibited, acid extrusion in multicellular HT29 and HCT116 spheroids (similar to 10,000 cells) was highly non-uniform and produced low pHi at the core. With depth, acid extrusion became relatively more DIDS-sensitive because the low extracellular pH at the spheroid core inhibits H+ flux more than HCO3- flux. HCO3- flux inhibition also decelerated HCT116 spheroid growth. In the absence of CO2/HCO3-, acid extrusion by H+ flux in HCT116 and MDA-MB-468 spheroids became highly non-uniform and inadequate at the core. This is because H+ transporters require extracellular mobile pH buffers, such asCO(2)/HCO3-, to overcome low H+ ion mobility and chaperone H+ ions away from cells. CO2/HCO3- exerts a dual effect: as substrate for membrane-bound HCO3- transporters and as a mobile buffer for facilitating extracellular diffusion of H+ ions extruded from cells. These processes can be augmented by carbonic anhydrase activity. We conclude that CO2/HCO3- is important for maintaining uniformly alkaline pH(i) in small, non-vascularized tumor growths and may be important for cancer disease progression.	[Hulikova, Alzbeta; Vaughan-Jones, Richard D.; Swietach, Pawel] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473	Royal Society; Medical Research Council; British Heart Foundation; British Heart Foundation [RG/08/016/26423] Funding Source: researchfish; Medical Research Council [G0700698] Funding Source: researchfish; MRC [G0700698] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Royal Society (to P.S.), Medical Research Council (to P.S.), and British Heart Foundation (to R.D.V.-J.).	ARONSON PS, 1985, ANNU REV PHYSIOL, V47, P545, DOI 10.1146/annurev.ph.47.030185.002553; Boron WF, 2004, ADV PHYSIOL EDUC, V28, P160, DOI 10.1152/advan.00045.2004; BORON WF, 1983, J GEN PHYSIOL, V81, P53, DOI 10.1085/jgp.81.1.53; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; CARLSSON J, 1988, INT J CANCER, V42, P715, DOI 10.1002/ijc.2910420515; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; DEHEMPTINNE A, 1987, CAN J PHYSIOL PHARM, V65, P970, DOI 10.1139/y87-154; DEITMER JW, 1989, J PHYSIOL-LONDON, V411, P179, DOI 10.1113/jphysiol.1989.sp017567; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GILLIES RJ, 1990, P NATL ACAD SCI USA, V87, P7414, DOI 10.1073/pnas.87.19.7414; IRVING M, 1990, BIOPHYS J, V57, P717, DOI 10.1016/S0006-3495(90)82592-3; Jones DT, 2006, CLIN CANCER RES, V12, P5384, DOI 10.1158/1078-0432.CCR-05-2380; Lauritzen G, 2010, EXP CELL RES, V316, P2538, DOI 10.1016/j.yexcr.2010.06.005; Lee AH, 1998, CANCER RES, V58, P1901; Leem CH, 1998, J PHYSIOL-LONDON, V509, P487, DOI 10.1111/j.1469-7793.1998.487bn.x; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Morgan PE, 2007, AM J PHYSIOL-CELL PH, V293, pC738, DOI 10.1152/ajpcell.00157.2007; MUELLERKLIESER WF, 1982, BRIT J CANCER, V45, P256, DOI 10.1038/bjc.1982.41; MURER H, 1976, BIOCHEM J, V154, P597, DOI 10.1042/bj1540597; ORLOWSKI J, 1992, J BIOL CHEM, V267, P9331; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; PASTOREK J, 1994, ONCOGENE, V9, P2877; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Romero MF, 2000, J BIOL CHEM, V275, P24552, DOI 10.1074/jbc.M003476200; Romero MF, 1997, NATURE, V387, P409, DOI 10.1038/387409a0; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sterling D, 2001, J BIOL CHEM, V276, P47886, DOI 10.1074/jbc.M105959200; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Svastova E, 2004, FEBS LETT, V577, P439, DOI 10.1016/j.febslet.2004.10.043; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Swietach P, 2008, J BIOL CHEM, V283, P20473, DOI 10.1074/jbc.M801330200; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Tureci O, 1998, P NATL ACAD SCI USA, V95, P7608, DOI 10.1073/pnas.95.13.7608; Vaughan-Jones RD, 2002, J PHYSIOL-LONDON, V541, P139, DOI 10.1113/jphysiol.2001.013267; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V428, P441, DOI 10.1113/jphysiol.1990.sp018221; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang CZ, 2000, J BIOL CHEM, V275, P35486, DOI 10.1074/jbc.C000456200; Wong P, 2002, BRIT J CANCER, V87, P238, DOI 10.1038/sj.bjc.6600424	50	67	70	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13815	13826		10.1074/jbc.M111.219899	http://dx.doi.org/10.1074/jbc.M111.219899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345798	Green Published, hybrid			2022-12-25	WOS:000289556200004
J	Jung, K; Lee, D; Lim, HS; Lee, SI; Kim, YJ; Lee, GM; Kim, SC; Koh, GY				Jung, Keehoon; Lee, Donghun; Lim, Hye Song; Lee, Sang-Il; Kim, Yeon Jung; Lee, Gyun Min; Kim, Sun Chang; Koh, Gou Young			Double Anti-angiogenic and Anti-inflammatory Protein Valpha Targeting VEGF-A and TNF-alpha in Retinopathy and Psoriasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SKIN INFLAMMATION; RHEUMATOID-ARTHRITIS; CANCER MODEL; IN-VIVO; RECEPTOR; MOUSE; NEOVASCULARIZATION	Pathological angiogenesis usually involves disrupted vascular integrity, vascular leakage, and infiltration of inflammatory cells, which are governed mainly by VEGF-A and TNF-alpha. Although many inhibitors targeting either VEGF-A or TNF-alpha have been developed, there is no single inhibitor molecule that simultaneously targets both molecules. Here, we designed and generated a novel chimeric decoy receptor (Valpha) that can simultaneously bind to VEGF-A and TNF-alpha and block their actions. In this experimental design, we have shown that Valpha, which is an effective synchronous blocker of VEGF-A and TNF-alpha, can drastically increase treatment effectiveness through its dual-blocking characteristics. Valpha contains the VEGF-A-binding domain of VEGFR1, the TNF-alpha-binding domain of TNFR2, and the Fc domain of IgG1. Valpha exhibited strong binding characteristics for its original counterparts, VEGF-A and TNF-alpha, but not for the extracellular matrix, resulting in a highly favorable pharmacokinetic profile in vivo. Compared with VEGF-Trap or Enbrel, both of which block either VEGF-A or TNF-alpha, singularly, Valpha is a highly effective molecule for reducing abnormal vascular tufts and the number of F4/80(+) macrophages in a retinopathy model. In addition, Valpha showed superior relief effects in a psoriasis model with regard to epidermal thickness and the area of blood and lymphatic vessels. Thus, the simultaneous blocking of VEGF-A and TNF-alpha using Valpha is an effective therapeutic strategy and cost-efficient for treatment of retinopathy and psoriasis.	[Jung, Keehoon; Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Biomed Sci & Engn, Taejon 305701, South Korea; [Jung, Keehoon; Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol & Stem Cells, Taejon 305701, South Korea; [Kim, Yeon Jung; Lee, Gyun Min; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea; [Lee, Donghun] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul 110744, South Korea; [Lim, Hye Song; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju 660702, South Korea; [Lim, Hye Song; Lee, Sang-Il] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Jinju 660702, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Gyeongsang National University; Gyeongsang National University	Koh, GY (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Biomed Sci & Engn, 373-1 Guseong Dong, Taejon 305701, South Korea.	gykoh@kaist.ac.kr	Lee, Gyun Min/C-2020-2011; Kim, Sun Chang/C-2026-2011; Koh, Gou Young/C-1615-2011; Kim, Sun/GSN-4867-2022	Jung, Keehoon/0000-0002-2199-5292	Ministry of Education, Science and Technology, Korea [R2009-0079390, R31-2009-000-10071-0]	Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation Grant R2009-0079390 (to G.Y.K.), World Class University (WCU) Grant R31-2009-000-10071-0 (to G.Y.K.), and a Korea Advanced Institute of Science and Technology (KAIST) institute grant (2009) funded by the Ministry of Education, Science and Technology, Korea.	Byrne AT, 2003, CLIN CANCER RES, V9, P5721; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chua RA, 2009, AUTOIMMUNITY, V42, P574, DOI 10.1080/08916930903002461; De Bandt M, 2003, J IMMUNOL, V171, P4853, DOI 10.4049/jimmunol.171.9.4853; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Halin C, 2008, AM J PATHOL, V173, P265, DOI 10.2353/ajpath.2008.071074; Hickey MJ, 1997, J IMMUNOL, V158, P3391; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068; Hwang SJ, 2005, PROTEIN EXPRES PURIF, V39, P175, DOI 10.1016/j.pep.2004.09.005; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Jung K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007403; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Nagashima M, 1999, CLIN EXP IMMUNOL, V116, P360; PEPPEL K, 1991, J EXP MED, V174, P1483, DOI 10.1084/jem.174.6.1483; Rojanasakul Y, 1999, MOL CELL BIOCHEM, V200, P119, DOI 10.1023/A:1007051402840; Ruch C, 2007, NAT STRUCT MOL BIOL, V14, P249, DOI 10.1038/nsmb1202; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Saishin Y, 2003, J CELL PHYSIOL, V195, P241, DOI 10.1002/jcp.10246; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; Schonthaler HB, 2009, P NATL ACAD SCI USA, V106, P21264, DOI 10.1073/pnas.0907550106; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shibuya M, 2001, INT J BIOCHEM CELL B, V33, P409, DOI 10.1016/S1357-2725(01)00026-7; Skoura A, 2007, J CLIN INVEST, V117, P2506, DOI 10.1172/JCI31123; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; Taylor PC, 2001, CURR OPIN RHEUMATOL, V13, P164, DOI 10.1097/00002281-200105000-00003; Teige I, 2009, J INVEST DERMATOL, V129, P1437, DOI 10.1038/jid.2008.375; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; Verheul HMW, 2007, CLIN CANCER RES, V13, P4201, DOI 10.1158/1078-0432.CCR-06-2553; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Young HS, 2006, J INVEST DERMATOL, V126, P453, DOI 10.1038/sj.jid.5700096	43	36	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14410	14418		10.1074/jbc.M111.228130	http://dx.doi.org/10.1074/jbc.M111.228130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345791	hybrid, Green Published			2022-12-25	WOS:000289556200062
J	Habchi, J; Blangy, S; Mamelli, L; Jensen, MR; Blackledge, M; Darbon, H; Oglesbee, M; Shu, YL; Longhi, S				Habchi, Johnny; Blangy, Stephanie; Mamelli, Laurent; Jensen, Malene Ringkjobing; Blackledge, Martin; Darbon, Herve; Oglesbee, Michael; Shu, Yaoling; Longhi, Sonia			Characterization of the Interactions between the Nucleoprotein and the Phosphoprotein of Henipavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; MEASLES-VIRUS NUCLEOPROTEIN; INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; NUCLEOCAPSID-BINDING DOMAIN; RESIDUAL DIPOLAR COUPLINGS; DISORDERED PROTEINS; CRYSTAL-STRUCTURE; STRUCTURE PREDICTION; STRUCTURAL DISORDER	The Henipavirus genome is encapsidated by the nucleoprotein (N) within a helical nucleocapsid that recruits the polymerase complex via the phosphoprotein (P). In a previous study, we reported that in henipaviruses, the N-terminal domain of the phosphoprotein and the C-terminal domain of the nucleoprotein (N-TAIL) are both intrinsically disordered. Here we show that Henipavirus N-TAIL domains are also disordered in the context of full-length nucleoproteins. We also report the cloning, purification, and characterization of the C-terminal X domains (P-XD) of Henipavirus phosphoproteins. Using isothermal titration calorimetry, we show that N-TAIL and P-XD form a 1:1 stoichiometric complex that is stable under NaCl concentrations as high as 1 M and has a K-D in the mu M range. Using far-UV circular dichroism and nuclear magnetic resonance, we show that P-XD triggers an increase in the alpha-helical content of N-TAIL. Using fluorescence spectroscopy, we show that P-XD has no impact on the chemical environment of a Trp residue introduced at position 527 of the Henipavirus N-TAIL domain, thus arguing for the lack of stable contacts between the C termini of N-TAIL and P-XD. Finally, we present a tentative structural model of the interaction in which a short, order-prone region of N-TAIL (alpha-MoRE; amino acids 473 493) adopts an alpha-helical conformation and is embedded between helices alpha 2 and alpha 3 of P-XD leading to a relatively small interface dominated by hydrophobic contacts. The present results provide the first detailed experimental characterization of the N-P interaction in henipaviruses and designate the N-TAIL-P-XD interaction as a valuable target for rational antiviral approaches.	[Habchi, Johnny; Blangy, Stephanie; Mamelli, Laurent; Darbon, Herve; Longhi, Sonia] Aix Marseille Univ, CNRS, UMR 6098, Lab Architecture & Fonct Macromol Biol, F-13288 Marseille 09, France; [Jensen, Malene Ringkjobing; Blackledge, Martin] UJF, Inst Biol Struct Jean Pierre Ebel, Prot Dynam & Flexibil NMR Grp, CEA,CNRS,UMR 5075, F-38027 Grenoble, France; [Oglesbee, Michael; Shu, Yaoling] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; University System of Ohio; Ohio State University	Longhi, S (corresponding author), Aix Marseille Univ, CNRS, UMR 6098, Lab Architecture & Fonct Macromol Biol, 163 Ave Luminy,Case 932, F-13288 Marseille 09, France.	Sonia.Longhi@afmb.univ-mrs.fr	LONGHI, Sonia/M-5305-2014	LONGHI, Sonia/0000-0002-6829-6771; Jensen, Malene R./0000-0003-0419-2196	Agence Nationale de la Recherche [ANR-08-PCVI-0020-01, ANR-09-BLAN-0100]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Agence Nationale de la Recherche, specific program "Physico-Chimie du Vivant", ANR-08-PCVI-0020-01, and in part by the ANR-specific program ANR-09-BLAN-0100.; Supported by a postdoctoral fellowship from the CNRS.	Albeck S, 2006, ACTA CRYSTALLOGR D, V62, P1184, DOI 10.1107/S090744490602991X; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assenberg R, 2010, ANTIVIR RES, V87, P149, DOI 10.1016/j.antiviral.2010.02.322; Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BHELLA D, 2007, MEASLES VIRUS NUCLEO, P37; Bischak CG, 2010, BIOPHYS J, V99, P1676, DOI 10.1016/j.bpj.2010.06.060; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Bourhis J.-M., 2005, Virologie (Montrouge), V9, P367, DOI 10.1684/vir.2011.2399; Bourhis J.M., 2007, MEASLES VIRUS NUCLEO, P1; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2010, J VIROL, V84, P6208, DOI 10.1128/JVI.00317-10; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Canard B, 2008, ANTIVIR RES, V78, P47, DOI 10.1016/j.antiviral.2007.09.007; Carsillo T, 2006, J VIROL, V80, P2904, DOI 10.1128/JVI.80.6.2904-2912.2006; Chan YP, 2004, J GEN VIROL, V85, P1675, DOI 10.1099/vir.0.19752-0; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; Coutard B, 2010, ANTIVIR RES, V87, P85, DOI 10.1016/j.antiviral.2010.02.326; Couturier M, 2010, J MOL RECOGNIT, V23, P301, DOI 10.1002/jmr.982; Curran J, 1999, ADV VIRUS RES, V54, P403, DOI 10.1016/S0065-3527(08)60373-5; DahlmanWright K, 1996, BIOCHEMISTRY-US, V35, P1323, DOI 10.1021/bi952409k; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2002, PROTEIN-STRUCT FUNCT, V30, P442, DOI DOI 10.1234/12345678; Dey S, 2010, J MOL BIOL, V398, P146, DOI 10.1016/j.jmb.2010.02.020; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dunker AK, 2010, CURR OPIN PHARMACOL, V10, P782, DOI 10.1016/j.coph.2010.09.005; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Ferron F, 2005, J GEN VIROL, V86, P743, DOI 10.1099/vir.0.80590-0; Fogg MJ, 2006, ACTA CRYSTALLOGR D, V62, P1196, DOI 10.1107/S0907444906030915; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; FONTANA A, 1995, FEBS LETT, V362, P266, DOI 10.1016/0014-5793(95)00237-4; Fontana A., 2010, INSTRUMENTAL ANAL IN, P569, DOI DOI 10.1002/9780470602614.CH20; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gely S, 2010, J MOL RECOGNIT, V23, P435, DOI 10.1002/jmr.1010; Gerard FCA, 2009, J MOL BIOL, V388, P978, DOI 10.1016/j.jmb.2009.03.061; Gorbalenya AE, 2010, ANTIVIR RES, V87, P95, DOI 10.1016/j.antiviral.2010.02.005; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Habchi J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011684; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; Ivanov I, 2010, J VIROL, V84, P3707, DOI 10.1128/JVI.02557-09; Jensen MR, 2008, J AM CHEM SOC, V130, P8055, DOI 10.1021/ja801332d; Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; KALININ NL, 1995, ANAL BIOCHEM, V228, P238, DOI 10.1006/abio.1995.1345; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Karlin D, 2002, VIROLOGY, V302, P420, DOI 10.1006/viro.2002.1634; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730; Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540; Kerdiles YM, 2006, VIRAL IMMUNOL, V19, P324, DOI 10.1089/vim.2006.19.324; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kingston RL, 2004, J VIROL, V78, P8630, DOI 10.1128/JVI.78.16.8630-8640.2004; Kingston RL, 2004, P NATL ACAD SCI USA, V101, P8301, DOI 10.1073/pnas.0402690101; Kiss R, 2008, FEBS LETT, V582, P2149, DOI 10.1016/j.febslet.2008.05.032; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leyrat C, 2010, PROTEIN PEPTIDE LETT, V17, P979, DOI 10.2174/092986610791498939; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Lou ZY, 2006, FEBS J, V273, P4538, DOI 10.1111/j.1742-4658.2006.05459.x; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09; Marion D, 2001, J BIOMOL NMR, V21, P75, DOI 10.1023/A:1011990021282; Mastrangelo E, 2007, J MOL BIOL, V372, P444, DOI 10.1016/j.jmb.2007.06.055; Meszaros B, 2007, J MOL BIOL, V372, P549, DOI 10.1016/j.jmb.2007.07.004; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morin B, 2006, J PHYS CHEM B, V110, P20596, DOI 10.1021/jp063708u; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Oglesbee M., 2007, MEASLES VIRUS NUCLEO, P53; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Omi-Furutani M, 2010, J VIROL, V84, P9793, DOI 10.1128/JVI.00339-10; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; RIBEIRO ED, 2009, J MOL BIOL; Ribeiro EA, 2008, J MOL BIOL, V382, P525, DOI 10.1016/j.jmb.2008.07.028; Sambrook J, 1989, MOL CLONING LAB; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Schuck P, 1997, ANNU REV BIOPH BIOM, V26, P541, DOI 10.1146/annurev.biophys.26.1.541; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LF, 2000, J VIROL, V74, P9972, DOI 10.1128/JVI.74.21.9972-9979.2000; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu B, 1999, BIOTECHNOL PROGR, V15, P81, DOI 10.1021/bp9801087; Yegambaram K, 2010, PROTEIN SCI, V19, P893, DOI 10.1002/pro.354; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	136	54	54	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13583	13602		10.1074/jbc.M111.219857	http://dx.doi.org/10.1074/jbc.M111.219857			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317293	Green Published, hybrid			2022-12-25	WOS:000289282200078
J	Jenkins, RW; Clarke, CJ; Canals, D; Snider, AJ; Gault, CR; Heffernan-Stroud, L; Wu, BX; Simbari, F; Roddy, P; Kitatani, K; Obeid, LM; Hannun, YA				Jenkins, Russell W.; Clarke, Christopher J.; Canals, Daniel; Snider, Ashley J.; Gault, Christopher R.; Heffernan-Stroud, Linda; Wu, Bill X.; Simbari, Fabio; Roddy, Patrick; Kitatani, Kazuyuki; Obeid, Lina M.; Hannun, Yusuf A.			Regulation of CC Ligand 5/RANTES by Acid Sphingomyelinase and Acid Ceramidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NIEMANN-PICK-DISEASE; DELTA-MEDIATED PHOSPHORYLATION; RANTES CHEMOKINE GENE; LUNG EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; BETA-GLUCOSIDASE 1; SECRETORY SPHINGOMYELINASE; SPHINGOSINE 1-PHOSPHATE; TNF-ALPHA; LYSOSOMAL SPHINGOMYELINASE	Acid sphingomyelinase (aSMase) generates the bioactive lipid ceramide (Cer) from hydrolysis of sphingomyelin (SM). However, its precise roles in regulating specific sphingolipid-mediated biological processes remain ill defined. Interestingly, the aSMase gene gives rise to two distinct enzymes, lysosomal sphingomyelinase (L-SMase) and secretory sphingomyelinase (S-SMase) via alternative trafficking of a shared protein precursor. Previously, our laboratory identified Ser(508) as a crucial residue for the constitutive and regulated secretion of S-SMase in response to inflammatory cytokines, and demonstrated a role for S-SMase in formation of select cellular Cer species (Jenkins, R. W., Canals, D., Idkowiak-Baldys, J., Simbari, F., Roddy, P., Perry, D. M., Kitatani, K., Luberto, C., and Hannun, Y. A. (2010) J. Biol. Chem. 285, 35706-35718). In the present study using a chemokine/cytokine screen, we identified the chemokine CCL5 (formerly known as RANTES) as a candidate-specific downstream target for aSMase. Regulation of CCL5 by aSMase was subsequently validated using both loss-of-function and gain-of-function models indicating that aSMase is both necessary and sufficient for CCL5 production. Interestingly, cells deficient in acid ceramidase (aCDase) also exhibited defects in CCL5 induction, whereas cells deficient in sphingosine kinase- 1 and -2 exhibited higher levels of CCL5, suggesting that sphingosine and not sphingosine 1-phosphate (S1P) is responsible for the positive signal to CCL5. Consistent with this, co-expression of aSMase and aCDase was sufficient to strongly induce CCL5. Taken together, these data identify a novel role for aSMase (particularly S-SMase) in chemokine elaboration by pro-inflammatory cytokines and highlight a novel and shared function for aSMase and aCDase.	[Jenkins, Russell W.; Clarke, Christopher J.; Canals, Daniel; Wu, Bill X.; Roddy, Patrick; Kitatani, Kazuyuki; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Snider, Ashley J.; Gault, Christopher R.; Heffernan-Stroud, Linda; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Snider, Ashley J.; Gault, Christopher R.; Heffernan-Stroud, Linda; Obeid, Lina M.] Ralph H Johnson Vet Affairs Hosp, Charleston, SC 29401 USA; [Simbari, Fabio] CSIC, Inst Adv Chem Catalonia, Dept Biomed Chem, ES-08034 Barcelona, Spain; [Kitatani, Kazuyuki] Tottori Univ Hosp, Dept Clin Lab, Yonago, Tottori 6838504, Japan	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Tottori University	Hannun, YA (corresponding author), 173 Ashley Ave,POB 250509, Charleston, SC 29425 USA.	hannun@musc.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021; Kitatani, Kazuyuki/H-7100-2019	Canals, Daniel/0000-0002-9293-5123; Kitatani, Kazuyuki/0000-0002-8516-6135; obeid, lina/0000-0002-0734-0847	National Institutes of Health [P01 CA097132]; NCI; MSTP Training [GM08716, GM062887]; NIGMS [CA097132]; American Heart Association [AHA 081509E]; Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain) [AP2006-02190]; Japan Society for the Promotion of Science [21890144]; NATIONAL CANCER INSTITUTE [P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008716, R01GM062887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MSTP Training; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Medical University of South Carolina Hollings Cancer Center Abney Foundation; Ministerio de Educacion y Ciencia (Spain)(Spanish Government); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA097132 (to Y. A. H.) from the NCI, MSTP Training Grant GM08716 (to R. W. J.), Grant GM062887 from the NIGMS (to L. M. O.), Grant CA097132 from the NCI (to L M. O.), American Heart Association Pre-doctoral Fellowship AHA 081509E (to R. W. J.), a Medical University of South Carolina Hollings Cancer Center Abney Foundation Scholarship (to R. W. J.), Ministerio de Educacion y Ciencia (Spain) Predoctoral Fellowship AP2006-02190 (to F. S.), and the Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (Start-up) 21890144 (to K. K.).	Ahn YT, 2007, MOL CELL BIOL, V27, P253, DOI 10.1128/MCB.01071-06; Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; BARTKE N, 2001, J LIPID RES S, V50, pS91; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Billich A, 2009, INT J BIOCHEM CELL B, V41, P1547, DOI 10.1016/j.biocel.2009.01.001; Boiardi L, 1999, CLIN EXP RHEUMATOL, V17, P419; Brinkman J, 2005, J INHERIT METAB DIS, V28, P13, DOI 10.1007/s10545-005-4416-9; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Casola A, 2002, AM J PHYSIOL-LUNG C, V283, pL1280, DOI 10.1152/ajplung.00162.2002; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Chandru H, 2007, GENE, V391, P150, DOI 10.1016/j.gene.2006.12.011; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Dhami R, 2006, MOL THER, V13, P556, DOI 10.1016/j.ymthe.2005.08.020; Dhami R, 2001, LAB INVEST, V81, P987, DOI 10.1038/labinvest.3780311; Doehner W, 2007, EUR HEART J, V28, P821, DOI 10.1093/eurheartj/ehl541; Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15; Elojeimy S, 2006, FEBS LETT, V580, P4751, DOI 10.1016/j.febslet.2006.07.071; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Gulbins E, 2006, AM J PHYSIOL-REG I, V290, pR11, DOI 10.1152/ajpregu.00416.2005; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; He XX, 2003, J BIOL CHEM, V278, P32978, DOI 10.1074/jbc.M301936200; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Jenkins RW, 2010, J BIOL CHEM, V285, P35706, DOI 10.1074/jbc.M110.125609; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Kapoor S, 2008, J HUM GENET, V53, P377, DOI 10.1007/s10038-008-0270-6; Kawata T, 2005, BIOCHEM BIOPH RES CO, V331, P640, DOI 10.1016/j.bbrc.2005.03.223; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kovacic JC, 2010, J CLIN INVEST, V120, P303, DOI 10.1172/JCI40364; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; Lebovic DI, 2004, J CLIN ENDOCR METAB, V89, P1397, DOI 10.1210/jc.2003-031010; Levy JA, 2009, J IMMUNOL, V182, P3945, DOI 10.4049/jimmunol.0990015; Lindstrom TM, 2008, MOL PHARMACOL, V74, P109, DOI 10.1124/mol.107.042838; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Makino Y, 2002, CLIN IMMUNOL, V102, P302, DOI 10.1006/clim.2001.5178; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Marathe S, 1998, J BIOL CHEM, V273, P4081, DOI 10.1074/jbc.273.7.4081; Maune S., 1996, Rhinology (Utrecht), V34, P210; Mendez-Samperio P, 2007, CELL IMMUNOL, V249, P94, DOI 10.1016/j.cellimm.2007.11.008; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Miyamoto NG, 2000, J NEUROIMMUNOL, V105, P78, DOI 10.1016/S0165-5728(00)00195-8; Moran CJ, 2002, CLIN CANCER RES, V8, P3803; Mori N, 2004, INT J CANCER, V111, P548, DOI 10.1002/ijc.20266; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; NELSON PJ, 1993, J IMMUNOL, V151, P2601; Nelson PJ, 2001, IMMUNITY, V14, P377, DOI 10.1016/S1074-7613(01)00118-2; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; ORCI L, 1991, CELL, V64, P1183; Ortiz BD, 1996, MOL CELL BIOL, V16, P202; Ortiz BD, 1997, IMMUNOL TODAY, V18, P468, DOI 10.1016/S0167-5699(97)01128-6; Oskeritzian CA, 2008, BLOOD, V111, P4193, DOI 10.1182/blood-2007-09-115451; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Roviezzo F, 2004, P NATL ACAD SCI USA, V101, P11170, DOI 10.1073/pnas.0401439101; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; SCHALL TJ, 1991, CYTOKINE, V3, P165, DOI 10.1016/1043-4666(91)90013-4; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Schissel SL, 1998, J BIOL CHEM, V273, P18250, DOI 10.1074/jbc.273.29.18250; Schissel SL, 1996, J BIOL CHEM, V271, P18431, DOI 10.1074/jbc.271.31.18431; Schuchman EH, 2007, J INHERIT METAB DIS, V30, P654, DOI 10.1007/s10545-007-0632-9; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Soria G, 2008, CYTOKINE, V44, P191, DOI 10.1016/j.cyto.2008.08.002; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; Takahashi T, 2002, J PEDIAT HEMATOL ONC, V24, P401, DOI 10.1097/00043426-200206000-00016; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; WANG E, 1991, J BIOL CHEM, V266, P14486; Wong ML, 2000, P NATL ACAD SCI USA, V97, P8681, DOI 10.1073/pnas.150098097; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zeidan YH, 2006, J BIOL CHEM, V281, P24695, DOI 10.1074/jbc.M604713200; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646	93	26	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13292	13303		10.1074/jbc.M110.163378	http://dx.doi.org/10.1074/jbc.M110.163378			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335555	Green Published, hybrid			2022-12-25	WOS:000289282200050
J	Lee, SA; Belyaeva, OV; Wu, LZ; Kedishvili, NY				Lee, Seung-Ah; Belyaeva, Olga V.; Wu, Lizhi; Kedishvili, Natalia Y.			Retinol Dehydrogenase 10 but Not Retinol/Sterol Dehydrogenase(s) Regulates the Expression of Retinoic Acid-responsive Genes in Human Transgenic Skin Raft Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; BINDING-PROTEIN; VITAMIN-A; CLONING; CANCER; DIFFERENTIATION; KERATINOCYTES; METABOLISM; OXIDATION; CELLS	Retinoic acid is essential for skin growth and differentiation, and its concentration in skin is controlled tightly. In humans, four different members of the short-chain dehydrogenase/reductase (SDR) superfamily of proteins were proposed to catalyze the rate-limiting step in the biosynthesis of retinoic acid (the oxidation of retinol to retinaldehyde). Epidermis contains at least three of these enzymes, but their relative importance for retinoic acid biosynthesis and regulation of gene expression during growth and differentiation of epidermis is not known. Here, we investigated the effect of the four human SDRs on retinoic acid biosynthesis, and their impact on growth and differentiation of keratinocytes using organotypic skin raft culture model of human epidermis. The results of this study demonstrate that ectopic expression of retinol dehydrogenase 10 (RDH10, SDR16C4) in skin rafts dramatically increases proliferation and inhibits differentiation of keratinocytes, consistent with the increased steady-state levels of retinoic acid and activation of retinoic acid-inducible genes in RDH10 rafts. In contrast, SDRs with dual retinol/sterol substrate specificity, namely retinol dehydrogenase 4 (RoDH4, SDR9C8), RoDH-like 3 alpha-hydroxysteroid dehydrogenase (RL-HSD, SDR9C6), and RDH-like SDR (RDHL, SDR9C4) do not affect the expression of retinoic acid-inducible genes but alter the expression levels of several components of extracellular matrix. These results reveal essential differences in the metabolic contribution of RDH10 versus retinol/sterol dehydrogenases to retinoic acid biosynthesis and provide the first evidence that non-retinoid metabolic products of retinol/sterol dehydrogenases affect gene expression in human epidermis.	[Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, Birmingham, AL 35294 USA; [Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Dent, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Sch Med, 720 20th St S,440B Kaul Genet Bldg, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891	National Institute on Alcohol Abuse and Alcoholism [AA12153]; National Institutes of Health [RR19231, P30 CA13148, P50 AT00477, U54 CA100949, P30 AR50948, P30 DK079337]; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism Grant AA12153 (to N. Y. K.). The University of Alabama-Birmingham Targeted Metabolomics and Proteomics Laboratory is supported by the National Institutes of Health Grants RR19231, P30 CA13148, P50 AT00477, U54 CA100949, P30 AR50948, and P30 DK079337.	ANDERSSON E, 1994, BBA-MOL CELL RES, V1224, P349, DOI 10.1016/0167-4889(94)90267-4; ASSELINEAU D, 1989, DEV BIOL, V133, P322, DOI 10.1016/0012-1606(89)90037-7; Banerjee NS, 2005, METH MOLEC MED, V119, P187; Baron JM, 2005, J INVEST DERMATOL, V125, P143, DOI 10.1111/j.0022-202X.2005.23791.x; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2007, ENDOCRINOLOGY, V148, P2148, DOI 10.1210/en.2006-1491; Belyaeva OV, 2006, GENOMICS, V88, P820, DOI 10.1016/j.ygeno.2006.06.004; Belyaeva OV, 2005, BIOCHEMISTRY-US, V44, P7035, DOI 10.1021/bi050226k; Bernard FX, 2002, EXP DERMATOL, V11, P59, DOI 10.1034/j.1600-0625.2002.110107.x; Biswas MG, 1997, J BIOL CHEM, V272, P15959, DOI 10.1074/jbc.272.25.15959; BUSCH C, 1992, J INVEST DERMATOL, V99, P795, DOI 10.1111/1523-1747.ep12614757; Chatellard-Gruaz D, 1998, J LIPID RES, V39, P1421; CHENG S, 1995, GENE DEV, V9, P2335, DOI 10.1101/gad.9.19.2335; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; Chetyrkin SV, 2001, ARCH BIOCHEM BIOPHYS, V386, P1, DOI 10.1006/abbi.2000.2203; Cheung C, 1999, BIOCHEM BIOPH RES CO, V261, P100, DOI 10.1006/bbrc.1999.0943; Chintala S, 2005, P NATL ACAD SCI USA, V102, P10964, DOI 10.1073/pnas.0502856102; Fisher GJ, 1996, FASEB J, V10, P1002, DOI 10.1096/fasebj.10.9.8801161; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gough WH, 1998, J BIOL CHEM, V273, P19778, DOI 10.1074/jbc.273.31.19778; Gudas Lorraine J., 1994, P443; Hedblom E, 1997, J BIOL CHEM, V272, P15346, DOI 10.1074/jbc.272.24.15346; Hoover F, 2001, J COMP NEUROL, V436, P324; Itoh Y, 2008, GLYCOBIOLOGY, V18, P74, DOI 10.1093/glycob/cwm118; Jin N, 2005, CELL TISSUE RES, V321, P173, DOI 10.1007/s00441-005-1130-8; Jurukovski V, 1999, MOL GENET METAB, V67, P62, DOI 10.1006/mgme.1999.2840; Kallberg Y, 2010, FEBS J, V277, P2375, DOI 10.1111/j.1742-4658.2010.07656.x; Kang S, 2005, CUTIS, V75, P10; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Karlsson T, 2003, BIOCHEM BIOPH RES CO, V303, P273, DOI 10.1016/S0006-291X(03)00332-2; Karlsson T, 2002, EXP DERMATOL, V11, P143, DOI 10.1034/j.1600-0625.2002.110206.x; Karlsson T, 2010, J DERMATOL SCI, V57, P207, DOI 10.1016/j.jdermsci.2009.12.013; Lapshina EA, 2003, BIOCHEMISTRY-US, V42, P776, DOI 10.1021/bi026836r; Leclerc EA, 2009, J CELL SCI, V122, P2699, DOI 10.1242/jcs.050302; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lorie EP, 2009, ARCH DERMATOL RES, V301, P475, DOI 10.1007/s00403-009-0937-7; Mangelsdorf David J., 1994, P319; Markova NG, 2003, MOL GENET METAB, V78, P119, DOI 10.1016/S1096-7192(02)00226-3; Matsumoto M, 2008, P NATL ACAD SCI USA, V105, P6720, DOI 10.1073/pnas.0709345105; Meyer-Hoffert U, 2010, J BIOL CHEM, V285, P32174, DOI 10.1074/jbc.M109.091850; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; NAPOLI JL, 1987, ARCH BIOCHEM BIOPHYS, V255, P95, DOI 10.1016/0003-9861(87)90298-0; Napoli JL, 1998, METH MOL B, V89, P29; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pure E, 2009, EXPERT OPIN THER TAR, V13, P967, DOI 10.1517/14728220903103841; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; Sani BP, 1997, BIOCHEM PHARMACOL, V53, P1049, DOI 10.1016/S0006-2952(97)00076-2; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Takehara A, 2007, CANCER RES, V67, P9704, DOI 10.1158/0008-5472.CAN-07-2099; Tang XH, 2008, EXP CELL RES, V314, P38, DOI 10.1016/j.yexcr.2007.07.016; Torma H, 1999, ARCH DERMATOL RES, V291, P339, DOI 10.1007/s004030050419; WILSON JL, 1992, CELL GROWTH DIFFER, V3, P471; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yi Y, 2010, J BIOL CHEM, V285, P21233, DOI 10.1074/jbc.M109.082875; Zafrakas M, 2006, INT J CANCER, V118, P1453, DOI 10.1002/ijc.21517	58	26	27	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13550	13560		10.1074/jbc.M110.181065	http://dx.doi.org/10.1074/jbc.M110.181065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345790	hybrid, Green Published			2022-12-25	WOS:000289282200075
J	Meur, G; Qian, QW; Xavier, GD; Pullen, TJ; Tsuboi, T; McKinnon, C; Fletcher, L; Tavare, JM; Hughes, S; Johnson, P; Rutter, GA				Meur, Gargi; Qian, Qingwen; Xavier, Gabriela da Silva; Pullen, Timothy J.; Tsuboi, Takashi; McKinnon, Caroline; Fletcher, Laura; Tavare, Jeremy M.; Hughes, Stephen; Johnson, Paul; Rutter, Guy A.			Nucleo-cytosolic Shuttling of FoxO1 Directly Regulates Mouse Ins2 but Not Ins1 Gene Expression in Pancreatic Beta Cells (MIN6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED INSULIN-SECRETION; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; RESPONSE ELEMENT; PROTEIN-KINASE; GLUCOSE; TRANSCRIPTION; ACTIVATION; BINDING; PROMOTER	The Forldiead box transcription factor FoxO1 regulates metabolic gene expression in mammals. FoxO1 activity is tightly controlled by phosphatidylinositol 3-kinase (PI3K) signaling, resulting in its phosphorylation and nuclear exclusion. We sought here to determine the mechanisms involved in glucose and insulin-stimulated nuclear shuttling of FoxO1 in pancreatic beta cells and its consequences for preproinsulin (Ins1, Ins2) gene expression. Nuclearlocalized endogenous FoxO1 translocated to the cytosol in response to elevated glucose (3 versus 16.7 mm) in human islet beta cells. Real-time confocal imaging of nucleo-cytosolic shuttling of a FoxO1-EGTP chimera in primary mouse and clonal MIN6 beta cells revealed a time-dependent glucose-responsive nuclear export, also mimicked by exogenous insulin, and blocked by suppressing insulin secretion. Constitutively active PI3K or protein kinase B/Akt exerted similar effects, while inhibitors of PI3K, but not of glycogen synthase kinase-3 or p70 S6 kinase, blocked nuclear export. FoxO1 overexpression reversed the activation by glucose of pancreatic duodenum homeobox-1 (Pdx1) transcription. Silencing of FoxO1 significantly elevated the expression of mouse Ins2, but not Ins1, mRNA at 3 mm glucose. Putative FoxO1 binding sites were identified in the distal promoter of rodent Ins2 genes and direct binding of FoxO1 to the Ins2 promoter was demonstrated by chromatin immunoprecipitation. A 915-bp glucose-responsive Ins2 promoter was inhibited by constitutively active FoxO1, an effect unaltered by simultaneous overexpression of PDX1. We conclude that nuclear import of FoxO1 contributes to the suppression of Pdx1 and ins2 gene expression at low glucose, the latter via a previously unsuspected and direct physical interaction with the Ins2 promoter.	[Meur, Gargi; Qian, Qingwen; Xavier, Gabriela da Silva; Pullen, Timothy J.; McKinnon, Caroline; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, London SW7 2AZ, England; [McKinnon, Caroline; Fletcher, Laura; Tavare, Jeremy M.] Univ Bristol, Sch Med Sci, Henry Wellcome Labs Integrated Cell Signalling, Bristol BS8 1TD, Avon, England; [McKinnon, Caroline; Fletcher, Laura; Tavare, Jeremy M.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Hughes, Stephen; Johnson, Paul] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Tsuboi, Takashi] Univ Tokyo, Dept Life Sci, Tokyo 1538902, Japan	Imperial College London; University of Bristol; University of Bristol; University of Oxford; University of Tokyo	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Sect Cell Biol, Div Diabet Endocrinol & Metab,Dept Med, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	g.rutter@imperial.ac.uk	Pullen, Timothy J/H-2143-2011; TSUBOI, Takashi/AAD-7976-2019	Pullen, Timothy J/0000-0002-6853-5701; TSUBOI, Takashi/0000-0001-8290-2021; da Silva Xavier, Gabriela/0000-0002-0678-012X; Meur, Gargi/0000-0002-8466-2997; Rutter, Guy/0000-0001-6360-0343	Juvenile Diabetes Research Fund (JDRF) [1-2003-235]; Wellcome Trust [067081/Z/02/Z, 081958/Z/07/Z]; Research Leave Fellowship; BBSRC; MRC (UK); European Union; MRC [G0401641, G7708269] Funding Source: UKRI; Medical Research Council [G0401641, G7708269] Funding Source: researchfish	Juvenile Diabetes Research Fund (JDRF)(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Research Leave Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Juvenile Diabetes Research Fund (JDRF) Project Grant 1-2003-235, Wellcome Trust Programme Grants 067081/Z/02/Z and 081958/Z/07/Z, and Research Leave Fellowship (to G. A. R.) as well as grants from the BBSRC and MRC (UK), and the European Union (FP6, Save Beta).	Ainscow EK, 2001, BIOCHEM J, V353, P175, DOI 10.1042/0264-6021:3530175; Andreolas C, 2002, DIABETES, V51, P2536, DOI 10.2337/diabetes.51.8.2536; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; Bouche C, 2010, P NATL ACAD SCI USA, V107, P4770, DOI 10.1073/pnas.1000002107; Briaud I, 2003, DIABETES, V52, P974, DOI 10.2337/diabetes.52.4.974; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cross SE, 2008, TRANSPLANTATION, V86, P907, DOI 10.1097/TP.0b013e318186df87; Deltour L, 2004, GENE EXPR PATTERNS, V5, P297, DOI 10.1016/j.modgep.2004.04.013; DHAND R, 1994, EMBO J, V13, P511, DOI 10.1002/j.1460-2075.1994.tb06289.x; Durham SK, 1999, ENDOCRINOLOGY, V140, P3140, DOI 10.1210/en.140.7.3140; ELAYAT AA, 1995, J ANAT, V186, P629; Finlay D, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-15; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; GERMAN M, 1995, DIABETES, V44, P1002, DOI 10.2337/diab.44.8.1002; Guillemain G, 2004, BIOCHEM J, V378, P219, DOI 10.1042/BJ20031549; Hettiarachchi KD, 2006, CELL BIOL TOXICOL, V22, P169, DOI 10.1007/s10565-006-0054-8; Kennedy HJ, 1997, J BIOL CHEM, V272, P20636, DOI 10.1074/jbc.272.33.20636; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lantz KA, 2005, CLIN SCI, V108, P195, DOI 10.1042/CS20040309; Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546; Leibiger B, 1998, P NATL ACAD SCI USA, V95, P9307, DOI 10.1073/pnas.95.16.9307; Leibiger IB, 1998, MOL CELL, V1, P933, DOI 10.1016/S1097-2765(00)80093-3; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Martinez SC, 2006, DIABETES, V55, P1581, DOI 10.2337/db05-0678; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; McKinnon CM, 2006, J BIOL CHEM, V281, P39358, DOI 10.1074/jbc.M605022200; Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Noordeen NA, 2010, DIABETES, V59, P153, DOI 10.2337/db08-0868; Rafiq I, 2000, J BIOL CHEM, V275, P15977, DOI 10.1074/jbc.275.21.15977; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rutter CA, 2000, NEWS PHYSIOL SCI, V15, P149; Rutter GA, 1999, CURR BIOL, V9, pR443, DOI 10.1016/S0960-9822(99)80277-2; Shih DQ, 2002, P NATL ACAD SCI USA, V99, P3818, DOI 10.1073/pnas.062605899; SOARES MB, 1985, MOL CELL BIOL, V5, P2090, DOI 10.1128/MCB.5.8.2090; Trumper A, 2001, MOL ENDOCRINOL, V15, P1559, DOI 10.1210/me.15.9.1559; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Xavier GD, 2003, BIOCHEM J, V371, P761; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	53	22	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13647	13656		10.1074/jbc.M110.204248	http://dx.doi.org/10.1074/jbc.M110.204248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335550	Green Published, hybrid			2022-12-25	WOS:000289282200083
J	Mushtaq, M; Nam, TS; Kim, UH				Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Uh-Hyun			Critical Role for CD38-mediated Ca2+ Signaling in Thrombin-induced Procoagulant Activity of Mouse Platelets and Hemostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CYCLIC ADP-RIBOSE; HEAVY-CHAIN IIA; NONMUSCLE MYOSIN; TYROSINE KINASE; STIMULATED PLATELETS; SYNTHESIZING CD38; ACIDIC ORGANELLES; GLYCOPROTEIN VI; CALCIUM	CD38, a multifunctional enzyme that catalyzes the synthesis of intracellular Ca2+ messengers, cyclic ADP-ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP), is known to be expressed on platelets. However, the role of CD38 in platelets remains unclear. Our present results show that treatment of platelets with thrombin results in a rapid and sustained Ca2+ signal, resulting from a coordinated interplay of Ca2+-mobilizing messengers, inositol 1,4,5-trisphosphate, cADP R, and NAADP. By dissecting the signaling pathway using various agents, we delineated that cADPR and NAADP are sequentially produced through CD38 internalization by protein kinase C via myosin heavy chain IIA following phospholipase C activation in thrombin-induced platelets. An inositol 1,4,5-trisphosphate receptor antagonist blocked the thrombin-induced formation of cADPR and NAADP as well as Ca2+ signals. An indispensable response of platelets relying on cytosolic calcium is the surface exposure of phosphatidylserine (PS), which implicates platelet procoagulant activity. Scrutinizing this parameter reveals that CD38(+/+) platelets fully express PS on the surface when stimulated with thrombin, whereas this response was decreased on CD38(-/-) platelets. Similarly, PS exposure and Ca2+ signals were attenuated when platelets were incubated with 8-bromo-cADPR, bafilomycin A1, and a PKC inhibitor. Furthermore, in vivo, CD38-deficient mice exhibited longer bleeding times and unstable formation of thrombus than wild type mice. These results demonstrate that CD38 plays an essential role in thrombin-induced procoagulant activity of platelets and hemostasis via Ca2+ signaling mediated by its products, cADPR and NAADP.	[Mushtaq, Mazhar; Nam, Tae-Sik; Kim, Uh-Hyun] Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju 561182, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Sch Med, Jeonju 561182, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Dept Biochem, Sch Med, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr	Mushtaq, Mazhar/L-3366-2019	Mushtaq, Mazhar/0000-0002-2126-924X; Kim, Uh-Hyun/0000-0003-3304-7190	Korea Science and Engineering Foundation (National Research Laboratory) [R0A-2007-000-20121-0]	Korea Science and Engineering Foundation (National Research Laboratory)(Korea Science and Engineering Foundation)	This work was supported by the Korea Science and Engineering Foundation (National Research Laboratory Grant R0A-2007-000-20121-0) (to U.-H. K.).	ARDLIE NG, 1986, THROMB RES, V42, P115, DOI 10.1016/0049-3848(86)90288-4; BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; DAVIES TA, 1989, J BIOL CHEM, V264, P19600; DeFlora A, 1997, J BIOL CHEM, V272, P12945, DOI 10.1074/jbc.272.20.12945; Giambelluca MS, 2007, BLOOD COAGUL FIBRIN, V18, P303, DOI 10.1097/MBC.0b013e3281223535; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Harper MT, 2010, J BIOL CHEM, V285, P19865, DOI 10.1074/jbc.M109.085654; Heemskerk JWM, 2005, TRENDS CARDIOVAS MED, V15, P86, DOI 10.1016/j.tcm.2005.03.003; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; IKEBE M, 1990, BIOCHEMISTRY-US, V29, P2713, DOI 10.1021/bi00463a014; Jardin I, 2008, TRENDS CARDIOVAS MED, V18, P57, DOI 10.1016/j.tcm.2007.12.004; KAWAMOTO S, 1989, J BIOL CHEM, V264, P2258; Keuren JFW, 2005, ARTERIOSCL THROM VAS, V25, P1499, DOI 10.1161/01.ATV.0000167526.31611.f6; KHAN WA, 1993, J BIOL CHEM, V268, P5063; Kriajevska M, 1998, J BIOL CHEM, V273, P9852, DOI 10.1074/jbc.273.16.9852; Lee HC, 2000, J MEMBRANE BIOL, V173, P1, DOI 10.1007/s002320001001; LEE VS, 1992, J BIOCHEM BIOPH METH, V24, P215, DOI 10.1016/0165-022X(94)90074-4; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Lopez JJ, 2005, BIOCHEM J, V390, P243, DOI 10.1042/BJ20050168; Ludowyke RI, 2006, J IMMUNOL, V177, P1492, DOI 10.4049/jimmunol.177.3.1492; LYONS RM, 1975, J CLIN INVEST, V56, P924, DOI 10.1172/JCI108172; Michelangeli F, 2005, CURR OPIN CELL BIOL, V17, P135, DOI 10.1016/j.ceb.2005.01.005; MOUSSAVI RS, 1993, MOL CELL BIOCHEM, V128, P219, DOI 10.1007/BF01076773; Ohlmann P, 1998, BIOCHEM J, V331, P431, DOI 10.1042/bj3310431; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Pestina TI, 1997, ARTERIOSCL THROM VAS, V17, P3278, DOI 10.1161/01.ATV.17.11.3278; Rah SY, 2007, J BIOL CHEM, V282, P5653, DOI 10.1074/jbc.M609478200; Rah SY, 2005, J BIOL CHEM, V280, P2888, DOI 10.1074/jbc.M409592200; Ramaschi G, 1996, BLOOD, V87, P2308, DOI 10.1182/blood.V87.6.2308.bloodjournal8762308; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Ribeiro JMC, 2001, J EXP BIOL, V204, P3887; Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200; Rosado JA, 2006, ARCH BIOCHEM BIOPHYS, V452, P9, DOI 10.1016/j.abb.2006.05.011; SIFFERT W, 1988, J BIOL CHEM, V263, P4223; Straussman R, 2001, J CELL SCI, V114, P3047; Torti M, 1998, FEBS LETT, V431, P19, DOI 10.1016/S0014-5793(98)00712-1; Torti M, 1998, FEBS LETT, V428, P200, DOI 10.1016/S0014-5793(98)00516-X; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; WATSON SP, 1988, BIOCHEM J, V249, P345, DOI 10.1042/bj2490345; Williamson P, 2001, BIOCHEMISTRY-US, V40, P8065, DOI 10.1021/bi001929z; Wolfs JL, 2006, BLOOD, V108, P2223, DOI 10.1182/blood-2006-01-009613; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	45	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12952	12958		10.1074/jbc.M110.207100	http://dx.doi.org/10.1074/jbc.M110.207100			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339289	Green Published, hybrid			2022-12-25	WOS:000289282200015
J	Schober, DA; Gill, MB; Yu, H; Gernert, DL; Jeffries, MW; Ornstein, PL; Kato, AS; Felder, CC; Bredt, DS				Schober, Douglas A.; Gill, Martin B.; Yu, Hong; Gernert, Douglas L.; Jeffries, Matthew W.; Ornstein, Paul L.; Kato, Akihiko S.; Felder, Christian C.; Bredt, David S.			Transmembrane AMPA Receptor Regulatory Proteins and Cornichon-2 Allosterically Regulate AMPA Receptor Antagonists and Potentiators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMDA GLUTAMATE-RECEPTOR; 2 DISTINCT MECHANISMS; SYNAPTIC PLASTICITY; AUXILIARY SUBUNITS; PARKINSONS-DISEASE; MOLECULAR-BIOLOGY; TARP GAMMA-8; STARGAZIN; TRAFFICKING; EXPRESSION	AMPA receptors mediate fast excitatory transmission in the brain. Neuronal AMPA receptors comprise GluA pore-forming principal subunits and can associate with multiple modulatory components, including transmembrane AMPA receptor regulatory proteins (TARPs) and CNIHs (cornichons). AMPA receptor potentiators and non-competitive antagonists represent potential targets for a variety of neuropsychiatric disorders. Previous studies showed that the AMPA receptor antagonist GYKI-53655 displaces binding of a potentiator from brain receptors but not from recombinant Cilia subunits. Here, we asked whether AMPA receptor modulatory subunits might resolve this discrepancy. We find that the cerebellar TARP, stargazin (gamma-2), enhances the binding affinity of the AMPA receptor potentiator [H-3]-LY450295 and confers sensitivity to displacement by non-competitive antagonists. In cerebellar membranes from stargazer mice, [H-3]-LY450295 binding is reduced and relatively resistant to displacement by non-competitive antagonists. Coexpression of AMPA receptors with CNIH-2, which is expressed in the hippocampus and at low levels in the cerebellar Purkinje neurons, confers partial sensitivity of [H-3] -LY450295 potentiator binding to displacement by non-competitive antagonists. Autoradiography of [H-3]-LY450295 binding to stargazer and gamma-8-deficient mouse brain sections, demonstrates that TARPs regulate the pharmacology of allosteric AMPA potentiators and antagonists in the cerebellum and hippocampus, respectively. These studies demonstrate that accessory proteins define AMPA receptor pharmacology by functionally linking allosteric AMPA receptor potentiator and antagonist sites.	[Jeffries, Matthew W.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA; [Schober, Douglas A.; Gill, Martin B.; Yu, Hong; Kato, Akihiko S.; Felder, Christian C.; Bredt, David S.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Discovery Neurosci Res, Indianapolis, IN 46285 USA; [Gernert, Douglas L.; Ornstein, Paul L.] Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Discovery Chem Res, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly	Bredt, DS (corresponding author), Eli Lilly & Co, Lilly Res Lab, Lilly Corp Ctr, Biotechnol Discovery Res, Indianapolis, IN 46285 USA.	dbredt@gmail.com	Ornstein, Paul/E-4212-2016	Ornstein, Paul/0000-0002-4335-1877; Felder, Christian/0000-0003-1134-8881				Arai AC, 2007, CURR DRUG TARGETS, V8, P583, DOI 10.2174/138945007780618490; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Bai F, 2003, NEUROPHARMACOLOGY, V44, P1013, DOI 10.1016/S0028-3908(03)00104-7; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Coombs ID, 2009, NEUROSCIENCE, V162, P656, DOI 10.1016/j.neuroscience.2009.01.004; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Fukaya M, 2006, EUR J NEUROSCI, V24, P2177, DOI 10.1111/j.1460-9568.2006.05081.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Grove SJA, 2010, J MED CHEM, V53, P7271, DOI 10.1021/jm1000419; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Linden AM, 2001, NEUROPHARMACOLOGY, V40, P1010, DOI 10.1016/S0028-3908(01)00013-2; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Menniti FS, 2000, MOL PHARMACOL, V58, P1310, DOI 10.1124/mol.58.6.1310; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; O'Neill MJ, 2007, CURR DRUG TARGETS, V8, P603, DOI 10.2174/138945007780618517; O'Neill MJ, 2005, CNS DRUG REV, V11, P77; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Shi Y, 2010, P NATL ACAD SCI USA, V107, P16315, DOI 10.1073/pnas.1011706107; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; TANG CM, 1991, SCIENCE, V254, P288, DOI 10.1126/science.1681589; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Ward SE, 2010, J MED CHEM, V53, P5801, DOI 10.1021/jm1005429; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Ziff EB, 2007, NEURON, V53, P627, DOI 10.1016/j.neuron.2007.02.006; ZORUMSKI CF, 1993, NEURON, V10, P61, DOI 10.1016/0896-6273(93)90242-J	63	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13134	13142		10.1074/jbc.M110.212522	http://dx.doi.org/10.1074/jbc.M110.212522			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343286	hybrid, Green Published			2022-12-25	WOS:000289282200034
J	Tian, YM; Yeoh, KK; Lee, MK; Eriksson, T; Kessler, BM; Kramer, HB; Edelmann, MJ; Willam, C; Pugh, CW; Schofield, CJ; Ratcliffe, PJ				Tian, Ya-Min; Yeoh, Kar Kheng; Lee, Myung Kyu; Eriksson, Tuula; Kessler, Benedikt M.; Kramer, Holger B.; Edelmann, Mariola J.; Willam, Carsten; Pugh, Christopher W.; Schofield, Christopher J.; Ratcliffe, Peter J.			Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SENSING PATHWAY; ANKYRIN REPEAT DOMAIN; ASPARAGINYL HYDROXYLASE; PROLYL 4-HYDROXYLASES; FACTOR HIF; TRANSCRIPTIONAL ACTIVITY; STRUCTURAL BASIS; FACTOR-ALPHA; FACTOR FIH; HIF-1-ALPHA	Hypoxia inducible factor (HIF) is regulated by dual pathways involving oxygen-dependent prolyl and asparaginyl hydroxylation of its alpha-subunits. Prolyl hydroxylation at two sites within a central degradation domain promotes association of HI F-alpha with the von Hippel-Lindau ubiquitin E3 ligase and destruction by the ubiquitin-proteasome pathways. Asparaginyl hydroxylation blocks the recruitment of p300/CBP co-activators to a C-terminal activation domain in HIF-alpha. These hydroxylations are catalyzed by members of the FOLD and 2-oxoglutarate (2-OG) oxygenase family. Activity of the enzymes is suppressed by hypoxia, increasing both the abundance and activity of the HIF transcriptional complex. We have used hydroxy residue-specific antibodies to compare and contrast the regulation of each site of prolyl hydroxylation (Pro(402), Pro(564)) with that of asparaginyl hydroxylation (Asn(803)) in human HIF-1 alpha. Our findings reveal striking differences in the sensitivity of these hydroxylations to hypoxia and to different inhibitor types of 2-OG oxygenases. Hydroxylation at the three sites in endogenous human HIF-1 alpha proteins was suppressed by hypoxia in the order Pro(402) > Pro(564) > Asn(803). In contrast to some predictions from in vitro studies, prolyl hydroxylation was substantially more sensitive than asparaginyl hydroxylation to inhibition by iron chelators and transition metal ions; studies of a range of different small molecule 2-OG analogues demonstrated the feasibility of selectively inhibiting either prolyl or asparaginyl hydroxylation within cells.	[Tian, Ya-Min; Eriksson, Tuula; Kessler, Benedikt M.; Kramer, Holger B.; Edelmann, Mariola J.; Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Yeoh, Kar Kheng; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Dept Chem, Oxford OX1 3TA, England; [Lee, Myung Kyu] Korea Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, Taejon 305333, South Korea; [Willam, Carsten] Univ Erlangen Nurnberg, Med Klin 4, D-91054 Erlangen, Germany	University of Oxford; University of Oxford; University of Erlangen Nuremberg	Ratcliffe, PJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.	pjr@well.ox.ac.uk	Kramer, Holger/AAL-4433-2020; Eriksson, Tuula/J-5984-2012; Kessler, Benedikt/AAY-8614-2021	Kramer, Holger/0000-0002-6400-0945; Kessler, Benedikt/0000-0002-8160-2446; Pugh, Chris/0000-0002-5170-1662; Ratcliffe, Peter/0000-0002-2853-806X; Edelmann, Mariola/0000-0003-0459-7716; Schofield, Christopher/0000-0002-0290-6565	Wellcome Trust; European Union; Malaysian government; Univerisiti Sains Malaysia	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Malaysian government; Univerisiti Sains Malaysia	This work was supported by the Wellcome Trust, the European Union 7th framework, the Malaysian government, and a Univerisiti Sains Malaysia fellowship (to K. K. Y.).	Banerji B, 2005, CHEM COMMUN, P5438, DOI 10.1039/b510707e; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Myllyharju J, 2009, CURR PHARM DESIGN, V15, P3878, DOI 10.2174/138161209789649457; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sowter HM, 2003, CANCER RES, V63, P6130; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	50	134	143	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13041	13051		10.1074/jbc.M110.211110	http://dx.doi.org/10.1074/jbc.M110.211110			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335549	Green Published, hybrid			2022-12-25	WOS:000289282200024
J	Bu, QY; Zhu, L; Dennis, MD; Yu, L; Lu, SEX; Person, MD; Tobin, EM; Browning, KS; Huq, E				Bu, Qingyun; Zhu, Ling; Dennis, Michael D.; Yu, Lu; Lu, Sheen X.; Person, Maria D.; Tobin, Elaine M.; Browning, Karen S.; Huq, Enamul			Phosphorylation by CK2 Enhances the Rapid Light-induced Degradation of Phytochrome Interacting Factor 1 in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; TRANSLATION INITIATION-FACTORS; REGULATED GENE-EXPRESSION; TRANSCRIPTION FACTORS; MEDIATED DEGRADATION; OSCILLATOR FUNCTION; SIGNALING NETWORKS; RED-LIGHT; PHOTOMORPHOGENESIS; SEEDLINGS	The phytochrome family of sensory photoreceptors interacts with phytochrome interacting factors (PIFs), repressors of photomorphogenesis, in response to environmental light signals and induces rapid phosphorylation and degradation of PIFs to promote photomorphogenesis. However, the kinase that phosphorylates PIFs is still unknown. Here we show that CK2 directly phosphorylates PIF1 at multiple sites. alpha 1 and alpha 2 subunits individually phosphorylated PIF1 weakly in vitro. However, each of four beta subunits strongly stimulated phosphorylation of PIF1 by alpha 1 or alpha 2. Mapping of the phosphorylation sites identified seven Ser/Thr residues scattered throughout PIF1. Ser/Thr to Ala scanning mutations at all seven sites eliminated CK2-mediated phosphorylation of PIF1 in vitro. Moreover, the rate of degradation of the Ser/Thr to Ala mutant PIF1 was significantly reduced compared with wild-type PIF1 in transgenic plants. In addition, hypocotyl lengths of the mutant PIF1 transgenic plants were much longer than the wild-type PIF1 transgenic plants under light, suggesting that the mutant PIF1 is suppressing photomorphogenesis. Taken together, these data suggest that CK2-mediated phosphorylation enhances the light-induced degradation of PIF1 to promote photomorphogenesis.	[Huq, Enamul] Univ Texas Austin, Sect Mol Cell & Dev Biol, Biol Labs 311 A6700, Austin, TX 78712 USA; [Dennis, Michael D.; Browning, Karen S.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Person, Maria D.; Browning, Karen S.; Huq, Enamul] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Lu, Sheen X.; Tobin, Elaine M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Los Angeles	Huq, E (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Biol Labs 311 A6700, 205 W 24th St, Austin, TX 78712 USA.	huq@mail.utexas.edu	Zhu, Ling/G-1142-2015	Dennis, Michael/0000-0002-0645-6864; Huq, Enamul/0000-0001-7692-5139	National Institutes of Health [GM-23167]; NIEHS National Institutes of Health [P30ES007784]; Department of Energy [DE-FG02-04ER15575]; National Science Foundation [MCB0214996, IOS-0822811, IOS-0849287]; Welch Foundation [F1339]; Direct For Biological Sciences [1052530] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-23167 (to E. M. T.) and NIEHS National Institutes of Health Grant P30ES007784 (to M. D. P.). This work was also supported by Department of Energy Grant DE-FG02-04ER15575, National Science Foundation Grant MCB0214996, and Welch Foundation Grant F1339 (to K. S. B.); and by National Science Foundation Grants IOS-0822811 and IOS-0849287 (to E. H.).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; Bae G, 2008, ANNU REV PLANT BIOL, V59, P281, DOI 10.1146/annurev.arplant.59.032607.092859; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Castillon A, 2009, GENETICS, V182, P161, DOI 10.1534/genetics.108.099887; Chen M, 2010, CELL, V141, P1230, DOI 10.1016/j.cell.2010.05.007; Daniel X, 2004, P NATL ACAD SCI USA, V101, P3292, DOI 10.1073/pnas.0400163101; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; Dennis MD, 2009, J BIOL CHEM, V284, P20615, DOI 10.1074/jbc.M109.007658; Duek PD, 2005, TRENDS PLANT SCI, V10, P51, DOI 10.1016/j.tplants.2004.12.005; Fankhauser C, 2008, TRENDS PLANT SCI, V13, P596, DOI 10.1016/j.tplants.2008.08.007; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Henriques R, 2009, CURR OPIN PLANT BIOL, V12, P49, DOI 10.1016/j.pbi.2008.10.009; Hornitschek P, 2009, EMBO J, V28, P3893, DOI 10.1038/emboj.2009.306; Huq E, 2006, TRENDS PLANT SCI, V11, P4, DOI 10.1016/j.tplants.2005.11.005; Huq E, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P151, DOI 10.1002/352760510X.ch7; Jang IC, 2010, PLANT CELL, V22, P2370, DOI 10.1105/tpc.109.072520; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Moon J, 2008, P NATL ACAD SCI USA, V105, P9433, DOI 10.1073/pnas.0803611105; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Park HJ, 2008, J BIOL CHEM, V283, P23264, DOI 10.1074/jbc.M801720200; Portoles S, 2007, PLANT J, V51, P966, DOI 10.1111/j.1365-313X.2007.03186.x; Quail PH, 2007, J INTEGR PLANT BIOL, V49, P11, DOI 10.1111/j.1744-7909.2006.00422.x; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Schafer E., 2006, FUNCTION SIGNAL TRAN, V3rd; Seo HS, 2003, NATURE, V423, P995, DOI 10.1038/nature01696; Shen H, 2005, PLANT J, V44, P1023, DOI 10.1111/j.1365-313X.2005.02606.x; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Shen Y, 2007, PLANT PHYSIOL, V145, P1043, DOI 10.1104/pp.107.105601; Shin J, 2009, P NATL ACAD SCI USA, V106, P7660, DOI 10.1073/pnas.0812219106; Stemmer C, 2003, BIOCHEMISTRY-US, V42, P3503, DOI 10.1021/bi027350d; Sugano S, 1998, P NATL ACAD SCI USA, V95, P11020, DOI 10.1073/pnas.95.18.11020; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	54	71	83	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.186882	http://dx.doi.org/10.1074/jbc.M110.186882			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330376	Green Published, hybrid			2022-12-25	WOS:000289077500021
J	Cheon, S; Lee, JH; Park, S; Bang, SI; Lee, WJ; Yoon, DY; Yoon, SS; Kim, T; Min, H; Cho, BJ; Lee, HJ; Lee, KW; Jeong, SH; Park, H; Cho, D				Cheon, Soyoung; Lee, Ji Hyung; Park, Sunyoung; Bang, Sa Ik; Lee, Wang Jae; Yoon, Do-Young; Yoon, Sung-Soo; Kim, Taesung; Min, Hyeyoung; Cho, Byung Joo; Lee, Hyong Joo; Lee, Ki Woong; Jeong, Seung Hwan; Park, Hyunjeong; Cho, Daeho			Overexpression of IL-32 alpha Increases Natural Killer Cell-mediated Killing through Up-regulation of Fas and UL16-binding protein 2 (ULBP2) Expression in Human Chronic Myeloid Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NKG2D IMMUNORECEPTOR; T-CELLS; INTERLEUKIN-32; ACTIVATION; CANCER; LIGANDS; ROLES; IL-32; APOPTOSIS; CYTOKINE	IL-32 was recently identified as a proinflammatory cytokine that is induced by IL-18 in natural killer (NK) cells and is highly correlated with inflammatory disorders. However, the relationship between IL-32 and tumor progression is still unknown. In this study, we investigated whether overexpression of IL-32 affects susceptibility of chronic myeloid leukemia (CML) cells to NK cells. Interestingly, IL-32 alpha-overexpressing CML cell lines, K562, Kcl22, and BV173, showed higher NK cell-mediated killing. Flow cytometry analysis revealed that overexpression of IL-32 alpha induced increased expression of Fas and UL16-binding protein 2 (ULBP2) in CML cells. The direct relationship between overexpression of surface molecules by IL-32 alpha and increased NK cell-mediated killing was confirmed by Fas or ULBP2 siRNA transfection. IL-32 alpha-induced Fas and ULBP2 expression are regulated p38 MAPK. In addition, the transcription factor Ets1 plays a key role in ULBP2 specific expression by IL-32 alpha overexpression in ULBP family members. Taken together, these data show that IL-32 alpha stimulates Fas and ULBP2 expression via activation of p38 MAPK, which increases NK susceptibility of CML cells. Enhanced NK cell susceptibility of CML cells by IL-32 alpha overexpression may improve the efficiency of NK cell-based immunotherapy.	[Cheon, Soyoung; Park, Sunyoung; Cho, Daeho] Sookmyung Womens Univ, Dept Life Sci, Seoul 140742, South Korea; [Lee, Ji Hyung] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Bang, Sa Ik] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Plast Surg, Seoul 136710, South Korea; [Lee, Wang Jae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110799, South Korea; [Lee, Wang Jae] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul 110799, South Korea; [Yoon, Do-Young] Konkuk Univ, Bio Mol Informat Ctr, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Yoon, Sung-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea; [Kim, Taesung] Korea Univ, Grad Sch, Sch Life Sci & Technol, Seoul 136701, South Korea; [Min, Hyeyoung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Cho, Byung Joo] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Ophthalmol, Seoul 143729, South Korea; [Lee, Hyong Joo; Lee, Ki Woong] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Lee, Ki Woong; Jeong, Seung Hwan] Namyang Dairy Co Ltd, Ctr Res & Dev, Gongju 314914, South Korea; [Park, Hyunjeong] Catholic Univ Korea, Coll Med, St Marys Hosp, Dept Dermatol, Seoul 137701, South Korea	Sookmyung Women's University; Konkuk University; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Seoul National University (SNU); Korea University; Chung Ang University; Konkuk University; Konkuk University Medical Center; Seoul National University (SNU); Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital	Park, H (corresponding author), Catholic Univ Korea, Coll Med, St Marys Hosp, Dept Dermatol, 62 Youido Dong, Seoul 150716, South Korea.	hjpark@catholic.ac.kr; cdhkor@sm.ac.kr	Yoon, Sung-Soo/J-2773-2012; Lee, Wang Jae/J-5586-2012; Lee, Ji Hyung/D-5374-2011	, Tae Sung/0000-0002-0384-4407	Korean government (Ministry of Education & Science Technology) [R11-2005-017-05003-0, 10033778]	Korean government (Ministry of Education & Science Technology)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by Grant 10033778 (2009) from the Ministry of Knowledge Economy and National Research Foundation of Korea Grant R11-2005-017-05003-0 funded by the Korean government (Ministry of Education & Science Technology).	BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Chen KC, 2009, J CELL BIOCHEM, V106, P93, DOI 10.1002/jcb.21979; Choi JD, 2009, IMMUNOLOGY, V126, P535, DOI 10.1111/j.1365-2567.2008.02917.x; Dai Zhiming, 2009, Genomics Proteomics & Bioinformatics, V7, P155, DOI 10.1016/S1672-0229(08)60045-5; Gannage M, 2008, TRANSPLANTATION, V85, P911, DOI 10.1097/TP.0b013e31816691ef; Gloire G, 2008, BIOCHEM PHARMACOL, V76, P1451, DOI 10.1016/j.bcp.2008.06.023; Goda C, 2006, INT IMMUNOL, V18, P233, DOI 10.1093/intimm/dxh339; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; Kim KE, 2007, ONCOGENE, V26, P1468, DOI 10.1038/sj.onc.1209926; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kondo M, 2009, IMMUNOLOGY, V128, pe589, DOI 10.1111/j.1365-2567.2008.03039.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee HR, 2009, IMMUNOL LETT, V123, P72, DOI 10.1016/j.imlet.2009.02.008; Liang SJ, 2005, INT IMMUNOPHARMACOL, V5, P839, DOI 10.1016/j.intimp.2004.12.016; Logan SK, 1996, J BIOL CHEM, V271, P774, DOI 10.1074/jbc.271.2.774; Lopez-Soto A, 2009, ONCOGENE, V28, P2370, DOI 10.1038/onc.2009.117; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Song H, 2008, IMMUNOL LETT, V120, P103, DOI 10.1016/j.imlet.2008.07.007; Sutherland CL, 2006, BLOOD, V108, P1313, DOI 10.1182/blood-2005-11-011320; Wajant H, 2006, CANC TREAT, V130, P141; Watanabe D, 2004, AM J PATHOL, V164, P1827, DOI 10.1016/S0002-9440(10)63741-8	29	35	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.159756	http://dx.doi.org/10.1074/jbc.M110.159756			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321117	hybrid, Green Published			2022-12-25	WOS:000289077500019
J	Vorster, PJ; Guo, J; Yoder, A; Wang, WF; Zheng, YF; Xu, XH; Yu, DY; Spear, M; Wu, YT				Vorster, Paul J.; Guo, Jia; Yoder, Alyson; Wang, Weifeng; Zheng, Yanfang; Xu, Xuehua; Yu, Dongyang; Spear, Mark; Wu, Yuntao			LIM Kinase 1 Modulates Cortical Actin and CXCR4 Cycling and Is Activated by HIV-1 to Initiate Viral Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CHEMOKINE RECEPTOR CXCR4; COFILIN PHOSPHORYLATION; T-LYMPHOCYTES; REVERSE TRANSCRIPTION; HUMAN MACROPHAGES; HOMOSEXUAL MEN; CDNA CLONING; NEF PROTEIN; CELL	Almost all viral pathogens utilize a cytoskeleton for their entry and intracellular transport. In HIV-1 infection, binding of the virus to blood resting CD4 T cells initiates a temporal course of cortical actin polymerization and depolymerization, a process mimicking the chemotactic response initiated from chemokine receptors. The actin depolymerization has been suggested to promote viral intracellular migration through cofilin-mediated actin treadmilling. However, the role of the virus-mediated actin polymerization in HIV infection is unknown, and the signaling molecules involved remain unidentified. Here we describe a pathogenic mechanism for triggering early actin polymerization through HIV-1 envelope-mediated transient activation of the LIM domain kinase (LIMK), a protein that phosphorylates cofilin. We demonstrate that HIV-mediated LIMK activation is through gp120-triggered transient activation of the Rack-PAK-LIMK pathway, and that knockdown of LIMK through siRNA decreases filamentous actin, increases CXCR4 trafficking, and diminishes viral DNA synthesis. These results suggest that HIV-mediated early actin polymerization may directly regulate the CXCR4 receptor during viral entry and is involved in viral DNA synthesis. Furthermore, we also demonstrate that in resting CD4 T cells, actin polymerization can be triggered through transient treatment with a pharmacological agent, okadaic acid, that activates LIMK and promotes HIV latent infection of resting CD4 T cells. Taken together, our results suggest that HIV hijacks LIMK to control the cortical actin dynamics for the initiation of viral infection of CD4 Tcells.	[Vorster, Paul J.; Guo, Jia; Yoder, Alyson; Wang, Weifeng; Zheng, Yanfang; Yu, Dongyang; Spear, Mark; Wu, Yuntao] George Mason Univ, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Xu, Xuehua] Georgetown Univ, Sch Med, Dept Oncol, Washington, DC 20057 USA	George Mason University; Georgetown University	Wu, YT (corresponding author), 10900 Univ Blvd, Manassas, VA 20110 USA.	ywu8@gmu.edu	Guo, Jia/L-2102-2013; wang, weifeng/N-4140-2013; xu, xuehua/R-1163-2019; Guo, Jia/C-8678-2014	xu, xuehua/0000-0002-3863-9593; Love, Zelda/0000-0002-2478-7720	NIAID National Institutes of Health [AI069981, 1R01AI081568]; New York City to Washington, D.C. AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069981, R01AI081568] Funding Source: NIH RePORTER	NIAID National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); New York City to Washington, D.C. AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by NIAID National Institutes of Health Grants AI069981 and 1R01AI081568 (to Y. W.). This work was also supported by the 2009 New York City to Washington, D.C. AIDS Ride (to Y. W.).	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Barrero-Villar M, 2009, J CELL SCI, V122, P103, DOI 10.1242/jcs.035873; Bernard O, 1996, GENOMICS, V35, P593, DOI 10.1006/geno.1996.0403; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Bukrinsky M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-85; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; CHOWERS MY, 1995, VIROLOGY, V212, P451, DOI 10.1006/viro.1995.1502; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dan C, 2001, J BIOL CHEM, V276, P32115, DOI 10.1074/jbc.M100871200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; DE BP, 1993, J BIOL CHEM, V268, P5703; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Fackler OT, 1997, EUR J BIOCHEM, V247, P843, DOI 10.1111/j.1432-1033.1997.00843.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Harmon B, 2008, J VIROL, V82, P9191, DOI 10.1128/JVI.00424-08; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Ikebe C, 1997, GENOMICS, V46, P504, DOI 10.1006/geno.1997.5060; Iyengar S, 1998, J VIROL, V72, P5251, DOI 10.1128/JVI.72.6.5251-5255.1998; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Liu Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.266pe23; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; NIEDERMAN TMJ, 1993, VIROLOGY, V197, P420, DOI 10.1006/viro.1993.1605; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; PFEIFFER JR, 1985, J CELL BIOL, V101, P2145, DOI 10.1083/jcb.101.6.2145; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Pontow SE, 2004, J VIROL, V78, P7138, DOI 10.1128/JVI.78.13.7138-7147.2004; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Signoret N, 1998, J CELL SCI, V111, P2819; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Singer II, 2001, J VIROL, V75, P3779, DOI 10.1128/JVI.75.8.3779-3790.2001; STAHL RE, 1982, AM J MED, V73, P171, DOI 10.1016/0002-9343(82)90174-7; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Ugolini S, 1997, J IMMUNOL, V159, P3000; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Wu YT, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-95; Xiao XD, 1999, P NATL ACAD SCI USA, V96, P7496, DOI 10.1073/pnas.96.13.7496; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zaitseva M, 2005, J LEUKOCYTE BIOL, V78, P1306, DOI 10.1189/jlb.0105043	62	72	74	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.182238	http://dx.doi.org/10.1074/jbc.M110.182238			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321123	Green Published, hybrid			2022-12-25	WOS:000289077500068
J	Wu, XM; Gao, H; Ke, WX; Hager, M; Xiao, S; Freeman, MR; Zhu, ZL				Wu, Xiaoming; Gao, Hong; Ke, Weixiong; Hager, Martin; Xiao, Sheng; Freeman, Michael R.; Zhu, Zhenglun			VentX trans-Activates p53 and p16(ink4a) to Regulate Cellular Senescence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR LEF-1; BETA-CATENIN; STEM-CELLS; IN-VIVO; INDUCE SENESCENCE; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; CANCER-TREATMENT	Cell senescence is a process of irreversible arrest of cell proliferation and plays an important role in tumor suppression. Recent studies showed that Wnt inhibition is a trigger of cellular senescence. Using methods of reverse genetics, we recently identified VentX, a human homolog of the vertebrate Xenopus Vent family of homeobox genes, as a novel Wnt repressor and a putative tumor suppressor in lymphocytic leukemia. Here, we show that VentX is a direct transcriptional activator of p53-p21 and p16(ink4a)-Rb tumor suppression pathways. Ectopic expression of VentX in cancer cells caused an irreversible cell cycle arrest with a typical senescence-like phenotype. Conversely, inhibition of VentX expression by RNA interference ameliorated chemotherapeutic agent-induced senescence in lymphocytic leukemia cells. The results of our study further reveal the mechanisms underlying tumor suppression function of VentX and suggest a role of VentX as a potential target in cancer prevention and treatment.	[Wu, Xiaoming; Gao, Hong; Ke, Weixiong; Zhu, Zhenglun] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med,Dept Med, Boston, MA 02115 USA; [Xiao, Sheng] Harvard Univ, Brigham & Womens Hosp, Dept Pathol, Sch Med, Boston, MA 02115 USA; [Hager, Martin; Freeman, Michael R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital	Zhu, ZL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Sch Med,Dept Med, Boston, MA 02115 USA.	zzhu@partners.org			National Institutes of Health; Department of Defense; American Cancer Society; Brigham and Women's Hospital	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Brigham and Women's Hospital	Supported by grants from the National Institutes of Health, Department of Defense, American Cancer Society, and research fund from Brigham and Women's Hospital. To whom correspondence should be addressed. Tel.: 617-732-5467; Fax: 617-730-5807; E-mail: zzhu@partners.org.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Agirre X, 2003, MOL CARCINOGEN, V38, P201, DOI 10.1002/mc.10159; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen YH, 2006, CANCER RES, V66, P8749, DOI 10.1158/0008-5472.CAN-06-0581; Choi YL, 2007, ONCOGENE, V26, P1245, DOI 10.1038/sj.onc.1209898; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Espada J, 2009, CLIN TRANSL ONCOL, V11, P411, DOI 10.1007/s12094-009-0380-4; Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Hara E, 1996, MOL CELL BIOL, V16, P859; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hemann MT, 2007, GENE DEV, V21, P1, DOI 10.1101/gad.1514207; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Kahlem P, 2004, J CLIN INVEST, V113, P169, DOI 10.1172/JCI200420784; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Omura-Minamisawa M, 2000, CLIN CANCER RES, V6, P1219; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rawat VPS, 2010, P NATL ACAD SCI USA, V107, P16946, DOI 10.1073/pnas.1001878107; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Roninson IB, 2003, CANCER RES, V63, P2705; Roninson IB, 2003, J CELL BIOCHEM, V88, P83, DOI 10.1002/jcb.10320; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Simon M, 2005, ONCOGENE, V24, P2410, DOI 10.1038/sj.onc.1208431; te Poele RH, 2002, CANCER RES, V62, P1876; Ye XF, 2007, MOL CELL, V27, P183, DOI 10.1016/j.molcel.2007.05.034; Ysebaert L, 2006, LEUKEMIA, V20, P1211, DOI 10.1038/sj.leu.2404239; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	46	13	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.206078	http://dx.doi.org/10.1074/jbc.M110.206078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325273	hybrid, Green Published			2022-12-25	WOS:000289077500080
J	Gebhardt, M; Hoffgaard, F; Hamacher, K; Kast, SM; Moroni, A; Thiel, G				Gebhardt, Manuela; Hoffgaard, Franziska; Hamacher, Kay; Kast, Stefan M.; Moroni, Anna; Thiel, Gerhard			Membrane Anchoring and Interaction between Transmembrane Domains are Crucial for K+ Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; PROTEINS; BINDING; RESIDUES; DYNAMICS; SEQUENCE; CONSURF; IDENTIFICATION	The small viral channel Kcv is a Kir-like K+ channel of only 94 amino acids. With this simple structure, the tetramer of Kcv represents the pore module of all complex K+ channels. To examine the structural contribution of the transmembrane domains (TMDs) to channel function, we performed Ala scanning mutagenesis of the two domains and tested the functionality of the mutants in a yeast complementation assay. The data reveal, in combination with computational models, that the upper halves of both TMDs, which face toward the external medium, are rather rigid, whereas the inner parts are more flexible. The rigidity of the outer TMD is conferred by a number of essential aromatic amino acids that face the membrane and probably anchor this domain in the bilayer. The inner TMD is intimately connected with the rigid part of the outer TMD via pi center dot center dot center dot pi interactions between a pair of aromatic amino acids. This structural principle is conserved within the viral K+ channels and also present in Kir2.2, implying a general importance of this architecture for K+ channel function.	[Gebhardt, Manuela; Thiel, Gerhard] Tech Univ Darmstadt, Inst Bot, D-64287 Darmstadt, Germany; [Hoffgaard, Franziska; Hamacher, Kay] Tech Univ Darmstadt, Computat Biol Grp, D-64287 Darmstadt, Germany; [Kast, Stefan M.] Tech Univ Dortmund, D-44227 Dortmund, Germany; [Moroni, Anna] Univ Milan, Dept Biol, I-20122 Milan, Italy; [Moroni, Anna] Univ Milan, CNR, Ist Biofis Milano, I-20122 Milan, Italy	Technical University of Darmstadt; Technical University of Darmstadt; Dortmund University of Technology; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Thiel, G (corresponding author), Schnittspahnstr 3-5, D-64287 Darmstadt, Germany.	thiel@bio.tu-darmstadt.de	moroni, anna/H-2097-2014	moroni, anna/0000-0002-1860-406X; Hamacher, Kay/0000-0002-6921-8345; Thiel, Gerhard/0000-0002-2335-1351	Deutsche Forschungsgemeinschaft [TH558/19-1]; Adolf-Messer-Stiftung; Fonds der Chemischen Industrie; European Drug Initiative on Channels and Transporters (EDICT) [201924]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Adolf-Messer-Stiftung; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); European Drug Initiative on Channels and Transporters (EDICT)(European Commission)	This work was supported in part by the Deutsche Forschungsgemeinschaft (to G. T. (TH558/19-1), the Adolf-Messer-Stiftung (to S. M. K.), the Fonds der Chemischen Industrie (to S. M. K.) and K. H.) and the European Drug Initiative on Channels and Transporters (EDICT) project EU FP7 (201924) (to A. M.).	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Balss J, 2008, P NATL ACAD SCI USA, V105, P12313, DOI 10.1073/pnas.0805709105; Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bhattacharyya R, 2003, J PROTEOME RES, V2, P255, DOI 10.1021/pr025584d; Bhosale S, 2006, ORG BIOMOL CHEM, V4, P3031, DOI 10.1039/b606487f; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; BRICKMANN J, 1995, DATA VISUALIZATION M, P83; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; de Planque MRR, 2003, MOL MEMBR BIOL, V20, P271, DOI 10.1080/09687680310001605352; Delaroque N, 2001, VIROLOGY, V287, P112, DOI 10.1006/viro.2001.1028; Di Cera E, 1998, CHEM REV, V98, P1563, DOI 10.1021/cr960135g; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FernandezRecio J, 1997, J MOL BIOL, V267, P184, DOI 10.1006/jmbi.1996.0831; Gazzarrini S, 2004, J BIOL CHEM, V279, P28443, DOI 10.1074/jbc.M401184200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hamacher K, 2008, GENE, V422, P30, DOI 10.1016/j.gene.2008.06.007; Hamacher K, 2006, J CHEM THEORY COMPUT, V2, P873, DOI 10.1021/ct050247s; Heyda J, 2010, J PHYS CHEM B, V114, P8744, DOI 10.1021/jp101031v; Holst B, 1998, MOL PHARMACOL, V53, P166, DOI 10.1124/mol.53.1.166; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Killian JA, 2003, FEBS LETT, V555, P134, DOI 10.1016/S0014-5793(03)01154-2; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nishio M, 1998, METH STEREO, P1; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; SHOEMAKER KR, 1990, BIOPOLYMERS, V29, P1, DOI 10.1002/bip.360290104; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tayefeh S, 2007, BIOCHEMISTRY-US, V46, P4826, DOI 10.1021/bi602468r; Tayefeh S, 2009, BIOPHYS J, V96, P485, DOI 10.1016/j.bpj.2008.09.050; Thiel G, 2011, BBA-BIOMEMBRANES, V1808, P580, DOI 10.1016/j.bbamem.2010.04.008; Tozzini V, 2010, Q REV BIOPHYS, V43, P333, DOI 10.1017/S0033583510000132; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Wang LJ, 2006, BIOCHEMISTRY-US, V45, P13750, DOI 10.1021/bi0615689; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c	46	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11299	11306		10.1074/jbc.M110.211672	http://dx.doi.org/10.1074/jbc.M110.211672			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310959	Green Published, hybrid			2022-12-25	WOS:000288797100042
J	Dovas, A; Gligorijevic, B; Chen, XM; Entenberg, D; Condeelis, J; Cox, D				Dovas, Athanassios; Gligorijevic, Bojana; Chen, Xiaoming; Entenberg, David; Condeelis, John; Cox, Dianne			Visualization of Actin Polymerization in Invasive Structures of Macrophages and Carcinoma Cells Using Photoconvertible beta-Actin-Dendra2 Fusion Proteins	PLOS ONE			English	Article							BARBED ENDS; N-WASP; PODOSOMES; ARGINYLATION; COFILIN; NUCLEATION; CORTACTIN	Actin polymerization controls a range of cellular processes, from intracellular trafficking to cell motility and invasion. Generation and elongation of free barbed ends defines the regions of actively polymerizing actin in cells and, consequently, is of importance in the understanding of the mechanisms through which actin dynamics are regulated. Herein we present a method that does not involve cell permeabilization and provides direct visualization of growing barbed ends using photoswitchable beta-actin - Dendra2 constructs expressed in murine macrophage and rat mammary adenocarcinoma cell lines. The method exploits the ability of photoconverted (red) G-actin species to become incorporated into pre-existing (green) actin filaments, visualized in two distinct wavelengths using TIRF microscopy. In growing actin filaments, photoconverted (red) monomers are added to the barbed end while only green monomers are recycled from the pointed end. We demonstrate that incorporation of actin into intact podosomes of macrophages occurs constitutively and is amenable to inhibition by cytochalasin D indicating barbed end incorporation. Additionally, actin polymerization does not occur in quiescent invadopodial precursors of carcinoma cells suggesting that the filaments are capped and following epidermal growth factor stimulation actin incorporation occurs in a single but extended peak. Finally, we show that Dendra2 fused to either the N- or the C-terminus of beta-actin profoundly affects its localization and incorporation in distinct F-actin structures in carcinoma cells, thus influencing the ability of monomers to be photoconverted. These data support the use of photoswitchable actin-Dendra2 constructs as powerful tools in the visualization of free barbed ends in living cells.	[Dovas, Athanassios; Gligorijevic, Bojana; Entenberg, David; Condeelis, John] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Dovas, A (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA.	dianne.cox@einstein.yu.edu	gligorijevic, bojana/AAV-9687-2020; Entenberg, David/AAT-2722-2020	Entenberg, David/0000-0003-0422-7264; gligorijevic, bojana/0000-0001-9071-7467; Cox, Dianne/0000-0002-0591-9767	NIH [GM07828, CA150344, CA100324]; Revson; NATIONAL CANCER INSTITUTE [R01CA150344, P01CA100324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Revson; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH (GM07828 to DC and CA150344 to JC, CA100324 to DE), and a postdoctoral fellowship from Revson to BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Ballestrem C, 1998, J CELL SCI, V111, P1649; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Campbell JJ, 2007, MICROSC RES TECHNIQ, V70, P1034, DOI 10.1002/jemt.20513; Chan AY, 1998, J CELL SCI, V111, P199; Condeelis J, 2005, BIOL CELL, V97, P97; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DesMarais V, 2009, CELL MOTIL CYTOSKEL, V66, P303, DOI 10.1002/cm.20361; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Gawden-Bone C, 2010, J CELL SCI, V123, P1427, DOI 10.1242/jcs.056515; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kashina AS, 2006, TRENDS CELL BIOL, V16, P610, DOI 10.1016/j.tcb.2006.10.001; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171; NERI A, 1982, J NATL CANCER I, V68, P507; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Saha S, 2010, MOL BIOL CELL, V21, P1350, DOI 10.1091/mbc.E09-09-0829; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Zicha D, 2003, SCIENCE, V300, P142, DOI 10.1126/science.1082026	25	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16485	10.1371/journal.pone.0016485	http://dx.doi.org/10.1371/journal.pone.0016485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339827	Green Published, Green Submitted, gold			2022-12-25	WOS:000287367600013
J	Jin, M; Wu, ZZ; Chen, L; Jaimes, J; Collins, D; Walters, ET; O'Neil, RG				Jin, Min; Wu, Zizhen; Chen, Ling; Jaimes, Jose; Collins, Diana; Walters, Edgar T.; O'Neil, Roger G.			Determinants of TRPV4 Activity following Selective Activation by Small Molecule Agonist GSK1016790A	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNEL; HEAT-EVOKED ACTIVATION; CALCIUM-ENTRY; PROTEIN; DOMAIN; MECHANISM; INSERTION	TRPV4 (Transient Receptor Potential Vanilloid 4) channels are activated by a wide range of stimuli, including hypotonic stress, non-noxious heat and mechanical stress and some small molecule agonists (e.g. phorbol ester 4 alpha-PDD). GSK1016790A (GSK101) is a recently discovered specific small molecule agonist of TRPV4. Its effects on physical determinants of TRPV4 activity were evaluated in HeLa cells transiently transfected with TRPV4 (HeLa-TRPV4). GSK101 (10 nM) causes a TRPV4 specific Ca2+ influx in HeLa-TRPV4 cells, but not in control transfected cells, which can be inhibited by ruthenium red and Ca2+-free medium more significantly at the early stage of the activation rather than the late stage, reflecting apparent partial desensitization. Western blot analysis showed that GSK101 activation did not induce an increase in TRPV4 expression at the plasma membrane, but caused an immediate and sustained downregulation of TRPV4 on the plasma membrane in HeLa-TRPV4 cells. Patch clamp analysis also revealed an early partial desensitization of the channel which was Ca2+-independent. FRET analysis of TRPV4 subunit assembly demonstrated that the GSK101-induced TRPV4 channel activation/desensitization was not due to alterations in homotetrameric channel formation on the plasma membrane. It is concluded that GSK101 specifically activates TRPV4 channels, leading to a rapid partial desensitization and downregulation of the channel expression on the plasma membrane. TRPV4 subunit assembly appears to occur during trafficking from the ER/Golgi to the plasma membrane and is not altered by agonist stimulation.	[Jin, Min; Wu, Zizhen; Chen, Ling; Jaimes, Jose; Collins, Diana; Walters, Edgar T.; O'Neil, Roger G.] Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Jin, M (corresponding author), Univ Texas Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX USA.	roger.g.oneil@uth.tmc.edu		Walters, Edgar/0000-0003-0718-102X	National Institutes of Health [R01 DK70950, R21 DE018522]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was received from National Institutes of Health R01 DK70950 and NIH R21 DE018522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso S, 2008, CELL CALCIUM, V43, P375, DOI 10.1016/j.ceca.2007.07.004; Alicia S, 2008, CELL CALCIUM, V44, P479, DOI 10.1016/j.ceca.2008.03.001; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gadzikowska Maria, 2002, Acta Pol Pharm, V59, P149; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gordon-Shaag A, 2008, CHANNELS, V2, P125, DOI 10.4161/chan.2.2.6026; Guler AD, 2002, J NEUROSCI, V22, P6408; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; Hisanaga E, 2009, DIABETES, V58, P174, DOI 10.2337/db08-0862; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Schumann F, 2009, J BIOL CHEM, V284, P24372, DOI 10.1074/jbc.M109.025635; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Shukla AK, 2010, J BIOL CHEM; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Stewart AP, 2010, BIOPHYS J, V99, P790, DOI 10.1016/j.bpj.2010.05.012; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Thorneloe KS, 2008, J PHARMACOL EXP THER, V326, P432, DOI 10.1124/jpet.108.139295; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; van de Graaf SFJ, 2006, PFLUG ARCH EUR J PHY, V452, P407, DOI 10.1007/s00424-006-0051-z; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu XP, 2009, CHANNELS, V3, P156, DOI 10.4161/chan.3.3.8555; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zhang LY, 2001, NEUROL RES, V23, P144, DOI 10.1179/016164101101198488	47	63	63	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16713	10.1371/journal.pone.0016713	http://dx.doi.org/10.1371/journal.pone.0016713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339821	Green Submitted, Green Published, gold			2022-12-25	WOS:000287367600016
J	Lizundia, R; Newman, C; Buesching, CD; Ngugi, D; Blake, D; Sin, YW; Macdonald, DW; Wilson, A; McKeever, D				Lizundia, Regina; Newman, Chris; Buesching, Christina D.; Ngugi, Daniel; Blake, Damer; Sin, Yung Wa; Macdonald, David W.; Wilson, Alan; McKeever, Declan			Evidence for a Role of the Host-Specific Flea (Paraceras melis) in the Transmission of Trypanosoma (Megatrypanum) pestanai to the European Badger	PLOS ONE			English	Article							MELES-MELES; CLETHRIONOMYS-GLAREOLUS; EURASIAN BADGER; RIBOSOMAL-RNA; RAT FLEA; PARASITES; ECTOPARASITES; TESTOSTERONE; COCCIDIOSIS; MORPHOLOGY	We investigated the epidemiology of Trypanosoma pestanai infection in European badgers (Meles meles) from Wytham Woods (Oxfordshire, UK) to determine prevalence rates and to identify the arthropod vector responsible for transmission. A total of 245 badger blood samples was collected during September and November 2009 and examined by PCR using primers derived from the 18S rRNA of T. pestanai. The parasite was detected in blood from 31% of individuals tested. T. pestanai was isolated from primary cultures of Wytham badger peripheral blood mononuclear cells and propagated continually in vitro. This population was compared with cultures of two geographically distinct isolates of the parasite by amplified fragment length polymorphism (AFLP) and PCR analysis of 18S rDNA and ITS1 sequences. High levels of genotypic polymorphism were observed between the isolates. PCR analysis of badger fleas (Paraceras melis) collected from infected individuals at Wytham indicated the presence of T. pestanai and this was confirmed by examination of dissected specimens. Wet smears and Giemsa-stained preparations from dissected fleas revealed large numbers of trypanosome-like forms in the hindgut, some of which were undergoing binary fission. We conclude that P. melis is the primary vector of T. pestanai in European badgers.	[Lizundia, Regina; Ngugi, Daniel; Blake, Damer; Wilson, Alan; McKeever, Declan] Univ London Royal Vet Coll, Hatfield, Herts, England; [Newman, Chris; Buesching, Christina D.; Sin, Yung Wa; Macdonald, David W.] Univ Oxford, Wildlife Conservat Res Unit, Dept Zool, Recanati Kaplan Ctr, Abingdon, Oxon, England	University of London; University of London Royal Veterinary College; University of Oxford	Lizundia, R (corresponding author), Univ London Royal Vet Coll, Hatfield, Herts, England.	dmckeever@rvc.ac.uk		Blake, Damer/0000-0003-1077-2306; Sin, Simon Yung Wa/0000-0003-2484-2897	Peoples' Trust for Endangered Species	Peoples' Trust for Endangered Species	The fieldwork was supported by a grant to DWM from the Peoples' Trust for Endangered Species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MA, 2000, PARASITOLOGY, V120, P255, DOI 10.1017/S0031182099005491; Bettencourt A, 1905, ARCH I R BACTERIAL, V1, P73; Blake DP, 2003, PARASITOL RES, V90, P473, DOI 10.1007/s00436-003-0890-x; BOSE R, 1993, J EUKARYOT MICROBIOL, V40, P788, DOI 10.1111/j.1550-7408.1993.tb04475.x; BRABIN L, 1992, ADV PARASIT, V31, P1, DOI 10.1016/S0065-308X(08)60020-2; Butler JM, 1996, ANIM BEHAV, V52, P621, DOI 10.1006/anbe.1996.0203; Cox R, 1999, J INSECT BEHAV, V12, P245, DOI 10.1023/A:1020923001987; Filipin MD, 2010, RES VET SCI, V89, P98, DOI 10.1016/j.rvsc.2010.01.016; Hamilton PB, 2007, MOL PHYLOGENET EVOL, V44, P15, DOI 10.1016/j.ympev.2007.03.023; Hamilton PB, 2005, MOL ECOL, V14, P3167, DOI 10.1111/j.1365-294X.2005.02602.x; Hamilton PB, 2005, INT J PARASITOL, V35, P431, DOI 10.1016/j.ijpara.2004.12.005; Hoare C. A., 1923, Parasitology Cambridge, V15, P365, DOI 10.1017/S0031182000014888; Hoare CA, 1972, TRYPANOSOMES MAMMALS, P3; KRUUK H, 1978, J ZOOL, V184, P1; Kruuk H, 1978, ECOLOGY SOCIOBIOLOGY, V4, P14; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; Macdonald DW, 1999, J ZOOL, V247, P65, DOI 10.1111/j.1469-7998.1999.tb00193.x; McCarthy G, 2009, VET CLIN PATH, V38, P381, DOI 10.1111/j.1939-165X.2009.00127.x; Minchin EA, 1911, BRIT MED J, V1911, P1309; MOHAMED HA, 1987, J PARASITOL, V73, P1050, DOI 10.2307/3282534; Molyneux D.H., 1976, P285; MOLYNEUX DH, 1969, ANN TROP MED PARASIT, V63, P229, DOI 10.1080/00034983.1969.11686624; MOLYNEUX DH, 1969, PARASITOLOGY, V59, P843, DOI 10.1017/S0031182000070360; Neal E., 1996, BADGERS; Newman C, 2001, PARASITOLOGY, V123, P133, DOI 10.1017/S0031182001008265; Noyes HA, 2002, PARASITOLOGY, V124, P185, DOI 10.1017/S0031182001001019; Olsson M, 2000, P ROY SOC B-BIOL SCI, V267, P2339, DOI 10.1098/rspb.2000.1289; PEIRCE M A, 1974, International Journal for Parasitology, V4, P439, DOI 10.1016/0020-7519(74)90055-1; RIOUX J. A., 1966, ANN PARASITOL HUM COMP, V41, P281; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Stevens JR, 1999, PARASITOLOGY, V118, P107, DOI 10.1017/S0031182098003473; Stevens JR, 1999, INT J PARASITOL, V29, P749, DOI 10.1016/S0020-7519(99)00016-8; Stevens JR, 2001, ADV PARASIT, V48, P1, DOI 10.1016/S0065-308X(01)48003-1; Stewart PD, 1999, ANIM BEHAV, V57, P153, DOI 10.1006/anbe.1998.0935; Strickland C, 1911, BRIT MED J, V1911, P1049, DOI 10.1136/bmj.1.2627.1049; Thekisoe OMM, 2007, PARASITOLOGY, V134, P967, DOI 10.1017/S0031182007002375; Thornton PD, 2005, VET ANAESTH ANALG, V32, P40, DOI 10.1111/j.1467-2995.2004.00163.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WEINSTEIN Y, 1984, J IMMUNOL, V132, P656	39	23	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16977	10.1371/journal.pone.0016977	http://dx.doi.org/10.1371/journal.pone.0016977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340028	Green Published, Green Submitted, gold			2022-12-25	WOS:000287367600028
J	Wang, PY; Pai, LM				Wang, Pei-Yu; Pai, Li-Mei			D-Cbl Binding to Drk Leads to Dose-Dependent Down-Regulation of EGFR Signaling and Increases Receptor-Ligand Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CLATHRIN-COATED PITS; TYROSINE KINASE; C-CBL; RING FINGER; V-CBL; DROSOPHILA OOGENESIS; NEGATIVE REGULATOR; IN-VIVO; PROTEIN	Proper control of Epidermal Growth Factor Receptor (EGFR) signaling is critical for normal development and regulated cell behaviors. Abnormal EGFR signaling is associated with tumorigenic process of various cancers. Complicated feedback networks control EGFR signaling through ligand production, and internalization-mediated destruction of ligand-receptor complexes. Previously, we found that two isoforms of D-Cbl, D-CblS and D-CblL, regulate EGFR signaling through distinct mechanisms. While D-CblL plays a crucial role in dose-dependent down-regulation of EGFR signaling, D-CblS acts in normal restriction of EGFR signaling and does not display dosage effect. Here, we determined the underlying molecular mechanism, and found that Drk facilitates the dose-dependent regulation of EGFR signaling through binding to the proline-rich motif of D-CblL, PR. Furthermore, the RING finger domain of D-CblL is essential for promoting endocytosis of the ligand-receptor complex. Interestingly, a fusion protein of the two essential domains of D-CblL, RING-PR, is sufficient to down-regulate EGFR signal in a dose-dependent manner by promoting internalization of the ligand, Gurken. Besides, RING-SH2(Drk), a fusion protein of the RING finger domain of D-Cbl and the SH2 domain of Drk, also effectively down-regulates EGFR signaling in Drosophila follicle cells, and suppresses the effects of constitutively activated EGFR. The RING-SH2(Drk) suppresses EGFR signaling by promoting the endosomal trafficking of ligand-receptor complexes, suggesting that Drk plays a negative role in EGFR signaling by enhancing receptor endocytosis through cooperating with the RING domain of D-Cbl. Interfering the recruitment of signal transducer, Drk, to the receptor by the RING-SH2(Drk) might further reduces EGFR signaling. The fusion proteins we developed may provide alternative strategies for therapy of cancers caused by hyper-activation of EGFR signaling.	[Wang, Pei-Yu; Pai, Li-Mei] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Pai, Li-Mei] Chang Gung Univ, Dept Biochem, Tao Yuan, Taiwan; [Pai, Li-Mei] Chang Gung Univ, Chang Gung Mol Med Res Ctr, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wang, PY (corresponding author), Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.	pai@mail.cgu.edu.tw		Pai, Li-Mei/0000-0002-1417-6432	Chang-Gung Memorial Hospital [CMRPD 180111]; National Science Council of Republic of China [NSC97-2311-B-182-001-MY3]; Ministry of Education, Taiwan, ROC [EMRPD180121]	Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, ROC(Ministry of Education, Taiwan)	This work was supported by grants from Chang-Gung Memorial Hospital (CMRPD 180111 to Li-Mei Pai), the National Science Council of Republic of China (NSC97-2311-B-182-001-MY3 to Li-Mei Pai) (http://web1.nsc.gov.tw/), and the Ministry of Education, Taiwan, ROC (EMRPD180121 to Li-Mei Pai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; Berg CA, 2005, TRENDS GENET, V21, P346, DOI 10.1016/j.tig.2005.04.010; CASTRILLON DH, 1993, GENETICS, V135, P489; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Chang WL, 2008, DEVELOPMENT, V135, P1923, DOI 10.1242/dev.017103; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; de Melker AA, 2004, J CELL SCI, V117, P5001, DOI 10.1242/jcs.01354; Donovan JA, 1996, J BIOL CHEM, V271, P26369, DOI 10.1074/jbc.271.42.26369; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Gonzalez-Gaitan Marcos, 2003, Cell, V115, P513, DOI 10.1016/S0092-8674(03)00932-2; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hime GR, 2001, MECH DEVELOP, V102, P235, DOI 10.1016/S0925-4773(01)00292-1; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lanzetti L, 2008, TRAFFIC, V9, P2011, DOI 10.1111/j.1600-0854.2008.00816.x; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; OKUTANI T, 1994, J BIOL CHEM, V269, P31310; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Pai LM, 2006, MECH DEVELOP, V123, P450, DOI 10.1016/j.mod.2006.04.001; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Reich A, 1999, DEVELOPMENT, V126, P4139; Robertson H, 2000, ONCOGENE, V19, P3299, DOI 10.1038/sj.onc.1203624; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stang E, 2004, MOL BIOL CELL, V15, P3591, DOI 10.1091/mbc.E04-01-0041; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Wang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001447; Wang ZX, 1996, SCIENCE, V272, P1935, DOI 10.1126/science.272.5270.1935; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707	61	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17097	10.1371/journal.pone.0017097	http://dx.doi.org/10.1371/journal.pone.0017097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340027	gold, Green Published, Green Submitted			2022-12-25	WOS:000287367600039
J	Moss, R; McCaw, JM; McVernon, J				Moss, Robert; McCaw, James M.; McVernon, Jodie			Diagnosis and Antiviral Intervention Strategies for Mitigating an Influenza Epidemic	PLOS ONE			English	Article							SWINE FLU EPIDEMIC; PANDEMIC INFLUENZA; DRUG-RESISTANCE; CONTAINMENT PLAN; GENERAL-PRACTICE; H1N1 2009; AUSTRALIA; TRANSMISSION; POPULATION; HOUSEHOLD	Background: Many countries have amassed antiviral stockpiles for pandemic preparedness. Despite extensive trial data and modelling studies, it remains unclear how to make optimal use of antiviral stockpiles within the constraints of healthcare infrastructure. Modelling studies informed recommendations for liberal antiviral distribution in the pandemic phase, primarily to prevent infection, but failed to account for logistical constraints clearly evident during the 2009 H1N1 outbreaks. Here we identify optimal delivery strategies for antiviral interventions accounting for logistical constraints, and so determine how to improve a strategy's impact. Methods and Findings: We extend an existing SEIR model to incorporate finite diagnostic and antiviral distribution capacities. We evaluate the impact of using different diagnostic strategies to decide to whom antivirals are delivered. We then determine what additional capacity is required to achieve optimal impact. We identify the importance of sensitive and specific case ascertainment in the early phase of a pandemic response, when the proportion of false-positive presentations may be high. Once a substantial percentage of ILI presentations are caused by the pandemic strain, identification of cases for treatment on syndromic grounds alone results in a greater potential impact than a laboratory-dependent strategy. Our findings reinforce the need for a decentralised system capable of providing timely prophylaxis. Conclusions: We address specific real-world issues that must be considered in order to improve pandemic preparedness policy in a practical and methodologically sound way. Provision of antivirals on the scale proposed for an effective response is infeasible using traditional public health outbreak management and contact tracing approaches. The results indicate to change the transmission dynamics of an influenza epidemic with an antiviral intervention, a decentralised system is required for contact identification and prophylaxis delivery, utilising a range of existing services and infrastructure in a "whole of society" response.	[Moss, Robert] Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Melbourne Sch Populat Hlth, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne	Moss, R (corresponding author), Univ Melbourne, Vaccine & Immunisat Res Grp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	rgmoss@unimelb.edu.au	Moss, Rob/R-4767-2018	Moss, Rob/0000-0002-4568-2012; McVernon, Jodie/0000-0001-9774-1961; McCaw, James/0000-0002-2452-3098	National Health and Medical Research Council (NHMRC) [358425, 410224, 566635]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding support was provided by the National Health and Medical Research Council (NHMRC) through Capacity Building (Grant 358425), Urgent Research (Grant 410224) and Career Development Award Schemes (J. McVernon, Grant 566635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2007, WHO GEN TECH REP; *AUSTR POST, 2009, 200809 AUSTR POST; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Catton MG, 2009, MED J AUSTRALIA, V191, P288, DOI 10.5694/j.1326-5377.2009.tb02789.x; Collins N, 2006, MED J AUSTRALIA, V185, pS66; Debarre F, 2007, J R SOC INTERFACE, V4, P893, DOI 10.1098/rsif.2007.1126; DOHA, 2008, AUSTR HLTH MAN PLAN; Eastwood K, 2009, RURAL REMOTE HEALTH, V9; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Edmunds WJ, 1997, P ROY SOC B-BIOL SCI, V264, P949, DOI 10.1098/rspb.1997.0131; Eizenberg P, 2009, MED J AUSTRALIA, V191, P151, DOI 10.5694/j.1326-5377.2009.tb02725.x; Ferguson JK, 2009, MED J AUSTRALIA, V191, P454, DOI 10.5694/j.1326-5377.2009.tb02886.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Foo H, 2009, J CLIN VIROL, V46, P384, DOI 10.1016/j.jcv.2009.09.019; Franco-Paredes Carlos, 2009, J Immune Based Ther Vaccines, V7, P2, DOI 10.1186/1476-8518-7-2; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grayson ML, 2009, MED J AUSTRALIA, V191, P150, DOI 10.5694/j.1326-5377.2009.tb02724.x; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; HANCOCK K, 2009, N ENGL J MED; Hurt AC, 2004, ANTIVIR RES, V62, P37, DOI 10.1016/j.antiviral.2003.11.008; Kamigaki T, 2009, PLOS CURR INFLUENZA; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; KELLY HA, 2010, MED J AUSTRALIA, V192, P1; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Kmietowicz Z, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2932; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Lipsitch M, 2009, N ENGL J MED; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Lokuge B, 2006, MED J AUSTRALIA, V184, P16, DOI 10.5694/j.1326-5377.2006.tb00089.x; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; McBryde E, 2009, EURO SURVEILL, V14; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; McCaw JM, 2009, MED J AUSTRALIA, V191, P136, DOI 10.5694/j.1326-5377.2009.tb02720.x; McCaw JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002362; McVernon J, 2010, AUST NZ J PUBL HEAL, V34, P113, DOI 10.1111/j.1753-6405.2010.00493.x; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MILLER E, 2010, LANCET; Moghadas SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001839; Moghadas SM, 2008, P ROY SOC B-BIOL SCI, V275, P1163, DOI 10.1098/rspb.2008.0016; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Nougairede A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009214; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Shortridge KF, 2006, LANCET, V367, P1374, DOI 10.1016/S0140-6736(06)68512-7; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; Swaminathan A, 2007, EMERG INFECT DIS, V13, P1541, DOI 10.3201/eid1310.070033; THORN F, 2009, VICTORIA GOVT GAZETT, pS175; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; World Health Organization, 2009, PAND INFL PREP RESP; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Xu Y, 2007, J THEOR BIOL, V248, P179, DOI 10.1016/j.jtbi.2007.05.009; Yang Y, 2009, BIOSTATISTICS, V10, P390, DOI 10.1093/biostatistics/kxn045	63	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14505	10.1371/journal.pone.0014505	http://dx.doi.org/10.1371/journal.pone.0014505			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21346794	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037000001
J	el Barzouhi, A; Elias-Smale, S; Dehghan, A; Vliegenthart-Proenca, R; Oudkerk, M; Hofman, A; Witteman, JCM				el Barzouhi, Abdelilah; Elias-Smale, Suzette; Dehghan, Abbas; Vliegenthart-Proenca, Rozemarijn; Oudkerk, Matthijs; Hofman, Albert; Witteman, Jacqueline C. M.			Renal Function Is Related to Severity of Coronary Artery Calcification in Elderly Persons: The Rotterdam Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; BEAM COMPUTED-TOMOGRAPHY; CARDIOVASCULAR-DISEASE; SERUM CREATININE; RISK-FACTOR; CLINICAL EPIDEMIOLOGY; YOUNG-ADULTS; PREDICTION; EVENTS	Background: Coronary artery calcification (CAC) has been proposed to be the underlying mechanism of the increased risk of coronary heart disease with reductions in glomerular filtration rate (GFR). Since renal function diminishes with aging we examined the association between GFR and CAC in the Rotterdam Study, a population-based study of elderly individuals. Methods: The study was performed in 1703 subjects without a history of coronary heart disease. GFR was estimated using the modification of diet in renal disease equation. We used analysis of covariance to test for mean differences in CAC between GFR tertiles. Results: The mean CAC scores in the middle and lowest GFR tertile did not significantly differ from the mean CAC score in the highest GFR tertile (geometric mean CAC score 4.1 and 4.3 vs 4.2). In a multivariable model the mean CAC score did also not differ between the GFR tertiles. As the interaction term between age and GFR was significant (P = 0.037), we divided the population in two age categories based on median age of 70 years. Below 70 years, the mean CAC scores did not differ between the GFR tertiles. Above median age, mean CAC score in the lowest GFR tertile was significantly higher than the mean CAC score in the highest tertile in a multivariable model (CAC 4.9 vs 4.5, p = 0.010). Conclusion: In this population-based study we observed that the association between CAC and GFR is modified by age. In participants at least 70 years of age, a decrease in GFR was associated with increased CAC.	[el Barzouhi, Abdelilah; Elias-Smale, Suzette; Dehghan, Abbas; Hofman, Albert; Witteman, Jacqueline C. M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Vliegenthart-Proenca, Rozemarijn; Oudkerk, Matthijs] Univ Groningen, Dept Radiobiol, Univ Med Ctr Groningen, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	el Barzouhi, A (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	a.barzouhiel@erasmusmc.nl	Elias-Smale, Suzette/F-2410-2014; Dehghan, Abbas/ABE-7377-2020; Dehghan, Abbas/B-9896-2008	Dehghan, Abbas/0000-0001-6403-016X; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Heart Foundation [2003B179]; Netherlands Organization for Scientific Research, Health Research and Development Council [28-2975, 97-1-364]; Municipality of Rotterdam	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research, Health Research and Development Council(Netherlands Organization for Scientific Research (NWO)); Municipality of Rotterdam	This study is supported by grants from the Netherlands Heart Foundation (2003B179), Netherlands Organization for Scientific Research, Health Research and Development Council (28-2975 and 97-1-364), and the Municipality of Rotterdam. None of the funders had any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abaci A, 2007, CORONARY ARTERY DIS, V18, P463, DOI 10.1097/MCA.0b013e3282c1fd86; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; APPEL G, 1991, KIDNEY INT, V39, P169, DOI 10.1038/ki.1991.22; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Cooper WA, 2006, CIRCULATION, V113, P1063, DOI 10.1161/CIRCULATIONAHA.105.580084; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Douville P, 2009, NEPHROL DIAL TRANSPL, V24, P97, DOI 10.1093/ndt/gfn473; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fox CS, 2004, KIDNEY INT, V66, P2017, DOI 10.1111/j.1523-1755.2004.00973.x; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Ix JH, 2008, J AM SOC NEPHROL, V19, P579, DOI 10.1681/ASN.2007070765; KAUFMANN RB, 1994, RADIOLOGY, V190, P347, DOI 10.1148/radiology.190.2.8284380; KEANE WF, 1993, AM J KIDNEY DIS, V21, P43, DOI 10.1016/0272-6386(93)70094-F; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Kramer H, 2005, J AM SOC NEPHROL, V16, P507, DOI 10.1681/ASN.2004070610; Kundhal K, 2005, NEPHRON CLIN PRACT, V101, pC47, DOI 10.1159/000086221; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Pajunen P, 2002, EUR J CLIN INVEST, V32, P472, DOI 10.1046/j.1365-2362.2002.01019.x; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schrier RW, 2006, J AM COLL CARDIOL, V47, P1, DOI 10.1016/j.jacc.2005.07.067; Seyahi N, 2007, AM J KIDNEY DIS, V49, P143, DOI 10.1053/j.ajkd.2006.10.016; Shields J P, 1996, Am J Card Imaging, V10, P91; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Tuttle KR, 2009, CLIN J AM SOC NEPHRO, V4, P1968, DOI 10.2215/CJN.01250209; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	44	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16738	10.1371/journal.pone.0016738	http://dx.doi.org/10.1371/journal.pone.0016738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311747	gold, Green Submitted, Green Published			2022-12-25	WOS:000287036200037
J	Xie, YY; Yang, D; He, QY; Songyang, Z				Xie, Yiying; Yang, Dong; He, Quanyuan; Songyang, Zhou			Zebrafish as a Model System to Study the Physiological Function of Telomeric Protein TPP1	PLOS ONE			English	Article							LENGTH REGULATOR TRF1; ADRENOCORTICAL DYSPLASIA; DAMAGE RESPONSE; HUMAN-DISEASE; COMPLEX; POT1; MOUSE; MICE; CELL; LOCALIZATION	Telomeres are specialized chromatin structures at the end of chromosomes. Telomere dysfunction can lead to chromosomal abnormalities, DNA damage responses, and even cancer. In mammalian cells, a six-protein complex (telosome/shelterin) is assembled on the telomeres through the interactions between various domain structures of the six telomere proteins (POT1, TPP1, TIN2, TRF1, TRF2 and RAP1), and functions in telomere maintenance and protection. Within the telosome, TPP1 interacts directly with POT1 and TIN2 and help to mediate telosome assembly. Mechanisms of telomere regulation have been extensively studied in a variety of model organisms. For example, the physiological roles of telomere-targeted proteins have been assessed in mice through homozygous inactivation. In these cases, early embryonic lethality has prevented further studies of these proteins in embryogenesis and development. As a model system, zebrafish offers unique advantages such as genetic similarities with human, rapid developmental cycles, and ease of manipulation of its embryos. In this report, we detailed the identification of zebrafish homologues of TPP1, POT1, and TIN2, and showed that the domain structures and interactions of these telosome components appeared intact in zebrafish. Importantly, knocking down TPP1 led to multiple abnormalities in zebrafish embryogenesis, including neural death, heart malformation, and caudal defect. And these embryos displayed extensive apoptosis. These results underline the importance of TPP1 in zebrafish embryogenesis, and highlight the feasibility and advantages of investigating the signaling pathways and physiological function of telomere proteins in zebrafish.	[Xie, Yiying; Yang, Dong; He, Quanyuan] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Songyang, Zhou] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Baylor College of Medicine; Sun Yat Sen University	Xie, YY (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	songyang@bcm.edu			NCI [CA133249]; NIGMS [GM081627]; Welch Foundation [Q-1673]; NATIONAL CANCER INSTITUTE [R01CA133249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI (http://www.nih.gov) CA133249, NIGMS (http://www.nih.gov) GM081627, and the Welch Foundation (http://www.welch1.org/) Q-1673. Z.S. is a Leukemia and Lymphoma Society Scholar (http://lls.org/hm_lls). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2005, BIOCHEM BIOPH RES CO, V331, P881, DOI 10.1016/j.bbrc.2005.03.211; Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49; BEAMER WG, 1994, J ENDOCRINOL, V141, P33, DOI 10.1677/joe.0.1410033; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen LY, 2007, MOL CELL BIOL; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; Corey DR, 2001, GENOME BIOL, V2; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Glickman NS, 2002, SEMIN CELL DEV BIOL, V13, P507, DOI 10.1016/S1084952102001040; Gornung E, 1998, GENOME, V41, P136, DOI 10.1139/gen-41-1-136; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Imamura S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003364; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Kajstura J, 2006, ANTIOXID REDOX SIGN, V8, P2125, DOI 10.1089/ars.2006.8.2125; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Keegan CE, 2005, HUM MOL GENET, V14, P113, DOI 10.1093/hmg/ddi011; Kim H, 2009, NAT STRUCT MOL BIOL, V16, P372, DOI 10.1038/nsmb.1575; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; McChesney PA, 2005, ZEBRAFISH, V1, P349, DOI 10.1089/zeb.2005.1.349; Nadal-Ginard B, 2003, J CLIN INVEST, V111, P1457, DOI 10.1172/JCI200318611; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; STARLING JA, 1990, NUCLEIC ACIDS RES, V18, P6881, DOI 10.1093/nar/18.23.6881; Tejera AM, 2010, DEV CELL, V18, P775, DOI [10.1016/j.devcel.2010.03.011, 10.1016/j.devce1.2010.03.011]; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Vlangos CN, 2009, DEV BIOL; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Xin HW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Yeh LK, 2008, J BIOL CHEM, V283, P506, DOI 10.1074/jbc.M707656200	43	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16440	10.1371/journal.pone.0016440	http://dx.doi.org/10.1371/journal.pone.0016440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311760	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200012
J	Zubko, E; Kunova, A; Meyer, P				Zubko, Elena; Kunova, Andrea; Meyer, Peter			Sense and Antisense Transcripts of Convergent Gene Pairs in Arabidopsis thaliana Can Share a Common Polyadenylation Region	PLOS ONE			English	Article							MESSENGER-RNA POLYADENYLATION; POSTTRANSCRIPTIONAL REGULATION; MOUSE GENES; EXPRESSION; RECEPTOR; OVERLAP; DEPENDS; SIGNALS; ELEMENT; GENOME	The Arabidopsis genome contains a large number of gene pairs that encode sense and antisense transcripts with overlapping 39 regions, indicative for a potential role of natural antisense transcription in regulating sense gene expression or transcript processing. When we mapped poly(A) transcripts of three plant gene pairs with long overlapping antisense transcripts, we identified an unusual transcript composition for two of the three gene pairs. Both genes pairs encoded a class of long sense transcripts and a class of short sense transcripts that terminate within the same polyadenylation region as the antisense transcripts encoded by the opposite strand. We find that the presence of the short sense transcript was not dependent on the expression of an antisense transcript. This argues against the assumption that the common termination region for sense and antisense poly(A) transcripts is the result of antisense-specific regulation. We speculate that for some genes evolution may have especially favoured alternative polyadenylation events that shorten transcript length for gene pairs with overlapping sense/antisense transcription, if this reduces the likelihood for dsRNA formation and transcript degradation.	[Zubko, Elena; Kunova, Andrea; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Zubko, E (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Kunova, Andrea/F-3769-2016; Kunova, Andrea/AAB-8717-2022	Kunova, Andrea/0000-0002-9210-4792; Kunova, Andrea/0000-0002-9210-4792	BBSRC; Epigenome Network of Excellence; BBSRC [BB/D015774/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D015774/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Epigenome Network of Excellence; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	E.Z. and A.K. were supported by BBSRC (http://www.bbsrc.ac.uk/) and by the Epigenome Network of Excellence (http://www.epigenome-noe.net/WWW/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batshake B, 1996, BIOCHEM BIOPH RES CO, V227, P70, DOI 10.1006/bbrc.1996.1469; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Carlile M, 2008, PHYSIOL GENOMICS, V34, P95, DOI 10.1152/physiolgenomics.00004.2008; Dahary D, 2005, GENOME RES, V15, P364, DOI 10.1101/gr.3308405; Danckwardt S, 2007, EMBO J, V26, P2658, DOI 10.1038/sj.emboj.7601699; de Jong M, 2006, PLANT J, V46, P708, DOI 10.1111/j.1365-313X.2006.02724.x; Delaney KJ, 2006, PLANT PHYSIOL, V140, P1507, DOI 10.1104/pp.105.070672; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; FEHER A, 1991, PLANT CELL TISS ORG, V27, P105, DOI 10.1007/BF00048214; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hedtke B, 2009, NUCLEIC ACIDS RES, V37, P3739, DOI 10.1093/nar/gkp241; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Jen CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r51; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; KOES RE, 1989, PLANT MOL BIOL, V12, P213, DOI 10.1007/BF00020506; Li VY, 2003, DEV DYNAM, V228, P606; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Loke JC, 2005, PLANT PHYSIOL, V138, P1457, DOI 10.1104/pp.105.060541; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; MANEN JF, 1993, PLANTA, V191, P289, DOI 10.1007/BF00199763; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; MUNROE SH, 1991, J BIOL CHEM, V266, P22083; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Schwartz AM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1377, DOI 10.1134/S0006297906120145; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vejlupkova Z, 2003, MAIZE GENETICS COOPE, V7, P24; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zubko E, 2007, PLANT J, V52, P1131, DOI 10.1111/j.1365-313X.2007.03309.x	41	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16769	10.1371/journal.pone.0016769	http://dx.doi.org/10.1371/journal.pone.0016769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311762	Green Published, Green Submitted, gold			2022-12-25	WOS:000287036200039
J	Colak, G; Keillor, JW; Johnson, GVW				Colak, Gozde; Keillor, Jeffrey W.; Johnson, Gail V. W.			Cytosolic Guanine Nucledotide Binding Deficient Form of Transglutaminase 2 (R580a) Potentiates Cell Death in Oxygen Glucose Deprivation	PLOS ONE			English	Article							ERYTHROCYTE BAND 4.2; TISSUE TRANSGLUTAMINASE; CYTOPLASMIC DOMAIN; GTP; FIBRONECTIN; EXPRESSION; INTERACTS; ADHESION; MUTATION; CALCIUM	Transglutaminase 2 (TG2) is a hypoxia-responsive protein that is a calcium-activated transamidating enzyme, a GTPase and a scaffolding/linker protein. Upon activation TG2 undergoes a large conformational change, which likely affects not only its enzymatic activities but its non-catalytic functions as well. The focus of this study was on the role of transamidating activity, conformation and localization of TG2 in ischemic cell death. Cells expressing a GTP binding deficient form of TG2 (TG2-R580A) with high basal transamidation activity and a more extended conformation showed significantly increased cell death in response to oxygen-glucose deprivation; however, targeting TG2-R580A to the nucleus abrogated its detrimental role in oxygen-glucose deprivation. Treatment of cells expressing wild type TG2, TG2-C277S (a transamidating inactive mutant) and TG2-R580A with Cp4d, a reversible TG2 inhibitor, did not affect cell death in response to oxygen-glucose deprivation. These findings indicate that the pro-cell death effects of TG2 are dependent on its localization to the cytosol and independent of its transamidation activity. Further, the conformational state of TG2 is likely an important determinant in cell survival and the prominent function of TG2 in ischemic cell death is as a scaffold to modulate cellular processes.	[Colak, Gozde; Johnson, Gail V. W.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA; [Keillor, Jeffrey W.] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada; [Johnson, Gail V. W.] Univ Rochester, Dept Anesthesiol, Rochester, NY USA	University of Rochester; Universite de Montreal; University of Rochester	Colak, G (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	gail_johnsonvoll@urmc.rochester.edu	Johnson, Gail V.W./K-4723-2012	Johnson, Gail V.W./0000-0003-3464-0404	National Institutes of Health [NS041744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant NS041744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHYUTHAN KE, 1987, J BIOL CHEM, V262, P1901; Ahn JS, 2008, BIOCHEM BIOPH RES CO, V376, P743, DOI 10.1016/j.bbrc.2008.09.048; Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Begg GE, 2006, J BIOL CHEM, V281, P12603, DOI 10.1074/jbc.M600146200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Caccamo D, 2004, AMINO ACIDS, V27, P373, DOI 10.1007/s00726-004-0117-1; Datta S, 2007, BIOCHEMISTRY-US, V46, P14819, DOI 10.1021/bi701422h; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; FILIANO AJ, 2010, NEUROBIOL DIS; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Gundemir S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006123; Ientile R, 2007, AMINO ACIDS, V33, P385, DOI 10.1007/s00726-007-0517-0; Ientile R, 2004, NEUROSCI LETT, V363, P173, DOI 10.1016/j.neulet.2004.04.003; Jang GY, 2010, ONCOGENE, V29, P356, DOI 10.1038/onc.2009.342; Keillor JW, 2008, CAN J CHEM, V86, P271, DOI 10.1139/V08-024; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KORSGREN C, 1988, J BIOL CHEM, V263, P10212; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; LORAND LG, 2003, NAT REV MOL CELL BIO; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; Milakovic T, 2004, J BIOL CHEM, V279, P8715, DOI 10.1074/jbc.M308479200; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Pardin C, 2008, CHEM BIOL DRUG DES, V72, P189, DOI 10.1111/j.1747-0285.2008.00696.x; Peng XJ, 1999, FEBS LETT, V446, P35, DOI 10.1016/S0014-5793(99)00018-6; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Ruan QM, 2007, J NEUROCHEM, V102, P25, DOI 10.1111/j.1471-4159.2007.04491.x; Satchwell TJ, 2009, BLOOD CELL MOL DIS, V42, P201, DOI 10.1016/j.bcmd.2009.01.005; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Smethurst PA, 1996, BIOCHEM J, V313, P803, DOI 10.1042/bj3130803; THORPE GHG, 1986, METHOD ENZYMOL, V133, P331; Tolentino PJ, 2004, J NEUROCHEM, V89, P1301, DOI 10.1111/j.1471-4159.2004.02436.x; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Tucholski J, 2002, J NEUROCHEM, V81, P780, DOI 10.1046/j.1471-4159.2002.00859.x; TURNER PM, 1989, BIOCHEMISTRY-US, V28, P628, DOI 10.1021/bi00428a032; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zhang JW, 1998, J NEUROCHEM, V71, P240	39	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16665	10.1371/journal.pone.0016665	http://dx.doi.org/10.1371/journal.pone.0016665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304968	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300111
J	Genet, F; Jourdan, C; Schnitzler, A; Lautridou, C; Guillemot, D; Judet, T; Poiraudeau, S; Denormandie, P				Genet, Francois; Jourdan, Claire; Schnitzler, Alexis; Lautridou, Christine; Guillemot, Didier; Judet, Thierry; Poiraudeau, Serge; Denormandie, Philippe			Troublesome Heterotopic Ossification after Central Nervous System Damage: A Survey of 570 Surgeries	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; HUMORAL-FACTORS; EARLY EXCISION; BONE-FORMATION; RISK-FACTORS; HEAD-TRAUMA; RESECTION; CLASSIFICATION; ELBOW	Background: Heterotopic ossification (HO) is a frequent complication after central nervous system (CNS) damage but has seldom been studied. We aimed to investigate features of HO for the first time in a large sample and the rate of early recurrence of HO in terms of the time of surgery. Methodology/Principal Findings: We retrospectively analyzed data from an anonymous prospective survey of patients undergoing surgery between May 1993 and November 2009 in our institution for troublesome HO related to acquired neurological disease. Demographic and HO characteristics and neurological etiologies were recorded. For 357 consecutive patients, we collected data on 539 first surgeries for HO (129 surgeries for multiple sites). During the follow-up, recurrences requiring another surgery appeared in 31 cases (5.8% [31/539]; 95% confidence interval [CI]: 3.8%-7.8%; 27 patients). Most HO requiring surgery occurred after traumatic brain injury (199 patients [55.7%]), then spinal cord injury (86 [24.0%]), stroke (42 [11.8%]) and cerebral anoxia (30 [8.6%]). The hip was the primary site of HO (328 [60.9%]), then the elbow (115 [21.3%]), knee (77 [14.3%]) and shoulder (19 [3.5%]). For all patients, 181 of the surgeries were performed within the first year after the CNS damage, without recurrence of HO. Recurrence was not associated with etiology (p = 0.46), sex (p = 1.00), age at CNS damage (p = 0.2), multisite localization (p = 0.34), or delay to surgery (p = 0.7). Conclusions/Significance: In patients with CNS damage, troublesome HO and recurrence occurs most frequently after traumatic brain injury and appears frequently in the hip and elbow. Early surgery for HO is not a factor of recurrence.	[Genet, Francois; Jourdan, Claire; Schnitzler, Alexis] Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Judet, Thierry; Denormandie, Philippe] Hop Raymond Poincare, Serv Chirurg Orthoped & Traumatol, Garches, France; [Guillemot, Didier] Hop Raymond Poincare, Unite Fonct Sante Publ, Garches, France; [Poiraudeau, Serge] Hop Cochin, Serv Med Phys & Readaptat, F-75674 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France.	francois.genet@rpc.aphp.fr	POIRAUDEAU, SERGE/P-5301-2016; Guillemot, Didier/AAN-3051-2020	Poiraudeau, Serge/0000-0002-1988-9124; Guillemot, Didier/0000-0002-8497-1765				Balboni TA, 2006, INT J RADIAT ONCOL, V65, P1289, DOI 10.1016/j.ijrobp.2006.03.053; Beingessner DM, 2000, J HAND SURG-AM, V25A, P483, DOI 10.1053/jhsu.2000.6922; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano C, 2009, ORTHOPEDICS, V32; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Cullen N, 2007, BRAIN INJURY, V21, P215, DOI 10.1080/02699050701202027; da Paz AC, 2007, MED HYPOTHESES, V68, P67, DOI 10.1016/j.mehy.2006.06.035; de Palma L, 2002, ORTHOPEDICS, V25, P665; Denys P, 1996, BRAIN INJURY, V10, P149, DOI 10.1080/026990596124656; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2009, J BONE JOINT SURG BR, V91B, P1493, DOI 10.1302/0301-620X.91B11.22305; HARAN M, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003321.PUB3; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; Melamed E, 2002, AM J PHYS MED REHAB, V81, P670, DOI 10.1097/00002060-200209000-00006; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Pelissier J., 2002, Annales de Readaptation et de Medecine Physique, V45, P188, DOI 10.1016/S0168-6054(02)00202-7; Riklin C, 2003, SPINAL CORD, V41, P192, DOI 10.1038/sj.sc.3101421; Rogers R C, 1988, Brain Inj, V2, P169, DOI 10.3109/02699058809150941; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; Shehab D, 2002, J NUCL MED, V43, P346; Silver J R, 1969, Paraplegia, V7, P220; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Toffoli AM, 2008, BRAIN INJURY, V22, P511, DOI 10.1080/02699050802158235; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	37	64	66	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16632	10.1371/journal.pone.0016632	http://dx.doi.org/10.1371/journal.pone.0016632			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304993	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300104
J	Kim, Y; Joshi, SD; Messner, WC; LeDuc, PR; Davidson, LA				Kim, YongTae; Joshi, Sagar D.; Messner, William C.; LeDuc, Philip R.; Davidson, Lance A.			Detection of Dynamic Spatiotemporal Response to Periodic Chemical Stimulation in a Xenopus Embryonic Tissue	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; INDUCTION; TRANSLOCATION; LOCALIZATION; SIGNALS; SPACE; CELLS; TIME	Embryonic development is guided by a complex and integrated set of stimuli that results in collective system-wide organization that is both time and space regulated. These regulatory interactions result in the emergence of highly functional units, which are correlated to frequency-modulated stimulation profiles. We have determined the dynamic response of vertebrate embryonic tissues to highly controlled, time-varying localized chemical stimulation using a microfluidic system with feedback control. Our approach has enabled localized spatiotemporal manipulation of the steroid hormone dexamethasone (DEX) in Animal Cap (AC) tissues isolated from gastrulating Xenopus embryos. Using this approach we investigated cell-scale responses to precisely controlled stimulation by tracking the redistribution of a GFP-tagged DEX-reporter constructed from the human glucocorticoid receptor (GR). We exposed defined regions of a single AC explant to different stimulation conditions-continuous stimulation, periodic stimulation, and no stimulation. We observed collective behavior of the GR transport into the nucleus was first-order. Furthermore, the dynamic response was well-modeled by a first-order differential equation with a single time derivative. The model predicted that responses to periodic stimulations closely matched the results of the frequency-based experiments. We find that stimulation with localized bursts versus continuous stimulation can result in highly distinct responses. This finding is critical as controlled space and time exposure to growth factors is a hallmark of complex processes in embryonic development. These complex responses to cellular signaling and transport machinery were similar to emergent behaviors in other complex systems, suggesting that even within a complex embryonic tissue, the overall system can converge toward a predictive first-order response.	[Kim, YongTae; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Kim, YongTae; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Kim, YongTae; Messner, William C.; LeDuc, Philip R.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Joshi, Sagar D.; Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Joshi, Sagar D.; Davidson, Lance A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, Y (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	lad43@pitt.edu	Kim, YongTae/A-9839-2010; LeDuc, Philip/M-1103-2014	LeDuc, Philip/0000-0001-6397-2905; Kim, YongTae/0000-0002-8835-8247	National Science Foundation, (NSF) [CMS0555513]; Office of Naval Research; National Institutes of Health [R01-HD044750]; American Heart Association; Dowd-ICES; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019259] Funding Source: NIH RePORTER	National Science Foundation, (NSF)(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Dowd-ICES; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Science Foundation, (NSF Grant Number CMS0555513), the Office of Naval Research, the National Institutes of Health (R01-HD044750), and the American Heart Association (Beginning Grant-in-Aid), and the Dowd-ICES Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi T, 2003, INT J DEV BIOL, V47, P405; Ariizumi T, 2001, INT J DEV BIOL, V45, P273; Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blitz IL, 2006, SEMIN CELL DEV BIOL, V17, P133, DOI 10.1016/j.semcdb.2005.11.002; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Carey KL, 1996, J CELL BIOL, V133, P985, DOI 10.1083/jcb.133.5.985; Chen X, 2006, J CELL BIOL, V174, P301, DOI 10.1083/jcb.200602062; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Davidson LA, 2004, GENE EXPR PATTERNS, V4, P457, DOI 10.1016/j.modgep.2004.01.001; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Francois P, 2009, NATURE, V461, pE1, DOI 10.1038/nature08305; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gilbert SF, 2006, DEV BIOL; Gomez-Uribe C, 2007, PLOS COMPUT BIOL, V3, P2487, DOI 10.1371/journal.pcbi.0030246; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; HUTCHISON KA, 1993, ANN NY ACAD SCI, V684, P35, DOI 10.1111/j.1749-6632.1993.tb32269.x; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Joshi SD, 2010, EXP CELL RES, V316, P103, DOI 10.1016/j.yexcr.2009.08.005; JOSHI SD, 2010, J VIS EXP, V39; KAYBK, 1991, METHOD CELL BIOL, V36, P663; KESSLER DS, 1994, SCIENCE, V266, P596, DOI 10.1126/science.7939714; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0; Kim Y, 2010, J AM CHEM SOC, V132, P1339, DOI 10.1021/ja9079572; Kim Y, 2009, LAB CHIP, V9, P2603, DOI 10.1039/b822423d; KOLM PJ, 1995, DEV BIOL, V171, P267, DOI 10.1006/dbio.1995.1279; Kowalczyk B, 2009, LANGMUIR, V25, P1905, DOI 10.1021/la803287u; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Kuczenski B, 2007, LAB CHIP, V7, P647, DOI 10.1039/b617065j; Kuczenski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004847; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Moussy Y, 2006, BIOTECHNOL PROGR, V22, P819, DOI 10.1021/bp060031j; Nieuwkoop PD, 1967, NORMAL TABLES XENOPU; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Okino MS, 1998, CHEM REV, V98, P391, DOI 10.1021/cr950223l; Pennathur S, 2008, LAB CHIP, V8, P383, DOI 10.1039/b801448p; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; SATER AK, 1993, DEV DYNAM, V197, P268, DOI 10.1002/aja.1001970405; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782; Smith JC, 2008, PHILOS T R SOC B, V363, P1387, DOI 10.1098/rstb.2007.2256; Smith JC, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002477; Vogel S., 2003, COMP BIOMECHANICS LI; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WILSON P, 1991, DEVELOPMENT, V112, P289; Wolpert Lewis, 2009, Int J Dev Biol, V53, P659, DOI 10.1387/ijdb.072559mr	48	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14624	10.1371/journal.pone.0014624	http://dx.doi.org/10.1371/journal.pone.0014624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305055	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000286834300008
J	Rogvi, RA; Mathiasen, R; Greisen, G				Rogvi, Rasmus A.; Mathiasen, Rene; Greisen, Gorm			Defining Smallness for Gestational Age in the Early Years of the Danish Medical Birth Registry	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; INTRAUTERINE GROWTH; PRENATAL EXPOSURE; CEREBRAL-PALSY; SWEDISH MEN; WEIGHT; RISK; PRETERM; TERM; ASSOCIATION	Background: Being born small for gestational age (SGA) is associated with decreased insulin sensitivity and increased blood pressure in childhood, but the association with clinical disease in early adulthood is less certain. The Danish Medical Birth Registry has registered all births in Denmark since 1973, but due to variable data quality, data is most often used only from 1981 onwards, and birth registers in other countries may have similar problems for the early years. We wanted to examine whether the data can be used for identification of children born SGA and used in future research. Methodology/Principal Findings: All persons born between 1974 and 1996 were identified in the Danish Medical Birth Registry (n = 1.704.890). Immigrants and children without data on gestational age and birth weight were excluded, and a total of 1.348.106 children were included in the analysis. The difference between the different variables used in the history of the registry were examined, and the quality of data in the birth registry from 1974-1981 was examined and compared to subsequent years. Data on birth weight and gestational age in the early years of the registry is inconsistent, and the identification of children born SGA is inaccurate, with 49% false-positives. The biggest source of error is due to the rough and inaccurate intervals used for gestational age. By using -3 standard deviations as a cut-off for the identification of children born SGA, the number of false-positives was reduced to 9%, while the amount of false-negatives were increased. Conclusion: Choosing -3 standard deviations for identifying children born SGA is a viable, though not optimal solution for identifying children born SGA. Overall the data in the registry is of sufficient quality to be used in further medical research.	[Rogvi, Rasmus A.; Mathiasen, Rene; Greisen, Gorm] Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Rogvi, RA (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark.	rasmus@rogvi.dk	Greisen, Gorm/AAA-6463-2022	Greisen, Gorm/0000-0001-8042-3262	Elsass Foundation	Elsass Foundation	The funds for data collection were granted by the Elsass Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAIR E, 1990, AM J OBSTET GYNECOL, V162, P229, DOI 10.1016/0002-9378(90)90856-3; Dahlquist G, 1996, BRIT MED J, V313, P1174, DOI 10.1136/bmj.313.7066.1174; DE ROOIJ, 2007, AM J CLIN NUTR, V86, P1219; de Rooij SR, 2006, DIABETES CARE, V29, P1897, DOI 10.2337/dc06-0460; Ehrenstein V, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-14; Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1511, DOI 10.1016/S0002-9378(96)70099-6; Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE; Jacobsson B, 2008, BJOG-INT J OBSTET GY, V115, P1250, DOI 10.1111/j.1471-0528.2008.01827.x; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Levy-Marchal Claire, 2004, Semin Neonatol, V9, P67, DOI 10.1016/j.siny.2003.08.001; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Lykke JA, 2009, OBSTET GYNECOL, V113, P1217, DOI 10.1097/AOG.0b013e3181a66f2d; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Pulver LS, 2009, PEDIATRICS, V123, pE1072, DOI 10.1542/peds.2008-3288; Reinehr T, 2009, EUR J ENDOCRINOL, V160, P579, DOI 10.1530/EJE-08-0914; Schack-Nielsen L, 2006, OBESITY, V14, P1257, DOI 10.1038/oby.2006.143; Selling KE, 2008, EPIDEMIOLOGY, V19, P63, DOI 10.1097/EDE.0b013e318159074b; *SUNDH, 2009, DOC DAN MED BIRTH RE; Willemsen RH, 2009, J CLIN ENDOCR METAB, V94, P1695, DOI 10.1210/jc.2008-1769	23	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16668	10.1371/journal.pone.0016668	http://dx.doi.org/10.1371/journal.pone.0016668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304958	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300113
J	Sarkari, F; Wang, XQ; Nguyen, T; Frappier, L				Sarkari, Feroz; Wang, Xueqi; Nguyen, Tin; Frappier, Lori			The Herpesvirus Associated Ubiquitin Specific Protease, USP7, Is a Negative Regulator of PML Proteins and PML Nuclear Bodies	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-1; 135-KDA CELLULAR-PROTEIN; TUMOR-SUPPRESSOR; ARSENIC TRIOXIDE; BINDING DOMAIN; E3 LIGASE; ANTIGEN 1; P53; HAUSP; ICP0	The PML tumor suppressor is the founding component of the multiprotein nuclear structures known as PML nuclear bodies (PML-NBs), which control several cellular functions including apoptosis and antiviral effects. The ubiquitin specific protease USP7 (also called HAUSP) is known to associate with PML-NBs and to be a tight binding partner of two herpesvirus proteins that disrupt PML NBs. Here we investigated whether USP7 itself regulates PML-NBs. Silencing of USP7 was found to increase the number of PML-NBs, to increase the levels of PML protein and to inhibit PML polyubiquitylation in nasopharyngeal carcinoma cells. This effect of USP7 was independent of p53 as PML loss was observed in p53-null cells. PML-NBs disruption was induced by USP7 overexpression independently of its catalytic activity and was induced by either of the protein interaction domains of USP7, each of which localized to PML-NBs. USP7 also disrupted NBs formed from some single PML isoforms, most notably isoforms I and IV. CK2 alpha and RNF4, which are known regulators of PML, were dispensable for USP7-associated PML-NB disruption. The results are consistent with a novel model of PML regulation where a deubiquitylase disrupts PML-NBs through recruitment of another cellular protein(s) to PML NBs, independently of its catalytic activity.	[Sarkari, Feroz; Wang, Xueqi; Nguyen, Tin; Frappier, Lori] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Sarkari, F (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	lori.frappier@utoronto.ca			Canadian Institutes of Health Research [93652]; National Cancer Institute of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS))	This work was supported by a research grant (93652) from the Canadian Institutes of Health Research and a National Cancer Institute of Canada studentship to F.S. L.F. is a tier 1 Canada Research Chair in Molecular Virology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antrobus R, 2008, VIRUS RES, V137, P64, DOI 10.1016/j.virusres.2008.05.017; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Cuchet D, 2011, J CELL SCI, V124, P280, DOI 10.1242/jcs.075390; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; EVERETT RD, 1994, EMBO J, V13, P5062, DOI 10.1002/j.1460-2075.1994.tb06835.x; Everett RD, 1998, J VIROL, V72, P6581, DOI 10.1128/JVI.72.8.6581-6591.1998; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Everett RD, 2008, J VIROL, V82, P8871, DOI 10.1128/JVI.00613-08; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Gambacorta M, 1996, AM J PATHOL, V149, P2023; Gong L, 2006, J BIOL CHEM, V281, P15869, DOI 10.1074/jbc.M511658200; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Holowaty MN, 2003, J BIOL CHEM, V278, P47753, DOI 10.1074/jbc.M307200200; Holowaty MN, 2003, J BIOL CHEM, V278, P29987, DOI 10.1074/jbc.M303977200; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; KOKEN MHM, 1995, ONCOGENE, V10, P1315; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lallemand-Breitenbach V, 2006, CELL, V126, P244, DOI 10.1016/j.cell.2006.07.004; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Malakhova OA, 2006, EMBO J, V25, P2358, DOI 10.1038/sj.emboj.7601149; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; MEREDITH M, 1995, VIROLOGY, V209, P174, DOI 10.1006/viro.1995.1241; MEREDITH M, 1994, VIROLOGY, V200, P457, DOI 10.1006/viro.1994.1209; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miller WH, 2002, CANCER RES, V62, P3893; Nathan JA, 2008, TRAFFIC, V9, P1130, DOI 10.1111/j.1600-0854.2008.00747.x; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ohbayashi N, 2008, BIOCHEM BIOPH RES CO, V371, P823, DOI 10.1016/j.bbrc.2008.04.179; Parkinson J, 2000, J VIROL, V74, P10006, DOI 10.1128/JVI.74.21.10006-10017.2000; Reineke EL, 2009, INT J BIOL SCI, V5, P366; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Saridakis V, 2005, MOL CELL, V18, P25, DOI 10.1016/j.molcel.2005.02.029; Sarkari F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000624; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shan J, 2008, Ernst Schering Found Symp Proc, P127; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Sivachandran N, 2010, J VIROL, V84, P11113, DOI 10.1128/JVI.01183-10; Sivachandran N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000170; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; SUN Y, 1992, P NATL ACAD SCI USA, V89, P6516, DOI 10.1073/pnas.89.14.6516; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang S, 2009, J VIROL, V83, P11704, DOI 10.1128/JVI.00931-09; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200	59	43	45	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16598	10.1371/journal.pone.0016598	http://dx.doi.org/10.1371/journal.pone.0016598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305000	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300095
J	Villard, PH; Barlesi, F; Armand, M; Dao, TMA; Pascussi, JM; Fouchier, F; Champion, S; Dufour, C; Ginies, C; Khalil, A; Amiot, MJ; Barra, Y; Seree, E				Villard, Pierre-Henri; Barlesi, Fabrice; Armand, Martine; Dao, Thi-Mai-Anh; Pascussi, Jean-Marc; Fouchier, Francis; Champion, Serge; Dufour, Claire; Ginies, Christian; Khalil, Ayman; Amiot, Marie-Josephe; Barra, Yves; Seree, Eric			CYP1A1 Induction in the Colon by Serum: Involvement of the PPAR alpha Pathway and Evidence for a New Specific Human PPRE alpha Site	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; LIPID-PEROXIDATION PRODUCTS; AH RECEPTOR; FATTY-ACIDS; VOLATILE BIOMARKERS; CYTOCHROME P4501A1; FOOD SOURCES; CANCER; DIETARY; WOMEN	Background: We previously showed that blood serum induced cytochrome P450 1A1 (CYP1A1) monooxygenase expression in vitro. Objective: Our purpose was (i) to identify the molecular mechanism involved and (ii) to characterize the inducer compound(s) in serum involved at least in part. Methods: Serum was fractionated on hydrophobic columns. PPAR alpha involvement was demonstrated by gene reporter assays, DNA mutagenesis and EMSA. Gene expression was evaluated by qRT-PCR. Serum samples were analyzed using HS-SPME-GC-MS. Results: The inductive effect of serum did not depend on the AhR pathway and was enhanced by cotransfection of PPAR alpha cDNA. Mutations in the PPAR response elements of the CYP1A1 gene promoter suppressed this effect. One of the PPRE sites appeared highly specific for human PPAR alpha, an unreported PPRE property. A link was found between CYP1A1 inducibility and serum hydrophobic compounds. Characterization of sera showed that hexanal, a metabolite produced by peroxidation of linoleic acid, was involved in CYP1A1 induction by serum, possibly along with other serum entities. Conclusion: We demonstrate that serum induces CYP1A1 via the PPAR alpha pathway and that hexanal is one of the serum inducers. The two PPRE sites within the CYP1A1 promoter are functional and one of them is specific for PPAR alpha.	[Villard, Pierre-Henri; Armand, Martine; Dao, Thi-Mai-Anh; Fouchier, Francis; Champion, Serge; Khalil, Ayman; Amiot, Marie-Josephe; Barra, Yves; Seree, Eric] INRA, UMR1260, Marseille, France; [Villard, Pierre-Henri; Armand, Martine; Dao, Thi-Mai-Anh; Fouchier, Francis; Champion, Serge; Khalil, Ayman; Amiot, Marie-Josephe; Barra, Yves; Seree, Eric] Univ Aix Marseille 2, Fac Med, IPHM IFR 125, Marseille, France; [Barlesi, Fabrice] Univ Aix Marseille 2, Assistance Publ Hop Marseille, Marseille, France; [Pascussi, Jean-Marc] Univ Perpignan, CNRS, UMR 5096, IRD, Montpellier, France; [Dufour, Claire; Ginies, Christian] Univ Avignon, INRA, UMR Safety & Qual Plant Prod 408, Avignon, France	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Avignon Universite; INRAE	Villard, PH (corresponding author), INRA, UMR1260, Marseille, France.	pierre-henri.villard@pharmacie.univ-mrs.fr; eric.seree@pharmacie.univ-mrs.fr	Amiot, Marie Josephe/C-4457-2015; Khalil, Ayman/F-4834-2019; ARMAND, Martine/O-5780-2016; pascussi, jean marc/F-9311-2013; AMIOT, MARIE JOSEPHE/N-8894-2019; Amiot, Marie Josephe/M-1203-2017	Khalil, Ayman/0000-0001-5054-7408; ARMAND, Martine/0000-0002-8712-6620; pascussi, jean marc/0000-0002-5168-5383; AMIOT, MARIE JOSEPHE/0000-0003-4563-4587; Amiot, Marie Josephe/0000-0003-4563-4587; Dufour, Claire/0000-0002-1745-7053	Assistance Publique - Ho'pitaux de Marseille [AP-HM 2001]	Assistance Publique - Ho'pitaux de Marseille	This study was promoted by the Assistance Publique - Ho'pitaux de Marseille (Promotion AP-HM 2001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Bakewell L, 2006, BRIT J NUTR, V96, P93, DOI 10.1079/BJN20061801; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Coste TC, 2008, CLIN CHEM, V54, P388, DOI 10.1373/clinchem.2007.094623; Deng CH, 2004, J CHROMATOGR B, V808, P269, DOI 10.1016/j.jchromb.2004.05.015; ESTERBAUER H, 1989, FREE RADICAL BIO MED, V7, P197, DOI 10.1016/0891-5849(89)90015-4; Eubank DW, 2001, J BIOL CHEM, V276, P30561, DOI 10.1074/jbc.M103019200; Fallone F, 2004, BIOCHEM BIOPH RES CO, V322, P551, DOI 10.1016/j.bbrc.2004.07.153; Folch J., 1957, J BIOL CHEM, V226, P498; Goode EL, 2007, CARCINOGENESIS, V28, P328, DOI 10.1093/carcin/bgl135; Guengerich FP, 2000, CARCINOGENESIS, V21, P345, DOI 10.1093/carcin/21.3.345; Guigal N, 2000, BIOCHEM BIOPH RES CO, V267, P572, DOI 10.1006/bbrc.1999.1959; HERNELL O, 1990, BIOCHEMISTRY-US, V29, P2041, DOI 10.1021/bi00460a012; Hihi AK, 2002, CELL MOL LIFE SCI, V59, P790, DOI 10.1007/s00018-002-8467-x; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Morita M, 2008, LIPIDS, V43, P589, DOI 10.1007/s11745-008-3170-9; Murtaugh MA, 2005, J NUTR, V135, P179, DOI 10.1093/jn/135.2.179; N'Guyen QB, 2002, BIOCHEM BIOPH RES CO, V297, P249, DOI 10.1016/S0006-291X(02)02177-0; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; OHTA A, 1990, LIPIDS, V25, P742, DOI 10.1007/BF02544044; Phelan D, 1998, ARCH BIOCHEM BIOPHYS, V357, P155, DOI 10.1006/abbi.1998.0814; POELLINGER L, 1983, J BIOL CHEM, V258, P3535; ROY D, 1992, ARCH BIOCHEM BIOPHYS, V296, P450, DOI 10.1016/0003-9861(92)90596-O; Savouret JF, 2001, J BIOL CHEM, V276, P3054, DOI 10.1074/jbc.M005988200; Schaldach CM, 1999, BIOCHEMISTRY-US, V38, P7594, DOI 10.1021/bi982861e; Seree E, 2004, GASTROENTEROLOGY, V127, P1436, DOI 10.1053/j.gastro.2004.08.023; Spiteller P, 2001, BBA-MOL CELL BIOL L, V1531, P188, DOI 10.1016/S1388-1981(01)00100-7; Stoll BA, 2002, EUR J CANCER PREV, V11, P319, DOI 10.1097/00008469-200208000-00002; VECCHINI F, 1994, BIOCHEM BIOPH RES CO, V201, P1205, DOI 10.1006/bbrc.1994.1833; Villard PH, 2007, BIOCHEM BIOPH RES CO, V364, P896, DOI 10.1016/j.bbrc.2007.10.084; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Weisburger JH, 2002, MUTAT RES-FUND MOL M, V506, P9, DOI 10.1016/S0027-5107(02)00147-1; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Widerak M, 2006, BIOCHIMIE, V88, P387, DOI 10.1016/j.biochi.2005.11.007; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Zock PL, 2001, CURR OPIN LIPIDOL, V12, P5, DOI 10.1097/00041433-200102000-00002	36	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14629	10.1371/journal.pone.0014629	http://dx.doi.org/10.1371/journal.pone.0014629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304969	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300011
J	Wolff, C; Schott, C; Porschewski, P; Reischauer, B; Becker, KF				Wolff, Claudia; Schott, Christina; Porschewski, Peter; Reischauer, Bilge; Becker, Karl-Friedrich			Successful Protein Extraction from Over-Fixed and Long-Term Stored Formalin-Fixed Tissues	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; E-CADHERIN; EXPRESSION; FIXATION; SECTIONS; DURATION	One of the major breakthroughs in molecular pathology during the last decade was the successful extraction of full-length proteins from formalin-fixed and paraffin-embedded (FFPE) clinical tissues. However, only limited data are available for the protein extraction efficiency of over-fixed tissues and FFPE blocks that had been stored for more than 15 years in pathology archives. In this study we evaluated the protein extraction efficiency of FFPE tissues which had been formalin-fixed for up to 144 hours and tissue blocks that were stored for 20 years, comparing an established and a new commercial buffer system. Although there is a decrease in protein yield with increasing fixation time, the new buffer system allows a protein recovery of 66% from 144 hours fixed tissues compared to tissues that were fixed for 6 hours. Using the established extraction procedure, less than 50% protein recovery was seen. Similarly, the protein extraction efficiency decreases with longer storage times of the paraffin blocks. Comparing the two buffer systems, we found that 50% more proteins can be extracted from FFPE blocks that were stored for 20 years when the new buffer system is used. Taken together, our data show that the new buffer system is superior compared to the established one. Because tissue fixation times vary in the routine clinical setting and pathology archives contain billions of FFPE tissues blocks, our data are highly relevant for research, diagnosis, and treatment of disease.	[Wolff, Claudia; Schott, Christina; Reischauer, Bilge; Becker, Karl-Friedrich] Tech Univ Munich, Inst Pathol, Munich, Germany; [Porschewski, Peter] Qiagen GmbH, Hilden, Germany	Technical University of Munich; QIAGEN GmbH	Wolff, C (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	kf.becker@lrz.tum.de	Becker, Karl-Friedrich/D-3636-2015	Becker, Karl-Friedrich/0000-0002-6801-4498	BMBF (Bundesministerium fur Bildung und Forschung) [01GR0805]	BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This study was supported by the NGFN (Nationale Genomforschungsnetz) Project of the BMBF (Bundesministerium fur Bildung und Forschung; www.bmbf.de; grant no. 01GR0805). The NGFN/BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PP (employee of Qiagen GmbH) participated in the experiment design and contributed reagents.	Addis MF, 2009, PROTEOMICS, V9, P3815, DOI 10.1002/pmic.200800971; Ahram M, 2003, PROTEOMICS, V3, P413, DOI 10.1002/pmic.200390056; Becker KF, 2007, J PATHOL, V211, P370, DOI 10.1002/path.2107; Becker KF, 2008, PROTEOM CLIN APPL, V2, P737, DOI 10.1002/prca.200780106; BECKER KF, 2008, TOPATJ, V2, P44; Bhudevi B, 2003, J VIROL METHODS, V109, P25, DOI 10.1016/S0166-0934(03)00040-5; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Chetty R, 2009, PANCREAS, V38, P338, DOI 10.1097/MPA.0b013e318183d74a; Chu WS, 2005, LAB INVEST, V85, P1416, DOI 10.1038/labinvest.3700337; Chung JY, 2008, PROTEOM CLIN APPL, V2, P1539, DOI 10.1002/prca.200800005; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790; Ikeda K, 1998, J HISTOCHEM CYTOCHEM, V46, P397, DOI 10.1177/002215549804600314; Krafft AE, 1997, MOL DIAGN, V2, P217, DOI 10.1016/S1084-8592(97)80032-X; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Nirmalan NJ, 2009, J PATHOL, V217, P497, DOI 10.1002/path.2504; Pryczynicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P128, DOI 10.2478/v10042-008-0089-1; Shi SR, 2006, J HISTOCHEM CYTOCHEM, V54, P739, DOI 10.1369/jhc.5B6851.2006; Specht K, 2001, AM J PATHOL, V158, P419, DOI 10.1016/S0002-9440(10)63985-5	20	50	50	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16353	10.1371/journal.pone.0016353	http://dx.doi.org/10.1371/journal.pone.0016353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305021	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300055
J	Famulski, JK; Vos, LJ; Rattner, JB; Chan, GK				Famulski, Jakub K.; Vos, Larissa J.; Rattner, Jerome B.; Chan, Gordon K.			Dynein/Dynactin-Mediated Transport of Kinetochore Components off Kinetochores and onto Spindle Poles Induced by Nordihydroguaiaretic Acid	PLOS ONE			English	Article							MITOTIC CHECKPOINT PROTEINS; ROUGH-DEAL; CYTOPLASMIC DYNEIN; AURORA-B; CENP-E; MICROTUBULE ATTACHMENT; HELA-CELLS; DYNAMICS; COMPLEX; ZW10	The mitotic checkpoint functions to ensure accurate chromosome segregation by regulating the progression from metaphase to anaphase. Once the checkpoint has been satisfied, it is inactivated in order to allow the cell to proceed into anaphase and complete the cell cycle. The minus end-directed microtubule motor dynein/dynactin has been implicated in the silencing of the mitotic checkpoint by "stripping'' checkpoint proteins off kinetochores. A recent study suggested that Nordihydroguaiaretic acid (NDGA) stimulates dynein/dynactin-mediated transport of its cargo including ZW10 (Zeste White 10). We analyzed the effects of NDGA on dynein/dynactin dependent transport of the RZZ (Zeste White 10, Roughdeal, Zwilch) complex as well as other kinetochore components from kinetochores to spindle poles. Through this approach we have catalogued several kinetochore and centromere components as dynein/dynactin cargo. These include hZW10, hZwilch, hROD, hSpindly, hMad1, hMad2, hCENP-E, hCdc27, cyclin-B and hMps1. Furthermore, we found that treatment with NDGA induced a robust accumulation and complete stabilization of hZW10 at spindle poles. This finding suggests that NDGA may not induce dynein/dynactin transport but rather interfere with cargo release. Lastly, we determined that NDGA induced accumulation of checkpoint proteins at the poles requires dynein/dynactin-mediated transport, hZW10 kinetochore localization and kinetochore-microtubule attachments but not tension or Aurora B kinase activity.	[Famulski, Jakub K.; Vos, Larissa J.; Chan, Gordon K.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Rattner, Jerome B.] Univ Calgary, Dept Anat & Cell Biol, Calgary, AB, Canada; [Chan, Gordon K.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Chan, Gordon K.] Univ Alberta, Sch Canc Engn & Imaging Sci, Edmonton, AB, Canada	University of Alberta; University of Calgary; University of Alberta; University of Alberta	Famulski, JK (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	gordonch@cancerboard.ab.ca	Chan, Gordon/AAN-7784-2020	Chan, Gordon/0000-0003-0497-9407	Canadian Institute of Health Research (CIHR); Alberta Cancer Research Institute (ACRI); NSERC; Canadian Foundation for Innovation; Alberta Heritage Foundation for Medical Research; Natural Sciences and Engineering Research Council of Canada; Alberta Science and Research Authority	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Research Institute (ACRI); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Science and Research Authority	J.K. Famulski is funded by a Canadian Graduate Scholarship Award from the Canadian Institute of Health Research (CIHR) and a graduate studentship from the Alberta Cancer Research Institute (ACRI). L.J. Vos is funded by a PGS-A graduate studentship from NSERC and a graduate studentship from ACRI. J.B. Rattner is funded by NSERC. G. K. Chan is funded by a CIHR New Investigator Award. This research is funded by grants from CIHR, ACRI, the Canadian Foundation for Innovation, the Alberta Heritage Foundation for Medical Research, Natural Sciences and Engineering Research Council of Canada and the Alberta Science and Research Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasaki K, 2007, MOL PHARMACOL, V71, P454, DOI 10.1124/mol.106.029611; Ban KH, 2007, DEV CELL, V13, P29, DOI 10.1016/j.devcel.2007.04.017; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Campbell MS, 2001, J CELL SCI, V114, P953; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Chan GKT, 2000, NAT CELL BIOL, V2, P944, DOI 10.1038/35046598; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan GKT, 1998, J CELL BIOL, V143, P49, DOI 10.1083/jcb.143.1.49; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Delacour-Larose M, 2004, CELL CYCLE, V3, P1418, DOI 10.4161/cc.3.11.1203; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Famulski JK, 2007, CURR BIOL, V17, P2143, DOI 10.1016/j.cub.2007.11.037; Fujiwara T, 1998, J BIOL CHEM, V273, P3068, DOI 10.1074/jbc.273.5.3068; Hori T, 2003, J CELL SCI, V116, P3347, DOI 10.1242/jcs.00645; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Jablonski SA, 1998, CHROMOSOMA, V107, P386, DOI 10.1007/s004120050322; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Li DY, 2010, MOL CELL BIOL, V30, P3384, DOI 10.1128/MCB.00258-10; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakamura M, 2003, BIOSCI BIOTECH BIOCH, V67, P151, DOI 10.1271/bbb.67.151; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Scaerou F, 2001, J CELL SCI, V114, P3103; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Starr DA, 2000, J CELL SCI, V113, P1939; Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; WENDELL KL, 1993, J CELL SCI, V104, P261; Williams BC, 2003, MOL BIOL CELL, V14, P1379, DOI 10.1091/mbc.E02-09-0624; WILLIAMS BC, 1992, J CELL BIOL, V118, P759, DOI 10.1083/jcb.118.4.759; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Yan XM, 2003, MOL CELL BIOL, V23, P1239, DOI 10.1128/MCB.23.4.1239-1250.2003; Yang ZY, 2003, CELL RES, V13, P275, DOI 10.1038/sj.cr.7290172	53	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16494	10.1371/journal.pone.0016494	http://dx.doi.org/10.1371/journal.pone.0016494			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305043	Green Published, gold, Green Submitted			2022-12-25	WOS:000286664100038
J	Itskov, PM; Vinnik, E; Diamond, ME				Itskov, Pavel M.; Vinnik, Ekaterina; Diamond, Mathew E.			Hippocampal Representation of Touch-Guided Behavior in Rats: Persistent and Independent Traces of Stimulus and Reward Location	PLOS ONE			English	Article							TACTILE INFORMATION; BARREL CORTEX; SPIKE TRAIN; MEMORY; PLACE; OBJECT; CELLS; MECHANISMS; DYNAMICS; PATTERNS	Understanding the mechanisms by which sensory experiences are stored remains a compelling challenge for neuroscience. Previous work has described how the activity of neurons in the sensory cortex allows rats to discriminate the physical features of an object contacted with their whiskers. But to date there is no evidence about how neurons represent the behavioural significance of tactile stimuli, or how they are encoded in memory. To investigate these issues, we recorded single-unit firing and local field potentials from the CA1 region of hippocampus while rats performed a task in which tactile stimuli specified reward location. On each trial the rat touched a textured plate with its whiskers, and then turned towards the Left or Right water spout. Two textures were associated with each reward location. To determine the influence of the rat's position on sensory coding, we placed it on a second platform in the same room where it performed the identical texture discrimination task. Over 25 percent of the sampled neurons encoded texture identity - their firing differed for two stimuli associated with the same reward location - and over 50 percent of neurons encoded the reward location with which the stimuli were associated. The neuronal population carried texture and reward location signals continuously, from the moment of stimulus contact until the end of reward collection. The set of neurons discriminating between one texture pair was found to be independent of, and partially overlapping, the set of neurons encoding the discrimination between a different texture pair. In a given neuron, the presence of a tactile signal was uncorrelated with the presence, magnitude, or timing of reward location signals. These experiments indicate that neurons in CA1 form a texture representation independently of the action the stimulus is associated with and retain the stimulus representation through reward collection.	[Itskov, Pavel M.; Vinnik, Ekaterina; Diamond, Mathew E.] SISSA, Sector Cognit Neurosci, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Itskov, PM (corresponding author), SISSA, Sector Cognit Neurosci, I-34014 Trieste, Italy.	itskovpa@gmail.com		Itskov, Pavel/0000-0002-2191-7083; Vinnik, Ekaterina/0000-0001-6853-1156; DIAMOND, Mathew Ernest/0000-0003-2286-4566	Human Frontier Science Program [RG0041/2009-C]; European Community [BIOTACT-21590]; Compagnia San Paolo; Italian Institute of Technology; Ministry of Economic Development	Human Frontier Science Program(Human Frontier Science Program); European Community(European Commission); Compagnia San Paolo(Compagnia di San Paolo); Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Ministry of Economic Development(Ministry of Economic Development, Italy)	This work was supported by grants from Human Frontier Science Program (contract RG0041/2009-C), the European Community (contract BIOTACT-21590), the Compagnia San Paolo, the Italian Institute of Technology through the BMI Project, and the Ministry of Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MI, 2003, J NEUROSCI, V23, P8827; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; FOX SE, 1981, EXP BRAIN RES, V41, P399; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; HEIMENDAHL MV, 2007, PLOS BIOL, V5, pE305, DOI DOI 10.1371/JOURNAL.PBIO.0050305; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jutras MJ, 2010, P NATL ACAD SCI USA, V107, P401, DOI 10.1073/pnas.0908378107; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Komorowski RW, 2009, J NEUROSCI, V29, P9918, DOI 10.1523/JNEUROSCI.1378-09.2009; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lottem E, 2009, J NEUROSCI, V29, P11686, DOI 10.1523/JNEUROSCI.0705-09.2009; Manns JR, 2009, LEARN MEMORY, V16, P616, DOI 10.1101/lm.1484509; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Packard MG, 1996, NEUROBIOL LEARN MEM, V65, P65, DOI 10.1006/nlme.1996.0007; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pereira A, 2007, P NATL ACAD SCI USA, V104, P18286, DOI 10.1073/pnas.0708611104; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Tulving E., 1972, ORG MEMORY, P423; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wiebe SP, 1999, J NEUROSCI, V19, P10562; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wolfe J, 2008, PLOS BIOL, V6, P1661, DOI 10.1371/journal.pbio.0060215; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	54	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16462	10.1371/journal.pone.0016462	http://dx.doi.org/10.1371/journal.pone.0016462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305039	Green Submitted, gold, Green Published			2022-12-25	WOS:000286664100034
J	Cury, JC; Araujo, FV; Coelho-Souza, SA; Peixoto, RS; Oliveira, JAL; Santos, HF; Davila, AMR; Rosado, AS				Cury, Juliano C.; Araujo, Fabio V.; Coelho-Souza, Sergio A.; Peixoto, Raquel S.; Oliveira, Joana A. L.; Santos, Henrique F.; Davila, Alberto M. R.; Rosado, Alexandre S.			Microbial Diversity of a Brazilian Coastal Region Influenced by an Upwelling System and Anthropogenic Activity	PLOS ONE			English	Article							CABO FRIO BRAZIL; GRADIENT GEL-ELECTROPHORESIS; ARCHAEAL ASSEMBLAGES; PLANKTONIC ARCHAEA; CLONE LIBRARIES; WATER MASSES; MARINE; BACTERIAL; BACTERIOPLANKTON; COMMUNITY	Background: Upwelling systems are characterised by an intense primary biomass production in the surface (warmest) water after the outcrop of the bottom (coldest) water, which is rich in nutrients. Although it is known that the microbial assemblage plays an important role in the food chain of marine systems and that the upwelling systems that occur in southwest Brazil drive the complex dynamics of the food chain, little is known about the microbial composition present in this region. Methodology/Principal Findings: We carried out a molecular survey based on SSU rRNA gene from the three domains of the phylogenetic tree of life present in a tropical upwelling region (Arraial do Cabo, Rio de Janeiro, Brazil). The aim was to analyse the horizontal and vertical variations of the microbial composition in two geographically close areas influenced by anthropogenic activity (sewage disposal/port activity) and upwelling phenomena, respectively. A lower estimated diversity of microorganisms of the three domains of the phylogenetic tree of life was found in the water of the area influenced by anthropogenic activity compared to the area influenced by upwelling phenomena. We observed a heterogenic distribution of the relative abundance of taxonomic groups, especially in the Archaea and Eukarya domains. The bacterial community was dominated by Proteobacteria, Cyanobacteria and Bacteroidetes phyla, whereas the microeukaryotic community was dominated by Metazoa, Fungi, Alveolata and Stramenopile. The estimated archaeal diversity was the lowest of the three domains and was dominated by uncharacterised marine Crenarchaeota that were most closely related to Marine Group I. Conclusions/Significance: The variety of conditions and the presence of different microbial assemblages indicated that the area of Arraial do Cabo can be used as a model for detailed studies that contemplate the correlation between pollution-indicating parameters and the depletion of microbial diversity in areas close to anthropogenic activity; functional roles and geochemical processes; phylogeny of the uncharacterised diversity; and seasonal variations of the microbial assemblages.	[Cury, Juliano C.; Peixoto, Raquel S.; Santos, Henrique F.; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Lab Mol Microbial Ecol, Rio de Janeiro, Brazil; [Araujo, Fabio V.] FFP UERJ, DCIEN, Microbiol Lab, Rio De Janeiro, Brazil; [Coelho-Souza, Sergio A.] Univ Fed Rio de Janeiro, INPeTAm IBCCF, Rio de Janeiro, Brazil; [Cury, Juliano C.; Oliveira, Joana A. L.; Davila, Alberto M. R.] Fiocruz MS, IOC, Lab Computat Biol & Syst, BR-21045900 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Cury, JC (corresponding author), Univ Fed Rio de Janeiro, Lab Mol Microbial Ecol, Rio de Janeiro, Brazil.	jccury@hotmail.com	Santos, Henrique/AAI-9410-2020; Coelho-Souza, Sergio/E-1856-2013; Rosado, Alexandre Soares/G-1955-2012; Dávila, Alberto M. R./AAJ-4647-2021; Araujo, Fábio/AAS-9624-2020; Peixoto, Raquel/V-2554-2019; Santos, Henrique Fragoso dos/G-3697-2014	Santos, Henrique/0000-0001-8850-7399; Rosado, Alexandre Soares/0000-0001-5135-1394; Dávila, Alberto M. R./0000-0002-6918-7673; Araujo, Fábio/0000-0002-1931-7302; Santos, Henrique Fragoso dos/0000-0001-8850-7399; Cury, Juliano/0000-0002-1450-5726; Coelho de Souza, Sergio Augusto/0000-0003-0701-6892; Peixoto, Raquel/0000-0002-9536-3132	Brazilian National Research Council (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	JCC, ASR and RSP greatly appreciate the support of Brazilian National Research Council (CNPq) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2007, FEMS MICROBIOL ECOL, V60, P98, DOI 10.1111/j.1574-6941.2006.00276.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APHA AWWA and WEF, 2000, STAND METH EXAM WAT; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bano N, 2004, APPL ENVIRON MICROB, V70, P781, DOI 10.1128/AEM.70.2.781-789.2004; Campos EJD, 2000, GEOPHYS RES LETT, V27, P751, DOI 10.1029/1999GL010502; Carvalho Wanderson Fernandes de, 2004, Braz. j. oceanogr., V52, P35, DOI 10.1590/S1679-87592004000100004; Castelao RM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025182; Cathrine SJ, 2009, MYCOL RES, V113, P100, DOI 10.1016/j.mycres.2008.08.009; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cheung MK, 2010, ISME J, V4, P1053, DOI 10.1038/ismej.2010.26; Church MJ, 2003, LIMNOL OCEANOGR, V48, P1893, DOI 10.4319/lo.2003.48.5.1893; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; DeLong EF, 2003, ASM NEWS, V69, P503; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diez B, 2001, APPL ENVIRON MICROB, V67, P2942, DOI 10.1128/AEM.67.7.2942-2951.2001; Dubelaar GBJ, 1999, CYTOMETRY, V37, P247, DOI 10.1002/(SICI)1097-0320(19991201)37:4<247::AID-CYTO1>3.0.CO;2-9; Durisch-Kaiser E, 2005, APPL ENVIRON MICROB, V71, P8099, DOI 10.1128/AEM.71.12.8099-8106.2005; Edgcomb VP, 2002, P NATL ACAD SCI USA, V99, P7658, DOI 10.1073/pnas.062186399; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Felsenstein J., 1993, PHYLOGENETIC INFEREN; FERREIRA C. E. L., 2004, J COASTAL RES, V3, P1340; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Fuhrman JA., 2008, MICROBIAL ECOLOGY OC, P45, DOI 10.1002/9780470281840.ch3; Galand PE, 2009, ENVIRON MICROBIOL, V11, P971, DOI 10.1111/j.1462-2920.2008.01822.x; Garren M, 2008, ENVIRON MICROBIOL, V10, P2299, DOI 10.1111/j.1462-2920.2008.01654.x; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; GONZALEZRODRIGUEZ E, 1992, J PLANKTON RES, V14, P289, DOI 10.1093/plankt/14.2.289; GONZALEZRODRIGUEZ E, 1994, HYDROBIOLOGIA, V294, P145, DOI 10.1007/BF00016855; GOOD IJ, 1956, BIOMETRIKA, V43, P45; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guenther M, 2008, MAR ECOL PROG SER, V363, P109, DOI 10.3354/meps07458; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hamilton AK, 2008, LIMNOL OCEANOGR, V53, P922, DOI 10.4319/lo.2008.53.3.0922; Hansson L, 2009, MAR ECOL PROG SER, V397, P89, DOI 10.3354/meps08429; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Hershberger PK, 2008, J PARASITOL, V94, P1055, DOI 10.1645/GE-1553.1; Heuer H., 1997, Modern soil microbiology., P353; Jebaraj CS, 2010, FEMS MICROBIOL ECOL, V71, P399, DOI 10.1111/j.1574-6941.2009.00804.x; Jukes T. H, 1969, MAMMALIAN PROTEIN ME, P21, DOI DOI 10.1093/BIOINFORMATICS/BTM404; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, V2, P243, DOI DOI 10.1002/9780470281840.CH8; KIRCHMAN DL, 1995, DEEP-SEA RES PT II, V42, P603, DOI 10.1016/0967-0645(95)00021-H; Koch K, 2009, ENVIRON MICROBIOL, V11, P657, DOI 10.1111/j.1462-2920.2008.01836.x; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lim E, PHYLOGENETIC D UNPUB; Lovejoy C, 2002, LIMNOL OCEANOGR, V47, P1819, DOI 10.4319/lo.2002.47.6.1819; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; Marshall WL, 2008, PROTIST, V159, P415, DOI 10.1016/j.protis.2008.03.003; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; McArthur J.V., 2006, MICROBIAL ECOLOGY EV; MCMANUS GB, 1988, MAR ECOL PROG SER, V43, P11, DOI 10.3354/meps043011; McManus GB, 2007, HYDROBIOLOGIA, V575, P69, DOI 10.1007/s10750-006-0279-9; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Moon-van der Staay S. Y, 2001, NATURE, V409, P607; Moyer CL, 1998, DEEP-SEA RES PT II, V45, P303, DOI 10.1016/S0967-0645(97)00081-7; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nagata T., 2008, MICROBIAL ECOLOGY OC, DOI [10.1002/9780470281840.ch7, DOI 10.1002/9780470281840.CH7]; Op den Camp HJM, 2007, BIOLOGY OF THE NITROGEN CYCLE, P245, DOI 10.1016/B978-044452857-5.50017-5; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Pereira GC, 2009, BRAZ J MICROBIOL, V40, P857, DOI [10.1590/S1517-83822009000400017, 10.1590/S1517-838220090004000017]; Pereira GC, 2009, ECOL MODEL, V220, P1506, DOI 10.1016/j.ecolmodel.2009.03.025; Pereira GC, 2008, BRAZ J OCEANOGR, V56, P1, DOI 10.1590/S1679-87592008000100001; Perreault NN, 2007, APPL ENVIRON MICROB, V73, P1532, DOI 10.1128/AEM.01729-06; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rodrigues RR, 2001, CONT SHELF RES, V21, P371, DOI 10.1016/S0278-4343(00)00094-7; Sambrook J, 2001, MOL CLONING LAB MANU; Santos HF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012437; Savin MC, 2004, MICROBIAL ECOL, V48, P51, DOI 10.1007/s00248-003-1033-8; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shannon C., 1964, MATH THEORY COMMUNIC; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; SOROKIN YI, 1979, HYDROBIOLOGIA, V62, P165, DOI 10.1007/BF00037508; Stoeck T, 2006, PROTIST, V157, P31, DOI 10.1016/j.protis.2005.10.004; Stoeck T, 2010, MOL ECOL, V19, P21, DOI 10.1111/j.1365-294X.2009.04480.x; Stoeck T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000728; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Terrado R, 2009, AQUAT MICROB ECOL, V56, P25, DOI 10.3354/ame01327; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tibbles BJ, 1996, AQUAT MICROB ECOL, V11, P239, DOI 10.3354/ame011239; Valentin JL, 2001, ECOL STU AN, V144, P97; VALENTIN JL, 1987, CONT SHELF RES, V7, P77, DOI 10.1016/0278-4343(87)90065-3; VALENTIN JL, 1984, HYDROBIOLOGIA, V113, P183, DOI 10.1007/BF00026607; VALENTIN JL, 1984, MAR BIOL, V82, P259, DOI 10.1007/BF00392407; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; VINOGRADOV ME, 1978, MAR BIOL, V48, P357, DOI 10.1007/BF00391640; Walsh DA, 2005, ENVIRON MICROBIOL, V7, P1655, DOI 10.1111/j.1462-2920.2005.00864.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001	98	40	43	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16553	10.1371/journal.pone.0016553	http://dx.doi.org/10.1371/journal.pone.0016553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304582	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900069
J	Matrisciano, F; Busceti, CL; Bucci, D; Orlando, R; Caruso, A; Molinaro, G; Cappuccio, I; Riozzi, B; Gradini, R; Motolese, M; Caraci, F; Copani, A; Scaccianoce, S; Melchiorri, D; Bruno, V; Battaglia, G; Nicoletti, F				Matrisciano, Francesco; Busceti, Carla L.; Bucci, Domenico; Orlando, Rosamaria; Caruso, Alessandra; Molinaro, Gemma; Cappuccio, Irene; Riozzi, Barbara; Gradini, Roberto; Motolese, Marta; Caraci, Filippo; Copani, Agata; Scaccianoce, Sergio; Melchiorri, Daniela; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando			Induction of the Wnt Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage	PLOS ONE			English	Article							CA3 PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; OPTICAL FRACTIONATOR; TAU-PHOSPHORYLATION; NEGATIVE MODULATOR; SIGNALING PATHWAY; LITHIUM TREATMENT; MAJOR DEPRESSION; APICAL DENDRITES; INDUCED ATROPHY	The identification of mechanisms that mediate stress-induced hippocampal damage may shed new light into the pathophysiology of depressive disorders and provide new targets for therapeutic intervention. We focused on the secreted glycoprotein Dickkopf-1 (Dkk-1), an inhibitor of the canonical Wnt pathway, involved in neurodegeneration. Mice exposed to mild restraint stress showed increased hippocampal levels of Dkk-1 and reduced expression of beta-catenin, an intracellular protein positively regulated by the canonical Wnt signalling pathway. In adrenalectomized mice, Dkk-1 was induced by corticosterone injection, but not by exposure to stress. Corticosterone also induced Dkk-1 in mouse organotypic hippocampal cultures and primary cultures of hippocampal neurons and, at least in the latter model, the action of corticosterone was reversed by the type-2 glucocorticoid receptor antagonist mifepristone. To examine whether induction of Dkk-1 was causally related to stress-induced hippocampal damage, we used doubleridge mice, which are characterized by a defective induction of Dkk-1. As compared to control mice, doubleridge mice showed a paradoxical increase in basal hippocampal Dkk-1 levels, but no Dkk-1 induction in response to stress. In contrast, stress reduced Dkk-1 levels in doubleridge mice. In control mice, chronic stress induced a reduction in hippocampal volume associated with neuronal loss and dendritic atrophy in the CA1 region, and a reduced neurogenesis in the dentate gyrus. Doubleridge mice were resistant to the detrimental effect of chronic stress and, instead, responded to stress with increases in dendritic arborisation and neurogenesis. Thus, the outcome of chronic stress was tightly related to changes in Dkk-1 expression in the hippocampus. These data indicate that induction of Dkk-1 is causally related to stress-induced hippocampal damage and provide the first evidence that Dkk-1 expression is regulated by corticosteroids in the central nervous system. Drugs that rescue the canonical Wnt pathway may attenuate hippocampal damage in major depression and other stress-related disorders.	[Matrisciano, Francesco; Orlando, Rosamaria; Caruso, Alessandra; Scaccianoce, Sergio; Melchiorri, Daniela; Bruno, Valeria; Nicoletti, Ferdinando] Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy; [Busceti, Carla L.; Bucci, Domenico; Molinaro, Gemma; Riozzi, Barbara; Motolese, Marta; Bruno, Valeria; Battaglia, Giuseppe; Nicoletti, Ferdinando] Ist Neurol Mediterraneo Neuromed, Pozzilli, Italy; [Cappuccio, Irene] Ist Casimiro Mondino, Pavia, Italy; [Gradini, Roberto] Univ Roma La Sapienza, Dept Expt Med, Rome, Italy; [Caraci, Filippo; Copani, Agata] Univ Catania, Dept Pharmaceut Sci, Catania, Italy; [Melchiorri, Daniela] Ist San Raffaele Pisana, Rome, Italy	Sapienza University Rome; IRCCS Neuromed; Sapienza University Rome; University of Catania; IRCCS San Raffaele Pisana	Matrisciano, F (corresponding author), Univ Roma La Sapienza, Dept Physiol & Pharmacol, Rome, Italy.	ferdinandonicoletti@hotmail.com	motolese, marta/G-8274-2011; Orlando, Rosamaria/AAA-4139-2021; Molinaro, Gemma/G-8822-2011; Nicoletti, Ferdinando/T-4898-2019; Busceti, Carla Letizia/F-9941-2011; Busceti, Carla Letizia/K-6485-2016; Battaglia, Giuseppe/A-7709-2010; bruno, Valeria/F-3146-2012; Riozzi, Barbara/A-8737-2013; Nicoletti, Ferdinando/K-4410-2016; Bucci, Domenico/G-6747-2011; Caraci, Filippo/K-2262-2016; Bucci, Domenico/AAA-5475-2019; Nicoletti, Ferdinando/A-2446-2010	motolese, marta/0000-0001-8211-7728; Orlando, Rosamaria/0000-0001-9369-1450; Busceti, Carla Letizia/0000-0002-1417-1893; Battaglia, Giuseppe/0000-0001-7571-3417; bruno, Valeria/0000-0003-4231-0739; Riozzi, Barbara/0000-0003-2050-1489; Caraci, Filippo/0000-0002-9867-6054; Bucci, Domenico/0000-0003-3239-2435; NICOLETTI, Ferdinando/0000-0003-3366-7269; Nicoletti, Ferdinando/0000-0003-0917-443X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Support was provided by institutional funds (Ricerca Corrente 2009-2010 from the Italian Ministry of Health to Istituto Neurologico Mediterraneo Neuromed, Pozzilli; Istituto C. Mondino, Pavia; and Istituto San Raffaele Pisana, Roma). Salaries to university people are from university funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 1998, J CEREBR BLOOD F MET, V18, P274, DOI 10.1097/00004647-199803000-00005; Adamska M, 2003, DEV BIOL, V255, P350, DOI 10.1016/S0012-1606(02)00114-8; Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; ARMANINI MP, 1990, BRAIN RES, V532, P7, DOI 10.1016/0006-8993(90)91734-X; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Brouwer JP, 2005, EUR J ENDOCRINOL, V152, P185, DOI 10.1530/eje.1.01828; Brown ES, 2004, BIOL PSYCHIAT, V55, P1, DOI 10.1016/S0006-3223(03)00473-6; Busceti CL, 2008, J NEUROSCI, V28, P3234, DOI 10.1523/JNEUROSCI.0159-08.2008; Busceti CL, 2007, EPILEPSIA, V48, P694, DOI 10.1111/j.1528-1167.2007.01055.x; Cappuccio I, 2005, J NEUROSCI, V25, P2647, DOI 10.1523/JNEUROSCI.5230-04.2005; Caraci F, 2008, NEUROCHEM RES, V33, P2401, DOI 10.1007/s11064-008-9710-0; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7; Conrad CD, 2007, J NEUROSCI, V27, P8278, DOI 10.1523/JNEUROSCI.2121-07.2007; Crochemore C, 2005, MOL PSYCHIATR, V10, P790, DOI 10.1038/sj.mp.4001679; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; de Jong IEM, 2007, BEHAV BRAIN RES, V177, P329, DOI 10.1016/j.bbr.2006.11.015; Donohue HS, 2006, NEUROSCIENCE, V140, P597, DOI 10.1016/j.neuroscience.2006.02.072; ELLIOTT EM, 1993, J NEUROCHEM, V61, P57, DOI 10.1111/j.1471-4159.1993.tb03537.x; Grotewold L, 2002, EMBO J, V21, P966, DOI 10.1093/emboj/21.5.966; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Haynes LE, 2001, NEUROSCIENCE, V104, P57, DOI 10.1016/S0306-4522(01)00070-7; Huang GJ, 2008, MOL PSYCHIATR, V13, P119, DOI 10.1038/sj.mp.4002104; Johnson SA, 2009, NEUROSCIENCE, V163, P34, DOI 10.1016/j.neuroscience.2009.06.005; Jope RS, 2002, MOL PSYCHIATR, V7, pS35, DOI 10.1038/sj.mp.4001017; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; King MA, 2002, METHODS, V28, P293, DOI 10.1016/S1046-2023(02)00235-9; Kleen JK, 2006, BEHAV NEUROSCI, V120, P842, DOI 10.1037/0735-7044.120.4.842; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; LAWRENCE MS, 1994, BRAIN RES, V646, P303, DOI 10.1016/0006-8993(94)90094-9; Lenox RH, 2000, J CLIN PSYCHIAT, V61, P5; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; McLaughlin KJ, 2007, BRAIN RES, V1161, P56, DOI 10.1016/j.brainres.2007.05.042; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morales-Medina JC, 2009, J CHEM NEUROANAT, V38, P266, DOI 10.1016/j.jchemneu.2009.05.009; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; Parker KJ, 2003, HORM BEHAV, V43, P60, DOI 10.1016/S0018-506X(02)00016-8; Roy M, 2003, NEUROENDOCRINOLOGY, V77, P24, DOI 10.1159/000068337; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SAPOLSKY RM, 1985, J NEUROSCI, V5, P1222; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; STUART DA, 1995, J NEUROSCI METH, V61, P5, DOI 10.1016/0165-0270(95)00017-O; Ueda J, 2005, AM J PHYSIOL-GASTR L, V288, pG842, DOI 10.1152/ajpgi.00463.2004; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WATANABE Y, 1992, HIPPOCAMPUS, V2, P431, DOI 10.1002/hipo.450020410; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Wexler EM, 2009, STEM CELLS, V27, P1130, DOI 10.1002/stem.36; Wood GE, 2004, P NATL ACAD SCI USA, V101, P3973, DOI 10.1073/pnas.0400208101; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A; Yusim A, 2000, BRAIN RES, V870, P109, DOI 10.1016/S0006-8993(00)02407-0	71	48	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16447	10.1371/journal.pone.0016447	http://dx.doi.org/10.1371/journal.pone.0016447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304589	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900050
J	Lim, EJ; Lu, TX; Blanchard, C; Rothenberg, ME				Lim, Eun Jin; Lu, Thomas X.; Blanchard, Carine; Rothenberg, Marc E.			Epigenetic Regulation of the IL-13-induced Human Eotaxin-3 Gene by CREB-binding Protein-mediated Histone 3 Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CC-CHEMOKINE; EPITHELIAL-CELLS; ACETYLTRANSFERASE ACTIVITY; EOSINOPHILIC ESOPHAGITIS; EXPRESSION; CBP; INTERLEUKIN-13; INFLAMMATION; TRANSCRIPTION; ASTHMA	The etiology of a variety of chronic inflammatory disorders has been attributed to the interaction of genetic and environmental factors. Herein, we identified a link between epigenetic regulation and IL-13-driven eotaxin-3 in the pathogenesis of chronic allergic inflammation. We first demonstrated that the cAMP-responsive element (CRE) site in the eotaxin-3 promoter affects IL-13-induced eotaxin-3 promoter activity. Furthermore, the CRE-binding protein-binding protein (CBP), a histone acetyltransferase, induced base-line and IL-13-induced eotaxin-3 promoter activity. Additionally, IL-13 treatment promoted global histone 3 acetylation as well as the formation of a complex containing CBP and STAT6 and the subsequent acetylation of histone 3 at the eotaxin-3 promoter. CBP gene silencing decreased IL-13-induced transcription of eotaxin-3. Conversely, inhibition of histone deacetylation increased IL-13-induced eotaxin-3 production. Clinical studies demonstrated markedly increased global acetylation of histone 3 in the inflamed tissue of patients with allergic inflammation. Collectively, these results identify an epigenetic mechanism involving CBP and chromatin remodeling in regulating IL-13-induced chemokine transcription.	[Lim, Eun Jin; Lu, Thomas X.; Blanchard, Carine; Rothenberg, Marc E.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Allergy & Immunol,Dept Pediat, Cincinnati, OH 45229 USA; [Lu, Thomas X.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Grad Program Mol & Dev Biol, Cincinnati, OH 45229 USA; [Lu, Thomas X.] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Phys Scientist Training Program, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Rothenberg, ME (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp, Div Allergy & Immunol,Dept Pediat, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	Rothenberg@cchmc.org		Lu, Thomas/0000-0001-9712-180X	National Institutes of Health [RO1 DK76893, U19 A1070235]; Food Allergy Project, Food and Anaphylaxis Network; Campaign Urging Research; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food Allergy Project, Food and Anaphylaxis Network; Campaign Urging Research; Buckeye Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK76893 and U19 A1070235. This work was also supported by the Food Allergy Project, Food and Anaphylaxis Network Grant, the Campaign Urging Research for Eosinophilic Disorders, and the Buckeye Foundation. M. E. R. has an equity interest in reslizumab,a drug being developed by Cephalon, Inc.	Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; ARANY Z, 1995, NATURE, V374, P81, DOI 10.1038/374081a0; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Barnes Peter J, 2009, Proc Am Thorac Soc, V6, P693, DOI 10.1513/pats.200907-071DP; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2005, CLIN EXP ALLERGY, V35, P1096, DOI 10.1111/j.1365-2222.2005.02299.x; Blanchard C, 2005, INT J BIOCHEM CELL B, V37, P2559, DOI 10.1016/j.biocel.2005.06.010; Blanchard Carine, 2008, Gastrointest Endosc Clin N Am, V18, P133, DOI 10.1016/j.giec.2007.09.016; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; Blanchard C, 2006, J ALLERGY CLIN IMMUN, V118, P1054, DOI 10.1016/j.jaci.2006.07.038; Chan EM, 2007, EXP HEMATOL, V35, P1782, DOI 10.1016/j.exphem.2007.07.015; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Foster PS, 2002, PHARMACOL THERAPEUT, V94, P253, DOI 10.1016/S0163-7258(02)00220-6; Fukasawa M, 2004, CLIN CANCER RES, V10, P3327, DOI 10.1158/1078-0432.CCR-03-0820; Furuta GT, 1997, GASTROENTEROLOGY, V113, P1560, DOI 10.1053/gast.1997.v113.pm9352858; Gingras S, 1999, NUCLEIC ACIDS RES, V27, P2722, DOI 10.1093/nar/27.13.2722; Goodman RH, 2000, GENE DEV, V14, P1553; Grausenburger R, 2010, J IMMUNOL, V185, P3489, DOI 10.4049/jimmunol.0903610; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Han S, 2007, IMMUNOL LETT, V108, P143, DOI 10.1016/j.imlet.2006.12.001; Ho SM, 2010, J ALLERGY CLIN IMMUN, V126, P453, DOI 10.1016/j.jaci.2010.07.030; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Ito K, 2007, PHARMACOL THERAPEUT, V116, P249, DOI 10.1016/j.pharmthera.2007.06.009; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karamouzis MV, 2007, CELL RES, V17, P324, DOI 10.1038/cr.2007.10; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kitaura M, 1999, J BIOL CHEM, V274, P27975, DOI 10.1074/jbc.274.39.27975; Konikoff MR, 2006, GASTROENTEROLOGY, V131, P1381, DOI 10.1053/j.gastro.2006.08.033; Kumar RK, 2009, DIS MODEL MECH, V2, P549, DOI 10.1242/dmm.001719; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Lim EJ, 2007, GENE, V386, P183, DOI 10.1016/j.gene.2006.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marmorstein R, 2001, CURR OPIN GENET DEV, V11, P155, DOI 10.1016/S0959-437X(00)00173-8; McDonald C, 1999, J INTERF CYTOK RES, V19, P711, DOI 10.1089/107999099313550; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Pearce EL, 2006, IMMUNOL REV, V211, P197, DOI 10.1111/j.0105-2896.2006.00399.x; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Reid JL, 1998, EMBO J, V17, P4469, DOI 10.1093/emboj/17.15.4469; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Rosato RR, 2003, CANCER BIOL THER, V2, P30; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; ROTHENBERG ME, 2004, CLIN IMMUNOL, V113, P29; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; Shinkai A, 1999, J IMMUNOL, V163, P1602; Su RC, 2008, J ALLERGY CLIN IMMUN, V121, P57, DOI 10.1016/j.jaci.2007.09.004; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; WALTON KM, 1990, MOL NEUROBIOL, V4, P197, DOI 10.1007/BF02780341; Wierda RJ, 2010, J CELL MOL MED, V14, P1225, DOI 10.1111/j.1582-4934.2010.01022.x; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang M, 2003, J ALLERGY CLIN IMMUN, V112, P935, DOI 10.1016/j.jaci.2003.08.010; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	65	33	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13193	13204		10.1074/jbc.M110.210724	http://dx.doi.org/10.1074/jbc.M110.210724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325281	Green Published			2022-12-25	WOS:000289282200040
J	Wu, XH; Chen, S; Orlando, SA; Yuan, J; Kim, ET; Munugalavadla, V; Mali, RS; Kapur, R; Yang, FC				Wu, Xiaohua; Chen, Shi; Orlando, Selina A.; Yuan, Jin; Kim, Edward T.; Munugalavadla, Veerendra; Mali, Raghuveer S.; Kapur, Reuben; Yang, Feng-Chun			p85 alpha Regulates Osteoblast Differentiation by Cross-talking with the MAPK Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; NEGATIVE REGULATION; SIGNALING PROMOTES; SUBUNIT P85-ALPHA; IN-VITRO; INHIBITION	Class IA phosphoinositide 3-kinase (PI3K) is involved in regulating many cellular functions including cell growth, proliferation, cell survival, and differentiation. The p85 regulatory subunit is a critical component of the PI3K signaling pathway. Mesenchymal stem cells (MSC) are multipotent cells that can be differentiated into osteoblasts (OBs), adipocytes, and chondrocytes under defined culture conditions. To determine whether p85 alpha subunit of PI3K affects biological functions of MSCs, bone marrow-derived wild type (WT) and p85 alpha-deficient (p85 alpha(-/-)) cells were employed in this study. Increased cell growth, higher proliferation rate and reduced number of senescent cells were observed in MSCs lacking p85 alpha compare with WT MSCs as evaluated by CFLT-F assay, thymidine incorporation assay, and beta-galactosidase staining, respectively. These functional changes are associated with the increased cell cycle, increased expression of cyclin cyclin E, and reduced expression of p16 and p19 in p85 alpha(-/-) MSCs. In addition, a time-dependent reduction in alkaline phosphatase (ALP) activity and osteocalcin mRNA expression was observed in p85 alpha(-/-) MSCs compared with WT MSCs, suggesting impaired osteoblast differentiation due to p85 alpha deficiency in MSCs. The impaired p85 alpha(-/-) osteoblast differentiation was associated with increased activation of Akt and MAPK. Importantly, bone morphogenic protein 2 (BMP2) was able to intensify the differentiation of osteoblasts derived from WT MSCs, whereas this process was significantly impaired as a result of p85 alpha deficiency. Addition of LY294002, a PI3K inhibitor, did not alter the differentiation of osteoblasts in either genotype. However, application of PD98059, a Mek/MAPK inhibitor, significantly enhanced osteoblast differentiation in WT and p85 alpha(-/-) MSCs. These results suggest that p85 alpha plays an essential role in osteoblast differentiation from MSCs by repressing the activation of MAP K pathway.	[Yang, Feng-Chun] Indiana Univ Sch Med, Canc Res Inst, Dept Pediat, Indianapolis, IN 46202 USA; [Wu, Xiaohua; Chen, Shi; Orlando, Selina A.; Yuan, Jin; Kim, Edward T.; Munugalavadla, Veerendra; Kapur, Reuben; Yang, Feng-Chun] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Kapur, Reuben] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Yang, Feng-Chun] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Yang, FC (corresponding author), Indiana Univ Sch Med, Canc Res Inst, Dept Pediat, 1044 W Walnut St,R4-427, Indianapolis, IN 46202 USA.	fyang@iupui.edu			National Institutes of Health [R01 HL075816, R01 HL077177]; Department of Defense (DOD) [NF043032, DOD073112]; March of Dimes [MOD 6-FY08-246]; Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075816, R01HL077177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DOD)(United States Department of Defense); March of Dimes(March of Dimes); Fanconi Anemia Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL075816 (to R. K.) and R01 HL077177 (to R. K.), and grants from the Department of Defense (DOD) NF043032 (to F.-C. Y.), DOD073112 (to F.-C. Y.), March of Dimes (MOD 6-FY08-246, to F.-C. Y.), and Fanconi Anemia Research Fund (to F.-C. Y.).	Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Boiret N, 2005, EXP HEMATOL, V33, P219, DOI 10.1016/j.exphem.2004.11.001; Brandstrom H, 2001, BIOCHEM BIOPH RES CO, V280, P831, DOI 10.1006/bbrc.2000.4223; Butt AJ, 2008, ADV EXP MED BIOL, V630, P189; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chackalaparampil I, 1996, ONCOGENE, V12, P1457; Chen QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015288; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Giuliani N, 2001, BLOOD, V98, P3527, DOI 10.1182/blood.V98.13.3527; Golden LH, 2004, BONE, V34, P3, DOI 10.1016/j.bone.2003.09.005; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Hamidouche Z, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-44; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hay E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008284; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Lee JH, 2010, BONE, V46, P1522, DOI 10.1016/j.bone.2010.02.013; Ling L, 2010, J BIOL CHEM, V285, P26233, DOI 10.1074/jbc.M110.122069; Luo J, 2005, CELL CYCLE, V4, P1309, DOI 10.4161/cc.4.10.2062; Mannova P, 2005, J VIROL, V79, P8742, DOI 10.1128/JVI.79.14.8742-8749.2005; Martin SK, 2010, J BONE MINER RES, V25, P2126, DOI 10.1002/jbmr.114; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Munugalavadla V, 2008, MOL CELL BIOL, V28, P7182, DOI 10.1128/MCB.00920-08; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; OWEN M, 1988, CIBA F SYMP, V136, P42; Payne KA, 2010, TISSUE ENG PT A, V16, P3647, DOI 10.1089/ten.TEA.2009.0738; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rifas L, 2007, J CELL BIOCHEM, V100, P824, DOI 10.1002/jcb.21132; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Taniguchi CM, 2010, CANCER RES, V70, P5305, DOI 10.1158/0008-5472.CAN-09-3399; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Ueki K, 2002, MOL CELL BIOL, V22, P965, DOI 10.1128/MCB.22.3.965-977.2002; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Windahl SH, 1999, J CLIN INVEST, V104, P895, DOI 10.1172/JCI6730; Wu M, 2006, ONCOGENE, V25, P2297, DOI 10.1038/sj.onc.1209264; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	59	19	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13512	13521		10.1074/jbc.M110.187351	http://dx.doi.org/10.1074/jbc.M110.187351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324896	Green Published, hybrid			2022-12-25	WOS:000289282200071
J	Abou-Jaoude, W; Chaves, M; Gouze, JL				Abou-Jaoude, Wassim; Chaves, Madalena; Gouze, Jean-Luc			A Theoretical Exploration of Birhythmicity in the p53-Mdm2 Network	PLOS ONE			English	Article							GENETIC REGULATORY NETWORKS; PIECEWISE-LINEAR MODELS; QUALITATIVE SIMULATION; ESCHERICHIA-COLI; FEEDBACK LOOP; P53; MDM2; OSCILLATIONS; DYNAMICS; SYSTEMS	Experimental observations performed in the p53-Mdm2 network, one of the key protein modules involved in the control of proliferation of abnormal cells in mammals, revealed the existence of two frequencies of oscillations of p53 and Mdm2 in irradiated cells depending on the irradiation dose. These observations raised the question of the existence of birhythmicity, i.e. the coexistence of two oscillatory regimes for the same external conditions, in the p53-Mdm2 network which would be at the origin of these two distinct frequencies. A theoretical answer has been recently suggested by Ouattara, Abou-Jaoude and Kaufman who proposed a 3-dimensional differential model showing birhythmicity to reproduce the two frequencies experimentally observed. The aim of this work is to analyze the mechanisms at the origin of the birhythmic behavior through a theoretical analysis of this differential model. To do so, we reduced this model, in a first step, into a 3-dimensional piecewise linear differential model where the Hill functions have been approximated by step functions, and, in a second step, into a 2-dimensional piecewise linear differential model by setting one autonomous variable as a constant in each domain of the phase space. We find that two features related to the phase space structure of the system are at the origin of the birhythmic behavior: the existence of two embedded cycles in the transition graph of the reduced models; the presence of a bypass in the orbit of the large amplitude oscillatory regime of low frequency. Based on this analysis, an experimental strategy is proposed to test the existence of birhythmicity in the p53-Mdm2 network. From a methodological point of view, this approach greatly facilitates the computational analysis of complex oscillatory behavior and could represent a valuable tool to explore mathematical models of biological rhythms showing sufficiently steep nonlinearities.	[Abou-Jaoude, Wassim; Chaves, Madalena; Gouze, Jean-Luc] INRIA Sophia Antipolis, COMORE Project Team, Sophia Antipolis, France		Abou-Jaoude, W (corresponding author), INRIA Sophia Antipolis, COMORE Project Team, Sophia Antipolis, France.	wabou@sophia.inria.fr	Chaves, Madalena/D-1182-2014	Chaves, Madalena/0000-0003-0647-9254; Gouze, Jean-Luc/0000-0001-7156-7934	INRIA-INSERM initiative action ColAge; INRIA	INRIA-INSERM initiative action ColAge; INRIA	This work was supported in part by the INRIA-INSERM initiative action ColAge. The authors thank INRIA for funding the post-doctoral stay of WAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abou-Jaoude W, 2009, J THEOR BIOL, V258, P561, DOI 10.1016/j.jtbi.2009.02.005; ALAMGIR M, 1983, J AM CHEM SOC, V105, P2500, DOI 10.1021/ja00346a080; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Casey R, 2006, J MATH BIOL, V52, P27, DOI 10.1007/s00285-005-0338-2; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; Ciliberto A, 2005, CELL CYCLE, V4, P488, DOI 10.4161/cc.4.3.1548; CITRI O, 1988, J PHYS CHEM-US, V92, P1865, DOI 10.1021/j100318a034; Dayarian A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000256; De Jong H, 2004, B MATH BIOL, V66, P301, DOI 10.1016/j.bulm.2003.08.010; DECROLY O, 1982, P NATL ACAD SCI-BIOL, V79, P6917, DOI 10.1073/pnas.79.22.6917; Edwards R, 2000, PHYSICA D, V146, P165, DOI 10.1016/S0167-2789(00)00130-5; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GLASS L, 1978, J MATH BIOL, V6, P207, DOI 10.1007/BF02547797; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GLASS L, 1975, J THEOR BIOL, V54, P85, DOI 10.1016/S0022-5193(75)80056-7; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Hirsch MW, 1988, NONLINEARITY, V1, P51, DOI 10.1088/0951-7715/1/1/003; Hirsch MW, 2003, LECT NOTES CONTROL I, V294; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Inoue T, 2001, J BIOL CHEM, V276, P45255, DOI 10.1074/jbc.M107477200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; Omholt SW, 1998, J THEOR BIOL, V195, P339, DOI 10.1006/jtbi.1998.0800; Ouattara DA, 2010, J THEOR BIOL, V264, P1177, DOI 10.1016/j.jtbi.2010.03.031; Ropers D, 2006, BIOSYSTEMS, V84, P124, DOI 10.1016/j.biosystems.2005.10.005; Snoussi E, 1989, DYNAMICS STABILITY S, V4, P189; Stommel JM, 2005, CELL CYCLE, V4, P411, DOI 10.4161/cc.4.3.1522; Strogatz H, 1994, NONLINEAR DYNAMICS C, P498; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; ZHU HR, 1994, J DIFFER EQUATIONS, V110, P143, DOI 10.1006/jdeq.1994.1063	42	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17075	10.1371/journal.pone.0017075	http://dx.doi.org/10.1371/journal.pone.0017075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340030	Green Submitted, Green Published, gold			2022-12-25	WOS:000287367600034
J	Zhang, FL; Shi, YP; Wang, LL; Sriram, S				Zhang, Fanglin; Shi, Yaping; Wang, Lily; Sriram, Subramaniam			Role of HDAC3 on p53 Expression and Apoptosis in T Cells of Patients with Multiple Sclerosis	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MEDICAL PROGRESS; CYCLE ARREST; TRICHOSTATIN; ACETYLATION; DISCOVERY; PATHWAY	Background: Histone deacetylase 3 (HDAC3) belongs to a family of proteins which plays an important role in protein acetylation, chromatin remodeling and transcription of genes, including those that are involved in cell proliferation and cell death. While increased expression of HDAC3 is seen in neoplastic cells, the role of HDAC3 in T cells and their role in autoimmune disease is not known. Methodology/Principal Findings: Applying Affymetrix GeneChip Human Gene 1.0 ST Array and the mixed effects model for gene set analysis, we compared gene expression profiles between multiple sclerosis (MS) patients and healthy controls (HC). Within the Apoptosis_GO gene set, the constitutive expression level of HDAC3 in peripheral blood mononuclear cell (PBMC) was significantly increased in MS patients when compared to controls. Following addition of trichostatin A (TSA), an inhibitor of HDAC3, we examined the expression of p53 by flow cytometry and p53 targeted genes by real time RT-PCR in MS and HC. Culture of PBMC with TSA resulted in increased expression of p53 in HC but not in MS patients. TSA treated T cells from MS patients also showed reduced sensitivity to apoptosis when compared to HC, which was independent of activation of p53 targeted pro-apoptotic genes. Conclusion/Significance: MS patients, when compared to controls, show an increased expression of HDAC3 and relative resistance to TSA induced apoptosis in T cells. Increased expression of HDAC3 in PBMC of MS patients may render putative autoreactive lymphocytes resistance to apoptosis and thereby contribute to autoimmunity.	[Zhang, Fanglin; Sriram, Subramaniam] Vanderbilt Univ Sch Med, Multiple Sclerosis Res Ctr, Dept Neurol, Nashville, TN 37203 USA; [Shi, Yaping; Wang, Lily] Vanderbilt Univ Sch Med, Dept Biostat, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Zhang, FL (corresponding author), Vanderbilt Univ Sch Med, Multiple Sclerosis Res Ctr, Dept Neurol, Nashville, TN 37203 USA.	Subramaniam.sriram@vanderbilt.edu	Zhang, Fang/HHN-2153-2022		National Multiple Sclerosis Society	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	National Multiple Sclerosis Society. The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFONSO PV, BLOOD; ALAMDARI N, AM J PHYSL REGUL INT, V299, pR509; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BIRAN A, INT J CANC; Brandl A, 2009, BIOL CELL, V101, P193, DOI 10.1042/BC20080158; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Cecconi D, 2009, PROTEOMICS, V9, P1952, DOI 10.1002/pmic.200701089; CHEN S, P NATL ACAD SCI US, V107, P11032; Chen XF, 2009, CANCER BIOTHER RADIO, V24, P689, DOI 10.1089/cbr.2009.0629; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Deng XQ, 2005, ANN NEUROL, V58, P577, DOI 10.1002/ana.20600; Di Gennaro E, 2009, CANCER BIOL THER, V8, P782, DOI 10.4161/cbt.8.9.8118; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Horiuchi M, 2009, J RHEUMATOL, V36, P1580, DOI 10.3899/jrheum.081115; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh Y, 2008, CURR PHARM DESIGN, V14, P529; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee EJ, 2008, INT J ONCOL, V33, P767, DOI 10.3892/ijo_00000063; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; MINAMIYA Y, TUMOUR BIOL; MORENO DA, 2003, BR J HAEMATOL; Munro KM, 2009, NEUROSIGNALS, V17, P311, DOI 10.1159/000231897; Murphy ME, 2004, CELL CYCLE, V3, P836; Noh EL, 2009, BIOCHEM BIOPH RES CO, V378, P326, DOI 10.1016/j.bbrc.2008.11.057; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Park H, 2008, INT J MOL MED, V22, P605, DOI 10.3892/ijmm_00000062; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Satoh J, 2007, NEUROSCI LETT, V422, P30, DOI 10.1016/j.neulet.2007.05.056; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Spurling CC, 2008, MOL CARCINOGEN, V47, P137, DOI 10.1002/mc.20373; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; Sykes SM, 2009, J BIOL CHEM, V284, P20197, DOI 10.1074/jbc.M109.026096; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000115; Wang L, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1484; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Zhang FL, 2009, IMMUNOLOGY, V128, pe905, DOI 10.1111/j.1365-2567.2009.03104.x; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; Zivadinov R, 2009, J NEUROIMMUNOL, V209, P123, DOI 10.1016/j.jneuroim.2009.01.023	54	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16795	10.1371/journal.pone.0016795	http://dx.doi.org/10.1371/journal.pone.0016795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346816	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600028
J	Wang, WL; Hong, JR; Lin, GH; Liu, WT; Gong, HY; Lu, MW; Lin, CC; Wu, JL				Wang, Wei-Lun; Hong, Jiann-Ruey; Lin, Gen-Hwa; Liu, Wangta; Gong, Hong-Yi; Lu, Ming-Wei; Lin, Ching-Chun; Wu, Jen-Leih			Stage-Specific Expression of TNF alpha Regulates Bad/Bid-Mediated Apoptosis and RIP1/ROS-Mediated Secondary Necrosis in Birnavirus-Infected Fish Cells	PLOS ONE			English	Article							VIRUS INDUCES APOPTOSIS; NF-KAPPA-B; GENE-EXPRESSION; IN-VITRO; DEATH; PROTEIN; KINASE; ACTIVATION; IDENTIFICATION; POLYPROTEIN	Infectious pancreatic necrosis virus (IPNV) can induce Bad-mediated apoptosis followed by secondary necrosis in fish cells, but it is not known how these two types of cell death are regulated by IPNV. We found that IPNV infection can regulate Bad/Bid-mediated apoptotic and Rip1/ROS-mediated necrotic death pathways via the up-regulation of TNF alpha in zebrafish ZF4 cells. Using a DNA microarray and quantitative RT-PCR analyses, two major subsets of differentially expressed genes were characterized, including the innate immune response gene TNF alpha and the pro-apoptotic genes Bad and Bid. In the early replication stage (0-6 h post-infection, or p.i.), we observed that the pro-inflammatory cytokine TNF alpha underwent a rapid sixfold induction. Then, during the early-middle replication stages (6-12 h p.i.), TNF alpha level was eight-fold induction and the pro-apoptotic Bcl-2 family members Bad and Bid were up-regulated. Furthermore, specific inhibitors of TNF alpha expression (AG-126 or TNF alpha-specific siRNA) were used to block apoptotic and necrotic death signaling during the early or early-middle stages of IPNV infection. Inhibition of TNF alpha expression dramatically reduced the Bad/Bid-mediated apoptotic and Rip1/ROS-mediated necrotic cell death pathways and rescued host cell viability. Moreover, we used Rip1-specific inhibitors (Nec-1 and Rip1-specific siRNA) to block Rip1 expression. The Rip1/ROS-mediated secondary necrotic pathway appeared to be reduced in IPNV-infected fish cells during the middle-late stage of infection (12-18 h p.i.). Taken together, our results indicate that IPNV triggers two death pathways via up-stream induction of the pro-inflammatory cytokine TNF alpha, and these results may provide new insights into the pathogenesis of RNA viruses.	[Wang, Wei-Lun; Wu, Jen-Leih] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Wang, Wei-Lun; Lin, Gen-Hwa; Liu, Wangta; Lin, Ching-Chun; Wu, Jen-Leih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Hong, Jiann-Ruey] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Gong, Hong-Yi; Lu, Ming-Wei] Natl Taiwan Ocean Univ, Dept Aquaculture, Chilung, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan Ocean University	Wang, WL (corresponding author), Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan.	jlwu@gate.sinica.edu.tw	Gong, Hong-Yi/ABE-2571-2020	Gong, Hong-Yi/0000-0002-6240-0582	National Science Council, Taiwan, Republic of China [NSC95-2313-B-001-004, NSC96-2313-B-001-001]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was funded by grants (NSC95-2313-B-001-004, NSC96-2313-B-001-001) awarded to Dr. Jen-Leih Wu from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict CA, 2003, CYTOKINE GROWTH F R, V14, P349, DOI 10.1016/S1359-6101(03)00030-3; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Chen PC, 2010, FISH SHELLFISH IMMUN, V28, P344, DOI 10.1016/j.fsi.2009.11.014; Chiu CL, 2010, APOPTOSIS, V15, P653, DOI 10.1007/s10495-010-0468-x; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; DOBOS P, 1977, J VIROL, V21, P242, DOI 10.1128/JVI.21.1.242-258.1977; DOBOS P, 1979, J VIROL, V32, P593, DOI 10.1128/JVI.32.2.593-605.1979; DUNCAN R, 1987, J VIROL, V61, P3655, DOI 10.1128/JVI.61.12.3655-3664.1987; DUNCAN R, 1991, VIROLOGY, V181, P541, DOI 10.1016/0042-6822(91)90887-H; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; HERMAN B, 1988, FASEB J, V2, P146, DOI 10.1096/fasebj.2.2.3342967; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hong JR, 2008, J FISH DIS, V31, P451, DOI 10.1111/j.1365-2761.2008.00928.x; Hong JR, 2005, J FISH DIS, V28, P133, DOI 10.1111/j.1365-2761.2004.00604.x; Hong JR, 1998, VIROLOGY, V250, P76, DOI 10.1006/viro.1998.9347; Hong JR, 2002, CELL DEATH DIFFER, V9, P113, DOI 10.1038/sj/cdd/4400933; Hong JR, 2002, VIROLOGY, V295, P217, DOI 10.1006/viro.2001.1336; Hong JR, 1999, J VIROL, V73, P5056, DOI 10.1128/JVI.73.6.5056-5063.1999; Hong JR, 1999, VIRUS RES, V63, P75, DOI 10.1016/S0168-1702(99)00060-X; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; JEURISSEN SHM, 1992, J VIROL, V66, P7383, DOI 10.1128/JVI.66.12.7383-7388.1992; KAIN SR, 1994, BIOTECHNIQUES, V17, P982; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; LaPatra SE, 2000, BLOOD CELL MOL DIS, V26, P445, DOI 10.1006/bcmd.2000.0320; Lee SB, 2006, J BIOL CHEM, V281, P36228, DOI 10.1074/jbc.M606702200; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; MAGYAR G, 1994, VIROLOGY, V204, P580, DOI 10.1006/viro.1994.1572; MAJNO G, 1995, AM J PATHOL, V146, P3; MEURER R, 1989, BIOCHEM BIOPH RES CO, V159, P763, DOI 10.1016/0006-291X(89)90060-0; Morgan MJ, 2008, CELL RES, V18, P343, DOI 10.1038/cr.2008.31; NICHOLSON BL, 1974, J VIROL, V14, P180, DOI 10.1128/JVI.14.1.180-182.1974; Rahman Masmudur M, 2006, PLoS Pathog, V2, pe4; Santi N, 2005, VIROLOGY, V342, P13, DOI 10.1016/j.virol.2005.07.028; Sato A, 2008, GENOMICS, V92, P9, DOI 10.1016/j.ygeno.2008.02.002; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Shakibaei M, 2005, ANTIOXID REDOX SIGN, V7, P482, DOI 10.1089/ars.2005.7.482; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Vanden Berghe T, 2007, MOL CELL, V26, P769, DOI 10.1016/j.molcel.2007.06.002; Vandenabeele P, 2008, TRENDS BIOCHEM SCI, V33, P352, DOI 10.1016/j.tibs.2008.05.007; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zheng LX, 2006, MOL CELL BIOL, V26, P3505, DOI 10.1128/MCB.26.9.3505-3513.2006	50	48	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16740	10.1371/journal.pone.0016740	http://dx.doi.org/10.1371/journal.pone.0016740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304825	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036600020
J	Kimura, J; Ichii, O; Otsuka, S; Kanazawa, T; Namiki, Y; Hashimoto, Y; Kon, Y				Kimura, Junpei; Ichii, Osamu; Otsuka, Saori; Kanazawa, Tomonori; Namiki, Yuka; Hashimoto, Yoshiharu; Kon, Yasuhiro			Quantitative and Qualitative Urinary Cellular Patterns Correlate with Progression of Murine Glomerulonephritis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TUBULAR EPITHELIAL-CELLS; PODOCYTE-ASSOCIATED MOLECULES; CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; GLOMERULAR-DISEASES; TELOMERIC REGION; IGA NEPHROPATHY; INJURY; COMPLEMENT	The kidney is a nonregenerative organ composed of numerous functional nephrons and collecting ducts (CDs). Glomerular and tubulointerstitial damages decrease the number of functional nephrons and cause anatomical and physiological alterations resulting in renal dysfunction. It has recently been reported that nephron constituent cells are dropped into the urine in several pathological conditions associated with renal functional deterioration. We investigated the quantitative and qualitative urinary cellular patterns in a murine glomerulonephritis model and elucidated the correlation between cellular patterns and renal pathology. Urinary cytology and renal histopathology were analyzed in BXSB/MpJ (BXSB; glomerulonephritis model) and C57BL/6 (B6; control) mice. Urinary cytology revealed that the number of urinary cells in BXSB mice changed according to the histometric score of glomerulonephritis and urinary albumin; however, no correlation was detected for the levels of blood urea nitrogen and creatinine. The expression of specific markers for podocytes, distal tubules (DTs), and CDs was detected in BXSB urine. Cells immunopositive for Wilms tumor 1 (podocyte marker) and interleukin-1 family, member 6 (damaged DT and CD marker) in the kidney significantly decreased and increased in BXSB versus B6, respectively. In the PCR array analysis of inflammatory cytokines and chemokines, Il10, Cxcl2, C3, and Il1rn showed relatively higher expression in BXSB kidneys than in B6 kidneys. In particular, the highest expression of C3 mRNA was detected in the urine from BXSB mice. Furthermore, C3 protein and mRNA were localized in the epithelia of damaged nephrons. These findings suggest that epithelial cells of the glomerulus, DT, and CD are dropped into the urine, and that these patterns are associated with renal pathology progression. We conclude that evaluation of urinary cellular patterns plays a key role in the early, noninvasive diagnosis of renal disease.	[Kimura, Junpei; Ichii, Osamu; Otsuka, Saori; Kanazawa, Tomonori; Kon, Yasuhiro] Hokkaido Univ, Anat Lab, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Namiki, Yuka; Hashimoto, Yoshiharu] Hokkaido Univ, Off Fac Dev & Teaching Enriched Vet Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kimura, J (corresponding author), Hokkaido Univ, Anat Lab, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	y-kon@vetmed.hokudai.ac.jp	kimura, junpei/GXM-5106-2022; Kon, Yasuhiro/F-8525-2012; Otsuka, Saori/F-8531-2012	Kon, Yasuhiro/0000-0002-8859-6122	Kuribayashi Foundation [21-1]; Hokkaido University; Japanese Association of Veterinary Anatomists in Obihiro [2010.9.16-18];  [21880002]	Kuribayashi Foundation; Hokkaido University; Japanese Association of Veterinary Anatomists in Obihiro; 	This work was supported by grants from Grant-in-Aid for Young Scientists (Start-Up, no. 21880002), the Kuribayashi Foundation (no. 21-1), and open-type research projects in Hokkaido University (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was chosen for the Encouragement Award (Undergraduate section) at the 150th Japanese Association of Veterinary Anatomists in Obihiro (2010.9.16-18). We sincerely thank all individuals involved in this study.	Abe K, 2004, CLIN EXP IMMUNOL, V136, P60, DOI 10.1111/j.1365-2249.2004.02411.x; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Barksby HE, 2007, CLIN EXP IMMUNOL, V149, P217, DOI 10.1111/j.1365-2249.2007.03441.x; BROOIMANS RA, 1991, J CLIN INVEST, V88, P379, DOI 10.1172/JCI115314; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Dalla Vestra M, 2003, DIABETES, V52, P1031, DOI 10.2337/diabetes.52.4.1031; David S, 1997, NEPHROL DIAL TRANSPL, V12, P51, DOI 10.1093/ndt/12.1.51; FINCO DR, 1976, J AM VET MED ASSOC, V168, P593; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Hara M, 1998, AM J NEPHROL, V18, P35, DOI 10.1159/000013302; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; Hara M, 2007, CLIN J AM SOC NEPHRO, V2, P231, DOI 10.2215/CJN.01470506; Ichii O, 2009, LUPUS, V18, P491, DOI 10.1177/0961203308098989; Ichii O, 2008, HISTOL HISTOPATHOL, V23, P411, DOI 10.14670/HH-23.411; Ichii O, 2010, LAB INVEST, V90, P459, DOI 10.1038/labinvest.2009.148; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kovesdy CP, 2009, NEPHROLOGY, V14, P408, DOI 10.1111/j.1440-1797.2009.01119.x; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Nakai S, 2008, THER APHER DIAL, V12, P428, DOI 10.1111/j.1744-9987.2008.00634.x; Nakamura T, 2000, NEPHROL DIAL TRANSPL, V15, P1379, DOI 10.1093/ndt/15.9.1379; Nakatsue T, 2005, KIDNEY INT, V67, P2239, DOI 10.1111/j.1523-1755.2005.00328.x; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Reiser J, 2002, NEPHROL DIAL TRANSPL, V17, P951, DOI 10.1093/ndt/17.6.951; RYAN GB, 1975, KIDNEY INT, V8, P219, DOI 10.1038/ki.1975.105; Sacks SH, 1996, J AM SOC NEPHROL, V7, P2314; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schocklmann HO, 1999, KIDNEY INT, V56, P1199, DOI 10.1046/j.1523-1755.1999.00710.x; Sheerin NS, 2008, FASEB J, V22, P1065, DOI 10.1096/fj.07-8719com; Skoberne A, 2009, AM J PHYSIOL-RENAL, V296, pF230, DOI 10.1152/ajprenal.90507.2008; Szeto CC, 2005, CLIN CHIM ACTA, V361, P182, DOI 10.1016/j.cccn.2005.05.016; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; UEKI A, 1987, IMMUNOLOGY, V61, P11; Wang G, 2008, EUR J ENDOCRINOL, V158, P317, DOI 10.1530/EJE-07-0708; Wang G, 2007, J RHEUMATOL, V34, P2358; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; White KE, 2002, DIABETES, V51, P3083, DOI 10.2337/diabetes.51.10.3083; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222	44	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16472	10.1371/journal.pone.0016472	http://dx.doi.org/10.1371/journal.pone.0016472			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304992	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300068
J	Liu, XC; Lin, ZR; Zhou, T; Zong, RR; He, H; Liu, Z; Ma, JX; Liu, ZG; Zhou, YP				Liu, Xiaochen; Lin, Zhirong; Zhou, Tong; Zong, Ronrong; He, Hui; Liu, Zhen; Ma, Jian-xing; Liu, Zuguo; Zhou, Yueping			Anti-Angiogenic and Anti-Inflammatory Effects of SERPINA3K on Corneal Injury	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; KALLIKREIN-BINDING PROTEIN; ENDOTHELIAL GROWTH-FACTOR; RETINAL NEOVASCULARIZATION; DIABETIC-NEPHROPATHY; VEGF; INHIBITOR; RECEPTOR; EYE; PURIFICATION	SERPINA3K is a member of the serine proteinase inhibitor ( SERPIN) family. Here we evaluated the therapeutic effects of SERPINA3K on neovascularization and inflammation in a rat cornea alkali burn model that is commonly employed to study corneal wounding. Topical treatment of the injured rat cornea with SERPINA3K ( 20 mu g/eye/day) for 7 days significantly decreased the neovascular area, compared with the groups treated with BSA or PBS. The SERPINA3K treatment also ameliorated the corneal inflammation as evaluated by the inflammatory index. Furthermore, SERPINA3K enhanced the recovery of corneal epithelium after the alkali injury. Toward the mechanism of action, SERPINA3K down-regulated the expression of the pro-angiogenic and pro-inflammatory factors, vascular endothelial growth factor and tumor necrosis factor-alpha and up-regulated the expression of the anti-angiogenic factor, pigment epithelium-derived factor. SERPINA3K specifically inhibited growth of vascular endothelial cells. Meanwhile, SERPINA3K significantly up-regulated the expression of EGFR in the corneal epithelium. These findings suggest that SERPINA3K has therapeutic potential for corneal inflammation and NV.	[Liu, Xiaochen; Lin, Zhirong; Zhou, Tong; Zong, Ronrong; He, Hui; Liu, Zhen; Liu, Zuguo; Zhou, Yueping] Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Peoples R China; [Ma, Jian-xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA	Xiamen University; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, XC (corresponding author), Xiamen Univ, Inst Eye, Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Peoples R China.	zuguol@yahoo.com; ypzhou@yahoo.com						Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Bressler NM, 2009, OPHTHALMOLOGY, V116, pS15, DOI 10.1016/j.ophtha.2009.06.048; CHAI KX, 1991, J BIOL CHEM, V266, P16029; CHAO J, 1990, J BIOL CHEM, V265, P16394; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fornoni A, 2008, CURR DIABETES REV, V4, P10, DOI 10.2174/157339908783502361; Gao G, 2003, DIABETOLOGIA, V46, P689, DOI 10.1007/s00125-003-1085-9; Gao GQ, 2001, FEBS LETT, V489, P270, DOI 10.1016/S0014-5793(01)02110-X; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Heo SH, 2010, J CELL PHYSIOL, V224, P734, DOI 10.1002/jcp.22175; Horsley MB, 2010, CURR OPIN OPHTHALMOL, V21, P112, DOI 10.1097/ICU.0b013e3283360aad; Jenkins Alicia, 2008, Diabetes Res Clin Pract, V82, pe5, DOI 10.1016/j.diabres.2008.06.019; Khaw PT, 2004, BRIT MED J, V328, P36, DOI 10.1136/bmj.328.7430.36; King GL, 2000, NEW ENGL J MED, V342, P349, DOI 10.1056/NEJM200002033420511; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Laria C, 1997, OPHTHALMIC RES, V29, P145, DOI 10.1159/000268009; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Michalova K, 2008, CURR ALLERGY ASTHM R, V8, P339, DOI 10.1007/s11882-008-0054-2; Miller JW, 1997, AM J PATHOL, V151, P13; Mori K, 2001, J CELL PHYSIOL, V188, P253, DOI 10.1002/jcp.1114; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Spranger J, 2001, DIABETES, V50, P2641, DOI 10.2337/diabetes.50.12.2641; Wang JJ, 2008, AM J PHYSIOL-RENAL, V294, pF1166, DOI 10.1152/ajprenal.00375.2007; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zhang B, 2010, P NATL ACAD SCI USA, V107, P6900, DOI 10.1073/pnas.0906764107; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhang B, 2009, INVEST OPHTH VIS SCI, V50, P3943, DOI 10.1167/iovs.08-2954; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje; Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330; ZHOU GX, 1992, J BIOL CHEM, V267, P25873	35	43	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16712	10.1371/journal.pone.0016712	http://dx.doi.org/10.1371/journal.pone.0016712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304961	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300127
J	Shankar, S; Nall, D; Tang, SN; Meeker, D; Passarini, J; Sharma, J; Srivastava, RK				Shankar, Sharmila; Nall, Dara; Tang, Su-Ni; Meeker, Daniel; Passarini, Jenna; Sharma, Jay; Srivastava, Rakesh K.			Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and Kras(G12D) Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							BREAST-CANCER; DRUG-RESISTANCE; PROSPECTIVE IDENTIFICATION; NONALCOHOLIC COMPOUNDS; MOLECULAR-MECHANISMS; SELF-RENEWAL; CARCINOMA; METASTASIS; NANOG; MARKER	Background: Cancer stem cells (CSCs) can proliferate and self-renew extensively due to their ability to express anti-apoptotic and drug resistant proteins, thus sustaining tumor growth. Therefore, the strategy to eradicate CSCs might have significant clinical implications. The objectives of this study were to examine the molecular mechanisms by which resveratrol inhibits stem cell characteristics of pancreatic CSCs derived from human primary tumors and Kras(G12D) transgenic mice. Methodology/Principal Findings: Human pancreatic CSCs (CD133(+)CD44(+)CD24(+)ESA(+)) are highly tumorigenic and form subcutaneous tumors in NOD/SCID mice. Human pancreatic CSCs expressing high levels of CD133, CD24, CD44, ESA, and aldehyde dehydrogenase also express significantly more Nanog, Oct-4, Notch1, MDR1 and ABCG2 than normal pancreatic tissues and primary pancreatic cancer cells. Similarly, CSCs from Kras(G12D) mice express significantly higher levels of Nanog and Oct-4 than pancreatic tissues from Pdx-Cre mice. Resveratrol inhibits the growth (size and weight) and development (PanIN lesions) of pancreatic cancer in Kras(G12D) mice. Resveratrol inhibits the self-renewal capacity of pancreatic CSCs derived from human primary tumors and Kras(G12D) mice. Resveratrol induces apoptosis by activating capase-3/7 and inhibiting the expression of Bcl-2 and XIAP in human CSCs. Resveratrol inhibits pluripotency maintaining factors (Nanog, Sox-2, c-Myc and Oct-4) and drug resistance gene ABCG2 in CSCs. Inhibition of Nanog by shRNA enhances the inhibitory effects of resveratrol on self-renewal capacity of CSCs. Finally, resveratrol inhibits CSC's migration and invasion and markers of epithelial-mesenchymal transition (Zeb-1, Slug and Snail). Conclusions/Significance: These data suggest that resveratrol inhibits pancreatic cancer stem cell characteristics in human and Kras(G12D) transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. In conclusion, resveratrol can be used for the management of pancreatic cancer.	[Shankar, Sharmila; Nall, Dara] Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA; [Tang, Su-Ni; Meeker, Daniel; Srivastava, Rakesh K.] Univ Kansas, Med Ctr, Ctr Canc, Dept Pharmacol Toxicol & Therapeut & Med, Kansas City, KS 66103 USA; [Passarini, Jenna; Sharma, Jay] Celprogen, San Pedro, CA USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Shankar, S (corresponding author), Univ Kansas, Med Ctr, Ctr Canc, Dept Pathol & Lab Med, Kansas City, KS 66103 USA.	rsrivastava@kumc.edu						Aggarwal BB, 2004, EXPERT OPIN INV DRUG, V13, P1327, DOI 10.1517/13543784.13.10.1327; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Alison MR, 2008, CELL TISSUE RES, V331, P109, DOI 10.1007/s00441-007-0510-7; BATTULA VL, 2010, STEM CELLS; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan C, 2008, INT J ONCOL, V33, P415, DOI 10.3892/ijo_00000023; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Clarke MF, 2008, ADV EXP MED BIOL, V617, P17, DOI 10.1007/978-0-387-69080-3_2; CLAY MR, 2010, HEAD NECK; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Delmas D, 2005, MOL NUTR FOOD RES, V49, P377, DOI 10.1002/mnfr.200400098; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Ding Xian-Zhong, 2002, Pancreas, V25, pe71, DOI 10.1097/00006676-200211000-00024; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Feick P, 2007, PANCREATOLOGY, V7, P124, DOI 10.1159/000104237; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gerloff A, 2010, INT J ENV RES PUB HE, V7, P1093, DOI 10.3390/ijerph7031093; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Harikumar KB, 2010, INT J CANCER, V127, P257, DOI 10.1002/ijc.25041; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoei-Hansen CE, 2004, MOL HUM REPROD, V10, P423, DOI 10.1093/molehr/gah059; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ischenko I, 2010, LANGENBECK ARCH SURG, V395, P1, DOI 10.1007/s00423-009-0502-z; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Kallifatidis G, 2008, GUT; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2009, METHODS MOL BIOL, V568, P161, DOI 10.1007/978-1-59745-280-9_10; LI G, 2010, CLIN EXP METASTASIS; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Lu KH, 2009, CHILD NERV SYST, V25, P543, DOI 10.1007/s00381-009-0826-6; Ma ZH, 2005, WORLD J GASTROENTERO, V11, P3171, DOI 10.3748/wjg.v11.i21.3171; Magee CJ, 2002, BEST PRACT RES CL GA, V16, P435, DOI 10.1053/bega.2002.0317; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; PAPAILIOU J, 2010, INT J COLORECTAL DIS; Pervaiz S, 2004, DRUG RESIST UPDATE, V7, P333, DOI 10.1016/j.drup.2004.11.001; Pfeiffer MJ, 2010, EUR UROL, V57, P246, DOI 10.1016/j.eururo.2009.01.015; RAIMONDI C, 2010, CURR CANC DRUG TARGE; Rasheed Z, 2010, J VIS EXP; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sarkar FH, 2010, CANCER METAST REV, V29, P383, DOI 10.1007/s10555-010-9233-4; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Shankar S, 2008, CLIN CANCER RES, V14, P6855, DOI 10.1158/1078-0432.CCR-08-0903; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4839, DOI 10.2741/2432; Shankar S, 2007, MOL CELL BIOCHEM, V304, P273, DOI 10.1007/s11010-007-9510-x; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; SINGH A, 2010, ONCOGENE; Singh SK, 2003, CANCER RES, V63, P5821; Srivastava RK, 2010, FRONT BIOSC IN PRESS; Sun SY, 2010, BIOCHEM BIOPH RES CO, V396, P843, DOI 10.1016/j.bbrc.2010.04.170; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tang Su-Ni, 2010, J Mol Signal, V5, P14, DOI 10.1186/1750-2187-5-14; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; Wang L, 2010, INT J CANC; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Wendt MK, 2009, FUTURE ONCOL, V5, P1145, DOI 10.2217/FON.09.90; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579	83	210	224	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16530	10.1371/journal.pone.0016530	http://dx.doi.org/10.1371/journal.pone.0016530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304978	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300078
J	Das, A; Xu, HB; Wang, XL; Yau, CL; Veazey, RS; Pahar, B				Das, Arpita; Xu, Huanbin; Wang, Xiaolei; Yau, Canddy L.; Veazey, Ronald S.; Pahar, Bapi			Double-Positive CD21+CD27+B Cells Are Highly Proliferating Memory Cells and Their Distribution Differs in Mucosal and Peripheral Tissues	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; NEONATAL RHESUS MACAQUES; CD4(+)CD8(+) T-CELLS; B-CELLS; HUMORAL IMMUNITY; POLYCLONAL ACTIVATION; HIV-INFECTION; LYMPHOCYTES; EXPRESSION; CD27	Background: Several B-cell defects arise in HIV infected patients, particularly in patients with chronic infection and high viral load. Loss of memory B cells (CD27(+) B cells) in peripheral blood and lymphoid tissues is one of the major B cell dysfunctions in HIV and simian immunodeficiency virus (SIV) infection. Despite several studies, definitive identification of memory B cells based on CD27 surface expression has not been described. Similarly, the rates of cell turnover in different B cell subpopulation from lymphoid and mucosal tissues have not been well documented. In this study, we demonstrate the presence of memory B cell populations and define their distribution, frequency and immunophenotype with regards to activation, proliferation, maturation, and antibody production in normal rhesus macaques from different lymphoid tissues. Methodology/Principal Findings: Thirteen healthy, uninfected rhesus macaques were selected for this study. CD20(+) B cells were isolated from peripheral blood and sorted based on CD27 and CD21 surface markers to define memory B cell population. All the B cell subpopulation was further characterized phenotypically and their cell turnover rates were evaluated in vivo following bromodeoxyuridine (BrdU) inoculation. Double positive (DP) CD21(+)CD27(+) B cells in both peripheral and lymphoid tissues are memory B cells, able to produce antibody by polyclonal activation, and without T cell help. Peripheral and lymphoid DP CD21(+)CD27(+) B cells were also able to become activated and proliferate at higher rates than other B cell subpopulations. Increased turnover of tonsillar memory B cells were identified compared to other tissues examined. Conclusions/Significance: We suggest that this DP memory B cells play a major role in the immune system and their function and proliferation might have an important role in HIV/SIV mediated B cell dysregulation and pathogenesis.	[Das, Arpita] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA; [Xu, Huanbin; Wang, Xiaolei; Veazey, Ronald S.; Pahar, Bapi] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Yau, Canddy L.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat, New Orleans, LA USA	Tulane University; Tulane University; Tulane University	Das, A (corresponding author), Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA.	bpahar@tulane.edu	Xu, Huanbin/S-4870-2019; Pahar, Bapi/AFM-3129-2022	Pahar, Bapi/0000-0003-1949-973X; Das, Arpita/0000-0002-5878-7091	National Institutes of Health [P20 RR020159, R21 AI080395, RR000164, 106719-40-RGRL]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020159, P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI080395] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by National Institutes of Health grants P20 RR020159, R21 AI080395 (BP) and RR000164, and amfAR grant-106719-40-RGRL (BP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Chong Y, 2004, AIDS RES HUM RETROV, V20, P219, DOI 10.1089/088922204773004941; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; De Milito A, 2001, AIDS, V15, P957, DOI 10.1097/00002030-200105250-00003; Erdei A, 2009, MOL IMMUNOL, V46, P2767, DOI 10.1016/j.molimm.2009.05.181; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Ivetic A, 2004, BIOCHEM SOC T, V32, P1118, DOI 10.1042/BST0321118; Kacani L, 2000, J VIROL, V74, P7997, DOI 10.1128/JVI.74.17.7997-8002.2000; Klein U, 1997, BLOOD, V89, P1288, DOI 10.1182/blood.V89.4.1288; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kuhrt D, 2010, J VIROL, V84, P2466, DOI 10.1128/JVI.01966-09; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; LIU YJ, 1988, EUR J IMMUNOL, V18, P355, DOI 10.1002/eji.1830180306; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Lu FX, 1999, INFECT IMMUN, V67, P6321; MAURER D, 1990, EUR J IMMUNOL, V20, P2679, DOI 10.1002/eji.1830201223; MAURER D, 1992, J IMMUNOL, V148, P3700; Miller CJ, 1997, J VIROL, V71, P1911, DOI 10.1128/JVI.71.3.1911-1921.1997; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Nagumo H, 1998, IMMUNOLOGY, V94, P388, DOI 10.1046/j.1365-2567.1998.00521.x; Pahar B, 2006, EUR J IMMUNOL, V36, P583, DOI 10.1002/eji.200535520; Pahar B, 2006, VACCINE, V24, P6839, DOI 10.1016/j.vaccine.2006.06.050; Pahar B, 2009, VIROLOGY, V387, P273, DOI 10.1016/j.virol.2009.02.014; Paramithiotis E, 1997, P NATL ACAD SCI USA, V94, P208, DOI 10.1073/pnas.94.1.208; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tangye SG, 2003, J IMMUNOL, V170, P261, DOI 10.4049/jimmunol.170.1.261; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Veazey RS, 1997, CLIN IMMUNOL IMMUNOP, V82, P230, DOI 10.1006/clin.1996.4318; Veazey RS, 2003, J VIROL, V77, P8783, DOI 10.1128/JVI.77.16.8783-8792.2003; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Wang XL, 2007, BLOOD, V109, P1174, DOI 10.1182/blood-2006-04-015172; Wang XL, 2008, BLOOD, V112, P4981, DOI 10.1182/blood-2008-05-160077; Williams MB, 1998, J IMMUNOL, V161, P4227; Zinkernagel RM, 2000, PHILOS T R SOC B, V355, P369, DOI 10.1098/rstb.2000.0576	51	27	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16524	10.1371/journal.pone.0016524	http://dx.doi.org/10.1371/journal.pone.0016524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304587	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900061
J	van Rijn, CM; Krijnen, H; Menting-Hermeling, S; Coenen, AML				van Rijn, Clementina M.; Krijnen, Hans; Menting-Hermeling, Saskia; Coenen, Anton M. L.			Decapitation in Rats: Latency to Unconsciousness and the 'Wave of Death'	PLOS ONE			English	Article							EVOKED-POTENTIALS; ELECTROENCEPHALOGRAM; EUTHANASIA; EEG; BROILERS; DEPTH	The question whether decapitation is a humane method of euthanasia in awake animals is being debated. To gather arguments in this debate, obsolete rats were decapitated while recording the EEG, both of awake rats and of anesthetized rats. Following decapitation a fast and global loss of power of the EEG was observed; the power in the 13-100 Hz frequency band, expressing cognitive activity, decreased according to an exponential decay function to half the initial value within 4 seconds. Whereas the pre-decapitation EEG of the anesthetized animals showed a burst suppression pattern quite different from the awake animals, the power in the postdecapitation EEG did not differ between the two groups. This might indicate that either the power of the EEG does not correlate well with consciousness or that consciousness is briefly regained in the anesthetized group after decapitation. Remarkably, after 50 seconds (awake group) or 80 seconds (anesthetized group) following decapitation, a high amplitude slow wave was observed. The EEG before this wave had more power than the signal after the wave. This wave might be due to a simultaneous massive loss of membrane potentials of the neurons. Still functioning ion channels, which keep the membrane potential intact before the wave, might explain the observed power difference. Two conclusions were drawn from this experiment. It is likely that consciousness vanishes within seconds after decapitation, implying that decapitation is a quick and not an inhumane method of euthanasia. It seems that the massive wave which can be recorded approximately one minute after decapitation reflects the ultimate border between life and death. This observation might have implications in the discussions on the appropriate time for organ donation.	[van Rijn, Clementina M.; Krijnen, Hans; Menting-Hermeling, Saskia; Coenen, Anton M. L.] Radboud Univ Nijmegen, Dept Biol Psychol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van Rijn, CM (corresponding author), Radboud Univ Nijmegen, Dept Biol Psychol, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	t.vanrijn@donders.ru.nl	van Rijn, Clementina/D-5828-2012	van Rijn, Clementina/0000-0002-1103-6338				ALLRED JB, 1986, J NUTR, V116, P1859, DOI 10.1093/jn/116.9.1859; Auyong DB, 2010, ANESTH ANALG, V110, P1428, DOI 10.1213/ANE.0b013e3181d27067; BURES J, 1957, PFLUG ARCH GES PHYS, V264, P325, DOI 10.1007/BF00364173; Chawla LS, 2009, J PALLIAT MED, V12, P1095, DOI 10.1089/jpm.2009.0159; COENEN AML, 1995, NEUROSCI BIOBEHAV R, V19, P447, DOI 10.1016/0149-7634(95)00010-C; DERR RF, 1991, LIFE SCI, V49, P1399, DOI 10.1016/0024-3205(91)90391-N; HOLSON RR, 1992, NEUROTOXICOL TERATOL, V14, P253, DOI 10.1016/0892-0362(92)90004-T; Hughes JR, 1999, J NEUROPSYCH CLIN N, V11, P190, DOI 10.1176/jnp.11.2.190; MIKESKA JA, 1975, LAB ANIM SCI, V25, P175; Prinz S, 2010, POULTRY SCI, V89, P1275, DOI 10.3382/ps.2009-00136; Raj ABM, 2004, ANIM WELFARE, V13, P159; van den Broek PLC, 2006, EUR J ANAESTH, V23, P391, DOI 10.1017/S0265021505001857; VANDERWOLF CH, 1988, BRAIN RES, V451, P340, DOI 10.1016/0006-8993(88)90780-9; Voss L, 2007, BEST PRACT RES-CLIN, V21, P313, DOI 10.1016/j.bpa.2007.04.003	14	43	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16514	10.1371/journal.pone.0016514	http://dx.doi.org/10.1371/journal.pone.0016514			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304584	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900060
J	Ohsakaya, S; Fujikawa, M; Hisabori, T; Yoshida, M				Ohsakaya, Shigenori; Fujikawa, Makoto; Hisabori, Toru; Yoshida, Masasuke			Knockdown of DAPIT (Diabetes-associated Protein in Insulin-sensitive Tissue) Results in Loss of ATP Synthase in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; RESOLUTION; F-1-ATPASE; ROTATION; DRIVEN; CELLS	It was found recently that a diabetes-associated protein in insulin-sensitive tissue (DAPIT) is associated with mitochondrial ATP synthase. Here, we report that the suppressed expression of DAPIT in DAPIT-knockdown HeLa cells causes loss of the population of ATP synthase in mitochondria. Consequently, DAPIT-knockdown cells show smaller mitochondrial ATP synthesis activity, slower growth in normal medium, and poorer viability in glucose-free medium than the control cells. The mRNA levels of alpha- and beta-subunits of ATP synthase remain unchanged by DAPIT knockdown. These results indicate a critical role of DAPIT in maintaining the ATP synthase population in mitochondria and raise an intriguing possibility of active role of DAPIT in cellular energy metabolism.	[Ohsakaya, Shigenori; Fujikawa, Makoto; Hisabori, Toru; Yoshida, Masasuke] Japan Sci & Technol Agcy, ATP Synth Regulat Project, Int Cooperat Res Project, Koto Ku, Tokyo 1350064, Japan; [Ohsakaya, Shigenori; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Dept Mol Biosci, Kyoto 6038555, Japan	Japan Science & Technology Agency (JST); Tokyo Institute of Technology; Kyoto Sangyo University	Yoshida, M (corresponding author), Japan Sci & Technol Agcy, ATP Synth Regulat Project, Int Cooperat Res Project, Koto Ku, 2-3-6 Aomi, Tokyo 1350064, Japan.	masasuke.yoshida@cc.kyoto-su.ac.jp	; Hisabori, Toru/E-5205-2014	Fujikawa, Makoto/0000-0002-8100-3718; Hisabori, Toru/0000-0003-2046-0277				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Carroll J, 2006, P NATL ACAD SCI USA, V103, P16170, DOI 10.1073/pnas.0607719103; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Fujikawa M, 2010, BIOCHEM BIOPH RES CO, V401, P538, DOI 10.1016/j.bbrc.2010.09.089; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Havlickova V, 2010, BBA-BIOENERGETICS, V1797, P1124, DOI 10.1016/j.bbabio.2009.12.009; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kagawa Y, 2010, P JPN ACAD B-PHYS, V86, P667, DOI 10.2183/pjab.86.667; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Paivarinne H, 2001, ACTA DIABETOL, V38, P83; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Rak M, 2009, BBA-MOL CELL RES, V1793, P108, DOI 10.1016/j.bbamcr.2008.07.001; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wittig I, 2008, BBA-BIOENERGETICS, V1777, P592, DOI 10.1016/j.bbabio.2008.04.027; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	25	50	51	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 10	2011	286	23					20292	20296		10.1074/jbc.M110.198523	http://dx.doi.org/10.1074/jbc.M110.198523			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	772WC	21345788	Green Published, hybrid			2022-12-25	WOS:000291267600017
J	Onoue, N; Yamashita, Y; Nagao, N; Goto, DB; Onouchi, H; Naito, S				Onoue, Noriyuki; Yamashita, Yui; Nagao, Nobuhiro; Goto, Derek B.; Onouchi, Hitoshi; Naito, Satoshi			S-Adenosyl-L-methionine Induces Compaction of Nascent Peptide Chain inside the Ribosomal Exit Tunnel upon Translation Arrest in the Arabidopsis CGS1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; MESSENGER-RNA DEGRADATION; TRYPTOPHAN INDUCTION; TRANSFERASE CENTER; ELONGATION ARREST; POSTTRANSCRIPTIONAL AUTOREGULATION; POLYPEPTIDE-CHAINS; STRUCTURAL BASIS; IN-VITRO; SITE	Expression of the Arabidopsis CGS1 gene, encoding the first committed enzyme of methionine biosynthesis, is feedback-regulated in response to S-adenosyl-L-methionine (AdoMet) at the mRNA level. This regulation is first preceded by temporal arrest of CGS1 translation elongation at the Ser-94 codon. AdoMet is specifically required for this translation arrest, although the mechanism by which AdoMet acts with the CGS1 nascent peptide remained elusive. We report here that the nascent peptide of CGS1 is induced to form a compact conformation within the exit tunnel of the arrested ribosome in an AdoMet-dependent manner. Cysteine residues introduced into CGS1 nascent peptide showed reduced ability to react with polyethyleneglycol maleimide in the presence of AdoMet, consistent with a shift into the ribosomal exit tunnel. Methylation protection and UV cross-link assays of 28 S rRNA revealed that induced compaction of nascent peptide is associated with specific changes in methylation protection and UV cross-link patterns in the exit tunnel wall. A 14-residue stretch of amino acid sequence, termed the MTO1 region, has been shown to act in cis for CGS1 translation arrest and mRNA degradation. This regulation is lost in the presence of mto1 mutations, which cause single amino acid alterations within MTO1. In this study, both the induced peptide compaction and exit tunnel change were found to be disrupted by mto1 mutations. These results suggest that the MTO1 region participates in the AdoMet-induced arrest of CGS1 translation by mediating changes of the nascent peptide and the exit tunnel wall.	[Onouchi, Hitoshi; Naito, Satoshi] Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan; [Onoue, Noriyuki; Yamashita, Yui; Nagao, Nobuhiro; Naito, Satoshi] Hokkaido Univ, Grad Sch Life Sci, Div Life Sci, Sapporo, Hokkaido 0608589, Japan; [Goto, Derek B.] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Onouchi, Hitoshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Japan Science & Technology Agency (JST)	Naito, S (corresponding author), Hokkaido Univ, Grad Sch Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan.	naito@abs.agr.hokudai.ac.jp	尾上, 典之/Q-8627-2019	ONOUE, Noriyuki/0000-0001-5765-4812; Naito, Satoshi/0000-0001-7006-5609	Japan Society for the Promotion of Science [20370016, 3032]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22119006]; Japan Science and Technology Agency [PJ34085001]; Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Scientific Research (B) 20370016 (to S.N.), Grant-in-aid for JSPS Fellows 3032 (to N.O.) from the Japan Society for the Promotion of Science, Grant-in-aid for Scientific Research on Innovative Areas 22119006 (to S.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by Core Research for Evolutional Science and Technology PJ34085001 (to H.O.) from the Japan Science and Technology Agency.; Supported by the Japan Society for the Promotion of Science.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bhushan S, 2010, MOL CELL, V40, P138, DOI 10.1016/j.molcel.2010.09.009; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Chiba Y, 2003, P NATL ACAD SCI USA, V100, P10225, DOI 10.1073/pnas.1831512100; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Cruz-Vera LR, 2008, J BACTERIOL, V190, P4791, DOI 10.1128/JB.00290-08; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gong F, 2001, P NATL ACAD SCI USA, V98, P8997, DOI 10.1073/pnas.171299298; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen JL, 2003, J MOL BIOL, V330, P1061, DOI 10.1016/S0022-2836(03)00668-5; Haraguchi Y, 2008, PLANT CELL PHYSIOL, V49, P314, DOI 10.1093/pcp/pcn005; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INABA K, 1994, PLANT PHYSIOL, V104, P881, DOI 10.1104/pp.104.3.881; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; Kim JS, 1996, PLANT MOL BIOL, V32, P1117, DOI 10.1007/BF00041395; Lambein I, 2003, PLANT CELL PHYSIOL, V44, P893, DOI 10.1093/pcp/pcg114; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; Matthews BF, 1999, BOOK SOIL P, P205; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1986, CELL, V47, P985, DOI 10.1016/0092-8674(86)90813-5; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Noah JW, 2003, BIOCHEMISTRY-US, V42, P14386, DOI 10.1021/bi035369q; Ominato K, 2002, J BIOL CHEM, V277, P36380, DOI 10.1074/jbc.M204645200; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Onouchi H, 2008, PLANT CELL PHYSIOL, V49, P549, DOI 10.1093/pcp/pcn028; Pogulis R J, 1996, Methods Mol Biol, V57, P167; PORSE BT, 1995, J MOL BIOL, V249, P1, DOI 10.1006/jmbi.1995.0276; Schaffitzel C, 2007, J STRUCT BIOL, V159, P302, DOI 10.1016/S1047-8477(07)00167-0; Schmeing TM, 2005, NATURE, V438, P520, DOI 10.1038/nature04152; Schmeing TM, 2005, MOL CELL, V20, P437, DOI 10.1016/j.molcel.2005.09.006; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Spevak CC, 2010, J BIOL CHEM, V285, P40933, DOI 10.1074/jbc.M110.164152; Suzuki A, 2001, PLANT CELL PHYSIOL, V42, P1174, DOI 10.1093/pcp/pce146; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; UELAND PM, 1982, PHARMACOL REV, V34, P223; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yang R, 2009, J BACTERIOL, V191, P3445, DOI 10.1128/JB.00096-09; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	60	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14903	14912		10.1074/jbc.M110.211656	http://dx.doi.org/10.1074/jbc.M110.211656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21335553	Green Published, hybrid			2022-12-25	WOS:000289788300020
J	Sanchez-Alavez, M; Osborn, O; Tabarean, IV; Holmberg, KH; Eberwine, J; Kahn, CR; Bartfai, T				Sanchez-Alavez, Manuel; Osborn, Olivia; Tabarean, Iustin V.; Holmberg, Kristina H.; Eberwine, James; Kahn, C. Ronald; Bartfai, Tamas			Insulin-like Growth Factor 1-mediated Hyperthermia Involves Anterior Hypothalamic Insulin Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I RECEPTOR; IGF-I; BODY-TEMPERATURE; RAT-BRAIN; LIFE-SPAN; TRANSGENIC MICE; HUMAN LONGEVITY; CELL-GROWTH; RESISTANCE; PROTEIN	The objective is to investigate the role of insulin-like growth factor 1 (IGF-1) in the regulation of core body temperature. Sequencing cDNA libraries from individual warm-sensitive neurons from the preoptic area (POA) of the hypothalamus, a region involved in the central control of thermoregulation, identified neurons that express both IGF-1 receptor (IGF-1R) and insulin receptor transcripts. The effects of administration of IGF-1 into the POA was measured by radiotelemetry monitoring of core temperature, brown adipose tissue (BAT) temperature, metabolic assessment, and imaging of BAT by positron emission tomography of 2-[F-18]fluoro-2-deoxyglucose uptake combined with computed tomography. IGF-1 injection into the POA caused dose-dependent hyperthermia that could be blocked by pretreatment with the IGF-1R tyrosine kinase inhibitor, PQ401. The IGF-1-evoked hyperthermia involved activation of brown adipose tissue and was accompanied by a switch from glycolysis to fatty acid oxidation as a source of energy as shown by lowered respiratory exchange ratio. Transgenic mice that lack neuronal insulin receptor expression in the brain (NIRKO mice) were unable to mount the full hyperthermic response to IGF-1, suggesting that the IGF-1 mediated hyperthermia is partly dependent on expression of functional neuronal insulin receptors. These data indicate a novel thermoregulatory role for both IGF-1R and neuronal insulin receptors in IGF-1 activation of BAT and hyperthermia. These central effects of IGF-1 signaling may play a role in regulation of metabolic rate, aging, and the risk of developing type 2 diabetes.	[Osborn, Olivia] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Sanchez-Alavez, Manuel; Tabarean, Iustin V.; Bartfai, Tamas] Scripps Res Inst, Dept Mol & Integrat Neurosci, Harold Dorris Neurol Inst, La Jolla, CA 92037 USA; [Holmberg, Kristina H.] Pfizer Ltd, Expt Biol Sci, Sandwich CT13 9NJ, Kent, England; [Eberwine, James] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA; [Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA 02215 USA	University of California System; University of California San Diego; Scripps Research Institute; Pfizer; University of Pennsylvania; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Osborn, O (corresponding author), 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oosborn@ucsd.edu; tbartfai@scripps.edu	osborn, olivia/R-1460-2018; Eberwine, James/B-2247-2010; Kahn, Ronald/AAY-2435-2021	osborn, olivia/0000-0003-0516-7937; Kahn, Ronald/0000-0002-7583-9228; Sanchez-Alavez, Manuel/0000-0002-8164-8452; Holmberg, Kristina/0000-0003-0760-3990	National Institutes of Health [R01NS043501, R01NS060799, DP1-OD-04117, DK31036]; The Harold L. Dorris Neurological Research Institute; The Skaggs Institute for Chemical Biology; The Ellison Medical Foundation; Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R37DK031036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043501, R01NS060799] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD004117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Harold L. Dorris Neurological Research Institute; The Skaggs Institute for Chemical Biology; The Ellison Medical Foundation(Lawrence Ellison Foundation); Commonwealth of Pennsylvania; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS043501 (to T.B.), R01NS060799 (to I.V.T.), DP1-OD-04117 (to J.E.), and DK31036 (to C.R.K.). This work was also supported by The Harold L. Dorris Neurological Research Institute, The Skaggs Institute for Chemical Biology, The Ellison Medical Foundation, and by Health Research Formula Funds from the Commonwealth of Pennsylvania. This is The Scripps Research Institute Manuscript 20540.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Arai Y, 2001, J GERONTOL A-BIOL, V56, pM79, DOI 10.1093/gerona/56.2.M79; Bailyes EM, 1997, BIOCHEM J, V327, P209, DOI 10.1042/bj3270209; Barbieri M, 2008, EXP GERONTOL, V43, P74, DOI 10.1016/j.exger.2007.06.003; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; Bonafe M, 2009, MOL CELL ENDOCRINOL, V299, P118, DOI 10.1016/j.mce.2008.10.038; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daftary SS, 2004, J NEUROENDOCRINOL, V16, P160, DOI 10.1111/j.0953-8194.2004.01149.x; Delafontaine P, 1998, EUR HEART J, V19, pG18; DEMEYTS P, 1994, HORM RES, V42, P152, DOI 10.1159/000184188; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Gable KL, 2006, MOL CANCER THER, V5, P1079, DOI 10.1158/1535-7163.MCT-05-0397; GarciaSegura LM, 1997, J NEUROCYTOL, V26, P479, DOI 10.1023/A:1018581407804; Hauck SJ, 2001, EXP BIOL MED, V226, P552; HAVRANKOVA J, 1978, P NATL ACAD SCI USA, V75, P5737, DOI 10.1073/pnas.75.11.5737; HAVRANKOVA J, 1979, J CLIN INVEST, V64, P636, DOI 10.1172/JCI109504; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KUZUYA H, 1993, DIABETES, V42, P696, DOI 10.2337/diabetes.42.5.696; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lynch CD, 1999, NEUROBIOL AGING, V20, P191, DOI 10.1016/S0197-4580(99)00032-9; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARKS JL, 1991, MOL ENDOCRINOL, V5, P1158, DOI 10.1210/mend-5-8-1158; Moloney AM, 2010, NEUROBIOL AGING, V31, P224, DOI 10.1016/j.neurobiolaging.2008.04.002; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Muzumdar RH, 2006, NEUROBIOL AGING, V27, P1308, DOI 10.1016/j.neurobiolaging.2005.07.007; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Olsson B, 2005, ENDOCRINOLOGY, V146, P920, DOI 10.1210/en.2004-1232; Paolisso G, 1997, J CLIN ENDOCR METAB, V82, P2204, DOI 10.1210/jc.82.7.2204; Rikke BA, 2003, MECH AGEING DEV, V124, P663, DOI 10.1016/S0047-6374(03)00003-4; Sanchez-Alavez M, 2010, DIABETES, V59, P43, DOI 10.2337/db09-1128; Sandhu MS, 2002, LANCET, V359, P1740, DOI 10.1016/S0140-6736(02)08655-5; Sonntag WE, 1999, NEUROSCIENCE, V88, P269, DOI 10.1016/S0306-4522(98)00192-4; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; WERTHER GA, 1989, J NEUROENDOCRINOL, V1, P369, DOI 10.1111/j.1365-2826.1989.tb00131.x; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yang J, 2005, EXP GERONTOL, V40, P867, DOI 10.1016/j.exger.2005.08.001	54	30	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14983	14990		10.1074/jbc.M110.188540	http://dx.doi.org/10.1074/jbc.M110.188540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21330367	Green Published, hybrid			2022-12-25	WOS:000289788300028
J	Wu, HX; Suzuki, T; Carey, B; Trapnell, BC; McCormack, FX				Wu, Huixing; Suzuki, Takuji; Carey, Brenna; Trapnell, Bruce C.; McCormack, Francis X.			Keratinocyte Growth Factor Augments Pulmonary Innate Immunity through Epithelium-driven, GM-CSF-dependent Paracrine Activation of Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; INDUCED LUNG INJURY; SURFACTANT PROTEIN-A; II CELLS; PSEUDOMONAS-AERUGINOSA; GENE-EXPRESSION; DEFICIENT MICE; HOST-DEFENSE; RATS; PHAGOCYTOSIS	Keratinocyte growth factor (KGF) is an epithelial mitogen that has been reported to protect the lungs from a variety of insults. In this study, we tested the hypothesis that KGF augments pulmonary host defense. We found that a single dose of intrapulmonary KGF enhanced the clearance of Escherichia coli or Pseudomonas aeruginosa instilled into the lungs 24 h later. KGF augmented the recruitment, phagocytic activity, and oxidant responses of alveolar macrophages, including lipopolysaccharide-stimulated nitric oxide release and zymosan-induced superoxide production. Less robust alveolar macrophage recruitment and activation was observed in mice treated with intraperitoneal KGF. KGF treatment was associated with increased levels of MIP1 gamma, LIX, VCAM, IGFBP-6, and GM-CSF in the bronchoalveolar lavage fluid. Of these, only GM-CSF recapitulated in vitro the macrophage activation phenotype seen in the KGF-treated animals. The KGF-stimulated increase in GM-CSF levels in lung tissue and alveolar lining fluid arose from the epithelium, peaked within 1 h, and was associated with STAT5 phosphorylation in alveolar macrophages, consistent with epithelium-driven paracrine activation of macrophage signaling through the KGF receptor/GM-CSF/GM-CSF receptor/JAK-STAT axis. Enhanced bacterial clearance did not occur in response to KGF administration in GM-CSF-/- mice, or in mice treated with a neutralizing antibody to GM-CSF. We conclude that KGF enhances alveolar host defense through GM-CSF-stimulated macrophage activation. KGF administration may constitute a promising therapeutic strategy to augment innate immune defenses in refractory pulmonary infections.	[Wu, Huixing; McCormack, Francis X.] Univ Cincinnati, Childrens Hosp Med Ctr, Div Pulm & Crit Care Med, Dept Internal Med, Cincinnati, OH 45267 USA; [Suzuki, Takuji; Carey, Brenna; Trapnell, Bruce C.] Univ Cincinnati, Childrens Hosp Med Ctr, Div Pulm Biol, Dept Pediat, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	McCormack, FX (corresponding author), POB 670564, Cincinnati, OH 45267 USA.	frank.mccormack@uc.edu	McCormack, Francis X./ABE-8398-2020	McCormack, Francis X./0000-0001-7168-9464	National Institutes of Health, NIAID [P01AI083222]; Department of Veteran Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083222] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veteran Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant P01AI083222 from the NIAID (to F. X. M.) and a Veterans Affairs Merit grant from the Department of Veteran Affairs (to F. X. M.).	Anderson Robert N, 2005, Natl Vital Stat Rep, V53, P1; Ballinger MN, 2006, AM J RESP CELL MOL, V34, P766, DOI 10.1165/rcmb.2005-0246OC; Berclaz PY, 2002, BLOOD, V100, P4193, DOI 10.1182/blood-2002-04-1102; BRAUCHLE M, 1994, ONCOGENE, V9, P3199; Chang YS, 2006, AM J RESP CELL MOL, V35, P268, DOI 10.1165/rcmb.2006-0037OC; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Charafeddine L, 1999, AM J PHYSIOL-LUNG C, V276, pL105, DOI 10.1152/ajplung.1999.276.1.L105; CHEDID M, 1994, J BIOL CHEM, V269, P10753; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; DEFRANCIS CJ, 2005, NATL HOSP DISCHARGE; Deterding RR, 1997, P ASSOC AM PHYSICIAN, V109, P254; DRANOFF G, 1994, SCIENCE, V264, P713, DOI 10.1126/science.8171324; Erdag G, 2004, MOL THER, V10, P76, DOI 10.1016/j.ymthe.2004.04.013; Fehrenbach H, 2000, HISTOCHEM CELL BIOL, V114, P49; Franco-Montoya ML, 2009, AM J PHYSIOL-LUNG C, V297, pL965, DOI 10.1152/ajplung.00136.2009; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Kuzmenko AI, 2005, J BIOL CHEM, V280, P25913, DOI 10.1074/jbc.M411344200; LeVine AM, 1999, J CLIN INVEST, V103, P563, DOI 10.1172/JCI5212; Li CL, 2001, DEV DYNAM, V222, P471, DOI 10.1002/dvdy.1205; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MANZKEINKE H, 1992, EUR J CELL BIOL, V57, P95; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Mason RJ, 2002, CHEST, V121, p77S, DOI 10.1378/chest.121.3_suppl.77S; Metcalf D, 1999, BLOOD, V93, P1579, DOI 10.1182/blood.V93.5.1579.405k01_1579_1585; Miceli R, 1999, J PHARMACOL EXP THER, V290, P464; Paine R, 2000, J IMMUNOL, V164, P2602, DOI 10.4049/jimmunol.164.5.2602; PANOS RJ, 1995, J CLIN INVEST, V96, P2026, DOI 10.1172/JCI118250; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; RUBIN JS, 1989, P NATL ACAD SCI USA, V86, P802, DOI 10.1073/pnas.86.3.802; Saeed FA, 1998, CLIN DIAGN LAB IMMUN, V5, P740, DOI 10.1128/CDLI.5.5.740-743.1998; Sanaie AR, 2002, J PERIODONTAL RES, V37, P66, DOI 10.1034/j.1600-0765.2002.t01-1-90770.x; Spielberger R, 2004, NEW ENGL J MED, V351, P2590, DOI 10.1056/NEJMoa040125; STANLEY E, 1994, P NATL ACAD SCI USA, V91, P5592, DOI 10.1073/pnas.91.12.5592; Takeoka M, 1997, AM J PHYSIOL-LUNG C, V272, pL1174, DOI 10.1152/ajplung.1997.272.6.L1174; Trapnell BC, 2002, ANNU REV PHYSIOL, V64, P775, DOI 10.1146/annurev.physiol.64.090601.113847; Viget NB, 2000, AM J PHYSIOL-LUNG C, V279, pL1199, DOI 10.1152/ajplung.2000.279.6.L1199; Whitsett JA, 2002, J CLIN INVEST, V109, P565, DOI 10.1172/JCI200215209; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yano T, 1996, AM J RESP CELL MOL, V15, P433, DOI 10.1165/ajrcmb.15.4.8879176; Yi ES, 1996, AM J PATHOL, V149, P1963; Young LR, 2006, J IMMUNOL, V176, P4361, DOI 10.4049/jimmunol.176.7.4361	41	22	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14932	14940		10.1074/jbc.M110.182170	http://dx.doi.org/10.1074/jbc.M110.182170			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343299	Green Published, hybrid			2022-12-25	WOS:000289788300023
J	Nurmohamed, S; Vincent, HA; Titman, CM; Chandran, V; Pears, MR; Du, DJ; Griffin, JL; Callaghan, AJ; Luisi, BF				Nurmohamed, Salima; Vincent, Helen A.; Titman, Christopher M.; Chandran, Vidya; Pears, Michael R.; Du, Dijun; Griffin, Julian L.; Callaghan, Anastasia J.; Luisi, Ben F.			Polynucleotide Phosphorylase Activity May Be Modulated by Metabolites in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA DEGRADOSOME; MESSENGER-RNA; SALMONELLA-ENTERICA; GLYCOLYTIC-ENZYMES; RIBONUCLEASE-II; DECAY; VIRULENCE; RECONSTITUTION; MITOCHONDRIA; DEGRADATION	RNA turnover is an essential element of cellular homeostasis and response to environmental change. Whether the ribonucleases that mediate RNA turnover can respond to cellular metabolic status is an unresolved question. Here we present evidence that the Krebs cycle metabolite citrate affects the activity of Escherichia coli polynucleotide phosphorylase (PNPase) and, conversely, that cellular metabolism is affected widely by PNPase activity. An E. coli strain that requires PNPase for viability has suppressed growth in the presence of increased citrate concentration. Transcriptome analysis reveals a PNPase-mediated response to citrate, and PNPase deletion broadly impacts on the metabolome. In vitro, citrate directly binds and modulates PNPase activity, as predicted by crystallographic data. Binding of metal-chelated citrate in the active site at physiological concentrations appears to inhibit enzyme activity. However, metal-free citrate is bound at a vestigial active site, where it stimulates PNPase activity. Mutagenesis data confirmed a potential role of this vestigial site as an allosteric binding pocket that recognizes metal-free citrate. Collectively, these findings suggest that RNA degradative pathways communicate with central metabolism. This communication appears to be part of a feedback network that may contribute to global regulation of metabolism and cellular energy efficiency.	[Vincent, Helen A.; Callaghan, Anastasia J.] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Lab, Portsmouth PO1 2DY, Hants, England; [Nurmohamed, Salima; Titman, Christopher M.; Chandran, Vidya; Pears, Michael R.; Du, Dijun; Griffin, Julian L.; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Portsmouth; University of Cambridge	Callaghan, AJ (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Lab, Portsmouth PO1 2DY, Hants, England.	Anastasia.Callaghan@port.ac.uk; bfl20@mole.bio.cam.ac.uk	Titman, Christopher M/M-2223-2013; Vincent, Helen/GZK-3422-2022	Titman, Christopher M/0000-0001-8698-8352; Darbari, Vidya/0000-0002-3387-5108	Wellcome Trust; Royal Society	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was supported by the Wellcome Trust (to B. F. L.) and Royal Society (to J.L.G. and A.J.C.).	Andrade JM, 2008, RNA, V14, P543, DOI 10.1261/rna.683308; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Awano N, 2008, J BACTERIOL, V190, P5924, DOI 10.1128/JB.00500-08; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Chandran V, 2006, J MOL BIOL, V358, P8, DOI 10.1016/j.jmb.2006.02.012; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Del Favero M, 2008, J BIOL CHEM, V283, P27355, DOI 10.1074/jbc.C800113200; Deutscher MP, 2006, NUCLEIC ACIDS RES, V34, P659, DOI 10.1093/nar/gkj472; DONOVAN WP, 1983, NUCLEIC ACIDS RES, V11, P265, DOI 10.1093/nar/11.2.265; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Erce MA, 2009, BBA-PROTEINS PROTEOM, V1794, P1107, DOI 10.1016/j.bbapap.2009.03.016; Gatewood ML, 2010, J BACTERIOL, V192, P4275, DOI 10.1128/JB.00367-10; Hardiman T, 2007, J BIOTECHNOL, V132, P359, DOI 10.1016/j.jbiotec.2007.08.029; Hardwick SW, 2011, NUCLEIC ACIDS RES, V39, P1449, DOI 10.1093/nar/gkq928; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Khemici V, 2004, MOL MICROBIOL, V54, P1422, DOI 10.1111/j.1365-2958.2004.04361.x; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Leroy A, 2002, MOL MICROBIOL, V45, P1231, DOI 10.1046/j.1365-2958.2002.03104.x; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x; Marcaida MJ, 2006, TRENDS BIOCHEM SCI, V31, P359, DOI 10.1016/j.tibs.2006.05.005; Mohanty BK, 2006, NUCLEIC ACIDS RES, V34, P5695, DOI 10.1093/nar/gkl684; Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997; Mohanty BK, 2003, MOL MICROBIOL, V50, P645, DOI 10.1046/j.1365-2958.2003.03724.x; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Nurmohamed S, 2009, J MOL BIOL, V389, P17, DOI 10.1016/j.jmb.2009.03.051; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Siculella L, 2010, MOL MICROBIOL, V77, P716, DOI 10.1111/j.1365-2958.2010.07240.x; Slornovic S, 2008, BBA-GENE REGUL MECH, V1779, P247, DOI 10.1016/j.bbagrm.2007.12.004; Stickney LM, 2005, J BACTERIOL, V187, P7214, DOI 10.1128/JB.187.21.7214-7221.2005; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; TUCKERMAN JR, 2011, J MOL BIOL IN PRESS; Viegas SC, 2007, NUCLEIC ACIDS RES, V35, P7651, DOI 10.1093/nar/gkm916; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059; Yang J, 2008, J BACTERIOL, V190, P3774, DOI 10.1128/JB.00147-08; Ygberg SE, 2006, INFECT IMMUN, V74, P1243, DOI 10.1128/IAI.74.2.1243-1254.2006	51	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14315	14323		10.1074/jbc.M110.200741	http://dx.doi.org/10.1074/jbc.M110.200741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324911	Green Published, hybrid			2022-12-25	WOS:000289556200054
J	Liu, Q; Siloto, RMP; Snyder, CL; Weselake, RJ				Liu, Qin; Siloto, Rodrigo M. P.; Snyder, Crystal L.; Weselake, Randall J.			Functional and Topological Analysis of Yeast Acyl-CoA:Diacylglycerol Acyltransferase 2, an Endoplasmic Reticulum Enzyme Essential for Triacylglycerol Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; DIACYLGLYCEROL ACYLTRANSFERASE; MEMBRANE-PROTEINS; CHEMICAL-MODIFICATION; HEPATIC STEATOSIS; DGAT2; MICE; IDENTIFICATION; COA; SUPERFAMILY	Acyl-CoA:diacylglycerol acyltransferase (EC 2.3.1.20) is a membrane protein present mainly in the endoplasmic reticulum. It catalyzes the final and committed step in the biosynthesis of triacylglycerol, which is the principal repository of fatty acids for energy utilization and membrane formation. 'Iwo distinct family members of acyl-CoA:diacylglycerol acyltransferase, known as DGAT1 and DGAT2, have been characterized in different organisms, including mammals, fungi, and plants. In this study, we characterized the functional role and topological orientation of signature motifs in yeast (Saccharomyces cerevisiae) DGAT2 using mutagenesis in conjunction with chemical modification. Our data provide evidence that both the N and C termini are oriented toward the cytosol and have different catalytic roles. A highly conserved motif, (YFP131)-Y-129, and a hydrophilic segment exclusive to yeast DGAT2 reside in a long endoplasmic reticulum luminal loop following the first transmembrane domain and play an essential role in enzyme catalysis. In addition, the strongly conserved His(195) within the motif HPHG, which may play a role in the active site of DGAT2, is likely embedded in the membrane. These results indicate some similarities to the topology model of murine DGAT2 but also reveal striking differences suggesting that the topological organization of DGAT2 is not ubiquitously conserved.	[Weselake, Randall J.] Univ Alberta, Agr Lipid Biotechnol Program, Dept Agr Food & Nutr Sci, Agr Forestry Ctr 4 10, Edmonton, AB T6G 2P5, Canada	University of Alberta	Weselake, RJ (corresponding author), Univ Alberta, Agr Lipid Biotechnol Program, Dept Agr Food & Nutr Sci, Agr Forestry Ctr 4 10, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca			Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canada Foundation for Innovation; University of Alberta	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of Alberta(University of Alberta)	This work was supported by Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation, and the University of Alberta.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; Choi CS, 2007, J BIOL CHEM, V282, P22678, DOI 10.1074/jbc.M704213200; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilstring CF, 2000, J BIOL CHEM, V275, P31488, DOI 10.1074/jbc.M005047200; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kroon JTM, 2006, PHYTOCHEMISTRY, V67, P2541, DOI 10.1016/j.phytochem.2006.09.020; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LITTLE D, 1994, BIOCHEM J, V304, P951, DOI 10.1042/bj3040951; Liu Q, 2010, BIOCHEMISTRY-US, V49, P3237, DOI 10.1021/bi9020499; Liu Y, 2008, BBA-MOL CELL BIOL L, V1781, P97, DOI 10.1016/j.bbalip.2008.01.001; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Persson B, 2006, STRUCTURAL GENOMICS, P5; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Siloto RMP, 2009, PLANT PHYSIOL BIOCH, V47, P456, DOI 10.1016/j.plaphy.2008.12.019; Snyder CL, 2009, NEW BIOTECHNOL, V26, P11, DOI 10.1016/j.nbt.2009.05.005; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Tamura N, 2001, J BIOL CHEM, V276, P20330, DOI 10.1074/jbc.M007993200; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	41	72	80	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13115	13126		10.1074/jbc.M110.204412	http://dx.doi.org/10.1074/jbc.M110.204412			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321129	Green Published, hybrid			2022-12-25	WOS:000289282200032
J	Xiong, L; Darwanto, A; Sharma, S; Herring, J; Hu, SY; Filippova, M; Filippov, V; Wang, YS; Chen, CS; Duerksen-Hughes, PJ; Sowers, LC; Zhang, KL				Xiong, Lei; Darwanto, Agus; Sharma, Seema; Herring, Jason; Hu, Shaoyan; Filippova, Maria; Filippov, Valery; Wang, Yinsheng; Chen, Chien-Shing; Duerksen-Hughes, Penelope J.; Sowers, Lawrence C.; Zhang, Kangling			Mass Spectrometric Studies on Epigenetic Interaction Networks in Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; MINICHROMOSOME MAINTENANCE PROTEIN; DNA-REPLICATION; HISTONE H2B; PAF1 COMPLEX; FATTY-ACID; HELICASE ACTIVITY; MAMMALIAN-CELLS; ADIPOSE-TISSUE; CANCER-CELLS	Arrest of cell differentiation is one of the leading causes of leukemia and other cancers. Induction of cell differentiation using pharmaceutical agents has been clinically attempted for the treatment of these cancers. Epigenetic regulation may be one of the underlying molecular mechanisms controlling cell proliferation or differentiation. Here, we report on the use of proteomics-based differential protein expression analysis in conjunction with quantification of histone modifications to decipher the interconnections among epigenetic modifications, their modifying enzymes or mediators, and changes in the associated pathways/networks that occur during cell differentiation. During phorbol-12-myristate 13-acetate-induced differentiation of U937 cells, fatty acid synthesis and its metabolic processing, the clathrin-coated pit endocytosis pathway, and the ubiquitin/26 S proteasome degradation pathways were up-regulated. In addition, global histone H3/H4 acetylation and H2B ubiquitination were down-regulated concomitantly with impaired chromatin remodeling machinery, RNA polymerase II complexes, and DNA replication. Differential protein expression analysis established the networks linking histone hypoacetylation to the down-regulated expression/activity of p300 and linking histone H2B ubiquitination to the RNA polymerase II-associated FACT-RTF1-PAF1 complex. Collectively, our approach has provided an unprecedentedly systemic set of insights into the role of epigenetic regulation in leukemia cell differentiation.	[Darwanto, Agus; Herring, Jason; Filippova, Maria; Filippov, Valery; Duerksen-Hughes, Penelope J.; Sowers, Lawrence C.; Zhang, Kangling] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Hu, Shaoyan; Chen, Chien-Shing] Loma Linda Univ, Sch Med, Div Med Oncol Hematol, Loma Linda, CA 92350 USA; [Xiong, Lei; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Sharma, Seema] Thermo Fisher Sci, Life Sci Mass Spectrometry, San Jose, CA 95134 USA	Loma Linda University; Loma Linda University; University of California System; University of California Riverside; Thermo Fisher Scientific	Zhang, KL (corresponding author), Loma Linda Univ, Sch Med, Dept Biochem, Loma Linda, CA 92350 USA.	kzhang@llu.edu	Sharma, Seema/GZL-2109-2022	Duerksen-Hughes, Penelope/0000-0002-0998-2157	National Institutes of Health [R01 DK082779, R01 CA84487, 1S10RR027643-01]; NATIONAL CANCER INSTITUTE [R01CA084487] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK082779 (to Y. W.), R01 CA84487 (to L. C. S.), and 1S10RR027643-01 (to K. Z.).	Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Agarwal MK, 2007, CANCER RES, V67, P116, DOI 10.1158/0008-5472.CAN-06-2835; Ait-Si-Ali S, 2000, ONCOGENE, V19, P2430, DOI 10.1038/sj.onc.1203562; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Bluml S, 2009, BLOOD, V114, P5481, DOI 10.1182/blood-2008-11-191429; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bourbon NA, 2001, AM J PHYSIOL-CELL PH, V280, pC1403, DOI 10.1152/ajpcell.2001.280.6.C1403; Brouillard F, 2003, J BIOL CHEM, V278, P39509, DOI 10.1074/jbc.M307123200; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chmura SJ, 1996, CANCER RES, V56, P2711; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046; Darwanto A, 2010, J BIOL CHEM, V285, P21868, DOI 10.1074/jbc.M110.126813; Dasgupta U, 2009, P NATL ACAD SCI USA, V106, P20063, DOI 10.1073/pnas.0911028106; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Falbo KB, 2009, MOL CELLS, V28, P149, DOI 10.1007/s10059-009-0127-7; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Follows GA, 2003, EMBO J, V22, P2798, DOI 10.1093/emboj/cdg250; HATTORI T, 1983, J CLIN INVEST, V72, P237, DOI 10.1172/JCI110962; Herring JL, 2009, CHEM RES TOXICOL, V22, P1060, DOI 10.1021/tx900027w; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Kristjuhan A, 2002, MOL CELL, V10, P925, DOI 10.1016/S1097-2765(02)00647-0; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; Lee JY, 2003, J LEUKOCYTE BIOL, V73, P862, DOI 10.1189/jlb.1202618; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Makowski AM, 2001, J BIOL CHEM, V276, P43499, DOI 10.1074/jbc.C100549200; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nordick K, 2008, EUKARYOT CELL, V7, P1158, DOI 10.1128/EC.00434-07; Olefsky JM, 2008, CELL, V134, P914, DOI 10.1016/j.cell.2008.09.001; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Plutzky J, 2009, NAT MED, V15, P618, DOI 10.1038/nm0609-618; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rivenbark AG, 2007, SCIENCE, V318, P403, DOI 10.1126/science.1150321; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Second TP, 2009, ANAL CHEM, V81, P7757, DOI 10.1021/ac901278y; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Stopka T, 2000, LEUKEMIA, V14, P1247, DOI 10.1038/sj.leu.2401807; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Wang N, 2010, ANAL CHEM, V82, P2262, DOI 10.1021/ac9023022; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; You ZY, 2008, J BIOL CHEM, V283, P24469, DOI 10.1074/jbc.M803212200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	63	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13657	13668		10.1074/jbc.M110.204800	http://dx.doi.org/10.1074/jbc.M110.204800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335548	hybrid, Green Published			2022-12-25	WOS:000289282200084
J	Xu, Y; Song, S; Moeller, A; Kim, N; Piao, S; Sim, SH; Kang, M; Yu, W; Cho, HS; Chang, I; Lee, K; Ha, NC				Xu, Yongbin; Song, Saemee; Moeller, Arne; Kim, Nahee; Piao, Shunfu; Sim, Se-Hoon; Kang, Mooseok; Yu, Wookyung; Cho, Hyun-Soo; Chang, Iksoo; Lee, Kangseok; Ha, Nam-Chul			Functional Implications of an Intermeshing Cogwheel-like Interaction between TolC and MacA in the Action of Macrolide-specific Efflux Pump MacAB-TolC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PERIPLASMIC COMPONENT; ATPASE ACTIVITY; BACTERIAL; TRANSPORTER; RECONSTITUTION; MICROSCOPY	Macrolide-specific efflux pump MacAB-TolC has been identified in diverse Gram-negative bacteria including Escherichia coli. The inner membrane transporter MacB requires the outer membrane factor TolC and the periplasmic adaptor protein MacA to form a functional tripartite complex. In this study, we used a chimeric protein containing the tip region of the TolC a-barrel to investigate the role of the TolC alpha-barrel tip region with regard to its interaction with MacA. The chimeric protein formed a stable complex with MacA, and the complex formation was abolished by substitution at the functionally essential residues located at the MacA alpha-helical tip region. Electron microscopic study delineated that this complex was made by tip-to-tip interaction between the tip regions of the alpha-barrels of TolC and MacA, which correlated well with the TolC and MacA complex calculated by molecular dynamics. Taken together, our results demonstrate that the MacA hexamer interacts with TolC in a tip-to-tip manner, and implies the manner by which MacA induces opening of the TolC channel.	[Song, Saemee; Sim, Se-Hoon; Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Program BK21, Res Ctr Biomol & Biosyst, Seoul 156756, South Korea; [Xu, Yongbin; Piao, Shunfu; Ha, Nam-Chul] Pusan Natl Univ, Res Inst Drug Dev, Dept Mfg Pharm, Pusan 609735, South Korea; [Moeller, Arne] Scripps Res Inst, La Jolla, CA 92037 USA; [Kim, Nahee; Cho, Hyun-Soo] Yonsei Univ, Coll Sci, Dept Biol, Seoul 120749, South Korea; [Kang, Mooseok; Yu, Wookyung; Chang, Iksoo] Pusan Natl Univ, Dept Phys, Ctr Proteome Biophys, Pusan 609735, South Korea	Chung Ang University; Pusan National University; Scripps Research Institute; Yonsei University; Pusan National University	Lee, K (corresponding author), Chung Ang Univ, Dept Life Sci, Program BK21, Res Ctr Biomol & Biosyst, Seoul 156756, South Korea.	kangseok@cau.ac.kr; hnc@pusan.ac.kr		Moeller, Arne/0000-0003-1101-5366; Yu, Wookyung/0000-0001-9835-930X	Korea Research Foundation [NRF-2010-0015298]; 21C Frontier Microbial Genomics and Application Center Program; Joint Center for Innovation in Membrane Protein Production for Structure Determination [RFA-RM-08-019]; Ministry of Education, Science & Technology, Republic of Korea [2008-0061984]; National Institutes of Health through the National Center for Research Resources [RR17573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); 21C Frontier Microbial Genomics and Application Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Joint Center for Innovation in Membrane Protein Production for Structure Determination; Ministry of Education, Science & Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the Korea Research Foundation (NRF-2010-0015298) (to N.-C. H.), and the 21C Frontier Microbial Genomics and Application Center Program (to K. L). This work was also supported by the Joint Center for Innovation in Membrane Protein Production for Structure Determination (Grant RFA-RM-08-019) (to A. M.), and the National Creative Research Initiatives (Center for Proteome Biophysics, Grant No. 2008-0061984) (to I. C.) from the Ministry of Education, Science & Technology, Republic of Korea.; We thank Erica Jacovetty for assistance with EM data collection. EM imaging was performed at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources P41 program (RR17573).	Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bavro VN, 2008, MOL CELL, V30, P114, DOI 10.1016/j.molcel.2008.02.015; DeLano WL, 2002, PYMOL USERS MANUAL; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lewis K, 2000, CURR BIOL, V10, pR678, DOI 10.1016/S0960-9822(00)00682-5; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Roseman AM, 2003, ULTRAMICROSCOPY, V94, P225, DOI 10.1016/S0304-3991(02)00333-9; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Zgurskaya HI, 2009, BBA-PROTEINS PROTEOM, V1794, P794, DOI 10.1016/j.bbapap.2008.10.010; Zgurskaya HI, 1999, P NATL ACAD SCI USA, V96, P7190, DOI 10.1073/pnas.96.13.7190	29	45	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13541	13549		10.1074/jbc.M110.202598	http://dx.doi.org/10.1074/jbc.M110.202598			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325274	Green Published			2022-12-25	WOS:000289282200074
J	Pham, L; Kaiser, B; Romsa, A; Schwarz, T; Gopalakrishnan, R; Jensen, ED; Mansky, KC				Lan Pham; Kaiser, Bria; Romsa, Amanda; Schwarz, Toni; Gopalakrishnan, Raj; Jensen, Eric D.; Mansky, Kim C.			HDAC3 and HDAC7 Have Opposite Effects on Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; HISTONE DEACETYLASE INHIBITORS; OSTEOBLAST DIFFERENTIATION; TRICHOSTATIN-A; FACTOR FAMILY; P38 MAPK; C-FOS; MITF; RUNX2; TARGET	Histone deacetylases (HDACs) are negative regulators of transcription. Endochondral bone formation including chondrocyte and osteoblast maturation is regulated by HDACs. Very little is known about the role HDACs play in osteoclast differentiation. It has been previously reported that HDAC inhibitors, trichostatin A and sodium butyrate, suppress osteoclast differentiation through multiple mechanisms. In this study, we report that suppression of HDAC3 expression similar to HDAC inhibitors inhibits osteoclast differentiation, whereas osteoclasts suppressed for HDAC7 expression had accelerated differentiation when compared with control cells. Mitf, a transcription factor, is necessary for osteoclast differentiation. We demonstrate that Mitf and HDAC7 interact in RAW 264 cells and osteoclasts. The transcriptional activity of Mitf is repressed by HDAC7. Lastly, we show that either the amino or the carboxyl terminus of HDAC7 is sufficient for transcriptional repression and that the repression of HDAC7 is insensitive to trichostatin A, indicating that HDAC7 represses Mitf at least in part by deacetylation-independent mechanism.	[Gopalakrishnan, Raj; Jensen, Eric D.] Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Lan Pham; Kaiser, Bria; Romsa, Amanda; Schwarz, Toni; Mansky, Kim C.] Univ Minnesota, Sch Dent, Dept Dev & Surg Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jensen, ED (corresponding author), Univ Minnesota, Sch Dent, Dept Diagnost & Biol Sci, 16-108B Moos Tower,515 Delaware St SE, Minneapolis, MN 55455 USA.	jens0709@umn.edu; kmansky@umn.edu		Mansky, Kim/0000-0002-2826-5030; Schwarz, Toni/0000-0001-8694-2282	National Institutes of Health [R03 DE020117, R01 AR056642]; NIDCR [T32 DE007288]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020117, T32DE007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R03 DE020117 (to E. D. J.) and R01 AR056642 (to R. G.) and MinnCResT Grant T32 DE007288 from the NIDCR (to L. P.).	Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bronisz A, 2006, MOL BIOL CELL, V17, P3897, DOI 10.1091/mbc.E06-05-0470; Dressel U, 2001, J BIOL CHEM, V276, P17007, DOI 10.1074/jbc.M101508200; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gottesfeld JM, 2009, FUTUR NEUROL, V4, P775, DOI 10.2217/FNL.09.55; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hayashi M, 2007, J CELL SCI, V120, P1350, DOI 10.1242/jcs.000067; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hershey CL, 2004, BONE, V34, P689, DOI 10.1016/j.bone.2003.08.014; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kao HY, 2000, GENE DEV, V14, P55; Kim HN, 2009, EUR J PHARMACOL, V623, P22, DOI 10.1016/j.ejphar.2009.09.025; Kim K, 2007, J IMMUNOL, V178, P5588, DOI 10.4049/jimmunol.178.9.5588; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mansky KC, 2002, J LEUKOCYTE BIOL, V71, P295; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Rahman MM, 2003, BLOOD, V101, P3451, DOI 10.1182/blood-2002-08-2622; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Routy JP, 2005, LANCET, V366, P523, DOI 10.1016/S0140-6736(05)67074-2; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Steingrimsson E, 2002, P NATL ACAD SCI USA, V99, P4477, DOI 10.1073/pnas.072071099; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Weilbaecher KN, 2001, MOL CELL, V8, P749, DOI 10.1016/S1097-2765(01)00360-4; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Yi T, 2007, EXP MOL MED, V39, P213, DOI 10.1038/emm.2007.24	45	63	65	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.216853	http://dx.doi.org/10.1074/jbc.M110.216853			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324898	Green Published, hybrid			2022-12-25	WOS:000289077500020
J	Ruprecht, J; Iwata, S; Rothery, RA; Weiner, JH; Maklashina, E; Cecchini, G				Ruprecht, Jonathan; Iwata, So; Rothery, Richard A.; Weiner, Joel H.; Maklashina, Elena; Cecchini, Gary			Perturbation of the Quinone-binding Site of Complex II Alters the Electronic Properties of the Proximal [3Fe-4S] Iron-Sulfur Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI SUCCINATE-DEHYDROGENASE; ESCHERICHIA-COLI; FUMARATE REDUCTASE; UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; MACROMOLECULAR STRUCTURES; CATALYTIC-ACTIVITY; LIGAND COMPLEXES; HEME-B; PROTEIN	Succinate-ubiquinone oxidoreductase (SQR) and menaquinol-fumarate oxidoreductase (QFR) from Escherichia coli are members of the complex II family of enzymes. SQR and QFR catalyze similar reactions with quinones; however, SQR preferentially reacts with higher potential ubiquinones, and QFR preferentially reacts with lower potential naphthoquinones. Both enzymes have a single functional quinone-binding site proximal to a [3Fe-4S] iron-sulfur cluster. A difference between SQR and QFR is that the redox potential of the [3Fe-4S] cluster in SQR is 140 mV higher than that found in QFR. This may reflect the character of the different quinones with which the two enzymes preferentially react. To investigate how the environment around the [3Fe-4S] cluster affects its redox properties and catalysis with quinones, a conserved amino acid proximal to the cluster was mutated in both enzymes. It was found that substitution of SdhB His-207 by threonine (as found in QFR) resulted in a 70-mV lowering of the redox potential of the cluster as measured by EPR. The converse substitution in QFR raised the redox potential of the cluster. X-ray structural analysis suggests that placing a charged residue near the [3Fe-4S] cluster is a primary reason for the alteration in redox potential with the hydrogen bonding environment having a lesser effect. Steady state enzyme kinetic characterization of the mutant enzymes shows that the redox properties of the [3Fe-4S] cluster have only a minor effect on catalysis.	[Maklashina, Elena; Cecchini, Gary] Vet Affairs Med Ctr, Div Mol Biol, San Francisco, CA 94121 USA; [Ruprecht, Jonathan; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Mol Biosci Div, London SW7 2AZ, England; [Rothery, Richard A.; Weiner, Joel H.] Univ Alberta, Membrane Prot Res Grp, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Imperial College London; University of Alberta; University of California System; University of California San Francisco	Cecchini, G (corresponding author), Vet Affairs Med Ctr, Div Mol Biol, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Cecchini@ucsf.edu		Ruprecht, Jonathan/0000-0002-1838-7245; Rothery, Richard/0000-0003-3265-1783	National Institutes of Health [GM61606]; Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Biotechnology and Biological Sciences Research Council [B17935]; Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency; Canadian Institutes of Health Research [MOP89735]; Biotechnology and Biological Sciences Research Council [BB/C505116/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Biotechnology and Biological Sciences Research Council(US Department of Veterans AffairsUK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant GM61606. This work was also supported by the Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Division; Biotechnology and Biological Sciences Research Council Grant B17935 with contributions from the Human Receptor Crystallography Project, Exploratory Research for Advanced Technology (ERATO), Japan Science and Technology Agency; and Canadian Institutes of Health Research Grant MOP89735.	ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; Afonine PV, 2005, CCP4 NEWSL, V42; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BREITER DR, 1991, J BIOL CHEM, V266, P18660; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Cheng VWT, 2006, J BIOL CHEM, V281, P27662, DOI 10.1074/jbc.M604900200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Evrard GX, 2007, ACTA CRYSTALLOGR D, V63, P108, DOI 10.1107/S0907444906023389; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; Hagerhall C, 1999, J BIOL CHEM, V274, P26157, DOI 10.1074/jbc.274.37.26157; Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x; Horsefield R, 2006, J BIOL CHEM, V281, P7309, DOI 10.1074/jbc.M508173200; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Huang LS, 2006, J BIOL CHEM, V281, P5965, DOI 10.1074/jbc.M511270200; Iverson TM, 1999, SCIENCE, V284, P1961, DOI 10.1126/science.284.5422.1961; Jang SB, 2000, BIOCHEMISTRY-US, V39, P641, DOI 10.1021/bi991694v; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOWAL AT, 1995, BIOCHEMISTRY-US, V34, P12284, DOI 10.1021/bi00038a024; KURNIVKOV IV, 2006, HARLEM; Lancaster CRD, 2002, BBA-BIOENERGETICS, V1553, P1, DOI 10.1016/S0005-2728(01)00240-7; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; Maklashina E, 2006, J BIOL CHEM, V281, P11357, DOI 10.1074/jbc.M512544200; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Maklashina E, 2001, J BIOL CHEM, V276, P18968, DOI 10.1074/jbc.M011270200; Maklashina E, 2006, J BIOL CHEM, V281, P26655, DOI 10.1074/jbc.M602938200; MORNINGSTAR JE, 1985, J BIOL CHEM, V260, P3631; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OHNISHI T, 1976, J BIOL CHEM, V251, P2105; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; Oyedotun KS, 2007, BBA-BIOENERGETICS, V1767, P1436, DOI 10.1016/j.bbabio.2007.09.008; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rothery RA, 1996, BIOCHEMISTRY-US, V35, P3247, DOI 10.1021/bi951584y; Ruprecht J, 2009, J BIOL CHEM, V284, P29836, DOI 10.1074/jbc.M109.010058; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stephens PJ, 1996, CHEM REV, V96, P2491, DOI 10.1021/cr950045w; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tran QM, 2007, P NATL ACAD SCI USA, V104, P18007, DOI 10.1073/pnas.0707732104; Tran QM, 2006, J BIOL CHEM, V281, P32310, DOI 10.1074/jbc.M607476200; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; WESTENBERG DJ, 1993, J BIOL CHEM, V268, P815; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yankovskaya V, 2003, SCIENCE, V299, P700, DOI 10.1126/science.1079605	50	24	24	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.209874	http://dx.doi.org/10.1074/jbc.M110.209874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310949	Green Published, hybrid			2022-12-25	WOS:000289077500086
J	Wu, YZ; Antony, S; Juhasz, A; Lu, JM; Ge, Y; Jiang, GJ; Roy, K; Doroshow, JH				Wu, Yongzhong; Antony, Smitha; Juhasz, Agnes; Lu, Jiamo; Ge, Yun; Jiang, Guojian; Roy, Krishnendu; Doroshow, James H.			Up-regulation and Sustained Activation of Stat1 Are Essential for Interferon-gamma (IFN-gamma)-induced Dual Oxidase 2 (Duox2) and Dual Oxidase A2 (DuoxA2) Expression in Human Pancreatic Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-TRACT EPITHELIUM; FAMILY NADPH OXIDASES; IFN-GAMMA; NOX FAMILY; SER-727 PHOSPHORYLATION; TYROSINE PHOSPHATASES; DUCTAL ADENOCARCINOMA; GENE-EXPRESSION; HOST-DEFENSE; TRANSCRIPTION	Dual oxidase 2 is a member of the NADPH oxidase (Nox) gene family that plays a critical role in the biosynthesis of thyroid hormone as well as in the inflammatory response of the upper airway mucosa and in wound healing, presumably through its ability to generate reactive oxygen species, including H2O2. The recently discovered overexpression of Duox2 in gastrointestinal malignancies, as well as our limited understanding of the regulation of Duox2 expression, led us to examine the effect of cytokines and growth factors on Duox2 in human tumor cells. We found that exposure of human pancreatic cancer cells to IFN-gamma (but not other agents) produced a profound up-regulation of the expression of Duox2, and its cognate maturation factor DuoxA2, but not other members of the Nox family. Furthermore, increased Duox2/DuoxA2 expression was closely associated with a significant increase in the production of both intracellular reactive oxygen species and extracellular H2O2. Examination of IFN-gamma-mediated signaling events demonstrated that in addition to the canonical Jak-Stat1 pathway, IFN-gamma activated the p38-MAPK pathway in pancreatic cancer cells, and both played an important role in the induction of Duox2 by IFN-gamma. Duox2 up-regulation following IFN-gamma exposure is also directly associated with the binding of Stat1 to elements of the Duox2 promoter. Our findings suggest that the pro-inflammatory cytokine IFN-gamma initiates a Duox2-mediated reactive oxygen cascade in human pancreatic cancer cells; reactive oxygen species production in this setting could contribute to the pathophysiologic characteristics of these tumors.	[Wu, Yongzhong; Antony, Smitha; Juhasz, Agnes; Lu, Jiamo; Ge, Yun; Jiang, Guojian; Doroshow, James H.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Roy, Krishnendu; Doroshow, James H.] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Doroshow, JH (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bldg 31,Rm 3A-44,31 Ctr Dr, Bethesda, MD 20892 USA.	doroshoj@mail.nih.gov			NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC011076] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by a NCI, National Institutes of Health, grant.	Alexandratou E, 2005, FREE RADICAL BIO MED, V39, P1119, DOI 10.1016/j.freeradbiomed.2005.06.006; Andrianifahanana M, 2007, ONCOGENE, V26, P7251, DOI 10.1038/sj.onc.1210532; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Caillou B, 2001, J CLIN ENDOCR METAB, V86, P3351, DOI 10.1210/jc.86.7.3351; Chatterjee-Kishore M, 2000, EMBO J, V19, P4111, DOI 10.1093/emboj/19.15.4111; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Edderkaoui M, 2005, AM J PHYSIOL-GASTR L, V289, pG1137, DOI 10.1152/ajpgi.00197.2005; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Esposito I, 2004, J CLIN PATHOL, V57, P630, DOI 10.1136/jcp.2003.014498; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Grasberger H, 2006, J BIOL CHEM, V281, P18269, DOI 10.1074/jbc.C600095200; Greer JB, 2009, CURR OPIN PHARMACOL, V9, P411, DOI 10.1016/j.coph.2009.06.011; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; HANCOCK JT, 1987, BIOCHEM J, V242, P103, DOI 10.1042/bj2420103; Harper RW, 2006, FEBS LETT, V580, P5150, DOI 10.1016/j.febslet.2006.08.048; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hill T, 2010, BIOCHEM BIOPH RES CO, V395, P270, DOI 10.1016/j.bbrc.2010.04.004; Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Kovarik P, 1999, P NATL ACAD SCI USA, V96, P13956, DOI 10.1073/pnas.96.24.13956; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Kumatori A, 2002, J BIOL CHEM, V277, P9103, DOI 10.1074/jbc.M109803200; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lee JK, 2007, GASTROENTEROLOGY, V133, P1637, DOI 10.1053/j.gastro.2007.08.022; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Linderholm AL, 2010, AM J PHYSIOL-LUNG C, V299, pL215, DOI 10.1152/ajplung.00015.2010; Luxen S, 2008, CANCER RES, V68, P1037, DOI 10.1158/0008-5472.CAN-07-5782; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; Matsuo Y, 2004, PANCREAS, V28, P344, DOI 10.1097/00006676-200404000-00025; Mochizuki T, 2006, ONCOGENE, V25, P3699, DOI 10.1038/sj.onc.1209406; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; Pandol S, 2009, CLIN GASTROENTEROL H, V7, pS44, DOI 10.1016/j.cgh.2009.07.039; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramsauer K, 2002, P NATL ACAD SCI USA, V99, P12859, DOI 10.1073/pnas.192264999; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523; Vaquero EC, 2004, J BIOL CHEM, V279, P34643, DOI 10.1074/jbc.M400078200; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yu JH, 2005, INT J BIOCHEM CELL B, V37, P1458, DOI 10.1016/j.biocel.2005.02.004	53	47	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191031	http://dx.doi.org/10.1074/jbc.M110.191031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321110	Green Published, hybrid			2022-12-25	WOS:000289077500039
J	Kiparissides, A; Koutinas, M; Moss, T; Newman, J; Pistikopoulos, EN; Mantalaris, A				Kiparissides, Alexandros; Koutinas, Michalis; Moss, Toby; Newman, John; Pistikopoulos, Efstratios N.; Mantalaris, Athanasios			Modelling the Delta1/Notch1 Pathway: In Search of the Mediator(s) of Neural Stem Cell Differentiation	PLOS ONE			English	Article							PROMOTES NEURONAL DIFFERENTIATION; FEEDBACK LOOP; OSCILLATORY EXPRESSION; NEGATIVE REGULATION; LATERAL INHIBITION; NERVOUS-SYSTEM; TIME DELAYS; P19 CELLS; NOTCH; HES1	The Notch1 signalling pathway has been shown to control neural stem cell fate through lateral inhibition of mash1, a key promoter of neuronal differentiation. Interaction between the Delta1 ligand of a differentiating cell and the Notch1 protein of a neighbouring cell results in cleavage of the trans-membrane protein, releasing the intracellular domain (NICD) leading to the up regulation of hes1. Hes1 homodimerisation leads to down regulation of mash1. Most mathematical models currently represent this pathway up to the formation of the HES1 dimer. Herein, we present a detailed model ranging from the cleavage of the NICD and how this signal propagates through the Delta1/Notch1 pathway to repress the expression of the proneural genes. Consistent with the current literature, we assume that cells at the self renewal state are represented by a stable limit cycle and through in silico experimentation we conclude that a drastic change in the main pathway is required in order for the transition from self-renewal to differentiation to take place. Specifically, a model analysis based approach is utilised in order to generate hypotheses regarding potential mediators of this change. Through this process of model based hypotheses generation and testing, the degradation rates of Hes1 and Mash1 mRNA and the dissociation constant of Mash1-E47 heterodimers are identified as the most potent mediators of the transition towards neural differentiation.	[Kiparissides, Alexandros; Koutinas, Michalis; Moss, Toby; Newman, John; Pistikopoulos, Efstratios N.; Mantalaris, Athanasios] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Biol Syst Engn Lab, Ctr Proc Syst Engn, London SW7 2AZ, England	Imperial College London	Kiparissides, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Biol Syst Engn Lab, Ctr Proc Syst Engn, London SW7 2AZ, England.	a.mantalaris@imperial.ac.uk	Koutinas, Michalis/D-9515-2016; Kiparissides, Alexandros/N-4970-2014; Kiparissides, Alexandros/ABH-5729-2020	Koutinas, Michalis/0000-0002-5371-4280; Kiparissides, Alexandros/0000-0003-2923-2481; Kiparissides, Alexandros/0000-0003-2923-2481; Pistikopoulos, Stratos/0000-0001-6220-818X	European Union [029104]	European Union(European Commission)	This work was supported by the European Union with the following projects: a) PROBACTYS (FP6 - NEST-PATHFINDER EU call on Synthetic Biology, Project Number 029104), b) PSYSMO (BBSRC - ERA-NET program on the Systems Biology of Microorganisms) and c) TARPOL (FP7 EU - KBBE Coordination Action for SynBio in Environmental Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000390; Akiyama H, 2003, DEV BRAIN RES, V140, P45, DOI 10.1016/S0165-3806(02)00574-6; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bae SK, 2000, DEVELOPMENT, V127, P2933; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Boudjelal M, 1997, GENE DEV, V11, P2052, DOI 10.1101/gad.11.16.2052; BRATLEY P, 1988, ACM T MATH SOFTWARE, V14, P88, DOI 10.1145/42288.214372; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen H, 1997, P NATL ACAD SCI USA, V94, P5355, DOI 10.1073/pnas.94.10.5355; Cossins J, 2002, DEVELOPMENT, V129, P2195; Dai JP, 2010, J CELL BIOCHEM, V110, P1457, DOI 10.1002/jcb.22703; Eun B, 2010, BRAIN RES, V1313, P1, DOI 10.1016/j.brainres.2009.11.078; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; FOX BL, 1986, ACM T MATH SOFTWARE, V12, P362, DOI 10.1145/22721.356187; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Jensen MH, 2003, FEBS LETT, V541, P176, DOI 10.1016/S0014-5793(03)00279-5; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kageyama R, 1999, CELL RES, V9, P179, DOI 10.1038/sj.cr.7290016; Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208; Kageyama R, 2009, CURR OPIN CELL BIOL, V21, P733, DOI 10.1016/j.ceb.2009.08.009; Kato H, 1997, DEVELOPMENT, V124, P4133; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Kiparissides A, 2009, IND ENG CHEM RES, V48, P7168, DOI 10.1021/ie900139x; Kocis L, 1997, ACM T MATH SOFTWARE, V23, P266, DOI 10.1145/264029.264064; KONTORAVDI C, 2010, COMPUTERS C IN PRESS; Koutinas M, 2010, ENVIRON MICROBIOL, V12, P1705, DOI 10.1111/j.1462-2920.2010.02245.x; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Kucherenko S, 2009, RELIAB ENG SYST SAFE, V94, P1135, DOI 10.1016/j.ress.2008.05.006; Lam MC, 2009, THESIS IMPERIAL COLL; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Momiji H, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021930; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; MOROKOFF WJ, 1993, SIAM J NUMER ANAL, V30, P1558, DOI 10.1137/0730081; MUSKAVITCH MAT, 1994, DEV BIOL, V166, P415, DOI 10.1006/dbio.1994.1326; Nagarsheth MH, 2006, J NEUROL SCI, V244, P111, DOI 10.1016/j.jns.2006.01.007; Sobol I.M., 1967, USSR COMP MATH MATH, V7, P86, DOI [DOI 10.1016/0041-5553(67)90144-9, 10.1016/0041-5553(67)90144-9]; Sriuranpong V, 2002, MOL CELL BIOL, V22, P3129, DOI 10.1128/MCB.22.9.3129-3139.2002; Veflingstad SR, 2005, PHYSICA D, V207, P254, DOI 10.1016/j.physd.2005.06.006; Vinals F, 2004, EMBO J, V23, P3527, DOI 10.1038/sj.emboj.7600360; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zeiser S, 2007, J COMPUT BIOL, V14, P984, DOI 10.1089/cmb.2007.0029	51	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14668	10.1371/journal.pone.0014668	http://dx.doi.org/10.1371/journal.pone.0014668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346804	Green Submitted, Green Published, gold			2022-12-25	WOS:000287077600004
J	Lin, TC; Lee, TC; Hsu, SL; Yang, CS				Lin, Tsung-Chieh; Lee, Tien-Chiang; Hsu, Shih-Lan; Yang, Chung-Shi			The Molecular Mechanism of Leptin Secretion and Expression Induced by Aristolochic Acid in Kidney Fibroblast	PLOS ONE			English	Article							BINDING PROTEIN-ALPHA; MOUSE OBESE GENE; TGF-BETA; RAT ADIPOCYTES; IN-VIVO; OB GENE; RECEPTOR; INSULIN; ACTIVATION; CELLS	Background: Leptin is a peptide hormone playing pivotal role in regulating food intake and energy expenditure. Growing evidence has suggested the pro-inflammatory and fibrogenic properties of leptin. In addition, patients with renal fibrosis have higher level of plasma leptin, which was due to the increased leptin production. Aristolochic acid (AA) is a botanical toxin characterized to associate with the development of renal fibrosis including tubulointerstitial fibrosis. However, whether leptin is upregulated to participate in AA-induced kidney fibrosis remain completely unknown. Methodology/Principal Findings: In this study, leptin expression was increased by sublethal dose of AA in kidney fibroblast NRK49f determined by enzyme-linked immunosorbent assay and Western blot. Data from real-time reverse transcriptase-polymerase chain reaction revealed that leptin was upregulated by AA at transcriptional level. DNA binding activity of CCAAT enhancer binding protein alpha (C/EBP alpha), one of the transcription factors for leptin gene, was enhanced in DNA affinity precipitation assay and chromatin immunoprecipitation experiments. Knockdown of C/EBP alpha expression by small interfering RNA markedly reduced AA-induced leptin expression. Moreover, AA promoted Akt interaction with p-PDK1, and increased phosphorylated activation of Akt. Akt knockdown, and inhibition of Akt signaling by LY294002 and mTOR inhibitor rapamycin reduced leptin expression. Furthermore, treatment of LY294002 or rapamycin significantly suppressed AAinduced C/EBP alpha DNA-binding activity. These results suggest that Akt and C/EBP alpha activation were involved in AA-regulated leptin expression. Conclusions/Significance: Our findings demonstrate the first that AA could induce secretion and expression of fibrogenic leptin in kidney fibroblasts, which reveal potential involvement of leptin in the progression of kidney fibrosis in aristolochic acid nephropathy.	[Lin, Tsung-Chieh; Yang, Chung-Shi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lee, Tien-Chiang; Hsu, Shih-Lan] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Yang, Chung-Shi] Ctr Nanomed Res, Natl Hlth Res Inst, Miaoli, Taiwan	National Defense Medical Center; Taichung Veterans General Hospital; National Health Research Institutes - Taiwan	Lin, TC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	h2326@vghtc.gov.tw; cyang@nhri.org.tw	Yang, Chung-Shi/E-3999-2010		Taichung Veterans General Hospital [TCVGH977313C, TCVGH-NCNU987901]; National Chi Nan University [TCVGH-NCNU987901]; National Science Council (Taiwan) [NSC98-3112-B-075A-001-]	Taichung Veterans General Hospital; National Chi Nan University; National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants from the Taichung Veterans General Hospital (TCVGH977313C), the Taichung Veterans General Hospital and National Chi Nan University (TCVGH-NCNU987901), and National Science Council (Taiwan) (NSC98-3112-B-075A-001-) to Dr. Shih-Lan Hsu. http://web1.nsc.gov.tw/mp.aspx?mp=7, http://www.vghtc.gov.tw/portal/english/introduction.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi S, 2007, MOL ENDOCRINOL, V21, P843, DOI 10.1210/me.2006-0244; Auwerx J, 1998, LANCET, V351, P737, DOI 10.1016/S0140-6736(97)06348-4; Barr VA, 1997, ENDOCRINOLOGY, V138, P4463, DOI 10.1210/en.138.10.4463; Bradley RL, 1999, DIABETES, V48, P272, DOI 10.2337/diabetes.48.2.272; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Chakrabarti P, 2008, MOL ENDOCRINOL, V22, P2260, DOI 10.1210/me.2008-0148; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Glasow A, 2001, J CLIN ENDOCR METAB, V86, P4472, DOI 10.1210/jc.86.9.4472; Han DC, 2001, KIDNEY INT, V59, P1315, DOI 10.1046/j.1523-1755.2001.0590041315.x; HE YF, 1995, J BIOL CHEM, V270, P28887, DOI 10.1074/jbc.270.48.28887; Hollenberg AN, 1997, J BIOL CHEM, V272, P5283, DOI 10.1074/jbc.272.8.5283; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Kumpers P, 2007, AM J PHYSIOL-RENAL, V293, pF1355, DOI 10.1152/ajprenal.00003.2007; Lan HY, 2003, CURR OPIN NEPHROL HY, V12, P25, DOI 10.1097/00041552-200301000-00005; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lee MJ, 2007, J BIOL CHEM, V282, P72, DOI 10.1074/jbc.M609518200; Lee MJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1230, DOI 10.1152/ajpendo.90927.2008; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Meng XJ, 2008, CARCINOGENESIS, V29, P1013, DOI 10.1093/carcin/bgn035; Merabet E, 1997, J CLIN ENDOCR METAB, V82, P847, DOI 10.1210/jc.82.3.847; Park S, 2010, HAEMATOL-HEMATOL J, V95, P819, DOI 10.3324/haematol.2009.013797; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Roberts ISD, 1997, J CLIN PATHOL, V50, P123, DOI 10.1136/jcp.50.2.123; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Takaya K, 1996, BIOCHEM BIOPH RES CO, V225, P75, DOI 10.1006/bbrc.1996.1133; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Villarreal D, 2000, KIDNEY INT, V58, P989, DOI 10.1046/j.1523-1755.2000.00256.x; Wang Yan-Yan, 2009, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V31, P476; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Yoshida T, 1996, EUR J ENDOCRINOL, V135, P619, DOI 10.1530/eje.0.1350619; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	40	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16654	10.1371/journal.pone.0016654	http://dx.doi.org/10.1371/journal.pone.0016654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304902	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600012
J	Foscarin, S; Ponchione, D; Pajaj, E; Leto, K; Gawlak, M; Wilczynski, GM; Rossi, F; Carulli, D				Foscarin, Simona; Ponchione, Danilo; Pajaj, Ermira; Leto, Ketty; Gawlak, Maciej; Wilczynski, Grzegorz M.; Rossi, Ferdinando; Carulli, Daniela			Experience-Dependent Plasticity and Modulation of Growth Regulatory Molecules at Central Synapses	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; ADULT VISUAL-CORTEX; CEREBELLAR GABAERGIC INTERNEURONS; CHONDROITIN SULFATE PROTEOGLYCAN; PERINEURONAL NETS; GENE-EXPRESSION; RAT CEREBELLUM; NERVOUS-SYSTEM; NEURITE GROWTH; MATRIX METALLOPROTEINASES	Structural remodeling or repair of neural circuits depends on the balance between intrinsic neuronal properties and regulatory cues present in the surrounding microenvironment. These processes are also influenced by experience, but it is still unclear how external stimuli modulate growth-regulatory mechanisms in the central nervous system. We asked whether environmental stimulation promotes neuronal plasticity by modifying the expression of growth-inhibitory molecules, specifically those of the extracellular matrix. We examined the effects of an enriched environment on neuritic remodeling and modulation of perineuronal nets in the deep cerebellar nuclei of adult mice. Perineuronal nets are meshworks of extracellular matrix that enwrap the neuronal perikaryon and restrict plasticity in the adult CNS. We found that exposure to an enriched environment induces significant morphological changes of Purkinje and precerebellar axon terminals in the cerebellar nuclei, accompanied by a conspicuous reduction of perineuronal nets. In the animals reared in an enriched environment, cerebellar nuclear neurons show decreased expression of mRNAs coding for key matrix components (as shown by real time PCR experiments), and enhanced activity of matrix degrading enzymes (matrix metalloproteinases 2 and 9), which was assessed by in situ zymography. Accordingly, we found that in mutant mice lacking a crucial perineuronal net component, cartilage link protein 1, perineuronal nets around cerebellar neurons are disrupted and plasticity of Purkinje cell terminal is enhanced. Moreover, all the effects of environmental stimulation are amplified if the afferent Purkinje axons are endowed with enhanced intrinsic growth capabilities, induced by overexpression of GAP-43. Our observations show that the maintenance and growth-inhibitory function of perineuronal nets are regulated by a dynamic interplay between pre-and postsynaptic neurons. External stimuli act on this interaction and shift the balance between synthesis and removal of matrix components in order to facilitate neuritic growth by locally dampening the activity of inhibitory cues.	[Foscarin, Simona; Ponchione, Danilo; Pajaj, Ermira; Leto, Ketty; Rossi, Ferdinando; Carulli, Daniela] Univ Turin, Dept Neurosci, NIT, Turin, Italy; [Foscarin, Simona; Ponchione, Danilo; Pajaj, Ermira; Leto, Ketty; Rossi, Ferdinando; Carulli, Daniela] Univ Turin, Neurosci Inst Cavalieri Ottolenghi Fdn NICO, Turin, Italy; [Gawlak, Maciej; Wilczynski, Grzegorz M.] Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, Warsaw, Poland	University of Turin; University of Turin; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Foscarin, S (corresponding author), Univ Turin, Dept Neurosci, NIT, Turin, Italy.	ferdinando.rossi@unito.it	Carulli, Daniela/AEQ-2246-2022	Gawlak, Maciej/0000-0002-7241-6326; Carulli, Daniela/0000-0003-1365-7063; Wilczynski, Grzegorz/0000-0001-6667-0291	International Foundation for Research in Paraplegia (IFP - Zurich); Regione Piemonte; MIUR; Polish-Norwegian; NENS	International Foundation for Research in Paraplegia (IFP - Zurich); Regione Piemonte(Regione Piemonte); MIUR(Ministry of Education, Universities and Research (MIUR)); Polish-Norwegian; NENS	The work was supported by the International Foundation for Research in Paraplegia (IFP - Zurich), Regione Piemonte, MIUR ex 60% and Polish-Norwegian Research Grant (to GW). SF was recipient of a NENS Stipend for Training Stay to visit the Nencki Institute in Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Baroncelli L, 2010, EXP NEUROL, V226, P100, DOI 10.1016/j.expneurol.2010.08.009; Boda E, 2009, J MOL NEUROSCI, V37, P238, DOI 10.1007/s12031-008-9128-9; Buffo A, 1997, J NEUROSCI, V17, P8778; Buffo A, 2000, J NEUROSCI, V20, P2275; Caroni P, 1997, J CELL BIOL, V136, P679, DOI 10.1083/jcb.136.3.679; Carulli D, 2006, J COMP NEUROL, V494, P559, DOI 10.1002/cne.20822; Carulli D, 2010, BRAIN, V133, P2331, DOI 10.1093/brain/awq145; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Corvetti L, 2005, J NEUROSCI, V25, P7150, DOI 10.1523/JNEUROSCI.0683-05.2005; Czipri M, 2003, J BIOL CHEM, V278, P39214, DOI 10.1074/jbc.M303329200; Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008; Fawcett JW, 2009, NAT MED, V15, P735, DOI 10.1038/nm0709-735; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Foscarin S, 2009, EUR J NEUROSCI, V30, P1837, DOI 10.1111/j.1460-9568.2009.06985.x; Gawlak M, 2009, NEUROSCIENCE, V158, P167, DOI 10.1016/j.neuroscience.2008.05.045; Ghiani CA, 2007, GLIA, V55, P966, DOI 10.1002/glia.20521; Gianola S, 2004, EUR J NEUROSCI, V19, P819, DOI 10.1111/j.0953-816X.2004.03190.x; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hoebeek FE, 2008, CEREBELLUM, V7, P547, DOI 10.1007/s12311-008-0086-0; Itano N, 2002, IUBMB LIFE, V54, P195, DOI 10.1080/15216540214929; Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P290, DOI 10.1006/nlme.1998.3828; Klintsova AY, 1999, CURR OPIN NEUROBIOL, V9, P203, DOI 10.1016/S0959-4388(99)80028-2; Leto K, 2006, J NEUROSCI, V26, P11682, DOI 10.1523/JNEUROSCI.3656-06.2006; Leto K, 2009, J NEUROSCI, V29, P7079, DOI 10.1523/JNEUROSCI.0957-09.2009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonetti G, 2010, BIOL PSYCHIAT, V67, P657, DOI 10.1016/j.biopsych.2009.12.022; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Miyata S, 2004, BRAIN RES, V1017, P163, DOI 10.1016/j.brainres.2004.05.034; Morita S, 2010, NEUROSCIENCE, V166, P1068, DOI 10.1016/j.neuroscience.2010.01.041; Muir EM, 2002, MOL BRAIN RES, V100, P103, DOI 10.1016/S0169-328X(02)00132-8; Nakamura H, 2000, J BIOL CHEM, V275, P38885, DOI 10.1074/jbc.M003875200; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Person AL, 2010, NEURON, V66, P550, DOI 10.1016/j.neuron.2010.04.024; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Powell CM, 2006, NEUROBIOL LEARN MEM, V85, P2, DOI 10.1016/j.nlm.2005.08.014; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Reeves TM, 2003, J NEUROSCI, V23, P10182; Reimers S, 2007, EUR J NEUROSCI, V25, P2640, DOI 10.1111/j.1460-9568.2007.05514.x; ROSSI F, 1987, NEUROSCIENCE, V22, P99, DOI 10.1016/0306-4522(87)90201-6; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Vaillant C, 1999, J NEUROSCI, V19, P4994; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Zuo J, 1998, J NEUROSCI, V18, P5203, DOI 10.1523/JNEUROSCI.18-14-05203.1998	55	87	87	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16666	10.1371/journal.pone.0016666	http://dx.doi.org/10.1371/journal.pone.0016666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304956	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300112
J	Davis, MI; Puhl, HL				Davis, Margaret I.; Puhl, Henry L., III			Nr4a1-eGFP Is a Marker of Striosome-Matrix Architecture, Development and Activity in the Extended Striatum	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MU-OPIOID RECEPTOR; COMPARTMENTAL ORGANIZATION; TRANSCRIPTION FACTORS; SUBSTANCE-P; DOPAMINE D1; RAT-BRAIN; NGFI-B; IMMUNOCYTOCHEMICAL LOCALIZATION; TOPOGRAPHICAL ORGANIZATION	Transgenic mice expressing eGFP under population specific promoters are widely used in neuroscience to identify specific subsets of neurons in situ and as sensors of neuronal activity in vivo. Mice expressing eGFP from a bacterial artificial chromosome under the Nr4a1 promoter have high expression within the basal ganglia, particularly within the striosome compartments and striatal-like regions of the extended amygdala (bed nucleus of the stria terminalis, striatal fundus, central amygdaloid nucleus and intercalated cells). Grossly, eGFP expression is inverse to the matrix marker calbindin 28K and overlaps with mu-opioid receptor immunoreactivity in the striatum. This pattern of expression is similar to Drd1, but not Drd2, dopamine receptor driven eGFP expression in structures targeted by medium spiny neuron afferents. Striosomal expression is strong developmentally where Nr4a1-eGFP expression overlaps with Drd1, TrkB, tyrosine hydroxylase and phospho-ERK, but not phospho-CREB, immunoreactivity in "dopamine islands''. Exposure of adolescent mice to methylphenidate resulted in an increase in eGFP in both compartments in the dorsolateral striatum but eGFP expression remained brighter in the striosomes. To address the role of activity in Nr4a1-eGFP expression, primary striatal cultures were prepared from neonatal mice and treated with forskolin, BDNF, SKF-83822 or high extracellular potassium and eGFP was measured fluorometrically in lysates. eGFP was induced in both neurons and contaminating glia in response to forskolin but SKF-83822, brain derived neurotrophic factor and depolarization increased eGFP in neuronal-like cells selectively. High levels of eGFP were primarily associated with Drd1+ neurons in vitro detected by immunofluorescence; however similar to 15% of the brightly expressing cells contained punctate met-enkephalin immunoreactivity. The Nr4a1-GFP mouse strain will be a useful model for examining the connectivity, physiology, activity and development of the striosome system.	[Davis, Margaret I.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD USA; [Puhl, Henry L., III] NIAAA, Lab Mol Physiol, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Davis, MI (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD USA.	midavis@mail.nih.gov	Davis, Margaret/F-4165-2010	Davis, Margaret/0000-0002-0489-8351; Puhl, Henry/0000-0003-3095-7201	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural and Biomedical Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural and Biomedical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural and Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama K, 2008, PROG NEURO-PSYCHOPH, V32, P1957, DOI 10.1016/j.pnpbp.2008.09.021; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Ammon S, 2003, MOL BRAIN RES, V112, P113, DOI 10.1016/S0169-328X(03)00057-3; Backman C, 2002, SYNAPSE, V44, P158, DOI 10.1002/syn.10065; Barth AL, 2007, CURR OPIN NEUROBIOL, V17, P567, DOI 10.1016/j.conb.2007.10.003; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berretta S, 1997, J NEUROSCI, V17, P4752; BONDY GP, 1991, CELL GROWTH DIFFER, V2, P203; Bourhis E, 2009, PSYCHOPHARMACOLOGY, V202, P635, DOI 10.1007/s00213-008-1343-0; BOWEN WD, 1981, P NATL ACAD SCI-BIOL, V78, P4818, DOI 10.1073/pnas.78.8.4818; Breuer O, 2005, NEUROSCI LETT, V385, P198, DOI 10.1016/j.neulet.2005.05.029; Bubser M, 2000, EUR J NEUROSCI, V12, P1591, DOI 10.1046/j.1460-9568.2000.00052.x; CAILLE I, 1995, EUR J NEUROSCI, V7, P714, DOI 10.1111/j.1460-9568.1995.tb00675.x; Canales JJ, 2005, NEUROBIOL LEARN MEM, V83, P93, DOI 10.1016/j.nlm.2004.10.006; Capper-Loup C, 2002, J NEUROSCI, V22, P6218; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Costantini LC, 1999, NEUROSCIENCE, V89, P505, DOI 10.1016/S0306-4522(98)00287-5; DESBAN M, 1993, NEUROSCIENCE, V57, P661, DOI 10.1016/0306-4522(93)90013-6; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; EBRAHIMI A, 1992, NEUROSCI RES, V14, P39, DOI 10.1016/S0168-0102(05)80005-7; EDLEY SM, 1984, BRAIN RES, V305, P27, DOI 10.1016/0006-8993(84)91116-8; FISHELL G, 1987, J NEUROSCI, V7, P1969; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fujiyama F, 2006, EUR J NEUROSCI, V24, P2813, DOI 10.1111/j.1460-9568.2006.05177.x; Fuxe K, 2003, NEUROSCIENCE, V119, P733, DOI 10.1016/S0306-4522(03)00148-9; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1987, J NEUROSCI, V7, P3935; GERFEN CR, 1992, TRENDS NEUROSCI, V15, P133, DOI 10.1016/0166-2236(92)90355-C; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GOTO S, 1989, EXP BRAIN RES, V77, P442, DOI 10.1007/BF00275004; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1984, NEUROSCIENCE, V13, P1157, DOI 10.1016/0306-4522(84)90293-8; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; Hartig W, 2003, J COMP NEUROL, V465, P1, DOI 10.1002/cne.10789; Hassoun AT, 2007, J NEUROSCI METH, V166, P178, DOI 10.1016/j.jneumeth.2007.07.008; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KANEKO T, 1995, NEUROSCI LETT, V184, P149, DOI 10.1016/0304-3940(94)11192-L; KANG SA, BIOCH PHARM, V80, P867; Kaoru T, 2010, NEUROSCIENCE, V166, P220, DOI 10.1016/j.neuroscience.2009.12.004; Katagiri Y, 2000, NAT CELL BIOL, V2, P435, DOI 10.1038/35017072; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; Koshimizu Y, 2008, EUR J NEUROSCI, V28, P2053, DOI 10.1111/j.1460-9568.2008.06502.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lam BYH, 2010, J NEUROCHEM, V112, P1065, DOI 10.1111/j.1471-4159.2009.06521.x; Lam BYH, 2009, J BIOL CHEM, V284, P12562, DOI 10.1074/jbc.M901121200; Lawhorn C, 2009, NEUROSCIENCE, V163, P109, DOI 10.1016/j.neuroscience.2009.05.021; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; LIU FC, 1995, J NEUROSCI, V15, P2367, DOI 10.1523/JNEUROSCI.15-03-02367.1995; LIU FC, 1992, J COMP NEUROL, V320, P304, DOI 10.1002/cne.903200304; Liu FC, 1998, DEV NEUROSCI-BASEL, V20, P229, DOI 10.1159/000017316; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lynch WJ, 2008, BRAIN RES, V1213, P166, DOI 10.1016/j.brainres.2008.02.106; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; Matamales M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004770; MILLHOUSE OE, 1986, J COMP NEUROL, V247, P246, DOI 10.1002/cne.902470209; Miura M, 2007, J NEUROSCI, V27, P9721, DOI 10.1523/JNEUROSCI.2993-07.2007; MURRIN LC, 1984, NEUROSCI LETT, V47, P155, DOI 10.1016/0304-3940(84)90422-1; No H, 2010, NEUROCHEM INT, V56, P620, DOI 10.1016/j.neuint.2010.01.005; OLSON L, 1972, BRAIN RES, V44, P283, DOI 10.1016/0006-8993(72)90385-X; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; PENNY GR, 1986, NEUROSCIENCE, V17, P1011, DOI 10.1016/0306-4522(86)90076-X; PERT CB, 1976, P NATL ACAD SCI USA, V73, P3729, DOI 10.1073/pnas.73.10.3729; RAO PA, 1991, DEV BRAIN RES, V60, P161, DOI 10.1016/0165-3806(91)90045-K; Seifert U, 1998, BRAIN RES, V795, P227, DOI 10.1016/S0006-8993(98)00298-4; SNYDERKELLER AM, 1991, J NEUROSCI, V11, P810; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; Tan A, 2000, J NEUROCHEM, V74, P2074, DOI 10.1046/j.1471-4159.2000.0742074.x; TEMPEL A, 1987, P NATL ACAD SCI USA, V84, P4308, DOI 10.1073/pnas.84.12.4308; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; VOORN P, 1989, J COMP NEUROL, V289, P189, DOI 10.1002/cne.902890202; Waclaw RR, 2010, J NEUROSCI, V30, P6944, DOI 10.1523/JNEUROSCI.5772-09.2010; Wang H, 1996, J COMP NEUROL, V375, P659, DOI 10.1002/(SICI)1096-9861(19961125)375:4<659::AID-CNE7>3.0.CO;2-0; Wang HB, 2007, NEUROSCI LETT, V425, P195, DOI 10.1016/j.neulet.2007.08.033; Wang JQ, 1996, BRAIN RES BULL, V39, P349, DOI 10.1016/0361-9230(96)00002-0; Werme M, 2000, MOL BRAIN RES, V76, P18, DOI 10.1016/S0169-328X(99)00327-7; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6; ZAHM DS, 1991, BRAIN RES, V552, P164, DOI 10.1016/0006-8993(91)90675-L; 1993, J COMP NEUROL, V337, P267	86	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16619	10.1371/journal.pone.0016619	http://dx.doi.org/10.1371/journal.pone.0016619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305052	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100051
J	Chen, C; Wei, Y; Hummel, M; Hoffmann, TK; Gross, M; Kaufmann, AM; Albers, AE				Chen, Chao; Wei, Yan; Hummel, Michael; Hoffmann, Thomas K.; Gross, Manfred; Kaufmann, Andreas M.; Albers, Andreas E.			Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1; BREAST-CANCER; TUMOR PROGRESSION; MARKER; IDENTIFICATION; PHENOTYPE; TUMORIGENICITY; SUBPOPULATION; POPULATIONS; METASTASIS	Initiation, growth, recurrence, and metastasis of head and neck squamous cell carcinomas (HNSCC) have been related to the behavior of cancer stem cells (CSC) that can be identified by their aldehyde-dehydrogenase-isoform-1 (ALDH1) activity. We quantified and enriched ALDH1(+) cells within HNSCC cell lines and subsequently characterized their phenotypical and functional properties like invasion capacity and epithelial-mesenchymal transition (EMT). Spheroid culture enriched CSC from five HNSCC cell lines by up to 5-fold. In spheroid-derived cells (SDC) and the parental monolayer-derived cell line ALDH1, CD44, CD24, E-Cadherin, alpha-SMA, and Vimentin expression was compared by flow-cytometry and immunofluorescence together with proliferation and cell cycle analysis. Invasion activity was evaluated by Matrigel assay and expression of stemness-related transcription factors (TF) Nanog, Oct3/4, Sox2 and EMT-related genes Snail1 and 2, and Twist by real-time PCR. All cell lines formed spheroids that could self-renew and be serially re-passaged. ALDH1 expression was significantly higher in SDC. ALDH1+ cells showed increased colony-formation. The proportion of cells with a putative CSC marker constellation of CD44(+)/CD24(-) was highly variable (0.5% to 96%) in monolayer and spheroid cultures and overlapped in 0%-33% with the CD44(+)/CD24(-)/ALDH1(+) cell subset. SDC had significantly higher invading activity. mRNA of the stemness-related genes Sox2, Nanog, and Oct3/4 was significantly increased in SDC of all cell lines. Twist was significantly increased in two while Snail2 showed a significant increase in one and a significant decrease in SDC of two cell lines. SDC had a higher G0 phase proportion, showed high-level expression of alpha-SMA and Vimentin, but significantly decreased E-Cadherin expression. HNSCC-lines harbor potential CSC, characterized by ALDH1 and stemness marker TF expression as well as properties like invasiveness, quiescence, and EMT. CSC can be enriched by anchorage-independent culture techniques, which may be important for the investigation of their contribution to therapy resistance, tumor recurrence and metastasis.	[Chen, Chao; Wei, Yan; Albers, Andreas E.] Charite, Dept Otolaryngol Head & Neck Surg, D-13353 Berlin, Germany; [Hummel, Michael] Charite, Dept Pathol, D-13353 Berlin, Germany; [Hoffmann, Thomas K.] Univ Essen Gesamthsch, Dept Otolaryngol Head & Neck Surg, Essen, Germany; [Gross, Manfred] Charite, Dept Audiol & Phoniatr, D-13353 Berlin, Germany; [Kaufmann, Andreas M.] Charite, Clin Gynecol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chen, C (corresponding author), Charite, Dept Otolaryngol Head & Neck Surg, D-13353 Berlin, Germany.	andreas.albers@charite.de	Albers, Andreas E./AAP-4669-2021; Albers, Andreas E./AAP-4649-2021	Albers, Andreas E./0000-0001-5614-9873; Albers, Andreas E./0000-0001-5614-9873; Hummel, Michael/0000-0001-6717-605X; Kaufmann, Andreas/0000-0001-7732-3009	Charite-Universitatsmedizin	Charite-Universitatsmedizin	The study was funded entirely by money from Charite-Universitatsmedizin. No external funding sources for this study were used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Ballo H, 1999, ANTICANCER RES, V19, P3827; Baum B, 2008, SEMIN CELL DEV BIOL, V19, P294, DOI 10.1016/j.semcdb.2008.02.001; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chen YC, 2010, ORAL ONCOL, V46, P158, DOI 10.1016/j.oraloncology.2009.11.007; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Ea CK, 2009, P NATL ACAD SCI USA, V106, P18972, DOI 10.1073/pnas.0910439106; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hay ED, 1995, ACTA ANAT, V154, P8; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ji JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008065; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MASHBERG A, 1993, NEW ENGL J MED, V328, P1783; MASTERS JRW, 2002, HEAD NECK CANC HUMAN, P185; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Perez-Pomares JM, 2002, ANAT RECORD, V268, P343, DOI 10.1002/ar.10165; Petersen OW, 2003, AM J PATHOL, V162, P391, DOI 10.1016/S0002-9440(10)63834-5; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Radisky DC, 2008, CELL STEM CELL, V2, P511, DOI 10.1016/j.stem.2008.05.007; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Santini MT, 1999, INT J RADIAT BIOL, V75, P787, DOI 10.1080/095530099139845; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sodek KL, 2009, INT J CANCER, V124, P2060, DOI 10.1002/ijc.24188; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Turley EA, 2008, NAT CLIN PRACT ONCOL, V5, P280, DOI 10.1038/ncponc1089; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	51	34	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16466	10.1371/journal.pone.0016466	http://dx.doi.org/10.1371/journal.pone.0016466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304586	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900054
J	Ezquer, F; Ezquer, M; Simon, V; Conget, P				Ezquer, Fernando; Ezquer, Marcelo; Simon, Valeska; Conget, Paulette			The Antidiabetic Effect of MSCs Is Not Impaired by Insulin Prophylaxis and Is Not Improved by a Second Dose of Cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEPATOCYTE GROWTH-FACTOR; VERSUS-HOST-DISEASE; BONE-MARROW-CELLS; STROMAL CELLS; ISLET TRANSPLANTATION; PROGENITOR CELLS; DIABETIC MICE; IN-VITRO; TISSUE-REPAIR	Type 1 diabetes mellitus (T1D) is due to autoimmune destruction of pancreatic beta-cells. Previously, we have shown that intravenously administered bone marrow-derived multipotent mesenchymal stromal cells (MSCs) allows pancreatic islet recovery, improves insulin secretion and reverts hyperglycemia in low doses streptozotocin (STZ)-induced diabetic mice. Here we evaluate whether insulin prophylaxis and the administration of a second dose of cells affect the antidiabetic therapeutic effect of MSC transplantation. Insulitis and subsequent elimination of pancreatic beta-cells was promoted in C57BL/6 mice by the injection of 40 mg/kg/day STZ for five days. Twenty-four days later, diabetic mice were distributed into experimental groups according to if they received or not insulin and/or one or two doses of healthy donor-derived MSCs. Three and half months later: glycemia, pancreatic islets number, insulinemia, glycated hemoglobin level and glucose tolerance were determined in animals that did not received exogenous insulin for the last 1.5 months. Also, we characterized MSCs isolated from mice healthy or diabetic. The therapeutic effect of MSC transplantation was observed in diabetic mice that received or not insulin prophylaxis. Improvements were similar irrespective if they received one or two doses of cells. Compared to MSCs from healthy mice, MSCs from diabetic mice had the same proliferation and adipogenic potentials, but were less abundant, with altered immunophenotype and no osteogenic potential. Our preclinical results should be taken into account when designing phase II clinical trials aimed to evaluate MSC transplantation in patients with T1D. Cells should be isolated form healthy donor, insulin prophylaxis could be maintained and a second dose, after an elapse of two months, appears unnecessary in the medium-term.	[Ezquer, Fernando; Ezquer, Marcelo; Simon, Valeska; Conget, Paulette] Univ Desarrollo, Clin Alemana, Fac Med, Inst Ciencias, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo	Ezquer, F (corresponding author), Univ Desarrollo, Clin Alemana, Fac Med, Inst Ciencias, Santiago, Chile.	pconget@udd.cl	Ezquer, Fernando/AHC-7601-2022	Ezquer, Marcelo/0000-0002-2064-3041; Ezquer, Fernando/0000-0002-7696-4215; Conget, Paulette/0000-0002-2530-7936	Fondo Nacional de Desarrollo Cientifico y Tecnologico [11085033]; Proyecto Bicentenario de Ciencia y Tecnologia [PSD-34]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Bicentenario de Ciencia y Tecnologia	This work was supported by grants Fondo Nacional de Desarrollo Cientifico y Tecnologico # 11085033 to F. E. and Proyecto Bicentenario de Ciencia y Tecnologia # PSD-34 to P. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Arsie MP, 2000, ACTA DIABETOL, V37, P1, DOI 10.1007/s005920070028; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Boumaza I, 2009, J AUTOIMMUN, V32, P33, DOI 10.1016/j.jaut.2008.10.004; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Dai CS, 2003, J BIOL CHEM, V278, P27080, DOI 10.1074/jbc.M211947200; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dong QY, 2008, CLIN INVEST MED, V31, pE328; Ezquer F, 2009, BIOL BLOOD MARROW TR, V15, P1354, DOI 10.1016/j.bbmt.2009.07.022; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; George M, 2002, J CLIN INVEST, V109, P1153, DOI 10.1172/JCI200212969; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Herold KC, 1997, J AUTOIMMUN, V10, P17, DOI 10.1006/jaut.1996.0108; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Izumida Y, 2005, BIOCHEM BIOPH RES CO, V333, P273, DOI 10.1016/j.bbrc.2005.05.100; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Karabatas LM, 2005, PANCREAS, V30, P318, DOI 10.1097/01.mpa.0000161888.02244.7a; Khan M, 2010, STEM CELLS IN PRESS; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Liu ZH, 2009, J CELL MOL MED, V13, P3427, DOI 10.1111/j.1582-4934.2008.00502.x; Marzorati S, 2007, EXPERT OPIN BIOL TH, V7, P1627, DOI 10.1517/14712598.7.11.1627; McCall MD, 2010, CLIN SCI, V118, P87, DOI 10.1042/CS20090072; Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; PAIK SG, 1980, P NATL ACAD SCI-BIOL, V77, P6129, DOI 10.1073/pnas.77.10.6129; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Stolzing A, 2010, CELLS TISSUES ORGANS, V191, P453, DOI 10.1159/000281826; Sun Y, 2007, CHINESE MED J-PEKING, V120, P771, DOI 10.1097/00029330-200705010-00007; Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721; TJALVE H, 1983, UPSALA J MED SCI, P145; Urban VS, 2008, STEM CELLS, V26, P244, DOI 10.1634/stemcells.2007-0267; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100	56	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16566	10.1371/journal.pone.0016566	http://dx.doi.org/10.1371/journal.pone.0016566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304603	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900073
J	Yamada, M; Ihara, M; Okamoto, Y; Maki, T; Washida, K; Kitamura, A; Hase, Y; Ito, H; Takao, K; Miyakawa, T; Kalaria, RN; Tomimoto, H; Takahashi, R				Yamada, Mahito; Ihara, Masafumi; Okamoto, Yoko; Maki, Takakuni; Washida, Kazuo; Kitamura, Akihiro; Hase, Yoshiki; Ito, Hidefumi; Takao, Keizo; Miyakawa, Tsuyoshi; Kalaria, Raj N.; Tomimoto, Hidekazu; Takahashi, Ryosuke			The Influence of Chronic Cerebral Hypoperfusion on Cognitive Function and Amyloid beta Metabolism in APP Overexpressing Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATHOGENESIS; WHITE-MATTER LESIONS; TRANSGENIC MICE; MOUSE MODEL; VASCULAR DEMENTIA; PLAQUE-FORMATION; WORKING-MEMORY; EXPRESSION; HYPOXIA; IMPAIRMENT	Background and Purpose: Cognitive impairment resulting from cerebrovascular insufficiency has been termed vascular cognitive impairment, and is generally accepted to be distinct from Alzheimer's disease resulting from a neurodegenerative process. However, it is clear that this simple dichotomy may need revision in light of the apparent occurrence of several shared features between Alzheimer's disease and vascular cognitive impairment. Nevertheless, it still remains largely unknown whether the burden of vascular-and Alzheimer-type neuropathology are independent or interdependent. Therefore, we investigated whether chronic cerebral hypoperfusion influences cognitive ability or amyloid beta deposition in amyloid precursor protein (APP) overexpressing transgenic mice. Methods: Two months old mice overexpressing a mutant form of the human APP bearing both the Swedish and Indiana mutations (APP(Sw/Ind)-Tg mice), or their wild-type littermates, were subjected to chronic cerebral hypoperfusion with bilateral common carotid artery stenosis (BCAS) using microcoils or sham operation. Barnes maze test performance and histopathological findings were analyzed at eight months old by 262 factorial experimental designs with four groups. Results: BCAS-operated APP(Sw/Ind)-Tg mice showed significantly impaired learning ability compared to the other three groups of mice. Two-way repeated measures analysis of variance showed a synergistic interaction between the APP genotype and BCAS operation in inducing learning impairment. The cognitive performances were significantly correlated with the neuronal densities. BCAS significantly reduced the density of Nissl-stained neurons and silver-stained cored plaques in the hippocampus of APP(Sw/Ind)-Tg mice but increased the amount of filter-trap amyloid beta in the extracellular-enriched soluble brain fraction, compared to those from sham operated mice. Conclusions: The results suggest interaction between chronic cerebral hypoperfusion and APP(Sw/Ind) overexpression in cognitive decline in mice through enhanced neuronal loss and altered amyloid beta metabolism.	[Yamada, Mahito; Ihara, Masafumi; Okamoto, Yoko; Maki, Takakuni; Washida, Kazuo; Kitamura, Akihiro; Hase, Yoshiki; Ito, Hidefumi; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan; [Takao, Keizo] Natl Inst Physiol Sci, Sect Behav Anal, Ctr Genet Anal Behav, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Aichi, Japan; [Kalaria, Raj N.] Newcastle Univ, Inst Ageing & Hlth, WRC, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Tsu, Mie 514, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; Newcastle University - UK; Mie University	Yamada, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto, Japan.	ihara@kuhp.kyoto-u.ac.jp	Kalaria, Raj/AAX-2630-2020; Ihara, Masafumi/O-5020-2019; Takao, Keizo/B-9527-2008; 眞木, 崇州/AAO-1160-2020; Miyakawa, Tsuyoshi/A-7741-2008	Ihara, Masafumi/0000-0002-7102-4048; Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200	Japanese Ministry of Education, Culture, Sports, Science and Technology; Mitsubishi Pharma Research Foundation; Medical Research Council [G0700718] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23390233] Funding Source: KAKEN; MRC [G0700718] Funding Source: UKRI	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grants-in-Aid for Exploratory Research and Integrative Brain Research (IBR-shien) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp), and a grant from the Mitsubishi Pharma Research Foundation (http://di.mt-pharma.co.jp/zaidan/default.htm) and by Global COE Program "Center for Frontier Medicine" funded by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, NAT MED, V10, P117, DOI 10.1038/nm0204-117; Arendash GW, 2004, NEUROREPORT, V15, P1751, DOI 10.1097/01.wnr.0000137183.68847.4e; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Deschaintre Y, 2009, NEUROLOGY, V73, P674, DOI 10.1212/WNL.0b013e3181b59bf3; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hemming ML, 2007, NEUROBIOL DIS, V26, P273, DOI 10.1016/j.nbd.2007.01.004; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Kalaria R, 2002, J NEUROL SCI, V203, P29, DOI 10.1016/S0022-510X(02)00256-3; Kalaria RN, 1996, PHARMACOL THERAPEUT, V72, P193, DOI 10.1016/S0163-7258(96)00116-7; Kitaguchi H, 2007, NEUROSCI LETT, V417, P128, DOI 10.1016/j.neulet.2007.02.021; Kitaguchi H, 2009, BRAIN RES, V1294, P202, DOI 10.1016/j.brainres.2009.07.078; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakaji K, 2006, STROKE, V37, P2816, DOI 10.1161/01.STR.0000244808.17972.55; Nicolakakis N, 2008, J NEUROSCI, V28, P9287, DOI 10.1523/JNEUROSCI.3348-08.2008; Nishio K, 2010, STROKE, V41, P1278, DOI 10.1161/STROKEAHA.110.581686; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Shibata M, 2007, STROKE, V38, P2826, DOI 10.1161/STROKEAHA.107.490151; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Zhang X, 2007, J BIOL CHEM, V282, P10873, DOI 10.1074/jbc.M608856200; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	38	62	63	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16567	10.1371/journal.pone.0016567	http://dx.doi.org/10.1371/journal.pone.0016567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305033	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900074
J	Chen, LP; Lai, YD; Li, DC; Zhu, XN; Yang, P; Li, WX; Zhu, W; Zhao, J; Li, XD; Xiao, YM; Zhang, Y; Xing, XM; Wang, Q; Zhang, B; Lin, YC; Zeng, JL; Zhang, SX; Liu, CX; Li, ZF; Zeng, XW; Lin, ZN; Zhuang, ZX; Chen, W				Chen, L-P; Lai, Y-D; Li, D-C; Zhu, X-N; Yang, P.; Li, W-X; Zhu, W.; Zhao, J.; Li, X-D; Xiao, Y-M; Zhang, Y.; Xing, X-M; Wang, Q.; Zhang, B.; Lin, Y-C; Zeng, J-L; Zhang, S-X; Liu, C-X; Li, Z-F; Zeng, X-W; Lin, Z-N; Zhuang, Z-X; Chen, W.			alpha 4 is highly expressed in carcinogen-transformed human cells and primary human cancers	ONCOGENE			English	Article						alpha 4; protein phosphatase 2A; cell transformation; human cancers	PROTEIN PHOSPHATASE 2A; SENSITIVE SIGNAL-TRANSDUCTION; TUMOR-SUPPRESSOR PP2A; CATALYTIC SUBUNIT; UBIQUITIN LIGASE; BINDING PROTEIN; OPITZ-SYNDROME; A-ALPHA; TARGETS; GROWTH	A regulator of the protein phosphatase 2A (PP2A), alpha 4, has been implicated in a variety of functions that regulate many cellular processes. To explore the role of alpha 4 in human cell transformation and tumorigenesis, we show that alpha 4 is highly expressed in human cells transformed by chemical carcinogens including benzo(a) pyrene, aflatoxin B(1), N-methyl-N'-nitro- N-nitrosoguanidine, nickel sulfate and in several hepatic and lung cancer cell lines. In addition, overexpression of a4 was detected in 87.5% (74/80) of primary hepatocellular carcinomas, 84.0% (21/25) of primary lung cancers and 81.8% (9/11) of primary breast cancers, indicating that a4 is ubiquitously highly expressed in human cancer. Functional studies revealed that elevated alpha 4 expression results in an increase in cell proliferation, promotion of cell survival and decreased PP2A-attributable activity. Importantly, ectopic expression of alpha 4 permits non-transformed human embryonic kidney cells (HEKTER) and L02R cells to form tumors in immunodeficient mice. Furthermore, we show that the highly expressed alpha 4 in transformed cells or human tumors is not regulated by DNA hypomethylation. A microRNA, miR-34b, that suppresses the expression of alpha 4 through specific binding to the 3'-untranslated region of alpha 4 is downregulated in transformed or human lung tumors. Taken together, these observations identify that alpha 4 possesses an oncogenic function. Reduction of PP2A activity due to an enhanced alpha 4-PP2A interaction contributes directly to chemical carcinogen-induced tumorigenesis. Oncogene (2011) 30, 2943-2953; doi:10.1038/onc.2011.20; published online 21 February 2011	[Chen, L-P; Lai, Y-D; Li, D-C; Zhu, X-N; Yang, P.; Li, W-X; Xiao, Y-M; Xing, X-M; Wang, Q.; Zhang, B.; Lin, Y-C; Zeng, J-L; Zhang, S-X; Liu, C-X; Li, Z-F; Zeng, X-W; Lin, Z-N; Zhuang, Z-X; Chen, W.] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Toxicol,Fac Prevent Med, Guangzhou 510080, Guangdong, Peoples R China; [Lai, Y-D] Guangzhou Med Coll, Inst Chem Carcinogenesis, Guangzhou, Guangdong, Peoples R China; [Li, W-X; Zhu, W.] Guangzhou Ctr Dis Control, Unit Toxicol, Guangzhou, Guangdong, Peoples R China; [Zhao, J.] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Thorac Surg, Guangzhou, Guangdong, Peoples R China; [Li, X-D] Sun Yat Sen Univ, Ctr Canc, Dept Thorac Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Y.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Zhuang, Z-X] Shenzhen Ctr Dis Control & Prevent, Dept Toxicol, Shenzhen, Peoples R China	Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Shenzhen Center for Disease Control & Prevention (SZCDC)	Chen, W (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Toxicol,Fac Prevent Med, 74 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.	chenwen@mail.sysu.edu.cn	ZHANG, BO/K-4561-2013; li, wenxue/K-7505-2014	ZHANG, BO/0000-0002-6352-1757; li, wenxue/0000-0002-0346-5300	NSFC [30925029, 30630055, 30800930, 30771832, 30901211]; National Key Basic Research and Development Program [2010CB912803]; National High Technology Research and Development Key Program of China [2008AA062504]; Ministry of Health of China [200902006]; Fundamental Research Funds for the Central Universities [10ykjc05, 10lgzd10]; Guangdong Province Universities and Colleges Pearl River	NSFC(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); National High Technology Research and Development Key Program of China(National High Technology Research and Development Program of China); Ministry of Health of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Province Universities and Colleges Pearl River	We thank Dr Richard Possemato for critical reading of the manuscript. This work was supported by a Distinguished Young Scholar of NSFC (30925029), Key Program of NSFC (30630055) and NSFC (30800930, 30771832, 30901211), National Key Basic Research and Development Program (2010CB912803), National High Technology Research and Development Key Program of China (2008AA062504), Ministry of Health of China (200902006), the Fundamental Research Funds for the Central Universities (10ykjc05 and 10lgzd10) and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS (2010).	Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen J, 1998, BIOCHEM BIOPH RES CO, V247, P827, DOI 10.1006/bbrc.1998.8792; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; Deichmann M, 2001, MELANOMA RES, V11, P577, DOI 10.1097/00008390-200112000-00004; DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Irigaray P, 2010, CARCINOGENESIS, V31, P135, DOI 10.1093/carcin/bgp252; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Ji WD, 2008, CARCINOGENESIS, V29, P1267, DOI 10.1093/carcin/bgn012; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Ma Ru-lin, 2008, Zhonghua Yufang Yixue Zazhi, V42, P395; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Onda M, 1997, GENOMICS, V46, P373, DOI 10.1006/geno.1997.5048; Pang YQ, 2008, TOXICOL APPL PHARM, V232, P478, DOI 10.1016/j.taap.2008.08.009; Pigazzi M, 2009, CANCER RES, V69, P2471, DOI 10.1158/0008-5472.CAN-08-3404; Prickett TD, 2007, MOL CELL BIOL, V27, P4217, DOI 10.1128/MCB.00067-07; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Zhang YY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000438	44	37	41	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	26					2943	2953		10.1038/onc.2011.20	http://dx.doi.org/10.1038/onc.2011.20			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21339737				2022-12-25	WOS:000292245100005
J	Li, Y; Bavarva, JH; Wang, Z; Guo, J; Qian, C; Thibodeau, SN; Golemis, EA; Liu, W				Li, Y.; Bavarva, J. H.; Wang, Z.; Guo, J.; Qian, C.; Thibodeau, S. N.; Golemis, E. A.; Liu, W.			HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression	ONCOGENE			English	Article						HEF1; Wnt signaling; colorectal cancer; tumorigenesis	ENDOTHELIAL GROWTH-FACTOR; BETA-CATENIN; COLORECTAL-CANCER; EXPRESSION; TRANSCRIPTION; ACTIVATION; MUTATIONS; PHOSPHORYLATION; RECEPTORS; EFFECTOR	Misregulation of the canonical Wnt/beta-catenin pathway and aberrant activation of Wnt signaling target genes are common in colorectal cancer (CRC) and contribute to cancer progression. Altered expression of human enhancer of filamentation 1 (HEF1; also known as NEDD9 or Cas-L) has been implicated in progression of melanoma, breast, and CRC. However, the regulation of HEF1 and the role of HEF1 in CRC tumorigenesis are not fully understood. We here identify HEF1 as a novel Wnt signaling target. The expression of HEF1 was upregulated by Wnt-3a, beta-catenin, and Dvl2 in a dose-dependent manner, and was suppressed following beta-catenin downregulation by shRNA. In addition, elevated HEF1 mRNA and protein levels were observed in CRC cell lines and primary tumor tissues, as well as in the colon and adenoma polyps of Apc(Min/+) mice. Moreover, HEF1 levels in human colorectal tumor tissues increased with the tumor grade. Chromatin immunoprecipitation (ChIP) assays and promoter analyses revealed three functional T-cell factor (TCF)-binding sites in the promoter of HEF1 responsible for HEF1 induction by Wnt signaling. Ectopic expression of HEF1 increased cell proliferation and colony formation, while downregulation of HEF1 in SW480 cells by shRNA had the opposite effects and inhibited the xenograft tumor growth. Furthermore, overexpression of HEF1 in SW480 cells promoted cell migration and invasion. Together, our results determined a novel role of HEF1 as a mediator of the canonical Wnt/beta-catenin signaling pathway for cell proliferation, migration, and tumorigenesis, as well as an important player in colorectal tumorigenesis and progression. HEF1 may represent an attractive candidate for drug targeting in CRC. Oncogene (2011) 30, 2633-2643; doi:10.1038/onc.2010.632; published online 14 February 2011	[Li, Y.; Bavarva, J. H.; Wang, Z.; Guo, J.; Qian, C.; Liu, W.] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Genet, New Orleans, LA 70112 USA; [Qian, C.; Thibodeau, S. N.; Liu, W.] Mayo Clin, Mayo Clin Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Golemis, E. A.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Mayo Clinic; Fox Chase Cancer Center	Liu, W (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Genet, 533 Bolivar St,CSRB 416, New Orleans, LA 70112 USA.	wliu2@lsuhsc.edu	LI, YINGCHUN/F-1238-2013	Golemis, Erica/0000-0003-3618-3673; Wang, Zemin/0000-0003-4189-578X	Louisiana Cancer Research Consortium; NIH [R01s CA63366, CA113342, CA06927]; NATIONAL CANCER INSTITUTE [R01CA113342, R01CA063366, P30CA006927, R29CA063366] Funding Source: NIH RePORTER	Louisiana Cancer Research Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Minjung Kim and Dr Lynda Chin (Harvard Medical School) for providing the shRNA-targeting HEF1. This study is supported by the funding from Louisiana Cancer Research Consortium (to WL). EAG is supported by NIH R01s CA63366 and CA113342, and by NIH core grant CA06927 (to Fox Chase Cancer Center).	Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Batistatou A, 2006, VIRCHOWS ARCH, V448, P763, DOI 10.1007/s00428-006-0183-8; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Easwaran V, 2003, CANCER RES, V63, P3145; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fashena SJ, 2002, J CELL SCI, V115, P99; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Law SF, 2000, MOL CELL BIOL, V20, P5184, DOI 10.1128/MCB.20.14.5184-5195.2000; LEONE A, 1993, ONCOGENE, V8, P2325; Letamendia A, 2001, J BONE JOINT SURG AM, V83A, pS31; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Merrill RA, 2004, DEV DYNAM, V231, P564, DOI 10.1002/dvdy.20159; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Richer JK, 2002, J BIOL CHEM, V277, P5209, DOI 10.1074/jbc.M110090200; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; van Seventer GA, 2001, EUR J IMMUNOL, V31, P1417, DOI 10.1002/1521-4141(200105)31:5<1417::AID-IMMU1417>3.0.CO;2-C; Velmurugan B, 2010, NEOPLASIA, V12, P95, DOI 10.1593/neo.91718; Xia DR, 2010, CANCER RES, V70, P824, DOI 10.1158/0008-5472.CAN-09-2105; Yasuhara R, 2010, J BIOL CHEM, V285, P317, DOI 10.1074/jbc.M109.053926; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	45	66	69	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	23					2633	2643		10.1038/onc.2010.632	http://dx.doi.org/10.1038/onc.2010.632			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21317929	Green Published, Green Accepted			2022-12-25	WOS:000291677800004
J	Chen, W; Li, L; Brod, T; Saeed, O; Thabet, S; Jansen, T; Dikalov, S; Weyand, C; Goronzy, J; Harrison, DG				Chen, Wei; Li, Li; Brod, Torben; Saeed, Omar; Thabet, Salim; Jansen, Thomas; Dikalov, Sergey; Weyand, Cornelia; Goronzy, Jorg; Harrison, David G.			Role of Increased Guanosine Triphosphate Cyclohydrolase-1 Expression and Tetrahydrobiopterin Levels upon T Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; SHEAR-STRESS; IFN-GAMMA; SUPEROXIDE; GENERATION; PHOSPHORYLATION; DIFFERENTIATION; BIOSYNTHESIS; MECHANISM; OXIDATION	Tetrahydrobiopterin (BH4) is an essential co-factor for the nitric-oxide (NO) synthases, and in its absence these enzymes produce superoxide (O(2)radical anion) rather than NO. The rate-limiting enzyme for BH4 production is guanosine triphosphate cyclohydrolase-1 (GTPCH-1). Because endogenously produced NO affects T cell function, we sought to determine whether antigen stimulation affected T cell GTPCH-1 expression and ultimately BH4 levels. Resting T cells had minimal expression of inducible NOS (NOS2), endothelial NOS (NOS3), and GTPCH-1 protein and nearly undetectable levels of BH4. Anti-CD3 stimulation of T cells robustly stimulated the coordinated expression of NOS2, NOS3, and GTPCH-1 and markedly increased both GTPCH-1 activity and T cell BH4 levels. The newly expressed GTPCH-1 was phosphorylated on serine 72 and pharmacological inhibition of casein kinase II reduced GTPCH-1 phosphorylation and blunted the increase in T cell BH4. Inhibition of GTPCH-1 with diaminohydroxypyrimidine (1 mmol/liter) prevented T cell BH4 accumulation, reduced NO production, and increased T cell O(2)radical anion. production, due to both NOS2 and NOS3 uncoupling. GTPCH-1 inhibition also promoted TH2 polarization in memory CD4 cells. Ovalbumin immunization of mice transgenic for an ovalbumin receptor (OT-II mice) confirmed a marked increase in T cell BH4 in vivo. These studies identify a previously unidentified consequence of T cell activation, promoting BH4 levels, NO production, and modulating T cell cytokine production.	[Chen, Wei; Li, Li; Brod, Torben; Saeed, Omar; Thabet, Salim; Jansen, Thomas; Dikalov, Sergey; Harrison, David G.] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA; [Chen, Wei; Li, Li; Brod, Torben; Saeed, Omar; Thabet, Salim; Jansen, Thomas; Dikalov, Sergey; Harrison, David G.] Emory Univ, Sch Med, Dept Med, Atlanta, GA 30322 USA; [Weyand, Cornelia; Goronzy, Jorg] Stanford Univ, Sch Med, Div Immunol, Palo Alto, CA 94304 USA; [Weyand, Cornelia; Goronzy, Jorg] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Harrison, David G.] Atlanta Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Emory University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Harrison, DG (corresponding author), Vanderbilt Univ, Div Clin Pharmacol, 533 Robinson Res Bldg, Nashville, TN 37232 USA.	david.g.harrison@vanderbilt.edu	Li, Li/C-8981-2011; Weyand, Cornelia/AAH-3343-2021	Chen, Wei/0000-0002-3973-340X; Goronzy, Jorg/0000-0001-7670-1856; Dikalov, Sergey/0000-0003-2976-6184	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058000, R01HL117913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044142, R56AI044142, R01AI108906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042527] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL117913, P01 HL058000] Funding Source: Medline; NIAID NIH HHS [R01 AI044142, R01 AI108906, R56 AI044142] Funding Source: Medline; NIAMS NIH HHS [R01 AR042527] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Benbernou N, 1997, IMMUNOLOGY, V91, P361, DOI 10.1046/j.1365-2567.1997.00260.x; Brahmachari S, 2009, J IMMUNOL, V183, P2045, DOI 10.4049/jimmunol.0800276; CAI H, 2005, METHODS MOL MED, P293; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Collins M, 2010, J LEUKOCYTE BIOL, V87, P691, DOI 10.1189/jlb.0409227; Collins M, 2010, MOL IMMUNOL, V47, P1665, DOI 10.1016/j.molimm.2010.03.009; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Duan YL, 2010, AM J RESP CELL MOL, V42, P491, DOI 10.1165/rcmb.2008-0469OC; Feuerer M, 2006, J IMMUNOL, V176, P2857, DOI 10.4049/jimmunol.176.5.2857; GAL EM, 1978, NEUROCHEM RES, V3, P69, DOI 10.1007/BF00964361; GROSS SS, 1992, J BIOL CHEM, V267, P25722; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Ibiza S, 2006, IMMUNITY, V24, P753, DOI 10.1016/j.immuni.2006.04.006; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; King MR, 2006, J IMMUNOL, V176, P2765, DOI 10.4049/jimmunol.176.5.2765; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Lee KC, 2010, LEUKEMIA, V24, P896, DOI 10.1038/leu.2010.11; Li L, 2010, CIRC RES, V106, P328, DOI 10.1161/CIRCRESAHA.109.210658; Miller AA, 2000, BRIT J PHARMACOL, V131, P29, DOI 10.1038/sj.bjp.0703528; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Niedbala W, 2002, P NATL ACAD SCI USA, V99, P16186, DOI 10.1073/pnas.252464599; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Patel KB, 2002, FREE RADICAL BIO MED, V32, P203, DOI 10.1016/S0891-5849(01)00777-8; POU S, 1992, J BIOL CHEM, V267, P24173; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Tai LK, 2002, ARTERIOSCL THROM VAS, V22, P1790, DOI 10.1161/01.ATV.0000034475.40227.40; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Toth M, 1997, PLACENTA, V18, P189, DOI 10.1016/S0143-4004(97)90092-8; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Wei CC, 2008, J BIOL CHEM, V283, P11734, DOI 10.1074/jbc.M709250200; Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102; Zhu YQ, 2005, J AM CHEM SOC, V127, P858, DOI 10.1021/ja0445645	39	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13846	13851		10.1074/jbc.M110.191023	http://dx.doi.org/10.1074/jbc.M110.191023			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343293	hybrid, Green Published			2022-12-25	WOS:000289556200007
J	Hammerstein, AF; Jayasinghe, L; Bayley, H				Hammerstein, Anne F.; Jayasinghe, Lakmal; Bayley, Hagan			Subunit Dimers of alpha-Hemolysin Expand the Engineering Toolbox for Protein Nanopores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICOMPONENT TOXIN; PORE; CHANNEL; FORMS; CYCLODEXTRIN; RECEPTORS; ADAPTER; LUMEN	Staphylococcal alpha-hemolysin (alpha HL) forms a heptameric pore that features a 14-stranded transmembrane beta-barrel. We attempted to force the alpha HL pore to adopt novel stoichiometries by oligomerizing subunit dimers generated by in vitro transcription and translation of a tandem gene. However, in vitro transcription and translation also produced truncated proteins, monomers, that were preferentially incorporated into oligomers. These oligomers were shown to be functional heptamers by single-channel recording and had a similar mobility to wild-type heptamers in SDS-polyacrylamide gels. Purified full-length subunit dimers were then prepared by using His-tagged protein. Again, single-channel recording showed that oligomers made from these dimers are functional heptamers, implying that one or more subunits are excluded from the central pore. Therefore, the alpha HL pore resists all structures except those that possess seven subunits immediately surrounding the central axis. Although we were not able to change the stoichiometry of the central pore of alpha HL by the concatenation of subunits, we extended our findings to prepare pores containing one subunit dimer and five monomers and purified them by SDS-PAGE. Two half-chelating ligands were then installed at adjacent sites, one on each subunit of the dimer. Single-channel recording showed that pores formed from this construct formed complexes with divalent metal ions in a similar fashion to pores containing two half-chelating ligands on the same subunit, confirming that the oligomers had assembled with seven subunits around the central lumen. The ability to incorporate subunit dimers into alpha HL pores increases the range of structures that can be obtained from engineered protein nanopores.	[Hammerstein, Anne F.; Jayasinghe, Lakmal; Bayley, Hagan] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford	Bayley, H (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3TA, England.	hagan.bayley@chem.ox.ac.uk		Bayley, Hagan/0000-0003-2499-6116	Medical Research Council; Medical Research Council [G0300122] Funding Source: researchfish; MRC [G0300122] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Banerjee A, 2010, P NATL ACAD SCI USA, V107, P8165, DOI 10.1073/pnas.0914229107; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bayley H, 2004, MOL MEMBR BIOL, V21, P209, DOI 10.1080/09687680410001716853; Bayley Hagan, 2008, V12, P251; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Braha O, 1997, CHEM BIOL, V4, P497, DOI 10.1016/S1074-5521(97)90321-5; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Cheley S, 1997, PROTEIN ENG, V10, P1433, DOI 10.1093/protein/10.12.1433; Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535; DE S, 2011, P NATL ACAD IN PRESS; Deamer DW, 2002, ACCOUNTS CHEM RES, V35, P817, DOI 10.1021/ar000138m; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Folgering JHA, 2005, PROTEIN SCI, V14, P2947, DOI 10.1110/ps.051679005; FREUND C, 1993, FEBS LETT, V320, P97, DOI 10.1016/0014-5793(93)80070-B; GOUAUX JE, 1994, P NATL ACAD SCI USA, V91, P12828, DOI 10.1073/pnas.91.26.12828; Gu LQ, 2001, J GEN PHYSIOL, V118, P481, DOI 10.1085/jgp.118.5.481; Hammerstein AF, 2010, ANGEW CHEM INT EDIT, V49, P5085, DOI 10.1002/anie.200906601; Howorka S, 1998, BIOTECHNIQUES, V25, P764, DOI 10.2144/98255bm03; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jayasinghe L, 2006, J BIOL CHEM, V281, P2195, DOI 10.1074/jbc.M510841200; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Kintzer AF, 2010, J MOL BIOL, V399, P741, DOI 10.1016/j.jmb.2010.04.041; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Maglia G, 2009, NAT NANOTECHNOL, V4, P437, DOI [10.1038/NNANO.2009.121, 10.1038/nnano.2009.121]; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Miles G, 2002, PROTEIN SCI, V11, P1813, DOI 10.1110/ps.0204002; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Miles G, 2001, BIOCHEMISTRY-US, V40, P8514, DOI 10.1021/bi010454o; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Panchal RG, 1996, NAT BIOTECHNOL, V14, P852, DOI 10.1038/nbt0796-852; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Sack JT, 2008, J GEN PHYSIOL, V131, P415, DOI 10.1085/jgp.200709939; Shin SH, 2007, ANGEW CHEM INT EDIT, V46, P7412, DOI 10.1002/anie.200700736; Siwy ZS, 2010, CHEM SOC REV, V39, P1115, DOI 10.1039/b909105j; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; Wu HC, 2007, J AM CHEM SOC, V129, P16142, DOI 10.1021/ja0761840; Zhou Y, 2003, J NEUROSCI, V23, P9004	42	17	33	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14324	14334		10.1074/jbc.M111.218164	http://dx.doi.org/10.1074/jbc.M111.218164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324910	Green Published, hybrid			2022-12-25	WOS:000289556200055
J	Chen, Y; Yue, S; Xie, L; Pu, XH; Jin, T; Cheng, SY				Chen, Yan; Yue, Shen; Xie, Lu; Pu, Xiao-hong; Jin, Tian; Cheng, Steven Y.			Dual Phosphorylation of Suppressor of Fused (Sufu) by PKA and GSK3 beta Regulates Its Stability and Localization in the Primary Cilium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNAL-TRANSDUCTION; GLI; MOUSE; TRANSCRIPTION; ASSOCIATION; DROSOPHILA; PARADIGMS; MECHANISM	Suppressor of fused (Sufu) is an essential negative regulator of the sonic hedgehog (Shh) pathway, but little is known about how Sufu itself is normally regulated. Here, we report that Sufu is phosphorylated at Ser-342 and Ser-346 by GSK3 beta and cAMP-dependent protein kinase A (PKA), respectively, and phosphorylation at this dual site stabilizes Sufu against Shh signaling-induced degradation. We further show that localization of Sufu in the primary cilium is induced by Shh signaling and is required for the turnover of both phosphorylated and total Sufu. Perturbing Sufu phosphorylation with PKA inhibitors or replacing Ser-346 with alanine reduced the stay and replacing Ser-342 and Ser-346 with aspartic acid prolonged the stay of Sufu in the cilia. Finally, ciliary localization of Gli2/3 also required Smo and was similarly influenced by perturbations of PKA activity or mutations at the dual Sufu phosphorylation site. Thus, Shh likely induced trafficking of phospho-Sufu into the primary cilium in a complex with Gli2/3, and dephosphorylation triggered a retrograde export, allowing Sufu to be degraded by the ubiquitin-proteasome system.	[Chen, Yan; Yue, Shen; Xie, Lu; Pu, Xiao-hong; Cheng, Steven Y.] Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Yan; Yue, Shen; Xie, Lu; Pu, Xiao-hong; Cheng, Steven Y.] Nanjing Med Univ, Ctr Regenerat Med, Nanjing 210029, Jiangsu, Peoples R China; [Jin, Tian] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	Nanjing Medical University; Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cheng, SY (corresponding author), Nanjing Med Univ, Dept Dev Genet, Ctr Canc Res, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	sycheng@njmu.edu.cn			Chinese National Science Foundation [30771079]; Chinese Ministry of Science and Technology [2009CB918403]; University Research Grant [08NMUM010]; National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001156] Funding Source: NIH RePORTER	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); University Research Grant; National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Chinese National Science Foundation Grant 30771079 (to S. Y. C.), 973 State Key Research Project of Chinese Ministry of Science and Technology Grant 2009CB918403 (to S. Y. C.), and University Research Grant 08NMUM010 (to S. Y.). This work was also supported in part by National Institutes of Health NIAID intramural fund (to T. J.).	Altaba ARI, 2008, CANCER CELL, V14, P281, DOI 10.1016/j.ccr.2008.09.007; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Cheng SY, 2008, ADV CANCER RES, V101, P29, DOI 10.1016/S0065-230X(08)00402-8; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; JACOB L, 2007, SCI STKE, pCM6, DOI DOI 10.1126/STKE.4072007CM6; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Paces-Fessy M, 2004, BIOCHEM J, V378, P353, DOI 10.1042/BJ20030786; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pearse RV, 1999, DEV BIOL, V212, P323, DOI 10.1006/dbio.1999.9335; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Silverman MA, 2009, TRENDS CELL BIOL, V19, P306, DOI 10.1016/j.tcb.2009.04.002; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang Y, 2007, CURR OPIN CELL BIOL, V19, P159, DOI 10.1016/j.ceb.2007.02.005; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403	42	80	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13502	13511		10.1074/jbc.M110.217604	http://dx.doi.org/10.1074/jbc.M110.217604			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317289	Green Published, hybrid			2022-12-25	WOS:000289282200070
J	Kortenoeven, MLA; van den Brandi, M; Wetzels, JFM; Deen, PMT				Kortenoeven, Marleen L. A.; van den Brandi, Michiel; Wetzels, Jack F. M.; Deen, Peter M. T.			Hypotonicity-induced Reduction of Aquaporin-2 Transcription in mpkCCD Cells Is Independent of the Tonicity Responsive Element, Vasopressin, and cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCT PRINCIPAL CELLS; NEPHROGENIC DIABETES-INSIPIDUS; MEDULLARY COLLECTING DUCT; NITRIC-OXIDE; WATER CHANNEL; CONCENTRATING MECHANISM; INDUCED ANTIDIURESIS; ESSENTIAL REGULATOR; BINDING PROTEIN; GENE-EXPRESSION	The syndrome of inappropriate antidiuretic hormone secretion is characterized by excessive water uptake and hyponatremia. The extent of hyponatremia, however, is less than anticipated, which is ascribed to a defense mechanism, the vasopressin-escape, and is suggested to involve a tonicity-determined down-regulation of the water channel aquaporin-2 (AQP2). The underlying mechanism, however, is poorly understood. To study this, we used the mouse cortical collecting duct (mpkCCD) cell line. MpkCCD cells, transfected with an AQP2-promoter luciferase construct showed a reduced and increased AQP2 abundance and transcription following culture in hypotonic and hypertonic medium, respectively. This depended on tonicity rather than osmolality and occurred independently of the vasopressin analog dDAVP, cAMP levels, or protein kinase A activity. Although prostaglandins and nitric oxide reduced AQP2 abundance, inhibition of their synthesis did not influence tonicity-induced AQP2 transcription. Also, cells in which the cAMP or tonicity-responsive element (CRE/TonE) in the AQP2-promoter were mutated showed a similar response to hypotonicity. Instead, the tonicity-responsive elements were pin-pointed to nucleotides -283 to -252 and -157 to -126 bp. In conclusion, our data indicate that hypotonicity reduces AQP2 abundance and transcription, which occurs independently of vasopressin, cAMP, and the known TonE and CRE in the AQP2-promoter. Increased prostaglandin and nitric oxide, as found in vivo, may contribute to reduced AQP2 in vasopressin-escape, but do not mediate the effect of hypotonicity on AQP2 transcription. Our data suggest that two novel segments (-283 to -252 and -157 to -126 bp) in the AQP2-promoter mediate the hypotonicity-induced AQP2 down-regulation during vasopressin-escape.	[Kortenoeven, Marleen L. A.; van den Brandi, Michiel; Deen, Peter M. T.] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Deen, PMT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Physiol, 286 Physiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	p.deen@fysiol.umcn.nl	van den Brand, Michiel/E-2900-2016; Deen, Peter MT/B-9854-2013; Deen, P.M.T./H-8023-2014; Wetzels, Jack F.M./A-1720-2014; Kortenoeven, Marleen/B-8565-2014	van den Brand, Michiel/0000-0001-8871-6254; Deen, Peter MT/0000-0002-7868-4655; Deen, P.M.T./0000-0002-7868-4655; Wetzels, Jack F.M./0000-0002-0650-6921; Kortenoeven, Marleen/0000-0001-9962-8276	Radboud University Nijmegen Medical Centre [2004.55]; Netherlands Organization for Scientific Research (NWO) [865.07.002]	Radboud University Nijmegen Medical Centre; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Radboud University Nijmegen Medical Centre (2004.55) and a VICI grant of the Netherlands Organization for Scientific Research (NWO, 865.07.002) (to P. M. T. D.).	Arreche N, 2008, VASC PHARMACOL, V49, P19, DOI 10.1016/j.vph.2008.04.001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SC, 2002, J BIOL CHEM, V277, P32498, DOI 10.1074/jbc.M202321200; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; Deen PMT, 1997, PFLUG ARCH EUR J PHY, V433, P780, DOI 10.1007/s004240050345; Ecelbarger CA, 1997, J CLIN INVEST, V99, P1852, DOI 10.1172/JCI119352; Fluhmann B, 1998, MOL CELL ENDOCRINOL, V139, P89, DOI 10.1016/S0303-7207(98)00070-7; Furuno M, 1996, AM J PHYSIOL-RENAL, V271, pF854, DOI 10.1152/ajprenal.1996.271.4.F854; GROSS PA, 1983, CIRC RES, V53, P794, DOI 10.1161/01.RES.53.6.794; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Hasler U, 2005, J AM SOC NEPHROL, V16, P1571, DOI 10.1681/ASN.2004110930; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; HEBERT RL, 1990, AM J PHYSIOL, V259, pF318, DOI 10.1152/ajprenal.1990.259.2.F318; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hozawa S, 1996, AM J PHYSIOL-CELL PH, V270, pC1695, DOI 10.1152/ajpcell.1996.270.6.C1695; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Jun DW, 2010, DIGEST DIS SCI, V55, P1296, DOI 10.1007/s10620-009-0852-y; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Kasono K, 2005, NEPHROL DIAL TRANSPL, V20, P509, DOI 10.1093/ndt/gfh677; Knepper MA, 1997, AM J PHYSIOL-RENAL, V272, pF3, DOI 10.1152/ajprenal.1997.272.1.F3; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; LEVINSKY NG, 1959, AM J PHYSIOL, V196, P451, DOI 10.1152/ajplegacy.1959.196.2.451; Li CL, 2006, J AM SOC NEPHROL, V17, P1657, DOI 10.1681/ASN.2005121381; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Li YD, 2006, J AM SOC NEPHROL, V17, P1063, DOI 10.1681/ASN.2005080884; Liu J, 2009, PLACENTA, V30, P66, DOI 10.1016/j.placenta.2008.10.009; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Murase T, 2003, AM J PHYSIOL-REG I, V284, pR354, DOI 10.1152/ajpregu.00065.2002; NADLER SP, 1992, AM J PHYSIOL, V262, pF229, DOI 10.1152/ajprenal.1992.262.2.F229; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; Neuhofer W, 2002, J PHYSIOL-LONDON, V543, P147, DOI 10.1113/jphysiol.2002.021931; Quinn PG, 2002, PROG NUCLEIC ACID RE, V72, P269, DOI 10.1016/S0079-6603(02)72072-2; SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321, DOI 10.1152/ajprenal.1979.236.4.F321; Sheen MR, 2009, KIDNEY INT, V75, P518, DOI 10.1038/ki.2008.601; VALTIN H, 1987, KIDNEY INT, V31, P634, DOI 10.1038/ki.1987.45; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443	38	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13002	13010		10.1074/jbc.M110.207878	http://dx.doi.org/10.1074/jbc.M110.207878			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324903	Green Published, hybrid			2022-12-25	WOS:000289282200020
J	Ho, HA; Kapadia, R; Al-Tahan, S; Ahmad, S; Ganesan, AK				Ho, Hsiang; Kapadia, Rubina; Al-Tahan, Sejad; Ahmad, Safoora; Ganesan, Anand K.			WIPI1 Coordinates Melanogenic Gene Transcription and Melanosome Formation via TORC1 Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; SACCHAROMYCES-CEREVISIAE; MAMMALIAN AUTOPHAGY; SKIN PIGMENTATION; PUNCTA-FORMATION; TRANSPORT; MELANOCYTES; COMPLEX; MOUSE	Recent studies implicate a role for WD repeat domain, phosphoinositide- interacting 1 (WIPI1) in the biogenesis of melanosomes, cell type-specific lysosome-related organelles. In this study, we determined that WIPI1, an ATG18 homologue that is shown to localize to both autophagosomes and early endosomes, inhibited mammalian target of rapamycin (MTOR) signaling, leading to increased transcription of melanogenic enzymes and the formation of mature melanosomes. WIPI1 suppressed the target of rapamycin complex 1 (TORC1) activity, resulting in glycogen synthase kinase 3 beta inhibition, beta-Catenin stabilization, and increased transcription of microphthalmia transcription factor and its target genes. WIPI1-depleted cells accumulated stage I melanosomes but lacked stage III-IV melanosomes. Inhibition of TORC1 by rapamycin treatment resulted in the accumulation of stage IV melanosomes but not autophagosomes, whereas starvation resulted in the formation of autophagosomes but not melanin accumulation. Taken together, our studies define a distinct role for WIPI1 and TORC1 signaling in controlling the transcription of melanogenic enzymes and melanosome maturation, a process that is distinct from starvation-induced autophagy.	[Ho, Hsiang; Ganesan, Anand K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Kapadia, Rubina; Al-Tahan, Sejad; Ahmad, Safoora; Ganesan, Anand K.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Ganesan, AK (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA.	aganesan@uci.edu			National Institutes of Health [1RO3AR057150, 1K08AR056001]; Biomedical Technology Resource Grant [P41-RR01192]; Dermatology Foundation; Joanna M. Nicolay Melanoma Foundation; graduate fellowship in alternatives in scientific research; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR057150, K08AR056001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Resource Grant; Dermatology Foundation; Joanna M. Nicolay Melanoma Foundation; graduate fellowship in alternatives in scientific research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO3AR057150 and 1K08AR056001 (to A. K. G.) and by Biomedical Technology Resource Grant P41-RR01192 (for the microscopy studies at the University of California, Irvine. This work was also supported by a Dermatology Foundation research grant.; Supported by a Joanna M. Nicolay Melanoma Foundation research scholar award and a graduate fellowship in alternatives in scientific research.	Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Busca R, 1996, J BIOL CHEM, V271, P31824, DOI 10.1074/jbc.271.50.31824; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Costin GE, 2007, FASEB J, V21, P976, DOI 10.1096/fj.06-6649rev; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09; Double KL, 2006, J NEURAL TRANSM, V113, P751, DOI 10.1007/s00702-006-0450-5; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Du JY, 2003, AM J PATHOL, V163, P333, DOI 10.1016/S0002-9440(10)63657-7; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; El-Mofty MA, 2007, DERMATOL CLIN, V25, P401, DOI 10.1016/j.det.2007.04.003; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Ferguson CJ, 2010, AUTOPHAGY, V6, P170, DOI 10.4161/auto.6.1.10626; Flinn RJ, 2010, MOL BIOL CELL, V21, P833, DOI 10.1091/mbc.E09-09-0756; Ganesan AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000298; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Georgakopoulos T, 2001, YEAST, V18, P1155, DOI 10.1002/yea.764; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Hajduch E, 2001, FEBS LETT, V492, P199, DOI 10.1016/S0014-5793(01)02242-6; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Hoashi T, 2005, J BIOL CHEM, V280, P14006, DOI 10.1074/jbc.M413692200; Hu DN, 2008, PHOTOCHEM PHOTOBIOL, V84, P639, DOI 10.1111/j.1751-1097.2008.00316.x; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kim JH, 2008, J INVEST DERMATOL, V128, P1227, DOI 10.1038/sj.jid.5701177; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Matsunaga K, 2009, AUTOPHAGY, V5, P876, DOI 10.4161/auto.9098; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nicolaus BJR, 2005, MED HYPOTHESES, V65, P791, DOI 10.1016/j.mehy.2005.04.011; Ohguchi K, 2005, J CELL PHYSIOL, V205, P444, DOI 10.1002/jcp.20421; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Passeron T, 2005, CLIN DERMATOL, V23, P56, DOI 10.1016/j.clindermatol.2004.09.013; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2009, METHOD ENZYMOL, V452, P247, DOI 10.1016/S0076-6879(08)03616-1; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roxrud I, 2010, BIOL CELL, V102, P293, DOI 10.1042/BC20090161; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Salopek TG, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P195; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; SHIBATA K, 1992, J BIOL CHEM, V267, P20584; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Truschel ST, 2009, TRAFFIC, V10, P1318, DOI 10.1111/j.1600-0854.2009.00955.x; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Weiss P, 2009, BIOCHEM J, V424, P89, DOI 10.1042/BJ20090957; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	69	59	66	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.200543	http://dx.doi.org/10.1074/jbc.M110.200543			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317285	Green Published, hybrid			2022-12-25	WOS:000289077500064
J	Ternes, P; Wobbe, T; Schwarz, M; Albrecht, S; Feussner, K; Riezman, I; Cregg, JM; Heinz, E; Riezman, H; Feussner, I; Warnecke, D				Ternes, Philipp; Wobbe, Tobias; Schwarz, Marnie; Albrecht, Sandra; Feussner, Kirstin; Riezman, Isabelle; Cregg, James M.; Heinz, Ernst; Riezman, Howard; Feussner, Ivo; Warnecke, Dirk			Two Pathways of Sphingolipid Biosynthesis Are Separated in the Yeast Pichia pastoris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; CERAMIDE SYNTHASES; GLUCOSYLCERAMIDE SYNTHASE; GROWTH-INHIBITION; GENE; PLANTS; IDENTIFICATION; PATHOGENICITY; AUREOBASIDIN; DESATURASE	Although the yeast Saccharomyces cerevisiae has only one sphingolipid class with a head group based on phosphoinositol, the yeast Pichia pastoris as well as many other fungi have a second class, glucosylceramide, which has a glucose head group. These two sphingolipid classes are in addition distinguished by a characteristic structure of their ceramide backbones. Here, we investigate the mechanisms controlling substrate entry into the glucosylceramide branch of the pathway. By a combination of enzymatic in vitro studies and lipid analysis of genetically engineered yeast strains, we show that the ceramide synthase Bar1p occupies a key branching point in sphingolipid biosynthesis in P. pastoris. By preferring dihydroxy sphingoid bases and C-16/C-18 acyl-coenzyme A as substrates, Bar1p produces a structurally well defined group of ceramide species, which is the exclusive precursor for glucosylceramide biosynthesis. Correlating with the absence of glucosylceramide in this yeast, a gene encoding Bar1p is missing in S. cerevisiae. We could not successfully investigate the second ceramide synthase in P. pastoris that is orthologous to S. cerevisiae Lag1p/Lac1p. By analyzing the ceramide and glucosylceramide species in a collection of P. pastoris knock-out strains in which individual genes encoding enzymes involved in glucosylceramide biosynthesis were systematically deleted, we show that the ceramide species produced by Bar1p have to be modified by two additional enzymes, sphingolipid Delta 4-desaturase and fatty acid alpha-hydroxylase, before the final addition of the glucose head group by the glucosylceramide synthase. Together, this set of four enzymes specifically defines the pathway leading to glucosylceramide biosynthesis.	[Ternes, Philipp; Schwarz, Marnie; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Wobbe, Tobias; Albrecht, Sandra; Heinz, Ernst; Warnecke, Dirk] Univ Hamburg, Biozentrum Klein Flottbek, D-22609 Hamburg, Germany; [Feussner, Kirstin] Univ Gottingen, Dept Mol Microbiol & Genet, D-37077 Gottingen, Germany; [Riezman, Isabelle; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Cregg, James M.] Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA	University of Gottingen; University of Hamburg; University of Gottingen; University of Geneva; Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences	Ternes, P (corresponding author), Gottinger Expt Lab Junge Leute eV, XLAB, Justus von Liebig Weg 8, D-37077 Gottingen, Germany.	pternes@xlab-goettingen.de; warnecke@botanik.uni-hamburg.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Ternes, Philipp/0000-0003-0886-5474; Riezman, Howard/0000-0003-4680-9422	Deutsche Forschungsgemeinschaft [TE 491/3-1, SFB470]; Swiss National Science Foundation; SystemsX.ch	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	This work was supported in part by Deutsche Forschungsgemeinschaft Grants TE 491/3-1 (to P. T.) and SFB470 (to S. A. and T. W.) and by the Swiss National Science Foundation and SystemsX.ch (evaluated by the Swiss National Science Foundation) (to H. R.).	BLIGH EG, 1959, CAN J MED SCI, V37, P911, DOI DOI 10.1139/O59-099; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; Chalfant C., 2010, SPHINGOLIPIDS SIGNAL; Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dickson RC, 1999, BBA-GEN SUBJECTS, V1426, P347, DOI 10.1016/S0304-4165(98)00135-4; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garton S, 2003, FEBS LETT, V538, P192, DOI 10.1016/S0014-5793(03)00163-7; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; Grilley MM, 1998, J BIOL CHEM, V273, P11062, DOI 10.1074/jbc.273.18.11062; Guan XL, 2006, YEAST, V23, P465, DOI 10.1002/yea.1362; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Haak D, 1997, J BIOL CHEM, V272, P29704, DOI 10.1074/jbc.272.47.29704; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Leipelt M, 2001, J BIOL CHEM, V276, P33621, DOI 10.1074/jbc.M104952200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li SJ, 2007, GENETICS, V176, P243, DOI 10.1534/genetics.106.068239; Li SJ, 2006, MOL BIOL CELL, V17, P1218, DOI 10.1091/mbc.E05-06-0533; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Marsh D, 2010, BBA-BIOMEMBRANES, V1798, P40, DOI 10.1016/j.bbamem.2009.10.010; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oura T, 2008, MICROBIOL-SGM, V154, P3795, DOI 10.1099/mic.0.2008/018788-0; Oura T, 2010, MICROBIOL-SGM, V156, P1234, DOI 10.1099/mic.0.033985-0; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Ramamoorthy V, 2007, MOL MICROBIOL, V66, P771, DOI 10.1111/j.1365-2958.2007.05955.x; Ramamoorthy V, 2009, EUKARYOT CELL, V8, P217, DOI 10.1128/EC.00255-08; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sperling P, 2000, BIOCHEM SOC T, V28, P638, DOI 10.1042/BST0280638; Sperling P, 1998, J BIOL CHEM, V273, P28590, DOI 10.1074/jbc.273.44.28590; Takakuwa N, 2008, FEMS YEAST RES, V8, P839, DOI 10.1111/j.1567-1364.2008.00407.x; Tani M, 2010, J BIOCHEM, V148, P565, DOI 10.1093/jb/mvq090; Ternes P, 2006, J BIOL CHEM, V281, P5582, DOI 10.1074/jbc.M512864200; Ternes P, 2002, J BIOL CHEM, V277, P25512, DOI 10.1074/jbc.M202947200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Warnecke D, 2003, CELL MOL LIFE SCI, V60, P919, DOI 10.1007/s00018-003-2243-4; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Zauner S, 2010, ADV EXP MED BIOL, V688, P249	55	53	58	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11401	11414		10.1074/jbc.M110.193094	http://dx.doi.org/10.1074/jbc.M110.193094			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21303904	Green Published, hybrid			2022-12-25	WOS:000288797100052
J	Opitz, D; Maier, B				Opitz, Dirk; Maier, Berenike			Rapid Cytoskeletal Response of Epithelial Cells to Force Generation by Type IV Pili	PLOS ONE			English	Article							CORTICAL PLAQUE-FORMATION; NEISSERIA-MENINGITIDIS; PATHOGENIC NEISSERIAE; ENDOTHELIAL-CELLS; DYNAMICS; MOTILITY; ACTIN; MECHANOTRANSDUCTION; PHOSPHORYLATION; CYTOPROTECTION	Many bacterial pathogens interfere with cellular functions including phagocytosis and barrier integrity. The human pathogen Neissieria gonorrhoeae generates grappling hooks for adhesion, spreading, and induction of signal cascades that lead to formation cortical plaques containing f-actin and ezrin. It is unclear whether high mechanical forces generated by type IV pili (T4P) are a direct signal that leads to cytoskeletal rearrangements and at which time scale the cytoskeletal response occurs. Here we used laser tweezers to mimic type IV pilus mediated force generation by T4P-coated beads on the order of 100pN. We found that actin-EGFP and ezrin-EGFP accumulated below pilus-coated beads when force was applied. Within 2 min, accumulation significantly exceeded controls without force or without pili, demonstrating that T4P-generated force rapidly induces accumulation of plaque proteins. This finding adds mechanical force to the many strategies by which bacteria modulate the host cell cytoskeleton.	[Opitz, Dirk; Maier, Berenike] Univ Munster, Inst Mol Zellbiol, Munster, Germany	University of Munster	Opitz, D (corresponding author), Univ Munster, Inst Mol Zellbiol, Munster, Germany.	maierb@uni-muenster.de	Maier, Berenike/B-2350-2016	Maier, Berenike/0000-0001-6971-9927; Giannakakou, Paraskevi/0000-0001-7378-262X	Deutsche Forschungsgemeinschaft [SFB 629, A12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The project was funded by the Deutsche Forschungsgemeinschaft through SFB 629, A12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; Ayala P, 2005, CELL MICROBIOL, V7, P1736, DOI 10.1111/j.1462-5822.2005.00586.x; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; BRETSCHER A, 1989, J CELL BIOL, V108, P921, DOI 10.1083/jcb.108.3.921; Brinton C., 1978, USES PILI GONORRHEA; Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5; Choidas A, 1998, EUR J CELL BIOL, V77, P81, DOI 10.1016/S0171-9335(98)80075-7; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Doulet N, 2006, J CELL BIOL, V173, P627, DOI 10.1083/jcb.200507128; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eugene E, 2002, J CELL SCI, V115, P1231; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Glogauer M, 1997, J CELL SCI, V110, P11; Hayward RD, 2006, NAT REV MICROBIOL, V4, P358, DOI 10.1038/nrmicro1391; Higashi DL, 2007, INFECT IMMUN, V75, P4743, DOI 10.1128/IAI.00687-07; Higashi DL, 2009, MICROBIOL-SGM, V155, P4084, DOI 10.1099/mic.0.032656-0; HOLZ C, PHYS REV LETT, V104; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lemichez E, 2010, NAT REV MICROBIOL, V8, P93, DOI 10.1038/nrmicro2269; Maier B, 2004, NAT STRUCT MOL BIOL, V11, P643, DOI 10.1038/nsmb783; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e17088	10.1371/journal.pone.0017088	http://dx.doi.org/10.1371/journal.pone.0017088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340023	Green Published, gold, Green Submitted			2022-12-25	WOS:000287367600037
J	Shah, I; Houck, K; Judson, RS; Kavlock, RJ; Martin, MT; Reif, DM; Wambaugh, J; Dix, DJ				Shah, Imran; Houck, Keith; Judson, Richard S.; Kavlock, Robert J.; Martin, Matthew T.; Reif, David M.; Wambaugh, John; Dix, David J.			Using Nuclear Receptor Activity to Stratify Hepatocarcinogens	PLOS ONE			English	Article							PREGNANE-X RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; THROUGHPUT SCREENING ASSAYS; PEROXISOME PROLIFERATOR; PYRETHROID PESTICIDES; AGONISTIC ACTIVITY; CLUSTER-ANALYSIS; CELL-LINE; INDUCTION; TOXICITY	Background: Nuclear receptors (NR) are a superfamily of ligand-activated transcription factors that control a range of cellular processes. Persistent stimulation of some NR is a non-genotoxic mechanism of rodent liver cancer with unclear relevance to humans. Here we report on a systematic analysis of new in vitro human NR activity data on 309 environmental chemicals in relationship to their liver cancer-related chronic outcomes in rodents. Results: The effects of 309 environmental chemicals on human constitutive androstane receptors (CAR/NR1I3), pregnane X receptor (PXR/NR1I2), aryl hydrocarbon receptor (AhR), peroxisome proliferator-activated receptors (PPAR/NR1C), liver X receptors (LXR/NR1H), retinoic X receptors (RXR/NR2B) and steroid receptors (SR/NR3) were determined using in vitro data. Hepatic histopathology, observed in rodents after two years of chronic treatment for 171 of the 309 chemicals, was summarized by a cancer lesion progression grade. Chemicals that caused proliferative liver lesions in both rat and mouse were generally more active for the human receptors, relative to the compounds that only affected one rodent species, and these changes were significant for PPAR (p < 0.001), PXR (p < 0.01) and CAR (p < 0.05). Though most chemicals exhibited receptor promiscuity, multivariate analysis clustered them into relatively few NR activity combinations. The human NR activity pattern of chemicals weakly associated with the severity of rodent liver cancer lesion progression (p < 0.05). Conclusions: The rodent carcinogens had higher in vitro potency for human NR relative to non-carcinogens. Structurally diverse chemicals with similar NR promiscuity patterns weakly associated with the severity of rodent liver cancer progression. While these results do not prove the role of NR activation in human liver cancer, they do have implications for nuclear receptor chemical biology and provide insights into putative toxicity pathways. More importantly, these findings suggest the utility of in vitro assays for stratifying environmental contaminants based on a combination of human bioactivity and rodent toxicity.	[Shah, Imran; Houck, Keith; Judson, Richard S.; Kavlock, Robert J.; Martin, Matthew T.; Reif, David M.; Wambaugh, John; Dix, David J.] US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency	Shah, I (corresponding author), US EPA, Natl Ctr Computat Toxicol, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	shah.imran@epa.gov	Houck, Keith/G-8654-2014; Shah, Syed I/B-8275-2011; Martin, Matthew/A-1982-2013; Wambaugh, John/AAM-4487-2020	Houck, Keith/0000-0002-0055-2249; Martin, Matthew/0000-0002-8096-9908; Wambaugh, John/0000-0002-4024-534X; Shah, Imran/0000-0003-0808-0140; Reif, David/0000-0001-7815-6767; Judson, Richard/0000-0002-2348-9633				ABDELLATIF AG, 1991, TOXICOL APPL PHARM, V111, P530, DOI 10.1016/0041-008X(91)90257-F; Balls M, 2006, ATLA-ALTERN LAB ANIM, V34, P1; Benjamini Y, 1995, CONTROLLING FALSE DI, DOI [10.1176/ajp.156.6, DOI 10.1176/AJP.156.6]; Boronat S, 2007, FEBS J, V274, P3327, DOI 10.1111/j.1742-4658.2007.05867.x; BUTLER EG, 1988, TOXICOL APPL PHARM, V93, P72, DOI 10.1016/0041-008X(88)90026-9; Chen HY, 2002, J TOXICOL ENV HEAL A, V65, P1419, DOI 10.1080/00984100290071243; Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103; Doe JE, 2006, CRIT REV TOXICOL, V36, P37, DOI 10.1080/10408440500534370; Dubois M, 1996, ECOTOX ENVIRON SAFE, V34, P205, DOI 10.1006/eesa.1996.0065; Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363, DOI 10.1289/ehp.02110363; Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023; Goetz AK, 2009, TOXICOLOGICAL SCI OF; Goetz AK, 2009, TOXICOL APPL PHARM, V238, P80, DOI 10.1016/j.taap.2009.04.016; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hurst CH, 2004, TOXICOL APPL PHARM, V199, P266, DOI 10.1016/j.taap.2003.11.028; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Judson R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-241; Judson R, 2009, ENVIRON HEALTH PERSP, V117, P685, DOI 10.1289/ehp.0800168; Judson RS, 2010, ENVIRON HEALTH PERSP, V118, P485, DOI 10.1289/ehp.0901392; KELCE WR, 1994, TOXICOL APPL PHARM, V126, P276, DOI 10.1006/taap.1994.1117; Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372; Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003; Lemaire G, 2006, LIFE SCI, V79, P1160, DOI 10.1016/j.lfs.2006.03.023; Lemaire G, 2006, TOXICOL SCI, V91, P501, DOI 10.1093/toxsci/kfj173; Lobenhofer EK, 2006, TOXICOL PATHOL, V34, P921, DOI 10.1080/01926230601072319; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martin MT, 2009, ENVIRON HEALTH PERSP, V117, P392, DOI 10.1289/ehp.0800074; Martinasso G, 2006, J TOXICOL ENV HEAL A, V69, P353, DOI 10.1080/15287390500227522; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Oliver JD, 2002, PHARMACOL TOXICOL, V91, P1, DOI 10.1034/j.1600-0773.2002.910101.x; Parker GJ, 2000, J BIOMOL SCREEN, V5, P77, DOI 10.1177/108705710000500204; Parsons L., 2004, SIGKDD EXPLOR NEWSL, V6, P90, DOI DOI 10.1145/1007730.1007731; Peffer RC, 2007, TOXICOL SCI, V99, P315, DOI 10.1093/toxsci/kfm154; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Scassellati-Sfozolini G., 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P11; Scollon EJ, 2009, DRUG METAB DISPOS, V37, P221, DOI 10.1124/dmd.108.022343; Sergent T, 2009, TOXICOL LETT, V184, P159, DOI 10.1016/j.toxlet.2008.11.009; Takeuchi S, 2008, CHEMOSPHERE, V74, P155, DOI 10.1016/j.chemosphere.2008.08.015; Takeuchi S, 2006, TOXICOL APPL PHARM, V217, P235, DOI 10.1016/j.taap.2006.08.011; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Washington Teresa, 2004, Int J Environ Res Public Health, V1, P12, DOI 10.3390/ijerph2004010012; Whitfield GK, 1999, J CELLULAR BIOCH, V75; Zhu ZR, 2004, J BIOMOL SCREEN, V9, P533, DOI 10.1177/1087057104264902	47	42	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14584	10.1371/journal.pone.0014584	http://dx.doi.org/10.1371/journal.pone.0014584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339822	Green Published, Green Submitted, gold			2022-12-25	WOS:000287367600001
J	Wu, BL; Blanchard-Letort, A; Liu, Y; Zhou, GH; Wang, XF; Elena, SF				Wu, Beilei; Blanchard-Letort, Alexandra; Liu, Yan; Zhou, Guanghe; Wang, Xifeng; Elena, Santiago F.			Dynamics of Molecular Evolution and Phylogeography of Barley yellow dwarf virus-PAV	PLOS ONE			English	Article							PLANT RNA VIRUSES; RECOMBINATION; SEQUENCES; DNA; PHYLOGENIES; HYPOTHESIS; PHENOTYPES; ALIGNMENT; SEROTYPE; RATES	Barley yellow dwarf virus (BYDV) species PAV occurs frequently in irrigated wheat fields worldwide and can be efficiently transmitted by aphids. Isolates of BYDV-PAV from different countries show great divergence both in genomic sequences and pathogenicity. Despite its economical importance, the genetic structure of natural BYDV-PAV populations, as well as of the mechanisms maintaining its high diversity, remain poorly explored. In this study, we investigate the dynamics of BYDV-PAV genome evolution utilizing time-structured data sets of complete genomic sequences from 58 isolates from different hosts obtained worldwide. First, we observed that BYDV-PAV exhibits a high frequency of homologous recombination. Second, our analysis revealed that BYDV-PAV genome evolves under purifying selection and at a substitution rate similar to other RNA viruses (3.158x10(-4) nucleotide substitutions/site/year). Phylogeography analyses show that the diversification of BYDV-PAV can be explained by local geographic adaptation as well as by host-driven adaptation. These results increase our understanding of the diversity, molecular evolutionary characteristics and epidemiological properties of an economically important plant RNA virus.	[Wu, Beilei; Liu, Yan; Zhou, Guanghe; Wang, Xifeng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Blanchard-Letort, Alexandra; Elena, Santiago F.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, E-46071 Valencia, Spain; [Elena, Santiago F.] Santa Fe Inst, Santa Fe, NM 87501 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); The Santa Fe Institute	Wu, BL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	xfwang@ippcaas.cn; sfelena@ibmcp.upv.es	Elena, Santiago F./A-4191-2011; Blanchard, Alexandra/AAM-5138-2020; Wang, Xifeng/A-6476-2016	Elena, Santiago F./0000-0001-8249-5593; Wang, Xifeng/0000-0002-4982-8947	Chinese National Key Basic Research Program (973 program) [2006CB100203]; Chinese Nature Science Foundation [30871622]; Spanish Ministry of Science and Innovation [BFU2009-06993]; Generalitat Valenciana [PROMETEO2010/019]	Chinese National Key Basic Research Program (973 program)(National Basic Research Program of China); Chinese Nature Science Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Chinese National Key Basic Research Program (973 program No. 2006CB100203) and by the Chinese Nature Science Foundation grant number 30871622. Work in Valencia was supported by the Spanish Ministry of Science and Innovation grant BFU2009-06993 and by Generalitat Valenciana grant PROMETEO2010/019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulila M, 2011, BIOCHIMIE, V93, P242, DOI 10.1016/j.biochi.2010.09.017; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Chay CA, 1996, PHYTOPATHOLOGY, V86, P370, DOI 10.1094/Phyto-86-370; Codoner FM, 2008, J GEN VIROL, V89, P1739, DOI 10.1099/vir.0.2008/000166-0; D'Arcy CJ., 2005, VIRUS TAXONOMY 8 REP, P891; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Du ZQ, 2007, J PLANT PATHOL, V89, P251; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elena SF, 2008, HEREDITY, V100, P478, DOI 10.1038/sj.hdy.6801088; Elena SF, 2007, ANNU REV ECOL EVOL S, V38, P27, DOI 10.1146/annurev.ecolsys.38.091206.095637; GAUNT BS, 2002, NEW PHYTOL, V154, P15; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Liu F, 2007, ARCH VIROL, V152, P1365, DOI 10.1007/s00705-007-0947-8; Malmstrom CM, 2007, J ECOL, V95, P1153, DOI 10.1111/j.1365-2745.2007.01307.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mastari J, 1998, PHYTOPATHOLOGY, V88, P818, DOI 10.1094/PHYTO.1998.88.8.818; Mayo MA, 1996, ADV VIRUS RES, V46, P413, DOI 10.1016/S0065-3527(08)60077-9; MILLER MA, 1997, ANNU REV PHYTOPATHOL, V35, P167; Miller WA, 2002, MOL PLANT PATHOL, V3, P177, DOI 10.1046/j.1364-3703.2002.00112.x; OSWALD JOHN W., 1951, PLANT DIS REPORTER, V35, P471; Pagan I, 2010, J VIROL, V84, P6177, DOI 10.1128/JVI.02160-09; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROCHOW WF, 1969, PHYTOPATHOLOGY, V59, P1580; ROCHOW WF, 1971, PLANT DIS REP, V55, P874; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; SLATKIN M, 1989, GENETICS, V123, P603; TAJIMA F, 1989, GENETICS, V123, P585; van Regenmortel MHV, 2000, ARCH VIROL, V145, P2227, DOI 10.1007/s007050070053; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Zhou G., 1987, SCI AGR SINICA, V20, P7	40	52	58	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16896	10.1371/journal.pone.0016896	http://dx.doi.org/10.1371/journal.pone.0016896			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326861	Green Published, gold			2022-12-25	WOS:000287037000031
J	Han, XN; Mann, E; Gilbert, S; Guan, YF; Steinbrecher, KA; Montrose, MH; Cohen, MB				Han, Xiaonan; Mann, Elizabeth; Gilbert, Shila; Guan, Yanfang; Steinbrecher, Kris A.; Montrose, Marshall H.; Cohen, Mitchell B.			Loss of Guanylyl Cyclase C (GCC) Signaling Leads to Dysfunctional Intestinal Barrier	PLOS ONE			English	Article							LIGHT-CHAIN KINASE; INFLAMMATORY-BOWEL-DISEASE; TIGHT JUNCTION DYSFUNCTION; EPITHELIAL-CELLS; IN-VIVO; IFN-GAMMA; ENTEROTOXIN RECEPTOR; COLORECTAL-CANCER; TRANSCRIPTION 5B; INTERFERON-GAMMA	Background: Guanylyl Cyclase C (GCC) signaling via uroguanylin (UGN) and guanylin activation is a critical mediator of intestinal fluid homeostasis, intestinal cell proliferation/apoptosis, and tumorigenesis. As a mechanism for some of these effects, we hypothesized that GCC signaling mediates regulation of intestinal barrier function. Methodology/Principal Findings: Paracellular permeability of intestinal segments was assessed in wild type (WT) and GCC deficient (GCC-/-) mice with and without lipopolysaccharide (LPS) challenge, as well as in UGN deficient (UGN-/-) mice. IFN gamma and myosin light chain kinase (MLCK) levels were determined by real time PCR. Expression of tight junction proteins (TJPs), phosphorylation of myosin II regulatory light chain (MLC), and STAT1 activation were examined in intestinal epithelial cells (IECs) and intestinal mucosa. The permeability of Caco-2 and HT-29 IEC monolayers, grown on Transwell filters was determined in the absence and presence of GCC RNA interference (RNAi). We found that intestinal permeability was increased in GCC-/- and UGN-/- mice compared to WT, accompanied by increased IFN gamma levels, MLCK and STAT1 activation in IECs. LPS challenge promotes greater IFN gamma and STAT1 activation in IECs of GCC-/- mice compared to WT mice. Claudin-2 and JAM-A expression were reduced in GCC deficient intestine; the level of phosphorylated MLC in IECs was significantly increased in GCC-/- and UGN-/- mice compared to WT. GCC knockdown induced MLC phosphorylation, increased permeability in IEC monolayers under basal conditions, and enhanced TNF alpha and IFN gamma-induced monolayer hyperpermeability. Conclusions/Significance: GCC signaling plays a protective role in the integrity of the intestinal mucosal barrier by regulating MLCK activation and TJ disassembly. GCC signaling activation may therefore represent a novel mechanism in maintaining the small bowel barrier in response to injury.	[Han, Xiaonan; Mann, Elizabeth; Gilbert, Shila; Steinbrecher, Kris A.; Cohen, Mitchell B.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA; [Guan, Yanfang; Montrose, Marshall H.] Univ Cincinnati, Dept Mol & Cellular Biol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Han, XN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA.	xiaonan.han@cchmc.org		Cohen, Mitchell/0000-0002-4412-350X; Han, Xiaonan/0000-0001-5368-6489	Clinical and Translational Research Award [KL2 RR026315]; Crohn's and Colitis Foundation of America; Cincinnati Children's Research Foundation; USPHS [R01 DK 47318, R21 DK074976, P30 DK0789392]; NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077, KL2TR000078] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR026315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047318, R21DK074976] Funding Source: NIH RePORTER	Clinical and Translational Research Award; Crohn's and Colitis Foundation of America; Cincinnati Children's Research Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Clinical and Translational Research Award KL2 RR026315 (XH), Crohn's and Colitis Foundation of America (XH), and Cincinnati Children's Research Foundation Trustee Award (XH), USPHS grants R01 DK 47318 (MC), R21 DK074976 (MHM), and P30 DK0789392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was completed in part in NIH-funded digestive health center (DHC) and Laser Mircodissection Core at Cincinnati Children's Hospital Medical Center. Eleana Laws provides a technical supports in genotyping mice.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Basu N, 2009, MOL CELL BIOL, V29, P5277, DOI 10.1128/MCB.00001-09; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Buccigrossi V, 2010, PEDIAT RES; Carrithers SL, 1996, P NATL ACAD SCI USA, V93, P14827, DOI 10.1073/pnas.93.25.14827; Ceponis PJM, 2003, INFECT IMMUN, V71, P1396, DOI 10.1128/IAI.71.3.1396-1404.2003; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; COHEN MB, 1995, BIOCHEM BIOPH RES CO, V209, P803, DOI 10.1006/bbrc.1995.1571; Drudy D, 2001, J MED MICROBIOL, V50, P526, DOI 10.1099/0022-1317-50-6-526; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; EUTAMENE H, 2009, NEUROGASTROENTEROL M; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Garin-Laflam MP, 2009, AM J PHYSIOL-GASTR L, V296, pG740, DOI 10.1152/ajpgi.90268.2008; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Guan YF, 2009, AM J PHYSIOL-GASTR L, V297, pG187, DOI 10.1152/ajpgi.90595.2008; Han X, 2009, GUT, V58, P49, DOI 10.1136/gut.2007.145094; Han XN, 2006, AM J PATHOL, V169, P1999, DOI 10.2353/ajpath.2006.060186; Han XN, 2010, GUT, V59, P1066, DOI 10.1136/gut.2009.203893; Han XN, 2005, GASTROENTEROLOGY, V129, P185, DOI 10.1053/j.gastro.2005.05.018; Han XN, 2004, SHOCK, V21, P261, DOI 10.1097/01.shk.0000112346.38599.10; Han XN, 2003, J PHARMACOL EXP THER, V307, P443, DOI 10.1124/jpet.103.056556; Han XN, 2003, SHOCK, V19, P229, DOI 10.1097/00024382-200303000-00006; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Johnston JM, 2009, AM J GASTROENTEROL, V104, P125, DOI 10.1038/ajg.2008.59; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Leclercq IA, 2003, GASTROENTEROLOGY, V124, P1451, DOI 10.1016/S0016-5085(03)00270-1; Li P, 2009, DRUG NEWS PERSPECT, V22, P313, DOI 10.1358/dnp.2009.22.6.1395254; Li P, 2007, AM J PATHOL, V171, P1847, DOI 10.2353/ajpath.2007.070198; Li P, 2007, GASTROENTEROLOGY, V133, P599, DOI 10.1053/j.gastro.2007.05.052; LIN JE, 2010, GASTROENTEROLOGY; Lin JE, 2009, FUTURE ONCOL, V5, P509, DOI 10.2217/FON.09.14; Lorenz JN, 2003, J CLIN INVEST, V112, P1244, DOI 10.1172/JCI200318743; Lubbe WJ, 2009, CANCER RES, V69, P3529, DOI 10.1158/0008-5472.CAN-09-0067; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mazzarella G, 2003, AM J PATHOL, V162, P1845, DOI 10.1016/S0002-9440(10)64319-2; Michl P, 2003, CANCER RES, V63, P6265; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Moriez R, 2005, AM J PATHOL, V167, P1071, DOI 10.1016/S0002-9440(10)61196-0; Mudter J, 2005, AM J GASTROENTEROL, V100, P64, DOI 10.1111/j.1572-0241.2005.40615.x; Olson TS, 2006, J EXP MED, V203, P541, DOI 10.1084/jem.20050407; Qian X, 2000, ENDOCRINOLOGY, V141, P3210, DOI 10.1210/en.141.9.3210; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Schwarz BT, 2007, GASTROENTEROLOGY, V132, P2383, DOI 10.1053/j.gastro.2007.02.052; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Song X, 2008, HISTOL HISTOPATHOL, V23, P673, DOI 10.14670/HH-23.673; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; Swenson ES, 1996, BIOCHEM BIOPH RES CO, V225, P1009, DOI 10.1006/bbrc.1996.1286; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Utech M, 2005, MOL BIOL CELL, V16, P5040, DOI 10.1091/mbc.E05-03-0193; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Wisner DM, 2008, J SURG RES, V144, P1, DOI 10.1016/j.jss.2007.03.059; Ye DM, 2006, AM J PHYSIOL-GASTR L, V290, pG496, DOI 10.1152/ajpgi.00318.2005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zhang W, 1999, FASEB J, V13, P913, DOI 10.1096/fasebj.13.8.913	62	50	51	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16139	10.1371/journal.pone.0016139	http://dx.doi.org/10.1371/journal.pone.0016139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305056	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300035
J	Hill, LD; York, TP; Kusanovic, JP; Gomez, R; Eaves, LJ; Romero, R; Strauss, JF				Hill, Lori D.; York, Timothy P.; Kusanovic, Juan P.; Gomez, Ricardo; Eaves, Lindon J.; Romero, Roberto; Strauss, Jerome F., III			Epistasis between COMT and MTHFR in Maternal-Fetal Dyads Increases Risk for Preeclampsia	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; SOLUBLE ENDOGLIN; DEVELOP PREECLAMPSIA; PARKINSONS-DISEASE; GROWTH RESTRICTION; ANGIOGENIC FACTORS; NORMAL-PREGNANCY; GESTATIONAL-AGE; SPIRAL ARTERIES	Preeclampsia is a leading cause of perinatal morbidity and mortality. This disorder is thought to be multifactorial in origin, with multiple genes, environmental and social factors, contributing to disease. One proposed mechanism is placental hypoxia-driven imbalances in angiogenic and anti-angiogenic factors, causing endothelial cell dysfunction. Catechol-O-methyltransferase (Comt)-deficient pregnant mice have a preeclampsia phenotype that is reversed by exogenous 2-methoxyestradiol (2-ME), an estrogen metabolite generated by COMT. 2-ME inhibits Hypoxia Inducible Factor 1 alpha, a transcription factor mediating hypoxic responses. COMT has been shown to interact with methylenetetrahydrofolate reductase (MTHFR), which modulates the availability of S-adenosylmethionine (SAM), a COMT cofactor. Variations in MTHFR have been associated with preeclampsia. By accounting for allelic variation in both genes, the role of COMT has been clarified. COMT allelic variation is linked to enzyme activity and four single nucleotide polymorphisms (SNPs) (rs6269, rs4633, rs4680, and rs4818) form haplotypes that characterize COMT activity. We tested for association between COMT haplotypes and the MTHFR 677 C -> T polymorphism and preeclampsia risk in 1103 Chilean maternal-fetal dyads. The maternal ACCG COMT haplotype was associated with reduced risk for preeclampsia (P = 0.004), and that risk increased linearly from low to high activity haplotypes (P = 0.003). In fetal samples, we found that the fetal ATCA COMT haplotype and the fetal MTHFR minor "T'' allele interact to increase preeclampsia risk (p = 0.022). We found a higher than expected number of patients with preeclampsia with both the fetal risk alleles alone (P = 0.052) and the fetal risk alleles in combination with a maternal balancing allele (P, 0.001). This non-random distribution was not observed in controls (P = 0.341 and P = 0.219, respectively). Our findings demonstrate a role for both maternal and fetal COMT in preeclampsia and highlight the importance of including allelic variation in MTHFR.	[Hill, Lori D.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Sch Med, Richmond, VA 23284 USA; [York, Timothy P.; Eaves, Lindon J.] Virginia Commonwealth Univ, Sch Med, Virginia Inst Psychiat & Behav Genet, Richmond, VA USA; [York, Timothy P.; Eaves, Lindon J.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, Richmond, VA USA; [Kusanovic, Juan P.; Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Kusanovic, Juan P.; Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA; [Kusanovic, Juan P.; Gomez, Ricardo] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Santiago, Chile; [Kusanovic, Juan P.; Gomez, Ricardo] Pontificia Univ Catolica Chile, Dept Obstet & Gynecol, Santiago, Chile	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad de Chile; Pontificia Universidad Catolica de Chile	Hill, LD (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Sch Med, Richmond, VA 23284 USA.	jfstrauss@vcu.edu	Kusanovic, Juan Pedro/R-8616-2019; Kusanovic, Juan Pedro/AAM-5782-2020; Romero, Roberto/A-5268-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Gomez, Ricardo/0000-0001-9267-304X; Romero, Roberto/0000-0002-4448-5121	NCMHD [P60 MD002256]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS [N01 HD-2-3342]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	NCMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported in part by grants from the NCMHD P60 MD002256 (JFS) and the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS, N01 HD-2-3342 (JFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologist, 2002, INT J GYNAECOL OBSTE, V77, P67; Annerbrink K, 2008, METABOLISM, V57, P708, DOI 10.1016/j.metabol.2008.01.012; BARNEA ER, 1988, AM J PERINAT, V5, P121, DOI 10.1055/s-2007-999669; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker CM, 2008, AM J PATHOL, V172, P534, DOI 10.2353/ajpath.2008.061244; Bialecka M, 2008, PHARMACOGENET GENOM, V18, P815, DOI 10.1097/FPC.0b013e328306c2f2; BROSENS I, 1967, J PATHOL BACTERIOL, V93, P569, DOI 10.1002/path.1700930218; BROSENS I, 1964, J OBSTET GYN BR COMM, V71, P222; BROSENS IA, 1988, TROPHOBLAST RES, V3, P61; Caniggia I, 2002, PLACENTA, V23, pS47, DOI 10.1053/plac.2002.0815; Canto P, 2008, HYPERTENS RES, V31, P1015, DOI 10.1291/hypres.31.1015; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Domschke K, 2007, AM J MED GENET B, V144B, P667, DOI 10.1002/ajmg.b.30494; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fan JB, 2005, BIOL PSYCHIAT, V57, P139, DOI 10.1016/j.biopsych.2004.10.018; Fowler Brian, 2005, Semin Vasc Med, V5, P77; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Glaser B, 2006, AM J PSYCHIAT, V163, P537, DOI 10.1176/appi.ajp.163.3.537; Glatt SJ, 2003, AM J PSYCHIAT, V160, P469, DOI 10.1176/appi.ajp.160.3.469; Goddard KAB, 2007, HUM HERED, V63, P1, DOI 10.1159/000097926; Gonzalez R, 2004, REV MED CHILE, V132, P1155; Halleland H, 2009, AM J MED GENET B, V150B, P403, DOI 10.1002/ajmg.b.30831; Huber JC, 2002, MATURITAS, V41, pS55; Ilhan N, 2008, ARCH MED RES, V39, P125, DOI 10.1016/j.arcmed.2007.07.009; Kadyrov M, 2006, AM J OBSTET GYNECOL, V194, P557, DOI 10.1016/j.ajog.2005.07.035; Kadyrov M, 2003, PLACENTA, V24, P540, DOI 10.1053/plac.2002.0946; Kanasaki K, 2008, NATURE, V453, P1117, DOI 10.1038/nature06951; Kosmas IP, 2004, J HYPERTENS, V22, P1655, DOI 10.1097/00004872-200409000-00004; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Large V, 1998, DIABETES METAB, V24, P409; Lee SB, 2010, AM J PATHOL, V176, P710, DOI 10.2353/ajpath.2010.090513; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Mannisto PT, 1999, PHARMACOL REV, V51, P593; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0; Parimi N, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-60; Powers RW, 2008, REPROD SCI, V15, P374, DOI 10.1177/1933719107311780; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raijmakers MTM, 2001, EUR J OBSTET GYN R B, V95, P226, DOI 10.1016/S0301-2115(00)00497-8; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROBERTS JM, 1991, AM J HYPERTENS, V4, P700, DOI 10.1093/ajh/4.8.700; ROBERTS JM, 1991, SEMIN PERINATOL, V15, P86; Roffman JL, 2008, P NATL ACAD SCI USA, V105, P17573, DOI 10.1073/pnas.0803727105; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2009, J MATERN-FETAL NEO M, V22, P636, DOI 10.1080/14767050902784171; Rutherford K, 2006, BIOCHEMISTRY-US, V45, P2178, DOI 10.1021/bi051988i; Salonen RH, 2000, AM J MED GENET, V91, P256; Sata F, 2006, PHARMACOGENET GENOM, V16, P775, DOI 10.1097/01.fpc.0000230116.49452.c0; Schneider JA, 1998, AM J HUM GENET, V62, P1258, DOI 10.1086/301836; Schwahn B, 2001, Am J Pharmacogenomics, V1, P189, DOI 10.2165/00129785-200101030-00004; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stevenson RE, 1997, AM J HUM GENET, V60, P229; Tai CH, 2002, ACTA MED OKAYAMA, V56, P1; Tworoger SS, 2004, OBES RES, V12, P972, DOI 10.1038/oby.2004.119; vanderPut NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111, DOI 10.1093/qjmed/90.2.111; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Walsh SW, 2007, TRENDS ENDOCRIN MET, V18, P365, DOI 10.1016/j.tem.2007.09.003; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	71	47	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16681	10.1371/journal.pone.0016681	http://dx.doi.org/10.1371/journal.pone.0016681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304959	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300120
J	Latrasse, D; Germann, S; Houba-Herin, N; Dubois, E; Bui-Prodhomme, D; Hourcade, D; Juul-Jensen, T; Le Roux, C; Majira, A; Simoncello, N; Granier, F; Taconnat, L; Renou, JP; Gaudin, V				Latrasse, David; Germann, Sophie; Houba-Herin, Nicole; Dubois, Emeline; Bui-Prodhomme, Duyen; Hourcade, Delphine; Juul-Jensen, Trine; Le Roux, Clementine; Majira, Amel; Simoncello, Nathalie; Granier, Fabienne; Taconnat, Ludivine; Renou, Jean-Pierre; Gaudin, Valerie			Control of Flowering and Cell Fate by LIF2, an RNA Binding Partner of the Polycomb Complex Component LHP1	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; SERINE/ARGININE-RICH PROTEINS; H3 LYSINE-9 METHYLATION; LIVING PLANT-CELLS; ARABIDOPSIS-THALIANA; HETEROCHROMATIN PROTEIN-1; GENE-EXPRESSION; DOMAIN PROTEINS; NONCODING RNAS; LOCUS-T	Polycomb Repressive Complexes (PRC) modulate the epigenetic status of key cell fate and developmental regulators in eukaryotes. The chromo domain protein LIKE HETEROCHROMATIN PROTEIN1 (LHP1) is a subunit of a plant PRC1-like complex in Arabidopsis thaliana and recognizes histone H3 lysine 27 trimethylation, a silencing epigenetic mark deposited by the PRC2 complex. We have identified and studied an LHP1-Interacting Factor2 (LIF2). LIF2 protein has RNA recognition motifs and belongs to the large hnRNP protein family, which is involved in RNA processing. LIF2 interacts in vivo, in the cell nucleus, with the LHP1 chromo shadow domain. Expression of LIF2 was detected predominantly in vascular and meristematic tissues. Loss-of-function of LIF2 modifies flowering time, floral developmental homeostasis and gynoecium growth determination. lif2 ovaries have indeterminate growth and produce ectopic inflorescences with severely affected flowers showing proliferation of ectopic stigmatic papillae and ovules in short-day conditions. To look at how LIF2 acts relative to LHP1, we conducted transcriptome analyses in lif2 and lhp1 and identified a common set of deregulated genes, which showed significant enrichment in stress-response genes. By comparing expression of LHP1 targets in lif2, lhp1 and lif2 lhp1 mutants we showed that LIF2 can either antagonize or act with LHP1. Interestingly, repression of the FLC floral transcriptional regulator in lif2 mutant is accompanied by an increase in H3K27 trimethylation at the locus, without any change in LHP1 binding, suggesting that LHP1 is targeted independently from LIF2 and that LHP1 binding does not strictly correlate with gene expression. LIF2, involved in cell identity and cell fate decision, may modulate the activity of LHP1 at specific loci, during specific developmental windows or in response to environmental cues that control cell fate determination. These results highlight a novel link between plant RNA processing and Polycomb regulation.	[Latrasse, David; Germann, Sophie; Houba-Herin, Nicole; Dubois, Emeline; Bui-Prodhomme, Duyen; Hourcade, Delphine; Juul-Jensen, Trine; Le Roux, Clementine; Majira, Amel; Simoncello, Nathalie; Granier, Fabienne; Gaudin, Valerie] INRA Ctr Versailles Grignon, Inst JP Bourgin, INRA AgroParisTech UMR1318, Versailles, France; [Germann, Sophie] Ctr Leon Berard, INSERM, U590, F-69373 Lyon, France; [Dubois, Emeline] CNRS, Ctr Genet Mol, FRE3144, Gif Sur Yvette, France; [Bui-Prodhomme, Duyen] INRA Ctr Bordeaux, UMR 619, Villenave Dornon, France; [Taconnat, Ludivine; Renou, Jean-Pierre] Unite Rech Genom Vegetale, Evry, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Latrasse, D (corresponding author), INRA Ctr Versailles Grignon, Inst JP Bourgin, INRA AgroParisTech UMR1318, Versailles, France.	valerie.gaudin@versailles.inra.fr	Le Roux, Clementine/B-4761-2018	Le Roux, Clementine/0000-0003-1689-6211; Gaudin, Valerie/0000-0002-1356-5567; Dubois, Emeline/0000-0002-2515-9128	INRA; French research ministry; French Cancer Research Association (ARC); Agence Nationale de la Recherche; Ile de France Canceropole; French Ministry of Research [ACI 03-3-135]; French Cancer Research Association; Canceropole Ile de France; INRA CJS;  [ANR-08-BLAN-0200]	INRA; French research ministry(Ministry of Research, France); French Cancer Research Association (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); Ile de France Canceropole(Region Ile-de-France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French Cancer Research Association(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile de France(Region Ile-de-France); INRA CJS; 	This work was supported by INRA, the French research ministry, the French Cancer Research Association (ARC), the Agence Nationale de la Recherche and the Ile de France Canceropole. SG was supported by PhD fellowships from the French Ministry of Research (ACI 03-3-135) and from the French Cancer Research Association, DL by the ANR-08-BLAN-0200 postdoctoral fellowship, TJJ by an INRA postdoctoral fellowship, NS by a Canceropole Ile de France PhD fellowship, and CL by a INRA CJS PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Aichinger E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000605; Ali GS, 2006, J CELL SCI, V119, P3527, DOI 10.1242/jcs.03144; ALVAREZ J, 1992, PLANT J, V2, P103, DOI 10.1111/j.1365-313X.1992.00103.x; Ameyar-Zazoua M, 2009, J BIOL CHEM, V284, P27974, DOI 10.1074/jbc.M109.037929; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Baurle I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002733; BECKER D, 1990, NUCLEIC ACIDS RES, V18, P203, DOI 10.1093/nar/18.1.203; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brancorsini S, 2008, CELL CYCLE, V7, P1415, DOI 10.4161/cc.7.10.5835; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Calonje M, 2008, PLANT CELL, V20, P277, DOI 10.1105/tpc.106.049957; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; CHEN D, 2010, CELL RES; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Cui HC, 2009, PLANT J, V58, P1016, DOI 10.1111/j.1365-313X.2009.03839.x; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Exner V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005335; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; FEDER N, 1968, AM J BOT, V55, P123, DOI 10.2307/2440500; Fletcher JC, 2001, DEVELOPMENT, V128, P1323; Fu ZQ, 2007, NATURE, V447, P284, DOI 10.1038/nature05737; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Germann S, 2006, PLANT J, V48, P153, DOI 10.1111/j.1365-313X.2006.02859.x; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Haynes KA, 2006, CURR BIOL, V16, P2222, DOI 10.1016/j.cub.2006.09.035; He YH, 2009, MOL PLANT, V2, P554, DOI 10.1093/mp/ssp005; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hennig L, 2009, TRENDS GENET, V25, P414, DOI 10.1016/j.tig.2009.07.002; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Hornyik C, 2010, BIOCHEM SOC T, V38, P1077, DOI 10.1042/BST0381077; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; James P, 1996, GENETICS, V144, P1425; Kalyna M, 2004, BIOCHEM SOC T, V32, P561, DOI 10.1042/BST0320561; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kellum R, 2003, CURR TOP MICROBIOL, V274, P53; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; KIM DH, 2008, P NATL ACAD SCI US; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kohler C, 2010, CURR OPIN GENET DEV, V20, P541, DOI 10.1016/j.gde.2010.04.015; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Lim MH, 2004, PLANT CELL, V16, P731, DOI 10.1105/tpc.019331; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu SM, 2007, PLANT J, V52, P914, DOI 10.1111/j.1365-313X.2007.03286.x; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; LORKOVIC ZJ, 2009, TRENDS PLANT SCI; Ludwig-Muller J, 2000, PLANT PHYSIOL, V123, P949, DOI 10.1104/pp.123.3.949; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Malyavantham KS, 2008, J CELL BIOCHEM, V105, P391, DOI 10.1002/jcb.21834; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Odoux E, 2003, ANN BOT-LONDON, V92, P437, DOI 10.1093/aob/mcg150; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Okamuro JK, 1996, P NATL ACAD SCI USA, V93, P13831, DOI 10.1073/pnas.93.24.13831; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Palanivelu R, 2000, PLANT J, V22, P187, DOI 10.1046/j.1365-313x.2000.00721.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Piacentini L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000670; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Poduska B, 2003, GENETICS, V163, P1457; Provart NJ., 2003, CURRENT COMPUTER MOL, V2003, P271; Prunet N, 2008, PLANT CELL, V20, P901, DOI 10.1105/tpc.107.053306; Quesada V, 2005, INT J DEV BIOL, V49, P773, DOI 10.1387/ijdb.051995vq; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; RIPOLL J, 2009, DEV BIOL; Rodrigues JCM, 2010, SEX PLANT REPROD, V23, P123, DOI 10.1007/s00497-009-0131-2; Sablowski R, 2007, J EXP BOT, V58, P899, DOI 10.1093/jxb/erm002; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; SCHATLOWSKI N, 2008, SEMIN CELL DEV BIOL; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Skinner DJ, 2004, PLANT CELL, V16, pS32, DOI 10.1105/tpc.015933; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Streitner C, 2008, PLANT J, V56, P239, DOI 10.1111/j.1365-313X.2008.03591.x; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Sung SB, 2006, NAT GENET, V38, P706, DOI 10.1038/ng1795; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; TERRANOVA R, 2008, DEV CELL; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Tillemans V, 2005, PLANT J, V41, P567, DOI 10.1111/j.1365-313X.2004.02321.x; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Vassallo MF, 2002, P NATL ACAD SCI USA, V99, P5919, DOI 10.1073/pnas.092025499; Voinnet O, 2003, TRENDS PLANT SCI, V8, P307, DOI 10.1016/S1360-1385(03)00129-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yoshida N, 2001, PLANT CELL, V13, P2471, DOI 10.1105/tpc.13.11.2471; Yu H, 2004, NAT GENET, V36, P157, DOI 10.1038/ng1286; Yu Y, 2004, PLANT J, V40, P699, DOI 10.1111/j.1365-313X.2004.02240.x; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhang X, 2007, NAT STRUCT MOL BIOL, V14, P869, DOI 10.1038/nsmb1283; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	135	51	55	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16592	10.1371/journal.pone.0016592	http://dx.doi.org/10.1371/journal.pone.0016592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304947	gold, Green Published			2022-12-25	WOS:000286834300094
J	McArt, DG; Zhang, SD				McArt, Darragh G.; Zhang, Shu-Dong			Identification of Candidate Small-Molecule Therapeutics to Cancer by Gene-Signature Perturbation in Connectivity Mapping	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TRANS-RETINOIC ACID; BREAST-CANCER; HEMATOPOIETIC-CELLS; CERVICAL-CANCER; COLON-CANCER; IN-VITRO; EXPRESSION; APOPTOSIS; ALPHA	Connectivity mapping is a recently developed technique for discovering the underlying connections between different biological states based on gene-expression similarities. The sscMap method has been shown to provide enhanced sensitivity in mapping meaningful connections leading to testable biological hypotheses and in identifying drug candidates with particular pharmacological and/or toxicological properties. Challenges remain, however, as to how to prioritise the large number of discovered connections in an unbiased manner such that the success rate of any following-up investigation can be maximised. We introduce a new concept, gene-signature perturbation, which aims to test whether an identified connection is stable enough against systematic minor changes (perturbation) to the gene-signature. We applied the perturbation method to three independent datasets obtained from the GEO database: acute myeloid leukemia (AML), cervical cancer, and breast cancer treated with letrozole. We demonstrate that the perturbation approach helps to identify meaningful biological connections which suggest the most relevant candidate drugs. In the case of AML, we found that the prevalent compounds were retinoic acids and PPAR gamma activators. For cervical cancer, our results suggested that potential drugs are likely to involve the EGFR pathway; and with the breast cancer dataset, we identified candidates that are involved in prostaglandin inhibition. Thus the gene-signature perturbation approach added real values to the whole connectivity mapping process, allowing for increased specificity in the identification of possible therapeutic candidates.	[McArt, Darragh G.; Zhang, Shu-Dong] Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland	Queens University Belfast	McArt, DG (corresponding author), Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland.	s.zhang@qub.ac.uk	Zhang, Shu-Dong/G-1269-2010	Zhang, Shu-Dong/0000-0002-7721-0167; McArt, Darragh/0000-0001-6426-8776	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu K, 2009, ANTICANCER RES, V29, P2195; Bilotas M, 2010, FERTIL STERIL, V93, P2513, DOI 10.1016/j.fertnstert.2009.08.058; BODEY GP, 1982, REV INFECT DIS, V4, P579; BORGUNDVAAG B, 1992, ENDOCRINOLOGY, V130, P3453, DOI 10.1210/en.130.6.3453; Braconi C, 2009, CANCER-AM CANCER SOC, V115, P3738, DOI 10.1002/cncr.24417; Calle EE, 1996, AM J EPIDEMIOL, V144, P645, DOI 10.1093/oxfordjournals.aje.a008976; CASS CE, 1992, CANCER RES, V52, P5879; Cheng CK, 2008, BLOOD, V112, P3391, DOI 10.1182/blood-2008-02-137083; De Preter K, 2009, CLIN CANCER RES, V15, P3690, DOI 10.1158/1078-0432.CCR-08-2699; Do B, 2007, J CHROMATOGR B, V845, P104, DOI 10.1016/j.jchromb.2006.07.057; Eads D, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng CL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-411; Friedman M, 2003, FOOD CHEM TOXICOL, V41, P61, DOI 10.1016/S0278-6915(02)00205-3; Gariglio P, 2009, ARCH MED RES, V40, P449, DOI 10.1016/j.arcmed.2009.08.002; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gil-Ad I, 2006, ONCOL REP, V15, P107; Gullans SR, 2006, NEW ENGL J MED, V355, P2042, DOI 10.1056/NEJMcibr065953; Haferlach Torsten, 2008, Hematology Am Soc Hematol Educ Program, P400, DOI 10.1182/asheducation-2008.1.400; Han M, 2008, EUR J OBSTET GYN R B, V138, P83, DOI 10.1016/j.ejogrb.2007.05.021; Hiscox S, 2009, MATURITAS, V63, P275, DOI 10.1016/j.maturitas.2009.05.008; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Kim HJ, 2007, CANCER RES, V67, P2595, DOI 10.1158/0008-5472.CAN-06-3043; Klopper JP, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-16; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Le XF, 1999, J BIOL CHEM, V274, P21651, DOI 10.1074/jbc.274.31.21651; Lee MH, 2009, CANCER RES, V69, P7449, DOI 10.1158/0008-5472.CAN-09-1266; Lin ZH, 2009, CLIN CANCER RES, V15, P570, DOI 10.1158/1078-0432.CCR-08-1813; del Campo JM, 2008, GYNECOL ONCOL, V110, pS72, DOI 10.1016/j.ygyno.2008.04.016; Mayani H, 2009, LEUKEMIA RES, V33, P624, DOI 10.1016/j.leukres.2008.11.011; McNamara S, 2008, CLIN CANCER RES, V14, P5311, DOI 10.1158/1078-0432.CCR-08-1081; Miller WR, 2007, PHARMACOGENET GENOM, V17, P813, DOI 10.1097/FPC.0b013e32820b853a; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; Park SJ, 2009, BIOCHEM PHARMACOL, V77, P1328, DOI 10.1016/j.bcp.2008.12.027; Park SJ, 2010, CANCER LETT, V292, P54, DOI 10.1016/j.canlet.2009.11.004; Roumier C, 2009, PHARMACOGENOMICS, V10, P1839, DOI [10.2217/pgs.09.130, 10.2217/PGS.09.130]; Rybaczyk LA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-134; Sabnis GJ, 2005, CANCER RES, V65, P3903, DOI 10.1158/0008-5472.CAN-04-4092; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; SAVA G, 1989, CLIN EXP METASTAS, V7, P671, DOI 10.1007/BF01753677; Sayan BS, 2010, BIOCHEM BIOPH RES CO, V391, P1748, DOI 10.1016/j.bbrc.2009.12.147; Schroder O, 2006, J LIPID RES, V47, P1071, DOI 10.1194/jlr.M600008-JLR200; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Seufferlein T, 2002, BRIT J CANCER, V86, P1188, DOI 10.1038/sj/bjc/6600186; Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Stirewalt DL, 2008, GENE CHROMOSOME CANC, V47, P8, DOI 10.1002/gcc.20500; Tallman MS, 1997, NEW ENGL J MED, V337, P1021, DOI 10.1056/NEJM199710093371501; Teranishi F, 2009, CANCER SCI, V100, P770, DOI 10.1111/j.1349-7006.2009.01084.x; Tsai DE, 2008, CLIN CANCER RES, V14, P5619, DOI 10.1158/1078-0432.CCR-07-5185; Waggoner SE, 2003, LANCET, V361, P2217, DOI 10.1016/S0140-6736(03)13778-6; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang JS, 2008, BASIC CLIN PHARMACOL, V103, P336, DOI 10.1111/j.1742-7843.2008.00298.x; Wendeburg L, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-26; Wiklund ED, 2010, INT J CANCER, V126, P28, DOI 10.1002/ijc.24813; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Yang EV, 2006, CANCER RES, V66, P10357, DOI 10.1158/0008-5472.CAN-06-2496; Zhan SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-389; Zhang SD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-258	65	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16382	10.1371/journal.pone.0016382	http://dx.doi.org/10.1371/journal.pone.0016382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305029	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300057
J	Thomas, B; Mandir, AS; West, N; Liu, Y; Andrabi, SA; Stirling, W; Dawson, VL; Dawson, TM; Lee, MK				Thomas, Bobby; Mandir, Allen S.; West, Neva; Liu, Ying; Andrabi, Shaida A.; Stirling, Wanda; Dawson, Valina L.; Dawson, Ted M.; Lee, Michael K.			Resistance to MPTP-Neurotoxicity in alpha-Synuclein Knockout Mice Is Complemented by Human alpha-Synuclein and Associated with Increased beta-Synuclein and Akt Activation	PLOS ONE			English	Article							DOPAMINERGIC NEURON LOSS; NIGRA PARS COMPACTA; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; LEWY BODY; TRANSGENIC MICE; UP-REGULATION; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; HIPPOCAMPAL SEROTONIN; STEREOLOGICAL METHODS	Genetic and biochemical abnormalities of alpha-synuclein are associated with the pathogenesis of Parkinson's disease. In the present study we investigated the in vivo interaction of mouse and human alpha-synuclein with the potent parkinsonian neurotoxin, MPTP. We find that while lack of mouse alpha-synuclein in mice is associated with reduced vulnerability to MPTP, increased levels of human alpha-synuclein expression is not associated with obvious changes in the vulnerability of dopaminergic neurons to MPTP. However, expressing human alpha-synuclein variants (human wild type or A53T) in the alpha-synuclein null mice completely restores the vulnerability of nigral dopaminergic neurons to MPTP. These results indicate that human alpha-synuclein can functionally replace mouse alpha-synuclein in regard to vulnerability of dopaminergic neurons to MPTP-toxicity. Significantly, alpha-synuclein null mice and wild type mice were equally sensitive to neurodegeneration induced by 2'NH2-MPTP, a MPTP analog that is selective for serotoninergic and noradrenergic neurons. These results suggest that effects of alpha-synuclein on MPTP like compounds are selective for nigral dopaminergic neurons. Immunoblot analysis of beta-synuclein and Akt levels in the mice reveals selective increases in beta-synuclein and phosphorylated Akt levels in ventral midbrain, but not in other brain regions, of alpha-synuclein null mice, implicating the a-synuclein-level dependent regulation of beta-synuclein expression in modulation of MPTP-toxicity by alpha-synuclein. Together these findings provide new mechanistic insights on the role alpha-synuclein in modulating neurodegenerative phenotypes by regulation of Akt-mediated cell survival signaling in vivo.	[Thomas, Bobby; Andrabi, Shaida A.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Neuroregenerat & Stem Cell Programs, Baltimore, MD USA; [Thomas, Bobby; Mandir, Allen S.; Andrabi, Shaida A.; Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [West, Neva; Liu, Ying; Stirling, Wanda; Lee, Michael K.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Dawson, Valina L.; Dawson, Ted M.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Thomas, B (corresponding author), Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA.	tdawson@jhmi.edu; mklee@umn.edu	Andrabi, Shaida/I-6167-2012; Lee, Michael K/D-9491-2013; Dawson, Valina/Y-9757-2019	Andrabi, Shaida/0000-0002-3305-2638; Lee, Michael K/0000-0001-5865-9682; Dawson, Valina/0000-0002-2915-3970	Morris K. Udall Parkinson's Disease Research Center; National Institutes of Health-National Institute of Neurological Disorders and Stroke [NS 38377, NS 38065]; NIH [NS06885, NS062165]; US Public Health Service [K08-NS020235]; Parkinson Disease Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS062165, R56NS038065, P01NS038065, R01NS060885, R01NS038065, P50NS038377] Funding Source: NIH RePORTER	Morris K. Udall Parkinson's Disease Research Center; National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Parkinson Disease Foundation; American Parkinson Disease Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Morris K. Udall Parkinson's Disease Research Center and National Institutes of Health-National Institute of Neurological Disorders and Stroke grants (NS 38377, NS 38065). B. T. is supported by NIH grants (NS06885 and NS062165). A. S. M. was supported by US Public Health Service Clinical Investigator Development Award (K08-NS020235), the Parkinson Disease Foundation International Grant and is a recipient of the George C. Cotzias Award of the American Parkinson Disease Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Andrews AM, 1996, MOL PHARMACOL, V50, P1511; ANDREWS AM, 1993, J NEUROCHEM, V60, P1167, DOI 10.1111/j.1471-4159.1993.tb03271.x; ANDREWS AM, 1993, J PHARMACOL EXP THER, V267, P1432; ANDREWS AM, 1993, EUR J PHARMACOL, V250, P215, DOI 10.1016/0014-2999(93)90384-T; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bergman H, 2002, MOVEMENT DISORD, V17, pS28, DOI 10.1002/mds.10140; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Daher JPL, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-34; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Dong ZZ, 2002, J NEUROBIOL, V53, P1, DOI 10.1002/neu.10094; Drolet RE, 2004, NEUROTOXICOLOGY, V25, P761, DOI 10.1016/j.neuro.2004.05.002; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; FAHERTY CJ, 2004, CELL DEATH PARKINSON; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, pR22; Fukuda T, 2001, NEUROPATHOLOGY, V21, P323, DOI 10.1046/j.1440-1789.2001.00402.x; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2004, J BIOL CHEM, V279, P23622, DOI 10.1074/jbc.M313784200; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Kalivendi SV, 2004, J BIOL CHEM, V279, P15240, DOI 10.1074/jbc.M312497200; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; KLIVENYI P, 2005, NEUROBIOL DIS; Kowall NW, 2000, NEUROREPORT, V11, P211, DOI 10.1097/00001756-200001170-00041; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lehmensiek V, 2002, NEUROREPORT, V13, P1279, DOI 10.1097/00001756-200207190-00013; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Maj MC, 2010, BIOCHEM BIOPH RES CO, V399, P331, DOI 10.1016/j.bbrc.2010.07.033; Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; NIETO M, 2005, NEUROBIOL AGING; Ohashi S, 2006, NEUROSCI LETT, V401, P183, DOI 10.1016/j.neulet.2006.03.017; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 1998, MOVEMENT DISORD, V13, P35; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Przedborski S, 2001, J NEUROCHEM, V76, P637, DOI 10.1046/j.1471-4159.2001.00174.x; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Robertson DC, 2004, J NEUROCHEM, V89, P1126, DOI 10.1111/j.1471-4159.2004.02378.x; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Schluter OM, 2003, NEUROSCIENCE, V118, P985, DOI 10.1016/S0306-4522(03)00036-8; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Tatton NA, 1997, NEUROSCIENCE, V77, P1037, DOI 10.1016/S0306-4522(96)00545-3; Thiruchelvam MJ, 2004, EUR J NEUROSCI, V19, P845, DOI 10.1111/j.0953-816X.2004.03139.x; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Thomas B, 2007, NEUROBIOL DIS, V26, P312, DOI 10.1016/j.nbd.2006.12.021; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2000, J NEUROCHEM, V74, P721, DOI 10.1046/j.1471-4159.2000.740721.x; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamada M, 2004, J NEUROCHEM, V91, P451, DOI 10.1111/j.1471-4159.2004.02728.x; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	73	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16706	10.1371/journal.pone.0016706	http://dx.doi.org/10.1371/journal.pone.0016706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304957	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300125
J	Via, M; Gignoux, CR; Roth, LA; Fejerman, L; Galanter, J; Choudhry, S; Toro-Labrador, G; Viera-Vera, J; Oleksyk, TK; Beckman, K; Ziv, E; Risch, N; Burchard, EG; Martinez-Cruzado, JC				Via, Marc; Gignoux, Christopher R.; Roth, Lindsey A.; Fejerman, Laura; Galanter, Joshua; Choudhry, Shweta; Toro-Labrador, Gladys; Viera-Vera, Jorge; Oleksyk, Taras K.; Beckman, Kenneth; Ziv, Elad; Risch, Neil; Burchard, Esteban Gonzalez; Martinez-Cruzado, Juan Carlos			History Shaped the Geographic Distribution of Genomic Admixture on the Island of Puerto Rico	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; NON-JEWISH AMERICANS; POPULATION-STRUCTURE; GENETIC ANCESTRY; AFRICAN-AMERICANS; SPANISH ANCESTRY; WIDE PATTERNS; ASSOCIATION; DIVERSITY; FREQUENCIES	Contemporary genetic variation among Latin Americans human groups reflects population migrations shaped by complex historical, social and economic factors. Consequently, admixture patterns may vary by geographic regions ranging from countries to neighborhoods. We examined the geographic variation of admixture across the island of Puerto Rico and the degree to which it could be explained by historic and social events. We analyzed a census-based sample of 642 Puerto Rican individuals that were genotyped for 93 ancestry informative markers (AIMs) to estimate African, European and Native American ancestry. Socioeconomic status (SES) data and geographic location were obtained for each individual. There was significant geographic variation of ancestry across the island. In particular, African ancestry demonstrated a decreasing East to West gradient that was partially explained by historical factors linked to the colonial sugar plantation system. SES also demonstrated a parallel decreasing cline from East to West. However, at a local level, SES and African ancestry were negatively correlated. European ancestry was strongly negatively correlated with African ancestry and therefore showed patterns complementary to African ancestry. By contrast, Native American ancestry showed little variation across the island and across individuals and appears to have played little social role historically. The observed geographic distributions of SES and genetic variation relate to historical social events and mating patterns, and have substantial implications for the design of studies in the recently admixed Puerto Rican population. More generally, our results demonstrate the importance of incorporating social and geographic data with genetics when studying contemporary admixed populations.	[Via, Marc; Roth, Lindsey A.; Galanter, Joshua; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Via, Marc; Gignoux, Christopher R.; Fejerman, Laura; Choudhry, Shweta; Ziv, Elad; Risch, Neil; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Fejerman, Laura; Ziv, Elad] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Choudhry, Shweta] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Toro-Labrador, Gladys; Martinez-Cruzado, Juan Carlos] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Viera-Vera, Jorge; Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Beckman, Kenneth] Univ Minnesota, Dept Genet Cell Biol & Dev Biol, Minneapolis, MN USA; [Risch, Neil] Kaiser Permanente, Div Res, Oakland, CA USA; [Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Puerto Rico; University of Puerto Rico Mayaguez; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Minnesota System; University of Minnesota Twin Cities; Kaiser Permanente; University of California System; University of California San Francisco	Via, M (corresponding author), Univ Barcelona, Lab Anthropol, Dept Anim Biol, Barcelona, Spain.	mvia@ub.edu; Esteban@sfgh.ucsf.edu; juancarlos.martinez@upr.edu	Ziv, Elad/L-5396-2014; Taras, Oleksyk/J-8805-2013; Via, Marc/L-6511-2014	Taras, Oleksyk/0000-0002-8148-3918; Via, Marc/0000-0002-9966-9921; Fejerman, Laura/0000-0003-3179-1151; Galanter, Joshua/0000-0002-2561-6384	National Institutes of Health [HL078885, HL088133, U19 AI077439, ES015794]; Flight Attendant Medical Research Institute (FAMRI); RWJ Amos Medical Faculty Development; American Thoracic Society 'Breakthrough Opportunities in Lung Disease' (BOLD); Tobacco-Related Disease Research Program New Investigator Award [15KT-0008]; Beatriu de Pinos Postdoctoral [BP-A 10144]; UCSF; Sandler Center for Basic Research in Asthma; Sandler Family Supporting Foundation; Direct For Education and Human Resources [0841338] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088133, R01HL078885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI); RWJ Amos Medical Faculty Development; American Thoracic Society 'Breakthrough Opportunities in Lung Disease' (BOLD); Tobacco-Related Disease Research Program New Investigator Award(University of California System); Beatriu de Pinos Postdoctoral; UCSF; Sandler Center for Basic Research in Asthma; Sandler Family Supporting Foundation; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (HL078885, HL088133, U19 AI077439, ES015794), Flight Attendant Medical Research Institute (FAMRI), and the RWJ Amos Medical Faculty Development Award to EGB, American Thoracic Society 'Breakthrough Opportunities in Lung Disease' (BOLD) Award and Tobacco-Related Disease Research Program New Investigator Award (15KT-0008) to SC, Beatriu de Pinos Postdoctoral Grant (2006 BP-A 10144) to MV, UCSF Chancellor's Fellowship to CG, and the Sandler Center for Basic Research in Asthma and the Sandler Family Supporting Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; ARCE CH, 1987, HISPANIC J BEHAV SCI, V9, P19, DOI 10.1177/073998638703090102; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; BAIZ EG, 2000, SIGLO BLANCO ESTUDIO, V16, pR18; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bryc K, 2010, P NATL ACAD SCI USA, V107, P8954, DOI 10.1073/pnas.0914618107; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burchard EG, 2005, AM J PUBLIC HEALTH, V95, P2161, DOI 10.2105/AJPH.2005.068668; Caulfield T, 2009, GENOME MED, V1, DOI 10.1186/gm8; Cavalli-Sforza Luigi Luca, 1994, HIST GEOGRAPHY HUMAN, pxi; Choudhry S, 2006, HUM GENET, V118, P652, DOI 10.1007/s00439-005-0071-3; Choudhry S, 2006, AM J RESP CRIT CARE, V174, P1086, DOI [10.1164/RCCM.200605-596OC, 10.1164/rccm.200605-596OC]; DECORDOBA PT, 1831, MEMORIAS GEOGRAFICAS; Diaz Soler Luis M., 2005, HIST ESCLAVITUD NEGR; Ellis NA, 1998, AM J HUM GENET, V63, P1685, DOI 10.1086/302167; Falush D, 2003, GENETICS, V164, P1567; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; FOTHERINGHAM AS, 2002, GEOGRAPHICALLY WEIGH, pR12; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gravlee CC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006821; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Huizing M, 2001, AM J HUM GENET, V69, P1022, DOI 10.1086/324168; ISAAKS EH, 1989, APPL GEOSTATISTICS, pR19; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; King R, 2002, ANTIQUITY, V76, P707, DOI 10.1017/S0003598X00091158; Klein Herbert S., 1986, AFRICAN SLAVERY LATI; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Martinez-Cruzado JC, 2005, AM J PHYS ANTHROPOL, V128, P131, DOI 10.1002/ajpa.20108; Martinez-Cruzado JC, 2001, HUM BIOL, V73, P491, DOI 10.1353/hub.2001.0056; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Mintz Sidney W, 1953, AM HIST REV, V33, P224; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Moscoso Francisco, 2008, CACIQUES ALDEAS POBL; Mullineaux LG, 2003, CANCER-AM CANCER SOC, V98, P597, DOI 10.1002/cncr.11533; Nazario M. Alvarez, 1974, ELEMENTO AFRONEGROID; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; PIAZZA A, 1981, P NATL ACAD SCI-BIOL, V78, P2638, DOI 10.1073/pnas.78.4.2638; Pritchard JK, 2000, GENETICS, V155, P945; Relethford JH, 2008, AM J PHYS ANTHROPOL, V136, P1, DOI 10.1002/ajpa.20789; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; SALZANO FM, 2002, EVOLUTION GENETICS L, pR16; SANGER JP, 1900, 1899 CENSUS REPORT P; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; STOLCKE V, 1974, MARRIAGE CLASS COLOU, pR10; TELLES EE, 1990, SOC SCI QUART, V71, P682; *US BUR CENS, 2001, CENS POP; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505	48	68	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16513	10.1371/journal.pone.0016513	http://dx.doi.org/10.1371/journal.pone.0016513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304981	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300074
J	Gherghe, CM; Duan, JZ; Gong, JC; Rojas, M; Klauber-Demore, N; Majesky, M; Deb, A				Gherghe, Costin M.; Duan, Jinzhu; Gong, Jucheng; Rojas, Mauricio; Klauber-Demore, Nancy; Majesky, Mark; Deb, Arjun			Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner	FASEB JOURNAL			English	Article						angiogenesis; vascular progenitor; paracrine	GENE-THERAPY; CELLS; INHIBITION; MECHANISMS	Human endothelial progenitor cells (hEPCs) participate in neovascularization of ischemic tissues. Function and number of hEPCs decline in patients with cardiovascular disease, and therapeutic strategies to enhance hEPC function remain an important field of investigation. The Wnt signaling system, comprising 19 lipophilic proteins, regulates vascular patterning in the developing embryo. However, the effects of Wnts on hEPCs and the adult vasculature remain unclear. We demonstrate here that Wnt1 is expressed in a subset of endothelial cells lining the murine embryonic dorsal aorta and is reactivated in malignant angiosarcoma, suggesting a strong association of Wnt1 with angiogenesis. We investigate the effects of Wnt1 in enhancing hEPC function and blood flow to ischemic tissues and show that Wnt1 enhances the proliferative and angiogenic functions of hEPCs in a hepatocyte growth factor (HGF)-dependent manner. Injection of Wnt1-expressing hEPCs increases blood flow and capillary density in murine ischemic hindlimbs. Furthermore, injection of Wnt1 protein alone similarly increases blood flow and capillary density in ischemic hindlimbs, and this effect is associated with increased HGF expression in ischemic muscle. These findings demonstrate that Wnt1, a marker of neural crest cells and hitherto unknown angiogenic function, is a novel angiogenic protein that is expressed in developing endothelial cells, exerts salutary effects on postnatal hEPCs, and can be therapeutically deployed to increase blood flow and angiogenesis in ischemic tissues.-Gherghe, C. M., Duan, J., Gong, J., Rojas, M., Klauber-Demore, N., Majesky, M., Deb, A. Wnt1 is a proangiogenic molecule, enhances human endothelial progenitor function, and increases blood flow to ischemic limbs in a HGF-dependent manner. FASEB J. 25, 1836-1843 (2011). www.fasebj.org	[Gherghe, Costin M.; Duan, Jinzhu; Gong, Jucheng; Rojas, Mauricio; Deb, Arjun] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Gherghe, Costin M.; Duan, Jinzhu; Gong, Jucheng; Deb, Arjun] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Klauber-Demore, Nancy] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Gherghe, Costin M.; Duan, Jinzhu; Gong, Jucheng; Rojas, Mauricio; Klauber-Demore, Nancy; Deb, Arjun] Univ N Carolina, UNC McAllister Heart Inst, Chapel Hill, NC 27599 USA; [Gherghe, Costin M.; Duan, Jinzhu; Gong, Jucheng; Klauber-Demore, Nancy; Deb, Arjun] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Majesky, Mark] Univ Washington, Sch Med, Dept Pediat, Div Cardiol,Seattle Childrens Res Inst, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Deb, A (corresponding author), Univ N Carolina, Dept Med, 3212B MBRB,Campus Box 7126,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	arjundeb@med.unc.edu	, UNC Flow Cytometry Core/AGU-9839-2022		National Institutes of Health; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [R01CA142657] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102190, R01HL093594, R00HL088317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the Mouse Histology Core (Virus and Flow Cytometry Core, University of North Carolina-Chapel Hill) for assistance with techniques. The authors thank Jackie Kylander and Taylor Kopple (Mouse Cardiovascular Core, University of North Carolina-Chapel Hill) for assistance with laser-Doppler scanning and Dr. Gobinda Sarkar (Mayo Clinic, Rochester, MN, USA) for critique of the manuscript. This work was supported by grants from the National Institutes of Health and Ellison Medical Foundation to A.D.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Becker GJ, 2002, J VASC INTERV RADIOL, V13, P7, DOI 10.1016/S1051-0443(07)60002-5; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Deb A, 2010, CIRCULATION, V121, P850, DOI 10.1161/CIR.0b013e3181d4c360; Dudek AZ, 2007, BRIT J CANCER, V97, P513, DOI 10.1038/sj.bjc.6603883; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; MASCKAUCHAN HTN, 2005, ANGIOGENESIS, V8, P43; Matsui H, 2007, STEM CELLS, V25, P2660, DOI 10.1634/stemcells.2006-0699; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; You L, 2004, CANCER RES, V64, P3474, DOI 10.1158/0008-5472.CAN-04-0115; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	24	27	30	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1836	1843		10.1096/fj.10-172981	http://dx.doi.org/10.1096/fj.10-172981			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21321190	Green Published			2022-12-25	WOS:000291023800007
J	Shrivastava, AN; Triller, A; Sieghart, W; Sarto-Jackson, I				Shrivastava, Amulya Nidhi; Triller, Antoine; Sieghart, Werner; Sarto-Jackson, Isabella			Regulation of GABA(A) Receptor Dynamics by Interaction with Purinergic P2X(2) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; CROSS-TALK; IMMUNOCYTOCHEMICAL DISTRIBUTION; MEMBRANE-RECEPTORS; INFLAMMATORY PAIN; LATERAL DIFFUSION; GLYCINE RECEPTORS; TNP-ATP; SUBUNITS; NEURONS	gamma-Aminobutyric acid type A receptors (GABA(A)Rs) in the spinal cord are evolving as an important target for drug development against pain. Purinergic P2X(2) receptors (P2X(2)Rs) are also expressed in spinal cord neurons and are known to cross-talk with GABA(A)Rs. Here, we investigated a possible "dynamic" interaction between GABAARs and P2X(2)Rs using co-immuno-precipitation and fluorescence resonance energy transfer (FRET) studies in human embryonic kidney (HEK) 293 cells along with co-localization and single particle tracking studies in spinal cord neurons. Our results suggest that a significant proportion of P2X(2)Rs forms a transient complex with GABA(A)Rs inside the cell, thus stabilizing these receptors and using them for co-trafficking to the cell surface, where P2X(2)Rs and GABA(A)Rs are primarily located extra-synaptically. Furthermore, agonist-induced activation of P2X(2)Rs results in a Ca2+ dependent as well as an apparently Ca2+-independent increase in the mobility and an enhanced degradation of GABA(A)Rs, whereas P2X(2)Rs are stabilized and form larger clusters. Antagonist-induced blocking of P2XRs results in co-stabilization of this receptor complex at the cell surface. These results suggest a novel mechanism where association of P2X(2)Rs and GABA(A)Rs could be used for specific targeting to neuronal membranes, thus providing an extrasynaptic receptor reserve that could regulate the excitability of neurons. We further conclude that blocking the excitatory activity of excessively released ATP under diseased state by P2XR antagonists could simultaneously enhance synaptic inhibition mediated by GABA(A)Rs.	[Shrivastava, Amulya Nidhi; Sieghart, Werner; Sarto-Jackson, Isabella] Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, A-1090 Vienna, Austria; [Shrivastava, Amulya Nidhi; Triller, Antoine] Ecole Normale Super, Inst Biol, F-75005 Paris, France; [Shrivastava, Amulya Nidhi; Triller, Antoine] INSERM, U1024, F-75005 Paris, France; [Shrivastava, Amulya Nidhi; Triller, Antoine] CNRS, UMR8197, F-75005 Paris, France	Medical University of Vienna; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Sarto-Jackson, I (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Biochem & Mol Biol, Spitalgasse 4, A-1090 Vienna, Austria.	isabella.sarto-jackson@meduniwien.ac.at	Sieghart, Werner/A-4877-2013	Sieghart, Werner/0000-0002-0443-0302; Shrivastava, Amulya Nidhi/0000-0002-1322-8018; TRILLER, Antoine/0000-0002-7530-1233	Medical University of Vienna; INSERM, Ecole Normale Superieure; Pierre-Gilles de Gennes Foundation	Medical University of Vienna; INSERM, Ecole Normale Superieure(Institut National de la Sante et de la Recherche Medicale (Inserm)); Pierre-Gilles de Gennes Foundation	This work was supported by the International Ph.D. Program "Cell Communication in Health and Disease" of the Medical University of Vienna and the Austrian Science Fund, INSERM, Ecole Normale Superieure, and a grant from the Pierre-Gilles de Gennes Foundation.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bardoni R, 1997, J NEUROSCI, V17, P5297; Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; BLEEHEN T, 1977, PAIN, V3, P367, DOI 10.1016/0304-3959(77)90066-5; Bobanovic LK, 2002, J NEUROSCI, V22, P4814, DOI 10.1523/JNEUROSCI.22-12-04814.2002; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bonneau S, 2005, IEEE T IMAGE PROCESS, V14, P1384, DOI 10.1109/TIP.2005.852794; Boue-Grabot E, 2004, J BIOL CHEM, V279, P52517, DOI 10.1074/jbc.M410223200; Boue-Grabot E, 2004, J BIOL CHEM, V279, P6967, DOI 10.1074/jbc.M307772200; Boue-Grabot E, 2003, J NEUROSCI, V23, P1246, DOI 10.1523/JNEUROSCI.23-04-01246.2003; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Charrier C, 2010, NAT NEUROSCI, V13, P1388, DOI 10.1038/nn.2645; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Collo G, 1996, J NEUROSCI, V16, P2495; Decker DA, 2009, AM J PHYSIOL-GASTR L, V296, pG1267, DOI 10.1152/ajpgi.00048.2009; Ding YN, 2000, J AUTONOM NERV SYST, V81, P289, DOI 10.1016/S0165-1838(00)00131-4; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Guerlet G, 2008, BIOCHEM BIOPH RES CO, V375, P405, DOI 10.1016/j.bbrc.2008.08.030; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Honore P, 2002, PAIN, V96, P99, DOI 10.1016/S0304-3959(01)00434-1; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Jarvis MF, 2001, BRIT J PHARMACOL, V132, P259, DOI 10.1038/sj.bjp.0703793; Jo YH, 1999, NAT NEUROSCI, V2, P241, DOI 10.1038/6344; Karanjia R, 2006, EUR J NEUROSCI, V23, P3259, DOI 10.1111/j.1460-9568.2006.04861.x; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Khakh BS, 2005, J NEUROSCI, V25, P6911, DOI 10.1523/JNEUROSCI.0561-05.2005; Khakh BS, 2001, P NATL ACAD SCI USA, V98, P5288, DOI 10.1073/pnas.081089198; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Knabl J, 2008, NATURE, V451, P330, DOI 10.1038/nature06493; Koles L, 2008, N-S ARCH PHARMACOL, V377, P1, DOI 10.1007/s00210-007-0222-2; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Labrakakis C, 2003, J PHYSIOL-LONDON, V549, P131, DOI 10.1113/jphysiol.2002.031963; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Machado P, 2011, J NEUROSCI, V31, P3, DOI 10.1523/JNEUROSCI.2533-10.2011; Masin M, 2006, J BIOL CHEM, V281, P4100, DOI 10.1074/jbc.M507735200; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Milan-Lobo L, 2009, MOL PHARMACOL, V76, P1196, DOI 10.1124/mol.109.059139; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Olsen RW, 2009, NEUROPHARMACOLOGY, V56, P141, DOI 10.1016/j.neuropharm.2008.07.045; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Renner M, 2009, J NEUROSCI, V29, P2926, DOI 10.1523/JNEUROSCI.4445-08.2009; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Sarto I, 2002, J BIOL CHEM, V277, P30656, DOI 10.1074/jbc.M203597200; Sarto-Jackson I, 2006, J NEUROCHEM, V96, P983, DOI 10.1111/j.1471-4159.2005.03626.x; Sarto-Jackson I, 2007, J BIOL CHEM, V282, P4354, DOI 10.1074/jbc.M609676200; Schicker K, 2009, BBA-MOL CELL RES, V1793, P325, DOI 10.1016/j.bbamcr.2008.09.014; SIEGHART W, 1995, PHARMACOL REV, V47, P181; Sokolova E, 2001, J NEUROSCI, V21, P4958, DOI 10.1523/JNEUROSCI.21-14-04958.2001; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Todd AJ, 1996, J NEUROSCI, V16, P974; Toulme E, 2007, J NEUROCHEM, V102, P1357, DOI 10.1111/j.1471-4159.2007.04640.x; Tretter V, 1997, J NEUROSCI, V17, P2728; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Trujillo CA, 2006, BIOCHEMISTRY-US, V45, P224, DOI 10.1021/bi051517w; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wirkner K, 2007, MOL NEUROBIOL, V36, P165, DOI 10.1007/s12035-007-0033-y; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Zeilhofer HU, 2008, NEUROSCI LETT, V437, P170, DOI 10.1016/j.neulet.2008.03.056; Zeilhofer HU, 2009, TRENDS PHARMACOL SCI, V30, P397, DOI 10.1016/j.tips.2009.05.007; ZEZULA J, 1991, FEBS LETT, V284, P15, DOI 10.1016/0014-5793(91)80750-W; Zhou XP, 1998, J PHYSIOL-LONDON, V513, P685, DOI 10.1111/j.1469-7793.1998.685ba.x	74	31	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14455	14468		10.1074/jbc.M110.165282	http://dx.doi.org/10.1074/jbc.M110.165282			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343285	Green Published, hybrid			2022-12-25	WOS:000289556200067
J	Jones, JC; Temple, BRS; Jones, AM; Dohlman, HG				Jones, Janice C.; Temple, Brenda R. S.; Jones, Alan M.; Dohlman, Henrik G.			Functional Reconstitution of an Atypical G Protein Heterotrimer and Regulator of G Protein Signaling Protein (RGS1) from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; CRYSTAL-STRUCTURE; BETA-SUBUNIT; ALPHA; GTP; DISSOCIATE; MG-2+	It has long been known that animal heterotrimeric G alpha beta gamma proteins are activated by cell-surface receptors that promote GTP binding to the G alpha subunit and dissociation of the heterotrimer. In contrast, the G alpha protein from Arabidopsis thaliana (AtGPA1) can activate itself without a receptor or other exchange factor. It is unknown how AtGPA1 is regulated by G beta gamma and the RGS (($) under bar regulator of ($) under barG protein ($) under bar signaling) protein AtRGS1, which is comprised of an RGS domain fused to a receptor-like domain. To better understand the cycle of G protein activation and inactivation in plants, we purified and reconstituted AtGPA1, full-length AtRGS1, and two putative G beta gamma dimers. We show that the Arabidopsis G alpha protein binds to its cognate G beta gamma dimer directly and in a nucleotide-dependent manner. Although animal G beta gamma dimers inhibit GTP binding to the G alpha subunit, AtGPA1 retains fast activation in the presence of its cognate G beta gamma dimer. We show further that the full-length AtRGS1 protein accelerates GTP hydrolysis and thereby counteracts the fast nucleotide exchange rate of AtGPA1 Finally, we show that AtGPA1 is less stable in complex with GDP than in complex with cap or the G beta gamma dimer. Molecular dynamics simulations and biophysical studies reveal that altered stability is likely due to increased dynamic motion in the N-terminal alpha-helix and Switch II of AtGPA1 Thus, despite profound differences in the mechanisms of activation, the Arabidopsis G protein is readily inactivated by its cognate RGS protein and forms a stable, GDP-bound, heterotrimeric complex similar to that found in animals.	[Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.; Dohlman, Henrik G.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Jones, Janice C.; Temple, Brenda R. S.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Temple, Brenda R. S.] Univ N Carolina, RL Juliano Struct Bioinformat Core Facil, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Jones, AM (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	alan_jones@unc.edu; henrik_dohlman@med.unc.edu		Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [GM080739, GM082892, GM065989]; NIGMS; Department of Energy [DE-FG02-05er1 5671]; National Science Foundation [MCB-0723515, MCB-0718202]; Ruth Kirchstein F32; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM080739, R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Ruth Kirchstein F32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM080739 and GM082892 (to H. G. D.) and GM065989 (to A. M. J.) from the NIGMS. This work was also supported by Department of Energy Grant DE-FG02-05er1 5671 and National Science Foundation Grants MCB-0723515 and MCB-0718202 (to A. M. J.).; Supported by a Ruth Kirchstein F32 postdoctoral award.	Adjobo-Hermans MJW, 2006, J CELL SCI, V119, P5087, DOI 10.1242/jcs.03284; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; Isom DG, 2011, PROTEINS, V79, P1034, DOI 10.1002/prot.22932; Isom DG, 2010, P NATL ACAD SCI USA, V107, P4908, DOI 10.1073/pnas.0910421107; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Mason MG, 2001, BBA-GENE STRUCT EXPR, V1520, P147, DOI 10.1016/S0167-4781(01)00262-7; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; NEAL SE, 1990, P NATL ACAD SCI USA, V87, P3562, DOI 10.1073/pnas.87.9.3562; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; Temple BRS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000962; Teotico DG, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000111; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang SY, 2008, J BIOL CHEM, V283, P13913, DOI 10.1074/jbc.M801376200; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Willard FS, 2004, METHOD ENZYMOL, V389, P320	31	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13143	13150		10.1074/jbc.M110.190355	http://dx.doi.org/10.1074/jbc.M110.190355			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325279	hybrid, Green Published			2022-12-25	WOS:000289282200035
J	Vicari, D; Foy, KC; Liotta, EM; Kaumaya, PTP				Vicari, Daniele; Foy, Kevin C.; Liotta, Eric M.; Kaumaya, Pravin T. P.			Engineered Conformation-dependent VEGF Peptide Mimics Are Effective in Inhibiting VEGF Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; BREAST-CANCER PATIENTS; IN-VITRO; CRYSTAL-STRUCTURE; NEUTRALIZING ANTIBODIES; ANGIOGENESIS INHIBITORS; ANGSTROM RESOLUTION; CIRCULAR-DICHROISM; TUMOR ANGIOGENESIS	Angiogenesis, or formation of new blood vessels, is crucial to cancer tumor growth. Tumor growth, progression, and metastasis are critically influenced by the production of the pro-angiogenic vascular endothelial growth factor (VEGF). Promising anti-angiogenic drugs are currently available; however, their susceptibilities to drug resistance and long term toxicity are serious impediments to their use, thus requiring the development of new therapeutic approaches for safe and effective angiogenic inhibitors. In this work, peptides were designed to mimic the VEGF-binding site to its receptor VEGFR-2. The VEGF conformational peptide mimic, VEGT-P3(CYC), included two artificial cysteine residues, which upon cyclization constrained the peptide in a loop native-like conformation to better mimic the anti-parallel structure of VEGF. The engineered cyclic VEGF mimic peptide demonstrated the highest affinity to VEGTR-2 by surface plasmon resonance assay. The VEGF peptide mimics were evaluated as inhibitors in several in vitro assays in which VEGF-dependent signaling pathways were observed. All VEGF mimics inhibited VEGFR-2 phosphorylation with VEGF-P3(CYC) showing the highest inhibitory effects when compared with unstructured peptides. Additionally, we show in several arigiogenic in vitro assays that all the VEGF mimics inhibited endothelial cell proliferation, migration, and network formation with the conformational VEGT-P3 (CYC) being the best. The VEGT-P3(CYC) also caused a significant delay in tumor development in a transgenic model of VEGF(+/-)Neu2-5(+/-). These results indicate that the structure-based design is important for the development of this peptidomimetic and for its anti-angiogenic effects.	[Vicari, Daniele; Foy, Kevin C.; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Vicari, Daniele; Foy, Kevin C.; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Liotta, Eric M.] Ohio State Univ, Sch Biomed Sci, Columbus, OH 43210 USA; [Kaumaya, Pravin T. P.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kaumaya, PTP (corresponding author), Ohio State Univ, Dept Microbiol, Ste 316 Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Kaumaya.1@osu.edu	Kaumaya, Pravin T. P/E-3354-2011					Ahmed SI, 2004, J CHEMOTHERAPY, V16, P59, DOI 10.1179/joc.2004.16.Supplement-1.59; Allen SD, 2005, J PEPT RES, V65, P591, DOI 10.1111/j.1399-3011.2005.00256.x; Allen SD, 2007, J IMMUNOL, V179, P472, DOI 10.4049/jimmunol.179.1.472; Anghelina M, 2004, STEM CELLS DEV, V13, P665, DOI 10.1089/scd.2004.13.665; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; Backer MV, 2001, J CONTROL RELEASE, V74, P349, DOI 10.1016/S0168-3659(01)00346-7; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2001, NAT BIOTECHNOL, V19, P20, DOI 10.1038/83457; Binetruy-Tournaire R, 2000, EMBO J, V19, P1525, DOI 10.1093/emboj/19.7.1525; Boguslawski G, 2004, J BIOL CHEM, V279, P5716, DOI 10.1074/jbc.M308625200; Boldicke T, 2001, STEM CELLS, V19, P24, DOI 10.1634/stemcells.19-1-24; Brown KJ, 1996, LAB INVEST, V75, P539; BUSH CA, 1978, BIOCHEMISTRY-US, V17, P4951, DOI 10.1021/bi00616a015; Butenas S, 2006, J THROMB HAEMOST, V4, P2411, DOI 10.1111/j.1538-7836.2006.02226.x; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; Dakappagari NK, 2000, CANCER RES, V60, P3782; Dakappagari NK, 2003, J IMMUNOL, V170, P4242, DOI 10.4049/jimmunol.170.8.4242; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Dass CR, 2006, PEPTIDES, V27, P3479, DOI 10.1016/j.peptides.2006.08.016; Deininger Michael, 2005, J Natl Compr Canc Netw, V3, P757; Drevs J, 2000, CANCER RES, V60, P4819; Ercil NE, 2005, PSYCHOPHARMACOLOGY, V180, P279, DOI 10.1007/s00213-005-2166-x; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; Farrara N, 2000, CURR OPIN BIOTECH, V11, P617, DOI 10.1016/S0958-1669(00)00153-1; Fear G, 2007, PHARMACOL THERAPEUT, V113, P354, DOI 10.1016/j.pharmthera.2006.09.001; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Garrett JT, 2007, J IMMUNOL, V178, P7120, DOI 10.4049/jimmunol.178.11.7120; Gong Y, 2007, LANCET ONCOL, V8, P203, DOI 10.1016/S1470-2045(07)70042-6; Grove AD, 2002, CLIN CANCER RES, V8, P3019; Herley MT, 1999, BIOCHEM BIOPH RES CO, V262, P731, DOI 10.1006/bbrc.1999.1282; Hiratsuka S, 2001, CANCER RES, V61, P1207; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Joppa MA, 2005, PEPTIDES, V26, P2294, DOI 10.1016/j.peptides.2005.03.002; Kanno S, 2000, ONCOGENE, V19, P2138, DOI 10.1038/sj.onc.1203533; Kaumaya Pravin T. P., 1993, Journal of Molecular Recognition, V6, P81, DOI 10.1002/jmr.300060206; KAUMAYA PTP, 1992, J BIOL CHEM, V267, P6338; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Keyt BA, 1996, J BIOL CHEM, V271, P5638, DOI 10.1074/jbc.271.10.5638; Konecny GE, 2004, CLIN CANCER RES, V10, P1706, DOI 10.1158/1078-0432.CCR-0951-3; Kostopoulos I, 2006, BREAST CANCER RES TR, V96, P251, DOI 10.1007/s10549-005-9062-2; Kremer C, 1997, CANCER RES, V57, P3852; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lee J, 1996, P NATL ACAD SCI USA, V93, P1988, DOI 10.1073/pnas.93.5.1988; Lei HT, 2002, J BIOL CHEM, V277, P43137, DOI 10.1074/jbc.M203103200; LENDER A, 1993, INT J PEPT PROT RES, V42, P509; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Milkiewicz M, 2006, INT J BIOCHEM CELL B, V38, P333, DOI 10.1016/j.biocel.2005.10.006; Moldovan L, 2005, EXP SUPPL, V94, P127; Morabito A, 2006, ONCOLOGIST, V11, P753, DOI 10.1634/theoncologist.11-7-753; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Ng IOL, 2001, AM J CLIN PATHOL, V116, P838; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; PERCZEL A, 1993, INT J PEPT PROT RES, V41, P223; Perona Rosario, 2006, Clin Transl Oncol, V8, P77, DOI 10.1007/s12094-006-0162-1; Petit AMV, 1997, AM J PATHOL, V151, P1523; Schramm R, 2003, TRANSPLANTATION, V75, P239, DOI 10.1097/01.TP.0000040869.19883.4A; Sebolt-Leopold JS, 2006, NATURE, V441, P457, DOI 10.1038/nature04874; Sepp-Lorenzino L, 2004, CANCER RES, V64, P751, DOI 10.1158/0008-5472.CAN-03-2871; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Shor Audrey C, 2008, Cancer Control, V15, P47; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; Sundaram R, 2002, BIOPOLYMERS, V66, P200, DOI 10.1002/bip.10258; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Verhoef C, 2006, CURR PHARM DESIGN, V12, P2623, DOI 10.2174/138161206777698756; Weigand Melanie, 2005, Angiogenesis, V8, P197, DOI 10.1007/s10456-005-9010-0; Wen XF, 2006, ONCOGENE, V25, P6986, DOI 10.1038/sj.onc.1209685; White FC, 1995, GROWTH FACTORS, V12, P289, DOI 10.3109/08977199509028967; Wiesmann C, 1998, BIOCHEMISTRY-US, V37, P17765, DOI 10.1021/bi9819327; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Wood JM, 2000, MEDICINA-BUENOS AIRE, V60, P41; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Yang SY, 2002, ARTERIOSCL THROM VAS, V22, P1797, DOI 10.1161/01.ATV.0000038995.31179.24; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	89	54	59	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13612	13625		10.1074/jbc.M110.216812	http://dx.doi.org/10.1074/jbc.M110.216812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321115	Green Published, hybrid			2022-12-25	WOS:000289282200080
J	Wang, LP; Ota, N; Romanova, EV; Sweedler, JV				Wang, Liping; Ota, Nobutoshi; Romanova, Elena V.; Sweedler, Jonathan V.			A Novel Pyridoxal 5 '-Phosphate-dependent Amino Acid Racemase in the Aplysia californica Central Nervous System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTIC ACID; INDUCED FLUORESCENCE DETECTION; MOLLUSK SCAPHARCA-BROUGHTONII; D-SERINE; CAPILLARY-ELECTROPHORESIS; NEURAL SAMPLES; RAT-BRAIN; D-ALANINE; GLUTAMATE; NEUROTRANSMISSION	D-Aspartate (D-Asp) is found in specific neurons, transported to neuronal terminals and released in a stimulation-dependent manner. Because D-Asp formation is not well understood, determining its function has proved challenging. Significant levels of D-Asp are present in the cerebral ganglion of the F- and C-clusters of the invertebrate Aplysia californica, and D-Asp appears to be involved in cell-cell communication in this system. Here, we describe a novel protein, DAR1, from A. californica that can convert aspartate and serine to their other chiral form in a pyridoxal 5'-phosphate (PLP)-dependent manner. DAR1 has a predicted length of 325 amino acids and is 55% identical to the bivalve aspartate racemase, EC 5.1.1.13, and 41% identical to the mammalian serine racemase, EC 5.1.1.18. However, it is only 14% identical to the recently reported mammalian aspartate racemase, DR, which is closely related to glutamate-oxaloacetate transaminase, EC 2.6.1.1. Using whole-mount immunohistochemistry staining of the A. californica central nervous system, we localized DAR1-like immunoreactivity to the medial region of the cerebral ganglion where the F- and C-clusters are situated. The biochemical and functional similarities between DAR1 and other animal serine and aspartate racemases make it valuable for examining PEP-dependent racemases, promising to increase our knowledge of enzyme regulation and ultimately, D-serine and D-Asp signaling pathways.	[Ota, Nobutoshi; Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wang, Liping; Sweedler, Jonathan V.] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA; [Romanova, Elena V.; Sweedler, Jonathan V.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Wang, Liping] Univ Illinois, Immunol Resource Ctr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Sweedler, JV (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave,63-5, Urbana, IL 61801 USA.	jsweedle@illinois.edu	Sweedler, Jonathan V/A-9405-2009	Sweedler, Jonathan V/0000-0003-3107-9922; Romanova, Elena/0000-0002-2040-3312	NINDS, National Institutes of Health [NS031609]; National Science Foundation (NSF) [CHE-04-00768, CHE-05-26692]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031609, R29NS031609] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by Award No. NS031609 from the NINDS, National Institutes of Health, and by Award Nos, CHE-04-00768 and CHE-05-26692 from the National Science Foundation (NSF).	Abe K, 2006, J BIOCHEM, V139, P235, DOI 10.1093/jb/mvj028; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; D'Aniello S, 2005, BIOCHEM J, V386, P331, DOI 10.1042/BJ20041070; Errico F, 2008, J NEUROSCI, V28, P10404, DOI 10.1523/JNEUROSCI.1618-08.2008; Errico F, 2009, REV NEUROSCIENCE, V20, P429; Fujisawa Y, 1999, J NEUROSCI, V19, P9618; Habl G, 2009, J NEURAL TRANSM, V116, P1657, DOI 10.1007/s00702-009-0312-z; HASHIMOTO A, 1993, NEUROSCI LETT, V152, P33, DOI 10.1016/0304-3940(93)90476-2; Kim PM, 2010, P NATL ACAD SCI USA, V107, P3175, DOI 10.1073/pnas.0914706107; Kirschner DL, 2007, ANAL CHEM, V79, P736, DOI 10.1021/ac061725+; Labrie V, 2009, HUM MOL GENET, V18, P3227, DOI 10.1093/hmg/ddp261; Lapainis T, 2008, J CHROMATOGR A, V1184, P144, DOI 10.1016/j.chroma.2007.10.098; LEWELLYNSMITH IJ, 1985, J HISTOCHEM CYTOCHEM, V33, P857; Mangas A, 2007, NEUROSCIENCE, V144, P654, DOI 10.1016/j.neuroscience.2006.09.045; Miao H, 2006, J NEUROCHEM, V97, P595, DOI 10.1111/j.1471-4159.2006.03791.x; Miao H, 2006, J CHROMATOGR A, V1106, P56, DOI 10.1016/j.chroma.2005.09.037; Morikawa A, 2003, ANAL BIOCHEM, V312, P66, DOI 10.1016/S0003-2697(02)00432-3; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NEIDLE A, 1990, LIFE SCI, V46, P1517, DOI 10.1016/0024-3205(90)90424-P; Neidle A, 2002, NEUROCHEM RES, V27, P1719, DOI 10.1023/A:1021607715824; Paez X, 2001, BIOPHARM DRUG DISPOS, V22, P273, DOI 10.1002/bdd.277; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Quan Z, 2003, ELECTROPHORESIS, V24, P1092, DOI 10.1002/elps.200390127; Sakai K, 1998, BRAIN RES, V808, P65, DOI 10.1016/S0006-8993(98)00599-X; Scanlan C, 2010, J NEUROCHEM, V115, P1234, DOI 10.1111/j.1471-4159.2010.07020.x; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Shibata K, 2003, COMP BIOCHEM PHYS B, V134, P713, DOI 10.1016/S1096-4959(03)00031-9; Shibata K, 2003, COMP BIOCHEM PHYS B, V134, P307, DOI 10.1016/S1096-4959(02)00267-1; Spinelli P, 2006, J CELL PHYSIOL, V206, P672, DOI 10.1002/jcp.20513; Topo E, 2010, AMINO ACIDS, V38, P1561, DOI 10.1007/s00726-009-0369-x; UEDA T, 1992, J CHROMATOGR, V593, P265, DOI 10.1016/0021-9673(92)80295-6; Verrall L, 2007, EUR J NEUROSCI, V26, P1657, DOI 10.1111/j.1460-9568.2007.05769.x; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yamashita T, 2004, EUR J BIOCHEM, V271, P4798, DOI 10.1111/j.1432-1033.2004.04445.x; Yoshimura T, 2008, FEBS J, V275, P3527, DOI 10.1111/j.1742-4658.2008.06516.x; Zaar K, 2002, J COMP NEUROL, V450, P272, DOI 10.1002/cne.10320; Zhao SL, 2005, TALANTA, V67, P212, DOI 10.1016/j.talanta.2005.02.032	38	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13765	13774		10.1074/jbc.M110.178228	http://dx.doi.org/10.1074/jbc.M110.178228			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343289	hybrid, Green Published			2022-12-25	WOS:000289282200094
J	Shivaraju, M; Camahort, R; Mattingly, M; Gerton, JL				Shivaraju, Manjunatha; Camahort, Raymond; Mattingly, Mark; Gerton, Jennifer L.			Scm3 Is a Centromeric Nucleosome Assembly Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE KINETOCHORE; E3 UBIQUITIN LIGASE; HISTONE H3 VARIANT; CENP-A; BUDDING YEAST; STRUCTURAL DETERMINANTS; TARGETING DOMAIN; DNA-SYNTHESIS; COILED-COILS; CHROMATIN	The Cse4 nucleosome at each budding yeast centromere must be faithfully assembled each cell cycle to specify the site of kinetochore assembly and microtubule attachment for chromosome segregation. Although Scm3 is required for the localization of the centromeric H3 histone variant Cse4 to centromeres, its role in nucleosome assembly has not been tested. We demonstrate that Scm3 is able to mediate the assembly of Cse4 nucleosomes in vitro, but not H3 nucleosomes, as measured by a supercoiling assay. Localization of Cse4 to centromeres and the assembly activity depend on an evolutionarily conserved core motif in Scm3, but localization of the CBF3 subunit Ndc10 to centromeres does not depend on this motif. The centromere targeting domain of Cse4 is sufficient for Scm3 nucleosome assembly activity. Assembly does not depend on centromeric sequence. We propose that Scm3 plays an active role in centromeric nucleosome assembly.	Stowers Inst Med Res, Kansas City, MO 64110 USA; [Shivaraju, Manjunatha] Open Univ, Milton Keynes MK7 6BJ, Bucks, England; [Gerton, Jennifer L.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Open University - UK; University of Kansas; University of Kansas Medical Center	Gerton, JL (corresponding author), 1000 E 50th St, Kansas City, MO 64110 USA.	jeg@stowers.org		Shivaraju, Manjunatha/0000-0001-6346-6279	National Institutes of Health [R01GM080477]; Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM080477. This work was also supported by the Stowers Institute for Medical Research.	Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Bloom K, 2006, CURR BIOL, V16, pR276, DOI 10.1016/j.cub.2006.03.054; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Chen YH, 2000, MOL CELL BIOL, V20, P7037, DOI 10.1128/MCB.20.18.7037-7048.2000; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; DOHENY KF, 1993, CELL, V73, P761, DOI 10.1016/0092-8674(93)90255-O; Espelin CW, 1997, J CELL BIOL, V139, P1383, DOI 10.1083/jcb.139.6.1383; Espelin CW, 2003, MOL BIOL CELL, V14, P4557, DOI 10.1091/mbc.E02-08-0533; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Fraschini R, 2001, MOL GENET GENOMICS, V266, P115, DOI 10.1007/s004380100533; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Hewawasam G, 2010, MOL CELL, V40, P444, DOI 10.1016/j.molcel.2010.10.014; Huang CC, 2011, MOL CELL BIOL, V31, P1030, DOI 10.1128/MCB.01191-10; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; NG R, 1987, MOL CELL BIOL, V7, P4522, DOI 10.1128/MCB.7.12.4522; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pinto I, 2000, EMBO J, V19, P1598, DOI 10.1093/emboj/19.7.1598; Ranjitkar P, 2010, MOL CELL, V40, P455, DOI 10.1016/j.molcel.2010.09.025; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Rodrigo-Brenni MC, 2004, MOL BIOL CELL, V15, P3366, DOI 10.1091/mbc.E03-12-0887; Sambrook J, 2001, MOL CLONING LAB MANU; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Visnapuu ML, 2009, NAT STRUCT MOL BIOL, V16, P1056, DOI 10.1038/nsmb.1655; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	52	41	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.183640	http://dx.doi.org/10.1074/jbc.M110.183640			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317428	hybrid, Green Published			2022-12-25	WOS:000289077500015
J	Marengo, B; De Ciucis, C; Ricciarelli, R; Passalacqua, M; Nitti, M; Zingg, JM; Marinari, UM; Pronzato, MA; Domenicotti, C				Marengo, Barbara; De Ciucis, Chiara; Ricciarelli, Roberta; Passalacqua, Mario; Nitti, Mariapaola; Zingg, Jean-Marc; Marinari, Umberto M.; Pronzato, Maria A.; Domenicotti, Cinzia			PKC delta Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage	PLOS ONE			English	Article							PROTEIN-KINASE-C; GLUTATHIONE DEPLETION; NADPH OXIDASE; INDUCED APOPTOSIS; OXIDATIVE STRESS; ACTIVATION; GROWTH; PHOSPHORYLATION; INHIBITION; ROTTLERIN	Neuroblastoma is a type of pediatric cancer. The sensitivity of neuroblastoma (NB) cancer cells to chemotherapy and radiation is inhibited by the presence of antioxidants, such as glutathione (GSH), which is crucial in counteracting the endogenous production of reactive oxygen species (ROS). We have previously demonstrated that cells depleted of GSH undergo apoptosis via oxidative stress and Protein kinase C (PKC) delta activation. In the present study, we transfected PKC delta in NB cells resistant to oxidative death induced by L-buthionine-S, R-sulfoximine (BSO), a GSH-depleting agent. Cell responses, in terms of ROS production, apoptosis and DNA damage were evaluated. Moreover, PKC delta activation was monitored by analyzing the phosphorylation status of threonine 505 residue, carrying out PKC activity assay and investigating the subcellular localization of the kinase. The cell responses obtained in BSO-resistant cells were also compared with those obtained in BSO-sensitive cells subjected to the same experimental protocol. Our results demonstrate, for the first time, that PKC delta induces DNA oxidation and ROS overproduction leading to apoptosis of BSO-resistant NB cells and potentiates the cytotoxic effects induced by BSO in sensitive cells. Moreover, PKC delta overexpression enhances the sensitivity of NB cells to etoposide, a well-characterised drug, commonly used in neuroblastoma therapy. Altogether our data provide evidence of a pro-oxidant role of PKC delta that might be exploited to design new therapeutic strategies aimed at selective killing of cancer cells and overcoming drug resistance. However, it becomes evident that a more detailed understanding of ROS-mediated signaling in cancer cells is necessary for the development of redox-modulated therapeutic approaches.	[Marengo, Barbara] Giannina Gaslini Inst, Genoa, Italy; [De Ciucis, Chiara; Ricciarelli, Roberta; Nitti, Mariapaola; Marinari, Umberto M.; Pronzato, Maria A.; Domenicotti, Cinzia] Univ Genoa, Gen Pathol Sect, Dept Expt Med, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Biochem Sect, Dept Expt Med, Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa	Marengo, B (corresponding author), Giannina Gaslini Inst, Genoa, Italy.	Cinzia.Domenicotti@unige.it	Marengo, Barbara/U-3934-2019; Ricciarelli, Roberta/AAE-8063-2019; Domenicotti, Cinzia/C-7786-2011; Passalacqua, Mario/W-1973-2019; Zingg, Jean-Marc/H-6960-2019; Nitti, Mariapaola/ABB-1067-2020	Passalacqua, Mario/0000-0003-2779-6259; Ricciarelli, Roberta/0000-0002-2053-2501	Italian Ministry of Universities [20077S9A32_002, 2008N9N9KL_002]; Genoa University; FONDAZIONE CARIGE	Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); Genoa University; FONDAZIONE CARIGE(Fondazione Carige)	This work was supported by grants from the Italian Ministry of Universities (PRIN n<SUP>o</SUP> 20077S9A32_002 and 2008N9N9KL_002), Genoa University and FONDAZIONE CARIGE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharam V, 2007, NEUROTOXICOLOGY, V28, P988, DOI 10.1016/j.neuro.2007.08.008; Anderson CP, 1999, EXP CELL RES, V246, P183, DOI 10.1006/excr.1998.4303; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Cacace AM, 1996, ONCOGENE, V13, P2517; Cavallo D, 2006, TOXICOLOGY, V223, P26, DOI 10.1016/j.tox.2006.03.003; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Day TW, 2009, MOL PHARMACOL, V76, P632, DOI 10.1124/mol.109.054999; de Bernardo S, 2004, J NEUROCHEM, V91, P667, DOI 10.1111/j.1471-4159.2004.02744.x; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Domenicotti C, 2003, FREE RADICAL BIO MED, V35, P504, DOI 10.1016/S0891-5849(03)00332-0; Ellerby LM, 2000, METHOD ENZYMOL, V322, P413; Emoto Y, 1996, BLOOD, V87, P1990; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Fulda S, 2003, CANCER LETT, V197, P131, DOI 10.1016/S0304-3835(03)00091-0; Gokce G, 2009, BIOCHEMISTRY-US, V48, P4980, DOI 10.1021/bi900030z; GOPALAKRISHNA R, 1987, FEBS LETT, V225, P233, DOI 10.1016/0014-5793(87)81164-X; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Heit I, 2001, ONCOGENE, V20, P5143, DOI 10.1038/sj.onc.1204657; Herrlich P, 2000, BIOCHEM PHARMACOL, V59, P35, DOI 10.1016/S0006-2952(99)00298-1; Hornia A, 1999, MOL CELL BIOL, V19, P7672; Hsieh HL, 2007, CELL SIGNAL, V19, P330, DOI 10.1016/j.cellsig.2006.07.006; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jiang XH, 2004, CANCER RES, V64, P5787, DOI 10.1158/0008-5472.CAN-03-1172; Kambhampati S, 2003, J BIOL CHEM, V278, P32544, DOI 10.1074/jbc.M301523200; Karlsson J, 2004, CLIN CANCER RES, V10, P3179, DOI 10.1158/1078-0432.CCR-03-0309; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li PF, 1999, CIRCULATION, V100, P967, DOI 10.1161/01.CIR.100.9.967; LI WQ, 1994, MOL CELL BIOL, V14, P6727, DOI 10.1128/MCB.14.10.6727; Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209; Marengo B, 2005, CANCER LETT, V228, P111, DOI 10.1016/j.canlet.2005.01.046; Marengo B, 2008, FREE RADICAL BIO MED, V44, P474, DOI 10.1016/j.freeradbiomed.2007.10.031; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Nitti M, 2007, NEUROSCI LETT, V416, P261, DOI 10.1016/j.neulet.2007.02.013; Nitti M, 2010, CELL SIGNAL, V22, P828, DOI 10.1016/j.cellsig.2010.01.007; Perletti GP, 1999, ONCOGENE, V18, P1251, DOI 10.1038/sj.onc.1202408; PESSINO A, 1995, BIOCHEM J, V312, P549, DOI 10.1042/bj3120549; Puhakka A, 2002, MUTAT RES-GEN TOX EN, V514, P7, DOI 10.1016/S1383-5718(01)00322-9; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Simon T, 2007, J CANCER RES CLIN, V133, P653, DOI 10.1007/s00432-007-0216-y; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; de Tudela MVP, 2010, J NEUROCHEM, V113, P819, DOI 10.1111/j.1471-4159.2010.06648.x; Wu WS, 2006, CANCER METAST REV, V25, P695, DOI 10.1007/s10555-006-9037-8; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284	54	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14661	10.1371/journal.pone.0014661	http://dx.doi.org/10.1371/journal.pone.0014661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326872	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037100003
J	Borst, A; Weber, F				Borst, Alexander; Weber, Franz			Neural Action Fields for Optic Flow Based Navigation: A Simulation Study of the Fly Lobula Plate Network	PLOS ONE			English	Article							MOTION-SENSITIVE NEURONS; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS; VISUAL RESPONSE PROPERTIES; GIANT VERTICAL CELLS; TANGENTIAL CELLS; BLOWFLY CALLIPHORA; HORIZONTAL CELLS; SELF-MOTION; DROSOPHILA-MELANOGASTER; MEMBRANE-PROPERTIES	Optic flow based navigation is a fundamental way of visual course control described in many different species including man. In the fly, an essential part of optic flow analysis is performed in the lobula plate, a retinotopic map of motion in the environment. There, the so-called lobula plate tangential cells possess large receptive fields with different preferred directions in different parts of the visual field. Previous studies demonstrated an extensive connectivity between different tangential cells, providing, in principle, the structural basis for their large and complex receptive fields. We present a network simulation of the tangential cells, comprising most of the neurons studied so far (22 on each hemisphere) with all the known connectivity between them. On their dendrite, model neurons receive input from a retinotopic array of Reichardt-type motion detectors. Model neurons exhibit receptive fields much like their natural counterparts, demonstrating that the connectivity between the lobula plate tangential cells indeed can account for their complex receptive field structure. We describe the tuning of a model neuron to particular types of ego-motion (rotation as well as translation around/along a given body axis) by its 'action field'. As we show for model neurons of the vertical system (VS-cells), each of them displays a different type of action field, i.e., responds maximally when the fly is rotating around a particular body axis. However, the tuning width of the rotational action fields is relatively broad, comparable to the one with dendritic input only. The additional intra-lobula-plate connectivity mainly reduces their translational action field amplitude, i.e., their sensitivity to translational movements along any body axis of the fly.	[Borst, Alexander; Weber, Franz] Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany	Max Planck Society	Borst, A (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurobiol, Martinsried, Germany.	borst@neuro.mpg.de			Max-Planck-Society	Max-Planck-Society(Max Planck Society)	This work was supported by the Max-Planck-Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1961, SENSORY COMMUNICATIO; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Borst A, 2003, VISION RES, V43, P1309, DOI 10.1016/S0042-6989(03)00092-0; Borst A, 1996, J COMPUT NEUROSCI, V3, P313, DOI 10.1007/BF00161091; BORST A, 1990, P NATL ACAD SCI USA, V87, P9363, DOI 10.1073/pnas.87.23.9363; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Britten KH, 2008, ANNU REV NEUROSCI, V31, P389, DOI 10.1146/annurev.neuro.29.051605.112953; Brotz TM, 1996, J NEUROPHYSIOL, V76, P1786, DOI 10.1152/jn.1996.76.3.1786; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; Cuntz H, 2007, P NATL ACAD SCI USA, V104, P10229, DOI 10.1073/pnas.0703697104; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; ECKERT H, 1983, J INSECT PHYSIOL, V29, P547, DOI 10.1016/0022-1910(83)90020-3; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; EGELHAAF M, 1993, J NEUROPHYSIOL, V69, P340, DOI 10.1152/jn.1993.69.2.340; Elyada YM, 2009, NAT NEUROSCI, V12, P327, DOI 10.1038/nn.2269; Farrow K, 2005, J NEUROSCI, V25, P3985, DOI 10.1523/JNEUROSCI.0168-05.2005; Farrow K, 2003, J NEUROSCI, V23, P9805; Farrow K, 2006, NAT NEUROSCI, V9, P1312, DOI 10.1038/nn1769; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Franz MO, 2000, BIOL CYBERN, V83, P185, DOI 10.1007/s004220000163; Franz MO, 2004, NEURAL COMPUT, V16, P2245, DOI 10.1162/0899766041941899; Gauck V, 1997, J COMP NEUROL, V381, P489; Gibson JJ, 1950, PERCEPTION VISUAL WO; Haag J, 2004, P NATL ACAD SCI USA, V101, P16333, DOI 10.1073/pnas.0407368101; Haag J, 2004, NAT NEUROSCI, V7, P628, DOI 10.1038/nn1245; Haag J, 2003, J COMP PHYSIOL A, V189, P363, DOI 10.1007/s00359-003-0410-6; Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334; Haag J, 1996, NATURE, V379, P639, DOI 10.1038/379639a0; Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719; Haag J, 2000, J NEUROPHYSIOL, V83, P1039, DOI 10.1152/jn.2000.83.2.1039; Haag J, 2001, J NEUROSCI, V21, P5685, DOI 10.1523/JNEUROSCI.21-15-05685.2001; Haag J, 2005, J COMP PHYSIOL A, V191, P445, DOI 10.1007/s00359-005-0605-0; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; Haag J, 2007, FRONT NEUROSCI-SWITZ, V1, P111, DOI 10.3389/neuro.01.1.1.008.2007; Haag J, 2007, J NEUROSCI, V27, P1992, DOI 10.1523/JNEUROSCI.4393-06.2007; Haag J, 2008, J NEUROSCI, V28, P14435, DOI 10.1523/JNEUROSCI.3603-08.2008; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P179, DOI 10.1007/BF00619212; HENGSTENBERG R, 1977, NATURE, V270, P338, DOI 10.1038/270338a0; HENGSTENBERG R, 1982, J COMP PHYSIOL, V149, P163, DOI 10.1007/BF00619211; Horstmann W, 2000, EUR J NEUROSCI, V12, P2157, DOI 10.1046/j.1460-9568.2000.00094.x; Huston SJ, 2008, PLOS BIOL, V6, P1468, DOI 10.1371/journal.pbio.0060173; Joesch M, 2008, CURR BIOL, V18, P368, DOI 10.1016/j.cub.2008.02.022; Kalb J, 2006, J NEUROSCI, V26, P7898, DOI 10.1523/JNEUROSCI.1327-06.2006; Karmeier K, 2006, J NEUROPHYSIOL, V96, P1602, DOI 10.1152/jn.00023.2006; Karmeier K, 2005, J NEUROPHYSIOL, V94, P2182, DOI 10.1152/jn.00278.2005; Karmeier K, 2003, J NEUROPHYSIOL, V90, P1626, DOI 10.1152/jn.00234.2003; KOENDERINK JJ, 1987, BIOL CYBERN, V56, P247, DOI 10.1007/BF00365219; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; Krapp HG, 1996, NATURE, V384, P463, DOI 10.1038/384463a0; Kurtz R, 2001, J NEUROSCI, V21, P6957, DOI 10.1523/JNEUROSCI.21-17-06957.2001; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lindemann JP, 2005, J NEUROSCI, V25, P6435, DOI 10.1523/JNEUROSCI.1132-05.2005; Nordstrom K, 2008, CURR BIOL, V18, P661, DOI 10.1016/j.cub.2008.03.061; Petrowitz R, 2000, J COMP PHYSIOL A, V186, P737, DOI 10.1007/s003590000127; Raghu SV, 2007, J COMP NEUROL, V502, P598, DOI 10.1002/cne.21319; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; REICHARDT W, 1987, J COMPUT PHYSL A, V161, P674; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Scott EK, 2002, J COMP NEUROL, V454, P470, DOI 10.1002/cne.10467; Weber F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015013; Wertz A, 2008, J NEUROSCI, V28, P3131, DOI 10.1523/JNEUROSCI.5460-07.2008; Wertz A, 2009, J NEUROSCI, V29, P14993, DOI 10.1523/JNEUROSCI.3786-09.2009; Wertz A, 2009, J COMP PHYSIOL A, V195, P1107, DOI 10.1007/s00359-009-0481-0	67	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16303	10.1371/journal.pone.0016303	http://dx.doi.org/10.1371/journal.pone.0016303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305019	Green Published, gold			2022-12-25	WOS:000286834300048
J	Takahashi, F; Chiba, N; Tajima, K; Hayashida, T; Shimada, T; Takahashi, M; Moriyama, H; Brachtel, E; Edelman, EJ; Ramaswamy, S; Maheswaran, S				Takahashi, F.; Chiba, N.; Tajima, K.; Hayashida, T.; Shimada, T.; Takahashi, M.; Moriyama, H.; Brachtel, E.; Edelman, E. J.; Ramaswamy, S.; Maheswaran, S.			Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib	ONCOGENE			English	Article						breast cancer; BTG2; invasion; metastasis; ErbB/HER pathway	TRANSLOCATION GENE-2 PROTEIN; ESTROGEN-RECEPTOR; CANCER PATIENTS; MOLECULAR SIGNATURE; PHASE-II; GROWTH; CELLS; CARCINOMA; PROGNOSIS; GRADE	The B-cell translocation gene-2 (BTG2), a p53-inducible gene, is suppressed in mammary epithelial cells during gestation and lactation. In human breast cancer, decreased BTG2 expression correlates with high tumor grade and size, p53 status, blood and lymph vessel invasion, local and metastatic recurrence and decrease in overall survival, suggesting that suppression of BTG2 has a critical role in disease progression. To analyze the role of BTG2 in breast cancer progression, BTG2 expression was knocked down in mammary epithelial cells. Suppression of BTG2 enhances the motility of cells in vitro and tumor growth and metastasis in vivo. The effects of BTG2 knockdown are mediated through stabilization of the human epidermal growth factor receptor (HER) ligands neuregulin and epiregulin and activation of the HER2 and HER3 receptors, leading to elevated AKT phosphorylation. Suppression of HER activation using the tyrosine kinase inhibitor lapatinib abrogates the effects of BTG2 knockdown, including the increased cell migration observed in vitro and the enhancement of tumorigenesis and metastasis in vivo. These results link BTG2-dependent effects on tumor progression to ErbB receptor signaling, and raise the possibility that targeted inhibition of this pathway may be relevant in the treatment of breast cancers that have reduced BTG2 expression. Oncogene (2011) 30, 3084-3095; doi: 10.1038/onc.2011.24; published online 21 February 2011	[Maheswaran, S.] Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Charlestown, MA 02129 USA; [Takahashi, F.; Chiba, N.; Tajima, K.; Hayashida, T.; Shimada, T.; Takahashi, M.; Moriyama, H.; Brachtel, E.; Edelman, E. J.; Ramaswamy, S.; Maheswaran, S.] Harvard Univ, Sch Med, Charlestown, MA USA; [Takahashi, F.; Chiba, N.; Tajima, K.; Hayashida, T.; Shimada, T.; Takahashi, M.; Edelman, E. J.; Ramaswamy, S.; Maheswaran, S.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Moriyama, H.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Brachtel, E.] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Maheswaran, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Dept Surg, Bldg 149,13th St, Charlestown, MA 02129 USA.	maheswaran@helix.mgh.harvard.edu			NIH/NCI [CA89138]; Susan G Komen for the Cure Grants [PDF0600282, KG090412]; ESSCO breast cancer research grant; NATIONAL CANCER INSTITUTE [R01CA089138] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen for the Cure Grants(Susan G. Komen Breast Cancer Foundation); ESSCO breast cancer research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Isselbacher, Haber, Engelman and Zou for critically reading the paper. This work was supported by the NIH/NCI Grant CA89138 (to SM), the Susan G Komen for the Cure Grants PDF0600282 and KG090412 (to SM) and ESSCO breast cancer research grant (to SM).	Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Calzolari F, 2008, NEOPLASIA, V10, P1373, DOI 10.1593/neo.08814; Cortes U, 2000, MOL CARCINOGEN, V27, P57, DOI 10.1002/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.3.CO;2-9; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Farioli-Vecchioli S, 2007, FASEB J, V21, P2215, DOI 10.1096/fj.06-7548com; Ficazzola MA, 2001, CARCINOGENESIS, V22, P1271, DOI 10.1093/carcin/22.8.1271; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gril B, 2008, JNCI-J NATL CANCER I, V100, P1092, DOI 10.1093/jnci/djn216; Guardavaccaro D, 2000, MOL CELL BIOL, V20, P1797, DOI 10.1128/MCB.20.5.1797-1815.2000; Ha TU, 2000, J BIOL CHEM, V275, P37101, DOI 10.1074/jbc.M005701200; Hayashida T, 2010, P NATL ACAD SCI USA, V107, P1100, DOI 10.1073/pnas.0912710107; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Hong JW, 2005, J BIOL CHEM, V280, P21256, DOI 10.1074/jbc.M500318200; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Huang E, 2003, LANCET, V361, P1590, DOI 10.1016/S0140-6736(03)13308-9; Hynes NE, 2001, ENDOCR-RELAT CANCER, V8, P151, DOI 10.1677/erc.0.0080151; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Julka PK, 2008, BRIT J CANCER, V98, P1327, DOI 10.1038/sj.bjc.6604322; Kawakubo H, 2004, ONCOGENE, V23, P8310, DOI 10.1038/sj.onc.1208008; Kawakubo H, 2006, CANCER RES, V66, P7075, DOI 10.1158/0008-5472.CAN-06-0379; Kedrin D, 2009, CLIN CANCER RES, V15, P3733, DOI 10.1158/1078-0432.CCR-08-2163; Konecny GE, 2008, BRIT J CANCER, V98, P1076, DOI 10.1038/sj.bjc.6604278; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; LIM IK, 1995, J CANCER RES CLIN, V121, P279, DOI 10.1007/BF01209594; Lim IK, 1998, MOL CARCINOGEN, V23, P25, DOI 10.1002/(SICI)1098-2744(199809)23:1<25::AID-MC4>3.0.CO;2-G; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Mauxion F, 2009, TRENDS BIOCHEM SCI, V34, P640, DOI 10.1016/j.tibs.2009.07.008; Melamed J, 2002, TISSUE CELL, V34, P28, DOI 10.1054/tice.2001.0220; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Sithanandam G, 2005, ONCOGENE, V24, P1847, DOI 10.1038/sj.onc.1208381; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Struckmann K, 2004, CANCER RES, V64, P1632, DOI 10.1158/0008-5472.CAN-03-1687; Tripathy D, 1992, Cancer Treat Res, V63, P15; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Winkler GS, 2010, J CELL PHYSIOL, V222, P66, DOI 10.1002/jcp.21919; Xue CS, 2006, CANCER RES, V66, P1418, DOI 10.1158/0008-5472.CAN-05-0550; Yu K, 2006, CLIN CANCER RES, V12, P3288, DOI 10.1158/1078-0432.CCR-05-1530; Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	62	46	47	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	27					3084	3095		10.1038/onc.2011.24	http://dx.doi.org/10.1038/onc.2011.24			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21339742				2022-12-25	WOS:000292510100008
J	Garcia-Marcos, M; Ghosh, P; Farquhar, MG				Garcia-Marcos, M.; Ghosh, P.; Farquhar, M. G.			Molecular basis of a novel oncogenic mutation in GNAO1	ONCOGENE			English	Article						oncoprotein; somatic mutation; heterotrimeric G protein; GAIP/RGS19; neoplasia; STAT3	GUANINE-NUCLEOTIDE-BINDING; PROTEIN ALPHA-SUBUNITS; RECEPTOR-MEDIATED ACTIVATION; GTPASE ACTIVITY; CELL-MIGRATION; NIH-3T3 CELLS; MUTANT; TRANSFORMATION; TUMORS; DOMAIN	Heterotrimeric G proteins are molecular switches that control signal transduction, and their dysregulation can promote oncogenesis. Somatic mutations in GNAS, GNAI2 and GNAQ genes induce oncogenesis by rendering G alpha subunits constitutively activated. Recently the first somatic mutation, arginine(243)-> histidine (R243H) in the GNAO1 (G alpha o) gene was identified in breast carcinomas and shown to promote oncogenic transformation when introduced into cells. Here, we provide the molecular basis for the oncogenic properties of the G alpha o R243H mutant. Using limited proteolysis assays, nucleotide-binding assays, and single-turnover and steady-state GTPase assays, we demonstrate that the oncogenic R234H mutation renders G alpha o constitutively active by accelerating the rate of nucleotide exchange; however, this mutation does not affect G alpha o's ability to become deactivated by GTPase-activating proteins (GAPs) or by its intrinsic GTPase activity. This mechanism differs from that of previously reported oncogenic mutations that impair GTPase activity and GAP sensitivity without affecting nucleotide exchange. The constitutively active G alpha o R243H mutant also enhances Src-STAT3 signaling in NIH-3T3 cells, a pathway previously shown to be directly triggered by active G alpha o proteins to promote cellular transformation. Based on structural analyses, we propose that the enhanced rate of nucleotide exchange in G alpha o R243H results from loss of the highly conserved electrostatic interaction of R243 with E43, located in the in the P-loop that represents the binding site for the alpha- and beta-phosphates of the nucleotide. We conclude that the novel R234H mutation imparts oncogenic properties to G alpha o by accelerating nucleotide exchange and rendering it constitutively active, thereby enhancing signaling pathways, for example, src-STAT3, responsible for neoplastic transformation. Oncogene (2011) 30, 2691-2696; doi:10.1038/onc.2010.645; published online 14 February 2011	[Garcia-Marcos, M.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego Sch Med, George E Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghosh, P.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Garcia-Marcos, M (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, San Diego Sch Med, George E Palade Labs Cellular & Mol Med, 9500 Gilman Dr,Room 218, La Jolla, CA 92093 USA.	mgarciamarcos@ucsd.edu			NIH [CA100768, DKI7780]; Susan G Komen postdoctoral fellowship [KG080079]; American Gastroenterology Association FDN; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); American Gastroenterology Association FDN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by NIH grants CA100768 and DKI7780 (to MGF). MGM was supported by a Susan G Komen postdoctoral fellowship KG080079 and PG by Burroughs Wellcome Fund and Research Scholar Award (American Gastroenterology Association FDN).	Barren B, 2006, MOL VIS, V12, P492; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bourne HR, 1997, NATURE, V389, P673, DOI 10.1038/39470; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DEVRIES L, 1995, P NATL ACAD SCI USA, V92, P11916, DOI 10.1073/pnas.92.25.11916; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Garcia-Marcos M, 2010, J BIOL CHEM, V285, P12765, DOI 10.1074/jbc.M109.045161; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2010, MOL BIOL CELL, V21, P2338, DOI 10.1091/mbc.E10-01-0028; Grishina G, 1998, J BIOL CHEM, V273, P15053, DOI 10.1074/jbc.273.24.15053; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P757; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; KROLL SD, 1992, J BIOL CHEM, V267, P23183; Lamba S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006833; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LINDER ME, 1990, J BIOL CHEM, V265, P8243; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200; PRASAD MVVSV, 1994, ONCOGENE, V9, P2425; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; VOYNOYASENETSKAYA TA, 1994, ONCOGENE, V9, P2559; Warner DR, 1999, P NATL ACAD SCI USA, V96, P4268, DOI 10.1073/pnas.96.8.4268; WONG YH, 1995, ONCOGENE, V10, P1927; XU NZ, 1993, P NATL ACAD SCI USA, V90, P6741, DOI 10.1073/pnas.90.14.6741; XU NZ, 1994, BIOCHEM BIOPH RES CO, V201, P603, DOI 10.1006/bbrc.1994.1744; Zurita AR, 2008, P NATL ACAD SCI USA, V105, P2363, DOI 10.1073/pnas.0712261105	41	43	44	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	23					2691	2696		10.1038/onc.2010.645	http://dx.doi.org/10.1038/onc.2010.645			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778CV	21317923	Green Accepted			2022-12-25	WOS:000291677800009
J	Schramedei, K; Morbt, N; Pfeifer, G; Lauter, J; Rosolowski, M; Tomm, JM; von Bergen, M; Horn, F; Brocke-Heidrich, K				Schramedei, K.; Moerbt, N.; Pfeifer, G.; Laeuter, J.; Rosolowski, M.; Tomm, J. M.; von Bergen, M.; Horn, F.; Brocke-Heidrich, K.			MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4	ONCOGENE			English	Article						miR-21; ANP32A; SMARCA4; prostate; post-transcriptional regulation	CELL-PROLIFERATION; MICRO-RNA; EXPRESSION; PROTEIN; MIR-21; BRG1; IDENTIFICATION; INVASION; COMPLEX; PREDICTION	MicroRNA-21 (miR-21) is a key regulator of oncogenic processes. It is significantly elevated in the majority of human tumors and functionally linked to cellular proliferation, survival and migration. In this study, we used two experimental-based strategies to search for novel miR-21 targets. On the one hand, we performed a proteomic approach using two-dimensional differential gel electrophoresis (2D-DIGE) to identify proteins suppressed upon enhanced miR-21 expression in LNCaP human prostate carcinoma cells. The tumor suppressor acidic nuclear phosphoprotein 32 family, member A (ANP32A) (alias pp32 or LANP) emerged as the most strongly downregulated protein. On the other hand, we applied a mathematical approach to select correlated gene sets that are negatively correlated with primary-miR-21 (pri-miR-21) expression in published transcriptome data from 114 B-cell lymphoma cases. Among these candidates, we found tumor suppressor SMARCA4 (alias BRG1) together with the already validated miR-21 target, PDCD4. ANP32A and SMARCA4, which are both involved in chromatin remodeling processes, were confirmed as direct miR-21 targets by immunoblot analysis and reporter gene assays. Furthermore, knock down of ANP32A mimicked the effect of enforced miR-21 expression by enhancing LNCaP cell viability, whereas overexpression of ANP32A in the presence of high miR-21 levels abrogated the miR-21 mediated effect. In A172 glioblastoma cells, enhanced ANP32A expression compensated for the effects of anti-miR- 21 treatment on cell viability and apoptosis. In addition, miR-21 expression clearly increased the invasiveness of LNCaP cells, an effect also seen in part upon downregulation of ANP32A. In conclusion, these results suggest that downregulation of ANP32A contributes to the oncogenic function of miR-21. Oncogene (2011) 30, 2975-2985; doi:10.1038/onc.2011.15; published online 14 February 2011	[Schramedei, K.; Pfeifer, G.; Horn, F.; Brocke-Heidrich, K.] Univ Leipzig, Inst Clin Immunol, Fac Med, D-04103 Leipzig, Germany; [Moerbt, N.; Tomm, J. M.; von Bergen, M.] UFZ Helmholtz Ctr Environm Res, UFZ, Dept Prote, Leipzig, Germany; [Laeuter, J.; Rosolowski, M.] Univ Leipzig, Inst Med Informat Stat & Epidemiol IMISE, Fac Med, D-04103 Leipzig, Germany; [von Bergen, M.] UFZ Helmholtz Ctr Environm Res, UFZ, Dept Metabol, Leipzig, Germany	Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Brocke-Heidrich, K (corresponding author), Univ Leipzig, Inst Clin Immunol, Fac Med, Johannisallee 30, D-04103 Leipzig, Germany.	kheid@medizin.uni-leipzig.de	von Bergen, Martin/D-7960-2011; Tomm, Janina M/F-8888-2014	von Bergen, Martin/0000-0003-2732-2977; Tomm, Janina M/0000-0001-8161-1812	DFG [BR2892/3-1]; Medical Faculty, University of Leipzig	DFG(German Research Foundation (DFG)); Medical Faculty, University of Leipzig	We thank Riccardo Dalla-Favera (New York) for kindly providing SUDHL-2 cells. The work was partly supported by the DFG grant BR2892/3-1 and a junior research grant by the Medical Faculty, University of Leipzig.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brody JR, 2007, MODERN PATHOL, V20, P1238, DOI 10.1038/modpathol.3800974; Brody JR, 1999, J BIOL CHEM, V274, P20053, DOI 10.1074/jbc.274.29.20053; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hoffarth S, 2008, CELL DEATH DIFFER, V15, P161, DOI 10.1038/sj.cdd.4402256; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jehmlich N, 2008, ISME J, V2, P1122, DOI 10.1038/ismej.2008.64; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lauter J, 2009, BIOMETRICAL J, V51, P235, DOI 10.1002/bimj.200800207; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Martin G, 2007, J BIOSCIENCES, V32, P1049, DOI 10.1007/s12038-007-0106-0; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Morbt N, 2009, PROTEOMICS, V9, P4920, DOI 10.1002/pmic.200800836; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; Pan W, 2009, J BIOL CHEM, V284, P6946, DOI 10.1074/jbc.M805801200; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rodriguez-Nieto S, 2009, CARCINOGENESIS, V30, P547, DOI 10.1093/carcin/bgp035; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Santos PM, 2007, OMICS, V11, P233, DOI 10.1089/omi.2007.0009; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selcuklu SD, 2009, BIOCHEM SOC T, V37, P918, DOI 10.1042/BST0370918; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Ulitzur N, 1997, P NATL ACAD SCI USA, V94, P5084, DOI 10.1073/pnas.94.10.5084; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wong AKC, 2000, CANCER RES, V60, P6171; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551; Yao Q, 2009, BIOCHEM BIOPH RES CO, V388, P539, DOI 10.1016/j.bbrc.2009.08.044; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	62	105	110	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	26					2975	2985		10.1038/onc.2011.15	http://dx.doi.org/10.1038/onc.2011.15			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21317927	hybrid, Green Published			2022-12-25	WOS:000292245100008
J	Valente, P; Fernandez-Carvajal, A; Camprubi-Robles, M; Gomis, A; Quirce, S; Viana, F; Fernandez-Ballester, G; Gonzalez-Ros, JM; Belmonte, C; Planells-Cases, R; Ferrer-Montiel, A				Valente, Pierluigi; Fernandez-Carvajal, Asia; Camprubi-Robles, Maria; Gomis, Ana; Quirce, Susana; Viana, Felix; Fernandez-Ballester, Gregorio; Gonzalez-Ros, Jose M.; Belmonte, Carlos; Planells-Cases, Rosa; Ferrer-Montiel, Antonio			Membrane-tethered peptides patterned after the TRP domain (TRPducins) selectively inhibit TRPV1 channel activity	FASEB JOURNAL			English	Article						pain; ionotropic receptors; pepducin; analgesia; inflammation	RECEPTOR POTENTIAL CHANNELS; VANILLOID RECEPTOR; CAPSAICIN RECEPTOR; SENSORY NEURONS; IN-VIVO; PAIN; THERMOSENSATION; IDENTIFICATION; DETERMINANTS; NOCICEPTION	The transient receptor potential vanilloid 1 (TRPV1) channel is a thermosensory receptor implicated in diverse physiological and pathological processes. The TRP domain, a highly conserved region in the C terminus adjacent to the internal channel gate, is critical for subunit tetramerization and channel gating. Here, we show that cell-penetrating, membrane-anchored peptides patterned after this protein domain are moderate and selective TRPV1 antagonists both in vitro and in vivo, blocking receptor activity in intact rat primary sensory neurons and their peripheral axons with mean decline time of 30 min. The most potent lipopeptide, TRP-p5, blocked all modes of TRPV1 gating with micromolar efficacy (IC50 < 10 mu M), without significantly affecting other thermoTRP channels. In contrast, its retrosequence or the corresponding sequences of other TRPV channels did not alter TRPV1 channel activity (IC50 > 100 mu M). TRP-p5 did not affect the capsaicin sensitivity of the vanilloid receptor. Our data suggest that TRP-p5 interferes with protein-protein interactions at the level of the TRP domain that are essential for the "conformational" change that leads to gate opening. Therefore, these palmitoylated peptides, which we termed TRPducins, are noncompetitive, voltage-independent, sequence-specific TRPV1 blockers. Our findings indicate that TRPducin-like peptides may embody a novel molecular strategy that can be exploited to generate a selective pharmacological arsenal for the TRP superfamily of ion channels.-Valente, P., Fernandez-Carvajal, A., Camprubi-Robles, M., Gomis, A., Quirce, S., Viana, F., Fernandez-Ballester, G., Gonzalez-Ros, J. M., Belmonte, C., Planells-Cases, R., Ferrer-Montiel, A. Membrane-tethered peptides patterned after the TRP domain (TRPducins) selectively inhibit TRPV1 channel activity. FASEB J. 25, 1628-1640 (2011). www.fasebj.org	[Valente, Pierluigi; Fernandez-Carvajal, Asia; Camprubi-Robles, Maria; Fernandez-Ballester, Gregorio; Gonzalez-Ros, Jose M.; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche 03202, Alicante, Spain; [Gomis, Ana; Quirce, Susana; Viana, Felix; Belmonte, Carlos] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Elche 03202, Alicante, Spain; [Planells-Cases, Rosa] Ctr Invest Principe Felipe, Valencia, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Prince Felipe Research Center	Ferrer-Montiel, A (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Av Univ S-N, Elche 03202, Alicante, Spain.	aferrer@umh.es	Viana, Felix/U-8533-2017; Valente, Pierluigi/AAF-2802-2021; Ferrer-Montiel, Antonio/C-3072-2015; Gomis, Ana/S-1854-2017; Carvajal, Asia Fernandez/G-8877-2015	Viana, Felix/0000-0003-1439-949X; Ferrer-Montiel, Antonio/0000-0002-2973-6607; Gomis, Ana/0000-0003-4651-7673; Gonzalez Ros, Jose Manuel/0000-0002-4804-6855; Fernandez-Carvajal, Asia/0000-0003-2741-1427	Spain Ministry of Science and Innovation [BFU2009-08346, BFU2008-0062, SAF2007-63193, BFU2009-07835, BFU2007-61855, BFU2008-04425]; Consolider-Ingenio [CSD2008-00005, CSD2007-00002]; la Generalitat Valenciana [Prometeo/2010/046]; Consejo Superior de Investigaciones Cientificas [2009-20I098]	Spain Ministry of Science and Innovation(Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); la Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)); Consejo Superior de Investigaciones Cientificas	The authors thank David Julius (University of California, San Francisco, USA) for providing rat TRPV1 cDNA, Ramon Latorre (Centro de Neurociencias de Valparaiso, Valparaiso, Chile) for rat HEK-TRPM8 cells, Ardem Patapoutian (Institute for Childhood and Neglected Diseases, La Jolla, CA, USA) for mouse CHO-TRPA1 cells, Johanna Lilja and Anna Forsby (University of Stockholm, Stockholm, Sweden) for rat SH-SY5Y-TRPV1 cells, and Ainara Lopez for testing the acetylated TRP-p5 peptide. This work was supported by Spain Ministry of Science and Innovation grants BFU2009-08346 to A. F.-M., BFU2008-0062 to J.M.G.R., SAF2007-63193 to R. P.-C., BFU2009-07835 to A. G., BFU2007-61855 to F. V., and BFU2008-04425 to C. B.; Consolider-Ingenio 2010 CSD2008-00005 to A. F.-M., J.M.G.-R., and R. P.-C., and CSD2007-00002 to A. G., F. V., and C. B.; la Generalitat Valenciana Prometeo/2010/046 to A. F.-M., F. V., and C. B.; and Intramural (Consejo Superior de Investigaciones Cientificas) Ref. 2009-20I098 to A. G. Author contributions: P. V., A. F.-C., S. Q., A. G., and M. C. performed the experiments; G.F.-B. carried out the molecular modeling; F. V., J.M., G. R, C. B., and R. P. contributed to discussion, data analysis, and writing of the paper; and A. F.-M. designed the experiments, analyzed the data, and wrote the paper.	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Blanes-Mira C, 2004, J NEUROCHEM, V88, P124, DOI 10.1046/j.1471-4159.2003.02133.x; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Camprubi-Robles M, 2009, FASEB J, V23, P3722, DOI 10.1096/fj.09-134346; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Fajardo O, 2008, J NEUROSCI, V28, P7863, DOI 10.1523/JNEUROSCI.1696-08.2008; Fajardo O, 2008, CHANNELS, V2, P429, DOI 10.4161/chan.2.6.7126; Fernandez-Ballester G, 2008, J MEMBRANE BIOL, V223, P161, DOI 10.1007/s00232-008-9123-7; Garcia-Martinez C, 2002, P NATL ACAD SCI USA, V99, P2374, DOI 10.1073/pnas.022285899; Garcia-Martinez C, 2006, J PAIN, V7, P735, DOI 10.1016/j.jpain.2006.03.008; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gomis A, 2004, ARTHRITIS RHEUM-US, V50, P314, DOI 10.1002/art.11421; Gomis A, 2007, PAIN, V130, P126, DOI 10.1016/j.pain.2006.11.012; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Khairatkar-Joshi N, 2009, TRENDS MOL MED, V15, P14, DOI 10.1016/j.molmed.2008.11.004; Kuliopulos A, 2003, LIFE SCI, V74, P255, DOI 10.1016/j.lfs.2003.09.012; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Lilja J, 2007, J NEUROSCI RES, V85, P1413, DOI 10.1002/jnr.21255; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Meseguer V, 2008, J NEUROSCI, V28, P576, DOI 10.1523/JNEUROSCI.4772-07.2008; Messeguer A, 2006, CURR NEUROPHARMACOL, V4, P1, DOI 10.2174/157015906775202995; Montell C, 2007, CURR BIOL, V17, pR885, DOI 10.1016/j.cub.2007.08.016; Petho G, 2004, PAIN, V109, P284, DOI 10.1016/j.pain.2004.01.038; Salazar H, 2009, NAT STRUCT MOL BIOL, V16, P704, DOI 10.1038/nsmb.1633; Sherkheli MA, 2008, PAK J PHARM SCI, V21, P370; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Viana F, 2009, EXPERT OPIN THER PAT, V19, P1787, DOI 10.1517/13543770903393771; Yang E, 2009, CANCER RES, V69, P6223, DOI 10.1158/0008-5472.CAN-09-0187; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	42	28	29	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1628	1640		10.1096/fj.10-174433	http://dx.doi.org/10.1096/fj.10-174433			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21307333	Green Submitted			2022-12-25	WOS:000290023800020
J	Roth, DM; Moseley, GW; Pouton, CW; Jans, DA				Roth, Daniela Martino; Moseley, Gregory W.; Pouton, Colin W.; Jans, David A.			Mechanism of Microtubule-facilitated "Fast Track" Nuclear Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-RELATED PROTEIN; DYNEIN LIGHT-CHAIN; GREEN FLUORESCENT PROTEIN; TARGETING SIGNAL; NUCLEOCYTOPLASMIC FLUX; LOCALIZATION SEQUENCE; CELLS; BINDING; KINASE; LC8	Although the microtubule (MT) cytoskeleton has been shown to facilitate nuclear import of specific cancer-regulatory proteins including p53, retinoblastoma protein, and parathyroid hormone-related protein (PTHrP), the MT association sequences (MTASs) responsible and the nature of the interplay between MT-dependent and conventional importin (IMP)-dependent nuclear translocation are unknown. Here we used site-directed mutagenesis, live cell imaging, and direct IMP and MT binding assays to map the MTAS of PTHrP for the first time, finding that it is within a short modular region (residues 82-108) that overlaps with the IMP beta 1-recognized nuclear localization signal (residues 66-108) of PTHrP. Importantly, fluorescence recovery after photobleaching experiments indicated that disruption of the MT network or mutation of the MTAS of PTHrP decreases the rate of nuclear import by 2-fold. Moreover, MTAS functions depend on mutual exclusivity of binding of PTHrP to MTs and IMP beta 1 such that, following MT-dependent trafficking toward the nucleus, perinuclear PTHrP can be displaced from MTs by IMP beta 1 prior to import into the nucleus. This is the first molecular definition of an MTAS that facilitates protein nuclear import as well as the first delineation of the mechanism whereby cargo is transferred directly from the cytoskeleton to the cellular nuclear import apparatus. The results have broad significance with respect to fundamental processes regulating cell physiology/transformation.	[Roth, Daniela Martino; Moseley, Gregory W.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Clayton, Vic 3800, Australia; [Pouton, Colin W.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia	Monash University; Monash University	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Nucl Signalling Lab, Box 13D, Clayton, Vic 3800, Australia.	david.jans@monash.edu	Pouton, Colin W/M-2049-2016	Pouton, Colin W/0000-0003-0224-3308; Jans, David/0000-0001-5115-4745; Moseley, Gregory/0000-0003-4516-3906	National Health and Medical Research Council, Australia [333013/384109, 384107]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council, Australia (Fellowship 333013/384109 and Project Grant 384107).	Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x; Alvisi G, 2009, J VIROL, V83, P9567, DOI 10.1128/JVI.00669-09; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; Baliga BC, 2003, J BIOL CHEM, V278, P4899, DOI 10.1074/jbc.M211512200; Campbell EA, 2003, ADV DRUG DELIVER REV, V55, P761, DOI 10.1016/S0169-409X(03)00049-8; CHI NC, 1995, J CELL BIOL, V130, P265, DOI 10.1083/jcb.130.2.265; Davis FJ, 2005, AM J PHYSIOL-HEART C, V288, pH1477, DOI 10.1152/ajpheart.00789.2004; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Harley VR, 2003, P NATL ACAD SCI USA, V100, P7045, DOI 10.1073/pnas.1137864100; HENDERSON JE, 1995, MOL CELL BIOL, V15, P4064; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Jans DA, 2000, BIOCHEM BIOPH RES CO, V270, P1055, DOI 10.1006/bbrc.2000.2559; Kartsogiannis V, 1997, BONE, V21, P385, DOI 10.1016/S8756-3282(97)00180-4; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lam MHC, 2001, BIOCHEM BIOPH RES CO, V282, P629, DOI 10.1006/bbrc.2001.4607; Lam MHC, 2001, TRAFFIC, V2, P812, DOI 10.1034/j.1600-0854.2001.21110.x; Lam MHC, 1999, J BIOL CHEM, V274, P18559, DOI 10.1074/jbc.274.26.18559; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; LANG I, 1986, J CELL BIOL, V102, P1183, DOI 10.1083/jcb.102.4.1183; Liang SH, 1999, ONCOGENE, V18, P2163, DOI 10.1038/sj.onc.1202350; Lixin R, 2001, BIOCHEM BIOPH RES CO, V284, P185, DOI 10.1006/bbrc.2001.4953; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Ma XY, 2007, BIOCHEMISTRY-US, V46, P7153, DOI 10.1021/bi700101n; Malki S, 2005, EXP CELL RES, V309, P468, DOI 10.1016/j.yexcr.2005.07.005; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Massfelder T, 1997, P NATL ACAD SCI USA, V94, P13630, DOI 10.1073/pnas.94.25.13630; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; MOSELEY JM, 1995, CRIT REV CL LAB SCI, V32, P299, DOI 10.3109/10408369509084687; Mueller S, 2002, J BIOL CHEM, V277, P7897, DOI 10.1074/jbc.M111937200; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; PETERS R, 1974, BIOCHIM BIOPHYS ACTA, V367, P282, DOI 10.1016/0005-2736(74)90085-6; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; Poisson N, 2001, J GEN VIROL, V82, P2691, DOI 10.1099/0022-1317-82-11-2691; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Pouton CW, 2007, ADV DRUG DELIVER REV, V59, P698, DOI 10.1016/j.addr.2007.06.010; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Roth DM, 2009, J CELL BIOCHEM, V107, P1160, DOI 10.1002/jcb.22218; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; ROTH DM, 2009, NUCL TRANSPORT, P154; Sepulveda VAT, 2002, ENDOCRINOLOGY, V143, P596, DOI 10.1210/en.143.2.596; Sorg G, 1999, BIOTECHNIQUES, V26, P858, DOI 10.2144/99265bm12; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Sunn KL, 2005, BIOCHEM J, V388, P509, DOI 10.1042/BJ20042040; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wagstaff KM, 2005, J FLUORESC, V15, P469, DOI 10.1007/s10895-005-2819-5; Whittaker GR, 2003, ADV DRUG DELIVER REV, V55, P733, DOI 10.1016/S0169-409X(03)00051-6; Whittaker GR, 2000, ANNU REV CELL DEV BI, V16, P627, DOI 10.1146/annurev.cellbio.16.1.627; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191; ZACKSENHAUS E, 1993, MOL CELL BIOL, V13, P4588, DOI 10.1128/MCB.13.8.4588	58	36	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14335	14351		10.1074/jbc.M110.210302	http://dx.doi.org/10.1074/jbc.M110.210302			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21339293	hybrid, Green Published			2022-12-25	WOS:000289556200056
J	Wei, JQ; Wang, WW; Chopra, I; Li, HF; Dougherty, CJ; Adi, J; Adi, N; Wang, HL; Webster, KA				Wei, Jianqin; Wang, Weiwen; Chopra, Ines; Li, Hui Fang; Dougherty, Christopher J.; Adi, Jennipher; Adi, Nikhil; Wang, Huilan; Webster, Keith A.			c-Jun N-terminal Kinase (JNK-1) Confers Protection against Brief but Not Extended Ischemia during Acute Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; FREE-RADICAL GENERATION; REPERFUSION INJURY; CELL-DEATH; NH2-TERMINAL KINASE; CARDIAC MYOCYTES; IN-VIVO; SUPPRESSES APOPTOSIS; SIGNALING PATHWAY; ACTIVATION	Brief periods of ischemia do not damage the heart and can actually protect against reperfusion injury caused by extended ischemia. It is not known what causes the transition from protection to irreversible damage as ischemia progresses. c-Jun N-terminal kinase-1 (JNK-1) is a stress-regulated kinase that is activated by reactive oxygen and thought to promote injury during severe acute myocardial infarction. Because some reports suggest that JNK-1 can also be protective, we hypothesized that the function of JNK-1 depends on the metabolic state of the heart at the time of reperfusion, a condition that changes progressively with duration of ischemia. Mice treated with JNK-1 inhibitors or transgenic mice wherein the JNK-1 gene was ablated were subjected to 5 or 20 min of ischemia followed by reperfusion. When JNK-1 was inactive, ischemia of only 5 min duration caused massive apoptosis, infarction, and negative remodeling that was equivalent to or greater than extended ischemia. Conversely, when ischemia was extended JNK-1 inactivation was protective. Mechanisms of the JNK-1 switch in function were investigated in vivo and in cultured cardiac myocytes. In vitro there was a comparable switch in the function of JNK-1 from protective when ATP levels were maintained during hypoxia to injurious when reoxygenation followed glucose and ATP depletion. Both apoptotic and necrotic death pathways were affected and responded reciprocally to JNK-1 inhibitors. JNK-1 differentially regulated Akt phosphorylation of the regulatory sites Ser-473 and Thr-450 and the catalytic Thr-308 site in vivo. The studies define a novel role for JNK-1 as a conditional survival kinase that protects the heart against brief but not protracted ischemia.	[Wei, Jianqin; Wang, Weiwen; Chopra, Ines; Li, Hui Fang; Dougherty, Christopher J.; Adi, Jennipher; Adi, Nikhil; Wang, Huilan; Webster, Keith A.] Univ Miami, Dept Mol & Cellular Pharmacol, Vasc Biol Inst, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Webster, KA (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Vasc Biol Inst, Miller Sch Med, Miami, FL 33136 USA.	kwebster@med.miami.edu		Wang, Weiwen/0000-0002-2468-5222; Webster, Keith A/0000-0002-6431-3642	National Institutes of Health [HL44578, HL92499]; Florida Heart Research Institute; Agatston Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044578, R01HL092499, R29HL044578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Heart Research Institute; Agatston Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL44578 and HL92499 (to K.A.W.). This work was also supported by grants from the Florida Heart Research Institute and the Agatston Research Institute.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bak MI, 1998, AM J PHYSIOL-CELL PH, V274, pC992, DOI 10.1152/ajpcell.1998.274.4.C992; Barbagelata A, 2007, J ELECTROCARDIOL, V40, P257, DOI 10.1016/j.jelectrocard.2007.01.007; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Buja LM, 2010, CARDIOVASC PATHOL, V19, P29, DOI 10.1016/j.carpath.2008.10.001; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Depre C, 2007, HEART FAIL REV, V12, P307, DOI 10.1007/s10741-007-9040-3; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Dougherty CJ, 2002, BIOCHEM J, V362, P561, DOI 10.1042/0264-6021:3620561; Duplain H, 2006, ADV EXP MED BIOL, V588, P157; Ferrandi C, 2004, BRIT J PHARMACOL, V142, P953, DOI 10.1038/sj.bjp.0705873; Frazier DP, 2007, AM J PHYSIOL-HEART C, V292, pH1675, DOI 10.1152/ajpheart.01132.2006; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Hausenloy DJ, 2008, NEW ENGL J MED, V359, P518, DOI 10.1056/NEJMe0803746; Hausenloy DJ, 2007, PHARMACOL THERAPEUT, V116, P173, DOI 10.1016/j.pharmthera.2007.06.005; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Heyndrickx GR, 2006, SEMIN CARDIOTHORAC V, V10, P236, DOI 10.1177/1089253206291137; Hoole SP, 2009, CIRCULATION, V119, P820, DOI 10.1161/CIRCULATIONAHA.108.809723; Hreniuk D, 2001, MOL PHARMACOL, V59, P867, DOI 10.1124/mol.59.4.867; Imahashi K, 2004, CIRC RES, V95, P734, DOI 10.1161/01.RES.0000143898.67182.4c; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaiser RA, 2005, J BIOL CHEM, V280, P32602, DOI 10.1074/jbc.M500684200; KINGSLEY PB, 1991, AM J PHYSIOL, V261, pH469, DOI 10.1152/ajpheart.1991.261.2.H469; Kloner RA, 2001, CIRCULATION, V104, P3158, DOI 10.1161/hc5001.100039; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; KUPPUSAMY P, 1994, P NATL ACAD SCI USA, V91, P3388, DOI 10.1073/pnas.91.8.3388; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Liang QR, 2003, EMBO J, V22, P5079, DOI 10.1093/emboj/cdg474; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Milano G, 2007, AM J PHYSIOL-HEART C, V292, pH1828, DOI 10.1152/ajpheart.01117.2006; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Mocanu MM, 2007, BRIT J PHARMACOL, V150, P833, DOI 10.1038/sj.bjp.0707155; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sadoshima J, 2002, J CLIN INVEST, V110, P271, DOI 10.1172/JCI200214938; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tian R, 2001, CIRCULATION, V103, P2961, DOI 10.1161/01.CIR.103.24.2961; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tran TH, 2007, J BIOL CHEM, V282, P20340, DOI 10.1074/jbc.M702210200; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200; Webster KA, 1999, J CLIN INVEST, V104, P239; Webster KA, 2007, TRENDS PHARMACOL SCI, V28, P492, DOI 10.1016/j.tips.2007.07.004; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yamashita K, 2001, CIRC RES, V88, P609, DOI 10.1161/01.RES.88.6.609; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Yu CF, 2004, MOL CELL, V13, P329, DOI 10.1016/S1097-2765(04)00028-0; Yung HW, 2003, J NEUROCHEM, V86, P1281, DOI 10.1046/j.1471-4159.2003.01946.x; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	61	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13995	14006		10.1074/jbc.M110.211334	http://dx.doi.org/10.1074/jbc.M110.211334			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324895	Green Published, hybrid			2022-12-25	WOS:000289556200022
J	Winbanks, CE; Wang, B; Beyer, C; Koh, P; White, L; Kantharidis, P; Gregorevic, P				Winbanks, Catherine E.; Wang, Bo; Beyer, Claudia; Koh, Phillip; White, Lloyd; Kantharidis, Phillip; Gregorevic, Paul			TGF-beta Regulates miR-206 and miR-29 to Control Myogenic Differentiation through Regulation of HDAC4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMING-GROWTH-FACTOR; HISTONE DEACETYLASES; SKELETAL MYOGENESIS; NUCLEAR EXPORT; MUSCLE; TRANSCRIPTION; EXPRESSION; PROMOTES; FAMILY; REPRESSION	MicroRNAs (miRs) are emerging as prominent players in the regulation of many biological processes, including myogenic commitment and skeletal muscle formation. Members of the TGF-beta family can influence the proliferation and myogenic differentiation of cells, although it is presently not clear what role miRNAs play in the TGF-beta-mediated control of myogenic differentiation. Here, we demonstrate in the myogenic C2C12 cell line, and in primary muscle cells, that miR-206 and miR-29-two miRs that act on transcriptional events implicated in muscle differentiation are down-regulated by TGF-beta. We further demonstrate that TGF-beta treatment of myogenic cells is associated with increased expression of histone deacetylase 4 (HDAC4), a key inhibitor of muscle differentiation that has been identified as a target for regulation by miR-206 and miR-29. We confirmed that increased expression of miR-206 and miR-29 resulted in the translational repression of HDAC4 in the presence or absence of TGF-beta via interaction with the HDAC4 3'-untranslated region. Importantly, we found that miR-206 and miR-29 can attenuate the inhibitory actions of TGF-beta on myogenic differentiation. Furthermore, we present evidence that the mechanism by which miR-206 and miR-29 can inhibit the TGF-beta-mediated up-regulation of HDAC4 is via the inhibition of Smad3 expression, a transducer of TGF-beta signaling. These findings identify a novel mechanism of interaction between TGF-beta and miR-206 and -29 in the regulation of myogenic differentiation through HDAC4.	[Winbanks, Catherine E.; Beyer, Claudia; White, Lloyd; Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Div Metab & Obes, Melbourne, Vic 8008, Australia; [Wang, Bo; Koh, Phillip; Kantharidis, Phillip] Baker IDI Heart & Diabet Inst, Div Diabet Complicat, Melbourne, Vic 8008, Australia; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Gregorevic, Paul] Univ Washington, Dept Neurol, Sch Med, Seattle, WA 98104 USA; [Gregorevic, Paul] Univ Melbourne, Dept Physiol, Melbourne, Vic 3000, Australia	Baker Heart and Diabetes Institute; Baker Heart and Diabetes Institute; Monash University; University of Washington; University of Washington Seattle; University of Melbourne	Gregorevic, P (corresponding author), POB 6492,St Kilda Rd, Central, Vic 8008, Australia.	paul.gregorevic@bakeridi.edu.au	Gregorevic, Paul/AAH-6040-2021; White, Lloyd J/L-7163-2013	Gregorevic, Paul/0000-0002-7418-8945; White, Lloyd J/0000-0003-0775-4975				Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Di Padova M, 2007, J BIOL CHEM, V282, P37650, DOI 10.1074/jbc.M707309200; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126; Ishikawa F, 2010, ONCOGENE, V29, P909, DOI 10.1038/onc.2009.387; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kollias HD, 2006, MOL CELL BIOL, V26, P6248, DOI 10.1128/MCB.00384-06; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; MARTIN JF, 1992, J BIOL CHEM, V267, P10956; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; Massague J, 2000, GENE DEV, V14, P627; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2001, MOL CELL BIOL, V21, P6312, DOI 10.1128/MCB.21.18.6312-6321.2001; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; Pei M, 2009, DIFFERENTIATION, V78, P260, DOI 10.1016/j.diff.2009.08.001; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; SANDLER MA, 1994, J BIOL CHEM, V269, P21500; Sato MM, 2009, BIOCHEM BIOPH RES CO, V383, P125, DOI 10.1016/j.bbrc.2009.03.142; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang SL, 2010, CANCER SCI, V101, P1108, DOI 10.1111/j.1349-7006.2010.01512.x; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545	48	211	225	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13805	13814		10.1074/jbc.M110.192625	http://dx.doi.org/10.1074/jbc.M110.192625			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324893	Green Published, hybrid			2022-12-25	WOS:000289556200003
J	Emara, M; Royer, PJ; Abbas, Z; Sewell, HF; Mohamed, GG; Singh, S; Peel, S; Fox, J; Shakib, F; Martinez-Pomares, L; Ghaemmaghamit, AM				Emara, Mohamed; Royer, Pierre-Joseph; Abbas, Zaigham; Sewell, Herb F.; Mohamed, Gihan Gebriel; Singh, Sonali; Peel, Samantha; Fox, Jane; Shakib, Farouk; Martinez-Pomares, Luisa; Ghaemmaghamit, Amir M.			Recognition of the Major Cat Allergen Fel d 1 through the Cysteine-rich Domain of the Mannose Receptor Determines Its Allergenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; DENDRITIC CELLS; D-I; LIGAND-BINDING; MONOCLONAL-ANTIBODIES; INDOOR ALLERGENS; IGE; EXPRESSION; ASTHMA; IGG2A	Dendritic cells are professional antigen-presenting cells that are specialized in antigen uptake and presentation. Allergy to cat has increased substantially in recent years and has been shown to be positively associated with asthma. We have recently shown that the mannose receptor (MR), a C-type lectin expressed by dendritic cells, recognizes various glycoallergens from diverse sources and is involved in promoting allergic responses to a major house dust mite allergen in vitro. Here we investigated the potential role of MR in allergic responses to Fel d 1, a major cat allergen. Eel d 1 binding to MR was confirmed by ELBA. Using blocking, gene silencing (siRNA) experiments, and MR knock-out (MR-/-) cells, we have demonstrated that MR plays a major role in internalization of Fel d 1 by human and mouse antigen-presenting cells. Intriguingly, unlike other glycoallergens, recognition of Fel d 1 by MR is mediated by the cysteine-rich domain, which correlates with the presence of sulfated carbohydrates in natural Fel d 1. WT and MR-/- mice were used to study the role of MR in allergic sensitization to Eel d 1 in vivo. MR-/- mice sensitized with cat dander extract and Eel d 1 produced significantly lower levels of total IgE, Eel d 1-specific-IgE and IgG1, the hallmarks of allergic response, compared with WT mice. Our data show for the first time that Fel d 1 is a novel ligand of the cysteine-rich domain of MR and that MR is likely to play a pivotal role in allergic sensitization to airborne allergens in vivo.	[Martinez-Pomares, Luisa] Univ Nottingham, Queens Med Ctr, Div Immunol, Sch Mol Med Sci, Nottingham NG7 2UH, England; [Peel, Samantha; Fox, Jane] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Singh, Sonali; Shakib, Farouk; Ghaemmaghamit, Amir M.] Univ Nottingham, Queens Med Ctr, Nottingham Resp Biomed Res Unit, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham	Martinez-Pomares, L (corresponding author), Univ Nottingham, Queens Med Ctr, Div Immunol, Sch Mol Med Sci, Nottingham NG7 2UH, England.	luisa.m@nottingham.ac.uk; amg@nottingham.ac.uk	Royer, Pierre-Joseph/D-4768-2015; Ghaemmaghami, Amir/AAP-2968-2020; Emara, Mohamed M./C-8220-2013	Royer, Pierre-Joseph/0000-0001-5534-7982; Ghaemmaghami, Amir/0000-0003-3160-8759; Emara, Mohamed M./0000-0001-7708-9435; Singh, Sonali/0000-0003-0600-9084; Martinez-Pomares, Luisa/0000-0002-2331-127X	Asthma UK [06/001]; Knut and Alice Wallenberg Foundation	Asthma UK; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported in part by Asthma UK Research Grant 06/001.; We thank the Proteomics Center at Sahlgrenska Academy (funded by a grant from the Knut and Alice Wallenberg Foundation) (University of Gothenburg) for technical assistance with regard to Glycan analysis and Nanoflow LC-MS/MS Fourier Transform Ion Cyclotron Resonance experiments.	Adedoyin J, 2007, J ALLERGY CLIN IMMUN, V119, P640, DOI 10.1016/j.jaci.2006.11.637; Adel-Patient K, 2000, J IMMUNOL METHODS, V235, P21, DOI 10.1016/S0022-1759(99)00210-0; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Carlsohn E, 2006, MOL CELL PROTEOMICS, V5, pS53; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; Custovic A, 1998, THORAX, V53, P33, DOI 10.1136/thx.53.1.33; DEGROOT H, 1988, J ALLERGY CLIN IMMUN, V82, P778, DOI 10.1016/0091-6749(88)90079-6; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; DUTFORT OA, 1991, MOL IMMUNOL, V28, P301; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engering AJ, 1997, ADV EXP MED BIOL, V417, P183; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; GELBER LE, 1993, AM REV RESPIR DIS, V147, P573, DOI 10.1164/ajrccm/147.3.573; Gijzen K, 2006, CURR PROTEIN PEPT SC, V7, P283, DOI 10.2174/138920306778018016; Glovsky M Michael, 2007, Methods Mol Biol, V378, P205, DOI 10.1007/978-1-59745-323-3_15; GRIFFITH IJ, 1992, GENE, V113, P263, DOI 10.1016/0378-1119(92)90405-E; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; HARRIS N, 1992, BLOOD, V80, P2363; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Ichikawa K, 1999, CLIN EXP ALLERGY, V29, P754; INABA K, 2009, CURR PROTOC IMMUNOL, V86; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Kato M, 2000, INT IMMUNOL, V12, P1511, DOI 10.1093/intimm/12.11.1511; KLEINETEBBE J, 1993, INT ARCH ALLERGY IMM, V100, P256, DOI 10.1159/000236421; Kristensen AK, 1997, BIOL CHEM, V378, P899; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Liam CK, 2002, RESPIROLOGY, V7, P345, DOI 10.1046/j.1440-1843.2002.00409.x; LOWENSTEIN H, 1985, ALLERGY, V40, P430, DOI 10.1111/j.1398-9995.1985.tb02682.x; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares Luisa, 2009, V531, P103, DOI 10.1007/978-1-59745-396-7_8; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; MOUNTFORD AP, 1994, PARASITE IMMUNOL, V16, P521, DOI 10.1111/j.1365-3024.1994.tb00306.x; MULLIN NP, 1994, J BIOL CHEM, V269, P28405; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Niggemann B, 2008, PEDIAT ALLERG IMM-UK, V19, P325, DOI 10.1111/j.1399-3038.2007.00651.x; Ormstad H, 2003, TOXICOLOGY, V188, P309, DOI 10.1016/S0300-483X(03)00078-7; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Platts-Mills TAE, 1997, J ALLERGY CLIN IMMUN, V100, pS2, DOI 10.1016/S0091-6749(97)70292-6; PONTOW SE, 1992, INT REV CYTOL, V137B, P221; Roost HP, 1999, J ALLERGY CLIN IMMUN, V104, P941, DOI 10.1016/S0091-6749(99)70072-2; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; SARSFIELD JK, 1976, ARCH DIS CHILD, V51, P186, DOI 10.1136/adc.51.3.186; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Syme RM, 2002, INFECT IMMUN, V70, P5972, DOI 10.1128/IAI.70.11.5972-5981.2002; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Terada T, 2006, CLIN IMMUNOL, V120, P45, DOI 10.1016/j.clim.2005.12.010; VANMILLIGEN FJ, 1994, J ALLERGY CLIN IMMUN, V93, P34, DOI 10.1016/0091-6749(94)90230-5; Wachholz Petra A, 2005, J Immunotoxicol, V1, P189, DOI 10.1080/15476910490919140	57	50	53	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13033	13040		10.1074/jbc.M111.220657	http://dx.doi.org/10.1074/jbc.M111.220657			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335554	hybrid, Green Published			2022-12-25	WOS:000289282200023
J	Sonder, SU; Saret, S; Tang, W; Sturdevant, DE; Porcella, SF; Siebenlist, U				Sonder, Soren Ulrik; Saret, Sun; Tang, Wanhu; Sturdevant, Dan E.; Porcella, Stephen F.; Siebenlist, Ulrich			IL-17-induced NF-kappa B Activation via CIKS/Act1 PHYSIOLOGIC SIGNIFICANCE AND SIGNALING MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILIZATION; ADAPTER PROTEIN CIKS/ACT1; EPITHELIAL-CELLS; GENE-EXPRESSION; NUCLEAR-PROTEIN; TNF-ALPHA; IL-17; RECEPTOR; ACT1; INTERLEUKIN-17	Interleukin-17 (IL-17) is essential in host defense against extracellular bacteria and fungi, especially at mucosal sites, but it also contributes significantly to inflammatory and autoimmune disease pathologies. Binding of IL-17 to its receptor leads to recruitment of adaptor protein CIKS/Act1 via heterotypic association of their respective SEFIR domains and activation of transcription factor NF-kappa B; it is not known whether CIKS and/or NE-kappa B are required for all gene induction events. Here we report that CIKS is essential for all IL-17-induced immediate-early genes in primary mouse embryo fibroblasts, whereas NF-kappa B is profoundly involved. We also identify a novel subdomain in the N terminus of CIKS that is essential for IL-17-mediated NF-kappa B activation. This domain is both necessary and sufficient for interaction between CIKS and TRAF6, an adaptor required for NF-kappa B activation. The ability of decoy peptides to block this interaction may provide a new therapeutic strategy for intervention in IL-17-driven autoimmune and inflammatory diseases.	[Sonder, Soren Ulrik; Saret, Sun; Tang, Wanhu; Siebenlist, Ulrich] NIA1D, Immunoregulat Lab, NIH, Rockville, MD 20852 USA; [Sturdevant, Dan E.; Porcella, Stephen F.] NIAID, Genom Unit, Res Technol Sect, Rocky Mt Labs,NIH, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), Bldg 10,Rm 11B15A, Bethesda, MD 20892 USA.	usiebenlist@niaid.nih.gov			National Institutes of Health NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001096, ZICAI001052] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health intramural research program of NIAID.	Andoh A, 2002, BBA-MOL CELL RES, V1591, P69, DOI 10.1016/S0167-4889(02)00250-1; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Awane M, 1999, J IMMUNOL, V162, P5337; Barlow JL, 2009, BIOFACTORS, V35, P178, DOI 10.1002/biof.24; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Heinemann S, 2006, J BIOL CHEM, V281, P8565, DOI 10.1074/jbc.M510891200; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Kanamori M, 2002, FEBS LETT, V532, P241, DOI 10.1016/S0014-5793(02)03688-8; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonardi A, 2000, J BIOL CHEM, V275, P271, DOI 10.1074/jbc.275.1.271; Leonardi A, 2000, P NATL ACAD SCI USA, V97, P10494, DOI 10.1073/pnas.190245697; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Li XX, 2008, CYTOKINE, V41, P105, DOI 10.1016/j.cyto.2007.09.015; Li XX, 2000, P NATL ACAD SCI USA, V97, P10489, DOI 10.1073/pnas.160265197; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Mauro C, 2003, BIOCHEM BIOPH RES CO, V309, P84, DOI 10.1016/S0006-291X(03)01532-8; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pisitkun P, 2010, ARTHRITIS RHEUM-US, V62, P3334, DOI 10.1002/art.27653; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Schluns KS, 1997, J IMMUNOL, V158, P2704; Shea PR, 2010, P NATL ACAD SCI USA, V107, P4693, DOI 10.1073/pnas.0906384107; Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sparna T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-226; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; UEDA A, 1994, J IMMUNOL, V153, P2052; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2008, J BIOL CHEM, V283, P32404, DOI 10.1074/jbc.M802148200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	49	100	102	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12881	12890		10.1074/jbc.M110.199547	http://dx.doi.org/10.1074/jbc.M110.199547			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335551	hybrid, Green Published			2022-12-25	WOS:000289282200008
J	Narita, H; Yamamoto, Y; Suzuki, M; Miyazaki, N; Yoshida, A; Kawai, K; Iwasaki, K; Nakagawa, A; Takai, Y; Sakisaka, T				Narita, Hirotaka; Yamamoto, Yasunori; Suzuki, Mamoru; Miyazaki, Naoyuki; Yoshida, Asuka; Kawai, Katsuhisa; Iwasaki, Kenji; Nakagawa, Atsushi; Takai, Yoshimi; Sakisaka, Toshiaki			Crystal Structure of the cis-Dimer of Nectin-1 IMPLICATIONS FOR THE ARCHITECTURE OF CELL-CELL JUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERPES-SIMPLEX VIRUS; IMMUNOGLOBULIN-LIKE LOOP; ADHESION MOLECULE; ADHERENS JUNCTIONS; POLIOVIRUS RECEPTOR; CLEFT LIP/PALATE; V-DOMAIN; CADHERIN; AFADIN; PROTEIN	In multicellular organisms, cells are interconnected by cell adhesion molecules. Nectins are immunoglobulin (Ig)-like cell adhesion molecules that mediate homotypic and heterotypic cell-cell adhesion, playing key roles in tissue organization. To mediate cell-cell adhesion, nectin molecules dimerize in cis on the surface of the same cell, followed by trans-dimerization of the cis-dimers between the neighboring cells. Previous cell biological studies deduced that the first Ig-like domain of nectin and the second Ig-like domain are involved in trans-dimerization and cis-dimerization, respectively. However, to understand better the steps involved in nectin adhesion, the structural basis for the dimerization of nectin must be determined. In this study, we determined the first crystal structure of the entire extracellular region of nectin-1. In the crystal, nectin-1 formed a V-shaped homophilic dimer through the first Ig-like domain. Structure-based site-directed mutagenesis of the first Ig-like domain identified four essential residues that are involved in the homophilic dimerization. Upon mutating the four residues, nectin-1 significantly decreased cis-dimerization on the surface of cultured cells and abolished the homophilic and heterophilic adhesion activities. These results indicate that, in contrast with the previous notion, our structure represents a cis-dimer. Thus, our findings clearly reveal the structural basis for the cis-dimerization of nectins through the first Ig-like domains.	[Yamamoto, Yasunori; Yoshida, Asuka; Kawai, Katsuhisa; Sakisaka, Toshiaki] Kobe Univ, Div Membrane Dynam, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Narita, Hirotaka; Suzuki, Mamoru; Nakagawa, Atsushi] Osaka Univ, Lab Supramol Crystallog, Res Ctr Struct & Funct Prote, Inst Prot Res, Suita, Osaka 5650871, Japan; [Miyazaki, Naoyuki; Iwasaki, Kenji] Osaka Univ, Lab Prot Synth & Express, Res Ctr Struct & Funct Prote, Inst Prot Res, Suita, Osaka 5650871, Japan; [Takai, Yoshimi] Kobe Univ, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan	Kobe University; Osaka University; Osaka University; Kobe University	Sakisaka, T (corresponding author), Kobe Univ, Div Membrane Dynam, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan.	sakisaka@med.kobe-u.ac.jp	Nakagawa, Atsushi/M-5731-2019; Suzuki, Mamoru/G-6576-2016; Miyazaki, Naoyuki/D-7435-2012; Nakagawa, Atsushi/D-4329-2009; Miyazaki, Naoyuki/P-3436-2018	Nakagawa, Atsushi/0000-0002-1700-7861; Suzuki, Mamoru/0000-0001-7071-5093; Miyazaki, Naoyuki/0000-0002-4880-7300; Nakagawa, Atsushi/0000-0002-1700-7861; Miyazaki, Naoyuki/0000-0002-4880-7300; Narita, Hirotaka/0000-0003-4604-9523	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for the National Project on Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Avila JR, 2006, AM J MED GENET A, V140A, P2562, DOI 10.1002/ajmg.a.31367; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong XH, 2006, J BIOL CHEM, V281, P10610, DOI 10.1074/jbc.M513459200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Honda T, 2003, BIOCHEM BIOPH RES CO, V306, P104, DOI 10.1016/S0006-291X(03)00919-7; Honda T, 2003, GENES CELLS, V8, P51, DOI 10.1046/j.1365-2443.2003.00616.x; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875; Krummenacher C, 2002, J VIROL, V76, P2424, DOI 10.1128/JVI.76.5.2424-2433.2002; LOPEZ M, 1995, GENE, V155, P261, DOI 10.1016/0378-1119(94)00842-G; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martinez WM, 2002, J VIROL, V76, P7255, DOI 10.1128/JVI.76.14.7255-7262.2002; McRorie D. K., 1993, SELF ASS SYSTEMS ANA; Miyahara M, 2000, J BIOL CHEM, V275, P613, DOI 10.1074/jbc.275.1.613; Mizoguchi A, 2002, J CELL BIOL, V156, P555, DOI 10.1083/jcb.200103113; Momose Y, 2002, BIOCHEM BIOPH RES CO, V293, P45, DOI 10.1016/S0006-291X(02)00183-3; Okabe N, 2004, DEV BIOL, V273, P244, DOI 10.1016/j.ydbio.2004.05.034; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sakisaka T, 2004, CURR OPIN CELL BIOL, V16, P513, DOI 10.1016/j.ceb.2004.07.007; Sakisaka T, 2001, J VIROL, V75, P4734, DOI 10.1128/JVI.75.10.4734-4743.2001; Sakisaka T, 2007, CURR OPIN CELL BIOL, V19, P593, DOI 10.1016/j.ceb.2007.09.007; Satoh-Horikawa K, 2000, J BIOL CHEM, V275, P10291, DOI 10.1074/jbc.275.14.10291; Scapoli L, 2006, ANN HUM GENET, V70, P410, DOI 10.1111/j.1469-1809.2005.00237.x; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; SPACEK J, 1974, J ANAT, V117, P487; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Struyf F, 2002, J VIROL, V76, P12940, DOI 10.1128/JVI.76.24.12940-12950.2002; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Takahashi K, 1999, J CELL BIOL, V145, P539, DOI 10.1083/jcb.145.3.539; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Tsukasaki Y, 2007, J MOL BIOL, V367, P996, DOI 10.1016/j.jmb.2006.12.022; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Yasumi M, 2003, BIOCHEM BIOPH RES CO, V302, P61, DOI 10.1016/S0006-291X(03)00106-2; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105	50	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.197368	http://dx.doi.org/10.1074/jbc.M110.197368			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325282	Green Published, hybrid			2022-12-25	WOS:000289077500077
J	Heller, C; Weisser, T; Mueller-Schickert, A; Rufer, E; Hoh, A; Leonhardt, RM; Knittler, MR				Heller, Corina; Weisser, Tanja; Mueller-Schickert, Antje; Rufer, Elke; Hoh, Alexander; Leonhardt, Ralf M.; Knittler, Michael R.			Identification of Key Amino Acid Residues That Determine the Ability of High Risk HPV16-E7 to Dysregulate Major Histocompatibility Complex Class I Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS TYPE-6; HISTONE DEACETYLASE; DOWN-REGULATION; E7 ONCOPROTEIN; CHROMATIN REPRESSION; IMMUNE EVASION; PROTEIN; TRANSCRIPTION	High risk human Papillomavirus (HPV) types are the major causative agents of cervical cancer. Reduced expression of major histocompatibility complex class I (MHC I) on HPV-infected cells might be responsible for insufficient T cell response and contribute to HPV-associated malignancy. The viral gene product required for subversion of MHC I synthesis is the E7 oncoprotein. Although it has been suggested that high and low risk HPVs diverge in their ability to dysregulate MHC I expression, it is not known what sequence determinants of HPV-E7 are responsible for this important functional difference. To investigate this, we analyzed the capability to affect MHC I of a set of chimeric E7 variants containing sequence elements from either high risk HPV16 or low risk HPV11. HPV16-E7, but not HPV11-E7, causes significant diminution of mRNA synthesis and surface presentation of MHC I, which depend on histone deacetylase activity. Our experiments demonstrate that the C-terminal region within the zinc finger domain of HPV-E7 is responsible for the contrasting effects of HPV11- and HPV16-E7 on MHC I. By using different loss- and gain-of-function mutants of HPV11- and HPV16-E7, we identify for the first time a residue variation at position 88 that is highly critical for HPV16-E7-mediated suppression of MHC I. Furthermore, our studies suggest that residues at position 78, 80, and 88 build a minimal functional unit within HPV16-E7 required for binding and histone deacetylase recruitment to the MHC I promoter. Taken together, our data provide new insights into how high risk HPV16-E7 dysregulates MHC I for immune evasion.	[Heller, Corina; Weisser, Tanja; Rufer, Elke; Hoh, Alexander; Knittler, Michael R.] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, D-72076 Tubingen, Germany; [Mueller-Schickert, Antje] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Leonhardt, Ralf M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA	Friedrich Loeffler Institute; University of Michigan System; University of Michigan; Yale University	Knittler, MR (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Immunol, Paul Ehrlich Str 28, D-72076 Tubingen, Germany.	michael.knittler@fli.bund.de		Leonhardt, Ralf Max/0000-0001-6673-8217	Friedrich-Loeffler-Institut; Cancer Research Institute	Friedrich-Loeffler-Institut; Cancer Research Institute	This work was supported by the Friedrich-Loeffler-Institut.; Supported by a fellowship from the Cancer Research Institute.	ANDROPHY EJ, 1987, EMBO J, V6, P989, DOI 10.1002/j.1460-2075.1987.tb04849.x; Antinore MJ, 1996, EMBO J, V15, P1950, DOI 10.1002/j.1460-2075.1996.tb00546.x; ARENDS MJ, 1993, HUM PATHOL, V24, P432, DOI 10.1016/0046-8177(93)90093-V; Armstrong DJ, 1997, VIROLOGY, V239, P238, DOI 10.1006/viro.1997.8885; Ashrafi GH, 2006, VIRUS RES, V120, P208, DOI 10.1016/j.virusres.2006.02.005; Ashrafi GH, 2005, INT J CANCER, V113, P276, DOI 10.1002/ijc.20558; Bonagura VR, 2004, HUM IMMUNOL, V65, P773, DOI 10.1016/j.humimm.2004.05.014; Bottley G, 2008, ONCOGENE, V27, P1794, DOI 10.1038/sj.onc.1210798; Brehm A, 1999, EMBO J, V18, P2449, DOI 10.1093/emboj/18.9.2449; Brodsky FM, 1999, IMMUNOL REV, V168, P199, DOI 10.1111/j.1600-065X.1999.tb01294.x; Burger RA, 1996, JNCI-J NATL CANCER I, V88, P1361, DOI 10.1093/jnci/88.19.1361; Chen SL, 1996, J VIROL, V70, P3502, DOI 10.1128/JVI.70.6.3502-3508.1996; CHEN SL, 1990, J VIROL, V64, P3226, DOI 10.1128/JVI.64.7.3226-3233.1990; COX JT, 1995, BAILLIERE CLIN OB GY, V9, P1, DOI 10.1016/S0950-3552(05)80357-8; Mora-Garcia MD, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-55; DEJONG WW, 1978, BIOCHEM BIOPH RES CO, V82, P532, DOI 10.1016/0006-291X(78)90907-5; Duensing A, 2008, VIROLOGY, V372, P157, DOI 10.1016/j.virol.2007.10.030; Dulat HJ, 2001, EUR J IMMUNOL, V31, P2217, DOI 10.1002/1521-4141(200107)31:7<2217::AID-IMMU2217>3.0.CO;2-E; Elliott T, 1997, IMMUNOL TODAY, V18, P375, DOI 10.1016/S0167-5699(97)01097-9; Garcia MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006422; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; GISSMANN L, 1982, J VIROL, V44, P393, DOI 10.1128/JVI.44.1.393-400.1982; GREENFIELD I, 1991, P NATL ACAD SCI USA, V88, P11217, DOI 10.1073/pnas.88.24.11217; Guan H, 2008, J VIROL, V82, P40, DOI 10.1128/JVI.01579-07; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Hiraiwa A, 1996, VIRUS GENES, V12, P27, DOI 10.1007/BF00369998; Hobbs CGL, 2006, CLIN EXP IMMUNOL, V145, P365, DOI 10.1111/j.1365-2249.2006.03125.x; HOWCROFT TK, 1993, EMBO J, V12, P3163, DOI 10.1002/j.1460-2075.1993.tb05985.x; Hwang SG, 2002, J BIOL CHEM, V277, P2923, DOI 10.1074/jbc.M109113200; Imamura T, 2006, J PEPT SCI, V12, P403, DOI 10.1002/psc.741; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Karre K, 1997, IMMUNOL REV, V155, P5, DOI 10.1111/j.1600-065X.1997.tb00935.x; KEATING PJ, 1995, BRIT J CANCER, V72, P405, DOI 10.1038/bjc.1995.346; Koopman LA, 2000, J EXP MED, V191, P961, DOI 10.1084/jem.191.6.961; Li H, 2006, BIOCHEM BIOPH RES CO, V349, P1315, DOI 10.1016/j.bbrc.2006.08.182; Li H, 2009, BIOCHEM BIOPH RES CO, V388, P383, DOI 10.1016/j.bbrc.2009.08.019; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; LUTZ PM, 1987, IMMUNOGENETICS, V25, P228, DOI 10.1007/BF00404692; Massimi P, 1997, VIROLOGY, V227, P255, DOI 10.1006/viro.1996.8315; MEYER TH, 1994, FEBS LETT, V351, P443, DOI 10.1016/0014-5793(94)00908-2; MUNGER K, 1991, J VIROL, V65, P3943; NISHIDA M, 1995, MOL CARCINOGEN, V13, P157, DOI 10.1002/mc.2940130305; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Ohlenschlager O, 2006, ONCOGENE, V25, P5953, DOI 10.1038/sj.onc.1209584; Orlando Valerio, 2002, Genes and Development, V16, P2039, DOI 10.1101/gad.1017402; Park JS, 2000, J BIOL CHEM, V275, P6764, DOI 10.1074/jbc.275.10.6764; Peaper DR, 2008, P NATL ACAD SCI USA, V105, P10477, DOI 10.1073/pnas.0805044105; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Schapiro F, 2000, J CELL BIOL, V148, P305, DOI 10.1083/jcb.148.2.305; Spitkovsky D, 2002, J BIOL CHEM, V277, P25576, DOI 10.1074/jbc.M201884200; Stern PL, 1996, ADV CANCER RES, V69, P175, DOI 10.1016/S0065-230X(08)60863-5; STRAIGHT SW, 1995, J VIROL, V69, P3185, DOI 10.1128/JVI.69.5.3185-3192.1995; Suprynowicz FA, 2008, ONCOGENE, V27, P1071, DOI 10.1038/sj.onc.1210725; Vambutas A, 2004, J INFECT DIS, V189, P871, DOI 10.1086/381764; Vambutas A, 2001, CLIN IMMUNOL, V101, P94, DOI 10.1006/clim.2001.5094; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vanhaecke T, 2004, BIOCHEM PHARMACOL, V68, P753, DOI 10.1016/j.bcp.2004.05.022; WILCZYNSKI SP, 1988, HUM PATHOL, V19, P697, DOI 10.1016/S0046-8177(88)80176-X; Williams DB, 1996, TRENDS CELL BIOL, V6, P267, DOI 10.1016/0962-8924(96)10020-9; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhang WH, 2001, J BIOL CHEM, V276, P40373, DOI 10.1074/jbc.C100505200; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao BW, 2006, VIROLOGY, V352, P338, DOI 10.1016/j.virol.2006.04.036; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	68	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10983	10997		10.1074/jbc.M110.199190	http://dx.doi.org/10.1074/jbc.M110.199190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21321113	Green Published, hybrid			2022-12-25	WOS:000288797100010
J	Ishikita, H				Ishikita, Hiroshi			Proton-Binding Sites of Acid-Sensing Ion Channel 1	PLOS ONE			English	Article							TRANSPORTER PROTEIN AMTB; ELECTROSTATIC MODELS; ENVIRONMENT; DYNAMICS; PORE	Acid-sensing ion channels (ASICs) are proton-gated cation channels that exist throughout the mammalian central and peripheral nervous systems. ASIC1 is the most abundant of all the ASICs and is likely to modulate synaptic transmission. Identifying the proton-binding sites of ASCI1 is required to elucidate its pH-sensing mechanism. By using the crystal structure of ASIC1, the protonation states of each titratable site of ASIC1 were calculated by solving the Poisson-Boltzmann equation under conditions wherein the protonation states of all these sites are simultaneously in equilibrium. Four acidic-acidic residue pairs-Asp238-Asp350, Glu220-Asp408, Glu239-Asp346, and Glu80-Glu417-were found to be highly protonated. In particular, the Glu80-Glu417 pair in the inner pore was completely protonated and possessed 2 H(+), implying its possible importance as a proton-binding site. The pK(a) of Glu239, which forms a pair with a possible pH-sensing site Asp346, differs among each homo-trimer subunit due to the different H-bond pattern of Thr237 in the different protein conformations of the subunits. His74 possessed a pK(a) of similar to 6-7. Conservation of His74 in the proton-sensitive ASIC3 that lacks a residue corresponding to Asp346 may suggest its possible pH-sensing role in proton-sensitive ASICs.	[Ishikita, Hiroshi] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Ishikita, Hiroshi] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Ishikita, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	hiro@cp.kyoto-u.ac.jp	Ishikita, Hiroshi/G-9864-2018	Ishikita, Hiroshi/0000-0002-5849-8150	JST PRESTO program; Ministry of Education, Science, Sport and Culture of Japan [21770163]; MEXT; Takeda Science Foundation	JST PRESTO program; Ministry of Education, Science, Sport and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the JST PRESTO program, Grant-in-Aid for Science Research from the Ministry of Education, Science, Sport and Culture of Japan (21770163), Special Coordination Fund for Promoting Science and Technology of MEXT, and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chen XM, 2006, J GEN PHYSIOL, V127, P267, DOI 10.1085/jgp.200509409; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; Ishikita H, 2005, P NATL ACAD SCI USA, V102, P16215, DOI 10.1073/pnas.0503826102; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P14772, DOI 10.1021/bi051099v; Ishikita H, 2005, FEBS LETT, V579, P3190, DOI 10.1016/j.febslet.2005.05.004; Ishikita H, 2007, FEBS LETT, V581, P4293, DOI 10.1016/j.febslet.2007.07.085; Ishikita H, 2007, J BIOL CHEM, V282, P25240, DOI 10.1074/jbc.M702788200; Ishikita H, 2007, J AM CHEM SOC, V129, P1210, DOI 10.1021/ja066208n; Ishikita H, 2010, FEBS LETT, V584, P3464, DOI 10.1016/j.febslet.2010.07.003; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Ullmann GM, 1999, EUR BIOPHYS J BIOPHY, V28, P533, DOI 10.1007/s002490050236; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16920	10.1371/journal.pone.0016920	http://dx.doi.org/10.1371/journal.pone.0016920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340031	gold, Green Published, Green Submitted			2022-12-25	WOS:000287367600025
J	Lu, F; Xue, W; Tian, C; Wang, GC; Niu, JF; Pan, GH; Hu, SN				Lue, Fang; Xue, Wei; Tian, Chao; Wang, Guangce; Niu, Jiangfeng; Pan, Guanghua; Hu, Songnian			The Bryopsis hypnoides Plastid Genome: Multimeric Forms and Complete Nucleotide Sequence	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; GREEN-ALGA; CHLOROPLAST GENOME; CATALYTIC INTRONS; GENE-TRANSFER; SEA SLUGS; ARCHITECTURE; REVEALS; CHLOROPHYTA; LAMOUROUX	Background: Bryopsis hypnoides Lamouroux is a siphonous green alga, and its extruded protoplasm can aggregate spontaneously in seawater and develop into mature individuals. The chloroplast of B. hypnoides is the biggest organelle in the cell and shows strong autonomy. To better understand this organelle, we sequenced and analyzed the chloroplast genome of this green alga. Principal Findings: A total of 111 functional genes, including 69 potential protein-coding genes, 5 ribosomal RNA genes, and 37 tRNA genes were identified. The genome size (153,429 bp), arrangement, and inverted-repeat (IR)-lacking structure of the B. hypnoides chloroplast DNA (cpDNA) closely resembles that of Chlorella vulgaris. Furthermore, our cytogenomic investigations using pulsed-field gel electrophoresis (PFGE) and southern blotting methods showed that the B. hypnoides cpDNA had multimeric forms, including monomer, dimer, trimer, tetramer, and even higher multimers, which is similar to the higher order organization observed previously for higher plant cpDNA. The relative amounts of the four multimeric cpDNA forms were estimated to be about 1, 1/2, 1/4, and 1/8 based on molecular hybridization analysis. Phylogenetic analyses based on a concatenated alignment of chloroplast protein sequences suggested that B. hypnoides is sister to all Chlorophyceae and this placement received moderate support. Conclusion: All of the results suggest that the autonomy of the chloroplasts of B. hypnoides has little to do with the size and gene content of the cpDNA, and the IR-lacking structure of the chloroplasts indirectly demonstrated that the multimeric molecules might result from the random cleavage and fusion of replication intermediates instead of recombinational events.	[Lue, Fang; Tian, Chao; Wang, Guangce; Niu, Jiangfeng] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Xue, Wei] Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China; [Lue, Fang; Xue, Wei; Hu, Songnian] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Pan, Guanghua] Tianjin Univ Sci & Technol, Coll Marine Sci & Engn, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tianjin University Science & Technology	Lu, F (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	gcwang@qdio.ac.cn	NIU, Jiangfeng/GWM-7257-2022; tian, chao/GYD-3462-2022; Hu, Songnian/C-6509-2013	Hu, Songnian/0000-0003-3966-3111	National Natural Science Foundation of China [30970302, 40806063, 30830015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (30970302, 40806063, and 30830015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; BACKERT S, 1995, CURR GENET, V28, P390, DOI 10.1007/BF00326439; Belanger AS, 2006, MOL GENET GENOMICS, V276, P464, DOI 10.1007/s00438-006-0156-2; Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; BURR F A, 1970, Phycologia, V9, P17, DOI 10.2216/i0031-8884-9-1-17.1; de Cambiaire JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-213; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; DENG XW, 1989, P NATL ACAD SCI USA, V86, P4156, DOI 10.1073/pnas.86.11.4156; Friedl T, 2002, EUR J PHYCOL, V37, P373, DOI 10.1017/S0967026202003712; Glockner G, 2000, J MOL EVOL, V51, P382; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Green BJ, 2000, PLANT PHYSIOL, V124, P331, DOI 10.1104/pp.124.1.331; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagopian JC, 2004, J MOL EVOL, V59, P464, DOI 10.1007/s00239-004-2638-3; Karol KG, 2001, SCIENCE, V294, P2351, DOI 10.1126/science.1065156; Karyn D, 1998, PLANT MOL BIOL REP, V16, P219; Kim GH, 2001, J CELL SCI, V114, P2009; KOLODNER R, 1975, BIOCHIM BIOPHYS ACTA, V402, P372, DOI 10.1016/0005-2787(75)90273-7; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Lee RE, 1999, PHYCOLOGY; Lehman RL, 1997, J PHYCOL, V33, P1055, DOI 10.1111/j.0022-3646.1997.01055.x; Lemieux C, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-2; Li D, 2009, RUSS J PLANT PHYSL+, V56, P110, DOI 10.1134/S1021443709010166; Lilly JW, 2001, PLANT CELL, V13, P245, DOI 10.1105/tpc.13.2.245; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MANHART JR, 1989, MOL GEN GENET, V216, P417, DOI 10.1007/BF00334385; MARIN A, 1992, MAR BIOL, V112, P677, DOI 10.1007/BF00346186; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Oldenburg DJ, 2004, J MOL BIOL, V335, P953, DOI 10.1016/j.jmb.2003.11.020; Oldenburg DJ, 1996, PLANT CELL, V8, P447, DOI 10.1105/tpc.8.3.447; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; PALMER JD, 1982, CELL, V29, P537, DOI 10.1016/0092-8674(82)90170-2; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Robbens S, 2007, MOL BIOL EVOL, V24, P956, DOI 10.1093/molbev/msm012; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Rumpho ME, 2000, PLANT PHYSIOL, V123, P29, DOI 10.1104/pp.123.1.29; SALGANIK RI, 1991, ELECTRON MICROSC REV, V4, P221, DOI 10.1016/0892-0354(91)90004-V; Sambrook J, 2001, MOL CLONING LAB MANU; Simpson CL, 2002, PLANT PHYSIOL, V129, P957, DOI 10.1104/pp.010908; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian C, 2005, ACTA OCEANOL SIN, V24, P150; TRENCH RK, 1969, J CELL BIOL, V42, P404, DOI 10.1083/jcb.42.2.404; TROWBRIDGE CD, 1991, ECOLOGY, V72, P1880, DOI 10.2307/1940985; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2002, MOL BIOL EVOL, V19, P24, DOI 10.1093/oxfordjournals.molbev.a003979; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Wakasugi T, 1997, P NATL ACAD SCI USA, V94, P5967, DOI 10.1073/pnas.94.11.5967; Wang GC, 2006, J INTEGR PLANT BIOL, V48, P190, DOI 10.1111/j.1744-7909.2006.00190.x; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Ye NH, 2005, J INTEGR PLANT BIOL, V47, P856, DOI 10.1111/j.1744-7909.2005.00050.x	61	27	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14663	10.1371/journal.pone.0014663	http://dx.doi.org/10.1371/journal.pone.0014663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339817	Green Published, gold			2022-12-25	WOS:000287367600003
J	Martiniova, L; Lu, J; Chiang, J; Bernardo, M; Lonser, R; Zhuang, ZP; Pacak, K				Martiniova, Lucia; Lu, Jie; Chiang, Jeffrey; Bernardo, Marcelino; Lonser, Russell; Zhuang, Zhengping; Pacak, Karel			Pharmacologic Modulation of Serine/Threonine Phosphorylation Highly Sensitizes PHEO in a MPC Cell and Mouse Model to Conventional Chemotherapy	PLOS ONE			English	Article							POLO-LIKE KINASE-1; DNA-DAMAGE; CANCER-CHEMOTHERAPY; PHEOCHROMOCYTOMA; INHIBITION; CYCLE; PARAGANGLIOMA; TEMOZOLOMIDE; DACARBAZINE; CYCLOPHOSPHAMIDE	Background: The failure of cytotoxic cancer regimens to cure the most drug-resistant, well-differentiated solid tumors has attributed to the heterogeneity of cell types that differ in their capacities for growth, differentiation, and metastases. We investigated the effect of LB1, a small molecule inhibitor of serine/threonine protein phosphatase 2A (PP2A), on its ability to inhibit a low growth fraction and highly drug-resistant solid neuroendocrine tumor, such as metastatic pheochromocytoma (PHEO). Subsequently, we evaluated the increased efficacy of chemotherapy combined with LB1. Methodology/Principal Findings: The effect of LB1 and temozolomide (TMZ), a standard chemotherapeutic agent that alone only transiently suppressed the growth and regression of metastatic PHEO, was evaluated in vitro on a single PHEO cell line and in vivo on mouse model of metastatic PHEO. In the present study, we show that metastatic PHEO, for which there is currently no cure, can be eliminated by combining LB1, thereby inhibiting PP2A, with TMZ. This new treatment approach resulted in long term, disease-free survival of up to 40% of animals bearing multiple intrahepatic metastases, a disease state that the majority of patients die from. Inhibition of PP2A was associated with prevention of G1/S phase arrest by p53 and of mitotic arrest mediated by polo-like kinase 1 (Plk-1). Conclusions/Significance: The elimination of DNA damage-induced defense mechanisms, through transient pharmacologic inhibition of PP2A, is proposed as a new approach for enhancing the efficacy of non-specific cancer chemotherapy regimens against a broad spectrum of low growth fraction tumors very commonly resistant to cytotoxic drugs.	[Martiniova, Lucia; Pacak, Karel] NICHHD, Reprod & Adult Endocrinol Program, NIH, Bethesda, MD 20892 USA; [Lu, Jie; Lonser, Russell; Zhuang, Zhengping] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD USA; [Chiang, Jeffrey] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Bernardo, Marcelino] NCI, Mol Imaging Program, NIH, Bethesda, MD 20892 USA; [Bernardo, Marcelino] NCI, Lab Anim Sci Program, SAIC Frederick, Frederick, MD 21701 USA; [Martiniova, Lucia] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Slovak Academy of Sciences	Martiniova, L (corresponding author), NICHHD, Reprod & Adult Endocrinol Program, NIH, Bethesda, MD 20892 USA.	zhuangp@ninds.nih.gov; karel@mail.nih.gov			National Institutes of Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute of Neurological Disorders and Stroke (NINDS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Programs of the National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Cancer Institute, and the National Institute of Neurological Disorders and Stroke (NINDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Baysal BE, 2008, J MED GENET, V45, P689, DOI 10.1136/jmg.2008.058560; Bazin PL, 2007, J NEUROSCI METH, V165, P111, DOI 10.1016/j.jneumeth.2007.05.024; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Bravo EL, 2009, HORM METAB RES, V41, P703, DOI 10.1055/s-0029-1224135; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Burnichon N, 2009, J CLIN ENDOCR METAB, V94, P2817, DOI 10.1210/jc.2008-2504; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Darzynkiewicz Z, 2009, EUR J PHARMACOL, V625, P143, DOI 10.1016/j.ejphar.2009.05.032; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Huang H, 2008, CANCER-AM CANCER SOC, V113, P2020, DOI 10.1002/cncr.23812; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; KOVACH JS, 2008, Patent No. 2008097561; Kulke MH, 2006, J CLIN ONCOL, V24, P401, DOI 10.1200/JCO.2005.03.6046; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MARTINIOVA L, 2010, ENDOCR RELAT CA 1122; Martiniova L, 2009, J MAGN RESON IMAGING, V29, P685, DOI 10.1002/jmri.21654; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mougey AM, 2007, HOSP PHYS, V43, P12; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Nomura K, 2009, J CLIN ENDOCR METAB, V94, P2850, DOI 10.1210/jc.2008-2697; PACAK K, 1995, ENDOCRINOLOGY, V136, P4814, DOI 10.1210/en.136.11.4814; PARDEE AB, 1975, P NATL ACAD SCI USA, V72, P4994, DOI 10.1073/pnas.72.12.4994; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Tischler AS, 2008, ENDOCR PATHOL, V19, P207, DOI 10.1007/s12022-008-9047-x; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhuang ZP, 2009, CELL CYCLE, V8, P3303, DOI 10.4161/cc.8.20.9689	36	34	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14678	10.1371/journal.pone.0014678	http://dx.doi.org/10.1371/journal.pone.0014678			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339823	Green Published, Green Submitted, gold			2022-12-25	WOS:000287367600007
J	Eaton, HE; Desrochers, G; Drory, SB; Metcalf, J; Angers, A; Brunetti, CR				Eaton, Heather E.; Desrochers, Guillaume; Drory, Samuel B.; Metcalf, Julie; Angers, Annie; Brunetti, Craig R.			SIMPLE/LITAF Expression Induces the Translocation of the Ubiquitin Ligase Itch towards the Lysosomal Compartments	PLOS ONE			English	Article							MARIE-TOOTH-DISEASE; EPIDERMAL-GROWTH-FACTOR; PROLINE-RICH LIGAND; TNF-ALPHA FACTOR; TRANSCRIPTION FACTOR; PROTEIN LIGASE; IDENTIFICATION; DEGRADATION; NEUROPATHY; DOMAIN	LITAF is a small cellular protein with an unknown function. The C-terminus of LITAF contains a highly conserved domain termed the SIMPLE-like domain (SLD), while the N-terminus contains two PPXY motifs that mediate protein-protein interactions with WW-domain containing proteins. LITAF also harbors two endosome/lysosome targeting sequences at its C-terminus, but there has been conflicting reports regarding its intracellular localization. Here, we demonstrate that LITAF is localized to the late endosome/lysosomal compartment in a variety of cell lines. We also show that Itch, a WW-domain containing protein, and LITAF strongly interact and that this interaction depends on the two PPXY motifs in the N-terminus of LITAF. Interestingly, co-expression of LITAF with Itch induces major changes in Itch intracellular localization, bringing Itch from the trans-Golgi network to lysosomes. We show that this re-localization is dependent upon the interaction with the PPXY sequences of LITAF, since disruption of these binding motifs completely abrogates Itch re-localization.	[Eaton, Heather E.; Metcalf, Julie; Brunetti, Craig R.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Desrochers, Guillaume; Drory, Samuel B.; Angers, Annie] Univ Montreal, Dept Sci Biol, Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada	Trent University; Universite de Montreal	Eaton, HE (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	craigbrunetti@trentu.ca	Angers, Annie/P-1217-2018	Angers, Annie/0000-0003-0131-256X; Drory, Samuel/0000-0001-9502-2023	Natural Science and Engineering Research Council (NSERC) of Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by Discovery Grants (Natural Science and Engineering Research Council (NSERC) of Canada) to A. A. and C. R. B. H. E. E. is the recipient of a NSERC postgraduate scholarship. S. B. D. was the recipient of a NSERC undergraduate scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Azakir BA, 2010, FEBS J, V277, P1319, DOI 10.1111/j.1742-4658.2010.07562.x; Azakir BA, 2009, CELL SIGNAL, V21, P1326, DOI 10.1016/j.cellsig.2009.03.020; Bennett CL, 2004, ANN NEUROL, V55, P713, DOI 10.1002/ana.20094; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Dupre S, 2001, CURR BIOL, V11, pR932, DOI 10.1016/S0960-9822(01)00558-9; Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Huang YZ, 2007, INFLAMM BOWEL DIS, V13, P120, DOI 10.1002/ibd.20010; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557; Kingston RE, 2003, CURR PROTOC MOL BIOL, V63, DOI DOI 10.1002/0471142727.MB0901S63; Kroeger Karen M, 2004, Methods Mol Biol, V259, P323; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Meggouh F, 2005, ANN NEUROL, V57, P589, DOI 10.1002/ana.20434; Moriwaki Y, 2001, J BIOL CHEM, V276, P23065, DOI 10.1074/jbc.M011660200; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Myokai F, 1999, P NATL ACAD SCI USA, V96, P4518, DOI 10.1073/pnas.96.8.4518; Oberst A, 2007, P NATL ACAD SCI USA, V104, P11280, DOI 10.1073/pnas.0701773104; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saifi GM, 2005, HUM MUTAT, V25, P372, DOI 10.1002/humu.20153; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tang XR, 2005, P NATL ACAD SCI USA, V102, P5132, DOI 10.1073/pnas.0501159102; Tang XR, 2003, P NATL ACAD SCI USA, V100, P4096, DOI 10.1073/pnas.0630562100	34	28	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16873	10.1371/journal.pone.0016873	http://dx.doi.org/10.1371/journal.pone.0016873			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326863	gold, Green Submitted, Green Published			2022-12-25	WOS:000287037000029
J	Stember, JN; Andersen, O				Stember, Joseph N.; Andersen, Olaf			A One-Dimensional Continuum Elastic Model for Membrane-Embedded Gramicidin Dimer Dissociation	PLOS ONE			English	Article							CHANNEL FUNCTION; PROTEIN FUNCTION; LIPID-BILAYERS; MECHANISM; ENERGETICS; DRUG	Membrane elastic properties, which are subject to alteration by compounds such as cholesterol, lipid metabolites and other amphiphiles, as well as pharmaceuticals, can have important effects on membrane proteins. A useful tool for measuring some of these effects is the gramicidin A channels, which are formed by transmembrane dimerization of non-conducting subunits that reside in each bilayer leaflet. The length of the conducting channels is less than the bilayer thickness, meaning that channel formation is associated with a local bilayer deformation. Electrophysiological studies have shown that the dimer becomes increasingly destabilized as the hydrophobic mismatch between the channel and the host bilayer increases. That is, the bilayer imposes a disjoining force on the channel, which grows larger with increasing hydrophobic mismatch. The energetic analysis of the channel-bilayer coupling is usually pursued assuming that each subunit, as well as the subunit-subunit interface, is rigid. Here we relax the latter assumption and explore how the bilayer junction responds to changes in this disjoining force using a simple one-dimensional energetic model, which reproduces key features of the bilayer regulation of gramicidin channel lifetimes.	[Stember, Joseph N.; Andersen, Olaf] Cornell Univ, Weill Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10021 USA	Cornell University	Stember, JN (corresponding author), Cornell Univ, Weill Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10021 USA.	js1569@nyumc.org	Stember, Joseph/AAK-9356-2020	Stember, Joseph/0000-0003-3169-9590	National Institutes of Health [GM021342, DA012923, DA012408]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408, P01DA012923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by National Institutes of Health grants GM021342, DA012923 and DA012408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2006, BIOPHYS J, V90, P3447, DOI 10.1529/biophysj.105.077073; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; ANDERSEN O, METH ENZYMOL, V171, P62; ANDERSEN O, METHODS MOL BIOL, V400; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Andersen OS, 2008, J GEN PHYSIOL, V131, P395, DOI 10.1085/jgp.200810012; Artigas P, 2006, MOL PHARMACOL, V70, P2015, DOI 10.1124/mol.106.026070; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; BUSATH D, 1998, BIOPHYS J, V53, P689; Dzikovski BG, 2004, BIOPHYS J, V87, P3504, DOI 10.1529/biophysj.104.044305; Eisenberg D., 1979, PHYS CHEM APPL LIFE; Evans E, 1995, FALK SYMP, V80, P59; Galbraith TP, 1998, FARADAY DISCUSS, V111, P159; Goulian M, 1998, BIOPHYS J, V74, P328, DOI 10.1016/S0006-3495(98)77790-2; HELFRICH P, 1990, BIOPHYS J, V57, P1075, DOI 10.1016/S0006-3495(90)82625-4; HUANG HW, 1986, BIOPHYS J, V50, P1061, DOI 10.1016/S0006-3495(86)83550-0; Hwang TC, 2003, BIOCHEMISTRY-US, V42, P13646, DOI 10.1021/bi034887y; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Lundbaek JA, 2008, J GEN PHYSIOL, V131, P421, DOI 10.1085/jgp.200709948; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; Miloshevsky GV, 2006, STRUCTURE, V14, P1241, DOI 10.1016/j.str.2006.06.007; Miloshevsky GV, 2004, BIOPHYS J, V86, P92, DOI 10.1016/S0006-3495(04)74087-4; Nielsen C, 1998, BIOPHYS J, V74, P1966, DOI 10.1016/S0006-3495(98)77904-4; Seddon AM, 2009, CHEM SOC REV, V38, P2509, DOI 10.1039/b813853m; Zhelev DV, 1998, BIOPHYS J, V75, P321, DOI 10.1016/S0006-3495(98)77516-2	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e15563	10.1371/journal.pone.0015563	http://dx.doi.org/10.1371/journal.pone.0015563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326605	Green Submitted, Green Published, gold			2022-12-25	WOS:000287037000007
J	Sutton-Grier, AE; Wright, JP; McGill, BM; Richardson, C				Sutton-Grier, Ariana E.; Wright, Justin P.; McGill, Bonnie M.; Richardson, Curtis			Environmental Conditions Influence the Plant Functional Diversity Effect on Potential Denitrification	PLOS ONE			English	Article							SPECIES RICHNESS; ELEVATED CO2; BIODIVERSITY; SOIL; CARBON; PRODUCTIVITY; COMMUNITIES; NITRIFICATION; AVAILABILITY; BACTERIAL	Global biodiversity loss has prompted research on the relationship between species diversity and ecosystem functioning. Few studies have examined how plant diversity impacts belowground processes; even fewer have examined how varying resource levels can influence the effect of plant diversity on microbial activity. In a field experiment in a restored wetland, we examined the role of plant trait diversity (or functional diversity, (FD)) and its interactions with natural levels of variability of soil properties, on a microbial process, denitrification potential (DNP). We demonstrated that FD significantly affected microbial DNP through its interactions with soil conditions; increasing FD led to increased DNP but mainly at higher levels of soil resources. Our results suggest that the effect of species diversity on ecosystem functioning may depend on environmental factors such as resource availability. Future biodiversity experiments should examine how natural levels of environmental variability impact the importance of biodiversity to ecosystem functioning.	[Sutton-Grier, Ariana E.; Richardson, Curtis] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27710 USA; [Wright, Justin P.; McGill, Bonnie M.] Duke Univ, Dept Biol, Durham, NC USA	Duke University; Duke University	Sutton-Grier, AE (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27710 USA.	ariana.suttongrier@gmail.com	Richardson, Curt/P-5905-2019; Wright, Justin/AAG-6461-2019; Richardson, Curtis J/A-8202-2009; McGill, Bonnie/AAT-7426-2020	Wright, Justin/0000-0002-9102-5347; McGill, Bonnie/0000-0002-5417-3519; Sutton-Grier, Ariana/0000-0002-1242-7728	National Science Foundation (NSF) [DEB0508763]; Association of University Women Educational Foundation; Society of Wetland Scientist Student Research Grant; Duke Wetlands Center Case Study Endowment; USDA Natural Resources Conservation Service; Smithsonian Environmental Research Center	National Science Foundation (NSF)(National Science Foundation (NSF)); Association of University Women Educational Foundation; Society of Wetland Scientist Student Research Grant; Duke Wetlands Center Case Study Endowment; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA)); Smithsonian Environmental Research Center(Smithsonian InstitutionSmithsonian Environmental Research Center)	This work was supported by National Science Foundation (NSF) Grant DEB0508763, an NSF Graduate Research Fellowship (http://www.nsfgrfp.org); an American Fellowship from the Association of University Women Educational Foundation (http://www.aauw.org/education/fga); a Society of Wetland Scientist Student Research Grant (http://www.sws.org/studentgrants); the Duke Wetlands Center Case Study Endowment (http://www.nicholas.duke.edu/wetland); and a grant from the USDA Natural Resources Conservation Service (http://www.nrcs.usda.gov). AS-G was also partially supported by a Smithsonian Fellowship from the Smithsonian Environmental Research Center (http://www.serc.si.edu/pro_training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; Bell T., 2009, BIODIVERSITY ECOSYST, P121, DOI DOI 10.1093/ACPROF:OSO/9780199547951.003.0009; Bouchard V, 2007, ECOLOGY, V88, P2903, DOI 10.1890/06-1144.1; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chabrerie O, 2001, ESTUARIES, V24, P1088, DOI 10.2307/1353020; Chung HG, 2007, GLOBAL CHANGE BIOL, V13, P980, DOI 10.1111/j.1365-2486.2007.01313.x; Clement JC, 2002, J ENVIRON QUAL, V31, P1025, DOI 10.2134/jeq2002.1025; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ettema CH, 1999, SOIL BIOL BIOCHEM, V31, P1609, DOI 10.1016/S0038-0717(99)00071-1; Eviner VT, 2003, ANNU REV ECOL EVOL S, V34, P455, DOI 10.1146/annurev.ecolsys.34.011802.132342; Farrar J, 2003, ECOLOGY, V84, P827, DOI 10.1890/0012-9658(2003)084[0827:HRCTFO]2.0.CO;2; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Gastine A, 2003, APPL SOIL ECOL, V24, P101, DOI 10.1016/S0929-1393(02)00137-3; Groffman P., 1994, CURRENT TOPICS WETLA, V1, P15, DOI DOI 10.1016/J.GEOMORPH.2006.01.010; GROFFMAN PM, 1987, PLANT SOIL, V97, P445, DOI 10.1007/BF02383235; Groffman PM, 1999, LT EC RES NETWK SER, V2, P272; Groffman PM, 2003, J ENVIRON QUAL, V32, P1144, DOI 10.2134/jeq2003.1144; Hall K., 2003, RECOMMENDED NATIVE P; He JS, 2002, OIKOS, V97, P337, DOI 10.1034/j.1600-0706.2002.970304.x; Hernandez ME, 2007, J ENVIRON QUAL, V36, P333, DOI 10.2134/jeq2006.0139; Hill AR, 2004, SOIL SCI SOC AM J, V68, P320, DOI 10.2136/sssaj2004.0320; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; Hume NP, 2002, SOIL SCI SOC AM J, V66, P1706, DOI 10.2136/sssaj2002.1706; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; KIRBY RM, 1971, SOIL CONSERVATION DU; Lanta V, 2006, ACTA OECOL, V29, P85, DOI 10.1016/j.actao.2005.08.003; Lin YF, 2002, ENVIRON POLLUT, V119, P413, DOI 10.1016/S0269-7491(01)00299-8; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Lowrance R, 2001, J ENVIRON QUAL, V30, P617, DOI 10.2134/jeq2001.302617x; Maynard D.G., 1993, SOIL SAMPLING METHOD, V1st ed., P39; McGill BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011618; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Patra AK, 2006, ENVIRON MICROBIOL, V8, P1005, DOI 10.1111/j.1462-2920.2006.00992.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Pinay G, 2007, SOIL BIOL BIOCHEM, V39, P33, DOI 10.1016/j.soilbio.2006.05.018; R Core Team, 2022, R LANG ENV STAT COMP; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V411, P824, DOI 10.1038/35081122; SCHIPPER LA, 1994, J ENVIRON QUAL, V23, P923, DOI 10.2134/jeq1994.00472425002300050012x; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Sutton-Grier AE, 2011, SOIL BIOL BIOCHEM, V43, P413, DOI 10.1016/j.soilbio.2010.11.009; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Voroney R.P., 1993, SOIL SAMPLING METHOD, P277; Wacker L, 2009, ECOLOGY, V90, P637, DOI 10.1890/07-1946.1; Wright JP, 2006, ECOL LETT, V9, P111, DOI 10.1111/j.1461-0248.2005.00850.x; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	58	18	20	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16584	10.1371/journal.pone.0016584	http://dx.doi.org/10.1371/journal.pone.0016584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311768	Green Submitted, Green Published, gold			2022-12-25	WOS:000287036200021
J	Jia, KZ; Zhu, Y; Zhang, YP; Li, Y				Jia, Kaizhi; Zhu, Yan; Zhang, Yanping; Li, Yin			Group II Intron-Anchored Gene Deletion in Clostridium	PLOS ONE			English	Article							ACETOBUTYLICUM ATCC 824; DOWN-REGULATION; ESCHERICHIA-COLI; TARGETRON VECTOR; PERFRINGENS; OVEREXPRESSION; DEHYDROGENASE; INACTIVATION; DISRUPTION; DIFFICILE	Clostridium plays an important role in commercial and medical use, for which targeted gene deletion is difficult. We proposed an intron-anchored gene deletion approach for Clostridium, which combines the advantage of the group II intron "ClosTron'' system and homologous recombination. In this approach, an intron carrying a fragment homologous to upstream or downstream of the target site was first inserted into the genome by retrotransposition, followed by homologous recombination, resulting in gene deletion. A functional unknown operon CAC1493-1494 located in the chromosome, and an operon ctfAB located in the megaplasmid of C. acetobutylicum DSM1731 were successfully deleted by using this approach, without leaving antibiotic marker in the genome. We therefore propose this approach can be used for targeted gene deletion in Clostridium. This approach might also be applicable for gene deletion in other bacterial species if group II intron retrotransposition system is established.	[Jia, Kaizhi; Zhu, Yan; Zhang, Yanping; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS	Jia, KZ (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	yli@im.ac.cn	Li, Yin/C-6644-2009; jia, kaizhi/D-5383-2011; zhu, yan/B-2915-2011; Zhang, Yanping/C-7114-2009; Zhu, Yan/M-3779-2016	Li, Yin/0000-0003-0995-3070; Zhu, Yan/0000-0001-7342-3782	National Basic Research Program of China (973 Project) [2007CB707803, 2011CBA00807]; National Science Foundation of China [31000024]; Chinese Academy of Sciences	National Basic Research Program of China (973 Project)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China (973 Project, #2007CB707803 and 2011CBA00807), National Science Foundation of China (31000024) and Hundreds Talents Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; Borden JR, 2010, METAB ENG, V12, P268, DOI 10.1016/j.ymben.2009.12.004; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; Camiade E, 2010, J BACTERIOL, V192, P2373, DOI 10.1128/JB.01546-09; Cartman ST, 2010, INT J MED MICROBIOL, V300, P387, DOI 10.1016/j.ijmm.2010.04.008; Chiarezza M, 2009, INFECT IMMUN, V77, P4421, DOI 10.1128/IAI.00548-09; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Dong HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009038; Emerson JE, 2009, MOL MICROBIOL, V74, P541, DOI 10.1111/j.1365-2958.2009.06812.x; Ezeji T, 2010, APPL MICROBIOL BIOT, V85, P1697, DOI 10.1007/s00253-009-2390-0; Ezeji TC, 2007, CURR OPIN BIOTECH, V18, P220, DOI 10.1016/j.copbio.2007.04.002; Green EM, 1996, MICROBIOL-SGM, V142, P2079, DOI 10.1099/13500872-142-8-2079; Green EM, 1996, APPL BIOCHEM BIOTECH, V57-8, P213, DOI 10.1007/BF02941702; Harris LM, 2002, J BACTERIOL, V184, P3586, DOI 10.1128/JB.184.13.3586-3597.2002; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Hebert CG, 2008, CURR OPIN BIOTECH, V19, P500, DOI 10.1016/j.copbio.2008.08.006; Jiang Y, 2009, METAB ENG, V11, P284, DOI 10.1016/j.ymben.2009.06.002; JOHNSTON NC, J LIPID RES, V71, P1953; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Lee SY, 2008, BIOTECHNOL BIOENG, V101, P209, DOI 10.1002/bit.22003; Liyanage H, 2001, APPL ENVIRON MICROB, V67, P2004, DOI 10.1128/AEM.67.5.2004-2010.2001; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Mendez M, 2008, J BACTERIOL, V190, P48, DOI 10.1128/JB.01407-07; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; Mullany P, 1996, GENE, V174, P145, DOI 10.1016/0378-1119(96)00511-2; Nakayama SI, 2008, APPL MICROBIOL BIOT, V78, P483, DOI 10.1007/s00253-007-1323-z; Nakotte S, 1998, APPL MICROBIOL BIOT, V50, P564, DOI 10.1007/s002530051335; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Otte B, 2009, APPL ENVIRON MICROB, V75, P7610, DOI 10.1128/AEM.01774-09; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Raju D, 2005, APPL ENVIRON MICROB, V71, P7618, DOI 10.1128/AEM.71.11.7618-7620.2005; Raju D, 2007, APPL ENVIRON MICROB, V73, P2048, DOI 10.1128/AEM.02500-06; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Rodriguez SA, 2009, METHODS, V49, P270, DOI 10.1016/j.ymeth.2009.04.011; Sambrook J, 2001, MOL CLONING LAB MANU; Scotcher MC, 2005, APPL ENVIRON MICROB, V71, P1987, DOI 10.1128/AEM.71.4.1987-1995.2005; Scotcher MC, 2005, J BACTERIOL, V187, P1930, DOI 10.1128/JB.187.6.1930-1936.2005; Sengupta S, 2008, NUCLEIC ACIDS RES, V36, P4310, DOI 10.1093/nar/gkn355; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; SHIMIZU T, 1994, J BACTERIOL, V176, P1616, DOI 10.1128/jb.176.6.1616-1623.1994; Sillers R, 2009, BIOTECHNOL BIOENG, V102, P38, DOI 10.1002/bit.22058; Tomas CA, 2003, APPL ENVIRON MICROB, V69, P4951, DOI 10.1128/AEM.69.8.4951-4965.2003; Tripathi SA, 2010, APPL ENVIRON MICROB, V76, P6591, DOI 10.1128/AEM.01484-10; Tummala SB, 2003, J BACTERIOL, V185, P3644, DOI 10.1128/JB.185.12.3644-3653.2003; Tummala SB, 2003, J BACTERIOL, V185, P1923, DOI 10.1128/JB.185.6.1923-1934.2003; Twine SM, 2009, J BACTERIOL, V191, P7050, DOI 10.1128/JB.00861-09; Underwood S, 2009, J BACTERIOL, V191, P7296, DOI 10.1128/JB.00882-09; Weingart OG, 2010, APPL ENVIRON MICROB, V76, P3293, DOI 10.1128/AEM.02937-09; WILKINSON SR, 1994, MICROBIOL-SGM, V140, P89, DOI 10.1099/13500872-140-1-89; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248	56	20	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16693	10.1371/journal.pone.0016693	http://dx.doi.org/10.1371/journal.pone.0016693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304965	gold, Green Submitted, Green Published			2022-12-25	WOS:000286834300123
J	Ruberto, G; Vassos, E; Lewis, CM; Tatarelli, R; Girardi, P; Collier, D; Frangou, S				Ruberto, Gaia; Vassos, Evangelos; Lewis, Cathryn M.; Tatarelli, Roberto; Girardi, Paolo; Collier, David; Frangou, Sophia			The Cognitive Impact of the ANK3 Risk Variant for Bipolar Disorder: Initial Evidence of Selectivity to Signal Detection during Sustained Attention	PLOS ONE			English	Article							SODIUM-CHANNELS; VISUAL-CORTEX; RATING-SCALE; CHANNELOPATHIES; ENDOPHENOTYPES; SENSITIVITY; MECHANISMS	Background: Abnormalities in cognition have been reported in patients with Bipolar Disorder (BD) and their first degree relatives, suggesting that susceptibility genes for BD may impact on cognitive processes. Recent genome-wide genetic studies have reported a strong association with BD in a single nucleotide polymorphism (SNP) (rs10994336) within ANK3, which codes for Ankyrin 3. This protein is involved in facilitating the propagation of action potentials by regulating the assembly of sodium gated ion channels. Since ANK3 influences the efficiency of transmission of neuronal impulses, allelic variation in this gene may have widespread cognitive effects. Preclinical data suggest that this may principally apply to sequential signal detection, a core process of sustained attention. Methodology/Principal Findings: One hundred and eighty-nine individuals of white British descent were genotyped for the ANK3 rs10994336 polymorphism and received diagnostic interviews and comprehensive neurocognitive assessment of their general intellectual ability, memory, decision making, response inhibition and sustained attention. Participants comprised euthymic BD patients (n = 47), their unaffected first-degree relatives (n = 75) and healthy controls (n = 67). The risk allele T was associated with reduced sensitivity in target detection (p = 0.0004) and increased errors of commission (p = 0.0018) during sustained attention regardless of diagnosis. We found no effect of the ANK3 genotype on general intellectual ability, memory, decision making and response inhibition. Conclusions/Significance: Our results suggest that allelic variation in ANK3 impacts cognitive processes associated with signal detection and this mechanism may relate to risk for BD. However, our results require independent replication and confirmation that ANK3 (rs10994336) is a direct functional variant.	[Ruberto, Gaia; Frangou, Sophia] Kings Coll London, Sect Neurobiol Psychosis, Inst Psychiat, London WC2R 2LS, England; [Vassos, Evangelos; Lewis, Cathryn M.; Collier, David] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, Sch Med, Div Genet & Mol Med, London WC2R 2LS, England; [Ruberto, Gaia; Tatarelli, Roberto; Girardi, Paolo] Univ Roma La Sapienza, Dept Psychiat, St Andrea Hosp, Med Sch 2, Rome, Italy	University of London; King's College London; University of London; King's College London; University of London; King's College London; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Ruberto, G (corresponding author), Kings Coll London, Sect Neurobiol Psychosis, Inst Psychiat, London WC2R 2LS, England.	sophia.frangou@kcl.ac.uk	Vassos, Evangelos/F-9825-2013; Lewis, Cathryn M/A-5225-2010; Frangou, Sophia/A-2672-2013; Lewis, Cathryn/M-8766-2019; Collier, David A/D-1649-2011	Vassos, Evangelos/0000-0001-6363-0438; Lewis, Cathryn M/0000-0002-8249-8476; Lewis, Cathryn/0000-0002-8249-8476; Collier, David A/0000-0003-4087-1559; Tatarelli, Roberto/0000-0003-4396-2632; Frangou, Sophia/0000-0002-3210-6470	Medical Research Council [G9817803B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardno AG, 1999, ARCH GEN PSYCHIAT, V56, P162, DOI 10.1001/archpsyc.56.2.162; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Cohen J., 1988, STAT POWER ANAL BEHA; Cunningham MO, 2004, P NATL ACAD SCI USA, V101, P7152, DOI 10.1073/pnas.0402060101; De Geus EJC, 2001, EUR PSYCHOL, V6, P241, DOI 10.1027//1016-9040.6.4.241; Dhingra NK, 2005, J NEUROSCI, V25, P8097, DOI 10.1523/JNEUROSCI.1962-05.2005; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; First MB, 2001, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1935, DOI 10.1152/jn.1997.78.4.1935; Frangou S, 2009, BIOCHEM SOC T, V37, P1085, DOI 10.1042/BST0371085; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Glahn DC, 2010, ARCH GEN PSYCHIAT, V67, P168, DOI 10.1001/archgenpsychiatry.2009.184; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HEATON RK, WISCONSIN CARD SORTI; Huang X, 2007, BIPOLAR DISORD, V9, P298, DOI 10.1111/j.1399-5618.2007.00429.x; Kumar CTS, 2010, SCHIZOPHR RES, V124, P152, DOI 10.1016/j.schres.2010.07.006; Lambert S, 1997, J NEUROSCI, V17, P7025; Lewis M, 2009, EUR PSYCHIAT, V24, P464, DOI 10.1016/j.eurpsy.2009.03.004; Maxwell M., 1992, MANUAL FOR THE FIGS; Meola G, 2009, J NEUROL NEUROSUR PS, V80, P360, DOI 10.1136/jnnp.2008.164046; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; NUECHTERLEIN KH, 1983, SCIENCE, V220, P327, DOI 10.1126/science.6836276; Nuechterlein KH, 1992, MANUAL COMPUTE UNPUB; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Schimpf R, 2009, HERZ, V34, P281, DOI 10.1007/s00059-009-3238-1; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Swann AC, 2003, J AFFECT DISORDERS, V73, P105, DOI 10.1016/S0165-0327(02)00328-2; Trenerry MR, STROOP NEUROPSYCHOLO; Wechsler D, WECHSLER ADULT INTEL; Wechsler D., WECHSLER MEMORY SCAL; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; Yanagita T, 2007, NEUROPHARMACOLOGY, V53, P881, DOI 10.1016/j.neuropharm.2007.08.018; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	45	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16671	10.1371/journal.pone.0016671	http://dx.doi.org/10.1371/journal.pone.0016671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304963	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300116
J	Spencer, B; Marr, RA; Gindi, R; Potkar, R; Michael, S; Adame, A; Rockenstein, E; Verma, IM; Masliah, E				Spencer, Brian; Marr, Robert A.; Gindi, Ryan; Potkar, Rewati; Michael, Sarah; Adame, Anthony; Rockenstein, Edward; Verma, Inder M.; Masliah, Eliezer			Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces A beta Toxicity in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA; TRANSGENIC MICE; PLAQUE-FORMATION; IN-VIVO; NEUTRAL ENDOPEPTIDASE; TAU PHOSPHORYLATION; PEPTIDE DEGRADATION; LENTIVIRAL VECTORS; NEPRILYSIN; OLIGOMERS	Alzheimer's disease (AD), an incurable, progressive neurodegenerative disorder, is the most common form of dementia. Therapeutic options have been elusive due to the inability to deliver proteins across the blood-brain barrier (BBB). In order to improve the therapeutic potential for AD, we utilized a promising new approach for delivery of proteins across the BBB. We generated a lentivirus vector expressing the amyloid beta-degrading enzyme, neprilysin, fused to the ApoB transport domain and delivered this by intra-peritoneal injection to amyloid protein precursor (APP) transgenic model of AD. Treated mice had reduced levels of A beta, reduced plaques and increased synaptic density in the CNS. Furthermore, mice treated with the neprilysin targeting the CNS had a reversal of memory deficits. Thus, the addition of the ApoB transport domain to the secreted neprilysin generated a non-invasive therapeutic approach that may be a potential treatment in patients with AD.	[Spencer, Brian; Gindi, Ryan; Potkar, Rewati; Michael, Sarah; Adame, Anthony; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Marr, Robert A.] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, Dept Neurosci, N Chicago, IL USA; [Verma, Inder M.] Salk Inst Biol Studies, Genet Lab, San Diego, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Rosalind Franklin University Medical & Science; Salk Institute; University of California System; University of California San Diego	Spencer, B (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			National Institutes of Health [AG022074, AG18440, AG010435]; NATIONAL INSTITUTE ON AGING [R37AG018440, P01AG010435, R01AG018440, P01AG022074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health AG022074, AG18440, AG010435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanitis DN, 2007, J NEUROCHEM, V103, P216, DOI 10.1111/j.1471-4159.2007.04704.x; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; CONNELLY JC, 1993, J LEUKOCYTE BIOL, V53, P685, DOI 10.1002/jlb.53.6.685; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Cuello AC, 2008, NEURODEGENER DIS, V5, P146, DOI 10.1159/000113686; Cuello AC, 2005, BRAIN PATHOL, V15, P66; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hof PR, 1996, J AM GERIATR SOC, V44, P857, DOI 10.1111/j.1532-5415.1996.tb03748.x; Hong CS, 2006, GENE THER, V13, P1068, DOI 10.1038/sj.gt.3302719; HOWELL S, 1995, PEPTIDES, V16, P647, DOI 10.1016/0196-9781(95)00021-B; Huang F, 1999, AM J PATHOL, V155, P1741, DOI 10.1016/S0002-9440(10)65489-2; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; IIJIMAANDO K, 2008, J BIOL CHEM; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2000, NAT MED, V6, P143, DOI 10.1038/72237; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liu YX, 2009, MOL THER, V17, P1381, DOI 10.1038/mt.2009.115; Marr RA, 2010, CURR ALZHEIMER RES, V7, P223, DOI 10.2174/156720510791050849; Marr RA, 2003, J NEUROSCI, V23, P1992; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meilandt WJ, 2009, J NEUROSCI, V29, P1977, DOI 10.1523/JNEUROSCI.2984-08.2009; Mohajeri MH, 2004, FEBS LETT, V562, P16, DOI 10.1016/S0014-5793(04)00169-3; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Pardridge WM, 2002, NEURON, V36, P555, DOI 10.1016/S0896-6273(02)01054-1; Pfeifer A, 2001, MOL THER, V3, P319, DOI 10.1006/mthe.2001.0276; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Poon HF, 2004, BRAIN RES, V1018, P86, DOI 10.1016/j.brainres.2004.05.048; Ray J, 1997, P NATL ACAD SCI USA, V94, P7047, DOI 10.1073/pnas.94.13.7047; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rose JB, 2009, J NEUROSCI, V29, P1115, DOI 10.1523/JNEUROSCI.4220-08.2009; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SHIPP MA, 1991, BLOOD, V78, P1834; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Spencer B. J., 2007, P NATL ACAD SCI US; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Terry Robert D., 1994, P179; Tian JZ, 2009, CURR ALZHEIMER RES, V6, P118, DOI 10.2174/156720509787602942; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Yamamoto M, 2008, J IMMUNOL, V181, P3877, DOI 10.4049/jimmunol.181.6.3877; Yang LL, 2009, J PHARM PHARMACOL, V61, P375, DOI [10.1211/jpp/61.03.0013, 10.1211/jpp.61.03.0013]	55	55	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16575	10.1371/journal.pone.0016575	http://dx.doi.org/10.1371/journal.pone.0016575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304989	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300089
J	Takahashi, N; Ohashi, S; Sadykov, MR; Mizutani-Ui, Y; Kobayashi, I				Takahashi, Noriko; Ohashi, Seishi; Sadykov, Marat R.; Mizutani-Ui, Yoko; Kobayashi, Ichizo			IS-Linked Movement of a Restriction-Modification System	PLOS ONE			English	Article							TOXIN-ANTITOXIN LOCI; MODIFICATION GENE; GENOME; SEQUENCE; ENDONUCLEASE; INSERTION; PLASMIDS; BEHAVIOR; ELEMENTS; ABSENCE	Potential mobility of restriction-modification systems has been suggested by evolutionary/bioinformatic analysis of prokaryotic genomes. Here we demonstrate in vivo movement of a restriction-modification system within a genome under a laboratory condition. After blocking replication of a temperature-sensitive plasmid carrying a PaeR7I restriction-modification system in Escherichia coli cells, the plasmid was found integrated into the chromosome of the surviving cells. Sequence analysis revealed that, in the majority of products, the restriction-modification system was linked to chromosomal insertion sequences (ISs). Three types of products were: (I) apparent co-integration of the plasmid and the chromosome at a chromosomal IS1 or IS5 copy (24/28 analyzed); (II) de novo insertion of IS1 with the entire plasmid except for a 1-3 bp terminal deletion (2/28); and (III) reciprocal crossing-over between the plasmid and the chromosome involving 1-3 bp of sequence identity (2/28). An R-negative mutation apparently decreased the efficiency of successful integration by two orders of magnitude. Reconstruction experiments demonstrated that the restriction-dependence was mainly due to selection against cells without proper integration: their growth was inhibited by the restriction enzyme action. These results demonstrate collaboration of a mobile element and a restriction-modification system for successful joint migration. This collaboration may have promoted the spread and, therefore, the long-term persistence of these complexes and restriction-modification systems in a wide range of prokaryotes.	[Takahashi, Noriko; Sadykov, Marat R.; Kobayashi, Ichizo] Univ Tokyo, Grad Sch Frontier Sci, Lab Social Genome Sci, Dept Med Genome Sci,Minato Ku, Tokyo, Japan; [Takahashi, Noriko; Ohashi, Seishi; Sadykov, Marat R.; Mizutani-Ui, Yoko; Kobayashi, Ichizo] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Ohashi, Seishi; Kobayashi, Ichizo] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Minato Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Takahashi, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Lab Social Genome Sci, Dept Med Genome Sci,Minato Ku, Tokyo, Japan.	ikobaya@ims.u-tokyo.ac.jp	Kobayashi, Ichizo/GVT-8377-2022; Sadykov, Marat/H-3147-2011	Sadykov, Marat/0000-0001-7090-1929; Kobayashi, Ichizo/0000-0002-3854-1879	Japan Society for the Promotion of Science (JSPS) [19790316, 19657002, 21370001]; MEXT; Uehara Memorial Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) (19790316, 19657002, 21370001, 19657002); the 21st century COE project and the Global COE project and the Medical Genome Science program from MEXT; Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ASAI T, 1993, EMBO J, V12, P3287, DOI 10.1002/j.1460-2075.1993.tb05998.x; Asakura Y, 2009, NUCLEIC ACIDS RES, V37, P3021, DOI 10.1093/nar/gkp148; AVILA P, 1984, MOL GEN GENET, V195, P288, DOI 10.1007/BF00332761; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BYRAPPA S, 1995, GENOME RES, V5, P404, DOI 10.1101/gr.5.4.404; Chen JH, 1998, J BACTERIOL, V180, P5279, DOI 10.1128/JB.180.19.5279-5283.1998; Chinen A, 2000, GENE, V259, P109, DOI 10.1016/S0378-1119(00)00459-5; Cousineau B, 2000, NATURE, V404, P1018, DOI 10.1038/35010029; ENGLER JA, 1981, GENE, V14, P155, DOI 10.1016/0378-1119(81)90111-6; Fukuda E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r163; Furuta Y, 2010, NUCLEIC ACIDS RES, V38, P2428, DOI 10.1093/nar/gkp1226; GAMAS P, 1985, NATURE, V317, P458, DOI 10.1038/317458a0; GINGERAS TR, 1983, P NATL ACAD SCI-BIOL, V80, P402, DOI 10.1073/pnas.80.2.402; Gunn JS, 1997, NUCLEIC ACIDS RES, V25, P4147, DOI 10.1093/nar/25.20.4147; Handa N, 2000, J BACTERIOL, V182, P2218, DOI 10.1128/JB.182.8.2218-2229.2000; Handa N, 2001, MOL MICROBIOL, V40, P932, DOI 10.1046/j.1365-2958.2001.02436.x; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; HURST GDD, 1992, NATURE, V356, P659, DOI 10.1038/356659a0; Ichige A, 2005, J BACTERIOL, V187, P6612, DOI 10.1128/JB.187.19.6612-6621.2005; IIDA S, 1986, GENE, V45, P233, DOI 10.1016/0378-1119(86)90260-X; Khan F, 2010, NUCLEIC ACIDS RES, V38, P3019, DOI 10.1093/nar/gkp1221; Kita K, 1999, J BACTERIOL, V181, P6822, DOI 10.1128/JB.181.21.6822-6827.1999; Kobayashi I, 2004, NUCL ACID M, V14, P19; Kobayashi I, 2004, PLASMID BIOLOGY, P105; Kobayashi I, 2001, NUCLEIC ACIDS RES, V29, P3742, DOI 10.1093/nar/29.18.3742; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P11095, DOI 10.1073/pnas.92.24.11095; Mochizuki A, 2006, GENETICS, V172, P1309, DOI 10.1534/genetics.105.042895; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; OCHMAN H, 1988, GENETICS, V120, P621; Ohno S, 2008, J BACTERIOL, V190, P2039, DOI 10.1128/JB.01319-07; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; POLARD P, 1994, J BACTERIOL, V176, P1192, DOI 10.1128/JB.176.4.1192-1196.1994; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Rochepeau P, 1997, MOL GEN GENET, V256, P387, DOI 10.1007/s004380050582; Sadykov M, 2003, MOL MICROBIOL, V48, P417, DOI 10.1046/j.1365-2958.2003.03464.x; SCHNETZ K, 1992, P NATL ACAD SCI USA, V89, P1244, DOI 10.1073/pnas.89.4.1244; STAHL MM, 1983, P NATL ACAD SCI-BIOL, V80, P2310, DOI 10.1073/pnas.80.8.2310; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; TAKAHASHI N, 1990, P NATL ACAD SCI USA, V87, P2790, DOI 10.1073/pnas.87.7.2790; Yahara K, 2009, P NATL ACAD SCI USA, V106, P18861, DOI 10.1073/pnas.0908404106	42	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16554	10.1371/journal.pone.0016554	http://dx.doi.org/10.1371/journal.pone.0016554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305031	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300085
J	Wit, N; Krijger, PHL; van den Berk, PCM; Jacobs, H				Wit, Niek; Krijger, Peter H. L.; van den Berk, Paul C. M.; Jacobs, Heinz			Lysine Residue 185 of Rad1 Is a Topological but Not a Functional Counterpart of Lysine Residue 164 of PCNA	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; DNA-POLYMERASE-ETA; 9-1-1 CHECKPOINT CLAMP; SOMATIC HYPERMUTATION; TRANSLESION SYNTHESIS; MOLECULAR-MECHANISMS; GENE HYPERMUTATION; DAMAGE RESPONSE; MOUSE; UBIQUITIN	Monoubiquitylation of the homotrimeric DNA sliding clamp PCNA at lysine residue 164 (PCNA(K164)) is a highly conserved, DNA damage-inducible process that is mediated by the E2/E3 complex Rad6/Rad18. This ubiquitylation event recruits translesion synthesis (TLS) polymerases capable of replicating across damaged DNA templates. Besides PCNA, the Rad6/Rad18 complex was recently shown in yeast to ubiquitylate also 9-1-1, a heterotrimeric DNA sliding clamp composed of Rad9, Rad1, and Hus1 in a DNA damage-inducible manner. Based on the highly similar crystal structures of PCNA and 9-1-1, K185 of Rad1 (Rad1(K185)) was identified as the only topological equivalent of PCNA(K164). To investigate a potential role of posttranslational modifications of Rad1(K185) in DNA damage management, we here generated a mouse model with a conditional deletable Rad1(K185R) allele. The Rad1(K185) residue was found to be dispensable for Chk1 activation, DNA damage survival, and class switch recombination of immunoglobulin genes as well as recruitment of TLS polymerases during somatic hypermutation of immunoglobulin genes. Our data indicate that Rad1(K185) is not a functional counterpart of PCNA(K164).	[Wit, Niek; Krijger, Peter H. L.; van den Berk, Paul C. M.; Jacobs, Heinz] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Wit, N (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	h.jacobs@nki.nl		Jacobs, Heinz/0000-0001-6227-9850; Krijger, Peter/0000-0003-1702-348X	Netherlands Organisation for Scientific Research [NWO 917.56.328]; Dutch Cancer foundation [NKI-2008-4112]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer foundation(KWF Kankerbestrijding)	This work was funded by the Netherlands Organisation for Scientific Research (VIDI program NWO 917.56.328) and the Dutch Cancer foundation (KWF grant NKI-2008-4112) to HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An LL, 2010, J BIOL CHEM, V285, P35267, DOI 10.1074/jbc.M110.161208; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Davies AA, 2010, CELL, V141, P1080, DOI 10.1016/j.cell.2010.04.039; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; Faili A, 2009, J IMMUNOL, V182, P6353, DOI 10.4049/jimmunol.0900177; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Guo C, 2008, J BIOL CHEM, V283, P4658, DOI 10.1074/jbc.M709275200; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Han L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-67; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; Jansen JG, 2007, MOL CELL, V28, P522, DOI 10.1016/j.molcel.2007.11.005; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Krijger PHL, 2009, J EXP MED, V206, P2603, DOI 10.1084/jem.20091707; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Langerak P, 2009, PHILOS T R SOC B, V364, P621, DOI 10.1098/rstb.2008.0223; Levitt PS, 2005, GENOMICS, V86, P212, DOI 10.1016/j.ygeno.2005.04.007; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, pR108, DOI 10.1016/S0960-9822(02)00674-7; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; van der Weyden L, 2005, GENESIS, V41, P171, DOI 10.1002/gene.20111; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Weiss RS, 2002, CURR BIOL, V12, P73, DOI 10.1016/S0960-9822(01)00626-1; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16669	10.1371/journal.pone.0016669	http://dx.doi.org/10.1371/journal.pone.0016669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304913	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300114
J	Yamauchi, JG; Nemecz, A; Quoc, TN; Muller, A; Schroeder, LF; Talley, TT; Lindstrom, J; Kleinfeld, D; Taylor, P				Yamauchi, John G.; Nemecz, Akos; Quoc Thang Nguyen; Muller, Arnaud; Schroeder, Lee F.; Talley, Todd T.; Lindstrom, Jon; Kleinfeld, David; Taylor, Palmer			Characterizing Ligand-Gated Ion Channel Receptors with Genetically Encoded Ca++ Sensors	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; HIGH-THROUGHPUT ELECTROPHYSIOLOGY; COGNITIVE DEFICITS; EXPRESSION; AGONIST; SUBUNIT; TRANSITIONS; ALZHEIMERS; REPORTERS; BINDING	We present a cell based system and experimental approach to characterize agonist and antagonist selectivity for ligand-gated ion channels (LGIC) by developing sensor cells stably expressing a Ca2+ permeable LGIC and a genetically encoded Forster (or fluorescence) resonance energy transfer (FRET)-based calcium sensor. In particular, we describe separate lines with human alpha 7 and human alpha 4 beta 2 nicotinic acetylcholine receptors, mouse 5-HT3A serotonin receptors and a chimera of human alpha 7/mouse 5-HT3A receptors. Complete concentration-response curves for agonists and Schild plots of antagonists were generated from these sensors and the results validate known pharmacology of the receptors tested. Concentration-response relations can be generated from either the initial rate or maximal amplitudes of FRET-signal. Although assaying at a medium throughput level, this pharmacological fluorescence detection technique employs a clonal line for stability and has versatility for screening laboratory generated congeners as agonists or antagonists on multiple subtypes of ligand-gated ion channels. The clonal sensor lines are also compatible with in vivo usage to measure indirectly receptor activation by endogenous neurotransmitters.	[Yamauchi, John G.; Nemecz, Akos; Talley, Todd T.; Taylor, Palmer] Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Yamauchi, John G.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Nemecz, Akos] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Quoc Thang Nguyen; Muller, Arnaud; Schroeder, Lee F.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Lindstrom, Jon] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania	Yamauchi, JG (corresponding author), Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	pwtaylor@ucsd.edu		Talley, Todd/0000-0002-1077-1947	National Institutes of Health (NIH) [R01-GM18360-39, U01-DA019372, R01-DA029706]; NSF [GK-12 0742551];  [GM-07752]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029706, R01DA030929, U01DA019372] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) grants R01-GM18360-39, U01-DA019372 (PT), and R01-DA029706 (DK). AN and JGY acknowledge support by training grant GM-07752. JGY also acknowledges support from NSF GK-12 0742551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneric SP, 2007, BIOCHEM PHARMACOL, V74, P1092, DOI 10.1016/j.bcp.2007.06.033; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Chavez-Noriega LE, 2000, NEUROPHARMACOLOGY, V39, P2543, DOI 10.1016/S0028-3908(00)00134-9; Craig PJ, 2004, EUR J PHARMACOL, V502, P31, DOI 10.1016/j.ejphar.2004.08.042; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Drobac E, 2010, J NEUROSCI RES, V88, P695, DOI 10.1002/jnr.22249; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Dunlop J, 2007, BIOCHEM PHARMACOL, V74, P1172, DOI 10.1016/j.bcp.2007.07.006; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Freedman R, 2008, AM J PSYCHIAT, V165, P1040, DOI 10.1176/appi.ajp.2008.07071135; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kleinfeld D, 2005, PLOS BIOL, V3, P1685, DOI 10.1371/journal.pbio.0030355; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Newhouse PA, 1997, DRUG AGING, V11, P206, DOI 10.2165/00002512-199711030-00005; NGUYEN QT, 2009, NAT NEUROSCI, V13, P127; Papke RL, 2005, NEUROSCI LETT, V378, P140, DOI 10.1016/j.neulet.2004.12.025; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; RIZZI JP, 1990, J MED CHEM, V33, P2721, DOI 10.1021/jm00172a007; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; ROSEN T, 1990, J MED CHEM, V33, P2715, DOI 10.1021/jm00172a006; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; Sidach SS, 2009, J NEUROSCI METH, V182, P17, DOI 10.1016/j.jneumeth.2009.05.014; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1981, J BIOL CHEM, V256, P6692; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; TAYLOR P, 1990, P1; Warpman U, 1995, NEUROREPORT, V6, P2419, DOI 10.1097/00001756-199511270-00033; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008	42	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16519	10.1371/journal.pone.0016519	http://dx.doi.org/10.1371/journal.pone.0016519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305050	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100042
J	Moreau, S; Verdenaud, M; Ott, T; Letort, S; de Billy, F; Niebel, A; Gouzy, J; de Carvalho-Niebel, F; Gamas, P				Moreau, Sandra; Verdenaud, Marion; Ott, Thomas; Letort, Sebastien; de Billy, Francoise; Niebel, Andreas; Gouzy, Jerome; de Carvalho-Niebel, Fernanda; Gamas, Pascal			Transcription Reprogramming during Root Nodule Development in Medicago truncatula	PLOS ONE			English	Article							SUBTRACTIVE HYBRIDIZATION APPROACH; FACTOR SIGNAL-TRANSDUCTION; FALSE DISCOVERY RATE; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-MELILOTI; GENE-EXPRESSION; ARBUSCULAR MYCORRHIZA; LOTUS-JAPONICUS; ARABIDOPSIS-THALIANA; POTENTIAL REGULATORS	Many genes which are associated with root nodule development and activity in the model legume Medicago truncatula have been described. However information on precise stages of activation of these genes and their corresponding transcriptional regulators is often lacking. Whether these regulators are shared with other plant developmental programs also remains an open question. Here detailed microarray analyses have been used to study the transcriptome of root nodules induced by either wild type or mutant strains of Sinorhizobium meliloti. In this way we have defined eight major activation patterns in nodules and identified associated potential regulatory genes. We have shown that transcription reprogramming during consecutive stages of nodule differentiation occurs in four major phases, respectively associated with (i) early signalling events and/or bacterial infection; plant cell differentiation that is either (ii) independent or (iii) dependent on bacteroid differentiation; (iv) nitrogen fixation. Differential expression of several genes involved in cytokinin biosynthesis was observed in early symbiotic nodule zones, suggesting that cytokinin levels are actively controlled in this region. Taking advantage of databases recently developed for M. truncatula, we identified a small subset of gene expression regulators that were exclusively or predominantly expressed in nodules, whereas most other regulators were also activated under other conditions, and notably in response to abiotic or biotic stresses. We found evidence suggesting the activation of the jasmonate pathway in both wild type and mutant nodules, thus raising questions about the role of jasmonate during nodule development. Finally, quantitative RT-PCR was used to analyse the expression of a series of nodule regulator and marker genes at early symbiotic stages in roots and allowed us to distinguish several early stages of gene expression activation or repression.	[Moreau, Sandra; Verdenaud, Marion; Ott, Thomas; Letort, Sebastien; de Billy, Francoise; Niebel, Andreas; Gouzy, Jerome; de Carvalho-Niebel, Fernanda; Gamas, Pascal] Inst Natl Rech Agronom, Ctr Natl Rech Sci, Lab Interact Plantes Microorganismes, Castanet Tolosan, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Moreau, S (corresponding author), Inst Natl Rech Agronom, Ctr Natl Rech Sci, Lab Interact Plantes Microorganismes, Castanet Tolosan, France.	Pascal.Gamas@toulouse.inra.fr	de Carvalho-Niebel, Fernanda/E-3762-2018; Gouzy, Jerome/AAH-4977-2020; Ott, Thomas/H-8192-2013; Ott, Thomas/G-7056-2011; NIEBEL, Andreas/AAL-7687-2020	de Carvalho-Niebel, Fernanda/0000-0002-5596-9420; Gouzy, Jerome/0000-0001-5695-4557; Ott, Thomas/0000-0002-4494-9811; Verdenaud, Marion/0000-0002-4071-0782; Niebel, Andreas/0000-0002-3402-8381; Moreau, Sandra/0000-0003-1643-7883; Gamas, Pascal/0000-0002-6253-4249	EU; INRA; Marie-Curie Intra-European Fellowship [024587-Nodule Remorin]; Agence Nationale de la Recherche [ANR LEGoo GPLA06026G, ANR SYMbiMICS PCS-08-GENO-106]	EU(European Commission); INRA; Marie-Curie Intra-European Fellowship(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by an EU grant (FP6 Grain Legume integrated project, GLIP) and an INRA grant (AgroBI). Thomas Ott was supported by a Marie-Curie Intra-European Fellowship (024587-Nodule Remorin) and Marion Verdenaud and Sebastien Letort by grants from the Agence Nationale de la Recherche (ANR LEGoo GPLA06026G for both, as well as ANR SYMbiMICS PCS-08-GENO-106 for M. Verdenaud). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; ARDOUREL M, 1994, PLANT CELL, V6, P1357, DOI 10.1105/tpc.6.10.1357; Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Barsch A, 2006, MOL PLANT MICROBE IN, V19, P998, DOI 10.1094/MPMI-19-0998; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bobik C, 2006, J BACTERIOL, V188, P4890, DOI 10.1128/JB.00251-06; Borisov AY, 2003, PLANT PHYSIOL, V131, P1009, DOI 10.1104/pp.102.016071; Bozso Z, 2009, PLANT MOL BIOL, V70, P627, DOI 10.1007/s11103-009-9496-8; Catoira R, 2001, DEVELOPMENT, V128, P1507; Combier JP, 2008, CURR PLANT SCI BIOT, V42, P221; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Cornbier JP, 2008, MOL PLANT MICROBE IN, V21, P1118, DOI 10.1094/MPMI-21-8-1118; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; Den Herder G, 2009, CURR OPIN PLANT BIOL, V12, P491, DOI 10.1016/j.pbi.2009.05.010; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Fedorova M, 2002, PLANT PHYSIOL, V130, P519, DOI 10.1104/pp.006833; Ferguson BJ, 2003, J PLANT GROWTH REGUL, V22, P47, DOI 10.1007/s00344-003-0032-9; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Floss DS, 2008, PLANT J, V56, P86, DOI 10.1111/j.1365-313X.2008.03575.x; Frugier F, 2000, GENE DEV, V14, P475; Frugier F, 2008, TRENDS PLANT SCI, V13, P115, DOI 10.1016/j.tplants.2008.01.003; GALLUSCI P, 1991, PLANT MOL BIOL, V17, P335, DOI 10.1007/BF00040629; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Gibson KE, 2008, ANNU REV GENET, V42, P413, DOI 10.1146/annurev.genet.42.110807.091427; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; Godiard L, 2007, MOL PLANT MICROBE IN, V20, P321, DOI 10.1094/MPMI-20-3-0321; Gruber V, 2009, MOL GENET GENOMICS, V281, P55, DOI 10.1007/s00438-008-0392-8; Grunwald U, 2009, PLANTA, V229, P1023, DOI 10.1007/s00425-008-0877-z; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hause B, 2009, PHYTOCHEMISTRY, V70, P1589, DOI 10.1016/j.phytochem.2009.07.003; Heckmann AB, 2006, PLANT PHYSIOL, V142, P1739, DOI 10.1104/pp.106.089508; Heidstra R, 1997, MOL PLANT MICROBE IN, V10, P215, DOI 10.1094/MPMI.1997.10.2.215; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Jones KM, 2008, P NATL ACAD SCI USA, V105, P704, DOI 10.1073/pnas.0709338105; Journet EP, 2001, MOL PLANT MICROBE IN, V14, P737, DOI 10.1094/MPMI.2001.14.6.737; Kiss E, 2009, PLANT PHYSIOL, V151, P1239, DOI 10.1104/pp.109.143933; Kuster H, 2007, PHYTOCHEMISTRY, V68, P19, DOI 10.1016/j.phytochem.2006.09.026; Kuppusamy KT, 2004, PLANT PHYSIOL, V136, P3682, DOI 10.1104/pp.104.045575; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Libault M, 2009, PLANT PHYSIOL, V151, P991, DOI 10.1104/pp.109.144105; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Marsh JF, 2007, PLANT PHYSIOL, V144, P324, DOI 10.1104/pp.106.093021; Mathesius U., 2007, MEDICAGO TRUNCATULA; Mathis R, 1999, MOL PLANT MICROBE IN, V12, P544, DOI 10.1094/MPMI.1999.12.6.544; Maunoury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009519; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Mithofer A, 2002, TRENDS PLANT SCI, V7, P440, DOI 10.1016/S1360-1385(02)02336-1; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P10217, DOI 10.1073/pnas.0402186101; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Murakami Y, 2006, DNA RES, V13, P255, DOI 10.1093/dnares/dsl017; Naito Y, 2000, PLANT PHYSIOL, V124, P1087, DOI 10.1104/pp.124.3.1087; Naoumkina M, 2007, P NATL ACAD SCI USA, V104, P17909, DOI 10.1073/pnas.0708697104; Naoumkina MA, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-132; Niebel FD, 1998, MOL PLANT MICROBE IN, V11, P504; NIEHAUS K, 1993, PLANTA, V190, P415; Oldroyd GED, 2003, PLANT PHYSIOL, V131, P1027, DOI 10.1104/pp.102.010710; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Peiter E, 2007, PLANT PHYSIOL, V145, P192, DOI 10.1104/pp.107.097261; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; PICHON M, 1992, PLANT CELL, V4, P1199, DOI 10.1105/tpc.4.10.1199; Puppo A, 2005, NEW PHYTOL, V165, P683, DOI 10.1111/j.1469-8137.2004.01285.x; Qu LJ, 2006, CURR OPIN PLANT BIOL, V9, P544, DOI 10.1016/j.pbi.2006.07.005; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Riely BK, 2007, PLANT J, V49, P208, DOI 10.1111/j.1365-313X.2006.02957.x; Rodo AP, 2008, J EXP BOT, V59, P2673, DOI 10.1093/jxb/ern137; Ruffel S, 2008, PLANT PHYSIOL, V146, P2020, DOI 10.1104/pp.107.115667; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; Sun JH, 2006, PLANT J, V46, P961, DOI 10.1111/j.1365-313X.2006.02751.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tellstrom V, 2007, PLANT PHYSIOL, V143, P825, DOI 10.1104/pp.106.090985; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tornero P, 2002, PLANT CELL, V14, P1005, DOI 10.1105/tpc.001032; Town CD, 2006, CURR OPIN PLANT BIOL, V9, P122, DOI 10.1016/j.pbi.2006.01.004; Tretner C, 2008, J EXP BOT, V59, P2847, DOI 10.1093/jxb/ern145; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VANDEWIEL C, 1990, PLANT CELL, V2, P1009, DOI 10.1105/tpc.2.10.1009; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; White J, 2007, PLANT PHYSIOL, V144, P604, DOI 10.1104/pp.107.097741; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Yang C, 1994, PLANT PHYSIOL, V98, P143	101	77	77	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16463	10.1371/journal.pone.0016463	http://dx.doi.org/10.1371/journal.pone.0016463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304580	Green Published, gold			2022-12-25	WOS:000286663900052
J	Grewal, JS; Pilgrim, MJ; Grewal, S; Kasman, L; Werner, P; Bruorton, ME; London, SD; London, L				Grewal, Jasvir S.; Pilgrim, Mark J.; Grewal, Suman; Kasman, Laura; Werner, Phillip; Bruorton, Mary E.; London, Steven D.; London, Lucille			Salivary glands act as mucosal inductive sites via the formation of ectopic germinal centers after site-restricted MCMV infection	FASEB JOURNAL			English	Article						mucosal immunity; viral immunity	CLASS SWITCH RECOMBINATION; SJOGRENS-SYNDROME PATIENTS; B-CELLS; T-CELL; STREPTOCOCCUS-MUTANS; LYMPHOID NEOGENESIS; IMMUNOGLOBULIN-A; DIFFERENTIAL EXPRESSION; AUTOANTIBODY PRODUCTION; MONOCLONAL-ANTIBODIES	We investigated the hypothesis that salivary gland inoculation stimulates formation of ectopic germinal centers (GCs), transforming the gland into a mucosal inductive site. Intraglandular infection of mice with murine cytomegalovirus (MCMV; control: UV-inactivated MCMV) induces salivary gland ectopic follicles comprising cognate interactions between CD4(+) and B220(+) lymphocytes, IgM(+) and isotype-switched IgG(+) and IgA(+) B cells, antigen presenting cells, and follicular dendritic cells. B cells coexpressed the GC markers GCT (57%) and GL7 (52%), and bound the lectin peanut agglutinin. Lymphoid follicles were characterized by a 2- to 3-fold increase in mRNA for CXCL13 (lymphoid neogenesis), syndecan-1 (plasma cells), Blimp-1 (plasma cell development/differentiation), and a 2- to 6-fold increase for activation-induced cytidine deaminase, PAX5, and the nonexcised rearranged DNA of an IgA class-switch event, supporting somatic hypermutation and class-switch recombination within the salivary follicles. Intraglandular inoculation also provided protection against a systemic MCMV challenge, as evidenced by decreased viral titers (10(5) plaque-forming units to undetectable), and restoration of normal salivary flow rates from a 6-fold decrease. Therefore, these features suggest that the salivary gland participates in oral mucosal immunity via generation of ectopic GCs, which function as ectopic mucosal inductive sites.-Grewal, J. S., Pilgrim, M. J., Grewal, S., Kasman, L., Werner, P., Bruorton, M. E., London, S. D., London, L. Salivary glands act as mucosal inductive sites via the formation of ectopic germinal centers after site-restricted MCMV infection. FASEB J. 25, 1680-1696 (2011). www.fasebj.org	[Grewal, Jasvir S.; Grewal, Suman; London, Steven D.; London, Lucille] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA; [Pilgrim, Mark J.; Kasman, Laura; Werner, Phillip; Bruorton, Mary E.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Werner, Phillip] Med Univ S Carolina, Coll Dent Med, Charleston, SC 29425 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Medical University of South Carolina; Medical University of South Carolina	London, L (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, 231 Dutchess Hall, Stony Brook, NY 11794 USA.	lucille.london@stonybrook.edu	Kasman, Laura/AAF-3536-2021	Kasman, Laura/0000-0002-8661-2918	MUSC; U.S. National Institutes of Health/National Institute of Dental and Craniofacial [1R01 DE016652]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016652] Funding Source: NIH RePORTER	MUSC; U.S. National Institutes of Health/National Institute of Dental and Craniofacial(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. S. Crowe for early work on the BrdU assay; Rick Peppler and the Medical University of South Carolina (MUSC) Hollings Cancer Center and Stony Brook University Research Flow Cytometry Core Facility; Dr. Margaret Kelly for her assistance with confocal microscopy; Dr. Jeffrey Reitzel for his assistance with the ELISPOT assay; and the Hollings Cancer Center Molecular Imaging Center. This work was supported by the MUSC Institutional Research Funds and U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research grant 1R01 DE016652 (S. D. L.). The authors declare no conflicting financial or commercial interests.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Amft N, 2001, SCAND J IMMUNOL, V54, P62, DOI 10.1046/j.1365-3083.2001.00970.x; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Bharhani MS, 2007, INT IMMUNOL, V19, P567, DOI 10.1093/intimm/dxm022; Bharhani MS, 2005, J IMMUNOL, V174, P3580, DOI 10.4049/jimmunol.174.6.3580; Bombardieri M, 2007, J IMMUNOL, V179, P4929, DOI 10.4049/jimmunol.179.7.4929; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Butcher EC, 2005, J IMMUNOL, V175, P1363; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; CEBRA JJ, 1989, IMMUNOL INVEST, V18, P545, DOI 10.3109/08820138909112262; Cervenak L, 2001, IMMUNOL LETT, V78, P89, DOI 10.1016/S0165-2478(01)00239-5; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cozine CL, 2005, CURR OPIN IMMUNOL, V17, P298, DOI 10.1016/j.coi.2005.04.007; DELVAL M, 1988, J VIROL, V62, P3965, DOI 10.1128/JVI.62.11.3965-3972.1988; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; EIDT S, 1993, J CLIN PATHOL, V46, P832, DOI 10.1136/jcp.46.9.832; FARRELL HE, 1990, J GEN VIROL, V71, P655, DOI 10.1099/0022-1317-71-3-655; Fernandez JA, 1999, VIROLOGY, V255, P40, DOI 10.1006/viro.1998.9575; FRENI MA, 1995, HEPATOLOGY, V22, P389, DOI 10.1002/hep.1840220203; GENCO RJ, 1969, NATURE, V221, P679, DOI 10.1038/221679a0; Hansen A, 2005, ARTHRITIS RHEUM-US, V52, P2109, DOI 10.1002/art.21129; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; Holtappels R, 2001, J VIROL, V75, P6584, DOI 10.1128/JVI.75.14.6584-6600.2001; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Inoue H, 1999, ORAL MICROBIOL IMMUN, V14, P21, DOI 10.1034/j.1399-302X.1999.140102.x; Jonsson MV, 2008, J ORAL PATHOL MED, V37, P515, DOI 10.1111/j.1600-0714.2008.00674.x; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; Kagami H, 1998, HUM GENE THER, V9, P305, DOI 10.1089/hum.1998.9.3-305; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Kasman LM, 2009, ORAL DIS, V15, P587, DOI 10.1111/j.1601-0825.2009.01600.x; Kawabata S, 1999, INFECT IMMUN, V67, P5863, DOI 10.1128/IAI.67.11.5863-5868.1999; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; LASZLO G, 1993, J IMMUNOL, V150, P5252; Le Pottier L, 2009, J IMMUNOL, V182, P3540, DOI 10.4049/jimmunol.0803588; Lin KI, 2002, MOL CELL BIOL, V22, P4771, DOI 10.1128/MCB.22.13.4771-4780.2002; Lindroth K, 2007, IMMUNOL LETT, V113, P70, DOI 10.1016/j.imlet.2007.07.018; LONDON SD, 1990, J IMMUNOL, V144, P3187; LONDON SD, 1987, J EXP MED, V165, P830, DOI 10.1084/jem.165.3.830; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Mason KL, 2008, ADV EXP MED BIOL, V635, P1, DOI 10.1007/978-0-387-09550-9_1; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; MCGHEE JR, 1975, J IMMUNOL, V114, P300; MEGA J, 1995, ADV EXP MED BIOL, V371, P1103; Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Murasawa M, 2002, EUR J IMMUNOL, V32, P291, DOI 10.1002/1521-4141(200201)32:1<291::AID-IMMU291>3.0.CO;2-L; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Nakamura H, 1999, LAB INVEST, V79, P261; Pilgrim MJ, 2007, EXP MOL PATHOL, V82, P269, DOI 10.1016/j.yexmp.2006.12.010; PLATT FM, 1992, CELL IMMUNOL, V143, P449, DOI 10.1016/0008-8749(92)90039-R; Reksten TR, 2009, RHEUMATOLOGY, V48, P1102, DOI 10.1093/rheumatology/kep149; RUSSELL MW, 1991, INFECT IMMUN, V59, P4061, DOI 10.1128/IAI.59.11.4061-4070.1991; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Salomonsson S, 2002, SCAND J IMMUNOL, V55, P336, DOI 10.1046/j.1365-3083.2002.01058.x; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Sankar V, 2002, ORAL DIS, V8, P275, DOI 10.1034/j.1601-0825.2002.02856.x; Scalzo AA, 2007, IMMUNOL CELL BIOL, V85, P46, DOI 10.1038/sj.icb.7100013; Seo KY, 2010, J IMMUNOL, V185, P3610, DOI 10.4049/jimmunol.1000680; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Smith DJ, 1997, INFECT IMMUN, V65, P4424, DOI 10.1128/IAI.65.11.4424-4430.1997; Smith DJ, 1996, INFECT IMMUN, V64, P3069, DOI 10.1128/IAI.64.8.3069-3073.1996; STARR SE, 1977, INFECT IMMUN, V17, P458, DOI 10.1128/IAI.17.2.458-462.1977; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; Szodoray P, 2005, SCAND J IMMUNOL, V62, P421, DOI 10.1111/j.1365-3083.2005.01688.x; Szodoray P, 2005, CLIN IMMUNOL, V117, P168, DOI 10.1016/j.clim.2005.06.016; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; TAUBMAN MA, 1974, INFECT IMMUN, V9, P1079, DOI 10.1128/IAI.9.6.1079-1091.1974; TAUBMAN MA, 1971, IMMUNOCHEMISTRY, V8, P1137, DOI 10.1016/0019-2791(71)90392-2; TAUBMAN MA, 1973, COMP IMMUNOLOGY ORAL, P138; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Tucker SN, 2004, VACCINE, V22, P2500, DOI 10.1016/j.vaccine.2003.12.034; Tucker SN, 2003, MOL THER, V8, P392, DOI 10.1016/S1525-0016(03)00180-1; Weyand CM, 2001, AM J PATHOL, V159, P787, DOI 10.1016/S0002-9440(10)61751-8; Xanthou G, 1999, CLIN EXP IMMUNOL, V118, P154; Xanthou G, 2001, ARTHRITIS RHEUM-US, V44, P408; Ye M, 2002, J VIROL, V76, P2100, DOI 10.1128/jvi.76.5.2100-2112.2002	85	20	20	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1680	1696		10.1096/fj.10-174656	http://dx.doi.org/10.1096/fj.10-174656			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21307334	Green Published			2022-12-25	WOS:000290023800024
J	Boehm, M; Romero, E; Reisinger, V; Yu, JF; Komenda, J; Eichacker, LA; Dekker, JP; Nixon, PJ				Boehm, Marko; Romero, Elisabet; Reisinger, Veronika; Yu, Jianfeng; Komenda, Josef; Eichacker, Lutz A.; Dekker, Jan P.; Nixon, Peter J.			Investigating the Early Stages of Photosystem II Assembly in Synechocystis sp PCC 6803 ISOLATION OF CP47 AND CP43 COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY CHLOROPHYLL STATES; ANTENNA PROTEIN COMPLEX; OXYGEN-EVOLVING CENTER; SP PCC-6803; CRYSTAL-STRUCTURE; SPECTROSCOPIC PROPERTIES; SYNECHOCOCCUS-ELONGATUS; ANGSTROM RESOLUTION; MANGANESE CLUSTER; CP43	Biochemical characterization of intermediates involved in the assembly of the oxygen-evolving Photosystem II (PSII) complex is hampered by their low abundance in the membrane. Using the cyanobacterium Synechocystis sp. PCC 6803, we describe here the isolation of the CP47 and CP43 subunits, which, during biogenesis, attach to a reaction center assembly complex containing D1, D2, and cytochrome b(559), with CP47 binding first. Our experimental approach involved a combination of His tagging, the use of a D1 deletion mutant that blocks PSII assembly at an early stage, and, in the case of CP47, the additional inactivation of the FtsH2 protease involved in degrading unassembled PSII proteins. Absorption spectroscopy and pigment analyses revealed that both CP47-His and CP43-His bind chlorophyll a and beta-carotene. A comparison of the low temperature absorption and fluorescence spectra in the Q(Y) region for CP47-His and CP43-His with those for CP47 and CP43 isolated by fragmentation of spinach PSII core complexes confirmed that the spectro-scopic properties are similar but not identical. The measured fluorescence quantum yield was generally lower for the proteins isolated from Synechocystis sp. PCC 6803, and a 1-3-nm blue shift and a 2-nm red shift of the 77 K emission maximum could be observed for CP47-His and CP43-His, respectively. Immunoblotting and mass spectrometry revealed the co-purification of PsbH, PsbL, and PsbT with CP47-His and of PsbK and Psb30/Ycf12 with CP43-His. Overall, our data support the view that CP47 and CP43 form preassembled pigment-protein complexes in vivo before their incorporation into the PSII complex.	[Nixon, Peter J.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Romero, Elisabet; Dekker, Jan P.] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Reisinger, Veronika; Eichacker, Lutz A.] Univ Stavanger, Ctr Organelle Res CORE, N-4021 Stavanger, Norway; [Komenda, Josef] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic	Imperial College London; Vrije Universiteit Amsterdam; Universitetet i Stavanger; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Nixon, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Wolfson Biochem Bldg,S Kensington Campus, London SW7 2AZ, England.	p.nixon@imperial.ac.uk	Komenda, Josef/H-4083-2014	Komenda, Josef/0000-0003-4588-0382; Yu, Jianfeng/0000-0001-7174-3803; Romero, Elisabet/0000-0003-3630-1617; Nixon, Peter/0000-0003-1952-6937	Engineering and Physical Sciences Research Council (EPSRC) [EP/F002070X/1]; Czech Academy of Science Institutional Research Concept [AV0Z50200510, IAA400200801]; BBSRC [BB/F020554/1, BB/E006388/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F020554/1, BB/E006388/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Czech Academy of Science Institutional Research Concept; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Engineering and Physical Sciences Research Council (EPSRC) Grant EP/F002070X/1 and in part by Czech Academy of Science Institutional Research Concept AV0Z50200510 and Grant Project IAA400200801.	ALFONSO M, 1994, BIOCHEMISTRY-US, V33, P10494, DOI 10.1021/bi00200a034; Andronis C, 1998, PLANT PHYSIOL, V117, P515, DOI 10.1104/pp.117.2.515; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boehm M, 2009, J BACTERIOL, V191, P6425, DOI 10.1128/JB.00644-09; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Debus RJ, 2001, BIOCHEMISTRY-US, V40, P3690, DOI 10.1021/bi002394c; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; GHANOTAKIS DF, 1989, BIOCHIM BIOPHYS ACTA, V974, P44, DOI 10.1016/S0005-2728(89)80164-1; Granvogl B, 2008, ANAL BIOCHEM, V383, P279, DOI 10.1016/j.ab.2008.08.038; Groot ML, 1999, BIOPHYS J, V77, P3328, DOI 10.1016/S0006-3495(99)77164-X; GROOT ML, 1995, BIOPHYS J, V68, P281, DOI 10.1016/S0006-3495(95)80186-4; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hughes JL, 2006, BIOCHEMISTRY-US, V45, P12345, DOI 10.1021/bi0614683; Iwata S, 2004, CURR OPIN STRUC BIOL, V14, P447, DOI 10.1016/j.sbi.2004.07.002; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Komenda J, 2006, J BIOL CHEM, V281, P1145, DOI 10.1074/jbc.M503852200; Komenda J, 2005, PLANT CELL PHYSIOL, V46, P1477, DOI 10.1093/pcp/pci159; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; KOMENDA J, 1995, BIOCHEMISTRY-US, V34, P9625, DOI 10.1021/bi00029a040; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Manna P, 1997, EUR J BIOCHEM, V247, P666, DOI 10.1111/j.1432-1033.1997.00666.x; Muh F, 2008, PLANT PHYSIOL BIOCH, V46, P238, DOI 10.1016/j.plaphy.2008.01.003; Neupane B, 2010, J AM CHEM SOC, V132, P4214, DOI 10.1021/ja908510w; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NIXON PJ, 1995, J BIOL CHEM, V270, P14919, DOI 10.1074/jbc.270.25.14919; NIXON PJ, 1992, BIOCHEMISTRY-US, V31, P10859, DOI 10.1021/bi00159a029; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Reppert M, 2008, J PHYS CHEM B, V112, P9934, DOI 10.1021/jp8013749; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; SHEN GZ, 1994, BIOCHEMISTRY-US, V33, P7379, DOI 10.1021/bi00189a044; Shen J.-R., 2010, 15 INT C PHOT BEIJ A; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Sugimoto I, 2003, J BIOL CHEM, V278, P45004, DOI 10.1074/jbc.M307537200; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219, DOI 10.1093/oxfordjournals.pcp.a029510; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V893, P267, DOI 10.1016/0005-2728(87)90048-X; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Wydrzynski T. J., 2005, PHOTOSYSTEM; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	44	69	71	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14812	14819		10.1074/jbc.M110.207944	http://dx.doi.org/10.1074/jbc.M110.207944			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21339295	Green Published, hybrid			2022-12-25	WOS:000289788300011
J	Crellin, PK; Brammananth, R; Coppel, RL				Crellin, Paul K.; Brammananth, Rajini; Coppel, Ross L.			Decaprenylphosphoryl-beta-D-Ribose 2 '-Epimerase, the Target of Benzothiazinones and Dinitrobenzamides, Is an Essential Enzyme in Mycobacterium smegmatis	PLOS ONE			English	Article							CELL-WALL; TUBERCULOSIS; MUTAGENESIS; ARABINAN; RESISTANCE; EXCHANGE; LAYERS	Background: The unique cell wall of bacteria of the suborder Corynebacterineae is essential for the growth and survival of significant human pathogens including Mycobacterium tuberculosis and Mycobacterium leprae. Drug resistance in mycobacteria is an increasingly common development, making identification of new antimicrobials a priority. Recent studies have revealed potent anti-mycobacterial compounds, the benzothiazinones and dinitrobenzamides, active against DprE1, a subunit of decaprenylphosphoribose 29 epimerase which forms decaprenylphosphoryl arabinose, the arabinose donor for mycobacterial cell wall biosynthesis. Despite the exploitation of Mycobacterium smegmatis in the identification of DprE1 as the target of these new antimicrobials and its use in the exploration of mechanisms of resistance, the essentiality of DprE1 in this species has never been examined. Indeed, direct experimental evidence of the essentiality of DprE1 has not been obtained in any species of mycobacterium. Methodology/Principal Findings: In this study we constructed a conditional gene knockout strain targeting the ortholog of dprE1 in M. smegmatis, MSMEG_6382. Disruption of the chromosomal copy of MSMEG_6382 was only possible in the presence of a plasmid-encoded copy of MSMEG_6382. Curing of this "rescue'' plasmid from the bacterial population resulted in a cessation of growth, demonstrating gene essentiality. Conclusions/Significance: This study provides the first direct experimental evidence for the essentiality of DprE1 in mycobacteria. The essentiality of DprE1 in M. smegmatis, combined with its conservation in all sequenced mycobacterial genomes, suggests that decaprenylphosphoryl arabinose synthesis is essential in all mycobacteria. Our findings indicate a lack of redundancy in decaprenylphosphoryl arabinose synthesis in M. smegmatis, despite the relatively large coding capacity of this species, and suggest that no alternative arabinose donors for cell wall biosynthesis exist. Overall, this study further validates DprE1 as a promising target for new anti-mycobacterial drugs.	[Crellin, Paul K.; Brammananth, Rajini; Coppel, Ross L.] Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Dept Microbiol, Clayton, Vic 3800, Australia	Monash University	Crellin, PK (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Struct & Fu, Dept Microbiol, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124; Crellin, Paul K/0000-0002-2017-4935	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics; National Health and Medical Research Council of Australia	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics and the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERBERG RJ, 1995, BIOTECHNIQUES, V18, P217; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; GUILHOT C, 1992, FEMS MICROBIOL LETT, V98, P181; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Makarov V, 2006, J ANTIMICROB CHEMOTH, V57, P1134, DOI 10.1093/jac/dkl095; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Pasca MR, 2010, ANTIMICROB AGENTS CH, V54, P1616, DOI 10.1128/AAC.01676-09; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Riccardi G, 2009, FUTURE MICROBIOL, V4, P597, DOI [10.2217/fmb.09.20, 10.2217/FMB.09.20]; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SOUTHERN EM, 1974, ANAL BIOCHEM, V62, P317, DOI 10.1016/0003-2697(74)90395-9; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; *WHO, 2009, WHO REP 2009 GLOB TU; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	25	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16869	10.1371/journal.pone.0016869	http://dx.doi.org/10.1371/journal.pone.0016869			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346818	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600032
J	Juncker-Jensen, A; Lund, LR				Juncker-Jensen, Anna; Lund, Leif R.			Phenotypic Overlap between MMP-13 and the Plasminogen Activation System during Wound Healing in Mice	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; MATRIX METALLOPROTEINASES; COLLAGENASE-3; EXPRESSION; CANCER; ANGIOGENESIS; DEGRADATION; INVASION; CONTRACTION; INHIBITOR	Background: Proteolytic degradation of extracellular matrix is a crucial step in the healing of incisional skin wounds. Thus, healing of skin wounds is delayed by either plasminogen-deficiency or by treatment with the broad-spectrum metalloproteinase (MP) inhibitor Galardin alone, while the two perturbations combined completely prevent wound healing. Both urokinase-type plasminogen activator and several matrix metallo proteinases (MMPs), such as MMP-3, -9 and -13, are expressed in the leading-edge keratinocytes of skin wounds, which may account for this phenotypic overlap between these classes of proteases. Methodology: To further test that hypothesis we generated Mmp13;Plau and Mmp13;Plg double-deficient mice in a cross between Mmp13- and Plau-deficient mice as well as Mmp13- and Plg-deficient mice. These mice were examined for normal physiology in a large cohort study and in a well-characterized skin wound healing model, in which we made incisional 20 mm-long full-thickness skin wounds. Principal Findings: While mice that are deficient in Mmp13 have a mean healing time indistinguishable to wild-type mice, wound healing in both Plau- and Plg-deficient mice is significantly delayed. Histological analysis of healed wounds revealed a significant increase in keratin 10/14 immunoreactive layers of kerationcytes in the skin surface in Mmp13; Plau double-deficient mice. Furthermore, we observe, by immunohistological analysis, an aberrant angiogenic pattern during wound healing induced by Plau-deficiency, which has not previously been described. Conclusions: We demonstrate a phenotypic overlap, defined as an additional delay in wound healing in the double-deficient mice compared to the individual single-deficient mice, between MMP-13 and the plasminogen activation system in the process of wound healing, but not during gestation and in postnatal development. Thus, a dual targeting of uPA and MMP-13 might be a possible future strategy in designing therapies aimed at tissue repair or other pathological processes, such as cancer invasion, where proteolytic degradation is a hallmark.	[Juncker-Jensen, Anna; Lund, Leif R.] Rigshosp, Finsen Lab, Copenhagen Bioctr, DK-2100 Copenhagen, Denmark; [Lund, Leif R.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Juncker-Jensen, A (corresponding author), Rigshosp, Finsen Lab, Copenhagen Bioctr, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	lrlund@sund.ku.dk			European Union [201279]; MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus" Foundation; Danish Cancer Society; Danish Cancer Research Foundation; "Agnes og Poul Friis" Foundation; Soren og Helene Hempels Legat; Lundbeck Foundation; Desiree og Niels Ydes Fond	European Union(European Commission); MICROENVIMET; Aage Bangs Foundation; "Grosserer Alfred Nielsen og Hustrus" Foundation; Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; "Agnes og Poul Friis" Foundation; Soren og Helene Hempels Legat; Lundbeck Foundation(Lundbeckfonden); Desiree og Niels Ydes Fond	This work is supported by grants from the European Union Grant 201279, MICROENVIMET, Aage Bangs Foundation, "Grosserer Alfred Nielsen og Hustrus" Foundation, Danish Cancer Society, the Danish Cancer Research Foundation, "Agnes og Poul Friis" Foundation, "Soren og Helene Hempels Legat", Lundbeck Foundation, and "Desiree og Niels Ydes Fond". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affara Nesrine I., 2009, V539, P1, DOI 10.1007/978-1-60327-003-8_1; Airola K, 1997, J INVEST DERMATOL, V109, P225, DOI 10.1111/1523-1747.ep12319441; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Almholt Kasper, 2008, P203, DOI 10.1007/978-0-387-69057-5_11; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Cazorla M, 1998, J PATHOL, V186, P144, DOI 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Frossing S, 2010, EXP DERMATOL, V19, pE234, DOI 10.1111/j.1600-0625.2009.01062.x; Goscinski MA, 2008, ONCOLOGY-BASEL, V75, P49, DOI 10.1159/000151741; Green KA, 2008, J INVEST DERMATOL, V128, P2092, DOI 10.1038/jid.2008.54; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; HALD A, 2010, DIS MODEL MECH; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hattori N, 2009, AM J PATHOL, V175, P533, DOI 10.2353/ajpath.2009.081080; Hiller O, 2000, J BIOL CHEM, V275, P33008, DOI 10.1074/jbc.M001836200; Johansson N, 1997, AM J PATHOL, V151, P499; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lemaitre Vincent, 2006, Birth Defects Research, V78, P1, DOI 10.1002/bdrc.20065; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Lund LR, 1996, DEVELOPMENT, V122, P181; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mingers AM, 1997, SEMIN THROMB HEMOST, V23, P259, DOI 10.1055/s-2007-996099; Moali C, 2009, EUR J DERMATOL, V19, P552, DOI 10.1684/ejd.2009.0770; Mohan R, 2002, J BIOL CHEM, V277, P2065, DOI 10.1074/jbc.M107611200; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Netzel-Arnett S, 2002, J BIOL CHEM, V277, P45154, DOI 10.1074/jbc.M206354200; Nielsen BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002959; Ogura Y, 2008, BRIT J DERMATOL, V159, P49, DOI 10.1111/j.1365-2133.2008.08576.x; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rakic JM, 2003, CELL MOL LIFE SCI, V60, P463, DOI 10.1007/s000180300039; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Romer J, 2001, J INVEST DERMATOL, V116, P353, DOI 10.1046/j.1523-1747.2001.01241.x; ROMER J, 1991, J INVEST DERMATOL, V97, P803, DOI 10.1111/1523-1747.ep12486833; Saghatelian A, 2004, P NATL ACAD SCI USA, V101, P10000, DOI 10.1073/pnas.0402784101; Schafer M, 2008, NAT REV MOL CELL BIO, V9, P628, DOI 10.1038/nrm2455; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Tkachuk VA, 2009, CAN J PHYSIOL PHARM, V87, P231, DOI 10.1139/Y08-113; Toriseva M, 2009, CELL MOL LIFE SCI, V66, P203, DOI 10.1007/s00018-008-8388-4; Uttamchandani M, 2007, J AM CHEM SOC, V129, P7848, DOI 10.1021/ja070870h; Wahlgren J, 2003, J ORAL PATHOL MED, V32, P100, DOI 10.1034/j.1600-0714.2003.00075.x; Zijlstra A, 2004, J BIOL CHEM, V279, P27633, DOI 10.1074/jbc.M313617200	58	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16954	10.1371/journal.pone.0016954	http://dx.doi.org/10.1371/journal.pone.0016954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326869	Green Published, gold, Green Submitted			2022-12-25	WOS:000287037000032
J	Cabezas, F; Lagos, J; Cespedes, C; Vio, CP; Bronfman, M; Marzolo, MP				Cabezas, Felipe; Lagos, Jonathan; Cespedes, Carlos; Vio, Carlos P.; Bronfman, Miguel; Marzolo, Maria-Paz			Megalin/LRP2 Expression Is Induced by Peroxisome Proliferator-Activated Receptor -Alpha and -Gamma: Implications for PPARs' Roles in Renal Function	PLOS ONE			English	Article							PROXIMAL TUBULAR CELLS; ANGIOTENSIN-II; GENE-EXPRESSION; MEDIATED ENDOCYTOSIS; ALBUMIN REABSORPTION; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; MICE LACKING; FATTY-ACIDS; PIOGLITAZONE	Background: Megalin is a large endocytic receptor with relevant functions during development and adult life. It is expressed at the apical surface of several epithelial cell types, including proximal tubule cells (PTCs) in the kidney, where it internalizes apolipoproteins, vitamins and hormones with their corresponding carrier proteins and signaling molecules. Despite the important physiological roles of megalin little is known about the regulation of its expression. By analyzing the human megalin promoter, we found three response elements for the peroxisomal proliferator-activated receptor (PPAR). The objective of this study was to test whether megalin expression is regulated by the PPARs. Methodology/Principal Findings: Treatment of epithelial cell lines with PPAR alpha or PPAR gamma ligands increased megalin mRNA and protein expression. The stimulation of megalin mRNA expression was blocked by the addition of specific PPAR alpha or PPAR gamma antagonists. Furthermore, PPAR bound to three PPAR response elements located in the megalin promoter, as shown by EMSA, and PPAR alpha and its agonist activated a luciferase construct containing a portion of the megalin promoter and the first response element. Accordingly, the activation of PPAR alpha and PPAR gamma enhanced megalin expression in mouse kidney. As previously observed, high concentrations of bovine serum albumin (BSA) decreased megalin in PTCs in vitro; however, PTCs pretreated with PPAR alpha and PPAR gamma agonists avoided this BSA-mediated reduction of megalin expression. Finally, we found that megalin expression was significantly inhibited in the PTCs of rats that were injected with BSA to induce tubulointerstitial damage and proteinuria. Treatment of these rats with PPAR gamma agonists counteracted the reduction in megalin expression and the proteinuria induced by BSA. Conclusions: PPAR alpha/gamma and their agonists positively control megalin expression. This regulation could have an important impact on several megalin-mediated physiological processes and on pathophysiologies such as chronic kidney disease associated with diabetes and hypertension, in which megalin expression is impaired.	[Cabezas, Felipe; Lagos, Jonathan; Bronfman, Miguel; Marzolo, Maria-Paz] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Santiago, Chile; [Cespedes, Carlos; Vio, Carlos P.] Pontificia Univ Catolica Chile, Dept Fisiol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Cabezas, F (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Alameda 340, Santiago, Chile.	mmarzolo@bio.puc.cl	Céspedes, Carlos Leonardo/D-3138-2013	Céspedes, Carlos Leonardo/0000-0002-3715-3268; , Carlos Cespedes/0000-0003-0297-7598; Vio, Carlos/0000-0003-1850-5958	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica, CHILE) [1070373]; Proyecto Nucleo Milenio [P07/011-F]; Fondos del Programa Iniciativa Cientifica Milenio (ICM) [1080590];  [PFB 12-2007]	Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica, CHILE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Nucleo Milenio; Fondos del Programa Iniciativa Cientifica Milenio (ICM); 	This work was supported by Grants: Fondecyt (Fondo Nacional de Investigacion Cientifica y Tecnologica, CHILE) Grants 1070373 and Proyecto Nucleo Milenio P07/011-F, Fondos del Programa Iniciativa Cientifica Milenio (ICM) (www.iniciativamilenio.cl) to MPM and 1080590 to CPV (www.fondecyt.cl). PFB 12-2007 to CPV and MB (www.fondecyt.cl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed NM, 2004, J BIOL CHEM, V279, P49747, DOI 10.1074/jbc.M408268200; Ambjorn M, 2008, J NEUROCHEM, V104, P21, DOI 10.1111/j.1471-4159.2007.05036.x; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Ardiles LG, 2006, KIDNEY INT, V69, P53, DOI 10.1038/sj.ki.5000005; Banks T, 2008, J HYPERTENS, V26, P468, DOI 10.1097/HJH.0b013e3282f2f0f3; Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bulhak AA, 2009, AM J PHYSIOL-HEART C, V296, pH719, DOI 10.1152/ajpheart.00394.2008; Calkin AC, 2006, NEPHROL DIAL TRANSPL, V21, P2399, DOI 10.1093/ndt/gfl212; Carro E, 2005, J NEUROSCI, V25, P10884, DOI 10.1523/JNEUROSCI.2909-05.2005; Caruso-Neves C, 2006, P NATL ACAD SCI USA, V103, P18810, DOI 10.1073/pnas.0605029103; Carvajal G, 2008, KIDNEY INT, V74, P585, DOI 10.1038/ki.2008.213; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Chinetti-Gbaguidi Giulia, 2005, Curr Atheroscler Rep, V7, P396, DOI 10.1007/s11883-005-0053-x; Christensen EI, 1998, RENAL FAILURE, V20, P191, DOI 10.3109/08860229809045102; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Cimini A, 2005, NEUROSCIENCE, V130, P325, DOI 10.1016/j.neuroscience.2004.09.043; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; CZEKAY RP, 1995, J CELL SCI, V108, P1433; DIETRICH MO, 2007, NEUROBIOL AGING; EDDY AA, 1989, AM J PATHOL, V135, P719; Erranz B, 2004, J LIPID RES, V45, P2185, DOI 10.1194/jlr.M400235-JLR200; Fang HL, 2005, MOL PHARMACOL, V67, P1257, DOI 10.1124/mol.104.005389; Fleming CE, 2009, J NEUROSCI, V29, P3220, DOI 10.1523/JNEUROSCI.6012-08.2009; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fujigaki Y, 2009, NEPHROL DIAL TRANSPL, V24, P2686, DOI 10.1093/ndt/gfp199; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; Giral H, 2007, TOXICOL IN VITRO, V21, P1066, DOI 10.1016/j.tiv.2007.03.021; Gonzalez-Villalobos R, 2006, AM J PHYSIOL-RENAL, V290, pF1270, DOI 10.1152/ajprenal.00164.2005; Gonzalez-Villalobos R, 2005, AM J PHYSIOL-RENAL, V288, pF420, DOI 10.1152/ajprenal.00243.2004; Guan YF, 2004, J AM SOC NEPHROL, V15, P2801, DOI 10.1097/01.ASN.0000139067.83419.46; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF1013, DOI 10.1152/ajprenal.1997.273.6.F1013; Guggino SE, 2007, NAT CLIN PRACT NEPHR, V3, P449, DOI 10.1038/ncpneph0541; Hama H, 2004, ENDOCRINOLOGY, V145, P3935, DOI 10.1210/en.2004-0074; Hayden MR, 2010, AM J NEPHROL, V31, P262, DOI 10.1159/000278757; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hosojima M, 2009, ENDOCRINOLOGY, V150, P871, DOI 10.1210/en.2008-0886; Ijpenberg A, 1997, J BIOL CHEM, V272, P20108, DOI 10.1074/jbc.272.32.20108; Imano E, 1998, DIABETES CARE, V21, P2135, DOI 10.2337/diacare.21.12.2135; Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Knutson A, 1998, DNA CELL BIOL, V17, P551, DOI 10.1089/dna.1998.17.551; Kumpers P, 2007, AM J PHYSIOL-RENAL, V293, pF1355, DOI 10.1152/ajprenal.00003.2007; Lee BH, 2009, PEDIATR NEPHROL, V24, P2211, DOI 10.1007/s00467-009-1238-2; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; Letavernier E, 2005, J AM SOC NEPHROL, V16, P2395, DOI 10.1681/ASN.2004090802; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Li RF, 2007, FEBS LETT, V581, P3311, DOI 10.1016/j.febslet.2007.06.017; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Liu W, 1998, EUR J CLIN INVEST, V28, P100; Madeddu P, 2001, KIDNEY INT, V59, P2233, DOI 10.1046/j.1523-1755.2001.00738.x; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Marino M, 2001, THYROID, V11, P47, DOI 10.1089/10507250150500667; Marzolo MP, 2003, TRAFFIC, V4, P273, DOI 10.1034/j.1600-0854.2003.00081.x; Maurer ME, 2005, J CELL SCI, V118, P5345, DOI 10.1242/jcs.02650; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; Miyazaki Y, 2007, KIDNEY INT, V72, P1367, DOI 10.1038/sj.ki.5002516; Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081; Nakamura T, 2000, J DIABETES COMPLICAT, V14, P250, DOI 10.1016/S1056-8727(00)00124-0; Nakamura T, 2001, METABOLISM, V50, P1193, DOI 10.1053/meta.2001.26703; Nakamura T, 2006, DIABETES-METAB RES, V22, P385, DOI 10.1002/dmrr.633; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Odera K, 2007, BIOGERONTOLOGY, V8, P505, DOI 10.1007/s10522-007-9093-7; Orlando RA, 1998, J AM SOC NEPHROL, V9, P1759; Oyama Y, 2005, LAB INVEST, V85, P522, DOI 10.1038/labinvest.3700240; Pan GD, 2005, WORLD J GASTROENTERO, V11, P6061, DOI 10.3748/wjg.v11.i38.6061; Park CW, 2006, DIABETES, V55, P885, DOI 10.2337/diabetes.55.04.06.db05-1329; Park CW, 2006, KIDNEY INT, V69, P1511, DOI 10.1038/sj.ki.5000209; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Roberts TJM, 2009, AM J PHYSIOL-HEART C, V297, pH1347, DOI 10.1152/ajpheart.00630.2009; Rokos CL, 1997, J BIOL CHEM, V272, P13452, DOI 10.1074/jbc.272.20.13452; Salas SP, 2007, HYPERTENSION, V50, P773, DOI 10.1161/HYPERTENSIONAHA.107.094540; Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65; Schupp M, 2005, DIABETES, V54, P3442, DOI 10.2337/diabetes.54.12.3442; Shibata T, 2000, BRIT J PHARMACOL, V130, P495, DOI 10.1038/sj.bjp.0703328; Spoelgen R, 2005, DEVELOPMENT, V132, P405, DOI 10.1242/dev.01580; Stanton BA, 2004, KIDNEY; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Toblli JE, 2009, NEPHROL DIAL TRANSPL, V24, P2384, DOI 10.1093/ndt/gfp103; Tojo A, 2003, HYPERTENS RES, V26, P413, DOI 10.1291/hypres.26.413; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Vinuesa E, 2008, AM J PHYSIOL-RENAL, V295, pF1554, DOI 10.1152/ajprenal.90250.2008; Vio CP, 2001, J AM SOC NEPHROL, V12, P649, DOI 10.1681/ASN.V124649; Watanabe T, 2004, PEDIATR NEPHROL, V19, P1305, DOI 10.1007/s00467-004-1605-y; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Wolf G, 2006, CONTRIB NEPHROL, V151, P175, DOI 10.1159/000095328; Yang Q, 2008, TOXICOL SCI, V101, P132, DOI 10.1093/toxsci/kfm206; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF966, DOI 10.1152/ajprenal.1999.277.6.F966; Yuseff MI, 2007, TRAFFIC, V8, P1215, DOI 10.1111/j.1600-0854.2007.00601.x; Zafiriou S, 2004, KIDNEY INT, V65, P1647, DOI 10.1111/j.1523-1755.2004.00574.x; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	98	41	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16794	10.1371/journal.pone.0016794	http://dx.doi.org/10.1371/journal.pone.0016794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311715	Green Published, Green Submitted, gold			2022-12-25	WOS:000287036200041
J	Alvarez-Loayza, P; White, JF; Torres, MS; Balslev, H; Kristiansen, T; Svenning, JC; Gil, N				Alvarez-Loayza, Patricia; White, James F., Jr.; Torres, Monica S.; Balslev, Henrik; Kristiansen, Thea; Svenning, Jens-Christian; Gil, Nathalie			Light Converts Endosymbiotic Fungus to Pathogen, Influencing Seedling Survival and Niche-Space Filling of a Common Tropical Tree, Iriartea deltoidea	PLOS ONE			English	Article							SPATIAL-PATTERNS; MORTALITY; ENDOPHYTES; BOTRYOSPHAERIACEAE; DIVERSIFICATION; DISTRIBUTIONS; POPULATIONS; DIVERSITY; DOMINANCE; SYMBIOSIS	Pathogens are hypothesized to play an important role in the maintenance of tropical forest plant species richness. Notably, species richness may be promoted by incomplete filling of niche space due interactions of host populations with their pathogens. A potentially important group of pathogens are endophytic fungi, which asymptomatically colonize plants and are diverse and abundant in tropical ecosystems. Endophytes may alter competitive abilities of host individuals and improve host fitness under stress, but may also become pathogenic. Little is known of the impacts of endophytes on niche-space filling of their hosts. Here we evaluate how a widespread fungal endophyte infecting a common tropical palm influences its recruitment and survival in natural ecosystems, and whether this impact is modulated by the abiotic environment, potentially constraining host niche-space filling. Iriartea deltoidea dominates many wet lowland Neotropical forests. Diplodia mutila is a common asymptomatic endophyte in mature plants; however, it causes disease in some seedlings. We investigated the effects of light availability on D. mutila disease expression. We found I. deltoidea seedlings to preferentially occur under shady conditions. Correspondingly, we also found that high light triggers endophyte pathogenicity, while low light favors endosymbiotic development, constraining recruitment of endophyte-infested seedlings to shaded understory by reducing seedling survival in direct light. Pathogenicity of D. mutila under high light is proposed to result from light-induced production of H2O2 by the fungus, triggering hypersensitivity, cell death, and tissue necrosis in the palm. This is the first study to demonstrate that endophytes respond to abiotic factors to influence plant distributions in natural ecosystems; and the first to identify light as a factor influencing where an endophyte is placed on the endosymbiont-pathogen continuum. Our findings show that pathogens can indeed constrain niche-space filling of otherwise successful tropical plant species, providing unoccupied niche space for other species.	[Alvarez-Loayza, Patricia; White, James F., Jr.; Torres, Monica S.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Alvarez-Loayza, Patricia] Duke Univ, Nicholas Sch Environm, Ctr Trop Conservat, Durham, NC 27708 USA; [Balslev, Henrik; Kristiansen, Thea; Svenning, Jens-Christian] Aarhus Univ, Ecoinformat & Biodivers Grp, Dept Biol Sci, Aarhus, Denmark; [Gil, Nathalie] Univ Nacl San Antonio de Abad, Cuzco, Peru	Rutgers State University New Brunswick; Duke University; Aarhus University	Alvarez-Loayza, P (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA.	pcaz@duke.edu	Balslev, Hendrik/AAE-4071-2020; Balslev, Henrik/J-9191-2013; Svenning, Jens-Christian/C-8977-2012; White, James F/C-2280-2009	Balslev, Henrik/0000-0002-7101-7120; Svenning, Jens-Christian/0000-0002-3415-0862; Alvarez-Loayza, Patricia/0000-0002-0090-4013; White, James/0000-0002-6780-7066	Rutgers University; Organization for Tropical Studies; Amazon Conservation Association (ACA); New Jersey Agricultural Experiment Station; Danish Natural Science Research Council [272-06-0476, 272-07-0242]; European Community [212631]	Rutgers University; Organization for Tropical Studies; Amazon Conservation Association (ACA); New Jersey Agricultural Experiment Station; Danish Natural Science Research Council(Danish Natural Science Research Council); European Community(European Commission)	P. Alvarez-Loayza was supported by Rutgers University Fellowship, Pre-Dissertation Travel Grant, and the Francis J. Bossuyt Fellowship from the Organization for Tropical Studies, and Amazon Conservation Association (ACA). This research was also financially supported by the New Jersey Agricultural Experiment Station, the Danish Natural Science Research Council (grants 272-06-0476 and 272-07-0242) and the European Community FP7 programme PALMS project (grant agreement 212631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios GN, 2005, PLANT PATHOLOGY; Alvarez-Loayza P, 2008, PLANT PATHOL, V57, P382, DOI 10.1111/j.1365-3059.2007.01747.x; ALVAREZLOAYZA P, 2009, THESIS RUTGERS U NEW; Arnold AE, 2007, J TROP ECOL, V23, P369, DOI 10.1017/S0266467407004038; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; CONNELL J H, 1971, P298; Crous PW, 2006, STUD MYCOL, P235, DOI 10.3114/sim.55.1.235; Damm U, 2007, MYCOLOGIA, V99, P664, DOI 10.3852/mycologia.99.5.664; Grubb PJ, 2008, ANN BOT-LONDON, V101, P1379, DOI 10.1093/aob/mcn047; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kristiansen T, 2009, ACTA OECOL, V35, P554, DOI 10.1016/j.actao.2009.05.001; Kuldau GA, 2000, BOOK SOIL P, P85; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Macia MJ, 2005, J TROP ECOL, V21, P613, DOI 10.1017/S0266467405002579; Mittler R, 1997, J CELL SCI, V110, P1333; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Panter SN, 2002, ADV BOT RES, V38, P251, DOI 10.1016/S0065-2296(02)38032-7; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Petrini O., 1986, MICROBIOLOGY PHYLLOS, P175; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; PITMAN NCA, 2007, OVERVIEW LOS AMIGOS; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; RAVISHANKAR JP, 1995, BOT MAR, V38, P413, DOI 10.1515/botm.1995.38.1-6.413; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P1265, DOI 10.1073/pnas.0913626107; Rodriguez R. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P261, DOI 10.1023/B:MITI.0000029922.31110.97; Schulz B, 1998, SYMBIOSIS, V25, P213; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Slippers Bernard, 2007, Fungal Biology Reviews, V21, P90, DOI 10.1016/j.fbr.2007.06.002; Sutton B. C., 1980, The Coelomycetes. Fungi imperfecti with pycnidia, acervuli and stromata.; Svenning JC, 1999, J TROP ECOL, V15, P355, DOI 10.1017/S0266467499000875; Svenning JC, 2001, BOT REV, V67, P1, DOI 10.1007/BF02857848; Terborgh J, 2001, J TROP ECOL, V17, P695, DOI 10.1017/S0266467401001511; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Wattenberg I., 1995, Ecotropica, V1, P21	43	104	108	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16386	10.1371/journal.pone.0016386	http://dx.doi.org/10.1371/journal.pone.0016386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305008	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300058
J	Crucitti, T; Jespers, V; Mulenga, C; Khondowe, S; Vandepitte, J; Buve, A				Crucitti, Tania; Jespers, Vicky; Mulenga, Chanda; Khondowe, Shepherd; Vandepitte, Judith; Buve, Anne			Non-Sexual Transmission of Trichomonas vaginalis in Adolescent Girls Attending School in Ndola, Zambia	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED DISEASES; HIV-1; INFECTION; EPIDEMIOLOGY; ACQUISITION; PREVALENCE; WOMEN; RISK; PCR	Objectives: To identify risk factors for trichomoniasis among young women in Ndola, Zambia. Method: The study was a cross-sectional study among adolescent girls aged 13-16 years in Ndola, Zambia. Study participants were recruited from schools in selected administrative areas that represented the different socio-economic strata in town. Consenting participants were interviewed about their socio-demographic characteristics; sexual behaviour; and hygiene practices. Self-administered vaginal swabs were tested for Trichomonas vaginalis. HSV-2 antibodies were determined on serum to validate the self-reported sexual activity. Results: A total of 460 girls participated in the study. The overall prevalence of trichomoniasis was 27.1%, 33.9% among girls who reported that they had ever had sex and 24.7% among virgins. In multivariate analysis the only statistically significant risk factor for trichomoniasis was inconsistent use of soap. For the virgins, none of the risk factors was significantly associated with trichomoniasis, but the association with use of soap (not always versus always) and type of toilet used (pit latrine/bush versus flush toilet) was of borderline significance. Conclusion: We found a high prevalence of trichomoniasis in girls in Ndola who reported that they had never had sex. We postulate that the high prevalence of trichomoniasis in virgins in Ndola is due to non-sexual transmission of trichomoniasis via shared bathing water and inconsistent use of soap.	[Crucitti, Tania] Inst Trop Med, HIV STI Reference Lab, B-2000 Antwerp, Belgium; [Jespers, Vicky; Vandepitte, Judith; Buve, Anne] Inst Trop Med, HIV STI Epidemiol & Control Unit, B-2000 Antwerp, Belgium; [Mulenga, Chanda; Khondowe, Shepherd] Trop Dis Res Ctr, Ndola, Zambia	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	Crucitti, T (corresponding author), Inst Trop Med, HIV STI Reference Lab, B-2000 Antwerp, Belgium.	tcrucitti@itg.be	Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAH-1902-2021; Crucitti, Tania/AAB-9967-2019	Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038	Directorate General for Development Cooperation of the Belgian Government [904100]	Directorate General for Development Cooperation of the Belgian Government	This study was made possible thanks to a grant from the Directorate General for Development Cooperation of the Belgian Government (AIDS Impuls Fonds no904100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Sarkodie Y, 2007, SEX TRANSM INFECT, V83, P130, DOI 10.1136/sti.2006.020941; ADUSARKODIE Y, 1995, GENITOURIN MED, V71, P199; BURCH TA, 1959, AM J TROP MED HYG, V8, P312, DOI 10.4269/ajtmh.1959.8.312; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Buve A, 2001, AIDS, V15, pS79, DOI 10.1097/00002030-200108004-00009; CATES W, 1993, AM J OBSTET GYNECOL, V169, P341, DOI 10.1016/0002-9378(93)90085-W; CHAPPAZ G, 1961, Rev Fr Gynecol Obstet, V56, P677; CHARLES SX, 1991, J TROP PEDIATRICS, V37, P90, DOI 10.1093/tropej/37.2.90; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Cotch MF, 1997, SEX TRANSM DIS, V24, P353, DOI 10.1097/00007435-199707000-00008; Crucitti T, 2003, SEX TRANSM INFECT, V79, P393, DOI 10.1136/sti.79.5.393; Crucitti T, 2010, SEX TRANSM DIS, V37, P223, DOI 10.1097/OLQ.0b013e3181c21f93; FOUTS A, 1980, J INFECT DIS, V41, P137; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; KENGNE P, 1994, CELL MOL BIOL, V40, P819; Kissinger P, 2009, SEX TRANSM DIS, V36, P11, DOI 10.1097/OLQ.0b013e318186decf; Krieger H, 1995, Gesundheitswesen, V57, P812; LAGA M, 1993, AIDS, V7, P95, DOI 10.1097/00002030-199301000-00015; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Peterson K, 2010, SEX TRANSM INFECT, V86, P353, DOI 10.1136/sti.2010.043125; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Shaio MF, 1997, J CLIN MICROBIOL, V35, P132, DOI 10.1128/JCM.35.1.132-138.1997; UNAIDS/WHO, 2008, UNAIDS WHO EP FACT S; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; 1957, TRICHOMONAS INFECT, P1239	26	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16310	10.1371/journal.pone.0016310	http://dx.doi.org/10.1371/journal.pone.0016310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305023	Green Published, gold			2022-12-25	WOS:000286834300049
J	Harner, S; Noessner, E; Nadas, K; Leumann-Runge, A; Schiemann, M; Faber, FL; Heinrich, J; Krauss-Etschmann, S				Harner, Susanne; Noessner, Elfriede; Nadas, Korinna; Leumann-Runge, Anke; Schiemann, Matthias; Faber, Fabienne L.; Heinrich, Joachim; Krauss-Etschmann, Susanne			Cord Blood V alpha 24-V beta 11(+) Natural Killer T Cells Display a Th2-Chemokine Receptor Profile and Cytokine Responses	PLOS ONE			English	Article							INVARIANT NKT CELLS; CUTTING EDGE; LYMPHOCYTES; SUBSETS; CD4(+); REQUIREMENTS; ENVIRONMENT; EXPRESSION; V-ALPHA-24; PROTECTION	Background: The fetal immune system is characterized by a Th2 bias but it is unclear how the Th2 predominance is established. Natural killer T (NKT) cells are a rare subset of T cells with immune regulatory functions and are already activated in utero. To test the hypothesis that NKT cells are part of the regulatory network that sets the fetal Th2 predominance, percentages of V alpha 24(+)V beta 11(+) NKT cells expressing Th1/Th2-related chemokine receptors (CKR) were assessed in cord blood. Furthermore, IL-4 and IFN-gamma secreting NKT cells were quantified within the single CKR+ subsets. Results: Cord blood NKT cells expressed the Th2-related CCR4 and CCR8 at significantly higher frequencies compared to peripheral blood NKT cells from adults, while CXCR3(+) and CCR5(+) cord blood NKT cells (Th1-related) were present at lower percentages. Within CD4(neg) CD8(neg) (DN) NKT cells, the frequency of IL-4 producing NKT cells was significantly higher in cord blood, while frequencies of IFN-gamma secreting DN NKT cells tended to be lower. A further subanalysis showed that the higher percentage of IL-4 secreting DN NKT cells was restricted to CCR3(+), CCR4(+), CCR5(+), CCR6(+), CCR7(+), CCR8(+) and CXCR4(+) DN subsets in cord blood. This resulted in significantly decreased IFN-gamma/IL-4 ratios of CCR3+, CCR6+ and CCR8+ cord blood DN NKT cells. Sequencing of VA24AJ18 T cell receptor (TCR) transcripts in sorted cord blood V alpha 24V beta 11 cells confirmed the invariant TCR alpha-chain ruling out the possibility that these cells represent an unusual subset of conventional T cells. Conclusions: Despite the heterogeneity of cord blood NKT cells, we observed a clear Th2-bias at the phenotypic and functional level which was mainly found in the DN subset. Therefore, we speculate that NKT cells are important for the initiation and control of the fetal Th2 environment which is needed to maintain tolerance towards self-antigens as well as non-inherited maternal antigens.	[Harner, Susanne; Krauss-Etschmann, Susanne] Ludwig Maximilians Univ Hosp, Comprehens Pneumol Ctr, Grosshadern, Germany; [Noessner, Elfriede] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Mol Immunol, Grosshadern, Germany; [Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Schiemann, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, Neuherberg, Germany; [Harner, Susanne; Nadas, Korinna; Leumann-Runge, Anke; Faber, Fabienne L.; Krauss-Etschmann, Susanne] Univ Munich, Childrens Hosp, D-8000 Munich, Germany; [Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Harner, S (corresponding author), Ludwig Maximilians Univ Hosp, Comprehens Pneumol Ctr, Grosshadern, Germany.	susanne.krauss-etschmann@med.uni-muenchen.de	Krauss-Etschmann, Susanne/H-5198-2018; Heinrich, Joachim/N-1720-2013	Krauss-Etschmann, Susanne/0000-0001-5945-5702; Heinrich, Joachim/0000-0002-9620-1629	Helmholtz Center Munich; Deutsche Forschungsgemeinschaft [SFB-TR36]	Helmholtz Center Munich(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was financed with resources provided by the Helmholtz Center Munich. This work was also supported by grants from the Deutsche Forschungsgemeinschaft SFB-TR36 (to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baev DV, 2004, BLOOD, V104, P4150, DOI 10.1182/blood-2004-04-1629; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO;2-I; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Ege MJ, 2008, J ALLERGY CLIN IMMUN, V122, P407, DOI 10.1016/j.jaci.2008.06.011; Eger KA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000050; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley M, 2000, IMMUNOLOGY, V100, P37, DOI 10.1046/j.1365-2567.2000.00001.x; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Huang Y, 2008, J IMMUNOL, V180, P2367, DOI 10.4049/jimmunol.180.4.2367; Kadowaki N, 2001, J EXP MED, V193, P1221, DOI 10.1084/jem.193.10.1221; Kawakami K, 2003, EUR J IMMUNOL, V33, P3322, DOI 10.1002/eji.200324254; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kumar H, 2000, J IMMUNOL, V165, P4797, DOI 10.4049/jimmunol.165.9.4797; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Nowak M, 2007, INT REV IMMUNOL, V26, P95, DOI 10.1080/08830180601070195; Pfefferle PI, 2008, J ALLERGY CLIN IMMUN, V122, P711, DOI 10.1016/j.jaci.2008.06.035; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Prell C, 2003, IMMUNOBIOLOGY, V208, P367, DOI 10.1078/0171-2985-00284; Prussin C, 1997, J IMMUNOL, V159, P5862; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Sandberg JK, 2004, P NATL ACAD SCI USA, V101, P7058, DOI 10.1073/pnas.0305986101; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; Tupin E, 2007, NAT REV MICROBIOL, V5, P405, DOI 10.1038/nrmicro1657; Uemura Y, 2008, INT IMMUNOL, V20, P405, DOI 10.1093/intimm/dxn001; van der Vliet HJJ, 2000, BLOOD, V95, P2440, DOI 10.1182/blood.V95.7.2440.007k35_2440_2442	34	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15714	10.1371/journal.pone.0015714	http://dx.doi.org/10.1371/journal.pone.0015714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305060	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300023
J	Larkin, EK; Gebretsadik, T; Koestner, N; Newman, MS; Liu, ZW; Carroll, KN; Minton, P; Woodward, K; Hartert, TV				Larkin, Emma K.; Gebretsadik, Tebeb; Koestner, Nathan; Newman, Mark S.; Liu, Zhouwen; Carroll, Kecia N.; Minton, Patricia; Woodward, Kim; Hartert, Tina V.			Agreement of Blood Spot Card Measurements of Vitamin D Levels with Serum, Whole Blood Specimen Types and a Dietary Recall Instrument	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; 25-HYDROXYVITAMIN D; HYPOVITAMINOSIS-D; NATIONAL-HEALTH; ASSAY; PREVENTION; ASTHMA; D-2	Background: The ability to measure 25-hydroxyvitamin D (25OHD) levels from blood spot cards can simplify sample collection versus samples obtained by venipuncture, particularly in populations in whom it is difficult to draw blood. We sought to validate the use of blood spot samples for the measurement of 25OHD compared to serum or whole blood samples and correlate the measured levels with intake estimated from dietary recall. Methods: Utilizing 109 biological mothers of infants enrolled in the Tennessee Children's Respiratory Initiative cohort, we measured 25OHD levels through highly selective liquid chromatography-tandem mass spectrometry on samples from blood spot cards, serum, and whole blood collected at enrollment. Dietary questionnaires (n = 65) were used to assess 25OHD intake by dietary recall. Sample collection measures were assessed for agreement and 25OHD levels for association with dietary 25OHD intake. Results: The mean absolute differences (95% CI) in 25OHD levels measured between whole blood and blood spot (n = 50 pairs) or serum and blood spot (n = 20) were 3.2 (95% CI: 1.6, 4.8) ng/ml and 1.5 (95% CI:-0.5,3.4) ng/mL. Intake by dietary recall was marginally associated with 25OHD levels after adjustment for current smoking and race in linear regression. Discussion: 25OHD levels determined by mass spectrometry from blood spot cards, serum and whole blood show relatively good agreement, although 25OHD levels are slightly lower when measured by blood spot cards. Blood spot samples are a less invasive means of obtaining 25OHD measurements, particularly in large population-based samples, or among children when venipuncture may decrease study participation.	[Larkin, Emma K.; Koestner, Nathan; Minton, Patricia; Woodward, Kim; Hartert, Tina V.] Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care, Nashville, TN 37203 USA; [Gebretsadik, Tebeb; Liu, Zhouwen] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Carroll, Kecia N.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Newman, Mark S.] ZRT Lab, Beaverton, OR USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Larkin, EK (corresponding author), Vanderbilt Univ, Dept Med, Div Allergy Pulm & Crit Care, Nashville, TN 37203 USA.	Emma.Larkin@Vanderbilt.edu			NIH [K24 AI 77930, CTSA RR24975 (Vanderbilt)]; Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Research Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This was a fee for service relationship with ZRT Laboratory who did not supply funding. Funding was supplied by NIH K24 AI 77930 (TVH), Thrasher Research Fund (TVH), NIH CTSA RR24975 (Vanderbilt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; BELSEY R, 1971, J CLIN ENDOCR METAB, V33, P554, DOI 10.1210/jcem-33-3-554; Binkley N, 2008, J CLIN ENDOCR METAB, V93, P1804, DOI 10.1210/jc.2007-2340; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; BREHM JM, 2010, J ALLERGY CLIN IMMUN; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Carter GD, 2009, ANN CLIN BIOCHEM, V46, P79, DOI 10.1258/acb.2008.008135; Chen HP, 2008, CLIN CHIM ACTA, V391, P6, DOI 10.1016/j.cca.2008.01.017; Eyles D, 2009, CLIN CHIM ACTA, V403, P145, DOI 10.1016/j.cca.2009.02.005; Eyles DW, 2010, PAEDIATR PERINAT EP, V24, P303, DOI 10.1111/j.1365-3016.2010.01105.x; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; GLOWACKI J, 2004, CURR OPIN ENDOCRINOL, V11, P353; HADDAD JG, 1971, J CLIN ENDOCR METAB, V33, P992, DOI 10.1210/jcem-33-6-992; Hartert TV, 2010, RESPIROLOGY, V15, P691, DOI 10.1111/j.1440-1843.2010.01743.x; Holick MF, 2005, J CLIN ENDOCR METAB, V90, P3128, DOI 10.1210/jc.2005-0162; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2004, J CLIN ENDOCR METAB, V89, P3149, DOI 10.1210/jc.2004-0682; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; LAI JK, 2010, MOL NUTR FOOD RES; Leino A, 2008, CLIN CHEM, V54, P2059, DOI 10.1373/clinchem.2008.111732; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Newman Mark S, 2009, J Diabetes Sci Technol, V3, P156; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Roth H J, 2001, Clin Lab, V47, P357; Roth HJ, 2008, ANN CLIN BIOCHEM, V45, P153, DOI 10.1258/acb.2007.007091; Singh RJ, 2010, METHODS MOL BIOL, V603, P509, DOI 10.1007/978-1-60761-459-3_50; Souberbielle JC, 2006, JOINT BONE SPINE, V73, P249, DOI 10.1016/j.jbspin.2006.01.003; Terry AH, 2005, CLIN CHEM, V51, P1565, DOI 10.1373/clinchem.2005.054239; Trang HM, 1998, AM J CLIN NUTR, V68, P854, DOI 10.1093/ajcn/68.4.854; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	36	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16602	10.1371/journal.pone.0016602	http://dx.doi.org/10.1371/journal.pone.0016602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304997	gold, Green Submitted, Green Published			2022-12-25	WOS:000286834300097
J	McMahon, SM; Metcalf, CJE; Woodall, CW				McMahon, Sean M.; Metcalf, Charlotte J. E.; Woodall, Christopher W.			High-Dimensional Coexistence of Temperate Tree Species: Functional Traits, Demographic Rates, Life-History Stages, and Their Physical Context	PLOS ONE			English	Article							NEOTROPICAL RAIN-FOREST; TRADE-OFFS; LONG-TERM; GROWTH; MORTALITY; CANOPY; RECRUITMENT; DIVERSITY; ABUNDANCE; PATTERNS	Theoretical models indicate that trade-offs between growth and survival strategies of tree species can lead to coexistence across life history stages (ontogeny) and physical conditions experienced by individuals. There exist predicted physiological mechanisms regulating these trade-offs, such as an investment in leaf characters that may increase survival in stressful environments at the expense of investment in bole or root growth. Confirming these mechanisms, however, requires that potential environmental, ontogenetic, and trait influences are analyzed together. Here, we infer growth and mortality of tree species given size, site, and light characteristics from forest inventory data from Wisconsin to test hypotheses about growth-survival trade-offs given species functional trait values under different ontogenetic and environmental states. A series of regression analyses including traits and rates their interactions with environmental and ontogenetic stages supported the relationships between traits and vital rates expected from the expectations from tree physiology. A combined model including interactions between all variables indicated that relationships between demographic rates and functional traits supports growth-survival trade-offs and their differences across species in high-dimensional niche space. The combined model explained 65% of the variation in tree growth and supports a concept of community coexistence similar to Hutchinson's n-dimensional hypervolume and not a low-dimensional niche model or neutral model.	[McMahon, Sean M.] Smithsonian Environm Res Ctr, Ctr Trop Forest Sci, Smithsonian Trop Res Inst, Edgewater, MD 21037 USA; [Metcalf, Charlotte J. E.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Woodall, Christopher W.] US Forest Serv, St Paul, MN USA	Smithsonian Institution; Smithsonian Environmental Research Center; Smithsonian Tropical Research Institute; University of Oxford; United States Department of Agriculture (USDA); United States Forest Service	McMahon, SM (corresponding author), Smithsonian Environm Res Ctr, Ctr Trop Forest Sci, Smithsonian Trop Res Inst, POB 28, Edgewater, MD 21037 USA.	mcmahons@si.edu		Woodall, Christopher/0000-0001-8076-6214	HSBC through the Smithsonian Tropical Research Institute; Smithsonian Institution	HSBC through the Smithsonian Tropical Research Institute; Smithsonian Institution(Smithsonian Institution)	HSBC Climate Partnership partially funded the work of SMM as a recent postdoctoral fellowship awarded through the Smithsonian Tropical Research Institute. The funders (HSBC Bank) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was through the Smithsonian Institution and has funded SMM's current postdoctoral position. This indirect support of SMM has no influence on the ability of the authors to follow all Plos ONE policies concerning data sharing and materials. There are no current external funding sources for this study.	Abe S, 1998, J VEG SCI, V9, P787, DOI 10.2307/3237044; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; BECHTOLD WA, 2005, FOREST INVENTORY ANA, pSRS80; Beckage B, 2003, ECOLOGY, V84, P1849, DOI 10.1890/0012-9658(2003)084[1849:SSAGOT]2.0.CO;2; BROKAW NVL, 1989, ECOLOGY, V70, P538, DOI 10.2307/1940196; Brown PM, 2005, ECOLOGY, V86, P3030, DOI 10.1890/05-0034; Cavender-Bares J, 2004, ECOL MONOGR, V74, P635, DOI 10.1890/03-4007; CENTRE WA, 2004, WOOD DENSITY DATABAS; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Clark DA, 2001, ECOLOGY, V82, P1460, DOI 10.1890/0012-9658(2001)082[1460:GTTCTH]2.0.CO;2; Clark DA, 1999, ECOL APPL, V9, P981, DOI 10.1890/1051-0761(1999)009[0981:ATGOTR]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Marks CO, 2007, EVOLUTION, V61, P455, DOI 10.1111/j.1742-4658.2007.00021.x; MCMAHON S, 2009, PREDICTIVE FRAMEWORK; Meinzer FC, 2003, OECOLOGIA, V134, P1, DOI 10.1007/s00442-002-1088-0; Metcalf CJE, 2009, J TROP ECOL, V25, P1, DOI 10.1017/S0266467408005646; MILTON K, 1994, J ECOL, V82, P79, DOI 10.2307/2261388; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Platt WJ, 2002, ECOLOGY, V83, P1566, DOI 10.1890/0012-9658(2002)083[1566:IOLSDP]2.0.CO;2; Poorter L, 2008, ECOLOGY, V89, P1908, DOI 10.1890/07-0207.1; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Team RDC, 2010, R LANG ENV STAT COMP; TILMAN GD, 1984, ECOLOGY, V65, P1445, DOI 10.2307/1939125; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	36	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16253	10.1371/journal.pone.0016253	http://dx.doi.org/10.1371/journal.pone.0016253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305020	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300046
J	Zhu, L; Sacco, T; Strata, P; Sacchetti, B				Zhu, Lan; Sacco, Tiziana; Strata, Piergiorgio; Sacchetti, Benedetto			Basolateral Amygdala Inactivation Impairs Learning-Induced Long-Term Potentiation in the Cerebellar Cortex	PLOS ONE			English	Article							REVERSIBLE INACTIVATION; ESSENTIAL INVOLVEMENT; MEMORY CONSOLIDATION; NEURONAL PLASTICITY; SYNAPTIC CHANGES; DENTATE GYRUS; FEAR MEMORIES; HEART-RATE; RATS; HIPPOCAMPUS	Learning to fear dangerous situations requires the participation of basolateral amygdala (BLA). In the present study, we provide evidence that BLA is necessary for the synaptic strengthening occurring during memory formation in the cerebellum in rats. In the cerebellar vermis the parallel fibers (PF) to Purkinje cell (PC) synapse is potentiated one day following fear learning. Pretraining BLA inactivation impaired such a learning-induced long-term potentiation (LTP). Similarly, cerebellar LTP is affected when BLA is blocked shortly, but not 6 h, after training. The latter result shows that the effects of BLA inactivation on cerebellar plasticity, when present, are specifically related to memory processes and not due to an interference with sensory or motor functions. These data indicate that fear memory induces cerebellar LTP provided that a heterosynaptic input coming from BLA sets the proper local conditions. Therefore, in the cerebellum, learning-induced plasticity is a heterosynaptic phenomenon that requires inputs from other regions. Studies employing the electrically-induced LTP in order to clarify the cellular mechanisms of memory should therefore take into account the inputs arriving from other brain sites, considering them as integrative units. Based on previous and the present findings, we proposed that BLA enables learning-related plasticity to be formed in the cerebellum in order to respond appropriately to new stimuli or situations.	[Zhu, Lan; Sacco, Tiziana; Strata, Piergiorgio; Sacchetti, Benedetto] Univ Turin, Dept Neurosci, Turin, Italy; [Strata, Piergiorgio; Sacchetti, Benedetto] Natl Inst Neurosci Italy, Turin, Italy	University of Turin	Zhu, L (corresponding author), Univ Leicester, Maurice Shock Med Sci Bldg, Leicester, Leics, England.	benedetto.sacchetti@unito.it	Sacchetti, Benedetto/AAG-2916-2022; Sacchetti, Benedetto/AFK-4141-2022	Sacchetti, Benedetto/0000-0002-8695-8310; Zhu, Lan/0000-0001-5643-1019	Italian Space Agency; European Community [512039]; MIUR, Regione Piemonte; Compagnia San Paolo Foundation	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); European Community(European Commission); MIUR, Regione Piemonte(Ministry of Education, Universities and Research (MIUR)Regione Piemonte); Compagnia San Paolo Foundation(Compagnia di San Paolo)	This work was supported by grants of the Italian Space Agency, the European Community [512039 contract number to P.S.], MIUR, Regione Piemonte and Compagnia San Paolo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 1999, J NEUROSCI, V19, P10530; BERNTSON GG, 1982, PHYSIOL PSYCHOL, V10, P2; BRIONI JD, 1989, BRAIN RES, V487, P105, DOI 10.1016/0006-8993(89)90945-1; Cavdar S, 2001, J ANAT, V198, P463, DOI 10.1046/j.1469-7580.2001.19840463.x; Chen SWC, 2006, J NEUROSCI, V26, P233, DOI 10.1523/JNEUROSCI.2890-05.2006; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dow R. S., 1958, PHYSL PATHOLOGY CERE; Dringenberg HC, 2004, EUR J NEUROSCI, V20, P557, DOI 10.1111/j.1460-9568.2004.03515.x; Frey S, 2001, J NEUROSCI, V21, P3697, DOI 10.1523/JNEUROSCI.21-10-03697.2001; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; HEATH RG, 1974, EXP NEUROL, V45, P268, DOI 10.1016/0014-4886(74)90118-6; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; IKEGAYA Y, 1995, BRAIN RES, V671, P351, DOI 10.1016/0006-8993(94)01403-5; KRUPA DJ, 1993, SCIENCE, V260, P989, DOI 10.1126/science.8493536; Lee T, 2004, J NEUROSCI, V24, P3242, DOI 10.1523/JNEUROSCI.5382-03.2004; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q; Maschke M, 2002, J NEUROL NEUROSUR PS, V72, P116, DOI 10.1136/jnnp.72.1.116; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Popescu AT, 2007, P NATL ACAD SCI USA, V104, P341, DOI 10.1073/pnas.0609831104; Poremba A, 1997, J NEUROSCI, V17, P5237; Saab CY, 2003, BRAIN RES REV, V42, P85, DOI 10.1016/S0165-0173(03)00151-6; Sacchetti B, 2005, NEUROSCIENTIST, V11, P217, DOI 10.1177/1073858405276428; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2002, EUR J NEUROSCI, V15, P143, DOI 10.1046/j.0953-816x.2001.01844.x; Sacchetti B, 2009, NEUROSCIENCE, V162, P756, DOI 10.1016/j.neuroscience.2009.01.064; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2001, EUR J NEUROSCI, V13, P2291, DOI 10.1046/j.0953-816x.2001.01609.x; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SANANES CB, 1992, BEHAV NEUROSCI, V106, P72, DOI 10.1037/0735-7044.106.1.72; Scelfo B, 2008, P NATL ACAD SCI USA, V105, P769, DOI 10.1073/pnas.0706342105; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schonewille M, 2010, NEURON, V67, P618, DOI 10.1016/j.neuron.2010.07.009; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; Schweighofer N, 2004, BRAIN RES REV, V44, P103, DOI 10.1016/j.brainresrev.2003.10.004; SEBASTIANI L, 1992, EXP BRAIN RES, V88, P193, DOI 10.1007/BF02259141; Seidenbecher T, 1997, P NATL ACAD SCI USA, V94, P1494, DOI 10.1073/pnas.94.4.1494; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Snider RS, 1944, J NEUROPHYSIOL, V7, P331, DOI 10.1152/jn.1944.7.6.331; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Stanton ME, 2000, BEHAV BRAIN RES, V110, P25, DOI 10.1016/S0166-4328(99)00182-5; SUPPLE WF, 1990, BEHAV NEUROSCI, V104, P934; SUPPLE WF, 1993, J NEUROSCI, V13, P3705; Vafaei AA, 2007, NEUROBIOL LEARN MEM, V88, P87, DOI 10.1016/j.nlm.2007.02.004; Vazdarjanova A, 2001, EUR J NEUROSCI, V14, P709, DOI 10.1046/j.0953-816x.2001.01696.x; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; Zhu L, 2007, EUR J NEUROSCI, V26, P219, DOI 10.1111/j.1460-9568.2007.05632.x	60	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16673	10.1371/journal.pone.0016673	http://dx.doi.org/10.1371/journal.pone.0016673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304962	Green Submitted, gold, Green Published			2022-12-25	WOS:000286834300117
J	Dumitrescu, L; Glenn, K; Brown-Gentry, K; Shephard, C; Wong, M; Rieder, MJ; Smith, JD; Nickerson, DA; Crawford, DC				Dumitrescu, Logan; Glenn, Kimberly; Brown-Gentry, Kristin; Shephard, Cynthia; Wong, Michelle; Rieder, Mark J.; Smith, Joshua D.; Nickerson, Deborah A.; Crawford, Dana C.			Variation in LPA Is Associated with Lp(a) Levels in Three Populations from the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PLASMA LIPOPROTEIN(A) CONCENTRATIONS; SINGLE-NUCLEOTIDE POLYMORPHISMS; NON-HISPANIC WHITES; WHOLE-GENOME ASSOCIATION; APOLIPOPROTEIN-A-I; AFRICAN-AMERICANS; LINKAGE-DISEQUILIBRIUM; SERUM-LIPOPROTEIN; ARTERY-DISEASE	The distribution of lipoprotein(a) [Lp(a)] levels can differ dramatically across diverse racial/ethnic populations. The extent to which genetic variation in LPA can explain these differences is not fully understood. To explore this, 19 LPA tagSNPs were genotyped in 7,159 participants from the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III is a diverse population-based survey with DNA samples linked to hundreds of quantitative traits, including serum Lp(a). Tests of association between LPA variants and transformed Lp(a) levels were performed across the three different NHANES subpopulations (non-Hispanic whites, non-Hispanic blacks, and Mexican Americans). At a significance threshold of p<0.0001, 15 of the 19 SNPs tested were strongly associated with Lp(a) levels in at least one subpopulation, six in at least two subpopulations, and none in all three subpopulations. In non-Hispanic whites, three variants were associated with Lp(a) levels, including previously known rs6919246 (p = 1.18x10(-30)). Additionally, 12 and 6 variants had significant associations in non-Hispanic blacks and Mexican Americans, respectively. The additive effects of these associated alleles explained up to 11% of the variance observed for Lp(a) levels in the different racial/ethnic populations. The findings reported here replicate previous candidate gene and genome-wide association studies for Lp(a) levels in European-descent populations and extend these findings to other populations. While we demonstrate that LPA is an important contributor to Lp(a) levels regardless of race/ethnicity, the lack of generalization of associations across all subpopulations suggests that specific LPA variants may be contributing to the observed Lp(a) between-population variance.	[Dumitrescu, Logan; Glenn, Kimberly; Brown-Gentry, Kristin; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA; [Dumitrescu, Logan; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Shephard, Cynthia; Wong, Michelle; Rieder, Mark J.; Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; University of Washington; University of Washington Seattle	Dumitrescu, L (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37203 USA.	crawford@chgr.mc.vanderbilt.edu	Crawford, Dana/O-5578-2019; Crawford, Dana/C-1054-2012	Crawford, Dana/0000-0002-6437-6248; Glenn, Kimberly/0000-0002-6765-5592	National Heart, Lung, and Blood Institute (NHLBI) [N01-HV-48195]; NIH [U01 HL66682, U01 HL66642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682, U01HL066642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Genotyping services were provided by the Johns Hopkins University under federal contract number (N01-HV-48195) from the National Heart, Lung, and Blood Institute (NHLBI). This work was funded, in part, by NIH grants U01 HL66682 (DAN) and U01 HL66642 (DAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 1998, HUM BIOL, V70, P477; [Anonymous], 2003, NATURE, V426, P789; Bamshad M, 2005, JAMA-J AM MED ASSOC, V294, P937, DOI 10.1001/jama.294.8.937; Barkley RA, 2003, J LIPID RES, V44, P1301, DOI 10.1194/jlr.M300163-JLR200; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Berglund L, 2004, ARTERIOSCL THROM VAS, V24, pE30; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; Boffa MB, 2004, CLIN BIOCHEM, V37, P333, DOI 10.1016/j.clinbiochem.2003.12.007; Boomsma D I, 2000, Twin Res, V3, P152, DOI 10.1375/136905200320565436; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Centers for Disease Control and Prevention, 2004, PLAN OP 3 NAT HLTH N; Centers for disease control and prevention, 1996, 3 NAT HLTH NUTR EX S; Chang MH, 2009, AM J EPIDEMIOL, V169, P54, DOI 10.1093/aje/kwn286; Chiu L, 2000, HUM BIOL, V72, P821; Choudhry Shweta, 2007, Proc Am Thorac Soc, V4, P226, DOI 10.1513/pats.200701-029AW; Chretien JP, 2006, J MED GENET, V43, P917, DOI 10.1136/jmg.2006.042119; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crawford DC, 2008, HUM HERED, V66, P199, DOI 10.1159/000143403; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Danesh J, 2000, CIRCULATION, V102, P1082, DOI 10.1161/01.CIR.102.10.1082; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GUYTON JR, 1985, ARTERIOSCLEROSIS, V5, P265, DOI 10.1161/01.ATV.5.3.265; HAFFNER SM, 1992, AM J EPIDEMIOL, V136, P1060, DOI 10.1093/oxfordjournals.aje.a116571; HEISS G, 1984, AM HEART J, V108, P807, DOI 10.1016/0002-8703(84)90676-8; Kamboh MI, 1997, AM J EPIDEMIOL, V146, P1011, DOI 10.1093/oxfordjournals.aje.a009229; Kraft HG, 1996, EUR J HUM GENET, V4, P74; KRAFT HG, 1995, HUM GENET, V95, P275; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Lanktree MB, 2009, J LIPID RES, V50, P768, DOI 10.1194/jlr.D800050-JLR200; Lohr S.L., 1999, SAMPLING DESIGN ANAL; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, pE116; Marcovina SM, 1996, J LIPID RES, V37, P2569; Marcovina SM, 2003, CLIN CHEM, V49, P1785, DOI 10.1373/clinchem.2003.023689; MOLITERNO DJ, 1995, ARTERIOSCL THROM VAS, V15, P850, DOI 10.1161/01.ATV.15.7.850; Mooser V, 1997, AM J HUM GENET, V61, P402, DOI 10.1086/514851; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Ogorelkova M, 2001, HUM MOL GENET, V10, P815, DOI 10.1093/hmg/10.8.815; PENDERGRASS S, 2010, BIODATA MIN IN PRESS; Pendergrass S, 2011, BIOCOMPUT-PAC SYM, P265; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rainwater DL, 1997, ATHEROSCLEROSIS, V128, P223, DOI 10.1016/S0021-9150(96)05993-X; Schmidt K, 2006, EUR J HUM GENET, V14, P190, DOI 10.1038/sj.ejhg.5201512; Scholz M, 1999, EUR J HUM GENET, V7, P169, DOI 10.1038/sj.ejhg.5200290; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SORRENTINO MJ, 1992, AM J MED, V93, P658, DOI 10.1016/0002-9343(92)90199-L; SRINIVASAN SR, 1991, CIRCULATION, V84, P160, DOI 10.1161/01.CIR.84.1.160; Steinberg KK, 1997, EPIDEMIOL REV, V19, P156, DOI 10.1093/oxfordjournals.epirev.a017938	51	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16604	10.1371/journal.pone.0016604	http://dx.doi.org/10.1371/journal.pone.0016604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305047	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100048
J	Jeyakunnar, M; Carlson, KE; Gunther, JR; Katzenellenbogen, JA				Jeyakunnar, M.; Carlson, Kathryn E.; Gunther, Jillian R.; Katzenellenbogen, John A.			Exploration of Dimensions of Estrogen Potency PARSING LIGAND BINDING AND COACTIVATOR BINDING AFFINITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ALPHA; TISSUE-SPECIFICITY; NUCLEAR RECEPTOR; PHARMACOLOGY; SELECTIVITY; ANTAGONISM; METABOLISM; GENISTEIN; BETA; KEY	The estrogen receptors, ER alpha and ER beta, are ligand-regulated transcription factors that control gene expression programs in target tissues. The molecular events underlying estrogen action involve minimally two steps, hormone binding to the ER ligand-binding domain followed by coactiyator recruitment to the ER.ligand complex; this ligand.receptor.coactivator triple complex then alters gene expression. Conceptually, the potency of an estrogen in activating a cellular response should reflect the affinities that characterize both steps involved in the assembly of the active ligand.receptor.coactivator complex. Thus, to better understand the molecular basis of estrogen potency, we developed a completely in vitro system (using radiometric and time-resolved FRET assays) to quantify independently three parameters: (a) the affinity of ligand binding to ER, (b) the affinity of coactivator binding to the ER.ligand complex, and (c) the potency of ligand recruitment of coactivator. We used this system to characterize the binding and potency of 12 estrogens with both ER alpha and ER beta. Some ligands showed good correlations between ligand binding affinity, coactivator binding affinity, and coactivator recruitment potency with both ERs, whereas others showed correlations with only one ER subtype or displayed discordant coactivator recruitment potencies. When ligands with low receptor binding affinity but high coactivator recruitment potencies to ER beta were evaluated in cell-based assays, elevation of cellular coactivator levels significantly and selectively improved their potency. Collectively, our results indicate that some low affinity estrogens may elicit greater cellular responses in those target cells that express higher levels of specific coactivators capable of binding to their ER complexes with high affinity.	[Jeyakunnar, M.; Carlson, Kathryn E.; Gunther, Jillian R.; Katzenellenbogen, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Katzenellenbogen, JA (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	jkatzene@uiuc.edu			National Institutes of Health [R37 DK015556, P01 AG024387, P50 AT006268]; National Research Service Awards [F30 ES016484-01, T32 GM070421]; National Center for Complementary & Integrative Health [P50AT006268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK015556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F30ES016484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM070421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG024387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Awards(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 DK015556, P01 AG024387, and P50 AT006268 (to J. A. K.). This work was also supported by National Research Service Awards F30 ES016484-01 and T32 GM070421 (to J. R. G.).	Barkhem T, 1998, MOL PHARMACOL, V54, P105, DOI 10.1124/mol.54.1.105; Berrodin TJ, 2009, MOL ENDOCRINOL, V23, P74, DOI 10.1210/me.2008-0366; Bhavnani BR, 2008, ENDOCRINOLOGY, V149, P4857, DOI 10.1210/en.2008-0304; Bramlett KS, 2001, MOL ENDOCRINOL, V15, P909, DOI 10.1210/me.15.6.909; Brawer Michael K, 2006, Rev Urol, V8 Suppl 2, pS35; Check J H, 2006, Clin Exp Obstet Gynecol, V33, P71; Check M L, 2004, Clin Exp Obstet Gynecol, V31, P299; Dai SY, 2008, P NATL ACAD SCI USA, V105, P7171, DOI 10.1073/pnas.0710802105; Dai SY, 2009, BIOCHEMISTRY-US, V48, P9668, DOI 10.1021/bi901149t; Escande A, 2006, BIOCHEM PHARMACOL, V71, P1459, DOI 10.1016/j.bcp.2006.02.002; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Grow DR, 2002, OBSTET GYN CLIN N AM, V29, P425, DOI 10.1016/S0889-8545(02)00009-8; Gunther JR, 2009, J BIOMOL SCREEN, V14, P181, DOI 10.1177/1087057108329349; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hsieh RW, 2008, STEROIDS, V73, P59, DOI 10.1016/j.steroids.2007.08.014; Iannone MA, 2004, MOL ENDOCRINOL, V18, P1064, DOI 10.1210/me.2003-0432; Jeyakumar M, 2008, BIOCHEMISTRY-US, V47, P7465, DOI 10.1021/bi800393u; KILBOURN MR, 1981, MOL PHARMACOL, V19, P388; Kim SH, 2005, MOL CELL PROTEOMICS, V4, P267, DOI 10.1074/mcp.M400192-MCP200; Kim SH, 2004, J AM CHEM SOC, V126, P4754, DOI 10.1021/ja039586q; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lascombe I, 2000, ENVIRON HEALTH PERSP, V108, P621, DOI 10.2307/3434882; Liu JW, 2003, MOL ENDOCRINOL, V17, P346, DOI 10.1210/me.2002-0331; Marini H, 2007, ANN INTERN MED, V146, P839, DOI 10.7326/0003-4819-146-12-200706190-00005; MINUTOLO F, 2009, MED RES REV MED; Monroe DG, 2003, J ENDOCRINOL, V176, P349, DOI 10.1677/joe.0.1760349; Nettles KW, 2004, MOL CELL, V13, P317, DOI 10.1016/S1097-2765(04)00054-1; Ruggiero RJ, 2002, J MIDWIFERY WOM HEAL, V47, P130, DOI 10.1016/S1526-9523(02)00233-7; SASSON S, 1988, MOL ENDOCRINOL, V2, P307, DOI 10.1210/mend-2-4-307; Scherr DS, 2003, J UROLOGY, V170, P1703, DOI 10.1097/01.ju.0000077558.48257.3d; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tamrazi A, 2005, MOL ENDOCRINOL, V19, P1516, DOI 10.1210/me.2004-0458; Tamrazi A, 2003, MOL ENDOCRINOL, V17, P2593, DOI 10.1210/me.2003-0239; Tamrazi A, 2002, MOL ENDOCRINOL, V16, P2706, DOI 10.1210/me.2002-0250; Walf AA, 2008, NEUROREPORT, V19, P789, DOI 10.1097/WNR.0b013e3282fe209c; Williamson-Hughes PS, 2006, MENOPAUSE, V13, P831, DOI 10.1097/01.gme.0000227330.49081.9e; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhou HB, 2009, BIOORG MED CHEM LETT, V19, P108, DOI 10.1016/j.bmcl.2008.11.006	40	58	59	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12971	12982		10.1074/jbc.M110.205112	http://dx.doi.org/10.1074/jbc.M110.205112			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321128	Green Published, hybrid			2022-12-25	WOS:000289282200017
J	Marcello, MR; Jia, WT; Leary, JA; Moore, KL; Evans, JP				Marcello, Matthew R.; Jia, Weitao; Leary, Julie A.; Moore, Kevin L.; Evans, Janice P.			Lack of Tyrosylprotein Sulfotransferase-2 Activity Results in Altered Sperm-Egg Interactions and Loss of ADAM3 and ADAM6 in Epididymal Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE O-SULFATION; ANGIOTENSIN-CONVERTING ENZYME; MAMMALIAN MEMBRANE BLOCK; AMINO-TERMINUS; P-SELECTIN; REPRODUCTIVE ADAMS; SECRETORY PATHWAY; MOLECULAR-CLONING; MALE-FERTILITY; PROTEIN IZUMO	Tyrosine O-sulfation is a post-translational modification catalyzed by two tyrosylprotein sulfotransferases (TPST-1 and TPST-2) in the trans-Golgi network. Tpst2-deficient mice have male infertility, sperm motility defects, and possible abnormalities in sperm-egg membrane interactions. Studies here show that compared with wild-type sperm, fewer Tpst2-null sperm bind to the egg membrane, but more of these bound sperm progress to membrane fusion. Similar outcomes were observed with wild-type sperm treated with the anti-sulfotyrosine antibody PSG2. The increased extent of sperm-egg fusion is not due to a failure of Tpst2-null sperm to trigger establishment of the egg membrane block to polyspermy. Anti-sulfotyrosine staining of sperm showed localization similar to that of IZUMO1, a sperm protein that is essential for gamete fusion, but we detected little to no tyrosine sulfation of IZUMO1 and found that IZUMO1 expression and localization were normal in Tpst2-null sperm. Turning to a discovery-driven approach, we used mass spectrometry to characterize sperm proteins that associated with PSG2. This identified ADAM6, a member of the A disintegrin and A metalloprotease (ADAM) family; members of this protein family are associated with multiple sperm functions. Subsequent studies revealed that Tpst2-null sperm lack ADAM6 and ADAM3. Loss of ADAM3 is strongly associated with male infertility and is observed in knockouts of male germ line-specific endoplasmic reticulum-resident chaperones, raising the possibility that TPST-2 may function in quality control in the secretory pathway. These data suggest that TPST-2-mediated tyrosine O-sulfation participates in regulating the sperm surface proteome or membrane order, ultimately affecting male fertility.	[Marcello, Matthew R.; Evans, Janice P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Jia, Weitao; Leary, Julie A.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Moore, Kevin L.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Moore, Kevin L.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Davis; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Evans, JP (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	jpevans@jhsph.edu	Evans, Janice/Q-8483-2019; Jia, W.T./E-7803-2012	Marcello, Matthew/0000-0001-7397-3282	National Institutes of Health [R01 HD037696, R01 HD045671, HD056022]; National Institute of Child Health and Human Development [T32 HD007276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007276, R01HD037696, R01HD045671] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD037696 and R01 HD045671 (to J. P. E.) and HD056022 (to K. L M. and J. A. L.). For a portion of this work, M. R. M. was supported by a training grant from the National Institute of Child Health and Human Development (T32 HD007276).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655; Beisswanger R, 1998, P NATL ACAD SCI USA, V95, P11134, DOI 10.1073/pnas.95.19.11134; BETTELHEIM FR, 1954, J AM CHEM SOC, V76, P2838, DOI 10.1021/ja01639a073; Borghei A, 2006, J BIOL CHEM, V281, P9423, DOI 10.1074/jbc.M513768200; Cha SW, 2009, CURR BIOL, V19, P1573, DOI 10.1016/j.cub.2009.07.062; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Choe H, 2009, METHOD ENZYMOL, V461, P147, DOI 10.1016/S0076-6879(09)05407-X; Colvin RA, 2006, MOL CELL BIOL, V26, P5838, DOI 10.1128/MCB.00556-06; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2; Fujihara Y, 2010, J CELL SCI, V123, P1531, DOI 10.1242/jcs.067363; Gao JM, 2003, J BIOL CHEM, V278, P37902, DOI 10.1074/jbc.M306061200; Gardner AJ, 2006, REPROD FERT DEVELOP, V18, P53, DOI 10.1071/RD05122; Gardner AJ, 2007, J CELL PHYSIOL, V212, P275, DOI 10.1002/jcp.21046; Gardner AJ, 2007, REPRODUCTION, V133, P383, DOI 10.1530/REP-06-0304; Goettsch S, 2006, J MOL BIOL, V361, P436, DOI 10.1016/j.jmb.2006.06.023; Goldberg E, 2010, J ANDROL, V31, P86, DOI 10.2164/jandrol.109.008367; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Han C, 2009, BIOL REPROD, V80, P1001, DOI 10.1095/biolreprod.108.073700; Hoffhines AJ, 2009, J BIOL CHEM, V284, P3096, DOI 10.1074/jbc.M808434200; HORTIN GL, 1989, P NATL ACAD SCI USA, V86, P1338, DOI 10.1073/pnas.86.4.1338; HUTTNER WB, 1982, NATURE, V299, P273, DOI 10.1038/299273a0; Ikawa M, 2001, DEV BIOL, V240, P254, DOI 10.1006/dbio.2001.0462; Ikawa M, 1997, NATURE, V387, P607, DOI 10.1038/42484; Ikawa M, 2011, J BIOL CHEM, V286, P5639, DOI 10.1074/jbc.M110.140152; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Inoue N, 2008, BIOCHEM BIOPH RES CO, V377, P910, DOI 10.1016/j.bbrc.2008.10.073; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; LEE RWH, 1983, J BIOL CHEM, V258, P1326; Moore KL, 2009, P NATL ACAD SCI USA, V106, P14741, DOI 10.1073/pnas.0908376106; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nishimura H, 2007, J BIOL CHEM, V282, P17900, DOI 10.1074/jbc.M702268200; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Ouyang YB, 1998, J BIOL CHEM, V273, P24770, DOI 10.1074/jbc.273.38.24770; Ouyang YB, 1998, P NATL ACAD SCI USA, V95, P2896, DOI 10.1073/pnas.95.6.2896; Ouyang YB, 2002, J BIOL CHEM, V277, P23781, DOI 10.1074/jbc.M202420200; PITTMAN DD, 1994, BIOCHEMISTRY-US, V33, P6952, DOI 10.1021/bi00188a026; PITTMAN DD, 1992, BIOCHEMISTRY-US, V31, P3315, DOI 10.1021/bi00128a003; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; ROSA P, 1992, J BIOL CHEM, V267, P12227; SAKO D, 1995, CELL, V83, P323, DOI 10.1016/0092-8674(95)90173-6; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Sosnik J, 2009, J CELL SCI, V122, P2741, DOI 10.1242/jcs.047225; Stein KK, 2005, BIOL REPROD, V73, P1032, DOI 10.1095/biolreprod.105.040972; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; Westmuckett AD, 2008, GEN COMP ENDOCR, V156, P145, DOI 10.1016/j.ygcen.2007.12.006; Whitten WK, 1971, ADV BIOSCI, V6, P129, DOI DOI 10.1016/B978-0-08-017571-3.50013-9; WILKINS PP, 1995, J BIOL CHEM, V270, P22677, DOI 10.1074/jbc.270.39.22677; Wortzman GB, 2005, MOL HUM REPROD, V11, P1, DOI 10.1093/molehr/gah125; Yamaguchi R, 2006, BIOL REPROD, V75, P760, DOI 10.1095/biolreprod.106.052977; Yamaguchi R, 2009, BIOL REPROD, V81, P142, DOI 10.1095/biolreprod.108.074021; Zhu GZ, 2009, MOL REPROD DEV, V76, P1106, DOI 10.1002/mrd.21076	58	39	54	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13060	13070		10.1074/jbc.M110.175463	http://dx.doi.org/10.1074/jbc.M110.175463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339297	Green Published, hybrid			2022-12-25	WOS:000289282200026
J	Moroni, M; Meyer, JO; Lahmann, C; Sivilotti, LG				Moroni, Mirko; Meyer, James O.; Lahmann, Carolina; Sivilotti, Lucia G.			In Glycine and GABA(A) Channels, Different Subunits Contribute Asymmetrically to Channel Conductance via Residues in the Extracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION CHANNELS; CYS-LOOP RECEPTORS; AMINO-ACIDS; TRANSMEMBRANE SEGMENT; STOICHIOMETRY; SELECTIVITY; DETERMINES; REGION; MUTATION	Single-channel conductance in Cys-loop channels is controlled by the nature of the amino acids in the narrowest parts of the ion conduction pathway, namely the second transmembrane domain (M2) and the intracellular helix. In cationic channels, such as Torpedo ACh nicotinic receptors, conductance is increased by negatively charged residues exposed to the extracellular vestibule. We now show that positively charged residues at the same loop 5 position boost also the conductance of anionic Cys-loop channels, such as glycine (alpha 1 and alpha 1 beta) and GABA(A) (alpha 1 beta 2 gamma 2) receptors. Charge reversal mutations here produce a greater decrease on outward conductance, but their effect strongly depends on which subunit carries the mutation. In the glycine alpha 1 beta receptor, replacing Lys with Glu in alpha 1 reduces single-channel conductance by 41%, but has no effect in the beta subunit. By expressing concatameric receptors with constrained stoichiometry, we show that this asymmetry is not explained by the subunit copy number. A similar pattern is observed in the alpha 1 beta 2 gamma 2 GABA(A) receptor, where only mutations in alpha 1 or beta 2 decreased conductance (to different extents). In both glycine and GABA receptors, the effect of mutations in different subunits does not sum linearly: mutations that had no detectable effect in isolation did enhance the effect of mutations carried by other subunits. As in the nicotinic receptor, charged residues in the extracellular vestibule of anionic Cys-loop channels influence elementary conductance. The size of this effect strongly depends on the direction of the ion flow and, unexpectedly, on the nature of the subunit that carries the residue.	[Moroni, Mirko; Meyer, James O.; Lahmann, Carolina; Sivilotti, Lucia G.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Sivilotti, LG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Med Sci Bldg,Gower St, London WC1E 6BT, England.	l.sivilotti@ucl.ac.uk	Sivilotti, Lucia/D-8919-2011; Moroni, Mirko/Q-1524-2018	Sivilotti, Lucia/0000-0003-2510-8424; 	MRC [G0400869]; Nuffield Science Bursary; Medical Research Council [G0400869] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nuffield Science Bursary; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC (Programme Grant G0400869, to L. G. S.) and by a Nuffield Science Bursary (to C. L.).	BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Brams M, 2011, J BIOL CHEM, V286, P4420, DOI 10.1074/jbc.M110.188730; Burzomato V, 2003, RECEPTOR CHANNEL, V9, P353, DOI 10.3109/714041016; Carland JE, 2009, J BIOL CHEM, V284, P2023, DOI 10.1074/jbc.M806618200; Chang YC, 1996, J NEUROSCI, V16, P5415; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; Dalziel JE, 2000, MOL PHARMACOL, V57, P875; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Gonzales EB, 2008, NEUROSCI LETT, V431, P184, DOI 10.1016/j.neulet.2007.11.039; Groot-Kormelink PJ, 2004, J GEN PHYSIOL, V123, P697, DOI 10.1085/jgp.200409042; Groot-Kormelink PJ, 2002, J NEUROSCI METH, V113, P207, DOI 10.1016/S0165-0270(01)00500-3; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; IMOTO K, 1991, FEBS LETT, V289, P193, DOI 10.1016/0014-5793(91)81068-J; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jensen ML, 2002, J BIOL CHEM, V277, P41438, DOI 10.1074/jbc.M205645200; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; KIENKER P, 1994, BIOPHYS J, V66, P325, DOI 10.1016/S0006-3495(94)80781-7; KONNO T, 1991, P ROY SOC B-BIOL SCI, V244, P69, DOI 10.1098/rspb.1991.0053; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; LIVESEY M, 2010, P BR PHARM SOC, V7, pP37; Meltzer RH, 2006, BIOPHYS J, V91, P1315, DOI 10.1529/biophysj.106.081448; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Mortensen M, 2010, J PHYSIOL-LONDON, V588, P1251, DOI 10.1113/jphysiol.2009.182444; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Song C, 2009, BBA-BIOMEMBRANES, V1788, P1466, DOI 10.1016/j.bbamem.2009.04.015; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; VILLARROEL A, 1992, P ROY SOC B-BIOL SCI, V249, P317, DOI 10.1098/rspb.1992.0121; VILLARROEL A, 1991, P ROY SOC B-BIOL SCI, V243, P69, DOI 10.1098/rspb.1991.0012; Wilkins ME, 2002, J NEUROSCI, V22, P5328; Zhou Y, 2003, J NEUROSCI, V23, P9004	42	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13414	13422		10.1074/jbc.M110.204610	http://dx.doi.org/10.1074/jbc.M110.204610			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343294	hybrid, Green Published			2022-12-25	WOS:000289282200061
J	Su, JY; Schlicker, C; Forchhammer, K				Su, Jiyong; Schlicker, Christine; Forchhammer, Karl			A Third Metal Is Required for Catalytic Activity of the Signal-transducing Protein Phosphatase M tPphA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE/THREONINE PHOSPHATASE; P-II; 2C; DEPHOSPHORYLATION; CONFORMATION; RESOLUTION; RESIDUES; BINDING	Protein phosphatase M (PPM) regulates key signaling pathways in prokaryotes and eukaryotes. Novel structures of bacterial PPM members revealed three divalent metal ions in their catalytic centers. The function of metal 3 (M3) remained unclear. To reveal its function, we created variants of tPphA from Thermosynechococcus elongatus in all metal-coordinating residues, and multiple variants were created for the M3 coordinating Asp-119 residue. The structures of variants D119A and D193A were resolved, showing loss of M3 binding but unaffected binding of M1 and M2 in the catalytic center of D119A, with the nucleophilic water molecule in the correct place. The catalytic activity of this variant was highly impaired. This and further structure-function analyses showed that M3 is required for catalysis by providing a water molecule as a proton donor during catalysis. Mutation of the homologue Asp residue in human PP2C alpha also caused loss of function, suggesting a general requirement of M3 in PPM-catalyzed reactions.	[Su, Jiyong; Forchhammer, Karl] Univ Tubingen, Dept Organism Interact, Interfac Inst Microbiol & Infect Med, D-72076 Tubingen, Germany; [Schlicker, Christine] Ruhr Univ Bochum, Dept Biophys, D-44801 Bochum, Germany	Eberhard Karls University of Tubingen; Ruhr University Bochum	Forchhammer, K (corresponding author), Univ Tubingen, Dept Organism Interact, Interfac Inst Microbiol & Infect Med, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de		Su, Jiyong/0000-0001-8406-1676	Deutsche Forschungsgemeinschaft [Fo195, GRK 685]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Fo195 and GRK 685 "Infection Biology" and Prof. Dr. Eckhard Hofmann.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arino J, 2011, EUKARYOT CELL, V10, P21, DOI 10.1128/EC.00249-10; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; EKMAN P, 1993, ANAL BIOCHEM, V214, P138, DOI 10.1006/abio.1993.1468; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Irmler A, 1997, MOL MICROBIOL, V26, P81, DOI 10.1046/j.1365-2958.1997.5521918.x; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Lai SM, 2005, MICROBIOL-SGM, V151, P1159, DOI 10.1099/mic.0.27585-0; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MACKINTOSH C, 1999, PROTEIN PHOSPHORYLAT, P153; Marley AE, 1996, BIOCHEM J, V320, P801, DOI 10.1042/bj3200801; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pullen KE, 2004, STRUCTURE, V12, P1947, DOI 10.1016/j.str.2004.09.008; Rantanen MK, 2007, FEBS J, V274, P3128, DOI 10.1111/j.1742-4658.2007.05845.x; Ruppert U, 2002, MOL MICROBIOL, V44, P855, DOI 10.1046/j.1365-2958.2002.02927.x; Schlicker C, 2008, J MOL BIOL, V376, P570, DOI 10.1016/j.jmb.2007.11.097; Shakir SM, 2010, J BACTERIOL, V192, P400, DOI 10.1128/JB.01221-09; Sugiura T, 2009, BIOMETALS, V22, P469, DOI 10.1007/s10534-009-9204-9; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076	25	31	32	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13481	13488		10.1074/jbc.M109.036467	http://dx.doi.org/10.1074/jbc.M109.036467			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21310952	hybrid, Green Published			2022-12-25	WOS:000289282200068
J	Hu, YF; Zhang, XX; Shi, YM; Zhou, YF; Zhang, W; Su, XD; Xia, B; Zhao, JD; Jin, CW				Hu, Yunfei; Zhang, Xinxin; Shi, Yunming; Zhou, Yanfeng; Zhang, Wei; Su, Xiao-Dong; Xia, Bin; Zhao, Jindong; Jin, Changwen			Structures of Anabaena Calcium-binding Protein CcbP INSIGHTS INTO CA(2+) SIGNALING DURING HETEROCYST DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPHTHERIA-TOXIN REPRESSOR; TORSION ANGLE DYNAMICS; EF-HAND PROTEINS; NMR EXPERIMENTS; NOE ASSIGNMENT; SH3 DOMAINS; HOMOLOGY; SRC; CYANOBACTERIA; PROGRAMS	Ca2+-binding proteins play pivotal roles in both eukaryotic and prokaryotic cells. CcbP from cyanobacterium Anabaena sp. strain PCC 7120 is a major Ca2+-binding protein involved in heterocyst differentiation, a process that forms specialized nitrogen-fixing cells. The three-dimensional structures of both Ca2+-free and Ca2+-bound forms of CcbP are essential for elucidating the Ca2+-signaling mechanism. However, CcbP shares low sequence identity with proteins of known structures, and its Ca2+-binding sites remain unknown. Here, we report the solution structures of CcbP in both Ca2+-free and Ca2+-bound forms determined by nuclear magnetic resonance spectroscopy. CcbP adopts an overall new fold and contains two Ca2+-binding sites with distinct Ca2+-binding abilities. Mutation of Asp(38) at the stronger Ca2+-binding site of CcbP abolished its ability to regulate heterocyst formation in vivo. Surprisingly, the beta-barrel subdomain of CcbP, which does not participate in Ca2+-binding, topologically resembles the Src homology 3 (SH3) domain and might act as a protein-protein interaction module. Our results provide the structural basis of the unique Ca2+ signaling mechanism during heterocyst differentiation.	[Hu, Yunfei; Zhang, Xinxin; Xia, Bin; Zhao, Jindong; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China; [Shi, Yunming; Zhang, Wei; Zhao, Jindong; Jin, Changwen] Peking Univ, State Key Lab Plant & Prot Engn, Beijing 100871, Peoples R China; [Xia, Bin; Zhao, Jindong] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Xia, Bin; Jin, Changwen] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Zhao, Jindong] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China	Peking University; Peking University; Peking University; Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Zhao, JD (corresponding author), Peking Univ, Coll Life Sci, Beijing Nucl Magnet Resonance Ctr, Beijing 100871, Peoples R China.	jzhao@pku.edu.cn; changwen@pku.edu.cn	Zhou, Yanfeng/B-3792-2012; Zhang, Wei/P-1532-2015		National Natural Science Foundation [30325010, 30230040]; Ministry of Science and Technology of China [2006CB910203, 2006AA02A323]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation Grants 30325010 (to C. J.) and 30230040 (to J. Z.) and Grants 2006CB910203 and 2006AA02A323 from the Ministry of Science and Technology of China (to C. J.).	Adams DG, 2000, CURR OPIN MICROBIOL, V3, P618, DOI 10.1016/S1369-5274(00)00150-8; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Bilwes AM, 1999, CELL, V96, P131, DOI 10.1016/S0092-8674(00)80966-6; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; FALZONE CJ, 1994, BIOCHEMISTRY-US, V33, P6052, DOI 10.1021/bi00186a004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; LODISH H, 2000, MOL CELL BIOL, P579; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Nekhai SA, 1997, BIOCHEM J, V325, P401, DOI 10.1042/bj3250401; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pearl FMG, 2003, NUCLEIC ACIDS RES, V31, P452, DOI 10.1093/nar/gkg062; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Qiu XY, 1996, BIOCHEMISTRY-US, V35, P12292, DOI 10.1021/bi960861d; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shi YM, 2006, P NATL ACAD SCI USA, V103, P11334, DOI 10.1073/pnas.0602839103; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Wang G, 1999, P NATL ACAD SCI USA, V96, P6119, DOI 10.1073/pnas.96.11.6119; Wolk CP, 2000, PROKARYOTIC DEVELOPMENT, P83; Wylie GP, 2005, BIOCHEMISTRY-US, V44, P40, DOI 10.1021/bi048035p; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhao YH, 2005, P NATL ACAD SCI USA, V102, P5744, DOI 10.1073/pnas.0501782102	48	18	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.201186	http://dx.doi.org/10.1074/jbc.M110.201186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330362	hybrid, Green Published			2022-12-25	WOS:000289077500052
J	Hwang, JY; Huang, WW; Arnold, LA; Huang, RL; Attia, RR; Connelly, M; Wichterman, J; Zhu, FY; Augustinaite, I; Austin, CP; Inglese, J; Johnson, RL; Guy, RK				Hwang, Jong Yeon; Huang, Wenwei; Arnold, Leggy A.; Huang, Ruili; Attia, Ramy R.; Connelly, Michele; Wichterman, Jennifer; Zhu, Fangyi; Augustinaite, Indre; Austin, Christopher P.; Inglese, James; Johnson, Ronald L.; Guy, R. Kiplin			Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; ESTROGEN-RECEPTOR; NUCLEAR RECEPTORS; LIGAND-BINDING; IN-VIVO; AMPHIBIAN METAMORPHOSIS; BIOLOGICAL EVALUATION; HIGH-THROUGHPUT; DRUG DISCOVERY; ION CHANNELS	Thyroid hormone receptors (TRs) are members of the nuclear hormone receptor (NR) superfamily and regulate development, growth, and metabolism. Upon binding thyroid hormone, TR undergoes a conformational change that allows the release of corepressors and the recruitment of coactivators, which in turn regulate target gene transcription. Although a number of TR antagonists have been developed, most are analogs of the endogenous hormone that inhibit ligand binding. In a screen for inhibitors that block the association of TR beta with steroid receptor coactivator 2 (SRC2), we identified a novel methylsulfonylnitrobenzoate (MSNB)-containing series that blocks this interaction at micromolar concentrations. Here we have studied a series of MSNB analogs and characterized their structure activity relationships. MSNB members do not displace thyroid hormone T-3 but instead act by direct displacement of SRC2. MSNB series members are selective for the TR over the androgen, vitamin D, and PPAR gamma NR members, and they antagonize thyroid hormone-activated transcription action in cells. The methylsulfonylnitro group is essential for TR beta antagonism. Side-chain alkylamine substituents showed better inhibitory activity than arylamine substituents. Mass spectrum analysis suggested that MSNB inhibitors bind irreversibly to Cys-298 within the AF-2 cleft of TR beta to disrupt SRC2 association.	[Hwang, Jong Yeon; Attia, Ramy R.; Connelly, Michele; Zhu, Fangyi; Augustinaite, Indre; Guy, R. Kiplin] St Jude Childrens Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Huang, Wenwei; Huang, Ruili; Wichterman, Jennifer; Austin, Christopher P.; Inglese, James; Johnson, Ronald L.] NHGRI, NIH Chem Genom Ctr, NIH, Bethesda, MD 20892 USA; [Arnold, Leggy A.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53211 USA	St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Wisconsin System; University of Wisconsin Milwaukee	Guy, RK (corresponding author), 262 Danny Thomas Pl,Mail Stop 1000, Memphis, TN 38105 USA.	kip.guy@stjude.org	Guy, Rodney/J-7107-2013; Huang, WW/GXH-0977-2022; Huang, Wenwei/AFO-1997-2022	Guy, Rodney/0000-0002-9638-2060; Arnold, Leggy/0000-0003-1411-1572	National Institutes of Health [DK58080]; NIH Roadmap for Medical Research; National Institutes of Health NHGRI; American Lebanese Syrian Associated Charities (ALSAC); St. Jude Children's Research Hospital (SJCRH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058080, R55DK058080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital (SJCRH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58080, the NIH Roadmap for Medical Research, and the National Institutes of Health NHGRI Intramural Research Program. This work was also supported by the American Lebanese Syrian Associated Charities (ALSAC) and the St. Jude Children's Research Hospital (SJCRH).	Alonso M, 2009, ENDOCRINOLOGY, V150, P3927, DOI 10.1210/en.2009-0093; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; ARNOLD LA, 2006, SCI STKE 2003, pPL3; Arnold LA, 2007, J MED CHEM, V50, P5269, DOI 10.1021/jm070556y; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Brent G A, 2000, Rev Endocr Metab Disord, V1, P27, DOI 10.1023/A:1010056202122; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Coleman MD, 2002, ENVIRON TOXICOL PHAR, V12, P7, DOI 10.1016/S1382-6689(01)00123-5; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Elbrecht A, 1999, J BIOL CHEM, V274, P7913, DOI 10.1074/jbc.274.12.7913; Escriva H, 2004, ESSAYS BIOCHEM, V40, P11, DOI 10.1042/bse0400011; Estebanez-Perpina E, 2007, MOL ENDOCRINOL, V21, P2919, DOI 10.1210/me.2007-0174; Feau C, 2009, ACS CHEM BIOL, V4, P834, DOI 10.1021/cb900143a; Feau C, 2009, J BIOMOL SCREEN, V14, P43, DOI 10.1177/1087057108326662; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; Fradet Yves, 2004, Expert Rev Anticancer Ther, V4, P37, DOI 10.1586/14737140.4.1.37; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Geistlinger TR, 2003, METHOD ENZYMOL, V364, P223; Gillies PS, 2000, DRUGS, V60, P333, DOI 10.2165/00003495-200060020-00009; Gilmer JF, 2005, EUR J PHARM SCI, V24, P315, DOI 10.1016/j.ejps.2004.11.006; Glickman JF, 2002, J BIOMOL SCREEN, V7, P3, DOI 10.1177/108705710200700102; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Grover GJ, 2004, ENDOCRINOLOGY, V145, P1656, DOI 10.1210/en.2003-0973; Gul M, 2005, ARZNEIMITTELFORSCH, V55, P332; Harvey CB, 2002, THYROID, V12, P441, DOI 10.1089/105072502760143791; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Huang H, 2007, ONCOGENE, V26, P258, DOI 10.1038/sj.onc.1209788; Hwang JY, 2009, J MED CHEM, V52, P3892, DOI 10.1021/jm9002704; Jamieson C, 2006, J MED CHEM, V49, P5029, DOI 10.1021/jm060379l; Jeyakumar M, 1997, MOL ENDOCRINOL, V11, P755, DOI 10.1210/me.11.6.755; JOHNSON RL, 2011, J BIOMOL SC IN PRESS; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kansra S, 2005, MOL CELL ENDOCRINOL, V239, P27, DOI 10.1016/j.mce.2005.04.008; Kojetin DJ, 2008, ENDOCR-RELAT CANCER, V15, P851, DOI 10.1677/ERC-07-0281; Kress E, 2009, MOL CELL ENDOCRINOL, V313, P36, DOI 10.1016/j.mce.2009.08.028; Lawrence JM, 2000, INT J CLIN PRACT, V54, P614; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lim W, 2002, J BIOL CHEM, V277, P35664, DOI 10.1074/jbc.M205608200; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; Meng CQ, 2001, BIOORG MED CHEM LETT, V11, P1823, DOI 10.1016/S0960-894X(01)00306-7; Mills NL, 2007, J BIOMOL SCREEN, V12, P946, DOI 10.1177/1087057107306128; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Morgan DL, 2001, INHAL TOXICOL, V13, P633, DOI 10.1080/08958370152409883; NERI R, 1972, ENDOCRINOLOGY, V91, P427, DOI 10.1210/endo-91-2-427; Nguyen NH, 2002, J MED CHEM, V45, P3310, DOI 10.1021/jm0201013; Oppenheimer JH, 1997, ENDOCR REV, V18, P462, DOI 10.1210/er.18.4.462; Parent AA, 2008, J MED CHEM, V51, P6512, DOI 10.1021/jm800698b; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Rodriguez AL, 2004, J MED CHEM, V47, P600, DOI 10.1021/jm030404c; Rouleau N, 2003, J BIOMOL SCREEN, V8, P191, DOI 10.1177/1087057103252605; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schellhammer Paul F, 2004, Clin Prostate Cancer, V2, P213, DOI 10.3816/CGC.2004.n.002; Shah V, 2008, MOL CELL ENDOCRINOL, V296, P69, DOI 10.1016/j.mce.2008.09.016; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Stumvoll M, 2002, ANN MED, V34, P217, DOI 10.1080/713782132; Valadares NF, 2008, J STEROID BIOCHEM, V112, P205, DOI 10.1016/j.jsbmb.2008.10.006; Vanhooke JL, 2004, BIOCHEMISTRY-US, V43, P4101, DOI 10.1021/bi036056y; Wang HW, 2007, CLIN CANCER RES, V13, P2488, DOI 10.1158/1078-0432.CCR-06-1592; Wang Y, 2006, P NATL ACAD SCI USA, V103, P9908, DOI 10.1073/pnas.0510596103; Webb P, 2002, J STEROID BIOCHEM, V83, P59, DOI 10.1016/S0960-0760(02)00270-4; Williams GR, 2000, MOL CELL BIOL, V20, P8329, DOI 10.1128/MCB.20.22.8329-8342.2000; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116; YAOITA Y, 1990, GENE DEV, V4, P1917, DOI 10.1101/gad.4.11.1917; ZOLLNER H, 1973, BIOCHEM PHARMACOL, V22, P1171, DOI 10.1016/0006-2952(73)90234-7	78	28	30	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.200436	http://dx.doi.org/10.1074/jbc.M110.200436			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321127	Green Published, hybrid			2022-12-25	WOS:000289077500003
J	Jung, GH; Barylko, B; Lu, DM; Shu, HJ; Yin, H; Albanesi, JP				Jung, Gwanghyun; Barylko, Barbara; Lu, Dongmei; Shu, Hongjun; Yin, Helen; Albanesi, Joseph P.			Stabilization of Phosphatidylinositol 4-Kinase Type II beta by Interaction with Hsp90	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONES; PROTEIN; MEMBRANE; GELDANAMYCIN; KINASE; PROTEASOME; PHOSPHOINOSITIDES; DEGRADATION; ACTIVATION; COMPLEX	Mammalian cells express two isoforms of type II phosphatidylinositol 4-kinase: PI4KII alpha and PI4KII beta. PI4KII alpha exists almost exclusively as a constitutively active integral membrane protein because of its palmitoylation (Barylko, B., Gerber, S. H., Binns, D. D., Grichine, N., Khvotchev, M., Sudhof, T. C., and Albanesi, J. P. (2001) J. Biol. Chem. 276, 7705-7708). In contrast, PI4KII beta is distributed almost evenly between membranes and cytosol. Whereas the palmitoylated membrane-bound pool is catalytically active, the cytosolic kinase is inactive (Wei, Y. J., Sun, H. Q., Yamamoto, M., Wlodarski, P., Kunii, K., Martinez, M., Barylko, B., Albanesi, J. P., and Yin, H. L. (2002) J. Biol. Chem. 277, 46586-46593; Jung, G., Wang, J., Wlodarski, P., Barylko, B., Binns, D. D., Shu, H., Yin, H. L., and Albanesi, J. P. (2008) Biochem. J. 409, 501-509). In this study, we identify the molecular chaperone Hsp90 as a binding partner of PI4KII beta, but not of PI4KII alpha. Geldanamycin (GA), a specific Hsp90 inhibitor, disrupts the Hsp90-PI4KII beta interaction and destabilizes PI4KII beta, reducing its half-life by 40% and increasing its susceptibility to ubiquitylation and proteasomal degradation. Cytosolic PI4KII beta is much more sensitive to GA treatment than is the integrally membrane-associated species. Exposure to GA induces a partial redistribution of PI4KII beta from the cytosol to membranes and, with brief GA treatments, a corresponding increase in cellular phosphatidylinositol 4-kinase activity. Stimuli such as PDGF receptor activation that also induce recruitment of the kinase to membranes disrupt the Hsp90-PI4KII beta interaction to a similar extent as GA treatment. These results support a model wherein Hsp90 interacts predominantly with the cytosolic, inactive pool of PI4KII beta, shielding it from proteolytic degradation but also sequestering it to the cytosol until an extracellular stimulus triggers its translocation to the Golgi or plasma membrane and subsequent activation.	[Jung, Gwanghyun; Barylko, Barbara; Shu, Hongjun; Albanesi, Joseph P.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75239 USA; [Lu, Dongmei; Yin, Helen] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75239 USA; [Shu, Hongjun] Univ Cincinnati, Dept Mol Oncogenesis, Genome Res Inst, Cincinnati, OH 45237 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati	Albanesi, JP (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Ln, Dallas, TX 75390 USA.	Joseph.Albanesi@UTSouthwestern.edu			National Institutes of Health [R01 GM075401, R01 GM066110]; American Heart Association Texas [0455005Y, 46259]; National Science Foundation [9982061]; Robert A. Welch Foundation [I-1200]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066110, R01GM075401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Texas(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM075401 (to J. P. A.) and R01 GM066110 (to H. Y.). This work was also supported by American Heart Association Texas Affiliate Grants 0455005Y and 46259 (to J. P. A.), National Science Foundation Grant 9982061 (to B. B.), and Robert A. Welch Foundation Grant I-1200 (to H. Y.).	An WG, 2000, CELL GROWTH DIFFER, V11, P355; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Barylko B, 2002, J BIOL CHEM, V277, P44366, DOI 10.1074/jbc.M203241200; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; Donze O, 2001, EMBO J, V20, P3771, DOI 10.1093/emboj/20.14.3771; Fernandis AZ, 2000, MOL IMMUNOL, V37, P273, DOI 10.1016/S0161-5890(00)00053-5; FLANAGAN CA, 1992, J BIOL CHEM, V267, P24117; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Heilmeyer LMG, 2003, IUBMB LIFE, V55, P59, DOI 10.1080/1521654031000090896; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jung G, 2008, BIOCHEM J, V409, P501, DOI 10.1042/BJ20070821; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mayer MP, 1999, CURR BIOL, V9, pR322, DOI 10.1016/S0960-9822(99)80203-6; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; Minogue S, 2006, J CELL SCI, V119, P571, DOI 10.1242/jcs.02752; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Schulte TW, 1997, BIOCHEM BIOPH RES CO, V239, P655, DOI 10.1006/bbrc.1997.7527; Shay KP, 2005, MOL CANCER RES, V3, P170; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tucker DE, 2008, J LEUKOCYTE BIOL, V84, P798, DOI 10.1189/jlb.0308197; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wei YJ, 2002, J BIOL CHEM, V277, P46586, DOI 10.1074/jbc.M206860200; Whitesell L, 1997, ONCOGENE, V14, P2809, DOI 10.1038/sj.onc.1201120; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	44	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.178616	http://dx.doi.org/10.1074/jbc.M110.178616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330372	Green Published, hybrid			2022-12-25	WOS:000289077500088
J	Heyes, DJ; Levy, C; Sakuma, M; Robertson, DL; Scrutton, NS				Heyes, Derren J.; Levy, Colin; Sakuma, Michiyo; Robertson, David L.; Scrutton, Nigel S.			A Twin-track Approach Has Optimized Proton and Hydride Transfer by Dynamically Coupled Tunneling during the Evolution of Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-DRIVEN ENZYME; CONFORMATIONAL-CHANGES; ACTIVATED ENZYME; PROTEIN DYNAMICS; SOLVENT; CATALYSIS; SITE; FLUCTUATIONS; MUTAGENESIS; ENZYMOLOGY	Protein dynamics are crucial for realizing the catalytic power of enzymes, but how enzymes have evolved to achieve catalysis is unknown. The light-activated enzyme protochlorophyllide oxidoreductase (POR) catalyzes sequential hydride and proton transfers in the photoexcited and ground states, respectively, and is an excellent system for relating the effects of motions to catalysis. Here, we have used the temperature dependence of isotope effects and solvent viscosity measurements to analyze the dynamics coupled to the hydride and proton transfer steps in three cyanobacterial PORs and a related plant enzyme. We have related the dynamic profiles of each enzyme to their evolutionary origin. Motions coupled to light-driven hydride transfer are conserved across all POR enzymes, but those linked to thermally activated proton transfer are variable. Cyanobacterial PORs require complex and solvent-coupled dynamic networks to optimize the proton donor-acceptor distance, but evolutionary pressures appear to have minimized such networks in plant PORs. POR from Gloeobacter violaceus has features of both the cyanobacterial and plant enzymes, suggesting that the dynamic properties have been optimized during the evolution of POR. We infer that the differing trajectories in optimizing a catalytic structure are related to the stringency of the chemistry catalyzed and define a functional adaptation in which active site chemistry is protected from the dynamic effects of distal mutations that might otherwise impact negatively on enzyme catalysis.	[Heyes, Derren J.; Levy, Colin; Sakuma, Michiyo; Scrutton, Nigel S.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DM, Lancs, England; [Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DM, Lancs, England.	derren.heyes@manchester.ac.uk; nigel.scrutton@manchester.ac.uk		Levy, Colin/0000-0002-9724-310X; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council, United Kingdom; Biotechnology and Biological Sciences Research Council [BB/D01963X/1] Funding Source: researchfish; BBSRC [BB/D01963X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, United Kingdom.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bandaria JN, 2009, J AM CHEM SOC, V131, P10151, DOI 10.1021/ja902120t; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Garcia-Viloca M, 2004, SCIENCE, V303, P186, DOI 10.1126/science.1088172; Gupta RS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-24; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Johannissen LO, 2007, J PHYS CHEM B, V111, P2631, DOI 10.1021/jp066276w; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Knapp MJ, 2002, EUR J BIOCHEM, V269, P3113, DOI 10.1046/j.1432-1033.2002.03022.x; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lebedev N, 2001, BIOCHEMISTRY-US, V40, P12562, DOI 10.1021/bi0105025; Masgrau L, 2004, ARCH BIOCHEM BIOPHYS, V428, P41, DOI 10.1016/j.abb.2004.03.013; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; NELISSEN B, 1995, MOL BIOL EVOL, V12, P1166; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Pudney CR, 2006, J AM CHEM SOC, V128, P14053, DOI 10.1021/ja0614619; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; SUZUKI JY, 1995, P NATL ACAD SCI USA, V92, P3749, DOI 10.1073/pnas.92.9.3749; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Yahashiri A, 2008, CHEMPHYSCHEM, V9, P980, DOI 10.1002/cphc.200800067	34	22	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11849	11854		10.1074/jbc.M111.219626	http://dx.doi.org/10.1074/jbc.M111.219626			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21317291	Green Published, hybrid			2022-12-25	WOS:000288797100091
J	Martin, FM; Xu, XL; von Lohneysen, K; Gilmartin, TJ; Friedman, JS				Martin, Florent M.; Xu, Xiuling; von Loehneysen, Katharina; Gilmartin, Timothy J.; Friedman, Jeffrey S.			SOD2 Deficient Erythroid Cells Up-Regulate Transferrin Receptor and Down-Regulate Mitochondrial Biogenesis and Metabolism	PLOS ONE			English	Article							LINKED SIDEROBLASTIC ANEMIA; MISSENSE MUTATION; DNA MUTATIONS; GENE-ONTOLOGY; PROTEIN CIA1; EXPRESSION; MYOPATHY; PATIENT; RNA; ERYTHROPOIESIS	Background: Mice irradiated and reconstituted with hematopoietic cells lacking manganese superoxide dismutase (SOD2) show a persistent hemolytic anemia similar to human sideroblastic anemia (SA), including characteristic intra-mitochondrial iron deposition. SA is primarily an acquired, clonal marrow disorder occurring in individuals over 60 years of age with uncertain etiology. Methodology/Principal Findings: To define early events in the pathogenesis of this murine model of SA, we compared erythroid differentiation of Sod2(-/-) and normal bone marrow cells using flow cytometry and gene expression profiling of erythroblasts. The predominant transcriptional differences observed include widespread down-regulation of mitochondrial metabolic pathways and mitochondrial biogenesis. Multiple nuclear encoded subunits of complexes I-IV of the electron transport chain, ATP synthase (complex V), TCA cycle and mitochondrial ribosomal proteins were coordinately downregulated in Sod2(-/-) erythroblasts. Despite iron accumulation within mitochondria, we found increased expression of transferrin receptor, Tfrc, at both the transcript and protein level in SOD2 deficient cells, suggesting deregulation of iron delivery. Interestingly, there was decreased expression of ABCb7, the gene responsible for X-linked hereditary SA with ataxia, a component required for iron-sulfur cluster biogenesis. Conclusions/Significance: These results indicate that in erythroblasts, mitochondrial oxidative stress reduces expression of multiple nuclear genes encoding components of the respiratory chain, TCA cycle and mitochondrial protein synthesis. An additional target of particular relevance for SA is iron: sulfur cluster biosynthesis. By decreasing transcription of components of cluster synthesis machinery, both iron utilization and regulation of iron uptake are impacted, contributing to the sideroblastic phenotype.	[Martin, Florent M.; Xu, Xiuling; von Loehneysen, Katharina; Friedman, Jeffrey S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Gilmartin, Timothy J.] Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Martin, FM (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	friedman@scripps.edu			NIH, NIDDK [R21DK075063, R01DK062473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062473] Funding Source: NIH RePORTER	NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Sources of support for this work were NIH grants R21DK075063 and R01DK062473 from the NIDDK. The website for the NIDDK is http://www2.niddk.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the this manuscript.	Alcindor T, 2002, BRIT J HAEMATOL, V116, P733, DOI 10.1046/j.0007-1048.2002.03378.x; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; BECK EA, 1967, ACTA HAEMATOL-BASEL, V38, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERGMANN AK, 2009, PEDIAT BLOOD CANC; Bottomley Sylvia S, 2006, Curr Hematol Rep, V5, P41; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Bykhovskaya Y, 2007, MOL GENET METAB, V91, P148, DOI 10.1016/j.ymgme.2007.02.006; Camaschella C, 2007, BLOOD, V110, P1353, DOI 10.1182/blood-2007-02-072520; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Fleming MD, 2002, SEMIN HEMATOL, V39, P270, DOI 10.1053/shem.2002.35637; Friedman JS, 2004, BLOOD, V104, P2565, DOI 10.1182/blood-2003-11-3858; Friedman JS, 2001, J EXP MED, V193, P925, DOI 10.1084/jem.193.8.925; Gattermann N, 2000, LEUKEMIA RES, V24, P141, DOI 10.1016/S0145-2126(99)00160-5; Gattermann N, 2004, BLOOD, V103, P1499, DOI 10.1182/blood-2003-07-2446; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Gattermann N, 1996, BRIT J HAEMATOL, V93, P845, DOI 10.1046/j.1365-2141.1996.d01-1724.x; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Martin FM, 2006, ANTIOXID REDOX SIGN, V8, P1217, DOI 10.1089/ars.2006.8.1217; Martin FM, 2005, EXP HEMATOL, V33, P1493, DOI 10.1016/j.exphem.2005.08.009; MARTIN FM, 2008, BRIT J HAEM IN PRESS; MAY A, 1994, BAILLIERE CLIN HAEM, V7, P851, DOI 10.1016/S0950-3536(05)80128-3; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Patton JR, 2005, J BIOL CHEM, V280, P19823, DOI 10.1074/jbc.M500216200; PEARSON HA, 1979, J PEDIATR-US, V95, P976, DOI 10.1016/S0022-3476(79)80286-3; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; SHARP RA, 1990, BRIT J CLIN PRACT, V44, P706; Shin MG, 2003, BLOOD, V101, P3118, DOI 10.1182/blood-2002-06-1825; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Spiegelman BM, 2007, NOVART FDN SYMP, V287, P60; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Srinivasan V, 2007, STRUCTURE, V15, P1246, DOI 10.1016/j.str.2007.08.009; Wallace D C, 2001, Novartis Found Symp, V235, P247; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang YL, 1999, AM J HEMATOL, V60, P83, DOI 10.1002/(SICI)1096-8652(199901)60:1<83::AID-AJH19>3.0.CO;2-N; YUNIS AA, 1980, CLIN HAEMATOL, V9, P607; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	52	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16894	10.1371/journal.pone.0016894	http://dx.doi.org/10.1371/journal.pone.0016894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326867	Green Submitted, Green Published, gold			2022-12-25	WOS:000287037000030
J	Kozmikova, I; Smolikova, J; Vlcek, C; Kozmik, Z				Kozmikova, Iryna; Smolikova, Jana; Vlcek, Cestmir; Kozmik, Zbynek			Conservation and Diversification of an Ancestral Chordate Gene Regulatory Network for Dorsoventral Patterning	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; HOMEOBOX GENE; BETA-CATENIN; SIGNALING PATHWAY; XENOPUS MESODERM; TRANSCRIPTIONAL REPRESSOR; NEGATIVE REGULATOR; DNA-BINDING; AMPHIOXUS; EMBRYOS	Formation of a dorsoventral axis is a key event in the early development of most animal embryos. It is well established that bone morphogenetic proteins (Bmps) and Wnts are key mediators of dorsoventral patterning in vertebrates. In the cephalochordate amphioxus, genes encoding Bmps and transcription factors downstream of Bmp signaling such as Vent are expressed in patterns reminiscent of those of their vertebrate orthologues. However, the key question is whether the conservation of expression patterns of network constituents implies conservation of functional network interactions, and if so, how an increased functional complexity can evolve. Using heterologous systems, namely by reporter gene assays in mammalian cell lines and by transgenesis in medaka fish, we have compared the gene regulatory network implicated in dorsoventral patterning of the basal chordate amphioxus and vertebrates. We found that Bmp but not canonical Wnt signaling regulates promoters of genes encoding homeodomain proteins AmphiVent1 and AmphiVent2. Furthermore, AmphiVent1 and AmphiVent2 promoters appear to be correctly regulated in the context of a vertebrate embryo. Finally, we show that AmphiVent1 is able to directly repress promoters of AmphiGoosecoid and AmphiChordin genes. Repression of genes encoding dorsal-specific signaling molecule Chordin and transcription factor Goosecoid by Xenopus and zebrafish Vent genes represents a key regulatory interaction during vertebrate axis formation. Our data indicate high evolutionary conservation of a core Bmp-triggered gene regulatory network for dorsoventral patterning in chordates and suggest that co-option of the canonical Wnt signaling pathway for dorsoventral patterning in vertebrates represents one of the innovations through which an increased morphological complexity of vertebrate embryo is achieved.	[Kozmikova, Iryna; Smolikova, Jana; Vlcek, Cestmir; Kozmik, Zbynek] Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Kozmikova, I (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Prague, Czech Republic.	kozmik@img.cas.cz	Kozmik, Zbynek/I-8807-2014	Kozmik, Zbynek/0000-0002-5850-2105	Grant Agency of Czech Academy of Sciences [IAA500520604, IAA500520908]; Academy of Sciences of the Czech Republic [AV0Z50520514]	Grant Agency of Czech Academy of Sciences; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Grant Agency of Czech Academy of Sciences (IAA500520604 and IAA500520908 to Z.K.). Institute of Molecular Genetics is supported by the Academy of Sciences of the Czech Republic (AV0Z50520514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston Z, 2009, DEVELOPMENT, V136, P3311, DOI 10.1242/dev.037770; Barkai N, 2009, FEBS J, V276, P1196, DOI 10.1111/j.1742-4658.2008.06854.x; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; CZERNY T, 1995, MOL CELL BIOL, V15, P2858; DALE L, 1992, DEVELOPMENT, V115, P573; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Friedle H, 2002, J BIOL CHEM, V277, P23872, DOI 10.1074/jbc.M201831200; Friedle H, 1998, EMBO J, V17, P2298, DOI 10.1093/emboj/17.8.2298; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Henningfeld KA, 2000, J BIOL CHEM, V275, P21827, DOI 10.1074/jbc.M000978200; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Holland LZ, 2007, INTEGR COMP BIOL, V47, P360, DOI 10.1093/icb/icm064; Holland LZ, 2005, DEV DYNAM, V233, P1430, DOI 10.1002/dvdy.20473; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Imai Y, 2001, DEVELOPMENT, V128, P2407; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101; Kawahara A, 2000, GENESIS, V28, P58, DOI 10.1002/1526-968X(200010)28:2<58::AID-GENE30>3.0.CO;2-N; Kobayashi M, 2001, DEV BIOL, V232, P315, DOI 10.1006/dbio.2001.0185; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kozmik Z, 2001, GENESIS, V29, P172, DOI 10.1002/gene.1021; Lapraz F, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000248; Larder R, 2009, J BIOL CHEM, V284, P16966, DOI 10.1074/jbc.M109.002485; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Melby AE, 2000, DEV BIOL, V224, P275, DOI 10.1006/dbio.2000.9780; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Moren A, 2000, ONCOGENE, V19, P4396, DOI 10.1038/sj.onc.1203798; Moretti PAB, 2001, GENOMICS, V76, P21, DOI 10.1006/geno.2001.6574; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Onai T, 2009, DEV BIOL, V332, P223, DOI 10.1016/j.ydbio.2009.05.571; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Plouhinec JL, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001701; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Sander V, 2007, EMBO J, V26, P2955, DOI 10.1038/sj.emboj.7601705; Schmidt JE, 1996, DEVELOPMENT, V122, P1711; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schubert M, 2000, EVOL DEV, V2, P85, DOI 10.1046/j.1525-142x.2000.00047.x; Schuler-Metz A, 2000, J BIOL CHEM, V275, P34365, DOI 10.1074/jbc.M003915200; Shimada A, 2008, DEVELOPMENT, V135, P281, DOI 10.1242/dev.011494; Trindade M, 1999, DEV BIOL, V216, P442, DOI 10.1006/dbio.1999.9507; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; Wolberger C, 1996, CURR OPIN STRUC BIOL, V6, P62, DOI 10.1016/S0959-440X(96)80096-0; YAMAMOTO T, 1975, MEDAKA KILLIFISH BIO; Yu JK, 2002, DEV DYNAM, V225, P289, DOI 10.1002/dvdy.10173; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472	61	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14650	10.1371/journal.pone.0014650	http://dx.doi.org/10.1371/journal.pone.0014650			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304903	Green Published, gold			2022-12-25	WOS:000287036600003
J	Vacher, C; Kossler, TM; Hochberg, ME; Weis, AE				Vacher, Corinne; Kossler, Tanya M.; Hochberg, Michael E.; Weis, Arthur E.			Impact of Interspecific Hybridization between Crops and Weedy Relatives on the Evolution of Flowering Time in Weedy Phenotypes	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RAPE BRASSICA-NAPUS; OILSEED RAPE; GENE FLOW; COMPETITION AFFECTS; BT TRANSGENES; F-1 HYBRIDS; WILD; PLANT; FITNESS	Background: Like conventional crops, some GM cultivars may readily hybridize with their wild or weedy relatives. The progressive introgression of transgenes into wild or weedy populations thus appears inevitable, and we are now faced with the challenge of determining the possible evolutionary effects of these transgenes. The aim of this study was to gain insight into the impact of interspecific hybridization between transgenic plants and weedy relatives on the evolution of the weedy phenotype. Methodology/Principal Findings: Experimental populations of weedy birdseed rape (Brassica rapa) and transgenic rapeseed (B. napus) were grown under glasshouse conditions. Hybridization opportunities with transgenic plants and phenotypic traits (including phenological, morphological and reproductive traits) were measured for each weedy individual. We show that weedy individuals that flowered later and for longer periods were more likely to receive transgenic pollen from crops and weed x crop hybrids. Because stem diameter is correlated with flowering time, plants with wider stems were also more likely to be pollinated by transgenic plants. We also show that the weedy plants with the highest probability of hybridization had the lowest fecundity. Conclusion/Significance: Our results suggest that weeds flowering late and for long periods are less fit because they have a higher probability of hybridizing with crops or weed x crop hybrids. This may result in counter-selection against this subset of weed phenotypes, and a shorter earlier flowering period. It is noteworthy that this potential evolution in flowering time does not depend on the presence of the transgene in the crop. Evolution in flowering time may even be counter-balanced by positive selection acting on the transgene if the latter was positively associated with maternal genes promoting late flowering and long flowering periods. Unfortunately, we could not verify this association in the present experiment.	[Vacher, Corinne] INRA, Biodiversite Genes & Communaute UMR1202, Cestas, France; [Vacher, Corinne; Hochberg, Michael E.] Univ Montpellier 2, Inst Sci Evolut, UMR5554, Montpellier, France; [Kossler, Tanya M.; Weis, Arthur E.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Vacher, Corinne] Duke Univ, Dept Biol, Durham, NC USA; [Weis, Arthur E.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of California System; University of California Irvine; Duke University; University of Toronto	Vacher, C (corresponding author), INRA, Biodiversite Genes & Communaute UMR1202, Cestas, France.	corinne.vacher@pierroton.inra.fr	Vacher, Corinne/J-1777-2012; Vacher, Corinne/Q-3182-2019; Vacher, Corinne/ABG-8163-2020	Vacher, Corinne/0000-0003-3023-6113; Vacher, Corinne/0000-0003-3023-6113	French Ministere de la Recherche et de l'Enseignement Superieur; United States National Science Foundation [DEB-034530]; National Science and Engineering Research Council of Canada	French Ministere de la Recherche et de l'Enseignement Superieur; United States National Science Foundation(National Science Foundation (NSF)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support came from the French Ministere de la Recherche et de l'Enseignement Superieur (Program: Impact of Biotechnologies in Agro-Ecosystems), and grants from the United States National Science Foundation (Grant: DEB-034530) and the National Science and Engineering Research Council of Canada to AEW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RJ, 1992, TRENDS ECOL EVOL, V7, P401, DOI 10.1016/0169-5347(92)90020-C; Allainguillaume J, 2006, MOL ECOL, V15, P1175, DOI 10.1111/j.1365-294X.2006.02856.x; [Anonymous], SAS STAT SOFTW VERS; Cresswell JE, 1995, FUNCT ECOL, V9, P829, DOI 10.2307/2389980; Cresswell JE, 2000, ECOL ENTOMOL, V25, P19, DOI 10.1046/j.1365-2311.2000.00230.x; Cummings CL, 2002, ECOL APPL, V12, P1661, DOI 10.1890/1051-0761(2002)012[1661:FSIASC]2.0.CO;2; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Di K, 2009, PEST MANAG SCI, V65, P753, DOI 10.1002/ps.1749; DORN LA, 1991, EVOLUTION, V45, P371, DOI 10.1111/j.1558-5646.1991.tb04411.x; Ellstrand N. C., 2003, DANGEROUS LIAISONS C; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; FitzJohn RG, 2007, EUPHYTICA, V158, P209, DOI 10.1007/s10681-007-9444-0; Franke DM, 2006, INT J PLANT SCI, V167, P83, DOI 10.1086/497648; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Halfhill MD, 2005, MOL ECOL, V14, P3177, DOI 10.1111/j.1365-294X.2005.02649.x; Halfhill MD, 2001, THEOR APPL GENET, V103, P659, DOI 10.1007/s001220100613; Hall L, 2000, WEED SCI, V48, P688, DOI 10.1614/0043-1745(2000)048[0688:PFBHRB]2.0.CO;2; Harper BK, 1999, NAT BIOTECHNOL, V17, P1125, DOI 10.1038/15114; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hauser TP, 1998, HEREDITY, V81, P429, DOI 10.1046/j.1365-2540.1998.00424.x; Hauser TP, 1997, AM J BOT, V84, P756, DOI 10.2307/2445811; Hegde SG, 2006, EVOLUTION, V60, P1187, DOI 10.1111/j.0014-3820.2006.tb01197.x; Johannessen MM, 2006, HEREDITY, V96, P360, DOI 10.1038/sj.hdy.6800796; Linder CR, 1998, THEOR APPL GENET, V96, P339, DOI 10.1007/s001220050746; Johannessen MM, 2006, EUPHYTICA, V150, P17, DOI 10.1007/s10681-006-9083-x; Pallett DW, 2006, ANN APPL BIOL, V148, P147, DOI 10.1111/j.1744-7348.2006.00049.x; Pertl M, 2002, HEREDITY, V89, P212, DOI 10.1038/sj.hdy.6800131; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Simard MJ, 2006, CAN J BOT, V84, P1842, DOI 10.1139/B06-135; Snow A, 2009, MOL ECOL, V18, P569, DOI 10.1111/j.1365-294X.2008.04063.x; Stewart CN, 1997, MOL ECOL, V6, P773, DOI 10.1046/j.1365-294X.1997.00239.x; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Vacher C, 2004, THEOR APPL GENET, V109, P806, DOI 10.1007/s00122-004-1696-7; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Warwick SI, 2003, THEOR APPL GENET, V107, P528, DOI 10.1007/s00122-003-1278-0; Weis AE, 2004, AM J BOT, V91, P825, DOI 10.3732/ajb.91.6.825; Weis AE, 2005, EVOL ECOL RES, V7, P161; Wilkinson MJ, 2003, SCIENCE, V302, P457, DOI 10.1126/science.1088200	44	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e14649	10.1371/journal.pone.0014649	http://dx.doi.org/10.1371/journal.pone.0014649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304909	Green Published, gold			2022-12-25	WOS:000287036600002
J	Bajardi, P; Poletto, C; Ramasco, JJ; Tizzoni, M; Colizza, V; Vespignani, A				Bajardi, Paolo; Poletto, Chiara; Ramasco, Jose J.; Tizzoni, Michele; Colizza, Vittoria; Vespignani, Alessandro			Human Mobility Networks, Travel Restrictions, and the Global Spread of 2009 H1N1 Pandemic	PLOS ONE			English	Article							INFLUENZA; STRATEGIES; SYSTEMS; IMPACT; MODEL	After the emergence of the H1N1 influenza in 2009, some countries responded with travel-related controls during the early stage of the outbreak in an attempt to contain or slow down its international spread. These controls along with self-imposed travel limitations contributed to a decline of about 40% in international air traffic to/from Mexico following the international alert. However, no containment was achieved by such restrictions and the virus was able to reach pandemic proportions in a short time. When gauging the value and efficacy of mobility and travel restrictions it is crucial to rely on epidemic models that integrate the wide range of features characterizing human mobility and the many options available to public health organizations for responding to a pandemic. Here we present a comprehensive computational and theoretical study of the role of travel restrictions in halting and delaying pandemics by using a model that explicitly integrates air travel and short-range mobility data with high-resolution demographic data across the world and that is validated by the accumulation of data from the 2009 H1N1 pandemic. We explore alternative scenarios for the 2009 H1N1 pandemic by assessing the potential impact of mobility restrictions that vary with respect to their magnitude and their position in the pandemic timeline. We provide a quantitative discussion of the delay obtained by different mobility restrictions and the likelihood of containing outbreaks of infectious diseases at their source, confirming the limited value and feasibility of international travel restrictions. These results are rationalized in the theoretical framework characterizing the invasion dynamics of the epidemics at the metapopulation level.	[Bajardi, Paolo; Poletto, Chiara; Tizzoni, Michele] Inst Sci Interchange ISI, Computat Epidemiol Lab, Turin, Italy; [Bajardi, Paolo] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Ramasco, Jose J.] Inst Fis Interdisciplinary Sistemas Complejos IFI, CSIC UIB, Palma de Mallorca, Spain; [Tizzoni, Michele] Politecn Torino, Scuola Dottorato, Turin, Italy; [Colizza, Vittoria] INSERM, U707, Paris, France; [Colizza, Vittoria] UPMC Univ Paris 06, Fac Med Pierre & Marie Curie, UMR S 707, Paris, France; [Colizza, Vittoria] Inst Sci Interchange ISI, Complex Syst Lagrange Lab, Turin, Italy; [Vespignani, Alessandro] Indiana Univ, Ctr Complex Networks & Syst Res CNetS, Sch Informat & Comp, Bloomington, IN USA; [Vespignani, Alessandro] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona; Polytechnic University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Bajardi, P (corresponding author), Inst Sci Interchange ISI, Computat Epidemiol Lab, Turin, Italy.	vittoria.colizza@inserm.fr; alexv@indiana.edu	Bajardi, Paolo/AAE-2416-2022; Tizzoni, Michele/H-6442-2016; Ramasco, Jose Javier/F-2860-2010; Tizzoni, Michele/AAE-8036-2020; Bajardi, Paolo/J-6180-2012	Bajardi, Paolo/0000-0001-8865-4495; Tizzoni, Michele/0000-0001-7246-2341; Ramasco, Jose Javier/0000-0003-2499-6095; Tizzoni, Michele/0000-0001-7246-2341; Poletto, Chiara/0000-0002-4051-1716; Colizza, Vittoria/0000-0002-2113-2374; Vespignani, Alessandro/0000-0003-3419-4205	National Institutes of Health [R21-DA024259]; Lilly Endowment [2008 1639-000]; EC-ICT [231807 (EPIWORK)]; EC-FET [233847 (DYNANETS)]; ERC [ERC-2007-Stg204863 (EPIFOR)];  [DTRA-1-0910039]; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment; EC-ICT; EC-FET; ERC(European Research Council (ERC)European Commission); ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work has been partially funded by the National Institutes of Health R21-DA024259 award, the Lilly Endowment grant 2008 1639-000 and the DTRA-1-0910039 award to AV; the EC-ICT contract no. 231807 (EPIWORK) to AV and VC; the EC-FET contract no. 233847 (DYNANETS) to AV, VC, and JJR; the ERC Ideas contract n.ERC-2007-Stg204863 (EPIFOR) to VC, PB, CP, and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Brownstein JS, 2006, PLOS MED, V3, P1826, DOI 10.1371/journal.pmed.0030401; CIESIN, 2005, GRIDD POP WORLD VERS; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Flahault A., 1991, MATH POPUL STUD, V3, P1; Flahault A, 2006, VACCINE, V24, P6751, DOI 10.1016/j.vaccine.2006.05.079; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Harris TE, 1989, THEORY BRANCHING PRO; *HLTH PROT AG HLTH, 2009, EURO SURVEILL, V14; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2002, ECOL LETT, V5, P20, DOI 10.1046/j.1461-0248.2002.00268.x; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Murray J.D, 2005, MATH BIOL; Novel influenza A(H1N1) investigation team, 2009, EURO SURVEILL, V14, P19295; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; *SECR COM TRANSP, 2009, B MENS EST OP; *SECR SAL, BROT INF RESP AG GLO; Tomba GS, 2008, MATH BIOSCI, V214, P70, DOI 10.1016/j.mbs.2008.02.009; Vazquez A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038702; Viboud C, 2006, PLOS MED, V3, P2159, DOI 10.1371/journal.pmed.0030503; 2010, INFLUENZA A H1N1 MEA	40	276	280	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16591	10.1371/journal.pone.0016591	http://dx.doi.org/10.1371/journal.pone.0016591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304943	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300093
J	Chapuis, E; Pages, S; Emelianoff, V; Givaudan, A; Ferdy, JB				Chapuis, Elodie; Pages, Sylvie; Emelianoff, Vanya; Givaudan, Alain; Ferdy, Jean-Baptiste			Virulence and Pathogen Multiplication: A Serial Passage Experiment in the Hypervirulent Bacterial Insect-Pathogen Xenorhabdus nematophila	PLOS ONE			English	Article							ENTOMOPATHOGENIC NEMATODES; EXPERIMENTAL EVOLUTION; GENUS XENORHABDUS; PHASE VARIATION; TRADE-OFF; PHOTORHABDUS; PARASITES; MOTILITY; ENTEROBACTERIACEAE; ADAPTATION	The trade-off hypothesis proposes that the evolution of pathogens' virulence is shaped by a link between virulence and contagiousness. This link is often assumed to come from the fact that pathogens are contagious only if they can reach high parasitic load in the infected host. In this paper we present an experimental test of the hypothesis that selection on fast replication can affect virulence. In a serial passage experiment, we selected 80 lines of the bacterial insect-pathogen Xenorhabdus nematophila to multiply fast in an artificial culture medium. This selection resulted in shortened lag phase in our selected bacteria. We then injected these bacteria into insects and observed an increase in virulence. This could be taken as a sign that virulence in Xenorhabdus is linked to fast multiplication. But we found, among the selected lineages, either no link or a positive correlation between lag duration and virulence: the most virulent bacteria were the last to start multiplying. We then surveyed phenotypes that are under the control of the flhDC super regulon, which has been shown to be involved in Xenorhabdus virulence. We found that, in one treatment, the flhDC regulon has evolved rapidly, but that the changes we observed were not connected to virulence. All together, these results indicate that virulence is, in Xenorhabdus as in many other pathogens, a multifactorial trait. Being able to grow fast is one way to be virulent. But other ways exist which renders the evolution of virulence hard to predict.	[Chapuis, Elodie; Emelianoff, Vanya] Ctr Biol & Management Populat, Montpellier, France; [Pages, Sylvie; Givaudan, Alain] Univ Montpellier 2, UMR INRA UM2 1133, Lab EMIP, Montpellier, France; [Ferdy, Jean-Baptiste] Univ Toulouse 3, UMR CNRS UPS 5174, Lab Evolut & Diversite Biol, F-31062 Toulouse, France	INRAE; Universite de Montpellier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS)	Chapuis, E (corresponding author), Ctr Biol & Management Populat, Montpellier, France.	ferdy@cict.fr	chapuis, elodie/AAF-8000-2021; Chapuis, Elodie/N-5406-2018	Chapuis, Elodie/0000-0003-2299-0992; FERDY, Jean-Baptiste/0000-0002-4020-1208	French National Research Agency [ANR-06-JCJC-0102]	French National Research Agency(French National Research Agency (ANR))	This work has been funded by the French National Research Agency (www.agence-nationale-recherche.fr, grant ANR-06-JCJC-0102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHURST RJ, 1982, J GEN MICROBIOL, V128, P3061; AKHURST RJ, 1988, J GEN MICROBIOL, V134, P1835; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Atkinson B., 2008, KINSHIP MIXED EFFECT; BAGHDIGUIAN S, 1993, BIOL CELL, V79, P177, DOI 10.1016/0248-4900(93)90254-C; Boemare N, 1997, SYMBIOSIS, V22, P167; BOEMARE NE, 1992, APPL ENVIRON MICROB, V58, P3032, DOI 10.1128/AEM.58.9.3032-3037.1992; Brillard J, 2001, APPL ENVIRON MICROB, V67, P2515, DOI 10.1128/AEM.67.6.2515-2525.2001; Chapuis E, 2009, J EVOLUTION BIOL, V22, P2104, DOI 10.1111/j.1420-9101.2009.01829.x; Cowles KN, 2007, CELL MICROBIOL, V9, P1311, DOI 10.1111/j.1462-5822.2006.00873.x; Dray S., 2007, R NEWS, V7, P47; Ebert D, 1998, SCIENCE, V282, P1432, DOI 10.1126/science.282.5393.1432; Ebert D, 2003, TRENDS MICROBIOL, V11, P15, DOI 10.1016/S0966-842X(02)00003-3; Emelianoff V, 2008, EVOLUTION, V62, P932, DOI 10.1111/j.1558-5646.2008.00319.x; Emelianoff V, 2007, PARASITOL RES, V100, P657, DOI 10.1007/s00436-006-0284-y; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; FENNER F, 1965, MYXOMATOSIS; Givaudan A, 2000, J BACTERIOL, V182, P107, DOI 10.1128/JB.182.1.107-115.2000; GIVAUDAN A, 1995, APPL ENVIRON MICROB, V61, P1408, DOI 10.1128/AEM.61.4.1408-1413.1995; Goodrich-Blair H, 2007, CURR OPIN MICROBIOL, V10, P225, DOI 10.1016/j.mib.2007.05.006; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Herrera M, 2007, PLOS PATHOG, V3, P498, DOI 10.1371/journal.ppat.0030053; JUBELIN G, DYNAMIC EXPRES UNPUB; Lanois A, 2008, MOL MICROBIOL, V68, P516, DOI 10.1111/j.1365-2958.2008.06168.x; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Oxman E, 2008, EVOLUTION, V62, P1547, DOI 10.1111/j.1558-5646.2008.00397.x; R Development Core Team, 2009, R FDN STAT COMP; Restif O, 2009, INFECT GENET EVOL, V9, P108, DOI 10.1016/j.meegid.2008.09.007; Richards GR, 2008, J BACTERIOL, V190, P4870, DOI 10.1128/JB.00358-08; Richards GR, 2009, CELL MICROBIOL, V11, P1025, DOI 10.1111/j.1462-5822.2009.01322.x; Sicard M, 2004, J EVOLUTION BIOL, V17, P985, DOI 10.1111/j.1420-9101.2004.00748.x; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Therneau T, 2009, SURVIVAL SURVIVAL AN; Tran EEH, 2009, APPL ENVIRON MICROB, V75, P4007, DOI 10.1128/AEM.02658-08; Vigneux F, 2008, J EVOLUTION BIOL, V21, P1245, DOI 10.1111/j.1420-9101.2008.01576.x; Vigneux F, 2007, J BIOL CHEM, V282, P9571, DOI 10.1074/jbc.M604301200; Volgyi A, 1998, APPL ENVIRON MICROB, V64, P1188; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240	42	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15872	10.1371/journal.pone.0015872	http://dx.doi.org/10.1371/journal.pone.0015872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305003	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300028
J	Ostermann, J; Reddy, EA; Shorter, MM; Muiruri, C; Mtalo, A; Itemba, DK; Njau, B; Bartlett, JA; Crump, JA; Thielman, NM				Ostermann, Jan; Reddy, Elizabeth A.; Shorter, Meghan M.; Muiruri, Charles; Mtalo, Antipas; Itemba, Dafrosa K.; Njau, Bernard; Bartlett, John A.; Crump, John A.; Thielman, Nathan M.			Who Tests, Who Doesn't, and Why? Uptake of Mobile HIV Counseling and Testing in the Kilimanjaro Region of Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; VOLUNTARY; COMMUNITY; ATTITUDES; STIGMA; INTERVENTION; HIV/AIDS; ZIMBABWE	Background: Optimally, expanded HIV testing programs should reduce barriers to testing while attracting new and high-risk testers. We assessed barriers to testing and HIV risk among clients participating in mobile voluntary counseling and testing (MVCT) campaigns in four rural villages in the Kilimanjaro Region of Tanzania. Methods: Between December 2007 and April 2008, 878 MVCT participants and 506 randomly selected community residents who did not access MVCT were surveyed. Gender-specific logistic regression models were used to describe differences in socioeconomic characteristics, HIV exposure risk, testing histories, HIV related stigma, and attitudes toward testing between MVCT participants and community residents who did not access MVCT. Gender-specific logistic regression models were used to describe differences in socioeconomic characteristics, HIV exposure risk, testing histories, HIV related stigma, and attitudes toward testing, between the two groups. Results: MVCT clients reported greater HIV exposure risk (OR 1.20 [1.04 to 1.38] for males; OR 1.11 [1.03 to 1.19] for females). Female MVCT clients were more likely to report low household expenditures (OR 1.47 [1.04 to 2.05]), male clients reported higher rates of unstable income sources (OR 1.99 [1.22 to 3.24]). First-time testers were more likely than non-testers to cite distance to testing sites as a reason for not having previously tested (OR 2.17 [1.05 to 4.48] for males; OR 5.95 [2.85 to 12.45] for females). HIV-related stigma, fears of testing or test disclosure, and not being able to leave work were strongly associated with non-participation in MVCT (ORs from 0.11 to 0.84). Conclusions: MVCT attracted clients with increased exposure risk and fewer economic resources; HIV related stigma and testing-related fears remained barriers to testing. MVCT did not disproportionately attract either first-time or frequent repeat testers. Educational campaigns to reduce stigma and fears of testing could improve the effectiveness of MVCT in attracting new and high-risk populations.	[Ostermann, Jan; Bartlett, John A.; Crump, John A.; Thielman, Nathan M.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA; [Ostermann, Jan] Duke Univ, Ctr Hlth Policy, Durham, NC USA; [Reddy, Elizabeth A.; Shorter, Meghan M.; Muiruri, Charles; Bartlett, John A.; Crump, John A.; Thielman, Nathan M.] Duke Univ, Med Ctr, Durham, NC USA; [Mtalo, Antipas; Itemba, Dafrosa K.] KIWAKKUKI Women AIDS Kilimanjaro, Moshi, Tanzania; [Njau, Bernard; Bartlett, John A.; Crump, John A.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Njau, Bernard; Bartlett, John A.; Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania	Duke University; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Ostermann, J (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27706 USA.	n.thielman@duke.edu	Crump, John A./AAZ-6412-2020; Njau, Bernard/AAI-2152-2020; Ostermann, Jan/GQB-4743-2022; Crump, John A./AAZ-6289-2020; Thielman, Nathan/R-5142-2019	Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Thielman, Nathan/0000-0001-8152-2879; Ostermann, Jan/0000-0002-8236-9500	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH) [P30 AI 64518]; Fogarty International Center AIDS International Training and Research Program [NIH D43 TW006732]; Duke Clinical Trials Unit and Clinical Research Sites [NIH U01 AI06984]; International Studies on AIDS Associated Coinfections (ISAAC) [NIH U01 AI-03-036]; AIDS Research and Training Grant [NIH T32 AI007392-18]; Hubert-Yeargan Center for Global Health, Duke University Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW006732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007392, P30AI064518] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Duke Clinical Trials Unit and Clinical Research Sites; International Studies on AIDS Associated Coinfections (ISAAC); AIDS Research and Training Grant; Hubert-Yeargan Center for Global Health, Duke University Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The primary source of funding for this study was the Duke University Center for AIDS Research (CFAR), supported by the National Institutes of Health (NIH; www.nih.gov) (P30 AI 64518). Various investigators were also supported by the following: Fogarty International Center AIDS International Training and Research Program (NIH D43 TW006732; Dr. Njau), Duke Clinical Trials Unit and Clinical Research Sites (NIH U01 AI06984: Drs. Bartlett, Crump, and Thielman), International Studies on AIDS Associated Coinfections (ISAAC) award (NIH U01 AI-03-036; Dr. Bartlett, Dr. Crump, Mrs. Itemba, Mr. Mtalo, Mr. Muiruri, and Dr. Thielman), AIDS Research and Training Grant (NIH T32 AI007392-18; Dr. Reddy), Hubert-Yeargan Center for Global Health, Duke University Medical Center (http://www.dukeglobalhealth.org) (Dr. Shorter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayenew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009702; Baiden F, 2007, J BIOSOC SCI, V39, P721, DOI 10.1017/S0021932006001829; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; Corbett EL, 2006, PLOS MED, V3, P1005, DOI 10.1371/journal.pmed.0030238; Day JH, 2003, AIDS CARE, V15, P665, DOI 10.1080/0954012030001595140; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Genberg BL, 2009, SOC SCI MED, V68, P2279, DOI 10.1016/j.socscimed.2009.04.005; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Mayhood MK, 2008, J CLIN MICROBIOL, V46, P3946, DOI 10.1128/JCM.01045-08; Mbopi-Keou FX, 2007, AIDS, V21, P1994, DOI 10.1097/QAD.0b013e3282f006c3; Middelkoop K, 2006, SEX TRANSM DIS, V33, P524, DOI 10.1097/01.olq.0000219295.50291.1d; MOHAMMED I, 2009, 16 C RETR OPP INF PO; Morin SF, 2006, JAIDS-J ACQ IMM DEF, V41, P218, DOI 10.1097/01.qai.0000179455.01068.ab; Nyanzi-Wakholi B, 2009, AIDS CARE, V21, P903, DOI 10.1080/09540120802657498; Nyblade L, 2006, CAN WE MEASURE HIV A; Ole-Nguyaine S, 2004, ANN TROP MED PARASIT, V98, P171, DOI 10.1179/000349804225003163; Pettifor A, 2010, AIDS BEHAV, V14, P913, DOI 10.1007/s10461-008-9462-5; *PROJ ACC, 2010, PHAS 3 RAND CONTR TR; Shorter MM, 2009, JAIDS-J ACQ IMM DEF, V52, P648, DOI 10.1097/QAI.0b013e3181b31a6a; *TANZ NAT BUR STAT, 2002, POP HOUS CENS VILL S; Tanzania Commission for AIDS (TACAIDS) ZACZ National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and Macro International Inc, 2008, TANZ HIV AIDS MAL IN; The United Republic of Tanzania Ministry of Health National AIDS Control Programme, 2005, NAT GUID VOL COUNS T; *WHO, 2009, GOV CIV SOC EXP ACC	26	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16488	10.1371/journal.pone.0016488	http://dx.doi.org/10.1371/journal.pone.0016488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	714UK	21304973	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300070
J	Krueger, F; Andrews, SR; Osborne, CS				Krueger, Felix; Andrews, Simon R.; Osborne, Cameron S.			Large Scale Loss of Data in Low-Diversity Illumina Sequencing Libraries Can Be Recovered by Deferred Cluster Calling	PLOS ONE			English	Article								Massively parallel DNA sequencing is capable of sequencing tens of millions of DNA fragments at the same time. However, sequence bias in the initial cycles, which are used to determine the coordinates of individual clusters, causes a loss of fidelity in cluster identification on Illumina Genome Analysers. This can result in a significant reduction in the numbers of clusters that can be analysed. Such low sample diversity is an intrinsic problem of sequencing libraries that are generated by restriction enzyme digestion, such as e4C-seq or reduced-representation libraries. Similarly, this problem can also arise through the combined sequencing of barcoded, multiplexed libraries. We describe a procedure to defer the mapping of cluster coordinates until low-diversity sequences have been passed. This simple procedure can recover substantial amounts of next generation sequencing data that would otherwise be lost.	[Krueger, Felix; Andrews, Simon R.] Babraham Inst, Bioinformat Grp, Cambridge, England; [Osborne, Cameron S.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Krueger, F (corresponding author), Babraham Inst, Bioinformat Grp, Cambridge, England.	cameron.osborne@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Krueger, Felix/J-3340-2019	Osborne, Cameron/0000-0003-4126-2499; Ficz, Gabriella/0000-0001-9313-9578; Krueger, Felix/0000-0002-5513-3324	BBSRC (UK); Leukaemia and Lymphoma Research; BBSRC [BBS/E/B/0000H212] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H212] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia and Lymphoma Research; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding provided by the BBSRC (UK). CSO is supported by a Bennett Research Fellowship from Leukaemia and Lymphoma Research (http://www.bbsrc.ac.uk/ and http://www.beatbloodcancers.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496	7	61	92	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16607	10.1371/journal.pone.0016607	http://dx.doi.org/10.1371/journal.pone.0016607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305042	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100049
J	Scheckhuber, CQ; Houthoofd, K; Weil, AC; Werner, A; De Vreese, A; Vanfleteren, JR; Osiewacz, HD				Scheckhuber, Christian Q.; Houthoofd, Koen; Weil, Andrea C.; Werner, Alexandra; De Vreese, Annemie; Vanfleteren, Jacques R.; Osiewacz, Heinz D.			Alternative Oxidase Dependent Respiration Leads to an Increased Mitochondrial Content in Two Long-Lived Mutants of the Ageing Model Podospora anserina	PLOS ONE			English	Article							LIFE-SPAN CONTROL; OXIDATIVE STRESS; DNA REARRANGEMENTS; COPPER; EXPRESSION; GENE; SENESCENCE; DIFFERENTIATION; RESTRICTION; BIOGENESIS	The retrograde response constitutes an important signalling pathway from mitochondria to the nucleus which induces several genes to allow compensation of mitochondrial impairments. In the filamentous ascomycete Podospora anserina, an example for such a response is the induction of a nuclear-encoded and iron-dependent alternative oxidase (AOX) occurring when cytochrome-c oxidase (COX) dependent respiration is affected. Several long-lived mutants are known which predominantly or exclusively respire via AOX. Here we show that two AOX-utilising mutants, grisea and PaCox17::ble, are able to compensate partially for lowered OXPHOS efficiency resulting from AOX-dependent respiration by increasing mitochondrial content. At the physiological level this is demonstrated by an elevated oxygen consumption and increased heat production. However, in the two mutants, ATP levels do not reach WT levels. Interestingly, mutant PaCox17:: ble is characterized by a highly increased release of the reactive oxygen species (ROS) hydrogen peroxide. Both grisea and PaCox17:: ble contain elevated levels of mitochondrial proteins involved in quality control, i. e. LON protease and the molecular chaperone HSP60. Taken together, our work demonstrates that AOX-dependent respiration in two mutants of the ageing model P. anserina is linked to a novel mechanism involved in the retrograde response pathway, mitochondrial biogenesis, which might also play an important role for cellular maintenance in other organisms.	[Scheckhuber, Christian Q.; Weil, Andrea C.; Werner, Alexandra; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Fac Biosci, Frankfurt, Germany; [Houthoofd, Koen; De Vreese, Annemie; Vanfleteren, Jacques R.] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium; [Houthoofd, Koen; De Vreese, Annemie; Vanfleteren, Jacques R.] Univ Ghent, Ctr Mol Phylogeny & Evolut, B-9000 Ghent, Belgium	Goethe University Frankfurt; Ghent University; Ghent University	Scheckhuber, CQ (corresponding author), Goethe Univ Frankfurt, Fac Biosci, Frankfurt, Germany.	scheckhuber@bio.uni-frankfurt.de	Osiewacz, Heinz D./D-3454-2011; Scheckhuber, Christian Q./A-6462-2012	Scheckhuber, Christian Q./0000-0002-2924-7547	European Commission [FP6-512020, FP6-518230]; Cluster of Excellence Macromolecular Complexes	European Commission(European CommissionEuropean Commission Joint Research Centre); Cluster of Excellence Macromolecular Complexes	The experimental work of the authors was supported by grants from the European Commission (contract FP6-512020, Acronym MiMage; contract FP6-518230, Acronym Proteomage) and the Cluster of Excellence Macromolecular Complexes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; BELCOUR L, 1981, CURR GENET, V3, P13, DOI 10.1007/BF00419575; Borghouts C, 2000, CURR GENET, V37, P268, DOI 10.1007/s002940050528; Borghouts C, 1997, P NATL ACAD SCI USA, V94, P10768, DOI 10.1073/pnas.94.20.10768; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Dufour E, 2000, P NATL ACAD SCI USA, V97, P4138, DOI 10.1073/pnas.070501997; Esser K., 1974, BACTERIA BACTERIOPHA, P531; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Hansen J, 2008, NEUROSCIENCE, V153, P474, DOI 10.1016/j.neuroscience.2008.01.070; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Karbowski M, 2001, J CELL SCI, V114, P281; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; Krause F, 2006, ANN NY ACAD SCI, V1067, P106, DOI 10.1196/annals.1354.013; KUCK U, 1981, CURR GENET, V3, P151, DOI 10.1007/BF00365719; KUCK U, 1985, CURR GENET, V10, P59, DOI 10.1007/BF00418494; Kunstmann B, 2009, AGING-US, V1, P1; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; Lambert AJ, 2004, EXP GERONTOL, V39, P289, DOI 10.1016/j.exger.2003.12.009; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; LECELLIER G, 1994, CURR GENET, V25, P122, DOI 10.1007/BF00309536; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lenaerts I, 2002, ANAL BIOCHEM, V311, P90, DOI 10.1016/S0003-2697(02)00397-4; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lorin S, 2001, MOL MICROBIOL, V42, P1259, DOI 10.1046/j.1365-2958.2001.02690.x; Lorin S, 2006, BBA-BIOENERGETICS, V1757, P604, DOI 10.1016/j.bbabio.2006.03.005; Luce K, 2010, PROTEIN METABOLISM H, P1; Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893; Maassen JA, 2002, J ENDOCRINOL INVEST, V25, P477, DOI 10.1007/BF03344042; Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449; Maxwell DP, 1999, P NATL ACAD SCI USA, V96, P8271, DOI 10.1073/pnas.96.14.8271; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Munkres KD., 1990, FUNG GENET NEWSLETT, V37, P24, DOI DOI 10.4148/1941-4765.1477; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Osiewacz HD, 2002, MECH AGEING DEV, V123, P755, DOI 10.1016/S0047-6374(01)00421-3; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; Osiewacz HD, 2010, ANN NY ACAD SCI, V1197, P54, DOI 10.1111/j.1749-6632.2010.05190.x; PRILLINGER H, 1977, MOL GEN GENET, V156, P333, DOI 10.1007/BF00267190; RIDDER R, 1992, CURR GENET, V21, P207, DOI 10.1007/BF00336843; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; RIZET G, 1953, CR HEBD ACAD SCI, V237, P838; Samper E, 2009, FREE RADICAL BIO MED, V46, P387, DOI 10.1016/j.freeradbiomed.2008.10.036; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6; Scheckhuber Christian Q., 2008, Biotechnology Journal, V3, P781, DOI 10.1002/biot.200800010; Sellem CH, 2007, FUNGAL GENET BIOL, V44, P648, DOI 10.1016/j.fgb.2006.09.005; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zintel S, 2010, EXP GERONTOL, V45, P525, DOI 10.1016/j.exger.2010.01.006	59	17	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16620	10.1371/journal.pone.0016620	http://dx.doi.org/10.1371/journal.pone.0016620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305036	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900082
J	Fiaschetti, G; Castelletti, D; Zoller, S; Schramm, A; Schroeder, C; Nagaishi, M; Stearns, D; Mittelbronn, M; Eggert, A; Westermann, F; Ohgaki, H; Shalaby, T; Pruschy, M; Arcaro, A; Grotzer, MA				Fiaschetti, G.; Castelletti, D.; Zoller, S.; Schramm, A.; Schroeder, C.; Nagaishi, M.; Stearns, D.; Mittelbronn, M.; Eggert, A.; Westermann, F.; Ohgaki, H.; Shalaby, T.; Pruschy, M.; Arcaro, A.; Grotzer, M. A.			Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma	ONCOGENE			English	Article						BMP7; MYC; medulloblastoma; brain tumor; pediatric cancer	C-MYC; BREAST-CANCER; CHOROID-PLEXUS; HUMAN PROSTATE; TUMOR-GROWTH; IN-VIVO; BMP; EXPRESSION; METASTASIS; RECEPTORS	Medulloblastoma (MB) is the most common malignant brain tumor in children. It is known that overexpression and/or amplification of the MYC oncogene is associated with poor clinical outcome, but the molecular mechanisms and the MYC downstream effectors in MB remain still elusive. Besides contributing to elucidate how progression of MB takes place, most importantly, the identification of novel MYC-target genes will suggest novel candidates for targeted therapy in MB. A group of 209 MYC-responsive genes was obtained from a complementary DNA microarray analysis of a MB-derived cell line, following MYC overexpression and silencing. Among the MYC-responsive genes, we identified the members of the bone morphogenetic protein (BMP) signaling pathway, which have a crucial role during the development of the cerebellum. In particular, the gene BMP7 was identified as a direct target of MYC. A positive correlation between MYC and BMP7 expression was documented by analyzing two distinct sets of primary MB samples. Functional studies in vitro using a small-molecule inhibitor of the BMP/SMAD signaling pathway reproduced the effect of the small interfering RNA-mediated silencing of BMP7. Both approaches led to a block of proliferation in a panel of MB cells and to inhibition of SMAD phosphorylation. Altogether, our findings indicate that high MYC levels drive BMP7 overexpression, promoting cell survival in MB cells. This observation suggests the potential relevance of targeting the BMP/SMAD pathway as a novel therapeutic approach for the treatment of childhood MB. Oncogene (2011) 30, 2823-2835; doi: 10.1038/onc.2011.10; published online 14 February 2011	[Fiaschetti, G.; Castelletti, D.; Shalaby, T.; Grotzer, M. A.] Univ Childrens Hosp, Dept Oncol, CH-8032 Zurich, Switzerland; [Zoller, S.] UZH ETH, Funct Genom Ctr Zurich, Zurich, Switzerland; [Schramm, A.; Eggert, A.] Univ Childrens Hosp Essen, Div Hematol Oncol, Essen, Germany; [Schroeder, C.; Westermann, F.] German Canc Res Ctr, Dept Tumor Genet, Heidelberg, Germany; [Nagaishi, M.; Ohgaki, H.] World Hlth Org, Int Agcy Res Canc, Sect Mol Pathol, Lyon, France; [Stearns, D.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Mittelbronn, M.] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, Frankfurt, Germany; [Pruschy, M.] Univ Zurich Hosp, Dept Radiat Oncol, CH-8091 Zurich, Switzerland; [Arcaro, A.] Univ Bern, Div Pediat Hematol Oncol, Dept Clin Res, Bern, Switzerland	University Children's Hospital Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); World Health Organization; International Agency for Research on Cancer (IARC); Johns Hopkins University; Goethe University Frankfurt; University of Zurich; University Zurich Hospital; University of Bern	Grotzer, MA (corresponding author), Univ Childrens Hosp, Dept Oncol, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	Michael.Grotzer@kispi.uzh.ch	Eggert, Angelika/AAE-6907-2022; Arcaro, Alexandre/G-1711-2010; Schramm, Alexander/G-5688-2010; Westermann, Frank/F-7509-2013	Eggert, Angelika/0000-0003-3476-8184; Arcaro, Alexandre/0000-0001-9107-2947; Schramm, Alexander/0000-0001-7670-7529; Grotzer, Michael/0000-0002-1154-2732; Mittelbronn, Michel/0000-0002-2998-052X; Pruschy, Martin/0000-0002-3124-9015	European Community [037260]	European Community(European Commission)	Giulio Fiaschetti and Deborah Castelletti were supported by the European Community FP6, project STREP (EET-pipeline, number: 037260).	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; Anderson GJ, 2008, NAT CHEM BIOL, V4, P15, DOI 10.1038/nchembio0108-15; Arihiro K, 2001, PATHOL INT, V51, P100, DOI 10.1046/j.1440-1827.2001.01164.x; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Behesti H, 2009, INT J BIOCHEM CELL B, V41, P435, DOI 10.1016/j.biocel.2008.06.017; Calvo MB, 2009, CLIN TRANSL ONCOL, V11, P126, DOI 10.1007/S12094-009-0328-8; Buijs JT, 2007, CANCER RES, V67, P8742, DOI 10.1158/0008-5472.CAN-06-2490; Buijs JT, 2007, AM J PATHOL, V171, P1047, DOI 10.2353/ajpath.2007.070168; Buijs JT, 2010, CURR PHARM DESIGN, V16, P1291; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engelhard HH, 2005, CANC TREAT, V125, P71; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Grimmer MR, 2008, GENE DEV, V22, P693, DOI 10.1101/gad.1657808; Grisaru S, 2001, DEV BIOL, V231, P31, DOI 10.1006/dbio.2000.0127; Grotzer MA, 2009, CURR CANCER DRUG TAR, V9, P176, DOI 10.2174/156800909787580962; Guessous F, 2008, J CELL PHYSIOL, V217, P577, DOI 10.1002/jcp.21542; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gurney JG, 2001, CURR OPIN ONCOL, V13, P160, DOI 10.1097/00001622-200105000-00005; Herms J, 2000, INT J CANCER, V89, P395; Iantosca MR, 1999, J NEUROSCI RES, V56, P248; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Krizhanovsky V, 2006, MECH DEVELOP, V123, P67, DOI 10.1016/j.mod.2005.09.005; Kunz F, 2006, NEUROPATHOLOGY, V26, P393, DOI 10.1111/j.1440-1789.2006.00694.x; Lamont JM, 2004, CLIN CANCER RES, V10, P5482, DOI 10.1158/1078-0432.CCR-03-0721; Langenfeld EM, 2003, CARCINOGENESIS, V24, P1445, DOI 10.1093/carcin/bgg100; Littlewood T D, 1990, Adv Dent Res, V4, P69; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Marino S, 2005, TRENDS MOL MED, V11, P17, DOI 10.1016/j.molmed.2004.11.008; Miyazaki H, 2004, ONCOGENE, V23, P9326, DOI 10.1038/sj.onc.1208127; Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Mulhern RK, 2005, J CLIN ONCOL, V23, P5511, DOI 10.1200/JCO.2005.00.703; Neben K, 2004, CANCER RES, V64, P3103, DOI 10.1158/0008-5472.CAN-03-3968; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Raida M, 2005, INT J ONCOL, V26, P1465; Redzic ZB, 2004, ADV DRUG DELIVER REV, V56, P1695, DOI 10.1016/j.addr.2004.07.005; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Stearns D, 2006, CANCER RES, V66, P673, DOI 10.1158/0008-5472.CAN-05-1580; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; von Bueren AO, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-19; Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yabe T, 2002, J NEUROSCI RES, V68, P161, DOI 10.1002/jnr.10210; Yan WS, 2007, CANCER RES, V67, P9117, DOI 10.1158/0008-5472.CAN-07-0996; Yanagita M, 2005, CYTOKINE GROWTH F R, V16, P309, DOI 10.1016/j.cytogfr.2005.02.007; Yanagita M, 2009, BIOFACTORS, V35, P113, DOI 10.1002/biof.15; Ye L, 2007, INT J ONCOL, V30, P521; Ye L, 2009, INT J MOL MED, V24, P591, DOI 10.3892/ijmm_00000269; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	73	21	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	25					2823	2835		10.1038/onc.2011.10	http://dx.doi.org/10.1038/onc.2011.10			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21317922				2022-12-25	WOS:000291977800003
J	Kuroshima, T; Aoyagi, M; Yasuda, M; Kitamura, T; Jehung, JP; Ishikawa, M; Kitagawa, Y; Totsuka, Y; Shindoh, M; Higashino, F				Kuroshima, T.; Aoyagi, M.; Yasuda, M.; Kitamura, T.; Jehung, J. P.; Ishikawa, M.; Kitagawa, Y.; Totsuka, Y.; Shindoh, M.; Higashino, F.			Viral-mediated stabilization of AU-rich element containing mRNA contributes to cell transformation	ONCOGENE			English	Article						adenovirus; AU-rich element; E4orf6; transformation; stabilization	ADENOVIRUS E4ORF6 PROTEIN; ORAL-CANCER CELLS; NUCLEAR EXPORT; E1B55K PROTEINS; LIGASE COMPLEX; HUR; DEGRADATION; P53; MECHANISM; SEQUENCE	E4orf6 is one of the oncogene products of adenovirus, and it also has an important role for transportation of cellular and viral messenger RNA (mRNA) during the late phase of virus infection. We previously revealed that E4orf6 controls the fate of AU-rich element (ARE) containing mRNA by perturbing the chromosome maintenance region 1-dependent export mechanism. Here, we show that E4orf6 stabilizes ARE-mRNA through the region required for its oncogenic activity and ubiquitin E3 ligase assembly. Cells that failed to stabilize ARE-mRNA after HuR knockdown were unable to produce colonies in soft agar, even when E4orf6 was expressed. Furthermore, the stabilized ARE-mRNA induced the transformation of rodent immortalized cells. These findings indicate that stabilized ARE-mRNA is necessary, if not all, for the oncogenic activity of E4orf6 and has the potential to transform cells, at least under a certain condition. Oncogene (2011) 30, 2912-2920; doi:10.1038/onc.2011.14; published online 14 February 2011	[Higashino, F.] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Kita Ku, Sapporo, Hokkaido 0608586, Japan; [Kuroshima, T.; Ishikawa, M.; Kitagawa, Y.] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Diag & Med, Sapporo, Hokkaido 0608586, Japan; [Yasuda, M.] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Mol Microbiol, Sapporo, Hokkaido 0608586, Japan; [Totsuka, Y.] Hokkaido Univ, Grad Sch Dent Med, Dept Oral & Maxillofacial Surg, Sapporo, Hokkaido 0608586, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Higashino, F (corresponding author), Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Kita Ku, North 13 West 7, Sapporo, Hokkaido 0608586, Japan.	fhigashi@den.hokudai.ac.jp	Shindoh, Masanobu/A-4799-2012; Kitagawa, Yoshimasa/F-6909-2012; Higashino, Fumihiro/F-8510-2012; Ishikawa, Makoto/D-5488-2012	Shindoh, Masanobu/0000-0002-7782-5823; 	Ministry of Education, Science and Culture of Japan; Akiyama Foundation	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Foundation	We thank T Dobner for donating the E4orf6 mutant and mutant adenovirus expression plasmids, H Ariga for donating the c-myc expression vector, K Yoshida for donating the c-fos expression vector and L Agami for donating the pSUPER plasmid. This work was supported, in part, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan, and by a Grant-in Aid from the Akiyama Foundation.	Aoyagi M, 2003, ONCOGENE, V22, P6919, DOI 10.1038/sj.onc.1206743; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Blanchette P, 2004, MOL CELL BIOL, V24, P9619, DOI 10.1128/MCB.24.21.9619-9629.2004; Blanchette P, 2008, J VIROL, V82, P2642, DOI 10.1128/JVI.02309-07; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; DOBBELSTEIN M, 1997, EMBO J, V16, P4267; Dobner T, 2001, CURR TOP MICROBIOL, V259, P25; Esclatine A, 2004, P NATL ACAD SCI USA, V101, P3603, DOI 10.1073/pnas.0400354101; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Gallouzi IE, 2001, RNA, V7, P1348, DOI 10.1017/s1355838201016089; Gallouzi IE, 2001, SCIENCE, V294, P1895, DOI 10.1126/science.1064693; Hasegawa H, 2009, BRIT J CANCER, V100, P1943, DOI 10.1038/sj.bjc.6605084; Higashino F, 2005, J CELL BIOL, V170, P15, DOI 10.1083/jcb.200405112; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Kakuguchi W, 2010, MOL CANCER RES, V8, P520, DOI 10.1158/1541-7786.MCR-09-0367; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779; Moore M, 1996, P NATL ACAD SCI USA, V93, P11295, DOI 10.1073/pnas.93.21.11295; Nevels M, 1997, P NATL ACAD SCI USA, V94, P1206, DOI 10.1073/pnas.94.4.1206; Nevels M, 2000, J VIROL, V74, P5168, DOI 10.1128/JVI.74.11.5168-5181.2000; Orlando JS, 2002, J VIROL, V76, P1475, DOI 10.1128/JVI.76.3.1475-1487.2002; Orlando JS, 1999, J VIROL, V73, P4600, DOI 10.1128/JVI.73.6.4600-4610.1999; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; SARNOW P, 1984, J VIROL, V49, P692, DOI 10.1128/JVI.49.3.692-700.1984; Shenk T. E., 2001, Fundamental virology, P1053; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Woo JL, 2007, J VIROL, V81, P575, DOI 10.1128/JVI.01725-06	32	14	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	26					2912	2920		10.1038/onc.2011.14	http://dx.doi.org/10.1038/onc.2011.14			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21317928	Green Submitted			2022-12-25	WOS:000292245100002
J	Montpellier, C; Tews, BA; Poitrimole, J; Rocha-Perugini, V; D'Arienzo, V; Potel, J; Zhang, XA; Rubinstein, E; Dubuisson, J; Cocquerel, L				Montpellier, Claire; Tews, Birke Andrea; Poitrimole, Julien; Rocha-Perugini, Vera; D'Arienzo, Valentina; Potel, Julie; Zhang, Xin A.; Rubinstein, Eric; Dubuisson, Jean; Cocquerel, Laurence			Interacting Regions of CD81 and Two of Its Partners, EWI-2 and EWI-2wint, and Their Effect on Hepatitis C Virus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRASPANIN-ENRICHED MICRODOMAINS; PROTEIN PALMITOYLATION; MEMBRANE-PROTEINS; MAJOR CD9; ASSOCIATION; CELLS; INTEGRIN; WEB; GLYCOPROTEIN; ORGANIZATION	CD81 is a tetraspanin protein that is involved in several essential cellular functions, as well as in the hepatitis C virus (HCV) infection. CD81 interacts with a high stoichiometry with its partner proteins EWI-2, EWI-2wint, and EWI-F. These latter proteins modify the functions of CD81 and can thereby potentially inhibit infection or modulate cell migration. Here, we characterized the cleavage of EWI-2 leading to the production of EWI-2wint, which has been shown to inhibit HCV infection. We determined the regions of EWI-2/EWI-2wint and CD81 that are important for their interaction and their functionality. More precisely, we identified a glycine zipper motif in the transmembrane domain of EWI-2/EWI-2wint that is essential for the interaction with CD81. In addition, we found that palmitoylation on two juxtamembranous cysteines in the cytosolic tail of EWI-2/EWI-2wint is required for their interaction with CD81 as well as with CD9, another tetraspanin. Thus, we have shown that palmitoylation of a tetraspanin partner protein can influence the interaction with a tetraspanin. We therefore propose that palmitoylation not only of tetraspanins, but also of their partner proteins is important in regulating the composition of complexes in tetraspanin networks. Finally, we identified the regions in CD81 that are necessary for its functionality in HCV entry and we demonstrated that EWI-2wint needs to interact with CD81 to exert its inhibitory effect on HCV infection.	[Montpellier, Claire; Tews, Birke Andrea; Poitrimole, Julien; Rocha-Perugini, Vera; D'Arienzo, Valentina; Potel, Julie; Dubuisson, Jean; Cocquerel, Laurence] Univ Lille Nord France, Ctr Infect & Immun Lille, Hepatitis Lab C, Pasteur Inst Lille,CNRS,UMR8204,INSERM,U1019, F-59021 Lille, France; [Rubinstein, Eric] INSERM, U1004, F-94807 Villejuif, France; [Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Vasc Biol Ctr, Memphis, TN 38163 USA; [Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cocquerel, L (corresponding author), HCV Lab, Ctr Infect & Immun Lille, IBL 1, Rue Pr Calmette,BP447, F-59021 Lille, France.	laurence.cocquerel@ibl.fr	Rubinstein, Eric/B-4650-2019; Rocha-Perugini, Vera/D-6977-2014; Cocquerel, Laurence/P-1951-2016; Dubuisson, Jean/E-6813-2016	Rubinstein, Eric/0000-0001-7623-9665; Rocha-Perugini, Vera/0000-0002-1761-9884; Cocquerel, Laurence/0000-0002-2136-5178; MONTPELLIER, Claire/0000-0002-3112-8491; Tews, Birke Andrea/0000-0002-8647-0497; Dubuisson, Jean/0000-0003-1626-7693	"Agence Nationale de Recherches sur le Sida et les hepatites virales" (ANRS); Fondation pour la Recherche Medicale; Marie Curie Intra European Fellowship	"Agence Nationale de Recherches sur le Sida et les hepatites virales" (ANRS)(ANRSFrench National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Marie Curie Intra European Fellowship(European Commission)	This work was supported in part by the "Agence Nationale de Recherches sur le Sida et les hepatites virales" (ANRS) and the "Fondation pour la Recherche Medicale."; Supported by a Fellowship of the ANRS and a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme.	Andre M, 2009, J PROTEOMICS, V73, P93, DOI 10.1016/j.jprot.2009.08.005; Bagot M, 1997, TISSUE ANTIGENS, V50, P439, DOI 10.1111/j.1399-0039.1997.tb02898.x; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Charrin S, 2003, BIOCHEM J, V373, P409, DOI 10.1042/BJ20030343; Charrin S, 2001, J BIOL CHEM, V276, P14329, DOI 10.1074/jbc.M011297200; Charrin S, 2009, J BIOL CHEM, V284, P31572, DOI 10.1074/jbc.M109.057927; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Clark KL, 2004, J BIOL CHEM, V279, P19401, DOI 10.1074/jbc.M312626200; Clark KL, 2001, J IMMUNOL, V167, P5115, DOI 10.4049/jimmunol.167.9.5115; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Flannery AR, 2010, J CELL BIOL, V191, P599, DOI 10.1083/jcb.201003021; Flint M, 1999, J VIROL, V73, P6782, DOI 10.1128/JVI.73.8.6782-6790.1999; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; Gruda R, 2007, J IMMUNOL, V179, P3655, DOI 10.4049/jimmunol.179.6.3655; Harris HJ, 2008, J VIROL, V82, P5007, DOI 10.1128/JVI.02286-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kolesnikova TV, 2004, BLOOD, V103, P3013, DOI 10.1182/blood-2003-07-2201; Krieger SE, 2010, HEPATOLOGY, V51, P1144, DOI 10.1002/hep.23445; LEMON SM, 2007, FIELDS VIROLOGY, P1253; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mee CJ, 2009, J VIROL, V83, P6211, DOI 10.1128/JVI.00246-09; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, EMBO REP, V10, P1220, DOI 10.1038/embor.2009.223; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Rocha-Perugini V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001866; Rocha-Perugini V, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-111; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Seigneuret M, 2006, BIOPHYS J, V90, P212, DOI 10.1529/biophysj.105.069666; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Silvie O, 2006, J CELL SCI, V119, P1992, DOI 10.1242/jcs.02911; Stipp CS, 2003, J CELL BIOL, V163, P1167, DOI 10.1083/jcb.200309113; Stipp CS, 2001, J BIOL CHEM, V276, P40545, DOI 10.1074/jbc.M107338200; Stipp CS, 2001, J BIOL CHEM, V276, P4853, DOI 10.1074/jbc.M009859200; Tham TN, 2010, INFECT IMMUN, V78, P204, DOI 10.1128/IAI.00661-09; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yalaoui S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000010; Yang XH, 2006, J BIOL CHEM, V281, P12976, DOI 10.1074/jbc.M510617200; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004; Zhang XA, 2003, CANCER RES, V63, P2665	52	43	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13954	13965		10.1074/jbc.M111.220103	http://dx.doi.org/10.1074/jbc.M111.220103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343309	Green Published, hybrid			2022-12-25	WOS:000289556200018
J	Song, ES; Rodgers, DW; Hersh, LB				Song, Eun Suk; Rodgers, David W.; Hersh, Louis B.			Mixed Dimers of Insulin-degrading Enzyme Reveal a Cis Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULYSIN; RECOGNITION; ATP	Insulin-degrading enzyme (IDE) exists primarily as a dimer being unique among the zinc metalloproteases in that it exhibits allosteric kinetics with small synthetic peptide substrates. In addition the IDE reaction rate is increased by small peptides that bind to a distal site within the substrate binding site. We have generated mixed dimers of IDE in which one or both subunits contain mutations that affect activity. The mutation Y609F in the distal part of the substrate binding site of the active subunit blocks allosteric activation regardless of the activity of the other subunit. This effect shows that substrate or small peptide activation occurs through a cis effect. A mixed dimer composed of one wild-type subunit and the other subunit containing a mutation that neither permits substrate binding nor catalysis (H112Q) exhibits the same turnover number per active subunit as wild-type IDE. In contrast, a mixed dimer in which one subunit contains the wild-type sequence and the other contains a mutation that permits substrate binding, but not catalysis (E111F), exhibits a decrease in turnover number. This indicates a negative trans effect of substrate binding at the active site. On the other hand, activation in trans is observed with extended substrates that occupy both the active and distal sites. Comparison of the binding of an amyloid beta peptide analog to wild-type IDE and to the Y609F mutant showed no difference in affinity, indicating that Y609 does not play a significant role in substrate binding at the distal site.	[Hersh, Louis B.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Hersh, Louis B.] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Hersh, LB (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, B283 BBSRB,741 S Limestone St, Lexington, KY 40536 USA.	lhersh@uky.edu			National Institutes of Health [DA02243, NS38041, P20 RR020171]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038041, R56NS038041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA02243, NS38041, and P20 RR020171.	Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; HARI J, 1987, ENDOCRINOLOGY, V120, P829, DOI 10.1210/endo-120-2-829; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Safavi A, 1996, BIOCHEMISTRY-US, V35, P14318, DOI 10.1021/bi960582q; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHII K, 1986, P NATL ACAD SCI USA, V83, P4147, DOI 10.1073/pnas.83.12.4147; Song ES, 2004, J BIOL CHEM, V279, P54216, DOI 10.1074/jbc.M411177200; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; Song ES, 2001, J BIOL CHEM, V276, P1152, DOI 10.1074/jbc.M008702200; Song ES, 2005, J BIOL CHEM, V280, P17701, DOI 10.1074/jbc.M501896200; Song ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009719; Yao HB, 2006, ARCH BIOCHEM BIOPHYS, V451, P175, DOI 10.1016/j.abb.2006.04.011	16	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13852	13858		10.1074/jbc.M110.191668	http://dx.doi.org/10.1074/jbc.M110.191668			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343292	Green Published, hybrid			2022-12-25	WOS:000289556200008
J	Hu, N; Zhang, JL; Cui, WJ; Kong, GY; Zhang, SA; Yue, L; Bai, X; Zhang, Z; Zhang, WY; Zhang, XD; Ye, LH				Hu, Nan; Zhang, Jianli; Cui, Wenjing; Kong, Guangyao; Zhang, Shuai; Yue, Lin; Bai, Xiao; Zhang, Zhao; Zhang, Weiying; Zhang, Xiaodong; Ye, Lihong			miR-520b Regulates Migration of Breast Cancer Cells by Targeting Hepatitis B X-interacting Protein and Interleukin-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MICRORNA-21 TARGETS; UP-REGULATION; EXPRESSION; HBXIP; METASTASIS; INVASION; PROLIFERATION; SUPPRESSION; SURVIVIN	MicroRNAs play important roles in tumor metastasis. Recently, we reported that the level of miR-520b is inversely related to the metastatic potential of breast cancer cells. In this study, we investigated the role of miR-520b in breast cancer cell migration. We found that miR-520b suppressed the migration of breast cancer cells with high metastatic potential, including M DA-MB-231 and LM-MCF-7 cells, although the inhibition of miR-520b enhanced the migration of low metastatic potential MCF-7 cells. We further discovered that miR-520b directly targets the 3'-untranslated region (3'UTR) of either hepatitis B X-interacting protein (HBXIP) or interleukin-8 (IL-8), which has been reported to contribute to cell migration. Surprisingly, tissue array assays showed that 75% (38:49) and 94% (36:38) of breast cancer tissues and metastatic lymph tissues, respectively, were positive for HBXIP expression. Moreover, overexpression of HBXIP was able to promote the migration of MCF-7 cells. Interestingly, HBXIP was able to regulate IL-8 transcription by NF-kappa B, suggesting that the two target genes of miR-520b are functionally connected, In addition, we found that miR-520b could indirectly regulate IL-8 transcription by targeting HBXIP. Thus, we conclude that miR-520b is involved in regulating breast cancer cell migration by targeting HBXIP and IL-8 via a network in which HBXIP promotes migration by stimulating NF-kappa B-mediated IL-8 expression. These studies point to HBXIP as a potential therapeutic target for breast cancer.	[Kong, Guangyao; Zhang, Shuai; Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Inst Mol Biol,Minist Educ,Dept Canc Res, Tianjin 300071, Peoples R China; [Hu, Nan; Zhang, Jianli; Cui, Wenjing; Yue, Lin; Bai, Xiao; Zhang, Zhao; Zhang, Weiying; Ye, Lihong] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Key Lab Mol Microbiol & Technol, Inst Mol Biol,Minist Educ,Dept Canc Res, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Kong, Guangyao/L-2162-2013	Zhang, Shuai/0000-0003-0272-0856	National Basic Research Program of China 973 Program [2007CB914804, 2007CB914802, 2009CB521702]; Natural Scientific Foundation of China [30770826, 81071623]; Tianjin Natural Scientific Foundation [08JCZDJC20700]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Scientific Foundation	This work was supported in part by National Basic Research Program of China 973 Program Grants 2007CB914804, 2007CB914802, and 2009CB521702, Natural Scientific Foundation of China Grants 30770826 and 81071623, and Tianjin Natural Scientific Foundation Grant 08JCZDJC20700.	Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bendrik C, 2009, J IMMUNOL, V182, P371, DOI 10.4049/jimmunol.182.1.371; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Braunstein S, 2008, MOL CANCER RES, V6, P78, DOI 10.1158/1541-7786.MCR-07-0339; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chavey C, 2008, MOL PHARMACOL, V74, P1359, DOI 10.1124/mol.108.047332; Sempere MC, 2008, CLIN TRANSL ONCOL, V10, P143, DOI 10.1007/s12094-008-0171-3; Cui W, 2010, CANCER BIOL THER, V10, P232; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Li Q, 2010, J GASTROEN HEPATOL, V25, P164, DOI 10.1111/j.1440-1746.2009.05971.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martin D, 2009, J BIOL CHEM, V284, P6038, DOI 10.1074/jbc.C800207200; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Minczuk M, 2005, FEBS J, V272, P5008, DOI 10.1111/j.1742-4658.2005.04910.x; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pan YZ, 2009, DRUG METAB DISPOS, V37, P2112, DOI 10.1124/dmd.109.027680; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Wang FZ, 2008, ACTA PHARMACOL SIN, V29, P83, DOI 10.1111/j.1745-7254.2008.00729.x; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Wu KM, 2008, P NATL ACAD SCI USA, V105, P6924, DOI 10.1073/pnas.0802085105; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yao C, 2007, INT J CANCER, V121, P1949, DOI 10.1002/ijc.22930; Ye Li-hong, 2006, Zhonghua Yi Xue Za Zhi, V86, P61; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	46	95	105	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13714	13722		10.1074/jbc.M110.204131	http://dx.doi.org/10.1074/jbc.M110.204131			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343296	Green Published, hybrid			2022-12-25	WOS:000289282200089
J	Dave, N; Guaita-Esteruelas, S; Gutarra, S; Frias, A; Beltran, M; Peiro, S; de Herreros, AG				Dave, Natlia; Guaita-Esteruelas, Sandra; Gutarra, Susana; Frias, Alex; Beltran, Manuel; Peiro, Sandra; Garcia de Herreros, Antonio			Functional Cooperation between Snail1 and Twist in the Regulation of ZEB1 Expression during Epithelial to Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; CADHERIN GENE-EXPRESSION; BREAST-CANCER; MUSCLE DIFFERENTIATION; TUMOR-METASTASIS; MIR-200 FAMILY; TGF-BETA; CELLS; REPRESSOR; PROTEIN	Snail1 and Zeb1 are E-cadherin-transcriptional repressors induced during epithelial mesenchymal transition (EMT). In this article we have analyzed the factors controlling Zeb1 expression during EMT. In NMuMG cells treated with TGF-beta, Snail1 RNA and protein are induced 1 h after addition of the cytokine preceding Zeb1 up-regulation that requires 6-8 h. Zeb1 gene expression is caused by increased RNA levels but also by enhanced protein stability and is markedly dependent on Snail1 because depletion of this protein prevents Zeb1 protein and RNA up-regulation. In addition to Snail1, depletion of the Twist transcriptional factor retards Zeb1 stimulation by TGF-beta or decreases Zeb1 expression in other cellular models indicating that this factor is also required for Zeb1 expression. Accordingly, Snail1 and Twist cooperate in the induction of Zeb1: co-transfection of both cDNAs is required for the maximal expression of ZEB1 mRNA. Unexpectedly, the expression of Snail1 and Twist shows a mutual dependence although to a different extent; whereas Twist depletion retards Snail1 up-regulation by TGF-beta, Snail1 is necessary for the rapid increase in Twist protein and later up-regulation of Twist1 mRNA induced by the cytokine. Besides this effect on Twist, Snail1 also induces the nuclear translocation of Ets1, another factor required for Zeb1 expression. Both Twist and Ets1 bind to the ZEB1 promoter although to different elements: whereas Ets1 interacts with the proximal promoter, Twist does it with a 700-bp sequence upstream of the transcription start site. These results indicate that Snail1 controls Zeb1 expression at multiple levels and acts cooperatively with Twist in the ZEB1 gene transcription induction.	[Dave, Natlia; Guaita-Esteruelas, Sandra; Gutarra, Susana; Frias, Alex; Beltran, Manuel; Peiro, Sandra; Garcia de Herreros, Antonio] Hosp del Mar, Inst Municipal Invest Med, Programa Recerca Canc, E-08003 Barcelona, Spain; [Garcia de Herreros, Antonio] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona 08003, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University	de Herreros, AG (corresponding author), Hosp del Mar, Inst Municipal Invest Med, Programa Recerca Canc, Parc Recerca Biomed Barcelona,Doctor Aiguade 88, E-08003 Barcelona, Spain.	agarcia@imim.es	de Herreros, A Garcia/H-3104-2014	de Herreros, A Garcia/0000-0001-5270-0808; Peiro, Sandra/0000-0001-9519-3877; Frias, Alex/0000-0002-4857-7904	Ministerio de Ciencia y Tecnologia [SAF2006-00339]; La Fundacion Cientifica de la Asociacion Espanola contra el Cancer; La Fundacio La Marato de TV3 [081731]; Instituto Carlos III-Fondos FEDER (RTICCC) [C03710, RD06/0020/0040]; Generalitat de Catalunya [2009SGR867]; la Asociacion Espanola contra el Cancer	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); La Fundacion Cientifica de la Asociacion Espanola contra el Cancer; La Fundacio La Marato de TV3; Instituto Carlos III-Fondos FEDER (RTICCC); Generalitat de Catalunya(Generalitat de Catalunya); la Asociacion Espanola contra el Cancer	This work was supported in part by Grant SAF2006-00339 from Ministerio de Ciencia y Tecnologia, grants from the La Fundacion Cientifica de la Asociacion Espanola contra el Cancer and La Fundacio La Marato de TV3 (081731) (to A. G. H.), Instituto Carlos III-Fondos FEDER (RTICCC, C03710, RD06/0020/0040), and Generalitat de Catalunya Grant 2009SGR867.; Supported by a postdoctoral contract from la Asociacion Espanola contra el Cancer.	Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Franci C, 2006, ONCOGENE, V25, P5134, DOI 10.1038/sj.onc.1209519; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hajra KM, 2002, CANCER RES, V62, P1613; HEBROK M, 1994, DEV BIOL, V165, P537, DOI 10.1006/dbio.1994.1273; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Palmer HG, 2004, NAT MED, V10, P917, DOI 10.1038/nm1095; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peiro S, 2006, NUCLEIC ACIDS RES, V34, P2077, DOI 10.1093/nar/gkl141; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Pham CG, 2007, MOL CELL BIOL, V27, P3920, DOI 10.1128/MCB.01219-06; Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vinas-Castells R, 2010, J BIOL CHEM, V285, P3794, DOI 10.1074/jbc.M109.065995; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099	30	194	201	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.168625	http://dx.doi.org/10.1074/jbc.M110.168625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317430	hybrid, Green Published			2022-12-25	WOS:000289077500016
J	Dennis, MK; Taneva, SG; Cornell, RB				Dennis, Melissa K.; Taneva, Svetla G.; Cornell, Rosemary B.			The Intrinsically Disordered Nuclear Localization Signal and Phosphorylation Segments Distinguish the Membrane Affinity of Two Cytidylyltransferase Isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; HAMSTER OVARY CELLS; RAT-LIVER CTP; BINDING DOMAIN; CTPPHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; INTRACELLULAR-LOCALIZATION; NEURITE OUTGROWTH; LIPID ACTIVATION; TERMINAL DOMAIN	Membrane phosphatidylcholine homeostasis is maintained in part by a sensing device in the key regulatory enzyme, CTP: phosphocholine cytidylyltransferase (CCT). CCT responds to decreases in membrane phosphatidylcholine content by reversible membrane binding and activation. Two prominent isoforms, CCT alpha and -beta(2), have nearly identical catalytic domains and very similar membrane binding amphipathic helical (M) domains but have divergent and structurally disordered N-terminal (N) and C-terminal phosphorylation (P) regions. We found that the binding affinity of purified CCT beta(2) for anionic membranes was weaker than CCT alpha by more than an order of magnitude. Using chimeric CCTs, insertion/deletion mutants, and truncated CCTs, we show that the stronger affinity of CCT alpha can be attributed in large part to the electrostatic membrane binding function of the polybasic nuclear localization signal (NLS) motif, present in the unstructured N-terminal segment of CCT alpha but lacking in CCT beta(2). The membrane partitioning of CCT beta(2) in cells enriched with the lipid activator, oleic acid, was also weaker than that of CCT alpha and was elevated by incorporation of the NLS motif. Thus, the polybasic NLS can function as a secondary membrane binding motif not only in vitro but in the context of cell membranes. A comparison of phosphorylated, dephosphorylated, and region P-truncated forms showed that the in vitro membrane affinity of CCT beta 2 is more sensitive than CCT alpha to phosphorylation status, which antagonizes membrane binding of both isoforms. These data provide a model wherein the primary membrane binding motif, an amphipathic helical domain, works in collaboration with other intrinsically disordered segments that modulate membrane binding strength. The NLS reinforces, whereas the phosphorylated tail antagonizes the attraction of domain M for anionic membranes.	[Dennis, Melissa K.; Taneva, Svetla G.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca			Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes for Health Research operating grant (to R. B. C.).	Agassandian M, 2005, J BIOL CHEM, V280, P21577, DOI 10.1074/jbc.M412409200; Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Arnold RS, 1997, BIOCHEMISTRY-US, V36, P6149, DOI 10.1021/bi970023z; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter JM, 2003, J BIOL CHEM, V278, P44988, DOI 10.1074/jbc.M307336200; Carter JM, 2008, J BIOL CHEM, V283, P202, DOI 10.1074/jbc.M706531200; Celton-Morizur S, 2004, MOL CELL BIOL, V24, P10621, DOI 10.1128/MCB.24.24.10621-10635.2004; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Galea CA, 2009, J PROTEOME RES, V8, P211, DOI 10.1021/pr800308v; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Gehrig K, 2009, J LIPID RES, V50, P966, DOI 10.1194/jlr.M800632-JLR200; GROBLEWSKI GE, 1995, J BIOL CHEM, V270, P1437, DOI 10.1074/jbc.270.3.1437; HATCH GM, 1992, J BIOL CHEM, V267, P15751; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; HOUWELING M, 1994, J BIOL CHEM, V269, P7544; Houweling M, 1996, EUR J CELL BIOL, V69, P55; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 2004, MOL CELL BIOL, V24, P4720, DOI 10.1128/MCB.24.11.4720-4733.2004; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JONES MK, 1992, J LIPID RES, V33, P287; Karim M, 2003, BBA-MOL CELL BIOL L, V1633, P1, DOI 10.1016/S1388-1981(03)00067-2; Lagace TK, 2000, J BIOL CHEM, V275, P14367, DOI 10.1074/jbc.275.19.14367; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lykidis A, 1998, J BIOL CHEM, V273, P14022, DOI 10.1074/jbc.273.22.14022; Lykidis A, 1999, J BIOL CHEM, V274, P26992, DOI 10.1074/jbc.274.38.26992; Lykidis A, 2001, BIOCHEMISTRY-US, V40, P494, DOI 10.1021/bi002140r; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MACDONALD JIS, 1995, BIOCHEM J, V312, P425, DOI 10.1042/bj3120425; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Northwood IC, 1999, J BIOL CHEM, V274, P26240, DOI 10.1074/jbc.274.37.26240; PELECH SL, 1982, J BIOL CHEM, V257, P4198; POEHLING HM, 1981, ELECTROPHORESIS, V2, P141, DOI 10.1002/elps.1150020304; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Ridsdale R, 2001, J BIOL CHEM, V276, P49148, DOI 10.1074/jbc.M103566200; Ridsdale R, 2010, AM J RESP CELL MOL, V43, P74, DOI 10.1165/rcmb.2009-0231OC; Ryan AJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P23, DOI 10.1016/j.abb.2006.01.007; SANGHERA JS, 1989, J BIOL CHEM, V264, P1215; SHIRATORI Y, 1995, J BIOL CHEM, V270, P29894; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva SG, 2005, BIOCHEMISTRY-US, V44, P9382, DOI 10.1021/bi050679p; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Tseu I, 2002, AM J RESP CELL MOL, V26, P506, DOI 10.1165/ajrcmb.26.4.4702; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Wang LM, 2005, MOL CELL BIOL, V25, P3357, DOI 10.1128/MCB.25.8.3357-3363.2005; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; WANG YL, 1995, J BIOL CHEM, V270, P17843, DOI 10.1074/jbc.270.30.17843; WANG YL, 1993, J BIOL CHEM, V268, P5512; WANG YL, 1993, J BIOL CHEM, V268, P5899; WANG YL, 1995, J BIOL CHEM, V270, P354, DOI 10.1074/jbc.270.1.354; WATKINS JD, 1991, J BIOL CHEM, V266, P21113; WATKINS JD, 1992, J BIOL CHEM, V267, P5686; WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68; Wieprecht M, 1996, J BIOL CHEM, V271, P9955, DOI 10.1074/jbc.271.17.9955; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951; YANG W, 1995, J BIOL CHEM, V270, P16503, DOI 10.1074/jbc.270.28.16503; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang DJ, 2000, J BIOL CHEM, V275, P35368, DOI 10.1074/jbc.M007099200	80	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.201715	http://dx.doi.org/10.1074/jbc.M110.201715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21303909	Green Published, hybrid			2022-12-25	WOS:000289077500049
J	Jurjut, OF; Nikolic, D; Singer, W; Yu, S; Havenith, MN; Muresan, RC				Jurjut, Ovidiu F.; Nikolic, Danko; Singer, Wolf; Yu, Shan; Havenith, Martha N.; Muresan, Raul C.			Timescales of Multineuronal Activity Patterns Reflect Temporal Structure of Visual Stimuli	PLOS ONE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; POPULATION CODE; CORTEX; INFORMATION; RESPONSES; DYNAMICS; SPACE; SYNCHRONIZATION; INTEGRATION; ACTIVATION	The investigation of distributed coding across multiple neurons in the cortex remains to this date a challenge. Our current understanding of collective encoding of information and the relevant timescales is still limited. Most results are restricted to disparate timescales, focused on either very fast, e.g., spike-synchrony, or slow timescales, e. g., firing rate. Here, we investigated systematically multineuronal activity patterns evolving on different timescales, spanning the whole range from spike-synchrony to mean firing rate. Using multi-electrode recordings from cat visual cortex, we show that cortical responses can be described as trajectories in a high-dimensional pattern space. Patterns evolve on a continuum of coexisting timescales that strongly relate to the temporal properties of stimuli. Timescales consistent with the time constants of neuronal membranes and fast synaptic transmission (5-20 ms) play a particularly salient role in encoding a large amount of stimulus-related information. Thus, to faithfully encode the properties of visual stimuli the brain engages multiple neurons into activity patterns evolving on multiple timescales.	[Jurjut, Ovidiu F.; Nikolic, Danko; Singer, Wolf; Yu, Shan; Havenith, Martha N.; Muresan, Raul C.] Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany; [Jurjut, Ovidiu F.; Muresan, Raul C.] Romanian Inst Sci & Technol, Dept Expt & Theoret Neurosci, Ctr Cognit & Neural Studies Coneural, Cluj Napoca, Romania; [Jurjut, Ovidiu F.; Nikolic, Danko; Singer, Wolf] Frankfurt Inst Adv Studies FIAS, Dept Neurosci, Frankfurt, Germany	Max Planck Society; Romanian Institute of Science & Technology	Jurjut, OF (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, D-60496 Frankfurt, Germany.	muresan@coneural.org	Yu, Shan/S-3123-2017; Nikolic, Danko/GZG-9635-2022; Havenith, Martha N./R-7855-2017; Muresan, Raul C/A-4650-2011; Singer, Wolf/D-6874-2012	Nikolic, Danko/0000-0002-9317-8494; Havenith, Martha N./0000-0002-2329-7500; Muresan, Raul C/0000-0001-7854-3775; yu, shan/0000-0002-4385-6306	CNCSIS/UEFISCSU [TE-11/2010, 23/28.07.2010]; Max Planck-Coneural Partner Group; DFG [NI 708/2-1]	CNCSIS/UEFISCSU(Consiliul National al Cercetarii Stiintifice (CNCS)); Max Planck-Coneural Partner Group; DFG(German Research Foundation (DFG))	This work was supported by a CNCSIS/UEFISCSU grant (TE-11/2010 contract no. 23/28.07.2010), a Max Planck-Coneural Partner Group, and a DFG grant (NI 708/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Adrian E.D., 1928, BASIS SENSATION ACTI; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Averbeck BB, 2004, TRENDS NEUROSCI, V27, P225, DOI 10.1016/j.tins.2004.02.006; Baker SN, 2000, NEURAL COMPUT, V12, P2597, DOI 10.1162/089976600300014863; Bathellier B, 2008, NEURON, V57, P586, DOI 10.1016/j.neuron.2008.02.011; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Biederlack J, 2006, NEURON, V52, P1073, DOI 10.1016/j.neuron.2006.11.012; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; DeBusk BC, 1997, J NEUROPHYSIOL, V78, P199, DOI 10.1152/jn.1997.78.1.199; Desbordes G, 2008, PLOS BIOL, V6, P2672, DOI 10.1371/journal.pbio.0060324; Eggermont JJ, 1998, NEUROSCI BIOBEHAV R, V22, P355, DOI 10.1016/S0149-7634(97)00021-3; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Feng WJ, 2010, NEUROREPORT, V21, P680, DOI 10.1097/WNR.0b013e32833ae9d1; Freeman W. J., 1994, NEURAL NETWORKS NEUR, P185; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Galan RF, 2004, NEURAL COMPUT, V16, P999, DOI 10.1162/089976604773135078; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; Goaillard JM, 2006, PHYSIOLOGY, V21, P197, DOI 10.1152/physiol.00063.2005; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Haeusler S, 2007, CEREB CORTEX, V17, P149, DOI 10.1093/cercor/bhj132; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnson DH, 2004, J COMPUT NEUROSCI, V16, P69, DOI 10.1023/B:JCNS.0000004842.04535.7c; Jurjut OF, 2009, J NEUROPHYSIOL, V102, P3766, DOI 10.1152/jn.00758.2009; KASPER EM, 1994, J COMP NEUROL, V339, P475, DOI 10.1002/cne.903390403; Kleppe IC, 1999, BIOPHYS J, V77, P1418, DOI 10.1016/S0006-3495(99)76990-0; Kohonen T, 1999, KOHONEN MAPS, P171, DOI 10.1016/B978-044450270-4/50013-9; Kohonen T., 2001, SPRINGER SERIES INFO; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Li WC, 2006, J NEUROSCI, V26, P4026, DOI 10.1523/JNEUROSCI.4727-05.2006; LINDE Y, 1980, IEEE T COMMUN, V28, P84, DOI 10.1109/TCOM.1980.1094577; Maldonado PE, 2007, NEUROSCIENCE, V144, P1536, DOI 10.1016/j.neuroscience.2006.11.021; Maldonado P, 2008, J NEUROPHYSIOL, V100, P1523, DOI 10.1152/jn.00076.2008; Muresan RC, 2007, J NEUROPHYSIOL, V97, P1911, DOI 10.1152/jn.01043.2006; Nikolic D., 2007, ADV NEURAL INFORM PR, V19, P1041, DOI [10.7551/mitpress/7503.003.0135, DOI 10.7551/MITPRESS/7503.003.0135]; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; PETERSSON M, 2010, THESIS STOCKHOLM; Pipa G, 2008, J COMPUT NEUROSCI, V25, P64, DOI 10.1007/s10827-007-0065-3; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; RADONS G, 1994, BIOL CYBERN, V71, P359, DOI 10.1007/BF00239623; Reinagel P, 2002, J NEUROSCI, V22, P6837; Roy SA, 2001, J NEUROSCI, V21, P2462, DOI 10.1523/JNEUROSCI.21-07-02462.2001; Rudolph M, 2003, J COMPUT NEUROSCI, V14, P239, DOI 10.1023/A:1023245625896; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Seo H, 2009, NATURE, V461, P50, DOI 10.1038/461050a; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Silberberg G, 2008, CURR OPIN NEUROBIOL, V18, P332, DOI 10.1016/j.conb.2008.08.009; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SPRUSTON N, 1992, J NEUROPHYSIOL, V67, P508, DOI 10.1152/jn.1992.67.3.508; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Yoshida M, 2008, EUR J NEUROSCI, V28, P1116, DOI 10.1111/j.1460-9568.2008.06409.x; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	69	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16758	10.1371/journal.pone.0016758	http://dx.doi.org/10.1371/journal.pone.0016758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346812	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600022
J	Zhang, YKJ; Guo, GL; Klaassen, CD				Zhang, Yu-Kun Jennifer; Guo, Grace L.; Klaassen, Curtis D.			Diurnal Variations of Mouse Plasma and Hepatic Bile Acid Concentrations as well as Expression of Biosynthetic Enzymes and Transporters	PLOS ONE			English	Article							ENTEROHEPATIC CIRCULATORY-SYSTEM; ORGANIC SOLUTE TRANSPORTER; PREGNANE-X-RECEPTOR; ALPHA-OST-BETA; CIRCADIAN DISTRIBUTION; LIGANDS; METABOLISM; LIVER; ASBT; GENE	Background: Diurnal fluctuation of bile acid (BA) concentrations in the enterohepatic system of mammals has been known for a long time. Recently, BAs have been recognized as signaling molecules beyond their well-established roles in dietary lipid absorption and cholesterol homeostasis. Methods and Results: The current study depicted diurnal variations of individual BAs detected by ultra-performance liquid chromatography/mass spectrometry (UPLC/MS) in serum and livers collected from C57BL/6 mice fed a regular chow or a chow containing cholestyramine (resin). Circadian rhythms of mRNA of vital BA-related nuclear receptors, enzymes, and transporters in livers and ilea were determined in control-and resin-fed mice, as well as in farnesoid X receptor (FXR) null mice. The circadian profiles of BAs showed enhanced bacterial dehydroxylation during the fasting phase and efficient hepatic reconjugation of BAs in the fed phase. The resin removed more than 90% of BAs with beta-hydroxy groups, such as muricholic acids and ursodeoxycholic acid, from serum and livers, but did not exert as significant influence on CA and CDCA in both compartments. Both resin-fed and FXR-null mouse models indicate that BAs regulate their own biosynthesis through the FXR-regulated ileal fibroblast growth factor 15. BA flux also influences the daily mRNA levels of multiple BA transporters. Conclusion: BA concentration and composition exhibit circadian variations in mouse liver and serum, which influences the circadian rhythms of BA metabolizing genes in liver and ileum. The diurnal variations of BAs appear to serve as a signal that coordinates daily nutrient metabolism in mammals.	[Zhang, Yu-Kun Jennifer; Guo, Grace L.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Zhang, YKJ (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	cklaasse@kumc.edu			National Institutes of Health [DK-081461, ES-009716, ES-009649, ES-013714, RR-021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081343, R01DK081461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009716, R01ES009649, R01ES013714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study is supported by National Institutes of Health grants DK-081461, ES-009716, ES-009649, ES-013714, and RR-021940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Anwer MS, 2004, HEPATOLOGY, V39, P581, DOI 10.1002/hep.20090; Balakrishnan A, 2006, MOL PHARMACEUT, V3, P223, DOI 10.1021/mp060022d; BOTHAM KM, 1983, EUR J BIOCHEM, V134, P191, DOI 10.1111/j.1432-1033.1983.tb07550.x; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cheng XG, 2006, DRUG METAB DISPOS, V34, P1863, DOI 10.1124/dmd.106.010520; Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014; Csanaky IL, 2011, HEPATOLOGY, V53, P272, DOI 10.1002/hep.23984; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Frankenberg T, 2006, AM J PHYSIOL-GASTR L, V290, pG912, DOI 10.1152/ajpgi.00479.2005; Galman C, 2005, GASTROENTEROLOGY, V129, P1445, DOI 10.1053/j.gastro.2005.09.009; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; HO KJ, 1976, J LIPID RES, V17, P600; HO KJ, 1976, AM J PHYSIOL, V230, P1331, DOI 10.1152/ajplegacy.1976.230.5.1331; Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Li H, 2005, AM J PHYSIOL-GASTR L, V288, pG60, DOI 10.1152/ajpgi.00170.2004; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Ma K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006843; Maher JM, 2005, DRUG METAB DISPOS, V33, P956, DOI 10.1124/dmd.105.003798; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Mottino AD, 2000, J PHARMACOL EXP THER, V293, P717; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; SCHALM SW, 1978, GUT, V19, P1006, DOI 10.1136/gut.19.11.1006; Stroeve JHM, 2010, LAB INVEST, V90, P1457, DOI 10.1038/labinvest.2010.107; Tanaka Y, 2009, TOXICOL SCI, V108, P247, DOI 10.1093/toxsci/kfp020; Thomas C, 2008, THYROID, V18, P167, DOI 10.1089/thy.2007.0255; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641; ZIBOH VA, 1961, J BIOL CHEM, V236, P387	38	68	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16683	10.1371/journal.pone.0016683	http://dx.doi.org/10.1371/journal.pone.0016683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346810	gold, Green Published, Green Submitted			2022-12-25	WOS:000287077600016
J	Domingo-Gil, E; Toribio, R; Najera, JL; Esteban, M; Ventoso, I				Domingo-Gil, Elena; Toribio, Rene; Luis Najera, Jose; Esteban, Mariano; Ventoso, Ivan			Diversity in Viral Anti-PKR Mechanisms: A Remarkable Case of Evolutionary Convergence	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; SINDBIS VIRUS-INFECTION; VACCINIA VIRUS; NS1 PROTEIN; TRANSGENIC MICE; INNATE IMMUNITY; HEPATITIS-C; HOST-RANGE; E3L GENE	Most viruses express during infection products that prevent or neutralize the effect of the host dsRNA activated protein kinase (PKR). Translation of Sindbis virus (SINV) mRNA escapes to PKR activation and eIF2 phosphorylation in infected cells by a mechanism that requires a stem loop structure in viral 26S mRNA termed DLP to initiate translation in the absence of functional eIF2. Unlike the rest of viruses tested, we found that Alphavirus infection allowed a strong PKR activation and eIF2 alpha phosphorylation in vitro and in infected animals so that the presence of DLP structure in mRNA was critical for translation and replication of SINV. Interestingly, infection of MEFs with some viruses that express PKR inhibitors prevented eIF2 alpha phosphorylation after superinfection with SINV, suggesting that viral anti-PKR mechanisms could be exchangeable. Thus, translation of SINV mutant lacking the DLP structure (Delta DLP) in 26S mRNA was partially rescued in cells expressing vaccinia virus (VV) E3 protein, a known inhibitor of PKR. This case of heterotypic complementation among evolutionary distant viruses confirmed experimentally a remarkable case of convergent evolution in viral anti-PKR mechanisms. Our data reinforce the critical role of PKR in regulating virus-host interaction and reveal the versatility of viruses to find different solutions to solve the same conflict.	[Domingo-Gil, Elena; Toribio, Rene; Ventoso, Ivan] Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain; [Domingo-Gil, Elena; Toribio, Rene; Ventoso, Ivan] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [Luis Najera, Jose; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Domingo-Gil, E (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Madrid, Spain.	iventoso@cbm.uam.es	Ventoso, Iván/N-4018-2014; Esteban, Mariano/ABG-5375-2020; Toribio, René/AAI-1444-2019	Ventoso, Iván/0000-0001-7887-3520; Esteban, Mariano/0000-0003-0846-2827; Toribio, René/0000-0002-4847-629X; Najera, jose Luis/0000-0001-7798-3330	Comunidad de Madrid; Ministerio de Ciencia e Innovacion [SAF2006-09810, SAF2008-02036]; Fundacion Mutua Madrilena [FMM 2008]; VIRUS-HOST programme	Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); VIRUS-HOST programme	This work was supported in part from the VIRUS-HOST interaction programme (Comunidad de Madrid) and by grants from the Ministerio de Ciencia e Innovacion (SAF2006-09810; SAF2008-02036) and the Fundacion Mutua Madrilena (FMM 2008). The institutional support from Fundacion Ramon Areces is also acknowledged. E.D was a recipient of VIRUS-HOST programme postdoctoral contract. R.T. was a recipient of the SAF2006-09810 contract and I.V. was a researcher of Ramon y Cajal Programme. The elaboration of this work took about 2 years and the estimated cost was 3000 euros excluding salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000; Binder GK, 2001, SCIENCE, V293, P303, DOI 10.1126/science.1059742; BLACK TL, 1993, J VIROL, V67, P791, DOI 10.1128/JVI.67.2.791-800.1993; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Burke CW, 2009, VIROLOGY, V395, P121, DOI 10.1016/j.virol.2009.08.039; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Domingo-Gil E, 2008, J VIROL, V82, P254, DOI 10.1128/JVI.01384-07; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Frolova EI, 2002, J VIROL, V76, P11254, DOI 10.1128/JVI.76.22.11254-11264.2002; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gorchakov R, 2004, J VIROL, V78, P8455, DOI 10.1128/JVI.78.16.8455-8467.2004; GREEN SR, 1992, GENE DEV, V6, P2478, DOI 10.1101/gad.6.12b.2478; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; He B, 1997, P NATL ACAD SCI USA, V94, P843, DOI 10.1073/pnas.94.3.843; Ikegami T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000287; JACKSON AC, 1988, LAB INVEST, V58, P503; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Mohr I, 2004, INT REV IMMUNOL, V23, P199, DOI 10.1080/08830180490265600; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; RODRIGUEZ JF, 1988, P NATL ACAD SCI USA, V85, P1667, DOI 10.1073/pnas.85.5.1667; Romano PR, 1998, MOL CELL BIOL, V18, P7304, DOI 10.1128/MCB.18.12.7304; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Rothenburg S, 2009, NAT STRUCT MOL BIOL, V16, P63, DOI 10.1038/nsmb.1529; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Stojdl DF, 2000, J VIROL, V74, P9580, DOI 10.1128/JVI.74.20.9580-9585.2000; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Suthar MS, 2009, CELL MICROBIOL, V11, P880, DOI 10.1111/j.1462-5822.2009.01311.x; TORIBIO R, 2010, P NATL ACAD SCI US; VANVALEN L, 1974, NATURE, V252, P298; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Webber C, 2004, CURR BIOL, V14, pR332, DOI 10.1016/j.cub.2004.04.016; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	55	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16711	10.1371/journal.pone.0016711	http://dx.doi.org/10.1371/journal.pone.0016711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311764	Green Submitted, gold, Green Published			2022-12-25	WOS:000287036200035
J	Clemons, A; Haugen, M; Le, C; Mori, A; Tomchaney, M; Severson, DW; Duman-Scheel, M				Clemons, Anthony; Haugen, Morgan; Le, Christy; Mori, Akio; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly			siRNA-Mediated Gene Targeting in Aedes aegypti Embryos Reveals That Frazzled Regulates Vector Mosquito CNS Development	PLOS ONE			English	Article							CRUSTACEAN ORCHESTIA-CAVIMANA; DISTANTLY RELATED ARTHROPODS; ANOPHELES-GAMBIAE; AXON GUIDANCE; AMPHIPOD CRUSTACEAN; COMMISSURAL AXONS; PROVIDES EVIDENCE; GENOME SEQUENCE; MIDLINE CELLS; NANOS NOS	Although mosquito genome projects uncovered orthologues of many known developmental regulatory genes, extremely little is known about the development of vector mosquitoes. Here, we investigate the role of the Netrin receptor frazzled (fra) during embryonic nerve cord development of two vector mosquito species. Fra expression is detected in neurons just prior to and during axonogenesis in the embryonic ventral nerve cord of Aedes aegypti (dengue vector) and Anopheles gambiae (malaria vector). Analysis of fra function was investigated through siRNA-mediated knockdown in Ae. aegypti embryos. Confirmation of fra knockdown, which was maintained throughout embryogenesis, indicated that microinjection of siRNA is an effective method for studying gene function in Ae. aegypti embryos. Loss of fra during Ae. aegypti development results in thin and missing commissural axons. These defects are qualitatively similar to those observed in Dr. melanogaster fra null mutants. However, the Aa. aegypti knockdown phenotype is stronger and bears resemblance to the Drosophila commissureless mutant phenotype. The results of this investigation, the first targeted knockdown of a gene during vector mosquito embryogenesis, suggest that although Fra plays a critical role during development of the Ae. aegypti ventral nerve cord, mechanisms regulating embryonic commissural axon guidance have evolved in distantly related insects.	[Clemons, Anthony; Le, Christy; Mori, Akio; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Clemons, Anthony; Le, Christy; Mori, Akio; Tomchaney, Michael; Severson, David W.; Duman-Scheel, Molly] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Clemons, Anthony; Haugen, Morgan; Severson, David W.; Duman-Scheel, Molly] Indiana Univ, Sch Med, Dept Med & Mol Genet, South Bend, IN 46615 USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Clemons, A (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	mscheel@nd.edu			University of Notre Dame College of Science; NIAID [R01AI081795-01]; NINDS [R15 NS 048904-0]; IUSM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS048904] Funding Source: NIH RePORTER	University of Notre Dame College of Science; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); IUSM; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Christy Le and Michael Tomchaney were supported by the University of Notre Dame College of Science Summer Undergraduate Research Fellowship program. This work was supported by the following awards to MDS: NIAID Award R01AI081795-01, NINDS Award R15 NS 048904-0, and an IUSM Research Support Funds Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adelman ZN, 2007, P NATL ACAD SCI USA, V104, P9970, DOI 10.1073/pnas.0701515104; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Browne WE, 2006, DEV GENES EVOL, V216, P581, DOI 10.1007/s00427-006-0074-7; Calvo E, 2005, INSECT BIOCHEM MOLEC, V35, P789, DOI 10.1016/j.ibmb.2005.02.007; Chen XH, 2008, ACTA CRYSTALLOGR E, V64, pM1253, DOI 10.1107/S1600536808028171; Christophers SR., 1960, AEDES AEGYPTI YELLOW; Clemons A, 2010, COLD SPRING HARB PRO; DOE CQ, 1993, DEV DROSOPHILA MELAN, P1091; Duman-Scheel M, 1999, DEVELOPMENT, V126, P2327; Duman-Scheel M, 2009, CURR DRUG TARGETS, V10, P602, DOI 10.2174/138945009788680428; Duman-Scheel M, 2007, EVOL DEV, V9, P131, DOI 10.1111/j.1525-142X.2007.00144.x; Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020; Gerberding M, 1999, DEV GENES EVOL, V209, P91, DOI 10.1007/s004270050231; Gerberding M, 2001, DEV BIOL, V235, P397, DOI 10.1006/dbio.2001.0302; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Goltsev Y, 2007, DEVELOPMENT, V134, P2415, DOI 10.1242/dev.02863; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HAUGEN M, 2010, COLD SPRING HARBOR P; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; JASINSKIENE N, 2007, J VISUALIZED EXPT, V5; Juhn J, 2008, INSECT MOL BIOL, V17, P545, DOI 10.1111/j.1365-2583.2008.00823.x; Juhn J, 2006, INSECT MOL BIOL, V15, P363, DOI 10.1111/j.1365-2583.2006.00655.x; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo NF, 2006, NAT PROTOC, V1, P1312, DOI 10.1038/nprot.2006.221; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Morlais I, 2003, MOL GENET GENOMICS, V269, P753, DOI 10.1007/s00438-003-0882-7; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; PATEL N, 1996, IN SITU HYBRIDIZATIO, P357; RAMINANI L N, 1975, International Journal of Insect Morphology and Embryology, V4, P517, DOI 10.1016/0020-7322(75)90028-8; RAMINANI LN, 1978, INT J INSECT MORPHOL, V7, P273, DOI 10.1016/0020-7322(78)90009-0; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Simanton W, 2009, EVOL DEV, V11, P260, DOI 10.1111/j.1525-142X.2009.00328.x; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25	40	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16730	10.1371/journal.pone.0016730	http://dx.doi.org/10.1371/journal.pone.0016730			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304954	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300128
J	Homberg, JR; Olivier, JDA; Blom, T; Arentsen, T; van Brunschot, C; Schipper, P; Korte-Bouws, G; van Luijtelaar, G; Reneman, L				Homberg, Judith R.; Olivier, Jocelien D. A.; Blom, Tom; Arentsen, Tim; van Brunschot, Chantal; Schipper, Pieter; Korte-Bouws, Gerdien; van Luijtelaar, Gilles; Reneman, Liesbeth			Fluoxetine Exerts Age-Dependent Effects on Behavior and Amygdala Neuroplasticity in the Rat	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SEROTONIN REUPTAKE INHIBITORS; PSA-NCAM EXPRESSION; PREPULSE INHIBITION; METABOLITE NORFLUOXETINE; POLYSIALIC ACID; REM-SLEEP; DEPRESSION; SERUM; BRAIN	The selective serotonin reuptake inhibitor (SSRI) Prozac (R) (fluoxetine) is the only registered antidepressant to treat depression in children and adolescents. Yet, while the safety of SSRIs has been well established in adults, serotonin exerts neurotrophic actions in the developing brain and thereby may have harmful effects in adolescents. Here we treated adolescent and adult rats chronically with fluoxetine (12 mg/kg) at postnatal day (PND) 25 to 46 and from PND 67 to 88, respectively, and tested the animals 7-14 days after the last injection when (nor) fluoxetine in blood plasma had been washed out, as determined by HPLC. Plasma (nor) fluoxetine levels were also measured 5 hrs after the last fluoxetine injection, and matched clinical levels. Adolescent rats displayed increased behavioral despair in the forced swim test, which was not seen in adult fluoxetine treated rats. In addition, beneficial effects of fluoxetine on wakefulness as measured by electroencephalography in adults was not seen in adolescent rats, and age-dependent effects on the acoustic startle response and prepulse inhibition were observed. On the other hand, adolescent rats showed resilience to the anorexic effects of fluoxetine. Exploratory behavior in the open field test was not affected by fluoxetine treatment, but anxiety levels in the elevated plus maze test were increased in both adolescent and adult fluoxetine treated rats. Finally, in the amygdala, but not the dorsal raphe nucleus and medial prefrontal cortex, the number of PSA-NCAM (marker for synaptic remodeling) immunoreactive neurons was increased in adolescent rats, and decreased in adult rats, as a consequence of chronic fluoxetine treatment. No fluoxetine-induced changes in 5-HT1A receptor immunoreactivity were observed. In conclusion, we show that fluoxetine exerts both harmful and beneficial age-dependent effects on depressive behavior, body weight and wakefulness, which may relate, in part, to differential fluoxetine-induced neuroplasticity in the amygdala.	[Homberg, Judith R.; Olivier, Jocelien D. A.; Blom, Tom; Arentsen, Tim; van Brunschot, Chantal; Schipper, Pieter] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Ctr Neurosci,Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Reneman, Liesbeth] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van Luijtelaar, Gilles] Radboud Univ Nijmegen, Ctr Cognit, Donders Inst Brain Cognit & Behav, Dept Biol Psychol, NL-6525 ED Nijmegen, Netherlands; [Korte-Bouws, Gerdien] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Homberg, JR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Ctr Neurosci,Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.	j.homberg@cns.umcn.nl	van Luijtelaar, Gilles/D-2290-2010; Homberg, Judith R/D-2473-2010; Homberg, J.R./N-4172-2019	Reneman, Liesbeth/0000-0002-5912-9971; Olivier, Jocelien/0000-0003-4654-9763	Netherlands organization for health research and development [916. 86.125]	Netherlands organization for health research and development(Netherlands Organization for Health Research and Development)	This work is funded by the Netherlands organization for health research and development (Veni nr. 916. 86.125), awarded to L. Reneman. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1998, J CHROMATOGR B, V707, P175, DOI 10.1016/S0378-4347(97)00588-4; Amat J, 2005, NAT NEUROSCI, V8, P365, DOI 10.1038/nn1399; Amsterdam JD, 1997, AM J PSYCHIAT, V154, P963; Argyropoulos SV, 2005, INT REV PSYCHIATR, V17, P237, DOI 10.1080/09540260500104458; BAKALIAN MJ, 1990, BRAIN RES, V528, P300, DOI 10.1016/0006-8993(90)91671-3; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bhansali P, 2007, J NEUROSCI, V27, P1467, DOI 10.1523/JNEUROSCI.4632-06.2007; Bhatia SK, 2007, AM FAM PHYSICIAN, V75, P73; Blier P, 2010, NEURON, V65, P1, DOI 10.1016/j.neuron.2009.12.028; Bourdeaux R, 1998, J PHARM PHARMACOL, V50, P1387, DOI 10.1111/j.2042-7158.1998.tb03364.x; Castro JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008618; Dityatev A, 2004, J NEUROSCI, V24, P9372, DOI 10.1523/JNEUROSCI.1702-04.2004; DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898; Dulawa SC, 1997, PSYCHOPHARMACOLOGY, V132, P125, DOI 10.1007/s002130050328; Duverneuil C, 2003, THER DRUG MONIT, V25, P565, DOI 10.1097/00007691-200310000-00005; Farid M, 2000, NEUROPSYCHOPHARMACOL, V23, P623, DOI 10.1016/S0893-133X(00)00163-9; Feige B, 2002, NEUROPSYCHOPHARMACOL, V26, P246, DOI 10.1016/S0893-133X(01)00314-1; FULLER RW, 1994, J NEURAL TRANSM-GEN, V96, P165, DOI 10.1007/BF01294784; GARATTINI S, 1989, BRIT J PSYCHIAT, V155, P41, DOI 10.1192/S0007125000291757; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/appi.ajp.2007.07030454; Giedke H, 2002, SLEEP MED REV, V6, P361, DOI 10.1053/smrv.2002.0235; Gogos A, 2005, PHARMACOL BIOCHEM BE, V81, P664, DOI 10.1016/j.pbb.2005.05.007; Gogos A, 2008, BEHAV PHARMACOL, V19, P548, DOI 10.1097/FBP.0b013e32830cd822; Grzegorzewska M, 2010, NEUROSCIENCE, V166, P122, DOI 10.1016/j.neuroscience.2009.12.015; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hefner K, 2007, BEHAV BRAIN RES, V182, P344, DOI 10.1016/j.bbr.2007.03.032; Hensler JG, 2002, NEUROPSYCHOPHARMACOL, V26, P565, DOI 10.1016/S0893-133X(01)00395-5; Homberg JR, 2008, PSYCHOPHARMACOLOGY, V200, P367, DOI 10.1007/s00213-008-1212-x; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Iniguez SD, 2010, BIOL PSYCHIAT, V67, P1057, DOI 10.1016/j.biopsych.2009.12.033; Ivarsson M, 2005, EUR J PHARMACOL, V522, P63, DOI 10.1016/j.ejphar.2005.08.050; Kecskemeti V, 2005, BRAIN RES BULL, V67, P126, DOI 10.1016/j.brainresbull.2005.06.027; Kirov R, 2002, NEUROSCI LETT, V322, P134, DOI 10.1016/S0304-3940(02)00096-4; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kurt Mehmet, 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P173; LaRoche RB, 2007, NEUROTOXICOL TERATOL, V29, P96, DOI 10.1016/j.ntt.2006.11.008; Lundmark J, 2001, THER DRUG MONIT, V23, P139, DOI 10.1097/00007691-200104000-00008; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Mason SS, 2009, EUR J PHARMACOL, V602, P306, DOI 10.1016/j.ejphar.2008.11.010; McEwen BS, 2004, EUR NEUROPSYCHOPHARM, V14, pS497, DOI 10.1016/j.euroneuro.2004.09.008; Monti JM, 2006, BEHAV BRAIN RES, V167, P245, DOI 10.1016/j.bbr.2005.09.025; Murray EA, 2007, TRENDS COGN SCI, V11, P489, DOI 10.1016/j.tics.2007.08.013; Norcross M, 2008, PSYCHOPHARMACOLOGY, V200, P413, DOI 10.1007/s00213-008-1215-7; Oh JE, 2009, NEUROPSYCHOPHARMACOL, V34, P2197, DOI 10.1038/npp.2009.47; Olfson M, 2006, ARCH GEN PSYCHIAT, V63, P865, DOI 10.1001/archpsyc.63.8.865; Olivier JDA, 2008, PSYCHOPHARMACOLOGY, V200, P243, DOI 10.1007/s00213-008-1201-0; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; ORSULAK PJ, 1988, CLIN CHEM, V34, P1875; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Popa D, 2008, J NEUROSCI, V28, P3546, DOI 10.1523/JNEUROSCI.4006-07.2008; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P624, DOI 10.1016/j.nlm.2006.12.001; Seki T, 1998, J NEUROSCI, V18, P3757; Shanahan NA, 2009, BIOL PSYCHIAT, V65, P401, DOI 10.1016/j.biopsych.2008.09.026; Simon GE, 2006, NEW ENGL J MED, V355, P2722, DOI 10.1056/NEJMp068270; SIPES TA, 1994, NEUROPHARMACOLOGY, V33, P441, DOI 10.1016/0028-3908(94)90074-4; SPEAR LP, 1983, DEV PSYCHOBIOL, V16, P83, DOI 10.1002/dev.420160203; Strauss WL, 2002, AM J PSYCHIAT, V159, P755, DOI 10.1176/appi.ajp.159.5.755; Thase ME, 1998, J CLIN PSYCHIAT, V59, P55; Usala T, 2008, EUR NEUROPSYCHOPHARM, V18, P62, DOI 10.1016/j.euroneuro.2007.06.001; vanLuijtelaar ELJM, 1997, ACTA NEUROBIOL EXP, V57, P113; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Varea E, 2007, NEUROPSYCHOPHARMACOL, V32, P803, DOI 10.1038/sj.npp.1301183; Varea E, 2009, NEUROBIOL AGING, V30, P808, DOI 10.1016/j.neurobiolaging.2007.08.016; Vazquez-Palacios G, 2010, PHARMACOL BIOCHEM BE, V94, P503, DOI 10.1016/j.pbb.2009.11.004; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; Yew DT, 2009, MICROSC RES TECHNIQ, V72, P684, DOI 10.1002/jemt.20717; Zito JM, 2002, PEDIATRICS, V109, P721, DOI 10.1542/peds.109.5.721	69	68	70	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16646	10.1371/journal.pone.0016646	http://dx.doi.org/10.1371/journal.pone.0016646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304948	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300106
J	Matsuo, K; Bettaieb, A; Nagata, N; Matsuo, I; Keilhack, H; Haj, FG				Matsuo, Kosuke; Bettaieb, Ahmed; Nagata, Naoto; Matsuo, Izumi; Keilhack, Heike; Haj, Fawaz G.			Regulation of Brown Fat Adipogenesis by Protein Tyrosine Phosphatase 1B	PLOS ONE			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; PHOSPHOINOSITIDE 3-KINASE; TRANSCRIPTIONAL CONTROL; GLUCOSE-UPTAKE; ENDOPLASMIC-RETICULUM; ENERGY-EXPENDITURE; 3T3-L1 ADIPOCYTES; BETA-CATENIN	Background: Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of insulin signaling and energy balance, but its role in brown fat adipogenesis requires additional investigation. Methodology/Principal Findings: To precisely determine the role of PTP1B in adipogenesis, we established preadipocyte cell lines from wild type and PTP1B knockout (KO) mice. In addition, we reconstituted KO cells with wild type, substrate-trapping (D/A) and sumoylation-resistant (K/R) PTP1B mutants, then characterized differentiation and signaling in these cells. KO, D/A- and WT-reconstituted cells fully differentiated into mature adipocytes with KO and D/A cells exhibiting a trend for enhanced differentiation. In contrast, K/R cells exhibited marked attenuation in differentiation and lipid accumulation compared with WT cells. Expression of adipogenic markers PPAR gamma, C/EBP alpha, C/EBP delta, and PGC1 alpha mirrored the differentiation pattern. In addition, the differentiation deficit in K/R cells could be reversed completely by the PPAR gamma activator troglitazone. PTP1B deficiency enhanced insulin receptor (IR) and insulin receptor substrate 1 (IRS1) tyrosyl phosphorylation, while K/R cells exhibited attenuated insulin-induced IR and IRS1 phosphorylation and glucose uptake compared with WT cells. In addition, substrate-trapping studies revealed that IRS1 is a substrate for PTP1B in brown adipocytes. Moreover, KO, D/A and K/R cells exhibited elevated AMPK and ACC phosphorylation compared with WT cells. Conclusions: These data indicate that PTP1B is a modulator of brown fat adipogenesis and suggest that adipocyte differentiation requires regulated expression of PTP1B.	[Matsuo, Kosuke; Bettaieb, Ahmed; Nagata, Naoto; Matsuo, Izumi; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Keilhack, Heike] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University of California System; University of California Davis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Matsuo, K (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	fghaj@ucdavis.edu	NAGATA, Naoto/D-9261-2012	NAGATA, Naoto/0000-0002-2389-2334	National Institutes of Health (NIH) [R01 CA49152, R56 DK084317]; Center for Health and Nutrition Research (University of California Davis); American Diabetes Association [7-06-JF-28]; Juvenile Diabetes Research Foundation [1-2009-337]; NATIONAL CANCER INSTITUTE [R01CA049152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Health and Nutrition Research (University of California Davis); American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Initial portions of this study were performed in the laboratory of Dr. Benjamin Neel (National Institutes of Health (NIH) grant R01 CA49152). This work was supported by a grant from the Center for Health and Nutrition Research (University of California Davis), a Junior Faculty Award from American Diabetes Association (7-06-JF-28), Research Grant from the Juvenile Diabetes Research Foundation (1-2009-337), and NIH grant R56 DK084317 to F. G. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided financial support for salary of personnel conducting the research and reagents used in these studies.	Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Camp HS, 2002, TRENDS MOL MED, V8, P442, DOI 10.1016/S1471-4914(02)02396-1; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Clark SF, 1998, J CELL BIOL, V140, P1211, DOI 10.1083/jcb.140.5.1211; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DELIBEGOVIC M, 2008, DIABETES; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Entingh AJ, 2003, J BIOL CHEM, V278, P33377, DOI 10.1074/jbc.M303056200; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Frevert EU, 1998, J BIOL CHEM, V273, P25480, DOI 10.1074/jbc.273.39.25480; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Koutnikova H, 2001, ANN MED, V33, P556, DOI 10.3109/07853890108995966; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Moyers JS, 1996, J BIOL CHEM, V271, P23111, DOI 10.1074/jbc.271.38.23111; Nave BT, 1996, BIOCHEM J, V318, P55, DOI 10.1042/bj3180055; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Valverde AM, 1999, DIABETES, V48, P2122, DOI 10.2337/diabetes.48.11.2122; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Winder WW, 1999, AM J PHYSIOL-ENDOC M, V277, pE1, DOI 10.1152/ajpendo.1999.277.1.E1; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Zabolotny JM, 2004, J BIOL CHEM, V279, P24844, DOI 10.1074/jbc.M310688200	62	30	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16446	10.1371/journal.pone.0016446	http://dx.doi.org/10.1371/journal.pone.0016446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305007	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300065
J	Penrod, NM; Poku, KA; Vaughn, DE; Asselbergs, FW; Brown, NJ; Moore, JH; Williams, SM				Penrod, Nadia M.; Poku, Kwabena A.; Vaughn, Douglas E.; Asselbergs, Folkert W.; Brown, Nancy J.; Moore, Jason H.; Williams, Scott M.			Epistatic Interactions in Genetic Regulation of t-PA and PAI-1 Levels in a Ghanaian Population	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; FIBRINOLYTIC SYSTEMS; BRADYKININ; POLYMORPHISMS; DISEASE; RELEASE	The proteins, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), act in concert to balance thrombus formation and degradation, thereby modulating the development of arterial thrombosis and excessive bleeding. PAI-1 is upregulated by the renin-angiotensin system (RAS), specifically by angiotensin II, the product of angiotensin converting enzyme (ACE) cleavage of angiotensin I, which is produced by the cleavage of angiotensinogen (AGT) by renin (REN). ACE indirectly stimulates the release of t-PA which, in turn, activates the corresponding fibrinolytic system. Single polymorphisms in these pathways have been shown to significantly impact plasma levels of t-PA and PAI-1 differently in Ghanaian males and females. Here we explore the involvement of epistatic interactions between the same polymorphisms in central genes of the RAS and fibrinolytic systems on plasma t-PA and PAI-1 levels within the same population (n = 992). Statistical modeling of pairwise interactions was done using two-way ANOVA between polymorphisms in the ETNK2, RENIN, ACE, PAI-1, t-PA, and AGT genes. The most significant interactions that associated with t-PA levels were between the ETNK2 A6135G and the REN T9435C polymorphisms in females (p = 0.006) and the REN T9435C and the TPA I/D polymorphisms (p = 0.005) in males. The most significant interactions for PAI-1 levels were with REN T9435C and the TPA I/D polymorphisms (p = 0.001) in females, and the association of REN G6567T with the TPA I/D polymorphisms (p = 0.032) in males. Our results provide evidence for multiple genetic effects that may not be detected using single SNP analysis. Because t-PA and PAI-1 have been implicated in cardiovascular disease these results support the idea that the genetic architecture of cardiovascular disease is complex. Therefore, it is necessary to consider the relationship between interacting polymorphisms of pathway specific genes that predict t-PA and PAI-1 levels.	[Penrod, Nadia M.; Moore, Jason H.] Dartmouth Med Sch, Dept Genet, Lebanon, NH USA; [Poku, Kwabena A.] Univ Ghana, Sch Business, Human Serv Management & Publ Adm, Legon, Ghana; [Vaughn, Douglas E.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Brown, Nancy J.] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Moore, Jason H.] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Williams, Scott M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA	Dartmouth College; University of Ghana; Vanderbilt University; Utrecht University; Utrecht University Medical Center; Vanderbilt University; Dartmouth College; Vanderbilt University	Penrod, NM (corresponding author), Dartmouth Med Sch, Dept Genet, Lebanon, NH USA.	smwilliams@chgr.mc.vanderbilt.edu	Williams, Scott/Q-4812-2019; Moore, Jason H./AAV-9645-2021; Williams, Scott/B-9491-2012; Asselbergs, Folkert W./ABD-6752-2021	Williams, Scott/0000-0002-4835-9544; Moore, Jason H./0000-0002-5015-1099; Asselbergs, Folkert W./0000-0002-1692-8669	National Institutes of Health [HL65234]; ZonMW Clinical Fellowship [90700342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMW Clinical Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL65234. Dr. F. W. Asselbergs is supported by a ZonMW Clinical Fellowship (grant 90700342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselbergs FW, 2007, J THROMB HAEMOST, V5, P313, DOI 10.1111/j.1538-7836.2007.02311.x; Asselbergs FW, 2007, HUM GENET, V122, P275, DOI 10.1007/s00439-007-0400-9; Asselbergs FW, 2007, GENOMICS, V89, P362, DOI 10.1016/j.ygeno.2006.11.004; Asselbergs FW, 2006, THROMB HAEMOSTASIS, V96, P471, DOI 10.1160/TH06-06-0335; Brown NJ, 1998, HYPERTENSION, V32, P965, DOI 10.1161/01.HYP.32.6.965; Brown NJ, 1999, HYPERTENSION, V33, P1431, DOI 10.1161/01.HYP.33.6.1431; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; FRANCIS RB, 1988, AM HEART J, V115, P776, DOI 10.1016/0002-8703(88)90878-2; Margaglione M, 1997, ARTERIOSCL THROM VAS, V17, P2082, DOI 10.1161/01.ATV.17.10.2082; MARGAGLIONE M, 1994, ARTERIOSCLER THROMB, V14, P1741, DOI 10.1161/01.ATV.14.11.1741; MEADE TW, 1993, LANCET, V342, P1076, DOI 10.1016/0140-6736(93)92062-X; MOORE JH, 2005, BIOESSAYS IN PRESS; Pattin KA, 2008, HUM GENET, V124, P19, DOI 10.1007/s00439-008-0522-8; Pretorius M, 2003, CIRCULATION, V107, P579, DOI 10.1161/01.CIR.0000046268.59922.A4; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHNEIDERMAN J, 1992, P NATL ACAD SCI USA, V89, P6998, DOI 10.1073/pnas.89.15.6998; Schoenhard JA, 2008, HUM GENET, V124, P479, DOI 10.1007/s00439-008-0573-x; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tian Y, 2006, J BIOL CHEM, V281, P28438, DOI 10.1074/jbc.M605861200; Williams SM, 2007, ETHNIC DIS, V17, P492	23	3	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16639	10.1371/journal.pone.0016639	http://dx.doi.org/10.1371/journal.pone.0016639			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304999	gold, Green Published			2022-12-25	WOS:000286834300105
J	Yun, CS; Nishida, H				Yun, Choong-Soo; Nishida, Hiromi			Distribution of Introns in Fungal Histone Genes	PLOS ONE			English	Article							MESSENGER-RNA; CELL-CYCLE; H2A GENE; EXPRESSION; MOUSE; SEQUENCE; UNIQUE	Saccharomycotina and Taphrinomycotina lack intron in their histone genes, except for an intron in one of histone H4 genes of Yarrowia lipolytica. On the other hand, Basidiomycota and Perizomycotina have introns in their histone genes. We compared the distributions of 81, 47, 79, and 98 introns in the fungal histone H2A, H2B, H3, and H4 genes, respectively. Based on the multiple alignments of the amino acid sequences of histones, we identified 19, 13, 31, and 22 intron insertion sites in the histone H2A, H2B, H3, and H4 genes, respectively. Surprisingly only one hot spot of introns in the histone H2A gene is shared between Basidiomycota and Perizomycotina, suggesting that most of introns of Basidiomycota and Perizomycotina were acquired independently. Our findings suggest that the common ancestor of Ascomycota and Basidiomycota maybe had a few introns in the histone genes. In the course of fungal evolution, Saccharomycotina and Taphrinomycotina lost the histone introns; Basidiomycota and Perizomycotina acquired other introns independently. In addition, most of the introns have sequence similarity among introns of phylogenetically close species, strongly suggesting that horizontal intron transfer events between phylogenetically distant species have not occurred recently in the fungal histone genes.	[Yun, Choong-Soo; Nishida, Hiromi] Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan	University of Tokyo	Yun, CS (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Agr Bioinformat Res Unit, Tokyo, Japan.	hnishida@iu.a.u-tokyo.ac.jp	YUN, Choong-Soo/C-7453-2017; Nishida, Hiromi/B-1635-2008	YUN, Choong-Soo/0000-0001-7128-2584	Institute for Fermentation, Osaka (IFO), Japan	Institute for Fermentation, Osaka (IFO), Japan(Institute for Fermentation (IFO))	This study was supported in part by a grant from the Institute for Fermentation, Osaka (IFO), Japan to HN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHABOUTE ME, 1993, BIOCHIMIE, V75, P523, DOI 10.1016/0300-9084(93)90057-Y; EHINGER A, 1990, MOL GEN GENET, V222, P416, DOI 10.1007/BF00633848; HARRIS ME, 1991, MOL CELL BIOL, V11, P2416, DOI 10.1128/MCB.11.5.2416; IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513; Kuramae EE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-134; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; MAY GS, 1987, GENE, V58, P59, DOI 10.1016/0378-1119(87)90029-1; Nishida H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-108; NISHIDA H, 1993, MOL BIOL EVOL, V10, P431; Nishida H, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-10; Nishida Hiromi, 1994, Mycoscience, V35, P361, DOI 10.1007/BF02268506; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Pearson WR, 1998, J MOL BIOL, V276, P71, DOI 10.1006/jmbi.1997.1525; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Wang H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-195; WOUDT LP, 1983, NUCLEIC ACIDS RES, V11, P5347, DOI 10.1093/nar/11.16.5347; Xu ZH, 2010, MYCOLOGIA, V102, P337, DOI 10.3852/08-189	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16548	10.1371/journal.pone.0016548	http://dx.doi.org/10.1371/journal.pone.0016548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304581	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900068
J	El-Maarri, O; Walier, M; Behne, F; van Uum, J; Singer, H; Diaz-Lacava, A; Nusgen, N; Niemann, B; Watzka, M; Reinsberg, J; van der Ven, H; Wienker, T; Stoffel-Wagner, B; Schwaab, R; Oldenburg, J				El-Maarri, Osman; Walier, Maja; Behne, Frank; van Ueuem, Jan; Singer, Heike; Diaz-Lacava, Amalia; Nuesgen, Nicole; Niemann, Barbara; Watzka, Matthias; Reinsberg, Jochen; van der Ven, Hans; Wienker, Thomas; Stoffel-Wagner, Birgit; Schwaab, Rainer; Oldenburg, Johannes			Methylation at Global LINE-1 Repeats in Human Blood Are Affected by Gender but Not by Age or Natural Hormone Cycles	PLOS ONE			English	Article							CPG ISLAND LOCI; IP-RP-HPLC; DNA-METHYLATION; STABLY EXPRESSES; HUMAN-CELLS; LIFE-SPAN; HYPOMETHYLATION; SITES; HYPERMETHYLATION; CARCINOGENESIS	Previously, we reported on inter-individual and gender specific variations of LINE-1 methylation in healthy individuals. In this study, we investigated whether this variability could be influenced by age or sex hormones in humans. To this end, we studied LINE-1 methylation in vivo in blood-derived DNA from individuals aged 18 to 64 years and from young healthy females at various hormone levels during the menstrual cycle. Our results show that no significant association with age was observed. However, the previously reported increase of LINE-1 methylation in males was reconfirmed. In females, although no correlation between LINE-1 or Alu methylation and hormone levels was observed, a significant stable individual specific level of methylation was noted. In vitro results largely confirmed these findings, as neither estrogen nor dihydrotestosterone affected LINE-1 or Alu methylation in Hek293T, HUVEC, or MDA-kb2 cell lines. In contrast, a decrease in methylation was observed in estrogen-treated T47-Kbluc cell lines strongly expressing estrogen receptor. The very low expression of estrogen receptor in blood cells could explain the observed insensitivity of methylation at LINE-1 to natural hormonal variations in females. In conclusion, neither natural cycle of hormones nor age has a detectable effect on the LINE-1 methylation in peripheral blood cells, while gender remains an important factor.	[El-Maarri, Osman; Behne, Frank; van Ueuem, Jan; Singer, Heike; Nuesgen, Nicole; Niemann, Barbara; Watzka, Matthias; Schwaab, Rainer; Oldenburg, Johannes] Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany; [Walier, Maja; Diaz-Lacava, Amalia; Wienker, Thomas] Univ Bonn, IMBIE, D-5300 Bonn, Germany; [Reinsberg, Jochen; van der Ven, Hans] Univ Bonn, Dept Gynecol Endocrinol & Reprod Med, D-5300 Bonn, Germany; [Stoffel-Wagner, Birgit] Univ Bonn, Inst Clin Chem & Clin Pharmacol, D-5300 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn	El-Maarri, O (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, D-5300 Bonn, Germany.	osman.elmaarri@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	El-Maarri, Osman/0000-0002-6859-5819; Oldenburg, Johannes/0000-0002-1585-4100	Institute of Experimental Hematology and Transfusion Medicine, University Clinic of Bonn; German Research Council [DFG EL 499/2-1]	Institute of Experimental Hematology and Transfusion Medicine, University Clinic of Bonn; German Research Council(German Research Foundation (DFG))	The study was supported by institutional fund of the Institute of Experimental Hematology and Transfusion Medicine, University Clinic of Bonn. Additionally the work in the lab of OEM is supported by a German Research Council grant (DFG EL 499/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aniagu SO, 2009, TOXICOLOGY, V256, P143, DOI 10.1016/j.tox.2008.10.017; Asquith B, 2009, TRENDS IMMUNOL, V30, P182, DOI 10.1016/j.it.2009.01.003; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Busque L, 2009, BLOOD, V113, P3472, DOI 10.1182/blood-2008-12-195677; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Choi IS, 2007, MODERN PATHOL, V20, P802, DOI 10.1038/modpathol.3800825; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; El-Maarri O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e25; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri Osman, 2004, Methods Mol Biol, V287, P195; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Figueiredo JC, 2009, CANCER EPIDEM BIOMAR, V18, P1041, DOI 10.1158/1055-9965.EPI-08-0926; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Iacopetta B, 2007, CANCER SCI, V98, P1454, DOI 10.1111/j.1349-7006.2007.00548.x; JINTARIDTH P, 2010, PHYSL GENOMICS; Kaneda A, 2004, CANCER SCI, V95, P58, DOI 10.1111/j.1349-7006.2004.tb03171.x; Knudsen PS, 2007, CYTOGENET GENOME RES, V116, P24, DOI 10.1159/000097414; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Pattamadilok J, 2008, INT J GYNECOL CANCER, V18, P711, DOI 10.1111/j.1525-1438.2007.01117.x; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Perrin D, 2007, ONCOGENE, V26, P2518, DOI 10.1038/sj.onc.1210039; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P1466, DOI 10.1289/ehp.0800497; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; STEINBACH KH, 1979, BLUT, V39, P27, DOI 10.1007/BF01008072; Swerdloff RS, 1998, BAILLIERE CLIN ENDOC, V12, P501, DOI 10.1016/S0950-351X(98)80267-X; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takai D, 2000, JPN J CLIN ONCOL, V30, P306, DOI 10.1093/jjco/hyd079; Tellez CS, 2009, MELANOMA RES, V19, P146, DOI 10.1097/CMR.0b013e32832b274e; THAYER RE, 1993, GENE, V133, P273, DOI 10.1016/0378-1119(93)90651-I; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; TOUGH DF, 1995, IMMUNOL RES, V14, P1, DOI 10.1007/BF02918494; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; WHITELAW DM, 1966, BLOOD-J HEMATOL, V28, P455, DOI 10.1182/blood.V28.3.455.455; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Wilson VS, 2004, TOXICOL SCI, V81, P69, DOI 10.1093/toxsci/kfh180; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Zhao ZR, 2010, P NATL ACAD SCI USA, V107, P5605, DOI 10.1073/pnas.0910578107	53	67	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e16252	10.1371/journal.pone.0016252	http://dx.doi.org/10.1371/journal.pone.0016252			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21311577	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600035
J	Hurley, JM; Cruz, JW; Ouyang, M; Woychik, NA				Hurley, Jennifer M.; Cruz, Jonathan W.; Ouyang, Ming; Woychik, Nancy A.			Bacterial Toxin RelE Mediates Frequent Codon-independent mRNA Cleavage from the 5 ' End of Coding Regions in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RIBOSOMES; SITE	The enzymatic activity of the RelE bacterial toxin component of the Escherichia coli RelBE toxin-antitoxin system has been extensively studied in vitro and to a lesser extent in vivo. These earlier reports revealed that 1) RelE alone does not exhibit mRNA cleavage activity, 2) RelE mediates mRNA cleavage through its association with the ribosome, 3) RelE-mediated mRNA cleavage occurs at the ribosomal A site and, 4) Cleavage of mRNA by RelE exhibits high codon specificity. More specifically, RelE exhibits a preference for the stop codons UAG and UGA and sense codons CAG and UCG in vitro. In this study, we used a comprehensive primer extension approach to map the frequency and codon specificity of RelE cleavage activity in vivo. We found extensive cleavage at the beginning of the coding region of five transcripts, ompA, lpp, ompF, rpsA, and tufA. We then mapped RelE cleavage sites across one short transcript (lpp) and two long transcripts (ompF and ompA). RelE cut all of these transcripts frequently and efficiently within the first similar to 100 codons, only occasionally cut beyond this point, and rarely cut at sites in proximity to the 3' end. Among 196 RelE sites in these five transcripts, there was no preference for CAG or UCG sense codons. In fact, bioinformatic analysis of the RelE cleavage sites failed to identify any sequence preferences. These results suggest a model of RelE function distinct from those proposed previously, because RelE directed frequent codon-independent mRNA cleavage coincident with the commencement of translation elongation.	[Hurley, Jennifer M.; Cruz, Jonathan W.; Woychik, Nancy A.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, Piscataway, NJ 08854 USA; [Ouyang, Ming] Univ Louisville, Dept Comp Sci & Comp Engn, Louisville, KY 40292 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Louisville	Woychik, NA (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Mol Genet Microbiol & Immunol, 675 Hoes Lane, Piscataway, NJ 08854 USA.	nancy.woychik@umdnj.edu		Hurley, Jennifer/0000-0002-1085-9391	National Institutes of Health [AI07403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health T32 Training Grant AI07403 (to J.M.H. and J.W.C.) awarded to S. Pestka.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Chen DQ, 2006, GENE THER MOL BIOL, V10A, P1; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Durbin R., 1998, BIOL SEQUENCE ANAL P; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	12	35	38	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14770	14778		10.1074/jbc.M110.108969	http://dx.doi.org/10.1074/jbc.M110.108969			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21324908	hybrid, Green Published			2022-12-25	WOS:000289788300006
J	Di Cairano, ES; Davalli, AM; Perego, L; Sala, S; Sacchi, VF; La Rosa, S; Finzi, G; Placidi, C; Capella, C; Conti, P; Centonze, VE; Casiraghi, F; Bertuzzi, F; Folli, F; Perego, C				Di Cairano, Eliana S.; Davalli, Alberto M.; Perego, Lucia; Sala, Silvia; Sacchi, V. Franca; La Rosa, Stefano; Finzi, Giovanna; Placidi, Claudia; Capella, Carlo; Conti, Paola; Centonze, Victoria E.; Casiraghi, Francesca; Bertuzzi, Federico; Folli, Franco; Perego, Carla			The Glial Glutamate Transporter 1 (GLT1) Is Expressed by Pancreatic beta-Cells and Prevents Glutamate-induced beta-Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; STIMULATED INSULIN-SECRETION; METABOTROPIC GLUTAMATE; OXIDATIVE STRESS; GLUCAGON-SECRETION; ALPHA-CELLS; NUDE-MICE; ISLETS; LANGERHANS; RECEPTOR	Glutamate is the major excitatory neurotransmitter of the central nervous system (CNS) and may induce cytotoxicity through persistent activation of glutamate receptors and oxidative stress. Its extracellular concentration is maintained at physiological concentrations by high affinity glutamate transporters of the solute carrier 1 family (SLC1). Glutamate is also present in islet of Langerhans where it is secreted by the alpha-cells and acts as a signaling molecule to modulate hormone secretion. Whether glutamate plays a role in islet cell viability is presently unknown. We demonstrate that chronic exposure to glutamate exerts a cytotoxic effect in clonal beta-cell lines and human islet beta-cells but not in alpha-cells. In human islets, glutamate-induced beta-cell cytotoxicity was associated with increased oxidative stress and led to apoptosis and autophagy. We also provide evidence that the key regulator of extracellular islet glutamate concentration is the glial glutamate transporter 1 (GLT1). GLT1 localizes to the plasma membrane of beta-cells, modulates hormone secretion, and prevents glutamate-induced cytotoxicity as shown by the fact that its down-regulation induced beta-cell death, whereas GLT1 up-regulation promoted beta-cell survival. In conclusion, the present study identifies GLT1 as a new player in glutamate homeostasis and signaling in the islet of Langerhans and demonstrates that beta-cells critically depend on its activity to control extracellular glutamate levels and cellular integrity.	[Davalli, Alberto M.; Casiraghi, Francesca; Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Centonze, Victoria E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Perego, Carla] Univ Milan, Dept Mol Sci Appl Biosyst, Lab Cell Physiol, I-20134 Milan, Italy; [Davalli, Alberto M.] Ist Sci San Raffaele, Diabet & Endocrinol Unit, Dept Internal Med, I-20132 Milan, Italy; [La Rosa, Stefano; Finzi, Giovanna; Placidi, Claudia; Capella, Carlo] Osped Circolo Varese, Dept Pathol, I-21100 Varese, Italy; [La Rosa, Stefano; Finzi, Giovanna; Placidi, Claudia; Capella, Carlo] Univ Insubria, Dept Human Morphol, I-21100 Varese, Italy; [Conti, Paola] Univ Milan, Dept Pharmaceut Sci P Pratesi, I-20133 Milan, Italy; [Bertuzzi, Federico] Osped Niguarda Ca Granda, I-20162 Milan, Italy	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Insubria; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Folli, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.	folli@uthscsa.edu; carla.perego@unimi.it	Casiraghi, Francesca/GLS-0884-2022; La+Rosa, Stefano/AAF-3366-2022; folli, franco/J-2795-2018; La+Rosa, Stefano/AFH-8608-2022; Conti, Paola/D-1266-2011; Perego, Carla/L-6147-2015	La+Rosa, Stefano/0000-0003-1941-2403; folli, franco/0000-0001-9824-5222; La+Rosa, Stefano/0000-0003-1941-2403; Perego, Carla/0000-0003-3027-1779; Conti, Paola/0000-0003-2140-0567	University Research Program; National Institutes of Health [RO1 DK080148]; Universita degli Studi di Milano; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080148] Funding Source: NIH RePORTER	University Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Universita degli Studi di Milano; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by University Research Program 2008 (to C.P.) and National Institutes of Health Grant RO1 DK080148 (to F.F.). E.S.D.C., A.M.D., F.F., and C.P. are inventors in a Patent Cooperation Treaty application.; Supported in part by the Universita degli Studi di Milano postgraduate fellowship program.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bai LQ, 2003, AM J PHYSIOL-GASTR L, V284, pG808, DOI 10.1152/ajpgi.00333.2002; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Bertrand G, 2002, J BIOL CHEM, V277, P32883, DOI 10.1074/jbc.M205326200; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Brice NL, 2002, DIABETOLOGIA, V45, P242, DOI 10.1007/s00125-001-0750-0; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cabrera O, 2008, CELL METAB, V7, P545, DOI 10.1016/j.cmet.2008.03.004; Cho JH, 2010, ENDOCRINOLOGY, V151, P1541, DOI 10.1210/en.2009-0362; CHOI DW, 1987, J NEUROSCI, V7, P357; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalli AM, 2008, CELL TRANSPLANT, V17, P1323, DOI 10.3727/096368908787648137; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Finzi G, 2005, ULTRASTRUCT PATHOL, V29, P525, DOI 10.1080/01913120500323563; Funicello M, 2004, MOL PHARMACOL, V66, P522; Gammelsaeter R, 2009, BIOCHEM BIOPH RES CO, V381, P378, DOI 10.1016/j.bbrc.2009.02.062; Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; MANFRAS BJ, 1994, BBA-BIOMEMBRANES, V1195, P185, DOI 10.1016/0005-2736(94)90026-4; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Matyja E, 2005, ULTRASTRUCT PATHOL, V29, P331, DOI 10.1080/01913120500214333; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; MOLNAR E, 1995, FEBS LETT, V371, P253, DOI 10.1016/0014-5793(95)00890-L; Montero F, 2007, BIOCHIMIE, V89, P1366, DOI 10.1016/j.biochi.2007.05.008; Morley P, 2000, NEUROL RES, V22, P379, DOI 10.1080/01616412.2000.11740687; Muroyama A, 2004, DIABETES, V53, P1743, DOI 10.2337/diabetes.53.7.1743; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Numazawa S, 2008, AM J PHYSIOL-CELL PH, V295, pC468, DOI 10.1152/ajpcell.00203.2008; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pacheco R, 2006, J IMMUNOL, V177, P6695, DOI 10.4049/jimmunol.177.10.6695; Perego C, 2000, J NEUROCHEM, V75, P1076, DOI 10.1046/j.1471-4159.2000.0751076.x; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uehara S, 2004, DIABETES, V53, P998, DOI 10.2337/diabetes.53.4.998; Weaver CD, 1998, J BIOL CHEM, V273, P1647, DOI 10.1074/jbc.273.3.1647; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977	56	43	45	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14007	14018		10.1074/jbc.M110.183517	http://dx.doi.org/10.1074/jbc.M110.183517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21335552	Green Published, hybrid			2022-12-25	WOS:000289556200023
J	De la Mota-Peynado, A; Chernoff, J; Beeser, A				De la Mota-Peynado, Alina; Chernoff, Jonathan; Beeser, Alexander			Identification of the Atypical MAPK Erk3 as a Novel Substrate for p21-activated Kinase (Pak) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; C-TERMINAL DOMAIN; LOOP PHOSPHORYLATION; SPECIFICITY; MECHANISM; PRAK/MK5; DOCKING; PATHWAY; DEFINES; TARGETS	The class I p21-activated kinases (Pak1-3) regulate many essential biological processes, including cytoskeletal rearrangement, cell cycle progression, apoptosis, and cellular transformation. Although many Pak substrates, including elements of MAPK signaling cascades, have been identified, it is likely that additional substrates remain to be discovered, Identification of such substrates, and determination of the consequences of their phosphorylation, is essential for a better understanding of class I Pak activity. To identify novel class I Pak substrates, we used recombinant Pak2 to screen high density protein microarrays. This approach identified the atypical MAPK Erk3 as a potential Pak2 substrate. Solution-based in vitro kinase assays using recombinant Erk3 confirmed the protein microarray results, and phospho-specific antisera identified serine 189, within the Erk3 activation loop, as a site directly phosphorylated by Pak2 in vitro. Erk3 protein is known to shuttle between the cytoplasm and the nucleus, and we showed that selective inhibition of class I Pak kinase activity in cells promoted increased nuclear accumulation of Erk3. Pak inhibition in cells additionally reduced the extent of Ser(189) phosphorylation and inhibited the formation of Erk3-Prak complexes. Collectively, our results identify the Erk3 protein as a novel class I Pak substrate and further suggest a role for Pak kinase activity in atypical MAP K signaling.	[De la Mota-Peynado, Alina; Beeser, Alexander] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [De la Mota-Peynado, Alina; Beeser, Alexander] Kansas State Univ, Mol Cellular & Dev Biol Program, Manhattan, KS 66506 USA; [Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	Kansas State University; Kansas State University; Fox Chase Cancer Center	Beeser, A (corresponding author), Kansas State Univ, Div Biol, 412-A Ackert Hall, Manhattan, KS 66506 USA.	albeeser@ksu.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [R01 CA58836]; Terry C. Johnson Center for Basic Cancer Research; NATIONAL CANCER INSTITUTE [R01CA058836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry C. Johnson Center for Basic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA58836 (to J. C.). This work was also supported by Terry C. Johnson Center for Basic Cancer Research (to A. B.).	Abe MK, 1999, MOL CELL BIOL, V19, P1301; Aberg E, 2009, J BIOL CHEM, V284, P19392, DOI 10.1074/jbc.M109.023283; Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng M, 1996, J BIOL CHEM, V271, P8951, DOI 10.1074/jbc.271.15.8951; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; Cotteret S, 2002, GENOME BIOL, V3; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Feilner T, 2005, MOL CELL PROTEOMICS, V4, P1558, DOI 10.1074/mcp.M500007-MCP200; Hayashi ML, 2007, P NATL ACAD SCI USA, V104, P11489, DOI 10.1073/pnas.0705003104; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Jakobi R, 2000, EUR J BIOCHEM, V267, P4414, DOI 10.1046/j.1432-1327.2000.01488.x; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; REESER A, 2005, J BIOL CHEM, V280, P36609; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schnack C, 2008, PROTEOMICS, V8, P1980, DOI 10.1002/pmic.200701063; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604; Xie XZ, 2005, CELL SIGNAL, V17, P461, DOI 10.1016/j.cellsig.2004.09.012	34	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13603	13611		10.1074/jbc.M110.181743	http://dx.doi.org/10.1074/jbc.M110.181743			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317288	Green Published, hybrid			2022-12-25	WOS:000289282200079
J	Grossoehme, N; Kehl-Fie, TE; Ma, Z; Adams, KW; Cowart, DM; Scott, RA; Skaar, EP; Giedroc, DP				Grossoehme, Nicholas; Kehl-Fie, Thomas E.; Ma, Zhen; Adams, Keith W.; Cowart, Darin M.; Scott, Robert A.; Skaar, Eric P.; Giedroc, David P.			Control of Copper Resistance and Inorganic Sulfur Metabolism by Paralogous Regulators in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RCNR; MYCOBACTERIUM-TUBERCULOSIS; METHICILLIN-RESISTANT; METAL SELECTIVITY; BACILLUS-SUBTILIS; REPRESSOR CSOR; HOMEOSTASIS; TAURINE; PROTEIN; DEHYDROGENASE	All strains of Staphylococcus aureus encode a putative copper-sensitive operon repressor (CsoR) and one other CsoR-like protein of unknown function. We show here that NWMN_1991 encodes a bona fide Cu(I)-inducible CsoR of a genetically unlinked copA-copZ copper resistance operon in S. aureus strain Newman. In contrast, an unannotated open reading frame found between NWMN_0027 and NWMN_0026 (denoted NWMN_0026.5) encodes a CsoR-like regulator that represses expression of adjacent genes by binding specifically to a pair of canonical operator sites positioned in the NWMN_0027-0026.5 intergenic region. Inspection of these regulated genes suggests a role in assimilation of inorganic sulfur from thiosulfate and vectorial sulfur transfer, and we designate NWMN_0026.5 as CstR (CsoR-like sulfur transferase repressor). Expression analysis demonstrates that CsoR and CstR control their respective regulons in response to distinct stimuli with no overlap in vivo. Unlike CsoR, CstR does not form a stable complex with Cu(I); operator binding is instead inhibited by oxidation of the intersubunit cysteine pair to a mixture of disulfide and trisulfide linkages by a likely metabolite of thiosulfate assimilation, sulfite. CsoR is unreactive toward sulfite under the same conditions. We conclude that CsoR and CstR are paralogs in S. aureus that function in the same cytoplasm to control distinct physiological processes.	[Grossoehme, Nicholas; Ma, Zhen; Giedroc, David P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Kehl-Fie, Thomas E.; Adams, Keith W.; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Cowart, Darin M.; Scott, Robert A.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Cowart, Darin M.; Scott, Robert A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Indiana University System; Indiana University Bloomington; Vanderbilt University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Skaar, EP (corresponding author), 1161 21st Ave S,A-5102 MCN, Nashville, TN 37232 USA.	eric.skaar@vanderbilt.edu; giedroc@indiana.edu	Ma, Zhen/A-7151-2012; Giedroc, David/A-8608-2018	Giedroc, David/0000-0002-2342-1620; Scott, Robert/0000-0003-2236-1336; Kehl-Fie, Thomas/0000-0001-8234-1113	National Institutes of Health [R01 GM042569]; Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; T32 HL094296; American Heart Association; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources;  [R01 GM042025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042569, R01GM042025, R01GM097225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southeastern Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); T32 HL094296; American Heart Association(American Heart Association); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM042569 (to D. P. G.), U54 AI057157 from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense (to E P. S.), and R01 GM042025 (to R. A. S.).; Supported by Grant T32 HL094296 to Vanderbilt University and a postdoctoral fellowship from the American Heart Association.; Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences, The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and the National Institutes of Health, National Center for Research Resources Biomedical Technology Program.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Baker J, 2010, APPL ENVIRON MICROB, V76, P150, DOI 10.1128/AEM.02268-09; BALL S, 1995, CAN J CHEM, V73, P716, DOI 10.1139/v95-091; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cipollone R, 2007, IUBMB LIFE, V59, P51, DOI 10.1080/15216540701206859; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Gaballa A, 2010, P NATL ACAD SCI USA, V107, P6482, DOI 10.1073/pnas.1000928107; GIEHL TJ, 1987, J GEN MICROBIOL, V133, P849; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; HELMANN JD, 2010, ANTIOXID RE IN PRESS; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Highlander SK, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-99; Hong JA, 2009, J MED CHEM, V52, P5485, DOI 10.1021/jm900728u; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2009, J MOL BIOL, V393, P514, DOI 10.1016/j.jmb.2009.08.038; KAU LS, 1987, J AM CHEM SOC, V109, P6433, DOI 10.1021/ja00255a032; Kehl-Fie TE, 2009, J BACTERIOL, V191, P4976, DOI 10.1128/JB.00123-09; Krejcik Z, 2008, ARCH MICROBIOL, V190, P159, DOI 10.1007/s00203-008-0386-2; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lithgow JK, 2004, J BACTERIOL, V186, P1579, DOI 10.1128/JB.186.6.1579-1590.2004; Liu T, 2008, BIOCHEMISTRY-US, V47, P10564, DOI 10.1021/bi801313y; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Ma Z, 2009, J AM CHEM SOC, V131, P18044, DOI 10.1021/ja908372b; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Moen AEF, 2010, FEMS IMMUNOL MED MIC, V58, P374, DOI 10.1111/j.1574-695X.2009.00649.x; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Osman D, 2010, J BIOL CHEM, V285, P25259, DOI 10.1074/jbc.M110.145953; Osman D, 2008, ADV APPL MICROBIOL, V65, P217, DOI 10.1016/S0065-2164(08)00608-4; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Santo CE, 2010, APPL ENVIRON MICROB, V76, P1341, DOI 10.1128/AEM.01952-09; Shibata H, 2007, CAN J MICROBIOL, V53, P1091, DOI 10.1139/W07-077; Sitthisak S, 2007, MICROBIOL-SGM, V153, P4274, DOI 10.1099/mic.0.2007/009860-0; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Solioz M, 2003, FEMS MICROBIOL REV, V27, P183, DOI 10.1016/S0168-6445(03)00053-6; Soutourina O, 2009, MOL MICROBIOL, V73, P194, DOI 10.1111/j.1365-2958.2009.06760.x; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tottey S, 2005, ACCOUNTS CHEM RES, V38, P775, DOI 10.1021/ar0300118; Voyich JM, 2009, J INFECT DIS, V199, P1698, DOI 10.1086/598967; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; Weaver L, 2010, J APPL MICROBIOL, V109, P2200, DOI 10.1111/j.1365-2672.2010.04852.x; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; White C, 2009, J BIOL CHEM, V284, P33949, DOI 10.1074/jbc.M109.070201; Wiethaus J, 2008, J BACTERIOL, V190, P487, DOI 10.1128/JB.01510-07; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	53	74	74	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13522	13531		10.1074/jbc.M111.220012	http://dx.doi.org/10.1074/jbc.M111.220012			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339296	Green Published, hybrid			2022-12-25	WOS:000289282200072
J	Konno, H; Isu, A; Kim, Y; Murakami-Fuse, T; Sugano, Y; Hisabori, T				Konno, Hiroki; Isu, Atsuko; Kim, Yusung; Murakami-Fuse, Tomoe; Sugano, Yasushi; Hisabori, Toru			Characterization of the Relationship between ADP- and epsilon-induced Inhibition in Cyanobacterial F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; ESCHERICHIA-COLI F1-ATPASE; NUCLEOTIDE-BINDING SITE; PROTON MOTIVE FORCE; C-TERMINAL DOMAIN; ADENOSINE-TRIPHOSPHATASE; CATALYTIC SITE; F-1 MOTOR; LAURYLDIMETHYLAMINE OXIDE; CONFORMATIONAL-CHANGES	The ATPase activity of chloroplast and bacterial F-1-ATPase is strongly inhibited by both the endogenous inhibitor epsilon and tightly bound ADP. Although the physiological significance of these inhibitory mechanisms is not very well known for the membrane-bound F0F1, these are very likely to be important in avoiding the futile ATP hydrolysis reaction and ensuring efficient ATP synthesis in vivo. In a previous study using the alpha(3)beta(3)gamma complex of F-1 obtained from the thermophilic cyanobacteria, Thermosynechococcus elongatus BP-1, we succeeded in determining the discrete stop position, similar to 80 degrees forward from the pause position for ATP binding, caused by epsilon-induced inhibition (epsilon-inhibition) during gamma rotation (Konno, H., Murakami-Fuse, T., RIM, F., Koyama, F., Ueoka-Nakanishi, H., Pack, C. G., Kinjo, M., and Hisabori, T. (2006) EMBO J. 25, 4596 4604). Because gamma in ADP-inhibited F-1 also pauses at the same position, ADP-induced inhibition (ADP-inhibition) was assumed to be linked to epsilon-inhibition. However, ADP-inhibition and epsilon-inhibition should be independent phenomena from each other because the ATPase core complex, alpha(3)beta(3)gamma, also lapses into the ADP-inhibition state. By way of thorough biophysical and biochemical analyses, we determined that the E subunit inhibition mechanism does not directly correlate with ADP-inhibition. We suggest here that the cyanobacterial ATP synthase epsilon subunit carries out an important regulatory role in acting as an independent "braking system" for the physiologically unfavorable ATP hydrolysis reaction.	[Konno, Hiroki; Isu, Atsuko; Kim, Yusung; Murakami-Fuse, Tomoe; Sugano, Yasushi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	; Hisabori, Toru/E-5205-2014	Sugano, Yasushi/0000-0001-8463-5131; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18074002]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 18074002 (to T. H) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan and by Management Expenses Grants for National Universities Corporations from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Aggeler R, 1996, J BIOL CHEM, V271, P13888, DOI 10.1074/jbc.271.23.13888; BARZVI D, 1982, J BIOENERG BIOMEMBR, V14, P467, DOI 10.1007/BF00743072; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRAGG PD, 1986, BIOCHIM BIOPHYS ACTA, V851, P385, DOI 10.1016/0005-2728(86)90075-7; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Digel JG, 1996, J BIOL CHEM, V271, P19976, DOI 10.1074/jbc.271.33.19976; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNN SD, 1987, BIOCHEMISTRY-US, V26, P4488, DOI 10.1021/bi00388a047; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; FELDMAN RI, 1985, J BIOL CHEM, V260, P3088; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; HISABORI T, 1992, J BIOL CHEM, V267, P4551; Hisabori T, 1997, EUR J BIOCHEM, V247, P1158, DOI 10.1111/j.1432-1033.1997.01158.x; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Johnson EA, 2002, BIOCHEMISTRY-US, V41, P2446, DOI 10.1021/bi011939f; Kaibara C, 1996, J BIOL CHEM, V271, P2433, DOI 10.1074/jbc.271.5.2433; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; KOMATSUTAKAKI M, 1989, J BIOL CHEM, V264, P17750; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; KUKI M, 1988, J BIOL CHEM, V263, P17437; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Matsui T, 1997, J BIOL CHEM, V272, P8215, DOI 10.1074/jbc.272.13.8215; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P1278, DOI 10.1021/bi00219a017; MINKOV IB, 1979, BIOCHEM BIOPH RES CO, V89, P1300, DOI 10.1016/0006-291X(79)92150-8; NELSON N, 1972, J BIOL CHEM, V247, P7657; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; Nowak KF, 2002, BIOCHEMISTRY-US, V41, P15130, DOI 10.1021/bi026594v; Peskova YB, 2000, BIOCHEMISTRY-US, V39, P11830, DOI 10.1021/bi0013694; RICHTER ML, 1984, J BIOL CHEM, V259, P7371; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Saita E, 2010, J BIOL CHEM, V285, P11411, DOI 10.1074/jbc.M109.099143; Samra HS, 2006, J BIOL CHEM, V281, P31041, DOI 10.1074/jbc.M603315200; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Stiggall D L, 1979, Methods Enzymol, V55, P308; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yasuno T, 2009, BIOCHEM BIOPH RES CO, V390, P230, DOI 10.1016/j.bbrc.2009.09.092; YOSHIDA M, 1979, J BIOL CHEM, V254, P9525; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	57	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13423	13429		10.1074/jbc.M110.155986	http://dx.doi.org/10.1074/jbc.M110.155986			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345803	Green Published, hybrid			2022-12-25	WOS:000289282200062
J	Sannai, P; Shuman, S				Sannai, Poulami; Shuman, Stewart			Functional Dissection of the DNA Interface of the Nucleotidyltransferase Domain of Chlorella Virus DNA Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; NICK RECOGNITION; ADENYLATE; ENZYME; SPECIFICITY; MECHANISM; FIDELITY; REPAIR	Chlorella virus DNA ligase (ChVLig) has pluripotent biological activity and an intrinsic nick-sensing function. ChVLig consists of three structural modules that envelop nicked DNA as a C-shaped protein clamp: a nucleotidyltransferase (NTase) domain and an 013 domain (these two are common to all DNA ligases) as well as a distinctive beta-hairpin latch module. The NTase domain, which performs the chemical steps of ligation, binds the major groove flanking the nick and the minor groove on the 3'-OH side of the nick. Here we performed a structure-guided mutational analysis of the NTase domain, surveying the effects of 35 mutations in 19 residues on ChVLig activity in vivo and in vitro, including biochemical tests of the composite nick sealing reaction and of the three component steps of the ligation pathway (ligase adenylylation, DNA adenylylation, and phosphodiester synthesis). The results highlight (i) key contacts by Thr-84 and Lys-173 to the template DNA strand phosphates at the outer margins of the DNA ligase footprint; (ii) essential contacts of Ser-41, Arg-42, Met-83, and Phe-75 with the 3'-OH strand at the nick; (iii) Arg-176 phosphate contacts at the nick and with ATP during ligase adenylylation; (iv) the role of Phe-44 in forming the protein clamp around the nicked DNA substrate; and (v) the importance of adenine-binding residue Phe-98 in all three steps of ligation. Kinetic analysis of single-turnover nick sealing by ChVLig-AMP underscored the importance of Phe-75-mediated distortion of the nick 3'-OH nucleoside in the catalysis of DNA 5'-adenylylation (step 2) and phosphodiester synthesis (step 3). Induced fit of the nicked DNA into a distorted conformation when bound within the ligase clamp may account for the nick-sensing capacity of ChVLig.	[Sannai, Poulami; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM63611]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063611] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM63611.	Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Crut A, 2008, P NATL ACAD SCI USA, V105, P6894, DOI 10.1073/pnas.0800113105; Deng JP, 2004, J MOL BIOL, V343, P601, DOI 10.1016/j.jmb.2004.08.041; El Omari K, 2006, J BIOL CHEM, V281, P1573, DOI 10.1074/jbc.M509658200; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Ho CK, 1997, J VIROL, V71, P1931, DOI 10.1128/JVI.71.3.1931-1937.1997; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Odell M, 1999, J BIOL CHEM, V274, P14032, DOI 10.1074/jbc.274.20.14032; Odell M, 2003, NUCLEIC ACIDS RES, V31, P5090, DOI 10.1093/nar/gkg665; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Piserchio A, 2010, J MOL BIOL, V395, P291, DOI 10.1016/j.jmb.2009.11.007; Shuman S, 1995, BIOCHEMISTRY-US, V34, P16138, DOI 10.1021/bi00049a029; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2009, J BIOL CHEM, V284, P17365, DOI 10.1074/jbc.R900017200; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P525, DOI 10.1093/nar/26.2.525; Sriskanda V, 1999, NUCLEIC ACIDS RES, V27, P3953, DOI 10.1093/nar/27.20.3953; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P4618, DOI 10.1093/nar/26.20.4618; Sriskanda V, 2002, J BIOL CHEM, V277, P9661, DOI 10.1074/jbc.M110613200; Sriskanda V, 2002, NUCLEIC ACIDS RES, V30, P903, DOI 10.1093/nar/30.4.903; Sriskanda V, 1998, NUCLEIC ACIDS RES, V26, P3536, DOI 10.1093/nar/26.15.3536	27	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13314	13326		10.1074/jbc.M111.226191	http://dx.doi.org/10.1074/jbc.M111.226191			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335605	hybrid, Green Published			2022-12-25	WOS:000289282200052
J	Takac, I; Schroder, K; Zhang, LL; Lardy, B; Anilkumar, N; Lambeth, JD; Shah, AM; Morel, F; Brandes, RP				Takac, Ina; Schroeder, Katrin; Zhang, Leilei; Lardy, Bernard; Anilkumar, Narayana; Lambeth, J. David; Shah, Ajay M.; Morel, Francoise; Brandes, Ralf P.			The E-loop Is Involved in Hydrogen Peroxide Formation by the NADPH Oxidase Nox4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN XANTHINE OXIDOREDUCTASE; SMOOTH-MUSCLE-CELLS; SUPEROXIDE-DISMUTASE; NAD(P)H OXIDASE; HOST-DEFENSE; DEHYDROGENASE; LOCALIZATION; REVEALS; HEME; ACTIVATION	In contrast to the NADPH oxidases Nox1 and Nox2, which generate superoxide (O-2(radical anion)), Nox4 produces hydrogen peroxide (H2O2). We constructed chimeric proteins and mutants to address the protein region that specifies which reactive oxygen species is produced. Reactive oxygen species were measured with luminol/horseradish peroxidase and Amplex Red for H2O2 versus L-012 and cytochrome c for O-2(radical anion). The third extracytosolic loop (E-loop) of Nox4 is 28 amino acids longer than that of Nox1 or Nox2. Deletion of E-loop amino acids only present in Nox4 or exchange of the two cysteines in these stretches switched Nox4 from H2O2 to O-2(radical anion) generation while preserving expression and intracellular localization. In the presence of an NO donor, the O-2(radical anion)-producing Nox4 mutants, but not wild-type Nox4, generated peroxynitrite, excluding artifacts of the detection system as the apparent origin of O-2(radical anion). In Cos7 cells, in which Nox4 partially localizes to the plasma membrane, an antibody directed against the E-loop decreased H2O2, but increased O-2(radical anion), formation by Nox4 without affecting Nox1-dependent O-2(radical anion) formation. The E-loop of Nox4 but not Nox1 and Nox2 contains a highly conserved histidine that could serve as a source for protons to accelerate spontaneous dismutation of superoxide to form H2O2. Mutation of this but not of four other conserved histidines also switched Nox4 from H2O2, to O-2(radical anion) formation, Thus, H2O2, formation is an intrinsic property of Nox4 that involves its E-loop. The structure of the E-loop may hinder O-2(radical anion) egress and/or provide a source for protons, allowing dismutation to form H2O2.	[Takac, Ina; Schroeder, Katrin; Brandes, Ralf P.] Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, D-60590 Frankfurt, Germany; [Zhang, Leilei; Lardy, Bernard; Morel, Francoise] Univ Grenoble 1, TIMC Imag UMR CNRS 5525, Grp Rech & Etud Proc Inflammatoire, F-38041 Grenoble 09, France; [Anilkumar, Narayana; Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, London SE5 9NU, England; [Lambeth, J. David] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Goethe University Frankfurt; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of London; King's College London; Emory University	Brandes, RP (corresponding author), Goethe Univ Frankfurt, Inst Kardiovaskulare Physiol, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	r.brandes@em.uni-frankfurt.de	Brandes, Ralf P/L-3058-2017; Schröder, Katrin/E-6874-2013	Brandes, Ralf P/0000-0002-8035-0048; Schröder, Katrin/0000-0002-3099-526X; Shah, Ajay/0000-0002-6547-0631	National Institutes of Health [R01 CA084138, R01 CA105116, P01 ES011163]; Leducq Foundation; British Heart Foundation; Deutsche Forschungsgemeinschaft [SFB815/TP1, SFB834/TPA2]; Excellence Cluster Cardio-pulmonary System (ECCPS); NATIONAL CANCER INSTITUTE [R01CA084138, R01CA105116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER; British Heart Foundation [RG/08/011/25922] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); British Heart Foundation(British Heart Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardio-pulmonary System (ECCPS)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA084138, R01 CA105116, and P01 ES011163 (to J. D. L.) and the Leducq Foundation and the British Heart Foundation (to A. M. S.). This work was also supported by grants from the Deutsche Forschungsgemeinschaft (SFB815/TP1 and SFB834/TPA2) and the Excellence Cluster Cardio-pulmonary System (ECCPS).	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Ameziane-El-Hassani R, 2005, J BIOL CHEM, V280, P30046, DOI 10.1074/jbc.M500516200; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; Asai R, 2007, J BIOCHEM, V141, P525, DOI 10.1093/jb/mvm054; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Harris CM, 1997, J BIOL CHEM, V272, P8370, DOI 10.1074/jbc.272.13.8370; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; KAWAHARA T, 2011, BIOCHEMISTR IN PRESS; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; Nisimoto Y, 2010, BIOCHEMISTRY-US, V49, P2433, DOI 10.1021/bi9022285; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Yu LX, 1998, P NATL ACAD SCI USA, V95, P7993, DOI 10.1073/pnas.95.14.7993; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001	35	379	388	1	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13304	13313		10.1074/jbc.M110.192138	http://dx.doi.org/10.1074/jbc.M110.192138			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343298	hybrid, Green Published			2022-12-25	WOS:000289282200051
J	Dai, JX; Zhao, L; Yang, HO; Guo, HZ; Fan, KX; Wang, HQ; Qian, WZ; Zhang, DP; Li, BH; Wang, H; Guo, YJ				Dai, Jianxing; Zhao, Lei; Yang, Haiou; Guo, Huaizu; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun			Identification of a Novel Functional Domain of Ricin Responsible for Its Potent Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-CHAIN; AMINO-ACIDS; SITE; ANTIBODIES; MUTAGENESIS; MECHANISM; CATALYSIS; PROTEINS; GENETICS; LECTINS	Ribosome-inactivating proteins (RIPs) are toxic N-glycosidases that depurinate the universally conserved alpha-sarcin loop of large rRNAs. They have received attention in biological and biomedical research because of their unique biological activities toward animals and human cells as cell-killing agents. A better understanding of the depurination mechanism of RIPs could allow us to develop potent neutralizing antibodies and to design efficient immunotoxins for clinical use. Among these RIPs, ricin exhibited remarkable efficacy in depurination activity and highly conserved tertiary structure with other RIPs. It can be considered as a prototype to investigate the depurination mechanism of RIPs. In the present study, we successfully identified a novel functional domain responsible for controlling the depurination activity of ricin, which is located far from the enzymatic active site reported previously. Our study indicated that ricin A-chain mAbs binding to this domain (an alpha-helix comprising the residues 99-106) exhibited an unusual potent neutralizing ability against ricin in vivo. To further investigate the potential role of the alpha-helix in regulating the catalytic activity of ricin, ricin A-chain variants with different flexibility of the alpha-helix were rationally designed. Our data clearly demonstrated that the flexibility of the alpha-helix is responsible for controlling the depurination activity of ricin and determining the extent of protein synthesis inhibition, suggesting that the conserved alpha-helix might be considered as a potential target for the prevention and treatment of RIP poisoning.	[Dai, Jianxing; Zhao, Lei; Yang, Haiou; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai 200433, Peoples R China; [Dai, Jianxing; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, State Key Lab Antibody Med & Targeting Therapy, Shanghai 201203, Peoples R China; [Dai, Jianxing; Fan, Kexing; Wang, Huaqing; Qian, Weizhu; Zhang, Dapeng; Li, Bohua; Wang, Hao; Guo, Yajun] Natl Engn Res Ctr Antibody Med, Shanghai Key Lab Cell Engn, Shanghai 201203, Peoples R China; [Yang, Haiou; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Med, Shanghai 200025, Peoples R China; [Yang, Haiou; Guo, Huaizu; Guo, Yajun] Shanghai Jiao Tong Univ, Minist Educ, Ctr Antibody Med, Sch Pharm, Shanghai 200025, Peoples R China; [Guo, Yajun] Peoples Liberat Army Gen Hosp, Ctr Canc, Beijing 100853, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese People's Liberation Army General Hospital	Guo, YJ (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, 800 Xiang Yin Rd, Shanghai 200433, Peoples R China.	yjguo@smmu.edu.cn	Li, Bo/AAA-8968-2020; Yang, Haiou/U-6328-2019	Li, Bo/0000-0002-7294-6888; Zhao, Lei/0000-0002-5884-2708	National Natural Science Foundation of China, Ministry of Science and Technology of China [973, 863]; National Key project for New Drug Creation and Manufacture, Shanghai Commission of Science and Technology [B905]; Program for Pujiang Scholar and Innovative Research Team in University	National Natural Science Foundation of China, Ministry of Science and Technology of China(Ministry of Science and Technology, ChinaNational Natural Science Foundation of China (NSFC)); National Key project for New Drug Creation and Manufacture, Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Program for Pujiang Scholar and Innovative Research Team in University	This work was supported by Program Project Grants 973 and 863 from the National Natural Science Foundation of China, Ministry of Science and Technology of China, by Grant B905 from the National Key project for New Drug Creation and Manufacture, Shanghai Commission of Science and Technology, Shanghai Leading Academic Discipline Project, and by the Program for Pujiang Scholar and Innovative Research Team in University.	Bowler BE, 2007, MOL BIOSYST, V3, P88, DOI 10.1039/b611895j; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang Q, 2002, INFECT IMMUN, V70, P4977, DOI 10.1128/IAI.70.9.4977-4986.2002; ContiFine BM, 1996, ANNU REV BIOPH BIOM, V25, P197; Daniel RM, 2003, ANNU REV BIOPH BIOM, V32, P69, DOI 10.1146/annurev.biophys.32.110601.142445; Day PJ, 1996, BIOCHEMISTRY-US, V35, P11098, DOI 10.1021/bi960880n; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Hartley MR, 2004, MINI-REV MED CHEM, V4, P487, DOI 10.2174/1389557043403828; Ho MC, 2009, P NATL ACAD SCI USA, V106, P20276, DOI 10.1073/pnas.0911606106; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Karginov AV, 2010, NAT BIOTECHNOL, V28, P743, DOI 10.1038/nbt.1639; KIM Y, 1992, PROTEIN ENG, V5, P775, DOI 10.1093/protein/5.8.775; KIM YS, 1992, BIOCHEMISTRY-US, V31, P3294, DOI 10.1021/bi00127a035; Kitaoka Y, 1998, EUR J BIOCHEM, V257, P255, DOI 10.1046/j.1432-1327.1998.2570255.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; MORRIS KN, 1992, P NATL ACAD SCI USA, V89, P4869, DOI 10.1073/pnas.89.11.4869; Motto M, 2004, MINI-REV MED CHEM, V4, P493, DOI 10.2174/1389557043403873; OLSNES S, 1975, EUR J BIOCHEM, V60, P281, DOI 10.1111/j.1432-1033.1975.tb21001.x; Pace CN, 1996, FASEB J, V10, P75, DOI 10.1096/fasebj.10.1.8566551; Pace CN, 1995, METHOD ENZYMOL, V259, P538; Pan YP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000878; READY MP, 1991, PROTEINS, V10, P270, DOI 10.1002/prot.340100311; Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Sturm MB, 2009, ANAL CHEM, V81, P2847, DOI 10.1021/ac8026433; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang YZ, 2008, BIOCHEM BIOPH RES CO, V372, P902, DOI 10.1016/j.bbrc.2008.05.152; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	32	31	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.196584	http://dx.doi.org/10.1074/jbc.M110.196584			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21303906	hybrid, Green Published			2022-12-25	WOS:000289077500032
J	Hachani, A; Lossi, NS; Hamilton, A; Jones, C; Bleves, S; Albesa-Jove, D; Filloux, A				Hachani, Abderrahman; Lossi, Nadine S.; Hamilton, Alexander; Jones, Cerith; Bleves, Sophie; Albesa-Jove, David; Filloux, Alain			Type VI Secretion System in Pseudomonas aeruginosa SECRETION AND MULTIMERIZATION OF VgrG PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTION; GENES; PREDICTION; STRAIN	Pseudomonas aeruginosa is a Gram-negative bacterium causing chronic infections in cystic fibrosis patients. Such infections are associated with an active type VI secretion system (T6SS), which consists of about 15 conserved components, including the AAA(+) ATPase, ClpV. The T6SS secretes two categories of proteins, VgrG and Hcp. Hcp is structurally similar to a phage tail tube component, whereas VgrG proteins show similarity to the puncturing device at the tip of the phage tube. In P. aeruginosa, three T6SSs are known. The expression of H1-T6SS genes is controlled by the RetS sensor. Here, 10 vgrG genes were identified in the PAO1 genome, among which three are co-regulated with H1-T6SS, namely vgrG1a/b/c. Whereas VgrG1a and VgrG1c were secreted in a ClpV1-dependent manner, secretion of VgrG1b was ClpV1-independent. We show that VgrG1a and VgrG1c form multimers, which confirmed the VgrG model predicting trimers similar to the tail spike. We demonstrate that Hcp1 secretion requires either VgrG1a or VgrG1c, which may act independently to puncture the bacterial envelope and give Hcp1 access to the surface. VgrG1b is not required for Hcp1 secretion. Thus, VgrG1b does not require H1-T6SS for secretion nor does H1-T6SS require VgrG1b for its function. Finally, we show that VgrG proteins are required for secretion of a genuine H1-T6SS substrate, Tse3. Our results demonstrate that VgrG proteins are not only secreted components but are essential for secretion of other T6SS substrates. Overall, we emphasize variability in behavior of three P. aeruginosa VgrGs, suggesting that, although very similar, distinct VgrGs achieve specific functions.	[Hachani, Abderrahman; Lossi, Nadine S.; Hamilton, Alexander; Jones, Cerith; Albesa-Jove, David; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; [Hamilton, Alexander] Univ Groningen, Univ Ctr Pharm, NL-9713 AV Groningen, Netherlands; [Bleves, Sophie] Aix Marseille Univ, CNRS, Lab Ingn Syst Macromol, F-13402 Marseille 20, France	Imperial College London; University of Groningen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Ctr Mol Microbiol & Infect, London SW7 2AZ, England.	a.filloux@imperial.ac.uk	Hachani, Abderrahman/AAV-3320-2020; Bleves, SOPHIE/HII-4948-2022; Jones, Cerith/AAH-5992-2020; Hachani, Abderrahman/H-1801-2013; Albesa-Jové, David/O-3822-2019; Albesa-Jové, David/F-5683-2016	Hachani, Abderrahman/0000-0001-8032-2154; Albesa-Jové, David/0000-0003-2904-8203; Albesa-Jové, David/0000-0003-2904-8203; Jones, Cerith/0000-0001-6275-0235	Network of Excellence [LSHB-CT-2005512061-EPG]; Wellcome Trust [WT091939]; Medical Research Council [G0800171/ID86344]; Royal Society; MRC [G0800171] Funding Source: UKRI; Medical Research Council [G0800171] Funding Source: researchfish	Network of Excellence; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by Network of Excellence Grant "EuroPathoGenomics" LSHB-CT-2005512061-EPG and by Wellcome Trust Grant WT091939.; Supported by Medical Research Council Grant G0800171/ID86344.; Supported by the Royal Society, Wellcome Trust Grant WT091939 and Medical Research Council Grant G0800171/ID86344.	Arisaka F, 2003, INT J BIOCHEM CELL B, V35, P16, DOI 10.1016/S1357-2725(02)00098-5; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Durand E., 2009, Infectious Disorders - Drug Targets, V9, P518; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Llosa M, 2009, MOL MICROBIOL, V73, P141, DOI 10.1111/j.1365-2958.2009.06751.x; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Mesyanzhinov VV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1190, DOI 10.1007/s10541-005-0064-9; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; Voulhoux R, 2000, J BACTERIOL, V182, P4051, DOI 10.1128/JB.182.14.4051-4058.2000; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861	39	109	113	3	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.193045	http://dx.doi.org/10.1074/jbc.M110.193045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325275	Green Published, hybrid			2022-12-25	WOS:000289077500046
J	Kellenberger, C; Leone, P; Coquet, L; Jouenne, T; Reichhart, JM; Roussel, A				Kellenberger, Christine; Leone, Philippe; Coquet, Laurent; Jouenne, Thierry; Reichhart, Jean-Marc; Roussel, Alain			Structure-Function Analysis of Grass Clip Serine Protease Involved in Drosophila Toll Pathway Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPHENOLOXIDASE ACTIVATION; CRYSTAL-STRUCTURE; TERNARY COMPLEX; CASCADE; INSECT; DOMAIN; PEPTIDOGLYCAN; PROTEINASE-2; SPECIFICITY; TRYPSINOGEN	Grass is a clip domain serine protease (SP) involved in a proteolytic cascade triggering the Toll pathway activation of Drosophila during an immune response. Epistasic studies position it downstream of the apical protease ModSP and upstream of the terminal protease Spaetzle-processing enzyme. Here, we report the crystal structure of Grass zymogen. We found that Grass displays a rather deep active site cleft comparable with that of proteases of coagulation and complement cascades. A key distinctive feature is the presence of an additional loop (75-loop) in the proximity of the activation site localized on a protruding loop. All biochemical attempts to hydrolyze the activation site of Grass failed, strongly suggesting restricted access to this region. The 75-loop is thus proposed to constitute an original mechanism to prevent spontaneous activation. A comparison of Grass with clip serine proteases of known function involved in analogous proteolytic cascades allowed us to define two groups, according to the presence of the 75-loop and the conformation of the clip domain. One group (devoid of the 75-loop) contains penultimate proteases whereas the other contains terminal proteases. Using this classification, Grass appears to be a terminal protease. This result is evaluated according to the genetic data documenting Grass function.	[Kellenberger, Christine; Roussel, Alain] Architecture & Fonct Macromol Biol UMR6098, F-13288 Marseille 09, France; [Leone, Philippe] Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France; [Coquet, Laurent; Jouenne, Thierry] Fac Sci Rouen, Plateforme Prote IFRMP23, F-76821 Mont St Aignan, France; [Reichhart, Jean-Marc] Inst Biol Mol & Cellulaire, UPR 9022, F-67084 Strasbourg, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Kellenberger, C (corresponding author), Architecture & Fonct Macromol Biol UMR6098, Parc Sci & Technol Luminy,Case 932,Ave Luminy, F-13288 Marseille 09, France.	Christine.Kellenberger@afmb.univ-mrs.fr	kellenberger, christine/AAV-9304-2020	jouenne, thierry/0000-0003-0994-9944; COQUET, Laurent/0000-0001-7778-7321	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by an Action Thematique et Incitative sur Programme of the Centre National de la Recherche Scientifique 2005-2009 (to A. R.) and by a grant from the Agence Nationale de la Recherche (to A. R. and J.-M. R.).	An CJ, 2009, J BIOL CHEM, V284, P19716, DOI 10.1074/jbc.M109.007112; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dissing M, 2001, EMBO J, V20, P2387, DOI 10.1093/emboj/20.10.2387; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gorman MJ, 2007, J BIOL CHEM, V282, P11742, DOI 10.1074/jbc.M611243200; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Han JF, 2000, P NATL ACAD SCI USA, V97, P9093, DOI 10.1073/pnas.97.16.9093; Huang RD, 2007, BIOCHEMISTRY-US, V46, P11431, DOI 10.1021/bi7010724; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kambris Z, 2006, CURR BIOL, V16, P808, DOI 10.1016/j.cub.2006.03.020; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; KATSUMI Y, 1995, EUR J BIOCHEM, V228, P870, DOI 10.1111/j.1432-1033.1995.tb20334.x; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200; Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2; LeMosy EK, 1999, TRENDS CELL BIOL, V9, P102, DOI 10.1016/S0962-8924(98)01494-9; Leone P, 2008, ACTA CRYSTALLOGR D, V64, P1165, DOI 10.1107/S0907444908030400; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Pasternak A, 2001, PROTEIN SCI, V10, P1331, DOI 10.1110/ps.44101; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Piao SF, 2007, J BIOL CHEM, V282, P10783, DOI 10.1074/jbc.M611556200; Rezaie AR, 2005, THROMB HAEMOSTASIS, V93, P1047, DOI 10.1160/TH04-11-0730; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Wang Y, 2008, INSECT BIOCHEM MOLEC, V38, P763, DOI 10.1016/j.ibmb.2008.04.008; Wang Y, 2007, INSECT BIOCHEM MOLEC, V37, P1015, DOI 10.1016/j.ibmb.2007.05.013	39	25	28	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.182741	http://dx.doi.org/10.1074/jbc.M110.182741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310954	Green Published, hybrid			2022-12-25	WOS:000289077500044
J	Mainwaring, LA; Kenney, AM				Mainwaring, L. A.; Kenney, A. M.			Divergent functions for eIF4E and S6 kinase by sonic hedgehog mitogenic signaling in the developing cerebellum	ONCOGENE			English	Article						sonic hedgehog; eIF4E; S6 kinase; proliferation	CELL-CYCLE PROGRESSION; TRANSLATION INITIATION; GROWTH-FACTOR; N-MYC; PROTEIN PHOSPHATASES; NEURONAL SURVIVAL; NERVOUS-SYSTEM; PHOSPHORYLATION; PROLIFERATION; PATHWAY	Cerebellar development entails rapid peri-natal proliferation of cerebellar granule neuron precursors (CGNPs), proposed cells-of-origin for certain medulloblastomas. CGNPs require insulin-like growth factor (IGF) for survival and sonic hedgehog (Shh)-implicated in medulloblastoma-for proliferation. The IGF-responsive kinase mammalian target of rapamycin (mTOR) drives proliferation-associated protein synthesis. We asked whether Shh signaling regulates mTOR targets to promote CGNP proliferation despite constitutive IGF signaling under proliferative and differentiation-promoting conditions. Surprisingly, Shh promoted eukaryotic initiation factor 4E (eIF4E) expression, but inhibited S6 kinase (S6K). In vivo, S6K activity specifically marked the CGNP population transitioning from proliferation-competent to post-mitotic. Indeed, eIF4E was required for CGNP proliferation, while S6K activation drove cell cycle exit. Protein phosphatase 2A (PP2A) inhibition rescued S6K activity. Moreover, Shh upregulated the PP2A B56 gamma subunit, which targets S6K for inactivation and was required for CGNP proliferation. These findings reveal unique developmental functions for eIF4E and S6 kinase wherein their activity is specifically uncoupled by mitogenic Shh signaling. Oncogene (2011) 30, 1784-1797; doi:10.1038/onc.2010.564; published online 21 February 2011	[Mainwaring, L. A.; Kenney, A. M.] Cornell Univ, Weill Med Coll, Biochem Cell & Mol Biol Program, New York, NY 10021 USA; [Mainwaring, L. A.; Kenney, A. M.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center	Kenney, AM (corresponding author), Vanderbilt Univ, Dept Neurosurg, Nashville, TN 37232 USA.	Anna.Kenney@vanderbilt.edu			NINDS [R01NS061070]; Handler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061070] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Handler Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank John Blenis (Harvard Medical School) for providing the HA-tagged S6 kinase plasmid. These studies were supported by grants to AMK from the NINDS (R01NS061070) and the Handler Foundation.	Altman J, 1997, DEV CEREBELLAR SYSTE; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dutton R, 1999, CLIN EXP PHARMACOL P, V26, P746, DOI 10.1046/j.1440-1681.1999.03108.x; Dutton R, 1999, J NEUROSCI, V19, P2601; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fogarty MP, 2007, P NATL ACAD SCI USA, V104, P2973, DOI 10.1073/pnas.0605770104; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goslin, 1998, CULTURING NERVE CELL, P419; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hepker J, 1997, DEVELOPMENT, V124, P549; Ho KS, 2002, CURR OPIN NEUROBIOL, V12, P57, DOI 10.1016/S0959-4388(02)00290-8; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MARES V, 1970, BRAIN RES, V23, P323, DOI 10.1016/0006-8993(70)90060-0; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Northcott PA, 2009, CANCER RES, V69, P3249, DOI 10.1158/0008-5472.CAN-08-4710; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Parathath SR, 2008, DEVELOPMENT, V135, P3291, DOI 10.1242/dev.022871; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sjostrom SK, 2005, DEV CELL, V9, P327, DOI 10.1016/j.devcel.2005.07.014; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; vonManteuffel SR, 1996, P NATL ACAD SCI USA, V93, P4076, DOI 10.1073/pnas.93.9.4076; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Ye P, 1996, DEV BRAIN RES, V95, P44	57	25	25	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2011	30	15					1784	1797		10.1038/onc.2010.564	http://dx.doi.org/10.1038/onc.2010.564			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	749ZM	21339731	Green Accepted			2022-12-25	WOS:000289512200006
J	Park, JH; Smith, RJ; Shieh, SY; Roeder, RG				Park, Jeong Hyeon; Smith, Rebecca J.; Shieh, Sheau-Yann; Roeder, Robert G.			The GAS41-PP2C beta Complex Dephosphorylates p53 at Serine 366 and Regulates Its Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASES; DNA-DAMAGE; PHOSPHORYLATION; TRANSCRIPTION; DEGRADATION; CHROMATIN; PATHWAY; 2C; INHIBITION; APOPTOSIS	The p53 tumor suppressor is principally regulated by post-translational modifications and proteasome-dependent degradation. Various kinases have been shown to phosphorylate p53, but little is known about the counteracting phosphatases. We demonstrate here that the newly identified complex GAS41-PP2C beta, and not PP2C beta alone, is specifically required for dephosphorylation of serine 366 on p53. Ectopic expression of GAS41 and PP2C beta reduces UV radiation-induced p53 up-regulation, thereby increasing the cell survival upon genotoxic DNA damage. To our knowledge, the GAS41-PP2C beta complex is the first example in which substrate specificity of a PP2C family member is controlled by an associated regulatory subunit. Because GAS41 is frequently amplified in human gliomas, our finding illustrates a novel oncogenic mechanism of GAS41 by p53 dephosphorylation.	[Park, Jeong Hyeon; Smith, Rebecca J.] Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand; [Shieh, Sheau-Yann] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Massey University; Academia Sinica - Taiwan; Rockefeller University	Park, JH (corresponding author), Massey Univ, Inst Mol Biosci, Palmerston North 4442, New Zealand.	J.Park@massey.ac.nz	Shieh, Sheau-Yann/N-9512-2018	Shieh, Sheau-Yann/0000-0002-5351-4430; Park, Jeong Hyeon/0000-0003-2294-6342; SMITH, REBECCA/0000-0002-1658-5635	National Institutes of Health [CA129325]; Massey University; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massey University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129325 (to R. G. R.) and by a Massey University Research Fund grant (to J. H. P.).	Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Fischer U, 1997, HUM MOL GENET, V6, P1817, DOI 10.1093/hmg/6.11.1817; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Klumpp S, 2006, BIOCHEM SOC T, V34, P1370, DOI 10.1042/BST0341370; Klumpp S, 2003, NEUROCHEM INT, V42, P555, DOI 10.1016/S0197-0186(02)00174-2; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Llanos S, 2006, CELL CYCLE, V5, P1880, DOI 10.4161/cc.5.16.3140; Lotem J, 2004, P NATL ACAD SCI USA, V101, P16022, DOI 10.1073/pnas.0406966101; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Park J, 2002, MOL CELL BIOL, V22, P1307, DOI 10.1128/MCB.22.5.1307-1316.2002; Park JH, 2006, MOL CELL BIOL, V26, P4006, DOI 10.1128/MCB.02185-05; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; Prajapati S, 2004, J BIOL CHEM, V279, P1739, DOI 10.1074/jbc.M306273200; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Zeisig DT, 2005, ONCOGENE, V24, P5525, DOI 10.1038/sj.onc.1208699	32	22	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10911	10917		10.1074/jbc.C110.210211	http://dx.doi.org/10.1074/jbc.C110.210211			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21317290	Green Published, hybrid			2022-12-25	WOS:000288797100003
J	Caputo, B; Santolamazza, F; Vicente, JL; Nwakanma, DC; Jawara, M; Palsson, K; Jaenson, T; White, BJ; Mancini, E; Petrarca, V; Conway, DJ; Besansky, NJ; Pinto, J; della Torre, A				Caputo, Beniamino; Santolamazza, Federica; Vicente, Jose L.; Nwakanma, Davis C.; Jawara, Musa; Palsson, Katinka; Jaenson, Thomas; White, Bradley J.; Mancini, Emiliano; Petrarca, Vincenzo; Conway, David J.; Besansky, Nora J.; Pinto, Joao; della Torre, Alessandra			The "Far-West'' of Anopheles gambiae Molecular Forms	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENOMIC DIVERGENCE; GENE-FLOW; COMPLEX; SPECIATION; DIFFERENTIATION; IDENTIFICATION; HYBRIDIZATION; CULICIDAE; SELECTION	The main Afrotropical malaria vector, Anopheles gambiae sensu stricto, is undergoing a process of sympatric ecological diversification leading to at least two incipient species (the M and S molecular forms) showing heterogeneous levels of divergence across the genome. The physically unlinked centromeric regions on all three chromosomes of these closely related taxa contain fixed nucleotide differences which have been found in nearly complete linkage disequilibrium in geographic areas of no or low M-S hybridization. Assays diagnostic for SNP and structural differences between M and S forms in the three centromeric regions were applied in samples from the western extreme of their range of sympatry, the only area where high frequencies of putative M/S hybrids have been reported. The results reveal a level of admixture not observed in the rest of the range. In particular, we found: i) heterozygous genotypes at each marker, although at frequencies lower than expected under panmixia; ii) virtually all possible genotypic combinations between markers on different chromosomes, although genetic association was nevertheless detected; iii) discordant M and S genotypes at two X-linked markers near the centromere, suggestive of introgression and inter-locus recombination. These results could be indicative either of a secondary contact zone between M and S, or of the maintenance of ancestral polymorphisms. This issue and the perspectives opened by these results in the study of the M and S incipient speciation process are discussed.	[Caputo, Beniamino; Santolamazza, Federica; Mancini, Emiliano; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy; [Vicente, Jose L.; Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, UEI Malaria & UEI Entomol Med, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Nwakanma, Davis C.; Jawara, Musa; Conway, David J.] MRC Labs, Banjul, Gambia; [Palsson, Katinka; Jaenson, Thomas] Uppsala Univ, Dept Systemat Biol, Med Entomol Unit, Uppsala, Sweden; [White, Bradley J.; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA; [Petrarca, Vincenzo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; MRC Laboratory Molecular Biology; Uppsala University; University of Notre Dame; Fondazione Cenci Bolognetti; Sapienza University Rome	Caputo, B (corresponding author), Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy.	ale.dellatorre@uniroma1.it	Vicente, José/I-2126-2012; J., Pinto/H-6177-2019; Caputo, Beniamino/I-2880-2015; Mancini, Emiliano/G-4771-2012; Pinto, Joao/C-2208-2012	J., Pinto/0000-0001-8572-7708; Caputo, Beniamino/0000-0002-5650-8773; Pinto, Joao/0000-0001-8572-7708; Santolamazza, Federica/0000-0001-5029-6733; Nwakanma, Davis/0000-0002-6706-6069; Conway, David/0000-0002-8711-3037; MANCINI, Emiliano/0000-0002-7988-4544	Medical Research Council of the UK; UNICEF/UNDP/World Bank/WHO [A50239]; I Faculty of Medicine of Universita "La Sapienza"; Universita "La Sapienza"; National Institutes of Health [R01-AI063508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063508] Funding Source: NIH RePORTER	Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UNICEF/UNDP/World Bank/WHO(World Health Organization); I Faculty of Medicine of Universita "La Sapienza"; Universita "La Sapienza"; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Field collections and laboratory analysis in The Gambia was supported by the Medical Research Council of the UK, with helpful facilitation from the Gambian National Malaria Control Programme. Laboratory analysis of Guinean samples received financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR, A50239). BC was partially supported by I Faculty of Medicine of Universita "La Sapienza". The work was supported by Universita "La Sapienza" (Progetti di Ricerca Universitari - 2009) and by R01-AI063508 grant to NJB from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calzetta M, 2008, AM J TROP MED HYG, V78, P169, DOI 10.4269/ajtmh.2008.78.169; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Carr IM, 2009, BIOINFORMATICS, V25, P3244, DOI 10.1093/bioinformatics/btp583; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gentile G, 2001, INSECT MOL BIOL, V10, P25, DOI 10.1046/j.1365-2583.2001.00237.x; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Ndiath MO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-136; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pombi M, 2006, AM J TROP MED HYG, V75, P901, DOI 10.4269/ajtmh.2006.75.901; Rauscher JT, 2002, MOL ECOL, V11, P2691, DOI 10.1046/j.1365-294X.2002.01640.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Santolamazza F, 2004, AM J TROP MED HYG, V70, P604, DOI 10.4269/ajtmh.2004.70.604; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Stump AD, 2005, P NATL ACAD SCI USA, V102, P15930, DOI 10.1073/pnas.0508161102; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2	39	54	54	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16415	10.1371/journal.pone.0016415	http://dx.doi.org/10.1371/journal.pone.0016415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347223	gold, Green Published, Green Submitted			2022-12-25	WOS:000287369200003
J	Hirsch, J; Misson, J; Crisp, PA; David, P; Bayle, V; Estavillo, GM; Javot, H; Chiarenza, S; Mallory, AC; Maizel, A; Declerck, M; Pogson, BJ; Vaucheret, H; Crespi, M; Desnos, T; Thibaud, MC; Nussaume, L; Marin, E				Hirsch, Judith; Misson, Julie; Crisp, Peter A.; David, Pascale; Bayle, Vincent; Estavillo, Gonzalo M.; Javot, Helene; Chiarenza, Serge; Mallory, Allison C.; Maizel, Alexis; Declerck, Marie; Pogson, Barry J.; Vaucheret, Herve; Crespi, Martin; Desnos, Thierry; Thibaud, Marie-Christine; Nussaume, Laurent; Marin, Elena			A Novel fry1 Allele Reveals the Existence of a Mutant Phenotype Unrelated to 5 '-> 3 ' Exoribonuclease (XRN) Activities in Arabidopsis thaliana Roots	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; 3(2),5-BISPHOSPHATE NUCLEOTIDASE; PHOSPHATE STARVATION; NEGATIVE REGULATOR; GENE; EXPRESSION; TOLERANCE; MERISTEM; FIERY1; DIFFERENTIATION	Background: Mutations in the FRY1/SAL1 Arabidopsis locus are highly pleiotropic, affecting drought tolerance, leaf shape and root growth. FRY1 encodes a nucleotide phosphatase that in vitro has inositol polyphosphate 1-phosphatase and 3',(2'),5'-bisphosphate nucleotide phosphatase activities. It is not clear which activity mediates each of the diverse biological functions of FRY1 in planta. Principal Findings: A fry1 mutant was identified in a genetic screen for Arabidopsis mutants deregulated in the expression of Pi High affinity Transporter 1;4 (PHT1;4). Histological analysis revealed that, in roots, FRY1 expression was restricted to the stele and meristems. The fry1 mutant displayed an altered root architecture phenotype and an increased drought tolerance. All of the phenotypes analyzed were complemented with the AHL gene encoding a protein that converts 3'-polyadenosine 5'-phosphate (PAP) into AMP and Pi. PAP is known to inhibit exoribonucleases (XRN) in vitro. Accordingly, an xrn triple mutant with mutations in all three XRNs shared the fry1 drought tolerance and root architecture phenotypes. Interestingly these two traits were also complemented by grafting, revealing that drought tolerance was primarily conferred by the rosette and that the root architecture can be complemented by long-distance regulation derived from leaves. By contrast, PHT1 expression was not altered in xrn mutants or in grafting experiments. Thus, PHT1 up-regulation probably resulted from a local depletion of Pi in the fry1 stele. This hypothesis is supported by the identification of other genes modulated by Pi deficiency in the stele, which are found induced in a fry1 background. Conclusions/Significance: Our results indicate that the 3',(2'),5'-bisphosphate nucleotide phosphatase activity of FRY1 is involved in long-distance as well as local regulatory activities in roots. The local up-regulation of PHT1 genes transcription in roots likely results from local depletion of Pi and is independent of the XRNs.	[Hirsch, Judith; Misson, Julie; David, Pascale; Bayle, Vincent; Javot, Helene; Chiarenza, Serge; Desnos, Thierry; Thibaud, Marie-Christine; Nussaume, Laurent; Marin, Elena] CNRS, CEA, DSV IBEB, Lab Biol Dev Plantes,UMR 6191, St Paul Les Durance, France; [Crisp, Peter A.; Estavillo, Gonzalo M.; Pogson, Barry J.] Australian Natl Univ, ARC Ctr Excellence Plant Energy Biol, Res Sch Biol, Canberra, ACT, Australia; [Mallory, Allison C.; Vaucheret, Herve] INRA, Inst Jean Pierre Bourgin, UMR 1318, F-78026 Versailles, France; [Maizel, Alexis] Univ Heidelberg, Dept Stem Cell Biol, Heidelberg, Germany; [Declerck, Marie; Crespi, Martin] CNRS, Inst Sci Vegetal, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); Australian National University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ruprecht Karls University Heidelberg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Hirsch, J (corresponding author), UMR BGPI, Campus Int Baillarguet,TA A54-K, Montpellier, France.	elena.marin@cea.fr	Javot, Helene/AAX-8986-2021; NUSSAUME, Laurent/AAA-5980-2022; Estavillo, Gonzalo/I-1774-2013; NUSSAUME, Laurent/AAB-8312-2020; Maizel, Alexis/D-3560-2012; Crespi, Martin/AAB-1424-2020; Crisp, Peter/AAE-7643-2021; Pogson, Barry/C-9953-2009	Javot, Helene/0000-0002-4577-2747; NUSSAUME, Laurent/0000-0002-9445-2563; Estavillo, Gonzalo/0000-0003-4634-5103; Maizel, Alexis/0000-0001-6843-1059; Crespi, Martin/0000-0002-5698-9482; Crisp, Peter/0000-0002-3655-0130; Pogson, Barry/0000-0003-1869-2423; DESNOS, Thierry/0000-0002-6585-1362; VAUCHERET, HERVE/0000-0002-9986-0988	ANR-GENOPLANT [RIBOROOT-ANR06 GPLA 011]; CEA agency; RNG (Reseau National des Genopoles, Evry, France)	ANR-GENOPLANT(French National Research Agency (ANR)); CEA agency; RNG (Reseau National des Genopoles, Evry, France)	This work was supported by an ANR-GENOPLANT grant (RIBOROOT-ANR06 GPLA 011) and the CEA agency. Array hybridizations have been partly supported by RNG (Reseau National des Genopoles, Evry, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Cazale AC, 2009, J EXP BOT, V60, P2653, DOI 10.1093/jxb/erp109; Chen H, 2010, PLANT CELL ENV; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kim BH, 2009, PLANT J, V58, P208, DOI 10.1111/j.1365-313X.2008.03770.x; Klimyuk VI, 1995, MOL GEN GENET, V249, P357, DOI 10.1007/BF00287097; Logemann E, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-16; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marin E, 2006, PLANT SCI, V171, P84, DOI 10.1016/j.plantsci.2006.02.014; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; PELSY F, 1991, PLANT SCI, V76, P109, DOI 10.1016/0168-9452(91)90224-V; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Sarrobert C, 2000, PLANT J, V24, P357, DOI 10.1046/j.1365-313x.2000.00884.x; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Stefanovic A, 2007, PLANT J, V50, P982, DOI 10.1111/j.1365-313X.2007.03108.x; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Van Norman JM, 2004, CURR BIOL, V14, P1739, DOI 10.1016/j.cub.2004.09.045; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Woo NS, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-27; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901	32	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16724	10.1371/journal.pone.0016724	http://dx.doi.org/10.1371/journal.pone.0016724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304819	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036600017
J	Zhang, CY; Wu, NN; Liu, J; Ge, QJ; Huang, Y; Ren, QA; Feng, QC; He, GL				Zhang, Chiyu; Wu, Nana; Liu, Jun; Ge, Qinjuan; Huang, Yan; Ren, Qian; Feng, Qingchuan; He, Guangli			HCV Subtype Characterization among Injection Drug Users: Implication for a Crucial Role of Zhenjiang in HCV Transmission in China	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; GENOTYPE DISTRIBUTION; GENETIC DIVERSITY; HIGH PREVALENCE; HEROIN USERS; HIV-1; EPIDEMIOLOGY; INFECTION; COINFECTION; SPREAD	Background: HCV transmission is closely associated with drug-trafficking routes in China. However, the transmission route of HCV in Eastern China remains unclear. Here, we investigate the role of Zhenjiang city of Jiangsu province, an important transportation hub linking Shanghai with other regions of China, in HCV transmission. Methodology/Principal Findings: A total of 141 whole blood samples were collected from injection drug users (IDUs) in Zhenjiang and then tested for HCV infection. Of them, 115 HCV positive plasmas were subjected to RNA extraction, RT-PCR amplification, and sequencing. The subtype characterization and the evolutionary origin of HCV strains circulating in Zhenjiang were determined using polygenetic or phylogeographic analyses. Seven HCV subtypes 1b, 2a, 3a, 3b, 6a, 6e and 6n were detected among Zhenjiang IDUs, showing a complex HCV epidemic. The most predominant subtypes were 3a (38%) and 1b (26.8%). Among these subtypes, subtypes 3b, 6n and 6e originated from Southwestern China (i.e., Yunnan and/or Guangxi), subtypes 2a and 6a from Southern China (i.e., Guangdong), subtype 1b from Central (i.e., Henan) and Northwestern (i.e., Xinjiang) China, and subtype 3a from Southwestern (i.e., Yunnan) and Northwestern (i.e., Xinjiang) China. From Zhenjiang, subtypes 1b and 2a were further spread to Eastern (i.e., Shanghai) and Northern (i.e., Beijing) China, respectively. Conclusions/Significance: The mixing of seven HCV subtypes in Zhenjiang from all quarters of China indicates that as an important middle station, Zhenjiang plays a crucial role in HCV transmission, just as it is important in population migration between other regions of China and Eastern China.	[Zhang, Chiyu; Wu, Nana; Liu, Jun; Huang, Yan; Ren, Qian; Feng, Qingchuan] Jiangsu Univ, Inst Life Sci, Jiangsu, Peoples R China; [Ge, Qinjuan; He, Guangli] Zhenjiang Ctr Dis Control & Prevent, Jiangsu, Peoples R China; [Feng, Qingchuan] Zhengzhou Univ, Coll Basic Med, Dept Cell Biol & Med Genet, Zhengzhou, Herts, Peoples R China	Jiangsu University; Zhengzhou University	Zhang, CY (corresponding author), Jiangsu Univ, Inst Life Sci, Jiangsu, Peoples R China.	zhangcy1999@hotmail.com			Jiangsu University; Jiangsu Health International Exchange Program	Jiangsu University; Jiangsu Health International Exchange Program	This study was supported by the "Top-notch personnel'' Project of Jiangsu University (to C. Zhang) and Jiangsu Health International Exchange Program (to G. He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; BAO YP, 2010, CURR OPIN PSYCHIAT; Beyrer C, 2000, AIDS, V14, P75, DOI 10.1097/00002030-200001070-00009; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Forns X, 1999, Clin Liver Dis, V3, P693, DOI 10.1016/S1089-3261(05)70234-8; Garten RJ, 2005, CLIN INFECT DIS, V41, pS18, DOI 10.1086/429491; Garten RJ, 2004, INT J EPIDEMIOL, V33, P182, DOI 10.1093/ije/dyh019; Lee YM, 2010, J MED VIROL, V82, P57, DOI 10.1002/jmv.21658; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Liu JY, 2008, CLIN INFECT DIS, V46, P1761, DOI 10.1086/587992; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Peng JS, 2008, VIRUS RES, V135, P191, DOI 10.1016/j.virusres.2008.01.017; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; STUYVER L, 1994, P NATL ACAD SCI USA, V91, P10134, DOI 10.1073/pnas.91.21.10134; Sullivan SG, 2007, INT J DRUG POLICY, V18, P118, DOI 10.1016/j.drugpo.2006.11.014; Sy Theodore, 2006, Int J Med Sci, V3, P41; Takebe Y, 2010, VACCINE, V28, pB39, DOI 10.1016/j.vaccine.2009.07.101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yu XF, 2001, AIDS, V15, P523, DOI 10.1097/00002030-200103090-00012; Zhang CY, 2002, J ACQ IMMUN DEF SYND, V29, P191, DOI 10.1097/00042560-200202010-00014; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang MH, 2010, OCCUP HLTH, V26, P2335; Zhou DXM, 2006, J MED VIROL, V78, P574, DOI 10.1002/jmv.20578	33	33	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16817	10.1371/journal.pone.0016817	http://dx.doi.org/10.1371/journal.pone.0016817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304823	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036600029
J	Sun, JL; Zhao, LN; Teng, LJ; Lin, F; Zhang, HN; Li, ZN; Gao, QA				Sun, Jialin; Zhao, Lina; Teng, Lijie; Lin, Feng; Zhang, Hongna; Li, Zhengnan; Gao, Qiang			Solid Tumor-Targeted Infiltrating Cytotoxic T Lymphocytes Retained by a Superantigen Fusion Protein	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STAPHYLOCOCCAL ENTEROTOXIN-A; SINGLE-CHAIN ANTIBODY; IFN-GAMMA; BISPECIFIC ANTIBODIES; APOPTOSIS; CELLS; EXPRESSION; THERAPY; MICE	Successful immune-mediated regression of solid tumors is difficult because of the small number of cytotoxic T lymphocytes (CTLs) that were traffic to the tumor site. Here, the targeting of tumor-specific infiltrating CTLs was dependent on a fusion protein consisting of human epidermal growth factor (EGF) and staphylococcal enterotoxin A (SEA) with the D227A mutation. EGF-SEA strongly restrained the growth of murine solid sarcoma 180 (S180) tumors (control versus EGF-SEA, mean tumor weight: 1.013 versus 0.197 g, difference = 0.816 g). In mice treated with EGF-SEA, CD4(+), CD8(+) and SEA-reactive T lymphocytes were enriched around the EGFR expressing tumor cells. The EGF receptors were potentially phosphorylated by EGF-SEA stimulation and the fusion protein promoted T cells to release the tumoricidal cytokines interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha). Intratumoral CTLs secreted cytolytic pore-forming perforins and granzyme B proteins near the surface of carcinomas, causing the death of many tumor cells. We additionally show that labeled EGF-SEA was directly targeted to the tumor tissue after intravenous (i.v.) injection. The findings demonstrate that antibody-like EGF-SEA plays an important role in arresting CTLs in the solid tumor site and has therapeutic potential as a tumor-targeting agent.	[Sun, Jialin; Zhao, Lina; Teng, Lijie; Lin, Feng; Zhang, Hongna; Li, Zhengnan; Gao, Qiang] Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Microbiol, Tianjin, Peoples R China	Tianjin University Science & Technology	Sun, JL (corresponding author), Tianjin Univ Sci & Technol, Coll Biotechnol, Minist Educ, Key Lab Ind Microbiol, Tianjin, Peoples R China.	jialinsun@tust.edu.cn	Sun, Jialin/GYV-0601-2022		Tianjin Science Program [06YFJZJC02600, 08JCZDJC15100]; National Natural Science Foundation of China [30770444, 31071126]	Tianjin Science Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported two grants (06YFJZJC02600 and 08JCZDJC15100) from the Tianjin Science Program (http://www.tstc.gov.cn/) and National Natural Science Foundation of China (No. 30770444, 31071126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano R, 2002, FEBS LETT, V528, P70, DOI 10.1016/S0014-5793(02)03254-4; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; Chavez-Galan L, 2009, CELL MOL IMMUNOL, V6, P15, DOI 10.1038/cmi.2009.3; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Dasgupta S, 2006, MOL THER, V13, P183, DOI 10.1016/j.ymthe.2005.06.481; DOHLSTEN M, 1995, P NATL ACAD SCI USA, V92, P9791, DOI 10.1073/pnas.92.21.9791; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; Elleman TC, 2001, BIOCHEMISTRY-US, V40, P8930, DOI 10.1021/bi010037b; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; FRENCH AR, 1995, J BIOL CHEM, V270, P4334, DOI 10.1074/jbc.270.9.4334; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; Hansson J, 1997, P NATL ACAD SCI USA, V94, P2489, DOI 10.1073/pnas.94.6.2489; HUANG IY, 1987, J BIOL CHEM, V262, P7006; LIU CC, 1995, IMMUNOL TODAY, V16, P194, DOI 10.1016/0167-5699(95)80121-9; Liu Q, 2003, EUR SURG RES, V35, P457, DOI 10.1159/000073383; Liu TF, 2005, CLIN CANCER RES, V11, P329; Loffler A, 2000, BLOOD, V95, P2098, DOI 10.1182/blood.V95.6.2098; Manzke O, 2001, INT J CANCER, V91, P516, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1069>3.0.CO;2-A; Melder RJ, 2002, NEOPLASIA, V4, P3, DOI 10.1038/sj.neo.7900209; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Ossina NK, 1997, J BIOL CHEM, V272, P16351, DOI 10.1074/jbc.272.26.16351; PFEIFFER A, 1990, GASTROENTEROLOGY, V98, P961, DOI 10.1016/0016-5085(90)90020-2; POCKAJ BA, 1994, CANCER, V73, P1731, DOI 10.1002/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H; Psarras K, 1998, PROTEIN ENG, V11, P1285, DOI 10.1093/protein/11.12.1285; Riccioli A, 2000, J IMMUNOL, V165, P743, DOI 10.4049/jimmunol.165.2.743; Riesenberg R, 2001, J HISTOCHEM CYTOCHEM, V49, P911, DOI 10.1177/002215540104900711; Rosendahl A, 1998, J IMMUNOL, V160, P5309; SCOTT J, 1983, SCIENCE, V221, P236, DOI 10.1126/science.6602382; SHAW JP, 1991, J BIOL CHEM, V266, P21118; SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7; Tordsson J, 2000, INT J CANCER, V87, P559, DOI 10.1002/1097-0215(20000815)87:4<559::AID-IJC16>3.0.CO;2-#; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; WHITESIDE TL, 1992, INVAS METAST, V12, P128; Xu XL, 1998, CANCER RES, V58, P2832; YOUNG JD, 1986, CELL, V46, P641, DOI 10.1016/0092-8674(86)90336-3	36	8	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16642	10.1371/journal.pone.0016642	http://dx.doi.org/10.1371/journal.pone.0016642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311755	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200026
J	Miller, CA; Hampton, O; Coarfa, C; Milosavljevic, A				Miller, Christopher A.; Hampton, Oliver; Coarfa, Cristian; Milosavljevic, Aleksandar			ReadDepth: A Parallel R Package for Detecting Copy Number Alterations from Short Sequencing Reads	PLOS ONE			English	Article							GENOMIC DISORDERS; MICROARRAYS; CANCER	Copy number alterations are important contributors to many genetic diseases, including cancer. We present the readDepth package for R, which can detect these aberrations by measuring the depth of coverage obtained by massively parallel sequencing of the genome. In addition to achieving higher accuracy than existing packages, our tool runs much faster by utilizing multi-core architectures to parallelize the processing of these large data sets. In contrast to other published methods, readDepth does not require the sequencing of a reference sample, and uses a robust statistical model that accounts for overdispersed data. It includes a method for effectively increasing the resolution obtained from low-coverage experiments by utilizing breakpoint information from paired end sequencing to do positional refinement. We also demonstrate a method for inferring copy number using reads generated by whole-genome bisulfite sequencing, thus enabling integrative study of epigenomic and copy number alterations. Finally, we apply this tool to two genomes, showing that it performs well on genomes sequenced to both low and high coverage. The readDepth package runs on Linux and MacOSX, is released under the Apache 2.0 license, and is available at http://code.google.com/p/readdepth/.	[Miller, Christopher A.; Hampton, Oliver; Milosavljevic, Aleksandar] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Miller, Christopher A.; Hampton, Oliver; Coarfa, Cristian; Milosavljevic, Aleksandar] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Miller, CA (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.	amilosav@bcm.edu	Miller, Christopher A./A-1060-2009	Miller, Christopher A./0000-0003-4266-6700	NIH, National Human Genome Research Institute [R01-HG004009, R21-HG004554]; National Cancer Institute [R33-CA114151]; NIH Epigenomics Roadmap Initiative, National Institute on Drug Addiction [U01 DA025956]; NATIONAL CANCER INSTITUTE [R33CA114151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004009, R21HG004554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA025956] Funding Source: NIH RePORTER	NIH, National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Epigenomics Roadmap Initiative, National Institute on Drug Addiction; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research has been funded by the NIH grants R01-HG004009 and R21-HG004554 from the National Human Genome Research Institute, R33-CA114151 from the National Cancer Institute, and the NIH Epigenomics Roadmap Initiative grant U01 DA025956 from the National Institute on Drug Addiction to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; [Anonymous], 2010, R LANG ENV STAT COMP; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Castle JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-244; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Coarfa C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-572; Cohen P., 2002, APPL MULTIPLE REGRES; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	25	146	166	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16327	10.1371/journal.pone.0016327	http://dx.doi.org/10.1371/journal.pone.0016327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305028	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300050
J	Simonson, TS; Xing, JC; Barrett, R; Jerah, E; Loa, P; Zhang, YH; Watkins, WS; Witherspoon, DJ; Huff, CD; Woodward, S; Mowry, B; Jorde, LB				Simonson, Tatum S.; Xing, Jinchuan; Barrett, Robert; Jerah, Edward; Loa, Peter; Zhang, Yuhua; Watkins, W. Scott; Witherspoon, David J.; Huff, Chad D.; Woodward, Scott; Mowry, Bryan; Jorde, Lynn B.			Ancestry of the Iban Is Predominantly Southeast Asian: Genetic Evidence from Autosomal, Mitochondrial, and Y Chromosomes	PLOS ONE			English	Article							AUSTRONESIAN-SPEAKING PEOPLES; MODERN HUMANS; POPULATION-GENETICS; LAST DEGLACIATION; HUMAN DISPERSALS; NEW-GUINEA; EAST-ASIA; DIVERSITY; GENOME; DNA	Humans reached present-day Island Southeast Asia (ISEA) in one of the first major human migrations out of Africa. Population movements in the millennia following this initial settlement are thought to have greatly influenced the genetic makeup of current inhabitants, yet the extent attributed to different events is not clear. Recent studies suggest that south-to-north gene flow largely influenced present-day patterns of genetic variation in Southeast Asian populations and that late Pleistocene and early Holocene migrations from Southeast Asia are responsible for a substantial proportion of ISEA ancestry. Archaeological and linguistic evidence suggests that the ancestors of present-day inhabitants came mainly from north-to-south migrations from Taiwan and throughout ISEA approximately 4,000 years ago. We report a large-scale genetic analysis of human variation in the Iban population from the Malaysian state of Sarawak in northwestern Borneo, located in the center of ISEA. Genome-wide single-nucleotide polymorphism (SNP) markers analyzed here suggest that the Iban exhibit greatest genetic similarity to Indonesian and mainland Southeast Asian populations. The most common non-recombining Y (NRY) and mitochondrial (mt) DNA haplogroups present in the Iban are associated with populations of Southeast Asia. We conclude that migrations from Southeast Asia made a large contribution to Iban ancestry, although evidence of potential gene flow from Taiwan is also seen in uniparentally inherited marker data.	[Simonson, Tatum S.; Xing, Jinchuan; Zhang, Yuhua; Watkins, W. Scott; Witherspoon, David J.; Huff, Chad D.; Jorde, Lynn B.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Barrett, Robert; Jerah, Edward; Loa, Peter] Univ Adelaide, Dept Psychiat, Adelaide, SA, Australia; [Barrett, Robert; Jerah, Edward; Loa, Peter] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Woodward, Scott] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Mowry, Bryan] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Mowry, Bryan] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	Utah System of Higher Education; University of Utah; University of Adelaide; Royal Adelaide Hospital; Queensland Centre for Mental Health Research; University of Queensland	Simonson, TS (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu	Xing, Jinchuan/A-2489-2012; Loa, Peter/T-3217-2019; Mowry, Bryan/G-5046-2010	Mowry, Bryan/0000-0002-4115-5645; Loa, Peter/0000-0001-7653-5392	Australian National Health and Medical Research Council [9937625, 49669]; NIH [GM-59290, T-32]; NSF [BCS-0218370]; University of Luxembourg; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Luxembourg; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Australian National Health and Medical Research Council grants 9937625, 49669; NIH Grant GM-59290 and NSF Grant BCS-0218370. Funding was provided by the University of Luxembourg Institute for Systems Biology Program to C.D.H. T.S.S. is supported by NIH Genetics Training Grant T-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BALLINGER SW, 1992, GENETICS, V130, P139; BARKER G, 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; BELLWOOD P, 1991, SCI AM, V265; Bellwood Peter, 1997, PREHISTORY INDOMALAY; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; BLANCHON P, 1995, GEOLOGY, V23, P4, DOI 10.1130/0091-7613(1995)023<0004:RDDTLD>2.3.CO;2; BLUST R, 1995, J WORLD PREHIST, V9, P453, DOI 10.1007/BF02221119; BROTHWELL DR, 1960, SARAWAK MUS J, V9, P323; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Chang YM, 2009, FORENSIC SCI INT-GEN, V3, pE77, DOI 10.1016/j.fsigen.2008.07.007; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Dhaliwal JS, 2010, TISSUE ANTIGENS, V75, P166, DOI 10.1111/j.1399-0039.2009.01410.x; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Diamond JM, 2000, NATURE, V403, P709, DOI 10.1038/35001685; DIAMOND JM, 1988, NATURE, V336, P308; EXCOFFIER L, 2006, EVOLUTIONARY BIOINFO, V1; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hill C, 2006, MOL BIOL EVOL, V23, P2480, DOI 10.1093/molbev/msl124; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Ke YH, 2001, SCIENCE, V292, P1151, DOI 10.1126/science.1060011; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Oota H, 2001, HUM BIOL, V73, P225, DOI 10.1353/hub.2001.0023; Oppenheimer S., 1998, EDEN E DROWNED CONTI; Pelejero C, 1999, EARTH PLANET SC LETT, V171, P661, DOI 10.1016/S0012-821X(99)00178-8; SATHIAMURTHY EVH, 2006, NATURAL HIST; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; Su B, 1999, AM J HUM GENET, V65, pA399; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Trivedi R, 2006, J HUM GENET, V51, P217, DOI 10.1007/s10038-005-0349-2; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Watkins WS, 2005, ANN HUM GENET, V69, P680, DOI 10.1046/j.1529-8817.2005.00200.x; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; WATKINS WS, 1995, HUM MOL GENET, V4, P1485, DOI 10.1093/hmg/4.9.1485; Wooding S, 2004, HUM GENET, V115, P221, DOI 10.1007/s00439-004-1130-x; Xing JC, 2009, GENOME RES, V19, P815, DOI 10.1101/gr.085589.108; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	50	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16338	10.1371/journal.pone.0016338	http://dx.doi.org/10.1371/journal.pone.0016338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305013	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300052
J	Chen, PL; Fann, CSJ; Chu, CC; Chang, CC; Chang, SW; Hsieh, HY; Lin, M; Yang, WS; Chang, TC				Chen, Pei-Lung; Fann, Cathy Shen-Jang; Chu, Chen-Chung; Chang, Chien-Ching; Chang, Su-Wei; Hsieh, Hsin-Yi; Lin, Marie; Yang, Wei-Shiung; Chang, Tien-Chun			Comprehensive Genotyping in Two Homogeneous Graves' Disease Samples Reveals Major and Novel HLA Association Alleles	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; LEUKOCYTE ANTIGEN REGION; GENOME-WIDE ASSOCIATION; HONG-KONG CHINESE; HISTOCOMPATIBILITY COMPLEX; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; JAPANESE PATIENTS; P-VALUES; POPULATION	Background: Graves' disease (GD) is the leading cause of hyperthyroidism and thyroid eye disease inherited as a complex trait. Although geoepidemiology studies showed relatively higher prevalence of GD in Asians than in Caucasians, previous genetic studies were contradictory concerning whether and/or which human leukocyte antigen (HLA) alleles are associated with GD in Asians. Methodology/Principal Findings: We conducted a case-control association study (499 unrelated GD cases and 504 controls) and a replication in an independent family sample (419 GD individuals and their 282 relatives in 165 families). To minimize genetic and phenotypic heterogeneity, we included only ethnic Chinese Han population in Taiwan and excluded subjects with hypothyroidism. We performed direct and comprehensive genotyping of six classical HLA loci (HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1) to 4-digit resolution. Combining the data of two sample populations, we found that B*46:01 (odds ratio under dominant model [OR] = 1.33, Bonferroni corrected combined P [P(Bc)] = 1.17x10(-2)), DPB1*05:01 (OR = 2.34, P(Bc) = 2.58x10(-10)), DQB1*03:02 (OR = 0.62, P(Bc) = 1.97x10(-2)), DRB1*15:01 (OR = 1.68, P(Bc) = 1.22x10(-2)) and DRB1*16:02 (OR = 2.63, P(Bc) = 1.46x10(-5)) were associated with GD. HLA-DPB1*05:01 is the major gene of GD in our population and singly accounts for 48.4% of population-attributable risk. Conclusions/Significance: These GD-associated alleles we identified in ethnic Chinese Hans, and those identified in other Asian studies, are totally distinct from the known associated alleles in Caucasians. Identification of population-specific association alleles is the critical first step for individualized medicine. Furthermore, comparison between different susceptibility/protective alleles across populations could facilitate generation of novel hypothesis about GD pathophysiology and indicate a new direction for future investigation.	[Chen, Pei-Lung] Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; [Chen, Pei-Lung; Yang, Wei-Shiung; Chang, Tien-Chun] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Fann, Cathy Shen-Jang; Chang, Chien-Ching; Chang, Su-Wei; Hsieh, Hsin-Yi] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Fann, Cathy Shen-Jang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chu, Chen-Chung; Lin, Marie] Mackay Mem Hosp, Transfus Med Lab, Dept Med Res, Taipei, Taiwan; [Yang, Wei-Shiung] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Yang, Wei-Shiung; Chang, Tien-Chun] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Taiwan University; National Taiwan University	Chen, PL (corresponding author), Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan.	wsyang@ntu.edu.tw; tienchunchang@ntu.edu.tw	Fann, Cathy SJ/F-9410-2010; Chen, Pei-Lung/A-3520-2010	Fann, Cathy SJ/0000-0001-9025-2276; Chen, Pei-Lung/0000-0002-5640-3074; YANG, WEI-SHIUNG/0000-0001-5087-373X; Chang, Tien-Chun/0000-0003-3385-2026	National Science Council, Taiwan (NSC) [91-3112-B-002-003, 92-3112-B-002-009, 93-3112-B-002-015, 95-3112-B-002-026, 96-3112-B-002-017, 97-3112-B-002-004]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council, Taiwan (NSC# 91-3112-B-002-003, 92-3112-B-002-009, 93-3112-B-002-015, 95-3112-B-002-026, 96-3112-B-002-017 and 97-3112-B-002-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayadi H, 2004, TRENDS ENDOCRIN MET, V15, P234, DOI 10.1016/j.tem.2004.05.002; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Brix TH, 1998, THYROID, V8, P727, DOI 10.1089/thy.1998.8.727; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; CAVAN DA, 1994, CLIN ENDOCRINOL, V40, P63, DOI 10.1111/j.1365-2265.1994.tb02444.x; CHAN SH, 1978, TISSUE ANTIGENS, V12, P109, DOI 10.1111/j.1399-0039.1978.tb01306.x; Chen PL, 2007, CLIN ENDOCRINOL, V66, P646, DOI 10.1111/j.1365-2265.2007.02787.x; CHO BY, 1987, TISSUE ANTIGENS, V30, P119; Chu CC, 2006, IMMUNOBIOLOGY HUMAN, P611; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; DONG RP, 1992, HUM IMMUNOL, V35, P165, DOI 10.1016/0198-8859(92)90101-R; Erlich HA, 2001, IMMUNITY, V14, P347, DOI 10.1016/S1074-7613(01)00115-7; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAWKINS BR, 1985, CLIN ENDOCRINOL, V23, P245, DOI 10.1111/j.1365-2265.1985.tb00220.x; Heward JM, 1998, J CLIN ENDOCR METAB, V83, P3394, DOI 10.1210/jc.83.10.3394; Huang SM, 2003, TISSUE ANTIGENS, V61, P154, DOI 10.1034/j.1399-0039.2003.00016.x; INOUE D, 1992, CLIN ENDOCRINOL, V36, P75, DOI 10.1111/j.1365-2265.1992.tb02905.x; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jacobson EM, 2008, J AUTOIMMUN, V30, P58, DOI 10.1016/j.jaut.2007.11.010; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kawasaki A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2516; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Kochi Y, 2010, NAT REV RHEUMATOL, V6, P290, DOI 10.1038/nrrheum.2010.23; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Meyer D, 2006, IMMUNOBIOLOGY HUMAN, P653; Middleton D, 2003, TISSUE ANTIGENS, V61, P403, DOI 10.1034/j.1399-0039.2003.00062.x; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; ONUMA H, 1994, HUM IMMUNOL, V39, P195, DOI 10.1016/0198-8859(94)90260-7; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Park MH, 2005, HUM IMMUNOL, V66, P741, DOI 10.1016/j.humimm.2005.03.001; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; SEKI T, 1993, HEPATOLOGY, V18, pA218, DOI 10.1016/0270-9139(93)92397-I; Shapira Y, 2010, J AUTOIMMUN, V34, pJ168, DOI 10.1016/j.jaut.2009.11.018; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Simmonds MJ, 2004, CLIN EXP IMMUNOL, V136, P1, DOI 10.1111/j.1365-2249.2004.02424.x; Sloka J S, 2005, J Autoimmune Dis, V2, P9, DOI 10.1186/1740-2557-2-9; Svejgaard A, 2008, IMMUNOGENETICS, V60, P275, DOI 10.1007/s00251-008-0295-1; Takahashi M, 2006, HUM IMMUNOL, V67, P47, DOI 10.1016/j.humimm.2006.02.023; Taylor JC, 2006, J CLIN ENDOCR METAB, V91, P646, DOI 10.1210/jc.2005-0686; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; TSAI K-S, 1989, Taiwan yixuehui zazhi, V88, P336; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Weetman AP, 2009, HORM METAB RES, V41, P421, DOI 10.1055/s-0029-1214415; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; WESTFALL PH, 1993, BIOMETRICS, V49, P941, DOI 10.2307/2532216; Wong GWK, 1999, CLIN ENDOCRINOL, V50, P493; Wongsurawat T, 2006, TISSUE ANTIGENS, V67, P79, DOI 10.1111/j.1399-0039.2005.00498.x; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; YEO PPB, 1989, TISSUE ANTIGENS, V34, P179, DOI 10.1111/j.1399-0039.1989.tb01734.x	56	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16635	10.1371/journal.pone.0016635	http://dx.doi.org/10.1371/journal.pone.0016635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21307958	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100052
J	Gozzi, A; Turrini, G; Piccoli, L; Massagrande, M; Amantini, D; Antolini, M; Martinelli, P; Cesari, N; Montanari, D; Tessari, M; Corsi, M; Bifone, A				Gozzi, Alessandro; Turrini, Giuliano; Piccoli, Laura; Massagrande, Mario; Amantini, David; Antolini, Marinella; Martinelli, Prisca; Cesari, Nicola; Montanari, Dino; Tessari, Michela; Corsi, Mauro; Bifone, Angelo			Functional Magnetic Resonance Imaging Reveals Different Neural Substrates for the Effects of Orexin-1 and Orexin-2 Receptor Antagonists	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; CEREBRAL BLOOD-VOLUME; PHARMACOLOGICAL MRI; DRUG DISCOVERY; KNOCKOUT MICE; RAT-BRAIN; SLEEP; NEURONS; REWARD; ACTIVATION	Orexins are neuro-modulatory peptides involved in the control of diverse physiological functions through interaction with two receptors, orexin-1 (OX1R) and orexin-2 (OX2R). Recent evidence in pre-clinical models points toward a putative dichotomic role of the two receptors, with OX2R predominantly involved in the regulation of the sleep/wake cycle and arousal, and the OX1R being more specifically involved in reward processing and motivated behaviour. However, the specific neural substrates underlying these distinct processes in the rat brain remain to be elucidated. Here we used functional magnetic resonance imaging (fMRI) in the rat to map the modulatory effect of selective OXR blockade on the functional response produced by D-amphetamine, a psychostimulant and arousing drug that stimulates orexigenic activity. OXR blockade was produced by GSK1059865 and JNJ1037049, two novel OX1R and OX2R antagonists with unprecedented selectivity at the counter receptor type. Both drugs inhibited the functional response to D-amphetamine albeit with distinct neuroanatomical patterns: GSK1059865 focally modulated functional responses in striatal terminals, whereas JNJ1037049 induced a widespread pattern of attenuation characterised by a prominent cortical involvement. At the same doses tested in the fMRI study, JNJ1037049 exhibited robust hypnotic properties, while GSK1059865 failed to display significant sleep-promoting effects, but significantly reduced drug-seeking behaviour in cocaine-induced conditioned place preference. Collectively, these findings highlight an essential contribution of the OX2R in modulating cortical activity and arousal, an effect that is consistent with the robust hypnotic effect exhibited by JNJ1037049. The subcortical and striatal pattern observed with GSK1059865 represent a possible neurofunctional correlate for the modulatory role of OX1R in controlling reward-processing and goal-oriented behaviours in the rat.	[Gozzi, Alessandro; Bifone, Angelo] Ist Italiano Tecnol, Ctr Nanotechnol Innovat, Pisa, Italy; [Gozzi, Alessandro; Turrini, Giuliano; Piccoli, Laura; Massagrande, Mario; Amantini, David; Antolini, Marinella; Martinelli, Prisca; Cesari, Nicola; Montanari, Dino; Tessari, Michela; Corsi, Mauro; Bifone, Angelo] GlaxoSmithKline Med Res Ctr, Verona, Italy	Istituto Italiano di Tecnologia - IIT; GlaxoSmithKline	Gozzi, A (corresponding author), Ist Italiano Tecnol, Ctr Nanotechnol Innovat, Pisa, Italy.	alessandro.gozzi@iit.it	Gozzi, Alessandro/K-6342-2016	Gozzi, Alessandro/0000-0002-5731-4137	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was funded by GlaxoSmithKline. The funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro G., 2009, Pyridine Derivatives Used to Treat Orexin Related Disorders, Patent No. [WO2009124956A1., 2009124956]; Aston-Jones G, 2009, NEUROPHARMACOLOGY, V56, P112, DOI 10.1016/j.neuropharm.2008.06.060; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Brisbare-Roch C, 2007, NAT MED, V13, P150, DOI 10.1038/nm1544; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen YCI, 2001, J MAGN RESON IMAGING, V14, P517, DOI 10.1002/jmri.1215; Coleman PJ, 2010, EXPERT OPIN THER PAT, V20, P307, DOI 10.1517/13543770903567085; Dugovic C, 2009, J PHARMACOL EXP THER, V330, P142, DOI 10.1124/jpet.109.152009; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Fadel J, 2002, J NEUROSCI, V22, P6742; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Ferrari L, 2010, J NEUROSCI METH, V186, P143, DOI 10.1016/j.jneumeth.2009.11.005; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gompf H, 2009, ANESTHESIOLOGY, V111, P1001, DOI 10.1097/ALN.0b013e3181b764b3; Gozzi A, 2008, PSYCHOPHARMACOLOGY, V201, P273, DOI 10.1007/s00213-008-1271-z; Gozzi A, 2008, NEUROPSYCHOPHARMACOL, V33, P1690, DOI 10.1038/sj.npp.1301547; Gozzi A, 2007, MAGN RESON IMAGING, V25, P826, DOI 10.1016/j.mri.2007.03.003; Gozzi A, 2010, PSYCHOPHARMACOLOGY, V209, P37, DOI 10.1007/s00213-009-1772-4; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Horan B, 2000, SYNAPSE, V35, P160, DOI 10.1002/(SICI)1098-2396(200002)35:2<160::AID-SYN9>3.3.CO;2-F; Kalvass JC, 2002, BIOPHARM DRUG DISPOS, V23, P327, DOI 10.1002/bdd.325; Kenakin T, 2006, J PHARMACOL EXP THER, V319, P710, DOI 10.1124/jpet.106.107375; Knutson B, 2007, PSYCHOPHARMACOLOGY, V191, P813, DOI 10.1007/s00213-006-0686-7; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Maquet P, 2000, J SLEEP RES, V9, P207; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McAtee LC, 2004, BIOORG MED CHEM LETT, V14, P4225, DOI 10.1016/j.bmcl.2004.06.032; Micheli F, 2007, J MED CHEM, V50, P5076, DOI 10.1021/jm0705612; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Paxinos G., 1998, RAT BRAIN STEREOTACT; Peyron C, 1998, J NEUROSCI, V18, P9996; Read KD, 2010, EXPERT OPIN DRUG MET, V6, P337, DOI 10.1517/17425250903559873; RUNLAKSHANA O, 1959, BRIT J PHARMACOL, V14, P48; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Scammell TE, 2005, NAT NEUROSCI, V8, P1286, DOI 10.1038/nn1005-1286; Schwarz A, 2004, SYNAPSE, V54, P1, DOI 10.1002/syn.20055; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Schwarz AJ, 2007, J NEUROSCI METH, V159, P346, DOI 10.1016/j.jneumeth.2006.07.017; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Schwarz AJ, 2003, MAGN RESON IMAGING, V21, P1191, DOI 10.1016/j.mri.2003.08.020; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Smith MI, 2003, NEUROSCI LETT, V341, P256, DOI 10.1016/S0304-3940(03)00066-1; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Willie JT, 2001, SLEEP, V24, pA24; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x; Zaharchuk G, 1999, STROKE, V30, P2197, DOI 10.1161/01.STR.30.10.2197	54	83	101	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16406	10.1371/journal.pone.0016406	http://dx.doi.org/10.1371/journal.pone.0016406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21307957	Green Submitted, Green Published, gold			2022-12-25	WOS:000286664100027
J	Tang, Y; Pan, XJ; Chen, Y; Tai, PC; Sui, SF				Tang, Ying; Pan, Xijiang; Chen, Yong; Tai, Phang C.; Sui, Sen-Fang			Dimeric SecA Couples the Preprotein Translocation in an Asymmetric Manner	PLOS ONE			English	Article							ESCHERICHIA-COLI; PROTEIN TRANSLOCATION; PRECURSOR PROTEINS; SIGNAL PEPTIDES; FULL-LENGTH; ATPASE; CHAPERONE; MEMBRANE; COMPLEX; MOTOR	The Sec translocase mediates the post-translational translocation of a number of preproteins through the inner membrane in bacteria. In the initiatory translocation step, SecB targets the preprotein to the translocase by specific interaction with its receptor SecA. The latter is the ATPase of Sec translocase which mediates the post-translational translocation of preprotein through the protein-conducting channel SecYEG in the bacterial inner membrane. We examined the structures of Escherichia coli Sec intermediates in solution as visualized by negatively stained electron microscopy in order to probe the oligomeric states of SecA during this process. The symmetric interaction pattern between the SecA dimer and SecB becomes asymmetric in the presence of proOmpA, and one of the SecA protomers predominantly binds to SecB/proOmpA. Our results suggest that during preprotein translocation, the two SecA protomers are different in structure and may play different roles.	[Tang, Ying; Pan, Xijiang; Chen, Yong; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Tai, Phang C.] Georgia State Univ, Dept Biol, Atlanta, GA USA	Tsinghua University; University System of Georgia; Georgia State University	Tang, Y (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Chen, Yong/AAF-9915-2020	Chen, Yong/0000-0001-5857-6086; Sui, Sen-Fang/0000-0001-5253-2592	National Natural Science Foundation of China [30830028]; National Basic Research program of China [2010CB833706/2010CB912400]; National Institutes of Health [GM34766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034766] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Natural Science Foundation of China (30830028), the National Basic Research program of China (2010CB833706/2010CB912400) (S.F.S.) and the National Institutes of Health (GM34766 to P.C.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud C, 2002, J BIOL CHEM, V277, P13724, DOI 10.1074/jbc.M200047200; Chen Y, 2008, J BIOL CHEM, V283, P28783, DOI 10.1074/jbc.C800160200; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; Economou A, 2002, MOL MEMBR BIOL, V19, P159, DOI 10.1080/09687680210152609; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Muller JP, 2000, BIOCHEM J, V348, P367, DOI 10.1042/0264-6021:3480367; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Randall LL, 1997, P NATL ACAD SCI USA, V94, P802, DOI 10.1073/pnas.94.3.802; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Triplett TL, 2001, J BIOL CHEM, V276, P19648, DOI 10.1074/jbc.M100098200; Wang HW, 2003, P NATL ACAD SCI USA, V100, P4221, DOI 10.1073/pnas.0737415100; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7; Zhou JH, 2005, MOL MICROBIOL, V58, P349, DOI 10.1111/j.1365-2958.2005.04842.x	26	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16498	10.1371/journal.pone.0016498	http://dx.doi.org/10.1371/journal.pone.0016498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304597	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900057
J	Serres, MP; Zlotek-Zlotkiewicz, E; Concha, C; Gurian-West, M; Daburon, V; Roberts, JM; Besson, A				Serres, M. P.; Zlotek-Zlotkiewicz, E.; Concha, C.; Gurian-West, M.; Daburon, V.; Roberts, J. M.; Besson, A.			Cytoplasmic p27 is oncogenic and cooperates with Ras both in vivo and in vitro	ONCOGENE			English	Article						p27 Kip1; Ras; Myc; mouse model; lung tumors	CELL-CYCLE PROGRESSION; CDK INHIBITORS; LUNG-CANCER; P27(KIP1) MISLOCALIZATION; DEPENDENT PHOSPHORYLATION; TUMOR SUPPRESSION; NUCLEAR EXPORT; MYC; LOCALIZATION; PROTEOLYSIS	p27(Kip1) (p27) can have opposing roles during malignant transformation depending on cellular context: on one hand it functions as a tumor suppressor by inhibiting cyclin-cyclin-dependent kinase (CDK) activity in the nucleus and on the other it may adopt an oncogenic role that is less well understood. To gain further insight into the roles played by p27 during tumorigenesis, we compared the susceptibility with urethane-induced tumorigenesis of two p27 mouse models, p27(-/-) and p27(CK-) knockin, in which p27 cannot bind or inhibit cyclin-CDKs. In this K-Ras-driven tumorigenesis model, p27(CK-) mice had an increase in both tumor number and aggressiveness compared with p27(-/-), indicating a cooperation between p27(CK-) and activated Ras. In the lung, increased tumorigenesis was associated with cytoplasmic localization of p27(CK-) and bronchiolaveolar stem cell amplification. The ability of p27(CK-) to cooperate with other oncogenes was not universal. When c-Myc was used as a transforming agent, p27 status became irrelevant and c-Myc was equally potent in transforming p27(+/+), p27(-/-) and p27(CK-) cells. In fact, c-Myc induced the degradation of wild-type p27 via the Skp-Cullin-F-box (SCF)-Skp2 pathway. In contrast, p27(CK-) levels were not affected by c-Myc expression, as p27(CK-) is insensitive to Skp2-mediated degradation because of its inability to bind cyclin E/CDK2. However, in presence of c-Myc, p27(CK-) remained mostly nuclear, providing an explanation for its inability to cooperate with Myc during transformation. Thus, we propose that the p27(CK-) protein needs to be localized in the cytoplasm in order to function as an oncogene, otherwise it just behaves similar to a null allele. Oncogene (2011) 30, 2846-2858; doi:10.1038/onc.2011.9; published online 14 February 2011	[Serres, M. P.; Zlotek-Zlotkiewicz, E.; Concha, C.; Daburon, V.; Besson, A.] CNRS, UMR 5088, ERL5294, F-31062 Toulouse 9, France; [Serres, M. P.; Zlotek-Zlotkiewicz, E.; Concha, C.; Daburon, V.; Besson, A.] Canc Res Ctr Toulouse, INSERM, UMR1037, Toulouse, France; [Serres, M. P.; Zlotek-Zlotkiewicz, E.; Concha, C.; Daburon, V.; Besson, A.] Univ Toulouse, Toulouse, France; [Gurian-West, M.; Roberts, J. M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Fred Hutchinson Cancer Center	Besson, A (corresponding author), CNRS, UMR 5088, ERL5294, 118 Route Narbonne,Batiment 4R3b1, F-31062 Toulouse 9, France.	abesson@cict.fr	zlotek-zlotkiewicz, ewa/M-1774-2015; Besson, Arnaud/J-6254-2014	Besson, Arnaud/0000-0002-9599-3943	Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale; NIH [1R01CA118043]; Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer; NATIONAL CANCER INSTITUTE [R01CA118043] Funding Source: NIH RePORTER	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MPS is supported by a studentship from the Ministere de l'Enseignement Superieur et de la Recherche. CC is supported by a fellowship from the Fondation pour la Recherche Medicale. This work was supported by NIH grant # 1R01CA118043 to JMR. AB is supported by grants from the Association pour la Recherche sur le Cancer and Ligue Nationale Contre le Cancer.	Berns K, 2000, ONCOGENE, V19, P4822, DOI 10.1038/sj.onc.1203879; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Chu S, 2010, LEUKEMIA, V24, P779, DOI 10.1038/leu.2010.24; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Fujita N, 2003, J BIOL CHEM, V278, P49254, DOI 10.1074/jbc.M306614200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Keller UB, 2007, EMBO J, V26, P2562, DOI 10.1038/sj.emboj.7601691; Kelly-Spratt KS, 2009, ONCOGENE, V28, P3652, DOI 10.1038/onc.2009.226; Kfir S, 2005, MOL CELL BIOL, V25, P8239, DOI 10.1128/MCB.25.18.8239-8250.2005; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu XD, 2000, ONCOGENE, V19, P5926, DOI 10.1038/sj.onc.1203991; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Martins CP, 2002, EMBO J, V21, P3739, DOI 10.1093/emboj/cdf364; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Muller D, 1997, ONCOGENE, V15, P2561, DOI 10.1038/sj.onc.1201440; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Old JB, 2010, MOL CANCER RES, V8, P353, DOI 10.1158/1541-7786.MCR-09-0232; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Sekimoto T, 2004, EMBO J, V23, P1934, DOI 10.1038/sj.emboj.7600198; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin I, 2005, J BIOL CHEM, V280, P6055, DOI 10.1074/jbc.M412367200; Short JD, 2008, CANCER RES, V68, P6496, DOI 10.1158/0008-5472.CAN-07-5756; Wu FY, 2006, CANCER RES, V66, P2162, DOI 10.1158/0008-5472.CAN-05-3304	51	57	59	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	25					2846	2858		10.1038/onc.2011.9	http://dx.doi.org/10.1038/onc.2011.9			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21317921				2022-12-25	WOS:000291977800005
J	Choi, DH; Kim, YJ; Kim, YG; Joh, TH; Beal, MF; Kim, YS				Choi, Dong-Hee; Kim, Youn-Jung; Kim, Young-Gun; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong			Role of Matrix Metalloproteinase 3-mediated alpha-Synuclein Cleavage in Dopaminergic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; TRANSGENIC MICE; LEWY BODIES; IN-VITRO; PATHOLOGICAL FORMS; SUBSTANTIA-NIGRA; AGGREGATION; DEMENTIA; MUTATION; MODEL	Evidence suggests that the C-terminal truncation of alpha-synuclein is equally important as aggregation of alpha-synuclein in Parkinson disease (PD). Our previous results showed that an endopeptidase, matrix metalloproteinase-3 (MMP3), was induced and activated in dopaminergic (DA) cells upon stress conditions. Here, we report that MMP3 cleaved alpha-synuclein in vitro and in vivo and that alpha-synuclein and MMP3 were co-localized in Lewy bodies (LB) in the postmortem brains of PD patients. Incubation of alpha-synuclein with the catalytic domain of MMP3 (cMMP3) resulted in generation of several peptides, and the peptide profiles of WT alpha-synuclein (WTsyn) and A53T mutant (A53Tsyn) were different. Combined analysis using mass spectrometry and N-terminal determination revealed that MMP3 generated C-terminally truncated peptides of amino acids 1-78, 1-91, and 1-93 and that A53Tsyn produced significantly higher quantities of these peptides. Similar sizes of peptides were detected in N27 DA cells under oxidative stress and RNA interference to knock down MMP3-attenuated peptide generation. Co-overexpression of cMMP3 with either WTsyn or A53Tsyn led to a reduction in Triton X-100-insoluble aggregates and an increase in protofibril-like small aggregates. In addition, overexpression of the 1-93-amino acid peptide in the substantia nigra led to DA neuronal loss without LB-like aggregate formation. The results strongly indicate that MMP3 digestion of alpha-synuclein in DA neurons plays a pivotal role in the progression of PD through modulation of alpha-synuclein in aggregation, LB formation, and neurotoxicity.	[Choi, Dong-Hee; Kim, Young-Gun; Joh, Tong H.; Beal, M. Flint; Kim, Yoon-Seong] Cornell Univ, Weill Med Coll, Neurol Neurosci Dept, New York, NY 10065 USA; [Choi, Dong-Hee] Konkuk Univ, Ctr Geriatr Neurosci Res, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Kim, Youn-Jung; Kim, Yoon-Seong] Kyung Hee Univ, Coll Nursing Sci, Seoul 130701, South Korea; [Kim, Yoon-Seong] Univ Cent Florida, Burnett Sch Biomed Sci, Coll Med, Orlando, FL 32827 USA	Cornell University; Konkuk University; Kyung Hee University; State University System of Florida; University of Central Florida	Kim, YS (corresponding author), 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	yskim@mail.ucf.edu		Kim, Young-Gun/0000-0002-8982-5230	Michael J. Fox Foundation Community; Korean Government [KRF-E00081]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062827] Funding Source: NIH RePORTER	Michael J. Fox Foundation Community; Korean Government(Korean Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Michael J. Fox Foundation Community Fast Track 2005 and National Research Foundation of Korea Grant KRF-E00081 funded by the Korean Government.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Baba M, 1998, AM J PATHOL, V152, P879; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Choi DH, 2008, J NEUROCHEM, V106, P405, DOI 10.1111/j.1471-4159.2008.05399.x; CHOI DH, 2011, ANTIOXID REDOX SIGNA; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; da Costa CA, 2006, J BIOL CHEM, V281, P9824, DOI 10.1074/jbc.M513903200; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Eguchi T, 2008, MOL CELL BIOL, V28, P2391, DOI 10.1128/MCB.01288-07; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Flex A, 2006, J GERONTOL A-BIOL, V61, P1065, DOI 10.1093/gerona/61.10.1065; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Guo SZ, 2006, BRAIN RES, V1111, P222, DOI 10.1016/j.brainres.2006.06.041; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Kasai T, 2008, NEUROSCI LETT, V436, P52, DOI 10.1016/j.neulet.2008.02.057; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kwan JA, 2004, FASEB J, V18, P690, DOI 10.1096/fj.02-1202fje; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Mandel RJ, 2004, CURR OPIN MOL THER, V6, P482; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Michell AW, 2007, CELL TRANSPLANT, V16, P461, DOI 10.3727/000000007783464911; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; O'Carroll SJ, 2000, BIOTECHNIQUES, V28, P408, DOI 10.2144/00283bm03; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	46	80	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14168	14177		10.1074/jbc.M111.222430	http://dx.doi.org/10.1074/jbc.M111.222430			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330369	Green Published, hybrid			2022-12-25	WOS:000289556200040
J	Hickman, DT; Lopez-Deber, MP; Ndao, DM; Silva, AB; Nand, D; Pihlgren, M; Giriens, V; Madani, R; St-Pierre, A; Karastaneva, H; Nagel-Steger, L; Willbold, D; Riesner, D; Nicolau, C; Baldus, M; Pfeifer, A; Muhs, A				Hickman, David T.; Lopez-Deber, Maria Pilar; Ndao, Dorin Mlaki; Silva, Alberto B.; Nand, Deepak; Pihlgren, Maria; Giriens, Valerie; Madani, Rime; St-Pierre, Annie; Karastaneva, Hristina; Nagel-Steger, Luitgard; Willbold, Dieter; Riesner, Detlev; Nicolau, Claude; Baldus, Marc; Pfeifer, Andrea; Muhs, Andreas			Sequence-independent Control of Peptide Conformation in Liposomal Vaccines for Targeting Protein Misfolding Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THIOFLAVINE-T INTERACTION; BETA-SHEET STRUCTURES; ALZHEIMERS-DISEASE; COMMON MECHANISM; IMMUNE-RESPONSE; AMYLOID FIBRILS; PRION PROTEIN; ANTIBODIES; OLIGOMERS; VACCINATION	Synthetic peptide immunogens that mimic the conformation of a target epitope of pathological relevance offer the possibility to precisely control the immune response specificity. Here, we performed conformational analyses using a panel of peptides in order to investigate the key parameters controlling their conformation upon integration into liposomal bilayers. These revealed that the peptide lipidation pattern, the lipid anchor chain length, and the liposome surface charge all significantly alter peptide conformation. Peptide aggregation could also be modulated post-liposome assembly by the addition of distinct small molecule beta-sheet breakers. Immunization of both mice and monkeys with a model liposomal vaccine containing beta-sheet aggregated lipopeptide (Palm1-15) induced polyclonal IgG antibodies that specifically recognized beta-sheet multimers over monomer or non-pathological native protein. The rational design of liposome-bound peptide immunogens with defined conformation opens up the possibility to generate vaccines against a range of protein misfolding diseases, such as Alzheimer disease.	[Hickman, David T.; Lopez-Deber, Maria Pilar; Ndao, Dorin Mlaki; Silva, Alberto B.; Pihlgren, Maria; Giriens, Valerie; Madani, Rime; St-Pierre, Annie; Pfeifer, Andrea; Muhs, Andreas] AC Immune SA, PSE B, EPFL, CH-1015 Lausanne, Switzerland; [Nand, Deepak; Baldus, Marc] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Karastaneva, Hristina; Nagel-Steger, Luitgard; Willbold, Dieter; Riesner, Detlev] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Willbold, Dieter] Forschungszentrum Julich, Inst Strukturbiol & Biophys ISB 3, D-52425 Julich, Germany; [Nicolau, Claude] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02115 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Utrecht University; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Tufts University	Muhs, A (corresponding author), AC Immune SA, PSE B, EPFL, CH-1015 Lausanne, Switzerland.	andreas.muhs@acimmune.com	Silva, Alberto B/H-3630-2011; Baldus, Marc/C-2737-2009; Willbold, Dieter/A-6280-2013; Nagel-Steger, Luitgard/H-6415-2013	Baldus, Marc/0000-0001-7068-5613; Willbold, Dieter/0000-0002-0065-7366; Nagel-Steger, Luitgard/0000-0001-5232-2149	Netherlands Organization for Scientific Research [700.26.121]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Solid-state NMR studies were supported by Netherlands Organization for Scientific Research Grant 700.26.121. D.R. is a member of the Board of Directors and Scientific Advisory Board of AC Immune SA.	Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; BURDICK D, 1992, J BIOL CHEM, V267, P546; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; Gao JJ, 2009, P NATL ACAD SCI USA, V106, P3071, DOI 10.1073/pnas.0812952106; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hock C, 2002, NAT MED, V8, P1270, DOI 10.1038/nm783; House E, 2009, J ALZHEIMERS DIS, V18, P811, DOI 10.3233/JAD-2009-1235; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jha S, 2009, J MOL BIOL, V389, P907, DOI 10.1016/j.jmb.2009.04.077; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Laczko I, 1998, BIOCHEM BIOPH RES CO, V249, P213, DOI 10.1006/bbrc.1998.9109; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LEVINE H, 1995, AMYLOID, V2, P1, DOI 10.3109/13506129509031881; LIEBMAN HA, 1985, P NATL ACAD SCI USA, V82, P3879, DOI 10.1073/pnas.82.11.3879; Lowik DWPM, 2003, ORG BIOMOL CHEM, V1, P1827, DOI 10.1039/b303749e; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Maji SK, 2009, J BIOL CHEM, V284, P23580, DOI 10.1074/jbc.M109.038133; Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r; Misumi S, 2006, J IMMUNOL, V176, P463, DOI 10.4049/jimmunol.176.1.463; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Muhs A, 2007, P NATL ACAD SCI USA, V104, P9810, DOI 10.1073/pnas.0703137104; Nicolau C, 2002, P NATL ACAD SCI USA, V99, P2332, DOI 10.1073/pnas.022627199; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pimentel TAPF, 2009, CHEM BIOL DRUG DES, V73, P53, DOI 10.1111/j.1747-0285.2008.00746.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Su HP, 2007, VIROLOGY, V368, P331, DOI 10.1016/j.virol.2007.06.042; TOSI PF, 1995, BIOCHEM BIOPH RES CO, V212, P494, DOI 10.1006/bbrc.1995.1997; Villard V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000645; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Weaver-Feldhaus JM, 2005, PROTEIN ENG DES SEL, V18, P527, DOI 10.1093/protein/gzi060; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Zhang QH, 2004, P NATL ACAD SCI USA, V101, P4752, DOI 10.1073/pnas.0400924101	49	59	64	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13966	13976		10.1074/jbc.M110.186338	http://dx.doi.org/10.1074/jbc.M110.186338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343310	Green Published, hybrid			2022-12-25	WOS:000289556200019
J	Ogata, N; Shinoda, Y; Wettschureck, N; Offermanns, S; Takeda, S; Nakamura, K; Segre, GV; Chung, U; Kawaguchi, H				Ogata, Naoshi; Shinoda, Yusuke; Wettschureck, Nina; Offermanns, Stefan; Takeda, Shu; Nakamura, Kozo; Segre, Gino V.; Chung, Ung-il; Kawaguchi, Hiroshi			G alpha(q) Signal in Osteoblasts Is Inhibitory to the Osteoanabolic Action of Parathyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; G-PROTEINS; BONE; RECEPTOR; EXPRESSION; PTH; ACTIVATION; SELECTIVITY; REGULATOR; KNOCKOUT	This study examined the role of the G alpha(q) signal constituted by G alpha(q) and G alpha(11) (encoded by Gn alpha(q) and Gn alpha(11), respectively), a major intracellular pathway of parathyroid hormone (PTH), in the PTH osteoanabolic action by the gain- and loss-of-function analyses. Transgenic mice with osteoblast-specific overexpression of the constitutively active Gn alpha(q) gene under the control of 2.3-kb type I collagen alpha 1 chain (Col1a1) promoter exhibited osteopenia with decreased bone formation parameters and did not respond to the daily PTH treatment. We then established osteoblast-specific Gn alpha(q) and Gn alpha(11) double-knock-out (cDKO) mice by crossing the 2.3-kb Col1a1 promoter-Cre recombinase transgenic mice and those with Gn alpha(q) gene flanked with loxP and global ablation of Gn alpha(11) (Col1a1-Cre(+/-);Gn alpha(fl/fl)(q);Gna(11)(-/-)) and found that the cDKO and single knock-out litterrnates of Gn alpha(q) or Gn alpha(11) exhibited normal bone volume and turnover under physiological conditions. With a daily injection of PTH, however, the cDKO mice, but not the single knock-out mice, showed higher bone volume and turnover than the wild-type littermates. Cultures of primary osteoblasts derived from cDKO and wild-type littermates confirmed enhancement of the PTH osteoanabolic action by the G alpha(q) signal deficiency in a cell-autonomous mechanism, in association with the membrane translocation of protein kinase C delta. This enhancement was reproduced by oyerexpression of regulator of G protein signaling-2, a G alpha(q) signal inhibitor, in osteoblastic MC3T3-E1 cells. Hence, the G alpha(q) signal plays an inhibitory role in the PTH osteoanabolic action, suggesting that its suppression may lead to a novel treatment in combination with PTH against osteoporosis.	[Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, Tokyo 1138655, Japan; [Ogata, Naoshi] Univ Tokyo, Dept Bone & Cartilage Regenerat Med, Tokyo 1138655, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1138655, Japan; [Wettschureck, Nina; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Takeda, Shu] Keio Univ, Sch Med, Dept Endocrinol & Metab, Tokyo 1608582, Japan; [Segre, Gino V.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA	University of Tokyo; University of Tokyo; University of Tokyo; Max Planck Society; Keio University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Dept Sensory & Motor Syst Med, 7-3-1 Bunkyo, Tokyo 1138655, Japan.	kawaguchi-ort@h.u-tokyo.ac.jp	takeda, shu/B-5195-2012; Wettschureck, Nina/L-3651-2017; Offermanns, Stefan/L-3313-2017	Wettschureck, Nina/0000-0001-6858-1460; Offermanns, Stefan/0000-0001-8676-6805	Japanese Ministry of Education,Culture, Sports, Science, and Technology [21390416, 22659267, 22390286]	Japanese Ministry of Education,Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 21390416, 22659267, and 22390286 from the Japanese Ministry of Education,Culture, Sports, Science, and Technology.	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Bellido T., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P358; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bikle DD, 2002, J BONE MINER RES, V17, P1570, DOI 10.1359/jbmr.2002.17.9.1570; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; Chang WZ, 2004, J BIOL CHEM, V279, P42438, DOI 10.1074/jbc.M405549200; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Dromey Jasmin R., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P51, DOI 10.2174/187153008783928352; Gudermann T, 1996, ANNU REV PHARMACOL, V36, P429; Hao JM, 2006, J MOL CELL CARDIOL, V41, P51, DOI 10.1016/j.yjmcc.2006.04.003; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kawano T, 2008, ENDOCRINOLOGY, V149, P4009, DOI 10.1210/en.2008-0034; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Knopp E, 2005, ENDOCRINOLOGY, V146, P1983, DOI 10.1210/en.2004-0770; Kronenberg HM, 2010, ANN NY ACAD SCI, V1192, P327, DOI 10.1111/j.1749-6632.2009.05251.x; Lampasso JD, 2006, INT J MOL MED, V17, P1125; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Ogata N, 2007, J BIOL CHEM, V282, P35757, DOI 10.1074/jbc.M611902200; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Partridge NC, 2006, ANN NY ACAD SCI, V1068, P187, DOI 10.1196/annals.1346.024; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sakamoto A, 2005, J BIOL CHEM, V280, P21369, DOI 10.1074/jbc.M500346200; Shinoda Y, 2010, J CELL BIOCHEM, V109, P755, DOI 10.1002/jcb.22454; Spiegel AM, 1997, HORM RES, V47, P89, DOI 10.1159/000185441; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Taboubi S, 2010, MOL BIOL CELL, V21, P946, DOI 10.1091/mbc.E09-06-0497; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Umayahara Y, 1999, J BIOL CHEM, V274, P10609, DOI 10.1074/jbc.274.15.10609; Weinstein LS, 2001, ENDOCR REV, V22, P675, DOI 10.1210/er.22.5.675; Wettschureck N, 2004, PHARMACOL THERAPEUT, V101, P75, DOI 10.1016/j.pharmthera.2003.10.005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; Yamada T, 2006, NAT MED, V12, P665, DOI 10.1038/nm1409; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511; Zou MX, 2006, CELL SIGNAL, V18, P1655, DOI 10.1016/j.cellsig.2006.01.012	45	17	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13733	13740		10.1074/jbc.M110.200196	http://dx.doi.org/10.1074/jbc.M110.200196			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345793	hybrid, Green Published			2022-12-25	WOS:000289282200091
J	Nakazawa, T				Nakazawa, Takefumi			Alternative Stable States Generated by Ontogenetic Niche Shift in the Presence of Multiple Resource Use	PLOS ONE			English	Article							TROPHIC CASCADES; REGIME SHIFTS; SIZE; PREY; ECOSYSTEMS; DYNAMICS; PREDATION	It has been suggested that when juveniles and adults use different resources or habitats, alternative stable states (ASS) may exist in systems coupled by an ontogenetic niche shift. However, mainly the simplest system, i.e., the one-consumer-two-resource system, has been studied previously, and little is known about the development of ASS existing in more complex systems. Here, I theoretically investigated the development of ASS caused by an ontogenetic niche shift in the presence of multiple resource use. I considered three independent scenarios; (i) additional resources, (ii) multiple habitats, and (iii) interstage resource sharing. The model analyses illustrate that relative balance between the total resource availability in the juvenile and adult habitats is crucial for the development of ASS. This balance is determined by factors such as local habitat productivity, subsidy inputs, colonization area, and foraging mobility. Furthermore, it is also shown that interstage resource sharing generally suppresses ASS. These results suggest that the anthropogenic impacts of habitat modifications (e.g., fragmentation and destruction) or interaction modifications (e.g., changes in ontogeny and foraging behavior) propagate through space and may cause or prevent regime shifts in the regional community structure.	[Nakazawa, Takefumi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Nakazawa, Takefumi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	Kyoto University; National Taiwan University	Nakazawa, T (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	take.nkzw@gmail.com			Japan Society for the Promotion of Science Research Fellowship for Young Scientists [2103033]; Excellent Young Researchers	Japan Society for the Promotion of Science Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Excellent Young Researchers	This research was supported by a Japan Society for the Promotion of Science Research Fellowship for Young Scientists (2103033) and Excellent Young Researchers Overseas Visit Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2009, ECOL LETT, V12, P462, DOI 10.1111/j.1461-0248.2009.01282.x; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; de Roos AM, 2002, ECOL MONOGR, V72, P271, DOI 10.1890/0012-9615(2002)072[0271:ONSAFB]2.0.CO;2; Doi H, 2009, POPUL ECOL, V51, P57, DOI 10.1007/s10144-008-0127-z; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; McCoy MW, 2009, OIKOS, V118, P87, DOI 10.1111/j.1600-0706.2008.16878.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; NAKAZAWA T, THEOR ECOL IN PRESS; Persson L, 1996, ECOLOGY, V77, P900, DOI 10.2307/2265510; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Takimoto G, 2003, AM NAT, V162, P93, DOI 10.1086/375540; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; WILBUR HM, 1980, ANNU REV ECOL SYST, V11, P67, DOI 10.1146/annurev.es.11.110180.000435	28	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14667	10.1371/journal.pone.0014667	http://dx.doi.org/10.1371/journal.pone.0014667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346805	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600003
J	Steibel, JP; Bates, RO; Rosa, GJM; Tempelman, RJ; Rilington, VD; Ragavendran, A; Raney, NE; Ramos, AM; Cardoso, FF; Edwards, DB; Ernst, CW				Steibel, Juan Pedro; Bates, Ronald O.; Rosa, Guilherme J. M.; Tempelman, Robert J.; Rilington, Valencia D.; Ragavendran, Ashok; Raney, Nancy E.; Ramos, Antonio Marcos; Cardoso, Fernando F.; Edwards, David B.; Ernst, Catherine W.			Genome-Wide Linkage Analysis of Global Gene Expression in Loin Muscle Tissue Identifies Candidate Genes in Pigs	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PIETRAIN RESOURCE POPULATION; MEAT QUALITY TRAITS; MICROARRAY EXPERIMENTS; COMPLEX; PROTEIN; OXIDOREDUCTASE; REDUCTASE; DESIGN; ERP18	Background: Nearly 6,000 QTL have been reported for 588 different traits in pigs, more than in any other livestock species. However, this effort has translated into only a few confirmed causative variants. A powerful strategy for revealing candidate genes involves expression QTL (eQTL) mapping, where the mRNA abundance of a set of transcripts is used as the response variable for a QTL scan. Methodology/Principal Findings: We utilized a whole genome expression microarray and an F-2 pig resource population to conduct a global eQTL analysis in loin muscle tissue, and compared results to previously inferred phenotypic QTL (pQTL) from the same experimental cross. We found 62 unique eQTL (FDR <10%) and identified 3 gene networks enriched with genes subject to genetic control involved in lipid metabolism, DNA replication, and cell cycle regulation. We observed strong evidence of local regulation (40 out of 59 eQTL with known genomic position) and compared these eQTL to pQTL to help identify potential candidate genes. Among the interesting associations, we found aldo-keto reductase 7A2 (AKR7A2) and thioredoxin domain containing 12 (TXNDC12) eQTL that are part of a network associated with lipid metabolism and in turn overlap with pQTL regions for marbling, % intramuscular fat (% fat) and loin muscle area on Sus scrofa (SSC) chromosome 6. Additionally, we report 13 genomic regions with overlapping eQTL and pQTL involving 14 local eQTL. Conclusions/Significance: Results of this analysis provide novel candidate genes for important complex pig phenotypes.	[Steibel, Juan Pedro; Bates, Ronald O.; Tempelman, Robert J.; Rilington, Valencia D.; Ragavendran, Ashok; Raney, Nancy E.; Ramos, Antonio Marcos; Cardoso, Fernando F.; Edwards, David B.; Ernst, Catherine W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Steibel, Juan Pedro] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Rosa, Guilherme J. M.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Cardoso, Fernando F.] Embrapa So Reg Anim Husb, Planaltina, RS, Brazil	Michigan State University; Michigan State University; University of Wisconsin System; University of Wisconsin Madison; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Steibel, JP (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	ernstc@msu.edu	Cardoso, Fernando/I-6585-2012; Rosa, Guilherme J. M. J. M./G-3862-2011; Tempelman, R. J./J-9566-2019	Rosa, Guilherme J. M. J. M./0000-0001-9172-6461; Tempelman, Robert/0000-0002-7833-6730; Ramos, Marcos/0000-0003-3450-0970; Cardoso, Fernando/0000-0002-4145-1049	USDA National Institute of Food and Agriculture [2004-35604-14580]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by National Research Initiative Competitive Grant no. 2004-35604-14580 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support from the US Swine Genome Coordinator for synthesis of oligonucleotides for the Pigoligoarray, and from the US National Animal Genome Research Program Bioinformatics Coordinator for server access is greatly appreciated.	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Bueno JSS, 2006, GENETICS, V174, P945, DOI 10.1534/genetics.106.057281; Cardoso FF, 2008, GENETICS, V180, P1679, DOI 10.1534/genetics.108.090969; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Cogburn LA, 2003, POULTRY SCI, V82, P939, DOI 10.1093/ps/82.6.939; de Koning DJ, 2007, POULTRY SCI, V86, P1501, DOI 10.1093/ps/86.7.1501; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Edwards DB, 2008, J ANIM SCI, V86, P254, DOI 10.2527/jas.2006-626; Edwards DB, 2008, J ANIM SCI, V86, P241, DOI 10.2527/jas.2006-625; GERRARD DE, 2003, TISSUE STRUCTURE ORG, P26; Haley C, 2006, ANIM GENET, V37, P10, DOI 10.1111/j.1365-2052.2006.01470.x; HALEY CS, 1994, GENETICS, V136, P1195; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kadarmideen HN, 2006, MAMM GENOME, V17, P548, DOI 10.1007/s00335-005-0169-x; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Lucca-Junior W, 2009, BRAZ J MED BIOL RES, V42, P164, DOI 10.1590/S0100-879X2009000200003; National Research Council, 1998, NUTR REQ SWIN, Vtenth; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Picklo MJ, 2001, BRAIN RES, V916, P229, DOI 10.1016/S0006-8993(01)02897-9; PONSUKSILI S, 2010, HEREDITY; Ponsuksili S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-572; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Rosa GJM, 2005, COMP FUNCT GENOM, V6, P123, DOI 10.1002/cfg.464; ROSSI ML, DNA REPAIR AMST, V9, P331; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Rowe ML, 2009, BIOCHEMISTRY-US, V48, P4596, DOI 10.1021/bi9003342; Satyanarayana A, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-9; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Watanabe TK, 1996, CYTOGENET CELL GENET, V73, P153, DOI 10.1159/000134329; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	40	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16766	10.1371/journal.pone.0016766	http://dx.doi.org/10.1371/journal.pone.0016766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346809	gold, Green Submitted, Green Published			2022-12-25	WOS:000287077600023
J	Whiteley, MH; Bell, JS; Rothman, DA				Whiteley, Mary H.; Bell, Jerold S.; Rothman, Debby A.			Novel Allelic Variants in the Canine Cyclooxgenase-2 (Cox-2) Promoter Are Associated with Renal Dysplasia in Dogs	PLOS ONE			English	Article							SHIH-TZU DOGS; JUVENILE NEPHROPATHY; INCOMPLETE PENETRANCE; POSTNATAL-DEVELOPMENT; FAMILIAL NEPHROPATHY; GENE; CYCLOOXYGENASE-2; DISEASE; MICE; TRANSCRIPTION	Renal dysplasia (RD) in dogs is a complex disease with a highly variable phenotype and mode of inheritance that does not follow a simple Mendelian pattern. Cox-2 (Cyclooxgenase-2) deficient mice have renal abnormalities and a pathology that has striking similarities to RD in dogs suggesting to us that mutations in the Cox-2 gene could be the cause of RD in dogs. Our data supports this hypothesis. Sequencing of the canine Cox-2 gene was done from clinically affected and normal dogs. Although no changes were detected in the Cox-2 coding region, small insertions and deletions of GC boxes just upstream of the ATG translation start site were found. These sequences are putative SP1 transcription factor binding sites that may represent important cis-acting DNA regulatory elements that govern the expression of Cox-2. A pedigree study of a family of Lhasa apsos revealed an important statistical correlation of these mutant alleles with the disease. We examined an additional 22 clinical cases from various breeds. Regardless of the breed or severity of disease, all of these had one or two copies of the Cox-2 allelic variants. We suggest that the unusual inheritance pattern of RD is due to these alleles, either by changing the pattern of expression of Cox-2 or making Cox-2 levels susceptible to influences of other genes or environmental factors that play an unknown but important role in the development of RD in dogs.	[Whiteley, Mary H.] DOGenes Inc, Peterborough, ON, Canada; [Bell, Jerold S.] Tufts Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA USA; [Rothman, Debby A.] Amer Lhasa Apso Club, Conifer, CO USA		Whiteley, MH (corresponding author), DOGenes Inc, Peterborough, ON, Canada.	info@dogenes.com			ASCT (American Shih tzu club); ALAC (American Lhasa Apso Club); AMSC (American Miniature Schnauzer Club); DOGenes Inc.	ASCT (American Shih tzu club); ALAC (American Lhasa Apso Club); AMSC (American Miniature Schnauzer Club); DOGenes Inc.	This research was funded in part by the ASCT (American Shih tzu club), ALAC (American Lhasa Apso Club), and the AMSC (American Miniature Schnauzer Club). The remainder of the funding was a capital expense of DOGenes Inc. Because one of the authors is employed by the funder, the funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abraham LA, 2003, AUST VET J, V81, P336, DOI 10.1111/j.1751-0813.2003.tb11507.x; APPLEBY SB, 1994, BIOCHEM J, V302, P723, DOI 10.1042/bj3020723; BOOTH K, 1990, VET REC, V127, P596; Bovee KC, 2003, P 28 WORLD C WORLD S; Davidson AG, 2007, J VET INTERN MED, V21, P394, DOI 10.1892/0891-6640(2007)21[394:GCOARH]2.0.CO;2; de Vooght KMK, 2009, CLIN CHEM, V55, P698, DOI 10.1373/clinchem.2008.120931; DeWitt D L, 1993, Am J Med, V95, p40S, DOI 10.1016/0002-9343(93)90396-7; DIBARTOLA SP, 1983, J AM VET MED ASSOC, V183, P693; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; EPSTEIN DJ, 2009, BRIEF FUNCT GENOMIC; HOPPE A, 1990, J SMALL ANIM PRACT, V31, P83, DOI 10.1111/j.1748-5827.1990.tb00728.x; Hoppe A, 2000, J SMALL ANIM PRACT, V41, P422, DOI 10.1111/j.1748-5827.2000.tb03237.x; HORSTER M, 1971, J CLIN INVEST, V50, P779, DOI 10.1172/JCI106549; JONASSON M, 2009, VETERINARPROGRAMMET, V25; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KERLIN RL, 1995, VET PATHOL, V32, P327, DOI 10.1177/030098589503200319; Khan KNM, 2001, VET PATHOL, V38, P116, DOI 10.1354/vp.38-1-116; Kim SH, 2005, ALLERGY, V60, P760, DOI 10.1111/j.1398-9995.2005.00780.x; KLEINMAN LI, 1973, J PHYSIOL-LONDON, V228, P91, DOI 10.1113/jphysiol.1973.sp010074; Komhoff M, 2000, KIDNEY INT, V57, P414; KRUGER JM, 1995, CONGENITAL HEREDITAR; Lobetti RG, 1996, J SMALL ANIM PRACT, V37, P552, DOI 10.1111/j.1748-5827.1996.tb02319.x; LUCKE VM, 1980, J SMALL ANIM PRACT, V21, P169, DOI 10.1111/j.1748-5827.1980.tb01229.x; MANDERINO DM, 1984, MOD VET PRACT, V65, P633; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; MORTON LD, 1990, VET PATHOL, V6, P455; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; NASH AS, 1988, VET REC, V123, P654; NASH AS, 1989, J SMALL ANIM PRACT, V30, P178, DOI 10.1111/j.1748-5827.1989.tb01529.x; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; O'Neill PG, 1993, FEBS LETT, V330, P156; OBRIEN TD, 1982, J AM VET MED ASSOC, V180, P658; Olenick CL, 1999, CAN VET J, V40, P425; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Peeters D, 2000, AUST VET J, V78, P162, DOI 10.1111/j.1751-0813.2000.tb10584.x; PICUT CA, 1987, VET PATHOL, V24, P156, DOI 10.1177/030098588702400209; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROBINSON WF, 1985, AUST VET J, V62, P109, DOI 10.1111/j.1751-0813.1985.tb07253.x; Roels S, 1997, J SMALL ANIM PRACT, V38, P115, DOI 10.1111/j.1748-5827.1997.tb03331.x; Schulze C, 1998, VET QUART, V20, P146, DOI 10.1080/01652176.1998.9694861; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; SIMMONS DL, 1992, PROSTAGLANDINS LEUKO, P67; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stanfield KM, 2003, BIRTH DEFECTS RES A, V67, P54, DOI 10.1002/bdra.10032; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; VILAFRANCA M, 1994, VET PATHOL, V3, P375; Wang SY, 2008, MUTAT RES-FUND MOL M, V638, P26, DOI 10.1016/j.mrfmmm.2007.08.011; ZENZIEGREGORY B, 1992, J BIOL CHEM, V267, P2823; ZENZIEGREGORY B, 1993, MOL CELL BIOL, V13, P3841, DOI 10.1128/MCB.13.7.3841; Zhang MZ, 1997, AM J PHYSIOL-RENAL, V273, pF994, DOI 10.1152/ajprenal.1997.273.6.F994	51	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16684	10.1371/journal.pone.0016684	http://dx.doi.org/10.1371/journal.pone.0016684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346820	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600017
J	Erauso, G; Lakhal, F; Bidault-Toffin, A; Le Chevalier, P; Bouloc, P; Paillard, C; Jacq, A				Erauso, Gael; Lakhal, Fatma; Bidault-Toffin, Adeline; Le Chevalier, Patrick; Bouloc, Philippe; Paillard, Christine; Jacq, Annick			Evidence for the Role of Horizontal Transfer in Generating pVT1, a Large Mosaic Conjugative Plasmid from the Clam Pathogen, Vibrio tapetis	PLOS ONE			English	Article							BROWN RING DISEASE; RUDITAPES-PHILIPPINARUM; VIRULENCE PLASMID; SHIGELLA-FLEXNERI; COMPLETE SEQUENCE; GENETIC ELEMENTS; CAUSATIVE AGENT; MANILA CLAM; IRON UPTAKE; HOST-RANGE	The marine bacterium Vibrio tapetis is the causative agent of the brown ring disease, which affects the clam Ruditapes philippinarum and causes heavy economic losses in North of Europe and in Eastern Asia. Further characterization of V. tapetis isolates showed that all the investigated strains harbored at least one large plasmid. We determined the sequence of the 82,266 bp plasmid pVT1 from the CECT4600(T) reference strain and analyzed its genetic content. pVT1 is a mosaic plasmid closely related to several conjugative plasmids isolated from Vibrio vulnificus strains and was shown to be itself conjugative in Vibrios. In addition, it contains DNA regions that have similarity with several other plasmids from marine bacteria (Vibrio sp., Shewanella sp., Listonella anguillarum and Photobacterium profundum). pVT1 contains a number of mobile elements, including twelve Insertion Sequences or inactivated IS genes and an RS1 phage element related to the CTXphi phage of V. cholerae. The genetic organization of pVT1 underscores an important role of horizontal gene transfer through conjugative plasmid shuffling and transposition events in the acquisition of new genetic resources and in generating the pVT1 modular organization. In addition, pVT1 presents a copy number of 9, relatively high for a conjugative plasmid, and appears to belong to a new type of replicon, which may be specific to Vibrionaceae and Shewanelleacae.	[Le Chevalier, Patrick] Univ Bretagne Occidentale, Lab Univ Biodiversite & Ecol Microbienne, Quimper, France; [Lakhal, Fatma; Bouloc, Philippe; Jacq, Annick] Univ Paris 11, CNRS, Inst Genet & Microbiol,UMR 8621, IFR115, F-91405 Orsay, France; [Erauso, Gael; Bidault-Toffin, Adeline; Paillard, Christine] Univ Bretagne Occidentale, CNRS, Inst Univ Europeen Mer, Lab Sci Environm Marin,UMR 6539, Plouzane, France	Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Erauso, G (corresponding author), Univ Aix Marseille 2, Lab Microbiol & Biotechnol Environm Chauds, IRD,UMR D180, ESIL Case 925, Marseille, France.	annick.jacq@u-psud.fr	Jacq, Annick/H-3896-2012; Bouloc, Philippe/ABA-5732-2021	Jacq, Annick/0000-0002-8526-5942; Bouloc, Philippe/0000-0003-4601-3387; Paillard, Christine/0000-0002-3812-0724	Groupement d'Interet Scientifique; Institut de Genomique Marine; Agence Nationale pour la Recherche [ANR-06-MIME-016-01]; Agence Universitaire de la Francophonie (AUF)	Groupement d'Interet Scientifique; Institut de Genomique Marine; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Agence Universitaire de la Francophonie (AUF)	This work was supported in part by the Groupement d'Interet Scientifique, "Institut de Genomique Marine" and by a grant ANR-06-MIME-016-01 from Agence Nationale pour la Recherche. Additional funding was from state funding to the host institutions. Fatma Lakhal received a fellowship from the Agence Universitaire de la Francophonie (AUF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; BENES V, 1993, GENE, V130, P151, DOI 10.1016/0378-1119(93)90360-F; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Biskri L, 2005, J BACTERIOL, V187, P1740, DOI 10.1128/JB.187.5.1740-1750.2005; Borrego JJ, 1996, INT J SYST BACTERIOL, V46, P480, DOI 10.1099/00207713-46-2-480; Borrego JJ, 1996, AQUAT LIVING RESOUR, V9, P125, DOI 10.1051/alr:1996016; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Bugge DA, 2007, FISH SHELLFISH IMMUN, V23, P188, DOI 10.1016/j.fsi.2006.10.006; Castro D, 1997, APPL ENVIRON MICROB, V63, P1449, DOI 10.1128/AEM.63.4.1449-1452.1997; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Chu CS, 2006, MICROBES INFECT, V8, P1931, DOI 10.1016/j.micinf.2005.12.026; CROSA JH, 1980, NATURE, V284, P566, DOI 10.1038/284566a0; Davis BM, 2002, EMBO J, V21, P4240, DOI 10.1093/emboj/cdf427; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Di Lorenzo M, 2003, J BACTERIOL, V185, P5822, DOI 10.1128/JB.185.19.5822-5830.2003; Dryselius R, 2007, RES MICROBIOL, V158, P479, DOI 10.1016/j.resmic.2007.04.007; Faruque SA, 2002, INFECT IMMUN, V70, P163, DOI 10.1128/IAI.70.1.163-170.2002; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; GUNN JS, 1995, J BACTERIOL, V177, P5040, DOI 10.1128/jb.177.17.5040-5047.1995; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Jennison AV, 2004, FEMS MICROBIOL REV, V28, P43, DOI 10.1016/j.femsre.2003.07.002; Jensen S, 2003, DIS AQUAT ORGAN, V53, P25, DOI 10.3354/dao053025; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kwong SM, 1998, FEMS MICROBIOL LETT, V158, P159, DOI 10.1111/j.1574-6968.1998.tb12815.x; Lakhal F, 2008, APPL ENVIRON MICROB, V74, P5750, DOI 10.1128/AEM.01043-08; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Le Chevalier P, 2003, J BASIC MICROB, V43, P414, DOI 10.1002/jobm.200310241; Leblond P, 1996, MOL MICROBIOL, V19, P261, DOI 10.1046/j.1365-2958.1996.366894.x; Lee CT, 2008, J BACTERIOL, V190, P1638, DOI 10.1128/JB.01484-07; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; LEROUX F, 2010, NUCL ACIDS RES  1004; LEROUX F, 2010, ENV MICROBIOL   0906; LOPEZ JR, 2010, RES VET SCI; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; PAILLARD C, 1990, CR ACAD SCI III-VIE, V310, P15; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P467, DOI 10.1051/alr:2004053; Paillard C, 2008, DIS AQUAT ORGAN, V81, P153, DOI 10.3354/dao01950; Pan L, 2010, J MICROBIOL BIOTECHN, V20, P1163, DOI 10.4014/jmb.1003.03007; Park KI, 2006, AQUACULTURE, V255, P610, DOI 10.1016/j.aquaculture.2005.12.011; Providenti MA, 2006, J MICROBIOL METH, V65, P476, DOI 10.1016/j.mimet.2005.09.007; Reid HI, 2003, AQUACULTURE, V221, P65, DOI 10.1016/S0044-8486(03)00060-7; Reynaud Y, 2008, APPL ENVIRON MICROB, V74, P3038, DOI 10.1128/AEM.02680-07; Sambrook J, 2001, MOL CLONING LAB MANU; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SORUM H, 1992, ANTIMICROB AGENTS CH, V36, P611, DOI 10.1128/AAC.36.3.611; Stork M, 2002, PLASMID, V48, P222, DOI 10.1016/S0147-619X(02)00111-7; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; Thompson FL, 2010, MOL MICROBIOL, V77, P1065, DOI 10.1111/j.1365-2958.2010.07286.x; Travers MA, 2009, J CELL BIOCHEM, V106, P152, DOI 10.1002/jcb.21990; Valiente E, 2008, FISH SHELLFISH IMMUN, V24, P134, DOI 10.1016/j.fsi.2007.10.007; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; WALTER MA, 1983, J BACTERIOL, V156, P880, DOI 10.1128/JB.156.2.880-887.1983; Zhang RF, 2007, J MICROBIOL, V45, P193; Zhang RF, 2009, MAR BIOTECHNOL, V11, P456, DOI 10.1007/s10126-008-9160-3	62	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16759	10.1371/journal.pone.0016759	http://dx.doi.org/10.1371/journal.pone.0016759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326607	Green Published, gold, Green Submitted			2022-12-25	WOS:000287037000018
J	Kita, A; Li, C; Yu, Y; Umeda, N; Doi, A; Yasuda, M; Ishiwata, S; Taga, A; Horiuchi, Y; Sugiura, R				Kita, Ayako; Li, Cuifang; Yu, Yang; Umeda, Nanae; Doi, Akira; Yasuda, Mitsuko; Ishiwata, Shunji; Taga, Atsushi; Horiuchi, Yoshitaka; Sugiura, Reiko			Role of the Small GTPase Rho3 in Golgi/Endosome Trafficking through Functional Interaction with Adaptin in Fission Yeast	PLOS ONE			English	Article							AFFINITY CAPILLARY-ELECTROPHORESIS; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; POLARIZED EXOCYTOSIS; DISTINCT PHENOTYPES; SECRETORY PATHWAY; EXOCYST COMPLEX; CELL-SEPARATION; GENE; PROTEIN	Background: We had previously identified the mutant allele of apm1(+) that encodes a homolog of the mammalian mu 1A subunit of the clathrin-associated adaptor protein-1 (AP-1) complex, and we demonstrated the role of Apm1 in Golgi/endosome trafficking, secretion, and vacuole fusion in fission yeast. Methodology/Principal Findings: In the present study, we isolated rho3+, which encodes a Rho-family small GTPase, an important regulator of exocystosis, as a multicopy-suppressor of the temperature-sensitive growth of the apm1-1 mutant cells. Overexpression of Rho3 suppressed the Cl- sensitivity and immunosuppressant sensitivity of the apm1-1 mutant cells. Overexpression of Rho3 also suppressed the fragmentation of vacuoles, and the accumulation of v-SNARE Syb1 in Golgi/endosomes and partially suppressed the defective secretion associated with apm1-deletion cells. Notably, electron microscopic observation of the rho3-deletion cells revealed the accumulation of abnormal Golgi-like structures, vacuole fragmentation, and accumulation of secretory vesicles; these phenotypes were very similar to those of the apm1-deletion cells. Furthermore, the rho3-deletion cells and apm1-deletion cells showed very similar phenotypic characteristics, including the sensitivity to the immunosuppressant FK506, the cell wall-damaging agent micafungin, Cl-, and valproic acid. Green fluorescent protein (GFP)-Rho3 was localized at Golgi/endosomes as well as the plasma membrane and division site. Finally, Rho3 was shown to form a complex with Apm1 as well as with other subunits of the clathrin-associated AP-1 complex in a GTP- and effector domain-dependent manner. Conclusions/Significance: Taken together, our findings reveal a novel role of Rho3 in the regulation of Golgi/endosome trafficking and suggest that clathrin-associated adaptor protein-1 and Rho3 co-ordinate in intracellular transport in fission yeast. To the best of our knowledge, this study provides the first evidence of a direct link between the small GTPase Rho and the clathrin-associated adaptor protein-1 in membrane trafficking.	[Kita, Ayako; Li, Cuifang; Yu, Yang; Umeda, Nanae; Doi, Akira; Yasuda, Mitsuko; Ishiwata, Shunji; Sugiura, Reiko] Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan; [Taga, Atsushi] Kinki Univ, Sch Pharmaceut Sci, Lab Pharmaceut Analyt Chem, Higashiosaka, Osaka 577, Japan; [Horiuchi, Yoshitaka] Kinki Univ, Life Sci Res Inst, Osakasayama, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Kindai University (Kinki University)	Kita, A (corresponding author), Kinki Univ, Sch Pharmaceut Sci, Lab Mol Pharmacogen, Higashiosaka, Osaka 577, Japan.	sugiurar@phar.kindai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [11J10625] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by Grant-in-Aid for Scientific Research on Innovative Areas, and research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.org.kobe-u.ac.jp/rna/english.html) (to RS). This work was also financially supported by "Antiaging Center Project" for Private Universities from Ministry of Education, Culture, Sports, Science and Technology (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; BEACH D, 1982, MOL GEN GENET, V187, P326, DOI 10.1007/BF00331138; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Brennwald P, 2007, FEBS LETT, V581, P2119, DOI 10.1016/j.febslet.2007.03.043; Cheng H, 2002, MOL BIOL CELL, V13, P2963, DOI 10.1091/mbc.01-09-0463; Edamatsu M, 2003, BIOCHEM BIOPH RES CO, V301, P641, DOI 10.1016/S0006-291X(03)00017-2; Gasman S, 2003, NAT CELL BIOL, V5, P195, DOI 10.1038/ncb935; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Imai J, 1996, GENETICS, V142, P359; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; Kita A, 2004, MOL BIOL CELL, V15, P2920, DOI 10.1091/mbc.E03-09-0659; Ma Y, 2009, GENES CELLS, V14, P1015, DOI 10.1111/j.1365-2443.2009.01327.x; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Taga A, 2008, J PHARMACEUT BIOMED, V46, P395, DOI 10.1016/j.jpba.2007.10.002; Taga A, 2010, J PHARMACEUT BIOMED, V53, P1332, DOI 10.1016/j.jpba.2010.07.009; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Toda T, 1996, MOL CELL BIOL, V16, P6752; Wang HY, 2003, GENETICS, V164, P1323; Wang HY, 2002, MOL BIOL CELL, V13, P515, DOI 10.1091/mbc.01-11-0542; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501	27	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16842	10.1371/journal.pone.0016842	http://dx.doi.org/10.1371/journal.pone.0016842			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304827	gold, Green Submitted, Green Published			2022-12-25	WOS:000287036600032
J	Xia, XA; Yan, JH; Shen, YF; Tang, KX; Yin, J; Zhang, YH; Yang, DJ; Liang, H; Ye, JP; Weng, JP				Xia, Xuan; Yan, Jinhua; Shen, Yunfeng; Tang, Kuanxiao; Yin, Jun; Zhang, Yanhua; Yang, Dongjie; Liang, Hua; Ye, Jianping; Weng, Jianping			Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FOXO TRANSCRIPTION FACTORS; ELEMENT-BINDING PROTEIN; INSULIN-RESISTANCE; MECHANISM DISTINCT; LIPID HOMEOSTASIS; MUSCLE ATROPHY; LIVER; EXPRESSION; CARBOHYDRATE	Berberine (BBR) is a compound originally identified in a Chinese herbal medicine Huanglian (Coptis chinensis French). It improves glucose metabolism in type 2 diabetic patients. The mechanisms involve in activation of adenosine monophosphate activated protein kinase (AMPK) and improvement of insulin sensitivity. However, it is not clear if BBR reduces blood glucose through other mechanism. In this study, we addressed this issue by examining liver response to BBR in diabetic rats, in which hyperglycemia was induced in Sprague-Dawley rats by high fat diet. We observed that BBR decreased fasting glucose significantly. Gluconeogenic genes, Phosphoenolpyruvate carboxykinase (PEPCK) and Glucose-6-phosphatase (G6Pase), were decreased in liver by BBR. Hepatic steatosis was also reduced by BBR and expression of fatty acid synthase (FAS) was inhibited in liver. Activities of transcription factors including Forkhead transcription factor O1 (FoxO1), sterol regulatory element-binding protein 1c (SREBP1) and carbohydrate responsive element-binding protein (ChREBP) were decreased. Insulin signaling pathway was not altered in the liver. In cultured hepatocytes, BBR inhibited oxygen consumption and reduced intracellular adenosine triphosphate (ATP) level. The data suggest that BBR improves fasting blood glucose by direct inhibition of gluconeogenesis in liver. This activity is not dependent on insulin action. The gluconeogenic inhibition is likely a result of mitochondria inhibition by BBR. The observation supports that BBR improves glucose metabolism through an insulin-independent pathway.	[Xia, Xuan; Yan, Jinhua; Shen, Yunfeng; Tang, Kuanxiao; Zhang, Yanhua; Liang, Hua; Weng, Jianping] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Yang, Dongjie] Sun Yat Sen Univ, Dept Gastrointestinal Pancreat Surg, Affiliated Hosp 1, Guangzhou, Peoples R China; [Yin, Jun; Ye, Jianping] Louisiana State Univ, Pennington Biomed Res Ctr, Eunice, LA USA	Sun Yat Sen University; Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University at Eunice	Xia, XA (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 3, Guangzhou, Peoples R China.	wjianp@mail.sysu.edu.cn	Ye, Jianping/N-1998-2017; xia, xuan/AAX-3796-2020	Ye, Jianping/0000-0003-3875-365X; xia, xuan/0000-0002-4788-1971; Weng, Jianping/0000-0002-7889-1697	973 Program of China [2006CB503902]; Program for Changjiang Scholars and Innovative Research Team in University (985 project) [PCSIRT 0947]; National Science Fund for Distinguished Young Scholars [81025005]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, P30DK072476, R56DK068036] Funding Source: NIH RePORTER	973 Program of China(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University (985 project)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by 973 Program of China 2006CB503902, Program for Changjiang Scholars and Innovative Research Team in University (985 project PCSIRT 0947), National Science Fund for Distinguished Young Scholars 81025005 (to Jianping Weng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto MC, 2003, TOXICOL LETT, V146, P37, DOI 10.1016/j.toxlet.2003.09.007; Bi Y, 2009, METABOLISM, V58, P779, DOI 10.1016/j.metabol.2009.01.011; Brusq JM, 2006, J LIPID RES, V47, P1281, DOI 10.1194/jlr.M600020-JLR200; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Cheng Z, 2006, BBA-GEN SUBJECTS, V1760, P1682, DOI 10.1016/j.bbagen.2006.09.007; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Ko BS, 2005, BIOL PHARM BULL, V28, P1431, DOI 10.1248/bpb.28.1431; Kong WJ, 2009, METABOLISM, V58, P109, DOI 10.1016/j.metabol.2008.08.013; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Liu YT, 2010, DRUG METAB DISPOS, V38, P1779, DOI 10.1124/dmd.110.033936; Lu SS, 2009, J ENDOCRINOL, V200, P159, DOI 10.1677/JOE-08-0419; MIKES V, 1985, J BIOENERG BIOMEMBR, V17, P23, DOI 10.1007/BF00744986; MIKES V, 1983, BIOCHIM BIOPHYS ACTA, V723, P231, DOI 10.1016/0005-2728(83)90122-6; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang HL, 2010, DIABETES, V59, P1879, DOI 10.2337/db10-0207; Wang Liang, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2017; Wang XL, 2005, LIFE SCI, V77, P3058, DOI 10.1016/j.lfs.2005.02.033; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Yin J, 2008, AM J PHYSIOL-ENDOC M, V294, pE148, DOI 10.1152/ajpendo.00211.2007; Yu YL, 2010, BIOCHEM PHARMACOL, V79, P1000, DOI 10.1016/j.bcp.2009.11.017; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; Zhang YF, 2008, J CLIN ENDOCR METAB, V93, P2559, DOI 10.1210/jc.2007-2404; Zhou LB, 2007, METABOLISM, V56, P405, DOI 10.1016/j.metabol.2006.10.025	34	201	230	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16556	10.1371/journal.pone.0016556	http://dx.doi.org/10.1371/journal.pone.0016556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304897	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600009
J	Bailey, I; Gibson, GG; Plant, K; Graham, M; Plant, N				Bailey, Ian; Gibson, G. Gordon; Plant, Kathryn; Graham, Mark; Plant, Nick			A PXR-Mediated Negative Feedback Loop Attenuates the Expression of CYP3A in Response to the PXR Agonist Pregnenalone-16 alpha-Carbonitrile	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; INTERACTION NETWORKS; NUCLEAR RECEPTORS; HUMAN HEPATOCYTES; LITHOCHOLIC ACID; OXIDATIVE STRESS; MICROARRAY DATA	The nuclear receptor superfamily of ligand-activated transcription factors plays a central role in the regulation of cellular responses to chemical challenge. Nuclear receptors are activated by a wide range of both endogenous and exogenous chemicals, and their target genes include those involved in the metabolism and transport of the activating chemical. Such target gene activation, thus, acts to remove the stimulating xenobiotic or to maintain homeostatic levels of endogenous chemicals. Given the dual nature of this system it is important to understand how these two roles are balanced, such that xenobiotics are efficiently removed while not impacting negatively on homeostasis of endogenous chemicals. Using DNA microarray technology we have examined the transcriptome response of primary rat hepatocytes to two nuclear receptor ligands: Pregnenalone-16 alpha-carbonitrile (PCN), a xenobiotic PXR agonist, and lithocholic acid, an endogenous mixed PXR/VDR/FXR agonist. We demonstrate that despite differences in the profile of activated nuclear receptors, transcriptome responses for these two ligands are broadly similar at lower concentrations, indicating a conserved general response. However, as concentrations of stimulating ligand rises, the transcriptome responses diverge, reflecting a need for specific responses to the two stimulating chemicals. Finally, we demonstrate a novel feed-back loop for PXR, whereby ligand-activation of PXR suppresses transcription of the PXR gene, acting to attenuate PXR protein expression levels at higher ligand concentrations. Through in silico simulation we demonstrate that this feed-back loop is an important factor to prevent hyperexpression of PXR target genes such as CYP3A and confirm these findings in vitro. This novel insight into the regulation of the PXR-mediated regulatory signal networks provides a potential mechanistic rationale for the robustness in steroid homeostasis within the cell.	[Bailey, Ian; Gibson, G. Gordon; Plant, Kathryn; Plant, Nick] Univ Surrey, Fac Hlth & Med Sci, Ctr Toxicol, Surrey, England; [Graham, Mark] AstraZeneca R&D Charnwood, Safety Assessment, Leicester, Leics, England	University of Surrey; AstraZeneca	Bailey, I (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Ctr Toxicol, Surrey, England.	N.Plant@Surrey.ac.uk	Plant, Nick/E-4510-2011	Plant, Nick/0000-0003-4332-8308; Plant, Kate/0000-0002-6120-5419; Bailey, Ian/0000-0001-9262-0669	AstraZeneca; The Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council [EP/E500293/1] Funding Source: researchfish	AstraZeneca(AstraZeneca); The Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by AstraZeneca and The Biotechnology and Biological Sciences Research Council (BBSRC). Dr. Mark Graham (AstraZeneca) provided input into the study design, data collection and analysis, and preparation of the manuscript.	Aouabdi S, 2006, DRUG METAB DISPOS, V34, P138, DOI 10.1124/dmd.105.006064; Bavner A, 2005, TRENDS ENDOCRIN MET, V16, P478, DOI 10.1016/j.tem.2005.10.005; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Sankary W, 2001, DRUG METAB DISPOS, V29, P1499; Eloranta JJ, 2005, METHOD ENZYMOL, V400, P511, DOI 10.1016/S0076-6879(05)00028-5; Gibson GG, 2006, DRUG METAB REV, V38, P31, DOI 10.1080/03602530600569810; Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200; Guzelian J, 2006, TOXICOL SCI, V94, P379, DOI 10.1093/toxsci/kfl116; Howe K, 2009, DRUG METAB DISPOS, V37, P391, DOI 10.1124/dmd.108.022921; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kamiya A, 2003, HEPATOLOGY, V37, P1375, DOI 10.1053/jhep.2003.50212; Khan AA, 2009, EUR J PHARM SCI, V37, P115, DOI 10.1016/j.ejps.2009.01.006; Kimura T, 2008, J HEALTH SCI, V54, P251, DOI 10.1248/jhs.54.251; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lichti-Kaiser K, 2009, J PHARMACOL EXP THER, V331, P65, DOI 10.1124/jpet.109.157180; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Makishima M, 2005, J PHARMACOL SCI, V97, P177, DOI 10.1254/jphs.FMJ04008X4; Masson D, 2005, ARTERIOSCL THROM VAS, V25, P2164, DOI 10.1161/01.ATV.0000183674.88817.fb; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nehring JA, 2007, P NATL ACAD SCI USA, V104, P10006, DOI 10.1073/pnas.0703512104; Nomoto M, 2009, BIOL PHARM BULL, V32, P172, DOI 10.1248/bpb.32.172; Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pascussi JM, 2005, J CLIN INVEST, V115, P177, DOI 10.1172/JCI200521867; Phillips A, 2005, DRUG METAB DISPOS, V33, P233, DOI 10.1124/dmd.104.001461; Plant KE, 2006, PHARMACOGENET GENOM, V16, P647, DOI 10.1097/01.fpc.0000220570.82842.4d; Plant N, 2004, TOXICOLOGY, V202, P21, DOI 10.1016/j.tox.2004.06.028; Plant N, 2009, XENOBIOTICA, V39, P597, DOI 10.1080/00498250903098218; Plant N, 2003, MOL TOXICOLOGY; Plant N, 2007, BBA-GEN SUBJECTS, V1770, P478, DOI 10.1016/j.bbagen.2006.09.024; Plant NJ, 2003, CURR OPIN DRUG DI DE, V6, P50; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Roberts RA, 1997, FUND APPL TOXICOL, V38, P107, DOI 10.1006/faat.1997.2331; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmiedlin-Ren P, 2001, DRUG METAB DISPOS, V29, P1446; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Slatter JG, 2006, XENOBIOTICA, V36, P902, DOI 10.1080/00498250600861694; Smirlis D, 2001, J BIOL CHEM, V276, P12822, DOI 10.1074/jbc.M005930200; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Tan KP, 2007, MOL PHARMACOL, V72, P1380, DOI 10.1124/mol.107.039370; Tateishi Y, 2006, MOL CELL BIOL, V26, P7966, DOI 10.1128/MCB.00713-06; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200; ZILLIACUS J, 1994, P NATL ACAD SCI USA, V91, P4175, DOI 10.1073/pnas.91.10.4175	51	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16703	10.1371/journal.pone.0016703	http://dx.doi.org/10.1371/journal.pone.0016703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311750	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200034
J	Hnilicova, J; Hozeifi, S; Duskova, E; Icha, J; Tomankova, T; Stanek, D				Hnilicova, Jarmila; Hozeifi, Samira; Duskova, Eva; Icha, Jaroslav; Tomankova, Tereza; Stanek, David			Histone Deacetylase Activity Modulates Alternative Splicing	PLOS ONE			English	Article							PRE-MESSENGER-RNA; FIBRONECTIN EIIIB EXON; II TRANSCRIPTION; SR PROTEINS; IN-VIVO; CHROMATIN; ELONGATION; POLYMERASE; ACETYLATION; RECRUITMENT	There is increasing evidence to suggest that splicing decisions are largely made when the nascent RNA is still associated with chromatin. Here we demonstrate that activity of histone deacetylases (HDACs) influences splice site selection. Using splicing-sensitive microarrays, we identified similar to 700 genes whose splicing was altered after HDAC inhibition. We provided evidence that HDAC inhibition induced histone H4 acetylation and increased RNA Polymerase II (Pol II) processivity along an alternatively spliced element. In addition, HDAC inhibition reduced co-transcriptional association of the splicing regulator SRp40 with the target fibronectin exon. We further showed that the depletion of HDAC1 had similar effect on fibronectin alternative splicing as global HDAC inhibition. Importantly, this effect was reversed upon expression of mouse HDAC1 but not a catalytically inactive mutant. These results provide a molecular insight into a complex modulation of splicing by HDACs and chromatin modifications.	[Hnilicova, Jarmila; Hozeifi, Samira; Duskova, Eva; Icha, Jaroslav; Tomankova, Tereza; Stanek, David] Inst Mol Genet AS CR, Dept RNA Biol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hnilicova, J (corresponding author), Inst Mol Genet AS CR, Dept RNA Biol, Prague, Czech Republic.	stanek@img.cas.cz	Stanek, David/G-9576-2013; Hnilicova, Jarmila/J-5019-2014; Dyskova, Tereza/A-3026-2015	Stanek, David/0000-0002-5865-175X; Hnilicova, Jarmila/0000-0002-0953-491X; Dyskova, Tereza/0000-0003-1705-4657; Icha, Jaroslav/0000-0002-0657-3278	Max Planck Society; Czech Science Foundation [P305/10/0424]; Academy of Sciences of the Czech Republic [KAN200520801, AV0Z50520514]	Max Planck Society(Max Planck Society); Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This project was supported by grants from the Max Planck Society (the Partner group program), the Czech Science Foundation (P305/10/0424) and from the Academy of Sciences of the Czech Republic (KAN200520801, AV0Z50520514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Blackwell L, 2008, LIFE SCI, V82, P1050, DOI 10.1016/j.lfs.2008.03.004; CAPUTI M, 1994, NUCLEIC ACIDS RES, V22, P1018, DOI 10.1093/nar/22.6.1018; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; de la Mata M, 2006, NAT STRUCT MOL BIOL, V13, P973, DOI 10.1038/nsmb1155; Du KY, 1997, MOL CELL BIOL, V17, P4096, DOI 10.1128/MCB.17.7.4096; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007; Gunderson FQ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000682; Hicks MJ, 2006, PLOS BIOL, V4, P943, DOI 10.1371/journal.pbio.0040147; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Huranova M, 2009, HUM MOL GENET, V18, P2014, DOI 10.1093/hmg/ddp125; Irimia M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005800; Kadener S, 2002, P NATL ACAD SCI USA, V99, P8185, DOI 10.1073/pnas.122246099; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Kotovic KM, 2003, MOL CELL BIOL, V23, P5768, DOI 10.1128/MCB.23.16.5768-5779.2003; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Lacadie SA, 2005, MOL CELL, V19, P65, DOI 10.1016/j.molcel.2005.05.006; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lim LP, 1998, MOL CELL BIOL, V18, P3900, DOI 10.1128/MCB.18.7.3900; Listerman I, 2006, NAT STRUCT MOL BIOL, V13, P815, DOI 10.1038/nsmb1135; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nahkuri S, 2009, CELL CYCLE, V8, P3420, DOI 10.4161/cc.8.20.9916; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; NORTON PA, 1993, BIOCHEM BIOPH RES CO, V195, P215, DOI 10.1006/bbrc.1993.2032; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; Pandya-Jones A, 2009, RNA, V15, P1896, DOI 10.1261/rna.1714509; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Roberts GC, 1998, NUCLEIC ACIDS RES, V26, P5568, DOI 10.1093/nar/26.24.5568; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Taplick J, 2001, J MOL BIOL, V308, P27, DOI 10.1006/jmbi.2001.4569; TILGNER H, 2009, NAT STRUCT MOL BIOL; Tyagi A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000470; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; White ES, 2008, J PATHOL, V216, P1, DOI 10.1002/path.2388; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhou JH, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S10	55	104	110	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16727	10.1371/journal.pone.0016727	http://dx.doi.org/10.1371/journal.pone.0016727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311748	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200036
J	Jaiswal, AS; Banerjee, S; Aneja, R; Sarkar, FH; Ostrov, DA; Narayan, S				Jaiswal, Aruna S.; Banerjee, Sanjeev; Aneja, Ritu; Sarkar, Fazlul H.; Ostrov, David A.; Narayan, Satya			DNA Polymerase beta as a Novel Target for Chemotherapeutic Intervention of Colorectal Cancer	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; BASE EXCISION-REPAIR; MISMATCH REPAIR; LONG-PATCH; CELL-LINES; PHASE-I; TEMOZOLOMIDE; APC; MUTATIONS; PROTEIN	Chemoprevention presents a major strategy for the medical management of colorectal cancer. Most drugs used for colorectal cancer therapy induce DNA-alkylation damage, which is primarily repaired by the base excision repair (BER) pathway. Thus, blockade of BER pathway is an attractive option to inhibit the spread of colorectal cancer. Using an in silico approach, we performed a structure-based screen by docking small-molecules onto DNA polymerase beta (Pol-beta) and identified a potent anti-Pol-beta compound, NSC-124854. Our goal was to examine whether NSC-124854 could enhance the therapeutic efficacy of DNA-alkylating agent, Temozolomide (TMZ), by blocking BER. First, we determined the specificity of NSC-124854 for Pol-beta by examining in vitro activities of APE1, Fen1, DNA ligase I, and Pol-beta-directed single nucleotide (SN)and long-patch (LP)-BER. Second, we investigated the effect of NSC-124854 on the efficacy of TMZ to inhibit the growth of mismatch repair (MMR)-deficient and MMR-proficient colon cancer cell lines using in vitro clonogenic assays. Third, we explored the effect of NSC-124854 on TMZ-induced in vivo tumor growth inhibition of MMR-deficient and MMR-proficient colonic xenografts implanted in female homozygous SCID mice. Our data showed that NSC-124854 has high specificity to Pol-beta and blocked Pol-beta-directed SN- and LP-BER activities in in vitro reconstituted system. Furthermore, NSC-124854 effectively induced the sensitivity of TMZ to MMR-deficient and MMR-proficient colon cancer cells both in vitro cell culture and in vivo xenograft models. Our findings suggest a potential novel strategy for the development of highly specific structure-based inhibitor for the prevention of colonic tumor progression.	[Jaiswal, Aruna S.; Narayan, Satya] Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Sch Med, Dept Pathol, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA; [Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Ostrov, David A.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; Barbara Ann Karmanos Cancer Institute; Wayne State University; University System of Georgia; Georgia State University; State University System of Florida; University of Florida	Jaiswal, AS (corresponding author), Univ Florida, Coll Med, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	snarayan@ufl.edu			National Cancer Institute, National Institutes of Health, Bethesda, MD, USA [R01 CA-097031, CA-100247]; NATIONAL CANCER INSTITUTE [R01CA100247, R01CA097031] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute, National Institutes of Health, Bethesda, MD, USA (R01 CA-097031 and CA-100247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P417; Adhikari S, 2008, ANTI-CANCER AGENT ME, V8, P351, DOI 10.2174/187152008784220366; Balusu R, 2007, BIOCHEMISTRY-US, V46, P13961, DOI 10.1021/bi701632e; Barcellos GB, 2008, CURR DRUG TARGETS, V9, P1084, DOI 10.2174/138945008786949388; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Brandes AA, 2002, ONCOLOGY-BASEL, V63, P38, DOI 10.1159/000065718; Cai W, 2010, BRIT J CANCER, V103, P1369, DOI 10.1038/sj.bjc.6605927; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P327, DOI 10.2174/138945010790711941; Deka J, 1999, ONCOGENE, V18, P5654, DOI 10.1038/sj.onc.1202944; Dhaliwal B., 2009, Infectious Disorders - Drug Targets, V9, P557; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fishel ML, 2007, CLIN CANCER RES, V13, P260, DOI 10.1158/1078-0432.CCR-06-1920; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hainsworth JD, 2010, CANCER-AM CANCER SOC, V116, P3663, DOI 10.1002/cncr.25275; Horton JK, 2007, DNA REPAIR, V6, P530, DOI 10.1016/j.dnarep.2006.10.016; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Jacob S, 2001, CANCER RES, V61, P6555; Jaiswal AS, 2008, CANCER LETT, V271, P272, DOI 10.1016/j.canlet.2008.06.024; Jaiswal AS, 2006, BIOCHEMISTRY-US, V45, P15903, DOI 10.1021/bi0607958; Jaiswal AS, 2009, MOL CANCER RES, V7, P1973, DOI 10.1158/1541-7786.MCR-09-0309; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kaina B, 2001, PROG NUCLEIC ACID RE, V68, P41; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; KARRAN P, 1994, BIOESSAYS, V16, P833, DOI 10.1002/bies.950161110; Kawate H, 1998, P NATL ACAD SCI USA, V95, P5116, DOI 10.1073/pnas.95.9.5116; Khan OA, 2008, BRIT J CANCER, V98, P1614, DOI 10.1038/sj.bjc.6604366; KOI M, 1994, CANCER RES, V54, P4308; Kouzmenko AP, 2008, ONCOGENE, V27, P4888, DOI 10.1038/onc.2008.127; Kroemer RT, 2007, CURR PROTEIN PEPT SC, V8, P312; Kundu CN, 2007, ONCOGENE, V26, P1428, DOI 10.1038/sj.onc.1209925; Kundu CN, 2007, CARCINOGENESIS, V28, P2089, DOI 10.1093/carcin/bgm125; Liu L, 1999, CLIN CANCER RES, V5, P2908; Liu Lili, 2004, Curr Opin Investig Drugs, V5, P623; Liu LL, 2002, CLIN CANCER RES, V8, P2985; Liu LL, 1996, CANCER RES, V56, P5375; Liu LL, 2006, CLIN CANCER RES, V12, P328, DOI 10.1158/1078-0432.CCR-05-2543; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Narayan S, 2005, J BIOL CHEM, V280, P6942, DOI 10.1074/jbc.M409200200; Narayan Satya, 2003, Mol Cancer, V2, P41, DOI 10.1186/1476-4598-2-41; NEWLANDS ES, 1992, BRIT J CANCER, V65, P287, DOI 10.1038/bjc.1992.57; Panda H, 2009, BIOCHEMISTRY-US, V48, P9952, DOI 10.1021/bi9010754; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Qian J, 2008, GASTROENTEROLOGY, V135, P152, DOI 10.1053/j.gastro.2008.03.074; Sarkaria JN, 2008, CLIN CANCER RES, V14, P2900, DOI 10.1158/1078-0432.CCR-07-1719; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Seiter K, 2002, J CLIN ONCOL, V20, P3249, DOI 10.1200/JCO.2002.01.030; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Spiro TP, 2001, CLIN CANCER RES, V7, P2309; Taverna P, 2000, CANCER CHEMOTH PHARM, V46, P507, DOI 10.1007/s002800000186; Taverna P, 2001, MUTAT RES-DNA REPAIR, V485, P269, DOI 10.1016/S0921-8777(01)00076-3; Tentori L, 1998, J PHARMACOL EXP THER, V285, P884; Thompson Patricia A, 2009, Expert Rev Gastroenterol Hepatol, V3, P369, DOI 10.1586/egh.09.28; Trivedi RN, 2008, MOL PHARMACOL, V74, P505, DOI 10.1124/mol.108.045112; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Trudeau ME, 2006, ANN ONCOL, V17, P952, DOI 10.1093/annonc/mdl056; Veselovsky A. V., 2003, Current Drug Targets - Infectious Disorders, V3, P33, DOI 10.2174/1568005033342145; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	67	38	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16691	10.1371/journal.pone.0016691	http://dx.doi.org/10.1371/journal.pone.0016691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311763	Green Published, gold			2022-12-25	WOS:000287036200032
J	Margam, VM; Coates, BS; Hellmich, RL; Agunbiade, T; Seufferheld, MJ; Sun, WL; Ba, MN; Sanon, A; Binso-Dabire, CL; Baoua, I; Ishiyaku, MF; Covas, FG; Srinivasan, R; Armstrong, J; Murdock, LL; Pittendrigh, BR				Margam, Venu M.; Coates, Brad S.; Hellmich, Richard L.; Agunbiade, Tolulope; Seufferheld, Manfredo J.; Sun, Weilin; Ba, Malick N.; Sanon, Antoine; Binso-Dabire, Clementine L.; Baoua, Ibrahim; Ishiyaku, Mohammad F.; Covas, Fernando G.; Srinivasan, Ramasamy; Armstrong, Joel; Murdock, Larry L.; Pittendrigh, Barry R.			Mitochondrial Genome Sequence and Expression Profiling for the Legume Pod Borer Maruca vitrata (Lepidoptera: Crambidae)	PLOS ONE			English	Article							TRANSFER-RNA GENES; MESSENGER-RNA; NUCLEOTIDE-SEQUENCE; PUNCTUATION MODEL; CODON USAGE; TRANSCRIPTION; DNA; DROSOPHILA; IDENTIFICATION; TRANSLATION	We report the assembly of the 14,054 bp near complete sequencing of the mitochondrial genome of the legume pod borer (LPB), Maruca vitrata (Lepidoptera: Crambidae), which we subsequently used to estimate divergence and relationships within the lepidopteran lineage. The arrangement and orientation of the 13 protein-coding, 2 rRNA, and 19 tRNA genes sequenced was typical of insect mitochondrial DNA sequences described to date. The sequence contained a high A+T content of 80.1% and a bias for the use of codons with A or T nucleotides in the 3rd position. Transcript mapping with midgut and salivary gland ESTs for mitochondrial genome annotation showed that translation from protein-coding genes initiates and terminates at standard mitochondrial codons, except for the coxI gene, which may start from an arginine CGA codon. The genomic copy of coxII terminates at a T nucleotide, and a proposed polyadenylation mechanism for completion of the TAA stop codon was confirmed by comparisons to EST data. EST contig data further showed that mature M. vitrata mitochondrial transcripts are monocistronic, except for bicistronic transcripts for overlapping genes nd4/nd4L and nd6/cytb, and a tricistronic transcript for atp8/atp6/coxIII. This processing of polycistronic mitochondrial transcripts adheres to the tRNA punctuated cleavage mechanism, whereby mature transcripts are cleaved only at intervening tRNA gene sequences. In contrast, the tricistronic atp8/atp6/coxIII in Drosophila is present as separate atp8/atp6 and coxIII transcripts despite the lack of an intervening tRNA. Our results indicate that mitochondrial processing mechanisms vary between arthropod species, and that it is crucial to use transcriptional information to obtain full annotation of mitochondrial genomes.	[Margam, Venu M.; Murdock, Larry L.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Coates, Brad S.; Hellmich, Richard L.] Iowa State Univ, USDA ARS, Corn Insect & Crop Genet Res Unit, Genet Lab, Ames, IA USA; [Agunbiade, Tolulope; Sun, Weilin; Pittendrigh, Barry R.] Univ Illinois, Dept Entomol, Champaign, IL 61820 USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Champaign, IL 61820 USA; [Ba, Malick N.; Sanon, Antoine; Binso-Dabire, Clementine L.] Inst Environm & Rech Agricoles INERA, Stn Kamboinse, Ouagadougou, Burkina Faso; [Baoua, Ibrahim] Inst Natl Rech Agron Niger, Maradi, Niger; [Ishiyaku, Mohammad F.] Ahmadu Bello Univ, Inst Agr Res, Dept Plant Sci, Zaria, Nigeria; [Covas, Fernando G.] Univ Puerto Rico, Mayaguez, PR USA; [Srinivasan, Ramasamy] AVRDC World Vegetable Ctr, Tainan, Taiwan; [Armstrong, Joel] Commonweatlth Sci & Ind Res Org, Black Mt, ACT, Australia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Ahmadu Bello University; Institute for Agricultural Research, Samaru, Zaria; University of Puerto Rico; University of Puerto Rico Mayaguez; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Margam, VM (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	pittendr@illinois.edu	Sanon, Antoine/H-7203-2016; Ramasamy, Srinivasan/N-1686-2019; Ba, Malick Niango/I-8557-2012; Armstrong, Joel/E-6873-2011; Margam, Venu M/E-5876-2010	Sanon, Antoine/0000-0002-2046-8503; Ramasamy, Srinivasan/0000-0002-8454-7331; Ba, Malick Niango/0000-0001-7323-8739; Margam, Venu/0000-0001-6510-4618; Coates, Brad/0000-0001-8908-1529	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development [EDH-A-00-07-00005]	Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development(United States Agency for International Development (USAID))	This research has been made possible through support provided to the Dry Grains Pulses Collaborative Research Support Program (CRSP) by the Bureau for Economic Growth, Agriculture, and Trade, U.S. Agency for International Development, under the terms of Grant No. EDH-A-00-07-00005. The opinions expressed herein are those of the authors and do not necessarily reflect the views of the U.S. Agency for International Development or the U.S. government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arodokoun DY, 2006, AGR ECOSYST ENVIRON, V113, P320, DOI 10.1016/j.agee.2005.10.014; BERTHIER F, 1986, NUCLEIC ACIDS RES, V14, P4519, DOI 10.1093/nar/14.11.4519; BINDRA OS, 1968, 2 ANN WORKSH PULS CR; Bobrowicz AJ, 2008, BIOCHEM SOC T, V36, P517, DOI 10.1042/BST0360517; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bravo JP, 2008, BRAZ ARCH BIOL TECHN, V51, P671, DOI 10.1590/S1516-89132008000400004; CHINH NT, 2000, LEGUMES RICE BASED C, P111; CHRISTIANSON TW, 1986, P NATL ACAD SCI USA, V83, P6277, DOI 10.1073/pnas.83.17.6277; CHURCHILL GA, 1989, B MATH BIOL, V51, P79; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Coates BS, 2005, INT J BIOL SCI, V1, P13; CROZIER RH, 1993, GENETICS, V133, P97; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hong GY, 2009, ACTA BIOCH BIOPH SIN, V41, P446, DOI 10.1093/abbs/gmp030; Huang CC, 2003, BIOCONTROL, V48, P407, DOI 10.1023/A:1024751300838; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Jiang Wen-Ping, 2010, Yichuan, V32, P153, DOI 10.3724/SP.J.1005.2010.00153; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; KASAMATSU H, 1971, P NATL ACAD SCI USA, V68, P2252, DOI 10.1073/pnas.68.9.2252; KATAYAMA J, 1984, B KYOTO PREFECT I AG, V12, P27; Kim I, 2006, INSECT MOL BIOL, V15, P217, DOI 10.1111/j.1365-2583.2006.00630.x; Kumar S, 2001, GENETICS, V158, P1321; Lee ES, 2006, GENE, V373, P52, DOI 10.1016/j.gene.2006.01.003; LEONARD M. D., 1931, Journal of Economic Entomology, V24, P466, DOI 10.1093/jee/24.2.466; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Margam VM, 2010, MOL BIOL REP; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Patnaik H. P., 1986, Legume Research, V9, P7; Piechota J, 2006, ACTA BIOCHIM POL, V53, P157; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; RAHEJA AJ, 1974, P 1 IITA GRAIN LEG I, P295; RAHMAN MM, 1989, BANG J SCI RES, V7, P27; Ruppel RF, 1962, AGR TROP, V18, P650; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Samuels AK, 2005, GENE, V349, P43, DOI 10.1016/j.gene.2004.12.037; Scheibye-Alsing K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-367; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; SHARMA HC, 1999, INFORM B ICRISAT, V55; SINGH SR, 1979, ANNU REV ENTOMOL, V24, P255, DOI 10.1146/annurev.en.24.010179.001351; Soeun M., 2001, Legumes in rice-based cropping systems in tropical Asia: constraints and opportunities, P4; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor T. A., 1967, Journal of the West African Science Association, V12, P111; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; Ulrichs Ch., 2001, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V13, P283; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW84, DOI 10.1093/nar/gkl227; Xia XH, 1996, GENETICS, V144, P1309; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zardoya R, 2001, P NATL ACAD SCI USA, V98, P7380, DOI 10.1073/pnas.111455498	71	49	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16444	10.1371/journal.pone.0016444	http://dx.doi.org/10.1371/journal.pone.0016444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311752	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200013
J	Dal-Pan, A; Pifferi, F; Marchal, J; Picq, JL; Aujard, F				Dal-Pan, Alexandre; Pifferi, Fabien; Marchal, Julia; Picq, Jean-Luc; Aujard, Fabienne		RESTRIKAL Consortium	Cognitive Performances Are Selectively Enhanced during Chronic Caloric Restriction or Resveratrol Supplementation in a Primate	PLOS ONE			English	Article							MOUSE LEMUR PRIMATES; DIETARY RESTRICTION; OXIDATIVE STRESS; RHESUS-MONKEYS; LIFE-SPAN; MEMORY; RATS; DISEASE; BEHAVIOR; SYSTEM	Effects of an 18-month treatment with a moderate, chronic caloric restriction (CR) or an oral supplementation with resveratrol (RSV), a potential CR mimetic, on cognitive and motor performances were studied in non-human primates, grey mouse lemurs (Microcebus murinus). Thirty-three adult male mouse lemurs were assigned to three different groups: a control (CTL) group fed ad libitum, a CR group fed 70% of the CTL caloric intake, and an RSV group (RSV supplementation of 200 mg.kg(-1).day(-1)) fed ad libitum. Three different cognitive tests, two motor tests, one emotional test and an analysis of cortisol level were performed in each group. Compared to CTL animals, CR or RSV animals did not show any change in motor performances evaluated by rotarod and jump tests, but an increase in spontaneous locomotor activity was observed in both groups. Working memory was improved by both treatments in the spontaneous alternation task. Despite a trend for CR group, only RSV supplementation increased spatial memory performances in the circular platform task. Finally, none of these treatments induced additional stress to the animals as reflected by similar results in the open field test and cortisol analyses compared to CTL animals. The present data provided the earliest evidence for a beneficial effect of CR or RSV supplementation on specific cognitive functions in a primate. Taken together, these results suggest that RSV could be a good candidate to mimic long-term CR effects and support the growing evidences that nutritional interventions can have beneficial effects on brain functions even in adults.	[Dal-Pan, Alexandre; Pifferi, Fabien; Marchal, Julia; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Picq, Jean-Luc] Univ Paris 08, Lab Psychopathol & Neuropsychol, UFR Psychol, St Denis, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite Paris-VIII	Dal-Pan, A (corresponding author), Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France.	aujard@mnhn.fr		Pifferi, Fabien/0000-0001-9316-1935	French National Research Agency [ANR-06-PNRA-010-01]; Foundation for French Medical Research	French National Research Agency(French National Research Agency (ANR)); Foundation for French Medical Research	This work was carried out with the financial support of The French National Research Agency (project ANR-06-PNRA-010-01) and the Foundation for French Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM J, 2009, REJUVENATION RES, V12; Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018; Anderson R, 2009, BBA-GEN SUBJECTS, V1790, P1059, DOI 10.1016/j.bbagen.2009.04.005; Antoniadis EA, 2000, BEHAV BRAIN RES, V111, P25, DOI 10.1016/S0166-4328(00)00145-5; Babovic D, 2008, NEUROSCIENCE, V155, P1021, DOI 10.1016/j.neuroscience.2008.07.006; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BATTIG K, 1960, J COMP PHYSIOL PSYCH, V53, P400, DOI 10.1037/h0047392; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Challet E, 2010, J COMP PHYSIOL B, V180, P631, DOI 10.1007/s00360-010-0451-4; Chen D, 2007, TRENDS MOL MED, V13, P64, DOI 10.1016/j.molmed.2006.12.004; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; DALPAN A, 2010, AGE DORDR; DAS D, 2010, HEART FAILURE REV; Denburg NL, 2003, EMOTION, V3, P239, DOI 10.1037/1528-3542.3.3.239; Dhenain M, 2003, MAGNET RESON MED, V50, P984, DOI 10.1002/mrm.10612; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, COMP BIOCHEM PHYS B, V136, P71, DOI 10.1016/S1096-4959(03)00172-6; GIROUD S, 2008, AM J PHYSIOL-REG I, pR1958; Giroud S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008823; Gold PE, 2005, NEUROBIOL AGING, V26, pS60, DOI 10.1016/j.neurobiolaging.2005.09.002; Grieve SM, 2005, HUM BRAIN MAPP, V25, P391, DOI 10.1002/hbm.20115; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ingram DK, 2007, NEUROSCIENCE, V145, P1359, DOI 10.1016/j.neuroscience.2006.10.031; INGRAM DK, 1987, J GERONTOL, V42, P78, DOI 10.1093/geronj/42.1.78; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; JONES DNC, 1995, J NEUROSCI, V15, P7282; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; KRASKA A, 2010, NEUROBIOLOGY AGING; Kumar A, 2007, PHARMACOLOGY, V79, P17, DOI 10.1159/000097511; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Markowska AL, 1999, NEUROBIOL AGING, V20, P177, DOI 10.1016/S0197-4580(99)00031-7; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; MEANS LW, 1993, PHYSIOL BEHAV, V54, P503, DOI 10.1016/0031-9384(93)90243-9; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; ROSSI L, 2008, NEUROCHEMICAL RES; SCHMATZ R, 2009, EUROPEAN J IN PRESS; Sharma M, 2002, LIFE SCI, V71, P2489, DOI 10.1016/S0024-3205(02)02083-0; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; SPINDLER SR, 2009, AGEING RES REV UNPUB; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Weatherall D., 2006, USE NONHUMAN PRIMATE; Weed JL, 1997, PHYSIOL BEHAV, V62, P97, DOI 10.1016/S0031-9384(97)00147-9; Weindruch R, 2001, J GERONTOL A-BIOL, V56, P20, DOI 10.1093/gerona/56.suppl_1.20; Wenk GL, 1997, NEUROBIOL LEARN MEM, V67, P85, DOI 10.1006/nlme.1996.3757; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30; Witte AV, 2009, P NATL ACAD SCI USA, V106, P1255, DOI 10.1073/pnas.0808587106; Wu AG, 2003, NEUROSCI LETT, V339, P166, DOI 10.1016/S0304-3940(03)00008-9; Yanai S, 2004, NEUROBIOL AGING, V25, P325, DOI 10.1016/S0197-4580(03)00115-5	52	93	95	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16581	10.1371/journal.pone.0016581	http://dx.doi.org/10.1371/journal.pone.0016581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304942	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300091
J	Otsubo, T; Akiyama, Y; Hashimoto, Y; Shimada, S; Goto, K; Yuasa, Y				Otsubo, Takeshi; Akiyama, Yoshimitsu; Hashimoto, Yutaka; Shimada, Shu; Goto, Kentaro; Yuasa, Yasuhito			MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; VASCULAR INTEGRITY; CYCLE ARREST; CANCER; MIR-126; GROWTH; DIFFERENTIATION; TARGETS; GENE	Background: SRY (sex-determining region Y)-box 2 (SOX2) is a crucial transcription factor for the maintenance of embryonic stem cell pluripotency and the determination of cell fate. Previously, we demonstrated that SOX2 plays important roles in growth inhibition through cell cycle arrest and apoptosis, and that SOX2 expression is frequently down-regulated in gastric cancers. However, the mechanisms underlying loss of SOX2 expression and its target genes involved in gastric carcinogenesis remain largely unknown. Here, we assessed whether microRNAs ( miRNAs) regulate SOX2 expression in gastric cancers. Furthermore, we attempted to find downstream target genes of SOX2 contributing to gastric carcinogenesis. Methodology/Principal Findings: We performed in silico analysis and focused on miRNA-126 (miR-126) as a potential SOX2 regulator. Gain-and loss-of function experiments and luciferase assays revealed that miR-126 inhibited SOX2 expression by targeting two binding sites in the 3'-untranslated region (3'-UTR) of SOX2 mRNA in multiple cell lines. In addition, miR-126 was highly expressed in some cultured and primary gastric cancer cells with low SOX2 protein levels. Furthermore, exogenous miR-126 over-expression as well as siRNA-mediated knockdown of SOX2 significantly enhanced the anchorage-dependent and -independent growth of gastric cancer cell lines. We next performed microarray analysis after SOX2 overexpression in a gastric cancer cell line, and found that expression of the placenta-specific 1 (PLAC1) gene was significantly down-regulated by SOX2 over-expression. siRNA- and miR-126-mediated SOX2 knockdown experiments revealed that miR-126 positively regulated PLAC1 expression through suppression of SOX2 expression in gastric cancer cells. Conclusions: Taken together, our results indicate that miR-126 is a novel miRNA that targets SOX2, and PLAC1 may be a novel downstream target gene of SOX2 in gastric cancer cells. These findings suggest that aberrant over-expression of miR-126 and consequent SOX2 down-regulation may contribute to gastric carcinogenesis.	[Otsubo, Takeshi; Akiyama, Yoshimitsu; Hashimoto, Yutaka; Shimada, Shu; Goto, Kentaro; Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Otsubo, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	yuasa.monc@tmd.ac.jp	Goto, Kentaro/ABF-8384-2021; Otsubo, Takeshi/G-6123-2014; Hashimoto, Yutaka/B-9821-2017	Goto, Kentaro/0000-0002-0089-9779; Hashimoto, Yutaka/0000-0003-2188-2957	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Society for the Promotion of Science (JSPS) A3 Foresight Program (YY and YA), and Research Fellowships of JSPS for Young Scientists (TO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cammarata G, 2010, AM J HEMATOL, V85, P331, DOI 10.1002/ajh.21667; Chen Jing, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P124; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fant M, 2010, PRENATAL DIAG, V30, P497, DOI 10.1002/pd.2506; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fujimori H, 2008, J HEPATOL, V48, P962, DOI 10.1016/j.jhep.2008.01.031; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Koslowski M, 2007, CANCER RES, V67, P9528, DOI 10.1158/0008-5472.CAN-07-1350; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li XL, 2004, INT J ONCOL, V24, P257; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Tani Y, 2007, J CANCER RES CLIN, V133, P263, DOI 10.1007/s00432-006-0165-x; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang J, 2008, BIOCHEM BIOPH RES CO, V377, P136, DOI 10.1016/j.bbrc.2008.09.089	36	141	160	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16617	10.1371/journal.pone.0016617	http://dx.doi.org/10.1371/journal.pone.0016617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304604	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900081
J	Wan, M; Godson, C; Guiry, PJ; Agerberth, B; Haeggstrom, JZ				Wan, Min; Godson, Catherine; Guiry, Patrick J.; Agerberth, Birgitta; Haeggstrom, Jesper Z.			Leukotriene B-4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A(4) and resolvin E1	FASEB JOURNAL			English	Article						cathelicidin; eicosanoid; inflammation; resolution	CYTOSOLIC PHOSPHOLIPASE A(2); GROWTH-FACTOR RECEPTOR; CATHELICIDIN PEPTIDE; ARACHIDONIC-ACID; B-4 RECEPTOR; ACTIVATION; EXPRESSION; LIGAND; INFLAMMATION; NEUTROPHILS	In humans, the antimicrobial peptide LL-37 and leukotriene B-4 (LTB4) are important proinflammatory mediators, whereas lipoxin A(4) (LXA(4)) and resolvin E1 (RvE1) possess anti-inflammatory, proresolving properties. Previously, we reported that LTB4 triggers LL-37 release from human neutrophils (PMNs) and, conversely, that LL-37 promotes LTB4 production from these cells. Here we show that this effect of LL-37 is mediated via the GPCR FPR2/ALX. LL-37 (5-30 mu g/ml) induces intracellular calcium mobilization in a dose-dependent manner, and the signal transduction leading to LTB4 release involves p38 MAP kinase and phosphorylation of cPLA(2). LXA(4), an endogenous lipid ligand of FPR2/ALX, and a stable LXA(4) analog [benzo-LXA(4)] were ineffective as stimuli at the concentrations of 0.1-10 nM for LTB4 release from PMNs. Likewise, the BLT1 ligand RvE1, a derivative of eicosapentaenoic acid, inhibited LTB4-induced LL-37 production from PMNs at 1-100 nM, whereas chemerin, a peptide ligand of the RvE1 receptor ChemR23, failed to block LTB4-induced LL-37 release at the same concentrations. Hence, in human neutrophils, binding of LL-37 to FPR2/ALX promotes LTB4 production, which can bind to BLT1 and elicit further LL-37 release. This proinflammatory circuit might be inhibited by LXA(4) and RvE1 acting at FPR2/ALX and BLT1, respectively, leading to dampened mediator release.-Wan, M., Godson, C., Guiry, P. J., Agerberth, B., Haeggstrom, J. Z. Leukotriene B-4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A(4) and resolvin E1. FASEB J. 25, 1697-1705 (2011). www.fasebj.org	[Wan, Min; Haeggstrom, Jesper Z.] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Agerberth, Birgitta] Karolinska Inst, Div Physiol Chem 1, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Godson, Catherine] Univ Coll Dublin, UCD Conway Inst, UCD Diabet Res Ctr, Dublin 2, Ireland; [Godson, Catherine] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Guiry, Patrick J.] Univ Coll Dublin, UCD Sch Chem & Chem Biol, Ctr Synth & Chem Biol, Dublin 2, Ireland	Karolinska Institutet; Karolinska Institutet; University College Dublin; University College Dublin; University College Dublin	Haeggstrom, JZ (corresponding author), Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se		Godson, Catherine/0000-0003-0655-1041	Swedish Research Council [10350, 11217, 20854, CERIC]; EC [005033, 201668]; Swedish Foundation for Strategic Research; Torsten and Ragnar Soderbergs Foundations; Enterprise Ireland; Science Foundation Ireland; Vallee Foundation; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); EC(European CommissionEuropean Commission Joint Research Centre); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Torsten and Ragnar Soderbergs Foundations; Enterprise Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Vallee Foundation; Karolinska Institutet(Karolinska Institutet)	This study was supported by the Swedish Research Council (10350, 11217, 20854, Linneus grant CERIC); Chronic Inflammation-Diagnosis and Therapy (CIDaT), EC FP6 and FP7 funding (005033, 201668); the Swedish Foundation for Strategic Research; the Torsten and Ragnar Soderbergs Foundations; Enterprise Ireland; and Science Foundation Ireland. J.Z.H. was supported by the Vallee Foundation and a Distinguished Professor Award from Karolinska Institutet. The authors report no conflicts of interest.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Bonnans C, 2002, AM J RESP CRIT CARE, V165, P1531, DOI 10.1164/rccm.200201-053OC; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Clish CB, 1999, P NATL ACAD SCI USA, V96, P8247, DOI 10.1073/pnas.96.14.8247; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Haworth O, 2008, NAT IMMUNOL, V9, P873, DOI 10.1038/ni.1627; HAWTHORNE AB, 1992, GUT, V33, P513, DOI 10.1136/gut.33.4.513; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; KENNEDY C, 1995, TRENDS PHARMACOL SCI, V16, P168, DOI 10.1016/S0165-6147(00)89010-0; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Le YY, 2000, IMMUNOL REV, V177, P185, DOI 10.1034/j.1600-065X.2000.17704.x; Lee HY, 2006, BIOCHEM PHARMACOL, V72, P860, DOI 10.1016/j.bcp.2006.06.022; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Maderna P, 2010, FASEB J, V24, P4240, DOI 10.1096/fj.10-159913; Mitchell D, 2004, AM J PATHOL, V164, P937, DOI 10.1016/S0002-9440(10)63181-1; Mitchell D, 2007, J BIOL CHEM, V282, P15606, DOI 10.1074/jbc.M611004200; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; O'Sullivan TP, 2007, J MED CHEM, V50, P5894, DOI 10.1021/jm060270d; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Planaguma A, 2008, AM J RESP CRIT CARE, V178, P574, DOI 10.1164/rccm.200801-061OC; Pouliot M, 2000, BIOCHEMISTRY-US, V39, P4761, DOI 10.1021/bi992551b; Qiu H, 2006, P NATL ACAD SCI USA, V103, P8161, DOI 10.1073/pnas.0602414103; Schauber J, 2006, EUR J GASTROEN HEPAT, V18, P615, DOI 10.1097/00042737-200606000-00007; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Syrbu SI, 1999, J IMMUNOL, V162, P2334; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	55	64	68	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1697	1705		10.1096/fj.10-175687	http://dx.doi.org/10.1096/fj.10-175687			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21307335				2022-12-25	WOS:000290023800025
J	Guo, L; Mishra, G; Taylor, K; Wang, XM				Guo, Liang; Mishra, Girish; Taylor, Kyle; Wang, Xuemin			Phosphatidic Acid Binds and Stimulates Arabidopsis Sphingosine Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE DILUTION KINETICS; PLANT STRESS RESPONSES; PHOSPHOLIPASE D-ALPHA; PLASMA-MEMBRANE; PROTEIN; SPHINGOSINE-1-PHOSPHATE; EXPRESSION; THALIANA; LOCALIZATION; ACTIVATION	Phosphatidic acid (PA) and phytosphingosine-1-phosphate (phyto-S1P) have both been identified as lipid messengers mediating plant response to abscisic acid (ABA). To determine the relationship of these messengers, we investigated the direct interaction of PA with Arabidopsis sphingosine kinases (SPHKs) that phosphorylate phytosphingosine to generate phyto-S1P. Two unique SPHK cDNAs were cloned from the annotated At4g21540 locus of Arabidopsis, and the two transcripts are differentially expressed in Arabidopsis tissues. Both SPHKs are catalytically active, phosphorylating various long-chain sphingoid bases (LCBs) and are associated with the tonoplast. They both interact with PA as demonstrated by lipid-filter binding, liposome binding, and surface plasmon resonance (SPR). SPHK1 and SPHK2 exhibited strong binding to 18:1/18:1, 16:0/18:1, and 16:0/18:2 PA, but poor binding to 16:0/16:0, 8:0/8:0, 18:0/18:0, and 18:2/18:2 PA. Surface dilution kinetics analysis indicates that PA stimulates SPHK activity by increasing the specificity constant through decreasing K-m(B). The results show that the annotated At4g21540 locus is actually comprised of two separate SPHK genes. PA binds to both SPHKs, and the interaction promotes lipid substrate binding to the catalytic site of the enzyme. The PA-SPHK interaction depends on the PA molecular species. The data suggest that these two Arabidopsis SPHKs are molecular targets of PA, and the PA stimulation of SPHK is part of the signaling networks in Arabidopsis.	[Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; Univ Missouri, Donald Danforth Plant Sci Ctr, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis; Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Saint Louis	Wang, XM (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.	wangxue@umsl.edu	Guo, Liang/AAW-4739-2021; Wang, Xuemin/M-2853-2013	Guo, Liang/0000-0001-7191-5062; wang, xuemin/0000-0002-6251-6745	National Science Foundation [IOS-0818740]; United States Department of Agriculture [2007-35318-18393]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by National Science Foundation Grant IOS-0818740 and United States Department of Agriculture Grant 2007-35318-18393.	Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Coursol S, 2005, PLANT PHYSIOL, V137, P724, DOI 10.1104/pp.104.055806; Coursol S, 2003, NATURE, V423, P651, DOI 10.1038/nature01643; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; DENNIS EA, 1973, ARCH BIOCHEM BIOPHYS, V158, P485, DOI 10.1016/0003-9861(73)90540-7; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Lu BB, 2009, J BIOL CHEM, V284, P17420, DOI 10.1074/jbc.M109.016014; Lynch DV, 2009, TRENDS PLANT SCI, V14, P463, DOI 10.1016/j.tplants.2009.06.008; Marion J, 2008, PLANT J, V56, P169, DOI 10.1111/j.1365-313X.2008.03596.x; Markham JE, 2007, RAPID COMMUN MASS SP, V21, P1304, DOI 10.1002/rcm.2962; Melendez AJ, 2002, SEMIN IMMUNOL, V14, P49, DOI 10.1006/smim.2001.0341; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Ng CKY, 2001, NATURE, V410, P596, DOI 10.1038/35069092; Nishiura H, 2000, BIOCHEM SOC T, V28, P747, DOI 10.1042/BST0280747; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Qin CB, 2002, J BIOL CHEM, V277, P49685, DOI 10.1074/jbc.M209598200; Stevenson JM, 1998, J BIOL CHEM, V273, P22761, DOI 10.1074/jbc.273.35.22761; Testerink C, 2004, PLANT J, V39, P527, DOI 10.1111/j.1365-313X.2004.02152.x; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Testerink C, 2007, J EXP BOT, V58, P3905, DOI 10.1093/jxb/erm243; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang CX, 2001, PLANT PHYSIOL, V127, P1102, DOI 10.1104/pp.010444; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Worrall D, 2008, PLANT J, V56, P64, DOI 10.1111/j.1365-313X.2008.03579.x; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; YOSHIDA S, 1986, PLANT PHYSIOL, V82, P807, DOI 10.1104/pp.82.3.807; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101; Zhang YB, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/17/175802	42	84	90	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13336	13345		10.1074/jbc.M110.190892	http://dx.doi.org/10.1074/jbc.M110.190892			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330371	Green Published, hybrid			2022-12-25	WOS:000289282200054
J	Frauer, C; Rottach, A; Meilinger, D; Bultmann, S; Fellinger, K; Hasenoder, S; Wang, MX; Qin, WH; Soding, J; Spada, F; Leonhardt, H				Frauer, Carina; Rottach, Andrea; Meilinger, Daniela; Bultmann, Sebastian; Fellinger, Karin; Hasenoeder, Stefan; Wang, Mengxi; Qin, Weihua; Soeding, Johannes; Spada, Fabio; Leonhardt, Heinrich			Different Binding Properties and Function of CXXC Zinc Finger Domains in Dnmt1 and Tet1	PLOS ONE			English	Article							DNA CYTOSINE-5 METHYLTRANSFERASE; ACUTE MYELOID-LEUKEMIA; CATALYTIC DOMAIN; MAMMALIAN DNA; METHYLATION; PROTEIN; MLL; GENE; REPLICATION; MAINTENANCE	Several mammalian proteins involved in chromatin and DNA modification contain CXXC zinc finger domains. We compared the structure and function of the CXXC domains in the DNA methyltransferase Dnmt1 and the methylcytosine dioxygenase Tet1. Sequence alignment showed that both CXXC domains have a very similar framework but differ in the central tip region. Based on the known structure of a similar MLL1 domain we developed homology models and designed expression constructs for the isolated CXXC domains of Dnmt1 and Tet1 accordingly. We show that the CXXC domain of Tet1 has no DNA binding activity and is dispensable for catalytic activity in vivo. In contrast, the CXXC domain of Dnmt1 selectively binds DNA substrates containing unmethylated CpG sites. Surprisingly, a Dnmt1 mutant construct lacking the CXXC domain formed covalent complexes with cytosine bases both in vitro and in vivo and rescued DNA methylation patterns in dnmt1(-/-) embryonic stem cells (ESCs) just as efficiently as wild type Dnmt1. Interestingly, neither wild type nor Delta CXXC Dnmt1 re-methylated imprinted CpG sites of the H19a promoter in dnmt1(-/-) ESCs, arguing against a role of the CXXC domain in restraining Dnmt1 methyltransferase activity on unmethylated CpG sites.	[Frauer, Carina; Rottach, Andrea; Meilinger, Daniela; Bultmann, Sebastian; Fellinger, Karin; Hasenoeder, Stefan; Wang, Mengxi; Qin, Weihua; Spada, Fabio; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Frauer, Carina; Rottach, Andrea; Meilinger, Daniela; Bultmann, Sebastian; Fellinger, Karin; Hasenoeder, Stefan; Wang, Mengxi; Qin, Weihua; Spada, Fabio; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich CIPSM, Planegg Martinsried, Germany; [Soeding, Johannes] Univ Munich, Gene Ctr Munich, Munich, Germany	University of Munich; University of Munich; University of Munich	Frauer, C (corresponding author), Univ Munich, Dept Biol 2, Planegg Martinsried, Germany.	f.spada@lmu.de; h.leonhardt@lmu.de	Söding, Johannes/A-3341-2013; Leonhardt, Heinrich/B-2791-2014; Spada, Fabio/J-4354-2013; Bultmann, Sebastian/AAC-7729-2020	Söding, Johannes/0000-0001-9642-8244; Spada, Fabio/0000-0002-7148-9013; 	Deutsche Forschungsgemeinschaft (DFG) [SFB646, TR5]; Nanosystem Initiative Munich (NIM); Center for NanoScience (CeNS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Nanosystem Initiative Munich (NIM); Center for NanoScience (CeNS)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, SFB646 and TR5; http://www.dfg.de/en/index.jsp), the Nanosystem Initiative Munich (NIM; http://www.nano-initiative-munich.de/) and the Center for NanoScience (CeNS; http://www.cens.de/) to HL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Bacolla A, 2001, J BIOL CHEM, V276, P18605, DOI 10.1074/jbc.M100404200; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Birke M, 2002, NUCLEIC ACIDS RES, V30, P958, DOI 10.1093/nar/30.4.958; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Easwaran HP, 2005, CELL CYCLE, V4, P453, DOI 10.4161/cc.4.3.1525; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fatemi M, 2001, J MOL BIOL, V309, P1189, DOI 10.1006/jmbi.2001.4709; Fellinger K, 2008, ANAL BIOCHEM, V373, P176, DOI 10.1016/j.ab.2007.10.016; Fellinger K, 2009, J CELL BIOCHEM, V106, P521, DOI 10.1002/jcb.22071; Frauer C, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1029; Frescas D, 2007, NATURE, V450, P309, DOI 10.1038/nature06255; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hino SI, 2001, MOL CELL BIOL, V21, P330, DOI 10.1128/MCB.21.1.330-342.2001; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Katoh M, 2004, INT J ONCOL, V25, P1193; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Lei H, 1996, DEVELOPMENT, V122, P3195; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Margot JB, 2000, J MOL BIOL, V297, P293, DOI 10.1006/jmbi.2000.3588; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohseni-Zadeh S, 2004, COMPUT BIOL CHEM, V28, P211, DOI 10.1016/j.compbiolchem.2004.03.002; Ono R, 2002, CANCER RES, V62, P4075; Pradhan M, 2008, BIOCHEMISTRY-US, V47, P10000, DOI 10.1021/bi8011725; Pradhan S, 2003, BIOCHEMISTRY-US, V42, P5321, DOI 10.1021/bi034160+; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schermelleh L, 2005, NAT METHODS, V2, P751, DOI 10.1038/NMETH794; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spada F, 2006, ADV ENZYME REGUL, V46, P224, DOI 10.1016/j.advenzreg.2006.01.011; Sporbert A, 2005, NUCLEIC ACIDS RES, V33, P3521, DOI 10.1093/nar/gki665; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tucker KL, 1996, GENE DEV, V10, P1008, DOI 10.1101/gad.10.8.1008; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zimmermann C, 1997, BIOL CHEM, V378, P393, DOI 10.1515/bchm.1997.378.5.393	65	71	76	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16627	10.1371/journal.pone.0016627	http://dx.doi.org/10.1371/journal.pone.0016627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311766	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036200025
J	Pezzulo, AA; Gutierrez, J; Duschner, KS; McConnell, KS; Taft, PJ; Ernst, SE; Yahr, TL; Rahmouni, K; Klesney-Tait, J; Stoltz, DA; Zabner, J				Pezzulo, Alejandro A.; Gutierrez, Jeydith; Duschner, Kelly S.; McConnell, Kelly S.; Taft, Peter J.; Ernst, Sarah E.; Yahr, Timothy L.; Rahmouni, Kamal; Klesney-Tait, Julia; Stoltz, David A.; Zabner, Joseph			Glucose Depletion in the Airway Surface Liquid Is Essential for Sterility of the Airways	PLOS ONE			English	Article							ARTERIAL TORTUOSITY SYNDROME; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; CANDIDATE GENE; SLC2A10 GLUT10; OBESE GENE; EPITHELIA; TRANSPORTERS; PNEUMONIA; CLONING	Diabetes mellitus predisposes the host to bacterial infections. Moreover, hyperglycemia has been shown to be an independent risk factor for respiratory infections. The luminal surface of airway epithelia is covered by a thin layer of airway surface liquid (ASL) and is normally sterile despite constant exposure to bacteria. The balance between bacterial growth and killing in the airway determines the outcome of exposure to inhaled or aspirated bacteria: infection or sterility. We hypothesized that restriction of carbon sources-including glucose-in the ASL is required for sterility of the lungs. We found that airway epithelia deplete glucose from the ASL via a novel mechanism involving polarized expression of GLUT-1 and GLUT-10, intracellular glucose phosphorylation, and low relative paracellular glucose permeability in well-differentiated cultures of human airway epithelia and in segments of airway epithelia excised from human tracheas. Moreover, we found that increased glucose concentration in the ASL augments growth of P. aeruginosa in vitro and in the lungs of hyperglycemic ob/ob and db/db mice in vivo. In contrast, hyperglycemia had no effect on intrapulmonary bacterial growth of a P. aeruginosa mutant that is unable to utilize glucose as a carbon source. Our data suggest that depletion of glucose in the airway epithelial surface is a novel mechanism for innate immunity. This mechanism is important for sterility of the airways and has implications in hyperglycemia and conditions that result in disruption of the epithelial barrier in the lung.	[Pezzulo, Alejandro A.; Gutierrez, Jeydith; Duschner, Kelly S.; McConnell, Kelly S.; Taft, Peter J.; Ernst, Sarah E.; Rahmouni, Kamal; Klesney-Tait, Julia; Stoltz, David A.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Yahr, Timothy L.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Pezzulo, AA (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu	Gutierrez, Jeydith/AAM-9438-2020; Rahmouni, Kamal/Y-1788-2019	Gutierrez, Jeydith/0000-0001-7596-1779; Pezzulo, Alejandro/0000-0001-7544-5109; Stoltz, David/0000-0003-0893-9015; Rahmouni, Kamal/0000-0001-5136-6748; Klesney-Tait, julia/0000-0002-0261-8395; Yahr, Timothy/0000-0001-9054-8704; Zabner, Joseph/0000-0002-9606-1339	University of Iowa Department of Internal Medicine; National Heart, Lung and Blood Institute [HL51670, HL091842]; National Institutes of Diabetes and Digestive and Kidney Diseases [DK54759]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL091842, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	University of Iowa Department of Internal Medicine; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a University of Iowa Department of Internal Medicine Translational Research Pilot Grant, and in part by National Heart, Lung and Blood Institute HL51670 and HL091842, National Institutes of Diabetes and Digestive and Kidney Diseases DK54759 and a Cystic Fibrosis Foundation RDP Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ampofo K, 2008, PEDIATRICS, V122, P229, DOI 10.1542/peds.2007-3192; Baker EH, 2007, J APPL PHYSIOL, V102, P1969, DOI 10.1152/japplphysiol.01425.2006; Baker EH, 2006, P NUTR SOC, V65, P227, DOI 10.1079/PNS2006499; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Beatson SA, 2002, J BACTERIOL, V184, P3598, DOI 10.1128/KB.184.13.3598-3604.2002; Bento JL, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-42; Brennan AL, 2007, J CYST FIBROS, V6, P101, DOI 10.1016/j.jcf.2006.03.009; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Coucke PJ, 2006, NAT GENET, V38, P452, DOI 10.1038/ng1764; Coucke PJ, 2003, J MED GENET, V40, P747, DOI 10.1136/jmg.40.10.747; CUSKEY SM, 1985, J BACTERIOL, V162, P865, DOI 10.1128/JB.162.3.865-871.1985; Dawson PA, 2001, MOL GENET METAB, V74, P186, DOI 10.1006/mgme.2001.3212; De Groot A, 2001, J BACTERIOL, V183, P959, DOI 10.1128/JB.183.3.959-967.2001; Fischer AJ, 2009, AM J RESP CELL MOL, V40, P189, DOI 10.1165/rcmb.2008-0240OC; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HOLTUG K, 1996, SCAND J GASTROENTE S, V216, P95; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; JOHANSON WG, 1969, NEW ENGL J MED, V281, P1137, DOI 10.1056/NEJM196911202812101; Kalsi KK, 2008, PFLUG ARCH EUR J PHY, V456, P991, DOI 10.1007/s00424-008-0459-8; Kalsi KK, 2009, PFLUG ARCH EUR J PHY, V457, P1061, DOI 10.1007/s00424-008-0576-4; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kornum JB, 2007, DIABETES CARE, V30, P2251, DOI 10.2337/dc06-2417; Landry JS, 2001, J GEN PHYSIOL, V117, P419, DOI 10.1085/jgp.117.5.419; LEE WS, 1994, J BIOL CHEM, V269, P12032; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Lin WH, 2006, DIABETOLOGIA, V49, P1214, DOI 10.1007/s00125-006-0218-3; Mager S, 2003, EUR J PHARMACOL, V479, P263, DOI 10.1016/j.ejphar.2003.08.075; McAlister FA, 2005, DIABETES CARE, V28, P810, DOI 10.2337/diacare.28.4.810; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; McVie-Wylie AJ, 2001, GENOMICS, V72, P113, DOI 10.1006/geno.2000.6457; Mohlke KL, 2005, MOL GENET METAB, V85, P323, DOI 10.1016/j.ymgme.2005.04.011; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Motulsky H., 1995, INTUITIVE BIOSTATIST; PEREZDIAZ J, 1977, AM J PHYSIOL, V232, pE394, DOI 10.1152/ajpendo.1977.232.4.E394; Philips BJ, 2005, THORAX, V60, P761, DOI 10.1136/thx.2004.035766; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Rakhimova E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001685; Reading PC, 1998, J VIROL, V72, P6884, DOI 10.1128/JVI.72.8.6884-6887.1998; RITCHINGS BW, 1995, INFECT IMMUN, V63, P4868, DOI 10.1128/IAI.63.12.4868-4876.1995; Saumon G, 1996, AM J PHYSIOL-LUNG C, V270, pL183, DOI 10.1152/ajplung.1996.270.2.L183; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Vardakas KZ, 2007, DIABETIC MED, V24, P1168, DOI 10.1111/j.1464-5491.2007.02234.x; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Wessels MW, 2004, AM J MED GENET A, V131A, P134, DOI 10.1002/ajmg.a.30272; WIDDICOMBE JH, 1995, RESP PHYSIOL, V99, P3, DOI 10.1016/0034-5687(94)00095-H; ZEIHER BG, 1995, J CLIN INVEST, V96, P2051, DOI 10.1172/JCI118253; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	54	78	81	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2011	6	1							e16166	10.1371/journal.pone.0016166	http://dx.doi.org/10.1371/journal.pone.0016166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OX	21311590	Green Submitted, gold, Green Published			2022-12-25	WOS:000286522200030
J	Qiu, P; Wheater, MK; Qiu, Y; Sosne, G				Qiu, Ping; Wheater, Michelle Kurpakus; Qiu, Yue; Sosne, Gabriel			Thymosin beta(4) inhibits TNF-alpha-induced NF-kappa B activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILK	FASEB JOURNAL			English	Article						cornea; actin; inflammation; cytokine; chemokine; focal adhesion	RELA/P65 NUCLEAR TRANSLOCATION; INFLAMMATORY MEDIATORS; ACTIN; BETA-4; CORNEAL; APOPTOSIS; BINDING; TRANSCRIPTION; PROTEIN; CELLS	The mechanisms by which thymosin beta 4 (T beta(4)) regulates the inflammatory response to injury are poorly understood. Previously, we demonstrated that ectopic T beta(4) treatment inhibits injury-induced proinflammatory cytokine and chemokine production. We have also shown that T beta(4) suppresses TNF-alpha-mediated NF-kappa B activation. Herein, we present novel evidence that T beta(4) directly targets the NF-kappa B RelA/p65 subunit. We find that enforced expression of T beta(4) interferes with TNF-alpha-mediated NF-kappa B activation, as well as downstream IL-8 gene transcription. These activities are independent of the G-actin-binding properties of T beta(4). T beta(4) blocks RelA/p65 nuclear translocation and targeting to the cognate kappa B site in the proximal region of the IL-8 gene promoter. T beta(4) also inhibits the sensitizing effects of its intracellular binding partners, PINCH-1 and ILK, on NF-kappa B activity after TNF-alpha stimulation. The identification of a functional regulatory role by T beta(4) and the focal adhesion proteins PINCH- 1 and ILK on NF-kappa B activity in this study opens a new window for scientific exploration of how T beta(4) modulates inflammation. In addition, the results of this study serve as a foundation for developing T beta(4) as a new anti-inflammatory therapy.-Qiu, P., Kurpakus Wheater, M., Qiu, Y., Sosne, G. Thymosin beta(4) inhibits TNF-alpha-induced NF-kappa B activation, IL-8 expression, and the sensitizing effects by its partners PINCH- 1 and ILK. FASEB J. 25, 1815-1826 (2011). www.fasebj.org	[Sosne, Gabriel] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Qiu, Ping; Qiu, Yue] Wayne State Univ, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI USA; [Wheater, Michelle Kurpakus] Univ Detroit, Dept Biomed & Diagnost Sci, Mercy Sch Dent, Detroit, MI 48221 USA	Wayne State University; Wayne State University; University of Detroit Mercy	Sosne, G (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, 540 E Canfield Ave,8314 Scott Hall, Detroit, MI 48201 USA.	gsosne@med.wayne.edu			U.S. National Institutes of Health [KO88EY13412]; Department of Anatomy and Cell Biology [P30EY04068]; Sinai Guild; Midwest Eye Banks and Transplantation Center; U.S. Army Medical Research Institute of Chemical Defense [W81XWH-09-P-0412]; Research to Prevent Blindness (New York, NY, USA); NATIONAL EYE INSTITUTE [P30EY004068, K08EY013412] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anatomy and Cell Biology; Sinai Guild; Midwest Eye Banks and Transplantation Center; U.S. Army Medical Research Institute of Chemical Defense; Research to Prevent Blindness (New York, NY, USA)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Hynda K. Kleinman for the critical reading of the manuscript and Dr. Linda D. Hazlett for her kind support. The authors are grateful to Dr. Chuanyue Wu (University of Pittsburgh, Pittsburgh, PA, USA) and Dr. Czeslaw S. Cierniewski (Nencki Institute of Experimental Biology, Warsaw, Poland) for supplying plasmids. The authors thank F. Zhang for technical support in manuscript preparation. This work was supported in part by grants from the U.S. National Institutes of Health (KO88EY13412) to G.S., the Department of Anatomy and Cell Biology (Core Vision grant P30EY04068), the Sinai Guild to G.S., the Midwest Eye Banks and Transplantation Center to G.S. and P.Q., and the U.S. Army Medical Research Institute of Chemical Defense (W81XWH-09-P-0412) to G.S. G.S. is a the recipient of a Physician Scientist Award from Research to Prevent Blindness (New York, NY, USA). G.S. is a nonsalaried medical and scientific board advisor to RegeneRx Biopharmaceuticals, Inc. (Rockville, MD, USA), which supplied the T beta<INF>4</INF>. The other authors declare no conflicting financial interests.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Babakov VN, 2008, EXP CELL RES, V314, P1030, DOI 10.1016/j.yexcr.2007.12.001; Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Baeuerle PA, 1998, CELL, V95, P729, DOI 10.1016/S0092-8674(00)81694-3; Bednarek R, 2008, J BIOL CHEM, V283, P1534, DOI 10.1074/jbc.M707539200; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Bodendorf S, 2007, ANN NY ACAD SCI, V1112, P418, DOI 10.1196/annals.1415.023; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; Cha HJ, 2003, J NATL CANCER I, V95, P1674, DOI 10.1093/jnci/djg100; Choi SY, 2007, BIOCHEM BIOPH RES CO, V362, P587, DOI 10.1016/j.bbrc.2007.08.031; Cuschieri J, 2003, SHOCK, V19, P433, DOI 10.1097/01.shk.0000051762.08171.ea; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Fan Y, 2009, DEV CELL, V16, P661, DOI 10.1016/j.devcel.2009.03.009; Fazal F, 2007, J BIOL CHEM, V282, P3940, DOI 10.1074/jbc.M608074200; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; HANNAPPEL E, 1987, J CHROMATOGR, V397, P279, DOI 10.1016/S0021-9673(01)85010-X; HEINTZ D, 1994, EUR J BIOCHEM, V223, P345, DOI 10.1111/j.1432-1033.1994.tb19000.x; Higashitsuji H, 2007, BIOCHEM BIOPH RES CO, V363, P879, DOI 10.1016/j.bbrc.2007.09.072; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Hsiao HL, 2006, CARCINOGENESIS, V27, P936, DOI 10.1093/carcin/bgi316; Huang CM, 2006, PROTEOMICS, V6, P5805, DOI 10.1002/pmic.200600163; Huang JY, 2004, EXP CELL RES, V298, P133, DOI 10.1016/j.yexcr.2004.04.019; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Inzitari R, 2009, J SEP SCI, V32, P57, DOI 10.1002/jssc.200800496; KUNSCH C, 1994, J IMMUNOL, V153, P153; Kupatt C, 2008, TRENDS CARDIOVAS MED, V18, P205, DOI 10.1016/j.tcm.2008.10.002; Kustermans G, 2008, BIOCHEM PHARMACOL, V76, P1214, DOI 10.1016/j.bcp.2008.08.017; Lee HR, 2009, IMMUNOL LETT, V123, P72, DOI 10.1016/j.imlet.2009.02.008; Lee SJ, 2008, FEBS LETT, V582, P2161, DOI 10.1016/j.febslet.2008.03.058; Leeanansaksiri W, 2004, CHEM BIODIVERS, V1, P1091, DOI 10.1002/cbdv.200490081; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Liu L, 2009, FEBS J, V276, P1459, DOI 10.1111/j.1742-4658.2009.06888.x; LOW TLK, 1982, J BIOL CHEM, V257, P1000; Marx J, 2007, SCIENCE, V316, P682, DOI 10.1126/science.316.5825.682; Miralles F, 2006, CURR OPIN CELL BIOL, V18, P261, DOI 10.1016/j.ceb.2006.04.009; Moon HS, 2006, EXP CELL RES, V312, P3425, DOI 10.1016/j.yexcr.2006.07.021; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Nummela P, 2006, CANCER RES, V66, P701, DOI 10.1158/0008-5472.CAN-05-2421; Oh SY, 2006, EXP CELL RES, V312, P1651, DOI 10.1016/j.yexcr.2006.01.030; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Philp D, 2003, FASEB J, V17, P2103, DOI 10.1096/fj.03-0121fje; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qiu P, 2002, MAMM GENOME, V13, P327, DOI 10.1007/s00335-001-2141-8; Qiu P, 2007, J CELL PHYSIOL, V212, P165, DOI 10.1002/jcp.21012; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Romeo GR, 2007, CIRC RES, V101, P357, DOI 10.1161/CIRCRESAHA.107.151399; Rossenu S, 2003, J BIOL CHEM, V278, P16642, DOI 10.1074/jbc.M208311200; Schillaci D, 2010, J APPL MICROBIOL, V108, P17, DOI 10.1111/j.1365-2672.2009.04394.x; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Sharma SM, 2009, OCUL IMMUNOL INFLAMM, V17, P403, DOI 10.3109/09273940903072443; Singh K, 2009, J BIOL CHEM, V284, P1267, DOI 10.1074/jbc.M801088200; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2005, INVEST OPHTH VIS SCI, V46, P2388, DOI 10.1167/iovs.04-1368; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Sosne G, 2006, EXP EYE RES, V83, P502, DOI 10.1016/j.exer.2006.02.001; Sosne G, 2010, FASEB J, V24, P2144, DOI 10.1096/fj.09-142307; SUN SC, 1994, P NATL ACAD SCI USA, V91, P1346, DOI 10.1073/pnas.91.4.1346; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524-6533.2002; Tapp H, 2009, BIOTECH HISTOCHEM, V84, P287, DOI 10.3109/10520290903116884; Trubiani O, 2000, HISTOCHEM CELL BIOL, V113, P369; Truhlar SME, 2006, P NATL ACAD SCI USA, V103, P18951, DOI 10.1073/pnas.0605794103; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yang H, 2008, NEUROCHEM RES, V33, P2269, DOI 10.1007/s11064-008-9712-y; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; Young JD, 1999, NAT MED, V5, P1424; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005	79	74	77	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1815	1826		10.1096/fj.10-167940	http://dx.doi.org/10.1096/fj.10-167940			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21343177	Green Published			2022-12-25	WOS:000291023800005
J	Wang, LT; Lin, CS; Chai, CY; Liu, KY; Chen, JY; Hsu, SH				Wang, L-T; Lin, C-S; Chai, C-Y; Liu, K-Y; Chen, J-Y; Hsu, S-H			Functional interaction of Ugene and EBV infection mediates tumorigenic effects	ONCOGENE			English	Article						EBV; LMP1; LMPIP; tumorigenesis	EPSTEIN-BARR-VIRUS; ENCODED LATENT MEMBRANE-PROTEIN-1; NASOPHARYNGEAL CARCINOMA-CELLS; ZIP TRANSCRIPTION FACTOR; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; BURKITT-LYMPHOMA; CYCLIN D1; LMP1; GROWTH	Epstein-Barr virus (EBV) infection is associated with many human neoplasms, in which EBV-derived latent membrane protein-1 (LMP1) appears to be critical, but its exact oncogenic mechanism remains to be defined. To this end, our initial microarray analyses identified a LMP1-inducible gene, Ugene, originally characterized as a binding partner for uracil DNA glycosylase 2, which is highly expressed in malignant colon cancer. In this report, it was found that Ugene, designated herein as LMP1-induced protein (LMPIP), was induced, in a time-dependent manner, in EBV-infected peripheral blood mononuclear cells and LMP1-transfected 293 cells. Functionally, when compared with mock-transfected cells, overexpression of LMPIP in nasopharyngeal carcinoma (NPC) cell lines resulted in a decrease in reactive oxygen species production and maintained mitochondria membrane potential (Delta psi) loss induced by H2O2. The NPC cells transfected with LMPIP also showed a decrease in G1 population and an increase in the cell population in sub-G1 and multiploid phase, concomitant with increased levels of cell cycle activators, including cyclin D1 and CDK4. In contrast, silencing of LMPIP expression in the NPC tumor cell lines with short hairpin RNA interference revealed significantly decreased cell population at G1/S phase, while the number of cells in multiploid phase increased. Significantly, NPC cells with LMPIP knock-down also showed a decrease in tumorigenic and transforming activity induced by ectopic LMP1 expression, as determined by analyses of soft agar foci and tumor size in nude mice. Further, elevated LMPIP expression was also noted in cytoplasm and nuclei in EBV-infected NPC tumor cell mass and non-EBV-infected tumor cell lines. These results suggested that LMPIP may have an important mediator role in EBV-mediated neoplasm and may serve as a new target for therapy of tumors induced by EBV infection. Oncogene (2011) 30, 2921-2932; doi:10.1038/onc.2011.16; published online 14 February 2011	[Wang, L-T; Lin, C-S; Liu, K-Y; Hsu, S-H] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Chai, C-Y] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Pathol, Kaohsiung 807, Taiwan; [Chen, J-Y] Natl Hlth Res Inst, Inst Canc Res, Zhunan, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Health Research Institutes - Taiwan	Hsu, SH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	jackhsu@kmu.edu.tw	Lin, Chang-Shen/D-5140-2009; Lin, Chang-Shen/X-2189-2019; Chen, Jen-Yang/D-2085-2010	Lin, Chang-Shen/0000-0001-7415-2187; Chai, Chee-Yin/0000-0003-0486-9742; Hsu, Shih Hsien/0000-0003-2102-0505; Wang, Li-Ting/0000-0002-3335-8055	National Science Council, Taiwan [NSC-97-2311-B-037-002-MY3, NSC-97-2314-B-037-015, NSC-98-2320-B- 037-026-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	We thank Dr SK Huang for critically reviewing this paper. This work was supported in part by Research Grants NSC-97-2311-B-037-002-MY3, NSC-97-2314-B-037-015 and NSC-98-2320-B- 037-026-MY3 from the National Science Council, Taiwan.	Ai MD, 2005, CELL RES, V15, P777, DOI 10.1038/sj.cr.7290347; Bartosz G, 2009, BIOCHEM PHARMACOL, V77, P1303, DOI 10.1016/j.bcp.2008.11.009; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Chang Y, 1998, LAB INVEST, V78, P715; Demetriades C, 2009, J VIROL, V83, P5269, DOI 10.1128/JVI.00097-09; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Eliopoulos AG, 1998, CURR BIOL, V8, pR196, DOI 10.1016/S0960-9822(98)70123-X; Esposito F, 2001, IUBMB LIFE, V52, P67, DOI 10.1080/15216540252774793; Fang CY, 2009, INT J CANCER, V124, P2016, DOI 10.1002/ijc.24179; Guo CG, 2008, CANCER RES, V68, P6118, DOI 10.1158/0008-5472.CAN-08-1259; Hour TC, 2010, BIOCHEM PHARMACOL, V80, P325, DOI 10.1016/j.bcp.2010.04.007; Hsu SH, 2005, CANCER RES, V65, P4041, DOI 10.1158/0008-5472.CAN-04-3658; Hsu SH, 2004, EXP CELL RES, V294, P185, DOI 10.1016/j.yexcr.2003.10.029; Hsu SH, 2001, MECH DEVELOP, V100, P177, DOI 10.1016/S0925-4773(00)00513-X; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; Kanegane H, 2002, CRIT REV ONCOL HEMAT, V44, P239, DOI 10.1016/S1040-8428(02)00115-4; Kieser A, 2008, BIOL CHEM, V389, P1261, DOI 10.1515/BC.2008.144; Kis LL, 2006, BLOOD, V107, P2928, DOI 10.1182/blood-2005-06-2569; Laurent A, 2005, CANCER RES, V65, P948; LIEBOWITZ D, 1992, J VIROL, V66, P4612, DOI 10.1128/JVI.66.7.4612-4616.1992; LINDAHL T, 1974, INT J CANCER, V13, P764, DOI 10.1002/ijc.2910130605; Liu MT, 2005, ONCOGENE, V24, P2635, DOI 10.1038/sj.onc.1208319; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Menon SG, 2003, CANCER RES, V63, P2109; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Munz C, 2008, SEMIN CANCER BIOL, V18, P381, DOI 10.1016/j.semcancer.2008.10.002; Pai S, 2001, SEMIN CANCER BIOL, V11, P455, DOI 10.1006/scbi.2001.0412; Queiroga EM, 2008, AM J CLIN PATHOL, V130, P186, DOI 10.1309/2CNAWY6GAR0VQAXX; Sakamaki T, 2006, MOL CELL BIOL, V26, P5449, DOI 10.1128/MCB.02074-05; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Soni V, 2007, ADV EXP MED BIOL, V597, P173; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Tsao SW, 2002, SEMIN CANCER BIOL, V12, P473, DOI 10.1016/S1044579X02000901; Yu JS, 2002, ONCOGENE, V21, P8047, DOI 10.1038/sj.onc.1205990	42	16	18	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	26					2921	2932		10.1038/onc.2011.16	http://dx.doi.org/10.1038/onc.2011.16			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21317926				2022-12-25	WOS:000292245100003
J	Kaur, S; Kuznetsova, SA; Pendrak, ML; Sipes, JM; Romeo, MJ; Li, ZQ; Zhang, LJ; Roberts, DD				Kaur, Sukhbir; Kuznetsova, Svetlana A.; Pendrak, Michael L.; Sipes, John M.; Romeo, Martin J.; Li, Zhuqing; Zhang, Lijuan; Roberts, David D.			Heparan Sulfate Modification of the Transmembrane Receptor CD47 Is Necessary for Inhibition of T Cell Receptor Signaling by Thrombospondin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-ASSOCIATED PROTEIN; PRECURSOR-LIKE PROTEIN-2; HAMSTER OVARY CELL; C-TERMINAL DOMAIN; CHONDROITIN SULFATE; CYCLOPHILIN-B; NITRIC-OXIDE; ACTIVATION; PROTEOGLYCANS; ADHESION	Cell surface proteoglycans on T cells contribute to retroviral infection, binding of chemokines and other proteins, and are necessary for some T cell responses to the matricellular glycoprotein thrombospondin-1. The major cell surface proteoglycans expressed by primary T cells and Jurkat T cells have an apparent M-r > 200,000 and are modified with chondroitin sulfate and heparan sulfate chains. Thrombospondin-1 bound in a heparin-inhibitable manner to this proteoglycan and to a soluble form released into the medium. Based on mass spectrometry, knockdown, and immunochemical analyses, the proteoglycan contains two major core proteins as follows: amyloid precursor-like protein-2 (APLP2, apparent M-r 230,000) and CD47 (apparent M-r > 250,000). CD47 is a known thrombospondin-1 receptor but was not previously reported to be a proteoglycan. This proteoglycan isoform of CD47 is widely expressed on vascular cells. Mutagenesis identified glycosaminoglycan modification of CD47 at Ser(64) and Ser(79). Inhibition of T cell receptor signaling by thrombospondin-1 was lost in CD47-deficient T cells that express the proteoglycan isoform of APLP2, indicating that binding to APLP2 is not sufficient. Inhibition of CD69 induction was restored in CD47-deficient cells by re-expressing CD47 or an S79A mutant but not by the S64A mutant. Therefore, inhibition of T cell receptor signaling by thrombospondin-1 is mediated by CD47 and requires its modification at Ser(64).	[Kaur, Sukhbir; Kuznetsova, Svetlana A.; Pendrak, Michael L.; Sipes, John M.; Romeo, Martin J.; Li, Zhuqing; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20982 USA; [Zhang, Lijuan] Ocean Univ China, Sch Med & Pharm, Qingdao 266003, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ocean University of China	Roberts, DD (corresponding author), NIH, Bldg 10,Rm 2A33,10 Ctr Dr, Bethesda, MD 20892 USA.	droberts@helix.nih.gov	Roberts, David D./A-9699-2008; Kaur, Sukhbir/ADW-6023-2022	Roberts, David D./0000-0002-2481-2981; Kaur, Sukhbir/0000-0003-0513-6225; Romeo, Martin/0000-0001-7941-1862	NCI; NATIONAL CANCER INSTITUTE [ZIASC009174, ZIASC009172] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program of the NCI.	ADAMS JC, 1994, MOL BIOL CELL, V5, P423, DOI 10.1091/mbc.5.4.423; Adams JC, 2001, J CELL BIOL, V152, P1169, DOI 10.1083/jcb.152.6.1169; Adams JC, 2008, J CELL SCI, V121, P784, DOI 10.1242/jcs.021006; Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Allain F, 2002, P NATL ACAD SCI USA, V99, P2714, DOI 10.1073/pnas.052284899; Asari A, 1996, OSTEOARTHR CARTILAGE, V4, P149, DOI 10.1016/S1063-4584(05)80324-3; Barazi HO, 2002, J BIOL CHEM, V277, P42859, DOI 10.1074/jbc.M206849200; Barazi HO, 2002, CANCER RES, V62, P1541; Bass MD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe18; Billard MJ, 2008, IMMUNOL CELL BIOL, V86, P381, DOI 10.1038/sj.icb.7100165; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; CATERSON B, 1985, FED PROC, V44, P386; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Chung JS, 2007, J IMMUNOL, V179, P5778, DOI 10.4049/jimmunol.179.9.5778; Cladera J, 2001, EMBO J, V20, P19, DOI 10.1093/emboj/20.1.19; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Deligny A, 2010, J BIOL CHEM, V285, P1701, DOI 10.1074/jbc.M109.018184; Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Floquet N, 2008, ARCH BIOCHEM BIOPHYS, V478, P103, DOI 10.1016/j.abb.2008.07.015; Frazier WA, 2010, NATURE SIGNALING GAT, DOI [10.1038/mp.a002870.01, DOI 10.1038/MP.A002870.01]; Gao AG, 1996, J BIOL CHEM, V271, P21, DOI 10.1074/jbc.271.1.21; Greenfield B, 1999, J BIOL CHEM, V274, P2511, DOI 10.1074/jbc.274.4.2511; Guo J, 1998, INVEST OPHTH VIS SCI, V39, P292; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Isenberg JS, 2008, CELL MOL LIFE SCI, V65, P728, DOI 10.1007/s00018-007-7488-x; Isenberg JS, 2008, BLOOD, V111, P613, DOI 10.1182/blood-2007-06-098392; Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e; Isenberg JS, 2006, CARDIOVASC RES, V71, P785, DOI 10.1016/j.cardiores.2006.05.024; Isenberg JS, 2009, MATRIX BIOL, V28, P110, DOI 10.1016/j.matbio.2009.01.002; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Isenberg JS, 2005, P NATL ACAD SCI USA, V102, P13141, DOI 10.1073/pnas.0502977102; Jury EC, 2007, J IMMUNOL, V179, P7975, DOI 10.4049/jimmunol.179.11.7975; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kirn-Safran C, 2009, CELL MOL LIFE SCI, V66, P3421, DOI 10.1007/s00018-009-0096-1; Lambert S, 2009, BLOOD, V113, P5176, DOI 10.1182/blood-2008-04-150342; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Li XF, 1999, J BIOL CHEM, V274, P27249, DOI 10.1074/jbc.274.38.27249; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Li ZQ, 2001, J IMMUNOL, V166, P2427, DOI 10.4049/jimmunol.166.4.2427; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lu H., 2010, GLYCOBIOL INSIGHTS, V2010, P13; Maile LA, 2008, MOL ENDOCRINOL, V22, P1226, DOI 10.1210/me.2007-0552; Makatsori E, 2001, BIOMED CHROMATOGR, V15, P413, DOI 10.1002/bmc.91; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Neto EH, 2007, BBA-MOL CELL RES, V1773, P176, DOI 10.1016/j.bbamcr.2006.09.026; Oravecz T, 1997, J IMMUNOL, V159, P4587; Pakula R, 2007, GLYCOBIOLOGY, V17, P492, DOI 10.1093/glycob/cwm009; Pan J, 2010, NAT BIOTECHNOL, V28, P203, DOI 10.1038/nbt0310-203; PANGALOS MN, 1995, J NEUROCHEM, V65, P762; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; Rebres RA, 2001, J BIOL CHEM, V276, P34607, DOI 10.1074/jbc.M106107200; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Roberts David D., 1994, Journal of Tissue Culture Methods, V16, P217, DOI 10.1007/BF01540654; ROBERTS DD, 1988, CANCER RES, V48, P6785; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Studelska DR, 2006, GLYCOBIOLOGY, V16, P65, DOI 10.1093/glycob/cwj037; Subramanian S, 2007, J BIOL CHEM, V282, P1805, DOI 10.1074/jbc.M603923200; SUN X, 1992, SEMIN THROMB HEMOST, V18, P243, DOI 10.1055/s-2007-1002430; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Watson K, 1999, J BIOL CHEM, V274, P21707, DOI 10.1074/jbc.274.31.21707; Weimann TK, 2003, EXP DERMATOL, V12, P204, DOI 10.1034/j.1600-0625.2003.00044.x; Wilson KE, 1999, J IMMUNOL, V163, P3621; Winzen U, 2003, J BIOL CHEM, V278, P30106, DOI 10.1074/jbc.M212676200; YABKOWITZ R, 1993, J IMMUNOL, V151, P149; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597; ZHANG LJ, 1995, J BIOL CHEM, V270, P27127, DOI 10.1074/jbc.270.45.27127	79	57	62	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14991	15002		10.1074/jbc.M110.179663	http://dx.doi.org/10.1074/jbc.M110.179663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343308	hybrid, Green Published			2022-12-25	WOS:000289788300029
J	Hafner-Bratkovic, I; Bester, R; Pristovsek, P; Gaedtke, L; Veranic, P; Gaspersic, J; Mancek-Keber, M; Avbelj, M; Polymenidou, M; Julius, C; Aguzzi, A; Vorberg, I; Jerala, R				Hafner-Bratkovic, Iva; Bester, Romina; Pristovsek, Primoz; Gaedtke, Lars; Veranic, Peter; Gaspersic, Jernej; Mancek-Keber, Mateja; Avbelj, Matevz; Polymenidou, Magdalini; Julius, Christian; Aguzzi, Adriano; Vorberg, Ina; Jerala, Roman			Globular Domain of the Prion Protein Needs to Be Unlocked by Domain Swapping to Support Prion Protein Conversion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; AMYLOID-LIKE FIBRILS; HYDROGEN/DEUTERIUM EXCHANGE; IN-VITRO; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; MAMMALIAN PRIONS; DISULFIDE BONDS; NMR STRUCTURE	Prion diseases are fatal transmissible neurodegenerative diseases affecting many mammalian species. The normal prion protein (PrP) converts into a pathological aggregated form, PrPSc, which is enriched in the beta-sheet structure. Although the high resolution structure of the normal PrP was determined, the structure of the converted form of PrP remains inaccessible to high resolution techniques. To map the PrP conversion process we introduced disulfide bridges into different positions within the globular domain of PrP, tethering selected secondary structure elements. The majority of tethered PrP mutants exhibited increased thermodynamic stability, nevertheless, they converted efficiently. Only the disulfides that tether subdomain B1-H1-B2 to subdomain H2-H3 prevented PrP conversion in vitro and in prion-infected cell cultures. Reduction of disulfides recovered the ability of these mutants to convert, demonstrating that the separation of subdomains is an essential step in conversion. Formation of disulfide-linked proteinase K-resistant dimers in fibrils composed of a pair of single cysteine mutants supports the model based on domain-swapped dimers as the building blocks of prion fibrils. In contrast to previously proposed structural models of PrPSc suggesting conversion of large secondary structural segments, we provide evidence for the conservation of secondary structural elements of the globular domain upon PrP conversion. Previous studies already showed that dimerization is the rate-limiting step in PrP conversion. We show that separation and swapping of subdomains of the globular domain is necessary for conversion. Therefore, we propose that the domain-swapped dimer of PrP precedes amyloid formation and represents a potential target for therapeutic intervention.	[Hafner-Bratkovic, Iva; Pristovsek, Primoz; Gaspersic, Jernej; Mancek-Keber, Mateja; Avbelj, Matevz; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Bester, Romina; Gaedtke, Lars; Vorberg, Ina] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Veranic, Peter] Univ Ljubljana, Sch Med, Inst Cell Biol, Ljubljana 1000, Slovenia; [Polymenidou, Magdalini; Julius, Christian; Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Jerala, Roman] EN FIST Ctr Excellence, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; Technical University of Munich; University of Ljubljana; University of Zurich; University Zurich Hospital; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Biotechnol, Hajdrihova 19, SI-1000 Ljubljana, Slovenia.	roman.jerala@ki.si	Aguzzi, Adriano/A-3351-2008; Polymenidou, Magdalini/D-2254-2014; Veranic, Peter/I-6276-2015; Jerala, Roman/H-9850-2015	Veranic, Peter/0000-0003-1999-9988; Aguzzi, Adriano/0000-0002-0344-6708; Pristovsek, Primoz/0000-0002-2304-1791; Hafner Bratkovic, Iva/0000-0001-5635-931X; Gaspersic, Jernej/0000-0003-2131-284X; Jerala, Roman/0000-0002-6337-5251	Slovenian Research Agency; EN-FIST Centre of Excellence; Sonderforschungsbereich [597 B14]; TSEUR; Novartis Research Foundation; Swiss National Foundation; European Union	Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence; Sonderforschungsbereich(German Research Foundation (DFG)); TSEUR; Novartis Research Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Union(European Commission)	This work was supported by grants from the Slovenian Research Agency (to I. H.-B. and R. J.), EN-FIST Centre of Excellence (to R. J.), Sonderforschungsbereich 597 B14 (to I. V.), the 6th framework European Union project, TSEUR (to A. A., R. J., and I. V.), the Novartis Research Foundation (to A. A.), and the Swiss National Foundation (to A. A.).	BESTWICK RK, 1988, P NATL ACAD SCI USA, V85, P5404, DOI 10.1073/pnas.85.15.5404; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; DeMarco ML, 2007, BIOCHEMISTRY-US, V46, P3045, DOI 10.1021/bi0619066; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Eghiaian F, 2004, P NATL ACAD SCI USA, V101, P10254, DOI 10.1073/pnas.0400014101; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gaspersic J, 2010, FEBS J, V277, P2038, DOI 10.1111/j.1742-4658.2010.07619.x; Glockshuber R, 1997, TRENDS BIOCHEM SCI, V22, P241, DOI 10.1016/S0968-0004(97)01070-0; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Hafner-Bratkovic I, 2008, J NEUROCHEM, V104, P1553, DOI 10.1111/j.1471-4159.2007.05105.x; Harris DA, 1999, CLIN MICROBIOL REV, V12, P429, DOI 10.1128/CMR.12.3.429; HUNTER N, 1993, J GEN VIROL, V74, P1025, DOI 10.1099/0022-1317-74-6-1025; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Kaimann T, 2008, J MOL BIOL, V376, P582, DOI 10.1016/j.jmb.2007.11.035; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Nazabal A, 2009, J MASS SPECTROM, V44, P965, DOI 10.1002/jms.1572; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; ROGERS M, 1991, J IMMUNOL, V147, P3568; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Shindoh R, 2009, J VIROL, V83, P3852, DOI 10.1128/JVI.01740-08; Sigurdson CJ, 2009, P NATL ACAD SCI USA, V106, P304, DOI 10.1073/pnas.0810680105; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Tycko R, 2010, BIOCHEMISTRY-US, V49, P9488, DOI 10.1021/bi1013134; Vakser IA, 1999, P NATL ACAD SCI USA, V96, P8477, DOI 10.1073/pnas.96.15.8477; Vieira TCRG, 2011, J AM CHEM SOC, V133, P334, DOI 10.1021/ja106725p; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Welker E, 2002, J BIOL CHEM, V277, P33477, DOI 10.1074/jbc.M204273200; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	70	76	76	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.213926	http://dx.doi.org/10.1074/jbc.M110.213926			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324909	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000289077500030
J	Nakano, N; Nishiyama, C; Yagita, H; Koyanagi, A; Ogawa, H; Okumura, K				Nakano, Nobuhiro; Nishiyama, Chiharu; Yagita, Hideo; Koyanagi, Akemi; Ogawa, Hideoki; Okumura, Ko			Notch1-mediated Signaling Induces MHC Class II Expression through Activation of Class II Transactivator Promoter III in Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; HEMATOPOIETIC-CELLS; DENDRITIC CELLS; T-CELLS; PU.1; CIITA; NOTCH; DIFFERENTIATION; FATE	Mast cells constitutively express Notch1 and Notch2 on the cell surface. Notch ligand Dll1 (Delta-like (1) under bar) stimulation induces MHC class II expression in mast cells and renders them as antigen-presenting cells. However, nothing is known about the mechanism by which Notch signaling induces MHC class II expression in mast cells. MHC class II genes are regulated by the class II transactivator (CIITA). In mice, transcription of the CIITA gene is controlled by three cell type-specific promoters (pI, pIII, and pIV). Here, we show that CIITA expression induced by Dll1 stimulation in mouse bone marrow-derived mast cells (BMMCs) depends critically on the signal mediated by Notch1 and that the most dominant promoter in Notch signaling-mediated CIITA expression in BMMCs is pIII, which is a lymphoid lineage-specific promoter. ChIP assays indicated that Notch signaling increased the binding of the transcription factor PU.1 to CIITA pIII in BMMCs. The knockdown of PU.1 expression using a specific siRNA suppressed Notch signaling-mediated CIITA expression, suggesting that PU. 1 contributes to the expression of MHC class II induced by Notch signaling in mast cells. Furthermore, we show that a portion of freshly isolated splenic mast cells express MHC class II and that the most dominant promoter of CIITA in mast cells is pIII. These findings indicate that activation of CIITA pIII plays an important role in MHC class II expression in mast cells.	[Nakano, Nobuhiro] Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, Tokyo 1138421, Japan; [Yagita, Hideo; Okumura, Ko] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 1138421, Japan; [Yagita, Hideo; Koyanagi, Akemi] Juntendo Univ, Sch Med, Biomed Res Ctr, Div Cell Biol, Tokyo 1138421, Japan	Juntendo University; Juntendo University; Juntendo University	Nakano, N (corresponding author), Juntendo Univ, Sch Med, Atopy Allergy Res Ctr, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	nbnakano@juntendo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Nakano, Nobuhiro/0000-0002-5317-5950	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a grant-in-aid for young scientists (to N. N.) and a grant-in-aid for scientific research (C) (to C. N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by a grant from the Takeda Science Foundation (to N. N.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Gurbuxani S, 2004, BLOOD, V103, P399, DOI 10.1182/blood-2003-05-1556; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Ito T, 2005, J IMMUNOL, V174, P376, DOI 10.4049/jimmunol.174.1.376; Ito T, 2009, INT IMMUNOL, V21, P803, DOI 10.1093/intimm/dxp048; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180; KIM KJ, 1979, J IMMUNOL, V122, P549; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kitamura Y, 2006, IMMUNOL ALLERGY CLIN, V26, P387, DOI 10.1016/j.iac.2006.05.004; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; LeibundGut-Landmann S, 2004, EUR J IMMUNOL, V34, P1513, DOI 10.1002/eji.200424964; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; MacDonald AS, 2008, J EXP MED, V205, P13, DOI 10.1084/jem.20072665; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Maeda K, 2010, J IMMUNOL, V185, P4252, DOI 10.4049/jimmunol.1001228; Moriyama Y, 2008, INT IMMUNOL, V20, P763, DOI 10.1093/intimm/dxn034; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nakano N, 2009, J ALLERGY CLIN IMMUN, V123, P74, DOI 10.1016/j.jaci.2008.10.040; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Nishiyama C, 2006, BIOSCI BIOTECH BIOCH, V70, P1, DOI 10.1271/bbb.70.1; Nishiyama C, 2004, BIOCHEM BIOPH RES CO, V313, P516, DOI 10.1016/j.bbrc.2003.11.145; Niwa Y, 2008, BIOCHEM BIOPH RES CO, V375, P95, DOI 10.1016/j.bbrc.2008.07.129; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Sakata-Yanagimoto M, 2008, P NATL ACAD SCI USA, V105, P7839, DOI 10.1073/pnas.0801074105; Sakata-Yanagimoto M, 2011, BLOOD, V117, P128, DOI 10.1182/blood-2010-07-289611; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Takagi A, 2006, BIOCHEM BIOPH RES CO, V347, P388, DOI 10.1016/j.bbrc.2006.05.215; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Tsuchiya S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-35; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	44	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.138966	http://dx.doi.org/10.1074/jbc.M110.138966			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321116	hybrid, Green Published			2022-12-25	WOS:000289077500018
J	Ah-Fong, AMV; Judelson, HS				Ah-Fong, Audrey M. V.; Judelson, Howard S.			New Role for Cdc14 Phosphatase: Localization to Basal Bodies in the Oomycete Phytophthora and Its Evolutionary Coinheritance with Eukaryotic Flagella	PLOS ONE			English	Article							CELL-DIVISION; CHROMOSOME SEGREGATION; C-ELEGANS; INFESTANS; CYCLE; CHLAMYDOMONAS; PROTEINS; GENE; STABILIZATION; MICROTUBULES	Cdc14 protein phosphatases are well known for regulating the eukaryotic cell cycle, particularly during mitosis. Here we reveal a distinctly new role for Cdc14 based on studies of the microbial eukaryote Phytophthora infestans, the Irish potato famine agent. While Cdc14 is transcribed constitutively in yeast and animal cells, the P. infestans ortholog is expressed exclusively in spore stages of the life cycle and not in vegetative hyphae where the bulk of mitosis takes place. PiCdc14 expression is first detected in nuclei at sporulation, and during zoospore formation the protein accumulates at the basal body, which is the site from which flagella develop. The association of PiCdc14 with basal bodies was supported by co-localization studies with the DIP13 basal body protein and flagellar beta-tubulin, and by demonstrating the enrichment of PiCdc14 in purified flagella-basal body complexes. Overexpressing PiCdc14 did not cause defects in growth or mitosis in hyphae, but interfered with cytoplasmic partitioning during zoosporogenesis. This cytokinetic defect might relate to its ability to bind microtubules, which was shown using an in vitro cosedimentation assay. The use of gene silencing to reveal the precise function of PiCdc14 in flagella is not possible since we showed previously that silencing prevents the formation of the precursor stage, sporangia. Nevertheless, the association of Cdc14 with flagella and basal bodies is consistent with their phylogenetic distribution in eukaryotes, as species that lack the ability to produce flagella generally also lack Cdc14. An ancestral role of Cdc14 in the flagellar stage of eukaryotes is thereby proposed.	[Ah-Fong, Audrey M. V.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ah-Fong, AMV (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu			National Institute of Food and Agriculture, United States Department of Agriculture [2008-35319-04536, 2008-35600-04686]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the National Institute of Food and Agriculture, United States Department of Agriculture, under agreement numbers 2008-35319-04536 and 2008-35600-04686. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Ah-Fong AMV, 2007, EUKARYOT CELL, V6, P2222, DOI 10.1128/EC.00328-07; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Clifford DM, 2008, BIOCHEM SOC T, V36, P436, DOI 10.1042/BST0360436; Cueille N, 2001, J CELL SCI, V114, P2649; Debec A, 2010, CELL MOL LIFE SCI, V67, P2173, DOI 10.1007/s00018-010-0323-9; Dulev S, 2009, P NATL ACAD SCI USA, V106, P14466, DOI 10.1073/pnas.0900190106; Fong AMVA, 2003, MOL MICROBIOL, V50, P487, DOI 10.1046/j.1365-2958.2003.03735.x; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Grandien K, 2001, GENE DEV, V15, P2161, DOI 10.1101/gad.200601; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Hardham AR, 2007, CELL MICROBIOL, V9, P31, DOI 10.1111/j.1462-5822.2006.00833.x; Hardham AR, 2001, MOL CELL BIOL FILAME, P127; HARPER JDI, 1995, PROTOPLASMA, V188, P225, DOI 10.1007/BF01280374; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; HYDE GJ, 1993, EUR J CELL BIOL, V62, P75; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1993, MOL GEN GENET, V239, P241, DOI 10.1007/BF00281624; Junttila MR, 2005, PROTEOMICS, V5, P1199, DOI 10.1002/pmic.200400991; Kaiser BK, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-27; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Krasinska L, 2007, EXP CELL RES, V313, P1225, DOI 10.1016/j.yexcr.2006.12.022; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; MALTESE CE, 1995, MYCOL RES, V99, P1175, DOI 10.1016/S0953-7562(09)80273-6; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; MARKS GE, 1965, CHROMOSOMA, V16, P681, DOI 10.1007/BF00285117; Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008; MCKEEN W E, 1984, Canadian Journal of Plant Pathology, V6, P40; Mitchell DR, 2007, ADV EXP MED BIOL, V607, P130; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Schindler K, 2009, CELL CYCLE, V8, P1090, DOI 10.4161/cc.8.7.8144; Schoppmeier J, 2005, CELL MOTIL CYTOSKEL, V61, P189, DOI 10.1002/cm.20074; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Trautmann S, 2005, CURR BIOL, V15, P1384, DOI 10.1016/j.cub.2005.06.039; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Vitulo N, 2007, EVOL BIOINFORM, V3, P121; WHITTAKER SL, 1992, MYCOL RES, V96, P355, DOI 10.1016/S0953-7562(09)80950-7; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127	46	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16725	10.1371/journal.pone.0016725	http://dx.doi.org/10.1371/journal.pone.0016725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340037	gold, Green Published, Green Submitted			2022-12-25	WOS:000287367600017
J	Opota, O; Gauthier, NC; Doye, A; Berry, C; Gounon, P; Lemichez, E; Pauron, D				Opota, Onya; Gauthier, Nils C.; Doye, Anne; Berry, Colin; Gounon, Pierre; Lemichez, Emmanuel; Pauron, David			Bacillus sphaericus Binary Toxin Elicits Host Cell Autophagy as a Response to Intoxication	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS LARVAE; PORE-FORMING TOXINS; VACUOLATING CYTOTOXIN; ANCHORED PROTEINS; PINOCYTIC PATHWAY; EPITHELIAL-CELLS; PIPIENS DIPTERA; TARGET RECEPTOR; ENDOSOMES; CULICIDAE	Bacillus sphaericus strains that produce the binary toxin (Bin) are highly toxic to Culex and Anopheles mosquitoes, and have been used since the late 1980s as a biopesticide for the control of these vectors of infectious disease agents. The Bin toxin produced by these strains targets mosquito larval midgut epithelial cells where it binds to Cpm1 (Culex pipiens maltase 1) a digestive enzyme, and causes severe intracellular damage, including a dramatic cytoplasmic vacuolation. The intoxication of mammalian epithelial MDCK cells engineered to express Cpm1 mimics the cytopathologies observed in mosquito enterocytes following Bin ingestion: pore formation and vacuolation. In this study we demonstrate that Bin-induced vacuolisation is a transient phenomenon that affects autolysosomes. In addition, we show that this vacuolisation is associated with induction of autophagy in intoxicated cells. Furthermore, we report that after internalization, Bin reaches the recycling endosomes but is not localized either within the vacuolating autolysosomes or within any other degradative compartment. Our observations reveal that Bin elicits autophagy as the cell's response to intoxication while protecting itself from degradation through trafficking towards the recycling pathways.	[Opota, Onya; Pauron, David] Univ Nice Sophia Antipolis, Inst Natl Rech Agron, UMR Interact Biot & Sante Vegetale, INRA 1301,CNRS 6243, Sophia Antipolis, France; [Gauthier, Nils C.; Doye, Anne; Lemichez, Emmanuel] UNSA, INSERM, U895, Ctr Mediterraneen Med Mol, Nice, France; [Berry, Colin] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Gounon, Pierre] Univ Nice Sophia Antipolis, Fac Sci, Ctr Commun Microscopie Elect Appl, Nice, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Cardiff University; UDICE-French Research Universities; Universite Cote d'Azur	Opota, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland.	onya.opota@epfl.ch; David.Pauron@sophia.inra.fr	Opota, Onya/K-5851-2017; Berry, Colin/A-4338-2010; Lemichez, Emmanuel/G-3559-2013	Opota, Onya/0000-0002-5421-0607; Berry, Colin/0000-0002-9943-548X; Lemichez, Emmanuel/0000-0001-9080-7761; Plummer, Beverley/0000-0002-6559-7237	Institut National de la Recherche Agronomique (Inra); Institut National de la Sante et de la Recherche Medicale (INSERM); French Ministere de la Education et de la Recherche	Institut National de la Recherche Agronomique (Inra); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Ministere de la Education et de la Recherche	The work depicted in this paper has been granted by two French governmental agencies, the Institut National de la Recherche Agronomique (Inra) and the Institut National de la Sante et de la Recherche Medicale (INSERM). Moreover, this work represents a substantial part of Dr. Onya Opota's PhD for which he received a fellowship from the French Ministere de la Education et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Charles JF, 1996, ANNU REV ENTOMOL, V41, P451, DOI 10.1146/annurev.en.41.010196.002315; CHARLES JF, 1987, ANN INST PASTEUR MIC, V138, P471, DOI 10.1016/0769-2609(87)90064-0; Cokmus C, 1997, J INVERTEBR PATHOL, V69, P197, DOI 10.1006/jipa.1997.4660; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Darboux I, 2002, P NATL ACAD SCI USA, V99, P5830, DOI 10.1073/pnas.092615399; Darboux I, 2001, INSECT BIOCHEM MOLEC, V31, P981, DOI 10.1016/S0965-1748(01)00046-7; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; de Melo JV, 2009, APPL ENVIRON MICROB, V75, P4782, DOI 10.1128/AEM.00811-09; Dorn BR, 2002, CELL MICROBIOL, V4, P1, DOI 10.1046/j.1462-5822.2002.00164.x; Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Gauthier NC, 2004, J BIOL CHEM, V279, P9481, DOI 10.1074/jbc.M312040200; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Ha SD, 2010, J BIOL CHEM, V285, P2120, DOI 10.1074/jbc.M109.065813; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Munafo DB, 2001, J CELL SCI, V114, P3619; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; NARASU ML, 1988, INDIAN J BIOCHEM BIO, V25, P253; OEI C, 1992, J GEN MICROBIOL, V138, P1515, DOI 10.1099/00221287-138-7-1515; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; OPOTA O, 2007, COMP BIOCH PHYSL B; Pauchet Y, 2005, CELL MICROBIOL, V7, P1335, DOI 10.1111/j.1462-5822.2005.00560.x; Ratner AJ, 2006, J BIOL CHEM, V281, P12994, DOI 10.1074/jbc.M511431200; Rich KA, 2003, CELL MICROBIOL, V5, P455, DOI 10.1046/j.1462-5822.2003.00292.x; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schwartz JL, 2001, J MEMBRANE BIOL, V184, P171, DOI 10.1007/s00232-001-0086-1; Schweitzer JK, 2005, J BIOL CHEM, V280, P41628, DOI 10.1074/jbc.M504497200; Silva-Filha MH, 1999, INSECT BIOCHEM MOLEC, V29, P711, DOI 10.1016/S0965-1748(99)00047-8; Silva-Filha MHNL, 2003, PESTIC BIOCHEM PHYS, V77, P138, DOI 10.1016/j.pestbp.2003.07.002; SINGH GJP, 1988, J INVERTEBR PATHOL, V52, P237, DOI 10.1016/0022-2011(88)90131-0; Soberon M, 2007, TOXICON, V49, P597, DOI 10.1016/j.toxicon.2006.11.008; Tan YK, 2009, AUTOPHAGY, V5, P734, DOI 10.4161/auto.5.5.8567; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Terebiznik MR, 2009, AUTOPHAGY, V5, P370, DOI 10.4161/auto.5.3.7663; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	49	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14682	10.1371/journal.pone.0014682	http://dx.doi.org/10.1371/journal.pone.0014682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339824	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000287367600008
J	Phipps, MC; Clem, WC; Catledge, SA; Xu, Y; Hennessy, KM; Thomas, V; Jablonsky, MJ; Chowdhury, S; Stanishevsky, AV; Vohra, YK; Bellis, SL				Phipps, Matthew C.; Clem, William C.; Catledge, Shane A.; Xu, Yuanyuan; Hennessy, Kristin M.; Thomas, Vinoy; Jablonsky, Michael J.; Chowdhury, Shafiul; Stanishevsky, Andrei V.; Vohra, Yogesh K.; Bellis, Susan L.			Mesenchymal Stem Cell Responses to Bone-Mimetic Electrospun Matrices Composed of Polycaprolactone, Collagen I and Nanoparticulate Hydroxyapatite	PLOS ONE			English	Article							FOCAL ADHESION KINASE; OSTEOGENIC DIFFERENTIATION; ILIAC CREST; TISSUE; SCAFFOLDS; NANOFIBERS; VITRO; VITRONECTIN; FIBERS; GRAFT	The performance of biomaterials designed for bone repair depends, in part, on the ability of the material to support the adhesion and survival of mesenchymal stem cells (MSCs). In this study, a nanofibrous bone-mimicking scaffold was electrospun from a mixture of polycaprolactone (PCL), collagen I, and hydroxyapatite (HA) nanoparticles with a dry weight ratio of 50/30/20 respectively (PCL/col/HA). The cytocompatibility of this tri-component scaffold was compared with three other scaffold formulations: 100% PCL (PCL), 100% collagen I (col), and a bi-component scaffold containing 80% PCL/20% HA (PCL/HA). Scanning electron microscopy, fluorescent live cell imaging, and MTS assays showed that MSCs adhered to the PCL, PCL/HA and PCL/col/HA scaffolds, however more rapid cell spreading and significantly greater cell proliferation was observed for MSCs on the tri-component bone-mimetic scaffolds. In contrast, the col scaffolds did not support cell spreading or survival, possibly due to the low tensile modulus of this material. PCL/col/HA scaffolds adsorbed a substantially greater quantity of the adhesive proteins, fibronectin and vitronectin, than PCL or PCL/HA following in vitro exposure to serum, or placement into rat tibiae, which may have contributed to the favorable cell responses to the tri-component substrates. In addition, cells seeded onto PCL/col/HA scaffolds showed markedly increased levels of phosphorylated FAK, a marker of integrin activation and a signaling molecule known to be important for directing cell survival and osteoblastic differentiation. Collectively these results suggest that electrospun bone-mimetic matrices serve as promising degradable substrates for bone regenerative applications.	[Phipps, Matthew C.; Xu, Yuanyuan; Hennessy, Kristin M.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Clem, William C.; Catledge, Shane A.; Thomas, Vinoy; Chowdhury, Shafiul; Stanishevsky, Andrei V.; Vohra, Yogesh K.; Bellis, Susan L.] Univ Alabama Birmingham, Ctr Nanoscale Mat & Biointegrat, Birmingham, AL 35294 USA; [Clem, William C.; Bellis, Susan L.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA; [Catledge, Shane A.; Thomas, Vinoy; Chowdhury, Shafiul; Stanishevsky, Andrei V.; Vohra, Yogesh K.] Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; [Jablonsky, Michael J.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Phipps, MC (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	ykvohra@uab.edu; bellis@uab.edu	THOMAS, VINOY/A-8016-2009	THOMAS, VINOY/0000-0002-1191-3353; Catledge, Shane/0000-0003-3202-3234	National Institute of Dental and Craniofacial Research (NIDCR) [R01DE013952]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR51539]; National Science Foundation (NSF) [CMS-0555778]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32EB004312]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB004312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013952] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Financial support was provided by: (1) National Institute of Dental and Craniofacial Research (NIDCR) under grant # R01DE013952 (YKV) http://www.nidcr.nih.gov/. (2) National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under grant # R01AR51539 (SLB) http://www.niams.nih.gov/. (3) National Science Foundation (NSF) Award # CMS-0555778 (AVS) http://www.nsf.gov/div/index.jsp?div=PHY. (4) WC Clem was supported by the NIH training Grant # T32EB004312 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) http://www.nibib.nih.gov/. (5) MC Phipps was supported by a Howard Hughes Med to Grad Fellowship http://www.hhmi.org/grants/institutions/medintograd.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292; BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z; Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313; BRIGHTON CT, 1995, CLIN ORTHOP RELAT R, P223; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Catledge SA, 2007, BIOMED MATER, V2, P142, DOI 10.1088/1748-6041/2/2/013; Chuenjitkuntaworn B, 2010, J BIOMED MATER RES A, V94A, P241, DOI 10.1002/jbm.a.32657; DARNEY PD, 1989, AM J OBSTET GYNECOL, V160, P1292, DOI 10.1016/S0002-9378(89)80015-8; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FERNYHOUGH JC, 1992, SPINE, V17, P1474, DOI 10.1097/00007632-199212000-00006; FREISS W, 1996, PHARM DEV TECHNOL, V1, P185; GEBB C, 1986, J BIOL CHEM, V261, P6698; Giancotti FG, 1997, CURR OPIN CELL BIOL, V9, P691, DOI 10.1016/S0955-0674(97)80123-8; Goulet JA, 1997, CLIN ORTHOP RELAT R, P76; Hennessy KM, 2008, BIOMATERIALS, V29, P3075, DOI 10.1016/j.biomaterials.2008.04.014; Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034; Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7; HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905; Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043; Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116; Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110; Lee JJ, 2009, J MATER SCI-MATER M, V20, P1927, DOI 10.1007/s10856-009-3743-z; Lee Kenneth J H, 2005, Spine J, V5, p217S, DOI 10.1016/j.spinee.2005.02.006; Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030; Marinucci L, 2003, J BIOMED MATER RES A, V67A, P504, DOI 10.1002/jbm.a.10082; Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u; Moursi AM, 1997, J CELL SCI, V110, P2187; Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197; Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104; Thomas V, 2006, J NANOSCI NANOTECHNO, V6, P487, DOI 10.1166/jnn.2006.097; Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w; Tzaphlidou M, 2005, BONE, V36, pS198; VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310; Venugopal J, 2008, J MATER SCI-MATER M, V19, P2039, DOI 10.1007/s10856-007-3289-x; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; WOODWARD SC, 1985, J BIOMED MATER RES, V19, P437, DOI 10.1002/jbm.820190408; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu YQ, 2004, J AM CERAM SOC, V87, P1988; Wutticharoenmongkol P, 2006, MACROMOL BIOSCI, V6, P70, DOI 10.1002/mabi.200500150; Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870	54	82	85	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16813	10.1371/journal.pone.0016813	http://dx.doi.org/10.1371/journal.pone.0016813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346817	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600030
J	Althaus, CL; De Boer, RJ				Althaus, Christian L.; De Boer, Rob J.			Implications of CTL-Mediated Killing of HIV-Infected Cells during the Non-Productive Stage of Infection	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; COMPLEX CLASS-I; DOWN-REGULATION; EXPRESSION KINETICS; VIRAL REPLICATION; TYPE-1 INFECTION; IMMUNE CONTROL; NEF PROTEIN; PLASMA	Patients infected with HIV exhibit orders of magnitude differences in their set-point levels of the plasma viral load. As to what extent this variation is due to differences in the efficacy of the cytotoxic T lymphocyte (CTL) response in these patients is unclear. Several studies have shown that HIV-infected CD4(+) T cells also present viral epitopes that are recognized by CTLs before the productive stage of infection, i.e., during the intracellular eclipse phase before the infected cell starts to produce new viral particles. Here, we use mathematical modeling to investigate the potential impact of early killing of HIV-infected cells on viral replication. We suggest that the majority of CTL-mediated killing could occur during the viral eclipse phase, and that the killing of virus-producing cells could be substantially lower at later stages due to MHC-I-down-regulation. Such a mechanism is in agreement with several experimental observations that include CD8(+) T cell depletion and antiretroviral drug treatment. This indicates a potentially important role of CTL-mediated killing during the non-productive stage of HIV-infected cells.	[Althaus, Christian L.; De Boer, Rob J.] Univ Utrecht, Utrecht, Netherlands	Utrecht University	Althaus, CL (corresponding author), Univ Utrecht, Utrecht, Netherlands.	christian.althaus@alumni.ethz.ch	de Boer, Rob/B-6050-2011; Althaus, Christian L./F-6008-2015	de Boer, Rob/0000-0002-2130-691X; Althaus, Christian L./0000-0002-5230-6760	Netherlands Organisation for Scientific Research [016.048.603]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	CLA and RJDB gratefully acknowledge financial support by the Netherlands Organisation for Scientific Research (VICI grant 016.048.603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2004, J VIROL, V78, P561, DOI 10.1128/JVI.78.2.561-567.2004; Althaus CL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.4; Althaus CL, 2009, J VIROL, V83, P7659, DOI 10.1128/JVI.01799-08; Althaus CL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000103; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; BALAMURALI M, 2010, J IMMUNOL; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Bonhoeffer S, 2003, TRENDS MICROBIOL, V11, P499, DOI 10.1016/j.tim.2003.09.002; Borghans JAM, 1996, B MATH BIOL, V58, P43, DOI 10.1016/0092-8240(95)00306-1; Borghans JAM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000920; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; Davenport MP, 2004, J VIROL, V78, P10096, DOI 10.1128/JVI.78.18.10096-10103.2004; De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548; De Boer RJ, 2007, J VIROL, V81, P2838, DOI 10.1128/JVI.01914-06; Dixit NM, 2004, ANTIVIR THER, V9, P237; FISCHER W, 2010, PLOS ONE, V5; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Ganusov VV, 2003, P ROY SOC B-BIOL SCI, V270, P1513, DOI 10.1098/rspb.2003.2401; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; Gruters RA, 2002, VACCINE, V20, P2011, DOI 10.1016/S0264-410X(02)00089-0; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kesmir C, 2003, IMMUNOGENETICS, V55, P437, DOI 10.1007/s00251-003-0585-6; Kesmir C, 2002, PROTEIN ENG, V15, P287, DOI 10.1093/protein/15.4.287; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kim EY, 2008, J VIROL, V82, P5631, DOI 10.1128/JVI.02749-07; Klatt NR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000747; Klenerman P, 1996, P NATL ACAD SCI USA, V93, P15323, DOI 10.1073/pnas.93.26.15323; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Lichterfeld M, 2005, TRENDS IMMUNOL, V26, P166, DOI 10.1016/j.it.2005.01.003; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Muller V, 2001, P ROY SOC B-BIOL SCI, V268, P235, DOI 10.1098/rspb.2000.1358; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nowak M. A., 2000, VIRUS DYNAMICS MATH; Pandrea I, 2008, J VIROL, V82, P3713, DOI 10.1128/JVI.02402-07; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Sacha JB, 2008, J VIROL, V82, P9293, DOI 10.1128/JVI.00749-08; Sacha JB, 2007, J VIROL, V81, P11703, DOI 10.1128/JVI.00926-07; Sacha JB, 2007, J IMMUNOL, V178, P2746, DOI 10.4049/jimmunol.178.5.2746; Sacha JB, 2010, J VIROL, V84, P10907, DOI 10.1128/JVI.01357-10; Sacha JB, 2009, P NATL ACAD SCI USA, V106, P9791, DOI 10.1073/pnas.0813106106; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SCHEPPLER JA, 1989, J IMMUNOL, V143, P2858; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sergeev RA, 2010, J THEOR BIOL, V263, P369, DOI 10.1016/j.jtbi.2009.11.003; Swigut T, 2004, J VIROL, V78, P13335, DOI 10.1128/JVI.78.23.13335-13344.2004; van Baalen CA, 2002, EUR J IMMUNOL, V32, P2644, DOI 10.1002/1521-4141(200209)32:9<2644::AID-IMMU2644>3.0.CO;2-R; Vojnov L, 2010, J VIROL, V84, P753, DOI 10.1128/JVI.01596-09; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wick WD, 2009, J VIROL, V83, P2349, DOI 10.1128/JVI.00821-08; Wong JK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000748; Yang OO, 1997, ADV IMMUNOL, V66, P273, DOI 10.1016/S0065-2776(08)60600-8	63	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e16468	10.1371/journal.pone.0016468	http://dx.doi.org/10.1371/journal.pone.0016468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326882	gold, Green Published			2022-12-25	WOS:000287037100009
J	Yong, J; Lacan, G; Dang, H; Hsieh, T; Middleton, B; Wasserfall, C; Tian, JD; Melega, WP; Kaufman, DL				Yong, Jing; Lacan, Goran; Dang, Hoa; Hsieh, Terry; Middleton, Blake; Wasserfall, Clive; Tian, Jide; Melega, William P.; Kaufman, Daniel L.			BCG Vaccine-Induced Neuroprotection in a Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BACILLE-CALMETTE-GUERIN; MYELIN BASIC-PROTEIN; DIABETES-PRONE MICE; REGULATORY T-CELLS; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; ANIMAL-MODEL	There is a growing interest in using vaccination with CNS antigens to induce autoreactive T cell responses that home to damaged areas in the CNS and ameliorate neurodegenerative disease. Neuroprotective vaccine studies have focused on administering oligodendrocyte antigens or Copaxone (R) in complete Freund's adjuvant (CFA). Theoretical considerations, however, suggest that vaccination with a neuronal antigen may induce more robust neuroprotective immune responses. We assessed the neuroprotective potential of vaccines containing tyrosine hydroxylase (a neuronal protein involved in dopamine synthesis) or Copaxone (R) in CFA in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Surprisingly, we observed that the main beneficial factor in these vaccines was the CFA. Since the major immunogenic component in CFA is Mycobacterium tuberculosis, which closely related to the bacille Calmette-Guerin (BCG) that is used in human vaccines, we tested BCG vaccination in the MPTP mouse model. We observed that BCG vaccination partially preserved markers of striatal dopamine system integrity and prevented an increase in activated microglia in the substantia nigra of MPTP-treated mice. These results support a new neuroprotective vaccine paradigm in which general (nonself-reactive) immune stimulation in the periphery can limit potentially deleterious microglial responses to a neuronal insult and exert a neurorestorative effect in the CNS. Accordingly, BCG vaccination may provide a new strategy to augment current treatments for a wide range of neuropathological conditions.	[Yong, Jing; Lacan, Goran; Dang, Hoa; Hsieh, Terry; Middleton, Blake; Tian, Jide; Melega, William P.; Kaufman, Daniel L.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wasserfall, Clive] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA	University of California System; University of California Los Angeles; State University System of Florida; University of Florida	Kaufman, DL (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	dkaufman@mednet.ucla.edu	Yong, Jing/I-2150-2012; wasserfall, clive/J-9078-2012; Kaufman, Daniel/AAU-1228-2021; Wasserfall, Clive/ABF-9385-2020	Yong, Jing/0000-0001-8579-1558; wasserfall, clive/0000-0002-3522-8932; Kaufman, Daniel/0000-0002-9844-5918; Wasserfall, Clive/0000-0002-3522-8932	American Parkinson's Disease Association; Michael J. Fox Foundation; National Institutes of Health [R21NS049121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS049121] Funding Source: NIH RePORTER	American Parkinson's Disease Association; Michael J. Fox Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Parkinson's Disease Association, the Michael J. Fox Foundation and the National Institutes of Health (R21NS049121) to DLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Armentero MT, 2006, NEUROBIOL DIS, V24, P492, DOI 10.1016/j.nbd.2006.08.016; Bakalash S, 2005, J MOL MED, V83, P904, DOI 10.1007/s00109-005-0689-6; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; BENNUN A, 1995, J IMMUNOL, V154, P2939; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boska MD, 2005, J NEUROSCI, V25, P1691, DOI 10.1523/JNEUROSCI.4364-04.2005; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Burl S, 2010, J IMMUNOL, V185, P2620, DOI 10.4049/jimmunol.1000552; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cruz A, 2006, J IMMUNOL, V177, P1416, DOI 10.4049/jimmunol.177.3.1416; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Czlonkowska Anna, 2002, Med Sci Monit, V8, pRA165; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Fine P., 1999, ISSUES RELATING USE; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hofstetter HH, 2003, J NEUROIMMUNOL, V134, P25, DOI 10.1016/S0165-5728(02)00358-2; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jones TB, 2004, J NEUROSCI, V24, P3752, DOI 10.1523/JNEUROSCI.0406-04.2004; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101; Kokovay E, 2005, NEUROBIOL DIS, V19, P471, DOI 10.1016/j.nbd.2005.01.023; Kumar M, 1999, IMMUNOLOGY, V97, P515; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Kurkowska-Jastrzebska I, 2005, NEUROSCIENCE, V131, P247, DOI 10.1016/j.neuroscience.2004.10.027; Laurie C, 2007, J NEUROIMMUNOL, V183, P60, DOI 10.1016/j.jneuroim.2006.11.009; McGeer PL, 2001, ADV NEUROL, V86, P83; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Meredith GE, 2008, ACTA NEUROPATHOL, V115, P385, DOI 10.1007/s00401-008-0350-x; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Moalem G, 2000, J AUTOIMMUN, V15, P331, DOI 10.1006/jaut.2000.0441; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Nevo U, 2003, TRENDS MOL MED, V9, P88, DOI 10.1016/S1471-4914(03)00024-8; O'Neil ML, 2006, SYNAPSE, V60, P465, DOI 10.1002/syn.20320; Olcott AP, 2005, J IMMUNOL, V175, P1991, DOI 10.4049/jimmunol.175.3.1991; Paolillo A, 2003, J NEUROL, V250, P247, DOI 10.1007/s00415-003-0967-6; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Pennathur S, 1999, J BIOL CHEM, V274, P34621, DOI 10.1074/jbc.274.49.34621; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Reynolds AD, 2010, J IMMUNOL, V184, P2261, DOI 10.4049/jimmunol.0901852; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Ristori G, 1999, NEUROLOGY, V53, P1588, DOI 10.1212/WNL.53.7.1588; Rodriguez M, 2007, NEUROBIOL DIS, V28, P316, DOI 10.1016/j.nbd.2007.07.024; Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sewell DL, 2003, CLIN DIAGN LAB IMMUN, V10, P564, DOI 10.1128/CDLi.10.4.564-572.2003; Stefanova N, 2007, MOVEMENT DISORD, V22, P2196, DOI 10.1002/mds.21671; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; TEITELBAUM D, 1988, P NATL ACAD SCI USA, V85, P9724, DOI 10.1073/pnas.85.24.9724; TEIXEIRA HC, 1995, IMMUNOL LETT, V46, P15, DOI 10.1016/0165-2478(95)00009-T; Tian JD, 1996, NAT MED, V2, P1348, DOI 10.1038/nm1296-1348; Tian J, 2009, DIABETES, V58, P1939, DOI 10.2337/db09-0451; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Yip HC, 1999, J IMMUNOL, V162, P3942	66	38	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16610	10.1371/journal.pone.0016610	http://dx.doi.org/10.1371/journal.pone.0016610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304945	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300098
J	Horn, S; Durka, W; Wolf, R; Ermala, A; Stubbe, A; Stubbe, M; Hofreiter, M				Horn, Susanne; Durka, Walter; Wolf, Ronny; Ermala, Aslak; Stubbe, Annegret; Stubbe, Michael; Hofreiter, Michael			Mitochondrial Genomes Reveal Slow Rates of Molecular Evolution and the Timing of Speciation in Beavers (Castor), One of the Largest Rodent Species	PLOS ONE			English	Article							PHYLOGENY; LONGEVITY; SUPPORT; CLOCK; FIBER; MODEL	Background: Beavers are one of the largest and ecologically most distinct rodent species. Little is known about their evolution and even their closest phylogenetic relatives have not yet been identified with certainty. Similarly, little is known about the timing of divergence events within the genus Castor. Methodology/Principal Findings: We sequenced complete mitochondrial genomes from both extant beaver species and used these sequences to place beavers in the phylogenetic tree of rodents and date their divergence from other rodents as well as the divergence events within the genus Castor. Our analyses support the phylogenetic position of beavers as a sister lineage to the scaly tailed squirrel Anomalurus within the mouse related clade. Molecular dating places the divergence time of the lineages leading to beavers and Anomalurus as early as around 54 million years ago (mya). The living beaver species, Castor canadensis from North America and Castor fiber from Eurasia, although similar in appearance, appear to have diverged from a common ancestor more than seven mya. This result is consistent with the hypothesis that a migration of Castor from Eurasia to North America as early as 7.5 mya could have initiated their speciation. We date the common ancestor of the extant Eurasian beaver relict populations to around 210,000 years ago, much earlier than previously thought. Finally, the substitution rate of Castor mitochondrial DNA is considerably lower than that of other rodents. We found evidence that this is correlated with the longer life span of beavers compared to other rodents. Conclusions/Significance: A phylogenetic analysis of mitochondrial genome sequences suggests a sister-group relationship between Castor and Anomalurus, and allows molecular dating of species divergence in congruence with paleontological data. The implementation of a relaxed molecular clock enabled us to estimate mitochondrial substitution rates and to evaluate the effect of life history traits on it.	[Horn, Susanne; Hofreiter, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Durka, Walter] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [Wolf, Ronny] Univ Leipzig, Dept Mol Evolut & Anim Systemat, Leipzig, Germany; [Ermala, Aslak] Finnish Game & Fisheries Res Inst, Helsinki, Finland; [Stubbe, Annegret; Stubbe, Michael] Univ Halle Wittenberg, Inst Zool, Wittenberg, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Natural Resources Institute Finland (Luke); Martin Luther University Halle Wittenberg	Horn, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	horn@eva.mpg.de	Durka, Walter/E-4667-2010; Hofreiter, Michael/A-3996-2017	Durka, Walter/0000-0002-6611-2246; Hofreiter, Michael/0000-0003-0441-4705	Volkswagen Foundation; Max Planck Society	Volkswagen Foundation(Volkswagen); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Volkswagen Foundation and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2003, MOL PHYLOGENET EVOL, V26, P409, DOI 10.1016/S1055-7903(02)00304-4; Baker B. W., 2003, BEAVER CASTOR CANADE, V2nd; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Choate JR, 1998, J MAMMAL, V79, P1416; Churakov G, 2010, MOL BIOL EVOL, V27, P1315, DOI 10.1093/molbev/msq019; Djoshkin W. W., 1972, BIBER ALTEN NEUEN WE; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x; Emerson BC, 2007, SYST BIOL, V56, P337, DOI 10.1080/10635150701258795; Farwick A, 2006, SYST BIOL, V55, P936, DOI 10.1080/10635150601064806; FLYNN LJ, 2007, EVOLUTION TERTIARY M; Galtier N, 2009, BIOL LETTERS, V5, P413, DOI 10.1098/rsbl.2008.0662; Gladenkov AY, 2002, PALAEOGEOGR PALAEOCL, V183, P321, DOI 10.1016/S0031-0182(02)00249-3; GREEN R, 2009, COLD SPRING HARB LAB; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Halley Duncan J., 2003, Lutra, V46, P91; HERVE P, 1997, J MOL EVOL, V45, P712; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Horner DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-16; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Hugueney M, 1996, PALEOBIOLOGY, V22, P507, DOI 10.1017/S0094837300016493; Jobson RW, 2010, MOL BIOL EVOL, V27, P840, DOI 10.1093/molbev/msp293; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Knapp M, 2009, MOL ECOL, V18, P1225, DOI 10.1111/j.1365-294X.2009.04088.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lavrov L. S., 1983, ACTA ZOOL FENN, V174, P87; Lin YH, 2002, GENE, V294, P119, DOI 10.1016/S0378-1119(02)00695-9; LINDSAY EH, 1984, ANNU REV EARTH PL SC, V12, P445, DOI 10.1146/annurev.ea.12.050184.002305; LYCHEV GF, 1983, ISTORIA EVOLUTSYA SI, P179; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Montgelard C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-321; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2014, TRACER V1 6; Rybczynski Natalia, 2007, Journal of Mammalian Evolution, V14, P1, DOI 10.1007/s10914-006-9017-3; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Stiller M, 2009, GENOME RES, V19, P1843, DOI 10.1101/gr.095760.109; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thomas JA, 2006, P NATL ACAD SCI USA, V103, P7366, DOI 10.1073/pnas.0510251103; VERON G, 1992, MAMMALIA, V56, P87, DOI 10.1515/mamm.1992.56.1.87; WARD OG, 1991, GENOME, V34, P324, DOI 10.1139/g91-053; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; WOOD AE, 1959, EVOLUTION, V13, P354, DOI 10.1111/j.1558-5646.1959.tb03022.x; Xu Xiaofeng, 1994, National Science Museum Monographs, V8, P77	51	44	46	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e14622	10.1371/journal.pone.0014622	http://dx.doi.org/10.1371/journal.pone.0014622			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21307956	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100007
J	Wang, Z; Xia, YA; Ji, XA				Wang, Zheng; Xia, Yuan; Ji, Xiang			Clutch Frequency Affects the Offspring Size-Number Trade-Off in Lizards	PLOS ONE			English	Article							EGG-SIZE; REPRODUCTIVE TRAITS; LACERTA-VIVIPARA; EVOLUTION; MANIPULATION; CONSTRAINTS; POPULATION; PLASTICITY; SELECTION; FITNESS	Background: Studies of lizards have shown that offspring size cannot be altered by manipulating clutch size in species with a high clutch frequency. This raises a question of whether clutch frequency has a key role in influencing the offspring size-number trade-off in lizards. Methodology/Principal Findings: To test the hypothesis that females reproducing more frequently are less likely to tradeoff offspring size against offspring number, we applied the follicle ablation technique to female Eremias argus (Lacertidae) from Handan (HD) and Gonghe (GH), the two populations that differ in clutch frequency. Follicle ablation resulted in enlargement of egg size in GH females, but not in HD females. GH females switched from producing a larger number of smaller eggs in the first clutch to a smaller number of larger eggs in the second clutch; HD females showed a similar pattern of seasonal shifts in egg size, but kept clutch size constant between the first two clutches. Thus, the egg size-number trade-off was evident in GH females, but not in HD females. Conclusions/Significance: As HD females (mean = 3.1 clutches per year) reproduce more frequently than do GH females (mean = 1.6 clutches per year), our data therefore validate the hypothesis tested. Our data also provide an inference that maximization of maternal fitness could be achieved in females by diverting a large enough, rather than a higher-than-usual, fraction of the available energy to individual offspring in a given reproductive episode.	[Wang, Zheng; Ji, Xiang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China; [Xia, Yuan] Hangzhou Normal Univ, Sch Life & Environm Sci, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Nanjing Normal University; Hangzhou Normal University	Wang, Z (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Biodivers & Biotechnol, Nanjing, Jiangsu, Peoples R China.	xji@mail.hz.zj.cn			Natural Science Foundation of China [30770378]; Chinese Ministry of Education [20070319006]; Nanjing Normal University [0319PM0902]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Nanjing Normal University	The project was supported by the Natural Science Foundation of China (30770378), Chinese Ministry of Education (20070319006) and Nanjing Normal University (0319PM0902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2001, SCIENCE, V292, P1710, DOI 10.1126/science.1059910; Ballinger R.E., 1983, P241; Bashey F, 2008, OIKOS, V117, P104, DOI 10.1111/j.2007.0030-1299.16094.x; BAUWENS D, 1987, HOLARCTIC ECOL, V10, P120; Bernardo J, 1996, AM ZOOL, V36, P216; Boersma M, 1997, EVOL ECOL, V11, P439, DOI 10.1023/A:1018484824003; Caley MJ, 2001, EVOLUTION, V55, P1245; Du WG, 2005, BIOL LETTERS, V1, P98, DOI 10.1098/rsbl.2004.0268; DUFAURE JP, 1961, ARCH ANAT MICROSC MO, V50, P309; Hao Qi-Lei, 2006, Acta Zoologica Sinica, V52, P1049; Janzen FJ, 2009, J EVOLUTION BIOL, V22, P2222, DOI 10.1111/j.1420-9101.2009.01838.x; Ji X, 2006, J COMP PHYSIOL B, V176, P521, DOI 10.1007/s00360-006-0074-y; Ji X, 2006, BIOL J LINN SOC, V88, P453, DOI 10.1111/j.1095-8312.2006.00633.x; Ji X, 2009, OECOLOGIA, V159, P689, DOI 10.1007/s00442-008-1252-2; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jordan MA, 2002, OECOLOGIA, V130, P44, DOI 10.1007/s004420100776; Li H, 2009, EVOL ECOL, V23, P777, DOI 10.1007/s10682-008-9272-2; Luo LG, 2010, J EXP BIOL, V213, P2073, DOI 10.1242/jeb.041137; Olsson M, 2002, FUNCT ECOL, V16, P135, DOI 10.1046/j.0269-8463.2001.00600.x; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Roff Derek, 2002, pi; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; Sinervo B, 1996, EVOLUTION, V50, P1299, DOI 10.1111/j.1558-5646.1996.tb02370.x; SINERVO B, 1991, J EXP ZOOL, V257, P252, DOI 10.1002/jez.1402570216; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Taborsky B, 2006, BIOL LETTERS, V2, P225, DOI 10.1098/rsbl.2005.0422; Uller T, 2010, OECOLOGIA, V162, P663, DOI 10.1007/s00442-009-1503-x; Wang Z, 2009, AMPHIBIA-REPTILIA, V30, P361, DOI 10.1163/156853809788795119; WINKLER DW, 1987, AM NAT, V129, P708, DOI 10.1086/284667; XIA Y, 2010, THESIS HANGZHOU NORM; ZHAO KT, 1999, FAUNA SINICA REPTILI, V2, P219	32	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16585	10.1371/journal.pone.0016585	http://dx.doi.org/10.1371/journal.pone.0016585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305034	Green Submitted, Green Published, gold			2022-12-25	WOS:000286663900077
J	Hilberath, JN; Carlo, T; Pfeffer, MA; Croze, RH; Hastrup, F; Levy, BD				Hilberath, Jan N.; Carlo, Troy; Pfeffer, Michael A.; Croze, Roxanne H.; Hastrup, Frantz; Levy, Bruce D.			Resolution of Toll-like receptor 4-mediated acute lung injury is linked to eicosanoids and suppressor of cytokine signaling 3	FASEB JOURNAL			English	Article						inflammation; lung elastance; vascular permeability; lipid mediators; macrophages	INFLAMMATION; MACROPHAGES; MICE; IDENTIFICATION; ASPIRATION; RESPONSES; PROTEINS; DELIVERY; PATHWAY; STRESS	The purpose of this study was to investigate roles for Toll-like receptor 4 (TLR4) in host responses to sterile tissue injury. Hydrochloric acid was instilled into the left mainstem bronchus of TLR4-defective (both C3H/HeJ and congenic C. C3-Tlr4(Lps-d)/J) and control mice to initiate mild, self-limited acute lung injury (ALI). Outcome measures included respiratory mechanics, barrier integrity, leukocyte accumulation, and levels of select soluble mediators. TLR4-defective mice were more resistant to ALI, with significantly decreased perturbations in lung elastance and resistance, resulting in faster resolution of these parameters [resolution interval (R-i); similar to 6 vs. 12 h]. Vascular permeability changes and oxidative stress were also decreased in injured HeJ mice. These TLR4-defective mice paradoxically displayed increased lung neutrophils [(HeJ) 24 x 10(3) vs. (control) 13 x 10(3) cells/bronchoalveolar lavage]. Proresolving mechanisms for TLR4-defective animals included decreased eicosanoid biosynthesis, including cysteinyl leukotrienes (80% mean decrease) that mediated CysLT1 receptor-dependent vascular permeability changes; and induction of lung suppressor of cytokine signaling 3 (SOCS3) expression that decreased TLR4-driven oxidative stress. Together, these findings indicate pivotal roles for TLR4 in promoting sterile ALI and suggest downstream provocative roles for cysteinyl leukotrienes and protective roles for SOCS3 in the intensity and duration of host responses to ALI.-Hilberath, J N., Carlo, T., Pfeffer, M. A., Croze, R. H., Hastrup, F., Levy, B. D. Resolution of Toll-like receptor 4-mediated acute lung injury is linked to eicosanoids and suppressor of cytokine signaling 3. FASEB J. 25, 1827-1835 (2011). www.fasebj.org	[Levy, Bruce D.] Brigham & Womens Hosp, Harvard Inst Med, Div Pulm & Crit Care Med, Dept Internal Med, Boston, MA 02115 USA; [Hilberath, Jan N.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Hilberath, Jan N.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Div Pulm & Crit Care Med, Dept Internal Med, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	blevy@partners.org		Hilberath, Jan N./0000-0002-0799-2941	National Institutes of Health [HL068669, HL090927]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090927, R01HL068669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge Bonna Ith for expert help with histology, and Anton Serhan for assistance with the transfection experiments. This study was supported by departmental funds (J.N.H.) and National Institutes of Health grants HL068669 and HL090927 (B.D.L.). B.D.L. is a coinventor on patents on the use of lipoxins in lung disease that are assigned to Brigham and Women's Hospital, which have been licensed for clinical development.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bonnans C, 2006, AM J PATHOL, V168, P1064, DOI 10.2353/ajpath.2006.051056; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Carpenter CT, 1998, CHEST, V114, P1653, DOI 10.1378/chest.114.6.1653; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Fang M, 2005, CELL MOL IMMUNOL, V2, P373; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Freire-de-Lima CG, 2006, J BIOL CHEM, V281, P38376, DOI 10.1074/jbc.M605146200; Fukunaga K, 2005, J IMMUNOL, V174, P5033, DOI 10.4049/jimmunol.174.8.5033; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Garantziotis S, 2010, AM J RESP CRIT CARE, V181, P666, DOI 10.1164/rccm.200903-0381OC; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gronert K, 2001, AM J PATHOL, V158, P3, DOI 10.1016/S0002-9440(10)63937-5; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Keller M, 2006, FASEB J, V20, P702, DOI 10.1096/fj.05-4075fje; Levy BD, 2007, FASEB J, V21, P3877, DOI 10.1096/fj.07-8653com; Liu X, 2008, MOL IMMUNOL, V45, P1405, DOI 10.1016/j.molimm.2007.08.018; Ma SF, 2005, AM J PHYSIOL-LUNG C, V289, pL468, DOI 10.1152/ajplung.00109.2005; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Peddibhotla S, 2009, P NATL ACAD SCI USA, V106, P5159, DOI 10.1073/pnas.0806671106; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ramirez Cruz Nora E, 2004, Rev Alerg Mex, V51, P210; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Rovati GE, 2007, THESCIENTIFICWORLDJO, V7, P1375, DOI 10.1100/tsw.2007.185; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2000, NAT IMMUNOL, V1, P13, DOI 10.1038/76865; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; UDAKA K, 1970, P SOC EXP BIOL MED, V133, P1384; VOGEL SN, 1994, INFECT IMMUN, V62, P4454, DOI 10.1128/IAI.62.10.4454-4459.1994; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yoshimura Akihiko, 2009, Keio Journal of Medicine, V58, P73; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	47	26	34	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2011	25	6					1827	1835		10.1096/fj.10-169896	http://dx.doi.org/10.1096/fj.10-169896			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	769NT	21321188	Green Published			2022-12-25	WOS:000291023800006
J	Kim, EK; Yun, SJ; Ha, JM; Kim, YW; Jin, IH; Yun, J; Shin, HK; Song, SH; Kim, JH; Lee, JS; Kim, CD; Bae, SS				Kim, E. K.; Yun, S. J.; Ha, J. M.; Kim, Y. W.; Jin, I. H.; Yun, J.; Shin, H. K.; Song, S. H.; Kim, J. H.; Lee, J. S.; Kim, C. D.; Bae, S. S.			Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis	ONCOGENE			English	Article						Akt; invasion; metastasis; mTOR; P-Rex1	FACTOR-I RECEPTOR; PROTEIN-KINASE-B; ACTIN CYTOSKELETON; INSULIN-RESISTANCE; BREAST-CANCER; GROWTH; MTOR; MOTILITY; AKT/PKB; INHIBITION	Mammalian target of rapamycin complex (mTORC) regulates a variety of cellular responses including proliferation, growth, differentiation and cell migration. In this study, we show that mammalian target of rapamycin complex 2 (mTORC2) regulates invasive cancer cell migration through selective activation of Akt1. Insulin-like growth factor-1 (IGF-1)-induced SKOV-3 cell migration was completely abolished by phosphatidylinositol 3-kinase (PI3K) (LY294002, 10 mu M) or Akt inhibitors (SH-5, 50 mu M), whereas inhibition of extracellular-regulated kinase by an ERK inhibitor (PD98059, 10 mu M) or inhibition of mammalian target of rapamycin complex 1 (mTORC1) by an mTORC1 inhibitor (Rapamycin, 100 nM) did not affect IGF-1-induced SKOV-3 cell migration. Inactivation of mTORC2 by silencing Rapamycin-insensitive companion of mTOR (Rictor), abolished IGF-1-induced SKOV-3 cell migration as well as activation of Akt. However, inactivation of mTORC1 by silencing of Raptor had no effect. Silencing of Akt1 but not Akt2 attenuated IGF-1-induced SKOV-3 cell migration. Rictor was preferentially associated with Akt1 rather than Akt2, and overexpression of Rictor facilitated IGF-1-induced Akt1 activation. Expression of PIP3-dependent Rac exchanger1 (P-Rex1), a Rac guanosine exchange factor and a component of the mTOR complex, strongly stimulated activation of Akt1. Furthermore, knockdown of P-Rex1 attenuated Akt activation as well as IGF-1-induced SKOV-3 cell migration. Silencing of Akt1 or P-Rex1 abolished IGF-1-induced SKOV-3 cell invasion. Finally, silencing of Akt1 blocked in vivo metastasis, whereas silencing of Akt2 did not. Given these results, we suggest that selective activation of Akt1 through mTORC2 and P-Rex1 regulates cancer cell migration, invasion and metastasis. Oncogene (2011) 30, 2954-2963; doi:10.1038/onc.2011.22; published online 21 February 2011	[Kim, E. K.; Yun, S. J.; Ha, J. M.; Kim, Y. W.; Jin, I. H.; Kim, C. D.; Bae, S. S.] Pusan Natl Univ, Sch Med, Dept Pharmacol, MRC Ischem Tissue Regenerat, Yangsan 626870, Kyungnam, South Korea; [Yun, J.] Dong A Univ, Sch Med, Dept Biochem, Yangsan, South Korea; [Shin, H. K.] Pusan Natl Univ, Sch Korean Med, Dept Anat, Yangsan 626870, Kyungnam, South Korea; [Song, S. H.] Pusan Natl Univ, Sch Med, Dept Internal Med, Yangsan 626870, Kyungnam, South Korea; [Kim, J. H.] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, Kyungnam, South Korea; [Lee, J. S.] Pusan Natl Univ, Sch Med, Dept Orthoped Surg, Yangsan 626870, Kyungnam, South Korea; [Kim, E. K.; Yun, S. J.; Ha, J. M.; Kim, Y. W.; Jin, I. H.; Kim, C. D.; Bae, S. S.] Pusan Natl Univ, Sch Med, Dept Pharmacol, MRC Med Res Inst, Yangsan 626870, Kyungnam, South Korea	Pusan National University; Pusan National University Hospital; Dong A University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Bae, SS (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, MRC Ischem Tissue Regenerat, Yangsan 626870, Kyungnam, South Korea.	sunsik@pusan.ac.kr			Korea government (MEST) [2010-0015808]; Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea [0920050]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea	This work was supported partly by the MRC program of the NRF (2010-0001247), a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2010-0015808), and the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (0920050).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Barber Mark A, 2006, Bull Cancer, V93, pE44; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dunn SE, 1998, CANCER RES, V58, P3353; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Grille SJ, 2003, CANCER RES, V63, P2172; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim EK, 2008, CELL SIGNAL, V20, P2030, DOI 10.1016/j.cellsig.2008.07.012; Kim EK, 2008, EXP MOL MED, V40, P445, DOI 10.3858/emm.2008.40.4.445; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sheng SJ, 2009, J CELL PHYSIOL, V218, P451, DOI 10.1002/jcp.21616; van Golen CM, 2006, CANCER RES, V66, P6570, DOI 10.1158/0008-5472.CAN-05-1448; Wu YP, 2002, CANCER RES, V62, P1030; Yun SJ, 2009, FEBS LETT, V583, P685, DOI 10.1016/j.febslet.2009.01.005; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	31	81	85	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	26					2954	2963		10.1038/onc.2011.22	http://dx.doi.org/10.1038/onc.2011.22			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21339740				2022-12-25	WOS:000292245100006
J	Chen, R; Dioum, EM; Hogg, RT; Gerard, RD; Garcia, JA				Chen, Rui; Dioum, Elhadji M.; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.			Hypoxia Increases Sirtuin 1 Expression in a Hypoxia-inducible Factor-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; FACTOR 2-ALPHA; TARGET GENE; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTORS; REGULATES EXPRESSION; VASCULAR DEVELOPMENT; DEACETYLASE SIRT1; FACTOR 1-ALPHA; HEART-FAILURE	Hypoxia-inducible factors (HIFs) are stress-responsive transcriptional regulators of cellular and physiological processes involved in oxygen metabolism. Although much is understood about the molecular machinery that confers HIF responsiveness to oxygen, far less is known about HIF isoform-specific mechanisms of regulation, despite the fact that HIF-1 and HIF-2 exhibit distinct biological roles. We recently determined that the stress-responsive genetic regulator sirtuin 1 (Sirt1) selectively augments HIF-2 signaling during hypoxia. However, the mechanism by which Sirt1 maintains activity during hypoxia is unknown. In this report, we demonstrate that Sirt1 gene expression increases in a HIF-dependent manner during hypoxia in Hep3B and in HT1080 cells. Impairment of HIF signaling affects Sirt1 deacetylase activity as decreased HIF-1 signaling results in the appearance of acetylated HIF-2 alpha, which is detected without pharmacological inhibition of Sirt1. We also find that Sirt1 augments HIF-2 mediated, but not HIF-1 mediated, transcriptional activation of the isolated Sirt1 promoter. These data in summary reveal a bidirectional link of HIF and Sirt1 signaling during hypoxia.	[Chen, Rui; Dioum, Elhadji M.; Garcia, Joseph A.] Vet Affairs N Texas Hlth Care Syst, Dept Med, Dallas, TX 75216 USA; [Chen, Rui; Dioum, Elhadji M.; Hogg, Richard T.; Gerard, Robert D.; Garcia, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Garcia, JA (corresponding author), Vet Affairs N Texas Hlth Care Syst, Dept Med, 4600 S Lancaster Rd, Dallas, TX 75216 USA.	joseph.garcia@utsouthwestern.edu		Garcia, Joseph/0000-0002-5621-7538; Chen, Rui/0000-0002-7003-6602	American Heart Association; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108104] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000446] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the American Heart Association and the Department of Veterans Affairs.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bracken CP, 2005, J BIOL CHEM, V280, P14240, DOI 10.1074/jbc.M409987200; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen L, 2007, J BIOL CHEM, V282, P12707, DOI 10.1074/jbc.M700423200; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Denu JM, 2003, TRENDS BIOCHEM SCI, V28, P41, DOI 10.1016/S0968-0004(02)00005-1; Ding K, 2005, INVEST OPHTH VIS SCI, V46, P1010, DOI 10.1167/iovs.04-0788; Dioum EM, 2008, INVEST OPHTH VIS SCI, V49, P2714, DOI 10.1167/iovs.07-1469; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Duan LJ, 2005, CIRCULATION, V111, P2227, DOI 10.1161/01.CIR.0000163580.98098.A3; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Huang Y, 2004, FASEB J, V18, P1138, DOI 10.1096/fj.04-1510fje; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohradanova A, 2008, BRIT J CANCER, V99, P1348, DOI 10.1038/sj.bjc.6604685; Oktay Y, 2007, J BIOL CHEM, V282, P11750, DOI 10.1074/jbc.M611133200; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Scortegagna M, 2003, BLOOD, V102, P1634, DOI 10.1182/blood-2003-02-0448; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2000, GENE DEV, V14, P1983; Sugino T, 2010, FEBS LETT, V584, P2821, DOI 10.1016/j.febslet.2010.04.063; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanno M, 2010, J BIOL CHEM, V285, P8375, DOI 10.1074/jbc.M109.090266; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	59	112	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13869	13878		10.1074/jbc.M110.175414	http://dx.doi.org/10.1074/jbc.M110.175414			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345792	Green Published, hybrid			2022-12-25	WOS:000289556200010
J	Shang, H; Han, XX; Shi, XL; Zuo, T; Goldin, M; Chen, D; Han, B; Sun, W; Wu, H; Wang, XQ; Zhang, LQ				Shang, Hong; Han, Xiaoxu; Shi, Xuanling; Zuo, Teng; Goldin, Mark; Chen, Dan; Han, Bing; Sun, Wei; Wu, Hao; Wang, Xinquan; Zhang, Linqi			Genetic and Neutralization Sensitivity of Diverse HIV-1 env Clones from Chronically Infected Patients in China	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; EPITOPE; GP120; SUBTYPE; GP41; GLYCOPROTEIN; SEROTYPES; VACCINE; BROAD	As HIV-1 continues to spread in China from traditional high risk populations to the general public, its genetic makeup has become increasingly complex. However, the impact of these genetic changes on the biological and neutralization sensitivity of the virus is unknown. The current study aims to characterize the genetic, biological, and neutralization sensitivity of HIV-1 identified in China between 2004 and 2007. Based on a total of 107 full-length envelope genes obtained directly from the infected patients, we found that those viruses fell into three major genetic groups: CRF01_AE, subtype B', and subtype C/CRF07_BC/CRF08_BC/B'C. Pseudotyped viruses built upon the viable env genes have demonstrated their substantial variability in mediating viral entry and in sensitivity to neutralization by subtype-specific plasma pools and broadly neutralizing monoclonal antibodies (bnmAb). Many viruses are resistant to one or more bnmAb, including those known to have high potency against diverse viruses from outside China. Sequence and structural analysis has revealed several mechanisms by which these resistant viruses escape recognition from bnmAb. We believe that these results will help us to better understand the impact of genetic diversity on the neutralizing sensitivity of the viruses and to facilitate the design of immunogens capable of eliciting antibodies with potency and breadth similar to those of bnmAb.	[Shang, Hong; Han, Xiaoxu] China Med Univ, Hosp 1, Minist Hlth, Dept Lab Med,Key Lab AIDS Immunol, Shenyang 110001, Peoples R China; [Shi, Xuanling; Zuo, Teng; Goldin, Mark; Chen, Dan; Han, Bing; Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Wang, Xinquan] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, Beijing 100084, Peoples R China; [Sun, Wei; Wu, Hao] Capital Univ Med Sci, YouAn Hosp, Dept Infect Dis, Beijing 100054, Peoples R China	China Medical University; Tsinghua University; Tsinghua University; Capital Medical University	Shang, H (corresponding author), China Med Univ, Hosp 1, Minist Hlth, Dept Lab Med,Key Lab AIDS Immunol, Shenyang 110001, Peoples R China.	hongshang100@hotmail.com; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022		National Science and Technology Major Project [2008ZX10001-001, 007, 011, 2009ZX10004-016]; National Basic Research Program (973 Program) [2006CB504200]; National Outstanding Youth Award [30825035]; National Natural Science Funds [30800969, U0832604]; Tsinghua University Initiative; Tsinghua Yue-Yuen Medical Sciences Fund; Liaoning Province, Institution of Higher Education [[2008]90]	National Science and Technology Major Project; National Basic Research Program (973 Program)(National Basic Research Program of China); National Outstanding Youth Award; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative; Tsinghua Yue-Yuen Medical Sciences Fund; Liaoning Province, Institution of Higher Education	This work was supported by National Science and Technology Major Project Grants 2008ZX10001-001, 007, 011, and 2009ZX10004-016; National Basic Research Program (also called the 973 Program) Grant 2006CB504200; National Outstanding Youth Award 30825035; National Natural Science Funds Grant 30800969 and U0832604; the Tsinghua University Initiative Scientific Research Program; and the Tsinghua Yue-Yuen Medical Sciences Fund, and High-Level Scholar Program of Liaoning Province, Institution of Higher Education [2008]90.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hoxie JA, 2010, ANNU REV MED, V61, P135, DOI 10.1146/annurev.med.60.042507.164323; Kostrikis LG, 1996, J VIROL, V70, P445, DOI 10.1128/JVI.70.1.445-458.1996; Kuiken Carla, 2003, AIDS Reviews, V5, P52; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; MASCOLA JR, 1994, J INFECT DIS, V169, P48, DOI 10.1093/infdis/169.1.48; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nie JH, 2010, JAIDS-J ACQ IMM DEF, V53, P440, DOI 10.1097/QAI.0b013e3181cb8300; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Rerks-Ngarm S, 2010, CURR OPIN HIV AIDS, V5, P435, DOI 10.1097/COH.0b013e32833c95c1; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Utachee P, 2010, J VIROL, V84, P4311, DOI 10.1128/JVI.02619-09; van Gils MJ, 2010, CURR HIV RES, V8, P579, DOI 10.2174/157016210794088254; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Weber J, 1996, J VIROL, V70, P7827, DOI 10.1128/JVI.70.11.7827-7832.1996; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang LQ, 1998, J VIROL, V72, P9307, DOI 10.1128/JVI.72.11.9307-9312.1998; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005	51	47	58	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14531	14541		10.1074/jbc.M111.224527	http://dx.doi.org/10.1074/jbc.M111.224527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21325278	Green Published, hybrid			2022-12-25	WOS:000289556200073
J	Hu, R; Liu, W; Li, H; Yang, L; Chen, C; Xia, ZY; Guo, LJ; Xie, H; Zhou, HD; Wu, XP; Luo, XH				Hu, Rong; Liu, Wei; Li, Hui; Yang, Li; Chen, Chao; Xia, Zhu-Ying; Guo, Li-Juan; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Luo, Xiang-Hang			A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA GENES; EXPRESSION; TRANSCRIPTION	Our recent study showed that miR-2861 promotes osteoblast differentiation by targeting histone deacetylase 5, resulting in increased runt-related transcription factor 2 (Runx2) protein production. Here we identified another new microRNA (miRNA) (miR-3960) that played a regulatory role in osteoblast differentiation through a regulatory feedback loop with miR-2861. miR-3960 and miR-2861 were found clustered at the same loci. miR-3960 was transcribed during bone morphogenic protein 2 (BMP2)-induced osteogenesis of ST2 stromal cells. Overexpression of miR-3960 promoted BMP2-induced osteo-blastogenesis. However, the inhibition of miR-3960 expression attenuated the osteoblastogenesis. Homeobox A2 (Hoxa2), a repressor of Runx2 expression, was confirmed to be a target of miR-3960. Electrophoretic mobility shift assay and chromatin immunoprecipitation experiments confirmed that Runx2 bound to the promoter of the miR-3960/miR-2861 cluster. Furthermore, overexpression of Runx2 induced miR-3960/miR2861 transcription, and block of Runx2 expression attenuated BMP2-induced miR-3960/miR-2861 transcription. Here we report that miR-3960 and miR-2861, transcribed together from the same miRNA polycistron, both function in osteoblast differentiation through a novel Runx2/miR-3960/miR-2861 regulatory feedback loop. Our findings provide new insights into the roles of miRNAs in osteoblast differentiation.	[Hu, Rong; Liu, Wei; Li, Hui; Yang, Li; Chen, Chao; Xia, Zhu-Ying; Guo, Li-Juan; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Luo, Xiang-Hang] Cent S Univ, Xiangya Hosp 2, Inst Endocrinol & Metab, Changsha 410011, Hunan, Peoples R China	Central South University	Luo, XH (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Endocrinol & Metab, 139 Middle Renmin Rd, Changsha 410011, Hunan, Peoples R China.	xianghangluo@hotmail.com	Xie, Hui/AAF-8152-2020	Zhou, Hou-De/0000-0001-9131-4141	National Natural Science Foundation from China [30870925, 81070696, 81000122]	National Natural Science Foundation from China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation Grants 30870925, 81070696, and 81000122 from China.	Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gao JS, 2010, NUCLEIC ACIDS RES, V38, P2775, DOI 10.1093/nar/gkp1242; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hagen JW, 2008, CELL CYCLE, V7, P2327, DOI 10.4161/cc.6447; Kahai S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007535; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Ko HY, 2009, FEBS J, V276, P4854, DOI 10.1111/j.1742-4658.2009.07185.x; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mizuno Y, 2008, BIOCHEM BIOPH RES CO, V368, P267, DOI 10.1016/j.bbrc.2008.01.073; Mizuno Y, 2009, FEBS LETT, V583, P2263, DOI 10.1016/j.febslet.2009.06.006; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Ro S, 2007, RNA, V13, P1693, DOI 10.1261/rna.640307; Roca H, 2008, NUCLEIC ACIDS RES, V36, P1723, DOI 10.1093/nar/gkn022; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trang P, 2008, Oncogene, V27 Suppl 2, pS52, DOI 10.1038/onc.2009.353; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	32	189	215	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.176099	http://dx.doi.org/10.1074/jbc.M110.176099			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21324897	Green Published, hybrid			2022-12-25	WOS:000289077500047
J	Carpaij, N; Willems, RJL; Rice, TW; Weinstein, RA; Hinds, J; Witney, AA; Lindsay, JA; Bonten, MJM; Fluit, AC				Carpaij, Neeltje; Willems, Rob J. L.; Rice, Thomas W.; Weinstein, Robert A.; Hinds, Jason; Witney, Adam A.; Lindsay, Jodi A.; Bonten, Marc J. M.; Fluit, Ad C.			Genetic Variation in Spatio-Temporal Confined USA300 Community-Associated MRSA Isolates: A Shift from Clonal Dispersion to Genetic Evolution?	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; METHICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; SKIN INFECTIONS; UNITED-STATES; STRAIN; PNEUMONIA; AUSTRALIA; SEQUENCE	Introduction: Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are increasingly isolated, with USA300-0114 being the predominant clone in the USA. Comparative whole genome sequencing of USA300 isolates collected in 2002, 2003 and 2005 showed a limited number of single nucleotide polymorphisms and regions of difference. This suggests that USA300 has undergone rapid clonal expansion without great genomic diversification. However, whole genome comparison of CA-MRSA has been limited to isolates belonging to USA300. The aim of this study was to compare the genetic repertoire of different CA-MRSA clones with that of HA-MRSA from the USA and Europe through comparative genomic hybridization (CGH) to identify genetic clues that may explain the successful and rapid emergence of CA-MRSA. Materials and Methods: Hierarchical clustering based on CGH of 48 MRSA isolates from the community and nosocomial infections from Europe and the USA revealed dispersed clustering of the 19 CA-MRSA isolates. This means that these 19 CA-MRSA isolates do not share a unique genetic make-up. Only the PVL genes were commonly present in all CA-MRSA isolates. However, 10 genes were variably present among 14 USA300 isolates. Most of these genes were present on mobile elements. Conclusion: The genetic variation present among the 14 USA300 isolates is remarkable considering the fact that the isolates were recovered within one month and originated from a confined geographic area, suggesting continuous evolution of this clone.	[Carpaij, Neeltje; Willems, Rob J. L.; Bonten, Marc J. M.; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Rice, Thomas W.] John H Stroger Jr Hosp Cook Cty Chicago, Div Infect Dis, Chicago, IL USA; [Weinstein, Robert A.] Rush Univ, Med Ctr, Dept Infect Dis, Chicago, IL 60612 USA; [Hinds, Jason; Witney, Adam A.] St Georges Univ London, Dept Cellular & Mol Med, Bacterial Microarray Grp, London, England	Utrecht University; Utrecht University Medical Center; John H Stroger Junior Hospital Cook County; Rush University; St Georges University London	Carpaij, N (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	N.Carpaij-2@umcutrecht.nl	Lindsay, Jodi/B-9565-2008; Lindsay, Jodi/ABH-8205-2020; Willems, Rob JL/E-3681-2010	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Willems, Rob JL/0000-0002-7370-0812; Witney, Adam/0000-0003-4561-7170; Hinds, Jason/0000-0002-2739-1908	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]; Wellcome Trust	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	M.J.M.B. was supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). We acknowledge The Wellcome Trust for funding BuG@S (the Bacterial Microarray Group at St George's University of London) for supply of the microarray and advice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam HJ, 2009, CAN J EMERG MED, V11, P439; Arvidsson PI, 2005, CHEM BIODIVERS, V2, P401, DOI 10.1002/cbdv.200590020; Bukhari EE, 2009, SAUDI MED J, V30, P1595; Carpaij N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-522; Coombs GW, 2009, COMMUN DIS INTELL, V33, P10; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Elston JWT, 2009, J HOSP INFECT, V72, P307, DOI 10.1016/j.jhin.2009.05.001; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fontanilla JM, 2010, J CLIN MICROBIOL, V48, P609, DOI 10.1128/JCM.02297-09; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2008, DIAGN MICR INFEC DIS, V61, P245, DOI 10.1016/j.diagmicrobio.2007.12.015; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Klein E, 2009, EMERG INFECT DIS, V15, P1925, DOI 10.3201/eid1512.081341; Larsen AR, 2009, J CLIN MICROBIOL, V47, P3765, DOI 10.1128/JCM.00934-09; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Monecke S, 2009, CLIN MICROBIOL INFEC, V15, P770, DOI 10.1111/j.1469-0691.2009.02792.x; National Committee for Clinical Laboratory Standards NCCLS, 2000, M7A5 NCCLS; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Otter JA, 2010, LANCET INFECT DIS, V10, P227, DOI 10.1016/S1473-3099(10)70053-0; Reed SB, 2001, INFECT IMMUN, V69, P1521, DOI 10.1128/IAI.69.3.1521-1527.2001; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; van der Flier M, 2003, Ned Tijdschr Geneeskd, V147, P1076; Witney AA, 2005, APPL ENVIRON MICROB, V71, P7504, DOI 10.1128/AEM.71.11.7504-7514.2005; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16419	10.1371/journal.pone.0016419	http://dx.doi.org/10.1371/journal.pone.0016419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326601	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000287037000009
J	Berdyshev, EV; Gorshkova, I; Usatyuk, P; Kalari, S; Zhao, YT; Pyne, NJ; Pyne, S; Sabbadini, RA; Garcia, JGN; Natarajan, V				Berdyshev, Evgeny V.; Gorshkova, Irina; Usatyuk, Peter; Kalari, Satish; Zhao, Yutong; Pyne, Nigel J.; Pyne, Susan; Sabbadini, Roger A.; Garcia, Joe G. N.; Natarajan, Viswanathan			Intracellular S1P Generation Is Essential for S1P-Induced Motility of Human Lung Endothelial Cells: Role of Sphingosine Kinase 1 and S1P Lyase	PLOS ONE			English	Article							SPHINGOSINE-1-PHOSPHATE LYASE; SPHINGOLIPID METABOLISM; RECEPTOR EDG-1; 1-PHOSPHATE; MIGRATION; PROTEIN; PROLIFERATION; TRANSPORTER; ACTIVATION; FAMILY	Background: Earlier we have shown that extracellular sphingosine-1-phosphate (S1P) induces migration of human pulmonary artery endothelial cells (HPAECs) through the activation of S1P(1) receptor, PKC epsilon, and PLD2-PKC zeta-Rac1 signaling cascade. As endothelial cells generate intracellular S1P, here we have investigated the role of sphingosine kinases (SphKs) and S1P lyase (S1PL), that regulate intracellular S1P accumulation, in HPAEC motility. Methodology/Principal Findings: Inhibition of SphK activity with a SphK inhibitor 2-(p-Hydroxyanilino)-4-(p-Chlorophenyl) Thiazole or down-regulation of Sphk1, but not SphK2, with siRNA decreased S1P(int), and attenuated S1P(ext) or serum-induced motility of HPAECs. On the contrary, inhibition of S1PL with 4-deoxypyridoxine or knockdown of S1PL with siRNA increased S1P(int) and potentiated motility of HPAECs to S1P(ext) or serum. S1P(ext) mediates cell motility through activation of Rac1 and IQGAP1 signal transduction in HPAECs. Silencing of SphK1 by siRNA attenuated Rac1 and IQGAP1 translocation to the cell periphery; however, knockdown of S1PL with siRNA or 4-deoxypyridoxine augmented activated Rac1 and stimulated Rac1 and IQGAP1 translocation to cell periphery. The increased cell motility mediated by down-regulation was S1PL was pertussis toxin sensitive suggesting "inside-out" signaling of intracellularly generated S1P. Although S1P did not accumulate significantly in media under basal or S1PL knockdown conditions, addition of sodium vanadate increased S1P levels in the medium and inside the cells most likely by blocking phosphatases including lipid phosphate phosphatases (LPPs). Furthermore, addition of anti-S1P mAb to the incubation medium blocked S1P(ext) or 4-deoxypyridoxine-dependent endothelial cell motility. Conclusions/Significance: These results suggest S1P(ext) mediated endothelial cell motility is dependent on intracellular S1P production, which is regulated, in part, by SphK1 and S1PL.	[Berdyshev, Evgeny V.; Gorshkova, Irina; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60680 USA; [Usatyuk, Peter; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Kalari, Satish] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA; [Zhao, Yutong] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA; [Pyne, Nigel J.; Pyne, Susan] Univ Strathclyde, Cell Biol Grp, Glasgow, Lanark, Scotland; [Sabbadini, Roger A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Sabbadini, Roger A.] Lpath Inc, San Diego, CA USA; [Berdyshev, Evgeny V.; Gorshkova, Irina; Usatyuk, Peter; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; City of Hope; Beckman Research Institute of City of Hope; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Strathclyde; California State University System; San Diego State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Berdyshev, EV (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60680 USA.	visnatar@uic.edu	Kalari, Satish/C-6967-2012; Pyne, Susan/AAF-5001-2019	Pyne, Susan/0000-0002-6608-9584; Pyne, Nigel/0000-0002-5657-4578	National Institutes of Health [R01 HL 079396]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091916, P01HL098050, R01HL079396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health R01 HL 079396 to V. Natarajan. This funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Lpath Inc. provided the anti-s1P antibody for experiments listed unnder Figure 13. Lpath did play a role in the decision to publish and in the preparation of the manuscript.	Alemany R, 2007, N-S ARCH PHARMACOL, V374, P413, DOI 10.1007/s00210-007-0132-3; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bandhuvula P, 2007, TRENDS MOL MED, V13, P210, DOI 10.1016/j.molmed.2007.03.005; Berdyshev EV, 2005, ANAL BIOCHEM, V339, P129, DOI 10.1016/j.ab.2004.12.006; Berdyshev EV, 2006, CELL SIGNAL, V18, P1779, DOI 10.1016/j.cellsig.2006.01.018; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Clair T, 2003, CANCER RES, V63, P5446; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; French KJ, 2003, CANCER RES, V63, P5962; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Gorshkova IA, 2005, FASEB J, V19, pA282; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Harvey KA, 2010, MOL CELL BIOCHEM, V342, P7, DOI 10.1007/s11010-010-0461-2; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kiss Z, 1997, FEBS LETT, V412, P197, DOI 10.1016/S0014-5793(97)00776-X; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; O'Brien N, 2009, J LIPID RES, V50, P2245, DOI 10.1194/jlr.M900048-JLR200; Olivera A, 2001, PROSTAG OTH LIPID M, V64, P123, DOI 10.1016/S0090-6980(01)00108-3; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Ozaki Harunobu, 2003, J Atheroscler Thromb, V10, P125; Pyne S, 2000, PHARMACOL THERAPEUT, V88, P115, DOI 10.1016/S0163-7258(00)00084-X; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Schwalm S, 2010, BRIT J PHARMACOL, V160, P1641, DOI 10.1111/j.1476-5381.2010.00818.x; Sensken SC, 2010, J IMMUNOL, V184, P4133, DOI 10.4049/jimmunol.0903358; Skoura A, 2009, CARDIOVASC RES, V82, P221, DOI 10.1093/cvr/cvp088; Spiegel S, 2003, BIOCHEM SOC T, V31, P1216; Taha TA, 2004, BBA-MOL CELL BIOL L, V1682, P48, DOI 10.1016/S1388-1981(04)00023-X; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Usatyuk PV, 2006, J BIOL CHEM, V281, P35554, DOI 10.1074/jbc.M607305200; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; van Koppen CJ, 2001, LIFE SCI, V68, P2535, DOI 10.1016/S0024-3205(01)01049-9; VASKOVSKY VE, 1975, J CHROMATOGR, V114, P129, DOI 10.1016/S0021-9673(00)85249-8; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Yu H, 2009, GENES CELLS, V14, P597, DOI 10.1111/j.1365-2443.2009.01295.x; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	55	38	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16571	10.1371/journal.pone.0016571	http://dx.doi.org/10.1371/journal.pone.0016571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304987	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000286834300088
J	Harvey, JJW; Lewsey, MG; Patel, K; Westwood, J; Heimstadt, S; Carr, JP; Baulcombe, DC				Harvey, Jagger J. W.; Lewsey, Mathew G.; Patel, Kanu; Westwood, Jack; Heimstaedt, Susanne; Carr, John P.; Baulcombe, David C.			An Antiviral Defense Role of AGO2 in Plants	PLOS ONE			English	Article							POTATO-VIRUS-X; SILENCING SUPPRESSOR; ARGONAUTE PROTEINS; RNA INTERFERENCE; DNA METHYLATION; SALICYLIC-ACID; ARABIDOPSIS; GENE; EXPRESSION; PATHWAY	Background: Argonaute (AGO) proteins bind to small-interfering (si) RNAs and micro (mi)RNAs to target RNA silencing against viruses, transgenes and in regulation of mRNAs. Plants encode multiple AGO proteins but, in Arabidopsis, only AGO1 is known to have an antiviral role. Methodology/Principal Findings: To uncover the roles of specific AGOs in limiting virus accumulation we inoculated turnip crinkle virus (TCV) to Arabidopsis plants that were mutant for each of the ten AGO genes. The viral symptoms on most of the plants were the same as on wild type plants although the ago2 mutants were markedly hyper-susceptible to this virus. ago2 plants were also hyper-susceptible to cucumber mosaic virus (CMV), confirming that the antiviral role of AGO2 is not specific to a single virus. For both viruses, this phenotype was associated with transient increase in virus accumulation. In wild type plants the AGO2 protein was induced by TCV and CMV infection. Conclusions/Significance: Based on these results we propose that there are multiple layers to RNA-mediated defense and counter-defense in the interactions between plants and their viruses. AGO1 represents a first layer. With some viruses, including TCV and CMV, this layer is overcome by viral suppressors of silencing that can target AGO1 and a second layer involving AGO2 limits virus accumulation. The second layer is activated when the first layer is suppressed because AGO2 is repressed by AGO1 via miR403. The activation of the second layer is therefore a direct consequence of the loss of the first layer of defense.	[Harvey, Jagger J. W.; Lewsey, Mathew G.; Patel, Kanu; Westwood, Jack; Heimstaedt, Susanne; Carr, John P.; Baulcombe, David C.] Univ Cambridge, Dept Plant Sci, Cambridge, England	University of Cambridge	Harvey, JJW (corresponding author), Int Livestock Res Inst, Nairobi, Kenya.	dcb40@cam.ac.uk	Carr, John Peter/N-7707-2019; Westwood, Jack/I-4325-2012; Lewsey, Mathew G/AAE-8530-2019; Carr, John/H-5646-2016	Carr, John Peter/0000-0002-5028-2160; Carr, John/0000-0002-5028-2160; Lewsey, Mathew/0000-0002-2631-4337; Baulcombe, David/0000-0003-0780-6878	Gatsby Charitable Foundation; Royal Society; U.S. National Science Foundation; Postdoctoral Research Fellowship [0512081]; Biotechnology and Biological Research Council [BB/D008204/1]; Leverhulme Trust [F/09 741/F]; Biotechnology and Biological Sciences Research Council [BB/C006739/1, BB/D008204/1, BB/C006739/2] Funding Source: researchfish; BBSRC [BB/D008204/1] Funding Source: UKRI	Gatsby Charitable Foundation; Royal Society(Royal Society of London); U.S. National Science Foundation(National Science Foundation (NSF)); Postdoctoral Research Fellowship; Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	DCB is a Royal Society Research Professor and the work was supported by the Gatsby Charitable Foundation (http://www.gatsby.org.uk) and the Royal Society (http://royalsociety.org/). JJWH was supported by U.S. National Science Foundation (http://www.nsf.gov) Postdoctoral Research Fellowship 0512081. MGL was supported by Biotechnology and Biological Research Council (http://www.bbsrc.ac.uk) Grant BB/D008204/1 and Leverhulme Trust (http://www.leverhulme.ac.uk) grant F/09 741/F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2007, CURR BIOL, V17, P1609, DOI 10.1016/j.cub.2007.08.039; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; CARPENTER CD, 1995, J MOL BIOL, V245, P608, DOI 10.1006/jmbi.1994.0050; Chiu MH, 2010, MOL PLANT PATHOL, V11, P641, DOI [10.1111/j.1364-3703.2010.00634.x, 10.1111/J.1364-3703.2010.00634.X]; Chivasa S, 1997, PLANT CELL, V9, P547, DOI 10.1105/tpc.9.4.547; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Diez J, 1998, METH MOL B, V81, P211; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Endres MW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000729; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; HACKER DL, 1992, VIROLOGY, V186, P1, DOI 10.1016/0042-6822(92)90055-T; Havecker ER, 2010, PLANT CELL, V22, P321, DOI 10.1105/tpc.109.072199; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Lewsey MG, 2009, J GEN VIROL, V90, P3010, DOI 10.1099/vir.0.014555-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; MCCONNELL JR, 1995, DEV GENET, V16, P358, DOI 10.1002/dvg.1020160409; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Naylor M, 1998, MOL PLANT MICROBE IN, V11, P860, DOI 10.1094/MPMI.1998.11.9.860; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sambrook J, 2001, MOL CLONING LAB MANU; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Thomas CL, 2003, VIROLOGY, V306, P33, DOI 10.1016/S0042-6822(02)00018-1; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603	38	236	247	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14639	10.1371/journal.pone.0014639	http://dx.doi.org/10.1371/journal.pone.0014639			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305057	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300020
J	Xie, H; Jing, XH; Li, X; Lin, ZS; Plant, E; Zoueva, O; Yang, H; Ye, ZP				Xie, Hang; Jing, Xianghong; Li, Xing; Lin, Zhengshi; Plant, Ewan; Zoueva, Olga; Yang, Hong; Ye, Zhiping			Immunogenicity and Cross-Reactivity of 2009-2010 Inactivated Seasonal Influenza Vaccine in US Adults and Elderly	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; ANTIBODY-RESPONSES; UNITED-STATES; VIRUS; CHILDREN; AGE; INFECTION; STRAINS; SERUM; MATCH	The campaign of 2009-2010 Northern Hemisphere seasonal vaccination was concurrent with the 2009 H1N1 pandemic. Using a hemagglutination inhibition (HAI) assay, we evaluated the immunogenicity and cross-reactivity of 2009-2010 inactivated trivalent influenza vaccine (TIV) in US adult and elderly populations. Vaccination of TIV resulted in a robust boost on the antibody response of all subjects to seasonal A/Brisbane/59/2007 (H1N1) and A/Uruguay/716/2007 (H3N2) with over 70% of recipients reaching a seroprotective titer of 40. B/Brisbane/60/2008 was the least immunogenic among the three seasonal vaccine strains with <30% of TIV recipients reaching a seroprotective titer of 40. TIV vaccination also induced a moderate boost on the pandemic specific antibody responses. Twenty-four percent of adults and 36% of elderly reached a seroprotective HAI titer of 40 or more against pandemic A/South Carolina/18/2009 (H1N1) after receiving TIV compared to 4% and 7% at the beginning of vaccination, respectively. In addition, 22% of adults and 34% of elderly showed an increase of 4-fold or more in A/South Carolina/18/2009 specific HAI titers after TIV vaccination. The pandemic specific cross-reactive antibodies strongly correlated with the post-vaccination HAI titers against the seasonal H3N2 vaccine strain in all subjects.	[Xie, Hang; Jing, Xianghong; Li, Xing; Lin, Zhengshi; Plant, Ewan; Zoueva, Olga; Ye, Zhiping] US FDA, Lab Resp Viral Dis, Div Viral Prod, Off Vaccine Res & Review, Bethesda, MD 20014 USA; [Yang, Hong] US FDA, Ctr Biol Evaluat & Res, Off Biostat & Epidemiol, Bethesda, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Xie, H (corresponding author), US FDA, Lab Resp Viral Dis, Div Viral Prod, Off Vaccine Res & Review, Bethesda, MD 20014 USA.	Hang.Xie@fda.hhs.gov; Zhiping.Ye@fda.hhs.gov	Plant, Ewan/AAB-1911-2020; Xie, Hang/AAC-9092-2019	Plant, Ewan/0000-0003-0166-5939; Xie, Hang/0000-0001-8318-5554	Center for Biologics Evaluation; Research/Food and Drug Administration	Center for Biologics Evaluation; Research/Food and Drug Administration	This study was supported by Center for Biologics Evaluation and Research/Food and Drug Administration institutional research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Ding H., 2010, Morbidity and Mortality Weekly Report, V59, P477; Eisenberg KW, 2008, PEDIATRICS, V122, P911, DOI 10.1542/peds.2007-3304; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Joshi AY, 2009, VACCINE, V27, P4457, DOI 10.1016/j.vaccine.2009.05.038; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; Labrosse B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011036; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Loeb M, 2010, EMERG INFECT DIS, V16, P719, DOI 10.3201/eid1604.091588; Mossad SB, 2008, CLEV CLIN J MED, V75, P865, DOI 10.3949/ccjm.75a.08088; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; World Health Organization, 2010, REC VIR INFL VACC US	27	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16650	10.1371/journal.pone.0016650	http://dx.doi.org/10.1371/journal.pone.0016650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304946	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300109
J	Ebbes, M; Bleymuller, WM; Cernescu, M; Nolker, R; Brutschy, B; Niemann, HH				Ebbes, Maria; Bleymueller, Willem M.; Cernescu, Mihaela; Noelker, Rolf; Brutschy, Bernd; Niemann, Hartmut H.			Fold and Function of the InlB B-repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INVASION PROTEIN-INLB; RECEPTOR TYROSINE KINASE; LEUCINE-RICH REPEAT; INTERNALIN MULTIGENE FAMILY; LASER MASS-SPECTROMETRY; LISTERIA-MONOCYTOGENES; MET RECEPTOR; SECONDARY-STRUCTURE; SURFACE PROTEIN; GW DOMAINS	Host cell invasion by the facultative intracellular pathogen Listeria monocytogenes requires the invasion protein InlB in many cell types. InlB consists of an N-terminal internalin domain that binds the host cell receptor tyrosine kinase Met and C-terminal GW domains that bind to glycosaminoglycans (GAGs). Met binding and activation is required for host cell invasion, while the interaction between GW domains and GAGs enhances this effect. Soluble InlB elicits the same cellular phenotypes as the natural Met ligand hepatocyte growth factor/scatter factor (HGF/SF), e. g. cell scatter. So far, little is known about the central part of InlB, the B-repeat. Here we present a structural and functional characterization of the InlB B-repeat. The crystal structure reveals a variation of the beta-grasp fold that is most similar to small ubiquitin-like modifiers (SUMOs). However, structural similarity also suggests a potential evolutionary relation to bacterial mucin-binding proteins. The B-repeat defines the prototype structure of a hitherto uncharacterized domain present in over a thousand bacterial proteins. Generally, this domain probably acts as a spacer or a receptor-binding domain in extracellular multi-domain proteins. In cellular assays the B-repeat acts synergistically with the internalin domain conferring to it the ability to stimulate cell motility. Thus, the B-repeat probably binds a further host cell receptor and thereby enhances signaling downstream of Met.	Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany; [Cernescu, Mihaela; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	University of Bielefeld; Goethe University Frankfurt	Niemann, HH (corresponding author), Univ Bielefeld, Dept Chem, Postfach 10 01 31, D-33501 Bielefeld, Germany.	Hartmut.Niemann@uni-bielefeld.de	Niemann, Hartmut/F-7947-2011; Cernescu, Mihaela/G-8956-2012	Niemann, Hartmut/0000-0002-8582-0360; 	Deutsche Forschungsgemeinschaft [1150]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Priority Program 1150 "Signal Pathways to the Cytoskeleton and Bacterial Pathogenesis" of the Deutsche Forschungsgemeinschaft.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Banerjee M, 2004, MOL MICROBIOL, V52, P257, DOI 10.1111/j.1365-2958.2003.03968.x; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bierne H, 2002, J CELL SCI, V115, P3357; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Braun L, 1999, MOL MICROBIOL, V34, P10, DOI 10.1046/j.1365-2958.1999.01560.x; Braun L, 1997, MOL MICROBIOL, V25, P285, DOI 10.1046/j.1365-2958.1997.4621825.x; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Copp J, 2003, J BIOL CHEM, V278, P7783, DOI 10.1074/jbc.M211666200; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; DELANO WL, 2002, WORLD WIDE WEB; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; Dortet L, 2010, MICROBES INFECT, V12, P919, DOI 10.1016/j.micinf.2010.07.009; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Dramsi S, 1997, INFECT IMMUN, V65, P1615, DOI 10.1128/IAI.65.5.1615-1625.1997; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferraris DM, 2010, J MOL BIOL, V395, P522, DOI 10.1016/j.jmb.2009.10.074; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Gilmour MW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-120; Graille M, 2001, STRUCTURE, V9, P679, DOI 10.1016/S0969-2126(01)00630-X; Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Jonquieres R, 1999, MOL MICROBIOL, V34, P902, DOI 10.1046/j.1365-2958.1999.01652.x; Jung C, 2009, MOL MICROBIOL, V72, P1196, DOI 10.1111/j.1365-2958.2009.06716.x; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KRISSINEL E, 2005, COMPLIFE; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Linden SK, 2008, ARCH MICROBIOL, V190, P101, DOI 10.1007/s00203-008-0358-6; Machner MP, 2003, MOL MICROBIOL, V48, P1525, DOI 10.1046/j.1365-2958.2003.03532.x; MacKenzie DA, 2009, J BIOL CHEM, V284, P32444, DOI 10.1074/jbc.M109.040907; Marino M, 2002, EMBO J, V21, P5623, DOI 10.1093/emboj/cdf558; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Mostowy S, 2009, CELL HOST MICROBE, V5, P510, DOI 10.1016/j.chom.2009.06.002; Niemann HH, 2008, J MOL BIOL, V377, P489, DOI 10.1016/j.jmb.2008.01.027; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2011, EUR J CELL BIOL, V90, P972, DOI 10.1016/j.ejcb.2010.11.014; ORENGO CA, 1994, NATURE, V372, P631, DOI 10.1038/372631a0; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Overington J.P., 1992, CURR OPIN STRUC BIOL, V2, P394, DOI 10.1016/0959-440X(92)90231-U; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perica T, 2010, CURR OPIN STRUC BIOL, V20, P367, DOI 10.1016/j.sbi.2010.03.007; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; Schulz GE, 2010, J MOL BIOL, V395, P834, DOI 10.1016/j.jmb.2009.10.044; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW137, DOI 10.1093/nar/gkl130; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yee A, 2002, P NATL ACAD SCI USA, V99, P1825, DOI 10.1073/pnas.042684599	62	29	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					15496	15506		10.1074/jbc.M110.189951	http://dx.doi.org/10.1074/jbc.M110.189951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21345802	Green Published, hybrid			2022-12-25	WOS:000289788300077
J	Yin, X; Johns, SC; Lawrence, R; Xu, D; Reddi, K; Bishop, JR; Varner, JA; Fuster, MM				Yin, Xin; Johns, Scott C.; Lawrence, Roger; Xu, Ding; Reddi, Krisanavane; Bishop, Joseph R.; Varner, Judith A.; Fuster, Mark M.			Lymphatic Endothelial Heparan Sulfate Deficiency Results in Altered Growth Responses to Vascular Endothelial Growth Factor-C (VEGF-C)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR LYMPHANGIOGENESIS; N-SULFOTRANSFERASE; BASEMENT-MEMBRANE; TRANSGENIC MICE; ANGIOGENESIS; BINDING; RECEPTOR; DISEASE; CELLS; ANGIOPOIETIN-1	Growth and remodeling of lymphatic vasculature occur during development and during various pathologic states. A major stimulus for this process is the unique lymphatic vascular endothelial growth factor-C (VEGF-C). Other endothelial growth factors, such as fibroblast growth factor-2 (FGF-2) or VEGF-A, may also contribute. Heparan sulfate is a linear sulfated polysaccharide that facilitates binding and action of some vascular growth factors such as FGF-2 and VEGF-A. However, a direct role for heparan sulfate in lymphatic endothelial growth and sprouting responses, including those mediated by VEGF-C, remains to be examined. We demonstrate that VEGF-C binds to heparan sulfate purified from primary lymphatic endothelia, and activation of lymphatic endothelial Erk1/2 in response to VEGF-C is reduced by interference with heparin or pretreatment of cells with heparinase, which destroys heparan sulfate. Such treatment also inhibited phosphorylation of the major VEGF-C receptor VEGFR-3 upon VEGF-C stimulation. Silencing lymphatic heparan sulfate chain biosynthesis inhibited VEGF-C-mediated Erk1/2 activation and abrogated VEGFR-3 receptor-dependent binding of VEGF-C to the lymphatic endothelial surface. These findings prompted targeting of lymphatic N-deacetylase/N-sulfotransferase-1 (Ndst1), a major sulfate-modifying heparan sulfate biosynthetic enzyme. VEGF-C-mediated Erk1/2 phosphorylation was inhibited in Ndst1-silenced lymphatic endothelia, and scratch-assay responses to VEGF-C and FGF-2 were reduced in Ndst1-deficient cells. In addition, lymphatic Ndst1 deficiency abrogated cell-based growth and proliferation responses to VEGF-C. In other studies, lymphatic endothelia cultured ex vivo from Ndst1 gene-targeted mice demonstrated reduced VEGF-C-and FGF-2-mediated sprouting in collagen matrix. Lymphatic heparan sulfate may represent a novel molecular target for therapeutic intervention.	[Yin, Xin; Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Med Serv, San Diego, CA 92161 USA; [Yin, Xin; Johns, Scott C.; Fuster, Mark M.] Vet Affairs San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Yin, Xin; Johns, Scott C.; Reddi, Krisanavane; Fuster, Mark M.] Univ Calif San Diego, Dept Med, Div Pulm & Crit Care, La Jolla, CA 92037 USA; [Lawrence, Roger; Xu, Ding; Bishop, Joseph R.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Varner, Judith A.; Fuster, Mark M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fuster, MM (corresponding author), Univ Calif San Diego, Dept Med, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	mfuster@ucsd.edu	Xu, Ding/B-2493-2009	Xu, Ding/0000-0001-9380-2712; Varner, Judith/0000-0002-9251-0600	Veterans Affairs; American Cancer Society [RSG-08-153-01-CSM]; Uniting Against Lung Cancer Foundation; National Institutes of Health [P01-HL57345-11]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057345] Funding Source: NIH RePORTER	Veterans Affairs(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); Uniting Against Lung Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Veterans Affairs Career Development Program, American Cancer Society Grant RSG-08-153-01-CSM, and Uniting Against Lung Cancer Foundation (to M. M. F.). This work was also supported in part by National Institutes of Health Grant P01-HL57345-11 (to Dr. Jeffrey D. Esko).	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; BAME KJ, 1989, J BIOL CHEM, V264, P8059; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Cohen-Kaplan V, 2008, INT J CANCER, V123, P2566, DOI 10.1002/ijc.23898; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kreuger J, 2006, ARTERIOSCL THROM VAS, V26, P1073, DOI 10.1161/01.ATV.0000217610.58032.b7; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Lawrence R, 2004, GLYCOBIOLOGY, V14, P467, DOI 10.1093/glycob/cwh057; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; Liersch R, 2007, THROMB HAEMOSTASIS, V98, P304, DOI 10.1160/TH07-04-0238; Longley RL, 1999, J CELL SCI, V112, P3421; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Mancardi S, 1999, EXP CELL RES, V246, P368, DOI 10.1006/excr.1998.4270; Morisada T, 2005, BLOOD, V105, P4649, DOI 10.1182/blood-2004-08-3382; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Shin WS, 2008, ANN NY ACAD SCI, V1131, P50, DOI 10.1196/annals.1413.005; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WATSON JV, 1987, CYTOMETRY, V8, P1, DOI 10.1002/cyto.990080101; Wissmann C, 2006, CLIN CANCER RES, V12, P6865, DOI 10.1158/1078-0432.CCR-06-1800; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	33	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14952	14962		10.1074/jbc.M110.206664	http://dx.doi.org/10.1074/jbc.M110.206664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21343305	Green Published, hybrid			2022-12-25	WOS:000289788300025
J	Hall, BS; Bot, C; Wilkinson, SR				Hall, Belinda S.; Bot, Christopher; Wilkinson, Shane R.			Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; TRYPANOTHIONE REDUCTASE; NITROHETEROCYCLIC DRUGS; NITROAROMATIC COMPOUNDS; CATALYTIC PROPERTIES; CHAGAS-DISEASE; FREE-RADICALS; CRUZI; RESISTANCE; BENZNIDAZOLE	The prodrug nifurtimox has been used for more than 40 years to treat Chagas disease and forms part of a recently approved combinational therapy that targets West African trypanosomiasis. Despite this, its mode of action is poorly understood, Detection of reactive oxygen and nitrogen intermediates in nifurtimox-treated extracts led to the proposal that this drug induces oxidative stress in the target cell. Here, we outline an alternative mechanism involving reductive activation by a eukaryotic type I nitroreductase. Several enzymes proposed to metabolize nifurtimox, including prostaglandin F2 alpha synthase and cytochrome P450 reductase, were overexpressed in bloodstream-form Trypanosoma brucei. Only cells with elevated levels of the nitroreductase displayed altered susceptibility to this nitrofuran, implying a key role in drug action. Reduction of nifurtimox by this enzyme was shown to be insensitive to oxygen and yields a product characterized by LC/MS as an unsaturated open-chain nitrite. This metabolite was shown to inhibit both parasite and mammalian cell growth at equivalent concentrations, in marked contrast to the parental prodrug. These experiments indicate that the basis for the selectivity of nifurtimox against T. brucei lies in the expression of a parasite-encoded type I nitroreductase.	[Hall, Belinda S.; Bot, Christopher; Wilkinson, Shane R.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London; Queen Mary University London	Wilkinson, SR (corresponding author), Mile End Rd, London E1 4NS, England.	s.r.wilkinson@qmul.ac.uk	Hall, Belinda/AGU-6214-2022; Bot, Christopher/E-9811-2011	Bot, Christopher/0000-0001-6225-4047; Hall, Belinda/0000-0002-3753-1978	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Baker N, 2011, MOL BIOCHEM PARASIT, V176, P55, DOI 10.1016/j.molbiopara.2010.11.010; BECKETT AH, 1959, J MED PHARMACEUT CH, V1, P155, DOI 10.1021/jm50003a003; Bern C, 2009, CLIN INFECT DIS, V49, pE52, DOI 10.1086/605091; Blumenstiel K, 1999, BIOCHEM PHARMACOL, V58, P1791, DOI 10.1016/S0006-2952(99)00264-6; Boiani M, 2010, BIOCHEM PHARMACOL, V79, P1736, DOI 10.1016/j.bcp.2010.02.009; BOLAND MP, 1991, BIOCHEM PHARMACOL, V41, P867, DOI 10.1016/0006-2952(91)90190-G; Bot C, 2010, ANTIMICROB AGENTS CH, V54, P4246, DOI 10.1128/AAC.00800-10; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Cenas N, 2006, J BIOL CHEM, V281, P5593, DOI 10.1074/jbc.M511972200; DOCAMPO R, 1979, ARCH BIOCHEM BIOPHYS, V197, P317, DOI 10.1016/0003-9861(79)90251-0; DOCAMPO R, 1981, J BIOL CHEM, V256, P930; FILALIMOUHIM A, 1991, J CHIM PHYS PCB, V88, P937, DOI 10.1051/jcp/1991880937; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; GAUTRET P, 2009, EURO SURVEILL, V14; GAVIN JJ, 1966, ARCH BIOCHEM BIOPHYS, V113, P399, DOI 10.1016/0003-9861(66)90205-0; GOIJMAN SG, 1985, BIOCHEM PHARMACOL, V34, P1331, DOI 10.1016/0006-2952(85)90514-3; GOIJMAN SG, 1985, BIOCHEM PHARMACOL, V34, P1457, DOI 10.1016/0006-2952(85)90684-7; Hall BS, 2010, ANTIMICROB AGENTS CH, V54, P1193, DOI 10.1128/AAC.01213-09; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; JOCKERSSCHERUBL MC, 1989, EUR J BIOCHEM, V180, P267, DOI 10.1111/j.1432-1033.1989.tb14643.x; KELLY JM, 1993, EUR J BIOCHEM, V218, P29, DOI 10.1111/j.1432-1033.1993.tb18348.x; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; MASON RP, 1975, BIOCHEM BIOPH RES CO, V67, P1267, DOI 10.1016/0006-291X(75)90163-1; MASON RP, 1975, BIOCHEMISTRY-US, V14, P1626, DOI 10.1021/bi00679a013; Maya JD, 1997, MOL BIOCHEM PARASIT, V86, P101, DOI 10.1016/S0166-6851(97)90010-4; MCCALLA DR, 1978, J BACTERIOL, V133, P10, DOI 10.1128/JB.133.1.10-16.1978; MCCALLA DR, 1971, CANCER RES, V31, P2184; MORENO SNJ, 1984, J BIOL CHEM, V259, P6298; Nivinskas H, 2001, ARCH BIOCHEM BIOPHYS, V385, P170, DOI 10.1006/abbi.2000.2127; Olry A, 2007, PLANT J, V51, P331, DOI 10.1111/j.1365-313X.2007.03140.x; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; Portal P, 2008, MOL BIOCHEM PARASIT, V160, P42, DOI 10.1016/j.molbiopara.2008.03.007; Prathalingham SR, 2007, ANTIMICROB AGENTS CH, V51, P755, DOI 10.1128/AAC.01360-06; Priotto G, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010039; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; SASTRY SS, 1984, MOL GEN GENET, V196, P379, DOI 10.1007/BF00328076; Schoneck R, 1997, EUR J BIOCHEM, V243, P739, DOI 10.1111/j.1432-1033.1997.00739.x; Sholler GLS, 2006, J PEDIAT HEMATOL ONC, V28, P693, DOI 10.1097/01.mph.0000212994.56812.f2; Sholler GLS, 2009, J PEDIAT HEMATOL ONC, V31, P187, DOI 10.1097/MPH.0b013e3181984d91; STREETER AJ, 1988, PHARMACEUT RES, V5, P434, DOI 10.1023/A:1015988401601; SWAMINATHAN S, 1984, CANCER RES, V44, P2331; SWAMINATHAN S, 1982, CANCER RES, V42, P4479; Viode C, 1999, BIOCHEM PHARMACOL, V57, P549, DOI 10.1016/S0006-2952(98)00324-4; Whiteway J, 1998, J BACTERIOL, V180, P5529, DOI 10.1128/JB.180.21.5529-5539.1998; Wilkinson SR, 2008, P NATL ACAD SCI USA, V105, P5022, DOI 10.1073/pnas.0711014105; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; Wu KB, 1997, ARCH BIOCHEM BIOPHYS, V347, P221, DOI 10.1006/abbi.1997.0344; XU WY, 1994, ANAL CHEM, V66, P4133, DOI 10.1021/ac00095a004	51	173	176	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13088	13095		10.1074/jbc.M111.230847	http://dx.doi.org/10.1074/jbc.M111.230847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345801	Green Published, hybrid			2022-12-25	WOS:000289282200029
J	Bengali, Z; Satheshkumar, PS; Yang, ZL; Weisberg, AS; Paran, N; Moss, B				Bengali, Zain; Satheshkumar, P. S.; Yang, Zhilong; Weisberg, Andrea S.; Paran, Nir; Moss, Bernard			Drosophila S2 Cells Are Non-Permissive for Vaccinia Virus DNA Replication Following Entry via Low pH-Dependent Endocytosis and Early Transcription	PLOS ONE			English	Article							INTRACELLULAR MATURE VIRION; MEMBRANE-PROTEIN; ESSENTIAL COMPONENT; INTERMEDIATE STAGE; A27L PROTEIN; IN-VITRO; GENE; EXPRESSION; FUSION; INFECTION	Vaccinia virus (VACV), a member of the chordopox subfamily of the Poxviridae, abortively infects insect cells. We have investigated VACV infection of Drosophila S2 cells, which are useful for protein expression and genome-wide RNAi screening. Biochemical and electron microscopic analyses indicated that VACV entry into Drosophila S2 cells depended on the VACV multiprotein entry-fusion complex but appeared to occur exclusively by a low pH-dependent endocytic mechanism, in contrast to both neutral and low pH entry pathways used in mammalian cells. Deep RNA sequencing revealed that the entire VACV early transcriptome, comprising 118 open reading frames, was robustly expressed but neither intermediate nor late mRNAs were made. Nor was viral late protein synthesis or inhibition of host protein synthesis detected by pulse-labeling with radioactive amino acids. Some reduction in viral early proteins was noted by Western blotting. Nevertheless, synthesis of the multitude of early proteins needed for intermediate gene expression was demonstrated by transfection of a plasmid containing a reporter gene regulated by an intermediate promoter. In addition, expression of a reporter gene with a late promoter was achieved by cotransfection of intermediate genes encoding the late transcription factors. The requirement for transfection of DNA templates for intermediate and late gene expression indicated a defect in viral genome replication in VACV-infected S2 cells, which was confirmed by direct analysis. Furthermore, VACV-infected S2 cells did not support the replication of a transfected plasmid, which occurs in mammalian cells and is dependent on all known viral replication proteins, indicating a primary restriction of DNA synthesis.	[Bengali, Zain; Satheshkumar, P. S.; Yang, Zhilong; Weisberg, Andrea S.; Paran, Nir; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bengali, Z (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	bmoss@nih.gov	Paran, Nir/AAC-1036-2020; Yang, Zhilong/E-8967-2010	Yang, Zhilong/0000-0001-8995-2654; Moss, Bernard/0000-0002-2154-8564	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001075, ZIAAI000307, ZIAAI000539] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengali Z, 2009, VIROLOGY, V389, P132, DOI 10.1016/j.virol.2009.04.012; Bisht H, 2008, J VIROL, V82, P8687, DOI 10.1128/JVI.00852-08; Brown E, 2006, J VIROL, V80, P9455, DOI 10.1128/JVI.01149-06; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Cherry S, 2008, CURR OPIN MICROBIOL, V11, P262, DOI 10.1016/j.mib.2008.05.007; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; De Silva FS, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-23; DELANGE AM, 1986, P NATL ACAD SCI USA, V83, P614, DOI 10.1073/pnas.83.3.614; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Earl PL, 1998, CURRENT PROTOCOLS MO; Foo CH, 2009, VIROLOGY, V385, P368, DOI 10.1016/j.virol.2008.12.019; Homann OR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-49; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; Izmailyan RA, 2006, J VIROL, V80, P8402, DOI 10.1128/JVI.00624-06; Katsafanas GC, 2004, J BIOL CHEM, V279, P52210, DOI 10.1074/jbc.M411033200; Katsafanas GC, 2007, CELL HOST MICROBE, V2, P221, DOI 10.1016/j.chom.2007.08.005; KECK JG, 1990, CELL, V61, P801, DOI 10.1016/0092-8674(90)90190-P; Klemperer N, 2001, J VIROL, V75, P12298, DOI 10.1128/JVI.75.24.12298-12307.2001; LANGRIDGE WHR, 1983, J INVERTEBR PATHOL, V42, P77, DOI 10.1016/0022-2011(83)90204-5; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; LEECHEN GJ, 1988, VIROLOGY, V163, P52, DOI 10.1016/0042-6822(88)90233-4; Li Y, 1997, J VIROL, V71, P9557, DOI 10.1128/JVI.71.12.9557-9562.1997; Li Y, 1998, VIROLOGY, V248, P74, DOI 10.1006/viro.1998.9241; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lin YCJ, 2008, J VIROL, V82, P5922, DOI 10.1128/JVI.02723-07; Magee WC, 2009, J VIROL METHODS, V161, P44, DOI 10.1016/j.jviromet.2009.05.012; MCDONALD WF, 1992, J VIROL, V66, P534, DOI 10.1128/JVI.66.1.534-547.1992; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Mercer J, 2010, P NATL ACAD SCI USA, V107, P9346, DOI 10.1073/pnas.1004618107; MERCHLINSKY M, 1988, CANCER CELL, V6, P87; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Moss B, 2007, FIELDS VIROLOGY; Nichols RJ, 2008, J VIROL, V82, P10247, DOI 10.1128/JVI.01035-08; Ojeda S, 2006, J VIROL, V80, P51, DOI 10.1128/JVI.80.1.51-61.2006; Ojeda S, 2006, J VIROL, V80, P9822, DOI 10.1128/JVI.00987-06; Paran N, 2009, CELL HOST MICROBE, V6, P563, DOI 10.1016/j.chom.2009.11.005; Sanz P, 1999, P NATL ACAD SCI USA, V96, P2692, DOI 10.1073/pnas.96.6.2692; Satheshkumar PS, 2009, J VIROL, V83, P12822, DOI 10.1128/JVI.01744-09; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; Senkevich TG, 2005, J VIROL, V79, P4744, DOI 10.1128/JVI.79.8.4744-4754.2005; Senkevich TG, 2004, J VIROL, V78, P2357, DOI 10.1128/JVI.78.5.2357-2366.2004; Senkevich TG, 2004, J VIROL, V78, P2348, DOI 10.1128/JVI.78.5.2348-2356.2004; Shatzer AN, 2008, VIROLOGY, V375, P236, DOI 10.1016/j.virol.2008.01.028; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Townsley AC, 2005, J VIROL, V79, P10988, DOI 10.1128/JVI.79.17.10988-10998.2005; Townsley AC, 2005, J VIROL, V79, P9458, DOI 10.1128/JVI.79.15.9458-9469.2005; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; VOS JC, 1988, EMBO J, V7, P3487, DOI 10.1002/j.1460-2075.1988.tb03224.x; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; WINOKUR PL, 1992, EMBO J, V11, P4111, DOI 10.1002/j.1460-2075.1992.tb05504.x; Wright CF, 2001, J BIOL CHEM, V276, P40680, DOI 10.1074/jbc.M102399200; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107	59	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17248	10.1371/journal.pone.0017248	http://dx.doi.org/10.1371/journal.pone.0017248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347205	Green Submitted, gold, Green Published			2022-12-25	WOS:000287369200030
J	Deng, YP; Meyer, SA; Guan, X; Escalon, BL; Ai, JM; Wilbanks, MS; Welti, R; Garcia-Reyero, N; Perkins, EJ				Deng, Youping; Meyer, Sharon A.; Guan, Xin; Escalon, Barbara Lynn; Ai, Junmei; Wilbanks, Mitchell S.; Welti, Ruth; Garcia-Reyero, Natalia; Perkins, Edward J.			Analysis of Common and Specific Mechanisms of Liver Function Affected by Nitrotoluene Compounds	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; HEMOGLOBIN ADDUCTS; 2,4,6-TRINITROTOLUENE TNT; PEROXISOME PROLIFERATOR; LIPID-METABOLISM; RETINOIC ACID; RAT-LIVER; PHASE-I; TOXICITY; STRESS	Background: Nitrotoluenes are widely used chemical manufacturing and munitions applications. This group of chemicals has been shown to cause a range of effects from anemia and hypercholesterolemia to testicular atrophy. We have examined the molecular and functional effects of five different, but structurally related, nitrotoluenes on using an integrative systems biology approach to gain insight into common and disparate mechanisms underlying effects caused by these chemicals. Methodology/Principal Findings: Sprague-Dawley female rats were exposed via gavage to one of five concentrations of one of five nitrotoluenes [2,4,6-trinitrotoluene (TNT), 2-amino-4,6-dinitrotoluene (2ADNT) 4-amino-2,6-dinitrotoulene (4ADNT), 2,4-dinitrotoluene (2,4DNT) and 2,6-dinitrotoluene (2,6DNT)] with necropsy and tissue collection at 24 or 48 h. Gene expression profile results correlated well with clinical data and liver histopathology that lead to the concept that hematotoxicity was followed by hepatotoxicity. Overall, 2,4DNT, 2,6DNT and TNT had stronger effects than 2ADNT and 4ADNT. Common functional terms, gene expression patterns, pathways and networks were regulated across all nitrotoluenes. These pathways included NRF2-mediated oxidative stress response, aryl hydrocarbon receptor signaling, LPS/IL-1 mediated inhibition of RXR function, xenobiotic metabolism signaling and metabolism of xenobiotics by cytochrome P450. One biological process common to all compounds, lipid metabolism, was found to be impacted both at the transcriptional and lipid production level. Conclusions/Significance: A systems biology strategy was used to identify biochemical pathways affected by five nitroaromatic compounds and to integrate data that tie biochemical alterations to pathological changes. An integrative graphical network model was constructed by combining genomic, gene pathway, lipidomic, and physiological endpoint results to better understand mechanisms of liver toxicity and physiological endpoints affected by these compounds.	[Deng, Youping] Rush Univ, Dept Internal Med, Ctr Canc, Med Ctr, Chicago, IL 60612 USA; [Meyer, Sharon A.] Univ Louisiana Monroe, Monroe, LA USA; [Guan, Xin] SpecProc Inc, Vicksburg, MS USA; [Escalon, Barbara Lynn; Wilbanks, Mitchell S.; Perkins, Edward J.] USA, Engn Res & Dev Ctr, Vicksburg, MS USA; [Ai, Junmei] Univ So Mississippi, Sch Comp, Hattiesburg, MS 39406 USA; [Welti, Ruth] Kansas State Univ, Div Biol Sci, Manhattan, KS 66506 USA; [Garcia-Reyero, Natalia] Jackson State Univ, Jackson, MS USA	Rush University; University of Louisiana System; University of Louisiana Monroe; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); University of Southern Mississippi; Kansas State University; Jackson State University	Deng, YP (corresponding author), Rush Univ, Dept Internal Med, Ctr Canc, Med Ctr, Chicago, IL 60612 USA.	youping_deng@rush.edu		Welti, Ruth/0000-0003-4373-2538	US Army [W912HZ-05-P-0145]; SpecPro Inc.	US Army(United States Department of DefenseUnited States Army); SpecPro Inc.	This project was supported by US Army Environmental Quality Program (contract #W912HZ-05-P-0145) and SpecPro Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2001, COMP BIOCHEM PHYS B, V129, P703, DOI 10.1016/S1096-4959(01)00389-X; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ASHBY J, 1985, ARCH TOXICOL, V58, P14, DOI 10.1007/BF00292610; ASSINK HA, 1984, J CLIN CHEM CLIN BIO, V22, P685; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Beigneux AP, 2000, J BIOL CHEM, V275, P16390, DOI 10.1074/jbc.M000953200; Beigneux AP, 2003, AM J PHYSIOL-ENDOC M, V284, pE228, DOI 10.1152/ajpendo.00155.2002; BERMUDEZ E, 1979, ENVIRON MUTAGEN, V1, P391, DOI 10.1002/em.2860010412; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; De Maio A, 1999, SHOCK, V11, P1, DOI 10.1097/00024382-199901000-00001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; ELLIS HV, 1980, MAMMALIAN TOXICITY M; ELLIS HV, 1978, MAMMALIAN TOXICITY M; Fairbanks VF, 1986, TXB CLIN CHEM, P1532; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Foreman JE, 2009, TOXICOL SCI, V110, P204, DOI 10.1093/toxsci/kfp077; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Glass Konsuela Y, 2005, Int J Environ Res Public Health, V2, P355, DOI 10.3390/ijerph2005020022; Gong PF, 2006, HEPATOLOGY, V43, P144, DOI 10.1002/hep.21004; Gong P, 2007, ENVIRON SCI TECHNOL, V41, P8195, DOI 10.1021/es0716352; Gust KA, 2009, TOXICOL SCI, V110, P168, DOI 10.1093/toxsci/kfp091; HALL RL, 2008, PRINCIPLES METHODS T, P1317; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hickey NJ, 2009, TOXICOL SCI, V111, P311, DOI 10.1093/toxsci/kfp160; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Homma-Takeda S, 2002, FREE RADICAL RES, V36, P555, DOI 10.1080/10715760290025933; Honeycutt ME, 1996, ECOTOX ENVIRON SAFE, V35, P282, DOI 10.1006/eesa.1996.0112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenkins TF, 2006, CHEMOSPHERE, V63, P1280, DOI 10.1016/j.chemosphere.2005.09.066; Johnson MS, 2007, ENVIRON TOXICOL CHEM, V26, P1481, DOI 10.1897/06-525.1; Jones CR, 2005, CARCINOGENESIS, V26, P133, DOI 10.1093/carcin/bgh286; Kim MS, 2007, METABOLISM, V56, P267, DOI 10.1016/j.metabol.2006.10.007; KOLLER BH, 1988, J IMMUNOL, V141, P897; LA DK, 1992, ARCH TOXICOL, V66, P633, DOI 10.1007/BF01981502; LA DK, 1992, CHEM-BIOL INTERACT, V83, P121, DOI 10.1016/0009-2797(92)90041-I; Lassen N, 2007, J BIOL CHEM, V282, P25668, DOI 10.1074/jbc.M702076200; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; LEVINE BS, 1990, FUND APPL TOXICOL, V15, P373, DOI 10.1016/0272-0590(90)90062-O; Luebker DJ, 2002, TOXICOLOGY, V176, P175, DOI 10.1016/S0300-483X(02)00081-1; Mashek DG, 2006, J BIOL CHEM, V281, P945, DOI 10.1074/jbc.M507646200; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Patel AA, 2009, J CLIN GASTROENTEROL, V43, P970, DOI 10.1097/MCG.0b013e3181b57475; Pirooznia M, 2008, BIOINFORMATICS, V24, P2561, DOI 10.1093/bioinformatics/btn441; POPP J A, 1991, P279; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; RAWAT A, 2010, PHYSL GENOMICS; Reddy G, 2000, INT J TOXICOL, V19, P169, DOI 10.1080/10915810050074937; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Rotondi M, 2007, EUR J ENDOCRINOL, V156, P409, DOI 10.1530/EJE-06-0735; Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171; Sabbioni A, 2006, CANCER EPIDEM BIOMAR, V15, P559, DOI 10.1158/1055-9965.EPI-05-0677; Sabbioni G, 2005, CARCINOGENESIS, V26, P1272, DOI 10.1093/carcin/bgi078; Sabbioni G, 1996, J CHROMATOGR B, V682, P243, DOI 10.1016/0378-4347(96)00083-7; Santoro MG, 2000, BIOCHEM PHARMACOL, V59, P55, DOI 10.1016/S0006-2952(99)00299-3; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sharp P.E., 1998, LAB RAT; Shipley JM, 2004, TOXICOL APPL PHARM, V199, P275, DOI 10.1016/j.taap.2003.12.020; SPANGGORD RJ, 1990, CHEM RES TOXICOL, V3, P551, DOI 10.1021/tx00018a010; Talmage Sylvia S., 1999, Reviews of Environmental Contamination and Toxicology, V161, P1; Tchounwou PB, 2001, ENVIRON TOXICOL, V16, P209, DOI 10.1002/tox.1026; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Travlos GS, 1996, TOXICOLOGY, V107, P17, DOI 10.1016/0300-483X(95)03197-N; Vacca LL., 1985, LAB MANUAL HISTOCHEM; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wintz H, 2006, TOXICOL SCI, V94, P71, DOI 10.1093/toxsci/kfl080; Yang XH, 2001, CANCER RES, V61, P348; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zuo Y, 2008, J BIOL CHEM, V283, P36624, DOI 10.1074/jbc.M807377200	76	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14662	10.1371/journal.pone.0014662	http://dx.doi.org/10.1371/journal.pone.0014662			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346803	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600001
J	Morris, JJ; Johnson, ZI; Szul, MJ; Keller, M; Zinser, ER				Morris, J. Jeffrey; Johnson, Zackary I.; Szul, Martin J.; Keller, Martin; Zinser, Erik R.			Dependence of the Cyanobacterium Prochlorococcus on Hydrogen Peroxide Scavenging Microbes for Growth at the Ocean's Surface	PLOS ONE			English	Article							OXIDATIVE STRESS; PHOTOCHEMICAL FORMATION; IRON SPECIATION; ATLANTIC-OCEAN; PACIFIC-OCEAN; PHYTOPLANKTON; LIGHT; SYNECHOCOCCUS; ECOTYPES; WATERS	The phytoplankton community in the oligotrophic open ocean is numerically dominated by the cyanobacterium Prochlorococcus, accounting for approximately half of all photosynthesis. In the illuminated euphotic zone where Prochlorococcus grows, reactive oxygen species are continuously generated via photochemical reactions with dissolved organic matter. However, Prochlorococcus genomes lack catalase and additional protective mechanisms common in other aerobes, and this genus is highly susceptible to oxidative damage from hydrogen peroxide (HOOH). In this study we showed that the extant microbial community plays a vital, previously unrecognized role in cross-protecting Prochlorococcus from oxidative damage in the surface mixed layer of the oligotrophic ocean. Microbes are the primary HOOH sink in marine systems, and in the absence of the microbial community, surface waters in the Atlantic and Pacific Ocean accumulated HOOH to concentrations that were lethal for Prochlorococcus cultures. In laboratory experiments with the marine heterotroph Alteromonas sp., serving as a proxy for the natural community of HOOH-degrading microbes, bacterial depletion of HOOH from the extracellular milieu prevented oxidative damage to the cell envelope and photosystems of co-cultured Prochlorococcus, and facilitated the growth of Prochlorococcus at ecologically-relevant cell concentrations. Curiously, the more recently evolved lineages of Prochlorococcus that exploit the surface mixed layer niche were also the most sensitive to HOOH. The genomic streamlining of these evolved lineages during adaptation to the high-light exposed upper euphotic zone thus appears to be coincident with an acquired dependency on the extant HOOH-consuming community. These results underscore the importance of (indirect) biotic interactions in establishing niche boundaries, and highlight the impacts that community-level responses to stress may have in the ecological and evolutionary outcomes for co-existing species.	[Morris, J. Jeffrey; Szul, Martin J.; Zinser, Erik R.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Johnson, Zackary I.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Keller, Martin] Oak Ridge Natl Lab, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Knoxville; Duke University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Morris, JJ (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	ezinser@utk.edu	Johnson, Zackary I/E-4601-2011; Keller, Martin/C-4416-2012	Johnson, Zackary I/0000-0003-0793-8512; Morris, James/0000-0001-9079-0082	NSF [OCE0526072, OCE0550798]; Phycological Society of America; Direct For Biological Sciences [0959630] Funding Source: National Science Foundation; Directorate For Geosciences [1031064] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Phycological Society of America; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grants OCE0526072 to ERZ and OCE0550798 to ZIJ, and a Phycological Society of America grant-in-aid to JJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; [Anonymous], 2002, PHOTOSYNTHETICA; Avery GB, 2005, MAR CHEM, V97, P236, DOI 10.1016/j.marchem.2005.03.006; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Bertilsson S, 2005, VIE MILIEU, V55, P225; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Fazzini RAB, 2010, ENVIRON MICROBIOL, V12, P2436, DOI 10.1111/j.1462-2920.2010.02217.x; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Bruyant F, 2005, LIMNOL OCEANOGR, V50, P850, DOI 10.4319/lo.2005.50.3.0850; Cavender-Bares KK, 1998, LIMNOL OCEANOGR, V43, P1383, DOI 10.4319/lo.1998.43.6.1383; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; COOPER WJ, 1988, ENVIRON SCI TECHNOL, V22, P1156, DOI 10.1021/es00175a004; COOPER WJ, 1983, SCIENCE, V220, P711, DOI 10.1126/science.220.4598.711; COOPER WJ, 1990, CAN J FISH AQUAT SCI, V47, P888, DOI 10.1139/f90-102; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; de-Bashan LE, 2008, J PHYCOL, V44, P938, DOI 10.1111/j.1529-8817.2008.00533.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DiTullio GR, 2003, MAR ECOL PROG SER, V255, P55, DOI 10.3354/meps255055; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; DRAPER WM, 1983, ARCH ENVIRON CON TOX, V12, P121, DOI 10.1007/BF01055010; DUBININ AV, 1992, MICROBIOLOGY+, V61, P41; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Dummermuth AL, 2003, J EXP MAR BIOL ECOL, V289, P103, DOI 10.1016/S0022-0981(03)00042-X; Eaton A. D., 2005, STANDARD METHODS EXA; Fogg G.E., 1987, ALGAL CULTURES PHYTO; Gerringa LJA, 2004, J SEA RES, V51, P3, DOI 10.1016/j.seares.2003.03.002; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; GOERICKE R, 1993, DEEP-SEA RES PT I, V40, P2283, DOI 10.1016/0967-0637(93)90104-B; Halliwell B., 2007, FREE RADICALS BIOL M; Halsey TA, 2004, INFECT IMMUN, V72, P1155, DOI 10.1128/IAI.72.2.1155-1158.2004; Hanson AK, 2001, MAR CHEM, V75, P69, DOI 10.1016/S0304-4203(01)00027-5; Hebrard M, 2009, J BACTERIOL, V191, P4605, DOI 10.1128/JB.00144-09; Heck DE, 2003, J BIOL CHEM, V278, P22432, DOI 10.1074/jbc.C300048200; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; JOHNSON KS, 1989, DEEP-SEA RES, V36, P241, DOI 10.1016/0198-0149(89)90136-2; Johnson ZI, 2004, MAR ECOL PROG SER, V283, P73, DOI 10.3354/meps283073; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kieber RJ, 2001, ATMOS ENVIRON, V35, P6041, DOI 10.1016/S1352-2310(01)00199-6; King DW, 2007, ANAL CHEM, V79, P4169, DOI 10.1021/ac062228w; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, Vsecond; Kojima K, 2007, MOL MICROBIOL, V65, P936, DOI 10.1111/j.1365-2958.2007.05836.x; Kranner I, 2005, P NATL ACAD SCI USA, V102, P3141, DOI 10.1073/pnas.0407716102; KUBITSCHEK HE, 1986, J BACTERIOL, V168, P1466, DOI 10.1128/jb.168.3.1466-1467.1986; LEPEZUNIGA JL, 1987, J IMMUNOL METHODS, V103, P145, DOI 10.1016/0022-1759(87)90253-5; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Marais GAB, 2008, GENETICA, V134, P205, DOI 10.1007/s10709-007-9226-6; Marchetti A, 2010, LIMNOL OCEANOGR, V55, P11, DOI 10.4319/lo.2010.55.1.0011; MILLER WL, 1994, MAR CHEM, V48, P17, DOI 10.1016/0304-4203(94)90059-0; MOFFETT JW, 1987, ENVIRON SCI TECHNOL, V21, P804, DOI 10.1021/es00162a012; Moore LR, 2007, LIMNOL OCEANOGR-METH, V5, P353, DOI 10.4319/lom.2007.5.353; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Morris JJ, 2008, APPL ENVIRON MICROB, V74, P4530, DOI 10.1128/AEM.02479-07; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; MOUGET JL, 1995, FEMS MICROBIOL ECOL, V18, P35, DOI 10.1016/0168-6496(95)00038-C; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Paerl HW, 1996, MICROB ECOL, V31, P225; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Partensky F, 1996, DEEP-SEA RES PT I, V43, P1191, DOI 10.1016/0967-0637(96)00056-8; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; Petasne RG, 1997, MAR CHEM, V56, P215, DOI 10.1016/S0304-4203(96)00072-2; Ras J, 2008, BIOGEOSCIENCES, V5, P353, DOI 10.5194/bg-5-353-2008; Richier S, 2005, J EXP BIOL, V208, P277, DOI 10.1242/jeb.01368; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Samuilov VD, 1999, BIOCHEMISTRY-MOSCOW+, V64, P47; Sarthou G, 2007, MAR CHEM, V104, P186, DOI 10.1016/j.marchem.2006.11.004; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schreiber U, 1996, FEBS LETT, V397, P131, DOI 10.1016/S0014-5793(96)01176-3; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; THOMPSON AW, 2009, THESIS MIT CAMBRIDGE; Ting CS, 2007, J BACTERIOL, V189, P4485, DOI 10.1128/JB.01948-06; TYTLER EM, 1984, FEMS MICROBIOL LETT, V23, P239; Van Mooy BAS, 2006, P NATL ACAD SCI USA, V103, P8607, DOI 10.1073/pnas.0600540103; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; Vieira-Silva S, 2010, TRENDS ECOL EVOL, V25, P319, DOI 10.1016/j.tree.2010.03.001; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Willey JD, 2004, J ATMOS CHEM, V47, P209, DOI 10.1023/B:JOCH.0000021087.19846.e1; Xenopoulos MA, 1997, PHOTOCHEM PHOTOBIOL, V66, P471, DOI 10.1111/j.1751-1097.1997.tb03175.x; Yuan JC, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000908; Yuan JC, 2000, ATMOS ENVIRON, V34, P3973, DOI 10.1016/S1352-2310(00)00167-9; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; ZEPP RG, 2002, ENVIRON SCI TECHNOL, V26, P313; ZIGLER JS, 1985, IN VITRO CELL DEV B, V21, P282; ZIKA RG, 1985, MAR CHEM, V17, P265, DOI 10.1016/0304-4203(85)90015-5; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	98	181	186	1	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16805	10.1371/journal.pone.0016805	http://dx.doi.org/10.1371/journal.pone.0016805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304826	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036600026
J	Mu, XD; Peng, HR; Pan, HY; Huard, J; Li, Y				Mu, Xiaodong; Peng, Hairong; Pan, Haiying; Huard, Johnny; Li, Yong			Study of Muscle Cell Dedifferentiation after Skeletal Muscle Injury of Mice with a Cre-Lox System	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; DEFINED FACTORS; GENE-THERAPY; FUSION; REGENERATION; EXPRESSION; MARROW; MOUSE; LINEAGES	Background: Dedifferentiation of muscle cells in the tissue of mammals has yet to be observed. One of the challenges facing the study of skeletal muscle cell dedifferentiation is the availability of a reliable model that can confidentially distinguish differentiated cell populations of myotubes and non-fused mononuclear cells, including stem cells that can coexist within the population of cells being studied. Methodology/Principal Findings: In the current study, we created a Cre/Lox-beta-galactosidase system, which can specifically tag differentiated multinuclear myotubes and myotube-generated mononuclear cells based on the activation of the marker gene, beta-galactosidase. By using this system in an adult mouse model, we found that beta-galactosidase positive mononuclear cells were generated from beta-galactosidase positive multinuclear myofibers upon muscle injury. We also demonstrated that these mononuclear cells can develop into a variety of different muscle cell lineages, i.e., myoblasts, satellite cells, and muscle derived stem cells. Conclusions/Significance: These novel findings demonstrated, for the first time, that cellular dedifferentiation of skeletal muscle cells actually occurs in mammalian skeletal muscle following traumatic injury in vivo.	[Mu, Xiaodong; Pan, Haiying; Huard, Johnny; Li, Yong] UPMC, Lab Mol Pathol, Stem Cell Res Ctr SCRC, Childrens Hosp, Pittsburgh, PA USA; [Mu, Xiaodong; Peng, Hairong; Huard, Johnny; Li, Yong] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Huard, Johnny; Li, Yong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Li, Yong] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mu, XD (corresponding author), UPMC, Lab Mol Pathol, Stem Cell Res Ctr SCRC, Childrens Hosp, Pittsburgh, PA USA.	yongli@pitt.edu	Mu, Xiaodong/A-2474-2012; Li, Yong/AAM-2367-2021	Li, Yong/0000-0001-7956-9600	Department of Defense (DOD) [W81XWH-06-1-0406, 23RYX9132N613]; National Institutes of Health [NIH1R21AR055725]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055725] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study received support from the Department of Defense (DOD, W81XWH-06-1-0406 & 23RYX9132N613) and the National Institutes of Health (NIH1R21AR055725) grants to Dr. Yong Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas O, 2009, BRIT J DERMATOL, V161, P228, DOI 10.1111/j.1365-2133.2009.09250.x; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Chen XP, 2005, MOL BIOL CELL, V16, P3140, DOI 10.1091/mbc.E05-03-0218; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee JY, 2002, HUM GENE THER, V13, P1201, DOI 10.1089/104303402320138989; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Y, 2010, JOVE-J VIS EXP, DOI [10.3791/2011, DOI 10.3791/2011]; Liu SV, 2008, STEM CELLS DEV, V17, P391, DOI 10.1089/scd.2008.0062; Loof S, 2007, CELL CYCLE, V6, P1096, DOI 10.4161/cc.6.9.4141; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Morrison JI, 2007, DEV DYNAM, V236, P481, DOI 10.1002/dvdy.21019; MU X, 2010, J CELLULAR MOL MED; Mu XD, 2010, AM J PATHOL, V177, P2399, DOI 10.2353/ajpath.2010.091121; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rodi N, 2004, TRENDS MOL MED, V10, P93, DOI 10.1016/j.molmed.2004.01.010; Ryffel GU, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng044; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Zhao Y, 2003, P NATL ACAD SCI USA, V100, P2426, DOI 10.1073/pnas.0536882100	30	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16699	10.1371/journal.pone.0016699	http://dx.doi.org/10.1371/journal.pone.0016699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304901	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000287036600014
J	Tilahun, AY; Holz, M; Wu, TT; David, CS; Rajagopalan, G				Tilahun, Ashenafi Y.; Holz, Marah; Wu, Tsung-Teh; David, Chella S.; Rajagopalan, Govindarajan			Interferon Gamma-Dependent Intestinal Pathology Contributes to the Lethality in Bacterial Superantigen-Induced Toxic Shock Syndrome	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; HUMAN-LEUKOCYTE ANTIGEN-DQ8; IFN-GAMMA; TRANSGENIC MICE; INTRANASAL EXPOSURE; BARRIER FUNCTION; ACTIVATION; DISEASE; MODEL; INDUCTION	Toxic shock syndrome (TSS) caused by the superantigen exotoxins of Staphylococcus aureus and Streptococcus pyogenes is characterized by robust T cell activation, profound elevation in systemic levels of multiple cytokines, including interferon-gamma (IFN-gamma), followed by multiple organ dysfunction and often death. As IFN-gamma possesses pro- as well as anti-inflammatory properties, we delineated its role in the pathogenesis of TSS. Antibody-mediated in vivo neutralization of IFN-gamma or targeted disruption of IFN-gamma gene conferred significant protection from lethal TSS in HLA-DR3 transgenic mice. Following systemic high dose SEB challenge, whereas the HLA-DR3. IFN-gamma(+/+) mice became sick and succumbed to TSS, HLA-DR3. IFN-gamma(-/-) mice appeared healthy and were significantly protected from SEB-induced lethality. SEB-induced systemic cytokine storm was significantly blunted in HLA-DR3. IFN-gamma(-/-) transgenic mice. Serum concentrations of several cytokines (IL-4, IL-10, IL-12p40 and IL-17) and chemokines (KC, rantes, eotaxin and MCP-1) were significantly lower in HLA-DR3. IFN-gamma(-/-) transgenic mice. However, SEB-induced T cell expansion in the spleens was unaffected and expansion of SEB-reactive TCR Vb8(+) CD4(+) and CD8(+) T cells was even more pronounced in HLA-DR3. IFN-gamma(-/-) transgenic mice when compared to HLA-DR3. IFN-gamma(+/+) mice. A systematic histopathological examination of several vital organs revealed that both HLA-DR3. IFN-gamma(+/+) and HLA-DR3. IFN-gamma(-/-) transgenic mice displayed comparable severe inflammatory changes in lungs, and liver during TSS. Remarkably, whereas the small intestines fromHLA-DR3. IFN-gamma(+/+) transgenic mice displayed significant pathological changes during TSS, the architecture of small intestines in HLA-DR3. IFN-gamma(-/-) transgenic mice was preserved. In concordance with these histopathological changes, the gut permeability to macromolecules was dramatically increased in HLA-DR3. IFN-gamma(+/+) but not HLA-DR3. IFN-gamma(-/-) mice during TSS. Overall, IFN-gamma seemed to play a lethal role in the immunopathogenesis of TSS by inflicting fatal small bowel pathology. Our study thus identifies the important role for IFN-gamma in TSS.	[Tilahun, Ashenafi Y.; Holz, Marah; David, Chella S.; Rajagopalan, Govindarajan] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Wu, Tsung-Teh] Mayo Clin, Coll Med, Dept Anat Pathol, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Tilahun, AY (corresponding author), Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA.	rajagopalan.govindarajan@mayo.edu			NIH [1R01AI068741]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068741] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH grant 1R01AI068741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; BILLIAU A, 1988, J IMMUNOL, V140, P1506; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Dinges MM, 2001, INFECT IMMUN, V69, P1256, DOI 10.1128/IAI.69.3.1256-1264.2001; FARRAR MA, 1993, ANNU REV IMMUNOL, V11, P571, DOI 10.1146/annurev.iy.11.040193.003035; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; HEINZEL FP, 1990, J IMMUNOL, V145, P2920; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; John CC, 2009, CLIN INFECT DIS, V49, P1893, DOI 10.1086/648441; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Lavoie PM, 1999, IMMUNOL REV, V168, P257, DOI 10.1111/j.1600-065X.1999.tb01297.x; Li HM, 1999, ANNU REV IMMUNOL, V17, P435, DOI 10.1146/annurev.immunol.17.1.435; MADARA JL, 1989, J CLIN INVEST, V83, P724, DOI 10.1172/JCI113938; Madsen JM, 2001, CLIN LAB MED, V21, P593; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; MIETHKE T, 1993, EUR J IMMUNOL, V23, P1494, DOI 10.1002/eji.1830230715; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Moreill P, 2009, MANDELL DOUGLAS BENN; Murray RJ, 2005, INTERN MED J, V35, pS106, DOI 10.1111/j.1444-0903.2005.00984.x; Nava P, 2010, IMMUNITY, V32, P392, DOI 10.1016/j.immuni.2010.03.001; Pinna GS, 2008, CURR OPIN INFECT DIS, V21, P263, DOI 10.1097/QCO.0b013e3282fbf9cd; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rajagopalan G, 2004, INFECT IMMUN, V72, P6733, DOI 10.1128/IAI.72.11.6733-6737.2004; Rajagopalan G, 2006, INFECT IMMUN, V74, P1284, DOI 10.1128/IAI.74.2.1284-1296.2006; Rajagopalan G, 2005, CLIN DIAGN LAB IMMUN, V12, P1119, DOI 10.1128/CDLI.12.9.1119-1122.2005; Rajagopalan G, 2003, TISSUE ANTIGENS, V62, P149, DOI 10.1034/j.1399-0039.2003.00088.x; Rajagopalan G, 2009, PHYSL GENOMICS, p9038592008; Rajagopalan G, 2006, INFECT IMMUN, V74, P6016, DOI 10.1128/IAI.00671-06; Rajagopalan G, 2006, SHOCK, V25, P647, DOI 10.1097/01.shk.0000209565.92445.7d; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Roy CJ, 2005, INFECT IMMUN, V73, P2452, DOI 10.1128/IAI.73.4.2452-2460.2005; Sheikh SZ, 2010, J IMMUNOL, V184, P4069, DOI 10.4049/jimmunol.0903600; Silverstein R, 2004, J ENDOTOXIN RES, V10, P147, DOI 10.1179/096805104225004879; Singh JA, COCHRANE DATABASE SY, V7; Takahashi N, 1998, LANCET, V351, P1614, DOI 10.1016/S0140-6736(97)11125-4; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tilahun AY, 2010, MOL THERAPY IN PRESS; TODD JK, 1985, ANNU REV MED, V36, P337; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Welcher BC, 2002, J INFECT DIS, V186, P501, DOI 10.1086/341828	50	33	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16764	10.1371/journal.pone.0016764	http://dx.doi.org/10.1371/journal.pone.0016764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304813	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600022
J	Watanabe, S; Wakasugi, K				Watanabe, Seiji; Wakasugi, Keisuke			Module M1 of Zebrafish Neuroglobin Acts as a Structural and Functional Protein Building Block for a Cell-Membrane-Penetrating Activity	PLOS ONE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; ARGININE-RICH PEPTIDES; BETA2/NEUROD PROTEIN; LIGAND-BINDING; IN-VIVO; TRANSDUCTION; HEMOGLOBIN; DELIVERY; OXYGEN; EXPRESSION	Neuroglobin (Ngb) is a recently discovered vertebrate globin that is expressed in the brain and can reversibly bind oxygen. Mammalian Ngb is involved in neuroprotection during oxidative stress that occurs, for example, during ischemia and reperfusion. Recently, we found that zebrafish, but not human, Ngb can translocate into cells. Moreover, we demonstrated that a chimeric ZHHH Ngb protein, in which the module M1 of human Ngb is replaced by the corresponding region of zebrafish Ngb, can penetrate cell membranes and protect cells against oxidative stress-induced cell death, suggesting that module M1 of zebrafish Ngb is important for protein transduction. Furthermore, we recently showed that Lys7, Lys9, Lys21, and Lys23 in module M1 of zebrafish Ngb are crucial for protein transduction activity. In the present study, we have investigated whether module M1 of zebrafish Ngb can be used as a building block to create novel cell-membrane penetrating folded proteins. First, we engineered a chimeric myoglobin (Mb), in which module M1 of zebrafish Ngb was fused to the N-terminus of full-length human Mb, and investigated its functional and structural properties. Our results showed that this chimeric Mb protein is stable and forms almost the same heme environment and alpha-helical structure as human wild-type Mb. In addition, we demonstrated that chimeric Mb has a cell-membrane-penetrating activity similar to zebrafish Ngb. Moreover, we found that glycosaminoglycan is crucial for the cell-membrane-penetrating activity of chimeric Mb as well as that of zebrafish Ngb. These results enable us to conclude that such module substitutions will facilitate the design and production of novel functional proteins.	[Watanabe, Seiji; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Watanabe, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616; Watanabe, Seiji/0000-0001-8038-7919	Japan Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [21117506]; JSPS	Japan Science and Technology(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Science and Technology (to K. W.) and Grant-in-Aid 21117506 for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. W.). S. W. was supported by the JSPS Research Fellowships for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Awenius C, 2001, BIOCHEM BIOPH RES CO, V287, P418, DOI 10.1006/bbrc.2001.5614; BLAKE CCF, 1979, NATURE, V277, P598, DOI 10.1038/277598a0; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fedorov A, 2003, GENOME RES, V13, P1155, DOI 10.1101/gr.1008203; Fordel E, 2006, NEUROSCI LETT, V410, P146, DOI 10.1016/j.neulet.2006.09.027; Fuchs C, 2004, J BIOL CHEM, V279, P24116, DOI 10.1074/jbc.M402011200; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Go M., 1985, Advances in Biophysics, V19, P91; GO M, 1983, P NATL ACAD SCI-BIOL, V80, P1964, DOI 10.1073/pnas.80.7.1964; GO M, 1981, NATURE, V291, P90, DOI 10.1038/291090a0; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; KERSANACH R, 1994, NATURE, V367, P387, DOI 10.1038/367387a0; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Kitatsuji C, 2007, J MOL BIOL, V368, P150, DOI 10.1016/j.jmb.2007.02.002; Li RC, 2008, NEUROBIOL AGING, V29, P1815, DOI 10.1016/j.neurobiolaging.2007.05.001; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Long MY, 1996, P NATL ACAD SCI USA, V93, P7727, DOI 10.1073/pnas.93.15.7727; Mendoza V, 2005, TRANSPL P, V37, P237, DOI 10.1016/j.transproceed.2004.12.270; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Noguchi H, 2005, DIABETES, V54, P2859, DOI 10.2337/diabetes.54.10.2859; Noguchi H, 2007, HUM GENE THER, V18, P10, DOI 10.1089/hum.2006.118; Peroni D, 2007, NEUROSCI LETT, V421, P110, DOI 10.1016/j.neulet.2007.05.046; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SHIH MC, 1988, SCIENCE, V242, P1164, DOI 10.1126/science.3055302; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Suzuki T, 1998, CELL MOL LIFE SCI, V54, P979, DOI 10.1007/s000180050227; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; VARADARAJAN R, 1989, BIOCHEMISTRY-US, V28, P3771, DOI 10.1021/bi00435a022; Wakasugi K, 2005, ANN NY ACAD SCI, V1053, P220, DOI 10.1196/annals.1344.020; Wakasugi K, 2005, BIOCHEM BIOPH RES CO, V330, P591, DOI 10.1016/j.bbrc.2005.03.021; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P2943, DOI 10.1021/bi0477539; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P225, DOI 10.1021/bi048313k; Wakasugi K, 1997, BIOPHYS CHEM, V68, P265, DOI 10.1016/S0301-4622(97)80556-X; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; WAKASUGI K, 1994, J BIOL CHEM, V269, P18750; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P5266, DOI 10.1021/bi800286m; Watanabe S, 2008, BIOCHEM BIOPH RES CO, V369, P695, DOI 10.1016/j.bbrc.2008.02.089; Watanabe S, 2010, FEBS LETT, V584, P2467, DOI 10.1016/j.febslet.2010.04.054; Wystub S, 2003, NEUROSCI LETT, V346, P114, DOI 10.1016/S0304-3940(03)00563-9; Zhang CG, 2002, BIOCHEM BIOPH RES CO, V290, P1411, DOI 10.1006/bbrc.2002.6360; Zhou GY, 2008, BIOTECHNOL APPL BIOC, V49, P25, DOI 10.1042/BA20070061	51	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16808	10.1371/journal.pone.0016808	http://dx.doi.org/10.1371/journal.pone.0016808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304818	Green Published, Green Submitted, gold			2022-12-25	WOS:000287036600027
J	Allentoft, ME; Oskam, C; Houston, J; Hale, ML; Gilbert, MTP; Rasmussen, M; Spencer, P; Jacomb, C; Willerslev, E; Holdaway, RN; Bunce, M				Allentoft, Morten E.; Oskam, Charlotte; Houston, Jayne; Hale, Marie L.; Gilbert, M. Thomas P.; Rasmussen, Morten; Spencer, Peter; Jacomb, Christopher; Willerslev, Eske; Holdaway, Richard N.; Bunce, Michael			Profiling the Dead: Generating Microsatellite Data from Fossil Bones of Extinct Megafauna-Protocols, Problems, and Prospects	PLOS ONE			English	Article							GENOTYPING ERRORS; SOUTH ISLAND; DNA; SAMPLES; MARKERS; MOA; POPULATIONS; LOCI; AMPLIFICATION; CONSEQUENCES	We present the first set of microsatellite markers developed exclusively for an extinct taxon. Microsatellite data have been analysed in thousands of genetic studies on extant species but the technology can be problematic when applied to low copy number (LCN) DNA. It is therefore rarely used on substrates more than a few decades old. Now, with the primers and protocols presented here, microsatellite markers are available to study the extinct New Zealand moa (Aves: Dinornithiformes) and, as with single nucleotide polymorphism (SNP) technology, the markers represent a means by which the field of ancient DNA can (preservation allowing) move on from its reliance on mitochondrial DNA. Candidate markers were identified using high throughput sequencing technology (GS-FLX) on DNA extracted from fossil moa bone and eggshell. From the 'shotgun' reads, >60 primer pairs were designed and tested on DNA from bones of the South Island giant moa (Dinornis robustus). Six polymorphic loci were characterised and used to assess measures of genetic diversity. Because of low template numbers, typical of ancient DNA, allelic dropout was observed in 36-70% of the PCR reactions at each microsatellite marker. However, a comprehensive survey of allelic dropout, combined with supporting quantitative PCR data, allowed us to establish a set of criteria that maximised data fidelity. Finally, we demonstrated the viability of the primers and the protocols, by compiling a full Dinornis microsatellite dataset representing fossils of c. 600-5000 years of age. A multi-locus genotype was obtained from 74 individuals (84% success rate), and the data showed no signs of being compromised by allelic dropout. The methodology presented here provides a framework by which to generate and evaluate microsatellite data from samples of much greater antiquity than attempted before, and opens new opportunities for ancient DNA research.	[Allentoft, Morten E.; Oskam, Charlotte; Houston, Jayne; Bunce, Michael] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Perth, WA, Australia; [Allentoft, Morten E.; Hale, Marie L.; Holdaway, Richard N.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Gilbert, M. Thomas P.; Rasmussen, Morten; Willerslev, Eske] Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Spencer, Peter] Murdoch Univ, Sch Biol Sci & Biotechnol, Wildlife Identificat Lab, Perth, WA, Australia; [Jacomb, Christopher] Univ Otago, Dept Anthropol, Dunedin, New Zealand; [Holdaway, Richard N.] Palaecol Res Ltd, Christchurch, New Zealand	Murdoch University; University of Canterbury; Murdoch University; University of Otago	Allentoft, ME (corresponding author), Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Perth, WA, Australia.	morten.allentoft@gmail.com; m.bunce@murdoch.edu.au	Willerslev, Eske/AAA-5686-2019; Oskam, Charlotte/N-4097-2018; Gilbert, Marcus TP/A-8936-2013; Spencer, Peter/T-1042-2019; Willerslev, Eske/A-9619-2011	Oskam, Charlotte/0000-0001-8886-2120; Gilbert, Marcus TP/0000-0002-5805-7195; Willerslev, Eske/0000-0002-7081-6748; Bunce, Michael/0000-0002-0302-4206; Allentoft, Morten/0000-0003-4424-3568; Spencer, Peter/0000-0002-4938-2615	Australian Research Council [DP0771971, FT0991741]; Royal Society of New Zealand [09-UOO-164, 06-PAL-001-EEB]	Australian Research Council(Australian Research Council); Royal Society of New Zealand(Royal Society of New Zealand)	Financial support was provided to MB by the Australian Research Council (DP0771971 and FT0991741), The Marsden Fund of the Royal Society of New Zealand (Contracts 09-UOO-164 to CJ, SPAR and 06-PAL-001-EEB to RNH Palaecol Research Ltd). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Allentoft ME, 2010, QUATERNARY SCI REV, V29, P753, DOI 10.1016/j.quascirev.2009.11.022; Allentoft ME, 2009, BIOTECHNIQUES, V46, P195, DOI 10.2144/000113086; Anderson CNK, 2005, BIOINFORMATICS, V21, P1733, DOI 10.1093/bioinformatics/bti154; Arandjelovic M, 2009, MOL ECOL RESOUR, V9, P28, DOI 10.1111/j.1755-0998.2008.02387.x; Balogh MK, 2003, FORENSIC SCI INT, V137, P188, DOI 10.1016/j.forsciint.2003.07.001; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bourke BP, 2010, CONSERV GENET, V11, P1837, DOI 10.1007/s10592-010-0076-x; Brennan PLR, 2008, MOL ECOL RESOUR, V8, P933, DOI 10.1111/j.1755-0998.2008.02122.x; Bunce M, 2003, NATURE, V425, P172, DOI 10.1038/nature01871; Bunce M, 2009, P NATL ACAD SCI USA, V106, P20646, DOI 10.1073/pnas.0906660106; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Clay C, 2010, CONSERV GENET RESOUR, V2, P301, DOI 10.1007/s12686-010-9211-8; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duckett PE, 2010, CONSERV GENET RESOUR, V2, P349, DOI 10.1007/s12686-010-9248-8; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Gagneux P, 1997, MOL ECOL, V6, P861, DOI 10.1111/j.1365-294X.1997.tb00140.x; Goossens B, 1998, MOL ECOL, V7, P1237, DOI 10.1046/j.1365-294x.1998.00407.x; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Huang Y, 2008, CYTOGENET GENOME RES, V121, P130, DOI 10.1159/000125838; Huynen L, 2003, NATURE, V425, P175, DOI 10.1038/nature01838; Kimwele CN, 1998, MOL ECOL, V7, P249; Maricic T, 2009, BIOTECHNIQUES, V46, P51, DOI 10.2144/000113042; Meyer M, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1095; Miller CR, 2002, GENETICS, V160, P357; MILLER JM, 2010, CONSERV GENET, DOI DOI 10.1007/S10592-10010-10149-X; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Morin PA, 2009, MOL ECOL RESOUR, V9, P498, DOI 10.1111/j.1755-0998.2008.02502.x; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Oskam CL, 2010, P ROY SOC B-BIOL SCI, V277, P1991, DOI 10.1098/rspb.2009.2019; Parsons KM, 2001, MOL ECOL NOTES, V1, P341, DOI 10.1046/j.1471-8278.2001.00098.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pertoldi C, 2001, P ROY SOC B-BIOL SCI, V268, P1775, DOI 10.1098/rspb.2001.1762; Petren K, 2010, PHILOS T R SOC B, V365, P1009, DOI 10.1098/rstb.2009.0316; Primmer CR, 1997, GENOME RES, V7, P471, DOI 10.1101/gr.7.5.471; Rawlence NJ, 2009, P ROY SOC B-BIOL SCI, V276, P3395, DOI 10.1098/rspb.2009.0755; Roeder AD, 2009, FORENSIC SCI INT-GEN, V3, P128, DOI 10.1016/j.fsigen.2008.12.004; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santana QC, 2009, BIOTECHNIQUES, V46, P217, DOI 10.2144/000113085; Sefc KM, 2003, AUK, V120, P982, DOI 10.1642/0004-8038(2003)120[0982:MAFMFS]2.0.CO;2; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tang B, 2003, GENOME, V46, P833, DOI [10.1139/g03-059, 10.1139/G03-059]; Taylor EL, 1999, MOL ECOL, V8, P1963, DOI 10.1046/j.1365-294x.1999.00778-4.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Oosterhout C, 2006, MOL ECOL NOTES, V6, P255, DOI 10.1111/j.1471-8286.2005.01082.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Ward WK, 1998, ANIM GENET, V29, P331; Wattier R, 1998, MOL ECOL, V7, P1569, DOI 10.1046/j.1365-294x.1998.00477.x; Whitehouse AM, 2001, MOL ECOL, V10, P2139, DOI 10.1046/j.0962-1083.2001.01356.x; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wood JR, 2008, QUATERNARY SCI REV, V27, P2593, DOI 10.1016/j.quascirev.2008.09.019; Wood Jamie R., 2008, Journal of Taphonomy, V6, P1; Worthy TH, 1996, J ROY SOC NEW ZEAL, V26, P275, DOI 10.1080/03014223.1996.9517514; WORTHY TH, 2002, LOST WORLD MOA; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2	59	39	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16670	10.1371/journal.pone.0016670	http://dx.doi.org/10.1371/journal.pone.0016670			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304955	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300115
J	Pecoraro, V; Zerulla, K; Lange, C; Soppa, J				Pecoraro, Vito; Zerulla, Karolin; Lange, Christian; Soppa, Joerg			Quantification of Ploidy in Proteobacteria Revealed the Existence of Monoploid, (Mero-)Oligoploid and Polyploid Species	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELL-CYCLE; REPLICATION; CHROMOSOME; RADIATION; GROWTH; GENE	Bacteria are generally assumed to be monoploid (haploid). This assumption is mainly based on generalization of the results obtained with the most intensely studied model bacterium, Escherichia coli (a gamma-proteobacterium), which is monoploid during very slow growth. However, several species of proteobacteria are oligo- or polyploid, respectively. To get a better overview of the distribution of ploidy levels, genome copy numbers were quantified in four species of three different groups of proteobacteria. A recently developed Real Time PCR approach, which had been used to determine the ploidy levels of halophilic archaea, was optimized for the quantification of genome copy numbers of bacteria. Slow-growing (doubling time 103 minutes) and fast-growing (doubling time 25 minutes) E. coli cultures were used as a positive control. The copy numbers of the origin and terminus region of the chromosome were determined and the results were in excellent agreement with published data. The approach was also used to determine the ploidy levels of Caulobacter crescentus (an alpha-proteobacterium) and Wolinella succinogenes (an epsilon-proteobacterium), both of which are monoploid. In contrast, Pseudomonas putida (a gamma-proteobacterium) contains 20 genome copies and is thus polyploid. A survey of the proteobacteria with experimentally-determined genome copy numbers revealed that only three to four of 11 species are monoploid and thus monoploidy is not typical for proteobacteria. The ploidy level is not conserved within the groups of proteobacteria, and there are no obvious correlations between the ploidy levels with other parameters like genome size, optimal growth temperature or mode of life.	[Pecoraro, Vito; Zerulla, Karolin; Lange, Christian; Soppa, Joerg] Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, Frankfurt, Germany	Goethe University Frankfurt	Pecoraro, V (corresponding author), Goethe Univ Frankfurt, Bioctr, Inst Mol Biosci, Frankfurt, Germany.	Soppa@bio.uni-frankfurt.de		Soppa, Jorg/0000-0002-6132-5840	German Research Council (DFG) [So264/16-1]	German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Council (DFG), Project So264/16-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLUND T, 1995, J BACTERIOL, V177, P6791, DOI 10.1128/jb.177.23.6791-6797.1995; BREMER H, 1996, ESCHERIA COLI SALMON; Breuert S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000092; Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; HELMSTETTER CH, 1996, ESCHERIA COLI SALMON; Hildenbrand C, 2011, J BACTERIOL, V193, P734, DOI 10.1128/JB.01016-10; Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004; Kern M, 2009, BBA-BIOENERGETICS, V1787, P646, DOI 10.1016/j.bbabio.2008.12.010; KITTEN T, 1992, GENETICS, V132, P311; Komaki K, 2000, INSECT BIOCHEM MOLEC, V30, P253, DOI 10.1016/S0965-1748(99)00125-3; KROGER A, 1994, CHROMATOFOCUSSING PR, P141; Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346; Mackwan RR, 2007, GENETICS, V176, P697, DOI 10.1534/genetics.106.069666; MALDONADO R, 1994, J BACTERIOL, V176, P3911, DOI 10.1128/JB.176.13.3911-3919.1994; MALDONADO R, 1992, GENETICS, V132, P869; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Nodop A, 2008, PLANT PHYSIOL, V147, P747, DOI 10.1104/pp.107.114058; POSTGATE JR, 1984, J GEN MICROBIOL, V130, P1597; Riddle NC, 2010, THEOR APPL GENET, V120, P341, DOI 10.1007/s00122-009-1113-3; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; SKARSTAD K, 1983, J BACTERIOL, V154, P656, DOI 10.1128/JB.154.2.656-662.1983; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Spence E, 2004, J BIOL CHEM, V279, P55792, DOI 10.1074/jbc.M411041200; Suh MH, 2000, GENETICA, V110, P101, DOI 10.1023/A:1017976920135; Takahama K, 2004, PLANT CELL PHYSIOL, V45, P333, DOI 10.1093/pcp/pch041; Thanbichler M, 2009, CURR OPIN MICROBIOL, V12, P715, DOI 10.1016/j.mib.2009.09.013; Tobiason DM, 2006, PLOS BIOL, V4, P1069, DOI 10.1371/journal.pbio.0040185; Tobiason DM, 2010, J BACTERIOL, V192, P2160, DOI 10.1128/JB.01593-09; Webb CD, 1998, MOL MICROBIOL, V28, P883, DOI 10.1046/j.1365-2958.1998.00808.x; Wolfe KH, 2001, NAT REV GENET, V2, P333, DOI 10.1038/35072009; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160	38	63	65	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16392	10.1371/journal.pone.0016392	http://dx.doi.org/10.1371/journal.pone.0016392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305010	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300060
J	Yang, Y; Dai, M; Wilson, TM; Omelchenko, I; Klimek, JE; Wilmarth, PA; David, LL; Nuttall, AL; Gillespie, PG; Shi, XR				Yang, Yue; Dai, Min; Wilson, Teresa M.; Omelchenko, Irina; Klimek, John E.; Wilmarth, Phillip A.; David, Larry L.; Nuttall, Alfred L.; Gillespie, Peter G.; Shi, Xiaorui			Na+/K+-ATPase alpha 1 Identified as an Abundant Protein in the Blood-Labyrinth Barrier That Plays an Essential Role in the Barrier Integrity	PLOS ONE			English	Article							COCHLEAR LATERAL WALL; TIGHT JUNCTION FORMATION; KIDNEY EPITHELIAL-CELLS; AMINO-ACID-SEQUENCE; QUIET-AGED GERBILS; STRIA VASCULARIS; NOISE EXPOSURE; KINASE-C; OCCLUDIN PHOSPHORYLATION; NA,K-ATPASE ACTIVITY	Background: The endothelial-blood/tissue barrier is critical for maintaining tissue homeostasis. The ear harbors a unique endothelial-blood/tissue barrier which we term "blood-labyrinth-barrier". This barrier is critical for maintaining inner ear homeostasis. Disruption of the blood-labyrinth-barrier is closely associated with a number of hearing disorders. Many proteins of the blood-brain-barrier and blood-retinal-barrier have been identified, leading to significant advances in understanding their tissue specific functions. In contrast, capillaries in the ear are small in volume and anatomically complex. This presents a challenge for protein analysis studies, which has resulted in limited knowledge of the molecular and functional components of the blood-labyrinth-barrier. In this study, we developed a novel method for isolation of the stria vascularis capillary from CBA/CaJ mouse cochlea and provided the first database of protein components in the blood-labyrinth barrier as well as evidence that the interaction of Na+/K+-ATPase alpha 1 (ATP1A1) with protein kinase C eta (PKC eta) and occludin is one of the mechanisms of loud sound-induced vascular permeability increase. Methodology/Principal Findings: Using a mass-spectrometry, shotgun-proteomics approach combined with a novel "sandwich-dissociation" method, more than 600 proteins from isolated stria vascularis capillaries were identified from adult CBA/CaJ mouse cochlea. The ion transporter ATP1A1 was the most abundant protein in the blood-labyrinth barrier. Pharmacological inhibition of ATP1A1 activity resulted in hyperphosphorylation of tight junction proteins such as occludin which increased the blood-labyrinth-barrier permeability. PKC eta directly interacted with ATP1A1 and was an essential mediator of ATP1A1-initiated occludin phosphorylation. Moreover, this identified signaling pathway was involved in the breakdown of the blood-labyrinth-barrier resulting from loud sound trauma. Conclusions/Significance: The results presented here provide a novel method for capillary isolation from the inner ear and the first database on protein components in the blood-labyrinth-barrier. Additionally, we found that ATP1A1 interaction with PKC eta and occludin was involved in the integrity of the blood-labyrinth-barrier.	[Yang, Yue; Dai, Min; Wilson, Teresa M.; Omelchenko, Irina; Nuttall, Alfred L.; Gillespie, Peter G.; Shi, Xiaorui] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA; [Nuttall, Alfred L.; Shi, Xiaorui] Shanghai Jiao Tong Univ, Renji Hosp, Dept Otolaryngol, Shanghai 200030, Peoples R China; [Shi, Xiaorui] Chinese Acad Med Sci, Inst Microcirculat, Beijing 100037, Peoples R China; [Shi, Xiaorui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; University of Michigan System; University of Michigan; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Oregon Health & Science University	Yang, Y (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	shix@ohsu.edu	Dai, Min/B-9908-2012	Barr-Gillespie, Peter/0000-0002-9787-5860	National Institutes of Health [R03-DC008888, R01-NIDCD DC010844, R01-DC000105, P30-DC005983]; Oregon Opportunity funds; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000105, R01DC010844, R03DC008888, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Opportunity funds; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants R03-DC008888 (X.S.), R01-NIDCD DC010844 (X.S.), R01-DC000105 (A.L.N.), P30-DC005983, and Oregon Opportunity funds to the Oregon Health & Science University Proteomics Shared Resource. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETZ WJ, 1980, NATURE, V287, P235, DOI 10.1038/287235a0; Calabria AR, 2006, DRUG DISCOV TODAY, V11, P792, DOI 10.1016/j.drudis.2006.07.006; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Clifford RE, 2009, ANN OTO RHINOL LARYN, V118, P417, DOI 10.1177/000348940911800604; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; DOI K, 1992, ACTA OTO-LARYNGOL, V112, P667, DOI 10.3109/00016489209137457; Durr E, 2004, NAT BIOTECHNOL, V22, P985, DOI 10.1038/nbt993; EISENBERG HM, 1979, SCIENCE, V206, P1083, DOI 10.1126/science.227060; Fechter LD, 2007, TOXICOL SCI, V98, P510, DOI 10.1093/toxsci/kfm101; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GRATTON MA, 1995, HEARING RES, V82, P44; GRATTON MA, 1995, HEARING RES, V83, P43, DOI 10.1016/0378-5955(94)00188-V; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hirose K, 2003, JARO, V4, P339, DOI 10.1007/s10162-002-3036-4; Hsu CJ, 2000, HEARING RES, V142, P203, DOI 10.1016/S0378-5955(00)00020-4; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Juhn S K, 2001, Int Tinnitus J, V7, P72; JUHN SK, 1981, ACTA OTO-LARYNGOL, V91, P529, DOI 10.3109/00016488109138538; Klein M, 2008, INFECTION, V36, P2, DOI 10.1007/s15010-007-7153-1; Lamm K, 1996, Audiol Neurootol, V1, P148; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Lin DW, 1997, OTOLARYNG HEAD NECK, V117, P530, DOI 10.1016/S0194-5998(97)70026-3; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; McFadden Sandra L., 2001, Noise Health, V3, P49; Minami SB, 2007, BRAIN RES, V1148, P83, DOI 10.1016/j.brainres.2007.02.021; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Motoyama A, 2008, ANAL CHEM, V80, P7187, DOI 10.1021/ac8013669; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Musch MW, 2006, AM J PHYSIOL-GASTR L, V290, pG222, DOI 10.1152/ajpgi.00301.2005; Muto S, 2000, KIDNEY INT, V57, P1617, DOI 10.1046/j.1523-1755.2000.00006.x; Nuttall Alfred L., 1999, Noise Health, V2, P17; Ohlemiller KK, 2008, HEARING RES, V245, P5, DOI 10.1016/j.heares.2008.08.007; OSADA S, 1990, J BIOL CHEM, V265, P22434; Pottiez G, 2009, BRAIN RES REV, V62, P83, DOI 10.1016/j.brainresrev.2009.09.004; Rajasekaran AK, 2003, ANN NY ACAD SCI, V986, P649, DOI 10.1111/j.1749-6632.2003.tb07276.x; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2007, AM J PHYSIOL-GASTR L, V292, pG124, DOI 10.1152/ajpgi.00297.2006; SANTI PA, 1978, OTOLARYNG HEAD NECK, V86, P354, DOI 10.1177/019459987808600229; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shi XR, 2009, AM J PATHOL, V174, P1692, DOI 10.2353/ajpath.2009.080739; SHULL GE, 1986, NATURE, V321, P429, DOI 10.1038/321429a0; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; Skou JC, 2004, BIOSCIENCE REP, V24, P436, DOI 10.1007/s10540-005-2740-9; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Stockwin LH, 2006, J PROTEOME RES, V5, P2996, DOI 10.1021/pr0601739; STUART RO, 1995, P NATL ACAD SCI USA, V92, P6072, DOI 10.1073/pnas.92.13.6072; Suzuki M, 2002, HEARING RES, V164, P12, DOI 10.1016/S0378-5955(01)00397-5; Suzuki T, 2009, P NATL ACAD SCI USA, V106, P61, DOI 10.1073/pnas.0802741106; Takeuchi S, 2001, HEARING RES, V155, P103, DOI 10.1016/S0378-5955(01)00252-0; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x	55	88	98	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16547	10.1371/journal.pone.0016547	http://dx.doi.org/10.1371/journal.pone.0016547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304972	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300082
J	Ding, H; Tsai, CG; Gutierrez, RA; Zhou, F; Buchy, P; Deubel, V; Zhou, P				Ding, Heng; Tsai, Cheguo; Gutierrez, Ramona Alikiiteaga; Zhou, Fan; Buchy, Philippe; Deubel, Vincent; Zhou, Paul			Superior Neutralizing Antibody Response and Protection in Mice Vaccinated with Heterologous DNA Prime and Virus Like Particle Boost against HPAI H5N1 Virus	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; LETHAL CHALLENGE; GENE DELIVERY; A VIRUS; IMMUNOGENICITY; IMMUNITY; FERRETS; VECTOR; SAFETY; IMMUNIZATION	Background: Although DNA plasmid and virus-like particle (VLP) vaccines have been individually tested against highly pathogenic avian influenza (HPAI) H5N1 viruses, the combination of both vaccines into a heterologous prime-boost strategy against HPAI H5N1 viruses has not been reported before. Methodology/Principal Findings: We constructed DNA plasmid encoding H5HA (A/Shenzhen/406H/06, subclade 2.3.4) and generated VLP expressing the same H5HA and N1NA. We then compared neutralizing antibody responses and immune protection elicited with heterologous DNA-VLP, homologous DNA-DNA and VLP-VLP prime-boost strategies against HPAI H5N1 viruses in mice. We demonstrate that DNA-VLP elicits the highest neutralizing antibody titers among the three prime-boost strategies, whereas DNA-DNA elicits higher neutralizing antibody titers than VLP-VLP. We show that although all three prime-boost strategies protect mice from death caused by 10 MLD50 of homologous and heterologous H5N1 challenge, only DNA-VLP and DNA-DNA protect mice from infection as manifested by no weight loss and no lung pathology. In addition, we show that although DNA-VLP and DNA-DNA protect mice from death caused by 1,000 MLD50 of homologous H5N1 challenge, only DNA-VLP protects mice from infection. Moreover, we show that after 1,000 MLD50 of heterologous H5N1 challenge, while all mice in PBS, VLP-VLP and DNA-DNA died, 3 of 6 mice in DNA-VLP actually survived. Finally, we show that DNA-VLP completely protects mice from infection after 1,000 MLD50 of homologous H5N1 challenge even when the challenge was administrated at 60 days post the boost. Conclusions/Significance: These results provide strong support for clinical evaluation of heterologous DNA-VLP prime-boost strategy as a public health intervention against a possible H5N1 pandemic.	[Ding, Heng; Tsai, Cheguo; Zhou, Fan; Zhou, Paul] Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Gutierrez, Ramona Alikiiteaga; Buchy, Philippe; Deubel, Vincent] Inst Pasteur Cambodia, Phnom Penh, Cambodia	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Ding, H (corresponding author), Chinese Acad Sci, Unit Antiviral Immun & Genet Therapy, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	blzhou@sibs.ac.cn	Cai, Cheguo/K-3747-2019	Zhou, Fan/0000-0001-9918-3422; BUCHY, Philippe/0000-0003-1372-3008	French Ministry of Health; Chinese National Science Foundation [30671922]; National Science and Technology Major Projects [2008ZX10001-010, 2009ZX10004-105, 2009ZX10004-016]; Li Ka-Shing Foundation of Hong Kong; EC (RIVERS)	French Ministry of Health; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects; Li Ka-Shing Foundation of Hong Kong; EC (RIVERS)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by research grants from the French Ministry of Health, the Chinese National Science Foundation (#30671922), National Science and Technology Major Projects (#2008ZX10001-010; #2009ZX10004-105; #2009ZX10004-016), the Li Ka-Shing Foundation of Hong Kong and the EC (RIVERS). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Bot Adrian, 1997, Frontiers in Bioscience (online), V2, pD173; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bublot M, 2007, AVIAN DIS, V51, P498, DOI 10.1637/7624-042706R.1; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Bukreyev A, 2005, J VIROL, V79, P13275, DOI 10.1128/JVI.79.21.13275-13284.2005; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen MW, 2008, P NATL ACAD SCI USA, V105, P13538, DOI 10.1073/pnas.0806901105; Crevar CJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-131; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Gonzalez-Fernandez A, 1998, IMMUNOLOGY, V93, P149; Gutierrez RA, 2009, VIRUSES-BASEL, V1, P335, DOI 10.3390/v1030335; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; Ikeno D, 2009, VACCINE, V27, P3121, DOI 10.1016/j.vaccine.2009.01.007; Kang SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004667; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Lu XH, 2006, VACCINE, V24, P6588, DOI 10.1016/j.vaccine.2006.05.039; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Pan ZM, 2010, CLIN VACCINE IMMUNOL, V17, P518, DOI 10.1128/CVI.00387-09; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rao S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002432; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rimmelzwaan GF, 1999, VACCINE, V17, P1355, DOI 10.1016/S0264-410X(98)00390-9; Sabarth N, 2010, VACCINE, V28, P650, DOI 10.1016/j.vaccine.2009.10.105; Sharpe M, 2007, VACCINE, V25, P6392, DOI 10.1016/j.vaccine.2007.06.009; Smith GJD, 2006, P NATL ACAD SCI USA, V103, P16936, DOI 10.1073/pnas.0608157103; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Steensels M, 2009, VACCINE, V27, P646, DOI 10.1016/j.vaccine.2008.11.044; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Szecsi J, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-70; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tsai CG, 2009, VACCINE, V27, P6777, DOI 10.1016/j.vaccine.2009.08.056; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; World Health Organization, CUM NUMB CONF HUM CA; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	50	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16563	10.1371/journal.pone.0016563	http://dx.doi.org/10.1371/journal.pone.0016563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305045	Green Published, gold			2022-12-25	WOS:000286664100043
J	Fierro-Gonzalez, JC; Cornils, A; Alcedo, J; Miranda-Vizuete, A; Swoboda, P				Fierro-Gonzalez, Juan Carlos; Cornils, Astrid; Alcedo, Joy; Miranda-Vizuete, Antonio; Swoboda, Peter			The Thioredoxin TRX-1 Modulates the Function of the Insulin-Like Neuropeptide DAF-28 during Dauer Formation in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; SITE-DIRECTED MUTAGENESIS; C-ELEGANS; LARVAL DEVELOPMENT; LIFE-SPAN; CHEMOSENSORY NEURONS; GENETIC-ANALYSIS; LONGEVITY; EXPRESSION; HOMOLOG	Thioredoxins comprise a conserved family of redox regulators involved in many biological processes, including stress resistance and aging. We report that the C. elegans thioredoxin TRX-1 acts in ASJ head sensory neurons as a novel modulator of the insulin-like neuropeptide DAF-28 during dauer formation. We show that increased formation of stress-resistant, long-lived dauer larvae in mutants for the gene encoding the insulin-like neuropeptide DAF-28 requires TRX-1 acting in ASJ neurons, upstream of the insulin-like receptor DAF-2. Genetic rescue experiments demonstrate that redox-independent functions of TRX-1 specifically in ASJ neurons are needed for the dauer formation constitutive (Daf-c) phenotype of daf-28 mutants. GFP reporters of trx-1 and daf-28 show opposing expression patterns in dauers (i.e. trx-1 is up-regulated and daf-28 is down-regulated), an effect that is not observed in growing L2/L3 larvae. In addition, functional TRX-1 is required for the down-regulation of a GFP reporter of daf-28 during dauer formation, a process that is likely subject to DAF-28-mediated feedback regulation. Our findings demonstrate that TRX-1 modulates DAF-28 signaling by contributing to the down-regulation of daf-28 expression during dauer formation. We propose that TRX-1 acts as a fluctuating neuronal signaling modulator within ASJ neurons to monitor the adjustment of neuropeptide expression, including insulin-like proteins, during dauer formation in response to adverse environmental conditions.	[Fierro-Gonzalez, Juan Carlos; Swoboda, Peter] Karolinska Inst, Ctr Biosci NOVUM, Dept Biosci & Nutr, Huddinge, Sweden; [Cornils, Astrid; Alcedo, Joy] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Miranda-Vizuete, Antonio] Univ Pablo de Olavide, CABD CSIC, Dept Fisiol Anat & Biol Celular, Seville, Spain; [Miranda-Vizuete, Antonio] Univ Seville, Consejo Super Invest Cient, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, Seville, Spain	Karolinska Institutet; Friedrich Miescher Institute for Biomedical Research; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Fierro-Gonzalez, JC (corresponding author), Karolinska Inst, Ctr Biosci NOVUM, Dept Biosci & Nutr, Huddinge, Sweden.	amirviz@upo.es; peter.swoboda@ki.se	IBIS, REDOX/J-7473-2017; Fierro-González, Juan Carlos/F-8430-2010; IBIS, FISIOLOGIA/O-9485-2015; Miranda-Vizuete, Antonio/D-6927-2012	Fierro-González, Juan Carlos/0000-0003-4871-1621; Miranda-Vizuete, Antonio/0000-0002-6856-5396; Alcedo, Joy/0000-0002-5279-6640; Swoboda, Peter/0000-0001-6416-8572	Swedish Foundation for Strategic Research; Swedish Research Council; NordForsk Nordic C. elegans Network; Instituto de Salud Carlos III [PI050065, PI080557]; Fondo Social Europeo, FEDER; Junta de Andalucia [CVI-3629, CVI-2697]; Novartis Research Foundation	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); NordForsk Nordic C. elegans Network; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Social Europeo, FEDER(European Social Fund (ESF)European Commission); Junta de Andalucia(Junta de Andalucia); Novartis Research Foundation	This study was supported by grants from The Swedish Foundation for Strategic Research, The Swedish Research Council and The NordForsk Nordic C. elegans Network to PS; from Instituto de Salud Carlos III (Projects PI050065 and PI080557, co-financed by Fondo Social Europeo, FEDER) and Junta de Andalucia (Projects CVI-3629 and CVI-2697) to AMV; and from The Novartis Research Foundation to JA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMODT EJ, 1991, SCIENCE, V252, P579, DOI 10.1126/science.2020855; Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Berndt C, 2008, BBA-MOL CELL RES, V1783, P641, DOI 10.1016/j.bbamcr.2008.02.003; Birnby DA, 2000, GENETICS, V155, P85; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BRENNER S, 1974, GENETICS, V77, P71; Carroll BT, 2006, J BIOL CHEM, V281, P35989, DOI 10.1074/jbc.M606086200; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Edgley M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf051; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Hahm JH, 2009, AGING CELL, V8, P473, DOI 10.1111/j.1474-9726.2009.00495.x; Hu P.J., 2007, DAUER, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; HUBER HE, 1986, J BIOL CHEM, V261, P5006; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Jee C, 2005, GENES CELLS, V10, P1203, DOI 10.1111/j.1365-2443.2005.00913.x; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kell A, 2007, FREE RADICAL BIO MED, V43, P1560, DOI 10.1016/j.freeradbiomed.2007.08.025; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Li Chris, 2008, WormBook, P1, DOI 10.1895/wormbook.1.142.1; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; MALONE EA, 1994, GENETICS, V136, P879; Malone EA, 1996, GENETICS, V143, P1193; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Miranda-Vizuete A, 2006, FEBS LETT, V580, P484, DOI 10.1016/j.febslet.2005.12.046; MULLER EGD, 1995, ARCH BIOCHEM BIOPHYS, V318, P356, DOI 10.1006/abbi.1995.1240; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; PellicenaPalle A, 1997, MECH DEVELOP, V62, P61, DOI 10.1016/S0925-4773(96)00650-8; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; RUSSEL M, 1986, J BIOL CHEM, V261, P4997; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Stiernagle Theresa, 2006, WormBook, P1; SWANSON MM, 1981, DEV BIOL, V84, P27, DOI 10.1016/0012-1606(81)90367-5; TONISSEN K, 1993, J BIOL CHEM, V268, P22485; VOWELS JJ, 1992, GENETICS, V130, P105; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532	57	15	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16561	10.1371/journal.pone.0016561	http://dx.doi.org/10.1371/journal.pone.0016561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304598	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900071
J	Goh, WI; Sudhaharan, T; Lim, KB; Sem, KP; Lau, CL; Ahmed, S				Goh, Wah Ing; Sudhaharan, Thankiah; Lim, Kim Buay; Sem, Kai Ping; Lau, Chew Ling; Ahmed, Sohail			Rif-mDia1 Interaction Is Involved in Filopodium Formation Independent of Cdc42 and Rac Effectors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BUNDLING ACTIVITY; GTPASE RIF; MIGRATING CELLS; MEMBRANE; FORMINS; COMPLEX; MDIA1; CYTOSKELETON; WAVE; REORGANIZATION	Filopodia are cellular protrusions important for axon guidance, embryonic development, and wound healing. The Rho GTPase Cdc42 is the best studied inducer of filopodium formation, and several of its effectors and their interacting partners have been linked to the process. These include IRSp53, N-WASP, Mena, and Eps8. The Rho GTPase, Rif, also drives filopodium formation. The signaling pathway by which Rif induces filopodia is poorly understood, with mDia2 being the only protein implicated to date. It is thus not clear how distinct the Rif-driven pathway for filopodium formation is from the one mediated by Cdc42. In this study, we characterize the dynamics of Rif-induced filopodia by time lapse imaging of live neuronal cells and show that Rif drives filopodium formation via an independent pathway that does not involve the Cdc42 effectors N-WASP and IRSp53, the IRSp53 binding partner Mena, or the Rac effectors WAVE1 and WAVE2. Rif formed filopodia in the absence of N-WASP or Mena and when IRSp53, WAVE1, or WAVE2 was knocked down by RNAi. Rif-mediated filopodial protrusion was instead reduced by silencing mDial expression or overexpressing a dominant negative mutant of mDial. mDial on its own was able to form filopodia. Data from acceptor photobleaching FRET studies of protein-protein interaction demonstrate that Rif interacts directly with mDia1 in filopodia but not with mDia2. Taken together, these results suggest a novel pathway for filopodia formation via Rif and mDial.	[Goh, Wah Ing; Sudhaharan, Thankiah; Lim, Kim Buay; Sem, Kai Ping; Lau, Chew Ling; Ahmed, Sohail] Inst Med Biol, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Goh, Wah Ing/0000-0001-6594-0640				Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; Arakawa Y, 2003, J CELL BIOL, V161, P381, DOI 10.1083/jcb.200210149; Beli P, 2008, NAT CELL BIOL, V10, P849, DOI 10.1038/ncb1745; Berger CN, 2009, CELL MICROBIOL, V11, P309, DOI 10.1111/j.1462-5822.2008.01254.x; Biyasheva A, 2004, J CELL SCI, V117, P837, DOI 10.1242/jcs.00921; Bu WY, 2009, J BIOL CHEM, V284, P11622, DOI 10.1074/jbc.M805940200; Carlier MF, 1999, CHEM BIOL, V6, pR235, DOI 10.1016/S1074-5521(99)80107-0; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Dixit R, 2008, NEUROSCI LETT, V440, P113, DOI 10.1016/j.neulet.2008.05.031; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Ellis S, 2000, CURR BIOL, V10, P1387, DOI 10.1016/S0960-9822(00)00777-6; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fan LF, 2010, J CELL SCI, V123, P1247, DOI 10.1242/jcs.061754; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fujiwara T, 2000, BIOCHEM BIOPH RES CO, V271, P626, DOI 10.1006/bbrc.2000.2671; Gad AKB, 2010, CELL SIGNAL, V22, P183, DOI 10.1016/j.cellsig.2009.10.001; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Harris ES, 2006, J BIOL CHEM, V281, P14383, DOI 10.1074/jbc.M510923200; He LS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni057; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Ishizaki T, 2001, NAT CELL BIOL, V3, P8; Kashiwagi H, 2005, J THROMB HAEMOST, V3, P361, DOI 10.1111/j.1538-7836.2004.01082.x; Kim HJ, 2006, J NEUROSCI, V26, P5849, DOI 10.1523/JNEUROSCI.4921-05.2006; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Loitto VM, 2007, EXP CELL RES, V313, P1295, DOI 10.1016/j.yexcr.2007.01.023; Machesky LM, 2008, FEBS LETT, V582, P2102, DOI 10.1016/j.febslet.2008.03.039; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McCroskery S, 2006, MOL CELL NEUROSCI, V33, P15, DOI 10.1016/j.mcn.2006.06.004; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Radha V, 2007, EXP CELL RES, V313, P2476, DOI 10.1016/j.yexcr.2007.03.019; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wood W, 2002, INT J BIOCHEM CELL B, V34, P726, DOI 10.1016/S1357-2725(01)00172-8; Woodring PJ, 2004, J CELL BIOL, V165, P493, DOI 10.1083/jcb.200312171; Xie Y, 2008, J CELL SCI, V121, P514, DOI 10.1242/jcs.013557; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yang CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005678; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	66	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13681	13694		10.1074/jbc.M110.182683	http://dx.doi.org/10.1074/jbc.M110.182683			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339294	Green Published, hybrid			2022-12-25	WOS:000289282200086
J	Ruiz, PA; Jarai, G				Ruiz, Pedro A.; Jarai, Gabor			Collagen I Induces Discoidin Domain Receptor (DDR) 1 Expression through DDR2 and a JAK2-ERK1/2-mediated Mechanism in Primary Human Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE EXPRESSION; TO-MESENCHYMAL TRANSITION; HEPATIC STELLATE CELLS; EXTRACELLULAR-MATRIX; STROMELYSIN-2 MMP-10; TYROSINE KINASES; BETA(1) INTEGRIN; GROWTH-FACTORS; 2 ACTIVATION; MIGRATION	Discoidin domain receptors (DDRs) DDR1 and DDR2 are receptor tyrosine kinases with the unique ability among receptor tyrosine kinases to respond to collagen. Several signaling molecules have been implicated in DDR signaling, including Shp-2, Src, and MAPK pathways, but a detailed understanding of these pathways and their transcriptional targets is still lacking. Similarly, the regulation of the expression of DDRs is poorly characterized with only a few inflammatory mediators, such as lipopolysaccharide and interleukin-1 beta identified as playing a role in DDR1 expression. DDRs have been reported to induce the expression of various genes including matrix metalloproteinases and bone morphogenetic proteins, but the regulatory mechanisms underlying DDR-induced gene expression remain to be determined. The aim of the present work was to elucidate the molecular mechanisms implicated in the expression of DDRs and to identify DDR-induced signaling pathways and target genes. Our data show that collagen I induces the expression of DDR1 in a dose- and time-dependent manner in primary human lung fibroblasts. Furthermore, activation of DDR2, JAK2, and ERK1/2 MAPK signaling pathways was essential for collagen I-induced DDR1 and matrix metalloproteinase 10 expression. Finally, inhibition of the ERK1/2 pathway abrogated DDR1 expression by blocking the recruitment of the transcription factor polyoma enhancer A-binding protein 3 to the DDR1 promoter. Our data provide new insights into the molecular mechanisms of collagen I-induced DDR1 expression and demonstrate an important role for ERK1/2 activation and the recruitment of polyoma enhancer-A binding protein 3 to the DDR1 promoter.	[Ruiz, Pedro A.; Jarai, Gabor] Novartis Inst Biomed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England	Novartis	Jarai, G (corresponding author), Novartis Inst Biomed Res, Resp Dis Area, Wirnblehurst Rd, Horsham RH12 5AB, W Sussex, England.	gabor.jarai@novartis.com		Ruiz-Castro, Pedro Antonio/0000-0001-7528-1474	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	This work was supported by the Postdoctoral Program of the Novartis Institutes for Biomedical Research.	ALVES F, 1995, ONCOGENE, V10, P609; Avivi-Green C, 2006, AM J RESP CRIT CARE, V174, P420, DOI 10.1164/rccm.200603-333OC; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Chen SC, 2008, BIOCHEM BIOPH RES CO, V374, P662, DOI 10.1016/j.bbrc.2008.07.092; Chin GS, 2001, PLAST RECONSTR SURG, V107, P769, DOI 10.1097/00006534-200103000-00018; Choi M, 2008, TOXICOL LETT, V182, P97, DOI 10.1016/j.toxlet.2008.08.019; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; Faraci E, 2003, MATRIX BIOL, V22, P373, DOI 10.1016/S0945-053X(03)00053-2; Faraci-Orf E, 2006, J CELL BIOCHEM, V97, P109, DOI 10.1002/jcb.20618; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Gilles C, 1998, CANCER RES, V58, P5529; Goetze S, 2001, ATHEROSCLEROSIS, V159, P93, DOI 10.1016/S0021-9150(01)00497-X; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Hou GP, 2002, CIRC RES, V90, P1147, DOI 10.1161/01.RES.0000022166.74073.F8; Ikeda K, 2002, J BIOL CHEM, V277, P19206, DOI 10.1074/jbc.M201078200; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Kerkela E, 2001, BRIT J CANCER, V84, P659, DOI 10.1054/bjoc.2000.1634; Koo DHH, 2006, FEBS LETT, V580, P15, DOI 10.1016/j.febslet.2005.11.035; Krampert M, 2004, MOL BIOL CELL, V15, P5242, DOI 10.1091/mbc.E04-02-0109; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; Madlener M, 1996, BIOCHEM J, V320, P659, DOI 10.1042/bj3200659; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Nelson AR, 2000, J CLIN ONCOL, V18, P1135, DOI 10.1200/JCO.2000.18.5.1135; Olaso E, 2002, J BIOL CHEM, V277, P3606, DOI 10.1074/jbc.M107571200; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Schnabl B, 2005, BIOCHEM BIOPH RES CO, V335, P87, DOI 10.1016/j.bbrc.2005.07.043; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; SELTZER JL, 1994, EXP CELL RES, V213, P365, DOI 10.1006/excr.1994.1211; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; SMITH RE, 1995, J LEUKOCYTE BIOL, V57, P782, DOI 10.1002/jlb.57.5.782; Su J, 2009, MOL CELL BIOCHEM, V330, P141, DOI 10.1007/s11010-009-0127-0; Theret N, 1999, HEPATOLOGY, V30, P462, DOI 10.1002/hep.510300236; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wahab NA, 2006, NEPHRON EXP NEPHROL, V104, pE129, DOI 10.1159/000094963; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wilkins JA, 1996, J BIOL CHEM, V271, P3046, DOI 10.1074/jbc.271.6.3046; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang K, 2005, J BIOL CHEM, V280, P39058, DOI 10.1074/jbc.M506921200; Yoshimura T, 2005, IMMUNOL RES, V31, P219, DOI 10.1385/IR:31:3:219	57	48	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12912	12923		10.1074/jbc.M110.143693	http://dx.doi.org/10.1074/jbc.M110.143693			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335558	Green Published, hybrid			2022-12-25	WOS:000289282200011
J	Plasencia, I; Survery, S; Ibragimova, S; Hansen, JS; Kjellbom, P; Helix-Nielsen, C; Johanson, U; Mouritsen, OG				Plasencia, Ines; Survery, Sabeen; Ibragimova, Sania; Hansen, Jesper S.; Kjellbom, Per; Helix-Nielsen, Claus; Johanson, Urban; Mouritsen, Ole G.			Structure and Stability of the Spinach Aquaporin SoPIP2;1 in Detergent Micelles and Lipid Membranes	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; WATER CHANNEL PROTEIN; LENS FIBER MEMBRANES; ESCHERICHIA-COLI; MIP FAMILY; GLYCEROL FACILITATOR; ELECTRON-MICROSCOPY; SECONDARY STRUCTURE; BILAYER MEMBRANES; FREEZE-FRACTURE	Background: SoPIP2;1 constitutes one of the major integral proteins in spinach leaf plasma membranes and belongs to the aquaporin family. SoPIP2;1 is a highly permeable and selective water channel that has been successfully overexpressed and purified with high yields. In order to optimize reconstitution of the purified protein into biomimetic systems, we have here for the first time characterized the structural stability of SoPIP2;1. Methodology/Principal Finding: We have characterized the protein structural stability after purification and after reconstitution into detergent micelles and proteoliposomes using circular dichroism and fluorescence spectroscopy techniques. The structure of SoPIP2;1 was analyzed either with the protein solubilized with octyl-beta-D-glucopyranoside (OG) or reconstituted into lipid membranes formed by E. coli lipids, diphytanoylphosphatidylcholine (DPhPC), or reconstituted into lipid membranes formed from mixtures of 1-palmitoyl-2-oleoyl-phosphatidylcholine (POPE), 1-palmitoyl-2-oleoyl-phosphatidylethanolamine (POPE), 1-palmitoyl-2-oleoyl-phosphatidylserine (POPS), and ergosterol. Generally, SoPIP2;1 secondary structure was found to be predominantly a-helical in accordance with crystallographic data. The protein has a high thermal structural stability in detergent solutions, with an irreversible thermal unfolding occurring at a melting temperature of 58 degrees C. Incorporation of the protein into lipid membranes increases the structural stability as evidenced by an increased melting temperature of up to 70 degrees C. Conclusion/Significance: The results of this study provide insights into SoPIP2;1 stability in various host membranes and suggest suitable choices of detergent and lipid composition for reconstitution of SoPIP2;1 into biomimetic membranes for biotechnological applications.	[Plasencia, Ines; Mouritsen, Ole G.] Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark; [Survery, Sabeen; Kjellbom, Per; Johanson, Urban] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Ibragimova, Sania; Helix-Nielsen, Claus] Tech Univ Denmark, DTU Phys, DK-2800 Lyngby, Denmark; [Hansen, Jesper S.] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark; [Ibragimova, Sania; Hansen, Jesper S.; Helix-Nielsen, Claus] Aquaporin AS, Copenhagen, Denmark	University of Southern Denmark; Lund University; Technical University of Denmark; Technical University of Denmark	Plasencia, I (corresponding author), Univ So Denmark, Dept Chem & Phys, MEMPHYS Ctr Biomembrane Phys, Odense, Denmark.	miplsen@memphys.sdu.dk	Helix-Nielsen, Claus/A-5979-2011; Johanson, Urban/D-4344-2015; Hélix-Nielsen, Claus/N-1054-2019; Johanson, Urban/AHE-8231-2022	Johanson, Urban/0000-0001-8862-128X; Hélix-Nielsen, Claus/0000-0002-9392-7133; Johanson, Urban/0000-0001-8862-128X; Survery, Sabeen/0000-0001-6740-5430; Mouritsen, Ole G./0000-0002-4258-8960; Hansen, Jesper Soendergaard/0000-0003-1638-1285	Sixth European Research Framework Programme [NMP4-CT-2006-033234]; Danish National Advanced Technology Foundation (Industrial biomimetic water membranes) [023-2007-1]; Danish National Research Foundation; Formas and the Swedish Research Council (VR)	Sixth European Research Framework Programme; Danish National Advanced Technology Foundation (Industrial biomimetic water membranes); Danish National Research Foundation(Danmarks Grundforskningsfond); Formas and the Swedish Research Council (VR)(Swedish Research Council)	This study has been undertaken in the MEMBAQ project ( Incorporation of Aquaporins in Membranes for Industrial Applications) supported by the Sixth European Research Framework Programme under contract [NMP4-CT-2006-033234] and the Danish National Advanced Technology Foundation (Industrial biomimetic water membranes) under contract [023-2007-1]. MEMPHYS-Center for Biomembrane Physics is supported by the Danish National Research Foundation. Financial support was also provided by Formas and the Swedish Research Council (VR). The funding agencies had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AERTS T, 1990, J BIOL CHEM, V265, P8675; Baba T, 1999, BBA-BIOMEMBRANES, V1421, P91, DOI 10.1016/S0005-2736(99)00114-5; BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7; BEURON F, 1995, J BIOL CHEM, V270, P17414, DOI 10.1074/jbc.270.29.17414; Biela A, 1999, PLANT J, V18, P565, DOI 10.1046/j.1365-313X.1999.00474.x; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Bron P, 1999, J STRUCT BIOL, V128, P287, DOI 10.1006/jsbi.1999.4196; Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Duchesne L, 2001, KIDNEY INT, V60, P422, DOI 10.1046/j.1523-1755.2001.060002422.x; Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800; Engel A, 2002, INT REV CYTOL, V215, P75; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Fraysse LC, 2005, BIOL CELL, V97, P519, DOI 10.1042/BC20040122; Galka JJ, 2008, BIOCHEMISTRY-US, V47, P3513, DOI 10.1021/bi7021409; Gaspar M, 2003, PLANT SCI, V165, P21, DOI 10.1016/S0168-9452(03)00117-1; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JANKO K, 1977, BIOCHIM BIOPHYS ACTA, V470, P8, DOI 10.1016/0005-2736(77)90057-8; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; KAMMERLOHER W, 1994, PLANT J, V6, P187, DOI 10.1046/j.1365-313X.1994.6020187.x; Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6; Konig N, 1997, J MOL BIOL, V265, P590, DOI 10.1006/jmbi.1996.0763; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDSEY H, 1979, BIOCHIM BIOPHYS ACTA, V555, P147, DOI 10.1016/0005-2736(79)90079-8; Manley DM, 2000, BIOCHEMISTRY-US, V39, P12303, DOI 10.1021/bi000703t; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nielsen CH, 2009, ANAL BIOANAL CHEM, V395, P697, DOI 10.1007/s00216-009-2960-0; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1994, J BIOL CHEM, V269, P1668; RAND RP, 1986, ANNU REV PHYSIOL, V48, P201; Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9; Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sehgal P, 2005, BBA-BIOMEMBRANES, V1716, P59, DOI 10.1016/j.bbamem.2005.08.006; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Stahlberg H, 2000, J STRUCT BIOL, V132, P133, DOI 10.1006/jsbi.2000.4317; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pD593, DOI 10.1093/nar/gkh077; Woodbury D J, 1999, Methods Enzymol, V294, P319; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134	50	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e14674	10.1371/journal.pone.0014674	http://dx.doi.org/10.1371/journal.pone.0014674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339815	Green Published, Green Submitted, gold			2022-12-25	WOS:000287367600005
J	Zappettini, S; Grilli, M; Lagomarsino, F; Cavallero, A; Fedele, E; Marchi, M				Zappettini, Stefania; Grilli, Massimo; Lagomarsino, Federica; Cavallero, Anna; Fedele, Ernesto; Marchi, Mario			Presynaptic Nicotinic alpha 7 and Non-alpha 7 Receptors Stimulate Endogenous GABA Release from Rat Hippocampal Synaptosomes through Two Mechanisms of Action	PLOS ONE			English	Article							SUBUNIT MESSENGER-RNAS; MOUSE-BRAIN SYNAPTOSOMES; CENTRAL-NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTORS; SYNAPTIC-TRANSMISSION; STRIATAL SYNAPTOSOMES; DOPAMINE RELEASE; SELECTIVE LIGAND; ACH RECEPTORS; ACID RELEASE	Background: Although converging evidence has suggested that nicotinic acetylcholine receptors (nAChR) play a role in the modulation of GABA release in rat hippocampus, the specific involvement of different nAChR subtypes at presynaptic level is still a matter of debate. In the present work we investigated, using selective alpha 7 and alpha 4 beta 2 nAChR agonists, the presence of different nAChR subtypes on hippocampal GABA nerve endings to assess to what extent and through which mechanisms they stimulate endogenous GABA release. Methodology/Findings: All agonists elicited GABA overflow. Choline (Ch)-evoked GABA overflow was dependent to external Ca2+, but unaltered in the presence of Cd2+, tetrodotoxin (TTX), dihydro-b-erythroidine (DH beta E) and 1-(4,4-Diphenyl-3- butenyl)-3-piperidinecarboxylic acid hydrochloride SKF 89976A. The effect of Ch was blocked by methyllycaconitine (MLA), alpha-bungarotoxin (alpha-BTX), dantrolene, thapsigargin and xestospongin C, suggesting that GABA release might be triggered by Ca2+ entry into synaptosomes through the alpha 7 nAChR channel with the involvement of calcium from intracellular stores. Additionally, 5-Iodo-A-85380 dihydrochloride (5IA85380) elicited GABA overflow, which was Ca2+ dependent, blocked by Cd2+, and significantly inhibited by TTX and DH beta E, but unaffected by MLA, SKF 89976A, thapsigargin and xestospongin C and dantrolene. These findings confirm the involvement of alpha 4 beta 2 nAChR in 5IA85380-induced GABA release that seems to occur following membrane depolarization and opening calcium channels. Conclusions/Significance: Rat hippocampal synaptosomes possess both alpha 7 and alpha 4 beta 2 nAChR subtypes, which can modulate GABA release via two distinct mechanisms of action. The finding that GABA release evoked by the mixture of sub-maximal concentration of 5IA85380 plus sub-threshold concentrations of Ch was significantly larger than that elicited by the sum of the effects of the two agonists is compatible with the possibility that they coexist on the same nerve terminals. These findings would provide the basis for possible selective pharmacological strategies to treat neuronal disorders that involve the dysfunction of hippocampal cholinergic system.	[Zappettini, Stefania; Grilli, Massimo; Lagomarsino, Federica; Cavallero, Anna; Fedele, Ernesto; Marchi, Mario] Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy; [Fedele, Ernesto; Marchi, Mario] Univ Genoa, Ctr Excellence Biomed Res, Genoa, Italy; [Marchi, Mario] Natl Inst Neurosci, Genoa, Italy	University of Genoa; University of Genoa	Zappettini, S (corresponding author), Univ Genoa, Dept Expt Med, Sect Pharmacol & Toxicol, Genoa, Italy.	marchi@pharmatox.unige.it	marchi, mario/C-4237-2008; Grilli, Massimo/C-4217-2008; Fedele, Ernesto/K-4839-2015	Grilli, Massimo/0000-0003-1046-7897; Fedele, Ernesto/0000-0002-0386-0925; mario, marchi/0000-0003-0263-9070; Zappettini, PharmD, PhD, PMP, Stefania/0000-0002-1238-9573	Italian Ministero Universita Ricerca [Nu 20072BTSR2_002]; Compagnia di San Paolo; University of Genoa [ALCOTRA 2007-2013]	Italian Ministero Universita Ricerca(Ministry of Education, Universities and Research (MIUR)); Compagnia di San Paolo(Compagnia di San Paolo); University of Genoa	This work was supported by the Italian Ministero Universita Ricerca to Prof. Mario Marchi (prot. Nu 20072BTSR2_002), by Compagnia di San Paolo, and by University of Genoa 'Progetto Ricerca Ateneo'; project AROMA (ALCOTRA 2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2000, BEHAV BRAIN RES, V113, P131, DOI 10.1016/S0166-4328(00)00208-4; Alkondon M, 2000, EUR J PHARMACOL, V393, P59, DOI 10.1016/S0014-2999(00)00006-6; Alkondon M, 1999, J NEUROSCI, V19, P2693; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Arnaiz-Cot JJ, 2008, EUR J NEUROSCI, V27, P1097, DOI 10.1111/j.1460-9568.2008.06077.x; Azam L, 2003, NEUROSCIENCE, V119, P965, DOI 10.1016/S0306-4522(03)00220-3; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Bancila V, 2009, J NEUROCHEM, V110, P570, DOI 10.1111/j.1471-4159.2009.06169.x; Bencherif M, 1998, J PHARMACOL EXP THER, V284, P886; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dickinson JA, 2007, J NEUROCHEM, V100, P1089, DOI 10.1111/j.1471-4159.2006.04273.x; Fisher JL, 1998, J PHYSIOLOGY-PARIS, V92, P209, DOI 10.1016/S0928-4257(98)80012-0; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Grilli M, 2008, J NEUROCHEM, V105, P2205, DOI 10.1111/j.1471-4159.2008.05307.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo JZ, 2002, NEUROSCIENCE, V110, P505, DOI 10.1016/S0306-4522(01)00579-6; Henderson Z, 2005, J PHYSIOL-LONDON, V562, P165, DOI 10.1113/jphysiol.2004.070300; Kanno T, 2005, BIOCHEM BIOPH RES CO, V338, P742, DOI 10.1016/j.bbrc.2005.10.044; KHIROUGH SS, 2002, J PHYSL, P425; Le Magueresse C, 2006, J PHYSIOL-LONDON, V576, P533, DOI 10.1113/jphysiol.2006.117572; LENA C, 1993, J NEUROSCI, V13, P2680, DOI 10.1523/JNEUROSCI.13-06-02680.1993; Lendvai B, 2008, PHYSIOL REV, V88, P333, DOI 10.1152/physrev.00040.2006; Lu Y, 1998, J PHARMACOL EXP THER, V287, P648; Marchi M, 2010, PROG NEUROBIOL, V92, P105, DOI 10.1016/j.pneurobio.2010.06.004; MARKS MJ, 1995, J PHARMACOL EXP THER, V274, P833; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; Marshall D, 1996, NEUROPHARMACOLOGY, V35, P1531, DOI 10.1016/S0028-3908(96)00117-7; McClure-Begley TD, 2009, MOL PHARMACOL, V75, P918, DOI 10.1124/mol.108.052274; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Mogg AJ, 2004, NEUROPHARMACOLOGY, V47, P848, DOI 10.1016/j.neuropharm.2004.06.013; Mukhin AG, 2000, MOL PHARMACOL, V57, P642, DOI 10.1124/mol.57.3.642; NAKAMURA Y, 1993, GLIA, V9, P48, DOI 10.1002/glia.440090107; Parodi M, 2006, NEUROCHEM INT, V48, P138, DOI 10.1016/j.neuint.2005.08.010; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sershen H, 1997, NEUROSCIENCE, V77, P121, DOI 10.1016/S0306-4522(96)00425-3; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Soliakov L, 1996, J NEUROCHEM, V67, P163; SOLIAKOV L, 1995, NEUROPHARMACOLOGY, V34, P1535, DOI 10.1016/0028-3908(95)00122-M; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Sudweeks SN, 2000, J PHYSIOL-LONDON, V527, P515, DOI 10.1111/j.1469-7793.2000.00515.x; Vizi ES, 1999, BRAIN RES REV, V30, P219, DOI 10.1016/S0165-0173(99)00016-8; VIZI ES, 1995, ANN NY ACAD SCI, V757, P84, DOI 10.1111/j.1749-6632.1995.tb17466.x; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; WONNACOTT S, 1989, PROG BRAIN RES, V79, P157	50	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16911	10.1371/journal.pone.0016911	http://dx.doi.org/10.1371/journal.pone.0016911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346795	gold, Green Submitted, Green Published			2022-12-25	WOS:000287077600033
J	Akiyama, H; Misawa, T; Ono, M; Uchida, C; Uchida, T				Akiyama, Hirotada; Misawa, Takuma; Ono, Masao; Uchida, Chiyoko; Uchida, Takafumi			Prolyl Isomerase Pin1 Protects Mice from Endotoxin Shock	PLOS ONE			English	Article							EXPRESSION; BINDING; GENE; PHOSPHORYLATION; MACROPHAGES; MECHANISMS; DISEASE; STAT3	Background: Prolyl isomerase Pin1 may be involved in innate immunity against microbial infection, but the mechanism how Pin1 controls the innate immunity is poorly understood. Methodology/Principal Findings: Injection of lipopolysaccharide (LPS) into the mice induces inflammatory pulmonary disorder and sometimes the serious damages lead to death. Comparing to the wild-type (WT) mice, the Pin1(-/-) mice showed more serious damages in lung and the lower survival rate after the LPS injection. We compared the levels of typical inflammatory cytokines. Pin1(-/-) mice overreacted to the LPS injection to produce inflammatory cytokines, especially IL-6 more than WT mice. We showed that Pin1 binds phosphorylated PU. 1 and they localize together in a nucleus. These results suggest that Pin1 controls the transcriptional activity of PU. 1 and suppresses overreaction of macrophage that causes serious damages in lung. Conclusions/Significance: Pin1 may protect the mice from serious inflammation by LPS injection by attenuating the increase of IL-6 transcription of the mouse macrophages.	[Akiyama, Hirotada; Misawa, Takuma; Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 980, Japan; [Ono, Masao] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 980, Japan; [Uchida, Chiyoko; Uchida, Takafumi] Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Akiyama, H (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Sci, Sendai, Miyagi 980, Japan.	uchidat@biochem.tohoku.ac.jp		Uchida, Takafumi/0000-0003-3665-4906	Ministry of Education, Culture, Sports, Science and Technology of Japan [20228006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Kiban S, No 20228006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; FREUNDLICH B, 1983, J IMMUNOL METHODS, V62, P31, DOI 10.1016/0022-1759(83)90107-2; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Hirotani T, 2005, J IMMUNOL, V174, P3650, DOI 10.4049/jimmunol.174.6.3650; Liu TZ, 2008, AM J PHYSIOL-CELL PH, V295, pC819, DOI 10.1152/ajpcell.00366.2007; Liu TZ, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-20; Liu WF, 2001, FEBS LETT, V496, P105, DOI 10.1016/S0014-5793(01)02411-5; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lufei C, 2007, ONCOGENE, V26, P7656, DOI 10.1038/sj.onc.1210567; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Takahashi K, 2008, CELL MOL LIFE SCI, V65, P359, DOI 10.1007/s00018-007-7270-0; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1	18	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14656	10.1371/journal.pone.0014656	http://dx.doi.org/10.1371/journal.pone.0014656			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326608	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037000005
J	Al Safadi, R; Mereghetti, L; Salloum, M; Lartigue, MF; Virlogeux-Payant, I; Quentin, R; Rosenau, A				Al Safadi, Rim; Mereghetti, Laurent; Salloum, Mazen; Lartigue, Marie-Frederique; Virlogeux-Payant, Isabelle; Quentin, Roland; Rosenau, Agnes			Two-Component System RgfA/C Activates the fbsB Gene Encoding Major Fibrinogen-Binding Protein in Highly Virulent CC17 Clone Group B Streptococcus	PLOS ONE			English	Article							INVASIVE NEONATAL DISEASE; GRAM-POSITIVE BACTERIA; HUMAN EPITHELIAL-CELLS; AGALACTIAE STRAINS; STAPHYLOCOCCUS-AUREUS; ENHANCED INVASIVENESS; POPULATION-STRUCTURE; SURFACE PROTEIN; EXPRESSION; SEQUENCE	Group B streptococcus (GBS) strains with the highest ability to bind to human fibrinogen belong to the highly invasive clonal complex (CC) 17. To investigate the fibrinogen-binding mechanisms of CC17 strains, we determined the prevalence of fibrinogen-binding genes (fbsA and fbsB), and fbs regulator genes (rogB encoding an fbsA activator, rovS encoding an fbsA repressor and rgf encoding a two-component system [TCS] whose role on fbs genes was not determined yet) in a collection of 134 strains representing the major CCs of the species. We showed that specific gene combinations were related to particular CCs; only CC17 strains contained the fbsA, fbsB, and rgf genes combination. Non polar rgfAC deletion mutants of three CC17 serotype III strains were constructed. They showed a 3.2- to 5.1-fold increase of fbsA transcripts, a 4.8- to 6.7-fold decrease of fbsB transcripts, and a 52% to 68% decreased fibrinogen-binding ability, demonstrating that the RgfA/RgfC TCS inhibits the fbsA gene and activates the fbsB gene. The relative contribution of the two fbs genes in fibrinogen-binding ability was determined by constructing isogenic fbsA, fbsB, deletion mutants of the three CC17 strains. The ability to bind to fibrinogen was reduced by 49% to 57% in Lambda fbsA mutants, and by 78% to 80% in Lambda fbsB mutants, suggesting that FbsB protein plays a greater role in the fibrinogen-binding ability of CC17 strains. Moreover, the relative transcription level of fbsB gene was 9.2- to 12.7-fold higher than that of fbsA gene for the three wild type strains. Fibrinogen-binding ability could be restored by plasmid-mediated expression of rgfAC, fbsA, and fbsB genes in the corresponding deletion mutants. Thus, our results demonstrate that a specific combination of fbs genes and fbs regulator genes account for the high fibrinogen-binding ability of CC17 strains that may participate to their enhanced invasiveness for neonates as compared to strains of other CCs.	[Al Safadi, Rim; Mereghetti, Laurent; Salloum, Mazen; Lartigue, Marie-Frederique; Quentin, Roland; Rosenau, Agnes] Univ Tours, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Feratif Rech Agents Transmissibles & Infecti, UFR Med, Tours, France; [Virlogeux-Payant, Isabelle] INRA, Infectiol Anim & Sante Publ UR1282, Nouzilly, France; [Mereghetti, Laurent] CHRU Tours, Hop Bretonneau, Serv Bacteriol Virol, Tours, France; [Lartigue, Marie-Frederique; Quentin, Roland; Rosenau, Agnes] CHRU Tours, Hop Trousseau, Serv Bacteriol & Hyg Hosp, Tours, France	Universite de Tours; INRAE; CHU Tours; CHU Tours	Al Safadi, R (corresponding author), Univ Tours, Equipe Accueil Bacteries & Risque Maternofoetal 3, Inst Feratif Rech Agents Transmissibles & Infecti, UFR Med, Tours, France.	rosenau@univ-tours.fr	Virlogeux-Payant, Isabelle/H-5800-2013; Lartigue, Marie-Frédérique/AAC-6060-2020; Lartigue, Marie-Frédérique/E-8444-2011	Lartigue, Marie-Frédérique/0000-0003-4948-7959; Lartigue, Marie-Frédérique/0000-0003-4948-7959; Virlogeux-Payant, Isabelle/0000-0003-4149-0168	Region Centre, France [200700025461]	Region Centre, France(Region Centre-Val de Loire)	This work was supported by grant no 200700025461 from the Region Centre, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Safadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010794; Bisharat N, 2005, MICROBIOL-SGM, V151, P1875, DOI 10.1099/mic.0.27826-0; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Bohnsack JF, 2008, J CLIN MICROBIOL, V46, P1285, DOI 10.1128/JCM.02105-07; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Chatellier S, 1997, J CLIN MICROBIOL, V35, P2573, DOI 10.1128/JCM.35.10.2573-2579.1997; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gutekunst H, 2004, INFECT IMMUN, V72, P3495, DOI 10.1128/IAI.72.6.3495-3504.2004; Gutekunst H, 2003, INFECT IMMUN, V71, P5056, DOI 10.1128/IAI.71.9.5056-5064.2003; Jacobsson K, 2003, VET MICROBIOL, V96, P103, DOI 10.1016/S0378-1135(03)00206-2; JANZON L, 1990, EMBO J, V9, P1391, DOI 10.1002/j.1460-2075.1990.tb08254.x; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Li S, 1997, FEMS MICROBIOL LETT, V152, P155, DOI 10.1016/S0378-1097(97)00195-X; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martins ER, 2007, J CLIN MICROBIOL, V45, P3224, DOI 10.1128/JCM.01182-07; MUSSER JM, 1989, P NATL ACAD SCI USA, V86, P4731, DOI 10.1073/pnas.86.12.4731; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Ogura M, 2010, ARCH MICROBIOL, V192, P569, DOI 10.1007/s00203-010-0586-4; Poyart C, 2008, EMERG INFECT DIS, V14, P1647, DOI 10.3201/eid1410.080185; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; QUENTIN R, 1995, J CLIN MICROBIOL, V33, P2576, DOI 10.1128/JCM.33.10.2576-2581.1995; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Rivera J, 2007, THROMB HAEMOSTASIS, V98, P503, DOI 10.1160/TH07-03-0233; Rolland K, 1999, J CLIN MICROBIOL, V37, P1892, DOI 10.1128/JCM.37.6.1892-1898.1999; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Salloum M, 2010, J CLIN MICROBIOL, V48, P1261, DOI 10.1128/JCM.01820-09; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Samen UM, 2006, INFECT IMMUN, V74, P5625, DOI 10.1128/IAI.00667-06; Schubert A, 2004, INFECT IMMUN, V72, P6197, DOI 10.1128/IAI.72.11.6197-6205.2004; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Tenenbaum T, 2005, INFECT IMMUN, V73, P4404, DOI 10.1128/IAI.73.7.4404-4409.2005; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200	45	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e14658	10.1371/journal.pone.0014658	http://dx.doi.org/10.1371/journal.pone.0014658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326613	gold, Green Published, Green Submitted			2022-12-25	WOS:000287037000006
J	Ma, FC; Zhang, HX; Zhai, Y; Huang, WF; Zhao, C; Ou, SQ; Zhou, H; Yuan, WZ; Wang, ZF; Wang, HX; Yue, W; Yu, LX; Li, PY; Xia, X; Cai, M; Zhang, Y; Cui, Y; He, FC; Ma, YL; Zhou, GQ				Ma, Fuchao; Zhang, Hongxing; Zhai, Yun; Huang, Wenfeng; Zhao, Chang; Ou, Shengqiu; Zhou, Hong; Yuan, Wenzhao; Wang, Zhifu; Wang, Hongxue; Yue, Wei; Yu, Lixia; Li, Peiyao; Xia, Xia; Cai, Mi; Zhang, Yang; Cui, Ying; He, Fuchu; Ma, Yilong; Zhou, Gangqiao			Functional Polymorphism-31C/G in the Promoter of BIRC5 Gene and Risk of Nasopharyngeal Carcinoma among Chinese	PLOS ONE			English	Article							HUMAN SURVIVIN GENE; SUSCEPTIBILITY; CANCER; ASSOCIATION; PATHWAYS; PROTEIN; REGION	Background: Baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5, also called as survivin) is a member of the inhibitor of apoptosis protein (IAP) family, which plays an important role in the occurrence and progression of cancer. Recently, a polymorphism in the promoter of BIRC5, -31C/G (rs9904341), was shown to influence BIRC5 expression. Methods: We examined whether the -31C/G was related to the risk of developing nasopharyngeal carcinoma (NPC) in a case-control population from Guangxi province in southern China, which consists of 855 patients with NPC and 1036 controls. This polymorphism was genotyped by TaqMan assay. The genetic associations with the occurrence and progression of NPC were estimated by logistic regression. Results: We observed a statistically significant increased occurrence of NPC associated with the CC genotype (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.13-1.73; P = 0.0020) compared with the genotypes containing G allele (CG + GG genotype). However, no significant association was observed for the -31C/G with the severity of NPC (as measured by tumor-node-metastasis staging system). Conclusion: Our findings suggest that the functional polymorphism -31C/G in the promoter of BIRC5 gene may play a role in mediating the susceptibility to NPC among Chinese.	[Ma, Fuchao; Zhang, Hongxing; Zhai, Yun; Huang, Wenfeng; Wang, Zhifu; Wang, Hongxue; Yue, Wei; Yu, Lixia; Li, Peiyao; Xia, Xia; Cai, Mi; Zhang, Yang; He, Fuchu; Zhou, Gangqiao] Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China; [Ma, Fuchao; Huang, Wenfeng; Zhao, Chang; Ou, Shengqiu; Zhou, Hong; Yuan, Wenzhao; Wang, Hongxue; Cui, Ying; Ma, Yilong] Guangxi Med Univ, Affiliated Canc Hosp, Nanning, Guangxi, Peoples R China; [He, Fuchu] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Academy of Military Medical Sciences - China; Guangxi Medical University; Fudan University	Ma, FC (corresponding author), Beijing Proteome Res Ctr, Beijing Inst Radiat Med, State Key Lab Prote, Beijing, Peoples R China.	mayl74@yahoo.cn; zhougq114@gmail.com		Huang, Wenfeng/0000-0002-3194-4368	Chinese National Science Fund for Creative Research Groups Program [30621063]; Chinese National Natural Science Foundation [30872929, 30901707, 30900819, 30901231]; Chinese State Key Laboratory of Proteomics [SKLP-Y200808]; Beijing Science & Technology NOVA program [2006A54]	Chinese National Science Fund for Creative Research Groups Program(Science Fund for Creative Research Groups); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese State Key Laboratory of Proteomics; Beijing Science & Technology NOVA program	This study was supported by grants from Chinese National Science Fund for Creative Research Groups Program (No. 30621063), Chinese National Natural Science Foundation (No. 30872929, 30901707, 30900819 and 30901231), Chinese State Key Laboratory of Proteomics (No. SKLP-Y200808), and Beijing Science & Technology NOVA program (No. 2006A54). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 1989, J CLIN EPIDEMIOL, V42, P659, DOI 10.1016/0895-4356(89)90009-7; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; [Anonymous], 1997, AJCC CANC STAGING MA; Bei JX, 2010, NAT GENET, V42, P599, DOI 10.1038/ng.601; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Cheng Zheng-Jiang, 2008, Ai Zheng, V27, P258; Cho WC, 2010, CANC REPORT ASIAN PA, P284; Cho WCS, 2010, EXPERT REV MOL DIAGN, V10, P699, DOI [10.1586/erm.10.64, 10.1586/ERM.10.64]; Deng L, 2002, ACTA BIOCH BIOPH SIN, V34, P16; Gazouli M, 2009, INT J COLORECTAL DIS, V24, P145, DOI 10.1007/s00384-008-0601-2; Goldsmith DB, 2002, CLIN OTOLARYNGOL, V27, P61, DOI 10.1046/j.0307-7772.2001.00529.x; He Y, 2005, J MED GENET, V42, P172, DOI 10.1136/jmg.2004.022616; Jalbout M, 2003, CANCER LETT, V193, P75, DOI 10.1016/S0304-3835(02)00697-3; Jang JS, 2008, LUNG CANCER, V60, P31, DOI 10.1016/j.lungcan.2007.09.008; Jiang YY, 2005, J NEUROSCI, V25, P6962, DOI 10.1523/JNEUROSCI.1446-05.2005; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li YH, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-1; Melet A, 2008, ADV EXP MED BIOL, V615, P47, DOI 10.1007/978-1-4020-6554-5_4; Nazar-Stewart V, 1999, CANCER EPIDEM BIOMAR, V8, P547; Nong LG, 2009, DNA CELL BIOL, V28, P507, DOI 10.1089/dna.2009.0912; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Reed JC, 2001, J CLIN INVEST, V108, P965, DOI 10.1172/JCI14123; Shi W, 2006, INT J CANCER, V119, P2467, DOI 10.1002/ijc.22107; Tang FQ, 2005, EXP ONCOL, V27, P96; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Xu Y, 2004, DNA CELL BIOL, V23, P527, DOI 10.1089/dna.2004.23.527; Yang L, 2009, DIGEST DIS SCI, V54, P1021, DOI 10.1007/s10620-008-0441-5; Yip KW, 2006, CLIN CANCER RES, V12, P5726, DOI 10.1158/1078-0432.CCR-06-0571; Zhou B, 2009, CANCER LETT, V275, P72, DOI 10.1016/j.canlet.2008.10.002; Zhou G, 2007, HUM MUTAT, V28, P1091, DOI 10.1002/humu.20570; Zhou GQ, 2007, CLIN CANCER RES, V13, P2627, DOI 10.1158/1078-0432.CCR-06-2281	36	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16748	10.1371/journal.pone.0016748	http://dx.doi.org/10.1371/journal.pone.0016748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304814	Green Submitted, gold, Green Published			2022-12-25	WOS:000287036600021
J	Han, BA; Searle, CL; Blaustein, AR				Han, Barbara A.; Searle, Catherine L.; Blaustein, Andrew R.			Effects of an Infectious Fungus, Batrachochytrium dendrobatidis, on Amphibian Predator-Prey Interactions	PLOS ONE			English	Article							BUFO-BOREAS; CHYTRID FUNGUS; WIDESPREAD OCCURRENCE; SELECTIVE PREDATION; POPULATION DECLINES; EMERGING DISEASE; ALARM RESPONSE; CHYTRIDIOMYCOSIS; BEHAVIOR; RISK	The effects of parasites and pathogens on host behaviors may be particularly important in predator-prey contexts, since few animal behaviors are more crucial for ensuring immediate survival than the avoidance of lethal predators in nature. We examined the effects of an emerging fungal pathogen of amphibians, Batrachochytrium dendrobatidis, on anti-predator behaviors of tadpoles of four frog species. We also investigated whether amphibian predators consumed infected prey, and whether B. dendrobatidis caused differences in predation rates among prey in laboratory feeding trials. We found differences in anti-predator behaviors among larvae of four amphibian species, and show that infected tadpoles of one species (Anaxyrus boreas) were more active and sought refuge more frequently when exposed to predator chemical cues. Salamander predators consumed infected and uninfected tadpoles of three other prey species at similar rates in feeding trials, and predation risk among prey was unaffected by B. dendrobatidis. Collectively, our results show that even sub-lethal exposure to B. dendrobatidis can alter fundamental anti-predator behaviors in some amphibian prey species, and suggest the unexplored possibility that indiscriminate predation between infected and uninfected prey (i.e., non-selective predation) could increase the prevalence of this widely distributed pathogen in amphibian populations. Because one of the most prominent types of predators in many amphibian systems is salamanders, and because salamanders are susceptible to B. dendrobatidis, our work suggests the importance of considering host susceptibility and behavioral changes that could arise from infection in both predators and prey.	[Han, Barbara A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Searle, Catherine L.; Blaustein, Andrew R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	University System of Georgia; University of Georgia; Oregon State University	Han, BA (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	han@uga.edu	Han, Barbara A/H-9363-2015	Han, Barbara A/0000-0002-9948-3078; Searle, Catherine/0000-0002-6607-2299	National Science Foundation [DEB0213851, IBN9977063]	National Science Foundation(National Science Foundation (NSF))	Funding sources for this work include the National Science Foundation Postdoctoral Research Fellowship in Bioinformatics and the Budweiser Conservation Fellowship to BAH; and the National Science Foundation Integrated Research Challenges in Environmental Biology Program (DEB0213851 and IBN9977063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zyoud F, 2004, J PEST SCI, V77, P197, DOI 10.1007/s10340-004-0054-5; ANDERSON RM, 1980, SCIENCE, V210, P658, DOI 10.1126/science.210.4470.658; Bakker TCM, 1997, ECOLOGY, V78, P1098, DOI 10.1890/0012-9658(1997)078[1098:PICIBA]2.0.CO;2; Barber I, 1996, P ROY SOC B-BIOL SCI, V263, P1095, DOI 10.1098/rspb.1996.0161; Benard MF, 2006, ECOLOGY, V87, P340, DOI 10.1890/05-0381; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; CALEF GW, 1973, ECOLOGY, V54, P741, DOI 10.2307/1935670; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Cohen J., 1988, STAT POWER ANAL BEHA; Cullen JM, 1974, J ZOOL, V172, P549; Davidson EW, 2003, COPEIA, P601, DOI 10.1643/CP-02-120R1; Duellman WE, 1986, BIOL AMPHIBIANS, P241; Duffy MA, 2007, OECOLOGIA, V153, P453, DOI 10.1007/s00442-007-0742-y; DUPRE RK, 1985, COPEIA, P462, DOI 10.2307/1444859; Ferrari MCO, 2009, ANIM BEHAV, V78, P11, DOI 10.1016/j.anbehav.2009.03.016; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gilbert MA, 2003, J PARASITOL, V89, P658, DOI 10.1645/GE-82R; Gosner K. L., 1960, Herpetologica, V16, P183; Griffin AS, 2004, LEARN BEHAV, V32, P131; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; HEWS DK, 1985, BEHAV NEURAL BIOL, V43, P47, DOI 10.1016/S0163-1047(85)91482-7; HEWS DK, 1988, ANIM BEHAV, V36, P125, DOI 10.1016/S0003-3472(88)80255-0; Hoff KV, 1999, TADPOLES, P215; Holt RD, 2007, AM NAT, V169, P690, DOI 10.1086/513188; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUDSON PJ, 1992, J ANIM ECOL, V61, P681, DOI 10.2307/5623; Jones GA, 2005, CROP PROT, V24, P185, DOI 10.1016/j.cropro.2004.07.002; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kielgast J, 2010, ANIM CONSERV, V13, P36, DOI 10.1111/j.1469-1795.2009.00297.x; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martin J, 1999, BEHAV ECOL, V10, P487, DOI 10.1093/beheco/10.5.487; Mathis A, 2000, CAN J ZOOL, V78, P1646, DOI 10.1139/cjz-78-9-1646; OHARA RK, 1982, BEHAV ECOL SOCIOBIOL, V11, P43, DOI 10.1007/BF00297665; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Padgett-Flohr Gretchen E., 2005, Herpetological Review, V36, P50; Padgett-Flohr Gretchen E., 2007, Herpetological Review, V38, P176; Parris MJ, 2004, OECOLOGIA, V140, P626, DOI 10.1007/s00442-004-1631-2; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; R.D.C. Team, 2010, R LANGUAGE ENV STAT; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Roy M, 2008, THEOR POPUL BIOL, V73, P319, DOI 10.1016/j.tpb.2007.12.008; Roy S, 2005, MATH METHOD APPL SCI, V28, P1257, DOI 10.1002/mma.607; SKELLY DK, 1990, ECOLOGY, V71, P2313, DOI 10.2307/1938642; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Therneau T, 2009, SURVIVAL SURVIVAL AN; Venesky MD, 2009, ECOHEALTH, V6, P565, DOI 10.1007/s10393-009-0272-7; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Watt PJ, 1997, ANIM BEHAV, V54, P865, DOI 10.1006/anbe.1996.0512; Whiles MR, 2006, FRONT ECOL ENVIRON, V4, P27, DOI 10.1890/1540-9295(2006)004[0027:TEOAPD]2.0.CO;2; Wildy EL, 1998, J HERPETOL, V32, P286, DOI 10.2307/1565312	60	17	18	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16675	10.1371/journal.pone.0016675	http://dx.doi.org/10.1371/journal.pone.0016675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311771	Green Published, gold			2022-12-25	WOS:000287036200030
J	Sudhaharan, T; Goh, WI; Sem, KP; Lim, KB; Bu, WY; Ahmed, S				Sudhaharan, Thankiah; Goh, Wah Ing; Sem, Kai Ping; Lim, Kim Buay; Bu, Wenyu; Ahmed, Sohail			Rho GTPase Cdc42 Is a Direct Interacting Partner of Adenomatous Polyposis Coli Protein and Can Alter Its Cellular Localization	PLOS ONE			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; ACTIN-FILAMENTS; FILOPODIA; MEMBRANE; COMPLEX; CELLS; POLARIZATION; PROGRESSION; TRANSPORT	Adenomatous Polyposis Coli (APC) is a tumor suppressor gene product involved in colon cancer. APC is a large multidomain molecule of 2843 amino acid residues and connects cell-cell adhesion, the F-actin/microtubule cytoskeleton and the nucleus. Here we show that Cdc42 interacts directly with the first three armadillo repeats of APC by yeast two-hybrid screens. We confirm the Cdc42-APC interaction using pulldown assays in vitro and FRET assays in vivo. Interestingly, Cdc42 interacts with APC at leading edge sites where F-actin is enriched. In contrast, Cdc42 interacts with the truncated mutant APC(1-1638) in cellular puncta associated with the golgi-lysozome pathway in transfected CHO cells. In HCT116 and SW480 cells, Cdc42 induces the relocalization of endogenous APC and the mutant APC(1-1338) to the plasma membrane and cellular puncta, respectively. Taken together, these data indicate that the Cdc42-APC interaction induces localization of both APC and mutant APC and may thus play a direct role in the functions of these proteins.	[Sudhaharan, Thankiah; Goh, Wah Ing; Sem, Kai Ping; Lim, Kim Buay; Bu, Wenyu; Ahmed, Sohail] Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Sudhaharan, T (corresponding author), Inst Med Biol, Neural Stem Cell Lab, Singapore, Singapore.	sohail.ahmed@imb.a-star.edu.sg		Goh, Wah Ing/0000-0001-6594-0640	Agency for Science, Technology and Research, Singapore	Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by Agency for Science, Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MT, 2001, LARYNGOSCOPE, V111, P1285, DOI 10.1097/00005537-200107000-00027; Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Brocardo M, 2008, TRENDS CELL BIOL, V18, P587, DOI 10.1016/j.tcb.2008.09.002; DePina AS, 1999, MICROSC RES TECHNIQ, V47, P93, DOI 10.1002/(SICI)1097-0029(19991015)47:2<93::AID-JEMT2>3.0.CO;2-P; Dikovskaya D, 2001, TRENDS CELL BIOL, V11, P378, DOI 10.1016/S0962-8924(01)02069-4; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Heinen CD, 2002, GASTROENTEROLOGY, V123, P751, DOI 10.1053/gast.2002.35382; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Keely PJ, 2001, LANCET, V358, P1744, DOI 10.1016/S0140-6736(01)06840-4; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lozano E, 2003, BIOESSAYS, V25, P452, DOI 10.1002/bies.10262; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Polo S, 2004, CURR OPIN CELL BIOL, V16, P156, DOI 10.1016/j.ceb.2004.02.003; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Senadheera D, 2001, INT J MOL MED, V8, P127; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Sudhaharan T, 2009, J BIOL CHEM, V284, P13602, DOI 10.1074/jbc.M900894200; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tregidgo C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937212; Wang B, 2005, AM J PHYSIOL-CELL PH, V288, pC1411, DOI 10.1152/ajpcell.00533.2004; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944	38	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16603	10.1371/journal.pone.0016603	http://dx.doi.org/10.1371/journal.pone.0016603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311754	Green Submitted, gold, Green Published			2022-12-25	WOS:000287036200022
J	Sandegren, L; Groenheit, R; Koivula, T; Ghebremichael, S; Advani, A; Castro, E; Pennhag, A; Hoffner, S; Mazurek, J; Pawlowski, A; Kan, B; Bruchfeld, J; Melefors, O; Kallenius, G				Sandegren, Linus; Groenheit, Ramona; Koivula, Tuija; Ghebremichael, Solomon; Advani, Abdolreza; Castro, Elsie; Pennhag, Alexandra; Hoffner, Sven; Mazurek, Jolanta; Pawlowski, Andrzej; Kan, Boris; Bruchfeld, Judith; Melefors, Ojar; Kallenius, Gunilla			Genomic Stability over 9 Years of an Isoniazid Resistant Mycobacterium tuberculosis Outbreak Strain in Sweden	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GYRASE MUTATIONS; STREPTOMYCIN RESISTANCE; EXTENSIVE TRANSMISSION; GENETIC POLYMORPHISMS; INSERTION SEQUENCES; CLINICAL-RELEVANCE; IS6110 INSERTION; BEIJING GENOTYPE; DRUG-RESISTANCE	In molecular epidemiological studies of drug resistant Mycobacterium tuberculosis (TB) in Sweden a large outbreak of an isoniazid resistant strain was identified, involving 115 patients, mainly from the Horn of Africa. During the outbreak period, the genomic pattern of the outbreak strain has stayed virtually unchanged with regard to drug resistance, IS6110 restriction fragment length polymorphism and spoligotyping patterns. Here we present the complete genome sequence analyses of the index isolate and two isolates sampled nine years after the index case as well as experimental data on the virulence of this outbreak strain. Even though the strain has been present in the community for nine years and passaged between patients at least five times in-between the isolates, we only found four single nucleotide polymorphisms in one of the later isolates and a small (4 amino acids) deletion in the other compared to the index isolate. In contrast to many other evolutionarily successful outbreak lineages (e. g. the Beijing lineage) this outbreak strain appears to be genetically very stable yet evolutionarily successful in a low endemic country such as Sweden. These findings further illustrate that the rate of genomic variation in TB can be highly strain dependent, something that can have important implications for epidemiological studies as well as development of resistance.	[Sandegren, Linus] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Groenheit, Ramona; Koivula, Tuija; Ghebremichael, Solomon; Advani, Abdolreza; Pennhag, Alexandra; Hoffner, Sven; Melefors, Ojar] Swedish Inst Infect Dis Control, Solna, Sweden; [Groenheit, Ramona; Hoffner, Sven; Mazurek, Jolanta; Melefors, Ojar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Koivula, Tuija; Castro, Elsie; Mazurek, Jolanta; Pawlowski, Andrzej] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Kan, Boris; Bruchfeld, Judith; Kallenius, Gunilla] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Solna, Sweden	Uppsala University; Swedish Institute for Infectious Disease Control; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sandegren, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Linus.Sandegren@imbim.uu.se	Sandegren, Linus/K-4638-2013; Källenius, Gunilla/AGZ-3956-2022; Melefors, Öjar/N-6164-2015	Sandegren, Linus/0000-0001-7382-9782; Melefors, Öjar/0000-0003-4115-1190; Mazurek, Jolanta/0000-0001-5023-0398; Kallenius, Gunilla/0000-0002-8921-0551; Groenheit, Ramona/0000-0003-2696-437X; Pawlowski, Andrzej/0000-0003-4555-6048	Swedish Heart-Lung Foundation; Swedish Research Council; Swedish International Development Cooperation Agency	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency	This work was financed by Swedish Heart-Lung Foundation (www.hjart-lungfonden.se/); Swedish Research Council (www.vr.se/); Swedish International Development Cooperation Agency (www.sida.se/) (to GK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Angeby KA, 2010, J ANTIMICROB CHEMOTH, V65, P946, DOI 10.1093/jac/dkq091; Asiimwe BB, 2008, INT J TUBERC LUNG D, V12, P386; Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Beggs ML, 2000, J CLIN MICROBIOL, V38, P2923, DOI 10.1128/JCM.38.8.2923-2928.2000; Bifani PJ, 1999, JAMA-J AM MED ASSOC, V282, P2321, DOI 10.1001/jama.282.24.2321; Borrell S, 2009, INT J TUBERC LUNG D, V13, P1456; Brossier F, 2006, J CLIN MICROBIOL, V44, P3659, DOI 10.1128/JCM.01054-06; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caminero JA, 2001, AM J RESP CRIT CARE, V164, P1165, DOI 10.1164/ajrccm.164.7.2101031; Caws M, 2006, J CLIN MICROBIOL, V44, P3934, DOI 10.1128/JCM.01181-06; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2006, PLOS PATHOG, V2, P603, DOI 10.1371/journal.ppat.0020061; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Ghebremichael S, 2008, MICROBES INFECT, V10, P699, DOI 10.1016/j.micinf.2008.03.006; Ghebremichael S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010893; Ginsburg AS, 2003, LANCET INFECT DIS, V3, P432, DOI 10.1016/S1473-3099(03)00671-6; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; Guo HL, 2006, J MED MICROBIOL, V55, P1527, DOI 10.1099/jmm.0.46718-0; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Herrera-Leon L, 2005, ANTIMICROB AGENTS CH, V49, P144, DOI 10.1128/AAC.49.1.144-147.2005; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Jenkins C, 2005, EMERG INFECT DIS, V11, P931; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kan B, 2008, INT J TUBERC LUNG D, V12, P199; Kato-Maeda M, 2001, GENOME RES, V11, P547, DOI 10.1101/gr.166401; Kiers A, 1997, INT J TUBERC LUNG D, V1, P239; Kim EY, 2010, J CLIN MICROBIOL, V48, P1422, DOI 10.1128/JCM.02210-09; Kocagoz T, 1996, ANTIMICROB AGENTS CH, V40, P1768, DOI 10.1128/AAC.40.8.1768; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Kong Y, 2005, J CLIN MICROBIOL, V43, P6048, DOI 10.1128/JCM.43.12.6048-6053.2005; Kruuner A, 2001, J CLIN MICROBIOL, V39, P3339, DOI 10.1128/JCM.39.9.3339-3345.2001; Lavender C, 2005, ANTIMICROB AGENTS CH, V49, P4068, DOI 10.1128/AAC.49.10.4068-4074.2005; Lillebaek T, 2004, INT J TUBERC LUNG D, V8, P1001; Marquina-Castillo B, 2009, IMMUNOLOGY, V128, P123, DOI 10.1111/j.1365-2567.2008.03004.x; McEvoy CRE, 2007, TUBERCULOSIS, V87, P393, DOI 10.1016/j.tube.2007.05.010; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Park H, 2006, J CLIN MICROBIOL, V44, P1619, DOI 10.1128/JCM.44.5.1619-1624.2006; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Piatek AS, 2000, ANTIMICROB AGENTS CH, V44, P103, DOI 10.1128/AAC.44.1.103-110.2000; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rhee JT, 1999, J CLIN MICROBIOL, V37, P1764, DOI 10.1128/JCM.37.6.1764-1770.1999; Ruddy MC, 2004, THORAX, V59, P279, DOI 10.1136/thx.2003.010405; Ryoo SW, 2007, J MICROBIOL, V45, P268; Safi H, 2004, MOL MICROBIOL, V52, P999, DOI 10.1111/j.1365-2958.2004.04037.x; Sampson SL, 2001, TUBERCULOSIS, V81, P305, DOI 10.1054/tube.2001.0304; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Soto CY, 2004, J CLIN MICROBIOL, V42, P212, DOI 10.1128/JCM.42.1.212-219.2004; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; ten Bokum AMC, 2008, TRENDS MICROBIOL, V16, P436, DOI 10.1016/j.tim.2008.06.003; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Viana-Niero C, 2004, MICROBIOL-SGM, V150, P967, DOI 10.1099/mic.0.26778-0; Wall S, 1999, MICROBIOL-SGM, V145, P3169, DOI 10.1099/00221287-145-11-3169; Warren RM, 2002, J CLIN MICROBIOL, V40, P1277, DOI 10.1128/JCM.40.4.1277-1282.2002; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; *WHO, 2009, GLOB TUB CONTR SHORT; [WHO IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance], 2008, 4 WHOIUATLD GLOB PRO; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127; Yang ZH, 2005, AM J RESP CRIT CARE, V171, P1436, DOI 10.1164/rccm.200408-1147OC; Yeh RW, 1998, J INFECT DIS, V177, P1107, DOI 10.1086/517406; Yesilkaya H, 2005, J BACTERIOL, V187, P6726, DOI 10.1128/JB.187.19.6726-6732.2005; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; 2006, MMWR MORB MORTAL WKL, V55, P301; 2006, EMERG INFECT DIS, V12, P736	79	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16647	10.1371/journal.pone.0016647	http://dx.doi.org/10.1371/journal.pone.0016647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304944	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300107
J	Sonawane, PJ; Sahu, BS; Sasi, BK; Geedi, P; Lenka, G; Mahapatra, NR				Sonawane, Parshuram J.; Sahu, Bhavani S.; Sasi, Binu K.; Geedi, Parimala; Lenka, Govinda; Mahapatra, Nitish R.			Functional Promoter Polymorphisms Govern Differential Expression of HMG-CoA Reductase Gene in Mouse Models of Essential Hypertension	PLOS ONE			English	Article							COENZYME-A REDUCTASE; ELEMENT-BINDING PROTEIN; CHROMOGRANIN-B GENE; C-FOS; TRANSCRIPTIONAL REGULATION; REAL-TIME; IN-VIVO; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; REGULATORY ELEMENTS; SIGNALING PATHWAY	3-Hydroxy-3-methylglutaryl-coenzyme A [HMG-CoA] reductase gene (Hmgcr) is a susceptibility gene for essential hypertension. Sequencing of the Hmgcr locus in genetically hypertensive BPH (blood pressure high), genetically hypotensive BPL (blood pressure low) and genetically normotensive BPN (blood pressure normal) mice yielded a number of single nucleotide polymorphisms (SNPs). BPH/BPL/BPN Hmgcr promoter-luciferase reporter constructs were generated and transfected into liver HepG2, ovarian CHO, kidney HEK-293 and neuronal N2A cells for functional characterization of the promoter SNPs. The BPH-Hmgcr promoter showed significantly less activity than the BPL-Hmgcr promoter under basal as well as nicotine/cholesterol-treated conditions. This finding was consistent with lower endogenous Hmgcr expression in liver and lower plasma cholesterol in BPH mice. Transfection experiments using 5'-promoter deletion constructs (strategically made to assess the functional significance of each promoter SNP) and computational analysis predicted lower binding affinities of transcription factors c-Fos, n-Myc and Max with the BPH-promoter as compared to the BPL-promoter. Corroboratively, the BPH promoter-luciferase reporter construct co-transfected with expression plasmids of these transcription factors displayed less pronounced augmentation of luciferase activity than the BPL construct, particularly at lower amounts of transcription factor plasmids. Electrophoretic mobility shift assays also showed diminished interactions of the BPH promoter with HepG2 nuclear proteins. Taken together, this study provides mechanistic basis for the differential Hmgcr expression in these mouse models of human essential hypertension and have implications for better understanding the role of this gene in regulation of blood pressure.	[Sonawane, Parshuram J.; Sahu, Bhavani S.; Sasi, Binu K.; Geedi, Parimala; Lenka, Govinda; Mahapatra, Nitish R.] Indian Inst Technol Madras, Dept Biotechnol, Cardiovasc Genet Lab, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Sonawane, PJ (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Cardiovasc Genet Lab, Madras, Tamil Nadu, India.	nmahapatra@iitm.ac.in	SASI, BINU K/B-3770-2008; SONAWANE, PARSHURAM/CAF-3202-2022; Mahapatra, Nitish R/D-4123-2014	SASI, BINU K/0000-0002-3325-9874; Mahapatra, Nitish R/0000-0002-0695-3510	Industrial Consultancy & Sponsored Research at IIT Madras; Council of Scientific & Industrial Research, Government of India	Industrial Consultancy & Sponsored Research at IIT Madras; Council of Scientific & Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from the Industrial Consultancy & Sponsored Research at IIT Madras and the Council of Scientific & Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDEKANI AM, 1989, LIFE SCI, V44, P919, DOI 10.1016/0024-3205(89)90490-6; Auvinen M, 2003, INT J BIOCHEM CELL B, V35, P496, DOI 10.1016/S1357-2725(02)00305-9; BLACKWOOD EM, 1991, COLD SPRING HARB SYM, V56, P109; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOCAN TMA, 1992, BIOCHIM BIOPHYS ACTA, V1123, P133, DOI 10.1016/0005-2760(92)90103-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1974, J BIOL CHEM, V249, P7306; Burkhardt R, 2008, ARTERIOSCL THROM VAS, V28, P2078, DOI 10.1161/ATVBAHA.108.172288; BUSCH SJ, 1990, J BIOL CHEM, V265, P22474; Chapman MJ, 2008, PHARMACOL THERAPEUT, V117, P354, DOI 10.1016/j.pharmthera.2007.10.004; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Chattopadhyay K, 2008, INDIAN J MED RES, V127, P571; Chen GP, 2008, ACTA PHARMACOL SIN, V29, P1181, DOI 10.1111/j.1745-7254.2008.00855.x; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cotterman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005799; CRAIG WY, 1993, BIOCHIM BIOPHYS ACTA, V1165, P249, DOI 10.1016/0005-2760(93)90133-T; Dewar BJ, 2002, J PHARMACOL EXP THER, V301, P930, DOI 10.1124/jpet.301.3.930; Di Croce L, 1999, MOL ENDOCRINOL, V13, P1225, DOI 10.1210/me.13.8.1225; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Donnelly LA, 2008, PHARMACOGENET GENOM, V18, P1021, DOI 10.1097/FPC.0b013e3283106071; DONY C, 1987, NATURE, V328, P711, DOI 10.1038/328711a0; Engfelt WH, 1998, J LIPID RES, V39, P2182; Fielding CJ, 2001, BBA-MOL CELL BIOL L, V1533, P175, DOI 10.1016/S1388-1981(01)00162-7; Freitas RN, 2010, EUR J CARDIOV PREV R, V17, P89, DOI 10.1097/HJR.0b013e328330be77; Freitas RN, 2009, J AM SOC HYPERTENS, V3, P238, DOI 10.1016/j.jash.2009.05.001; Fries RS, 2004, HYPERTENSION, V43, P1301, DOI 10.1161/01.HYP.0000127708.96195.E6; Friese RS, 2005, AM J HYPERTENS, V18, P633, DOI 10.1016/j.amjhyper.2004.11.037; Friese RS, 2010, PHYSIOL GENOMICS, V40, P195, DOI 10.1152/physiolgenomics.00164.2009; Gauthier BR, 1998, BIOCHEM BIOPH RES CO, V247, P280, DOI 10.1006/bbrc.1998.8777; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; HASHIMOTO K, 1989, ENDOCRINOLOGY, V125, P1161, DOI 10.1210/endo-125-3-1161; Hsu M, 2006, BIOCHEM BIOPH RES CO, V343, P738, DOI 10.1016/j.bbrc.2006.03.036; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Hu M, 2002, MOL CELL NEUROSCI, V21, P616, DOI 10.1006/mcne.2002.1202; Jarvis CM, 2007, J CARDIOVASC NURS, V22, P429, DOI 10.1097/01.JCN.0000297387.21626.88; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; JUREVICS HA, 1994, J LIPID RES, V35, P112; Karla N, 2004, J BIOL CHEM, V279, P25313, DOI 10.1074/jbc.M400932200; KATO K, 1990, MOL CELL BIOL, V10, P486, DOI 10.1128/MCB.10.2.486; LATHA MS, 1993, INDIAN J MED RES-B, V98, P44; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Lim HH, 2001, J VASC RES, V38, P228, DOI 10.1159/000051051; Liu Q, 2007, FASEB J, V21, P61, DOI 10.1096/fj.06-5841com; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUSKEY KL, 1987, MOL CELL BIOL, V7, P1881, DOI 10.1128/MCB.7.5.1881; Mahapatra NR, 2006, J NEUROCHEM, V99, P119, DOI 10.1111/j.1471-4159.2006.04128.x; Mahapatra NR, 2000, ENDOCRINOLOGY, V141, P3668, DOI 10.1210/en.141.10.3668; Mahapatra NR, 2003, J BIOL CHEM, V278, P19986, DOI 10.1074/jbc.M207983200; Mayerhofer A, 2002, MICROSC RES TECHNIQ, V59, P503, DOI 10.1002/jemt.10228; Mayerhofer A, 2003, LIFE SCI, V72, P2039, DOI 10.1016/S0024-3205(03)00081-X; Medina MW, 2010, DISCOV MED, V9, P495; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; MIHYEON J, 2003, NEUROSCI RES COMMUN, V32, P11; Mule G, 2006, Minerva Cardioangiol, V54, P173; Naito M, 2009, AM J PATHOL, V174, P54, DOI 10.2353/ajpath.2009.080602; Ngo TT, 2002, J BIOL CHEM, V277, P33901, DOI 10.1074/jbc.M202135200; OSBORNE TF, 1991, J BIOL CHEM, V266, P13947; PARKER RA, 1990, J LIPID RES, V31, P1271; Perini G, 2005, P NATL ACAD SCI USA, V102, P12117, DOI 10.1073/pnas.0409097102; REYNOLDS GA, 1985, J BIOL CHEM, V260, P369; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schlager G, 1997, LAB ANIM SCI, V47, P288; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schuller HM, 2007, LIFE SCI, V80, P2274, DOI 10.1016/j.lfs.2007.03.006; Shimono A, 1999, MECH DEVELOP, V83, P39, DOI 10.1016/S0925-4773(99)00025-8; SMITH JR, 1988, J BIOL CHEM, V263, P18480; Sweileh W, 2000, MOL BRAIN RES, V75, P293, DOI 10.1016/S0169-328X(99)00302-2; Tacer K, 2002, J LIPID RES, V43, P82; TAM SP, 1991, J BIOL CHEM, V266, P16764; Toyohara J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008961; Tsuneoka M, 1997, ONCOGENE, V14, P2301, DOI 10.1038/sj.onc.1201067; TURLEY SD, 1981, J LIPID RES, V22, P551; Valentine JD, 1996, ENDOCRINOLOGY, V137, P622, DOI 10.1210/en.137.2.622; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Walker BR, 1996, HYPERTENSION, V27, P190, DOI 10.1161/01.HYP.27.2.190; Wang FC, 2010, ANAL BIOCHEM, V399, P211, DOI 10.1016/j.ab.2009.12.029; WENZEL A, 1991, EMBO J, V10, P3703, DOI 10.1002/j.1460-2075.1991.tb04938.x; Xu J, 2003, J PHARMACOL EXP THER, V307, P1148, DOI 10.1124/jpet.103.055178	82	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16661	10.1371/journal.pone.0016661	http://dx.doi.org/10.1371/journal.pone.0016661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304971	gold, Green Submitted, Green Published			2022-12-25	WOS:000286834300110
J	Kang, TH; Guibinga, GH; Friedmann, T				Kang, Tae Hyuk; Guibinga, Ghiabe-Henri; Friedmann, Theodore			HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene?	PLOS ONE			English	Article							LESCH-NYHAN-DISEASE; NEURAL STEM-CELLS; DOPAMINERGIC-NEURONS; PRIMARY CULTURES; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; ONTOLOGY; CATENIN; MODEL	We have used microarray-based methods of global gene expression together with quantitative PCR and Western blot analysis to identify dysregulation of genes and aberrant cellular processes in human fibroblasts and in SH-SY5Y neuroblastoma cells made HPRT-deficient by transduction with a retrovirus stably expressing an shRNA targeted against HPRT. Analysis of the microarray expression data by Gene ontology (GO) and Gene Set Enrichment Analysis (GSEA) as well as significant pathway analysis by GeneSpring GX10 and Panther Classification System reveal that HPRT deficiency is accompanied by aberrations in a variety of pathways known to regulate neurogenesis or to be implicated in neurodegenerative disease, including the canonical Wnt/beta-catenin and the Alzheimer's disease/presenilin signaling pathways. Dysregulation of the Wnt/beta-catenin pathway is confirmed by Western blot demonstration of cytosolic sequestration of beta-catenin during in vitro differentiation of the SH-SY5Y cells toward the neuronal phenotype. We also demonstrate that two key transcription factor genes known to be regulated by Wnt signaling and to be vital for the generation and function of dopaminergic neurons; i.e., Lmx1a and Engrailed 1, are down-regulated in the HPRT knockdown SH-SY5Y cells. In addition to the Wnt signaling aberration, we found that expression of presenilin-1 shows severely aberrant expression in HPRT-deficient SH-SY5Y cells, reflected by marked deficiency of the 23 kDa C-terminal fragment of presenilin-1 in knockdown cells. Western blot analysis of primary fibroblast cultures from two LND patients also shows dysregulated presenilin-1 expression, including aberrant proteolytic processing of presenilin-1. These demonstrations of dysregulated Wnt signaling and presenilin-1 expression together with impaired expression of dopaminergic transcription factors reveal broad pleitropic neuro-regulatory defects played by HPRT expression and suggest new directions for investigating mechanisms of aberrant neurogenesis and neuropathology in LND and potential new targets for restoration of effective signaling in this neuro-developmental defect.	[Kang, Tae Hyuk] Univ Calif San Diego, San Diego Sch Med, Dept Pediat, Ctr Neural Circuit & Behav, La Jolla, CA 92093 USA; Univ Calif San Diego, San Diego Sch Med, San Diego Rady Childrens Hosp, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University of California System; University of California San Diego	Kang, TH (corresponding author), Univ Calif San Diego, San Diego Sch Med, Dept Pediat, Ctr Neural Circuit & Behav, La Jolla, CA 92093 USA.	tfriedmann@ucsd.edu	Pillay, Nischalan/F-9536-2012; Xie, Huangming/B-2260-2012		National Institutes of Health (NIH) [DK082840]; Lesch Nyhan Disease Children's Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK082840] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lesch Nyhan Disease Children's Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies have been supported by National Institutes of Health (NIH) DK082840 and by the Lesch Nyhan Disease Children's Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boer P, 2001, NEUROSCI LETT, V303, P45, DOI 10.1016/S0304-3940(01)01716-5; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Castelo-Branco G, 2006, NEURODEGENER DIS, V3, P5, DOI 10.1159/000092086; Ceballos-Picot I, 2009, HUM MOL GENET, V18, P2317, DOI 10.1093/hmg/ddp164; Cristini S, 2010, HUM MOL GENET, V19, P1939, DOI 10.1093/hmg/ddq072; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; Ernst M, 1996, NEW ENGL J MED, V334, P1568, DOI 10.1056/NEJM199606133342403; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; Guibinga GH, 2010, MOL THER, V18, P54, DOI 10.1038/mt.2009.178; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jinnah HA, 2006, BRAIN, V129, P1201, DOI 10.1093/brain/awl056; JINNAH HA, 2000, METABOLIC MOL BASES, P2537; Kiewe P, 2009, ANN HEMATOL, V88, P1177, DOI 10.1007/s00277-009-0751-5; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Lewers JC, 2008, NEUROSCIENCE, V152, P761, DOI 10.1016/j.neuroscience.2007.10.065; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; Machon O, 2007, DEV BIOL, V311, P223, DOI 10.1016/j.ydbio.2007.08.038; Martorana A, 2009, NEUROPSYCHOPHARMACOL, V34, P2323, DOI 10.1038/npp.2009.60; MEREDITH JE, 2010, BIOCHEM BIOPH RES CO, V299, P744; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murayama M, 1998, FEBS LETT, V433, P73, DOI 10.1016/S0014-5793(98)00886-2; PAGE T, 1982, CLIN CHEM, V28, P1181; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Reeves S, 2010, NEUROBIOL DIS, V37, P477, DOI 10.1016/j.nbd.2009.11.005; Rezai-Zadeh K, 2009, J CELL MOL MED, V13, P574, DOI 10.1111/j.1582-4934.2008.00344.x; ROSE SD, 2006, NATURE METHOD, DOI DOI 10.1038/NMETH919; Saito Y, 1999, NEUROPEDIATRICS, V30, P66, DOI 10.1055/s-2007-973462; Sanfilippo Antonio, 2009, International Journal of Computational Biology and Drug Design, V2, P221, DOI 10.1504/IJCBDD.2009.030114; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Seeger M, 1997, P NATL ACAD SCI USA, V94, P5090, DOI 10.1073/pnas.94.10.5090; Small DH, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-7; Smith DW, 2007, METAB BRAIN DIS, V22, P39, DOI 10.1007/s11011-007-9044-7; Smith DW, 2000, MOL THER, V1, P486, DOI 10.1006/mthe.2000.0057; Song S, 2007, MOL THER, V15, P1432, DOI 10.1038/sj.mt.6300199; Steiner H, 1998, J BIOL CHEM, V273, P32322, DOI 10.1074/jbc.273.48.32322; STROOPER BD, 2001, J CELL BIOL, V152, pF17; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun HM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S23; Uemura K, 2003, J NEUROSCI RES, V73, P166, DOI 10.1002/jnr.10641; Visser JE, 2002, DEV BRAIN RES, V133, P127, DOI 10.1016/S0165-3806(02)00280-8; Visser JE, 2000, BRAIN RES REV, V32, P449, DOI 10.1016/S0165-0173(99)00094-6; Wang HY, 2003, SCIENCE, V300, P1529, DOI 10.1126/science.1085259; Wong DF, 1996, P NATL ACAD SCI USA, V93, P5539, DOI 10.1073/pnas.93.11.5539; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	48	25	27	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16572	10.1371/journal.pone.0016572	http://dx.doi.org/10.1371/journal.pone.0016572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305049	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100045
J	Temperton, B; Gilbert, JA; Quinn, JP; McGrath, JW				Temperton, Ben; Gilbert, Jack A.; Quinn, John P.; McGrath, John W.			Novel Analysis of Oceanic Surface Water Metagenomes Suggests Importance of Polyphosphate Metabolism in Oligotrophic Environments	PLOS ONE			English	Article							PHOSPHATE ACQUISITION GENES; INORGANIC POLYPHOSPHATE; ESCHERICHIA-COLI; MARINE-BACTERIA; GENOME SEQUENCE; FORCE DRIVES; PHOSPHORUS; KINASE; DATABASE; TRANSPORT	Polyphosphate is a ubiquitous linear homopolymer of phosphate residues linked by high-energy bonds similar to those found in ATP. It has been associated with many processes including pathogenicity, DNA uptake and multiple stress responses across all domains. Bacteria have also been shown to use polyphosphate as a way to store phosphate when transferred from phosphate-limited to phosphate-rich media - a process exploited in wastewater treatment and other environmental contaminant remediation. Despite this, there has, to date, been little research into the role of polyphosphate in the survival of marine bacterioplankton in oligotrophic environments. The three main proteins involved in polyphosphate metabolism, Ppk1, Ppk2 and Ppx are multi-domain and have differential inter-domain and inter-gene conservation, making unbiased analysis of relative abundance in metagenomic datasets difficult. This paper describes the development of a novel Isofunctional Homolog Annotation Tool (IHAT) to detect homologs of genes with a broad range of conservation without bias of traditional expect-value cutoffs. IHAT analysis of the Global Ocean Sampling (GOS) dataset revealed that genes associated with polyphosphate metabolism are more abundant in environments where available phosphate is limited, suggesting an important role for polyphosphate metabolism in marine oligotrophs.	[Temperton, Ben; Quinn, John P.; McGrath, John W.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Temperton, Ben] Plymouth Marine Lab, Plymouth, Devon, England	Queens University Belfast; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Plymouth Marine Laboratory	Temperton, B (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	btemperton@gmail.com	Temperton, Ben/AAE-2785-2021; Gilbert, Jack/AAF-3270-2019	Temperton, Ben/0000-0002-3667-8302	Northern Ireland Department of Education and Learning	Northern Ireland Department of Education and Learning	This work was supported by the Northern Ireland Department of Education and Learning Programme for Government Studentship (www.delni.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Beszteri B, 2010, ISME J, V4, P1075, DOI 10.1038/ismej.2010.29; BRADBEER C, 1993, J BACTERIOL, V175, P3146, DOI 10.1128/JB.175.10.3146-3150.1993; Brown MRW, 2008, TRENDS BIOCHEM SCI, V33, P284, DOI 10.1016/j.tibs.2008.04.005; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; CHARLES TC, 1993, J BACTERIOL, V175, P6614, DOI 10.1128/jb.175.20.6614-6625.1993; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Crawley M. J, 2002, STAT COMPUTING INTRO; Dyhrman ST, 2007, OCEANOGRAPHY, V20, P110, DOI 10.5670/oceanog.2007.54; Eddy Sean R, 2009, Genome Inform, V23, P205; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P111, DOI 10.1111/j.1462-2920.2008.01745.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; HAROLD FM, 1964, J GEN MICROBIOL, V35, P81, DOI 10.1099/00221287-35-1-81; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jensen R.A., 2001, GENOME BIOL, V2, P1002, DOI DOI 10.3201/eid1412.080591; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; KORNBERG A, 1995, J BACTERIOL, V177, P491, DOI 10.1128/jb.177.3.491-496.1995; Li WZ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-359; Lindsey JK, 1999, J ROY STAT SOC C-APP, V48, P553, DOI 10.1111/1467-9876.00171; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Malekzadeh F, 2002, WORLD J MICROB BIOT, V18, P295, DOI 10.1023/A:1015215718810; MALONEY PC, 1974, P NATL ACAD SCI USA, V71, P3896, DOI 10.1073/pnas.71.10.3896; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; McGrath JW, 2003, ADV APPL MICROBIOL, V52, P75, DOI 10.1016/S0065-2164(03)01003-7; McMahon KD, 2002, APPL ENVIRON MICROB, V68, P4971, DOI 10.1128/AEM.68.10.4971-4978.2002; Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698; Miyake T, 1999, DNA Res, V6, P103; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Nagata T, 2006, APPL MICROBIOL BIOT, V72, P777, DOI 10.1007/s00253-006-0336-3; Nahalka J, 2009, ORG BIOMOL CHEM, V7, P1778, DOI 10.1039/b822549b; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Oksanen J., 2007, R PACKAGE VERSION, V1, P8; Orchard ED, 2010, LIMNOL OCEANOGR, V55, P2161, DOI 10.4319/lo.2010.55.5.2161; Partensky F, 2010, ANNU REV MAR SCI, V2, P305, DOI 10.1146/annurev-marine-120308-081034; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; Pinney JW, 2005, NUCLEIC ACIDS RES, V33, P1399, DOI 10.1093/nar/gki285; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; Shiba T, 2000, BIOCHEMISTRY-MOSCOW+, V65, P315; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tetu SG, 2009, ISME J, V3, P835, DOI 10.1038/ismej.2009.31; Thomas S, 2010, ISME J, V4, P459, DOI 10.1038/ismej.2009.129; Trelstad PL, 1999, APPL ENVIRON MICROB, V65, P3780; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; WANNER BL, 1993, J CELL BIOCHEM, V51, P47, DOI 10.1002/jcb.240510110; White AE, 2009, P NATL ACAD SCI USA, V106, P21013, DOI 10.1073/pnas.0912475107; Woods IG, 2000, GENOME RES, V10, P1903, DOI 10.1101/gr.10.12.1903; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	70	41	43	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16499	10.1371/journal.pone.0016499	http://dx.doi.org/10.1371/journal.pone.0016499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305044	gold, Green Submitted, Green Published			2022-12-25	WOS:000286664100039
J	Bjorkman, C; Kindvall, O; Hoglund, S; Lilja, A; Barring, L; Eklund, K				Bjorkman, Christer; Kindvall, Oskar; Hoglund, Solveig; Lilja, Anna; Barring, Lars; Eklund, Karin			High Temperature Triggers Latent Variation among Individuals: Oviposition Rate and Probability for Outbreaks	PLOS ONE			English	Article							EPIRRITA-AUTUMNATA LEPIDOPTERA; LIFE-HISTORY TRAITS; CLIMATE-CHANGE; CHITTY HYPOTHESIS; COUPLED MODEL; UNCERTAINTIES; CIRCULATION; SENSITIVITY; RESOLUTION; EVOLUTION	Background: It is anticipated that extreme population events, such as extinctions and outbreaks, will become more frequent as a consequence of climate change. To evaluate the increased probability of such events, it is crucial to understand the mechanisms involved. Variation between individuals in their response to climatic factors is an important consideration, especially if microevolution is expected to change the composition of populations. Methodology/Principal Findings: Here we present data of a willow leaf beetle species, showing high variation among individuals in oviposition rate at a high temperature (20 degrees C). It is particularly noteworthy that not all individuals responded to changes in temperature; individuals laying few eggs at 20 degrees C continued to do so when transferred to 12 degrees C, whereas individuals that laid many eggs at 20 degrees C reduced their oviposition and laid the same number of eggs as the others when transferred to 12 degrees C. When transferred back to 20 degrees C most individuals reverted to their original oviposition rate. Thus, high variation among individuals was only observed at the higher temperature. Using a simple population model and based on regional climate change scenarios we show that the probability of outbreaks increases if there is a realistic increase in the number of warm summers. The probability of outbreaks also increased with increasing heritability of the ability to respond to increased temperature. Conclusions/Significance: If climate becomes warmer and there is latent variation among individuals in their temperature response, the probability for outbreaks may increase. However, the likelihood for microevolution to play a role may be low. This conclusion is based on the fact that it has been difficult to show that microevolution affect the probability for extinctions. Our results highlight the urge for cautiousness when predicting the future concerning probabilities for extreme population events.	[Bjorkman, Christer; Hoglund, Solveig; Eklund, Karin] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Kindvall, Oskar] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden; [Lilja, Anna; Barring, Lars] Swedish Meteorol & Hydrol Inst, Rossby Ctr, Norrkoping, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish Meteorological & Hydrological Institute	Bjorkman, C (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	christer.bjorkman@slu.se			Mistra Future Forests [FOR 2008/019]; Formas [217-2005-1326]; Swedish Energy Agency [30599-1]; Mistra-SWECIA [FOR 2006/160]	Mistra Future Forests; Formas(Swedish Research Council Formas); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Mistra-SWECIA	Funding for this work was provided by the following: 1. Dnr FOR 2008/019 (Mistra Future Forests) - http://www.mistra.org/mistraenglish/research.4.39aa239f11a8dd8de6b80004117.html. 2. Dnr 217-2005-1326 (Formas) - http://www.formas.se/default_529.aspx. 3. Proj.nr. 30599-1 (Swedish Energy Agency) http://www. energimyndigheten.se/en/. 4. Dnr FOR 2006/160 (Mistra-SWECIA) - http://www.mistra.org/mistraenglish/research.4.39aa239f11a8dd8de6b80004117.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha H.G., 1954, DISTRIBUTION ABUNDAN, P782; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Berggren A, 2009, OIKOS, V118, P1121, DOI 10.1111/j.1600-0706.2009.17558.x; Berryman A.A., 1987, P3; Bjorkman C, 2006, AGR FOREST ENTOMOL, V8, P97, DOI 10.1111/j.1461-9555.2006.00288.x; Bjorkman C, 2000, POPUL ECOL, V42, P91, DOI 10.1007/s101440050013; Bjorkman C, 2004, ECOL APPL, V14, P1624, DOI 10.1890/03-5341; Bjorkman C., 2000, Agricultural and Forest Entomology, V2, P131, DOI 10.1046/j.1461-9563.2000.00058.x; BLECK R, 1992, J PHYS OCEANOGR, V22, P1486, DOI 10.1175/1520-0485(1992)022<1486:SDTTIA>2.0.CO;2; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BOONSTRA R, 1987, EVOLUTION, V41, P929, DOI 10.1111/j.1558-5646.1987.tb05868.x; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Chu Y.-I., 1986, P77; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Dalin P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005487; Deque M, 2007, CLIMATIC CHANGE, V81, P53, DOI 10.1007/s10584-006-9228-x; DEQUE M, 1994, CLIM DYNAM, V10, P249, DOI 10.1007/BF00208992; Deque M, 2007, GLOBAL PLANET CHANGE, V57, P16, DOI 10.1016/j.gloplacha.2006.11.030; Fleming RA, 1998, ENVIRON MONIT ASSESS, V49, P235, DOI 10.1023/A:1005818108382; Gibelin AL, 2003, CLIM DYNAM, V20, P327, DOI 10.1007/s00382-002-0277-1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Harrington R, 2001, AGR FOREST ENTOMOL, V3, P233, DOI 10.1046/j.1461-9555.2001.00120.x; Holopainen JK, 2004, CAN J FOREST RES, V34, P94, DOI [10.1139/x03-203, 10.1139/X03-203]; Hourdin F, 2006, CLIM DYNAM, V27, P787, DOI 10.1007/s00382-006-0158-0; Jungclaus JH, 2006, J CLIMATE, V19, P3952, DOI 10.1175/JCLI3827.1; KENDALL DA, 1996, BM40048714REP ETSU H, P44; Kjellstrom E., 2005, 140 YEAR SIMULATION; Kjellstrom E, 2011, TELLUS A, V63, P24, DOI 10.1111/j.1600-0870.2010.00475.x; KREBS CJ, 1978, CAN J ZOOL, V56, P2463, DOI 10.1139/z78-335; Larsson S, 2000, OIKOS, V89, P440, DOI 10.1034/j.1600-0706.2000.890303.x; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; MAISNER N, 1974, FORSTSCHADLINGE EURO, V2, P202; Masson-Delmotte V, 2018, SPEC REP GLOB WARM 1; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; NILSSEN A, 1990, ENTOMOL EXP APPL, V57, P39, DOI 10.1007/BF00349594; OHGUSHI T, 1995, POPULATION DYNAMICS, P251; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Peterson NA, 1996, ENVIRON ENTOMOL, V25, P147, DOI 10.1093/ee/25.1.147; Rall BC, 2010, GLOBAL CHANGE BIOL, V16, P2145, DOI 10.1111/j.1365-2486.2009.02124.x; Roeckner E, 2006, J CLIMATE, V19, P3771, DOI 10.1175/JCLI3824.1; Roff Derek A., 1992; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Roy M, 2003, BIOCONTROL, V48, P57, DOI 10.1023/A:1021289832664; RUOHOMAKI K, 1992, ECOL ENTOMOL, V17, P69, DOI 10.1111/j.1365-2311.1992.tb01041.x; Samuelsson P, 2011, TELLUS A, V63, P4, DOI 10.1111/j.1600-0870.2010.00478.x; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; *SMHI, 1999, WEATH WAT; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Tenow O, 1999, J APPL ECOL, V36, P111, DOI 10.1046/j.1365-2664.1999.00385.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; WATT WB, 1992, P NATL ACAD SCI USA, V89, P10608, DOI 10.1073/pnas.89.22.10608; WILLIAMS DW, 1995, ENVIRON ENTOMOL, V24, P1, DOI 10.1093/ee/24.1.1; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x	60	9	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16590	10.1371/journal.pone.0016590	http://dx.doi.org/10.1371/journal.pone.0016590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304605	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900078
J	Leppiniemi, J; Maatta, JAE; Hammaren, H; Soikkeli, M; Laitaoja, M; Janis, J; Kulomaa, MS; Hytonen, VP				Leppiniemi, Jenni; Maatta, Juha A. E.; Hammaren, Henrik; Soikkeli, Mikko; Laitaoja, Mikko; Janis, Janne; Kulomaa, Markku S.; Hytonen, Vesa P.			Bifunctional Avidin with Covalently Modifiable Ligand Binding Site	PLOS ONE			English	Article							CIRCULARLY PERMUTED AVIDINS; BIOTIN-BINDING; CHICKEN AVIDIN; CRYSTAL-STRUCTURE; QUATERNARY STRUCTURE; HIGH-AFFINITY; CHAIN AVIDIN; STREPTAVIDIN; PROTEIN; COMPLEX	The extensive use of avidin and streptavidin in life sciences originates from the extraordinary tight biotin-binding affinity of these tetrameric proteins. Numerous studies have been performed to modify the biotin-binding affinity of (strept) avidin to improve the existing applications. Even so, (strept) avidin greatly favours its natural ligand, biotin. Here we engineered the biotin-binding pocket of avidin with a single point mutation S16C and thus introduced a chemically active thiol group, which could be covalently coupled with thiol-reactive molecules. This approach was applied to the previously reported bivalent dual chain avidin by modifying one binding site while preserving the other one intact. Maleimide was then coupled to the modified binding site resulting in a decrease in biotin affinity. Furthermore, we showed that this thiol could be covalently coupled to other maleimide derivatives, for instance fluorescent labels, allowing intratetrameric FRET. The bifunctional avidins described here provide improved and novel tools for applications such as the biofunctionalization of surfaces.	[Leppiniemi, Jenni; Maatta, Juha A. E.; Hammaren, Henrik; Soikkeli, Mikko; Kulomaa, Markku S.; Hytonen, Vesa P.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Leppiniemi, Jenni; Maatta, Juha A. E.; Hammaren, Henrik; Soikkeli, Mikko; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Laitaoja, Mikko; Janis, Janne] Univ Eastern Finland, Dept Chem, Joensuu, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland	Leppiniemi, J (corresponding author), Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland.	vesa.hytonen@uta.fi	Leppiniemi, Jenni/A-6641-2016; Hytonen, Vesa P./E-8855-2013; Jänis, Janne/B-7326-2014; Kulomaa, Markku S/C-9063-2014; Leppiniemi, Jenni/S-6262-2019; Määttä, Juha/A-6629-2016	Leppiniemi, Jenni/0000-0002-7225-1648; Hytonen, Vesa P./0000-0002-9357-1480; Leppiniemi, Jenni/0000-0002-7225-1648; Määttä, Juha/0000-0003-3885-6149; Laitaoja, Mikko/0000-0003-4516-8627; Hammaren, Henrik/0000-0002-8534-2530	Tampere Graduate Program in Biomedicine and Biotechnology; Academy of Finland [SA 121236, SA 115976]; Finnish Funding Agency for Technology and Innovation [TEKES 40055/08]	Tampere Graduate Program in Biomedicine and Biotechnology; Academy of Finland(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by Tampere Graduate Program in Biomedicine and Biotechnology, the Academy of Finland [SA 121236, SA 115976] and the Finnish Funding Agency for Technology and Innovation [TEKES 40055/08]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airenne KJ, 1997, PROTEIN EXPRES PURIF, V9, P100, DOI 10.1006/prep.1996.0660; Aslan FM, 2005, P NATL ACAD SCI USA, V102, P8507, DOI 10.1073/pnas.0503112102; BAYER EA, 1995, BBA-GENE STRUCT EXPR, V1263, P60, DOI 10.1016/0167-4781(95)00077-T; Dixon RW, 2002, J ORG CHEM, V67, P1827, DOI 10.1021/jo991846s; Eisenberg-Domovich Y, 2005, ACTA CRYSTALLOGR D, V61, P528, DOI 10.1107/S0907444905003914; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Freitag S, 1999, P NATL ACAD SCI USA, V96, P8384, DOI 10.1073/pnas.96.15.8384; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; Gruber HJ, 1998, BBA-GEN SUBJECTS, V1381, P203, DOI 10.1016/S0304-4165(98)00029-4; Helppolainen SH, 2008, BBA-PROTEINS PROTEOM, V1784, P1002, DOI 10.1016/j.bbapap.2008.04.010; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hyre DE, 2000, PROTEIN SCI, V9, P878, DOI 10.1110/ps.9.5.878; Hytonen VP, 2006, J MOL BIOL, V359, P1352, DOI 10.1016/j.jmb.2006.04.044; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; Kada G, 1999, BBA-GEN SUBJECTS, V1427, P33, DOI 10.1016/S0304-4165(98)00178-0; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Kopetzki E, 2002, Patent, Patent No. [US6391571 (B1), 6391571]; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Marttila AT, 2003, BIOCHEM J, V369, P249, DOI 10.1042/BJ20020886; Morag E, 1996, BIOCHEM J, V316, P193, DOI 10.1042/bj3160193; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Reznik GO, 1998, P NATL ACAD SCI USA, V95, P13525, DOI 10.1073/pnas.95.23.13525; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5	31	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16576	10.1371/journal.pone.0016576	http://dx.doi.org/10.1371/journal.pone.0016576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305032	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900076
J	Goparaju, CM; Blasberg, JD; Volinia, S; Palatini, J; Ivanov, S; Donington, JS; Croce, C; Carbone, M; Yang, H; Pass, HI				Goparaju, C. M.; Blasberg, J. D.; Volinia, S.; Palatini, J.; Ivanov, S.; Donington, J. S.; Croce, C.; Carbone, M.; Yang, H.; Pass, H. I.			Onconase mediated NFK beta downregulation in malignant pleural mesothelioma	ONCOGENE			English	Article						mesothelioma; microRNA; multidrug resistance	CYTOTOXIC RIBONUCLEASE ONCONASE; TYROSINE KINASE INHIBITOR; HUMAN LUNG-CANCER; KAPPA-B; ANTITUMOR RIBONUCLEASE; CELL-LINES; EXPRESSION PROFILES; RADIATION RESPONSE; INDUCED APOPTOSIS; DRUG-RESISTANCE	Treatment of malignant pleural mesothelioma (MPM) with Ranpirnase (Onconase) results in disruption of protein translation and cell apoptosis. We hypothesize that Onconase exerts an effect via downregulation of nuclear factor kappa B (NFK beta) by specific microRNAs (miRNAs) and that interference of this pathway could have implications for MPM resistance to chemotherapy. Three immortalized MPM cell lines (H2959, H2373 and H2591) were exposed to Onconase at 0-20 mu g/ml. Cell counts were measured at 48 and 72 h. Gene expression in miRNA-enriched RNA was validated by reverse transcription-PCR (RT-PCR). The functional implications of miRNA expression were evaluated by transfecting miRNA mimics or inhibitors into MPM cell lines, and performing Matrigel invasion, cell proliferation, soft agar colony formation and scratch closure assays. Effects on NFK beta expression and downstream targets including ABC transporters, BCL-xl and IAP were assessed by RT-PCR and western blotting. Treatment with 20 mu g/ml of Onconase significantly decreased cell count and invasion. Hsa-miR-17* was significantly upregulated and hsa-miR-30c was significantly downregulated by Onconase treatment in all cell lines. Forced expression of hsa-miR-17* mimic and hsa-miR-30c inhibitor each significantly decreased functional activity of Onconase in all assays. NFKB1 (p50) expression and downstream targets were also decreased with Onconase treatment, as well as with forced expression of miRNA mimic and inhibitors. Onconase treatment caused a significant decrease in cell proliferation, invasion and in expression of certain miRNAs. Recapitulation of the resultant miRNA expression pattern with hsa-miR-17* mimic and hsa-miR-30c inhibitor resulted in downregulation of NFKB1 and reduced malignant behavior in functional assays. Thus, Onconase likely exerts its antitumor effect through these miRNAs. Oncogene (2011) 30, 2767-2777; doi: 10.1038/onc.2010.643; published online 14 February 2011	[Goparaju, C. M.; Donington, J. S.; Pass, H. I.] NYU, Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA; [Blasberg, J. D.] Columbia Univ Coll Phys & Surg, St Lukes Roosevelt Med Ctr, Dept Gen Surg, New York, NY 10032 USA; [Volinia, S.; Palatini, J.; Croce, C.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Ivanov, S.] Vanderbilt Univ, Med Ctr, Dept Otolaryngol, Nasville, TN USA; [Carbone, M.; Yang, H.] Univ Hawaii, Canc Res Ctr Hawaii, Honolulu, HI 96813 USA	New York University; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Vanderbilt University; Cancer Research Center of Hawaii; University of Hawaii System	Pass, HI (corresponding author), NYU, Med Ctr, Dept Cardiothorac Surg, 530 1st Ave,Suite 9V, New York, NY 10016 USA.	Harvey.Pass@nyumc.org	Young, Richard A/F-6495-2012; Volinia, Stefano/A-3029-2010; Volinia, Stefano/AAA-9264-2019	Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Pass, Harvey/0000-0003-3222-3471; Palatini, Jeffrey/0000-0001-9280-4417; Ivanov, Sergey/0000-0001-9770-7237	NCI/NIH EDRN Biomarker Discovery Laboratory [UO1CA1111295, 1PO1 CA114047-D1A1]; NATIONAL CANCER INSTITUTE [P01CA114047] Funding Source: NIH RePORTER	NCI/NIH EDRN Biomarker Discovery Laboratory(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ranpirnase was provided by AlphaCell Corporation, Paramus, NJ, USA. We also wish to acknowledge the generous support of Belluck and Fox, LPA for this project. Supported by NCI/NIH EDRN Biomarker Discovery Laboratory Grant UO1CA1111295 to Dr Pass and 1PO1 CA114047-D1A1 to Dr Carbone.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ardelt B, 2007, INT J ONCOL, V31, P663; Ardelt B, 2003, CELL CYCLE, V2, P22, DOI 10.4161/cc.2.1.232; Barnhart BC, 2003, CELL, V114, P148, DOI 10.1016/S0092-8674(03)00561-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao XB, 2007, CANCER BIOL THER, V6, P246, DOI 10.4161/cbt.6.2.3626; Carbone M, 2007, ONCOGENE, V26, P6959, DOI 10.1038/sj.onc.1210515; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deptala A, 1998, INT J ONCOL, V13, P11; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Gillet JP, 2007, BBA-REV CANCER, V1775, P237, DOI 10.1016/j.bbcan.2007.05.002; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; Gordon GJ, 2007, J PATHOL, V211, P439, DOI 10.1002/path.2120; Halicka DH, 2002, INT J ONCOL, V21, P1245; Iordanov MS, 2000, CANCER RES, V60, P1983; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kasashima K, 2004, BIOCHEM BIOPH RES CO, V322, P403, DOI 10.1016/j.bbrc.2004.07.130; Kaufman AJ, 2008, EXPERT REV ANTICANC, V8, P293, DOI 10.1586/14737140.8.2.293; Kbeck A, 2008, FUTURE ONCOL, V4, P341, DOI 10.2217/14796694.4.3.341; Khokhar NZ, 2001, CLIN CANCER RES, V7, P3199; Kim DH, 2007, ADV EXP MED BIOL, V599, P53; Kobe B, 1996, J MOL BIOL, V264, P1028, DOI 10.1006/jmbi.1996.0694; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lee I, 2008, EXPERT OPIN BIOL TH, V8, P813, DOI 10.1517/14712598.8.6.813 ; Lee I, 2007, IN VIVO, V21, P721; Lee JE, 2008, BIODRUGS, V22, P53, DOI 10.2165/00063030-200822010-00006; Littlejohn JE, 2008, INT J CANCER, V123, P202, DOI 10.1002/ijc.23452; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MIKULSKI SM, 1992, BRIT J CANCER, V66, P304, DOI 10.1038/bjc.1992.261; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Pavlakis N, 2006, EXPERT OPIN BIOL TH, V6, P391, DOI 10.1517/14712598.6.4.391; Porta C, 2008, BIOL-TARGETS THER, V2, P601; RECK M, 2009, J CLIN ONCOL S, V27, pNIL96; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robledo R, 1999, J CELL PHYSIOL, V180, P158, DOI 10.1002/(SICI)1097-4652(199908)180:2<158::AID-JCP3>3.0.CO;2-R; Rybak SM, 1996, J NATL CANCER I, V88, P747, DOI 10.1093/jnci/88.11.747; Saxena SK, 2002, J BIOL CHEM, V277, P15142, DOI 10.1074/jbc.M108115200; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Shi Z, 2009, ONCOL REP, V21, P483, DOI 10.3892/or_00000248; Shukla S, 2009, DRUG METAB DISPOS, V37, P359, DOI 10.1124/dmd.108.024612; Singh UP, 2007, J MOL BIOL, V371, P93, DOI 10.1016/j.jmb.2007.04.071; Soini Y, 2001, ANN ONCOL, V12, P1239, DOI 10.1023/A:1012292230480; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Symanowski J, 2009, J THORAC ONCOL, V4, P149, DOI 10.1097/JTO.0b013e318194f991; Tsai SY, 2004, INT J ONCOL, V25, P1745; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; WU YN, 1993, J BIOL CHEM, V268, P10686; Yang HN, 2006, P NATL ACAD SCI USA, V103, P10397, DOI 10.1073/pnas.0604008103; Yang HN, 2008, CURR TREAT OPTION ON, V9, P147, DOI 10.1007/s11864-008-0067-z; Zhao H, 2008, CELL CYCLE, V7, P3258, DOI 10.4161/cc.7.20.6855	57	47	52	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	24					2767	2777		10.1038/onc.2010.643	http://dx.doi.org/10.1038/onc.2010.643			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21317924	Green Accepted			2022-12-25	WOS:000291678500007
J	Chou, TF; Deshaies, RJ				Chou, Tsui-Fen; Deshaies, Raymond J.			Quantitative Cell-based Protein Degradation Assays to Identify and Classify Drugs That Target the Ubiquitin-Proteasome System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-NITROSTYRENE DERIVATIVES; AAA-ATPASE CDC48/P97; ELEVATED EXPRESSION; P97; INHIBITORS; ER; RECOGNITION; PROGNOSIS; COMPLEX; APOPTOSIS	We have generated a set of dual-reporter human cell lines and devised a chase protocol to quantify proteasomal degradation of a ubiquitin fusion degradation (UFD) substrate, a ubiquitin ligase CRL2(VHL) substrate, and a ubiquitin-independent substrate. Well characterized inhibitors that target different aspects of the ubiquitin-proteasome system can be distinguished by their distinctive patterns of substrate stabilization, enabling assignment of test compounds as inhibitors of the proteasome, ubiquitin chain formation or perception, CRL activity, or the UFD-p97 pathway. We confirmed that degradation of the UFD but not the CRL2(VHL) or ubiquitin-independent substrates depends on p97 activity. We optimized our suite of assays to establish conditions suitable for high-throughput screening and then validated their performance by screening against 160 cell-permeable protein kinase inhibitors. This screen identified Syk inhibitor III as an irreversible p97/vasolin containing protein inhibitor (IC50 = 1.7 mu M) that acts through Cys-522 within the D2 ATPase domain. Our work establishes a high-throughput screening-compatible pipeline for identification and classification of small molecules, cDNAs, or siRNAs that target components of the ubiquitin-proteasome system.	[Chou, Tsui-Fen; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Deshaies, Raymond J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Chou, TF (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	tfchou@caltech.edu; deshaies@caltech.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354	National Institutes of Health [R03 MH085687]; Howard Hughes Medical Institute; Multiple Myeloma Research Foundation; Weston Havens Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Multiple Myeloma Research Foundation; Weston Havens Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R03 MH085687. This work was also supported by the Howard Hughes Medical Institute.; Supported by a 2008 Fellows Grant Program Award from the Multiple Myeloma Research Foundation, the Howard Hughes Medical Institute, and the Weston Havens Foundation. To whom correspondence may be addressed. E-mail: tfchou@caltech.edu.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Alvarez-Castelao B, 2009, J BIOL CHEM, V284, P28253, DOI 10.1074/jbc.M109.004101; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beskow A, 2009, J MOL BIOL, V394, P732, DOI 10.1016/j.jmb.2009.09.050; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Boyault C, 2006, EMBO J, V25, P3357, DOI 10.1038/sj.emboj.7601210; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Colson Kathleen, 2004, Clin J Oncol Nurs, V8, P473, DOI 10.1188/04.CJON.473-480; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding WX, 2007, APOPTOSIS, V12, P2233, DOI 10.1007/s10495-007-0142-0; Eldridge AG, 2010, CELL DEATH DIFFER, V17, P4, DOI 10.1038/cdd.2009.82; Elofsson M, 1999, CHEM BIOL, V6, P811, DOI 10.1016/S1074-5521(99)80128-8; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Golbik R, 1999, BIOL CHEM, V380, P1049, DOI 10.1515/BC.1999.131; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kimbrel EA, 2009, MOL IMAGING, V8, P140, DOI 10.2310/7290.2009.00007; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Milhazes N, 2006, BIOORGAN MED CHEM, V14, P4078, DOI 10.1016/j.bmc.2006.02.006; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Noguchi M, 2005, J BIOL CHEM, V280, P41332, DOI 10.1074/jbc.M509700200; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Patel S, 2008, EXPERT OPIN INV DRUG, V17, P1865, DOI 10.1517/13543780802493366 ; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2003, J CLIN ONCOL, V21, P447, DOI 10.1200/JCO.2003.06.068; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	49	49	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16546	16554		10.1074/jbc.M110.215319	http://dx.doi.org/10.1074/jbc.M110.215319			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21343295	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000290301900003
J	Wands, AM; Wang, N; Lum, JK; Hsieh, J; Fierke, CA; Mapp, AK				Wands, Amberlyn M.; Wang, Ningkun; Lum, Jenifer K.; Hsieh, John; Fierke, Carol A.; Mapp, Anna K.			Transient-state Kinetic Analysis of Transcriptional Activator center dot DNA Complexes Interacting with a Key Coactivator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TERMINAL TRANSACTIVATION DOMAIN; IN-VIVO; STRUCTURAL BASIS; CROSS-LINKING; PROTEIN; MEDIATOR; BINDING; RECOGNITION; MECHANISM	Several lines of evidence suggest that the prototypical amphipathic transcriptional activators Gal4, Gcn4, and VP16 interact with the key coactivator Med15 (Gal11) during transcription initiation despite little sequence homology. Recent cross-linking data further reveal that at least two of the activators utilize the same binding surface within Med15 for transcriptional activation. To determine whether these three activators use a shared binding mechanism for Med15 recruitment, we characterized the thermodynamics and kinetics of Med15 center dot activator center dot DNA complex formation by fluorescence titration and stopped-flow techniques. Combination of each activator center dot DNA complex with Med15 produced biphasic time courses. This is consistent with a minimum two-step binding mechanism composed of a bimolecular association step limited by diffusion, followed by a conformational change in the Med15 center dot activator center dot DNA complex. Furthermore, the equilibrium constant for the conformational change (K-2) correlates with the ability of an activator to stimulate transcription. VP16, the most potent of the activators, has the largest K-2 value, whereas Gcn4, the least potent, has the smallest value. This correlation is consistent with a model in which transcriptional activation is regulated at least in part by the rearrangement of the Med15 center dot activator center dot DNA ternary complex. These results are the first detailed kinetic characterization of the transcriptional activation machinery and provide a framework for the future design of potent transcriptional activators.	[Wands, Amberlyn M.; Hsieh, John; Fierke, Carol A.; Mapp, Anna K.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lum, Jenifer K.; Mapp, Anna K.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Fierke, Carol A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wang, Ningkun; Fierke, Carol A.; Mapp, Anna K.] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fierke, CA (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	fierke@umich.edu; amapp@umich.edu	, Dr Anna Mapp/GPX-8261-2022	Wang, Ningkun/0000-0003-3545-5323	National Institutes of Health [GM65330, GM55387]; Novartis Young Investigator Award; Pharmaceutical Sciences Training Program Training Grant [GM7767]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767, R01GM065330, R01GM055387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Young Investigator Award; Pharmaceutical Sciences Training Program Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM65330 (to A. K. M.) and GM55387 (to C. A. F.). This work was supported by a Novartis Young Investigator Award (to A. K. M.) and by Pharmaceutical Sciences Training Program Training Grant GM7767 (to A. M. W. and N. W.).	Ansari AZ, 1998, P NATL ACAD SCI USA, V95, P13543, DOI 10.1073/pnas.95.23.13543; Archer CT, 2010, NUCLEIC ACIDS RES, V38, P789, DOI 10.1093/nar/gkp1066; CHANG J, 1995, J BIOL CHEM, V270, P25014, DOI 10.1074/jbc.270.42.25014; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Demchenko AP, 2001, J MOL RECOGNIT, V14, P42, DOI 10.1002/1099-1352(200101/02)14:1<42::AID-JMR518>3.0.CO;2-8; DONALDSON L, 1992, J BIOL CHEM, V267, P1411; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferreira ME, 2005, J BIOL CHEM, V280, P21779, DOI 10.1074/jbc.M502627200; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Hermann S, 2001, J BIOL CHEM, V276, P40127, DOI 10.1074/jbc.M103793200; Hidalgo P, 2001, GENE DEV, V15, P1007, DOI 10.1101/gad.873901; Hong MQ, 2008, STRUCTURE, V16, P1019, DOI 10.1016/j.str.2008.03.015; Hsieh J, 2009, RNA, V15, P1565, DOI 10.1261/rna.1639409; Jeong CJ, 2001, BIOCHEMISTRY-US, V40, P9421, DOI 10.1021/bi010011k; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; JOHNSON KA, 1986, METHOD ENZYMOL, V134, P677; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kim DH, 2009, BMB REP, V42, P411, DOI 10.5483/BMBRep.2009.42.7.411; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee LW, 2010, J BIOL CHEM, V285, P11033, DOI 10.1074/jbc.R109.075044; Liang SD, 1996, MOL CELL BIOL, V16, P3773; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; Majmudar CY, 2009, ANGEW CHEM INT EDIT, V48, P7021, DOI 10.1002/anie.200902669; Mapp AK, 2007, ACS CHEM BIOL, V2, P62, DOI 10.1021/cb600463w; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Paal K, 1997, NUCLEIC ACIDS RES, V25, P1050, DOI 10.1093/nar/25.5.1050; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PTASHNE M, 2002, GENES SIGNALS; Rea AM, 2009, BIOCHEMISTRY-US, V48, P7556, DOI 10.1021/bi900805s; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Thoden JB, 2008, J BIOL CHEM, V283, P30266, DOI 10.1074/jbc.M805200200; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Volkman HM, 2005, J AM CHEM SOC, V127, P4649, DOI 10.1021/ja042761y; Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu YB, 1996, EMBO J, V15, P3951, DOI 10.1002/j.1460-2075.1996.tb00769.x; Wu ZQ, 2003, J AM CHEM SOC, V125, P12390, DOI 10.1021/ja036685v; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	49	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.207589	http://dx.doi.org/10.1074/jbc.M110.207589			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21317429	Green Published, hybrid			2022-12-25	WOS:000290022800063
J	Kar, P; Nelson, C; Parekh, AB				Kar, Pulak; Nelson, Charmaine; Parekh, Anant B.			Selective Activation of the Transcription Factor NFAT1 by Calcium Microdomains near Ca2+ Release-activated Ca2+ (CRAC) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-LYMPHOCYTES; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; MAST-CELLS; CALCINEURIN; CALMODULIN; INACTIVATION; OSCILLATIONS; MECHANISM; MESSENGER	NFATs are a family of Ca2+-dependent transcription factors that play a central role in the morphogenesis, development, and physiological activities of numerous distinct cell types and organ systems. Here, we visualize NFAT1 movement in and out of the nucleus in response to transient activation of store-operated Ca2+ release-activated Ca2+(CRAC) channels in nonexcitable cells. We show that NFAT migration is exquisitely sensitive to Ca2+ microdomains near open CRAC channels. Another Ca2+-permeable ion channel (TRPC3) was ineffective in driving NFAT1 to the nucleus. NFAT1 movement is temporally dissociated from the time course of the Ca2+ signal and remains within the nucleus for 10 times longer than the duration of the trigger Ca2+ signal. Kinetic analyses of each step linking CRAC channel activation to NFAT1 nuclear residency reveals that the rate-limiting step is transcription factor exit from the nucleus. The slow deactivation of NFAT provides a mechanism whereby Ca2+-dependent responses can be sustained despite the termination of the initial Ca2+ signal and helps explain how gene expression in nonexcitable cells can continue after the primary stimulus has been removed.	[Kar, Pulak; Nelson, Charmaine; Parekh, Anant B.] Univ Oxford, Dept Physiol, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			Medical Research Council (United Kingdom); British Heart Foundation; MRC [G1000813] Funding Source: UKRI; Medical Research Council [G1000813] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (United Kingdom) and the British Heart Foundation Centre of Excellence award.	Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Kummerow C, 2009, IMMUNOL REV, V231, P132, DOI 10.1111/j.1600-065X.2009.00811.x; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Parekh AB, 2000, P NATL ACAD SCI USA, V97, P12933, DOI 10.1073/pnas.97.24.12933; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2008, J PHYSIOL-LONDON, V586, P3043, DOI 10.1113/jphysiol.2008.153460; Parekh AB, 2008, CELL CALCIUM, V44, P6, DOI 10.1016/j.ceca.2007.12.006; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200	39	92	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14795	14803		10.1074/jbc.M111.220582	http://dx.doi.org/10.1074/jbc.M111.220582			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21325277	hybrid, Green Published			2022-12-25	WOS:000289788300009
J	Ouedraogo, JP; Hagen, S; Spielvogel, A; Engelhardt, S; Meyer, V				Ouedraogo, Jean Paul; Hagen, Silke; Spielvogel, Anja; Engelhardt, Susanne; Meyer, Vera			Survival Strategies of Yeast and Filamentous Fungi against the Antifungal Protein AFP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL INTEGRITY; HOST-PATHOGEN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-GIGANTEUS; CHITIN SYNTHESIS; PLASMA-MEMBRANE; CALCOFLUOR WHITE; BASIC CONCEPTS; NIGER; PATHWAY	The activities of signaling pathways are critical for fungi to survive antifungal attack and to maintain cell integrity. However, little is known about how fungi respond to antifungals, particularly if these interact with multiple cellular targets. The antifungal protein AFP is a very potent inhibitor of chitin synthesis and membrane integrity in filamentous fungi and has so far not been reported to interfere with the viability of yeast strains. With the hypothesis that the susceptibility of fungi toward AFP is not merely dependent on the presence of an AFP-specific target at the cell surface but relies also on the cell's capacity to counteract AFP, we used a genetic approach to decipher defense strategies of the naturally AFP-resistant strain Saccharomyces cerevisiae. The screening of selected strains from the yeast genomic deletion collection for AFP-sensitive phenotypes revealed that a concerted action of calcium signaling, TOR signaling, cAMP-protein kinase A signaling, and cell wall integrity signaling is likely to safeguard S. cerevisiae against AFP. Our studies uncovered that the yeast cell wall gets fortified with chitin to defend against AFP and that this response is largely dependent on calcium/Crz1p signaling. Most importantly, we observed that stimulation of chitin synthesis is characteristic for AFP-resistant fungi but not for AFP-sensitive fungi, suggesting that this response is a successful strategy to protect against AFP. We finally propose the adoption of the damage-response framework of microbial pathogenesis for the interactions of antimicrobial proteins and microorganisms in order to comprehensively understand the outcome of an antifungal attack.	[Hagen, Silke; Spielvogel, Anja; Engelhardt, Susanne; Meyer, Vera] Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, D-13355 Berlin, Germany; [Ouedraogo, Jean Paul; Meyer, Vera] Leiden Univ, Inst Biol, Dept Mol Microbiol & Biotechnol, NL-2333 BE Leiden, Netherlands	Technical University of Berlin; Leiden University; Leiden University - Excl LUMC	Meyer, V (corresponding author), Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, Gustav Meyer Allee 25, D-13355 Berlin, Germany.	vera.meyer@tu-berlin.de		Meyer, Vera/0000-0002-2298-2258; Ouedraogo, Jean-Paul/0000-0002-9735-6235; Spielvogel, Anja/0000-0001-9345-6821	Federal Ministry of Economics and Technology (AiF) [13305N]; German Academic Exchange Service	Federal Ministry of Economics and Technology (AiF)(Federal Ministry for Economic Affairs and Energy (BMWi)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Federal Ministry of Economics and Technology (AiF) Grant 13305N) and by a grant from the German Academic Exchange Service (to J.P.O.).	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274; Barakat H, 2010, APPL MICROBIOL BIOT, V87, P617, DOI 10.1007/s00253-010-2508-4; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bennett JW, 1991, MORE GENE MANIPULATI; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Binder U, 2010, EUKARYOT CELL, V9, P1374, DOI 10.1128/EC.00050-10; Brachmann CB, 1998, YEAST, V14, P115; CABIB E, 1992, J GEN MICROBIOL, V138, P97, DOI 10.1099/00221287-138-1-97; CAMPOSOLIVAS R, 1995, BIOCHEMISTRY-US, V34, P3009, DOI 10.1021/bi00009a032; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999; Casadevall A, 2000, INFECT IMMUN, V68, P6511, DOI 10.1128/IAI.68.12.6511-6518.2000; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chopra R, 1999, APPL ENVIRON MICROB, V65, P2267; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; del Pozo AM, 2002, J BIOL CHEM, V277, P46179, DOI 10.1074/jbc.M207472200; Fortwendel JR, 2009, ANTIMICROB AGENTS CH, V53, P476, DOI 10.1128/AAC.01154-08; FRANTZ S, 2005, BIOCHIM BIOPHYS ACTA, V437, P11; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Grossmann G, 2008, J CELL BIOL, V183, P1075, DOI 10.1083/jcb.200806035; Hagen S, 2007, APPL ENVIRON MICROB, V73, P2128, DOI 10.1128/AEM.02497-06; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Leiter E, 2005, ANTIMICROB AGENTS CH, V49, P2445, DOI 10.1128/AAC.49.6.2445-2453.2005; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Meyer V, 2002, MOL GENET GENOMICS, V266, P747, DOI 10.1007/s00438-001-0609-6; MEYER V, 2011, APPL ENV MI IN PRESS; Meyer V, 2008, APPL MICROBIOL BIOT, V78, P17, DOI 10.1007/s00253-007-1291-3; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Plaine A, 2008, FUNGAL GENET BIOL, V45, P1404, DOI 10.1016/j.fgb.2008.08.003; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Rodicio R, 2010, YEAST, V27, P531, DOI 10.1002/yea.1785; RONCERO C, 1988, J BACTERIOL, V170, P1945, DOI 10.1128/jb.170.4.1945-1949.1988; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Sambrook J, 2001, MOL CLONING LAB MANU; Sanz M, 2004, MICROBIOL-SGM, V150, P3229, DOI 10.1099/mic.0.27352-0; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tamaki H, 2007, J BIOSCI BIOENG, V104, P245, DOI 10.1263/jbb.104.245; Theis T, 2005, RES MICROBIOL, V156, P47, DOI 10.1016/j.resmic.2004.08.006; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; TRACEY MV, 1955, MOD METHOD PLANT, V2, P264; VANGORCOM RFM, 1988, NUCLEIC ACIDS RES, V16, P9052, DOI 10.1093/nar/16.18.9052; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang NN, 2006, MOL BIOL CELL, V17, P3409, DOI 10.1091/mbc.E06-03-0177; Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565; Ziman M, 1996, MOL BIOL CELL, V7, P1909, DOI 10.1091/mbc.7.12.1909; Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835	63	44	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					13859	13868		10.1074/jbc.M110.203588	http://dx.doi.org/10.1074/jbc.M110.203588			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21343301	Green Published, hybrid			2022-12-25	WOS:000289556200009
J	Akhtart, K; Broekelnnann, TJ; Song, HW; Turk, J; Brett, TJ; Mecham, RP; Adair-Kirk, TL				Akhtart, Kamal; Broekelnnann, Thomas J.; Song, Haowei; Turk, John; Brett, Tom J.; Mecham, Robert P.; Adair-Kirk, Tracy L.			Oxidative Modifications of the C-terminal Domain of Tropoelastin Prevent Cell Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPRAVALVULAR AORTIC-STENOSIS; SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; ELASTIN GENE; VASCULAR MORPHOGENESIS; SUPEROXIDE DISMUTASE; CUTIS LAXA; DISEASE; EXPRESSION; INTEGRIN	Tropoelastin (TE), the soluble monomer of elastin, is synthesized by elastogenic cells, such as chondrocytes, fibroblasts, and smooth muscle cells (SMCs). The C-terminal domain of TE interacts with cell receptors, and these interactions play critical roles in elastic fiber assembly. We recently found that oxidation of TE prevents elastic fiber assembly. Here, we examined the effects of oxidation of TE on cell interactions. We found that SMCs bind to TE through heparan sulfate (HS), whereas fetal lung fibroblasts (WI-38 cells) bind through integrin a,alpha(v)beta(3) and HS. In addition, we found that oxidation of TE by peroxynitrite (ONOO-) prevented binding of SMCs and WI-38 cells and other elastogenic cells, human dermal fibroblasts and fetal bovine chondrocytes. Because the C-terminal domain of TE has binding sites for both HS and integrin, we examined the effects of oxidation of a synthetic peptide derived from the C-terminal 25 amino acids of TE (CT-25) on cell binding. The CT-25 peptide contains the only two Cys residues in TE juxtaposed to a cluster of positively charged residues (RKRK) that are important for cell binding. ONOO- treatment of the CT-25 peptide prevented cell binding, whereas reduction of the CT-25 peptide had no effect. Mass spectrometric and circular dichroism spectroscopic analyses showed that ONOO- treatment modified both Cys residues in the CT-25 peptide to sulfonic acid derivatives, without altering the secondary structure. These data suggest that the mechanism by which ONOO- prevents cell binding to TE is by introducing negatively charged sulfonic acid residues near the positively charged cluster.	[Akhtart, Kamal; Song, Haowei; Turk, John; Brett, Tom J.; Mecham, Robert P.; Adair-Kirk, Tracy L.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Broekelnnann, Thomas J.; Mecham, Robert P.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Adair-Kirk, TL (corresponding author), 660 S Euclid Ave,Box 8052, St Louis, MO 63110 USA.	tkirk@dom.wustl.edu	Brett, Thomas/AAC-9147-2019	Brett, Thomas/0000-0002-6871-6676	National Institutes of Health [PO1HL29594]; NHLBI [HL53325]; USPHS [R37-DK34388, P41-RR00954, P60-DK20579, P30-DK56341]; Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053325, P01HL029594, R37HL053325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034388, P60DK020579, P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Alpha-1 Foundation; Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation; American Lung Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1HL29594 and HL53325 from NHLBI and Grants R37-DK34388, P41-RR00954, P60-DK20579, and P30-DK56341 from USPHS. This work was also supported by Alpha-1 Foundation, Alan A. and Edith L. Wolff Charitable Trust/Barnes-Jewish Hospital Foundation, and American Lung Association.	Akhtar K, 2010, J BIOL CHEM, V285, P37396, DOI 10.1074/jbc.M110.126789; Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977; Assoian RK, 1996, J CLIN INVEST, V98, P2436, DOI 10.1172/JCI119059; Baranek T, 2007, J IMMUNOL, V179, P6184, DOI 10.4049/jimmunol.179.9.6184; Bass MD, 2008, J CELL BIOL, V181, P1013, DOI 10.1083/jcb.200711129; Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; BROWN PL, 1992, BIOCHEM BIOPH RES CO, V186, P549, DOI 10.1016/S0006-291X(05)80843-5; Chen YR, 2002, J BIOL CHEM, V277, P29781, DOI 10.1074/jbc.M200709200; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; Debret R, 2006, J INVEST DERMATOL, V126, P1860, DOI 10.1038/sj.jid.5700337; Deslee G, 2009, EUR RESPIR J, V34, P324, DOI 10.1183/09031936.00123008; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fearon IM, 2009, J MOL CELL CARDIOL, V47, P372, DOI 10.1016/j.yjmcc.2009.05.013; Floquet N, 2005, MATRIX BIOL, V24, P271, DOI 10.1016/j.matbio.2005.03.002; HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kelleher CM, 2005, AM J RESP CELL MOL, V33, P355, DOI 10.1165/rcmb.2005-0206OC; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200; Krettek A, 2003, ARTERIOSCL THROM VAS, V23, P582, DOI 10.1161/01.ATV.0000064372.78561.A5; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Li DY, 1997, HUM MOL GENET, V6, P1021, DOI 10.1093/hmg/6.7.1021; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Maeda I, 2007, J BIOCHEM, V142, P627, DOI 10.1093/jb/mvm170; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; OLSEN DR, 1988, J BIOL CHEM, V263, P6465; OOYAMA T, 1987, ARTERIOSCLEROSIS, V7, P593, DOI 10.1161/01.ATV.7.6.593; Pierce RA, 1997, AM J PHYSIOL-LUNG C, V272, pL452, DOI 10.1152/ajplung.1997.272.3.L452; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RAINES EW, 1993, BRIT HEART J, V69, pS30; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002; RONGIOLETTI F, 1995, DERMATOLOGY, V191, P19, DOI 10.1159/000246478; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002; Song HW, 2010, J BIOL CHEM, V285, P33843, DOI 10.1074/jbc.M110.153197; Stiebellehner L, 2003, AM J PHYSIOL-LUNG C, V285, pL819, DOI 10.1152/ajplung.00062.2003; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Waller JM, 2006, SKIN RES TECHNOL, V12, P145, DOI 10.1111/j.0909-752X.2006.00146.x; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Yamakura F, 1998, J BIOL CHEM, V273, P14085, DOI 10.1074/jbc.273.23.14085; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Yoneda A, 2003, MATRIX BIOL, V22, P25, DOI 10.1016/S0945-053X(03)00010-6; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853; Zhang MC, 1999, J BIOL CHEM, V274, P981, DOI 10.1074/jbc.274.2.981	55	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13574	13582		10.1074/jbc.M110.192088	http://dx.doi.org/10.1074/jbc.M110.192088			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21321118	Green Published, hybrid			2022-12-25	WOS:000289282200077
J	Lawan, A; Al-Harthi, S; Cadalbert, L; McCluskey, AG; Shweash, M; Grassia, G; Grant, A; Boyd, M; Currie, S; Plevin, R				Lawan, Ahmed; Al-Harthi, Sameer; Cadalbert, Laurence; McCluskey, Anthony G.; Shweash, Muhannad; Grassia, Gianluca; Grant, Anne; Boyd, Marie; Currie, Susan; Plevin, Robin			Deletion of the Dual Specific Phosphatase-4 (DUSP-4) Gene Reveals an Essential Non-redundant Role for MAP Kinase Phosphatase-2 (MKP-2) in Proliferation and Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL-KINASE; PROTECTS ENDOTHELIAL-CELLS; DOUBLE-STRAND BREAKS; SIGNALING PATHWAYS; OXIDATIVE STRESS; EXPRESSION; APOPTOSIS; ACTIVATION; JNK; CANCER	Mitogen-activated protein kinase phosphatase-2 (MKP-2) is a type 1 nuclear dual specific phosphatase (DUSP) implicated in a number of cancers. We examined the role of MKP-2 in the regulation of MAP kinase phosphorylation, cell proliferation, and survival responses in mouse embryonic fibroblasts (MEFs) derived from a novel MKP-2 (DUSP-4) deletion mouse. We show that serum and PDGF induced ERK-dependent MKP-2 expression in wild type METs but not in MKP-2(-/-) MEFs. PDGF stimulation of sustained ERK phosphorylation was enhanced in MKP-2(-/-) MEFs, whereas anisomycin-induced JNK was only marginally increased. However, marked effects upon cell growth parameters were observed. Cellular proliferation rates were significantly reduced in MKP-2(-/-) MEFs and associated with a significant increase in cell doubling time. Infection with adenoviral MKP-2 reversed the decrease in proliferation. Cell cycle analysis revealed a block in G(2)/M phase transition associated with cyclin B accumulation and enhanced cdc2 phosphorylation. MEFs from MKP-2(-/-) mice also showed enhanced apoptosis when stimulated with anisomycin correlated with increased caspase-3 cleavage and gamma H2AX phosphorylation. Increased apoptosis was reversed by adenoviral MKP-2 infection and correlated with selective inhibition of JNK signaling. Collectively, these data demonstrate for the first time a critical non-redundant role fir MKP-2 in regulating cell cycle progression and apoptosis.	[Lawan, Ahmed; Al-Harthi, Sameer; Cadalbert, Laurence; McCluskey, Anthony G.; Shweash, Muhannad; Grassia, Gianluca; Grant, Anne; Boyd, Marie; Currie, Susan; Plevin, Robin] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	Plevin, R (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 27 Taylor St, Glasgow G4 0NR, Lanark, Scotland.	r.plevin@strath.ac.uk	Shweash, Muhannad/E-1741-2019; Alharthi, Sameer/J-7710-2012; Grassia, Gianluca/H-7677-2019	Shweash, Muhannad/0000-0003-4373-9465; Grassia, Gianluca/0000-0001-7846-5594; Currie, Susan/0000-0002-4237-4428; Cadalbert, Laurence/0000-0003-1333-2146; Plevin, Robin/0000-0002-7849-1220; Boyd, Marie/0000-0003-4120-2218	Nigerian Government; University of Strathclyde; government of Saudi Arabia	Nigerian Government; University of Strathclyde; government of Saudi Arabia	This work was supported by a studentship from the Nigerian Government and the University of Strathclyde (to A. L.) and a scholarship from government of Saudi Arabia (to S. A.).	Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Albrecht EA, 2009, INFLAMM RES, V58, P30, DOI 10.1007/s00011-008-8156-9; Arnoldussen YJ, 2009, MOL CELL ENDOCRINOL, V309, P1, DOI 10.1016/j.mce.2009.05.019; Brondello JM, 1997, J BIOL CHEM, V272, P1368, DOI 10.1074/jbc.272.2.1368; Cadalbert L, 2005, CELL SIGNAL, V17, P1254, DOI 10.1016/j.cellsig.2005.01.003; Cadalbert LC, 2010, CELL SIGNAL, V22, P357, DOI 10.1016/j.cellsig.2009.10.002; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dadakhujaev S, 2009, AUTOPHAGY, V5, P103, DOI 10.4161/auto.5.1.7276; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Hasegawa T, 2008, ONCOGENE, V27, P5684, DOI 10.1038/onc.2008.182; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ianzini F, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-11; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Li MX, 2003, J BIOL CHEM, V278, P41059, DOI 10.1074/jbc.M307149200; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Meszaros JG, 2000, AM J PHYSIOL-CELL PH, V278, pC154, DOI 10.1152/ajpcell.2000.278.1.C154; MISRAPRESS A, 1995, J BIOL CHEM, V270, P14587, DOI 10.1074/jbc.270.24.14587; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Ohneseit PA, 2005, RADIOTHER ONCOL, V75, P237, DOI 10.1016/j.radonc.2005.03.025; Osto E, 2008, CIRCULATION, V118, P2073, DOI 10.1161/CIRCULATIONAHA.108.765032; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Robinson CJM, 2001, CELL SIGNAL, V13, P29, DOI 10.1016/S0898-6568(00)00121-2; Rosini P, 2004, J BIOL CHEM, V279, P14016, DOI 10.1074/jbc.M305356200; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Sieben NLG, 2005, J CLIN ONCOL, V23, P7257, DOI 10.1200/JCO.2005.02.2541; Sloss CM, 2005, CELL SIGNAL, V17, P709, DOI 10.1016/j.cellsig.2004.10.010; Suzuki T, 2003, HYPERTENSION, V42, P342, DOI 10.1161/01.HYP.0000084602.06114.AD; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Tresini M, 2007, J BIOL CHEM, V282, P4136, DOI 10.1074/jbc.M604955200; Wang JL, 2007, J BIOL CHEM, V282, P18521, DOI 10.1074/jbc.M610538200; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010; Wu JJ, 2005, J BIOL CHEM, V280, P16461, DOI 10.1074/jbc.M501762200; Yip-Schneider MT, 2001, BIOCHEM BIOPH RES CO, V280, P992, DOI 10.1006/bbrc.2001.4243; Yokoyama A, 1997, BIOCHEM BIOPH RES CO, V239, P746, DOI 10.1006/bbrc.1997.7547; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	45	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12933	12943		10.1074/jbc.M110.181370	http://dx.doi.org/10.1074/jbc.M110.181370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317287	Green Published, hybrid			2022-12-25	WOS:000289282200013
J	Yuga, M; Gomi, K; Klionsky, DJ; Shintani, T				Yuga, Masaki; Gomi, Katsuya; Klionsky, Daniel J.; Shintani, Takahiro			Aspartyl Aminopeptidase Is Imported from the Cytoplasm to the Vacuole by Selective Autophagy in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETING PATHWAY; ALPHA-MANNOSIDASE; BUDDING YEAST; TRANSPORT; PROTEIN; MECHANISM; UBIQUITIN; MEMBRANE; RECEPTOR; MUTANTS	Macroautophagy is a catabolic process by which cytosolic components are sequestered by double membrane vesicles called autophagosomes and sorted to the lysosomes/vacuoles to be degraded. Saccharomyces cerevisiae has adapted this mechanism for constitutive transport of the specific vacuolar hydrolases aminopeptidase I (Ape1) and alpha-mannosidase (Ams1); this process is called the cytoplasm to vacuole targeting (Cvt) pathway. The precursor form of Ape1 self-assembles into an aggregate-like structure in the cytosol that is then recognized by Atg19 in a propeptide-dependent manner. The interaction between Atg19 and autophagosome-forming machineries allows selective packaging of the Ape1-Atg19 complex by the autophagosome-like Cvt vesicle. Amsl also forms oligomers and utilizes the Ape1 transport system by interacting with Atg19. Although the mechanism of selective transport of the Cvt cargoes has been well studied, it is unclear whether proteins other than Ape1 and Ams1 are transported via the Cvt pathway. We describe here that aspartyl aminopeptidase (Yhr113w/Ape4) is the third Cvt cargo, which is similar in primary structure and subunit organization to Ape1. Ape4 has no propeptide, and it does not self-assemble into aggregates. However, it binds to Atg19 in a site distinct from the Ape1- and Ams1-binding sites, allowing it to "piggyback" on the Ape1 transport system. In growing conditions, a small portion of Ape4 localizes in the vacuole, but its vacuolar transport is accelerated by nutrient starvation, and it stably resides in the vacuole lumen. We propose that the cytosolic Ape4 is redistributed to the vacuole when yeast cells need more active vacuolar degradation.	[Shintani, Takahiro] Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klionsky, Daniel J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Tohoku University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shintani, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Dept Bioind Informat & Genom, Aoba Ku, 1-1 Tsutsumidori Amamiyamachi, Sendai, Miyagi 9818555, Japan.	shintani@biochem.tohoku.ac.jp	SHINTANI, Takahiro/ABE-1267-2020	Shintani, Takahiro/0000-0001-6630-5892	Sapporo Bioscience Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	Sapporo Bioscience Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Sapporo Bioscience Foundation (to T. S.).	Amberg DC, 2005, METHODS YEAST GENETI, P199; Andrei-Selmer C, 2001, J BIOL CHEM, V276, P11606, DOI 10.1074/jbc.M003846200; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; ENENKEL C, 1993, J BIOL CHEM, V268, P7036; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; James P, 1996, GENETICS, V144, P1425; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kim J, 1997, J CELL BIOL, V137, P609, DOI 10.1083/jcb.137.3.609; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; METZ G, 1976, BIOCHIM BIOPHYS ACTA, V429, P933, DOI 10.1016/0005-2744(76)90338-7; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Scott SV, 1997, J CELL BIOL, V138, P37, DOI 10.1083/jcb.138.1.37; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Shintani T, 2008, METHOD ENZYMOL, V451, P43, DOI 10.1016/S0076-6879(08)03204-7; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Watanabe Y, 2010, J BIOL CHEM, V285, P30026, DOI 10.1074/jbc.M110.143545; Wilk S, 1998, J BIOL CHEM, V273, P15961, DOI 10.1074/jbc.273.26.15961; YASUHARA T, 1994, J BIOL CHEM, V269, P13644; Yokoyama R, 2006, FEBS J, V273, P192, DOI 10.1111/j.1742-4658.2005.05057.x; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	46	60	63	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13704	13713		10.1074/jbc.M110.173906	http://dx.doi.org/10.1074/jbc.M110.173906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343297	Green Published, hybrid			2022-12-25	WOS:000289282200088
J	Ramstedt, M; Nakao, R; Wai, SN; Uhlin, BE; Boily, JF				Ramstedt, Madeleine; Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric; Boily, Jean-Francois			Monitoring Surface Chemical Changes in the Bacterial Cell Wall MULTIVARIATE ANALYSIS OF CRYO-X-RAY PHOTOELECTRON SPECTROSCOPY DATA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-AERUGINOSA; OUTER-MEMBRANE; ESCHERICHIA-COLI; XPS ANALYSIS; LIPOPOLYSACCHARIDE; SALMONELLA; ENVELOPE	Gram-negative bacteria can alter the composition of the lipopolysaccharide (LPS) layer of the outer membrane as a response to different growth conditions and external stimuli. These alterations can, for example, promote attachment to surfaces and biofilm formation. The changes occur in the outermost layer of the cell and may consequently influence interactions between bacterial cells and surrounding host tissue, as well as other surfaces. Microscopic analyses, fractionation of bacterial cells, or other traditional microbiological assays have previously been used to study these alterations. These methods can, however, be time consuming and do not always give detailed chemical information about the bacterial cell surface. We here present an analytical method that provides chemical information on the outermost portion of bacterial cells with respect to protein, peptidoglycan, lipid, and polysaccharide content. The method involves cryo-x-ray photoelectron spectroscopy analyses of the outermost portion (within similar to 10 nm of the surface) of intact bacterial cells followed by a multivariate curve resolution analysis of carbon spectra. It can be used as a tool for characterizing and monitoring variations in the chemical composition of bacterial cell walls or of isolated outer membrane vesicles, variations that result from e. g. mutations or external stimuli. The method enabled us to predict accurately the alterations in polysaccharide content and surface chemistries of a set of well characterized Escherichia coli LPS mutants. The described approach may moreover be applied to monitor surface chemical composition of other biological samples.	[Ramstedt, Madeleine; Boily, Jean-Francois] Umea Univ, Dept Chem, SE-90187 Umea, Sweden; [Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Nakao, Ryoma; Wai, Sun Nyunt; Uhlin, Bernt Eric] Umea Univ, Lab Mol Infect Med Sweden, SE-90187 Umea, Sweden; [Nakao, Ryoma] Natl Inst Infect Dis, Dept Bacteriol, Tokyo 1628640, Japan	Umea University; Umea University; Umea University; National Institute of Infectious Diseases (NIID)	Ramstedt, M (corresponding author), Umea Univ, Dept Chem, SE-90187 Umea, Sweden.	madeleine.ramstedt@chem.umu.se	Uhlin, Bernt Eric/AAO-6292-2021; Ramstedt, Madeleine/E-7852-2011	Uhlin, Bernt Eric/0000-0002-2991-8072; Ramstedt, Madeleine/0000-0003-2646-8501; Wai, Sun Nyunt/0000-0003-4793-4671	Curth Nilsson Foundation for Scientific Research; Swedish Research Council; Wallenberg and Kempe foundations	Curth Nilsson Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wallenberg and Kempe foundations	Supported by the Curth Nilsson Foundation for Scientific Research. To whom correspondence should be addressed: Dept. of Chemistry, Umea University, SE-90187 Umea, Sweden. Tel.: 46-90-786-6328; Fax: 46-90-786-7655; E-mail: madeleine.ramstedt@chem.umu.se.; Supported by the Swedish Research Council.; Supported by the Swedish Research Council as well as the Wallenberg and Kempe foundations.	Ahimou F, 2007, J COLLOID INTERF SCI, V309, P49, DOI 10.1016/j.jcis.2007.01.055; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BIELIG H, 2011, INFECT IMMU IN PRESS; Briggs D., 1992, HIGH RESOLUTION XPS; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; DEPETRIS S, 1967, J ULTRA MOL STRUCT R, V19, P45, DOI 10.1016/S0022-5320(67)80059-5; Dufrene YF, 1997, J BACTERIOL, V179, P1023, DOI 10.1128/jb.179.4.1023-1028.1997; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Flemming CA, 1999, BIOFOULING, V13, P213; GOLUB GH, 1970, NUMER MATH, V14, P403, DOI 10.1007/BF02163027; HANCOCK IC, 1991, MICROBIAL CELL SURFA, P23; HOCHELLA MF, 1988, REV MINERAL, V18, P573; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; KADURUGAMUWA JL, 1993, ANTIMICROB AGENTS CH, V37, P715, DOI 10.1128/AAC.37.4.715; KOPLOW J, 1974, J BACTERIOL, V117, P527, DOI 10.1128/JB.117.2.527-543.1974; Leone L, 2006, SURF INTERFACE ANAL, V38, P202, DOI 10.1002/sia.2184; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; Metzler D. E, 2001, BIOCH CHEM REACTIONS, V2; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Ramstedt M, 2002, SURF INTERFACE ANAL, V34, P632, DOI 10.1002/sia.1376; Rouxhet PG, 2008, SURF INTERFACE ANAL, V40, P718, DOI 10.1002/sia.2779; Sabra W, 2003, MICROBIOL-SGM, V149, P2789, DOI 10.1099/mic.0.26443-0; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Shroll RM, 2002, BIOPOLYMERS, V65, P395, DOI 10.1002/bip.10279; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Strauss J, 2009, J MOL RECOGNIT, V22, P347, DOI 10.1002/jmr.955; van der Mei HC, 2000, SURF SCI REP, V39, P3; Yao X, 1999, J BACTERIOL, V181, P6865, DOI 10.1128/JB.181.22.6865-6875.1999	30	36	38	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.209536	http://dx.doi.org/10.1074/jbc.M110.209536			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330374	Green Published, hybrid			2022-12-25	WOS:000289077500053
J	Gan, XQ; Wang, JY; Su, B; Wu, DQ				Gan, Xiaoqing; Wang, Jiyong; Su, Bing; Wu, Dianqing			Evidence for Direct Activation of mTORC2 Kinase Activity by Phosphatidylinositol 3,4,5-Trisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PARTNER; MOTIF PHOSPHORYLATION; ACTIN CYTOSKELETON; MAMMALIAN TARGET; TOR COMPLEXES; SIGNAL RELAY; RICTOR; GROWTH; RAPTOR; IDENTIFICATION	mTORC2 (mammalian target of rapamycin complex 2) plays important roles in signal transduction by regulating an array of downstream effectors, including protein kinase AKT. However, its regulation by upstream regulators remains poorly characterized. Although phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P-3) is known to regulate the phosphorylation of AKT Ser(473), the hydrophobic motif (HM) site, by mTORC2, it is not clear whether PtdIns(3,4,5)P-3 can directly regulate mTORC2 kinase activity. Here, we used two membrane-docked AKT mutant proteins, one with and the other without the pleckstrin homology (PH) domain, as substrates for mTORC2 to dissect the roles of PtdIns(3,4,5)P-3 in AKT HM phosphorylation in cultured cells and in vitro kinase assays. In HEK293T cells, insulin and constitutively active mutants of small GTPase H-Ras and PI3K could induce HM phosphorylation of both AKT mutants, which was blocked by the PI3K inhibitor LY294002. Importantly, PtdIns(3,4,5)P-3 was able to stimulate the phosphorylation of both AKT mutants by immunoprecipitated mTOR2 complexes in an in vitro kinase assay. In both in vivo and in vitro assays, the AKT mutant containing the PH domain appeared to be a better substrate than the one without the PH domain. Therefore, these results suggest that PtdIns(3,4,5)P-3 can regulate HM phosphorylation by mTORC2 via multiple mechanisms. One of the mechanisms is to directly stimulate the kinase activity of mTORC2.	[Gan, Xiaoqing; Wang, Jiyong; Su, Bing; Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Gan, Xiaoqing; Wang, Jiyong; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Wu, DQ (corresponding author), Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA.	dan.wu@yale.edu			National Institutes of Health [HL070694, CA132317, CA139395]; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, P01HL070694, R01HL108430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL070694, CA132317, and CA139395 (to D. W.).	Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Lee S, 1999, MOL BIOL CELL, V10, P2829, DOI 10.1091/mbc.10.9.2829; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wabnitz GH, 2006, J IMMUNOL, V176, P1668, DOI 10.4049/jimmunol.176.3.1668; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206	34	144	152	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10998	11002		10.1074/jbc.M110.195016	http://dx.doi.org/10.1074/jbc.M110.195016			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310961	hybrid, Green Published			2022-12-25	WOS:000288797100011
J	Weinstock-Guttman, B; Zivadinov, R; Cutter, G; Tamano-Blanco, M; Marr, K; Badgett, D; Carl, E; Elfadil, M; Kennedy, C; Benedict, RHB; Ramanathan, M				Weinstock-Guttman, Bianca; Zivadinov, Robert; Cutter, Gary; Tamano-Blanco, Miriam; Marr, Karen; Badgett, Darlene; Carl, Ellen; Elfadil, Makki; Kennedy, Cheryl; Benedict, Ralph H. B.; Ramanathan, Murali			Chronic Cerebrospinal Vascular Insufficiency Is Not Associated with HLA DRB1*1501 Status in Multiple Sclerosis Patients	PLOS ONE			English	Article							VENOUS INSUFFICIENCY; DIAGNOSIS; HLA-DRB1; GENETICS; ALLELES; DISEASE; RISK; FLOW	Background: Chronic cerebrospinal venous insufficiency (CCSVI) was described as a vascular condition characterized by anomalies of veins outside the skull was reported to be associated with multiple sclerosis (MS). The objective was to assess the associations between HLA DRB1*1501 status and the occurrence of CCSVI in MS patients. Methodology/Principal Findings: This study included 423 of 499 subjects enrolled in the Combined Transcranial and Extracranial Venous Doppler Evaluation (CTEVD) study. The HLA DRB1*1501 status was obtained in 268 MS patients and 155 controls by genotyping rs3135005, a SNP associated with DRB1*1501 status. All subjects underwent a clinical examination and Doppler scan of the head and neck. The frequency of CCSVI was higher (OR = 4.52, P < 0.001) in the MS group 56.0% vs. 21.9% in the controls group and also higher in the progressive MS group 69.8% vs. 49.5% in the non-progressive MS group. The 51.9% frequency of HLA DRB1*1501 positivity (HLA(+)) in MS was higher compared (OR = 2.33, P < 0.001) to 31.6% to controls. The HLA+ frequency in the non-progressive (51.6%) and progressive MS groups (52.3%) was similar. The frequency of HLA(+) CCSVI+ was 40.7% in progressive MS, 27.5% in non-progressive MS and 8.4% in controls. The presence of CCSVI was independent of HLA DRB1*1501 status in MS patients. Conclusions/Significance: The lack of strong associations of CCSVI with HLA DRB1*1501 suggests that the role of the underlying associations of CCSVI in MS should be interpreted with caution. Further longitudinal studies should determine whether interactions between these factors can contribute to disease progression in MS.	[Weinstock-Guttman, Bianca; Zivadinov, Robert; Marr, Karen; Carl, Ellen; Elfadil, Makki; Kennedy, Cheryl] SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA; [Cutter, Gary] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Tamano-Blanco, Miriam; Badgett, Darlene; Ramanathan, Murali] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Weinstock-Guttman, B (corresponding author), SUNY Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY 14260 USA.	Murali@Buffalo.Edu	Zivadinov, Robert/Q-2054-2019; Weinstock-Guttman, Bianca/AAI-4694-2021; Cutter, Gary/AAY-5392-2021; Carl, Ellen/AAC-9162-2020	Zivadinov, Robert/0000-0002-7799-1485; Weinstock-Guttman, Bianca/0000-0001-6732-151X; Cutter, Gary/0000-0002-8455-980X; Carl, Ellen/0000-0002-0930-8285	Buffalo Neuroimaging Analysis Center and Baird MS Center; Jacobs Neurological Institute; University of Buffalo; Direct MS Foundation; Jacquemin Family Foundation; Estee Lauder Companies	Buffalo Neuroimaging Analysis Center and Baird MS Center; Jacobs Neurological Institute; University of Buffalo; Direct MS Foundation; Jacquemin Family Foundation; Estee Lauder Companies	This study was funded by internal resources of the Buffalo Neuroimaging Analysis Center and Baird MS Center, the Jacobs Neurological Institute, and the University of Buffalo. In addition, the authors received support from the Direct MS Foundation, the Jacquemin Family Foundation, Suzanne Brown, Estee Lauder Companies, Greg Gibb, Roland Kurman, Carmen and Suzzanne Linderman, Liliana Macreanu, Jill and Larry Nolan, Tactical Technologies, The Flowers4MS Foundation, and The Pink Door. Suzanne Brown, Greg Gibb, Roland Kurman, Carmen and Suzzanne Linderman, Liliana Macreanu, and Jill and Larry Nolan donated as private individuals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Brouillard P, 2007, HUM MOL GENET, V16, pR140, DOI 10.1093/hmg/ddm211; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; DeLuca GC, 2007, P NATL ACAD SCI USA, V104, P20896, DOI 10.1073/pnas.0707731105; Dickinson JL, 2009, MULT SCLER, V15, P563, DOI 10.1177/1352458509102459; Doepp F, 2010, ANN NEUROL, V68, P173, DOI 10.1002/ana.22085; Ferlini A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-64; Vasconcelos CCF, 2009, J NEUROIMMUNOL, V214, P101, DOI 10.1016/j.jneuroim.2009.06.009; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hojnacki D, 2010, INT ANGIOL, V29, P127; Hu HT, 2008, J INVEST DERMATOL, V128, P2325, DOI 10.1038/jid.2008.89; Kantarci OH, 2008, SEMIN NEUROL, V28, P7, DOI 10.1055/s-2007-1019125; Khatri VP, 2001, ANN SURG, V233, P282, DOI 10.1097/00000658-200102000-00019; Koc Z, 2007, EUR J RADIOL, V61, P267, DOI 10.1016/j.ejrad.2006.09.008; Limaye N, 2009, HUM MOL GENET, V18, pR65, DOI 10.1093/hmg/ddp002; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Ramagopalan SV, 2007, NEW ENGL J MED, V357, P2199; Singh AV, 2009, J CEREBR BLOOD F MET, V29, P1867, DOI 10.1038/jcbfm.2009.180; Sundstrom P, 2010, ANN NEUROL, V68, P255, DOI 10.1002/ana.22132; Weatherby SJM, 2001, J NEUROL, V248, P304, DOI 10.1007/s004150170205; Zamboni P, 2009, J NEUROL NEUROSUR PS, V80, P392, DOI 10.1136/jnnp.2008.157164; Zamboni P, 2006, J ROY SOC MED, V99, P589, DOI 10.1258/jrsm.99.11.589; Zamboni P, 2009, J VASC SURG, V50, P1348, DOI 10.1016/j.jvs.2009.07.096; Zamboni P, 2009, J NEUROL SCI, V282, P21, DOI 10.1016/j.jns.2008.11.027; Zivadinov R, 2010, RADIOLOGY IN PRESS; Zivadinov R, 2010, NEUROLOGY IN PRESS; Zivadinov R, 2010, AM J NEUROR IN PRESS	29	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16802	10.1371/journal.pone.0016802	http://dx.doi.org/10.1371/journal.pone.0016802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21340025	Green Published, gold, Green Submitted			2022-12-25	WOS:000287367600020
J	Geis, C; Weishaupt, A; Grunewald, B; Wultsch, T; Reif, A; Gerlach, M; Dirkx, R; Solimena, M; Perani, D; Heckmann, M; Toyka, KV; Folli, F; Sommer, C				Geis, Christian; Weishaupt, Andreas; Gruenewald, Benedikt; Wultsch, Thomas; Reif, Andreas; Gerlach, Manfred; Dirkx, Ron; Solimena, Michele; Perani, Daniela; Heckmann, Manfred; Toyka, Klaus V.; Folli, Franco; Sommer, Claudia			Human Stiff-Person Syndrome IgG Induces Anxious Behavior in Rats	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; SPINAL-CORD-INJURY; 65-KDA ISOFORM; ANXIETY; ANTIBODIES; AUTOANTIBODIES; ENCEPHALITIS; CIRCUITS; DISORDER; EPILEPSY	Background: Anxiety is a heterogeneous behavioral domain playing a role in a variety of neuropsychiatric diseases. While anxiety is the cardinal symptom in disorders such as panic disorder, co-morbid anxious behavior can occur in a variety of diseases. Stiff person syndrome (SPS) is a CNS disorder characterized by increased muscle tone and prominent agoraphobia and anxiety. Most patients have high-titer antibodies against glutamate decarboxylase (GAD) 65. The pathogenic role of these autoantibodies is unclear. Methodology/Principal Findings: We re-investigated a 53 year old woman with SPS and profound anxiety for GABA-A receptor binding in the amygdala with (11) C-flumazenil PET scan and studied the potential pathogenic role of purified IgG from her plasma filtrates containing high-titer antibodies against GAD 65. We passively transferred the IgG fraction intrathecally into rats and analyzed the effects using behavioral and in vivo electrophysiological methods. In cell culture, we measured the effect of patient IgG on GABA release from hippocampal neurons. Repetitive intrathecal application of purified patient IgG in rats resulted in an anxious phenotype resembling the core symptoms of the patient. Patient IgG selectively bound to rat amygdala, hippocampus, and frontal cortical areas. In cultured rat hippocampal neurons, patient IgG inhibited GABA release. In line with these experimental results, the GABA-A receptor binding potential was reduced in the patient's amygdala/hippocampus complex. No motor abnormalities were found in recipient rats. Conclusion/Significance: The observations in rats after passive transfer lead us to propose that anxiety-like behavior can be induced in rats by passive transfer of IgG from a SPS patient positive for anti-GAD 65 antibodies. Anxiety, in this case, thus may be an antibody-mediated phenomenon with consecutive disturbance of GABAergic signaling in the amygdala region.	[Geis, Christian; Weishaupt, Andreas; Gruenewald, Benedikt; Toyka, Klaus V.; Sommer, Claudia] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Wultsch, Thomas; Reif, Andreas] Univ Wurzburg, Dept Psychiat, D-8700 Wurzburg, Germany; [Dirkx, Ron] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, D-8700 Wurzburg, Germany; [Heckmann, Manfred] Univ Wurzburg, Inst Physiol, D-8700 Wurzburg, Germany; [Heckmann, Manfred] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-8700 Wurzburg, Germany; [Dirkx, Ron; Solimena, Michele] Tech Univ Dresden, Carl Gustav Carus Med Sch, D-8027 Dresden, Germany; [Perani, Daniela] Ist Sci San Raffaele, Div Neurosci, Dept Nucl Med, I-20132 Milan, Italy; [Perani, Daniela] Univ Vita Salute San Raffaele, Div Neurosci, Milan, Italy; [Folli, Franco] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, Dept Med, San Antonio, TX 78229 USA	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; Technische Universitat Dresden; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Texas System; University of Texas Health San Antonio	Geis, C (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	Geis_C@klinik.uni-wuerzburg.de	Solimena, Michele/GVS-5990-2022; Perani, Daniela/AAN-3221-2020; Sommer, Claudia/A-9820-2010; folli, franco/J-2795-2018; Solimena, Michele/E-1275-2011	Sommer, Claudia/0000-0002-7064-5002; folli, franco/0000-0001-9824-5222; Heckmann, Manfred/0000-0002-4874-1735	Deutsche Forschungsgemeinschaft [SFB 581, TP A7]; IZKF; University of Wurzburg;  [SFB TRR 58];  [TP Z2];  [KFO 125];  [TP 4];  [RE 1632/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF; University of Wurzburg; ; ; ; ; 	The work was supported by Deutsche Forschungsgemeinschaft SFB 581, TP A7; SFB TRR 58, TP Z2; KFO 125, TP 4; RE 1632/5; IZKF, and University Research Funds of the University of Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli R, 2005, NEUROLOGY, V64, P1961, DOI 10.1212/01.WNL.0000163984.71993.FE; Anagnostaras SG, 1999, NAT NEUROSCI, V2, P780, DOI 10.1038/12146; Aroniadou-Anderjaska V, 2007, AMINO ACIDS, V32, P305, DOI 10.1007/s00726-006-0415-x; Barron DH, 1938, J PHYSIOL-LONDON, V92, P276, DOI 10.1113/jphysiol.1938.sp003603; Bergado-Acosta JR, 2008, LEARN MEMORY, V15, P163, DOI 10.1101/lm.705408; Black JL, 1998, PSYCHOSOMATICS, V39, P38, DOI 10.1016/S0033-3182(98)71379-9; Byts N, 2008, CELL DEATH DIFFER, V15, P783, DOI 10.1038/cdd.2008.1; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dalakas MC, 2008, CURR NEUROL NEUROSCI, V8, P48, DOI 10.1007/s11910-008-0009-y; Dalakas MC, 2000, NEUROLOGY, V55, P1531, DOI 10.1212/WNL.55.10.1531; Davis KM, 2000, BIOCHEM BIOPH RES CO, V267, P777, DOI 10.1006/bbrc.1999.2038; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Floeter MK, 1998, NEUROLOGY, V51, P85, DOI 10.1212/WNL.51.1.85; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geis C, 2010, BRAIN, V133, P3166, DOI 10.1093/brain/awq253; Gerlach M, 1996, BRAIN RES, V741, P142, DOI 10.1016/S0006-8993(96)00915-8; Hayashi M, 2008, P NATL ACAD SCI USA, V105, P2175, DOI 10.1073/pnas.0712171105; Henningsen P, 2003, J NEUROL NEUROSUR PS, V74, P462, DOI 10.1136/jnnp.74.4.462; Irani SR, 2010, BRAIN, V133, P2734, DOI 10.1093/brain/awq213; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; KUNKELBAGDEN E, 1993, EXP NEUROL, V119, P153, DOI 10.1006/exnr.1993.1017; Lai MZ, 2010, LANCET NEUROL, V9, P776, DOI 10.1016/S1474-4422(10)70137-X; Lancaster E, 2010, LANCET NEUROL, V9, P67, DOI 10.1016/S1474-4422(09)70324-2; Lee JK, 2005, EXP NEUROL, V196, P430, DOI 10.1016/j.expneurol.2005.08.018; Levy LM, 2005, ARCH NEUROL-CHICAGO, V62, P970, DOI 10.1001/archneur.62.6.970; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; Manto MU, 2007, ANN NEUROL, V61, P544, DOI 10.1002/ana.21123; MEINCK HM, 1994, J NEUROL, V241, P157; Meinck HM, 2002, MOVEMENT DISORD, V17, P853, DOI 10.1002/mds.10279; Murinson B B, 2001, CNS Spectr, V6, P427; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perani D, 2007, MOVEMENT DISORD, V22, P1030, DOI 10.1002/mds.21441; Raju R, 2006, BRAIN, V129, P3270, DOI 10.1093/brain/awl245; Rakocevic G, 2004, ARCH NEUROL-CHICAGO, V61, P902, DOI 10.1001/archneur.61.6.902; SCHMIDT RF, 1971, ERG PHYSIOL BIOL CH, V63, P20, DOI 10.1007/BFb0047741; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; SOLIMENA M, 1988, NEW ENGL J MED, V318, P1012, DOI 10.1056/NEJM198804213181602; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; Sommer C, 2005, LANCET, V365, P1406, DOI 10.1016/S0140-6736(05)66376-3; Wultsch T, 2007, J NEURAL TRANSM-SUPP, P69; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9	45	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16775	10.1371/journal.pone.0016775	http://dx.doi.org/10.1371/journal.pone.0016775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346811	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600025
J	Wong, YF; Kopp, JB; Roberts, C; Scambler, PJ; Abe, Y; Rankin, AC; Dutt, N; Hendry, BM; Xu, QH				Wong, Yuen Fei; Kopp, Jeffrey B.; Roberts, Catherine; Scambler, Peter J.; Abe, Yoshifusa; Rankin, Alexandra C.; Dutt, Neelanjana; Hendry, Bruce M.; Xu, Qihe			Endogenous Retinoic Acid Activity in Principal Cells and Intercalated Cells of Mouse Collecting Duct System	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; VACUOLAR H+-ATPASE; DEPENDENT ACTIVATION; NEPHRON DEVELOPMENT; MOLECULAR-CLONING; GENE-EXPRESSION; KIDNEY; RECEPTORS; RATS; ORGANOGENESIS	Background: Retinoic acid is the bioactive derivative of vitamin A, which plays an indispensible role in kidney development by activating retinoic acid receptors. Although the location, concentration and roles of endogenous retinoic acid in postnatal kidneys are poorly defined, there is accumulating evidence linking post-natal vitamin A deficiency to impaired renal concentrating and acidifying capacity associated with increased susceptibility to urolithiasis, renal inflammation and scarring. The aim of this study is to examine the presence and the detailed localization of endogenous retinoic acid activity in neonatal, young and adult mouse kidneys, to establish a fundamental ground for further research into potential target genes, as well as physiological and pathophysiological roles of endogenous retinoic acid in the post-natal kidneys. Methodology/Principal Findings: RARE-hsp68-lacZ transgenic mice were employed as a reporter for endogenous retinoic acid activity that was determined by X-gal assay and immunostaining of the reporter gene product, beta-galactosidase. Double immunostaining was performed for beta-galactosidase and markers of kidney tubules to localize retinoic acid activity. Distinct pattern of retinoic acid activity was observed in kidneys, which is higher in neonatal and 1- to 3-week-old mice than that in 5- and 8-week-old mice. The activity was present specifically in the principal cells and the intercalated cells of the collecting duct system in all age groups, but was absent from the glomeruli, proximal tubules, thin limbs of Henle's loop and distal tubules. Conclusions/Significance: Endogenous retinoic acid activity exists in principal cells and intercalated cells of the mouse collecting duct system after birth and persists into adulthood. This observation provides novel insights into potential roles for endogenous retinoic acid beyond nephrogenesis and warrants further studies to investigate target genes and functions of endogenous retinoic acid in the kidney after birth, particularly in the collecting duct system.	[Wong, Yuen Fei; Rankin, Alexandra C.; Hendry, Bruce M.; Xu, Qihe] Kings Coll London, Dept Renal Med, London WC2R 2LS, England; [Dutt, Neelanjana] Kings Coll Hosp London, Dept Histopathol, London, England; [Kopp, Jeffrey B.; Abe, Yoshifusa] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Roberts, Catherine; Scambler, Peter J.] Inst Child Hlth, Mol Med Unit, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of London; University College London	Wong, YF (corresponding author), Kings Coll London, Dept Renal Med, London WC2R 2LS, England.	qihe.xu@kcl.ac.uk	Wong, Yuen Fei/N-2615-2017; Yoshifusa, Abe/AAX-5923-2021; Kopp, Jeffrey B/O-2681-2015; Wong, Yuen Fei/AAE-2086-2020; Scambler, Peter/AAZ-6026-2020; Scambler, Peter J/C-4998-2008	Wong, Yuen Fei/0000-0002-8761-2848; Kopp, Jeffrey B/0000-0001-9052-186X; Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628	Kidney Research United Kingdom project [RP29/2/06]; National Institutes of Health [Z01 DK043308]; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish; Kidney Research UK [IN1/2010] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043412, Z01DK043308] Funding Source: NIH RePORTER	Kidney Research United Kingdom project(Kidney Research UK (KRUK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Kidney Research United Kingdom project grant (RP29/2/06) awarded to QX and BMH and a National Institutes of Health Intramural Program grant (Z01 DK043308) to JBK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bhat PV, 1998, J HISTOCHEM CYTOCHEM, V46, P1025, DOI 10.1177/002215549804600906; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; de Groh ED, 2010, J AM SOC NEPHROL, V21, P794, DOI 10.1681/ASN.2009080851; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Finberg KE, 2003, GENE, V318, P25, DOI 10.1016/S0378-1119(03)00790-X; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; GIJBELS MJJ, 1992, CELL TISSUE RES, V268, P197, DOI 10.1007/BF00338069; Grases F, 1998, CLIN CHIM ACTA, V269, P147, DOI 10.1016/S0009-8981(97)00198-8; Higgins CC, 1935, J AMER MED ASSOC, V104, P1296, DOI 10.1001/jama.1935.02760150008002; Islam MR, 2008, AM J PHYSIOL-RENAL, V295, pF1845, DOI 10.1152/ajprenal.90355.2008; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kavukcu S, 2001, PEDIATR NEPHROL, V16, P689, DOI 10.1007/s004670100606; Kovacikova J, 2006, KIDNEY INT, V70, P1706, DOI 10.1038/sj.ki.5001851; Liebler S, 2004, AM J PHYSIOL-RENAL, V286, pF458, DOI 10.1152/ajprenal.00173.2003; Lin M, 2003, J BIOL CHEM, V278, P9856, DOI 10.1074/jbc.M211417200; Ma WB, 2002, J HISTOCHEM CYTOCHEM, V50, P1421, DOI 10.1177/002215540205001015; Marin MP, 2005, J NUTR, V135, P695, DOI 10.1093/jn/135.4.695; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Quinlan J, 2007, AM J PHYSIOL-RENAL, V293, pF987, DOI 10.1152/ajprenal.00098.2007; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Schmidt CK, 2003, ANAL BIOCHEM, V315, P36, DOI 10.1016/S0003-2697(02)00662-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Vilar J, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133668; Wagner J, 2001, NEPHROL DIAL TRANSPL, V16, P441, DOI 10.1093/ndt/16.3.441; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Xu QH, 2010, NEPHRON EXP NEPHROL, V114, pE127, DOI 10.1159/000276587; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; ZILE M, 1972, J NUTR, V102, P1255, DOI 10.1093/jn/102.10.1255	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16770	10.1371/journal.pone.0016770	http://dx.doi.org/10.1371/journal.pone.0016770			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326615	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037000020
J	Dong, JA; Yan, D; Chen, SY				Dong, Jian; Yan, Dong; Chen, Shao-yu			Stabilization of Nrf2 Protein by D3T Provides Protection against Ethanol-Induced Apoptosis in PC12 Cells	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; NEURAL CREST CELLS; TRANSCRIPTION FACTOR NRF2; INDUCED OXIDATIVE STRESS; ANTIOXIDANT RESPONSE ELEMENT; CUL3-BASED E3 LIGASE; SIGNALING PATHWAY; IN-VIVO; PROTEASOMAL DEGRADATION; MOUSE EMBRYOS	Previous studies have demonstrated that maternal ethanol exposure induces a moderate increase in Nrf2 protein expression in mouse embryos. Pretreatment with the Nrf2 inducer, 3H-1, 2-dithiole-3-thione (D3T), significantly increases the Nrf2 protein levels and prevents apoptosis in ethanol-exposed embryos. The present study, using PC12 cells, was designed to determine whether increased Nrf2 stability is a mechanism by which D3T enhances Nrf2 activation and subsequent antioxidant protection. Ethanol and D3T treatment resulted in a significant accumulation of Nrf2 protein in PC 12 cells. CHX chase analysis has shown that ethanol treatment delayed the degradation of Nrf2 protein in PC12 cells. A significantly greater decrease in Nrf2 protein degradation was observed in the cells treated with D3T alone or with both ethanol and D3T. In addition, D3T treatment significantly reduced ethanol-induced apoptosis. These results demonstrate that the stabilization of Nrf2 protein by D3T confers protection against ethanol-induced apoptosis.	[Dong, Jian; Yan, Dong] Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA; [Chen, Shao-yu] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Peoria	Dong, JA (corresponding author), Univ N Carolina, Bowles Ctr Alcohol Studies, Chapel Hill, NC 27515 USA.	sychen@uic.edu			NIH from the National Institute on Alcohol Abuse and Alcoholism [AA017446, AA013908, AA11605]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017446, K01AA013908, P60AA011605, P50AA011605] Funding Source: NIH RePORTER	NIH from the National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by NIH grants AA017446, AA013908, and AA11605 from the National Institute on Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Burd L, 2004, AM J MED GENET C, V127C, P1, DOI 10.1002/ajmg.c.30009; Burton NC, 2006, NEUROTOXICOLOGY, V27, P1094, DOI 10.1016/j.neuro.2006.07.019; Cao ZX, 2006, EXP BIOL MED, V231, P1353, DOI 10.1177/153537020623100809; CARTWRIGHT MM, 1995, ALCOHOL CLIN EXP RES, V19, P378, DOI 10.1111/j.1530-0277.1995.tb01519.x; Chen SY, 2000, J PHARMACOL EXP THER, V294, P134; Chen SY, 2004, FASEB J, V18, P1234, DOI 10.1096/fj.03-0850fje; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; Chen SY, 1996, ALCOHOL CLIN EXP RES, V20, P1071, DOI 10.1111/j.1530-0277.1996.tb01948.x; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Danilov CA, 2009, GLIA, V57, P645, DOI 10.1002/glia.20793; DE A, 1994, J BIOL CHEM, V269, P26697; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019; Dong J, 2010, TOXICOL LETT, V193, P94, DOI 10.1016/j.toxlet.2009.12.012; Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1111/j.1530-0277.2001.tb02156.x; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Gong PF, 2006, J BIOL CHEM, V281, P14573, DOI 10.1074/jbc.M600613200; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; He XQ, 2007, TOXICOL SCI, V98, P298, DOI 10.1093/toxsci/kfm081; Henderson George I., 1999, Frontiers in Bioscience, V4, pd541, DOI 10.2741/Henderson; Huang Y, 2006, PHYSIOL GENOMICS, V24, P144, DOI 10.1152/physiolgenomics.00258.2005; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Knorr-Wittmann C, 2005, FREE RADICAL BIO MED, V39, P1438, DOI 10.1016/j.freeradbiomed.2005.07.003; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Koh K, 2009, BIOCHEM BIOPH RES CO, V380, P449, DOI 10.1016/j.bbrc.2009.01.082; Korashy HM, 2006, DRUG METAB DISPOS, V34, P152, DOI 10.1124/dmd.105.005397; KOTCH LE, 1992, AM J MED GENET, V44, P168, DOI 10.1002/ajmg.1320440210; KOTCH LE, 1995, TERATOLOGY, V52, P128, DOI 10.1002/tera.1420520304; Kotlo KU, 2003, ONCOGENE, V22, P797, DOI 10.1038/sj.onc.1206077; Kwak MK, 2001, MUTAT RES-FUND MOL M, V480, P305, DOI 10.1016/S0027-5107(01)00190-7; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Luo J, 1999, ALCOHOL CLIN EXP RES, V23, P644, DOI 10.1111/j.1530-0277.1999.tb04166.x; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Munday R, 2004, CARCINOGENESIS, V25, P1721, DOI 10.1093/carcin/bgh162; NAPPER RMA, 1995, J COMP NEUROL, V362, P283, DOI 10.1002/cne.903620210; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Oberdoerster J, 1998, J PHARMACOL EXP THER, V287, P359; Otieno MA, 2000, FREE RADICAL BIO MED, V28, P944, DOI 10.1016/S0891-5849(00)00175-1; PANTAZIS NJ, 1992, ALCOHOL, V9, P171, DOI 10.1016/0741-8329(92)90048-F; Ramachandran V, 2003, J NEUROSCI RES, V74, P577, DOI 10.1002/jnr.10767; Smith SM, 1997, ALCOHOL HEALTH RES W, V21, P287; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Teng L, 2006, ADV EXP MED BIOL, V589, P206; Tran TD, 2005, ALCOHOL CLIN EXP RES, V29, P117, DOI 10.1097/01.ALC.0000150004.53870.E1; WEST JR, 1994, METAB BRAIN DIS, V9, P291, DOI 10.1007/BF02098878; Yan D, 2010, BIOCHEM PHARMACOL, V80, P144, DOI 10.1016/j.bcp.2010.03.004; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang JD, 2009, BIOCHEM BIOPH RES CO, V386, P750, DOI 10.1016/j.bbrc.2009.06.129	58	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16845	10.1371/journal.pone.0016845	http://dx.doi.org/10.1371/journal.pone.0016845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304811	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600033
J	Juyal, G; Prasad, P; Senapati, S; Midha, V; Sood, A; Amre, D; Juyal, RC; Thelma, BK				Juyal, Garima; Prasad, Pushplata; Senapati, Sabyasachi; Midha, Vandana; Sood, Ajit; Amre, Devendra; Juyal, Ramesh C.; Thelma, B. K.			An Investigation of Genome-Wide Studies Reported Susceptibility Loci for Ulcerative Colitis Shows Limited Replication in North Indians	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; JAPANESE PATIENTS; RISK LOCI; ASSOCIATION; IL23R; ATG16L1; POPULATION; MULTIPLE; GENE	Genome-Wide Association studies (GWAS) of both Crohn's Disease (CD) and Ulcerative Colitis (UC) have unearthed over 40 risk conferring variants. Recently, a meta-analysis on UC revealed several loci, most of which were either previously associated with UC or CD susceptibility in populations of European origin. In this study, we attempted to replicate these findings in an ethnically distinct north Indian UC cohort. 648 UC cases and 850 controls were genotyped using Infinium Human 660W-quad. Out of 59 meta-analysis index SNPs, six were not in the SNP array used in the study. Of the remaining 53 SNPs, four were found monomorphic. Association (p<0.05) at 25 SNPs was observed, of which 15 were CD specific. Only five SNPs namely rs2395185 (HLA-DRA), rs3024505 (IL10), rs6426833 (RNF186), rs3763313 (BTNL2) and rs2066843 (NOD2) retained significance after Bonferroni correction. These results (i) reveal limited replication of Caucasian based meta-analysis results; (ii) reiterate overlapping molecular mechanism(s) in UC and CD; (iii) indicate differences in genetic architecture between populations; and (iv) suggest that resources such as HapMap need to be extended to cover diverse ethnic populations. They also suggest a systematic GWAS in this terrain may be insightful for identifying population specific IBD risk conferring loci and thus enable cross-ethnicity fine mapping of disease loci.	[Juyal, Garima; Prasad, Pushplata; Senapati, Sabyasachi; Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Midha, Vandana; Sood, Ajit] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India; [Amre, Devendra] Univ Montreal, Dept Pediat, Montreal, PQ H3C 3J7, Canada; [Amre, Devendra] Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Juyal, Ramesh C.] Natl Inst Immunol, New Delhi 110067, India	University of Delhi; Dayanand Medical College & Hospital; Universite de Montreal; Universite de Montreal; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Juyal, G (corresponding author), Univ Delhi, Dept Genet, South Campus, New Delhi, India.	thelmabk@gmail.com	Singh, Pushplata/ABH-9083-2020; AMRE, DEVENDRA K/D-4988-2015	Singh, Pushplata/0000-0002-4273-6898; Senapati, Sabyasachi/0000-0002-9448-7432; Thelma, B.K/0000-0002-2154-5443; juyal, garima/0000-0002-3857-9578	Dept. of Biotechnology, New Delhi, India [BT/01/COE/07/UDSC]	Dept. of Biotechnology, New Delhi, India	Research grant #BT/01/COE/07/UDSC from Dept. of Biotechnology, New Delhi, India is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Budarf ML, 2009, TRENDS GENET, V25, P137, DOI 10.1016/j.tig.2009.01.001; Buning C, 2007, ALIMENT PHARM THERAP, V26, P1025, DOI 10.1111/j.1365-2036.2007.03446.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen B, 2009, J GENET, V88, P191, DOI 10.1007/s12041-009-0027-9; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Juyal G, 2007, ALIMENT PHARM THER, V26, P1325, DOI 10.1111/j.1365-2036.2007.03524.x; Kakuta Y, 2006, GUT, V55, P1527, DOI 10.1136/gut.2006.100297; Madsen KL, 2000, GASTROENTEROLOGY, V118, pA817, DOI 10.1016/S0016-5085(00)85409-8; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rajkumar R, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-23; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2007, J HUM GENET, V52, P575, DOI 10.1007/s10038-007-0156-z; Yang SK, 2009, INFLAMM BOWEL DIS, V15, P1385, DOI 10.1002/ibd.20921; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	32	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16565	10.1371/journal.pone.0016565	http://dx.doi.org/10.1371/journal.pone.0016565			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304977	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300087
J	Liu, YB; Mei, C; Koh, J; Sun, LH; Ji, LH				Liu, Yanbin; Mei, Chong; Koh, John; Sun, Longhua; Ji, Lianghui			Tartronate Semialdehyde Reductase Defines a Novel Rate-Limiting Step in Assimilation and Bioconversion of Glycerol in Ustilago maydis	PLOS ONE			English	Article							GENE-CLUSTER; ESCHERICHIA-COLI; CARBON SOURCE; METABOLISM; DIFFERENTIATION; TRANSFORMATION; TRANSCRIPTION; BIOSYNTHESIS; MUTANTS; PATHWAY	Background: Glycerol is a by-product of biodiesel production. Currently, it has limited applications with low bioconversion efficiency to most metabolites reported. This is partly attributed to the poor knowledge on the glycerol metabolic pathway in bacteria and fungi. Methodology/Principal Findings: We have established a fast screening method for identification of genes that improve glycerol utilization in Ustilago maydis. This was done by comparing the growth rates of T-DNA tagged mutant colonies on solid medium using glycerol as the sole carbon source. We present a detailed characterization of one of the mutants, GUM1, which contains a T-DNA element inserted into the promoter region of UM02592 locus (MIPS Ustilago maydis database, MUMDB), leading to enhanced and constitutive expression of its mRNA. We have demonstrated that um02592 encodes a functional tartronate semialdehyde reductase (Tsr1), which showed dual specificity to cofactors NAD(+) and NADP(+) and strong substrate specificity and enantioselectivity for (D)-glycerate. Improved glycerol assimilation in GUM1 was associated with elevated expression of tsr1 mRNA and this could be phenocopied by over-expression of the gene. Glycolipid accumulation was reduced by 45.2% in the knockout mutant whereas introduction of an extra copy of tsr1 driven by the glyceraldehyde phosphate dehydrogenase promoter increased it by 40.4%. Conclusions/Significance: Our results demonstrate that tartronate semialdehyde reductase (TSR) plays an important role in glycerol assimilation in U. maydis and defines a novel target in genetic engineering for improved conversion of glycerol to higher value products. Our results add significant depth to the understanding of the glycerol metabolic pathway in fungi. We have demonstrated, for the first time, a biological role of a eukaryotic TSR.	[Liu, Yanbin; Mei, Chong; Koh, John; Sun, Longhua; Ji, Lianghui] Natl Univ Singapore, Biomat & Biocatalysts Grp, Temasek Life Sci Lab, Singapore 117548, Singapore	National University of Singapore	Liu, YB (corresponding author), Natl Univ Singapore, Biomat & Biocatalysts Grp, Temasek Life Sci Lab, 1 Res Link, Singapore 117548, Singapore.	jilh@tll.org.sg		Ji, Lianghui/0000-0001-9030-3731	Singapore Economic Development Board; Temasek Trust	Singapore Economic Development Board(Singapore Economic Development Board); Temasek Trust	This work was funded by the Singapore Economic Development Board (http://www.edb.gov.sg) and Temasek Trust (http://www.temasekholdings.com.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNARD N, 1995, BIOCHEM BIOPH RES CO, V208, P895, DOI 10.1006/bbrc.1995.1419; BOLKER M, 1995, MOL GEN GENET, V248, P547, DOI 10.1007/BF02423450; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006; COURTRIGHT JB, 1975, J BACTERIOL, V124, P497, DOI 10.1128/JB.124.1.497-502.1975; da Silva GP, 2009, BIOTECHNOL ADV, V27, P30, DOI 10.1016/j.biotechadv.2008.07.006; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; Dharmadi Y, 2006, BIOTECHNOL BIOENG, V94, P821, DOI 10.1002/bit.21025; GOTTO AM, 1961, BIOCHEM J, V81, P273, DOI 10.1042/bj0810273; HAWES JW, 1995, BIOCHEMISTRY-US, V34, P4231, DOI 10.1021/bi00013a012; Heimel K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001035; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Hewald S, 2006, APPL ENVIRON MICROB, V72, P5469, DOI 10.1128/AEM.00506-06; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Inoh Y, 2004, J CONTROL RELEASE, V94, P423, DOI 10.1016/j.jconrel.2003.10.020; Isoda H, 1997, BIOSCI BIOTECH BIOCH, V61, P609, DOI 10.1271/bbb.61.609; Ji LH, 2010, FUNGAL GENET BIOL, V47, P279, DOI 10.1016/j.fgb.2010.01.002; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; KOHN LD, 1968, J BIOL CHEM, V243, P2465; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; NORTH MJ, 1973, FEBS LETT, V35, P67, DOI 10.1016/0014-5793(73)80578-2; OCHMAN H, 1988, GENETICS, V120, P621; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Teichmann B, 2007, MOL MICROBIOL, V66, P525, DOI 10.1111/j.1365-2958.2007.05941.x; Teichmann B, 2010, APPL ENVIRON MICROB, V76, P2633, DOI 10.1128/AEM.02211-09; Thompson JC, 2006, APPL ENG AGRIC, V22, P261; TOM GD, 1978, ARCH MICROBIOL, V117, P259, DOI 10.1007/BF00738544; VIRCA GD, 1990, BIOTECHNIQUES, V8, P370; VISWANATHREDDY M, 1977, MOL GEN GENET, V153, P29, DOI 10.1007/BF01035993; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yu KO, 2010, BIORESOURCE TECHNOL, V101, P4157, DOI 10.1016/j.biortech.2010.01.066; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhao XX, 1999, CANCER RES, V59, P482	36	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16438	10.1371/journal.pone.0016438	http://dx.doi.org/10.1371/journal.pone.0016438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305026	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300064
J	Southwell, AL; Bugg, CW; Kaltenbach, LS; Dunn, D; Butland, S; Weiss, A; Paganetti, P; Lo, DC; Patterson, PH				Southwell, Amber L.; Bugg, Charles W.; Kaltenbach, Linda S.; Dunn, Denise; Butland, Stefanie; Weiss, Andreas; Paganetti, Paolo; Lo, Donald C.; Patterson, Paul H.			Perturbation with Intrabodies Reveals That Calpain Cleavage Is Required for Degradation of Huntingtin Exon 1	PLOS ONE			English	Article							MUTANT HUNTINGTIN; DISEASE; TOXICITY; AGGREGATION; PROTEOLYSIS; FRAGMENTS; GENE; PATHOLOGY; MODULATE; PROTEIN	Background: Proteolytic processing of mutant huntingtin (mHtt), the protein that causes Huntington's disease (HD), is critical for mHtt toxicity and disease progression. mHtt contains several caspase and calpain cleavage sites that generate N-terminal fragments that are more toxic than full-length mHtt. Further processing is then required for the degradation of these fragments, which in turn, reduces toxicity. This unknown, secondary degradative process represents a promising therapeutic target for HD. Methodology/Principal Findings: We have used intrabodies, intracellularly expressed antibody fragments, to gain insight into the mechanism of mutant huntingtin exon 1 (mHDx-1) clearance. Happ1, an intrabody recognizing the proline-rich region of mHDx-1, reduces the level of soluble mHDx-1 by increasing clearance. While proteasome and macroautophagy inhibitors reduce turnover of mHDx-1, Happ1 is still able to reduce mHDx-1 under these conditions, indicating Happ1-accelerated mHDx-1 clearance does not rely on these processes. In contrast, a calpain inhibitor or an inhibitor of lysosomal pH block Happ1-mediated acceleration of mHDx-1 clearance. These results suggest that mHDx-1 is cleaved by calpain, likely followed by lysosomal degradation and this process regulates the turnover rate of mHDx-1. Sequence analysis identifies amino acid (AA) 15 as a potential calpain cleavage site. Calpain cleavage of recombinant mHDx-1 in vitro yields fragments of sizes corresponding to this prediction. Moreover, when the site is blocked by binding of another intrabody, V(L)12.3, turnover of soluble mHDx-1 in living cells is blocked. Conclusions/Significance: These results indicate that calpain-mediated removal of the 15 N-terminal AAs is required for the degradation of mHDx-1, a finding that may have therapeutic implications.	[Southwell, Amber L.; Butland, Stefanie] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada; [Southwell, Amber L.; Bugg, Charles W.; Patterson, Paul H.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Kaltenbach, Linda S.; Dunn, Denise; Lo, Donald C.] Duke Univ, Med Ctr, Dept Neurobiol, Ctr Drug Discovery, Durham, NC 27710 USA; [Weiss, Andreas; Paganetti, Paolo] Novartis Pharma AG, Novartis Inst BioMed Res, Neurosci Discovery, Basel, Switzerland	Child & Family Research Institute; University of British Columbia; California Institute of Technology; Duke University; Novartis	Southwell, AL (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	php@caltech.edu	Paganetti, Paolo/AAF-8039-2020	Butland, Stefanie/0000-0002-5427-8951; Southwell, Amber/0000-0002-6353-5008; Paganetti, Paolo/0000-0003-1896-6324	Hereditary Disease Foundation; NINDS [5RO1NS055298]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055298] Funding Source: NIH RePORTER	Hereditary Disease Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the Hereditary Disease Foundation (www.hdfoundation.org) and the NINDS 5RO1NS055298 (www.ninds.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Colby DW, 2004, J MOL BIOL, V342, P901, DOI 10.1016/j.jmb.2004.07.054; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kaltenbach LS, 2010, J BIOMOL SCREEN, V15, P806, DOI 10.1177/1087057110373392; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Majumder P, 2007, CELL MOL NEUROBIOL, V27, P1127, DOI 10.1007/s10571-007-9220-7; Mende-Mueller LM, 2001, J NEUROSCI, V21, P1830, DOI 10.1523/JNEUROSCI.21-06-01830.2001; Qin ZH, 2004, ACTA PHARMACOL SIN, V25, P1243; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; SOUTHWELL AL, 2010, REV NEUROSC IN PRESS; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; THAKUR AK, 2009, NAT STRUCT MOL BIOL; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Todde V, 2009, BBA-MOL BASIS DIS, V1792, P3, DOI 10.1016/j.bbadis.2008.10.016; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001	33	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16676	10.1371/journal.pone.0016676	http://dx.doi.org/10.1371/journal.pone.0016676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304966	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000286834300119
J	Xiang, XR; Phung, Y; Feng, MQ; Nagashima, K; Zhang, JL; Broaddus, VC; Hassan, R; FitzGerald, D; Ho, M				Xiang, Xinran; Phung, Yen; Feng, Mingqian; Nagashima, Kunio; Zhang, Jingli; Broaddus, V. Courtney; Hassan, Raffit; FitzGerald, David; Ho, Mitchell			The Development and Characterization of a Human Mesothelioma In Vitro 3D Model to Investigate Immunotoxin Therapy	PLOS ONE			English	Article							E-CADHERIN; MALIGNANT MESOTHELIOMA; MULTICELLULAR SPHEROIDS; APOPTOTIC RESISTANCE; SOLID TUMORS; LUNG-CANCER; CELL-LINES; TAXOL; ADENOCARCINOMA; CHEMOTHERAPY	Background: Tumor microenvironments present significant barriers to penetration by antibodies and immunoconjugates. Tumor microenvironments, however, are difficult to study in vitro. Cells cultured as monolayers exhibit less resistance to therapy than those grown in vivo and an alternative research model more representative of the in vivo tumor is more desirable. SS1P is an immunotoxin composed of the Fv portion of a mesothelin-specific antibody fused to a bacterial toxin that is presently undergoing clinical trials in mesothelioma. Methodology/Principal Findings: Here, we examined how the tumor microenvironment affects the penetration and killing activity of SS1P in a new three-dimensional (3D) spheroid model cultured in vitro using the human mesothelioma cell line (NCI-H226) and two primary cell lines isolated from the ascites of malignant mesothelioma patients. Mesothelioma cells grown as monolayers or as spheroids expressed comparable levels of mesothelin; however, spheroids were at least 100 times less affected by SS1P. To understand this disparity in cytotoxicity, we made fluorescence-labeled SS1P molecules and used confocal microscopy to examine the time course of SS1P penetration within spheroids. The penetration was limited after 4 hours. Interestingly, we found a significant increase in the number of tight junctions in the core area of spheroids by electron microscopy. Expression of E-Cadherin, a protein involved in the assembly and sealing of tight junctions and highly expressed in malignant mesothelioma, was found significantly increased in spheroids as compared to monolayers. Moreover, we found that siRNA silencing and antibody inhibition targeting E-Cadherin could enhance SS1P immunotoxin therapy in vitro. Conclusion/Significance: This work is one of the first to investigate immunotoxins in 3D tumor spheroids in vitro. This initial description of an in vitro tumor model may offer a simple and more representative model of in vivo tumors and will allow for further investigations of the microenvironmental effects on drug penetration and tumor cell killing. We believe that the methods developed here may apply to the studies of other tumor-targeting antibodies and immunoconjugates in vitro.	[Xiang, Xinran; Phung, Yen; Feng, Mingqian; Zhang, Jingli; Hassan, Raffit; FitzGerald, David; Ho, Mitchell] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Nagashima, Kunio] Sci Applicat Int Corp Frederick Inc, Frederick, MD USA; [Broaddus, V. Courtney] Univ Calif San Francisco, Lung Biol Ctr, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of California System; University of California San Francisco	Xiang, XR (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405; Xiang, Xinran/0000-0001-6422-436X	National Institutes of Health (NIH); National Cancer Institute (NCI); Center for Cancer Research; Mesothelioma Applied Research Foundation; NCI, NIH [HHSN26120080001E]; NATIONAL CANCER INSTITUTE [ZIABC010816, ZIABC010891] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research, in part by the NCI Director's Intramural Innovation Award for Principal Investigators (MH), in part by a Mesothelioma Applied Research Foundation Grant in Honor of Craig Kozicki (MH), and in part with federal funds from the NCI, NIH, under contract HHSN26120080001E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Contreras RG, 2002, PFLUG ARCH EUR J PHY, V444, P467, DOI 10.1007/s00424-002-0827-8; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Daubriac J, 2009, CELL DEATH DIFFER, V16, P1146, DOI 10.1038/cdd.2009.32; Decker T, 2004, BLOOD, V103, P2718, DOI 10.1182/blood-2003-04-1317; Desoize B, 2000, CRIT REV ONCOL HEMAT, V36, P193, DOI 10.1016/S1040-8428(00)00086-X; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Green SK, 2004, MOL CANCER THER, V3, P149; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hassan R, 2007, CLIN CANCER RES, V13, P7166, DOI 10.1158/1078-0432.CCR-07-1592; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Kitazume H, 2000, CANCER CYTOPATHOL, V90, P55, DOI 10.1002/(SICI)1097-0142(20000225)90:1<55::AID-CNCR8>3.0.CO;2-P; LECHNER JF, 1985, P NATL ACAD SCI USA, V82, P3884, DOI 10.1073/pnas.82.11.3884; Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2; Marchevsky AM, 2008, ARCH PATHOL LAB MED, V132, P397, DOI 10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; Oury TD, 1998, HUM PATHOL, V29, P1382, DOI 10.1016/S0046-8177(98)90006-5; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Simsir A, 1999, DIAGN CYTOPATHOL, V20, P125, DOI 10.1002/(SICI)1097-0339(199903)20:3<125::AID-DC3>3.0.CO;2-V; Steele JPC, 2005, LUNG CANCER, V49, pS49, DOI 10.1016/j.lungcan.2005.03.009; Wang YH, 2002, CANCER RES, V62, P6434; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Yaziji H, 2006, MODERN PATHOL, V19, P514, DOI 10.1038/modpathol.3800534; Zhang YJ, 2008, CLIN CANCER RES, V14, P7981, DOI 10.1158/1078-0432.CCR-08-0324; Zhang YJ, 2007, P NATL ACAD SCI USA, V104, P17099, DOI 10.1073/pnas.0708101104; Zhang YJ, 2006, CLIN CANCER RES, V12, P4695, DOI 10.1158/1078-0432.CCR-06-0346; Zhang YJ, 2010, CANCER RES, V70, P1082, DOI 10.1158/0008-5472.CAN-09-2405	35	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e14640	10.1371/journal.pone.0014640	http://dx.doi.org/10.1371/journal.pone.0014640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305058	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300021
J	Kim, J; Hwangbo, J; Wong, PKY				Kim, Jeesun; Hwangbo, Jeon; Wong, Paul K. Y.			p38 MAPK-Mediated Bmi-1 Down-Regulation and Defective Proliferation in ATM-Deficient Neural Stem Cells Can Be Restored by Akt Activation	PLOS ONE			English	Article							SELF-RENEWAL; OXIDATIVE STRESS; PROTEIN-KINASE; CHROMATIN-ASSOCIATION; PURKINJE NEURONS; EXPRESSION; GROWTH; SURVIVAL; CYCLE	A-T (ataxia telangiectasia) is a genetic disease caused by a mutation in the Atm (A-T mutated) gene that leads to neurodegeneration. Despite an increase in the numbers of studies in this area in recent years, the mechanisms underlying neurodegeneration in human A-T are still poorly understood. Previous studies demonstrated that neural stem cells (NSCs) isolated from the subventricular zone (SVZ) of Atm(-/-) mouse brains show defective self-renewal and proliferation, which is accompanied by activation of chronic p38 mitogen-activated protein kinase (MAPK) and a lower level of the polycomb protein Bmi-1. However, the mechanism underlying Bmi-1 down-regulation and its relevance to defective proliferation in Atm(-/-) NSCs remained unclear. Here, we show that over-expression of Bmi-1 increases self-renewal and proliferation of Atm(-/-) NSCs to normal, indicating that defective proliferation in Atm(-/-) NSCs is a consequence of down-regulation of Bmi-1. We also demonstrate that epidermal growth factor (EGF)-induced Akt phosphorylation renders Bmi-1 resistant to the proteasomal degradation, leading to its stabilization and accumulation in the nucleus. However, inhibition of the Akt-dependent Bmi-1 stabilizing process by p38 MAPK signaling reduces the levels of Bmi-1. Treatment of the Atm(-/-) NSCs with a specific p38 MAPK inhibitor SB203580 extended Bmi-1 posttranscriptional turnover and H2A ubiquitination in Atm(-/-) SCs. Our observations demonstrate the molecular basis underlying the impairment of self-renewal and proliferation in Atm(-/-) SCs through the p38 MAPK-Akt-Bmi-1-p21 signaling pathway.	[Kim, Jeesun; Wong, Paul K. Y.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Hwangbo, Jeon] Kyung Hee Univ, Dept Genet Engn, Suwon, South Korea; [Hwangbo, Jeon] Kyung Hee Univ, Grad Sch Biotechnol, Suwon, South Korea	University of Texas System; UTMD Anderson Cancer Center; Kyung Hee University; Kyung Hee University	Kim, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	pkwong@mdanderson.org			MD Anderson Cancer Center; Longevity Foundation in Austin, Texas; A-T Children's Project in Deerfield Beach, Florida	MD Anderson Cancer Center; Longevity Foundation in Austin, Texas; A-T Children's Project in Deerfield Beach, Florida	This work was supported by fellowship from the Odyssey Program of MD Anderson Cancer Center, and by funds from the Longevity Foundation (formally, A-T Foundation) in Austin, Texas and A-T Children's Project in Deerfield Beach, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DM, 2000, GENE DEV, V15, P554; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bhattacharyya J, 2009, ANN HEMATOL, V88, P333, DOI 10.1007/s00277-008-0603-8; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Chen P, 2003, J NEUROSCI, V23, P11453; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez I, 2004, MOL CELL BIOL, V24, P3607, DOI 10.1128/MCB.24.9.3607-3622.2004; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Kim J, 2009, STEM CELLS, V27, P1987, DOI 10.1002/stem.125; Kim J, 2009, J BIOL CHEM, V284, P14396, DOI 10.1074/jbc.M808116200; Lee B, 2006, FEBS LETT, V580, P5177, DOI 10.1016/j.febslet.2006.08.064; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li JX, 2006, J NEUROSCI, V26, P7839, DOI 10.1523/JNEUROSCI.1624-06.2006; Li ZZ, 2006, J BIOL CHEM, V281, P20643, DOI 10.1074/jbc.M602461200; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Obuse C, 2004, GENES CELLS, V9, P105, DOI 10.1111/j.1365-2443.2004.00705.x; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Soulez M, 1999, ONCOGENE, V18, P2739, DOI 10.1038/sj.onc.1202613; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Voncken JW, 1999, J CELL SCI, V112, P4627; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wong P. K., 2010, NEURODEGENERATION TH, P1; Yang SR, 2006, STEM CELLS, V24, P292, DOI 10.1634/stemcells.2005-0221; Zuluaga S, 2007, CELL SIGNAL, V19, P62, DOI 10.1016/j.cellsig.2006.05.032	36	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16615	10.1371/journal.pone.0016615	http://dx.doi.org/10.1371/journal.pone.0016615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305053	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100050
J	Staats, HF; Fielhauer, JR; Thompson, AL; Tripp, AA; Sobel, AE; Maddaloni, M; Abraham, SN; Pascual, DW				Staats, Herman F.; Fielhauer, Jeffrey R.; Thompson, Afton L.; Tripp, Alice A.; Sobel, Ashley E.; Maddaloni, Massimo; Abraham, Soman N.; Pascual, David W.			Mucosal Targeting of a BoNT/A Subunit Vaccine Adjuvanted with a Mast Cell Activator Enhances Induction of BoNT/A Neutralizing Antibodies in Rabbits	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NASAL LYMPHOID-TISSUE; BOTULINUM NEUROTOXIN; PROTECTIVE ANTIGEN; INFLUENZA VACCINE; CHOLERA-TOXIN; INTRANASAL IMMUNIZATION; MONOCLONAL-ANTIBODIES; SYSTEMIC IMMUNITY; BELLS-PALSY	Background: We previously reported that the immunogenicity of Hc beta tre, a botulinum neurotoxin A (BoNT/A) immunogen, was enhanced by fusion to an epithelial cell binding domain, Ad2F, when nasally delivered to mice with cholera toxin (CT). This study was performed to determine if Ad2F would enhance the nasal immunogenicity of Hc beta tre in rabbits, an animal model with a nasal cavity anatomy similar to humans. Since CT is not safe for human use, we also tested the adjuvant activity of compound 48/80 (C48/80), a mast cell activating compound previously determined to safely exhibit nasal adjuvant activity in mice. Methods: New Zealand White or Dutch Belted rabbits were nasally immunized with Hc beta tre or Hc beta tre-Ad2F alone or combined with CT or C48/80, and serum samples were tested for the presence of Hc beta tre-specific binding (ELISA) or BoNT/A neutralizing antibodies. Results: Hc beta tre-Ad2F nasally administered with CT induced serum anti-Hc beta tre IgG ELISA and BoNT/A neutralizing antibody titers greater than those induced by Hc beta tre + CT. C48/80 provided significant nasal adjuvant activity and induced BoNT/A-neutralizing antibodies similar to those induced by CT. Conclusions: Ad2F enhanced the nasal immunogenicity of Hc beta tre, and the mast cell activator C48/80 was an effective adjuvant for nasal immunization in rabbits, an animal model with a nasal cavity anatomy similar to that in humans.	[Staats, Herman F.; Fielhauer, Jeffrey R.; Thompson, Afton L.; Tripp, Alice A.; Sobel, Ashley E.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Staats, Herman F.; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Staats, Herman F.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA; [Maddaloni, Massimo; Pascual, David W.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Duke University; Duke University; Duke University; Duke University; Montana State University System; Montana State University Bozeman	Staats, HF (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	herman.staats@duke.edu	Pascual, David/AAC-2248-2022	Staats, Herman/0000-0003-1039-1087	NIH [R01 AI064879, R21 AI059591, R01 AI078938]; Rocky Mountain Research Center of Excellence, NIH [U54 AI06537]; Montana Agricultural Station; U.S. Department of Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078938, R01AI064879, R21AI059591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077159] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Research Center of Excellence, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana Agricultural Station; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 AI064879, R21 AI059591, R01 AI078938, and Rocky Mountain Research Center of Excellence, NIH U54 AI06537, and in part by Montana Agricultural Station and U.S. Department of Agriculture Formula Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 1997, VACCINE, V15, P307, DOI 10.1016/S0264-410X(96)00175-2; Allegranzi B, 2007, J HOSP INFECT, V65, P115, DOI 10.1016/S0195-6701(07)60027-9; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baldwin MR, 2005, INFECT IMMUN, V73, P6998, DOI 10.1128/IAI.73.10.6998-7005.2005; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; Boyaka PN, 2000, AM J PATHOL, V157, P2023, DOI 10.1016/S0002-9440(10)64841-9; Boyaka PN, 2003, J IMMUNOL, V170, P5636, DOI 10.4049/jimmunol.170.11.5636; Bradney CP, 2002, J VIROL, V76, P517, DOI 10.1128/JVI.76.2.517-524.2002; Brandtzaeg P, 2003, INT J PEDIATR OTORHI, V67, pS69, DOI 10.1016/j.ijporl.2003.08.018; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; Chen D, 2002, AIDS RES HUM RETROV, V18, P715, DOI 10.1089/088922202760072348; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; Coucke D, 2009, VACCINE, V27, P1279, DOI 10.1016/j.vaccine.2008.12.013; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; Debertin AS, 2003, CLIN EXP IMMUNOL, V134, P503, DOI 10.1111/j.1365-2249.2003.02311.x; Egan MA, 2004, VACCINE, V22, P3774, DOI 10.1016/j.vaccine.2004.03.011; Ginalski K, 2000, FEBS LETT, V482, P119, DOI 10.1016/S0014-5793(00)01954-2; Gwinn WM, 2010, VACCINE, V28, P6901, DOI 10.1016/j.vaccine.2010.08.006; GWINN WM, 2010, VACCINE; Harris SL, 2003, INFECT IMMUN, V71, P275, DOI 10.1128/IAI.71.1.275-286.2003; HEIMSCH RC, 1970, P SOC EXP BIOL MED, V135, P151; Huang J, 2007, HUM VACCINES, V3, P90, DOI 10.4161/hv.3.3.4011; Jodar L, 2001, VACCINE, V19, P1594, DOI 10.1016/S0264-410X(00)00358-3; Kermode M, 2004, HEALTH PROMOT INT, V19, P95, DOI 10.1093/heapro/dah110; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kleinstreuer C, 2008, ANNU REV BIOMED ENG, V10, P195, DOI 10.1146/annurev.bioeng.10.061807.160544; Kobayashi R, 2005, J IMMUNOL, V174, P2190, DOI 10.4049/jimmunol.174.4.2190; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Maddaloni M, 2006, J IMMUNOL, V177, P5524, DOI 10.4049/jimmunol.177.8.5524; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; MARINARO M, 1995, J IMMUNOL, V155, P4621; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; McCloskey N, 1997, J IMMUNOL METHODS, V205, P67, DOI 10.1016/S0022-1759(97)00059-8; McGowen AL, 2009, VACCINE, V27, P3544, DOI 10.1016/j.vaccine.2009.03.069; McLachlan JB, 2008, NAT MED, V14, P536, DOI 10.1038/nm1757; Millner VS, 2010, SOUTH MED J, V103, P993, DOI 10.1097/SMJ.0b013e3181eda3d5; MORO PL, 2010, AM J OBSTET GYNECOLO; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Newman SP, 2004, CRIT REV THER DRUG, V21, P21, DOI 10.1615/CritRevTherDrugCarrierSyst.v21.20; Nir Y, 2003, AM J TROP MED HYG, V68, P341, DOI 10.4269/ajtmh.2003.68.341; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Nordone SK, 2006, AIDS RES HUM RETROV, V22, P558, DOI 10.1089/aid.2006.22.558; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Reid S, 2009, INT J STD AIDS, V20, P295, DOI 10.1258/ijsa.2008.008441; RUSNAK JM, 2009, HUM VACCIN, V5; SCHLESINGER Y, 1992, JAMA-J AM MED ASSOC, V267, P1489, DOI 10.1001/jama.267.11.1489; Schoggins JW, 2005, J VIROL, V79, P11627, DOI 10.1128/JVI.79.18.11627-11637.2005; Simecka JW, 2000, INFECT IMMUN, V68, P672, DOI 10.1128/IAI.68.2.672-679.2000; SINGH BR, 1989, TOXICON, V27, P403, DOI 10.1016/0041-0101(89)90202-X; Smith LA, 2007, CRIT REV IMMUNOL, V27, P303, DOI 10.1615/CritRevImmunol.v27.i4.20; Smith LA, 2009, VACCINE, V27, pD33, DOI 10.1016/j.vaccine.2009.08.059; SNIDER DP, 1994, J IMMUNOL, V153, P647; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Staats HF, 2007, INFECT IMMUN, V75, P5443, DOI 10.1128/IAI.00529-07; Staats HF, 1996, J IMMUNOL, V157, P462; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; *WHO, 2002, 231 WHO; Wu HY, 1997, SCAND J IMMUNOL, V46, P506, DOI 10.1046/j.1365-3083.1997.d01-159.x; Wu HY, 1997, IMMUNOL RES, V16, P187, DOI 10.1007/BF02786362; Zuercher AW, 2002, EUR J IMMUNOL, V32, P3191, DOI 10.1002/1521-4141(200211)32:11<3191::AID-IMMU3191>3.0.CO;2-0	67	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16532	10.1371/journal.pone.0016532	http://dx.doi.org/10.1371/journal.pone.0016532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304600	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900064
J	Wang, DV; Tsien, JZ				Wang, Dong V.; Tsien, Joe Z.			Conjunctive Processing of Locomotor Signals by the Ventral Tegmental Area Neuronal Population	PLOS ONE			English	Article							GABA-CONTAINING NEURONS; DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; REWARD; ENCODE; TRANSMISSION; PROJECTIONS; ADDICTION; MOVEMENT; BEHAVIOR	The ventral tegmental area (VTA) plays an essential role in reward and motivation. How the dopamine (DA) and non-DA neurons in the VTA engage in motivation-based locomotor behaviors is not well understood. We recorded activity of putative DA and non-DA neurons simultaneously in the VTA of awake mice engaged in motivated voluntary movements such as wheel running. Our results revealed that VTA non-DA neurons exhibited significant rhythmic activity that was correlated with the animal's running rhythms. Activity of putative DA neurons also correlated with the movement behavior, but to a lesser degree. More importantly, putative DA neurons exhibited significant burst activation at both onset and offset of voluntary movements. These findings suggest that VTA DA and non-DA neurons conjunctively process locomotor-related motivational signals that are associated with movement initiation, maintenance and termination.	[Wang, Dong V.] E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE & STCSM, Shanghai 200062, Peoples R China; [Wang, Dong V.; Tsien, Joe Z.] Georgia Hlth Sci Univ, Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA USA	East China Normal University; University System of Georgia; Augusta University	Wang, DV (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Lab MOE & STCSM, Shanghai 200062, Peoples R China.	jtsien@mcg.edu			NIMH [MH060236]; NIA [AG024022, AG034663, AG025918]; Georgia Research Alliance;  [USAMRA00002]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034663, R01AG024022, R01AG025918] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Georgia Research Alliance; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from NIMH (MH060236), NIA (AG024022, AG034663 and AG025918), USAMRA00002, and Georgia Research Alliance (all to JZT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Belke TW, 2005, BEHAV PROCESS, V68, P165, DOI 10.1016/j.beproc.2004.12.006; BENINGER RJ, 1983, BRAIN RES REV, V6, P173, DOI 10.1016/0165-0173(83)90038-3; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Cannon CM, 2003, J NEUROSCI, V23, P10827; Carr DB, 2000, SYNAPSE, V38, P114, DOI 10.1002/1098-2396(200011)38:2<114::AID-SYN2>3.0.CO;2-R; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fields HL, 2007, ANNU REV NEUROSCI, V30, P289, DOI 10.1146/annurev.neuro.30.051606.094341; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; GRACE AA, 1984, J NEUROSCI, V4, P2877; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Jin X, 2010, NATURE, V466, P457, DOI 10.1038/nature09263; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Laviolette SR, 2001, EUR J NEUROSCI, V13, P1009, DOI 10.1046/j.1460-9568.2001.01458.x; Lee RS, 2001, J NEUROSCI, V21, P1757; Lin LN, 2006, J NEUROSCI METH, V155, P28, DOI 10.1016/j.jneumeth.2005.12.032; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; MILLR JD, 1983, BRAIN RES, V273, P133, DOI 10.1016/0006-8993(83)91101-0; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Narayanan Nandakumar S., 2009, V489, P135, DOI 10.1007/978-1-59745-543-5_7; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Puryear CB, 2010, BEHAV NEUROSCI, V124, P234, DOI 10.1037/a0018865; Redgrave P, 2008, BRAIN RES REV, V58, P322, DOI 10.1016/j.brainresrev.2007.10.007; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Steffensen SC, 2001, BRAIN RES, V906, P190, DOI 10.1016/S0006-8993(01)02581-1; Stobbs SH, 2004, J PHARMACOL EXP THER, V311, P282, DOI 10.1124/jpet.104.071860; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	44	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16528	10.1371/journal.pone.0016528	http://dx.doi.org/10.1371/journal.pone.0016528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304590	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900063
J	Palmieri, D; Valentino, T; D'Angelo, D; De Martino, I; Postiglione, I; Pacelli, R; Croce, CM; Fedele, M; Fusco, A				Palmieri, D.; Valentino, T.; D'Angelo, D.; De Martino, I.; Postiglione, I.; Pacelli, R.; Croce, C. M.; Fedele, M.; Fusco, A.			HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents	ONCOGENE			English	Article						HMGA; ATM; DNA repair	DNA-DAMAGE RESPONSE; GROUP-A PROTEINS; ATAXIA-TELANGIECTASIA; RADIOSENSITIZING AGENT; IONIZING-RADIATION; KINASE; GENE; P53; TARGET; TUMORIGENESIS	DNA-damaging therapies represent a keystone in cancer treatment. Unfortunately, many tumors often relapse because of a group of cancer cells, which are resistant to conventional therapies. High-mobility group A (HMGA) proteins has a key role in cell transformation, and their overexpression is a common feature of human malignant neoplasias, representing a poor prognostic index often correlated to anti-cancer drug resistance. Our previous results demonstrated that HMGA1 is a substrate of ataxia-telangiectasia mutated (ATM), the main cellular sensor of genotoxic stress. Here we also report that HMGA2, the other member of the HMGA family, is a novel substrate of ATM. Interestingly, we found that HMGA proteins positively regulate ATM gene expression. Moreover, induction of ATM kinase activity by DNA-damaging agents enhances HMGA-dependent transcriptional activation of ATM promoter, suggesting that ATM expression is modulated by a DNA-damage-and HMGA-dependent positive feedback loop. Finally, inhibition of HMGA expression in mouse embryonic fibroblasts and in cancer cells strongly reduces ATM protein levels, impairing the cellular DNA-damage response and enhancing the sensitivity to DNA-damaging agents. These findings indicate this novel HMGA-ATM pathway as a new potential target to improve the effectiveness of conventional anti-neoplastic treatments on the genotoxic-drug resistant cancer cells. Oncogene (2011) 30, 3024-3035; doi: 10.1038/onc.2011.21; published online 21 February 2011	[Palmieri, D.; Valentino, T.; D'Angelo, D.; De Martino, I.; Postiglione, I.; Fedele, M.; Fusco, A.] Univ Naples Federico II, CNR, Dipartimento Biol & Patol Cellulare & Mol, Ist Endocrinol & Oncol Sperimentale,Fac Med & Chi, Naples, Italy; [Pacelli, R.] CNR, Ist Biostrutture & Bioimmagini, I-80125 Naples, Italy; [Palmieri, D.; Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA; [Fusco, A.] NOGEC Naples Oncogenom Ctr CEINGE, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Fusco, A (corresponding author), CNR, Ist Oncol & Endocrinol Sperimentale G Salvatore, Dipartimento Biol & Patol Cellulare & Mol, Via Pansini 5, I-80131 Naples, Italy.	afusco@napoli.com	D'Angelo, Daniela/GVT-9143-2022; Young, Richard A/F-6495-2012; Fedele, Monica/C-1417-2015; Pacelli, Roberto/AFS-0333-2022	Young, Richard A/0000-0001-8855-8647; Fedele, Monica/0000-0002-9171-1312; Palmieri, Dario/0000-0002-0797-4268; Fusco, Alfredo/0000-0003-3332-5197; Pacelli, Roberto/0000-0002-2048-7675	Associazione Italiana Ricerca sul Cancro (AIRC); Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	We thank V Costanzo for revision of the paper and I Pellegrino for technical support. We are grateful to MB Kastan for providing the pFLAG-ATM expression construct and to D Ginsberg for the pLuc-ATM reporter vector. This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC). DP is recipient of a fellowship from Fondazione Italiana per la Ricerca sul Cancro (FIRC).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Berkovich E, 2003, ONCOGENE, V22, P161, DOI 10.1038/sj.onc.1206144; Berlingieri MT, 2002, ONCOGENE, V21, P2971, DOI 10.1038/sj.onc.1205368; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chiappetta G, 1996, ONCOGENE, V13, P2439; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Fedele M, 2001, CANCER RES, V61, P4583; Fedele M, 2001, CARCINOGENESIS, V22, P1583, DOI 10.1093/carcin/22.10.1583; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Fedele M, 2010, BBA-GENE REGUL MECH, V1799, P48, DOI 10.1016/j.bbagrm.2009.11.007; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gueven N, 2003, GENE CHROMOSOME CANC, V38, P157, DOI 10.1002/gcc.10261; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoyos JM, 2004, CANCER RES, V64, P5728, DOI 10.1158/0008-5472.CAN-04-1410; Jackson SP, 2009, BIOCHEM SOC T, V37, P483, DOI 10.1042/BST0370483; JOHNSON KR, 1989, MOL CELL BIOL, V9, P2114, DOI 10.1128/MCB.9.5.2114; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEYN MS, 1994, INT J RADIAT BIOL, V66, pS141; Nagpal S, 1999, J BIOL CHEM, V274, P22563, DOI 10.1074/jbc.274.32.22563; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Pentimalli F, 2008, EUR J CANCER, V44, P2668, DOI 10.1016/j.ejca.2008.07.033; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; PIERANTONI GM, 2006, CELL DEATH DIFFER, V5, P2045; Reeves R, 2005, DNA REPAIR, V4, P926, DOI 10.1016/j.dnarep.2005.04.010; REEVES R, 1990, J BIOL CHEM, V265, P8573; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarkaria JN, 2001, SEMIN RADIAT ONCOL, V11, P316, DOI 10.1053/srao.2001.26030; Sarkaria JN, 1998, CANCER RES, V58, P4375; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wood LJ, 2000, CANCER RES, V60, P4256; Xu Y, 1998, MOL CELL BIOL, V18, P4385, DOI 10.1128/MCB.18.7.4385; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	41	45	47	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	27					3024	3035		10.1038/onc.2011.21	http://dx.doi.org/10.1038/onc.2011.21			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21339738				2022-12-25	WOS:000292510100003
J	Chang, TJ; Wang, R; Olson, DJH; Mousseau, DD; Ross, ARS; Wu, LY				Chang, Tuanjie; Wang, Rui; Olson, Douglas J. H.; Mousseau, Darrell D.; Ross, Andrew R. S.; Wu, Lingyun			Modification of Akt1 by methylglyoxal promotes the proliferation of vascular smooth muscle cells	FASEB JOURNAL			English	Article						cell signaling; cell cycle; hypertension	AKT/PROTEIN KINASE-B; PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; INSULIN-RESISTANCE; OXIDATIVE STRESS; SKELETAL-MUSCLE; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; HYPERTENSION	Methylglyoxal (MG), a reactive dicarbonyl molecule, can modify protein to form advanced glycation endproducts. Increased MG level has been implicated in proliferative vascular diseases, but the underlying mechanisms are not clear yet. The serine/threonine kinase, Akt, regulates multiple signaling pathways that control cell proliferation. Using mass spectrometric analysis, we have detected the modification of Akt1 by MG at Cys(77). This structural modification increased Akt1 phosphorylation at Ser(473) and Thr(308). Akt1 phosphorylation and activity were also increased by MG treatment (< 50 mu M) in cultured vascular smooth muscle cells (VSMCs). MG treatment of VSMCs led to increased DNA synthesis (EC50 = 5.8 mu M), cell proliferation, phosphorylation of p21 and glycogen synthase kinase-3 alpha/beta (GSK-3 alpha/beta), and increased cyclin-dependent kinase 2 (CDK2) activity. These effects of MG were significantly inhibited by silencing Akt1 or by an Akt inhibitor. Overexpression of Akt1 Cys(77)Ser mutant in HEK-293 cells increased cell proliferation and DNA synthesis, concurrent with an increase in Akt1 activity, which could not be further augmented by MG treatment. It is concluded that MG-induced VSMC proliferation is mediated by the activation of Akt1 via the modification of Akt1 at Cys(77).-Chang, T., Wang, R., Olson, D.J.H., Mousseau, D.D., Ross, A.R.S., Wu, L. Modification of Akt1 by methylglyoxal promotes the proliferation of vascular smooth muscle cells. FASEB J. 25, 1746-1757 (2011). www.fasebj.org	[Chang, Tuanjie; Wu, Lingyun] Univ Saskatchewan, Dept Pharmacol, Coll Med, Saskatoon, SK S7N 5E5, Canada; [Mousseau, Darrell D.] Univ Saskatchewan, Cell Signalling Lab, Saskatoon, SK S7N 5E5, Canada; [Wang, Rui] Lakehead Univ, Dept Biol, Fac Sci & Environm Study, Thunder Bay, ON P7B 5E1, Canada; [Olson, Douglas J. H.] CNR, Inst Plant Biotechnol, Saskatoon, SK, Canada; [Ross, Andrew R. S.] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	University of Saskatchewan; University of Saskatchewan; Lakehead University; Fisheries & Oceans Canada	Wu, LY (corresponding author), Univ Saskatchewan, Dept Pharmacol, Coll Med, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	lily.wu@usask.ca	Wang, Rui/C-7824-2012	Wang, Rui/0000-0003-3825-3620	Canadian Institutes of Health Research (CIHR) [MOP-68938]; Heart and Stroke Foundation of Canada; Heart and Stroke Foundation of Saskatchewan	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Heart and Stroke Foundation of Saskatchewan	T.C. was supported by a postdoctoral fellowship from the Gasotransmitter Research and Training (GREAT) program of the Canadian Institutes of Health Research (CIHR) and Heart and Stroke Foundation of Canada. This work was supported by operating grants from CIHR (MOP-68938) and the Heart and Stroke Foundation of Saskatchewan to L.W.	Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Benkirane K, 2006, HYPERTENSION, V47, P102, DOI 10.1161/01.HYP.0000196728.05488.c3; Biswas A, 2008, BIOCHEM J, V409, P771, DOI 10.1042/BJ20071006; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Chang TJ, 2005, FREE RADICAL BIO MED, V38, P286, DOI 10.1016/j.freeradbiomed.2004.10.034; Chang TJ, 2006, CAN J PHYSIOL PHARM, V84, P1229, DOI 10.1139/Y06-077; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cozzone D, 2008, DIABETOLOGIA, V51, P512, DOI 10.1007/s00125-007-0913-8; Dai YX, 2007, J PSYCHIATR NEUROSCI, V32, P323; DHAR A, 2011, DIABETES IN PRESS; Du J, 2000, J CELL BIOCHEM, V77, P333, DOI 10.1002/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO;2-Q; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Gao Y, 2006, BIOCHEMISTRY-US, V45, P15654, DOI 10.1021/bi061410o; GILGOMEZ G, 2003, METH MOL B, V282, P131; HADRAVA V, 1989, HYPERTENSION, V13, P589, DOI 10.1161/01.HYP.13.6.589; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Hsuuw YD, 2005, J CELL PHYSIOL, V205, P379, DOI 10.1002/jcp.20408; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jia XM, 2006, FASEB J, V20, P1555, DOI 10.1096/fj.05-5478fje; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mostafa AA, 2007, MOL CELL BIOCHEM, V302, P35, DOI 10.1007/s11010-007-9422-9; Nagaraj RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P110, DOI 10.1016/S0003-9861(02)00067-X; Ndisang JF, 2003, BLOOD, V101, P3893, DOI 10.1182/blood-2002-08-2608; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Rondinone CM, 1999, DIABETOLOGIA, V42, P819, DOI 10.1007/s001250051232; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B; Tanner FC, 2003, HYPERTENSION, V42, P184, DOI 10.1161/01.HYP.0000082360.65547.7C; THORNALLEY PJ, 1989, DIABETES RES CLIN PR, V7, P115, DOI 10.1016/0168-8227(89)90101-0; Wang H, 2007, CLIN BIOCHEM, V40, P1232, DOI 10.1016/j.clinbiochem.2007.07.016; Wang XX, 2008, J HYPERTENS, V26, P765, DOI 10.1097/HJH.0b013e3282f4a13c; Wang XX, 2005, J HYPERTENS, V23, P1565, DOI 10.1097/01.hjh.0000173778.85233.1b; Wei ZL, 2009, CELL SIGNAL, V21, P161, DOI 10.1016/j.cellsig.2008.10.005; Wu LY, 2006, CAN J PHYSIOL PHARM, V84, P129, DOI 10.1139/Y05-137; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2004, J BIOL CHEM, V279, P49199, DOI 10.1074/jbc.M408997200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zeng JM, 2005, CHEM RES TOXICOL, V18, P1232, DOI 10.1021/tx050074u; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	49	38	41	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2011	25	5					1746	1757		10.1096/fj.10-178053	http://dx.doi.org/10.1096/fj.10-178053			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21321187				2022-12-25	WOS:000290023800030
J	Fortian, A; Gonzalez, E; Castano, D; Falcon-Perez, JM; Millet, O				Fortian, Arola; Gonzalez, Esperanza; Castano, David; Falcon-Perez, Juan M.; Millet, Oscar			Intracellular Rescue of the Uroporphyrinogen III Synthase Activity in Enzymes Carrying the Hotspot Mutation C73R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ERYTHROPOIETIC PORPHYRIA; BONE-MARROW-TRANSPLANTATION; PROTEIN; PHENOTYPE; GENE; DISEASE; IDENTIFICATION; GENOTYPE	A single mutation (C73R) in the enzyme uroporphyrinogen III synthase (UROIIIS) is responsible for more than one-third of all of the reported cases of the rare autosomal disease congenital erythropoietic porphyria (CEP). CEP patients carrying this hotspot mutation develop a severe phenotype of the disease, including reduced life expectancy. Here, we have investigated the molecular basis for the functional deficit in the mutant enzyme both in vitro and in cellular systems. We show that a Cys in position 73 is not essential for the catalytic activity of the enzyme but its mutation to Arg speeds up the process of irreversible unfolding and aggregation. In the mammalian cell milieu, the mutant protein levels decrease to below the detection limit, whereas wild type UROIIIS can be detected easily. The disparate response is not produced by differences at the level of transcription, and the results with cultured cells and in vitro are consistent with a model where the protein becomes very unstable upon mutation and triggers a degradation mechanism via the proteasome. Mutant protein levels can be restored upon cell treatment with the proteasome inhibitor MG132. The intracellularly recovered C73R-UROIIIS protein shows enzymatic activity, paving the way for a new line of therapeutic intervention in CEP patients.	[Fortian, Arola; Castano, David; Millet, Oscar] Ctr Invest Cooperat Biociencias, Struct Biol Unit, Derio 48160, Vizcaya, Spain; [Gonzalez, Esperanza; Falcon-Perez, Juan M.] Ctr Invest Cooperat Biociencias, Metabol Unit, Derio 48160, Vizcaya, Spain		Millet, O (corresponding author), CICbioGUNE, Bizkaia Technol Pk,Bldg 800, Derio 48160, Spain.	omillet@cicbiogune.es	Falcon-Perez, Juan M/F-5920-2011; González, Esperanza/H-5450-2015; González, Esperanza/AAK-4097-2020; Millet, Oscar/F-9696-2011	González, Esperanza/0000-0002-3831-4596; González, Esperanza/0000-0002-3831-4596; Millet, Oscar/0000-0001-8748-4105; Falcon-Perez, Juan M/0000-0003-3133-0670; , Arola/0000-0002-6848-2953	Department of Industry, Tourism; Trade of the Basque government; Innovation Technology Department of Bizkaia County; Ministerio de Ciencia y Tecnologia [CTQ2006-09101/BQU, CTQ2009-10353/BQU]; Fundacion Ramon Areces	Department of Industry, Tourism; Trade of the Basque government; Innovation Technology Department of Bizkaia County; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces	This work was supported by the Department of Industry, Tourism, and Trade of the Basque government (Etortek Research Programs 2005/2007), the Innovation Technology Department of Bizkaia County, the Ministerio de Ciencia y Tecnologia (CTQ2006-09101/BQU and CTQ2009-10353/BQU), The Fundacion Ramon Areces, and the Ramon y Cajal program (to J. M. F. P.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bishop DF, 2006, AM J HUM GENET, V78, P645, DOI 10.1086/502667; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Cunha L, 2008, PROTEINS, V71, P855, DOI 10.1002/prot.21755; Dsnick RJ, 2002, BRIT J HAEMATOL, V117, P779, DOI 10.1046/j.1365-2141.2002.03557.x; Duncan RF, 2005, FEBS J, V272, P5244, DOI 10.1111/j.1742-4658.2005.04921.x; Dupuis-Girod S, 2005, EUR J PEDIATR, V164, P104, DOI 10.1007/s00431-004-1575-x; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fontanellas A, 1996, EUR J HUM GENET, V4, P274; Fortian A, 2009, BIOCHEMISTRY-US, V48, P454, DOI 10.1021/bi801731q; Frank J, 1998, ANN HUM GENET, V62, P225, DOI 10.1046/j.1469-1809.1998.6230225.x; Ged C, 2009, CELL MOL BIOL, V55, P53, DOI 10.1170/T838; HART GJ, 1985, BIOCHEM J, V232, P151, DOI 10.1042/bj2320151; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Lagarde C, 1998, ANN DERMATOL VENER, V125, P114; Mathews MAA, 2001, EMBO J, V20, P5832, DOI 10.1093/emboj/20.21.5832; Puertollano R, 1999, MOL BIOL CELL, V10, P3435, DOI 10.1091/mbc.10.10.3435; Ruggeri B, 2009, ADV PHARMACOL, V57, P91, DOI 10.1016/S1054-3589(08)57003-7; Schenkein D, 2002, CLIN LYMPHOMA, V3, P49, DOI 10.3816/CLM.2002.n.011; Schubert HL, 2008, BIOCHEMISTRY-US, V47, P8648, DOI 10.1021/bi800635y; Schubert HL, 2002, BIOCHEM SOC T, V30, P595, DOI 10.1042/bst0300595; ShoolinginJordan PM, 1997, METHOD ENZYMOL, V281, P327; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tezcan I, 1998, BLOOD, V92, P4053, DOI 10.1182/blood.V92.11.4053.423k38_4053_4058; To-Figueras J, 2007, BLOOD CELL MOL DIS, V38, P242, DOI 10.1016/j.bcmd.2006.12.001; TSAI SF, 1987, ANAL BIOCHEM, V166, P120, DOI 10.1016/0003-2697(87)90554-9; XU WM, 1995, J CLIN INVEST, V95, P905, DOI 10.1172/JCI117742	31	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13127	13133		10.1074/jbc.M110.205849	http://dx.doi.org/10.1074/jbc.M110.205849			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343304	Green Published, hybrid			2022-12-25	WOS:000289282200033
J	Cardarelli, F; Serresi, M; Albanese, A; Bizzarri, R; Beltram, F				Cardarelli, Francesco; Serresi, Michela; Albanese, Alberto; Bizzarri, Ranieri; Beltram, Fabio			Quantitative Analysis of Tat Peptide Binding to Import Carriers Reveals Unconventional Nuclear Transport Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ARGININE-RICH MOTIF; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNALS; ALPHA; PROTEIN; RECOGNITION; BETA; RNA; SEQUENCE	A detailed study of nuclear import mediated by the HIV-1 Tat peptide ((47)YGRKKRRQRRR(57), Tat(RRR)) is reported. Fluorescence-based measurements, calibration of protein concentrations, and binding assays are exploited to address the physicochemical mechanisms of Tat peptide recognition by the classical importin alpha (Imp alpha) and importin beta (Imp beta) receptors both in vitro and in intact cells. We show that TatRRR is an unconventional nuclear localization sequence that binds directly to both Imp alpha and Imp beta carriers in the absence of competitors (in vitro), whereas this property is silenced in the actual cellular environment. In the latter case, Imp alpha/beta-dependent nuclear import can be successfully restored by replacing the "RRR" stretch with "GGG". We apply a recently developed method to determine quantitatively Tat(GGG) affinity for each receptor. Based on these results, we can rationalize previous controversial reports on the Tat peptide and provide coherent guidelines for the design of novel intracellular targeting sequences.	[Cardarelli, Francesco; Serresi, Michela; Bizzarri, Ranieri; Beltram, Fabio] IIT, NEST, Ctr Nanotechnol Innovat, I-56127 Pisa, Italy; [Albanese, Alberto; Bizzarri, Ranieri; Beltram, Fabio] CNR, Scuola Normale Super, Ist Nanosci, I-56127 Pisa, Italy	Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa	Cardarelli, F (corresponding author), IIT, NEST, Ctr Nanotechnol Innovat, Piazza San Silvestro 12, I-56127 Pisa, Italy.	francesco.cardarelli@iit.it; m.serresi@sns.it	Bizzarri, Ranieri/H-1779-2011; Beltram, Fabio/L-9486-2019; Bizzarri, Ranieri/ABH-8343-2020; Beltram, Fabio/F-2920-2013	Bizzarri, Ranieri/0000-0002-8222-2672; Beltram, Fabio/0000-0002-6081-436X; Beltram, Fabio/0000-0002-6081-436X				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; BERKHOUT B, 1989, CELL, V59, P273, DOI 10.1016/0092-8674(89)90289-4; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Cardarelli F, 2009, J BIOL CHEM, V284, P36638, DOI 10.1074/jbc.M109.036699; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; DELLING U, 1991, P NATL ACAD SCI USA, V88, P6234, DOI 10.1073/pnas.88.14.6234; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Serresi M, 2009, ANAL BIOANAL CHEM, V393, P1123, DOI 10.1007/s00216-008-2489-7; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Truant R, 1999, MOL CELL BIOL, V19, P1210; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574	29	19	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203083	http://dx.doi.org/10.1074/jbc.M110.203083			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21321119	hybrid, Green Published			2022-12-25	WOS:000289077500043
J	Nagpal, K; Plantinga, TS; Sirois, CM; Monks, BG; Latz, E; Netea, MG; Golenbock, DT				Nagpal, Kamalpreet; Plantinga, Theo S.; Sirois, Cherilyn M.; Monks, Brian G.; Latz, Eicke; Netea, Mihai G.; Golenbock, Douglas T.			Natural Loss-of-function Mutation of Myeloid Differentiation Protein 88 Disrupts Its Ability to Form Myddosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CONTAINING ADAPTER PROTEIN; TOLL-LIKE-RECEPTORS; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSE; INNATE IMMUNITY; MYD88; POLYMORPHISMS; SUSCEPTIBILITY	Myeloid differentiation protein 88 (MyD88) is a key signaling adapter in Toll-like receptor (TLR) signaling. MyD88 is also one of the most polymorphic adapter proteins. We screened the reported nonsynonymous coding mutations in MyD88 to identify variants with altered function. In reporter assays, a death domain variant, S34Y, was found to be inactive. Importantly, in reconstituted macrophage-like cell lines derived from knockout mice, MyD88 S34Y was severely compromised in its ability to respond to all MyD88-dependent TLR ligands. Unlike wildtype MyD88, S34Y is unable to form distinct foci in the cells but is present diffused in the cytoplasm. We observed that IRAK4 co-localizes with MyD88 in these aggregates, and thus these foci appear to be "Myddosomes." The MyD88 S34Y loss-of-function mutant demonstrates how proper cellular localization of MyD88 to the Myddosome is a feature required for MyD88 function.	[Nagpal, Kamalpreet; Sirois, Cherilyn M.; Monks, Brian G.; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HD Nijmegen, Netherlands; [Plantinga, Theo S.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HD Nijmegen, Netherlands; [Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; Radboud University Nijmegen; Radboud University Nijmegen; University of Bonn	Golenbock, DT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	douglas.golenbock@umassmed.edu	Latz, Eicke/H-3951-2014; Monks, Brian/B-8362-2015; Netea, Mihai/N-5155-2014; Plantinga, Theo S./A-6895-2015	Latz, Eicke/0000-0003-1488-5666; Monks, Brian/0000-0003-4008-3093; Plantinga, Theo S./0000-0003-4990-6084; Sirois, Cherilyn M./0000-0002-5472-4288	National Institutes of Health [AI084048, GM54060]; Netherlands Organization for Scientific Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, U19AI084048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060, R01GM054060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grants AI084048 and GM54060.; Supported by a Vici grant from The Netherlands Organization for Scientific Research.	Akahoshi M, 2008, LUPUS, V17, P568, DOI 10.1177/0961203308089340; De Jager PL, 2006, ARTHRITIS RHEUM, V54, P1279, DOI 10.1002/art.21755; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamann L, 2006, CLIN CHIM ACTA, V364, P303, DOI 10.1016/j.cca.2005.07.017; HAWLEY RG, 1994, GENE THER, V1, P136; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Jaunin F, 1998, EXP CELL RES, V243, P67, DOI 10.1006/excr.1998.4131; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu YH, 2010, J IMMUNOL, V185, P3391, DOI 10.4049/jimmunol.0903147; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540	30	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11875	11882		10.1074/jbc.M110.199653	http://dx.doi.org/10.1074/jbc.M110.199653			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21325272	hybrid, Green Published			2022-12-25	WOS:000288797100094
J	Vo, MN; Yang, XL; Schimmel, P				Vo, My-Nuong; Yang, Xiang-Lei; Schimmel, Paul			Dissociating Quaternary Structure Regulates Cell-signaling Functions of a Secreted Human tRNA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTORS CXCR1; INDUCED INTERNALIZATION; CYTOKINE ACTIVITIES; DISEASE; ACTIVATION; DIMER; AMINOACYLATION; INTERMEDIATE; ANGIOGENESIS; TRANSLATION	Many tRNA synthetases are homodimers that are catalytically inactive as monomers. An example is the 528-amino acid human tyrosyl-tRNA synthetase, which is made up of an N-terminal catalytic unit (TyrRS(Mini)) and a 164-amino acid C-domain. Although native TyrRS has no known cytokine functions, natural proteolysis of secreted TyrRS releases TyrRS(Mini), which not only has the same aminoacylation activity as native TyrRS but also has strong activity for stimulating migration of polymorphonuclear leukocytes. The migration-stimulating activity is dependent on an ELR tripeptide motif, similar to that in CXC cytokines like IL-8, and also has the familiar bell-shaped concentration dependence seen for CXC cytokines. Here we show that in contrast to IL-8, where the bell-shaped dependence arises from the effects of CXCR1/2 receptor internalization, TyrRS(Mini) does not induce internalization of CXCR1/2. A rationally designed non-associating monomer and a non-dissociating dimer were constructed. With these constructs, the bell-shaped concentration dependence of leukocyte migration was shown to arise from the agonist (for migration) activity of the catalytically inactive monomer and the antagonist activity of the catalytically active dimer. Thus, the dissociating quaternary structure of TyrRS(Mini) regulates two opposing cytokine activities and suggests the possibility of dissociating quaternary structures regulating novel functions of other tRNA synthetases.	Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Yang, XL (corresponding author), BCC379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xlyang@scripps.edu; schimmel@scripps.edu	Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health from the NCI [CA92577]; National Foundation for Cancer Research; National Institutes of Health [GM23562]; NATIONAL CANCER INSTITUTE [R01CA092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92577 (from the NCI) and GM23562 (to P. S.). This work was also supported by a fellowship from the National Foundation for Cancer Research.	Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Bonnefond L, 2005, BIOCHIMIE, V87, P873, DOI 10.1016/j.biochi.2005.03.008; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Ewalt KL, 2002, BIOCHEMISTRY-US, V41, P13344, DOI 10.1021/bi020537k; Feniger-Barish R, 1999, CYTOKINE, V11, P996, DOI 10.1006/cyto.1999.0510; Guo M, 2010, J PHYS CHEM B, V114, P16273, DOI 10.1021/jp1082517; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JONES DH, 1985, BIOCHEMISTRY-US, V24, P5852, DOI 10.1021/bi00342a024; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kapoor M, 2009, CHEM BIOL, V16, P531, DOI 10.1016/j.chembiol.2009.03.006; Levine SM, 2003, CURR OPIN RHEUMATOL, V15, P708, DOI 10.1097/00002281-200311000-00005; Liu JM, 2002, BIOCHEMISTRY-US, V41, P14232, DOI 10.1021/bi0205395; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Richardson RM, 1998, J BIOL CHEM, V273, P23830, DOI 10.1074/jbc.273.37.23830; Rose JJ, 2004, J BIOL CHEM, V279, P24372, DOI 10.1074/jbc.M401364200; SALDANHA RJ, 1995, BIOCHEMISTRY-US, V34, P1275, DOI 10.1021/bi00004a022; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; WARD WHJ, 1988, BIOCHEMISTRY-US, V27, P5525, DOI 10.1021/bi00415a021; Yang XL, 2007, CHEM BIOL, V14, P1323, DOI 10.1016/j.chembiol.2007.10.016; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yaremchuk A, 2002, EMBO J, V21, P3829, DOI 10.1093/emboj/cdf373	38	20	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11563	11568		10.1074/jbc.C110.213876	http://dx.doi.org/10.1074/jbc.C110.213876			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21310955	Green Published, hybrid			2022-12-25	WOS:000288797100066
J	Conway, MJ; Cruz, L; Alam, S; Christensen, ND; Meyers, C				Conway, Michael J.; Cruz, Linda; Alam, Samina; Christensen, Neil David; Meyers, Craig			Cross-Neutralization Potential of Native Human Papillomavirus N-Terminal L2 Epitopes	PLOS ONE			English	Article							HPV INFECTION; PROPAGATION; FEATURES; PROTEIN; SURFACE; DNA	Background: Human papillomavirus (HPV) capsids are composed of 72 pentamers of the major capsid protein L1, and an unknown number of L2 minor capsid proteins. An N-terminal "external loop" of L2 contains cross-neutralizing epitopes, and native HPV16 virions extracted from 20-day-old organotypic tissues are neutralized by anti-HPV16 L2 antibodies but virus from 10-day-old cultures are not, suggesting that L2 epitopes are more exposed in mature, 20-day virions. This current study was undertaken to determine whether cross-neutralization of other HPV types is similarly dependent on time of harvest and to screen for the most effective cross-neutralizing epitope in native virions. Methodology and Principal Findings: Neutralization assays support that although HPV16 L2 epitopes were only exposed in 20-day virions, HPV31 or HPV18 epitopes behaved differently. Instead, HPV31 and HPV18 L2 epitopes were exposed in 10-day virions and remained so in 20-day virions. In contrast, presumably due to sequence divergence, HPV45 was not cross-neutralized by any of the anti-HPV16 L2 antibodies. We found that the most effective cross-neutralizing antibody was a polyclonal antibody named anti-P56/75 #1, which was raised against a peptide consisting of highly conserved HPV16 L2 amino acids 56 to 75. Conclusions and Significance: This is the first study to determine the susceptibility of multiple, native high-risk HPV types to neutralization by L2 antibodies. Multiple anti-L2 antibodies were able to cross-neutralize HPV16, HPV31, and HPV18. Only neutralization of HPV16 depended on the time of tissue harvest. These data should inform attempts to produce a second-generation, L2-based vaccine.	[Conway, Michael J.; Cruz, Linda; Alam, Samina; Meyers, Craig] Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA; [Christensen, Neil David] Penn State Univ, Dept Pathol, Coll Med, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Conway, MJ (corresponding author), Penn State Univ, Dept Microbiol & Immunol, Coll Med, Hershey, PA 17033 USA.	cmm10@psu.edu	alam, samina/V-1599-2018		NIAID [R01AI57988]; Pennsylvania Commonwealth Department of Health [410005094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057988] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Commonwealth Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a PHS Grant from the NIAID (R01AI57988), and MJC was supported by TSF GRSA SAP#410005094 from the Pennsylvania Commonwealth Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belnap DM, 1996, J MOL BIOL, V259, P249, DOI 10.1006/jmbi.1996.0317; Bossis L, 2005, J VIROL, V79, P6723, DOI 10.1128/JVI.79.11.6723-6731.2005; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Buck CB, 2008, J VIROL, V82, P5190, DOI 10.1128/JVI.02726-07; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; Culp TD, 2003, J VIROL METHODS, V111, P135, DOI 10.1016/S0166-0934(03)00170-8; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Fligge C, 2001, J VIROL, V75, P7727, DOI 10.1128/JVI.75.16.7727-7731.2001; Jagu S, 2009, JNCI-J NATL CANCER I, V101, P782, DOI 10.1093/jnci/djp106; Kondo K, 2007, VIROLOGY, V358, P266, DOI 10.1016/j.virol.2006.08.037; Liu WJ, 1997, VIROLOGY, V227, P474, DOI 10.1006/viro.1996.8348; McLaughlin-Drubin ME, 2004, VIROLOGY, V322, P213, DOI 10.1016/j.virol.2004.02.011; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Pastrana DV, 2005, VIROLOGY, V337, P365, DOI 10.1016/j.virol.2005.04.011; SMITH LH, 1995, J INVEST DERMATOL, V105, P438, DOI 10.1111/1523-1747.ep12321173; Trus BL, 1997, NAT STRUCT BIOL, V4, P413, DOI 10.1038/nsb0597-413; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	21	32	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16405	10.1371/journal.pone.0016405	http://dx.doi.org/10.1371/journal.pone.0016405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346798	Green Published, gold, Green Submitted			2022-12-25	WOS:000287077600006
J	Ryu, S; Joshi, N; McDonnell, K; Woo, J; Choi, H; Gao, DC; McCombie, WR; Mittal, V				Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Woo, Jongchan; Choi, Hyejin; Gao, Dingcheng; McCombie, William R.; Mittal, Vivek			Discovery of Novel Human Breast Cancer MicroRNAs from Deep Sequencing Data by Analysis of Pri-MicroRNA Secondary Structures	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MESENCHYMAL TRANSITION; TUMOR INVASION; METASTASIS; EXPRESSION; IDENTIFICATION; DEREGULATION; GENOMICS; FAMILY; CELLS	MicroRNAs (miRNAs) are key regulators of gene expression and contribute to a variety of biological processes. Abnormal miRNA expression has been reported in various diseases including pathophysiology of breast cancer, where they regulate protumorigenic processes including vascular invasiveness, estrogen receptor status, chemotherapy resistance, invasion and metastasis. The miRBase sequence database, a public repository for newly discovered miRNAs, has grown rapidly with approximately > 10,000 entries to date. Despite this rapid growth, many miRNAs have not yet been validated, and several others are yet to be identified. A lack of a full complement of miRNAs has imposed limitations on recognizing their important roles in cancer, including breast cancer. Using deep sequencing technology, we have identified 189 candidate novel microRNAs in human breast cancer cell lines with diverse tumorigenic potential. We further show that analysis of 500-nucleotide pri-microRNA secondary structure constitutes a reliable method to predict bona fide miRNAs as judged by experimental validation. Candidate novel breast cancer miRNAs with stem lengths of greater than 30 bp resulted in the generation of precursor and mature sequences in vivo. On the other hand, candidates with stem length less than 30 bp were less efficient in producing mature miRNA. This approach may be used to predict which candidate novel miRNA would qualify as bona fide miRNAs from deep sequencing data with approximately 90% accuracy.	[Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Choi, Hyejin; Gao, Dingcheng; Mittal, Vivek] Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA; [Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Choi, Hyejin; Gao, Dingcheng; Mittal, Vivek] Cornell Univ, New York, NY 10021 USA; [Ryu, Seongho; Joshi, Natasha; McDonnell, Kevin; Choi, Hyejin; Gao, Dingcheng; Mittal, Vivek] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Woo, Jongchan] Rockefeller Univ, Plant Mol Biol Lab, New York, NY 10021 USA; [McCombie, William R.] Cold Spring Harbor Lab, New York, NY USA	Cornell University; Cornell University; Cornell University; Rockefeller University; Cold Spring Harbor Laboratory	Ryu, S (corresponding author), Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA.	vim2010@med.cornell.edu	Gao, Dingcheng/P-5889-2019; Choi, Hyejin/ABC-5099-2020	Choi, Hyejin/0000-0002-4884-2747; McCombie, W. Richard/0000-0003-1899-0682	Neuberger Berman Lung Cancer laboratory; The Robert I. Goldman Foundation	Neuberger Berman Lung Cancer laboratory; The Robert I. Goldman Foundation	This work was supported by funding from the Neuberger Berman Lung Cancer laboratory and The Robert I. Goldman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hager G, 2009, NAT METHODS, V6, P254, DOI 10.1038/nmeth0409-254; Huang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008206; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YC, 2009, RNA, V15, P1483, DOI 10.1261/rna.1702009; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Ritchie W, 2007, RNA, V13, P457, DOI 10.1261/rna.366507; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	35	26	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e16403	10.1371/journal.pone.0016403	http://dx.doi.org/10.1371/journal.pone.0016403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346806	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600005
J	Trauner, A; Bennett, MH; Williams, HD				Trauner, Andrej; Bennett, Mark H.; Williams, Huw D.			Isolation of Bacterial Ribosomes with Monolith Chromatography	PLOS ONE			English	Article							ESCHERICHIA-COLI; ACTIVE RIBOSOMES; PURIFICATION; SEPARATION; SUPPORTS; SUBUNITS; COLUMNS; RNA	We report the development of a rapid chromatographic method for the isolation of bacterial ribosomes from crude cell lysates in less than ten minutes. Our separation is based on the use of strong anion exchange monolithic columns. Using a simple stepwise elution program we were able to purify ribosomes whose composition is comparable to those isolated by sucrose gradient ultracentrifugation, as confirmed by quantitative proteomic analysis (iTRAQ). The speed and simplicity of this approach could accelerate the study of many different aspects of ribosomal biology.	[Trauner, Andrej; Bennett, Mark H.; Williams, Huw D.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England	Imperial College London	Trauner, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	h.d.williams@imperial.ac.uk		Williams, Huw/0000-0003-2225-6413; Trauner, Andrej/0000-0002-6260-9829	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencina M, 2004, J SEP SCI, V27, P801, DOI 10.1002/jssc.200401784; Beringer M, 2005, J BIOL CHEM, V280, P36065, DOI 10.1074/jbc.M507961200; Bousquet Jean, 2006, Paediatr Drugs, V8, P235, DOI 10.2165/00148581-200608040-00003; Brne P, 2007, J CHROMATOGR A, V1144, P120, DOI 10.1016/j.chroma.2006.12.044; Ederth J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn992; FABRY M, 1981, BIOCHIM BIOPHYS ACTA, V652, P139, DOI 10.1016/0005-2787(81)90217-3; Halbeisen RE, 2009, METHODS, V48, P306, DOI 10.1016/j.ymeth.2009.04.003; JELENC PC, 1980, ANAL BIOCHEM, V105, P369, DOI 10.1016/0003-2697(80)90472-8; Josic D, 2007, J CHROMATOGR A, V1144, P2, DOI 10.1016/j.chroma.2006.11.082; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KIRILLOV SV, 1978, NUCLEIC ACIDS RES, V5, P4305, DOI 10.1093/nar/5.11.4305; Kramberger P, 2007, J CHROMATOGR A, V1144, P143, DOI 10.1016/j.chroma.2006.10.055; LEGOFFIC F, 1974, FEBS LETT, V41, P69, DOI 10.1016/0014-5793(74)80956-7; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lost Isabelle, 2008, V432, P321, DOI 10.1007/978-1-59745-028-7_22; Maguire BA, 2008, RNA, V14, P188, DOI 10.1261/rna.692408; Miyazaki C, 1999, VACCINE, V17, P245, DOI 10.1016/S0264-410X(98)00191-1; SARUYAMA H, 1986, ANAL BIOCHEM, V159, P12, DOI 10.1016/0003-2697(86)90300-3; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Simons SP, 2009, ANAL BIOCHEM, V395, P77, DOI 10.1016/j.ab.2009.07.042; Smrekar F, 2008, J CHROMATOGR B, V861, P177, DOI 10.1016/j.jchromb.2007.05.048; Strancar Ales, 2002, Adv Biochem Eng Biotechnol, V76, P49	22	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16273	10.1371/journal.pone.0016273	http://dx.doi.org/10.1371/journal.pone.0016273			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326610	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037000008
J	Larue, BL; Padilla, PA				LaRue, Bobby L.; Padilla, Pamela A.			Environmental and Genetic Preconditioning for Long-Term Anoxia Responses Requires AMPK in Caenorhabditis elegans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ISCHEMIA-REPERFUSION INJURY; C-ELEGANS; LIFE-SPAN; SUSPENDED ANIMATION; OXIDATIVE STRESS; HYPOXIA; OXYGEN; METABOLISM; SURVIVAL	Background: Preconditioning environments or therapeutics, to suppress the cellular damage associated with severe oxygen deprivation, is of interest to our understanding of diseases associated with oxygen deprivation. Wildtype C. elegans exposed to anoxia enter into a state of suspended animation in which energy-requiring processes reversibly arrest. C. elegans at all developmental stages survive 24-hours of anoxia exposure however, the ability of adult hermaphrodites to survive three days of anoxia significantly decreases. Mutations in the insulin-like signaling receptor (daf-2) and LIN-12/Notch (glp-1) lead to an enhanced long-term anoxia survival phenotype. Methodology/Principal Findings: In this study we show that the combined growth environment of 25 degrees C and a diet of HT115 E. coli will precondition adult hermaphrodites to survive long-term anoxia; many of these survivors have normal movement after anoxia treatment. Animals fed the drug metformin, which induces a dietary-restriction like state in animals and activates AMPK in mammalian cell culture, have a higher survival rate when exposed to long-term anoxia. Mutations in genes encoding components of AMPK (aak-2, aakb-1, aakb-2, aakg-2) suppress the environmentally and genetically induced long-term anoxia survival phenotype. We further determine that there is a correlation between the animals that survive long-term anoxia and increased levels of carminic acid staining, which is a fluorescent dye that incorporates in with carbohydrates such as glycogen. Conclusions/Significance: We conclude that small changes in growth conditions such as increased temperature and food source can influence the physiology of the animal thus affecting the responses to stress such as anoxia. Furthermore, this supports the idea that metformin should be further investigated as a therapeutic tool for treatment of oxygen-deprived tissues. Finally, the capacity for an animal to survive long bouts of severe oxygen deprivation is likely dependent on specific subunits of the heterotrimeric protein AMPK and energy stores such as carbohydrates.	[LaRue, Bobby L.; Padilla, Pamela A.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA	University of North Texas System; University of North Texas Denton	Larue, BL (corresponding author), Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA.	ppadilla@unt.edu			National Science Foundation [0747391]; Division Of Integrative Organismal Systems [0747391] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (NSF CAREER 0747391) to P. A. Padilla. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Chan K, 2010, MOL BIOL CELL, V21, P2161, DOI 10.1091/mbc.E09-07-0614; COOPER AF, 1970, J NEMATOL, V2, P305; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Fuson AL, 2003, J EXP BIOL, V206, P4139, DOI 10.1242/jeb.00654; Gems D, 1998, GENETICS, V150, P129; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Hajeri VA, 2010, MOL BIOL CELL, V21, P712, DOI 10.1091/mbc.E09-09-0787; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; HOCHACHKA PW, 1986, INTENS CARE MED, V12, P127; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hochachka PW, 2000, ADV EXP MED BIOL, V475, P311; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaeberlein M, 2009, CELL CYCLE, V8, P2324, DOI 10.4161/cc.8.15.9126; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Liu D, 2009, INT J BIOCHEM CELL B, V41, P2315, DOI 10.1016/j.biocel.2009.05.021; LUTZ PL, 1992, ANNU REV PHYSIOL, V54, P601, DOI 10.1146/annurev.physiol.54.1.601; Mabon ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007937; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; MARSHALL PN, 1974, STAIN TECHNOL, V49, P19, DOI 10.3109/10520297409116931; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; Mendenhall AR, 2009, PHYSIOL GENOMICS, V36, P167, DOI 10.1152/physiolgenomics.90278.2008; MENDENHALL AR, 2006, GENETICS; Menger MD, 2007, TRANSPL P, V39, P485, DOI 10.1016/j.transproceed.2007.01.022; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; MURRY CE, 1990, CIRC RES, V66, P913, DOI 10.1161/01.RES.66.4.913; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; O'Farrell PH, 2001, J CLIN INVEST, V107, P671, DOI 10.1172/JCI12562; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Padilla PA, 2001, P NATL ACAD SCI USA, V12, P12; Paiva MA, 2010, CARDIOVASC DRUG THER, V24, P25, DOI 10.1007/s10557-010-6222-3; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Podrabsky JE, 2007, J EXP BIOL, V210, P2253, DOI 10.1242/jeb.005116; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; Powers SK, 2007, MED SCI SPORT EXER, V39, P1529, DOI 10.1249/mss.0b013e3180d099c1; Ravingerova T, 2007, MOL CELL BIOCHEM, V297, P111, DOI 10.1007/s11010-006-9335-z; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sendoel A, 2010, NATURE, V465, P577, DOI 10.1038/nature09141; Shao ZY, 2009, GENETICS, V183, P821, DOI 10.1534/genetics.109.107284; Shen C, 2003, ANN NY ACAD SCI, V995, P191, DOI 10.1111/j.1749-6632.2003.tb03222.x; SULSTON JE, 1974, GENETICS, V77, P95; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Yang X, 2010, CARDIOVASC DRUGS THE; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	73	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16790	10.1371/journal.pone.0016790	http://dx.doi.org/10.1371/journal.pone.0016790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304820	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600024
J	Ray, KC; Bell, KM; Yan, JB; Gu, GQ; Chung, CH; Washington, MK; Means, AL				Ray, Kevin C.; Bell, Kayla M.; Yan, Jingbo; Gu, Guoqiang; Chung, Christine H.; Washington, M. Kay; Means, Anna L.			Epithelial Tissues Have Varying Degrees of Susceptibility to Kras(G12D)-Initiated Tumorigenesis in a Mouse Model	PLOS ONE			English	Article							PANCREATIC INTRAEPITHELIAL NEOPLASIA; ONCOGENIC K-RAS; DUCTAL ADENOCARCINOMA; TUMOR PROGRESSION; HUMAN CANCERS; ADULT MICE; EXPRESSION; CELLS; KRAS; PROLIFERATION	Activating mutations in the Kras gene are commonly found in some but not all epithelial cancers. In order to understand the susceptibility of different epithelial tissues to Kras-induced tumorigenesis, we introduced one of the most common Kras mutations, Kras(G12D), broadly in epithelial tissues. We used a mouse model in which the G12D mutation is placed in the endogenous Kras locus controlled by inducible, Cre-mediated recombination in tissues expressing cytokeratin 19 including the oral cavity, GI tract, lungs, and ducts of the liver, kidney, and the pancreas. Introduction of the Kras(G12D) mutation in adult mouse tissues led to neoplastic changes in some but not all of these tissues. Notably, many hyperplasias, metaplasias and adenomas were observed in the oral cavity, stomach, colon and lungs, suggesting that exposure to products of the outside environment promotes Kras(G12D)-initiated tumorigenesis. However, environmental exposure did not consistently correlate with tumor formation, such as in the small intestine, suggesting that there are also intrinsic differences in susceptibility to Kras activation. The pancreas developed small numbers of mucinous metaplasias with characteristics of early stage pancreatic intraepithelial neoplasms (PanINs), supporting the hypothesis that pancreatic ducts have the potential to give rise pancreatic cancer.	[Ray, Kevin C.; Bell, Kayla M.; Means, Anna L.] Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA; [Yan, Jingbo; Gu, Guoqiang; Means, Anna L.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA; [Chung, Christine H.] Johns Hopkins Univ Sch Med, Dept Oncol, Baltimore, MD USA; [Washington, M. Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Johns Hopkins University; Vanderbilt University	Ray, KC (corresponding author), Vanderbilt Univ, Dept Surg, Med Ctr, Nashville, TN 37240 USA.	anna.means@vanderbilt.edu			NIH [R21CA123061, P50CA095103, R01DK065949, P30DK058404]; NATIONAL CANCER INSTITUTE [P50CA095103, R21CA123061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065949, P30DK058404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R21CA123061 (ALM), P50CA095103 (ALM and MKW), R01DK065949 (GG) and P30DK058404 (MKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Blaine SA, 2010, DEVELOPMENT; Caulin C, 2004, CANCER RES, V64, P5054, DOI 10.1158/0008-5472.CAN-04-1488; CHESA PG, 1987, P NATL ACAD SCI USA, V84, P3234, DOI 10.1073/pnas.84.10.3234; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christensen BC, 2009, CARCINOGENESIS, V30, P1003, DOI 10.1093/carcin/bgp099; Coffey RJ, 2007, J CLIN INVEST, V117, P70, DOI 10.1172/JCI30491; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Feldmann G, 2007, J HEPATO-BILIARY-PAN, V14, P224, DOI 10.1007/s00534-006-1166-5; Friday BB, 2005, BBA-REV CANCER, V1756, P127, DOI 10.1016/j.bbcan.2005.08.001; FURTH ME, 1987, ONCOGENE, V1, P47; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Hashimoto Y, 2010, CARCINOGENESIS, V31, P777, DOI 10.1093/carcin/bgq013; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Ji BA, 2009, GASTROENTEROLOGY, V137, P1072, DOI 10.1053/j.gastro.2009.05.052; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karanjawala ZE, 2008, AM J SURG PATHOL, V32, P188, DOI 10.1097/PAS.0b013e31815701f3; Lea IA, 2007, CARCINOGENESIS, V28, P1851, DOI 10.1093/carcin/bgm176; LEON J, 1987, MOL CELL BIOL, V7, P1535, DOI 10.1128/MCB.7.4.1535; Luttges J, 1999, VIRCHOWS ARCH, V435, P461, DOI 10.1007/s004280050428; Means AL, 2005, DEVELOPMENT, V132, P3767, DOI 10.1242/dev.01925; Means AL, 2008, GENESIS, V46, P318, DOI 10.1002/dvg.20397; Mita H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-198; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nakajima M, 1998, PATHOL INT, V48, P944; Nikitin AY, 2004, CANCER RES, V64, P2307, DOI 10.1158/0008-5472.CAN-03-3376; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Schlage WK, 1998, TOXICOL PATHOL, V26, P324, DOI 10.1177/019262339802600307; Sheu JJC, 2009, CANCER RES, V69, P2568, DOI 10.1158/0008-5472.CAN-08-3199; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	45	86	88	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16786	10.1371/journal.pone.0016786	http://dx.doi.org/10.1371/journal.pone.0016786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311774	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200040
J	Dros, J; Maarsingh, OR; van der Windt, DAWM; Oort, FJ; ter Riet, G; de Rooij, SEJA; Schellevis, FG; van der Horst, HE; van Weert, HCPM				Dros, Jacquelien; Maarsingh, Otto R.; van der Windt, Danielle A. W. M.; Oort, Frans J.; ter Riet, Gerben; de Rooij, Sophia E. J. A.; Schellevis, Francois G.; van der Horst, Henriette E.; van Weert, Henk C. P. M.			Profiling Dizziness in Older Primary Care Patients: An Empirical Study	PLOS ONE			English	Article							PERSISTENT DIZZINESS; MULTIPLE IMPUTATION; GENERAL-PRACTICE; PREVALENCE; COMMUNITY; SYMPTOMS; UPDATE	Background: The diagnostic approach to dizzy, older patients is not straightforward as many organ systems can be involved and evidence for diagnostic strategies is lacking. A first differentiation in diagnostic subtypes or profiles may guide the diagnostic process of dizziness and can serve as a classification system in future research. In the literature this has been done, but based on pathophysiological reasoning only. Objective: To establish a classification of diagnostic profiles of dizziness based on empirical data. Design: Cross-sectional study. Participants and Setting: 417 consecutive patients of 65 years and older presenting with dizziness to 45 primary care physicians in the Netherlands from July 2006 to January 2008. Methods: We performed tests, including patient history, and physical and additional examination, previously selected by an international expert panel and based on an earlier systematic review. We used the results of these tests in a principal component analysis for exploration, data-reduction and finally differentiation into diagnostic dizziness profiles. Results: Demographic data and the results of the tests yielded 221 variables, of which 49 contributed to the classification of dizziness into six diagnostic profiles, that may be named as follows: "frailty'', "psychological'', "cardiovascular'', "presyncope'', "non-specific dizziness'' and "ENT''. These explained 32% of the variance. Conclusions: Empirically identified components classify dizziness into six profiles. This classification takes into account the heterogeneity and multicausality of dizziness and may serve as starting point for research on diagnostic strategies and can be a first step in an evidence based diagnostic approach of dizzy older patients.	[Dros, Jacquelien; ter Riet, Gerben; van Weert, Henk C. P. M.] Univ Amsterdam, Acad Med Ctr, Dept Family Med, NL-1105 AZ Amsterdam, Netherlands; [Maarsingh, Otto R.; van der Windt, Danielle A. W. M.; Schellevis, Francois G.; van der Horst, Henriette E.] Vrije Univ Amsterdam Med Ctr, Dept Family Med, Amsterdam, Netherlands; [Maarsingh, Otto R.; van der Windt, Danielle A. W. M.; Schellevis, Francois G.; van der Horst, Henriette E.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van der Windt, Danielle A. W. M.] Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele, Staffs, England; [Oort, Frans J.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [de Rooij, Sophia E. J. A.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Geriatr Med Sect, NL-1105 AZ Amsterdam, Netherlands; [Schellevis, Francois G.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Keele University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Institute for Health Services Research	Dros, J (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Family Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.dros@amc.uva.nl	Maarsingh, Otto/AAD-1553-2022; Maarsingh, Otto R/C-9100-2012; Riet, Gerben ter/A-6943-2011	Riet, Gerben ter/0000-0002-2231-7637; Oort, Frans/0000-0003-1823-7105; Maarsingh, Otto/0000-0002-3747-9217	Netherlands Organisation for Health Research and Development (ZonMw) [4200.0018]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 4200.0018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branch W., APPROACH PATIENT DIZ; Brignole M, 2004, EUROPACE, V6, P467, DOI 10.1016/j.eupc.2004.08.008; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; COLLEDGE NR, 1994, AGE AGEING, V23, P117, DOI 10.1093/ageing/23.2.117; Costello A.B., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8, DOI 10.7275/JYJ1-4868]; DRACHMAN DA, 1972, NEUROLOGY, V22, P323, DOI 10.1212/WNL.22.4.323; Dros J, 2010, CAN MED ASSOC J, V182, pE621, DOI 10.1503/cmaj.080910; Fife TD, 2000, NEUROLOGY, V55, P1431, DOI 10.1212/WNL.55.10.1431; Hanley K, 2002, BRIT J GEN PRACT, V52, P809; Hoffman RM, 1999, AM J MED, V107, P468, DOI 10.1016/S0002-9343(99)00260-0; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; KROENKE K, 1992, ANN INTERN MED, V117, P898, DOI 10.7326/0003-4819-117-11-898; Laupacis A, 2007, ANN INTERN MED, V147, P273, DOI 10.7326/0003-4819-147-4-200708210-00180; Maarsingh OR, 2010, ANN FAM MED, V8, P196, DOI 10.1370/afm.1116; Maarsingh OR, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-2; Maarsingh OR, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-12; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; Nazareth I, 2006, J PSYCHOSOM RES, V60, P395, DOI 10.1016/j.jpsychores.2005.07.011; Newman-Toker DE, 2007, MAYO CLIN PROC, V82, P1329, DOI 10.4065/82.11.1329; *NIH CLIN EXC, CLIN KNOWL SUMM; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Sloane P D, 1994, J Am Board Fam Pract, V7, P1; Sloane PD, 2001, ANN INTERN MED, V134, P823, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00005; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; VANDERLINDEN MW, 2004, 2 DUTCH NATL SURVEY; Vereeck L, 2006, B-ENT, V2, P75; Verheij AAA, 2002, HUISARTS WET, V45, P601; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16481	10.1371/journal.pone.0016481	http://dx.doi.org/10.1371/journal.pone.0016481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304984	Green Published, Green Accepted, gold			2022-12-25	WOS:000286834300069
J	Kawano-Yamashita, E; Koyanagi, M; Shichida, Y; Oishi, T; Tamotsu, S; Terakita, A				Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Shichida, Yoshinori; Oishi, Tadashi; Tamotsu, Satoshi; Terakita, Akihisa			Beta-Arrestin Functionally Regulates the Non-Bleaching Pigment Parapinopsin in Lamprey Pineal	PLOS ONE			English	Article							RECEPTOR KINASES; PHOTORECEPTOR CELLS; LAMPETRA-JAPONICA; RIVER LAMPREY; S-ANTIGEN; PROTEIN; RHODOPSIN; ORGAN; ENDOCYTOSIS; APOPTOSIS	The light response of vertebrate visual cells is achieved by light-sensing proteins such as opsin-based pigments as well as signal transduction proteins, including visual arrestin. Previous studies have indicated that the pineal pigment parapinopsin has evolutionally and physiologically important characteristics. Parapinopsin is phylogenetically related to vertebrate visual pigments. However, unlike the photoproduct of the visual pigment rhodopsin, which is unstable, dissociating from its chromophore and bleaching, the parapinopsin photoproduct is stable and does not release its chromophore. Here, we investigated arrestin, which regulates parapinopsin signaling, in the lamprey pineal organ, where parapinopsin and rhodopsin are localized to distinct photoreceptor cells. We found that beta-arrestin, which binds to stimulated G protein-coupled receptors (GPCRs) other than opsin-based pigments, was localized to parapinopsin-containing cells. This result stands in contrast to the localization of visual arrestin in rhodopsin-containing cells. Beta-arrestin bound to cultured cell membranes containing parapinopsin light-dependently and translocated to the outer segments of pineal parapinopsin-containing cells, suggesting that beta-arrestin binds to parapinopsin to arrest parapinopsin signaling. Interestingly, beta-arrestin colocalized with parapinopsin in the granules of the parapinopsin-expressing cell bodies under light illumination. Because beta-arrestin, which is a mediator of clathrin-mediated GPCR internalization, also served as a mediator of parapinopsin internalization in cultured cells, these results suggest that the granules were generated light-dependently by beta-arrestin-mediated internalization of parapinopsins from the outer segments. Therefore, our findings imply that beta-arrestin-mediated internalization is responsible for eliminating the stable photoproduct and restoring cell conditions to the original dark state. Taken together with a previous finding that the bleaching pigment evolved from a non-bleaching pigment, vertebrate visual arrestin may have evolved from a "beta-like'' arrestin by losing its clathrin-binding domain and its function as an internalization mediator. Such changes would have followed the evolution of vertebrate visual pigments, which generate unstable photoproducts that independently decay by chromophore dissociation.	[Kawano-Yamashita, Emi; Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 558, Japan; [Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan; [Oishi, Tadashi] Nara Saho Coll, Nara, Japan; [Tamotsu, Satoshi] Nara Womens Univ, Grad Sch Humanities & Sci, Nara 630, Japan	Osaka Metropolitan University; Kyoto University; Nara Womens University	Kawano-Yamashita, E (corresponding author), Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 558, Japan.	terakita@sci.osaka-cu.ac.jp		Terakita, Akihisa/0000-0002-8379-8913; Koyanagi, Mitsumasa/0000-0002-7741-918X	Japanese Ministry of Education, Science, Sports, and Culture; Yamada Science Foundation; Naito Foundation; Japan Society for the Promotion of Science for Young Scientists; Grants-in-Aid for Scientific Research [22687005] Funding Source: KAKEN	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (to A.T. and M.K.), the Yamada Science Foundation (to A.T.) and the Naito Foundation (to A.T. and M.K.). E.K-Y. is supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Blackshaw S, 1997, J NEUROSCI, V17, P8083; COLLIN JP, 1986, NEUROSCIENCE, V19, P657, DOI 10.1016/0306-4522(86)90288-5; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawano E, 2006, ZOOL SCI, V23, P277, DOI 10.2108/zsj.23.277; Kawano-Yamashita E, 2007, J EXP BIOL, V210, P3821, DOI 10.1242/jeb.007161; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Nakagawa M, 2002, EUR J BIOCHEM, V269, P5112, DOI 10.1046/j.1432-1033.2002.03240.x; Orem NR, 2006, J CELL SCI, V119, P3141, DOI 10.1242/jcs.03052; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAMEJIMA M, 1989, CELL TISSUE RES, V258, P219; Satoh AK, 2005, CURR BIOL, V15, P1722, DOI 10.1016/j.cub.2005.08.064; Shichida Y, 2003, PHOTOCH PHOTOBIO SCI, V2, P1237, DOI 10.1039/b300434a; TAMOTSU S, 1990, CELL TISSUE RES, V262, P205, DOI 10.1007/BF00309875; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; Tsukamoto H, 2010, PHOTOCH PHOTOBIO SCI, V9, P1435, DOI 10.1039/c0pp00168f; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16402	10.1371/journal.pone.0016402	http://dx.doi.org/10.1371/journal.pone.0016402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305016	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300061
J	Lappano, R; Recchia, AG; De Francesco, EM; Angelone, T; Cerra, MC; Picard, D; Maggiolini, M				Lappano, Rosamaria; Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Angelone, Tommaso; Cerra, Maria Carmela; Picard, Didier; Maggiolini, Marcello			The Cholesterol Metabolite 25-Hydroxycholesterol Activates Estrogen Receptor alpha-Mediated Signaling in Cancer Cells and in Cardiomyocytes	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; SMOOTH-MUSCLE-CELLS; BREAST-CANCER; OVARIAN-CANCER; LEYDIG-CELLS; IN-VITRO; TESTICULAR MACROPHAGES; INDUCED APOPTOSIS; LIPID-METABOLISM	Background: The hydroxylated derivatives of cholesterol, such as the oxysterols, play important roles in lipid metabolism. In particular, 25-hydroxycholesterol (25HC) has been implicated in a variety of metabolic events including cholesterol homeostasis and atherosclerosis. 25HC is detectable in human plasma after ingestion of a meal rich in oxysterols and following a dietary cholesterol challenge. In addition, the levels of oxysterols, including 25HC, have been found to be elevated in hypercholesterolemic serum. Methodology/Principal Findings: Here, we demonstrate that the estrogen receptor (ER) alpha mediates gene expression changes and growth responses induced by 25HC in breast and ovarian cancer cells. Moreover, 25HC exhibits the ER alpha-dependent ability like 17 beta-estradiol (E2) to inhibit the up-regulation of HIF-1 alpha and connective tissue growth factor by hypoxic conditions in cardiomyocytes and rat heart preparations and to prevent the hypoxia-induced apoptosis. Conclusions/Significance: The estrogen action exerted by 25HC may be considered as an additional factor involved in the progression of breast and ovarian tumors. Moreover, the estrogen-like activity of 25HC elicited in the cardiovascular system may play a role against hypoxic environments.	[Lappano, Rosamaria; Recchia, Anna Grazia; De Francesco, Ernestina Marianna; Cerra, Maria Carmela; Maggiolini, Marcello] Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy; [Angelone, Tommaso] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Picard, Didier] Univ Geneva, Dept Biol Cellulaire, Geneva, Switzerland	University of Calabria; University of Calabria; University of Geneva	Lappano, R (corresponding author), Univ Calabria, Dept Pharmacobiol, I-87036 Arcavacata Di Rende, Italy.	marcellomaggiolini@yahoo.it	Recchia, Anna Grazia/ABA-5228-2020; Maggiolini, Marcello/Z-4729-2019; Angelone, Tommaso/AAM-1230-2020; Lappano, Rosamaria/Z-4857-2019	Angelone, Tommaso/0000-0001-7797-7862; Recchia, Anna Grazia/0000-0001-5748-2002; Maggiolini, Marcello/0000-0002-7485-854X; Cerra, Maria Carmela/0000-0002-2091-928X; Lappano, Rosamaria/0000-0002-9374-9701	Associazione Italiana per la Ricerca sul Cancro (AIRC) [8925/2009]; Ministero dell'Universita e Ricerca Scientifica e Tecnologica (MIUR)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e Ricerca Scientifica e Tecnologica (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, project n. 8925/2009) (http://www.airc.it/) and Ministero dell'Universita e Ricerca Scientifica e Tecnologica (MIUR) (http://www.istruzione.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MS, 2004, J MOL CELL CARDIOL, V36, P393, DOI 10.1016/j.yjmcc.2003.12.004; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Burkard I, 2007, ATHEROSCLEROSIS, V194, P71, DOI 10.1016/j.atherosclerosis.2006.09.026; Cerra MC, 2006, BASIC RES CARDIOL, V101, P43, DOI 10.1007/s00395-005-0547-2; Chen J, 2003, AM J PATHOL, V162, P1283, DOI 10.1016/S0002-9440(10)63924-7; Chen JX, 2009, NEUROSCI BULL, V25, P67, DOI 10.1007/s12264-009-1215-6; Chen JJ, 2002, BIOL REPROD, V66, P1336, DOI 10.1095/biolreprod66.5.1336; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Cho J, 2006, J STEROID BIOCHEM, V100, P18, DOI 10.1016/j.jsbmb.2006.03.002; Choi YK, 2008, FREE RADICAL RES, V42, P544, DOI 10.1080/10715760802146062; Cicha I, 2006, CLIN HEMORHEOL MICRO, V35, P203; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dai S, 2003, INT J RADIAT ONCOL, V55, P1027, DOI 10.1016/S0360-3016(02)04507-8; Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Daniels A, 2009, ACTA PHYSIOL, V195, P321, DOI 10.1111/j.1748-1716.2008.01936.x; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DuSell CD, 2008, TRENDS PHARMACOL SCI, V29, P510, DOI 10.1016/j.tips.2008.07.003; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Fabian CJ, 2005, J CLIN ONCOL, V23, P1644, DOI 10.1200/JCO.2005.11.005; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Flototto T, 2001, HORM METAB RES, V33, P451, DOI 10.1055/s-2001-16936; Foster JS, 1996, MOL ENDOCRINOL, V10, P488, DOI 10.1210/me.10.5.488; Furberg AS, 2004, J NATL CANCER I, V96, P1152, DOI 10.1093/jnci/djh216; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerstner B, 2009, J NEUROSCI RES, V87, P2078, DOI 10.1002/jnr.22023; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Guo XM, 2005, J BIOL CHEM, V280, P19704, DOI 10.1074/jbc.M501244200; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Hewitt SC, 2003, REPRODUCTION, V125, P143, DOI 10.1530/rep.0.1250143; Higgins DF, 2003, KIDNEY INT, V64, P2079, DOI 10.1046/j.1523-1755.2003.00306.x; Hishikawa K, 1999, CIRCULATION, V100, P2108, DOI 10.1161/01.CIR.100.20.2108; HODIS HN, 1992, ATHEROSCLEROSIS, V96, P125, DOI 10.1016/0021-9150(92)90059-P; Hong KH, 2006, CLIN EXP IMMUNOL, V146, P362, DOI 10.1111/j.1365-2249.2006.03199.x; Hua KQ, 2009, ONCOL REP, V21, P893, DOI 10.3892/or_00000300; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Jeanes HL, 2008, J ENDOCRINOL, V197, P493, DOI 10.1677/JOE-08-0071; JOHNSON KA, 1994, J LIPID RES, V35, P2241; KANDUTSCH AA, 1974, J BIOL CHEM, V249, P6057; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Kazi AA, 2007, ENDOCRINOLOGY, V148, P2363, DOI 10.1210/en.2006-1394; Kim Jin Kyung, 2006, Nucl Recept Signal, V4, pe013; Kim JK, 2006, J BIOL CHEM, V281, P6760, DOI 10.1074/jbc.M511024200; Kondo S, 2002, CARCINOGENESIS, V23, P769, DOI 10.1093/carcin/23.5.769; Krick S, 2005, AM J RESP CELL MOL, V32, P395, DOI 10.1165/rcmb.2004-0314OC; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Lappano R, 2009, MOL NUTR FOOD RES, V53, P845, DOI 10.1002/mnfr.200800331; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Lemaire-Ewing S, 2009, CELL BIOL TOXICOL, V25, P127, DOI 10.1007/s10565-008-9063-0; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Ling SH, 2006, CLIN SCI, V111, P107, DOI 10.1042/CS20050084; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Maggiolini M, 2001, MOL PHARMACOL, V60, P595; Malhotra R, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-9; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; NGUYEN VP, 2010, J ANGIOGENES RES, V11, P2; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; Oemar BS, 1997, CIRCULATION, V95, P831; Osborne CK, 2005, J CLIN ONCOL, V23, P1616, DOI 10.1200/JCO.2005.10.036; Paige LA, 1999, P NATL ACAD SCI USA, V96, P3999, DOI 10.1073/pnas.96.7.3999; Patten RD, 2006, TRENDS CARDIOVAS MED, V16, P69, DOI 10.1016/j.tcm.2006.01.002; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pedram A, 2005, J BIOL CHEM, V280, P26339, DOI 10.1074/jbc.M414409200; Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Rimon E, 2008, ENDOCRINOLOGY, V149, P2952, DOI 10.1210/en.2007-1099; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Salehi F, 2008, J TOXICOL ENV HEAL B, V11, P301, DOI 10.1080/10937400701876095; Santagati S, 1997, MOL ENDOCRINOL, V11, P938, DOI 10.1210/me.11.7.938; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Sharma I, 2010, FERTIL STERIL, V94, P63, DOI 10.1016/j.fertnstert.2009.01.141; Shimo T, 2001, ONCOLOGY-BASEL, V61, P315, DOI 10.1159/000055339; Sovershaev MA, 2006, AM J PHYSIOL-HEART C, V291, pH1554, DOI 10.1152/ajpheart.01171.2005; Stoll BA, 2002, INT J OBESITY, V26, P747, DOI 10.1038/sj.ijo.0801998; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; Travert C, 2006, REPROD TOXICOL, V22, P564, DOI 10.1016/j.reprotox.2006.05.006; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Velazquez E, 2006, NEUROPHARMACOLOGY, V51, P229, DOI 10.1016/j.neuropharm.2006.03.017; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; Xie D, 2001, CANCER RES, V61, P8917; Yi JM, 2009, BIOCHEM BIOPH RES CO, V378, P842, DOI 10.1016/j.bbrc.2008.11.142; Yokoyama S, 1999, INT J ONCOL, V15, P565; Zhao CY, 2009, ENDOCRINE, V36, P224, DOI 10.1007/s12020-009-9233-8; Zhao LQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-24; Zhao ZQ, 2004, CURR OPIN PHARMACOL, V4, P159, DOI 10.1016/j.coph.2003.10.010	92	79	83	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16631	10.1371/journal.pone.0016631	http://dx.doi.org/10.1371/journal.pone.0016631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304949	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300103
J	Zhong, L; Wang, DQ; Gan, XN; Yang, T; He, SP				Zhong, Lei; Wang, Dengqiang; Gan, Xiaoni; Yang, Tong; He, Shunping			Parallel Expansions of Sox Transcription Factor Group B Predating the Diversifications of the Arthropods and Jawed Vertebrates	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; GENE FAMILY; MOLECULAR PHYLOGENY; DIVERGENCE TIMES; DOMAIN PROTEINS; ORIGIN; EXPRESSION; EVOLUTION; DICHAETE; DUPLICATION	Group B of the Sox transcription factor family is crucial in embryo development in the insects and vertebrates. Sox group B, unlike the other Sox groups, has an unusually enlarged functional repertoire in insects, but the timing and mechanism of the expansion of this group were unclear. We collected and analyzed data for Sox group B from 36 species of 12 phyla representing the major metazoan clades, with an emphasis on arthropods, to reconstruct the evolutionary history of SoxB in bilaterians and to date the expansion of Sox group B in insects. We found that the genome of the bilaterian last common ancestor probably contained one SoxB1 and one SoxB2 gene only and that tandem duplications of SoxB2 occurred before the arthropod diversification but after the arthropod-nematode divergence, resulting in the basal repertoire of Sox group B in diverse arthropod lineages. The arthropod Sox group B repertoire expanded differently from the vertebrate repertoire, which resulted from genome duplications. The parallel increases in the Sox group B repertoires of the arthropods and vertebrates are consistent with the parallel increases in the complexity and diversification of these two important organismal groups.	[Zhong, Lei; Wang, Dengqiang; Gan, Xiaoni; Yang, Tong; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China; [Zhong, Lei; Wang, Dengqiang; Gan, Xiaoni] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhong, L (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Wuhan, Peoples R China.	clad@ihb.ac.cn			National Natural Science Foundation of China [30530120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant No. 30530120 from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; Chipman AD, 2010, BIOESSAYS, V32, P60, DOI 10.1002/bies.200900130; Cremazy F, 2001, MECH DEVELOP, V109, P371, DOI 10.1016/S0925-4773(01)00529-9; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gabriel WN, 2007, DEV GENES EVOL, V217, P421, DOI 10.1007/s00427-007-0152-5; Galay-Burgos M, 2004, COMP BIOCHEM PHYS B, V137, P279, DOI 10.1016/j.cbpc.2003.12.002; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Graves JAM, 2002, TRENDS GENET, V18, P259, DOI 10.1016/S0168-9525(02)02666-5; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guth SIE, 2008, CELL MOL LIFE SCI, V65, P3000, DOI 10.1007/s00018-008-8138-7; Hedges S. Blair, 2009, P383; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jager M, 2006, MOL PHYLOGENET EVOL, V39, P468, DOI 10.1016/j.ympev.2005.12.005; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kamachi Y, 1999, MOL CELL BIOL, V19, P107; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koopman P, 2004, GENE, V328, P177, DOI 10.1016/j.gene.2003.12.008; Kuraku S, 2009, MOL BIOL EVOL, V26, P47, DOI 10.1093/molbev/msn222; Kuroiwa A, 2002, CYTOGENET GENOME RES, V98, P189, DOI 10.1159/000069803; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; Larroux C, 2006, EVOL DEV, V8, P150, DOI 10.1111/j.1525-142X.2006.00086.x; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Leveugle M, 2004, J MOL EVOL, V58, P168, DOI 10.1007/s00239-003-2538-y; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Maddison D. R., 2007, TREE LIFE WEB PROJEC; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; McKimmie C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-26; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Meulemans D, 2007, INT J BIOL SCI, V3, P356; Nambu PA, 1996, DEVELOPMENT, V122, P3467; Ohno S, 1999, CELL MOL LIFE SCI, V55, P824, DOI 10.1007/s000180050336; Ohno S., 1970, P1; Overton PM, 2007, DEVELOPMENT, V134, P2807, DOI 10.1242/dev.02878; Overton PM, 2002, DEVELOPMENT, V129, P4219; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Phochanukul N, 2010, INT J BIOCHEM CELL B, V42, P453, DOI 10.1016/j.biocel.2009.06.013; Pioro HL, 2006, DEV GENES EVOL, V216, P417, DOI 10.1007/s00427-006-0078-3; Pisani D, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-1; Russell SRH, 1996, DEVELOPMENT, V122, P3669; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Sanchez-Soriano N, 2000, DEV BIOL, V220, P307, DOI 10.1006/dbio.2000.9648; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311; Soriano NS, 1998, DEVELOPMENT, V125, P3989; Soullier S, 1999, J MOL EVOL, V48, P517, DOI 10.1007/PL00006495; Taguchi S, 2002, ZOOL SCI, V19, P57, DOI 10.2108/zsj.19.57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Weiss J, 2003, MOL CELL BIOL, V23, P8084, DOI 10.1128/MCB.23.22.8084-8091.2003; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wilson MJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-120; Yang Tong, 2007, Acta Zootaxonomica Sinica, V32, P890; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	69	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16570	10.1371/journal.pone.0016570	http://dx.doi.org/10.1371/journal.pone.0016570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21305035	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900075
J	Anania, MC; Sensi, M; Radaelli, E; Miranda, C; Vizioli, MG; Pagliardini, S; Favini, E; Cleris, L; Supino, R; Formelli, F; Borrello, MG; Pierotti, MA; Greco, A				Anania, M. C.; Sensi, M.; Radaelli, E.; Miranda, C.; Vizioli, M. G.; Pagliardini, S.; Favini, E.; Cleris, L.; Supino, R.; Formelli, F.; Borrello, M. G.; Pierotti, M. A.; Greco, A.			TIMP3 regulates migration, invasion and in vivo tumorigenicity of thyroid tumor cells	ONCOGENE			English	Article						TIMP3; thyroid tumors; PTC	TISSUE INHIBITOR; GENE-EXPRESSION; DOWN-REGULATION; CARCINOMA; CANCER; GROWTH; METALLOPROTEINASE-3; ANGIOGENESIS; METHYLATION; LINE	Papillary thyroid carcinoma (PTC) arises from the thyroid follicular epithelium and represents the most frequent thyroid malignancy. PTC is associated with gene rearrangements generating RET/PTC and TRK oncogenes, and to the BRAFV600E activating point mutation. A role of tumor-suppressor genes in the pathogenesis of PTC has not been assessed yet. The tissue inhibitor of metalloproteinase-3 (TIMP3) gene, encoding a metalloproteinases inhibitor and capable of inhibiting growth, angiogenesis, invasion and metastasis of several cancers, was found to be silenced by promoter methylation in a consistent fraction of PTCs, in association with tumor aggressiveness and BRAFV600E mutation, thus suggesting an oncosuppressor role. To explore this possibility, in this study we performed gene expression and functional studies. Analysis of gene expression data produced in our laboratory as well as meta-analysis of publicly available data sets confirmed the downregulation of TIMP3 gene expression in PTC with respect to normal thyroid. The functional consequences of TIMP3 downregulation were investigated in the PTC-derived NIM1 cell line, in which the expression of TIMP3 is silenced. Restoration of TIMP3 expression by exposure to soluble TIMP3 protein or by complementary DNA transfection had no effect on the growth rate of NIM1 cells. Instead, it affected the adhesive, migratory and invasive capabilities of NIM1 cells by modulating several proteins involved in these processes. A striking effect was observed in vivo, as TIMP3 reduced the tumorigenicity of NIM1 cells by repressing angiogenesis and macrophage infiltration. Our data indicate that the loss of TIMP3 expression exerts a functional role in the pathogenesis of PTC. Oncogene (2011) 30, 3011-3023; doi:10.1038/onc.2011.18; published online 21 February 2011	[Anania, M. C.; Miranda, C.; Vizioli, M. G.; Pagliardini, S.; Borrello, M. G.; Greco, A.] IRCCS Fdn Ist Nazl Tumori, Mol Mechanisms Unit, I-20133 Milan, Italy; [Sensi, M.] IRCCS Fdn Ist Nazl Tumori, Funct Genom Core Facil, I-20133 Milan, Italy; [Sensi, M.] IRCCS Fdn Ist Nazl Tumori, Human Tumors Immunobiol Unit, I-20133 Milan, Italy; [Radaelli, E.] Univ Milan, Fac Vet Med, Dept Vet Pathol, Milan, Italy; [Radaelli, E.] Fdn Filarete, Mouse & Anim Pathol Lab, Milan, Italy; [Favini, E.; Supino, R.] IRCCS Fdn Ist Nazl Tumori, Mol Pharmacol Unit, I-20133 Milan, Italy; [Cleris, L.; Formelli, F.] IRCCS Fdn Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Chemoprevent Unit, I-20133 Milan, Italy; [Pierotti, M. A.] IRCCS Fdn Ist Nazl Tumori, Sci Directorate, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Greco, A (corresponding author), IRCCS Fdn Ist Nazl Tumori, Mol Mechanisms Unit, Via GA Amadeo 42, I-20133 Milan, Italy.	angela.greco@istitutotumori.mi.it	Sensi, Marialuisa/K-5631-2014; Borrello, Maria Grazia/C-3161-2017; Pierotti, Marco Alessandro/AAC-4728-2022; Cleris, Loredana/T-3144-2018; Greco, Angela/C-1953-2017; Anania, Maria Chiara/B-9339-2017; Anania, Maria Chiara/N-4853-2019; Oliveira Ribeiro, Ciro Alberto de/A-5199-2008	Sensi, Marialuisa/0000-0002-7643-0248; Borrello, Maria Grazia/0000-0002-6854-2848; Pierotti, Marco Alessandro/0000-0002-7431-8332; Cleris, Loredana/0000-0001-8778-7931; Greco, Angela/0000-0003-2994-0349; Anania, Maria Chiara/0000-0003-4012-1870; Anania, Maria Chiara/0000-0003-4012-1870; Oliveira Ribeiro, Ciro Alberto de/0000-0002-3168-9272	AIRC, ACC [4472]; Ministry of Health and Progetto Strategico Istituzionale (PSI) 5xmille	AIRC, ACC(Fondazione AIRC per la ricerca sul cancro); Ministry of Health and Progetto Strategico Istituzionale (PSI) 5xmille	We thank Drs Daniele Lecis, Francesca Micciche and Anna De Filippo for providing reagents and advice for the detection of soluble TNF alpha and ALCAM, and Mrs Cristina Mazzadi for secretarial help. This work was supported by AIRC grant N. 4472, ACC, Ministry of Health and Progetto Strategico Istituzionale (PSI) 5xmille, 2008.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Akslen LA, 2000, HUM PATHOL, V31, P439, DOI 10.1053/1-ip.2000.6548; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; [Anonymous], 1988, BRIT J CANCER, V58, P109, DOI 10.1038/bjc.1988.174; Bachman KE, 1999, CANCER RES, V59, P798; Barski D, 2010, BRAIN PATHOL, V20, P623, DOI 10.1111/j.1750-3639.2009.00340.x; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Calabro V, 1996, INT J CANCER, V67, P29, DOI 10.1002/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.0.CO;2-1; Degl'Innocenti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012701; Detoraki A, 2009, J ALLERGY CLIN IMMUN, V123, P1142, DOI 10.1016/j.jaci.2009.01.044; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Ferrario C, 2008, LAB INVEST, V88, P474, DOI 10.1038/labinvest.2008.17; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Greco A, 2009, Q J NUCL MED MOL IM, V53, P440; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hedinger, 2012, HISTOLOGICAL TYPING; Hu SY, 2006, INT J CANCER, V119, P2322, DOI 10.1002/ijc.22110; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Margineanu Eliana, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P432; Masson D, 2010, EUR J CANCER, V46, P1430, DOI 10.1016/j.ejca.2010.01.009; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Nakamura M, 2005, LAB INVEST, V85, P165, DOI 10.1038/labinvest.3700223; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Russell JP, 2003, ONCOGENE, V22, P4569, DOI 10.1038/sj.onc.1206759; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Spurbeck WW, 2002, BLOOD, V100, P3361, DOI 10.1182/blood.V100.9.3361; TOHYAMA K, 1992, JPN J CANCER RES, V83, P153, DOI 10.1111/j.1349-7006.1992.tb00080.x; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Vizioli MG, 2010, ONCOGENE, V29, P3835, DOI 10.1038/onc.2010.136; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Xing MZ, 2007, ENDOCRINOLOGY, V148, P948, DOI 10.1210/en.2006-0927; Xing MZ, 2008, OTOLARYNG CLIN N AM, V41, P1135, DOI 10.1016/j.otc.2008.07.001; ZEKI K, 1993, J CLIN ENDOCR METAB, V76, P127, DOI 10.1210/jc.76.1.127; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; Zuo H, 2010, CANCER RES, V70, P1389, DOI 10.1158/0008-5472.CAN-09-2812	46	65	67	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2011	30	27					3011	3023		10.1038/onc.2011.18	http://dx.doi.org/10.1038/onc.2011.18			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21339735				2022-12-25	WOS:000292510100002
J	Mudduluru, G; Ceppi, P; Kumarswamy, R; Scagliotti, GV; Papotti, M; Allgayer, H				Mudduluru, G.; Ceppi, P.; Kumarswamy, R.; Scagliotti, G. V.; Papotti, M.; Allgayer, H.			Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer	ONCOGENE			English	Article						non-small cell lung cancer; breast cancer; colorectal cancer; Axl; microRNA	VASCULAR SMOOTH-MUSCLE; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; CPG METHYLATION; GAS6; CELLS; APOPTOSIS; METASTASIS; MICRORNAS; SURVIVAL	Axl is a receptor that induces proliferation, migration and invasion in cancer. In this study, we show that specific microRNAs (miRNAs) target the 3'-UTR of Axl. Luciferase-reporter assays with wild-type and deleted miR-34 and miR-199a/b seed sequences of Axl 3'-UTR confirmed the specificity of targeting. An inverse correlation between Axl protein and miR-34a expression in a panel of non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and breast cancer (BRC) cell lines was observed, while miR-199a/b expression was completely suppressed. Pre-miR transfection inhibited in vitro migration and invasion and, in vivo, reduced the number of distant lung-or liver-metastases in a chorion-allantoic-membrane (CAM) assay. Moreover, methylation-specific PCR on bisulfite-converted DNA obtained from the cell lines showed that the miR-34a promoter methylation status was inversely correlated with its expression, and that miR-199a/b promoter regions were methylated in all cells tested. In a panel of NSCLC tissues (n = 44), miR-34a and miR-199a/b were found to be downregulated and significantly co-expressed. A lower expression of all three miRs was significantly associated with squamous histo-types, and, in a preliminary series, NSCLC patients with miR-34a upregulation showed a positive association towards a longer survival. These results indicate that Axl receptor expression can be regulated by miR-34a and miR-199a/b, which are suppressed by promoter methylation in solid cancer cells. Oncogene (2011) 30, 2888-2899; doi:10.1038/onc.2011.13; published online 14 February 2011	[Allgayer, H.] Univ Heidelberg, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit German Canc Res Ctr DKFZ Heidelbe, Med Fac Mannheim, D-68167 Mannheim, Germany; [Mudduluru, G.; Ceppi, P.; Kumarswamy, R.; Allgayer, H.] German Canc Res Ctr DKFZ Heidelberg, Mannheim, Germany; [Ceppi, P.; Scagliotti, G. V.; Papotti, M.] Univ Turin, San Luigi Hosp, Dept Clin & Biol Sci, Orbassano, Italy	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Turin	Allgayer, H (corresponding author), Univ Heidelberg, Dept Expt Surg Mol Oncol Solid Tumors, Collaborat Unit German Canc Res Ctr DKFZ Heidelbe, Med Fac Mannheim, D-68167 Mannheim, Germany.	heike.allgayer@umm.de	Kumarswamy, Regalla/AAC-5766-2019; Ceppi, Paolo/GPS-8668-2022	Ceppi, Paolo/0000-0002-3632-8476; Scagliotti, Giorgio/0000-0001-6646-958X	Alfried Krupp von Bohlen und Halbach Foundation, Essen; Hella-Buhler-Foundation, Heidelberg; Dr Ingrid zu Solms Foundation, Frankfurt/Main; Hector Foundation, Weinheim, Germany; FRONTIER Excellence Initiative of the University of Heidelberg; BMBF, Bonn, Germany; Walter Schulz Foundation, Munich, Germany	Alfried Krupp von Bohlen und Halbach Foundation, Essen; Hella-Buhler-Foundation, Heidelberg; Dr Ingrid zu Solms Foundation, Frankfurt/Main; Hector Foundation, Weinheim, Germany; FRONTIER Excellence Initiative of the University of Heidelberg; BMBF, Bonn, Germany(Federal Ministry of Education & Research (BMBF)); Walter Schulz Foundation, Munich, Germany	HA was supported by Alfried Krupp von Bohlen und Halbach Foundation, Essen, Hella-Buhler-Foundation, Heidelberg, Dr Ingrid zu Solms Foundation, Frankfurt/Main, Hector Foundation, Weinheim, Germany, FRONTIER Excellence Initiative of the University of Heidelberg, the BMBF, Bonn, Germany, and Walter Schulz Foundation, Munich, Germany. We thank Erika Hillerich and Laura Nelson for excellent help and critical appraisal of the manuscript.	Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Budagian V, 2005, MOL CELL BIOL, V25, P9324, DOI 10.1128/MCB.25.21.9324-9339.2005; Burchert A, 1998, ONCOGENE, V16, P3177, DOI 10.1038/sj.onc.1201865; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Cheung HH, 2010, BRIT J CANCER, V102, P419, DOI 10.1038/sj.bjc.6605505; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Goruppi S, 1997, MOL CELL BIOL, V17, P4442, DOI 10.1128/MCB.17.8.4442; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Lee WP, 2002, ONCOGENE, V21, P329, DOI 10.1038/sj.onc.1205066; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lujambio A, 2009, CELL CYCLE, V8, P377, DOI 10.4161/cc.8.3.7526; McCloskey P, 1997, J BIOL CHEM, V272, P23285, DOI 10.1074/jbc.272.37.23285; Melaragno MG, 2004, J MOL CELL CARDIOL, V37, P881, DOI 10.1016/j.yjmcc.2004.06.018; Mudduluru G, 2008, BIOSCIENCE REP, V28, P161, DOI 10.1042/BSR20080046; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Sainaghi PP, 2005, J CELL PHYSIOL, V204, P36, DOI 10.1002/jcp.20265; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Tili Esmerina, 2007, Future Oncol, V3, P521, DOI 10.2217/14796694.3.5.521; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Valeri N, 2009, MAMM GENOME, V20, P573, DOI 10.1007/s00335-009-9206-5; van Ginkel PR, 2004, CANCER RES, V64, P128, DOI 10.1158/0008-5472.CAN-03-0245; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; WEINBERG RA, 1995, ANN NY ACAD SCI, V758, P331, DOI 10.1111/j.1749-6632.1995.tb24838.x; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wu CW, 2002, ANTICANCER RES, V22, P1071; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	45	190	202	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	25					2888	2899		10.1038/onc.2011.13	http://dx.doi.org/10.1038/onc.2011.13			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21317930				2022-12-25	WOS:000291977800008
J	Qi, XQ; Loiseau, F; Chan, WL; Yan, YH; Wei, ZQ; Milroy, LG; Myers, RM; Ley, SV; Read, RJ; Carrell, RW; Zhou, AW				Qi, Xiaoqiang; Loiseau, Francois; Chan, Wee Lee; Yan, Yahui; Wei, Zhenquan; Milroy, Lech-Gustav; Myers, Rebecca M.; Ley, Steven V.; Read, Randy J.; Carrell, Robin W.; Zhou, Aiwu			Allosteric Modulation of Hormone Release from Thyroxine and Corticosteroid-binding Globulins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MECHANISM; ANTITHROMBIN; HEPARIN; ALPHA-1-ANTITRYPSIN; ACTIVATION; SERPINS; MODEL; SUPERFAMILY; TRANSITION	The release of hormones from thyroxine-binding globulin (TBG) and corticosteroid-binding globulin (CBG) is regulated by movement of the reactive center loop in and out of the beta-sheet A of the molecule. To investigate how these changes are transmitted to the hormone-binding site, we developed a sensitive assay using a synthesized thyroxine fluorophore and solved the crystal structures of reactive loop cleaved TBG together with its complexes with thyroxine, the thyroxine fluorophores, furosemide, and mefenamic acid. Cleavage of the reactive loop results in its complete insertion into the beta-sheet A and a substantial but incomplete decrease in binding affinity in both TBG and CBG. We show here that the direct interaction between residue Thr(342) of the reactive loop and Tyr(241) of the hormone binding site contributes to thyroxine binding and release following reactive loop insertion. However, a much larger effect occurs allosterically due to stretching of the connecting loop to the top of the D helix (hD), as confirmed in TBG with shortening of the loop by three residues, making it insensitive to the S-to-R transition. The transmission of the changes in the hD loop to the binding pocket is seen to involve coherent movements in the s2/3B loop linked to the hD loop by Lys(243), which is, in turn, linked to the s4/5B loop, flanking the thyroxine-binding site, by Arg(378). Overall, the coordinated movements of the reactive loop, hD, and the hormone binding site allow the allosteric regulation of hormone release, as with the modulation demonstrated here in response to changes in temperature.	[Zhou, Aiwu] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Dept Haematol, Cambridge CB2 0XY, England; [Loiseau, Francois; Milroy, Lech-Gustav; Myers, Rebecca M.; Ley, Steven V.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Qi, Xiaoqiang] Nanjing Univ, Dept Biochem, Nanjing 210098, Peoples R China	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Nanjing University	Zhou, AW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust, Dept Haematol, MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	awz20@cam.ac.uk	Read, Randy J/L-1418-2013; Ley, Steven V/O-7712-2016	Read, Randy J/0000-0001-8273-0047; Ley, Steven V/0000-0002-7816-0042; Chan, Wee Lee/0000-0001-9672-3841; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation; Wellcome Trust; Isaac Newton Trust of the University of Cambridge; Diamond Light Source	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust of the University of Cambridge; Diamond Light Source	This work was supported by the British Heart Foundation, the Wellcome Trust, the Isaac Newton Trust of the University of Cambridge, and the Diamond Light Source.	Adamczyk M, 1998, BIOCONJUGATE CHEM, V9, P23, DOI 10.1021/bc9701353; Beauchamp NJ, 1998, BLOOD, V92, P2696, DOI 10.1182/blood.V92.8.2696.420a43_2696_2706; Cameron A, 2010, J CLIN ENDOCR METAB, V95, P4689, DOI 10.1210/jc.2010-0942; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Clark A.R., 1996, ENZYMOLOGY LABFAX, P199; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1993, P CCP4 STUD WEEK DAT; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; Grasberger H, 2002, BIOCHEM J, V365, P311, DOI 10.1042/BJ20020014; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2006, TRENDS BIOCHEM SCI, V31, P427, DOI 10.1016/j.tibs.2006.06.005; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Janssen OE, 2002, J CLIN ENDOCR METAB, V87, P1217, DOI 10.1210/jc.87.3.1217; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; Klieber MA, 2007, J BIOL CHEM, V282, P29594, DOI 10.1074/jbc.M705014200; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lin HY, 2010, MOL CELL ENDOCRINOL, V316, P3, DOI 10.1016/j.mce.2009.06.015; Lin HY, 2009, J BIOL CHEM, V284, P884, DOI 10.1074/jbc.M807376200; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; Perogamvros I, 2010, J CLIN ENDOCR METAB, V95, pE142, DOI 10.1210/jc.2010-0746; Refetoff S, 1996, HORM RES, V45, P128, DOI 10.1159/000184775; ROSS HA, 1992, CLIN CHEM, V38, P880; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STOCKIGT JR, 1985, J CLIN ENDOCR METAB, V60, P1025, DOI 10.1210/jcem-60-5-1025; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhou AW, 2008, J MOL BIOL, V380, P244, DOI 10.1016/j.jmb.2008.05.012; Zhou AW, 2006, P NATL ACAD SCI USA, V103, P13321, DOI 10.1073/pnas.0604080103	36	38	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2011	286	18								10.1074/jbc.M110.171082	http://dx.doi.org/10.1074/jbc.M110.171082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	756ON	21325280	Green Published, hybrid			2022-12-25	WOS:000290022800056
J	Rai, R; Varma, SPMV; Shinde, N; Ghosh, S; Kumaran, SP; Skariah, G; Laloraya, S				Rai, Ragini; Varma, Satya P. M. V.; Shinde, Nikhil; Ghosh, Shilpa; Kumaran, Srikala P.; Skariah, Geena; Laloraya, Shikha			Small Ubiquitin-related Modifier Ligase Activity of Mms21 Is Required for Maintenance of Chromosome Integrity during the Unperturbed Mitotic Cell Division Cycle in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION STRESS; NUCLEAR-PORE COMPLEX; SMC5/6 COMPLEX; SUMO LIGASE; SMC5-SMC6 COMPLEX; FISSION YEAST; REPAIR; PROTEINS; DAMAGE; CAFFEINE	The SUMO ligase activity of Mms21/Nse2, a conserved member of the Smc5/6 complex, is required for resisting extrinsically induced genotoxic stress. We report that the Mms21 SUMO ligase activity is also required during the unchallenged mitotic cell cycle in Saccharomyces cerevisiae. SUMO ligase-defective cells were slow growing and spontaneously incurred DNA damage. These cells required caffeine-sensitive Mec1 kinase-dependent checkpoint signaling for survival even in the absence of extrinsically induced genotoxic stress. SUMO ligase-defective cells were sensitive to replication stress and displayed synthetic growth defects with DNA damage checkpoint-defective mutants such as mec1, rad9, and rad24. MMS21 SUMO ligase and mediator of replication checkpoint 1 gene (MRC1) were epistatic with respect to hydroxyurea-induced replication stress or methyl methanesulfonate-induced DNA damage sensitivity. Subjecting Mms21 SUMO ligase-deficient cells to transient replication stress resulted in enhancement of cell cycle progression defects such as mitotic delay and accumulation of hyperploid cells. Consistent with the spontaneous activation of the DNA damage checkpoint pathway observed in the Mms21-mediated sumoylation-deficient cells, enhanced frequency of chromosome breakage and loss was detected in these mutant cells. A mutation in the conserved cysteine 221 that is engaged in coordination of the zinc ion in Loop 2 of the Mms21 SPL-RING E3 ligase catalytic domain resulted in strong replication stress sensitivity and also conferred slow growth and Mec1 dependence to unchallenged mitotically dividing cells. Our findings establish Mms21-mediated sumoylation as a determinant of cell cycle progression and maintenance of chromosome integrity during the unperturbed mitotic cell division cycle in budding yeast.	[Rai, Ragini; Varma, Satya P. M. V.; Shinde, Nikhil; Ghosh, Shilpa; Kumaran, Srikala P.; Skariah, Geena; Laloraya, Shikha] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Laloraya, S (corresponding author), Indian Inst Sci, Dept Biochem, CV Raman Ave, Bangalore 560012, Karnataka, India.	slaloraya@biochem.iisc.ernet.in	Laloraya, Shikha/W-2027-2019	Laloraya, Shikha/0000-0002-2843-309X	Wellcome Trust [GR063263MA]; Council for Scientific and Industrial Research, India; Department of Biotechnology	Wellcome Trust(Wellcome TrustEuropean Commission); Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by a Wellcome Trust International Senior Research Fellowship in Biomedical Science (Grant GR063263MA) and by a grant from the Council for Scientific and Industrial Research, India (to S. L.).; Supported by a Department of Biotechnology junior research fellowship.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Chavez A, 2010, J BIOL CHEM, V285, P11922, DOI 10.1074/jbc.M109.041277; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; De Piccoli G, 2006, NAT CELL BIOL, V8, P1032, DOI 10.1038/ncb1466; De Piccoli G, 2009, CHROMOSOME RES, V17, P251, DOI 10.1007/s10577-008-9016-8; Duan XY, 2009, MOL CELL, V35, P657, DOI 10.1016/j.molcel.2009.06.032; Emili A, 1998, MOL CELL, V2, P183, DOI 10.1016/S1097-2765(00)80128-8; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Friedel AM, 2009, CURR OPIN CELL BIOL, V21, P237, DOI 10.1016/j.ceb.2009.01.017; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huang CE, 2005, PHILOS T ROY SOC B, V360, P537, DOI 10.1098/rstb.2004.1609; Huang DL, 2003, GENE DEV, V17, P1741, DOI 10.1101/gad.1089203; Huang LX, 2009, PLANT J, V60, P666, DOI 10.1111/j.1365-313X.2009.03992.x; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Ishida T, 2009, PLANT CELL, V21, P2284, DOI 10.1105/tpc.109.068072; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; KRAKOFF IH, 1968, CANCER RES, V28, P1559; LEHMANN AR, 1995, MOL CELL BIOL, V15, P7067; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McDonald WH, 2003, J BIOL CHEM, V278, P45460, DOI 10.1074/jbc.M308828200; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; PRAKASH S, 1977, GENETICS, V87, P229; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Saitoh H, 1997, TRENDS BIOCHEM SCI, V22, P374, DOI 10.1016/S0968-0004(97)01102-X; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sergeant J, 2005, MOL CELL BIOL, V25, P172, DOI 10.1128/MCB.25.1.172-184.2005; SIKORSKI RS, 1989, GENETICS, V122, P19; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; TOLMACH LJ, 1977, RADIAT RES, V71, P653, DOI 10.2307/3574633; Torres-Rosell J, 2005, NAT CELL BIOL, V7, P412, DOI 10.1038/ncb1239; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	61	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14516	14530		10.1074/jbc.M110.157149	http://dx.doi.org/10.1074/jbc.M110.157149			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21324902	hybrid, Green Published			2022-12-25	WOS:000289556200072
J	Wu, YT; Ouyang, WM; Lazorchak, AS; Liu, D; Shen, HM; Su, B				Wu, You-Tong; Ouyang, Weiming; Lazorchak, Adam S.; Liu, Dou; Shen, Han-Ming; Su, Bing			mTOR Complex 2 Targets Akt for Proteasomal Degradation via Phosphorylation at the Hydrophobic Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-B; GLUCOSE-HOMEOSTASIS; NEGATIVE REGULATOR; FETAL-GROWTH; ACTIVATION; AKT/PKB; CELLS; UBIQUITINATION; STABILITY; PATHWAY	The protein kinase Akt (also known as protein kinase B) is a critical signaling hub downstream of various cellular stimuli such as growth factors that control cell survival, growth, and proliferation. The activity of Akt is tightly regulated, and the aberrant activation of Akt is associated with diverse human diseases including cancer. Although it is well documented that the mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of the Akt hydrophobic motif (Ser-473 in Akt1) is essential for full Akt activation, it remains unclear whether this phosphorylation has additional roles in regulating Akt activity. In this study, we found that abolishing Akt Ser-473 phosphorylation stabilizes Akt following agonist stimulation. The Akt Ser-473 phosphorylation promotes a Lys-48-linked polyubiquitination of Akt, resulting in its rapid proteasomal degradation. Moreover, blockade of this proteasomal degradation pathway prolongs agonist-induced Akt activation. These data reveal that mTORC2 plays a central role in regulating the Akt protein life cycle by first stabilizing Akt protein folding through the turn motif phosphorylation and then by promoting Akt protein degradation through the hydrophobic motif phosphorylation. Taken together, this study reveals that the Akt Ser-473 phosphorylation-dependent ubiquitination and degradation is an important negative feedback regulation that specifically terminates Akt activation.	[Wu, You-Tong; Ouyang, Weiming; Lazorchak, Adam S.; Liu, Dou; Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Wu, You-Tong; Ouyang, Weiming; Lazorchak, Adam S.; Liu, Dou; Su, Bing] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Wu, You-Tong; Shen, Han-Ming] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Yong Loo Lin Sch Med, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore	Yale University; Yale University; National University of Singapore	Shen, HM (corresponding author), 16 Med Dr, Singapore 117597, Singapore.	ephshm@nus.edu.sg; bing.su@yale.edu	SHEN, Han-Ming/B-5942-2011	SHEN, Han-Ming/0000-0001-7369-5227	National Institutes of Health [AI063348]; Department of Defense [PR093728]; Singapore Biomedical Research Council [08/1/21/19/554]; National University of Singapore; Leukemia & Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National University of Singapore(National University of Singapore); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI063348. This work was also supported by Department of Defense Grant PR093728 (to B. S.) and Singapore Biomedical Research Council Grant 08/1/21/19/554 (to H.-M.S.).; Supported by a research scholarship from the National University of Singapore.; Supported by a fellowship from the Leukemia & Lymphoma Society.	Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Adhikari A, 2009, DEV CELL, V16, P485, DOI 10.1016/j.devcel.2009.04.001; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Cheng J, 2005, MOL CELL BIOL, V25, P5955, DOI 10.1128/MCB.25.14.5955-5964.2005; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Du KY, 2005, ONCOGENE, V24, P7401, DOI 10.1038/sj.onc.1209099; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Elghazi L, 2009, TRENDS ENDOCRIN MET, V20, P243, DOI 10.1016/j.tem.2009.03.002; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Lazorchak AS, 2010, MOL CELL, V39, P433, DOI 10.1016/j.molcel.2010.07.031; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin-Berenjeno I, 2009, CANCER CELL, V16, P449, DOI 10.1016/j.ccr.2009.11.017; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Peterson RT, 1999, CURR BIOL, V9, pR521, DOI 10.1016/S0960-9822(99)80326-1; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Restuccia DF, 2009, SCIENCE, V325, P1083, DOI 10.1126/science.1179972; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Sale EM, 2008, CELL MOL LIFE SCI, V65, P113, DOI 10.1007/s00018-007-7274-9; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Xiang T, 2008, CANCER RES, V68, P10040, DOI 10.1158/0008-5472.CAN-08-3009; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200	39	54	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14190	14198		10.1074/jbc.M111.219923	http://dx.doi.org/10.1074/jbc.M111.219923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21321111	Green Published, hybrid			2022-12-25	WOS:000289556200042
J	Perides, G; Weiss, ER; Michael, ES; Laukkarinen, JM; Duffield, JS; Steer, ML				Perides, George; Weiss, Eric R.; Michael, Emily S.; Laukkarinen, Johanna M.; Duffield, Jeremy S.; Steer, Michael L.			TNF-alpha-dependent Regulation of Acute Pancreatitis Severity by Ly-6C(hi) Monocytes in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; MACROPHAGES; ABLATION; INJURY; MODEL; INTERLEUKIN-1; DISTINCT; SUBSETS; RELEASE; PRODUCE	The roles of monocytes/macrophages and their mechanisms of action in the regulation of pancreatitis are poorly understood. To address these issues, we have employed genetically altered mouse strains that either express the human diphtheria toxin receptor (DTR) coupled to the CD11b promoter or have global deletion of TNF-alpha. Targeted, conditional depletion of monocytes/macrophages was achieved by administration of diphtheria toxin (DT) to CD11b-DTR mice. We show that in the absence of DT administration, pancreatitis is associated with an increase in pancreatic content of Ly-6C(hi) monocytes/macrophages but that this response is prevented by prior administration of DT to CD11b-DTR mice. DT administration also reduces pancreatic edema and acinar cell injury/necrosis in two dissimilar experimental models of acute pancreatitis (a secretagogue-induced model and a model elicited by retrograde pancreatic duct infusion of sodium taurocholate). In the secretagogue-elicited model, the DT-induced decrease in pancreatitis severity is reversed by adoptive transfer of purified Ly-6C(hi) monocytes harvested from non-DT-treated CD11b-DTR mice or by the transfer of purified Ly-6C(hi) monocytes harvested from TNF-alpha(+/+) donor mice, but it is not reversed by the transfer of Ly-6C(hi) monocytes harvested from TNF-alpha(-/-) donors. Our studies indicate that the Ly-6C(hi) monocyte subset regulates the severity of pancreatitis by promoting pancreatic edema and acinar cell injury/necrosis and that this phenomenon is dependent upon the expression of TNF-alpha by those cells. They suggest that therapies targeting Ly-6C(hi) monocytes and/or TNF-alpha expression by Ly-6C(hi) monocytes might prove beneficial in the prevention or treatment of acute pancreatitis.	[Perides, George; Weiss, Eric R.; Michael, Emily S.; Laukkarinen, Johanna M.; Steer, Michael L.] Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA; [Laukkarinen, Johanna M.] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, FI-33521 Tampere, Finland; [Duffield, Jeremy S.] Univ Washington, Dept Med, Seattle, WA 98109 USA	Tufts Medical Center; Tampere University; Tampere University Hospital; University of Washington; University of Washington Seattle	Perides, G (corresponding author), Tufts Med Ctr, Dept Surg, 750 Washington St, Boston, MA 02115 USA.	gperides@tuftsmedicalcenter.org			National Institutes of Health [DK073200, DK31396]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091327, R01DK084077, R01DK031396, R37DK031396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073200 (to J. S. D.) and DK31396 (to M. L S.).	An GY, 2008, CIRCULATION, V117, P3227, DOI 10.1161/CIRCULATIONAHA.108.771048; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bhatia M, 2000, J PATHOL, V190, P117; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Denham W, 1997, GASTROENTEROLOGY, V113, P1741, DOI 10.1053/gast.1997.v113.pm9352880; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fink GW, 1996, J SURG RES, V63, P369, DOI 10.1006/jsre.1996.0278; Frangogiannis NG, 2007, CIRCULATION, V115, P584, DOI 10.1161/CIRCULATIONAHA.106.646091; Frossard JL, 2002, CRIT CARE MED, V30, P1541, DOI 10.1097/00003246-200207000-00024; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GREWAL HP, 1994, AM J SURG, V167, P214, DOI 10.1016/0002-9610(94)90076-0; Gukovskaya AS, 1997, J CLIN INVEST, V100, P1853, DOI 10.1172/JCI119714; Hughes CB, 1996, PANCREAS, V13, P22, DOI 10.1097/00006676-199607000-00003; Jaffray C, 2000, J GASTROINTEST SURG, V4, P370, DOI 10.1016/S1091-255X(00)80015-3; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; Laukkarinen JM, 2008, J BIOL CHEM, V283, P20703, DOI 10.1074/jbc.M801779200; Laukkarinen JM, 2007, GUT, V56, P1590, DOI 10.1136/gut.2007.124230; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Norman J, 1997, J INTERF CYTOK RES, V17, P113, DOI 10.1089/jir.1997.17.113; NORMAN JG, 1995, ARCH SURG-CHICAGO, V130, P966; Pulichino AM, 2008, AM J RESP CELL MOL, V39, P324, DOI 10.1165/rcmb.2007-0186OC; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Shifrin AL, 2005, SURGERY, V137, P545, DOI 10.1016/j.surg.2005.01.004; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Van Acker GJD, 2007, J BIOL CHEM, V282, P22140, DOI 10.1074/jbc.M702225200; Yang J, 1998, SHOCK, V10, P169, DOI 10.1097/00024382-199809000-00004	33	38	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13327	13335		10.1074/jbc.M111.218388	http://dx.doi.org/10.1074/jbc.M111.218388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343291	Green Published, hybrid			2022-12-25	WOS:000289282200053
J	Nishimichi, N; Hayashita-Kinoh, H; Chen, C; Matsuda, H; Sheppard, D; Yokosaki, Y				Nishimichi, Norihisa; Hayashita-Kinoh, Hiromi; Chen, Chun; Matsuda, Haruo; Sheppard, Dean; Yokosaki, Yasuyuki			Osteopontin Undergoes Polymerization in Vivo and Gains Chemotactic Activity for Neutrophils Mediated by Integrin alpha 9 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THROMBIN-CLEAVED OSTEOPONTIN; TISSUE TRANSGLUTAMINASE; ALPHA(9)BETA(1) INTEGRIN; RHEUMATOID-ARTHRITIS; CROSS-LINKING; ADHESIVE PROPERTIES; SPLICE VARIANTS; BREAST-CANCER; UP-REGULATION; BINDING-SITE	Osteopontin (OPN) is an integrin-binding inflammatory cytokine that undergoes polymerization catalyzed by transglutaminase 2. We have previously reported that polymeric OPN (polyOPN), but not unpolymerized OPN (OPN*), attracts neutrophils in vitro by presenting an acquired binding site for integrin alpha 9 beta 1. Among many in vitro substrates for transglutaminase 2, only a few have evidence for in vivo polymerization and concomitant function. Although polyOPN has been identified in bone and aorta, the in vivo functional significance of polyOPN is unknown. To determine whether OPN polymerization contributes to neutrophil recruitment in vivo, we injected OPN* into the peritoneal space of mice. Polymeric OPN was detected by immunoblotting in the peritoneal wash of mice injected with OPN*, and both intraperitoneal and plasma OPN* levels were higher in mice injected with a polymerization-incompetent mutant, confirming that OPN* polymerizes in vivo. OPN* injection induced neutrophil accumulation, which was significantly less following injection of a mutant OPN that was incapable of polymerization. The importance of in vivo polymerization was further confirmed with cystamine, a transglutaminase inhibitor, which blocked the polymerization and attenuated OPN*-mediated neutrophil recruitment. The thrombin-cleaved N-terminal fragment of OPN, another ligand for alpha 9 beta 1, was not responsible for neutrophil accumulation because a thrombin cleavage-incompetent mutant recruited similar numbers of neutrophils as wild type OPN*. Neutrophil accumulation in response to both wild type and thrombin cleavage-incompetent OPN* was reduced in mice lacking the integrin alpha 9 subunit in leukocytes, indicating that alpha 9 beta 1 is required for polymerization-induced recruitment. We have illustrated a physiological role of molecular polymerization by demonstrating acquired chemotactic properties for OPN.	[Nishimichi, Norihisa; Hayashita-Kinoh, Hiromi; Yokosaki, Yasuyuki] Hiroshima Univ, Cell Matrix Frontier Lab, Minami Ku, Biomed Res Unit, Hiroshima 7348551, Japan; [Nishimichi, Norihisa; Matsuda, Haruo] Hiroshima Univ, Immunobiol Lab, Dept Mol & Appl Biosci, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Nishimichi, Norihisa; Yokosaki, Yasuyuki] Hiroshima Univ, Hlth Adm Ctr, Higashihiroshima 7398514, Japan; [Chen, Chun; Sheppard, Dean] Univ Calif San Francisco, Lung Biol Ctr, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Chen, Chun; Sheppard, Dean] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Hiroshima University; Hiroshima University; Immuno-Biological Laboratories Co. Ltd.; Hiroshima University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yokosaki, Y (corresponding author), Hiroshima Univ, Cell Matrix Frontier Lab, Minami Ku, Biomed Res Unit, 216 Biomed Res Bldg,1-2-3 Kasumi, Hiroshima 7348551, Japan.	yokosaki@hiroshima-u.ac.jp		Hayashita-Kinoh, Hiromi/0000-0002-0986-4177	National Institutes of Health [HL64353]; Japanese Ministry of Science, Sports, and Culture; Japan New Energy and Industrial Technology Development Organization; Tsuchiya Memorial Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Ministry of Science, Sports, and Culture; Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Tsuchiya Memorial Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL64353 (to D.S.). This work was also supported by a grant-in-aid from the Japanese Ministry of Science, Sports, and Culture (to H.M. and Y.Y.), by a grant from the Japan New Energy and Industrial Technology Development Organization (to N.N., H.M., and Y.Y.), and by a grant from the Tsuchiya Memorial Medical Foundation (to Y.Y.).	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Caccamo D, 2010, AMINO ACIDS, V38, P653, DOI 10.1007/s00726-009-0428-3; Chae S, 2009, INT J ONCOL, V35, P1409, DOI 10.3892/ijo_00000458; CHANG JY, 1985, EUR J BIOCHEM, V151, P217, DOI 10.1111/j.1432-1033.1985.tb09091.x; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Giachelli CM, 1998, AM J PATHOL, V152, P353; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; He B, 2006, ONCOGENE, V25, P2192, DOI 10.1038/sj.onc.1209248; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 1997, J BIOL CHEM, V272, P22736, DOI 10.1074/jbc.272.36.22736; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LORAND L, 1978, J SUPRAMOL STR CELL, V9, P427, DOI 10.1002/jss.400090313; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mambole A, 2010, J LEUKOCYTE BIOL, V88, P321, DOI 10.1189/jlb.1009704; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mirza M, 2008, INT J CANCER, V122, P889, DOI 10.1002/ijc.23204; Nemes Z, 2009, J BIOL CHEM, V284, P27252, DOI 10.1074/jbc.M109.033969; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Rittling SR, 2002, J BIOL CHEM, V277, P9175, DOI 10.1074/jbc.M109028200; Ross EA, 2006, BLOOD, V107, P1178, DOI 10.1182/blood-2005-07-2692; SAITOH Y, 1995, LAB INVEST, V72, P55; Saldanha-Gama RF, 2010, BBA-MOL CELL RES, V1803, P848, DOI 10.1016/j.bbamcr.2010.03.012; Sato Y, 2008, ATHEROSCLEROSIS, V200, P303, DOI 10.1016/j.atherosclerosis.2008.02.001; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Shang T, 1999, J LEUKOCYTE BIOL, V66, P809, DOI 10.1002/jlb.66.5.809; Shio K, 2010, J RHEUMATOL, V37, P704, DOI 10.3899/jrheum.090582; Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201; SINGH RP, 1990, J EXP MED, V171, P1931, DOI 10.1084/jem.171.6.1931; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Sullivan J, 2009, SURGERY, V146, P232, DOI 10.1016/j.surg.2009.03.036; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Yamaguchi Y, 2010, BIOCHEM BIOPH RES CO, V393, P487, DOI 10.1016/j.bbrc.2010.02.030; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yan W, 2010, NEURO-ONCOLOGY, V12, P765, DOI 10.1093/neuonc/noq006; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yung S, 2009, PERITON DIALYSIS INT, V29, pS21; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	59	42	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11170	11178		10.1074/jbc.M110.189258	http://dx.doi.org/10.1074/jbc.M110.189258			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21321126	Green Published, hybrid			2022-12-25	WOS:000288797100027
J	Jin, GL; Reitman, ZJ; Spasojevic, I; Batinic-Haberle, I; Yang, JA; Schmidt-Kittler, O; Bigner, DD; Yan, H				Jin, Genglin; Reitman, Zachary J.; Spasojevic, Ivan; Batinic-Haberle, Ines; Yang, Jian; Schmidt-Kittler, Oleg; Bigner, Darell D.; Yan, Hai			2-Hydroxyglutarate Production, but Not Dominant Negative Function, Is Conferred by Glioma-Derived NADP(+)-Dependent Isocitrate Dehydrogenase Mutations	PLOS ONE			English	Article							INTEGRATED GENOMIC ANALYSIS; IDH1 MUTATIONS; GLIOBLASTOMA; LEUKEMIA; CANCERS	Background: Gliomas frequently contain mutations in the cytoplasmic NADP(+)-dependent isocitrate dehydrogenase (IDH1) or the mitochondrial NADP(+)-dependent isocitrate dehydrogenase (IDH2). Several different amino acid substitutions recur at either IDH1 R132 or IDH2 R172 in glioma patients. Genetic evidence indicates that these mutations share a common gain of function, but it is unclear whether the shared function is dominant negative activity, neomorphic production of (R)-2-hydroxyglutarate (2HG), or both. Methodology/Principal Findings: We show by coprecipitation that five cancer-derived IDH1 R132 mutants bind IDH1-WT but that three cancer-derived IDH2 R172 mutants exert minimal binding to IDH2-WT. None of the mutants dominant-negatively lower isocitrate dehydrogenase activity at physiological (40 mu M) isocitrate concentrations in mammalian cell lysates. In contrast to this, all of these mutants confer 10- to 100-fold higher 2HG production to cells, and glioma tissues containing IDH1 R132 or IDH2 R172 mutations contain high levels of 2HG compared to glioma tissues without IDH mutations (54.4 vs. 0.1 mg 2HG/g protein). Conclusions: Binding to, or dominant inhibition of, WT IDH1 or IDH2 is not a shared feature of the IDH1 and IDH2 mutations, and thus is not likely to be important in cancer. The fact that the gain of the enzymatic activity to produce 2HG is a shared feature of the IDH1 and IDH2 mutations suggests that this is an important function for these mutants in driving cancer pathogenesis.	[Jin, Genglin; Reitman, Zachary J.; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA; [Jin, Genglin; Reitman, Zachary J.; Bigner, Darell D.; Yan, Hai] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Clin Pharmacol Lab, Dept Med,Duke Comprehens Canc Ctr, Durham, NC 27710 USA; [Batinic-Haberle, Ines] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA; [Yang, Jian; Schmidt-Kittler, Oleg] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Duke University; Duke University; Duke University; Duke University; Johns Hopkins University; Johns Hopkins Medicine	Jin, GL (corresponding author), Duke Univ, Med Ctr, Pediat Brain Tumor Fdn Inst, Preston Robert Tisch Brain Tumor Ctr Duke, Durham, NC 27710 USA.	yan00002@mc.duke.edu	Jin, Genglin/F-6868-2011; Yang, Jian/B-9451-2012	Reitman, Zachary/0000-0002-9122-9550	American Cancer Society [10-126-01-CCE]; Pediatric Brain Tumor Foundation Institute;  [1R01CA140316]; NATIONAL CANCER INSTITUTE [R01CA140316] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Pediatric Brain Tumor Foundation Institute; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by American Cancer Society Research Scholar Grant 10-126-01-CCE (www.cancer.org), The Pediatric Brain Tumor Foundation Institute Grant (http://www.pbtfus.org/), and 1R01CA140316 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Frezza C, 2010, CANCER CELL, V17, P7, DOI 10.1016/j.ccr.2009.12.031; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Lopez GY, 2010, BIOCHEM BIOPH RES CO, V398, P585, DOI 10.1016/j.bbrc.2010.06.125; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; POST GR, 1992, MOL CHEM NEUROPATHOL, V16, P303, DOI 10.1007/BF03159976; REITMAN ZJ, 2010, J NATL CANCER I, V127, P245; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Struys EA, 2004, CLIN CHEM, V50, P1391, DOI 10.1373/clinchem.2004.033399; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yan H, 2009, CANCER RES, V69, P9157, DOI 10.1158/0008-5472.CAN-09-2650; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	21	84	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16812	10.1371/journal.pone.0016812	http://dx.doi.org/10.1371/journal.pone.0016812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326614	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037000024
J	Bo, M; Bertolino, M; Borghini, M; Castellano, M; Harriague, AC; Di Camillo, CG; Gasparini, G; Misic, C; Povero, P; Pusceddu, A; Schroeder, K; Bavestrello, G				Bo, Marzia; Bertolino, Marco; Borghini, Mireno; Castellano, Michela; Harriague, Anabella Covazzi; Di Camillo, Cristina Gioia; Gasparini, GianPietro; Misic, Cristina; Povero, Paolo; Pusceddu, Antonio; Schroeder, Katrin; Bavestrello, Giorgio			Characteristics of the Mesophotic Megabenthic Assemblages of the Vercelli Seamount (North Tyrrhenian Sea)	PLOS ONE			English	Article							COMMUNITIES; ECOLOGY; KELP; FAUNA; ENDEMISM; PACIFIC; IMPACTS; BIOLOGY; BIOTA; FOOD	The biodiversity of the megabenthic assemblages of the mesophotic zone of a Tyrrhenian seamount (Vercelli Seamount) is described using Remotely Operated Vehicle (ROV) video imaging from 100 m depth to the top of the mount around 61 m depth. This pinnacle hosts a rich coralligenous community characterized by three different assemblages: (i) the top shows a dense covering of the kelp Laminaria rodriguezii; (ii) the southern side biocoenosis is mainly dominated by the octocorals Paramuricea clavata and Eunicella cavolinii; while (iii) the northern side of the seamount assemblage is colonized by active filter-feeding organisms such as sponges (sometimes covering 100% of the surface) with numerous colonies of the ascidian Diazona violacea, and the polychaete Sabella pavonina. This study highlights, also for a Mediterranean seamount, the potential role of an isolated rocky peak penetrating the euphotic zone, to work as an aggregating structure, hosting abundant benthic communities dominated by suspension feeders, whose distribution may vary in accordance to the geomorphology of the area and the different local hydrodynamic conditions.	[Bo, Marzia; Bertolino, Marco; Di Camillo, Cristina Gioia; Pusceddu, Antonio; Bavestrello, Giorgio] Univ Politecn Marche, Ancona, Italy; [Castellano, Michela; Harriague, Anabella Covazzi; Misic, Cristina; Povero, Paolo] Univ Genoa, Genoa, Italy; [Borghini, Mireno; Gasparini, GianPietro; Schroeder, Katrin] CNR, ISMRA, Sez La Spezia, Pozzuolo Di Lerici, Italy	Marche Polytechnic University; University of Genoa; Consiglio Nazionale delle Ricerche (CNR)	Bo, M (corresponding author), Univ Politecn Marche, Ancona, Italy.	m.bo@univpm.it	Galparsoro, Ibon/B-8386-2009; Di Camillo, Cristina/AAI-5960-2021; Schroeder, Katrin/C-7490-2009; CNR, Ismar/P-1247-2014	Galparsoro, Ibon/0000-0002-5031-525X; Schroeder, Katrin/0000-0001-7991-9121; Bo, Marzia/0000-0001-8400-6722; COVAZZI HARRIAGUE, Sandra Anabella/0000-0003-0378-5395; Di Camillo, Cristina/0000-0002-4031-8158; MISIC, CRISTINA/0000-0002-2577-1800; CNR, Ismar/0000-0001-5351-1486; Castellano, Michela/0000-0001-6101-0112; BERTOLINO, Marco/0000-0003-3233-303X	Italian Ministry of Research and Instruction; Global Census of Marine Life on Seamounts (CenSeam, New Zealand)	Italian Ministry of Research and Instruction; Global Census of Marine Life on Seamounts (CenSeam, New Zealand)	This work was undertaken within the PRIN (Progetti di Rilevante Interesse Nazionale) project Tyrrhenian Seamounts ecosystems: an Integrated Study (TySEc) financed by the Italian Ministry of Research and Instruction and by the Global Census of Marine Life on Seamounts (CenSeam, New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R., 2009, P 1 MED S CONS COR O, P147; Anderson MJ, 2003, J STAT COMPUT SIM, V73, P85, DOI 10.1080/00949650215733; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2002, MEDATLAS; ARTALE V, 1994, J GEOPHYS RES-OCEANS, V99, P14127, DOI 10.1029/94JC00284; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Barberi F., 1978, INITIAL REPORTS DEEP, V42, P509, DOI 10.2973/ dsdp.proc.42-1.118.1978; Barberi M, 1989, MEM SOC GEOL ITAL, V36, P41; BEDFORD AP, 1984, ESTUAR COAST SHELF S, V18, P97, DOI 10.1016/0272-7714(84)90009-X; Bernardino AF, 2010, DEEP-SEA RES PT I, V57, P708, DOI 10.1016/j.dsr.2010.03.004; BERRILL NJ, 1948, J MAR BIOL ASSOC UK, V27, P389, DOI 10.1017/S0025315400025443; BERRISFORD C D, 1969, Transactions of the Royal Society of South Africa, V38, P387; BIRKELAND C, 1971, Northwest Science, V45, P193; BLANC J, 1967, ANN I OCEANOGR PARIS, V45, P257; Blanc JJ, 1964, ANN I OCEANOGR PARIS, V4, P219; Bo M, 2011, ITAL J ZOOL, V78, P231, DOI 10.1080/11250001003652619; Bo M, 2009, MAR ECOL PROG SER, V397, P53, DOI 10.3354/meps08185; Boehlert G.W., 1987, WILEY, V43, P319, DOI [DOI 10.1029/GM043P0319, 10.1029/GM043P0319]; Budillon G, 2009, DEEP-SEA RES PT II, V56, P713, DOI 10.1016/j.dsr2.2008.07.027; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; Cecere E, 1988, OEBALIA, V14, P43; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Coma R, 2000, TRENDS ECOL EVOL, V15, P448, DOI 10.1016/S0169-5347(00)01970-4; de Forges BR, 2000, NATURE, V405, P944, DOI 10.1038/35016066; Duggins DO, 1997, MAR BIOL, V128, P489, DOI 10.1007/s002270050115; Fava F., 2007, Biologia Marina Mediterranea, V14, P180; Galil Bella, 1998, Senckenbergiana Maritima, V28, P111; Gallignani P, 1973, GIOR GEO, V2, P1; Genesseaux M, 1986, CR HEBD ACAD SCI, V302, P785; Genin A, 2004, J MARINE SYST, V50, P3, DOI 10.1016/j.jmarsys.2003.10.008; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GENIN A, 1992, DEEP-SEA RES, V39, P293, DOI 10.1016/0198-0149(92)90110-F; Genin Amatzia, 2007, Fish and Aquatic Resources Series, V12, P85; Giaccone G, 1967, NOVA THALASSIA, V3, P1; Giaccone Giuseppe, 1997, Lagascalia, V19, P129; Hall-Spencer J, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P135; Harmelin Jean-Georges, 1995, Marine Life, V4, P5; KENSLEY B, 1980, Annals of the South African Museum, V83, P13; Kitchingman A., 2007, SEAMOUNTS ECOLOGY FI, V12, P26, DOI DOI 10.1002/9780470691953.CH2; Koslow JA, 1997, AM SCI, V85, P168; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; LUNING K, 1982, SYNTHETIC DEGRADATIV, P47; Massuti E, 2005, SCI MAR, V69, P167, DOI 10.3989/scimar.2005.69n1167; Matsumoto AK, 2005, ERLANGEN EARTH CONF, P345, DOI 10.1007/3-540-27673-4_17; Matsumoto AK, 2010, MAR ECOL PROG SER, V399, P81, DOI 10.3354/meps08392; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McClain CR, 2007, J BIOGEOGR, V34, P2001, DOI 10.1111/j.1365-2699.2007.01783.x; McClain CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004141; McDaniel N., 2003, BIOL OBSERVATIONS BO; Mistri M, 1996, ITAL J ZOOL, V63, P221, DOI 10.1080/11250009609356137; Nair R, 1994, P 10 S IT ASS LIMN O, P65; Norderhaug KM, 2003, MAR ECOL PROG SER, V255, P135, DOI 10.3354/meps255135; OCEANA, 2005, FOND ERMENEGILDO ZEG, V72, DOI [10.1016/0038-092X(86)90130-1, DOI 10.1016/0038-092X(86)90130-1]; Panetta P., 1985, Oebalia, V11, P767; Parin NV, 1997, ADV MAR BIOL, V32, P145; PARKER T, 1994, BIOL BULL-US, V187, P336, DOI 10.2307/1542290; PERRONE A, 1985, J MOLLUS STUD, V51, P102, DOI 10.1093/oxfordjournals.mollus.a065878; Piepenburg D, 2004, ARCH FISH MAR RES, V51, P55; RAYMORE PA, 1982, PAC SCI, V36, P15; Robin C, 1986, CR HEBD ACAD SCI, V303, P1165; Rogers A.D., 2007, SEAMOUNTS ECOLOGY FI, P3343; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; Samadi Sarah, 2007, Fish and Aquatic Resources Series, V12, P119; Sara M., 1987, NATO ASI Series Series G Ecological Sciences, V13, P205; Schaal G, 2010, J SEA RES, V63, P24, DOI 10.1016/j.seares.2009.09.002; Strusi A., 1985, Oebalia, V11, P379; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; Tzetlin AB, 2007, HYDROBIOLOGIA, V355, P91; UCHUPI E, 1989, DEEP-SEA RES, V36, P1443, DOI 10.1016/0198-0149(89)90094-0; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; UNEP, 2003, WHIT COR COMM CAN SE; VARNAVAS SP, 1988, MAR GEOL, V81, P205, DOI 10.1016/0025-3227(88)90027-8; Vetrano A, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005680; Wilson RR, 1987, GEOPHYS MONOGR SER, P355, DOI DOI 10.1029/GM043P0355; Zhuleva EV, 1988, OCEANOL, V27, P808	77	106	107	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16357	10.1371/journal.pone.0016357	http://dx.doi.org/10.1371/journal.pone.0016357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304906	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036600007
J	Nexo, BA; Christensen, T; Frederiksen, J; Moller-Larsen, A; Oturai, AB; Villesen, P; Hansen, B; Nissen, KK; Laska, MJ; Petersen, TS; Bonnesen, S; Hedemand, A; Wu, TT; Wang, XJ; Zhang, XQ; Brudek, T; Maric, R; Sondergaard, HB; Sellebjerg, F; Brusgaard, K; Kjeldbjerg, AL; Rasmussen, HB; Nielsen, AL; Nyegaard, M; Petersen, T; Borglum, AD; Pedersen, FS				Nexo, Bjorn A.; Christensen, Tove; Frederiksen, Jette; Moller-Larsen, Anne; Oturai, Annette B.; Villesen, Palle; Hansen, Bettina; Nissen, Kari K.; Laska, Magdalena J.; Petersen, Trine S.; Bonnesen, Sandra; Hedemand, Anne; Wu, Tingting; Wang, Xinjie; Zhang, Xiuqing; Brudek, Tomasz; Maric, Romana; Sondergaard, Helle B.; Sellebjerg, Finn; Brusgaard, Klaus; Kjeldbjerg, Anders L.; Rasmussen, Henrik B.; Nielsen, Anders L.; Nyegaard, Mette; Petersen, Thor; Borglum, Anders D.; Pedersen, Finn S.			The Etiology of Multiple Sclerosis: Genetic Evidence for the Involvement of the Human Endogenous Retrovirus HERV-Fc1	PLOS ONE			English	Article							VIRUS; ASSOCIATION; INFECTION	We have investigated the role of human endogenous retroviruses in multiple sclerosis by analyzing the DNA of patients and controls in 4 cohorts for associations between multiple sclerosis and polymorphisms near viral restriction genes or near endogenous retroviral loci with one or more intact or almost-intact genes. We found that SNPs in the gene TRIM5 were inversely correlated with disease. Conversely, SNPs around one retroviral locus, HERV-Fc1, showed a highly significant association with disease. The latter association was limited to a narrow region that contains no other known genes. We conclude that HERV-Fc1 and TRIM5 play a role in the etiology of multiple sclerosis. If these results are confirmed, they point to new modes of treatment for multiple sclerosis.	[Nexo, Bjorn A.; Hansen, Bettina; Nissen, Kari K.; Laska, Magdalena J.; Petersen, Trine S.; Bonnesen, Sandra; Hedemand, Anne; Nielsen, Anders L.; Nyegaard, Mette; Borglum, Anders D.] Univ Aarhus, Dept Human Genet, Aarhus C, Denmark; [Christensen, Tove; Moller-Larsen, Anne; Brudek, Tomasz; Maric, Romana] Univ Aarhus, Dept Med Microbiol, Aarhus C, Denmark; [Frederiksen, Jette] Glostrup Cty Hosp, Dept Neurol, Glostrup, Denmark; [Oturai, Annette B.; Sondergaard, Helle B.; Sellebjerg, Finn] Copenhagen Univ Hosp, Danish Multiple Sclerosis Res Ctr, Dept Neurol, Copenhagen, Denmark; [Villesen, Palle] Univ Aarhus, Bioinformat Res Ctr, Aarhus C, Denmark; [Laska, Magdalena J.] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Wu, Tingting; Wang, Xinjie; Zhang, Xiuqing] BGI Shenzhen, Shenzhen, Peoples R China; [Brusgaard, Klaus] Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark; [Kjeldbjerg, Anders L.; Pedersen, Finn S.] Univ Aarhus, Dept Mol Biol, Aarhus C, Denmark; [Rasmussen, Henrik B.] Psychiat Ctr Sct Hans, Res Inst Biol Psychiat, Roskilde, Denmark	Aarhus University; Aarhus University; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; Beijing Genomics Institute (BGI); University of Southern Denmark; Odense University Hospital; Aarhus University	Nexo, BA (corresponding author), Univ Aarhus, Dept Human Genet, Aarhus C, Denmark.	nexo@humgen.au.dk	Nyegaard, Mette/G-4443-2012; Nyegaard, Mette/M-3379-2019; Nielsen, Anders Lade L/Q-9604-2016; Brusgaard, Klaus/AGE-8988-2022	Nyegaard, Mette/0000-0003-4973-8543; Nyegaard, Mette/0000-0003-4973-8543; Nielsen, Anders Lade L/0000-0003-4372-9961; frederiksen, jette/0000-0003-1661-7438; Laska, Magdalena Janina/0000-0001-5188-3446; Borglum, Anders/0000-0001-8627-7219; Petersen, Thor/0000-0001-5633-2600; Brusgaard, Klaus/0000-0002-2096-4988; Brudek, Tomasz/0000-0001-5453-1817; Villesen, Palle/0000-0001-7589-8781; Sellebjerg, Finn/0000-0002-1333-9623; Christensen, Tove/0000-0003-3977-6677; Sondergaard, Helle Bach/0000-0001-9435-0658	The Lundbeck Foundation; The Danish Multiple Sclerosis Society; Warwara Larsens Fond; The NovoNordisk Foundation; The Villum Kann Rasmussen Foundation	The Lundbeck Foundation(Lundbeckfonden); The Danish Multiple Sclerosis Society; Warwara Larsens Fond; The NovoNordisk Foundation(Novo Nordisk Foundation); The Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by The Lundbeck Foundation, The Danish Multiple Sclerosis Society, Warwara Larsens Fond, The NovoNordisk Foundation and The Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; CHATTOPADHYAY SK, 1975, P NATL ACAD SCI USA, V72, P906, DOI 10.1073/pnas.72.3.906; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; CLEMENTS JE, 1988, ANNU REV IMMUNOL, V6, P139, DOI 10.1146/annurev.iy.06.040188.001035; GARDNER MB, 1993, GENETICA, V91, P199, DOI 10.1007/BF01435998; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hansen T, 2005, MULT SCLER J, V11, P504, DOI 10.1191/1352458505ms1220oa; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Pepin M, 1998, VET RES, V29, P341; PINCUS T, 1971, J EXP MED, V133, P1234, DOI 10.1084/jem.133.6.1234; ROWE WP, 1972, J EXP MED, V136, P1272, DOI 10.1084/jem.136.5.1272; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tristem M, 2000, J VIROL, V74, P3715, DOI 10.1128/JVI.74.8.3715-3730.2000; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076	17	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16652	10.1371/journal.pone.0016652	http://dx.doi.org/10.1371/journal.pone.0016652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311761	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200028
J	Sutherland, TD; Church, JS; Hu, XA; Huson, MG; Kaplan, DL; Weisman, S				Sutherland, Tara D.; Church, Jeffrey S.; Hu, Xiao; Huson, Mickey G.; Kaplan, David L.; Weisman, Sarah			Single Honeybee Silk Protein Mimics Properties of Multi-Protein Silk	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; SIMILLIMA-XANTHOPTERA CAMERON; ALPHA-KERATIN FIBERS; COILED-COIL; STRUCTURAL-CHARACTERIZATION; FIBROUS PROTEINS; SPECTROSCOPY; BETA; TRANSITION; COMPLEXES	Honeybee silk is composed of four fibrous proteins that, unlike other silks, are readily synthesized at full-length and high yield. The four silk genes have been conserved for over 150 million years in all investigated bee, ant and hornet species, implying a distinct functional role for each protein. However, the amino acid composition and molecular architecture of the proteins are similar, suggesting functional redundancy. In this study we compare materials generated from a single honeybee silk protein to materials containing all four recombinant proteins or to natural honeybee silk. We analyse solution conformation by dynamic light scattering and circular dichroism, solid state structure by Fourier Transform Infrared spectroscopy and Raman spectroscopy, and fiber tensile properties by stress-strain analysis. The results demonstrate that fibers artificially generated from a single recombinant silk protein can reproduce the structural and mechanical properties of the natural silk. The importance of the four protein complex found in natural silk may lie in biological silk storage or hierarchical self-assembly. The finding that the functional properties of the mature material can be achieved with a single protein greatly simplifies the route to production for artificial honeybee silk.	[Sutherland, Tara D.; Weisman, Sarah] Entomol Commonwealth Sci & Res Org CSIRO, Canberra, ACT, Australia; [Church, Jeffrey S.; Huson, Mickey G.] Mat Sci & Engn CSIRO, Geelong, Vic, Australia; [Hu, Xiao; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Tufts University	Sutherland, TD (corresponding author), Entomol Commonwealth Sci & Res Org CSIRO, Canberra, ACT, Australia.	Tara.Sutherland@csiro.au	Huson, Mickey/K-2474-2012; Hu, Xiao/F-2403-2012; Weisman, Sarah/B-5091-2009; Sutherland, Tara/B-5635-2009	Huson, Mickey/0000-0003-1859-7805; Hu, Xiao/0000-0002-2579-2820; Sutherland, Tara/0000-0001-5211-4593	CSIRO, Australia; United States Air Force Office of Scientific Research	CSIRO, Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was funded by CSIRO, Australia and the United States Air Force Office of Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTBURY W. T., 1933, PHILOS TRANS ROY SOC LONDON, VA232, P333; ATKINS EDT, 1967, J MOL BIOL, V24, P139, DOI 10.1016/0022-2836(67)90099-X; Colthup N. B., 1990, INTRO INFRARED RAMAN, P216; Damaschun G, 1998, BIOCHEMISTRY-MOSCOW+, V63, P259; Feughelman M., 1997, MECH PROPERTIES STRU, P16; Flower N. E., 1967, Journal of the Royal Microscopical Society, V86, P297; Frushour B.G., 1975, ADV INFRARED RAMAN S, V1, P35; Heimburg T, 1999, BIOCHEMISTRY-US, V38, P12727, DOI 10.1021/bi983079h; HEPBURN HR, 1979, INSECT BIOCHEM, V9, P69, DOI 10.1016/0020-1790(79)90028-3; HEPBURN HR, 1988, APIDOLOGIE, V19, P25, DOI 10.1051/apido:19880102; Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d; Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109; ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017; Kameda T, 2005, Z NATURFORSCH C, V60, P906; Kameda T, 2009, INT J BIOL MACROMOL, V44, P64, DOI 10.1016/j.ijbiomac.2008.10.004; Kameda T, 2010, BIOMACROMOLECULES, V11, P1009, DOI 10.1021/bm901472a; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Li XC, 2010, J STRUCT BIOL, V170, P313, DOI 10.1016/j.jsb.2010.01.016; MATTICE WL, 1976, BIOCHEMISTRY-US, V15, P4264, DOI 10.1021/bi00664a020; Meng FG, 2001, BIOCHIMIE, V83, P953, DOI 10.1016/S0300-9084(01)01340-2; PARKER W, 1992, BIOPHYS J, V61, P1435, DOI 10.1016/S0006-3495(92)81949-5; Peng XN, 2004, ACTA CHIM SINICA, V62, P2127; Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x; REYNOLDS JA, 1970, J BIOL CHEM, V245, P5161; Rudall K.M., 1962, COMP BIOCHEM PHYSIOL, V4, P397; Rusconi F, 2001, ANAL BIOCHEM, V295, P31, DOI 10.1006/abio.2001.5164; Sezutsu H, 2007, BIOSCI BIOTECH BIOCH, V71, P2725, DOI 10.1271/bbb.70326; Shi JH, 2008, BIOMATERIALS, V29, P2820, DOI 10.1016/j.biomaterials.2008.03.020; Sutherland TD, 2007, MOL BIOL EVOL, V24, P2424, DOI 10.1093/molbev/msm171; Sutherland TD, 2006, GENOME RES, V16, P1414, DOI 10.1101/gr.5052606; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519; Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021; Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5; Wilson E.O., 1971, INSECT SOC; WORTMANN FJ, 1994, TEXT RES J, V64, P737, DOI 10.1177/004051759406401206; YOUNG CY, 1978, J PHYS CHEM-US, V82, P1375, DOI 10.1021/j100501a011; Zhang K, 2010, P NATL ACAD SCI USA, V107, P9502, DOI 10.1073/pnas.0912066107; ZHOU NE, 1994, PROTEIN ENG, V7, P1365, DOI 10.1093/protein/7.11.1365	39	47	51	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16489	10.1371/journal.pone.0016489	http://dx.doi.org/10.1371/journal.pone.0016489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311767	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036200018
J	Ha, JW; Schwahn, AB; Downard, KM				Ha, Ji-won; Schwahn, Alexander B.; Downard, Kevin M.			Proteotyping to Establish Gene Origin within Reassortant Influenza Viruses	PLOS ONE			English	Article							H1N1 INFLUENZA; MASS; ANTIGENICITY; EVOLUTION; VACCINE	The application of a rapid and direct proteotyping approach with which to identify the gene origin of viral antigens in a reassortant influenza strain is demonstrated. The reassortant strain, constructed for a vaccine against type A 2009 H1N1 pandemic influenza, contains genes derived from a wild-type pandemic strain (A/California/7/2009) and an egg adapted high-growth strain (denoted NYMC X-157) derived from an earlier A/Puerto Rico/8/34 strain. The proteotyping approach employs modern proteomics methods and high resolution mass spectrometry to correctly establish that the genes of the surface antigens, hemagglutinin and neuraminidase, are derived from the A/California/7/2009 strain while those for nucleoprotein and matrix protein M1 antigens are derived from the NYMC X-157 strain. This is achieved for both gel-separated antigens and those from a whole vaccine digest. Furthermore, signature peptides detected in the mass spectra of the digested antigens enable the engineered reassortant strain to be identified as a type A virus of the H1N1 subtype in accord with earlier studies. The results demonstrate that proteotyping approach provides a more direct and rapid approach over RT-PCR with which to characterize reassortant strains of the influenza virus at the molecular protein level. Given that these strains pose the greatest risk to human and animal health and have been responsible for all human pandemics of the 20th and 21st centuries, there is a vital need for the origins and evolutionary history of these strains to be rapidly established.	[Ha, Ji-won; Schwahn, Alexander B.; Downard, Kevin M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Ha, JW (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	k.downard@sydney.edu.au	Ha, Ji Won/AAB-7949-2019	Downard, Kevin/0000-0003-0904-4141	Australian Research Council [DP1010101702, DP0770619]; Australian Research Council Linkage Infrastructure Equipment Facility (LIEF) [LE0668439]; University of Sydney	Australian Research Council(Australian Research Council); Australian Research Council Linkage Infrastructure Equipment Facility (LIEF)(Australian Research Council); University of Sydney(University of Sydney)	This research was supported by Australian Research Council Discovery Project grants (DP1010101702 and DP0770619) awarded to K. M. Downard. A. B. Schwahn was supported by an Australian Research Council Discovery Project grant (DP0770619) awarded to K. M. Downard. The FT-ICR mass spectrometer used in these investigations was purchased with funds provided by an Australian Research Council Linkage Infrastructure Equipment Facility (LIEF) grant (LE0668439) and the University of Sydney. The PanVax H1N1 vaccine was kindly donated by CSL Biotherapies, CSL Limited, Melbourne, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Kiselar JG, 1999, BIOCHEMISTRY-US, V38, P14185, DOI 10.1021/bi991609j; KISO M, 2010, PLOS PATHOGENS, V6; Lee EY, 2010, J VIROL METHODS, V165, P133, DOI 10.1016/j.jviromet.2009.10.022; Morrissey B, 2006, PROTEOMICS, V6, P2034, DOI 10.1002/pmic.200500642; Morrissey B, 2007, J VIROL METHODS, V145, P106, DOI 10.1016/j.jviromet.2007.05.015; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Perez N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007668; Pramanik BN, 2002, PROTEIN SCI, V11, P2676, DOI 10.1110/ps.0213702; Sakamoto S, 1996, J VIROL METHODS, V56, P161, DOI 10.1016/0166-0934(95)01909-X; SCHWAHN AB, 2010, J VIROL MET IN PRESS; Schwahn AB, 2010, EUR J MASS SPECTROM, V16, P321, DOI 10.1255/ejms.1056; Schwahn AB, 2010, ANAL CHEM, V82, P4584, DOI 10.1021/ac100594j; Schwahn AB, 2010, J VIROL METHODS, V165, P178, DOI 10.1016/j.jviromet.2010.01.015; Schwahn AB, 2009, ANALYST, V134, P2253, DOI 10.1039/b912234f; Schwahn AB, 2009, ANAL CHEM, V81, P3500, DOI 10.1021/ac900026f; Schwahn AB, 2009, J IMMUNOASS IMMUNOCH, V30, P245, DOI 10.1080/15321810903084350; Shu LP, 1996, EUR J EPIDEMIOL, V12, P63, DOI 10.1007/BF00144430; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182	25	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e15771	10.1371/journal.pone.0015771	http://dx.doi.org/10.1371/journal.pone.0015771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305059	gold, Green Submitted, Green Published			2022-12-25	WOS:000286834300026
J	Taylor, SM; Messina, JP; Hand, CC; Juliano, JJ; Muwonga, J; Tshefu, AK; Atua, B; Emch, M; Meshnick, SR				Taylor, Steve M.; Messina, Jane P.; Hand, Carla C.; Juliano, Jonathan J.; Muwonga, Jeremie; Tshefu, Antoinette K.; Atua, Benjamin; Emch, Michael; Meshnick, Steven R.			Molecular Malaria Epidemiology: Mapping and Burden Estimates for the Democratic Republic of the Congo, 2007	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM TRANSMISSION; INFECTIONS; MORBIDITY; MORTALITY; CARRIAGE; CHILDREN; FULANI; AREA; AGE	Background: Epidemiologic data on malaria are scant in many high-burden countries including the Democratic Republic of the Congo (DRC), which suffers the second-highest global burden of malaria. Malaria control efforts in regions with challenging infrastructure require reproducible and efficient surveillance. We employed new high-throughput molecular testing to characterize the state of malaria control in the DRC and estimate childhood mortality attributable to excess malaria transmission. Methods and Findings: The Demographic and Health Survey was a cross-sectional, population-based cluster household survey of adults aged 15-59 years in 2007 employing structured questionnaires and dried blood spot collection. Parasitemia was detected by real-time PCR, and survey responses measured adoption of malaria control measures and under-5 health indices. The response rate was 99% at the household level, and 8,886 households were surveyed in 300 clusters; from 8,838 respondents molecular results were available. The overall prevalence of parasitemia was 33.5% (95% confidence interval [C.I.] 32-34.9); P. falciparum was the most prevalent species, either as monoinfection (90.4%; 95% C.I. 88.8-92.1) or combined with P. malariae (4.9%; 95% C.I. 3.7-5.9) or P. ovale (0.6%; 95% C.I. 0.1-0.9). Only 7.7% (95% CI 6.8-8.6) of households with children under 5 owned an insecticide-treated bednet (ITN), and only 6.8% (95% CI 6.1-7.5) of under-fives slept under an ITN the preceding night. The overall under-5 mortality rate was 147 deaths per 1,000 live births (95% C.I. 141153) and between clusters was associated with increased P. falciparum prevalence; based on the population attributable fraction, 26,488 yearly under-5 deaths were attributable to excess malaria transmission. Conclusions: Adult P. falciparum prevalence is substantial in the DRC and is associated with under-5 mortality. Molecular testing offers a new, generalizable, and efficient approach to characterizing malaria endemicity in underserved countries.	[Taylor, Steve M.; Hand, Carla C.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Taylor, Steve M.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA; [Messina, Jane P.; Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Messina, Jane P.; Emch, Michael] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Juliano, Jonathan J.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA; [Muwonga, Jeremie] Lab Natl Reference SIDA, Kinshasa, DEM REP CONGO; [Muwonga, Jeremie] IST LNRS, Kinshasa, DEM REP CONGO; [Tshefu, Antoinette K.] Univ Kinshasa, Ecole Sante Publ, Fac Med, Kinshasa, DEM REP CONGO; [Atua, Benjamin] PNLP, Kinshasa, DEM REP CONGO	University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Universite de Kinshasa	Taylor, SM (corresponding author), Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	stevemyertaylor@gmail.com		Cerami, Carla/0000-0002-7634-0955	UNC Gillings School of Global Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	UNC Gillings School of Global Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by a Gillings Innovation Laboratory award from the UNC Gillings School of Global Public Health (to SRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alker AP, 2008, TROP MED INT HEALTH, V13, P1384, DOI 10.1111/j.1365-3156.2008.02150.x; [Anonymous], 2008, WORLD MAL REP 2008; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Conrad Joseph, 1999, HEART DARKNESS; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; DUREN A N, 1951, Ann Soc Belg Med Trop (1920), V31, P129; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Guerra CA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-17; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; JIMA D, MALAR J, V9, P58; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Marques PX, 2005, INT J BIOL SCI, V1, P96; Messina JP, 2010, SOC SCI MED, V71, P1428, DOI 10.1016/j.socscimed.2010.07.025; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; RAJARATNAM JK, PLOS MED, V7; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Reyburn H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2066; RIEDEL N, MALAR J, V9, P37; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Roux AVD, 2005, J INFECT DIS, V191, pS25, DOI 10.1086/425288; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; SNOUNOU G, 1993, T ROY SOC TROP MED H, V87, P649, DOI 10.1016/0035-9203(93)90274-T; SNOW RW, 1995, PARASITOL TODAY, V11, P188, DOI 10.1016/0169-4758(95)80156-1; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Sullivan D, 2010, EPIDEMIOL REV, V32, P175, DOI 10.1093/epirev/mxq013; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; Vafa M, 2007, MICROBES INFECT, V9, P1043, DOI 10.1016/j.micinf.2007.04.011; Zwetyenga J, 1999, T ROY SOC TROP MED H, V93, P375, DOI 10.1016/S0035-9203(99)90122-0	40	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16420	10.1371/journal.pone.0016420	http://dx.doi.org/10.1371/journal.pone.0016420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305011	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300063
J	Yan, LQ; Della Coletta, L; Powell, KL; Shen, JJ; Thames, H; Aldaz, CM; MacLeod, MC				Yan, Leqin; Della Coletta, Luis; Powell, K. Leslie; Shen, Jianjun; Thames, Howard; Aldaz, C. Marcelo; MacLeod, Michael C.			Activation of the Canonical Wnt/beta-Catenin Pathway in ATF3-Induced Mammary Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ATF3; STRESS-INDUCIBLE GENE; BETA-CATENIN; BREAST-CANCER; SIGNALING PATHWAY; INDUCED APOPTOSIS; CYCLIN D1; C-JUN; COLORECTAL-CANCER; EPITHELIAL-CELLS	Female transgenic mice that constitutively overexpress the transcription factor ATF3 in the basal epithelium of the mammary gland develop mammary carcinomas with high frequency, but only if allowed to mate and raise pups early in life. This transgenic mouse model system reproduces some features of human breast cancer in that about 20% of human breast tumor specimens exhibit overexpression of ATF3 in the tumor cells. The ATF3-induced mouse tumors are phenotypically similar to mammary tumors induced by overexpression of activating Wnt/beta-catenin pathway genes. We now show that the Wnt/beta-catenin pathway is indeed activated in ATF3-induced tumors. beta-catenin is transcriptionally up-regulated in the tumors, and high levels of nuclear beta-catenin are seen in tumor cells. A reporter gene for Wnt/beta-catenin pathway activity, TOPGAL, is up-regulated in the tumors and several downstream targets of Wnt signaling, including Ccnd1, Jun, Axin2 and Dkk4, are also expressed at higher levels in ATF3-induced tumors compared to mammary glands of transgenic females. Several positive-acting ligands for this pathway, including Wnt3, Wnt3a, Wnt7b, and Wnt5a, are significantly overexpressed in tumor tissue, and mRNA for Wnt3 is about 5-fold more abundant in transgenic mammary tissue than in non-transgenic mammary tissue. Two known transcriptional targets of ATF3, Snai1 and Snai2, are also overexpressed in the tumors, and Snail and Slug proteins are found to be located primarily in the nuclei of tumor cells. In vitro knockdown of Atf3 expression results in significant decreases in expression of Wnt7b, Tcf7, Snai2 and Jun, suggesting that these genes may be direct transcriptional targets of ATF3 protein. By chromatin immunoprecipitation analysis, both ATF3 and JUN proteins appear to bind to a particular subclass of AP-1 sites upstream of the transcriptional start sites of each of these genes.	[Yan, Leqin; Della Coletta, Luis; Powell, K. Leslie; Shen, Jianjun; Aldaz, C. Marcelo; MacLeod, Michael C.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA; [Thames, Howard] Univ Texas MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yan, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX USA.	mcmacleod@mdanderson.org	Aldaz, C. Marcelo/E-7868-2011	Aldaz, C. Marcelo/0000-0002-2453-2939	 [R01 CA116620];  [P30 CA016672];  [P30 ES007784]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA116620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by R01 CA116620 (MCM) and by Center grants P30 CA016672 and P30 ES007784. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Bertolo C, 2008, AM J CLIN PATHOL, V130, P414, DOI 10.1309/J3QV9763DYPV338D; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; Hai T, 1999, GENE EXPRESSION, V7, P321; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin Z, 2001, BRIT J CANCER, V85, P69, DOI 10.1054/bjoc.2001.1853; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Miyoshi K, 2002, ONCOGENE, V21, P5548, DOI 10.1038/sj.onc.1205686; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; Perez S, 2001, ONCOGENE, V20, P1135, DOI 10.1038/sj.onc.1204200; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; SMEAL T, 1994, EMBO J, V13, P6006, DOI 10.1002/j.1460-2075.1994.tb06946.x; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Veeck J, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-83; Virmani AK, 2001, CLIN CANCER RES, V7, P1998; Wang AJ, 2007, MOL CARCINOGEN, V46, P476, DOI 10.1002/mc.20298; Wang A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-46; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Wolfgang CD, 2000, J BIOL CHEM, V275, P16865, DOI 10.1074/jbc.M909637199; Wolfgang CD, 1997, MOL CELL BIOL, V17, P6700, DOI 10.1128/MCB.17.11.6700; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	58	45	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16515	10.1371/journal.pone.0016515	http://dx.doi.org/10.1371/journal.pone.0016515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304988	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300075
J	Du, LY; Leung, VHC; Zhang, XJ; Zhou, J; Chen, M; He, W; Zhang, HY; Chan, CCS; Poon, VKM; Zhao, GY; Sun, SH; Cai, LF; Zhou, YS; Zheng, BJ; Jiang, S				Du, Lanying; Leung, Virtual Ho-Chuen; Zhang, Xiujuan; Zhou, Jie; Chen, Min; He, Wu; Zhang, Hai-Ying; Chan, Chris C. S.; Poon, Vincent Kwok-Man; Zhao, Guangyu; Sun, Shihui; Cai, Lifeng; Zhou, Yusen; Zheng, Bo-Jian; Jiang, Shibo			A Recombinant Vaccine of H5N1 HA1 Fused with Foldon and Human IgG Fc Induced Complete Cross-Clade Protection against Divergent H5N1 Viruses	PLOS ONE			English	Article							RECEPTOR-BINDING DOMAIN; POTENT NEUTRALIZING ANTIBODIES; INFLUENZA-A VIRUS; AVIAN INFLUENZA; IMMUNE-RESPONSES; SWINE FLU; PROTEIN; HEMAGGLUTININ; IMMUNOGENICITY; INFECTION	Development of effective vaccines to prevent influenza, particularly highly pathogenic avian influenza (HPAI) caused by influenza A virus (IAV) subtype H5N1, is a challenging goal. In this study, we designed and constructed two recombinant influenza vaccine candidates by fusing hemagglutinin 1 (HA1) fragment of A/Anhui/1/2005(H5N1) to either Fc of human IgG (HA1-Fc) or foldon plus Fc (HA1-Fdc), and evaluated their immune responses and cross-protection against divergent strains of H5N1 virus. Results showed that these two recombinant vaccines induced strong immune responses in the vaccinated mice, which specifically reacted with HA1 proteins and an inactivated heterologous H5N1 virus. Both proteins were able to cross-neutralize infections by one homologous strain (clade 2.3) and four heterologous strains belonging to clades 0, 1, and 2.2 of H5N1 pseudoviruses as well as three heterologous strains (clades 0, 1, and 2.3.4) of H5N1 live virus. Importantly, immunization with these two vaccine candidates, especially HA1-Fdc, provided complete cross-clade protection against high-dose lethal challenge of different strains of H5N1 virus covering clade 0, 1, and 2.3.4 in the tested mouse model. This study suggests that the recombinant fusion proteins, particularly HA1-Fdc, could be developed into an efficacious universal H5N1 influenza vaccine, providing cross-protection against infections by divergent strains of highly pathogenic H5N1 virus.	[Du, Lanying; Zhang, Xiujuan; He, Wu; Cai, Lifeng; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA; [Leung, Virtual Ho-Chuen; Zhou, Jie; Chen, Min; Zhang, Hai-Ying; Chan, Chris C. S.; Poon, Vincent Kwok-Man; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Zhao, Guangyu; Sun, Shihui; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, Beijing, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol MOE MOH, Shanghai 200032, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China	New York Blood Center; University of Hong Kong; Beijing Institute of Microbiology & Epidemiology; Fudan University; Fudan University	Du, LY (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.	bzheng@hkucc.hku.hk; sjiang@nybloodcenter.org	Jiang, Shibo/L-4500-2014; Zhou, Jie/E-9839-2010; Zhang, Xiujuan/AAG-9780-2020	Jiang, Shibo/0000-0001-8283-7135; Poon, Vincent kwok-man/0000-0002-7737-8912; ZHOU, Jie/0000-0002-2948-3873	New York Blood Center [NYB000068]; Research Fund for the Control of Infectious Diseases; Health, Welfare and Food Bureau of the Hong Kong SAR Government; National 973 Basic Research Program of China [2005CB523001]	New York Blood Center; Research Fund for the Control of Infectious Diseases; Health, Welfare and Food Bureau of the Hong Kong SAR Government; National 973 Basic Research Program of China(National Basic Research Program of China)	This study was supported by an intramural fund of the New York Blood Center (NYB000068), by the Research Fund for the Control of Infectious Diseases, the Health, Welfare and Food Bureau of the Hong Kong SAR Government, and by the National 973 Basic Research Program of China (2005CB523001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bodewes R, 2010, J VIROL, V84, P7943, DOI 10.1128/JVI.00549-10; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Butler D, 2009, NATURE, V458, P1082, DOI 10.1038/4581082a; Chen HY, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-33; Chen X, 2010, J BIOL CHEM, V285, P25506, DOI 10.1074/jbc.M110.101170; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Du CL, 2008, APPL MICROBIOL BIOT, V79, P195, DOI 10.1007/s00253-008-1427-0; Du LY, 2008, J IMMUNOL, V180, P948, DOI 10.4049/jimmunol.180.2.948; Du LY, 2007, VACCINE, V25, P2832, DOI 10.1016/j.vaccine.2006.10.031; Du LY, 2010, BIOCHEM BIOPH RES CO, V397, P580, DOI 10.1016/j.bbrc.2010.05.161; Du LY, 2009, VIROLOGY, V393, P144, DOI 10.1016/j.virol.2009.07.018; Du LY, 2009, BIOCHEM BIOPH RES CO, V384, P486, DOI 10.1016/j.bbrc.2009.05.003; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2004, BIOCHEM BIOPH RES CO, V324, P773, DOI 10.1016/j.bbrc.2004.09.106; Holman DH, 2008, VACCINE, V26, P2627, DOI 10.1016/j.vaccine.2008.02.053; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kreijtz JHCM, 2009, VACCINE, V27, P6296, DOI 10.1016/j.vaccine.2009.03.020; Leroux-Roels I, 2010, VACCINE, V28, P849, DOI 10.1016/j.vaccine.2009.10.017; Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Martyn JC, 2009, ARCH VIROL, V154, P1129, DOI 10.1007/s00705-009-0423-8; Nayak B, 2010, J VIROL, V84, P2408, DOI 10.1128/JVI.02135-09; Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200; Patel A, 2009, VACCINE, V27, P3083, DOI 10.1016/j.vaccine.2009.03.023; Prabakaran M, 2010, J VIROL, V84, P3201, DOI 10.1128/JVI.02175-09; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Qi Z, 2010, BIOCHEM BIOPH RES CO, V398, P506, DOI 10.1016/j.bbrc.2010.06.109; Scalera NM, 2009, POSTGRAD MED, V121, P43, DOI 10.3810/pgm.2009.09.2051; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Shoji Y, 2009, VACCINE, V27, P1087, DOI 10.1016/j.vaccine.2008.11.108; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Szecsi J, 2009, J INFECT DIS, V200, P181, DOI 10.1086/599840; Tao P, 2009, VIRAL IMMUNOL, V22, P273, DOI 10.1089/vim.2009.0017; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Xie QM, 2009, POULTRY SCI, V88, P1608, DOI 10.3382/ps.2009-00092; Zhang SL, 2008, J VIROL METHODS, V154, P99, DOI 10.1016/j.jviromet.2008.08.016; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; 2009, MMWR MORB MORTAL WKL, V58, P585	47	34	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16555	10.1371/journal.pone.0016555	http://dx.doi.org/10.1371/journal.pone.0016555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304591	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900070
J	Gautam, US; Chauhan, S; Tyagi, JS				Gautam, Uma Shankar; Chauhan, Santosh; Tyagi, Jaya Sivaswami			Determinants Outside the DevR C-Terminal Domain Are Essential for Cooperativity and Robust Activation of Dormancy Genes in Mycobacterium tuberculosis	PLOS ONE			English	Article							DNA-BINDING DOMAIN; RESPONSE REGULATOR; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; ESCHERICHIA-COLI; HYPOXIC RESPONSE; 2-COMPONENT SYSTEM; BACILLUS-SUBTILIS; PHOSPHORYLATION; PROTEIN	Background: DevR (also called as DosR) is a two-domain response regulator of the NarL subfamily that controls dormancy adaptation of Mycobacterium tuberculosis (M. tb). In response to inducing signals such as hypoxia and ascorbic acid, the N-terminal receiver domain of DevR (DevR(N)) is phosphorylated at Asp54. This results in DevR binding to DNA via its C-terminal domain (DevR(C)) and subsequent induction of the DevR regulon. The mechanism of phosphorylation-mediated activation is not known. The present study was designed to understand the role of the N- and C-terminal domains of DevR in DevR regulon genes activation. Methodology/Principal Findings: Towards deciphering the activation mechanism of DevR, we compared the DNA binding properties of DevR(C) and DevR and correlated the findings with their ability to activate gene expression. We show that isolated DevR(C) can interact with DNA, but only with the high affinity site of a representative target promoter. Therefore, one role of DevR(N) is to mask the intrinsic DNA binding function of DevR(C). However, unlike phosphorylated DevR, isolated DevR(C) does not interact with the adjacent low affinity binding site suggesting that a second role of DevR(N) is in cooperative binding to the secondary site. Transcriptional analysis shows that consistent with unmasking of its DNA binding property, DevR(C) supports the aerobic induction, albeit feebly, of DevR regulon genes but is unable to sustain gene activation during hypoxia. Conclusions/Significance: DevR is a unique response regulator that employs a dual activation mechanism including relief of inhibition and cooperative interaction with binding sites. Importantly, both these functions reside outside the C-terminal domain. DevR(N) is also essential for stabilizing DevR and sustaining autoregulation under hypoxia. Hence, both domains of DevR are required for robust transcription activation.	[Gautam, Uma Shankar; Chauhan, Santosh; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Gautam, US (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	jstyagi@aiims.ac.in	Chauhan, Santosh/K-3031-2019; Uma S Gautam, MSc/H-3474-2019; GAUTAM, UMA/AAI-1531-2021	Chauhan, Santosh/0000-0001-9167-5107; Uma S Gautam, MSc/0000-0003-0326-6325; 	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by a grant from the Department of Biotechnology, Government of India to JST. JST is thankful to the Department of Biotechnology, Government of India for a Tata Innovation Fellowship. USG and SC are thankful to the Council for Scientific and Industrial Research (CSIR) for Senior Research Associateship (Scientist's Pool Scheme) and Research Associateship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi G, 2005, MICROBIOL-SGM, V151, P4045, DOI 10.1099/mic.0.28333-0; Boon C, 2002, J BACTERIOL, V184, P6760, DOI 10.1128/JB.184.24.6760-6767.2002; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan S, 2008, J BACTERIOL, V190, P5394, DOI 10.1128/JB.00488-08; Chauhan S, 2008, J BACTERIOL, V190, P4301, DOI 10.1128/JB.01308-07; Chauhan S, 2009, J BACTERIOL, V191, P6075, DOI 10.1128/JB.00310-09; DARE S, 1994, NUCLEIC ACIDS RES, V22, P1555; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; De Majumdar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009448; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; GALINIER A, 1994, J BIOL CHEM, V269, P23784; Grange JM, 1992, TUBERCLE LUNG DIS, P73249; GRIMSLEY JK, 1994, J BIOL CHEM, V269, P16977; Gupta RK, 2009, J MED CHEM, V52, P6324, DOI 10.1021/jm900358q; HARLOCKER SL, 1995, J BIOL CHEM, V270, P26849, DOI 10.1074/jbc.270.45.26849; Hoch JA, 1995, 2 COMPONENT SIGNAL T; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jeon Y, 2001, J BIOL CHEM, V276, P40873, DOI 10.1074/jbc.M104855200; KAHN D, 1991, MOL MICROBIOL, V5, P987, DOI 10.1111/j.1365-2958.1991.tb00774.x; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leoni L, 2003, BIOCHEM BIOPH RES CO, V303, P926, DOI 10.1016/S0006-291X(03)00450-9; Malhotra V, 2004, FEMS MICROBIOL LETT, V231, P237, DOI 10.1016/S0378-1097(04)00002-3; Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; NAKASHIMA K, 1991, J BIOL CHEM, V266, P10775; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; PORTER SC, 1993, GENE DEV, V7, P2258, DOI 10.1101/gad.7.11.2258; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Rodrigue S, 2007, J BACTERIOL, V189, P1505, DOI 10.1128/JB.01371-06; Saini DK, 2005, J BIOMOL SCREEN, V10, P215, DOI 10.1177/1087057104272090; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; STEAD WW, 1967, AM REV RESPIR DIS, V95, P729; Taneja NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010860; Valdivia RH, 1996, GENE, V173, P47, DOI 10.1016/0378-1119(95)00706-7; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; WEISS V, 1992, P NATL ACAD SCI USA, V89, P5088, DOI 10.1073/pnas.89.11.5088; Wickstrum JR, 2007, J BACTERIOL, V189, P4984, DOI 10.1128/JB.00530-07; Wisedchaisri G, 2005, J MOL BIOL, V354, P630, DOI 10.1016/j.jmb.2005.09.048; Wisedchaisri G, 2008, J MOL BIOL, V378, P227, DOI 10.1016/j.jmb.2008.02.029	46	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16500	10.1371/journal.pone.0016500	http://dx.doi.org/10.1371/journal.pone.0016500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304599	Green Published, Green Submitted, gold			2022-12-25	WOS:000286663900058
J	Hou, X; Liu, JE; Liu, W; Liu, CY; Liu, ZY; Sun, ZY				Hou, X.; Liu, J-E; Liu, W.; Liu, C-Y; Liu, Z-Y; Sun, Z-Y			A new role of NUAK1: directly phosphorylating p53 and regulating cell proliferation	ONCOGENE			English	Article						NUAK1; p53; LKB1; cell proliferation; phosphorylation	TUMOR INVASION; KINASE; LKB1; ARK5; IDENTIFICATION; ACTIVATION; GROWTH; CANCER; SENESCENCE; EXPRESSION	It has been suggested that adenosine monophosphate-activated protein kinase (AMPK) and 12 AMPK-related kinases (ARK), including novel (nua) kinase family 1 (NUAK1), are activated by master kinase LKB1, a major tumor suppressor. Apart from evidence to suggest that NUAK1 participates in induction of tumor survival, invasion and p53-independent cellular senescence, its detailed biological functions remain unclear. Here we showed that in the presence of wild-type LKB1, NUAK1 directly interacts with and phosphorylates p53 in vitro and in vivo. The phosphorylation of p53 induced by LKB1 required the kinase activity of NUAK1 and phosphorylation of NUAK1 at Thr211 by LKB1 was essential for its kinase activity, which leads to the conclusion that LKB1 activates NUAK1 and regulates phosphorylation of p53 through the NUAK1 kinase, at least partially. LKB1/NUAK1 activation leads to cell cycle arrest at the G(1)/S border by inducing expression of p21/WAF1. Under the regulation of LKB1, NUAK1 interacts with p53 in the nucleus and binds to the p53-responsive element of p21/WAF1 promoter. These findings have highlighted a novel role for NUAK1 in LKB1-related signaling pathways; NUAK1 can regulate cell proliferation and exert tumor suppression through direct interaction with p53. Oncogene (2011) 30, 2933-2942; doi:10.1038/onc.2011.19; published online 14 February 2011	[Hou, X.; Liu, J-E; Liu, W.; Liu, C-Y; Liu, Z-Y; Sun, Z-Y] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Inner Mongolia, Peoples R China	Inner Mongolia University	Hou, X (corresponding author), Inner Mongolia Univ, Coll Life Sci, 235 Daxue W Rd, Hohhot 010021, Inner Mongolia, Peoples R China.	houxinliu@yahoo.com.cn	Liu, June/C-7871-2009		Science and Technology Foundation of Education Ministry of China [209025]; Inner Mongolia National Natural Science Foundation [2009ZD007]	Science and Technology Foundation of Education Ministry of China; Inner Mongolia National Natural Science Foundation	We thank Professor Tingmao Hu for helpful discussion. We are grateful to Dr Jinghua Yan for providing the plasmids. This study was supported by the Key Project of the Science and Technology Foundation of Education Ministry of China (209025) and the Key Project of the Inner Mongolia National Natural Science Foundation (2009ZD007).	Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jimenez AI, 2003, CANCER RES, V63, P1382; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Kusakai G, 2004, J EXP CLIN CANC RES, V23, P263; Kusakai G, 2004, AM J PATHOL, V164, P987, DOI 10.1016/S0002-9440(10)63186-0; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Niesler CU, 2007, EXP PHYSIOL, V92, P207, DOI 10.1113/expphysiol.2006.034736; ONCOGENE W, ONCOGENE; Resnick-Silverman L, 1998, GENE DEV, V12, P2102, DOI 10.1101/gad.12.14.2102; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Suzuki A, 2005, J BIOL CHEM, V280, P31557, DOI 10.1074/jbc.M503714200; Suzuki A, 2004, ONCOGENE, V23, P7067, DOI 10.1038/sj.onc.1207963; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Suzuki A, 2003, ONCOGENE, V22, P6177, DOI 10.1038/sj.onc.1206899; Suzuki A, 2003, J BIOL CHEM, V278, P48, DOI 10.1074/jbc.M206025200; Suzuki A, 2006, J BIOL CHEM, V281, P13915, DOI 10.1074/jbc.M511354200; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Woods DB, 2001, EXP CELL RES, V264, P56, DOI 10.1006/excr.2000.5141; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	32	49	55	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	26					2933	2942		10.1038/onc.2011.19	http://dx.doi.org/10.1038/onc.2011.19			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21317932				2022-12-25	WOS:000292245100004
J	To, WS; Midwood, KS				To, Wing S.; Midwood, Kim S.			Identification of Novel and Distinct Binding Sites within Tenascin-C for Soluble and Fibrillar Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA FIBRONECTIN; EXTRACELLULAR-MATRIX; HEPARIN-BINDING; FOCAL ADHESION; III MODULES; HUMAN-SKIN; CELL; FIBRILLOGENESIS; DOMAINS; REGION	Interactions between fibronectin and tenascin-C within the extracellular matrix provide specific environmental cues that dictate tissue structure and cell function. The major binding site for fibronectin lies within the fibronectin type III-like repeats (TNfn) of tenascin-C. Here, we systematically screened TNfn domains for their ability to bind to both soluble and fibrillar fibronectin. All TNfn domains containing the TNfn3 module interact with soluble fibronectin. However, TNfn domains bind differentially to fibrillar fibronectin. This distinct binding pattern is dictated by the fibrillar conformation of FN. TNfn1-3, but not TNfn3-5, binds to immature fibronectin fibrils, and additional TNfn domains are required for binding to mature fibrils. Multiple binding sites for distinct regions of fibronectin exist within tenascin-C. TNfn domains comprise a binding site for the N-terminal 70-kDa domain of fibronectin that is freely available and a binding site for the central binding domain of fibronectin that is cryptic in full-length tenascin-C. The 70-kDa and central binding domain regions are key for fibronectin matrix assembly; accordingly, binding of several TNfn domains to these regions inhibits fibronectin fibrillogenesis. These data highlight the complexity of protein-protein binding, the importance of protein conformation on these interactions, and the implications for the physiological assembly of complex threedimensional matrices.	[To, Wing S.; Midwood, Kim S.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Dept Matrix Biol,Kennedy Inst, London W6 8LH, England	Imperial College London; University of Oxford	Midwood, KS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Rheumatol, Dept Matrix Biol,Kennedy Inst, 65 Aspenlea Rd, London W6 8LH, England.	k.midwood@imperial.ac.uk			MRC [G0700108] Funding Source: UKRI; Medical Research Council [G0700108] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; Bencharit S, 2007, J MOL BIOL, V367, P303, DOI 10.1016/j.jmb.2006.10.017; BUSBY TF, 1995, J BIOL CHEM, V270, P18558, DOI 10.1074/jbc.270.31.18558; Chen Y, 2007, BIOCHEM BIOPH RES CO, V361, P391, DOI 10.1016/j.bbrc.2007.07.014; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; CHIQUETEHRISMANN R, 1991, CELL REGUL, V2, P927, DOI 10.1091/mbc.2.11.927; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; CHUNG CY, 1995, J BIOL CHEM, V270, P29012, DOI 10.1074/jbc.270.48.29012; Chung CY, 1997, J CELL SCI, V110, P1413; Craig D, 2001, P NATL ACAD SCI USA, V98, P5590, DOI 10.1073/pnas.101582198; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Ghert MA, 2001, CELL STRUCT FUNCT, V26, P179; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; HOFFMAN S, 1987, P NATL ACAD SCI USA, V84, P2523, DOI 10.1073/pnas.84.8.2523; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; INGHAM KC, 1990, BIOCHEM J, V272, P605, DOI 10.1042/bj2720605; Jang JH, 2004, J BIOL CHEM, V279, P25562, DOI 10.1074/jbc.M403170200; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kusubata M, 1999, J INVEST DERMATOL, V113, P906, DOI 10.1046/j.1523-1747.1999.00802.x; Lange K, 2007, CANCER RES, V67, P6163, DOI 10.1158/0008-5472.CAN-06-3348; Latijnhouwers MA, 1996, J PATHOL, V178, P30, DOI 10.1002/(SICI)1096-9896(199601)178:1<30::AID-PATH442>3.0.CO;2-7; LIGHTNER VA, 1990, J CELL SCI, V95, P263; Magnusson MK, 1998, ARTERIOSCL THROM VAS, V18, P1363, DOI 10.1161/01.ATV.18.9.1363; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Midwood KS, 2002, MOL BIOL CELL, V13, P3601, DOI 10.1091/mbc.E02-05-0292; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021; Orend G, 2003, ONCOGENE, V22, P3917, DOI 10.1038/sj.onc.1206618; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Ramos DM, 1998, INT J CANCER, V75, P680, DOI 10.1002/(SICI)1097-0215(19980302)75:5<680::AID-IJC4>3.3.CO;2-2; RIOU JF, 1990, DEV BIOL, V137, P305, DOI 10.1016/0012-1606(90)90256-I; ROCCO M, 1983, J BIOL CHEM, V258, P4545; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Sechler JL, 2001, J CELL BIOL, V154, P1081, DOI 10.1083/jcb.200102034; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; To WS, 2010, MATRIX BIOL, V29, P573, DOI 10.1016/j.matbio.2010.08.003; TRESSEL T, 1991, BIOCHEM J, V274, P731, DOI 10.1042/bj2740731; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Wenk MB, 2000, J CELL BIOL, V150, P913, DOI 10.1083/jcb.150.4.913; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; WILSON CL, 1992, J CELL BIOL, V119, P923, DOI 10.1083/jcb.119.4.923	45	16	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14881	14891		10.1074/jbc.M110.189019	http://dx.doi.org/10.1074/jbc.M110.189019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21324901	Green Published, hybrid			2022-12-25	WOS:000289788300018
J	Williams, AL; Bielopolski, N; Meroz, D; Lam, AD; Passmore, DR; Ben-Tal, N; Ernst, SA; Ashery, U; Stuenkel, EL				Williams, Antionette L.; Bielopolski, Noa; Meroz, Daphna; Lam, Alice D.; Passmore, Daniel R.; Ben-Tal, Nir; Ernst, Stephen A.; Ashery, Uri; Stuenkel, Edward L.			Structural and Functional Analysis of Tomosyn Identifies Domains Important in Exocytotic Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; CHROMAFFIN CELLS; CORE COMPLEXES; PROTEIN; MEMBRANE; FUSION; SUMOYLATION; MECHANISMS; EXPRESSION	Tomosyn is a 130-kDa cytosolic R-SNARE protein that associates with Q-SNAREs and reduces exocytotic activity. Two paralogous genes, tomosyn-1 and -2, occur in mammals and produce seven different isoforms via alternative splicing. Here, we map the structural differences between the yeast homologue of m-tomosyn-1, Sro7, and tomosyn genes/isoforms to identify domains critical to the regulation of exocytotic activity to tomosyn that are outside the soluble N-ethylmaleimide-sensitive attachment receptor motif. Homology modeling of m-tomosyn-1 based on the known structure of yeast Sro7 revealed a highly conserved functional conformation but with tomosyn containing three additional loop domains that emanate from a beta-propeller core. Notably, deletion of loops 1 and 3 eliminates tomosyn inhibitory activity on secretion without altering its soluble N-ethylmaleimide-sensitive attachment receptor pairing with syntaxin1A. By comparison, deletion of loop 2, which contains the hypervariable splice region, did not reduce the ability of tomosyn to inhibit regulated secretion. However, exon variation within the hypervariable splice region resulted in significant differences in protein accumulation of tomosyn-2 isoforms. Functional analysis of s-tomosyn-1, m-tomosyn-1, m-tomosyn-2, and xb-tomosyn-2 demonstrated that they exert similar inhibitory effects on elevated K+-induced secretion in PC12 cells, although m-tomosyn-2 was novel in strongly augmenting basal secretion. Finally, we report that m-tomosyn-1 is a target substrate for SUMO 2/3 conjugation and that mutation of this small ubiquitin-related modifier target site (Lys-730) enhances m-tomosyn-1 inhibition of secretion without altering interaction with syntaxin1A. Together these results suggest that multiple domains outside the R-SNARE of tomosyn are critical to the efficacy of inhibition by tomosyn on exocytotic secretion.	[Williams, Antionette L.; Lam, Alice D.; Passmore, Daniel R.; Stuenkel, Edward L.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Mol & Dev Biol, Ann Arbor, MI 48109 USA; [Bielopolski, Noa; Ashery, Uri] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiol, IL-69978 Tel Aviv, Israel; [Meroz, Daphna; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Tel Aviv University; Tel Aviv University	Stuenkel, EL (corresponding author), 7807 Med Sci Bldg 2,1137 E Catherine St, Ann Arbor, MI 48109 USA.	esterm@umich.edu	Williams, Antionette/GQP-2255-2022	Ashery, Uri/0000-0001-6338-7888; Ben-Tal, Nir/0000-0001-6901-832X; Stuenkel, Edward/0000-0001-8225-5725	National Institutes of Health [NS053978]; Tel Aviv University, Tel Aviv, Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tel Aviv University, Tel Aviv, Israel; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS053978. D. M. was supported by the Edmond J. Safra Bioinformatics Program, Tel Aviv University, Tel Aviv, Israel.	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Cheviet S, 2006, J CELL SCI, V119, P2912, DOI 10.1242/jcs.03037; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gangar A, 2005, CURR BIOL, V15, P1136, DOI 10.1016/j.cub.2005.05.046; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Gladycheva SE, 2004, J PHYSIOL-LONDON, V558, P857, DOI 10.1113/jphysiol.2004.067249; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2007, J PHYSIOL-LONDON, V585, P705, DOI 10.1113/jphysiol.2007.138321; Gracheva EO, 2007, J NEUROSCI, V27, P10176, DOI 10.1523/JNEUROSCI.2339-07.2007; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kagami M, 1998, GENETICS, V149, P1717; Katoh M, 2004, INT J ONCOL, V24, P737; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Musch A, 2002, MOL BIOL CELL, V13, P158, DOI 10.1091/mbc.01-10-0496; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sen N, 2010, TRENDS NEUROSCI, V33, P493, DOI 10.1016/j.tins.2010.07.004; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; WICK PF, 1993, J BIOL CHEM, V268, P10983; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Yamamoto Y, 2010, J BIOL CHEM, V285, P40943, DOI 10.1074/jbc.M110.156893; Yamamoto Y, 2010, BIOCHEM BIOPH RES CO, V399, P24, DOI 10.1016/j.bbrc.2010.07.026; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yizhar O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002694; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	53	34	34	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14542	14553		10.1074/jbc.M110.215624	http://dx.doi.org/10.1074/jbc.M110.215624			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330375	hybrid, Green Published			2022-12-25	WOS:000289556200074
J	He, LJ; Shobnam, N; Wimley, WC; Hristova, K				He, Lijuan; Shobnam, Nadia; Wimley, William C.; Hristova, Kalina			FGFR3 Heterodimerization in Achondroplasia, the Most Common Form of Human Dwarfism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTORS; TRANSMEMBRANE DOMAIN; ACANTHOSIS NIGRICANS; CROUZON-SYNDROME; MUTATIONS; ACTIVATION; DIMERIZATION; DISORDERS; ENERGETICS	The G380R mutation in the transmembrane domain of fibroblast growth factor receptor 3 (FGFR3) causes achondroplasia, the most common form of human dwarfism. Achondroplasia is a heterozygous disorder, and thus the affected individuals express both wild-type and mutant FGFR3. Yet heterodimerization in achondroplasia has not been characterized thus far. To investigate the formation of FGFR3 heterodimers in cellular membranes, we designed an FGFR3 construct that lacks the kinase domain, and we monitored the formation of inactive heterodimers between this construct and wild-type and mutant FGFR3. The formation of the inactive heterodimers depleted the pool of full-length receptors capable of forming active homodimers and ultimately reduced their phosphorylation. By analyzing the effect of the truncated FGFR3 on full-length receptor phosphorylation, we demonstrated that FGFR3 WT/G380R heterodimers form with lower probability than wild-type FGFR3 homodimers at low ligand concentration. These results further our knowledge of FGFR3-associated bone disorders.	[He, Lijuan; Shobnam, Nadia; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Wimley, William C.] Tulane Univ, Sch Med, Dept Biochem, New Orleans, LA 70112 USA	Johns Hopkins University; Tulane University	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	kh@jhu.edu	Hristova, Kalina/A-3326-2010		National Institutes of Health [GM068619, GM095930, GM060000]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619, R01GM095930, R01GM060000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM068619, GM095930 (to K. H.), and GM060000 (to W. C. W.).	Bell CA, 2000, MOL BIOL CELL, V11, P3589, DOI 10.1091/mbc.11.10.3589; Bevington P.R., 1969, DATA REDUCTION ERROR; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Han X, 2006, BIOPHYS J, V91, P3736, DOI 10.1529/biophysj.106.092247; Harada D, 2009, J BONE MINER METAB, V27, P9, DOI 10.1007/s00774-008-0009-7; He LJ, 2010, J BIOL CHEM, V285, P30103, DOI 10.1074/jbc.M109.094086; He LJ, 2008, J MOL BIOL, V384, P1130, DOI 10.1016/j.jmb.2008.10.036; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Li E, 2006, J MOL BIOL, V356, P600, DOI 10.1016/j.jmb.2005.11.077; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Li E, 2010, CELL ADHES MIGR, V4, P249, DOI 10.4161/cam.4.2.10725; Li Y, 1997, ONCOGENE, V14, P1397, DOI 10.1038/sj.onc.1200983; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Merzlyakov M, 2006, J MOL BIOL, V358, P1, DOI 10.1016/j.jmb.2006.01.086; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Passos-Bueno MR, 1999, HUM MUTAT, V14, P115; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; PONSETI IV, 1970, J BONE JOINT SURG AM, VA 52, P701, DOI 10.2106/00004623-197052040-00004; Raffioni S, 1998, J BIOL CHEM, V273, P35250, DOI 10.1074/jbc.273.52.35250; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Vajo Z, 2000, ENDOCR REV, V21, P23, DOI 10.1210/er.21.1.23; van Rhijn BWG, 2002, EUR J HUM GENET, V10, P819, DOI 10.1038/sj.ejhg.5200883; WILKIE AOM, 1995, CURR BIOL, V5, P500; You M, 2006, BIOCHEMISTRY-US, V45, P5551, DOI 10.1021/bi060113g	29	30	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13272	13281		10.1074/jbc.M110.205583	http://dx.doi.org/10.1074/jbc.M110.205583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21324899	Green Published, hybrid			2022-12-25	WOS:000289282200048
J	Cao, AR; Rabinovich, R; Xu, MX; Xu, XQ; Jin, VX; Farnham, PJ				Cao, Alina R.; Rabinovich, Roman; Xu, Maoxiong; Xu, Xiaoqin; Jin, Victor X.; Farnham, Peggy J.			Genome-wide Analysis of Transcription Factor E2F1 Mutant Proteins Reveals That N- and C-terminal Protein Interaction Domains Do Not Participate in Targeting E2F1 to the Human Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROFOLATE-REDUCTASE PROMOTER; DNA-BINDING-SITES; FAMILY-MEMBER; IN-VIVO; COMPLEX-FORMATION; EPITHELIAL-CELLS; DP FAMILY; ACTIVATION; GENE; IDENTIFICATION	Previous studies of E2F family members have suggested that protein-protein interactions may be the mechanism by which E2F proteins are recruited to specific genomic regions. We have addressed this hypothesis on a genome-wide scale using ChIP-seq analysis of MCF7 cell lines that express tagged wild type and mutant E2F1 proteins. First, we performed ChIP-seq for tagged WT E2F1. Then, we analyzed E2F1 proteins that lacked the N-terminal SP1 and cyclin A binding domains, the C-terminal transactivation and pocket protein binding domains, and the internal marked box domain. Surprisingly, we found that the ChIP-seq patterns of the mutant proteins were identical to that of WT E2F1. However, mutation of the DNA binding domain abrogated all E2F1 binding to the genome. These results suggested that the interaction between the E2F1 DNA binding domain and a consensus motif may be the primary determinant of E2F1 recruitment. To address this possibility, we analyzed the in vivo binding sites for the in vitro-derived consensus E2F1 motif (TTTSSCGC) and also performed de novo motif analysis. We found that only 12% of the ChIP-seq peaks contained the TTTSSCGC motif. De novo motif analysis indicated that most of the in vivo sites lacked the 5` half of the in vitro-derived consensus, having instead the in vivo consensus of CGCGC. In summary, our findings do not provide support for the model that protein-protein interactions are involved in recruiting E2F1 to the genome, but rather suggest that recognition of a motif found at most human promoters is the critical determinant.	[Farnham, Peggy J.] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Cao, Alina R.; Rabinovich, Roman; Xu, Xiaoqin] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Xu, Maoxiong; Jin, Victor X.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University of Southern California; University of California System; University of California Davis; University System of Ohio; Ohio State University	Farnham, PJ (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Biochem & Mol Biol, 1450 Biggy St,NRT 6503,Mail Code 9601, Los Angeles, CA 90089 USA.	pfarnham@usc.edu		Farnham, Peggy/0000-0003-4469-7914	United States Public Health Service [CA45240, HG004558]; National Institutes of Health [GM007377]; NATIONAL CANCER INSTITUTE [R29CA045240, R01CA045240] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007377] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States Public Health Service Grants CA45240 and HG004558.; Supported in part by National Institutes of Health Molecular and Cellular Biology Training Grant GM007377.	BANDARA LR, 1993, EMBO J, V12, P4317, DOI 10.1002/j.1460-2075.1993.tb06116.x; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Cress WD, 1996, MOL CELL BIOL, V16, P2119; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; DeGregori J, 2006, CURR MOL MED, V6, P739; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; EMILI A, 1995, J BIOL CHEM, V270, P13674, DOI 10.1074/jbc.270.23.13674; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fry CJ, 1999, J BIOL CHEM, V274, P15883, DOI 10.1074/jbc.274.22.15883; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, EMBO J, V23, P1336, DOI 10.1038/sj.emboj.7600134; HAGEMEIER C, 1993, NUCLEIC ACIDS RES, V21, P4998, DOI 10.1093/nar/21.22.4998; Halaban R, 1998, ONCOGENE, V16, P2489, DOI 10.1038/sj.onc.1201773; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1994, J VIROL, V68, P5027, DOI 10.1128/JVI.68.8.5027-5035.1994; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Jin VX, 2009, BIOINFORMATICS, V25, P3191, DOI 10.1093/bioinformatics/btp570; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Karlseder J, 1996, MOL CELL BIOL, V16, P1659; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Lan X, 2011, BIOINFORMATICS, V27, P428, DOI 10.1093/bioinformatics/btq669; Lang SE, 2001, J BIOL CHEM, V276, P32627, DOI 10.1074/jbc.M102067200; Lee TA, 2000, ONCOGENE, V19, P2257, DOI 10.1038/sj.onc.1203556; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Logan N, 2004, ONCOGENE, V23, P5138, DOI 10.1038/sj.onc.1207649; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; MAJELLO B, 1995, ONCOGENE, V10, P1841; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; MEANS AL, 1992, MOL CELL BIOL, V12, P1054, DOI 10.1128/MCB.12.3.1054; Milton A, 2006, ONCOGENE, V25, P3212, DOI 10.1038/sj.onc.1209343; ORMONDROYD E, 1995, ONCOGENE, V11, P1437; Pearson A, 1997, ONCOGENE, V15, P2643, DOI 10.1038/sj.onc.1201451; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Revenko AS, 2010, MOL CELL BIOL, V30, P5260, DOI 10.1128/MCB.00484-10; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogers KT, 1996, P NATL ACAD SCI USA, V93, P7594, DOI 10.1073/pnas.93.15.7594; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; SCHILLING LJ, 1995, CELL GROWTH DIFFER, V6, P541; Schilling Lynda J., 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P19; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Shin EK, 1996, J BIOL CHEM, V271, P12261, DOI 10.1074/jbc.271.21.12261; Slansky JE, 1996, BIOESSAYS, V18, P55, DOI 10.1002/bies.950180111; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Trouche D, 1996, NUCLEIC ACIDS RES, V24, P4139, DOI 10.1093/nar/24.21.4139; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10321, DOI 10.1073/pnas.93.19.10321; WADE M, 1995, J BIOL CHEM, V270, P9783, DOI 10.1074/jbc.270.17.9783; WADE M, 1992, MOL CELL BIOL, V12, P4364, DOI 10.1128/MCB.12.10.4364; WU CL, 1995, MOL CELL BIOL, V15, P2536; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; ZHANG YH, 1995, ONCOGENE, V10, P2085; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	74	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.217158	http://dx.doi.org/10.1074/jbc.M110.217158			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310950	hybrid, Green Published			2022-12-25	WOS:000289077500012
J	Xiao, KH; Shenoy, SK				Xiao, Kunhong; Shenoy, Sudha K.			beta(2)-Adrenergic Receptor Lysosomal Trafficking Is Regulated by Ubiquitination of Lysyl Residues in Two Distinct Receptor Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AGONIST-PROMOTED UBIQUITINATION; CLATHRIN-MEDIATED ENDOCYTOSIS; BETA-ADRENERGIC-RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; 7-TRANSMEMBRANE RECEPTORS; SIGNALING PATHWAYS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; DOWN-REGULATION	Agonist stimulation of the beta(2)-adrenergic receptors (beta(2)ARs) leads to their ubiquitination and lysosomal degradation. Inhibition of lysosomal proteases results in the stabilization and retention of internalized full-length beta(2)ARs in the lysosomes, whereas inhibition of proteasomal proteases stabilizes newly synthesized beta(2)ARs in nonlysosomal compartments. Additionally, a lysine-less beta(2)AR(0K-beta(2)AR) that is deficient in ubiquitination and degradation is not sorted to lysosomes unlike the WT beta(2)AR, which is sorted to lysosomes. Thus, lysosomes are the primary sites for the degradation of agonist-activated, ubiquitinated beta(2)ARs. To identify the specific site(s) of ubiquitination required for lysosomal sorting of the beta(2)AR, four mutants, with lysines only in one intracellular domain, namely, loop 1, loop 2, loop 3, and carboxyl tail were generated. All of these receptor mutants coupled to G proteins, recruited beta-arrestin2, and internalized just as the WT beta(2)AR. However, only loop 3 and carboxyl tail beta(2)ARs with lysines in the third intracellular loop or in the carboxyl tail were ubiquitinated and sorted for lysosomal degradation. As a complementary approach, we performed MS-based proteomic analyses to directly identify ubiquitination sites within the beta(2)AR. We overexpressed and purified the beta(2)AR from HEK-293 cells with or without prior agonist exposure and subjected trypsin-cleaved beta(2)AR to LC-MS/MS analyses. We identified ubiquitinated lysines in the third intracellular loop (Lys-263 and Lys-270) and in the carboxyl tail (Lys-348, Lys-372, and Lys-375) of the beta(2)AR. These findings introduce a new concept that two distinct domains in the beta(2)AR are involved in ubiquitination and lysosomal degradation, contrary to the generalization that such regulatory mechanisms occur mainly at the carboxyl tails of GPCRs and other transmembrane receptors.	[Xiao, Kunhong] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Duke University; Duke University	Xiao, KH (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	khxiao@receptor-biol.duke.edu; sudha@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; Xiao, Kunhong/AAG-4275-2020	Shenoy, Sudha/0000-0002-2565-4663; Xiao, Kunhong/0000-0002-1069-1226	National Institutes of Health [HL080525]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080525 (to S. K. S.).	BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; BARAK LS, 1994, J BIOL CHEM, V269, P2790; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; CARON MG, 1979, J BIOL CHEM, V254, P2923; Chakir K, 2003, MOL PHARMACOL, V64, P1048, DOI 10.1124/mol.64.5.1048; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Freeman K, 2001, J CLIN INVEST, V107, P967, DOI 10.1172/JCI12083; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hall RA, 2004, SEMIN CELL DEV BIOL, V15, P281, DOI 10.1016/j.semcdb.2003.12.017; Hanania NA, 2010, CURR OPIN PULM MED, V16, P1, DOI 10.1097/MCP.0b013e328333def8; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Lefkowitz RJ, 2008, NAT BIOTECHNOL, V26, P189, DOI 10.1038/nbt0208-189; Liang W, 2008, BIOCHEMISTRY-US, V47, P11750, DOI 10.1021/bi800219q; Lin FT, 1997, J BIOL CHEM, V272, P31051, DOI 10.1074/jbc.272.49.31051; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Moore RH, 1999, J CELL SCI, V112, P329; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; Parola AL, 1997, ANAL BIOCHEM, V254, P88, DOI 10.1006/abio.1997.2361; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shenoy SK, 2009, P NATL ACAD SCI USA, V106, P6650, DOI 10.1073/pnas.0901083106; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Walker JKL, 1999, J BIOL CHEM, V274, P31515, DOI 10.1074/jbc.274.44.31515; Wojcikiewicz RJH, 2004, TRENDS PHARMACOL SCI, V25, P35, DOI 10.1016/j.tips.2003.11.008; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	65	40	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.203091	http://dx.doi.org/10.1074/jbc.M110.203091			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330366	Green Published, hybrid			2022-12-25	WOS:000289077500089
J	Alard, JE; Hillion, S; Guillevin, L; Saraux, A; Pers, JO; Youinou, P; Jamin, C				Alard, Jean-Eric; Hillion, Sophie; Guillevin, Loic; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe			Autoantibodies to Endothelial Cell Surface ATP Synthase, the Endogenous Receptor for Hsp60, Might Play a Pathogenic Role in Vasculatides	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; SYSTEMIC AUTOIMMUNE-DISEASES; RENAL TUBULAR-ACIDOSIS; SJOGRENS-SYNDROME; INTRACELLULAR PH; FLOW-CYTOMETRY; ANTIBODIES; VASCULITIS; HEAT-SHOCK-PROTEIN-60; APOPTOSIS	Background: Heat shock protein (hsp) 60 that provides "danger signal" binds to the surface of resting endothelial cells (EC) but its receptor has not yet been characterized. In mitochondria, hsp60 specifically associates with adenosine triphosphate (ATP) synthase. We therefore examined the possible interaction between hsp60 and ATP synthase on EC surface. Methodology/Principal Findings: Using Far Western blot approach, co-immunoprecipitation studies and surface plasmon resonance analyses, we demonstrated that hsp60 binds to the beta-subunit of ATP synthase. As a cell surface-expressed molecule, ATP synthase is potentially targeted by anti-EC-antibodies (AECAs) found in the sera of patients suffering vasculitides. Based on enzyme-linked immunosorbent assay and Western blotting techniques with F1-ATP synthase as substrate, we established the presence of anti-ATP synthase antibodies at higher frequency in patients with primary vasculitides (group I) compared with secondary vasculitides (group II). Anti-ATP synthase reactivity from group I patients was restricted to the beta-subunit of ATP synthase, whereas those from group II was directed to the alpha-, beta- and gamma-subunits. Cell surface ATP synthase regulates intracellular pH (pHi). In low extracellular pH medium, we detected abnormal decreased of EC pHi in the presence of anti-ATP synthase antibodies, irrespective of their fine reactivities. Interestingly, soluble hsp60 abrogated the anti-ATP synthase-induced pHi down-regulation. Conclusions/Significance: Our results indicate that ATP synthase is targeted by AECAs on the surface of EC that induce intracellular acidification. Such pathogenic effect in vasculitides can be modulated by hsp60 binding on ATP synthase which preserves ATP synthase activity.	[Alard, Jean-Eric; Hillion, Sophie; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Univ Brest, EA2216 Immunol & Pathol, Brest, France; [Alard, Jean-Eric; Hillion, Sophie; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Univ Brest, IFR SclnBioS 148, Brest, France; [Alard, Jean-Eric; Hillion, Sophie; Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Univ Europeenne Bretagne, Brest, France; [Guillevin, Loic] Hop Cochin, Dept Internal Med, F-75674 Paris, France; [Saraux, Alain; Pers, Jacques-Olivier; Youinou, Pierre; Jamin, Christophe] Ctr Hosp Univ, Brest, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; Universite de Bretagne Occidentale	Alard, JE (corresponding author), Univ Brest, EA2216 Immunol & Pathol, Brest, France.	youinou@univ-brest.fr	HILLION, Sophie/I-9747-2019; Pers, Jacques-Olivier/AGG-7221-2022	Hillion, Sophie/0000-0002-3354-0981	Conseil regional de Bretagne	Conseil regional de Bretagne(Region Bretagne)	Jean-Eric Alard was supported by the "Conseil regional de Bretagne". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alard JE, 2008, CLIN REV ALLERG IMMU, V35, P66, DOI 10.1007/s12016-007-8062-x; Alard JE, 2007, AUTOIMMUN REV, V6, P438, DOI 10.1016/j.autrev.2007.01.012; Alard JE, 2009, FASEB J, V23, P2772, DOI 10.1096/fj.08-128785; Alessandri C, 2006, ADV CLIN CHEM, V42, P297, DOI 10.1016/S0065-2423(06)42008-4; Arakaki N, 2003, MOL CANCER RES, V1, P931; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Binder RJ, 2004, TISSUE ANTIGENS, V64, P442, DOI 10.1111/j.1399-0039.2004.00299.x; BREEDVELD FC, 1986, ARCH INTERN MED, V146, P1009, DOI 10.1001/archinte.146.5.1009; Champagne E, 2006, CURR OPIN LIPIDOL, V17, P279, DOI 10.1097/01.mol.0000226120.27931.76; Chi SL, 2007, CANCER RES, V67, P4716, DOI 10.1158/0008-5472.CAN-06-1094; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Domiciano DS, 2009, LUPUS, V18, P1233, DOI 10.1177/0961203309346654; Dubaniewicz A, 2010, AUTOIMMUN REV, V9, P419, DOI 10.1016/j.autrev.2009.11.015; Franck P, 1996, J BIOTECHNOL, V46, P187, DOI 10.1016/0168-1656(95)00189-1; George J, 1999, ARTERIOSCL THROM VAS, V19, P505, DOI 10.1161/01.ATV.19.3.505; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Guilpain P, 2008, CLIN REV ALLERG IMMU, V35, P59, DOI 10.1007/s12016-007-8069-3; GUR H, 1987, ANN RHEUM DIS, V46, P617, DOI 10.1136/ard.46.8.617; Habich C, 2007, CELL MOL LIFE SCI, V64, P742, DOI 10.1007/s00018-007-6413-7; Habich C, 2002, J IMMUNOL, V168, P569, DOI 10.4049/jimmunol.168.2.569; Jamin C, 2005, ARTHRITIS RHEUM-US, V52, P4028, DOI 10.1002/art.21401; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; KALDI K, 1994, BIOCHEM J, V301, P329, DOI 10.1042/bj3010329; Marches R, 2001, P NATL ACAD SCI USA, V98, P3434, DOI 10.1073/pnas.061028998; Mavragani CP, 2006, NAT CLIN PRACT RHEUM, V2, P252, DOI 10.1038/ncprheum0165; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; PRASAD TK, 1990, MOL CELL BIOL, V10, P3979, DOI 10.1128/MCB.10.8.3979; Radojkovic C, 2009, ARTERIOSCL THROM VAS, V29, P1125, DOI 10.1161/ATVBAHA.109.187997; Rajaiah R, 2009, AUTOIMMUN REV, V8, P388, DOI 10.1016/j.autrev.2008.12.004; Revelen R, 2002, CLIN EXP RHEUMATOL, V20, P19; Revelen R, 2000, CLIN CHEM, V46, P273; Ronda N, 2007, AUTOANTIBODIES, 2ND EDITION, P725, DOI 10.1016/B978-044452763-9/50094-9; Savage COS, 2000, BRIT MED J, V320, P1325, DOI 10.1136/bmj.320.7245.1325; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Soy M, 2005, RHEUMATOL INT, V26, P86, DOI 10.1007/s00296-005-0587-9; Sprenger RR, 2004, ELECTROPHORESIS, V25, P156, DOI 10.1002/elps.200305675; STATER EC, 1967, METHOD ENZYMOL, V10, P48; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; VACIRCA D, 2010, AUTOANTIBODIES ADENO, DOI DOI 10.1016/J.NEUROBIOLAGING.2010.05.013; Wahl ML, 2002, ENDOTHELIUM-J ENDOTH, V9, P205, DOI 10.1080/10623320213633; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644; Wick MC, 2008, CELL STRESS CHAPERON, V13, P275, DOI 10.1007/s12192-008-0044-2; XU QB, 1992, ARTERIOSCLER THROMB, V12, P789, DOI 10.1161/01.ATV.12.7.789; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Zheng JB, 1999, BIOCHEM BIOPH RES CO, V261, P499, DOI 10.1006/bbrc.1999.1063	45	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2011	6	2							e14654	10.1371/journal.pone.0014654	http://dx.doi.org/10.1371/journal.pone.0014654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IO	21326874	Green Published, Green Submitted, gold			2022-12-25	WOS:000287037100002
J	Lee, JP; Bae, JB; Yang, SH; Cha, RH; Seong, EY; Park, YJ; Ha, J; Park, MH; Paik, JH; Kim, YS				Lee, Jung Pyo; Bae, Jong Bin; Yang, Seung Hee; Cha, Ran-hui; Seong, Eun Young; Park, Yang Jin; Ha, Jongwon; Park, Myoung Hee; Paik, Jin Ho; Kim, Yon Su			Genetic Predisposition of Donors Affects the Allograft Outcome in Kidney Transplantation; Polymorphisms of Stromal-Derived Factor-1 and CXC Receptor 4	PLOS ONE			English	Article							PROGENITOR-CELL RECRUITMENT; CXCL12-G801A POLYMORPHISM; CHEMOKINE RECEPTORS; SDF-1; EXPRESSION; REJECTION; INJURY; LIVER; IMPACT; CANCER	Genetic interaction between donor and recipient may dictate the impending responses after transplantation. In this study, we evaluated the role of the genetic predispositions of stromal-derived factor-1 (SDF1) [rs1801157 (G>A)] and CXC receptor 4 (CXCR4) [rs2228014 (C>T)] on renal allograft outcomes. A total of 335 pairs of recipients and donors were enrolled. Biopsy-proven acute rejection (BPAR) and long-term graft survival were traced. Despite similar allele frequencies between donors and recipients, minor allele of SDF1 rs1801157 (GA+AA) from donor, not from recipients, has a protective effect on the development of BPAR compared to wild type donor (GG) (P = 0.005). Adjustment for multiple covariates did not affect this result (odds ratio 0.39, 95% C.I 0.20-0.76, P = 0.006). CXCR4 rs2228014 polymorphisms from donor or recipient did not affect the incidence of acute rejection. SDF1 was differentially expressed in renal tubular epithelium with acute rejection according to genetic variations of donor rs1801157 showing higher expressions in the grafts from GG donors. Contrary to the development of BPAR, the presence of minor allele rs1801157 A, especially homozygocity, predisposed poor graft survival (P = 0.001). This association was significant after adjusting for several risk factors (hazard ratio 3.01; 95% C.I = 1.19-7.60; P = 0.020). The allelic variation of recipients, however, was not associated with graft loss. A donor-derived genetic polymorphism of SDF1 has influenced the graft outcome. Thus, the genetic predisposition of donor should be carefully considered in transplantation.	[Lee, Jung Pyo; Yang, Seung Hee; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Cha, Ran-hui] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Seong, Eun Young] Pusan Natl Univ, Sch Med, Dept Internal Med, Pusan, South Korea; [Park, Yang Jin; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Park, Myoung Hee] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Park, Myoung Hee] Seoul Natl Univ, Clin Res Inst, Seoul, South Korea; [Paik, Jin Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University; Pusan National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, JP (corresponding author), Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea.	yonsukim@snu.ac.kr	Ha, Jong Won/E-3893-2012; Park, Myoung Hee/J-5483-2012; Kim, Yon Su/J-2743-2012		Ministry of Health and Welfare, Republic of Korea [03-PJ10-PG13-GD01-0002]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Health 21 R&D project. Ministry of Health and Welfare, Republic of Korea (03-PJ10-PG13-GD01-0002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Cha RH, 2009, NEPHROL DIAL TRANSPL, V24, P2919, DOI 10.1093/ndt/gfp317; Chang SC, 2009, ANN SURG ONCOL, V16, P2323, DOI 10.1245/s10434-009-0501-x; Ghilardi G, 2008, CYTOKINE, V41, P24, DOI 10.1016/j.cyto.2007.10.007; Goddard S, 2001, TRANSPLANTATION, V72, P1957, DOI 10.1097/00007890-200112270-00016; Halloran PF, 2001, AM J PATHOL, V158, P215, DOI 10.1016/S0002-9440(10)63960-0; Hirata H, 2007, CLIN CANCER RES, V13, P5056, DOI 10.1158/1078-0432.CCR-07-0859; Hoffmann U, 2006, CLIN TRANSPLANT, V20, P712, DOI 10.1111/j.1399-0012.2006.00540.x; Khademi B, 2008, PATHOL ONCOL RES, V14, P45, DOI 10.1007/s12253-008-9007-2; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kucia M, 2004, J MOL HISTOL, V35, P233; NAUMANN U, PLOS ONE, V5, pE9175; Neusser MA, 2010, KIDNEY INT, V77, P801, DOI 10.1038/ki.2010.6; Ponziani V, 2008, LEUKEMIA, V22, P669, DOI 10.1038/sj.leu.2404938; Rabin RL, 1999, J IMMUNOL, V162, P3840; Schroppel B, 2002, AM J TRANSPLANT, V2, P640, DOI 10.1034/j.1600-6143.2002.20709.x; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	23	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16710	10.1371/journal.pone.0016710	http://dx.doi.org/10.1371/journal.pone.0016710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304904	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036600016
J	Wang, GZ; Luo, HY; Meng, K; Wang, YR; Huang, HQ; Shi, PJ; Pan, X; Yang, PL; Diao, QY; Zhang, HF; Yao, B				Wang, Guozeng; Luo, Huiying; Meng, Kun; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Pan, Xia; Yang, Peilong; Diao, Qiyu; Zhang, Hongfu; Yao, Bin			High Genetic Diversity and Different Distributions of Glycosyl Hydrolase Family 10 and 11 Xylanases in the Goat Rumen	PLOS ONE			English	Article							BACTERIAL COMMUNITY; LIGNIN REMOVAL; DIRECT CLONING; EXPRESSION; PROTEIN; METAGENOMICS; MULTIPLICITY; SPECIFICITY; STRAINS; PROGRAM	Background: The rumen harbors a complex microbial ecosystem for efficient hydrolysis of plant polysaccharides which are the main constituent of the diet. Xylanase is crucial for hemicellulose hydrolysis and plays an important role in the plant cell wall degradation. Xylanases of ruminal strains were widely studied, but few studies have focused on their diversity in rumen microenvironment. Methodology/Principal Findings: We explored the genetic diversity of xylanases belonging to two major glycosyl hydrolase families (GH 10 and 11) in goat rumen contents by analyzing the amplicons generated with two degenerate primer sets. Fifty-two distinct GH 10 and 35 GH 11 xylanase gene fragments (similarity <95%) were retrieved, and most had low identities with known sequences. Based on phylogenetic analysis, all GH 10 xylanase sequences fell into seven clusters, and 88.5% of them were related to xylanases from Bacteroidetes. Five clusters of GH 11 xylanase sequences were identified. Of these, 85.7% were related to xylanases from Firmicutes, and 14.3% were related to those of rumen fungi. Two full-length xylanase genes (one for each family) were directly cloned and expressed in Escherichia coli. Both the recombinant enzymes showed substantial xylanase activity, and were purified and characterized. Combined with the results of sheep rumen, Bacteroidetes and Firmicutes are the two major phyla of xylan-degrading microorganisms in rumen, which is distinct from the representatives of other environments such as soil and termite hindgut, suggesting that xylan-degrading microorganisms are environment specific. Conclusion/Significance: The numerous new xylanase genes suggested the functional diversity of xylanase in the rumen microenvironment which may have great potential applications in industry and agriculture. The phylogenetic diversity and different distributions of xylanase genes will help us understand their roles in plant cell wall degradation in the rumen microenvironment.	[Wang, Guozeng; Luo, Huiying; Meng, Kun; Wang, Yaru; Huang, Huoqing; Shi, Pengjun; Pan, Xia; Yang, Peilong; Diao, Qiyu; Yao, Bin] Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China; [Zhang, Hongfu] Chinese Acad Agr Sci, State Key Lab Anim Nutr, Inst Anim Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Wang, GZ (corresponding author), Chinese Acad Agr Sci, Key Lab Feed Biotechnol, Minist Agr, Feed Res Inst, Beijing, Peoples R China.	yaobin@caas-bio.net.cn		Wang, Guozeng/0000-0001-6547-0490	Key Program of Transgenic Plant Breeding [2008ZX08011-005]; Earmarked Fund for Modern Agro-industry Technology Research System [NYCYTX-42-G2-05]; Agricultural Science and Technology Conversion Funds [2008GB23260388]	Key Program of Transgenic Plant Breeding; Earmarked Fund for Modern Agro-industry Technology Research System; Agricultural Science and Technology Conversion Funds	This work was supported by the Key Program of Transgenic Plant Breeding (2008ZX08011-005), the Earmarked Fund for Modern Agro-industry Technology Research System (NYCYTX-42-G2-05), and the Agricultural Science and Technology Conversion Funds (grant 2008GB23260388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Bunzel M, 2003, ERNAHRUNGS UMSCHAU, V50, P469; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Dalrymple BP, 1999, APPL ENVIRON MICROB, V65, P3660; de Segura BG, 1998, FEMS MICROBIOL LETT, V164, P47, DOI 10.1111/j.1574-6968.1998.tb13066.x; Dehority BA, 2000, APPL ENVIRON MICROB, V66, P2921, DOI 10.1128/AEM.66.7.2921-2927.2000; Dick LK, 2005, APPL ENVIRON MICROB, V71, P3184, DOI 10.1128/AEM.71.6.3184-3191.2005; Dodd D, 2009, J BACTERIOL, V191, P3328, DOI 10.1128/JB.01628-08; Edwards JE, 2004, ANTON LEEUW INT J G, V86, P263, DOI 10.1023/B:ANTO.0000047942.69033.24; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Flint HJ, 1997, BBA-PROTEIN STRUCT M, V1337, P161, DOI 10.1016/S0167-4838(96)00213-0; FLINT HJ, 1994, CURR MICROBIOL, V29, P139, DOI 10.1007/BF01570754; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; GASPARIC A, 1995, APPL ENVIRON MICROB, V61, P2958, DOI 10.1128/AEM.61.8.2958-2964.1995; GILBERT HJ, 1992, MOL MICROBIOL, V6, P2065, DOI 10.1111/j.1365-2958.1992.tb01379.x; Guo B, 2009, APPL MICROBIOL BIOT, V84, P1107, DOI 10.1007/s00253-009-2056-y; Hayashi H, 2005, CAN J MICROBIOL, V51, P251, DOI 10.1139/W04-136; Hopkins MJ, 2001, GUT, V48, P198, DOI 10.1136/gut.48.2.198; Huang HQ, 2010, APPL MICROBIOL BIOT, V87, P1141, DOI 10.1007/s00253-010-2613-4; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; KOPECNY J, 1988, FOLIA MICROBIOL, V33, P208, DOI 10.1007/BF02925906; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Leser TD, 2000, APPL ENVIRON MICROB, V66, P3290, DOI 10.1128/AEM.66.8.3290-3296.2000; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JR, 2005, FEMS MICROBIOL LETT, V251, P233, DOI 10.1016/j.femsle.2005.08.008; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Miller MEB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006650; Morrison M, 2010, MICROB ECOL, V59, P212, DOI 10.1007/s00248-009-9562-4; Ohgren K, 2007, BIORESOURCE TECHNOL, V98, P2503, DOI 10.1016/j.biortech.2006.09.003; Qi M, 2008, APPL ENVIRON MICROB, V74, P987, DOI 10.1128/AEM.02514-07; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shi PJ, 2008, LETT APPL MICROBIOL, V46, P132, DOI 10.1111/j.1472-765X.2007.02274.x; Singh B, 2008, ANAEROBE, V14, P138, DOI 10.1016/j.anaerobe.2008.03.002; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weimer PJ, 2010, J DAIRY SCI, V93, P5902, DOI 10.3168/jds.2010-3500; Wouters J, 2001, ACTA CRYSTALLOGR D, V57, P1813, DOI 10.1107/S0907444901015153; Yang B, 2004, BIOTECHNOL BIOENG, V86, P88, DOI 10.1002/bit.20043	48	18	22	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16731	10.1371/journal.pone.0016731	http://dx.doi.org/10.1371/journal.pone.0016731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304822	Green Submitted, Green Published, gold			2022-12-25	WOS:000287036600018
J	Yamamoto, M; Kondo, E; Takeuchi, M; Harashima, A; Otani, T; Tsuji-Takayama, K; Yamasaki, F; Kumon, H; Kibata, M; Nakamura, S				Yamamoto, Mayuko; Kondo, Eisaku; Takeuchi, Makoto; Harashima, Akira; Otani, Takeshi; Tsuji-Takayama, Kazue; Yamasaki, Fumiyuki; Kumon, Hiromi; Kibata, Masayoshi; Nakamura, Shuji			miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3; UMBILICAL-CORD BLOOD; T-CELL LINES; OXIDATIVE STRESS; FOXP3 EXPRESSION; MESSENGER-RNA; TARGET GENES; REG-CELLS; MICRORNAS; ACTIVATION	MicroRNAs (miRNAs) play important roles in regulating post-transcriptional gene repression in a variety of immunological processes. In particular, much attention has been focused on their roles in regulatory T (Treg) cells which are crucial for maintaining peripheral tolerance and controlling T cell responses. Recently, we established a novel type of human Treg cell line, termed HOZOT, multifunctional cells exhibiting a CD4(+) CD8(+) phenotype. In this study, we performed miRNA profiling to identify signature miRNAs of HOZOT, and therein identified miR-155. Although miR-155 has also been characterized as a signature miRNA for FOXP3(+) natural Treg (nTreg) cells, it was expressed quite differently in HOZOT cells. Under both stimulatory and non-stimulatory conditions, miR-155 expression remained at low levels in HOZOT, while its expression in nTreg and conventional T cells remarkably increased after stimulation. We next searched candidate target genes of miR-155 through bioinformatics, and identified FOXO3a, a negative regulator of Akt signaling, as a miR-155 target gene. Further studies by gain-and loss-of-function experiments supported a role for miR-155 in the regulation of FOXO3a protein expression in conventional T and HOZOT cells.	[Yamamoto, Mayuko; Takeuchi, Makoto; Harashima, Akira; Otani, Takeshi; Tsuji-Takayama, Kazue; Kibata, Masayoshi; Nakamura, Shuji] Hayashibara Biochem Labs Inc, Res Ctr, Inst Cell Biol, Okayama, Japan; [Kondo, Eisaku] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol, Okayama, Japan; [Kondo, Eisaku] Aichi Canc Ctr Res Inst, Div Oncol Pathol, Nagoya, Aichi, Japan; [Yamasaki, Fumiyuki] Kurashiki Med Ctr, Kurashiki, Okayama, Japan; [Kumon, Hiromi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama, Japan	Hayashibara Biochemical Laboratories, Inc.; Okayama University; Aichi Cancer Center; Okayama University	Yamamoto, M (corresponding author), Hayashibara Biochem Labs Inc, Res Ctr, Inst Cell Biol, Okayama, Japan.	m_yamamoto@hayashibara.co.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [50019]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by a grant from the Special Coordination Funds for Promoting Science and Technology of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)'s FY2006 "Creation of Innovation Centers for Advanced Interdisciplinary Research Areas" (project; 50019) Scheme in Japan (http://okayama-u.net/medic/icont/english/mainpage/programe.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Harashima A, 2002, BLOOD, V100, P4440, DOI 10.1182/blood-2002-03-0864; Harashima A, 2009, MOL IMMUNOL, V46, P3310, DOI 10.1016/j.molimm.2009.07.023; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakamura S, 2007, EXP HEMATOL, V35, P287, DOI 10.1016/j.exphem.2006.10.011; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Sugimoto A, 2009, EXP HEMATOL, V37, P1454, DOI 10.1016/j.exphem.2009.10.002; Suzuki M, 2009, EXP HEMATOL, V37, P92, DOI 10.1016/j.exphem.2008.09.010; Tait ED, 2009, NAT IMMUNOL, V10, P457, DOI 10.1038/ni0509-457; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Tsuji-Takayama K, 2008, EXP HEMATOL, V36, P181, DOI 10.1016/j.exphem.2007.09.010; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Yamamoto M, 2008, LEUKEMIA RES, V32, P651, DOI 10.1016/j.leukres.2007.08.020; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	44	44	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16841	10.1371/journal.pone.0016841	http://dx.doi.org/10.1371/journal.pone.0016841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304824	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600031
J	Hoye, BJ; Buttemer, WA				Hoye, Bethany J.; Buttemer, William A.			Inexplicable Inefficiency of Avian Molt? Insights from an Opportunistically Breeding Arid-Zone Species, Lichenostomus penicillatus	PLOS ONE			English	Article							WHITE-CROWNED SPARROWS; FEMALE PIED FLYCATCHERS; BASAL METABOLIC-RATE; TRADE-OFF; REPRODUCTIVE SUCCESS; PASSER-DOMESTICUS; BODY-COMPOSITION; SEASONAL-CHANGES; IMMUNE FUNCTION; PARENTAL CARE	The majority of bird species studied to date have molt schedules that are not concurrent with other energy demanding life history stages, an outcome assumed to arise from energetic trade-offs. Empirical studies reveal that molt is one of the most energetically demanding and perplexingly inefficient growth processes measured. Furthermore, small birds, which have the highest mass-specific basal metabolic rates (BMRm), have the highest costs of molt per gram of feathers produced. However, many small passerines, including white-plumed honeyeaters (WPHE; Lichenostomus penicillatus), breed in response to resource availability at any time of year, and do so without interrupting their annual molt. We examined the energetic cost of molt in WPHE by quantifying weekly changes in minimum resting metabolic rate (RMRmin) during a natural-molt period in 7 wild-caught birds. We also measured the energetic cost of feather replacement in a second group of WPHEs that we forced to replace an additional 25% of their plumage at the start of their natural molt period. Energy expenditure during natural molt revealed an energy conversion efficiency of just 6.9% (+/- 0.57) close to values reported for similar-sized birds from more predictable north-temperate environments. Maximum increases in RMRmin during the molt of WPHE, at 82% (+/- 5.59) above individual pre-molt levels, were some of the highest yet reported. Yet RMRmin maxima during molt were not coincident with the peak period of feather replacement in naturally molting or plucked birds. Given the tight relationship between molt efficiency and mass-specific metabolic rate in all species studied to date, regardless of life-history pattern (Efficiency (%) = 35.720.10(-0.494BMRm); r(2) = 0.944; p = <0.0001), there appears to be concomitant physiological costs entrained in the molt period that is not directly due to feather replacement. Despite these high total expenditures, the protracted molt period of WPHE significantly reduces these added costs on a daily basis.	[Hoye, Bethany J.; Buttemer, William A.] Univ Wollongong, Inst Conservat Biol, Sch Biol Sci, Wollongong, NSW, Australia; [Hoye, Bethany J.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Buttemer, William A.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Waurn Ponds, Vic, Australia	University of Wollongong; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Hoye, BJ (corresponding author), Univ Wollongong, Inst Conservat Biol, Sch Biol Sci, Wollongong, NSW, Australia.	b.hoye@nioo.knaw.nl	Buttemer, William A/F-9573-2019; Hoye, Bethany J/A-4486-2010; Bond, Alexander L/A-3786-2010	Buttemer, William A/0000-0003-3176-4452; Hoye, Bethany J/0000-0001-9502-5582; 	Australian Research Council [DP0453021]; Institute for Conservation Biology at the University of Wollongong	Australian Research Council(Australian Research Council); Institute for Conservation Biology at the University of Wollongong	The Australian Research Council (DP0453021) and the Institute for Conservation Biology at the University of Wollongong contributed funds for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alodan MA, 1999, POULTRY SCI, V78, P171, DOI 10.1093/ps/78.2.171; Astheimer LB, 2002, EMU, V102, P19, DOI 10.1071/MU01031; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; Bourgeon S, 2007, ECOSCIENCE, V14, P519, DOI 10.2980/1195-6860(2007)14[519:HAILIK]2.0.CO;2; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; BUTTEMER WA, 1991, J COMP PHYSIOL B, V161, P427; Buttemer WA, 2003, J COMP PHYSIOL B, V173, P223, DOI 10.1007/s00360-003-0326-z; Buttemer WA, 2000, J AVIAN BIOL, V31, P479, DOI 10.1034/j.1600-048X.2000.310407.x; Chapman A, 1995, TROP ZOOL, V8, P227, DOI 10.1080/03946975.1995.10539283; CHILGREN JD, 1977, AUK, V94, P677, DOI 10.2307/4085264; CHILGREN JD, 1977, AUK, V94, P169; CRAIG A, 1983, IBIS, V125, P346, DOI 10.1111/j.1474-919X.1983.tb03120.x; Dawson A, 2003, IBIS, V145, pE69, DOI 10.1046/j.1474-919X.2003.00161.x; DEGRAW WA, 1985, COMP BIOCHEM PHYS A, V81, P889, DOI 10.1016/0300-9629(85)90925-9; DIETZ MW, 1992, PHYSIOL ZOOL, V65, P1217, DOI 10.1086/physzool.65.6.30158276; FARNER DS, 1960, ANAT REC, V137, P354; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Freed LA, 2005, CONDOR, V107, P753, DOI 10.1650/7820.1; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hahn TP, 1998, ECOLOGY, V79, P2365, DOI 10.1890/0012-9658(1998)079[2365:RSIAOB]2.0.CO;2; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hemborg C, 1999, ANN ZOOL FENN, V36, P1; Hemborg C, 2001, OECOLOGIA, V129, P206, DOI 10.1007/s004420100710; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Jacobs JD, 2000, CONDOR, V102, P35, DOI 10.1650/0010-5422(2000)102[0035:ECOLCS]2.0.CO;2; KEAST A, 1968, J ZOOL, V155, P185; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; Macdonald BCT, 2000, RANGELAND J, V22, P5, DOI 10.1071/RJ0000005; Martin LB, 2005, CAN J ZOOL, V83, P780, DOI 10.1139/Z05-062; Murphy Mary E., 1996, P158; MURPHY ME, 1995, COMP BIOCHEM PHYS A, V111, P385, DOI 10.1016/0300-9629(95)00039-A; MURPHY ME, 1992, ORNIS SCAND, V23, P304, DOI 10.2307/3676654; Nava MP, 2001, CAN J ZOOL, V79, P145, DOI 10.1139/cjz-79-1-145; Newton I, 2005, IBIS, V147, P667, DOI 10.1111/j.1474-919X.2005.00439.x; NEWTON I, 1968, CONDOR, V70, P323, DOI 10.2307/1365926; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Pap PL, 2010, ARDEA, V98, P105, DOI 10.5253/078.098.0113; Portugal SJ, 2007, J EXP BIOL, V210, P1391, DOI 10.1242/jeb.004598; Ricklefs RE, 2000, CONDOR, V102, P9, DOI 10.1650/0010-5422(2000)102[0009:DDEOAT]2.0.CO;2; Sanz JJ, 1997, J AVIAN BIOL, V28, P157, DOI 10.2307/3677309; SCHIELTZ PC, 1995, COMP BIOCHEM PHYS A, V112, P265, DOI 10.1016/0300-9629(95)00097-6; Schmidt-Nielsen K, 1979, ANIMAL PHYSL; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Silverin B, 1999, J AVIAN BIOL, V30, P255, DOI 10.2307/3677351; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; Svensson E, 1997, BEHAV ECOL, V8, P92, DOI 10.1093/beheco/8.1.92; WARD P, 1968, IBIS, V110, P203, DOI 10.1111/j.1474-919X.1968.tb00443.x; WIJANDTS H, 1984, ARDEA, V72, P1; Wikelski M, 2008, PHILOS T R SOC B, V363, P411, DOI 10.1098/rstb.2007.2147; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; YOUNG VR, 1992, ENERGY METABOLISM, P439; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; [No title captured]	57	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16230	10.1371/journal.pone.0016230	http://dx.doi.org/10.1371/journal.pone.0016230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311594	Green Published, gold			2022-12-25	WOS:000287036200009
J	Laidre, ME				Laidre, Mark E.			Meaningful Gesture in Monkeys? Investigating whether Mandrills Create Social Culture	PLOS ONE			English	Article							CHIMPANZEES PAN-TROGLODYTES; WILD CHIMPANZEES; ANIMAL CULTURES; CAPTIVE CHIMPANZEES; CUSTOM; IMITATION; SPHINX; COMMUNICATION; TRANSMISSION; CONVENTIONS	Background: Human societies exhibit a rich array of gestures with cultural origins. Often these gestures are found exclusively in local populations, where their meaning has been crafted by a community into a shared convention. In nonhuman primates like African monkeys, little evidence exists for such culturally-conventionalized gestures. Methodology/Principal Findings: Here I report a striking gesture unique to a single community of mandrills (Mandrillus sphinx) among nineteen studied across North America, Africa, and Europe. The gesture was found within a community of 23 mandrills where individuals old and young, female and male covered their eyes with their hands for periods which could exceed 30 min, often while simultaneously raising their elbow prominently into the air. This 'Eye covering' gesture has been performed within the community for a decade, enduring deaths, removals, and births, and it persists into the present. Differential responses to Eye covering versus controls suggested that the gesture might have a locally-respected meaning, potentially functioning over a distance to inhibit interruptions as a 'do not disturb' sign operates. Conclusions/Significance: The creation of this gesture by monkeys suggests that the ability to cultivate shared meanings using novel manual acts may be distributed more broadly beyond the human species. Although logistically difficult with primates, the translocation of gesturers between communities remains critical to experimentally establishing the possible cultural origin and transmission of nonhuman gestures.	[Laidre, Mark E.] Princeton Univ, Dept Ecol & Evolut Biol, Inst Neurosci, Princeton, NJ 08544 USA	Princeton University	Laidre, ME (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	mlaidre@berkeley.edu			Animal Behavior Society; Princeton University Graduate School Centennial Fellowship in the Sciences and Engineering; National Science Foundation	Animal Behavior Society; Princeton University Graduate School Centennial Fellowship in the Sciences and Engineering; National Science Foundation(National Science Foundation (NSF))	Support was derived from an Animal Behavior Society grant, a Princeton University Graduate School Centennial Fellowship in the Sciences and Engineering, and a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KA, 2002, J ZOOL, V258, P131, DOI 10.1017/S0952836902001267; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bonner JohnT., 1980, EVOLUTION CULTURE AN; Bonnie KE, 2006, PRIMATES, V47, P27, DOI 10.1007/s10329-005-0141-0; Bonnie KE, 2007, P ROY SOC B-BIOL SCI, V274, P367, DOI 10.1098/rspb.2006.3733; Boyd R., 2005, ORIGIN EVOLUTION CUL; Byrne R., 2006, INT J PSYCHOL PSYCHO, V6, P215; Byrne RW, 2004, TRENDS COGN SCI, V8, P341, DOI 10.1016/j.tics.2004.06.002; Call J, 2001, CYBERNET SYST, V32, P97, DOI 10.1080/019697201300001821; Call J., 2007, GESTURAL COMMUNICATI; Cartmill EA, 2007, CURR BIOL, V17, P1345, DOI 10.1016/j.cub.2007.06.069; CUSTANCE DM, 1995, BEHAVIOUR, V132, P837, DOI 10.1163/156853995X00036; Dawkins R., 1978, P282; de Waal F., 2001, APE SUSHI MASTER CUL; De Waal FBM, 2003, ANN NY ACAD SCI, V1000, P7, DOI 10.1196/annals.1280.003; De Waal Frans, 2009, QUESTION ANIMAL CULT, P19; DeWaal FBM, 1997, AM J PRIMATOL, V43, P339, DOI 10.1002/(SICI)1098-2345(1997)43:4<339::AID-AJP5>3.0.CO;2-Y; DEWAAL FBM, 1993, CHILD DEV, V64, P897, DOI 10.2307/1131225; Durham WH., 1991, COEVOLUTION GENES CU; Eibl-Eibesfeldt I., 1972, NONVERBAL COMMUNICAT, P297; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Kendal RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006541; Kroeber A. L., 1952, CULTURE CRITICAL REV; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Kuczaj Stan A. II, 2006, Aquatic Mammals, V32, P413, DOI 10.1578/AM.32.4.2006.413; Kummer Hans, 1995, QUEST SACRED BABOON; Laidre ME, 2008, ANIM COGN, V11, P179, DOI 10.1007/s10071-007-0121-4; Laidre ME, 2009, J COMP PSYCHOL, V123, P34, DOI 10.1037/a0013129; Laidre ME, 2005, BEHAVIOUR, V142, P455, DOI 10.1163/1568539054012038; Laidre ME, 2005, ETHOLOGY, V111, P143, DOI 10.1111/j.1439-0310.2004.01051.x; Laland K., 2009, QUESTION ANIMAL CULT, P1; Laland K. N., 2009, QUESTION ANIMAL CULT; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Liebal Katja, 2007, GESTURAL COMMUNICATI; Liebal Katja, 2006, GESTURE, V6, P1, DOI [10.1075/gest.6.1.02lie, DOI 10.1075/GEST.6.1.02LIE]; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mc Grew WC, 2001, CURR ANTHROPOL, V42, P148, DOI 10.1086/318441; McGrew W., 2009, QUESTION ANIMAL CULT, P41; MCGREW WC, 1978, MAN, V13, P234, DOI 10.2307/2800247; McGrew William, 2004, CULTURED CHIMPANZEE; Nakamura M, 2000, PRIMATES, V41, P237, DOI 10.1007/BF02557594; NISHIDA T, 1980, J HUM EVOL, V9, P117, DOI 10.1016/0047-2484(80)90068-8; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Pika S, 2006, CURR BIOL, V16, pR191, DOI 10.1016/j.cub.2006.02.037; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Sapolsky RM, 2006, CURR ANTHROPOL, V47, P641, DOI 10.1086/504162; Smith W.J., 1977, BEHAV COMMUNICATING; Smuts B, 2002, COGNITIVE ANIMAL, P301; Tanaka I, 1998, ANIM BEHAV, V56, P1229, DOI 10.1006/anbe.1998.0891; Tomasello M, 2002, COGNITIVE ANIMAL, P293; Tomasello M., 1997, EVOLUTION COMMUNICAT, V1, P223, DOI [DOI 10.1075/EOC.1.2.04TOM, 10.1075/eoc.1.2.04tom]; Topal J, 2006, ANIM COGN, V9, P355, DOI 10.1007/s10071-006-0051-6; Whiten A, 2004, LEARN BEHAV, V32, P36; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069	59	14	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e14610	10.1371/journal.pone.0014610	http://dx.doi.org/10.1371/journal.pone.0014610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311591	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200001
J	Novota, P; Zinocker, S; Norden, J; Wang, XN; Sviland, L; Opitz, L; Salinas-Riester, G; Rolstad, B; Dickinson, AM; Walter, L; Dressel, R				Novota, Peter; Zinocker, Severin; Norden, Jean; Wang, Xiao Nong; Sviland, Lisbet; Opitz, Lennart; Salinas-Riester, Gabriela; Rolstad, Bent; Dickinson, Anne M.; Walter, Lutz; Dressel, Ralf			Expression Profiling of Major Histocompatibility and Natural Killer Complex Genes Reveals Candidates for Controlling Risk of Graft versus Host Disease	PLOS ONE			English	Article							INFLAMMATORY FACTOR-I; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; SKIN-EXPLANT MODEL; RAT; MHC; POLYMORPHISMS; PROTEIN; IDENTIFICATION; SEQUENCE	Background: The major histocompatibility complex (MHC) is the most important genomic region that contributes to the risk of graft versus host disease (GVHD) after haematopoietic stem cell transplantation. Matching of MHC class I and II genes is essential for the success of transplantation. However, the MHC contains additional genes that also contribute to the risk of developing acute GVHD. It is difficult to identify these genes by genetic association studies alone due to linkage disequilibrium in this region. Therefore, we aimed to identify MHC genes and other genes involved in the pathophysiology of GVHD by mRNA expression profiling. Methodology/Principal Findings: To reduce the complexity of the task, we used genetically well-defined rat inbred strains and a rat skin explant assay, an in-vitro-model of the graft versus host reaction (GVHR), to analyze the expression of MHC, natural killer complex (NKC), and other genes in cutaneous GVHR. We observed a statistically significant and strong up or down regulation of 11 MHC, 6 NKC, and 168 genes encoded in other genomic regions, i.e. 4.9%, 14.0%, and 2.6% of the tested genes respectively. The regulation of 7 selected MHC and 3 NKC genes was confirmed by quantitative real-time PCR and in independent skin explant assays. In addition, similar regulations of most of the selected genes were observed in GVHD-affected skin lesions of transplanted rats and in human skin explant assays. Conclusions/Significance: We identified rat and human MHC and NKC genes that are regulated during GVHR in skin explant assays and could therefore serve as biomarkers for GVHD. Several of the respective human genes, including HLA-DMB, C2, AIF1, SPR1, UBD, and OLR1, are polymorphic. These candidates may therefore contribute to the genetic risk of GVHD in patients.	[Novota, Peter; Dressel, Ralf] Univ Gottingen, Dept Cellular & Mol Immunol, Gottingen, Germany; [Zinocker, Severin; Rolstad, Bent] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway; [Norden, Jean; Wang, Xiao Nong; Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sviland, Lisbet] Univ Bergen, Dept Pathol, Haukeland Sykehus, Sect Pathol,Gades Inst, Bergen, Norway; [Opitz, Lennart; Salinas-Riester, Gabriela] Univ Gottingen, Transcriptome Anal Lab, Gottingen, Germany; [Walter, Lutz] German Primate Ctr, Dept Primate Genet, Gottingen, Germany	University of Gottingen; University of Oslo; Newcastle University - UK; University of Bergen; Haukeland University Hospital; University of Gottingen; Deutsches Primatenzentrum (DPZ)	Novota, P (corresponding author), Inst Rheumatol, Dept Mol Biol & Immunogenet, Slupi 4, Prague 12850 2, Czech Republic.	rdresse@gwdg.de	Walter, Lutz/I-2606-2017; Dressel, Ralf/R-7065-2016; Zinöcker, Severin/G-9026-2011	Walter, Lutz/0000-0001-9408-3131; Dressel, Ralf/0000-0002-1651-1214; Zinöcker, Severin/0000-0003-1730-0125	European Union [MRTN-CT-2004-512253]; Research Council of Norway [ES420977]; Norwegian Cancer Society [41978271522-PR-2006-0467]	European Union(European Commission); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society)	This study was supported by the grant MRTN-CT-2004-512253 (TRANS-NET) from the European Union to A. M. D, B. R., and R. D. and by grant ES420977 from the Research Council of Norway and a grant #41978271522-PR-2006-0467 from the Norwegian Cancer Society to B. R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun JA, 1997, BONE MARROW TRANSPL, V19, P1023, DOI 10.1038/sj.bmt.1700788; AGUADO B, 1995, GENOMICS, V25, P650, DOI 10.1016/0888-7543(95)80007-9; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aly TA, 2008, DIABETES, V57, P770, DOI 10.2337/db07-0900; Arora M, 2009, J CLIN ONCOL, V27, P1644, DOI 10.1200/JCO.2008.18.7740; Autieri MV, 2002, CIRCULATION, V106, P2218, DOI 10.1161/01.CIR.0000035652.71915.00; BAKER KS, 1995, BONE MARROW TRANSPL, V15, P595; Baron C, 2007, PLOS MED, V4, P69, DOI 10.1371/journal.pmed.0040023; Bates EFM, 1997, EUR J IMMUNOL, V27, P2471, DOI 10.1002/eji.1830271002; Beck S, 1999, NATURE, V401, P921, DOI 10.1038/44853; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buzzeo MP, 2008, CELL TRANSPLANT, V17, P489, DOI 10.3727/096368908785096042; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chen Q, 2003, CIRCULATION, V107, P3146, DOI 10.1161/01.CIR.0000074207.85796.36; Curry JL, 2003, ARCH PATHOL LAB MED, V127, P289; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Dickinson AM, 2008, INT J IMMUNOGENET, V35, P375, DOI 10.1111/j.1744-313X.2008.00790.x; Dickinson AM, 2004, BRIT J HAEMATOL, V127, P479, DOI 10.1111/j.1365-2141.2004.05216.x; Dickinson AM, 2002, NAT MED, V8, P410, DOI 10.1038/nm0402-410; DICKINSON AM, 1988, BONE MARROW TRANSPL, V3, P323; Dickinson AM, 2001, HUM IMMUNOL, V62, P1266, DOI 10.1016/S0198-8859(01)00324-X; Dickinson Anne M., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000488; Dressel R, 2001, IMMUNOL REV, V184, P82, DOI 10.1034/j.1600-065x.2001.1840108.x; Flomenberg N, 2004, BLOOD, V104, P1923, DOI 10.1182/blood-2004-03-0803; Gunther E, 2001, IMMUNOGENETICS, V53, P520, DOI 10.1007/s002510100361; Hahn T, 2008, J CLIN ONCOL, V26, P5728, DOI 10.1200/JCO.2008.17.6545; Hipp MS, 2005, MOL CELL BIOL, V25, P3483, DOI 10.1128/MCB.25.9.3483-3491.2005; Holm SJ, 2003, EXP DERMATOL, V12, P435, DOI 10.1034/j.1600-0625.2003.00048.x; Horton R, 2008, IMMUNOGENETICS, V60, P1, DOI 10.1007/s00251-007-0262-2; Hu HZ, 1999, IMMUNOLOGY, V98, P379, DOI 10.1046/j.1365-2567.1999.00881.x; Hurt P, 2004, GENOME RES, V14, P631, DOI 10.1101/gr.1987704; Ichiba T, 2003, BLOOD, V102, P763, DOI 10.1182/blood-2002-09-2748; Ioannidu S, 2001, J IMMUNOL, V166, P3957, DOI 10.4049/jimmunol.166.6.3957; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; KLEMPNAUER J, 1989, IMMUNOGENETICS, V30, P81, DOI 10.1007/BF02421535; KLEMPNAUER J, 1983, TRANSPL P, V15, P1308; Kraft JR, 2000, J EXP MED, V192, P613, DOI 10.1084/jem.192.5.613; Kveberg L, 2010, J LEUKOCYTE BIOL, V88, P87, DOI 10.1189/jlb.0110039; Lambert JC, 2003, J MED GENET, V40, P424, DOI 10.1136/jmg.40.6.424; LANDGREBE J, 2004, IN SILICO BIOL, V4, P461; Lau P, 2000, IMMUNOGENETICS, V51, P148, DOI 10.1007/s002510050023; Leong LYW, 1999, J IMMUNOL, V162, P743; LERNER KG, 1974, TRANSPLANT P, V6, P367; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malkki M, 2007, BIOL BLOOD MARROW TR, V13, P986, DOI 10.1016/j.bbmt.2007.05.007; Mallya M, 2002, GENOMICS, V80, P113, DOI 10.1006/geno.2002.6794; Mallya M, 2006, PROTEIN SCI, V15, P2244, DOI 10.1110/ps.062242606; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Morel J, 2003, J RHEUMATOL, V30, P1485; Mulcahy H, 2006, IMMUNOGENETICS, V57, P893, DOI 10.1007/s00251-005-0057-2; Naper C, 1999, EUR J IMMUNOL, V29, P2046, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;2046::AID-IMMU2046&gt;3.0.CO;2-Z; Naper C, 2005, J IMMUNOL, V174, P2702, DOI 10.4049/jimmunol.174.5.2702; Novota P, 2008, TRANSPLANTATION, V85, P1809, DOI 10.1097/TP.0b013e31817753f7; Oh SJ, 2008, BONE MARROW TRANSPL, V41, P1047, DOI 10.1038/bmt.2008.37; Pawlik A, 2008, TISSUE ANTIGENS, V72, P171, DOI 10.1111/j.1399-0039.2008.01086.x; Petersdorf EW, 2007, PLOS MED, V4, P59, DOI 10.1371/journal.pmed.0040008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raasi S, 2001, J BIOL CHEM, V276, P35334, DOI 10.1074/jbc.M105139200; Rollinger-Holzinger I, 2000, J IMMUNOL, V164, P3169, DOI 10.4049/jimmunol.164.6.3169; SALGAR SK, 1995, IMMUNOGENETICS, V42, P244, DOI 10.1007/BF00176441; Schilling D, 2001, ONCOGENE, V20, P7992, DOI 10.1038/sj.onc.1204965; Shen L, 2006, J BIOL CHEM, V281, P15304, DOI 10.1074/jbc.M600054200; Socie G, 2004, BLOOD, V103, P50, DOI 10.1182/blood-2003-03-0909; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Sugerman PB, 2004, AM J PATHOL, V164, P2189, DOI 10.1016/S0002-9440(10)63776-5; Sviland L, 2001, HUM IMMUNOL, V62, P1277, DOI 10.1016/S0198-8859(01)00318-4; Takahashi N, 2008, EXP HEMATOL, V36, P1760, DOI 10.1016/j.exphem.2008.07.007; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Utans U, 1996, TRANSPLANTATION, V61, P1387, DOI 10.1097/00007890-199605150-00018; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velardi A, 2008, SEMIN IMMUNOPATHOL, V30, P489, DOI 10.1007/s00281-008-0136-1; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370; Yakoub-Agha I, 2006, J CLIN ONCOL, V24, P5695, DOI 10.1200/JCO.2006.08.0952; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	79	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16582	10.1371/journal.pone.0016582	http://dx.doi.org/10.1371/journal.pone.0016582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305040	gold, Green Published, Green Submitted			2022-12-25	WOS:000286664100046
J	Banasik, K; Justesen, JM; Hornbak, M; Krarup, NT; Gjesing, AP; Sandholt, CH; Jensen, TS; Grarup, N; Andersson, A; Jorgensen, T; Witte, DR; Sandbaek, A; Lauritzen, T; Thorens, B; Brunak, S; Sorensen, TIA; Pedersen, O; Hansen, T				Banasik, Karina; Justesen, Johanne M.; Hornbak, Malene; Krarup, Nikolaj T.; Gjesing, Anette P.; Sandholt, Camilla H.; Jensen, Thomas S.; Grarup, Niels; Andersson, Asa; Jorgensen, Torben; Witte, Daniel R.; Sandbaek, Annelli; Lauritzen, Torsten; Thorens, Bernard; Brunak, Soren; Sorensen, Thorkild I. A.; Pedersen, Oluf; Hansen, Torben			Bioinformatics-Driven Identification and Examination of Candidate Genes for Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; HEPATIC STEATOSIS; INSULIN-RESISTANCE; STEATOHEPATITIS; EXPRESSION; ASSOCIATION; POPULATION; PREVALENCE; METABOLISM; COMPLEXES	Objective: Candidate genes for non-alcoholic fatty liver disease (NAFLD) identified by a bioinformatics approach were examined for variant associations to quantitative traits of NAFLD-related phenotypes. Research Design and Methods: By integrating public database text mining, trans-organism protein-protein interaction transferal, and information on liver protein expression a protein-protein interaction network was constructed and from this a smaller isolated interactome was identified. Five genes from this interactome were selected for genetic analysis. Twenty-one tag single-nucleotide polymorphisms (SNPs) which captured all common variation in these genes were genotyped in 10,196 Danes, and analyzed for association with NAFLD-related quantitative traits, type 2 diabetes (T2D), central obesity, and WHO-defined metabolic syndrome (MetS). Results: 273 genes were included in the protein-protein interaction analysis and EHHADH, ECHS1, HADHA, HADHB, and ACADL were selected for further examination. A total of 10 nominal statistical significant associations (P < 0.05) to quantitative metabolic traits were identified. Also, the case-control study showed associations between variation in the five genes and T2D, central obesity, and MetS, respectively. Bonferroni adjustments for multiple testing negated all associations. Conclusions: Using a bioinformatics approach we identified five candidate genes for NAFLD. However, we failed to provide evidence of associations with major effects between SNPs in these five genes and NAFLD-related quantitative traits, T2D, central obesity, and MetS.	[Banasik, Karina; Justesen, Johanne M.; Hornbak, Malene; Krarup, Nikolaj T.; Gjesing, Anette P.; Sandholt, Camilla H.; Grarup, Niels; Pedersen, Oluf; Hansen, Torben] Hagedorn Res Inst, Gentofte, Denmark; [Banasik, Karina; Jorgensen, Torben; Sorensen, Thorkild I. A.; Pedersen, Oluf] Univ Copenhagen, Inst Biomed Sci, Copenhagen, Denmark; [Jensen, Thomas S.; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Hornbak, Malene; Andersson, Asa] Univ Copenhagen, Fac Pharmaceut Sci, Copenhagen, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Witte, Daniel R.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Thorens, Bernard] Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland; [Sorensen, Thorkild I. A.] Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark	Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Technical University of Denmark; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; Aarhus University; University of Lausanne; Aarhus University; University of Southern Denmark	Banasik, K (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	kabs@hagedorn.dk	Justesen, Johanne Marie/AAY-4210-2021; Pedersen, Oluf/AAG-8015-2020; Witte, Daniel/AAF-9535-2019; Witte, Daniel R/C-1722-2008; Banasik, Karina/G-1728-2013; Banasik, Karina/S-3475-2019; Justesen, Johanne Marie/L-6023-2015; Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018; Grarup, Niels/K-2807-2015; Gjesing, Anette/ACC-7521-2022; Brunak, Soren/O-6621-2016	Justesen, Johanne Marie/0000-0002-0484-8522; Witte, Daniel/0000-0002-0769-2922; Witte, Daniel R/0000-0002-0769-2922; Banasik, Karina/0000-0003-2489-2499; Justesen, Johanne Marie/0000-0002-0484-8522; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Gjesing, Anette/0000-0003-4580-1576; Krarup, Nikolaj/0000-0002-1660-4832; Krarup, Nikolaj Thure/0000-0001-6526-8663; Hansen, Torben/0000-0001-8748-3831; /0000-0003-4360-7710; Jorgensen, Torben/0000-0001-9453-2830; Brunak, Soren/0000-0003-0316-5866	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care; Danish Health Research Council; European Commission [LSHM-CT-2005-018734]; Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences); Danish Research Council; Danish Centre for Health Technology Assessment, Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care; Danish Health Research Council; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Diabetes Association; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Centre for Health Technology Assessment, Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health; Danish Heart Foundation; Danish Pharmaceutical Association; Augustinus Foundation; Ib Henriksen Foundation; Becket Foundation	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LuCAMP, www.lucamp.org), the Danish Health Research Council, "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP http://www.hepadip.org), which is supported by the European Commission as an integrated project under the 6th Framework Programme (LSHM-CT-2005-018734), the Danish Diabetes Association, the Danish Council for Independent Research (Medical Sciences). The Inter99 was initiated by T. Jorgensen (Principal Investigator), K. Borch-Johnsen (co-Principal Investigator), H. Ibsen and T. F. Thomsen. The steering committee comprises the former two and C. Pisinger. The study was financially supported by research grants from the Danish Research Council, the Danish Centre for Health Technology Assessment, Research Foundation of Copenhagen County, Ministry of Internal Affaires and Health, the Danish Heart Foundation, the Danish Pharmaceutical Association, the Augustinus Foundation, the Ib Henriksen Foundation, the Becket Foundation and the Danish Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albrechtsen A, 2007, GENETICS, V176, P1197, DOI 10.1534/genetics.107.071696; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; de Alwis NMW, 2008, CURR DIABETES REP, V8, P156, DOI 10.1007/s11892-008-0027-9; Duvnjak M, 2009, WORLD J GASTROENTERO, V15, P6023, DOI 10.3748/wjg.15.6023; Eaton S, 1996, CLIN SCI, V90, P307, DOI 10.1042/cs0900307; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juge-Aubry CE, 2001, BIOCHEM J, V353, P253, DOI 10.1042/0264-6021:3530253; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kohjima M, 2007, INT J MOL MED, V20, P351; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Leonard JF, 2006, PROTEOMICS, V6, P1915, DOI 10.1002/pmic.200500251; Marchesini G, 2006, Minerva Cardioangiol, V54, P229; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyazaki M, 2010, J TOXICOL SCI, V35, P131, DOI 10.2131/jts.35.131; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Neuschwander-Tetri BA, 2007, CURR OPIN GASTROEN, V23, P193, DOI 10.1097/MOG.0b013e32801421a9; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Pinzani M, 2008, NAT CLIN PRACT GASTR, V5, P95, DOI 10.1038/ncpgasthep1025; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Sparso T, 2007, MOL GENET METAB, V90, P205, DOI 10.1016/j.ymgme.2006.10.007; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsuneto A, 2010, HYPERTENS RES, V33, P638, DOI 10.1038/hr.2010.45; Willner IR, 2001, AM J GASTROENTEROL, V96, P2957; World Health Organization Study G, 1999, TECH REP SER WHO NCD; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; ZHANG BW, 1992, P NATL ACAD SCI USA, V89, P7541, DOI 10.1073/pnas.89.16.7541; Zhang X, 2009, HEPATOLOGY	38	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16542	10.1371/journal.pone.0016542	http://dx.doi.org/10.1371/journal.pone.0016542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21339799	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900066
J	Cheung, LWT; Mak, ASC; Cheung, ANY; Ngan, HYS; Leung, PCK; Wong, AST				Cheung, L. W. T.; Mak, A. S. C.; Cheung, A. N. Y.; Ngan, H. Y. S.; Leung, P. C. K.; Wong, A. S. T.			P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin	ONCOGENE			English	Article						ovarian cancer; GnRH; P-cadherin; p(120ctn); motility; IGF-1R	TYROSINE PHOSPHORYLATION; PROGNOSTIC-FACTOR; RHO-GTPASES; EXPRESSION; ACTIVATION; ADHESION; KINASE; EPITHELIUM; INDUCTION; INVASION	Gonadotropin-releasing hormone (GnRH) is a potent prometastatic factor in ovarian cancer, but the intracellular signaling events are not well understood. The classical G alpha(q)-phospholipase C signal transduction pathway known to operate in the pituitary is not involved in GnRH actions at non-pituitary targets. Here we showed that GnRH treatment of ovarian cancer cells led to a rapid and remarkable tyrosine phosphorylation of p120 catenin (p120(ctn)), which was mediated by P-cadherin. The use of P-cadherin small interfering RNA or neutralizing antibodies to inhibit P-cadherin expression and function resulted in diminished p120(ctn) activation, confirming that the effect was P-cadherin specific. On exploring how P-cadherin, which lacks intrinsic kinase activity, might regulate the activation of p120ctn, we found that P-cadherin could induce the ligand-independent activation of insulin-like growth factor-1 receptor (IGF-1R). Inhibition of IGF-1R expression or its activity significantly inhibited GnRH-induced p120(ctn) activation, and the subsequent cell migration and invasion. In addition, we showed that IGF-1R regulation by P-cadherin was associated with complex formation between IGF-1R and P-cadherin, and this regulation was also observed to be in vivo correlated with metastasis. Furthermore, using a mouse model of ovarian cancer metastasis, GnRH receptor knockdown was shown to diminish peritoneal dissemination of tumors and ascites formation. These findings suggest for the first time that GnRH can initiate an outside-in p120(ctn) signal transduction through the cross-talk between P-cadherin and IGF-1R, thus providing a novel molecular mechanism by which GnRH may control the high level of aggressiveness and invasion and metastasis potential that are characteristic of ovarian cancer. Oncogene (2011) 30, 2964-2974; doi:10.1038/onc.2011.7; published online 14 February 2011	[Cheung, L. W. T.; Mak, A. S. C.; Wong, A. S. T.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Cheung, A. N. Y.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Ngan, H. Y. S.] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Leung, P. C. K.] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of British Columbia	Wong, AST (corresponding author), Univ Hong Kong, Sch Biol Sci, 4S-14 Kadoorie Biological Sci Bldg,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	awong1@hku.hk	Wong, Alice/AFJ-4595-2022; Cheung, Annie Nga Yin/C-4231-2009	Wong, Alice/0000-0002-0676-6475; Leung, Peter/0000-0003-3152-3800; Ngan, Hextan Y S/0000-0003-3945-159X; Cheung, Lydia Wai Ting/0000-0003-1137-3200; Cheung, Annie Nga Yin/0000-0002-1584-7568	Hong Kong Research Grant Council [778108]; HKU	Hong Kong Research Grant Council(Hong Kong Research Grants Council); HKU(University of Hong Kong)	We thank Dr N Auersperg for cell lines. This work was supported by Hong Kong Research Grant Council 778108 and HKU Outstanding Young Researcher Award (AST Wong).	Alonso L, 2009, CLIN TRANSL ONCOL, V11, P748, DOI 10.1007/s12094-009-0437-4; Brokaw J, 2007, GROWTH FACTORS, V25, P346, DOI 10.1080/08977190701838402; Chen GTC, 2002, MOL REPROD DEV, V62, P289, DOI 10.1002/mrd.10121; Cheung LWT, 2010, ONCOGENE, V29, P2427, DOI 10.1038/onc.2009.523; Cheung LWT, 2008, FEBS J, V275, P5479, DOI 10.1111/j.1742-4658.2008.06677.x; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Choi JH, 2008, CANCER RES, V68, P5716, DOI 10.1158/0008-5472.CAN-08-0001; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Du J, 1996, BIOCHEM BIOPH RES CO, V218, P934, DOI 10.1006/bbrc.1996.0165; Dunn SE, 1998, CANCER RES, V58, P3353; Ellerbroek SM, 2001, CANCER RES, V61, P1855; EMONS G, 1989, EUR J CANCER CLIN ON, V25, P215, DOI 10.1016/0277-5379(89)90011-4; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; GRZES A, 1978, ENDOKRINOLOGIE, V71, P40; HODIVALA KJ, 1994, J CELL BIOL, V124, P589, DOI 10.1083/jcb.124.4.589; Holzman JL, 2007, AM J PHYSIOL-RENAL, V292, pF1219, DOI 10.1152/ajprenal.00214.2006; IRMER G, 1995, CANCER RES, V55, P817; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KAWAMURA Y, 1980, FERTIL STERIL, V34, P444; Liao JK, 2003, BIOCHEM SOC T, V31, P66, DOI 10.1042/bst0310066; Morali OG, 2001, ONCOGENE, V20, P4942, DOI 10.1038/sj.onc.1204660; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Patel IS, 2003, INT J CANCER, V106, P172, DOI 10.1002/ijc.11086; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pennisi PA, 2002, CANCER RES, V62, P6529; Pon YL, 2008, CANCER RES, V68, P6524, DOI 10.1158/0008-5472.CAN-07-6302; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Soubry A, 2005, CANCER RES, V65, P2224, DOI 10.1158/0008-5472.CAN-04-2020; Spentzos D, 2007, ENDOCR-RELAT CANCER, V14, P781, DOI 10.1677/ERC-06-0073; Spring CM, 2005, EXP CELL RES, V305, P253, DOI 10.1016/j.yexcr.2005.01.007; Steele IA, 2001, ONCOGENE, V20, P5878, DOI 10.1038/sj.onc.1204755; Sundfeldt K, 2003, MOL CELL ENDOCRINOL, V202, P89, DOI 10.1016/S0303-7207(03)00068-6; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Takahari D, 2009, ONCOLOGY-BASEL, V76, P42, DOI 10.1159/000178164; Wilkinson SJ, 2008, HUM PATHOL, V39, P1197, DOI 10.1016/j.humpath.2007.12.011; Wong AST, 1999, INT J CANCER, V81, P180; Yin M, 2009, AM J TRANSL RES, V1, P101	43	24	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	26					2964	2974		10.1038/onc.2011.7	http://dx.doi.org/10.1038/onc.2011.7			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	785QZ	21317933				2022-12-25	WOS:000292245100007
J	Di Bartolo, ND; Hvorup, RN; Locher, KP; Booth, PJ				Di Bartolo, Natalie D.; Hvorup, Rikki N.; Locher, Kaspar P.; Booth, Paula J.			In Vitro Folding and Assembly of the Escherichia coli ATP-binding Cassette Transporter, BtuCD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL MEMBRANE-PROTEIN; ABC TRANSPORTER; HISTIDINE PERMEASE; MUTATIONS; GENE; PURIFICATION; STABILITY; MECHANISM; SUBUNIT; COMPLEX	Studies on membrane protein folding have focused on monomeric alpha-helical proteins and a major challenge is to extend this work to larger oligomeric membrane proteins. Here, we study the Escherichia coli (E. coli) ATP-binding cassette (ABC) transporter that imports vitamin B-12 (the BtuCD protein) and use it as a model system for investigating the folding and assembly of a tetrameric membrane protein complex. Our work takes advantage of the modular organization of BtuCD, which consists of two transmembrane protein subunits, BtuC, and two cytoplasmically located nucleotide-binding protein subunits, BtuD. We show that the BtuCD transporter can be re-assembled from both prefolded and partly unfolded, urea denatured BtuC and BtuD subunits. The in vitro re-assembly leads to a BtuCD complex with the correct, native, BtuC and BtuD subunit stoichiometry. The highest rates of ATP hydrolysis were achieved for BtuCD re-assembled from partly unfolded subunits. This supports the idea of cooperative folding and assembly of the constituent protein subunits of the BtuCD transporter. BtuCD folding also provides an opportunity to investigate how a protein that contains both membrane-bound and aqueous subunits coordinates the folding requirements of the hydrophobic and hydrophilic subunits.	[Di Bartolo, Natalie D.; Booth, Paula J.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Hvorup, Rikki N.] Univ Queensland, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Locher, Kaspar P.] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	University of Bristol; University of Queensland; Swiss Federal Institutes of Technology Domain; ETH Zurich	Booth, PJ (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England.	paula.booth@bristol.ac.uk		Booth, Paula Jane/0000-0003-3893-360X	Biotechnology and Biosciences Research Council; European Union via the European Membrane Protein Consortium (EMeP); Swiss National Science Foundation	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union via the European Membrane Protein Consortium (EMeP); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by a Biotechnology and Biosciences Research Council PhD studentship (to N. D. B.), the European Union via the European Membrane Protein Consortium (EMeP), and the Swiss National Science Foundation (to K. L.).	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Barrera FN, 2005, BIOCHEMISTRY-US, V44, P14344, DOI 10.1021/bi050845t; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Bezrukov SM, 2000, CURR OPIN COLLOID IN, V5, P237, DOI 10.1016/S1359-0294(00)00061-3; Biemans-Oldehinkel E, 2006, FEBS LETT, V580, P1023, DOI 10.1016/j.febslet.2005.11.079; Bjelic S, 2006, BIOCHEMISTRY-US, V45, P8931, DOI 10.1021/bi0608156; Booth PJ, 2006, CURR OPIN STRUC BIOL, V16, P480, DOI 10.1016/j.sbi.2006.06.004; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; Booth PJ, 1996, BIOCHEMISTRY-US, V35, P5103, DOI 10.1021/bi953053f; Booth PJ, 2001, CRIT REV BIOCHEM MOL, V36, P501, DOI 10.1080/20014091074246; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; Daley DO, 2008, CURR OPIN STRUC BIOL, V18, P420, DOI 10.1016/j.sbi.2008.04.006; Davidson AL, 1997, J BACTERIOL, V179, P5458, DOI 10.1128/jb.179.17.5458-5464.1997; Davidson AL, 1996, J BIOL CHEM, V271, P4858; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kulajta C, 2006, J MOL BIOL, V355, P989, DOI 10.1016/j.jmb.2005.11.039; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lees JG, 2004, ANAL BIOCHEM, V332, P285, DOI 10.1016/j.ab.2004.06.002; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Liu PQ, 1998, P NATL ACAD SCI USA, V95, P3495, DOI 10.1073/pnas.95.7.3495; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; LONDON E, 1982, J BIOL CHEM, V257, P7003; Lorch M, 2004, J MOL BIOL, V344, P1109, DOI 10.1016/j.jmb.2004.09.090; Mateu MG, 1999, NAT STRUCT BIOL, V6, P191; MILLA ME, 1995, BIOCHEMISTRY-US, V34, P3344, DOI 10.1021/bi00010a025; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Mourez M, 1998, MOL MICROBIOL, V30, P353, DOI 10.1046/j.1365-2958.1998.01070.x; Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Riley ML, 1997, BIOCHEMISTRY-US, V36, P192, DOI 10.1021/bi962199r; Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Rumfeldt JAO, 2008, PROG BIOPHYS MOL BIO, V98, P61, DOI 10.1016/j.pbiomolbio.2008.05.004; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Senior AE, 1998, BIOCHEMISTRY-US, V37, P831, DOI 10.1021/bi9719962; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Stenberg F, 2007, J MOL BIOL, V371, P765, DOI 10.1016/j.jmb.2007.05.045; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Veen HW, 1997, SEMIN CANCER BIOL, V8, P183, DOI 10.1006/scbi.1997.0064; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856	59	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18807	18815		10.1074/jbc.M110.176891	http://dx.doi.org/10.1074/jbc.M110.176891			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21345797	hybrid, Green Published			2022-12-25	WOS:000290785700053
J	Toivonen, HT; Meinander, A; Asaoka, T; Westerlund, M; Pettersson, F; Mikhailov, A; Eriksson, JE; Saxen, H				Toivonen, Hannu T.; Meinander, Annika; Asaoka, Tomoko; Westerlund, Mia; Pettersson, Frank; Mikhailov, Andrey; Eriksson, John E.; Saxen, Henrik			Modeling Reveals That Dynamic Regulation of c-FLIP Levels Determines Cell-to-Cell Distribution of CD95-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED APOPTOSIS; CASPASE ACTIVATION; SIGNALING COMPLEX; PETRI NETS; DEATH; BISTABILITY; DEGRADATION; ROBUSTNESS; NETWORKS; PATHWAYS	The expression levels of caspase-8 inhibitory c-FLIP proteins play an important role in regulating death receptor-mediated apoptosis, as their concentration at the moment when the death-inducing signaling complex (DISC) is formed determines the outcome of the DISC signal. Experimental studies have shown that c-FLIP proteins are subject to dynamic turnover and that their stability and expression levels can be rapidly altered. Even though the influence of c-FLIP on the apoptotic behavior of a single cell has been captured in mathematical simulation studies, the effect of c-FLIP turnover and stability has not been investigated. In this study, a mathematical model of apoptosis was developed to analyze how the dynamic turnover and stability of the c-FLIP isoforms regulate apoptotic signaling for both individual cells and cell populations. Intercellular parameter and concentration distributions were used to describe the behavior of cell populations. Monte-Carlo simulations of cell populations showed that c-FLIP turnover is a key determinant of death receptor responses. The fact that the developed model simulates the state of whole cell populations makes it possible to validate it by comparison with empirical data. The proposed modeling approach can be used to further determine limiting factors in the DISC signaling process.	[Meinander, Annika; Asaoka, Tomoko; Mikhailov, Andrey; Eriksson, John E.] Abo Akad Univ, Dept Biosci, FI-20500 Turku, Finland; [Pettersson, Frank; Saxen, Henrik] Abo Akad Univ, Dept Chem Engn, FI-20500 Turku, Finland; [Toivonen, Hannu T.; Westerlund, Mia] Abo Akad Univ, Dept Informat Technol, FI-20500 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Abo Akad Univ, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Univ Turku, FI-20520 Turku, Finland	Abo Akademi University; Abo Akademi University; Abo Akademi University; Abo Akademi University; University of Turku; University of Turku	Eriksson, JE (corresponding author), Abo Akad Univ, Dept Biosci, Tykistokatu 6B, FI-20500 Turku, Finland.	john.eriksson@abo.fi; henrik.saxen@abo.fi	Saxen, Henrik/K-5134-2019; Meinander, Annika/E-9260-2017; Saxen, Henrik/I-8352-2014; Pettersson, Frank/AAZ-5408-2020	Meinander, Annika/0000-0002-3878-2293; Saxen, Henrik/0000-0002-5671-8367; Asaoka, Tomoko/0000-0001-5141-2353	Finnish Funding Agency for Technology and Innovation; Abo Akademi University; Turku Graduate School for Biomedical Sciences; Academy of Finland; Sigrid Juselius Foundation; Finnish Cancer Foundations; Research Institute of the Abo Akademi University Foundation	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); Abo Akademi University; Turku Graduate School for Biomedical Sciences; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Foundations; Research Institute of the Abo Akademi University Foundation	This work was in part supported by the Finnish Funding Agency for Technology and Innovation and Abo Akademi University, the Academy of Finland, the Sigrid Juselius Foundation, Finnish Cancer Foundations, and the Research Institute of the Abo Akademi University Foundation.; Supported by the Turku Graduate School for Biomedical Sciences.	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; ALBERGHINA L, 2005, SYSTEMS BIOL DEFINIT; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bluthgen N, 2003, J THEOR BIOL, V225, P293, DOI 10.1016/S0022-5193(03)00247-9; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Harrington HA, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-26; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Kaunisto A, 2009, CELL DEATH DIFFER, V16, P1215, DOI 10.1038/cdd.2009.35; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Li C, 2007, J BIOSCIENCES, V32, P113; Meinander A, 2007, J IMMUNOL, V178, P3944, DOI 10.4049/jimmunol.178.6.3944; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Shi B, 2009, J BIOL CHEM, V284, P14513, DOI 10.1074/jbc.M807918200; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stucki JW, 2005, J THEOR BIOL, V234, P123, DOI 10.1016/j.jtbi.2004.11.011; Tran SEF, 2003, CELL DEATH DIFFER, V10, P1137, DOI 10.1038/sj.cdd.4401278; Ueffing N, 2008, CELL DEATH DIFFER, V15, P773, DOI 10.1038/sj.cdd.4402314	34	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2011	286	21					18375	18382		10.1074/jbc.M110.177097	http://dx.doi.org/10.1074/jbc.M110.177097			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	766ME	21324892	hybrid, Green Published			2022-12-25	WOS:000290785700010
J	Li, Y; Xu, SQ; Giles, A; Nakamura, K; Lee, JW; Hou, XY; Donmez, G; Li, J; Luo, ZJ; Walsh, K; Guarente, L; Zang, MW				Li, Yu; Xu, Shanqin; Giles, Amber; Nakamura, Kazuto; Lee, Jong Woo; Hou, Xiuyun; Donmez, Gizem; Li, Ji; Luo, Zhijun; Walsh, Kenneth; Guarente, Leonard; Zang, Mengwei			Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver	FASEB JOURNAL			English	Article						unfolded protein response; XBP-1 splicing; mTORC1; hepatic steatosis; insulin signaling	UNFOLDED PROTEIN RESPONSE; SMALL-MOLECULE ACTIVATORS; DIET-INDUCED OBESITY; ER STRESS; GLUCOSE-HOMEOSTASIS; METABOLIC DISEASE; MOUSE MODELS; LDL RECEPTOR; LIFE-SPAN; KINASE	Endoplasmic reticulum (ER) stress has been implicated in the pathophysiology of human type 2 diabetes (T2DM). Although SIRT1 has a therapeutic effect on metabolic deterioration in T2DM, the precise mechanisms by which SIRT1 improves insulin resistance remain unclear. Here, we demonstrate that adenovirus-mediated overexpression of SIRT1 in the liver of diet-induced insulin-resistant low-density lipoprotein receptor-deficient mice and of genetically obese ob/ob mice attenuates hepatic steatosis and ameliorates systemic insulin resistance. These beneficial effects were associated with decreased mammalian target of rapamycin complex 1 (mTORC1) activity, inhibited the unfolded protein response (UPR), and enhanced insulin receptor signaling in the liver, leading to decreased hepatic gluconeogenesis and improved glucose tolerance. The tunicamycin-induced splicing of X-box binding protein-1 and expression of GRP78 and CHOP were reduced by resveratrol in cultured cells in a SIRT1-dependent manner. Conversely, SIRT1-deficient mouse embryonic fibroblasts challenged with tunicamycin exhibited markedly increased mTORC1 activity and impaired ER homeostasi and insulin signaling. These effects were abolished by mTORC1 inhibition by rapamycin in human HepG2 cells. These studies indicate that SIRT1 serves as a negative regulator of UPR signaling in T2DM and that SIRT1 attenuates hepatic steatosis, ameliorates insulin resistance, and restores glucose homeostasis, largely through the inhibition of mTORC1 and ER stress.-Li, Y., Xu, S., Giles, A., Nakamura, K., Lee, J. W., Hou, X., Donmez, G., Li,J., Luo, Z., Walsh, K., Guarente, L., Zang, M. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J. 25, 1664-1679 (2011). www.fasebj.org	[Zang, Mengwei] Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Luo, Zhijun] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Donmez, Gizem; Guarente, Leonard] MIT, Dept Biol, Paul F Glenn Lab, Cambridge, MA USA; [Li, Ji] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA	Boston University; Boston University; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zang, MW (corresponding author), Boston Univ, Sch Med, Dept Med, Vasc Biol Sect,Whitaker Cardiovasc Inst, 650 Albany St,X725, Boston, MA 02118 USA.	mwzang1@bu.edu	Li, Yu/B-1071-2014; Luo, Zhijun/AAE-9302-2019; Yalcin, Gizem Donmez/AAG-5056-2019	Luo, Zhijun/0000-0001-8105-5289; Yalcin, Gizem Donmez/0000-0002-5121-8232; Giles, Amber/0000-0002-8721-1825; Li, Yu/0000-0001-6910-5933; Luo, Zhijun/0000-0003-3509-4046; Zang, Mengwei/0000-0002-2502-2586	National Institutes of Health (NIH) [DK 076942, PO1HL068758]; Robert Dawson Evans Junior Faculty; Paul F. Glenn Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076942] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Dawson Evans Junior Faculty; Paul F. Glenn Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors greatly appreciate Dr. Richard A. Cohen for insightful advice. The authors also thank Dr. Pere Puigserver (Harvard Medical School, Boston, MA, USA) for kindly providing the adenoviral vector encoding Flag-tagged SIRT1 and Dr. Ling Qi (Cornell University, Ithaca, NY, USA) for important suggestions. The authors are grateful to Kimberly Wong and Karlene A. Maitland-Toolan for technical assistance. This work is supported by National Institutes of Health (NIH) grants DK 076942 and PO1HL068758 and the Robert Dawson Evans Junior Faculty Merit Award to M.Z. and by grants from NIH and the Paul F. Glenn Foundation to L. G.	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Armour SM, 2009, AGING-US, V1, P515, DOI 10.18632/aging.100056; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Birkenfeld AL, 2009, DIABETES, V58, pA387; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rodriguez-Sanabria F, 2010, MOL CELL BIOCHEM, V343, P59, DOI 10.1007/s11010-010-0498-2; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schreyer SA, 2002, AM J PHYSIOL-ENDOC M, V282, pE207, DOI 10.1152/ajpendo.2002.282.1.E207; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zuccollo A, 2005, CIRCULATION, V112, P3001, DOI 10.1161/CIRCULATIONAHA.105.581892	53	226	245	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2011	25	5					1664	1679		10.1096/fj.10-173492	http://dx.doi.org/10.1096/fj.10-173492			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	756OU	21321189	Green Published			2022-12-25	WOS:000290023800023
J	Liu, XH; Du, Q; Wang, Z; Zhu, DY; Huang, Y; Li, N; Wei, TD; Xu, SJ; Gu, LC				Liu, Xiuhua; Du, Qian; Wang, Zhi; Zhu, Deyu; Huang, Yan; Li, Ning; Wei, Tiandi; Xu, Sujuan; Gu, Lichuan			Crystal Structure and Biochemical Features of EfeB/YcdB from Escherichia coli O157 ASP(235) PLAYS DIVERGENT ROLES IN DIFFERENT ENZYME-CATALYZED PROCESSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; HEME-DEGRADING ENZYMES; STAPHYLOCOCCUS-AUREUS; PROTOPORPHYRIN-IX; IRON TRANSPORT; OXYGENASE; VIRULENCE; MECHANISM; PROTEINS; BACTERIA	EfeB/YcdB is a member of the dye-decolorizing peroxidase (DyP) protein family. A recent study has shown that this protein can extract iron from heme without breaking the tetrapyrrole ring. We report the crystal structure of EfeB from Escherichia coli O157 bound to heme at 1.95 angstrom resolution. The EfeB monomer contains two domains. The heme molecule is located in a large hydrophobic pocket in the C-terminal domain. Along loop connecting the two domains extensively interacts with the heme, which is a distinctive structural feature of EfeB homologues. A large tunnel formed by this loop and the beta-sheet of C-terminal domain provides a potential cofactor/substrate binding site. Biochemical data show that the production of protoporphyrin IX (PPIX) is closely related to the peroxidation activity. The mutant D235N keeps nearly the same activity of guaiacol peroxidase as the wild-type protein, whereas the corresponding mutation in the classic DyP protein family completely abolished the peroxidation activity. These results suggest that EfeB is a unique member of the DyP protein family. In addition, dramatically enhanced fluorescence excitation and emission of EfeB-PPIX was observed, implying this protein may be used as a red color fluorescence marker.	[Liu, Xiuhua; Du, Qian; Wang, Zhi; Zhu, Deyu; Huang, Yan; Li, Ning; Wei, Tiandi; Xu, Sujuan; Gu, Lichuan] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Gu, LC (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lcgu@sdu.edu.cn	Du, Qian/AAF-1111-2019	Du, Qian/0000-0001-7438-9838	State Key Laboratory of Microbial Technology, Shandong University; Hi-Tech Research and Development Program of China [2006AA02A324]	State Key Laboratory of Microbial Technology, Shandong University; Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the State Key Laboratory of Microbial Technology, Shandong University and Grant 2006AA02A324 from the Hi-Tech Research and Development Program of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arcovito A, 2008, ARCH BIOCHEM BIOPHYS, V475, P7, DOI 10.1016/j.abb.2008.03.026; Banci L, 1997, J BIOTECHNOL, V53, P253, DOI 10.1016/S0168-1656(97)01677-5; Beitlich T, 2007, J SYNCHROTRON RADIAT, V14, P11, DOI 10.1107/S0909049506049806; Bonacorsi SPP, 2000, INFECT IMMUN, V68, P2096, DOI 10.1128/IAI.68.4.2096-2101.2000; Cao J, 2007, MOL MICROBIOL, V65, P857, DOI 10.1111/j.1365-2958.2007.05802.x; Cartron ML, 2007, ACTA CRYSTALLOGR F, V63, P37, DOI 10.1107/S174430910604509X; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; GOODIN DB, 1993, BIOCHEMISTRY-US, V32, P3313, DOI 10.1021/bi00064a014; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; Kumar D, 2005, J AM CHEM SOC, V127, P8204, DOI 10.1021/ja0446956; Lasovsky J, 2007, LUMINESCENCE, V22, P501, DOI 10.1002/bio.995; LAW D, 1995, INFECT IMMUN, V63, P700, DOI 10.1128/IAI.63.2.700-702.1995; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993; MARGALIT R, 1983, BIOCHEM J, V209, P547, DOI 10.1042/bj2090547; Matsui T, 2010, INORG CHEM, V49, P3602, DOI 10.1021/ic901869t; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; McNicholas PM, 1997, FEMS MICROBIOL LETT, V146, P143, DOI 10.1016/S0378-1097(96)00467-3; Muller M, 2005, MOL MEMBR BIOL, V22, P113, DOI 10.1080/09687860500041809; Nagy G, 2002, INFECT IMMUN, V70, P4406, DOI 10.1128/IAI.70.8.4406-4413.2002; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rajasekaran MB, 2010, BIOMETALS, V23, P1, DOI 10.1007/s10534-009-9262-z; Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; SCHWARTZ S, 1983, CLIN CHEM, V29, P2061; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Sturm A, 2006, J BIOL CHEM, V281, P13972, DOI 10.1074/jbc.M511891200; Sugano Y, 2007, J BIOL CHEM, V282, P36652, DOI 10.1074/jbc.M706996200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; VANDENBERG JWO, 1988, CLIN CHEM, V34, P2125; WELINDER KG, 1992, BIOCHEM SOC T, V20, P337, DOI 10.1042/bst0200337; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Wilks A, 2002, ANTIOXID REDOX SIGN, V4, P603, DOI 10.1089/15230860260220102; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Yoshida T, 2000, J INORG BIOCHEM, V82, P33, DOI 10.1016/S0162-0134(00)00156-2; Zubieta C, 2007, PROTEINS, V69, P223, DOI 10.1002/prot.21550	50	64	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14922	14931		10.1074/jbc.M110.197780	http://dx.doi.org/10.1074/jbc.M110.197780			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21324904	Green Published, hybrid			2022-12-25	WOS:000289788300022
J	Coleman, KA; Greenberg, RA				Coleman, Kara A.; Greenberg, Roger A.			The BRCA1-RAP80 Complex Regulates DNA Repair Mechanism Utilization by Restricting End Resection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; HOMOLOGOUS RECOMBINATION; CANCER SUSCEPTIBILITY; DAMAGE RESPONSE; TARGETS BRCA1; PROTEIN; DOMAIN; CTIP; ATM; LANDSCAPE	The tumor suppressor protein BRCA1 is a constituent of several different protein complexes and is required for homology-directed repair (HDR) of DNA double strand breaks (DSBs). The most recently discovered BRCA1-RAP80 complex is recruited to ubiquitin structures on chromatin surrounding the break. Deficiency of any member of this complex confers hypersensitivity to DNA-damaging agents by undefined mechanisms. In striking contrast to other BRCA1-containing complexes that are known to promote HDR, we demonstrate that the BRCA1-RAP80 complex restricts end resection in S/G(2) phase of the cell cycle, thereby limiting HDR. RAP80 or BRCC36 deficiency resulted in elevated Mre 11-CtIP-dependent 5' end resection with a concomitant increase in HDR mechanisms that rely on 3' single-stranded overhangs. We propose a model in which the BRCA1-RAP80 complex limits nuclease accessibility to DSBs, thus preventing excessive end resection and potentially deleterious homology-directed DSB repair mechanisms that can impair genome integrity.	[Coleman, Kara A.; Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd,BRB 2-3,Rm 513, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			National Institutes of Health, NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; National Institutes of Health [T32-GM-007229, T32-CA-115299]; NATIONAL CANCER INSTITUTE [K08CA106597, T32CA115299, R01CA138835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant 1R01CA138835-01 and K08 Awards 1K08CA106597-01 and 3K08CA106597-04S1 (to R. A.G.) and National Institutes of Health Grants T32-GM-007229 and T32-CA-115299 (to K. A. C.).	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Anantha RW, 2007, J BIOL CHEM, V282, P35910, DOI 10.1074/jbc.M704645200; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; HU Y, 2011, GENES DEV IN PRESS; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Iijima J, 2010, CANCER RES, V70, P8467, DOI 10.1158/0008-5472.CAN-10-0267; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kao GD, 2001, ONCOGENE, V20, P3486, DOI 10.1038/sj.onc.1204445; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Nikkila J, 2009, ONCOGENE, V28, P1843, DOI 10.1038/onc.2009.33; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Potts PR, 2006, EMBO J, V25, P3377, DOI 10.1038/sj.emboj.7601218; Rahman N, 1998, ANNU REV GENET, V32, P95, DOI 10.1146/annurev.genet.32.1.95; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wilson DM, 2007, MUTAT RES-FUND MOL M, V616, P11, DOI 10.1016/j.mrfmmm.2006.11.017; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	69	160	166	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13669	13680		10.1074/jbc.M110.213728	http://dx.doi.org/10.1074/jbc.M110.213728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335604	hybrid, Green Published			2022-12-25	WOS:000289282200085
J	Foy, KC; Liu, ZZ; Phillips, G; Miller, M; Kaumaya, PTP				Foy, Kevin C.; Liu, Zhenzhen; Phillips, Gary; Miller, Megan; Kaumaya, Pravin T. P.			Combination Treatment with HER-2 and VEGF Peptide Mimics Induces Potent Anti-tumor and Anti-angiogenic Responses in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEU DIFFERENTIATION FACTOR; HUMAN-BREAST-CANCER; MONOCLONAL-ANTIBODY; ENDOMETRIAL CANCER; GENE AMPLIFICATION; DISULFIDE BONDS; ERBB RECEPTORS; TUMOR-GROWTH; EXPRESSION	HER-2 is a member of the EGF receptor family and is overexpressed in 20-30% of breast cancers. HER-2 overexpression causes increased expression of VEGF at both the RNA and protein levels. HER-2 and VEGF are therefore considered good targets for cancer treatment, which has led to the development of two humanized monoclonal antibodies (mAb) pertuzumab and bevacizumab. Although passive immunotherapy with these Abs are approved for treatment of advanced breast cancer, a number of concerns exist. Treatment is expensive, has a limited duration of action, and is usually accompanied by serious side effects. We hypothesized that therapy with conformational peptide mimics aimed at blocking receptor-ligand interaction is potentially safer with little toxicity, cheaper with a longer half-life, and has greater penetrating abilities than inAbs. We designed and synthesized peptides based on the binding of HER-2 with pertuzumab and VEGF with VEGFR2. We show that treatment with the peptide mimics induces potent anti-tumor responses in vitro as determined by cell viability, proliferation, and HER2 phosphorylation assays. We also demonstrate in a transplantable BALB/c mouse tumor model that treatment with the peptide mimics resulted in a greater delay in tumor growth and development. Similarly, treatment with the peptide mimics inhibited angiogenesis in vivo as assessed by a Matrigel plug assay. To address the problem of degradability of L-amino acid peptides in vivo, we synthesized the retro-inverso D-peptide mimics that resulted in higher efficacy in treatment. Our study shows that combination treatment with HER-2 and VEGF peptide mimics provides greater efficacy than individual treatments.	[Foy, Kevin C.; Miller, Megan; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Liu, Zhenzhen; Kaumaya, Pravin T. P.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Foy, Kevin C.; Miller, Megan; Kaumaya, Pravin T. P.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Phillips, Gary; Kaumaya, Pravin T. P.] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Kaumaya, PTP (corresponding author), Ohio State Univ, Dept Microbiol, Ste 316 Med Res Facil,420 W 12th Ave, Columbus, OH 43210 USA.	Kaumaya.1@osu.edu	Kaumaya, Pravin T. P/E-3354-2011	Miller, Mitchell/0000-0003-1626-4943	NCI [84356]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 84356 from NCI.	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Allen SD, 2005, J PEPT RES, V65, P591, DOI 10.1111/j.1399-3011.2005.00256.x; Allen SD, 2007, J IMMUNOL, V179, P472, DOI 10.4049/jimmunol.179.1.472; BARBACCI EG, 1995, J BIOL CHEM, V270, P9585, DOI 10.1074/jbc.270.16.9585; Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; BEERLI RR, 1995, MOL CELL BIOL, V15, P6496; BERCHUCK A, 1991, AM J OBSTET GYNECOL, V164, P15, DOI 10.1016/0002-9378(91)90615-X; Carpenito C, 2002, INT J RADIAT ONCOL, V54, P1473, DOI 10.1016/S0360-3016(02)03921-4; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Casella I, 2003, BLOOD, V101, P1316, DOI 10.1182/blood-2002-07-2184; Chorev M, 2005, BIOPOLYMERS, V80, P67, DOI 10.1002/bip.20219; CHOREV M, 1995, TRENDS BIOTECHNOL, V13, P438, DOI 10.1016/S0167-7799(00)88999-4; Cirisano FD, 1996, J SOC GYNECOL INVEST, V3, P99, DOI 10.1016/1071-5576(96)00001-9; Cobleigh MA, 2003, SEMIN ONCOL, V30, P117, DOI 10.1053/j.seminoncol.2003.08.013; Dakappagari NK, 2005, J PEPT RES, V65, P189, DOI 10.1111/j.1399-3011.2005.00212.x; Dakappagari NK, 2005, J BIOL CHEM, V280, P54, DOI 10.1074/jbc.M411020200; Dakappagari NK, 2000, CANCER RES, V60, P3782; Dakappagari NK, 2003, J IMMUNOL, V170, P4242, DOI 10.4049/jimmunol.170.8.4242; Eskens FALM, 2006, EUR J CANCER, V42, P3127, DOI 10.1016/j.ejca.2006.09.015; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; Ferrara N, 2004, ONCOLOGIST, V9, P2, DOI 10.1634/theoncologist.9-suppl_1-2; Fischer PM, 2003, CURR PROTEIN PEPT SC, V4, P339, DOI 10.2174/1389203033487054; Fletcher MD, 1998, CHEM REV, V98, P763, DOI 10.1021/cr970468t; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Garrett JT, 2007, J IMMUNOL, V178, P7120, DOI 10.4049/jimmunol.178.11.7120; GOODMAN M, 1992, BIOORG KHIM+, V18, P1375; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GRAUSPORTA D, 1995, MOL CELL BIOL, V15, P1182; Grothey Axel, 2006, Oncology (Williston Park), V20, P21; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; HOUCK KA, 1991, MOL ENDOCRINOL, V5, P1806, DOI 10.1210/mend-5-12-1806; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kaumaya PTP, 2009, J CLIN ONCOL, V27, P5270, DOI 10.1200/JCO.2009.22.3883; Kaumaya PTP, 2006, INT J PEPT RES THER, V12, P65, DOI 10.1007/s10989-005-9000-5; KERN JA, 1990, CANCER RES, V50, P5184; Kim DW, 2006, INT J RADIAT ONCOL, V64, P38, DOI 10.1016/j.ijrobp.2005.02.008; Li B, 2002, HYPERTENSION, V39, P1095, DOI 10.1161/01.HYP.0000018588.56950.7A; Mimura K, 2005, BRIT J CANCER, V92, P1253, DOI 10.1038/sj.bjc.6602499; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Morrison C, 2006, J CLIN ONCOL, V24, P2376, DOI 10.1200/JCO.2005.03.4827; Nagy P, 2005, CANCER RES, V65, P473; NIEHANS GA, 1993, JNCI-J NATL CANCER I, V85, P1230, DOI 10.1093/jnci/85.15.1230; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oshima RG, 2004, CANCER RES, V64, P169, DOI 10.1158/0008-5472.CAN-03-1944; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PRESS MF, 1990, ONCOGENE, V5, P953; Riemer AB, 2004, J IMMUNOL, V173, P394, DOI 10.4049/jimmunol.173.1.394; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Rugo HS, 2004, ONCOLOGIST, V9, P43, DOI 10.1634/theoncologist.9-suppl_1-43; Ryan AJ, 2005, BRIT J CANCER, V92, pS6, DOI 10.1038/sj.bjc.6602603; Saito H, 1998, BRIT J CANCER, V78, P1573, DOI 10.1038/bjc.1998.725; Scholl S, 2001, ANN ONCOL, V12, P81, DOI 10.1023/A:1011192622688; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; SLAMON DJ, 1987, NEW ENGL J MED, V317, P955, DOI 10.1056/NEJM198710083171509; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Soll R, 2000, J PEPT SCI, V6, P387, DOI 10.1002/1099-1387(200008)6:8<387::AID-PSC267>3.0.CO;2-M; Srinivasan M, 2002, J IMMUNOL, V169, P2180, DOI 10.4049/jimmunol.169.4.2180; Srinivasan M, 2001, J IMMUNOL, V167, P578, DOI 10.4049/jimmunol.167.1.578; Steele JT, 2006, CANC IMMUNOTHERAPY R; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Sundaram R, 2004, J BIOL CHEM, V279, P24141, DOI 10.1074/jbc.M313210200; Taylor EM, 2000, J PHARMACOL EXP THER, V295, P190; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vicari D, 2011, J BIOL CHEM, V286, P13612, DOI 10.1074/jbc.M110.216812; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yano T, 2006, ONCOL REP, V15, P65	73	41	47	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13626	13637		10.1074/jbc.M110.216820	http://dx.doi.org/10.1074/jbc.M110.216820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21325276	hybrid, Green Published			2022-12-25	WOS:000289282200081
J	Suzuki, H; Lee, K; Matsuoka, M				Suzuki, Hiroaki; Lee, Kikyo; Matsuoka, Masaaki			TDP-43-induced Death Is Associated with Altered Regulation of BIM and Bcl-xL and Attenuated by Caspase-mediated TDP-43 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; TRANSGENIC MOUSE MODEL; DNA-BINDING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; ER STRESS; CELLULAR TOXICITY; OXIDATIVE STRESS; DROSOPHILA MODEL; MOTONEURON LOSS	Abnormal aggregates of transactive response DNA-binding protein-43 (TDP-43) and its hyperphosphorylated and N-terminal truncated C-terminal fragments (CTFs) are deposited as major components of ubiquitinated inclusions in most cases of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U). The mechanism underlying the contribution of TDP-43 to the pathogenesis of these neurodegenerative diseases remains unknown. In this study, we found that a 2-5-fold increase in TDP-43 expression over the endogenous level induced death of NSC34 motor neuronal cells and primary cortical neurons. TDP-43-induced death is associated with up-regulation of Bim expression and down-regulation of Bcl-xL expression. siRNA-mediated reduction of Bim expression attenuates TDP-43-induced death. Accumulated evidence indicates that caspases are activated in neurons of ALS and FTLD-U patients, and activated caspase-mediated cleavage of TDP-43 generates CTFs of TDP-43. Here, we further found that the ER (endoplasmic reticulum) stress- or staurosporine-mediated activation of caspases leads to cleavage of TDP-43 at Asp(89) and Asp(169), generating CTF35 (TDP-43-(90-414)) and CTF27 (TDP-43-(170- 414)) in cultured neuronal cells. In contrast to TDP-43, CTF27 is unable to induce death while it forms aggregates. CTF35 was weaker than full-length TDP-43 in inducing death. A cleavage-resistant mutant of TDP-43 (TDP-43-D89E/D169E) showed stronger death-inducing activity than wild-type TDP-43. These results suggest that disease-related activation of caspases may attenuate TDP-43-induced toxicity by promoting TDP-43 cleavage.	[Suzuki, Hiroaki; Lee, Kikyo; Matsuoka, Masaaki] Tokyo Med & Dent Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan	Tokyo Medical & Dental University (TMDU)	Matsuoka, M (corresponding author), Tokyo Med & Dent Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp			Scientific Research Young Scientist [(B) 22790261]; Nakabayashi Trust	Scientific Research Young Scientist(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nakabayashi Trust	This work was supported in part by Grant-in-aid for Scientific Research Young Scientist (B) 22790261 and the Nakabayashi Trust for ALS research (to H. S.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; Dennis JS, 2009, NEUROSCIENCE, V158, P745, DOI 10.1016/j.neuroscience.2008.10.030; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Gamas P, 2009, LEUKEMIA, V23, P1500, DOI 10.1038/leu.2009.60; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Hanson KA, 2010, J BIOL CHEM, V285, P11068, DOI 10.1074/jbc.C109.078527; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Hashimoto Y, 2000, J BIOL CHEM, V275, P34541, DOI 10.1074/jbc.M005332200; Hetz C, 2007, CELL DEATH DIFFER, V14, P1386, DOI 10.1038/sj.cdd.4402166; Huang C, 2010, INT J BIOL SCI, V6, P396; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Kanekura K, 2009, MOL NEUROBIOL, V39, P81, DOI 10.1007/s12035-009-8054-3; Kasai T, 2009, ACTA NEUROPATHOL, V117, P55, DOI 10.1007/s00401-008-0456-1; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Lee J, 2009, FASEB J, V23, P1739, DOI 10.1096/fj.08-121046; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Su JH, 2000, EXP NEUROL, V163, P9, DOI 10.1006/exnr.2000.7340; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Suzuki M, 2010, ACTA NEUROL SCAND, V122, P367, DOI 10.1111/j.1600-0404.2010.01321.x; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Vukosavic S, 1999, J NEUROCHEM, V73, P2460, DOI 10.1046/j.1471-4159.1999.0732460.x; Wakeyama H, 2007, J BONE MINER RES, V22, P1631, DOI 10.1359/JBMR.070619; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	48	79	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13171	13183		10.1074/jbc.M110.197483	http://dx.doi.org/10.1074/jbc.M110.197483			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21339291	Green Published, hybrid			2022-12-25	WOS:000289282200038
J	Lee, KJ; Lin, YF; Chou, HY; Yajima, H; Fattah, KR; Lee, SC; Chen, BPC				Lee, Kyung-Jong; Lin, Yu-Fen; Chou, Han-Yi; Yajima, Hirohiko; Fattah, Kazi R.; Lee, Sheng-Chung; Chen, Benjamin P. C.			Involvement of DNA-dependent Protein Kinase in Normal Cell Cycle Progression through Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; INDUCED REPLICATION STRESS; CATALYTIC SUBUNIT; PHOSPHORYLATION SITES; KINETOCHORE CAPTURE; MITOTIC SPINDLE; IN-VIVO; CHECKPOINT; DAMAGE; LOCALIZATION	The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) plays an important role in DNA double-strand break (DSB) repair as the underlying mechanism of the non-homologous end joining pathway. When DSBs occur, DNA-PKcs is rapidly phosphorylated at both the Thr-2609 and Ser-2056 residues, and such phosphorylations are critical for DSB repair. In this study we report that, in addition to responding to DSBs, DNA-PKcs is activated and phosphorylated in normal cell cycle progression through mitosis. Mitotic induction of DNA-PKcs phosphorylation is closely associated with the spindle apparatus at centrosomes and kinetochores. Furthermore, depletion of DNA-PKcs protein levels or inhibition of DNA-PKcs kinase activity results in the delay of mitotic transition because of chromosome misalignment. These results demonstrate for the first time that DNA-PKcs, in addition to its role in DSB repair, is a critical regulator of mitosis and could modulate microtubule dynamics in chromosome segregation.	[Lee, Kyung-Jong; Lin, Yu-Fen; Yajima, Hirohiko; Fattah, Kazi R.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, Dallas, TX 75390 USA; [Chou, Han-Yi; Lee, Sheng-Chung] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 10051, Taiwan	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Taiwan University	Chen, BPC (corresponding author), Univ Texas SW Med Ctr Dallas, Div Mol Radiat Biol, Dept Radiat Oncol, 2201 Inwood Rd, Dallas, TX 75390 USA.	benjamin.chen@utsouthwestern.edu	Lin, Yu-Fen/A-2570-2016		National Institutes of Health [CA50519]; National Aeronautics and Space Administration [NNX07AP84G]; National Science Council, Taiwan [NSC96-2321-B002-008]; NATIONAL CANCER INSTITUTE [R37CA050519, R01CA050519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA50519. This work was also supported by National Aeronautics and Space Administration Grant NNX07AP84G and National Science Council, Taiwan Grant NSC96-2321-B002-008.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Douglas P, 2002, BIOCHEM J, V368, P243, DOI 10.1042/BJ20020973; Douglas P, 2007, MOL CELL BIOL, V27, P1581, DOI 10.1128/MCB.01962-06; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; LEE KS, 1995, MOL CELL BIOL, V15, P7143; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Ma YM, 2005, J BIOL CHEM, V280, P33839, DOI 10.1074/jbc.M507113200; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; Peng YL, 2002, CANCER RES, V62, P6400; Ruis BL, 2008, MOL CELL BIOL, V28, P6182, DOI 10.1128/MCB.00355-08; Shang ZF, 2010, CANCER RES, V70, P3657, DOI 10.1158/0008-5472.CAN-09-3362; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195	31	60	61	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.212969	http://dx.doi.org/10.1074/jbc.M110.212969			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21330363	hybrid, Green Published			2022-12-25	WOS:000289077500090
J	Yabe, T; Hosoda-Yabe, R; Kanamaru, Y; Kiso, M				Yabe, Tomio; Hosoda-Yabe, Ritsuko; Kanamaru, Yoshihiro; Kiso, Makoto			A Peptide Found by Phage Display Discriminates a Specific Structure of a Trisaccharide in Heparin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURITE OUTGROWTH; SULFATE PROTEOGLYCANS; ANTITHROMBIN-III; BINDING; ACTIVATION; EXPRESSION; MECHANISM; DOMAINS; PROTEIN; 3-O-SULFOTRANSFERASE	A number of recent studies have shown that heparan sulfate can control several important biological events on the cell surface through changes in sulfation pattern. The in vivo modification of sugar chains with sulfates, however, is complicated, and the discrimination of different sulfation patterns is difficult. Heparin, which is primarily produced by mast cells, is closely approximated by the structural analog heparan sulfate. Screening of heparin-associating peptides using phage display and antithrombin-bound affinity chromatography identified a peptide, heparin-associating peptide Y (HappY), that acts as a target of immobilized heparin. The peptide consists of 12 amino acid residues with characteristic three arginines and exclusively binds to heparin and heparan sulfate but does not associate with other glycosaminoglycans. HappY recognizes three consecutive monosaccharide residues in heparin through its three arginine residues. HappY should be a useful probe to detect heparin and heparan sulfate in studies of glycobiology.	[Yabe, Tomio; Hosoda-Yabe, Ritsuko; Kanamaru, Yoshihiro] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, Gifu 5011193, Japan; [Kiso, Makoto] Gifu Univ, Fac Appl Biol Sci, Dept Appl Bioorgan Chem, Gifu 5011193, Japan; [Hosoda-Yabe, Ritsuko; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan	Gifu University; Gifu University; Kyoto University	Yabe, T (corresponding author), 1-1 Yanagido, Gifu 5011193, Japan.	yabet@gifu-u.ac.jp	Yabe, Tomio/B-5900-2013	Yabe, Tomio/0000-0002-9295-8560	Japan Society for the Promotion of Science (JSPS) [17101007, 16770108]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Japan Society for the Promotion of Science (JSPS) Grant-in-aid for Scientific Research (S) 17101007 (to M. K.) and for Young Scientists (B) 16770108 (to T. Y.).	Arocas V, 1999, BIOCHEMISTRY-US, V38, P10196, DOI 10.1021/bi990686b; Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200; BASS S, 1990, PROTEINS, V8, P309, DOI 10.1002/prot.340080405; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brito AS, 2008, BIOORGAN MED CHEM, V16, P9588, DOI 10.1016/j.bmc.2008.09.020; Brown RA, 2003, BRIT J PHARMACOL, V139, P845, DOI 10.1038/sj.bjp.0705291; Bruinsma IB, 2010, ACTA NEUROPATHOL, V119, P211, DOI 10.1007/s00401-009-0577-1; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; Deng LW, 1999, VIROLOGY, V253, P271, DOI 10.1006/viro.1998.9509; Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200; DISCHE Z, 1957, BIOCHIM BIOPHYS ACTA, V24, P193, DOI 10.1016/0006-3002(57)90163-4; Gao YG, 2005, MOL CELLS, V19, P350; GROOTENHUIS PDJ, 1991, J AM CHEM SOC, V113, P2743, DOI 10.1021/ja00007a058; HIRSH J, 1992, BLOOD, V79, P1; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kuberan B, 2004, J BIOL CHEM, V279, P5053, DOI 10.1074/jbc.C300492200; LAM LH, 1976, BIOCHEM BIOPH RES CO, V69, P570, DOI 10.1016/0006-291X(76)90558-1; Laremore TN, 2009, CURR OPIN CHEM BIOL, V13, P633, DOI 10.1016/j.cbpa.2009.08.017; Li F, 2008, J BIOL CHEM, V283, P34294, DOI 10.1074/jbc.M806015200; Linhardt RJ, 2003, J MED CHEM, V46, P2551, DOI 10.1021/jm030176m; Liu J, 1996, J BIOL CHEM, V271, P27072, DOI 10.1074/jbc.271.43.27072; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; MACHOVICH R, 1975, BIOCHIM BIOPHYS ACTA, V412, P13, DOI 10.1016/0005-2795(75)90334-7; McKeehan WL, 1999, J BIOL CHEM, V274, P21511, DOI 10.1074/jbc.274.31.21511; Middeldorp S, 2008, THROMB RES, V122, P753, DOI 10.1016/j.thromres.2007.07.004; Munoz E, 2006, BIOCHEM BIOPH RES CO, V339, P597, DOI 10.1016/j.bbrc.2005.11.051; Onoue S, 2003, LIFE SCI, V73, P2793, DOI 10.1016/S0024-3205(03)00705-7; OOSTA GM, 1981, P NATL ACAD SCI-BIOL, V78, P829, DOI 10.1073/pnas.78.2.829; Purushothaman A, 2007, J BIOL CHEM, V282, P19442, DOI 10.1074/jbc.M700630200; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Tashiro K, 1999, BIOCHEM J, V340, P119, DOI 10.1042/0264-6021:3400119; Teixeira MM, 1996, J LEUKOCYTE BIOL, V59, P389, DOI 10.1002/jlb.59.3.389; ten Dam GB, 2009, HISTOCHEM CELL BIOL, V132, P117, DOI 10.1007/s00418-009-0592-2; Thompson SM, 2009, J BIOL CHEM, V284, P35621, DOI 10.1074/jbc.M109.009712; Timmer NM, 2010, NEUROSCI RES, V66, P380, DOI 10.1016/j.neures.2009.12.012; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Wang JG, 2002, INFLAMM RES, V51, P435, DOI 10.1007/PL00012403; WEILER JM, 1992, J IMMUNOL, V148, P3210; WRIGHT TC, 1989, J BIOL CHEM, V264, P1534; Yabe T, 2005, GLYCOBIOLOGY, V15, P982, DOI 10.1093/glycob/cwi090; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u	56	4	5	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.172155	http://dx.doi.org/10.1074/jbc.M110.172155			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21335559	hybrid, Green Published			2022-12-25	WOS:000289077500054
J	Chen, L; Cai, Y; Jin, JJ; Florens, L; Swanson, SK; Washburn, MP; Conaway, JW; Conaway, RC				Chen, Lu; Cai, Yong; Jin, Jingji; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Joan Weliky; Conaway, Ronald C.			Subunit Organization of the Human INO80 Chromatin Remodeling Complex AN EVOLUTIONARILY CONSERVED CORE COMPLEX CATALYZES ATP-DEPENDENT NUCLEOSOME REMODELING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEINS; SPECTRAL ABUNDANCE FACTORS; SACCHAROMYCES-CEREVISIAE; IDENTIFICATION TECHNOLOGY; SHOTGUN PROTEOMICS; TRANSCRIPTION; REPAIR; EXPRESSION; NUCLEOTIDE; PEPTIDES	We previously identified and purified a human ATP-dependent chromatin remodeling complex with similarity to the Saccharomyces cerevisiae INO80 complex (Jin, J., Cai, Y., Yao, T., Gottschalk, A. J., Florens, L., Swanson, S. K., Gutierrez, J. L., Coleman, M. K., Workman, J. L., Mushegian, A., Washburn, M. P., Conaway, R. C., and Conaway, J. W. (2005) J. Biol. Chem. 280, 41207-41212) and demonstrated that it is composed of (i) a Snf2 family ATPase (hIno80) related in sequence to the S. cerevisiae Ino80 ATPase; (ii) seven additional evolutionarily conserved subunits orthologous to yeast INO80 complex subunits; and (iii) six apparently metazoan-specific subunits. In this report, we present evidence that the human INO80 complex is composed of three modules that assemble with three distinct domains of the hIno80 ATPase. These modules include (i) one that is composed of the N terminus of the hIno80 protein and all of the metazoan-specific subunits and is not required for ATP dependent nucleosome remodeling; (ii) a second that is composed of the hIno80 Snf2-like ATPase/helicase and helicase-SANT-associated/ post-HSA (HSA/PTH) domain, the actin-related proteins Arp4 and Arp8, and the GLI-Kruppel family transcription factor YY1; and (iii) a third that is composed of the hIno80 Snf2 ATPase domain, the Ies2 and Ies6 proteins, the AAA(+) ATPases Tip49a and Tip49b, and the actin-related protein Arp5. Through purification and characterization of hINO80 complex subassemblies, we demonstrate that ATP-dependent nucleosome remodeling by the hINO80 complex is catalyzed by a core complex comprising the hIno80 protein HSA/PTH and Snf2 ATPase domains acting in concert with YY1 and the complete set of its evolutionarily conserved subunits. Taken together, our findings shed new light on the structure and function of the INO80 chromatin-remodeling complex.	[Chen, Lu; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Joan Weliky; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Chen, Lu; Conaway, Joan Weliky; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Cai, Yong; Jin, Jingji] Jilin Univ, Coll Life Sci, Changchun 130012, Jilin Province, Peoples R China	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; Jilin University	Conaway, RC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	rcc@stowers.org	Chen, Lu/AAN-4886-2021	Chen, Lu/0000-0002-4571-7975; Washburn, Michael/0000-0001-7568-2585; Conaway, Joan/0000-0002-2786-0663; Florens, Laurence/0000-0002-9310-6650	National Institutes of Health through the NIGMS [GM41628]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041628, R01GM041628] Funding Source: NIH RePORTER	National Institutes of Health through the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41628 through the NIGMS (to R. C. C. and J. W. C.).	ACTIVITIES IN, 2007, NUMBER MARCH, V67, P2283; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Hur SK, 2010, CELL MOL LIFE SCI, V67, P2283, DOI 10.1007/s00018-010-0337-3; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Owen-Hughes T, 1999, METH MOL B, V119, P319; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Park EJ, 2010, BIOCHEM J, V431, P179, DOI 10.1042/BJ20100988; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu S, 2007, NAT STRUCT MOL BIOL, V14, P1165, DOI 10.1038/nsmb1332; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	35	83	97	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11283	11289		10.1074/jbc.M111.222505	http://dx.doi.org/10.1074/jbc.M111.222505			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21303910	hybrid, Green Published			2022-12-25	WOS:000288797100040
J	Masson, O; Prebois, C; Derocq, D; Meulle, A; Dray, C; Daviaud, D; Quilliot, D; Valet, P; Muller, C; Liaudet-Coopman, E				Masson, Olivier; Prebois, Christine; Derocq, Danielle; Meulle, Aline; Dray, Cedric; Daviaud, Danielle; Quilliot, Didier; Valet, Philippe; Muller, Catherine; Liaudet-Coopman, Emmanuelle			Cathepsin-D, a Key Protease in Breast Cancer, Is Up-Regulated in Obese Mouse and Human Adipose Tissue, and Controls Adipogenesis	PLOS ONE			English	Article							GENE-EXPRESSION; PROCATHEPSIN-D; GROWTH-FACTORS; IN-VIVO; CELLS; METASTASIS; ADIPOCYTES; TUMOR; DIFFERENTIATION; PROLIFERATION	The aspartic protease cathepsin-D (cath-D) is overexpressed by human epithelial breast cancer cells and is closely correlated with poor prognosis in breast cancer. The adipocyte is one of the most prominent cell types in the tumor-microenvironment of breast cancer, and clinical studies have shown that obesity increases the incidence of breast cancer. Here, we provide the first evidence that cath-D expression is up-regulated in adipose tissue from obese human beings, as well as in adipocytes from the obese C57BI6/J mouse. Cath-D expression is also increased during human and mouse adipocyte differentiation. We show that cath-D silencing in 3T3-F442A murine preadipocytes leads to lipid-depleted cells after adipogenesis induction, and inhibits of the expression of PPAR gamma, HSL and aP2 adipocyte differentiation markers. Altogether, our findings demonstrate the key role of cath-D in the control of adipogenesis, and suggest that cath-D may be a novel target in obesity.	[Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] INSERM, U896, Montpellier, France; [Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] Univ Montpellier 1, Montpellier, France; [Masson, Olivier; Prebois, Christine; Derocq, Danielle; Liaudet-Coopman, Emmanuelle] CRLC Val Aurelle Paul Lamarque, Montpellier, France; [Meulle, Aline; Dray, Cedric; Daviaud, Danielle; Valet, Philippe] Univ Toulouse, UPS, Inst Med Mol Rangueil, Toulouse, France; [Meulle, Aline; Muller, Catherine] CNRS, Inst Pharmacol & Struct Biol, UMR 5089, Toulouse, France; [Dray, Cedric; Daviaud, Danielle; Valet, Philippe] Fac Med Toulouse, INSERM, U858, F-31073 Toulouse, France; [Quilliot, Didier] CHU Nancy, Serv Diabetol Malad Metabol & Nutr, Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Nancy	Masson, O (corresponding author), Inst Rech Cancerol Montpellier, IRCM, Montpellier, France.	e.liaudet@valdorel.fnclcc.fr	Meulle, Aline/M-6370-2014; Liaudet-Coopman, Emmanuelle/N-4744-2017; Valet, Philippe/N-7472-2017; MULLER, Catherine/M-2185-2018; MULLER, Catherine/E-2060-2011; dray, cedric/N-7440-2017; Quillot, Didier/ABB-5326-2021	Liaudet-Coopman, Emmanuelle/0000-0001-9313-9690; Valet, Philippe/0000-0001-6520-7393; DRAY, Cedric/0000-0002-4712-791X	'Institut National de la Sante et de la Recherche Medicale; University of Montpellier I; Canceropole Grand Sud-Ouest; Institut National du Cancer [PL2006_035]	'Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; Canceropole Grand Sud-Ouest; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by the 'Institut National de la Sante et de la Recherche Medicale', the University of Montpellier I, the Canceropole Grand Sud-Ouest and the Institut National du Cancer (INCA grants PL2006_035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andarawewa KL, 2005, CANCER RES, V65, P10862, DOI 10.1158/0008-5472.CAN-05-1231; Beaujouin M, 2010, J CELL SCI, V123, P3336, DOI 10.1242/jcs.070938; Berchem G, 2002, ONCOGENE, V21, P5951, DOI 10.1038/sj.onc.1205745; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; CAPONY F, 1987, J CELL BIOL, V104, P253, DOI 10.1083/jcb.104.2.253; CAPONY F, 1989, CANCER RES, V49, P3904; CAVAILLES V, 1988, NUCLEIC ACIDS RES, V16, P1903, DOI 10.1093/nar/16.5.1903; CAVAILLES V, 1989, MOL ENDOCRINOL, V3, P552, DOI 10.1210/mend-3-3-552; Felbor U, 2002, P NATL ACAD SCI USA, V99, P7883, DOI 10.1073/pnas.112632299; Ferrandina G, 1997, BRIT J CANCER, V76, P661, DOI 10.1038/bjc.1997.442; Foekens JA, 1999, BRIT J CANCER, V79, P300, DOI 10.1038/sj.bjc.6990048; FUSEK M, 1994, BIOCHEM J, V303, P775, DOI 10.1042/bj3030775; GARCIA M, 1990, ONCOGENE, V5, P1809; Gesta S, 2003, HORM METAB RES, V35, P158, DOI 10.1055/s-2003-39070; Glondu M, 2001, ONCOGENE, V20, P6920, DOI 10.1038/sj.onc.1204843; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Iyengar Puneeth, 2003, Pediatr Diabetes, V4, P32, DOI 10.1034/j.1399-5448.2003.00029.x; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; Laurent-Matha V, 2005, J CELL BIOL, V168, P489, DOI 10.1083/jcb.200403078; LIAUDET E, 1994, ONCOGENE, V9, P1145; LIAUDET E, 1995, CELL GROWTH DIFFER, V6, P1045; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; MAQUOI N, 2002, P NATL ACAD SCI USA, V99, P15345; Masson O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007422; Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345; Moazed B, 2002, CAN J PHYSIOL PHARM, V80, P515, DOI 10.1139/Y02-067; MUTKA AL, 2009, J NEUROCHEM; NAOUR N, J CLIN ENDOCRINOL ME, V95, P1861; Nicotra G, 2010, CANCER BIOMARK, V7, P47, DOI 10.3233/CBM-2010-0143; Ohri SS, 2008, INT J ONCOL, V32, P491; Prawitt J, 2008, EXP CELL RES, V314, P814, DOI 10.1016/j.yexcr.2007.11.011; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rochefort H, 1999, APMIS, V107, P86, DOI 10.1111/j.1699-0463.1999.tb01530.x; ROCHEFORT H, 1992, EUR J CANCER, V28A, P1780, DOI 10.1016/0959-8049(92)90003-K; Rodriguez J, 2005, INT J BIOL MARKER, V20, P103, DOI 10.1177/172460080502000204; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Taleb S, 2006, ENDOCRINOLOGY, V147, P4950, DOI 10.1210/en.2006-0386; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Vashishta A, 2007, INT J ONCOL, V30, P1223; Vashishta Aruna, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P385; WESTLEY B, 1980, CELL, V20, P353, DOI 10.1016/0092-8674(80)90621-2; Westley BR, 1999, BRIT J CANCER, V79, P189, DOI 10.1038/sj.bjc.6690032; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443; Yang M, 2007, NAT CELL BIOL, V9, P970, DOI 10.1038/ncb1623; Xiao Y, 2006, J CLIN ENDOCR METAB, V91, P4520, DOI 10.1210/jc.2005-2486; Zhou H, 2009, ACTA BIOCH BIOPH SIN, V41, P910, DOI 10.1093/abbs/gmp085	52	45	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16452	10.1371/journal.pone.0016452	http://dx.doi.org/10.1371/journal.pone.0016452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311773	gold, Green Submitted, Green Published			2022-12-25	WOS:000287036200014
J	Cai, X; Wang, R; Filloux, A; Waksman, G; Meng, GY				Cai, Xun; Wang, Rui; Filloux, Alain; Waksman, Gabriel; Meng, Guoyu			Structural and Functional Characterization of Pseudomonas aeruginosa CupB Chaperones	PLOS ONE			English	Article							PROTEIN SECRETION; USHER; BIOFILM; INFECTIONS; BIOGENESIS; PARAMETERS; COMPLEX	Pseudomonas aeruginosa, an important human pathogen, is estimated to be responsible for,10% of nosocomial infections worldwide. The pathogenesis of P. aeruginosa starts from its colonization in the damaged tissue or medical devices (e. g. catheters, prothesis and implanted heart valve etc.) facilitated by several extracellular adhesive factors including fimbrial pili. Several clusters containing fimbrial genes have been previously identified on the P. aeruginosa chromosome and named cup [1]. The assembly of the CupB pili is thought to be coordinated by two chaperones, CupB2 and CupB4. However, due to the lack of structural and biochemical data, their chaperone activities remain speculative. In this study, we report the 2.5 A crystal structure of P. aeruginosa CupB2. Based on the structure, we further tested the binding specificity of CupB2 and CupB4 towards CupB1 (the presumed major pilus subunit) and CupB6 (the putative adhesin) using limited trypsin digestion and strep-tactin pull-down assay. The structural and biochemical data suggest that CupB2 and CupB4 might play different, but not redundant, roles in CupB secretion. CupB2 is likely to be the chaperone of CupB1, and CupB4 could be the chaperone of CupB4:CupB5:CupB6, in which the interaction of CupB4 and CupB6 might be mediated via CupB5.	[Cai, Xun; Meng, Guoyu] Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, Sch Med,State Key Lab Med Genom, Shanghai 200030, Peoples R China; [Wang, Rui; Waksman, Gabriel] UCL Birkbeck, Inst Struct & Mol Biol, London, England; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London, England	Chinese Academy of Sciences; Shanghai Jiao Tong University; University of London; Birkbeck University London; University College London; Imperial College London	Cai, X (corresponding author), Shanghai Jiao Tong Univ, Rui Jin Hosp, Shanghai Inst Hematol, Sch Med,State Key Lab Med Genom, Shanghai 200030, Peoples R China.	a.filloux@imperial.ac.uk; guoyumeng@shsmu.edu.cn		Meng (meng), Guoyu (guo yu)/0000-0001-7904-2382	Shanghai Institute of Higher Learning; National Natural Science Foundation of China [31070645, 30871105]; Wellcome Trust, the United Kingdom [08087]; BBSRC [BB/I018484/1] Funding Source: UKRI; MRC [G0800002] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I018484/1] Funding Source: researchfish; Medical Research Council [G0800002] Funding Source: researchfish	Shanghai Institute of Higher Learning; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wellcome Trust, the United Kingdom(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by "The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institute of Higher Learning" (to GM), the research grants 31070645 and 30871105 of the National Natural Science Foundation of China (to GM and XC) and a research grant 08087 from the Wellcome Trust, the United Kingdom (to GM and GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bann JG, 2004, P NATL ACAD SCI USA, V101, P17389, DOI 10.1073/pnas.0408072101; BODEY GP, 1983, REV INFECT DIS, V5, P279; Chorell E, 2010, J MED CHEM, V53, P5690, DOI 10.1021/jm100470t; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Filloux A, 2003, M S-MED SCI, V19, P77, DOI 10.1051/medsci/200319177; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Geme JWS, 2009, TRENDS MICROBIOL, V17, P355, DOI 10.1016/j.tim.2009.06.002; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; Hodak H, 2007, RES MICROBIOL, V158, P631, DOI 10.1016/j.resmic.2007.08.001; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; KUEHN MJ, 1993, SCIENCE, V262, P1234, DOI 10.1126/science.7901913; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Ruer S, 2007, J BACTERIOL, V189, P3547, DOI 10.1128/JB.00093-07; Sauer FG, 2000, CURR OPIN STRUC BIOL, V10, P548, DOI 10.1016/S0959-440X(00)00129-9; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; Tommassen J, 2010, MICROBIOL-SGM, V156, P2587, DOI 10.1099/mic.0.042689-0; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Veesenmeyer JL, 2009, CRIT CARE MED, V37, P1777, DOI 10.1097/CCM.0b013e31819ff137; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zavialov A, 2007, FEMS MICROBIOL REV, V31, P478, DOI 10.1111/j.1574-6976.2007.00075.x; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	35	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16583	10.1371/journal.pone.0016583	http://dx.doi.org/10.1371/journal.pone.0016583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304995	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000286834300092
J	Ghavami, S; Mutawe, MM; Sharma, P; Yeganeh, B; McNeill, KD; Klonisch, T; Unruh, H; Kashani, HH; Schaafsma, D; Los, M; Halayko, AJ				Ghavami, Saeid; Mutawe, Mark M.; Sharma, Pawan; Yeganeh, Behzad; McNeill, Karol D.; Klonisch, Thomas; Unruh, Helmut; Kashani, Hessam H.; Schaafsma, Dedmer; Los, Marek; Halayko, Andrew J.			Mevalonate Cascade Regulation of Airway Mesenchymal Cell Autophagy and Apoptosis: A Dual Role for p53	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; MITOCHONDRIAL PERMEABILITY TRANSITION; COENZYME-A REDUCTASE; SMOOTH-MUSCLE-CELLS; CANCER-CELLS; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; INDUCE APOPTOSIS; MAMMALIAN-CELLS; DEATH	Statins inhibit the proximal steps of cholesterol biosynthesis, and are linked to health benefits in various conditions, including cancer and lung disease. We have previously investigated apoptotic pathways triggered by statins in airway mesenchymal cells, and identified reduced prenylation of small GTPases as a primary effector mechanism leading to p53-mediated cell death. Here, we extend our studies of statin-induced cell death by assessing endpoints of both apoptosis and autophagy, and investigating their interplay and coincident regulation. Using primary cultured human airway smooth muscle (HASM) and human airway fibroblasts (HAF), autophagy, and autophagosome formation and flux were assessed by transmission electron microscopy, cytochemistry (lysosome number and co-localization with LC3) and immunoblotting (LC3 lipidation and Atg 12-5 complex formation). Chemical inhibition of autophagy increased simvastatin-induced caspase activation and cell death. Similarly, Atg5 silencing with shRNA, thus preventing Atg5-12 complex formation, increased proapoptotic effects of simvastatin. Simvastatin concomitantly increased p53-dependent expression of p53 up-regulated modulator of apoptosis (PUMA), NOXA, and damage-regulated autophagy modulator (DRAM). Notably both mevalonate cascade inhibition-induced autophagy and apoptosis were p53 dependent: simvastatin increased nuclear p53 accumulation, and both cyclic pifithrin-alpha and p53 shRNAi partially inhibited NOXA, PUMA expression and caspase-3/7 cleavage (apoptosis) and DRAM expression, Atg5-12 complex formation, LC3 lipidation, and autophagosome formation (autophagy). Furthermore, the autophagy response is induced rapidly, significantly delaying apoptosis, suggesting the existence of a temporally coordinated p53 regulation network. These findings are relevant for the development of statin-based therapeutic approaches in obstructive airway disease.	[Ghavami, Saeid; Mutawe, Mark M.; Sharma, Pawan; Yeganeh, Behzad; McNeill, Karol D.; Kashani, Hessam H.; Schaafsma, Dedmer; Halayko, Andrew J.] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Ghavami, Saeid; Sharma, Pawan; Yeganeh, Behzad; Kashani, Hessam H.; Halayko, Andrew J.] Univ Manitoba, Natl Training Program Allergy & Asthma, Winnipeg, MB, Canada; [Klonisch, Thomas] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Unruh, Helmut; Halayko, Andrew J.] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Ghavami, Saeid; Mutawe, Mark M.; Sharma, Pawan; Yeganeh, Behzad; McNeill, Karol D.; Kashani, Hessam H.; Schaafsma, Dedmer; Halayko, Andrew J.] Manitoba Inst Child Hlth, Biol Breathing Grp, Winnipeg, MB, Canada; [Los, Marek] Linkoping Univ, Integrat Regenerat Med Ctr IGEN, Dept Clin & Expt Med, Linkoping, Sweden	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Linkoping University	Ghavami, S (corresponding author), Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada.	ahalayk@cc.umanitoba.ca	Ghavami, Saeid/Q-8918-2016; Kashani, Hessam H./S-7968-2017; Ghavami, Saeid/GLT-0606-2022; Sharma, Pawan/D-4314-2016; Klonisch, Thomas/W-9923-2019	Kashani, Hessam H./0000-0003-2581-1769; Ghavami, Saeid/0000-0001-5948-508X; Sharma, Pawan/0000-0002-2904-2306; Halayko, Andrew/0000-0002-7865-4552; Yeganeh, Behzad/0000-0002-2315-7620; Los, Marek/0000-0001-9518-1411; Schaafsma, Dedmer/0000-0003-0898-7973	Canadian Institutes of Health Research (CIHR); GlaxoSmithKline Collaborative Innovation Research Fund; Manitoba Institute of Child Health (MICH); Canada Foundation for Innovation; Parker B Francis Fellowship in Pulmonary Research; Manitoba Health Research Council; CIHR; Natural Sciences and Engineering Research Council of Canada (NSERC); DFG Deutsche Krebshilfe [SFB 773, GRK 1302]; Landesstiftung BW [P-PS-ASII/11]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GlaxoSmithKline Collaborative Innovation Research Fund(GlaxoSmithKline); Manitoba Institute of Child Health (MICH); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Parker B Francis Fellowship in Pulmonary Research; Manitoba Health Research Council; CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); DFG Deutsche Krebshilfe; Landesstiftung BW	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), GlaxoSmithKline Collaborative Innovation Research Fund, Manitoba Institute of Child Health (MICH), and Canada Foundation for Innovation. SG is supported by a Parker B Francis Fellowship in Pulmonary Research. DS is supported by a CIHR Postdoctoral Fellowship. PS is supported by the Manitoba Health Research Council, MICH and CIHR. TK acknowledges the support by the Natural Sciences and Engineering Research Council of Canada (NSERC). ML thankfully acknowledges the support from DFG (SFB 773, GRK 1302) Deutsche Krebshilfe, and Landesstiftung BW (P-PS-ASII/11). AJH holds a Canada Research Chair in Airway Cell and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Araki M, 2008, BIOCHEM BIOPH RES CO, V367, P462, DOI 10.1016/j.bbrc.2007.12.166; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Bensaad K, 2007, TRENDS CELL BIOL, V17, P286, DOI 10.1016/j.tcb.2007.04.004; Blanco-Colio LM, 2002, ATHEROSCLEROSIS, V161, P17, DOI 10.1016/S0021-9150(01)00613-X; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Ghavami S, 2008, J CELL MOL MED, V12, P1005, DOI 10.1111/j.1582-4934.2008.00129.x; Ghavami Saeid, 2005, P323, DOI 10.1007/0-387-23695-3_15; Ghavami S, 2010, BBA-MOL CELL RES, V1803, P452, DOI 10.1016/j.bbamcr.2009.12.005; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Green DR, 2006, CELL, V126, P30, DOI 10.1016/j.cell.2006.06.032; Guijarro C, 1998, CIRC RES, V83, P490, DOI 10.1161/01.RES.83.5.490; Harhaji L, 2007, EUR J PHARMACOL, V568, P89, DOI 10.1016/j.ejphar.2007.04.041; Horiguchi A, 2004, CLIN CANCER RES, V10, P8648, DOI 10.1158/1078-0432.CCR-04-1568; Hsieh CH, 2008, TOXICOL SCI, V102, P150, DOI 10.1093/toxsci/kfm298; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; JONES KD, 1994, BIOCHEM BIOPH RES CO, V205, P1681, DOI 10.1006/bbrc.1994.2861; Kaneta S, 2003, ATHEROSCLEROSIS, V170, P237, DOI 10.1016/S0021-9150(03)00301-0; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li XW, 2002, J BIOL CHEM, V277, P15309, DOI 10.1074/jbc.M201253200; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Naureckas ET, 1999, AM J RESP CRIT CARE, V160, P2062, DOI 10.1164/ajrccm.160.6.9903131; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; PEREZSALA D, 1995, J BIOL CHEM, V270, P6235, DOI 10.1074/jbc.270.11.6235; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Rosenfeldt MT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001306; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sanchez CA, 2008, CANCER INVEST, V26, P698, DOI 10.1080/07357900701874658; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023	57	77	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16523	10.1371/journal.pone.0016523	http://dx.doi.org/10.1371/journal.pone.0016523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304979	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300076
J	Mayer, ML; Sheridan, JA; Blohmke, CJ; Turvey, SE; Hancock, REW				Mayer, Matthew L.; Sheridan, Jared A.; Blohmke, Christoph J.; Turvey, Stuart E.; Hancock, Robert E. W.			The Pseudomonas aeruginosa Autoinducer 3O-C12 Homoserine Lactone Provokes Hyperinflammatory Responses from Cystic Fibrosis Airway Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; QUORUM-SENSING MOLECULE; TRANSMEMBRANE CONDUCTANCE REGULATOR; GENE-EXPRESSION; IL-8 PRODUCTION; N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; ANTIINFLAMMATORY TARGET; LUNG INFECTION; IN-VIVO; ACTIVATION	The discovery of novel antiinflammatory targets to treat inflammation in the cystic fibrosis (CF) lung stands to benefit patient populations suffering with this disease. The Pseudomonas aeruginosa quorum sensing autoinducer N-3oxododecanoyl homoserine lactone (3O-C12) is an important bacterial virulence factor that has been reported to induce proinflammatory cytokine production from a variety of cell types. The goal of this study was to examine the ability of 3O-C12 to induce proinflammatory cytokine production in normal and CF bronchial epithelial cells, and better understand the cellular mechanisms by which this cytokine induction occurs. 3O-C12 was found to induce higher levels of IL-6 production in the CF cell lines IB3-1 and CuFi, compared to their corresponding control cell lines C38 and NuLi. Systems biology and network analysis revealed a high predominance of over-represented innate immune pathways bridged together by calcium-dependant transcription factors governing the transcriptional responses of A549 airway cells to stimulation with 3O-C12. Using calcium-flux assays, 3O-C12 was found to induce larger and more sustained increases in intracellular calcium in IB3-1 cells compared to C38, and blocking this calcium flux with BAPTA-AM reduced the production of IL-6 by IB3-1 to the levels produced by C38. These data suggest that 3O-C12 induces proinflammatory cytokine production in airway epithelial cells in a calcium-dependent manner, and that dysregulated calcium storage or signalling in CF cells results in an increased production of proinflammatory cytokines.	[Mayer, Matthew L.; Sheridan, Jared A.; Hancock, Robert E. W.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Mayer, Matthew L.; Sheridan, Jared A.; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Blohmke, Christoph J.; Turvey, Stuart E.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 1M9, Canada; [Blohmke, Christoph J.; Turvey, Stuart E.] BC Childrens Hosp, Child & Family Res Inst, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; Child & Family Research Institute; University of British Columbia	Mayer, ML (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	bob@cmdr.ubc.ca	Hancock, Robert E. W./E-1145-2013; Turvey, Stuart/HGV-1191-2022	Hancock, Robert E. W./0000-0001-5989-8503; Turvey, Stuart/0000-0003-1599-1065	Foundation for the National Institutes of Health; Bill and Melinda Gates Foundation; Canadian Institutes for Health Research (CIHR); Grand Challenges in Global Health Initiative; Genome BC for the Pathogenomics of Innate Immunity; Michael Smith Foundation; Canadian Cystic Fibrosis Foundation; British Columbia Lung Association; CIHR Team in Mutagenesis and Infectious Diseases	Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Grand Challenges in Global Health Initiative; Genome BC for the Pathogenomics of Innate Immunity; Michael Smith Foundation(Michael Smith Foundation for Health Research); Canadian Cystic Fibrosis Foundation; British Columbia Lung Association; CIHR Team in Mutagenesis and Infectious Diseases(Canadian Institutes of Health Research (CIHR))	The lab of REWH receives funding from the Foundation for the National Institutes of Health, the Bill and Melinda Gates Foundation, and the Canadian Institutes for Health Research (CIHR) for two separate program grants from the Grand Challenges in Global Health Initiative and Genome BC for the Pathogenomics of Innate Immunity research program grant. M.L.M. holds a CIHR M.D./Ph.D. studentship and a Michael Smith Foundation for Health Research trainee award. C.J.B. was supported by the Canadian Cystic Fibrosis Foundation. S.E.T. holds a Career Development Award from the Canadian Child Health Clinician Scientist Program (a CIHR Strategic Training Program) and is funded by operating grants from the Canadian Cystic Fibrosis Foundation, British Columbia Lung Association, and the CIHR Team in Mutagenesis and Infectious Diseases. R.E.W.H. is a Canada Research Chair in Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara N, 2009, J AM CHEM SOC, V131, P10610, DOI 10.1021/ja903292v; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; Bjarnsholt T, 2010, NAT PROTOC, V5, P282, DOI 10.1038/nprot.2009.205; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Blohmke CJ, 2010, J IMMUNOL, V185, P7731, DOI 10.4049/jimmunol.1001513; Boontham P, 2008, CLIN SCI, V115, P343, DOI 10.1042/CS20080018; Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081; Bryan A, 2010, MICROBES INFECT, V12, P1042, DOI 10.1016/j.micinf.2010.07.006; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Delgado MA, 2006, INFECT IMMUN, V74, P2975, DOI 10.1128/IAI.74.5.2975-2984.2006; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Erickson DL, 2002, INFECT IMMUN, V70, P1783, DOI 10.1128/IAI.70.4.1783-1790.2002; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Gomperts BN, 2006, J IMMUNOL, V176, P1916, DOI 10.4049/jimmunol.176.3.1916; Hartman G, 1998, LANCET, V351, P848, DOI 10.1016/S0140-6736(05)70282-8; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Horke S, 2010, BIOCHEM J, V426, P73, DOI 10.1042/BJ20091414; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ierano T, 2010, INNATE IMMUN-LONDON, V16, P354, DOI 10.1177/1753425909347400; Imamura Y, 2005, J MED MICROBIOL, V54, P515, DOI 10.1099/jmm.0.46004-0; Jacobi CA, 2009, INT J MED MICROBIOL, V299, P509, DOI 10.1016/j.ijmm.2009.03.005; Joseph T, 2005, AM J PHYSIOL-LUNG C, V288, pL471, DOI 10.1152/ajplung.00066.2004; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Levy H, 2009, PEDIATR PULM, V44, P580, DOI 10.1002/ppul.21026; Li HT, 2009, MED MICROBIOL IMMUN, V198, P113, DOI 10.1007/s00430-009-0111-z; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Martino MEB, 2009, J BIOL CHEM, V284, P14904, DOI 10.1074/jbc.M809180200; Miyairi S, 2006, J MED MICROBIOL, V55, P1381, DOI 10.1099/jmm.0.46658-0; Moker N, 2010, J BACTERIOL, V192, P1946, DOI 10.1128/JB.01231-09; Mookherjee N, 2009, MOL BIOSYST, V5, P483, DOI 10.1039/b813787k; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; Ornatowski W, 2007, J CLIN INVEST, V117, P3489, DOI 10.1172/JCI31499; Palfreyman RW, 1997, INFECT IMMUN, V65, P617, DOI 10.1128/IAI.65.2.617-622.1997; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Schwarzer C, 2010, J BIOL CHEM, V285, P34850, DOI 10.1074/jbc.M110.167668; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Smith RS, 2002, J IMMUNOL, V169, P2636, DOI 10.4049/jimmunol.169.5.2636; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Tabary O, 2006, CELL SIGNAL, V18, P652, DOI 10.1016/j.cellsig.2005.06.004; Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Vikstrom E, 2010, EUR J CELL BIOL, V89, P584, DOI 10.1016/j.ejcb.2010.03.002; Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhu H, 2008, EYE CONTACT LENS, V34, P179, DOI 10.1097/ICL.0b013e318159afde; Zimmermann S, 2006, INFECT IMMUN, V74, P5687, DOI 10.1128/IAI.01940-05	58	51	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16246	10.1371/journal.pone.0016246	http://dx.doi.org/10.1371/journal.pone.0016246			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305014	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300044
J	Ott, CE; Grunhagen, J; Jager, M; Horbelt, D; Schwill, S; Kallenbach, K; Guo, G; Manke, T; Knaus, P; Mundlos, S; Robinson, PN				Ott, Claus Eric; Gruenhagen, Johannes; Jaeger, Marten; Horbelt, Daniel; Schwill, Simon; Kallenbach, Klaus; Guo, Gao; Manke, Thomas; Knaus, Petra; Mundlos, Stefan; Robinson, Peter N.			MicroRNAs Differentially Expressed in Postnatal Aortic Development Downregulate Elastin via 3 ' UTR and Coding-Sequence Binding Sites	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MESSENGER-RNA; FIBER FORMATION; MARKED LONGEVITY; D-ASPARTATE; TGF-BETA; PROTEIN; TRANSCRIPTION; TARGETS; COLLAGEN	Elastin production is characteristically turned off during the maturation of elastin-rich organs such as the aorta. MicroRNAs (miRNAs) are small regulatory RNAs that down-regulate target mRNAs by binding to miRNA regulatory elements (MREs) typically located in the 3' UTR. Here we show a striking up-regulation of miR-29 and miR-15 family miRNAs during murine aortic development with commensurate down-regulation of targets including elastin and other extracellular matrix (ECM) genes. There were a total of 14 MREs for miR-29 in the coding sequences (CDS) and 3' UTR of elastin, which was highly significant, and up to 22 miR-29 MREs were found in the CDS of multiple ECM genes including several collagens. This overrepresentation was conserved throughout mammalian evolution. Luciferase reporter assays showed synergistic effects of miR-29 and miR-15 family miRNAs on 3' UTR and coding-sequence elastin constructs. Our results demonstrate that multiple miR-29 and miR-15 family MREs are characteristic for some ECM genes and suggest that miR-29 and miR-15 family miRNAs are involved in the down-regulation of elastin in the adult aorta.	[Ott, Claus Eric; Gruenhagen, Johannes; Jaeger, Marten; Guo, Gao; Mundlos, Stefan; Robinson, Peter N.] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Jaeger, Marten; Mundlos, Stefan; Robinson, Peter N.] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Horbelt, Daniel; Knaus, Petra] Free Univ Berlin, Inst Biochem, D-1000 Berlin, Germany; [Schwill, Simon; Kallenbach, Klaus] Univ Heidelberg Hosp, Dept Cardiac Surg, Heidelberg, Germany; [Manke, Thomas; Mundlos, Stefan; Robinson, Peter N.] Max Planck Inst Mol Genet, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Ruprecht Karls University Heidelberg; Max Planck Society	Ott, CE (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	peter.robinson@charite.de	Manke, Thomas/L-9075-2019; Ott, Claus E/G-1936-2011; Mundlos, Stefan/ABH-9585-2020; Ott, Claus/U-8226-2019	Ott, Claus E/0000-0003-3627-3791; Ott, Claus/0000-0003-3627-3791; Robinson, Peter/0000-0002-0736-9199; Mundlos, Stefan/0000-0002-9788-3166	National Marfan Foundation; European Commission (FAD) [HEALTH-F2-2008-200647]; Deutsche Forschungsgemeinschaft [DFG SFB 760]; Sonnenfeld Fellowship	National Marfan Foundation; European Commission (FAD)(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld Fellowship	This work was supported by grants from the National Marfan Foundation, the European Commission (FAD; HEALTH-F2-2008-200647), and the Deutsche Forschungsgemeinschaft (DFG SFB 760). D.H. is supported by a Sonnenfeld Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booms P, 2006, J MOL CELL CARDIOL, V40, P234, DOI 10.1016/j.yjmcc.2005.11.009; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; DEGROOT ACG, 2006, TRENDS CARDIOVAS MED, V16, P1; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HINEK A, 1995, EXP CELL RES, V220, P312, DOI 10.1006/excr.1995.1321; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Jawien J, 2008, J PHYSIOL PHARMACOL, V59, P239; JOHNSON DJ, 1995, CIRC RES, V77, P1107, DOI 10.1161/01.RES.77.6.1107; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; Ketting RF, 2009, DEV CELL, V16, P487, DOI 10.1016/j.devcel.2009.03.014; Kielty CM, 2002, J CELL SCI, V115, P2817; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Kuang PP, 2002, AM J PHYSIOL-CELL PH, V283, pC58, DOI 10.1152/ajpcell.00314.2001; Kucich U, 1997, AM J RESP CELL MOL, V17, P10, DOI 10.1165/ajrcmb.17.1.2816; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lei J, 1998, AM J PHYSIOL-RENAL, V274, pF252, DOI 10.1152/ajprenal.1998.274.2.F252; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; Neumann C, 2008, INVEST OPHTH VIS SCI, V49, P1464, DOI 10.1167/iovs.07-1053; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pierce RA, 2006, AM J PHYSIOL-LUNG C, V291, pL391, DOI 10.1152/ajplung.00441.2004; POWELL JT, 1992, ATHEROSCLEROSIS, V97, P201, DOI 10.1016/0021-9150(92)90132-Z; Rigoutsos I, 2009, CANCER RES, V69, P3245, DOI 10.1158/0008-5472.CAN-09-0352; Ritz-Timme S, 2003, BRIT J DERMATOL, V149, P951, DOI 10.1111/j.1365-2133.2003.05618.x; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Sysa P, 2009, DNA CELL BIOL, V28, P425, DOI 10.1089/dna.2009.0884; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, CIRC RES, V104, P138, DOI 10.1161/CIRCRESAHA.108.192492; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	68	89	93	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16250	10.1371/journal.pone.0016250	http://dx.doi.org/10.1371/journal.pone.0016250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305018	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300045
J	Dixon, BP; Henry, J; Siroky, BJ; Chu, A; Groen, PA; Bissler, JJ				Dixon, Bradley P.; Henry, Jeff; Siroky, Brian J.; Chu, Albert; Groen, Pamela A.; Bissler, John J.			Cell Cycle Control and DNA Damage Response of Conditionally Immortalized Urothelial Cells	PLOS ONE			English	Article							EPITHELIAL-CELLS; BARRIER FUNCTION; URINARY-BLADDER; TRANSGENIC MICE; HIGH NACL; IN-VIVO; EXPRESSION; CULTURE; LINES; ESTABLISHMENT	Background: Children with complex urogenital anomalies often require bladder reconstruction. Gastrointestinal tissues used in bladder augmentations exhibit a greatly increased risk of malignancy, and the bladder microenvironment may play a role in this carcinogenesis. Investigating the influences of the bladder microenvironment on gastrointestinal and urothelial cell cycle checkpoint activation and DNA damage response has been limited by the lack of an appropriate well-differentiated urothelial cell line system. Methodology/Principal Findings: To meet this need, we have developed a well-differentiated conditionally immortalized urothelial cell line by isolating it from the H-2K(b)-tsA58 transgenic mouse. These cells express a thermosensitive SV40 large T antigen that can be deactivated by adjustment of cell culture conditions, allowing the cell line to regain normal control of the cell cycle. The isolated urothelial cell line demonstrates a polygonal, dome-shaped morphology, expresses cytokeratin 18, and exhibits well-developed tight junctions. Adaptation of the urothelial cell line to hyperosmolal culture conditions induces expression of both cytokeratin 20 and uroplakin II, markers of a superficial urothelial cell or "umbrella cell.'' This cell line can be maintained indefinitely in culture under permissive conditions but when cultured under non-permissive conditions, large T antigen expression is reduced substantially, leading to increased p53 activity and reduced cellular proliferation. Conclusions/Significance: This new model of urothelial cells, along with gastrointestinal cell lines previously derived from the H-2K(b)-tsA58 transgenic mouse, will be useful for studying the potential mechanisms of carcinogenesis of the augmented bladder.	[Dixon, Bradley P.; Henry, Jeff; Siroky, Brian J.; Chu, Albert; Bissler, John J.] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA; [Groen, Pamela A.] Cincinnati Childrens Hosp Med Ctr, Div Pathol & Lab Med, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dixon, BP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA.	john.bissler@cchmc.org		Dixon, Bradley/0000-0003-3704-0922; Bissler, John/0000-0001-9685-9183	Kidney Foundation of Greater Cincinnati; William Cooper Procter Pediatric Research Award; National Institutes of Health [K12 HD028827, R01 DK061458]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061458] Funding Source: NIH RePORTER	Kidney Foundation of Greater Cincinnati; William Cooper Procter Pediatric Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work described herein was funded by a Kidney Foundation of Greater Cincinnati Research Award, the William Cooper Procter Pediatric Research Award, and an institutional allocation of funding from a Child Health Research Career Development Award from the National Institutes of Health (K12 HD028827) to BPD, and grant funding from the National Institutes of Health (R01 DK061458) to JJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Boffetta P, 2008, SCAND J UROL NEPHROL, V42, P45, DOI 10.1080/03008880802283664; Boyle P, 2008, WORLD CANC REPORT 20; Chapman EJ, 2006, ONCOGENE, V25, P5037, DOI 10.1038/sj.onc.1209513; Chapman EJ, 2008, MOL CANCER RES, V6, P1154, DOI 10.1158/1541-7786.MCR-07-2168; Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Dixon BP, 2009, MUTAT RES-FUND MOL M, V670, P88, DOI 10.1016/j.mrfmmm.2009.07.010; Dmitrieva NI, 2004, P NATL ACAD SCI USA, V101, P2317, DOI 10.1073/pnas.0308463100; Dmitrieva NI, 2003, AM J PHYSIOL-RENAL, V285, pF266, DOI 10.1152/ajprenal.00060.2003; Feliers D, 2005, KIDNEY INT, V68, P1648, DOI 10.1111/j.1523-1755.2005.00575.x; FILMER RB, 1990, J UROLOGY, V143, P671, DOI 10.1016/S0022-5347(17)40055-3; Han XL, 2007, CHINESE MED J-PEKING, V120, P405; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Husmann DA, 2009, THER ADV UROL, V1, P5, DOI 10.1177/1756287209104163; Ivil KD, 2007, UROLOGY, V70, P905, DOI 10.1016/j.urology.2007.06.1121; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Kiltie AE, 2010, CURR OPIN GENET DEV, V20, P218, DOI 10.1016/j.gde.2010.01.002; King LE, 2010, VIROLOGY, V406, P95, DOI 10.1016/j.virol.2010.06.033; Koch S, 2009, ANN NY ACAD SCI, V1165, P220, DOI 10.1111/j.1749-6632.2009.04025.x; Koizumi M, 2005, SURGERY, V138, P125, DOI 10.1016/j.surg.2005.06.008; Kotoh S, 1997, J UROLOGY, V157, P1054, DOI 10.1016/S0022-5347(01)65140-1; Kreft ME, 2005, FOLIA BIOL-PRAGUE, V51, P126; Kreft ME, 2002, CELL BIOL INT, V26, P63, DOI 10.1006/cbir.2001.0829; Kwon ED, 1996, AM J PHYSIOL-RENAL, V271, pF230, DOI 10.1152/ajprenal.1996.271.1.F230; Langley RR, 2009, INT J ONCOL, V35, P665, DOI 10.3892/ijo_00000378; Lobban ED, 1998, AM J PATHOL, V153, P1957, DOI 10.1016/S0002-9440(10)65709-4; LUCAS SB, 1982, E AFR MED J, V59, P345; MOLL R, 1988, AM J PATHOL, V132, P123; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; National Cancer Institute, SEER STAT FACT SHEET; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Ricceri F, 2010, DNA REPAIR, V9, P191, DOI 10.1016/j.dnarep.2009.12.002; RIGBY CC, 1970, BRIT J CANCER, V24, P746, DOI 10.1038/bjc.1970.89; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Sun TT, 2006, AM J PHYSIOL-RENAL, V291, pF9, DOI 10.1152/ajprenal.00035.2006; Truschel ST, 1999, J BIOL CHEM, V274, P15020, DOI 10.1074/jbc.274.21.15020; Tyagi S, 2006, J UROLOGY, V176, P1673, DOI 10.1016/j.juro.2006.06.088; Veys CA, 2004, OCCUP MED-OXFORD, V54, P322, DOI 10.1093/occmed/kqh010; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; WU XR, 1994, J BIOL CHEM, V269, P13716; Zhang Z, 2004, P NATL ACAD SCI USA, V101, P9491, DOI 10.1073/pnas.0402961101	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16595	10.1371/journal.pone.0016595	http://dx.doi.org/10.1371/journal.pone.0016595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305048	Green Published, Green Submitted, gold			2022-12-25	WOS:000286664100047
J	Ramos, E; Torre, EA; Bushey, AM; Gurudatta, BV; Corces, VG				Ramos, Edward; Torre, Eduardo A.; Bushey, Ashley M.; Gurudatta, B. V.; Corces, Victor G.			DNA Topoisomerase II Modulates Insulator Function in Drosophila	PLOS ONE			English	Article							CHROMATIN INSULATOR; NUCLEAR-ORGANIZATION; GENOME ORGANIZATION; GYPSY INSULATOR; GENE-REGULATION; 3 DIMENSIONS; CTCF; PROTEINS; MELANOGASTER; TRANSCRIPTION	Insulators are DNA sequences thought to be important for the establishment and maintenance of cell-type specific nuclear architecture. In Drosophila there are several classes of insulators that appear to have unique roles in gene expression. The mechanisms involved in determining and regulating the specific roles of these insulator classes are not understood. Here we report that DNA Topoisomerase II modulates the activity of the Su(Hw) insulator. Downregulation of Topo II by RNAi or mutations in the Top2 gene result in disruption of Su(Hw) insulator function. This effect is mediated by the Mod(mdg4)2.2 protein, which is a unique component of the Su(Hw) insulator complex. Co-immunoprecipitation and yeast two-hybrid experiments show that Topo II and Mod(mdg4) 2.2 proteins directly interact. In addition, mutations in Top2 cause a slight decrease of Mod(mdg4) 2.2 transcript but have a dramatic effect on Mod(mdg4) 2.2 protein levels. In the presence of proteasome inhibitors, normal levels of Mod(mdg4) 2.2 protein and its binding to polytene chromosomes are restored. Thus, Topo II is required to prevent Mod(mdg4) 2.2 degradation and, consequently, to stabilize Su(Hw) insulator-mediated chromatin organization.	[Ramos, Edward; Torre, Eduardo A.; Bushey, Ashley M.; Gurudatta, B. V.; Corces, Victor G.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Bushey, Ashley M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Emory University; Johns Hopkins University	Ramos, E (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	vcorces@emory.edu		Wood, Ashley/0000-0002-8713-601X; Corces, Victor/0000-0001-5140-4337	National Institutes of Health [GM35463, CA133106]; NATIONAL CANCER INSTITUTE [K01CA133106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by U.S. Public Health Service Awards to VC (GM35463) and ER (CA133106) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bartkuhn M, 2009, EMBO J, V28, P877, DOI 10.1038/emboj.2009.34; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dorman ER, 2007, SEMIN CELL DEV BIOL, V18, P682, DOI 10.1016/j.semcdb.2007.08.009; Feng JM, 2008, CANC BIOL THER, V7; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Golovnin A, 2008, EMBO REP, V9, P440, DOI 10.1038/embor.2008.32; Gomes NP, 2010, GENE DEV, V24, P1022, DOI 10.1101/gad.1881010; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Gurudatta B. V., 2009, Briefings in Functional Genomics & Proteomics, V8, P276, DOI 10.1093/bfgp/elp032; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; HOOVER KK, 1993, GENETICS, V135, P507; HOOVER KK, 1992, GENETICS, V132, P691; JACKSON DA, 1992, CELL BIOL INT REP, V16, P687, DOI 10.1016/S0309-1651(05)80013-X; Jiang N, 2009, MOL CELL BIOL, V29, P3556, DOI 10.1128/MCB.01748-08; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Nabirochkin S, 1998, J BIOL CHEM, V273, P2473, DOI 10.1074/jbc.273.4.2473; NEGRE N, PLOS GENET, V6; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; PETERSEN NS, 1994, GENETICS, V136, P173; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994; Schaaf CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006202; Smith ST, 2009, DEV BIOL, V328, P518, DOI 10.1016/j.ydbio.2008.12.039; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Valastyan S, 2009, GENE DEV, V23, P2592, DOI 10.1101/gad.1832709; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; von Metzler I, 2009, EXP CELL RES, V315, P2471, DOI 10.1016/j.yexcr.2009.04.019; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8	53	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16562	10.1371/journal.pone.0016562	http://dx.doi.org/10.1371/journal.pone.0016562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304601	Green Published, gold			2022-12-25	WOS:000286663900072
J	Wang, W; Li, JM				Wang, Wei; Li, Jinming			Identification of Natural Bispecific Antibodies against Cyclic Citrullinated Peptide and Immunoglobulin G in Rheumatoid Arthritis	PLOS ONE			English	Article							HUMAN IGG4; SUBCLASS DISTRIBUTION; ANTI-CCP; AUTOANTIBODIES	Background: Previous studies indicate that natural bispecific antibodies can be readily produced in vivo when the body is simultaneously stimulated with 2 distinct antigens. Patients with rheumatoid arthritis (RA) usually exhibit persistent immune responses to various autoantigens, raising the possibility that natural bispecific antibodies against 2 distinct autoantigens might exist. Methodology/Principal Findings: We identified the presence of natural bispecific antibodies against cyclic citrullinated peptide (CCP) and immunoglobulin G (IgG) in RA patients' sera by means of a double-antigen sandwich enzyme-linked immunosorbent assay (ELISA). The spontaneous emergence of bispecific antibodies was confirmed by mixing different proportions of 1 anti-CCP-positive serum and 1 rheumatoid factor (RF)-positive serum in vitro. Among the tested samples, positive correlations were found between the presence of bispecific antibodies and both IgG4 anti-CCP antibodies and IgG4 RF (r = 0.507, p < 0.001 and r = 0.249, p = 0.044, respectively), suggesting that the IgG4 subclass is associated with this phenomenon. Furthermore, bispecific antibodies were selectively generated when several anti-CCP- and RF-positive sera were mixed pairwise, indicating that factors other than the monospecific antibody titers may also contribute to the production of the natural bispecific antibodies. Conclusions/Significance: We successfully identified the presence of natural bispecific antibodies. Our results suggest that these antibodies originate from anti-CCP and RF in the sera of RA patients. The natural occurrence of bispecific antibodies in human diseases may provide new insights for a better understanding of the diseases. Further investigations are needed to elucidate their precise generation mechanisms and explore their clinical significance in disease development and progression in a larger study population.	[Wang, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100037, Peoples R China; [Wang, Wei; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Hospital	Wang, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100037, Peoples R China.	ljm63hn@yahoo.com.cn						Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Attar SM, 2009, SAUDI MED J, V30, P446; AVRAMEAS S, 1971, IMMUNOCHEMISTRY, V8, P1175, DOI 10.1016/0019-2791(71)90395-8; Chapuy-Regaud S, 2005, CLIN EXP IMMUNOL, V139, P542, DOI 10.1111/j.1365-2249.2004.02708.x; COHEN PL, 1987, J IMMUNOL, V139, P1466; Engelmann R, 2008, RHEUMATOLOGY, V47, P1489, DOI 10.1093/rheumatology/ken336; Ferri S, 1988, Scand J Rheumatol Suppl, V75, P223; Forslind K, 2004, ANN RHEUM DIS, V63, P1090, DOI 10.1136/ard.2003.014233; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Lee Ashley Nicole, 2008, Clin Lab Sci, V21, P15; Lopez-Hoyos M, 2004, RHEUMATOLOGY, V43, P655, DOI 10.1093/rheumatology/keh143; Ortona E, 2008, AUTOIMMUN REV, V7, P579, DOI 10.1016/j.autrev.2008.06.001; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Selby C, 1999, ANN CLIN BIOCHEM, V36, P704, DOI 10.1177/000456329903600603; STONE R, 1987, J CLIN PATHOL, V40, P107, DOI 10.1136/jcp.40.1.107; TANIMOTO K, 1976, ANN RHEUM DIS, V35, P240, DOI 10.1136/ard.35.3.240; Wang W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010879	21	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16527	10.1371/journal.pone.0016527	http://dx.doi.org/10.1371/journal.pone.0016527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304585	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900062
J	Wesolowski, LG; Delaney, KP; Lampe, MA; Nesheim, SR				Wesolowski, Laura G.; Delaney, Kevin P.; Lampe, Margaret A.; Nesheim, Steven R.			False-Positive Human Immunodeficiency Virus Enzyme Immunoassay Results in Pregnant Women	PLOS ONE			English	Article							WESTERN BLOTS; INDETERMINATE; TESTS; RISK; DELIVERY; ADULTS; LABOR; CARE	Objective: Examine whether false-positive HIV enzyme immunoassay (EIA) test results occur more frequently among pregnant women than among women who are not pregnant and men (others). Design: To obtain a large number of pregnant women and others tested for HIV, we identified specimens tested at a national laboratory using Genetic Systems HIV-1/HIV-2 Plus O EIA from July 2007 to June 2008. Methods: Specimens with EIA repeatedly reactive and Western blot-negative or indeterminate results were considered EIA false-positive. We compared the false-positive rate among uninfected pregnant women and others, adjusting for HIV prevalence. Among all reactive EIAs, we evaluated the proportion of false-positives, positive predictive value (PPV), and Western blot bands among indeterminates, by pregnancy status. Results: HIV prevalence was 0.06% among 921,438 pregnant women and 1.34% among 1,103,961 others. The false-positive rate was lower for pregnant women than others (0.14% vs. 0.21%, odds ratio 0.65 [95% confidence interval 0.61, 0.70]). Pregnant women with reactive EIAs were more likely than others (p < 0.01) to have Western blot-negative (52.9% vs. 9.8%) and indeterminate results (17.0% vs. 3.7%) and lower PPV (30% vs. 87%). The p24 band was detected more often among pregnant women (p < 0.01). Conclusions: False-positive HIV EIA results were rare and occurred less frequently among pregnant women than others. Pregnant women with reactive EIAs were more likely to have negative and indeterminate Western blot results due to lower HIV prevalence and higher p24 reactivity, respectively. Indeterminate results may complicate clinical management during pregnancy. Alternative methods are needed to rule out infection in persons with reactive EIAs from low prevalence populations.	[Wesolowski, Laura G.; Delaney, Kevin P.; Lampe, Margaret A.; Nesheim, Steven R.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Wesolowski, LG (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	lig7@cdc.gov	Delaney, Kevin/HHS-1060-2022		Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this project was provided by the Centers for Disease Control and Prevention (CDC). CDC staff designed the analysis, decided to publish the data, and prepared the manuscript. The study was based on existing laboratory data collected at a commercial laboratory.	American College of Obstetrics and Gynecology Committee on Obstetric Practice, 2008, Obstet Gynecol, V112, P739, DOI 10.1097/AOG.0b013e318188d29c; Anderson JE, 2006, MATERN CHILD HLTH J, V10, P413, DOI 10.1007/s10995-006-0120-0; Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; [Anonymous], 1999, Pediatrics, V104, P128; [Anonymous], HIV TEST ALG STAT RE; [Anonymous], RETROVIRAL TESTING Q; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; CELUM CL, 1991, J INFECT DIS, V164, P656, DOI 10.1093/infdis/164.4.656; CELUM CL, 1994, ARCH INTERN MED, V154, P1129, DOI 10.1001/archinte.154.10.1129; Doran TI, 2000, ARCH FAM MED, V9, P924, DOI 10.1001/archfami.9.9.924; Garcia T, 2009, J MED MICROBIOL, V58, P1529, DOI 10.1099/jmm.0.008599-0; Greenland S., 1998, MODERN EPIDEMIOLOGY, P343; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Havens PL, 2008, PEDIATRICS, V122, P1127, DOI 10.1542/peds.2008-2175; JACKSON JB, 1995, TRANSFUSION, V35, P98, DOI 10.1046/j.1537-2995.1995.35295125746.x; Jamieson DJ, 2007, AM J OBSTET GYNECOL, V197, pS72, DOI 10.1016/j.ajog.2007.03.067; Laperche S, 2003, TRANSFUSION, V43, P1428, DOI 10.1046/j.1537-2995.2003.00541.x; MIDTHUN K, 1990, J INFECT DIS, V162, P1379, DOI 10.1093/infdis/162.6.1379; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; *PUBL HLTH SERV TA, 2009, PUBL HLTH SERV TASK; Rahangdale L, 2007, JAIDS-J ACQ IMM DEF, V46, P376, DOI 10.1097/QAI.0b013e3181576888; Rich JD, 1998, J ACQ IMMUN DEF SYND, V17, P376, DOI 10.1097/00042560-199804010-00013; Wesolowski LG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001524	23	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16538	10.1371/journal.pone.0016538	http://dx.doi.org/10.1371/journal.pone.0016538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304592	gold, Green Published			2022-12-25	WOS:000286663900065
J	Stielow, B; Bratek, Z; Orczan, AKI; Rudnoy, S; Hensel, G; Hoffmann, P; Klenk, HP; Goker, M				Stielow, Benjamin; Bratek, Zoltan; Orczan, Akos Kund I.; Rudnoy, Szabolcs; Hensel, Gunnar; Hoffmann, Peter; Klenk, Hans-Peter; Goeker, Markus			Species Delimitation in Taxonomically Difficult Fungi: The Case of Hymenogaster	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MOLECULAR PHYLOGENETICS; DNA TAXONOMY; DIVERSITY; CORTINARIUS; AGARICALES; UNITS; BIODIVERSITY; SEQUENCES; TAXA	Background: False truffles are ecologically important as mycorrhizal partners of trees and evolutionarily highly interesting as the result of a shift from epigeous mushroom-like to underground fruiting bodies. Since its first description by Vittadini in 1831, inappropriate species concepts in the highly diverse false truffle genus Hymenogaster has led to continued confusion, caused by a large variety of prevailing taxonomical opinions. Methodology: In this study, we reconsidered the species delimitations in Hymenogaster based on a comprehensive collection of Central European taxa comprising more than 140 fruiting bodies from 20 years of field work. The ITS rDNA sequence dataset was subjected to phylogenetic analysis as well as clustering optimization using OPTSIL software. Conclusions: Among distinct species concepts from the literature used to create reference partitions for clustering optimization, the broadest concept resulted in the highest agreement with the ITS data. Our results indicate a highly variable morphology of H. citrinus and H. griseus, most likely linked to environmental influences on the phenology (maturity, habitat, soil type and growing season). In particular, taxa described in the 19(th) century frequently appear as conspecific. Conversely, H. niveus appears as species complex comprising seven cryptic species with almost identical macro-and micromorphology. H. intermedius and H. huthii are described as novel species, each of which with a distinct morphology intermediate between two species complexes. A revised taxonomy for one of the most taxonomically difficult genera of Basidiomycetes is proposed, including an updated identification key. The (semi-)automated selection among species concepts used here is of importance for the revision of taxonomically problematic organism groups in general.	[Stielow, Benjamin; Hoffmann, Peter; Klenk, Hans-Peter; Goeker, Markus] DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany; [Bratek, Zoltan; Orczan, Akos Kund I.; Rudnoy, Szabolcs] ELTE Univ, Dept Plant Physiol & Mol Plant Biol, Budapest, Hungary; [Hensel, Gunnar] Fungarium Gunnar Hensel, Merseburg, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Eotvos Lorand University	Stielow, B (corresponding author), DSMZ German Collect Microorganisms & Cell Culture, Braunschweig, Germany.	markus.goeker@dsmz.de	Bratek, Zoltan/AAG-3027-2020; Göker, Markus/AAX-6258-2021; Bratek, Zoltan/AGZ-4630-2022; Rudnóy, Szabolcs/C-5005-2012	Bratek, Zoltan/0000-0001-6953-5132; Göker, Markus/0000-0002-5144-6200; Bratek, Zoltan/0000-0001-6953-5132; Rudnóy, Szabolcs/0000-0002-2726-1687	Anyos Jedlik Programme; National Technology Programme	Anyos Jedlik Programme; National Technology Programme	ZB's work was supported by a project under the Anyos Jedlik Programme entitled MIKOQUAL and by the project under the National Technology Programme entitled QUTAOMEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Auch AF, 2010, STAND GENOMIC SCI, V2, P142, DOI 10.4056/sigs.541628; BEATON G, 1985, Kew Bulletin, V40, P167, DOI 10.2307/4108493; Berkeley MJ., 1844, ANN MAG NAT HIST, V13, P340, DOI [10.1080/03745484409442617, DOI 10.1080/03745484409442617]; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bidartondo MI, 2008, SCIENCE, V319, P1616, DOI 10.1126/science.319.5870.1616a; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2003, TRENDS ECOL EVOL, V18, P268, DOI 10.1016/S0169-5347(03)00102-2; BOUGHER NL, 1993, MYCOLOGIA, V85, P273, DOI 10.2307/3760462; Bougher NL, 2001, AUST SYST BOT, V14, P439, DOI 10.1071/SB00002; Boyle H, 2006, MYCOL RES, V110, P369, DOI 10.1016/j.mycres.2005.11.015; BRENNER DJ, 1973, INT J SYST BACTERIOL, V23, P298, DOI 10.1099/00207713-23-4-298; CASTELLANO M A, 1990, Australian Systematic Botany, V3, P653, DOI 10.1071/SB9900653; CASTELLANO MA, 1994, PLANT SOIL, V159, P37, DOI 10.1007/BF00000093; CORDA ACJ, 1842, ICONES FUNGORUM ANLE; Crous PW, 2004, STUD MYCOL, P19; CUNNINGHAM G. H., 1934, PROC LINNEAN SOC N S WALES, V59, P156; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DODGE CARROLL W., 1934, ANN MISSOURI BOT GARDEN, V21, P625, DOI 10.2307/2394189; Doolittle WF, 2009, COLD SH Q B, V74, P197, DOI 10.1101/sqb.2009.74.002; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferguson JWH, 2002, BIOL J LINN SOC, V75, P509, DOI 10.1046/j.1095-8312.2002.00042.x; FISCHER E, 1933, NAT PFL A, V7, P72; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; FOGEL R, 1985, MYCOLOGIA, V77, P72, DOI 10.2307/3793250; FOGEL R, 1985, MYCOLOGIA, V77, P732, DOI 10.2307/3793282; FRANCIS AA, 2003, AUSTRALASIAN MYCOLOG, V21, P81; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Froslev TG, 2007, MOL PHYLOGENET EVOL, V44, P217, DOI 10.1016/j.ympev.2006.11.013; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2003, MYCOLOGIA, V95, P1155, DOI 10.2307/3761917; Goker M, 2010, EVOL BIOINFORM, V6, P97; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; GROSS G, 1980, MYCOTAXON, V93, P241; HAWKER LE, 1954, PHILOS T R SOC B, V237, P429, DOI 10.1098/rstb.1954.0002; Helgason T, 2003, FEMS MICROBIOL LETT, V229, P127, DOI 10.1016/S0378-1097(03)00802-4; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; HESSE R, 1890, HYPOGAEEN DEUTSCHLAN, V2; Hosaka K, 2006, MYCOLOGIA, V98, P949, DOI 10.3852/mycologia.98.6.949; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Julich W, 1984, NICHTBLATTERPILZE GA; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lange M, 1956, DAN BOT ARK, V16, P1; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Leliaert F, 2009, MOL PHYLOGENET EVOL, V53, P122, DOI 10.1016/j.ympev.2009.06.004; Massee G, 1891, GREVILLEA, V19, P94; MASSEE G, 1898, KEW B MISCELLANEOUS, V138, P124; MASSEE GE, 1901, KEW B MISC INFORM, V175, P158; MASSEE GE, 1899, KEW B MISC INFORM, V153, P180; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; McNeill J., 2006, V146, P1; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Montecchi A, 2000, FUNGI IPOGEI EUROPA; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; PEGLER DN, 1993, BRIT TRUFFLES REVISI; Peintner U, 2004, MYCOLOGIA, V96, P1042, DOI 10.2307/3762088; Peintner U, 2001, AM J BOT, V88, P2168, DOI 10.2307/3558378; Pilat A, 1958, FLORA CSR GASTEROMYC; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SMITH AH, 1966, MYCOLOGIA, V58, P100, DOI 10.2307/3756992; SOEHNER E, 1962, MONOGRAPHISCHE STUDI; Sokal RR, 1963, PRINCIPLES NUMERICAL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stielow B, 2010, MYCOL PROG, V9, P195, DOI 10.1007/s11557-009-0625-1; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; TAMM H, 2010, MYCOLOGICAL IN PRESS, DOI DOI 10.1007/S11557-010-0659-4; Tindall BJ, 2008, INT J SYST EVOL MICR, V58, P1987, DOI 10.1099/ijs.0.2008/006155-0; Tringe SG, 2005, NAT REV GENET, V6, P805, DOI 10.1038/nrg1709; TULASNE LR, 1843, HIST MONOGRAPHIE CHA; Vittadini C., 1831, MONOGRAPHIA TUBERACE; White T., 1990, PCR PROTOCOLS GUIDE, P315; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Wubet T, 2006, MYCOL RES, V110, P1059, DOI 10.1016/j.mycres.2006.04.005	81	26	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2011	6	1							e15614	10.1371/journal.pone.0015614	http://dx.doi.org/10.1371/journal.pone.0015614			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712IZ	21311589	Green Submitted, gold, Green Published			2022-12-25	WOS:000286661400009
J	Hondares, E; Iglesias, R; Giralt, A; Gonzalez, FJ; Giralt, M; Mampel, T; Villarroya, F				Hondares, Elayne; Iglesias, Roser; Giralt, Albert; Gonzalez, Frank J.; Giralt, Marta; Mampel, Teresa; Villarroya, Francesc			Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES ENERGY-EXPENDITURE; INSULIN SENSITIVITY; PPAR-ALPHA; METABOLIC REGULATOR; GLUCOSE-METABOLISM; LIPID-METABOLISM; GENE-EXPRESSION; BLOOD-FLOW; MICE; FIBROBLAST-GROWTH-FACTOR-21	FGF21 is a novel metabolic regulator involved in the control of glucose homeostasis, insulin sensitivity, and ketogenesis. The liver has been considered the main site of production and release of FGF21 into the blood. Here, we show that, after thermogenic activation, brown adipose tissue becomes a source of systemic FGF21. This is due to a powerful cAMP-mediated pathway of regulation of FGF21 gene transcription. Norepinephrine, acting via beta-adrenergic, cAMP-mediated, mechanisms and subsequent activation of protein kinase A and p38 MAPK, induces FGF21 gene transcription and also FGT21 release in brown adipocytes. ATF2 binding to the FGF21 gene promoter mediates cAMP-dependent induction of FGF21 gene transcription. FGF21 release by brown fat in vivo was assessed directly by analyzing arteriovenous differences in FGF21 concentration across interscapular brown fat, in combination with blood flow to brown adipose tissue and assessment of FGF21 half-life. This analysis demonstrates that exposure of rats to cold induced a marked release of FGF21 by brown fin in vivo, in association with a reduction in systemic FGF21 half-life. The present findings lead to the recognition of a novel pathway of regulation the FGF21 gene and an endocrine role of brown fat, as a source of FGF21 that may be especially relevant in conditions of activation of thermogenic activity.	[Hondares, Elayne] Univ Barcelona, Dept Biochem & Mol Biol, Fac Biol, E-08028 Barcelona, Catalonia, Spain; [Hondares, Elayne; Iglesias, Roser; Giralt, Albert; Giralt, Marta; Mampel, Teresa; Villarroya, Francesc] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Catalonia, Spain; [Hondares, Elayne; Iglesias, Roser; Giralt, Albert; Giralt, Marta; Mampel, Teresa; Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona 08028, Catalonia, Spain; [Gonzalez, Frank J.] NCI, Met Lab, NIH, Bethesda, MD 20892 USA	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hondares, E (corresponding author), Univ Barcelona, Dept Biochem & Mol Biol, Fac Biol, Avda Diagonal 645, E-08028 Barcelona, Catalonia, Spain.	hondareselayne@ub.edu	Mampel, Teresa/C-5571-2017; Villarroya, Francesc/K-4357-2014; Giralt, Marta/A-4756-2013; Iglesias, Roser/C-5561-2017	Giralt, Marta/0000-0001-7968-4190; Iglesias, Roser/0000-0002-7107-8097; Giralt, Albert/0000-0003-4498-063X; Villarroya, Francesc/0000-0003-1266-9142	Ministerio de Ciencia e Innovacion [SAF2008-01896]; Institut de Salud Carlos III [PI081715]; Generalitat de Catalunya (Spain) [2009SGR284]; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Institut de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from Ministerio de Ciencia e Innovacion (SAF2008-01896), the Institut de Salud Carlos III (PI081715), and the Generalitat de Catalunya (Spain) (2009SGR284).	Arner P, 2008, FEBS LETT, V582, P1725, DOI 10.1016/j.febslet.2008.04.038; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BUKOWIECKI LJ, 1989, CAN J PHYSIOL PHARM, V67, P382, DOI 10.1139/y89-062; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carmona MC, 2005, BIOCHEM J, V389, P47, DOI 10.1042/BJ20050009; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; FERNANDEZ JA, 1987, BIOCHEM J, V243, P281, DOI 10.1042/bj2430281; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; JONES RG, 1984, BIOSCIENCE REP, V4, P421, DOI 10.1007/BF01122507; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; LANSBERG L, 1983, AUTONOMIC REGULATION, P99; Mai K, 2009, DIABETES, V58, P1532, DOI 10.2337/db08-1775; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; MURAMATSU AL, 1989, MOL CELL BIOL, V9, P831; Petrovic N, 2008, AM J PHYSIOL-ENDOC M, V295, pE287, DOI 10.1152/ajpendo.00035.2008; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	33	423	438	2	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					12983	12990		10.1074/jbc.M110.215889	http://dx.doi.org/10.1074/jbc.M110.215889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21317437	Green Published, hybrid			2022-12-25	WOS:000289282200018
J	Ingaranno, M; Beckett, D				Ingaranno, Maria; Beckett, Dorothy			Biotinylation, a Post-translational Modification Controlled by the Rate of Protein-Protein Association	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HOLOCARBOXYLASE SYNTHETASE; PYROCOCCUS-HORIKOSHII OT3; CARBOXYL CARRIER PROTEIN; ACETYL-COA CARBOXYLASE; COLI BIOTIN REPRESSOR; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; TRANSCRIPTIONAL SWITCH; LIGASE; SEQUENCE	Biotin protein ligases catalyze specific covalent linkage of the coenzyme biotin to biotin-dependent carboxylases. The reaction proceeds in two steps, including synthesis of an adenylated intermediate followed by biotin transfer to the carboxylase substrate. In this work specificity in the transfer reaction was investigated using single turnover stopped-flow and quench-flow assays. Cognate and noncognate reactions were measured using the enzymes and minimal biotin acceptor substrates from Escherichia coli, Pyro coccus horikoshii, and Homo sapiens. The kinetic analysis demonstrates that for all enzyme-substrate pairs the bimolecular rate of association of enzyme with substrate limits post-translational biotinylation. In addition, in noncognate reactions the three enzymes displayed a range of selectivities. These results highlight the importance of protein-protein binding kinetics for specific biotin addition to carboxylases and provide one mechanism for determining biotin distribution in metabolism.	[Ingaranno, Maria; Beckett, Dorothy] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Beckett, D (corresponding author), Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20742 USA.	dbeckett@umd.edu			National Institutes of Health [R01-GM46511, S10-RR15899]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM46511 and S10-RR15899.	ABBOTT J, 1993, BIOCHEMISTRY-US, V32, P9649, DOI 10.1021/bi00088a017; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; Bagautdinov B, 2007, ACTA CRYSTALLOGR F, V63, P334, DOI 10.1107/S1744309107011967; BAKER H, 1962, ANAL BIOCHEM, V3, P31, DOI 10.1016/0003-2697(62)90041-6; Brown PH, 2004, J MOL BIOL, V337, P857, DOI 10.1016/j.jmb.2004.01.041; Chapman-Smith A, 1999, J BIOL CHEM, V274, P1449, DOI 10.1074/jbc.274.3.1449; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Daniels KG, 2010, BIOCHEMISTRY-US, V49, P5358, DOI 10.1021/bi1003958; Eisenstein E, 1999, BIOCHEMISTRY-US, V38, P13077, DOI 10.1021/bi991241q; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gonzalez JM, 1998, EXTREMOPHILES, V2, P123, DOI 10.1007/s007920050051; Healy S, 2009, PROTEIN SCI, V18, P314, DOI 10.1002/pro.37; Ingaramo M, 2009, J BIOL CHEM, V284, P30862, DOI 10.1074/jbc.M109.046201; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; LANE MD, 1964, J BIOL CHEM, V239, P2865; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CK, 2010, FEBS LETT, V584, P675, DOI 10.1016/j.febslet.2009.12.059; LEONDELRIO A, 1995, P NATL ACAD SCI USA, V92, P4626, DOI 10.1073/pnas.92.10.4626; LEONDELRIO A, 1994, J BIOL CHEM, V269, P22964; MARINI P, 1995, J BACTERIOL, V177, P7003, DOI 10.1128/jb.177.23.7003-7006.1995; Nenortas E, 1996, J BIOL CHEM, V271, P7559, DOI 10.1074/jbc.271.13.7559; Polyak SW, 1999, J BIOL CHEM, V274, P32847, DOI 10.1074/jbc.274.46.32847; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Slavoff SA, 2008, J AM CHEM SOC, V130, P1160, DOI 10.1021/ja076655i; Streaker ED, 2006, BIOCHEMISTRY-US, V45, P6417, DOI 10.1021/bi052599r; Venezia CF, 2009, BIOCHEMISTRY-US, V48, P9084, DOI 10.1021/bi9010495; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weaver LH, 2001, PROTEIN SCI, V10, P2618, DOI 10.1110/ps.ps.32701; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Zhao HY, 2008, J MOL BIOL, V380, P223, DOI 10.1016/j.jmb.2008.04.068; Zhao HY, 2009, J MOL BIOL, V389, P336, DOI 10.1016/j.jmb.2009.04.009	34	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13071	13078		10.1074/jbc.M110.183624	http://dx.doi.org/10.1074/jbc.M110.183624			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343300	Green Published, hybrid			2022-12-25	WOS:000289282200027
J	Collier, MEW; Ettelaie, C				Collier, Mary E. W.; Ettelaie, Camille			Regulation of the Incorporation of Tissue Factor into Microparticles by Serine Phosphorylation of the Cytoplasmic Domain of Tissue Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL MICROPARTICLES; IN-VITRO; VASCULAR-DISEASE; CELLS; MECHANISM; PROLIFERATION; ISOMERIZATION; ACTIVATION; GENERATION; RELEASE	The mechanisms that regulate the incorporation and release of tissue factors (TFs) into cell-derived microparticles are as yet unidentified. In this study, we have explored the regulation of TF release into microparticles by the phosphorylation of serine residues within the cytoplasmic domain of TF. Wild-type and mutant forms of TF, containing alanine and aspartate substitutions at Ser(253) and Ser(258), were overexpressed in coronary artery and dermal microvascular endothelial cells and microparticle release stimulated with PAR2 agonist peptide (PAR2-AP). The release of TF antigen and activity was then monitored. In addition, the phosphorylation state of the two serine residues within the released microparticles and the cells was monitored for 150 min. The release of wild-type TF as procoagulant microparticles peaked at 90 min and declined thereafter in both cell types. The TF within these microparticles was phosphorylated at Ser(253) but not at Ser(258). Aspartate substitution of Ser(253) resulted in rapid release of TF antigen but not activity, whereas TF release was reduced and delayed by alanine substitution of Ser(253) or aspartate substitution of Ser(258). Alanine substitution of Ser(258) prolonged the release of TF following PAR2-AP activation. The release of TF was concurrent with phosphorylation of Ser(253) and was followed by dephosphorylation at 120 min and phosphorylation of Ser(258). We propose a sequential mechanism in which the phosphorylation of Ser(253) through PAR2 activation results in the incorporation of TF into microparticles, simultaneously inducing Ser(258) phosphorylation. Phosphorylation of Ser(258) in turn promotes the dephosphorylation of Ser(253) and suppresses the release of TF.	[Collier, Mary E. W.; Ettelaie, Camille] Univ Hull, Biomed Sect, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Hull	Ettelaie, C (corresponding author), Univ Hull, Biomed Sect, Dept Biol Sci, Cottingham Rd, Kingston Upon Hull HU6 7RX, N Humberside, England.	C.Ettelaie@hull.ac.uk			Yorkshire Cancer Research	Yorkshire Cancer Research	This work was supported in part by Yorkshire Cancer Research.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Carson SD, 2000, THROMB HAEMOSTASIS, V84, P657; Collier MEW, 2010, ARTERIOSCL THROM VAS, V30, P1810, DOI 10.1161/ATVBAHA.110.211854; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Curti AM, 2009, J THROMB HAEMOST, V7, P701, DOI 10.1111/j.1538-7836.2009.03304.x; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Dorfleutner A, 2003, BLOOD, V102, P3998, DOI 10.1182/blood-2003-04-1149; Ettelaie C, 1996, ARTERIOSCL THROM VAS, V16, P639, DOI 10.1161/01.ATV.16.5.639; Ettelaie C, 1999, FEBS LETT, V463, P341, DOI 10.1016/S0014-5793(99)01663-4; Ettelaie C, 2008, MICROVASC RES, V76, P152, DOI 10.1016/j.mvr.2008.07.007; Hussein MNA, 2008, THROMB RES, V121, P865, DOI 10.1016/j.thromres.2007.08.005; Jimenez JJ, 2005, ADV CLIN CHEM, V39, P131, DOI 10.1016/S0065-2423(04)39005-0; Lakota K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/146872; Li C, 2008, CANCER IMMUNOL IMMUN, V57, P1347, DOI 10.1007/s00262-008-0469-6; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; MAYNARD JR, 1975, J CLIN INVEST, V55, P814, DOI 10.1172/JCI107992; Mody RS, 1997, BIOCHEMISTRY-US, V36, P7869, DOI 10.1021/bi9701235; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Nasu J, 1998, CLIN EXP IMMUNOL, V113, P379; Nomura S, 2008, THROMB RES, V123, P8, DOI 10.1016/j.thromres.2008.06.006; Ott I, 1998, J CELL BIOL, V140, P1241, DOI 10.1083/jcb.140.5.1241; Pilzer D, 2005, SPRINGER SEMIN IMMUN, V27, P375, DOI 10.1007/s00281-005-0004-1; Pradier A, 2008, J VASC RES, V45, P19, DOI 10.1159/000109074; Rak J, 2006, Vnitr Lek, V52 Suppl 1, P135; Sapet C, 2006, BLOOD, V108, P1868, DOI 10.1182/blood-2006-04-014175; Schecter AD, 2000, CIRC RES, V87, P126, DOI 10.1161/01.RES.87.2.126; Sen Mehmet, 2009, Open Spectrosc J, V3, P58; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026; ZIONCHECK TF, 1992, J BIOL CHEM, V267, P3561	30	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.195214	http://dx.doi.org/10.1074/jbc.M110.195214			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310953	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000289077500011
J	Ito, T; Yamakuchi, M; Lowenstein, CJ				Ito, Takashi; Yamakuchi, Munekazu; Lowenstein, Charles J.			Thioredoxin Increases Exocytosis by Denitrosylating N-Ethylmaleimide-sensitive Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; TRANSGENIC MICE; PROTEIN DENITROSYLATION; S-NITROSYLATION; OVEREXPRESSION; INFLAMMATION; CATALYZES; DECOMPOSITION; GLUTATHIONE; EXPRESSION	Exocytosis involves membrane fusion between granules and the plasma membrane. Nitric oxide (NO) inhibits exocytosis by chemically modifying N-ethylmaleimide-sensitive factor (NSF), a key component of the exocytic machinery. However, cells recover the ability to release messenger molecules within hours of exposure to NO through unknown mechanisms. We now identify thioredoxin (TRX1) as a denitrosylase that reverses NO inhibition of exocytosis. Endogenously synthesized NO increases S-nitrosylated NSF levels, but S-nitrosylated NSF levels decrease within 3 h after exposure to NO. We found that NO increases the interaction between TRX1 and NSF, and endogenous TRX1 removes NO from S-nitrosylated NSF. Knockdown of TRX1 increases the level of S-nitrosylated NSF, prolongs the inhibition of exocytosis, and suppresses leukocyte adhesion. Taken together, these data show that TRX1 promotes exocytosis by denitrosylating NSF. Our findings suggest that TRX1 might regulate exocytosis in a variety of physiological settings, such as vascular inflammation, thrombosis, and insulin release.	[Lowenstein, Charles J.] Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, Rochester, NY 14642 USA; Univ Rochester, Dept Med, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Lowenstein, CJ (corresponding author), Univ Rochester, Aab Cardiovasc Res Inst, Sch Med & Dent, Box CVRI,601 Elmwood Ave, Rochester, NY 14642 USA.	charles_lowenstein@urmc.rochester.edu		Lowenstein, Charles/0000-0003-0485-7514				Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Burke-Gaffney A, 2005, TRENDS PHARMACOL SCI, V26, P398, DOI 10.1016/j.tips.2005.06.005; Cirino G, 2003, TRENDS PHARMACOL SCI, V24, P91, DOI 10.1016/S0165-6147(02)00049-4; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; Ebrahimian T, 2008, ANTIOXID REDOX SIGN, V10, P1127, DOI 10.1089/ars.2007.1985; Grisham MB, 1999, AM J PHYSIOL-GASTR L, V276, pG315, DOI 10.1152/ajpgi.1999.276.2.G315; Hattori I, 2004, ANTIOXID REDOX SIGN, V6, P81, DOI 10.1089/152308604771978372; Hausladen A, 2001, P NATL ACAD SCI USA, V98, P10108, DOI 10.1073/pnas.181199698; Hoshino T, 2003, AM J RESP CRIT CARE, V168, P1075, DOI 10.1164/rccm.200209-982OC; Hoshino Y, 2007, ANTIOXID REDOX SIGN, V9, P689, DOI 10.1089/ars.2007.1575; Hou YC, 1996, BIOCHEM BIOPH RES CO, V228, P88, DOI 10.1006/bbrc.1996.1620; Huang Y, 2005, NEURON, V46, P533, DOI 10.1016/j.neuron.2005.03.028; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jourd'heuil D, 1999, ARCH BIOCHEM BIOPHYS, V361, P323, DOI 10.1006/abbi.1998.1010; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Kubes P, 2000, AM J MED, V109, P150, DOI 10.1016/S0002-9343(00)00480-0; KUWADA M, 1980, J BIOCHEM-TOKYO, V88, P859, DOI 10.1093/oxfordjournals.jbchem.a133040; Lefer AM, 1999, AM J PHYSIOL-GASTR L, V276, pG572, DOI 10.1152/ajpgi.1999.276.3.G572; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lima B., J S CIRC RES, V106, P633; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lowenstein CJ, 2007, CARDIOVASC RES, V75, P240, DOI 10.1016/j.cardiores.2007.03.024; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Nakamura H, 2002, IMMUNOL LETT, V82, P165, DOI 10.1016/S0165-2478(02)00033-0; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Sakurai A, 2004, J CELL PHYSIOL, V198, P22, DOI 10.1002/jcp.10377; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; Shioji K, 2002, CIRCULATION, V106, P1403, DOI 10.1161/01.CIR.0000027817.55925.B4; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; Tao L, 2004, P NATL ACAD SCI USA, V101, P11471, DOI 10.1073/pnas.0402941101; Trujillo M, 1998, J BIOL CHEM, V273, P7828, DOI 10.1074/jbc.273.14.7828; Turoczi T, 2003, J MOL CELL CARDIOL, V35, P695, DOI 10.1016/S0022-2828(03)00117-2; Verdoucq L, 1999, J BIOL CHEM, V274, P19714, DOI 10.1074/jbc.274.28.19714; Wei SJ, 2000, CANCER RES, V60, P6688; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Yoshida T, 2005, ANN NY ACAD SCI, V1055, P1, DOI 10.1196/annals.1323.002; Zamora R, 2000, MOL MED, V6, P347, DOI 10.1007/BF03401781	52	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11179	11184		10.1074/jbc.M110.201780	http://dx.doi.org/10.1074/jbc.M110.201780			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21324905	Green Published, hybrid			2022-12-25	WOS:000288797100028
J	Blahnik, KR; Dou, L; Echipare, L; Iyengar, S; O'Geen, H; Sanchez, E; Zhao, YJ; Marra, MA; Hirst, M; Costello, JF; Korf, I; Farnham, PJ				Blahnik, Kimberly R.; Dou, Lei; Echipare, Lorigail; Iyengar, Sushma; O'Geen, Henriette; Sanchez, Erica; Zhao, Yongjun; Marra, Marco A.; Hirst, Martin; Costello, Joseph F.; Korf, Ian; Farnham, Peggy J.			Characterization of the Contradictory Chromatin Signatures at the 3 ' Exons of Zinc Finger Genes	PLOS ONE			English	Article							METHYLATION; EPIGENETICS; GENOME; HETEROCHROMATIN; POLYCOMB; REGIONS; BINDING	The H3K9me3 histone modification is often found at promoter regions, where it functions to repress transcription. However, we have previously shown that 3' exons of zinc finger genes (ZNFs) are marked by high levels of H3K9me3. We have now further investigated this unusual location for H3K9me3 in ZNF genes. Neither bioinformatic nor experimental approaches support the hypothesis that the 3' exons of ZNFs are promoters. We further characterized the histone modifications at the 3' ZNF exons and found that these regions also contain H3K36me3, a mark of transcriptional elongation. A genome-wide analysis of ChIP-seq data revealed that ZNFs constitute the majority of genes that have high levels of both H3K9me3 and H3K36me3. These results suggested the possibility that the ZNF genes may be imprinted, with one allele transcribed and one allele repressed. To test the hypothesis that the contradictory modifications are due to imprinting, we used a SNP analysis of RNA-seq data to demonstrate that both alleles of certain ZNF genes having H3K9me3 and H3K36me3 are transcribed. We next analyzed isolated ZNF 3' exons using stably integrated episomes. We found that although the H3K36me3 mark was lost when the 3' ZNF exon was removed from its natural genomic location, the isolated ZNF 3' exons retained the H3K9me3 mark. Thus, the H3K9me3 mark at ZNF 3' exons does not impede transcription and it is regulated independently of the H3K36me3 mark. Finally, we demonstrate a strong relationship between the number of tandemly repeated domains in the 3' exons and the H3K9me3 mark. We suggest that the H3K9me3 at ZNF 3' exons may function to protect the genome from inappropriate recombination rather than to regulate transcription.	[Blahnik, Kimberly R.; Iyengar, Sushma] Univ Calif Davis, Genet Grad Grp, Davis, CA 95616 USA; [Dou, Lei; Echipare, Lorigail; O'Geen, Henriette; Sanchez, Erica; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Dou, Lei] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA; [Zhao, Yongjun; Marra, Marco A.; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC, Canada; [Costello, Joseph F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Brain Tumor Res Ctr, Dept Neurosurg, San Francisco, CA 94143 USA; [Korf, Ian] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Farnham, Peggy J.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; British Columbia Cancer Agency; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California Davis; University of Southern California	Blahnik, KR (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.	pfarnham@usc.edu	Hirst, Martin/B-7684-2016; Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Farnham, Peggy/0000-0003-4469-7914	National Institutes of Health [R01CA45250, U54HG004558, NIH R01HG004348, U01ES017154]; George and Dorothy Zolk Fellowship; National Science Foundation [IIS-0612326]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004348, U54HG004558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George and Dorothy Zolk Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health [R01CA45250, U54HG004558, NIH R01HG004348, and U01ES017154]; the George and Dorothy Zolk Fellowship; and the National Science Foundation [IIS-0612326]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Crews D, 2010, HORM-INT J ENDOCRINO, V9, P41, DOI 10.14310/horm.2002.1251; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; FRIETZE S, ZNF274 RECR IN PRESS; Grayson DR, 2009, EPIGENETICS-US, V4, P144, DOI 10.4161/epi.4.3.8534; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; HARRIS RA, 2010, NATURE BIOT IN PRESS; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iwamoto K, 2009, NEUROPSYCHOBIOLOGY, V60, P5, DOI 10.1159/000234811; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; WIENCKE JK, 2007, ONCOGENE; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016	31	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17121	10.1371/journal.pone.0017121	http://dx.doi.org/10.1371/journal.pone.0017121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347206	Green Submitted, gold, Green Published			2022-12-25	WOS:000287369200024
J	Darpolor, MM; Molthen, RC; Schmainda, KM				Darpolor, Moses M.; Molthen, Robert C.; Schmainda, Kathleen M.			Multimodality Imaging of Abnormal Vascular Perfusion and Morphology in Preclinical 9L Gliosarcoma Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUSCEPTIBILITY CONTRAST MRI; BLOOD-VOLUME MAPS; IONIZING-RADIATION; IN-VIVO; PERMEABILITY FACTOR; DEXAMETHASONE; ANGIOGENESIS; TUMORS; AGENT	Background: This study demonstrates that a dynamic susceptibility contrast-magnetic resonance imaging (DSC-MRI) perfusion parameter may indicate vascular abnormality in a brain tumor model and reflects an effect of dexamethasone treatment. In addition, X-ray computed tomography (CT) measurements of vascular tortuosity and tissue markers of vascular morphology were performed to investigate the underpinnings of tumor response to dexamethasone. Methodology/Principal Findings: One cohort of Fisher 344 rats (N = 13), inoculated intracerebrally with 9L gliosarcoma cells, was treated with dexamethasone (i.p. 3 mg/kg/day) for five consecutive days, and another cohort (N = 11) was treated with equal volume of saline. Longitudinal DSC-MRI studies were performed at the first (baseline), third and fifth day of treatments. Relative cerebral blood volume (rCBV) was significantly reduced on the third day of dexamethasone treatment (0.65 +/-.13) as compared to the fifth day during treatment (1.26 +/-.19, p<0.05). In saline treated rats, relative CBV gradually increased during treatment (0.89 +/-.13, 1.00 +/-.21, 1.13 +/-.23) with no significant difference on the third day of treatment (p>0.05). In separate serial studies, microfocal X-ray CT of ex vivo brain specimens (N = 9) and immunohistochemistry for endothelial cell marker anti-CD31 (N = 8) were performed. Vascular morphology of ex vivo rat brains from micro-CT analysis showed hypervascular characteristics in tumors, and both vessel density (41.32 +/- 2.34 branches/mm(3), p<0.001) and vessel tortuosity (p<0.05) were significantly reduced in tumors of rats treated with dexamethasone compared to saline (74.29 +/- 3.51 branches/mm(3)). The vascular architecture of rat brain tissue was examined with anti-CD31 antibody, and dexamethasone treated tumor regions showed reduced vessel area (16.45 +/- 1.36 mu m(2)) as compared to saline treated tumor regions (30.83 +/- 4.31 mu m(2), p<0.001) and non-tumor regions (22.80 +/- 1.11 mu m(2), p<0.01). Conclusions/Significance: Increased vascular density and tortuosity are culprit to abnormal perfusion, which is transiently reduced during dexamethasone treatment.	[Darpolor, Moses M.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA; [Molthen, Robert C.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Darpolor, Moses M.; Schmainda, Kathleen M.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Schmainda, Kathleen M.] Med Coll Wisconsin, Dept Radiol, Milwaukee, WI 53226 USA	Marquette University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Darpolor, MM (corresponding author), Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA.	kathleen@mcw.edu	Darpolor, Moses/AAJ-8016-2020; Molthen, Robert/A-3757-2008	Darpolor, Moses/0000-0002-5172-8101; Schmainda, Kathleen/0000-0001-6402-2602	NIH/NCI [R01 CA082500]; Marquette University; NATIONAL CANCER INSTITUTE [R01CA082500] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marquette University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by NIH/NCI R01 CA082500 and GAANN grant (Marquette University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Baish JW, 2000, CANCER RES, V60, P3683; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bello L, 2001, CANCER RES, V61, P7501; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Gorski DH, 1999, CANCER RES, V59, P3374; Gorski DH, 1998, CANCER RES, V58, P5686; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Johnson RH, 1998, PHYS MED BIOL, V43, P929, DOI 10.1088/0031-9155/43/4/020; Kadambi A, 2001, CANCER RES, V61, P2404; Karau KL, 2001, AM J PHYSIOL-HEART C, V281, pH2747, DOI 10.1152/ajpheart.2001.281.6.H2747; Lee CG, 2000, CANCER RES, V60, P5565; Machein MR, 1999, NEUROPATH APPL NEURO, V25, P104; Mauceri HJ, 1998, NATURE, V394, P287, DOI 10.1038/28412; Moffat BA, 2006, CLIN CANCER RES, V12, P1525, DOI 10.1158/1078-0432.CCR-05-1408; Molthen RC, 2004, J APPL PHYSIOL, V97, P2372, DOI 10.1152/japplphysiol.00454.2004; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; Portnow J, 2002, NEURO-ONCOLOGY, V4, P22, DOI 10.1093/neuonc/4.1.22; Quarles CC, 2007, MAGN RESON MED, V57, P680, DOI 10.1002/mrm.21193; Quarles CC, 2005, TECHNOL CANCER RES T, V4, P245, DOI 10.1177/153303460500400303; Quarles CC, 2005, MAGN RESON MED, V53, P1307, DOI 10.1002/mrm.20497; Robb RA, 2001, IEEE T MED IMAGING, V20, P854, DOI 10.1109/42.952724; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; ROBB RA, 1989, COMPUT MED IMAG GRAP, V13, P433, DOI 10.1016/0895-6111(89)90285-1; Shalinsky DR, 1999, CLIN CANCER RES, V5, P1905; SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504; Wolff JEA, 1997, KLIN PADIATR, V209, P275, DOI 10.1055/s-2008-1043962; WOLFF JEA, 1993, BRAIN RES, V604, P79, DOI 10.1016/0006-8993(93)90354-P; Yuan F, 1996, P NATL ACAD SCI USA, V93, P14765, DOI 10.1073/pnas.93.25.14765	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16621	10.1371/journal.pone.0016621	http://dx.doi.org/10.1371/journal.pone.0016621			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305001	gold, Green Submitted, Green Published			2022-12-25	WOS:000286834300100
J	Gotzek, D; Robertson, HM; Wurm, Y; Shoemaker, D				Gotzek, Dietrich; Robertson, Hugh M.; Wurm, Yannick; Shoemaker, DeWayne			Odorant Binding Proteins of the Red Imported Fire Ant, Solenopsis invicta: An Example of the Problems Facing the Analysis of Widely Divergent Proteins	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; MULTIPLE SEQUENCE ALIGNMENT; AMINO-ACID SITES; CHEMOSENSORY PROTEINS; GENOME ANNOTATION; GROUP HYMENOPTERA; GENE FAMILY; EVOLUTION; INFERENCE; ACCURACY	We describe the odorant binding proteins (OBPs) of the red imported fire ant, Solenopsis invicta, obtained from analyses of an EST library and separate 454 sequencing runs of two normalized cDNA libraries. We identified a total of 18 putative functional OBPs in this ant. A third of the fire ant OBPs are orthologs to honey bee OBPs. Another third of the OBPs belong to a lineage-specific expansion, which is a common feature of insect OBP evolution. Like other OBPs, the different fire ant OBPs share little sequence similarity (similar to 20%), rendering evolutionary analyses difficult. We discuss the resulting problems with sequence alignment, phylogenetic analysis, and tests of selection. As previously suggested, our results underscore the importance for careful exploration of the sensitivity to the effects of alignment methods for data comprising widely divergent sequences.	[Gotzek, Dietrich; Wurm, Yannick] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL USA; [Shoemaker, DeWayne] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA	University of Lausanne; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Gotzek, D (corresponding author), Natl Museum Nat Hist, Dept Entomol, Smithsonian Inst, Washington, DC 20560 USA.	gotzekd@si.edu	Wurm, Yannick/A-9525-2009	Wurm, Yannick/0000-0002-3140-2809; Shoemaker, DeWayne/0000-0003-3659-8393	USDA-AFRI	USDA-AFRI(United States Department of Agriculture (USDA))	Part of this study was funded by USDA-AFRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Boussau B, 2010, TRENDS ECOL EVOL, V25, P224, DOI 10.1016/j.tree.2009.09.007; Calvello M, 2005, INSECT BIOCHEM MOLEC, V35, P297, DOI 10.1016/j.ibmb.2005.01.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2003, BIOINFORMATICS, V19, P1404, DOI 10.1093/bioinformatics/btg158; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Fletcher W, 2010, MOL BIOL EVOL, V27, P2257, DOI 10.1093/molbev/msq115; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gonzalez D, 2009, INSECT MOL BIOL, V18, P395, DOI 10.1111/j.1365-2583.2009.00883.x; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Gotzek D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007713; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guntur KVP, 2004, ARCH INSECT BIOCHEM, V57, P101, DOI 10.1002/arch.20019; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Higgins D, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P68; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; Ishida Y, 2002, NATURWISSENSCHAFTEN, V89, P505, DOI 10.1007/s00114-002-0368-1; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Krieger MJB, 2005, MOL BIOL EVOL, V22, P2090, DOI 10.1093/molbev/msi203; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003762; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Martin W, 2007, TRENDS GENET, V23, P478, DOI 10.1016/j.tig.2007.08.007; Morgenstern B, 2003, BIOINFORMATICS, V19, P425, DOI 10.1093/bioinformatics/btf882; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Morrison DA, 2009, SYST BIOL, V58, P150, DOI 10.1093/sysbio/syp009; Nielsen R, 1998, GENETICS, V148, P929; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Opperdoes FR, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P313; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 2005, CHEM SENSES, V30, pI291, DOI 10.1093/chemse/bjh229; Pitts JP, 2005, ZOOL SCR, V34, P493, DOI 10.1111/j.1463-6409.2005.00203.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Rambaut A., 2007, TRACER V1 5; Redelings BD, 2005, SYST BIOL, V54, P401, DOI 10.1080/10635150590947041; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ross KG, 1997, GENETICS, V145, P961; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sanchez-Gracia A, 2009, HEREDITY, V103, P208, DOI 10.1038/hdy.2009.55; Smith CD, 2010, MOL ECOL, V19, P31, DOI 10.1111/j.1365-294X.2009.04438.x; STEEL MA, 1993, NATURE, V364, P440, DOI 10.1038/364440a0; Suchard MA, 2006, BIOINFORMATICS, V22, P2047, DOI 10.1093/bioinformatics/btl175; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vogt Richard G., 2003, P391, DOI 10.1016/B978-012107151-6/50016-5; Wang J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r9; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Wurm Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x	72	36	40	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16289	10.1371/journal.pone.0016289	http://dx.doi.org/10.1371/journal.pone.0016289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305009	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300047
J	Nicolle, A; Hansson, LA; Brodersen, J; Nilsson, PA; Bronmark, C				Nicolle, Alice; Hansson, Lars-Anders; Brodersen, Jakob; Nilsson, P. Anders; Bronmark, Christer			Interactions between Predation and Resources Shape Zooplankton Population Dynamics	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; CLIMATE-DRIVEN CHANGES; BOTTOM-UP; TOP-DOWN; FISH PREDATION; PLANKTON DYNAMICS; RUTILUS-RUTILUS; TROPHIC INTERACTIONS; NUTRIENT ENRICHMENT; FOOD LIMITATION	Identifying the relative importance of predation and resources in population dynamics has a long tradition in ecology, while interactions between them have been studied less intensively. In order to disentangle the effects of predation by juvenile fish, algal resource availability and their interactive effects on zooplankton population dynamics, we conducted an enclosure experiment where zooplankton were exposed to a gradient of predation of roach (Rutilus rutilus) at different algal concentrations. We show that zooplankton populations collapse under high predation pressure irrespective of resource availability, confirming that juvenile fish are able to severely reduce zooplankton prey when occurring in high densities. At lower predation pressure, however, the effect of predation depended on algal resource availability since high algal resource supply buffered against predation. Hence, we suggest that interactions between mass-hatching of fish, and the strong fluctuations in algal resources in spring have the potential to regulate zooplankton population dynamics. In a broader perspective, increasing spring temperatures due to global warming will most likely affect the timing of these processes and have consequences for the spring and summer zooplankton dynamics.	[Nicolle, Alice; Hansson, Lars-Anders; Brodersen, Jakob; Nilsson, P. Anders; Bronmark, Christer] Lund Univ, Inst Ecol Limnol, Lund, Sweden	Lund University	Nicolle, A (corresponding author), Lund Univ, Inst Ecol Limnol, Lund, Sweden.	Alice.nicolle@limnol.lu.se	Hansson, Lars-Anders/HCI-2735-2022; Nilsson, Anders/H-6836-2014	Nilsson, Anders/0000-0002-3541-9835; Hansson, Lars-Anders/0000-0002-3035-1317	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR); Royal Physiographic Society in Lund	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR)(Swedish Research Council); Royal Physiographic Society in Lund	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS; www.formas.se), the Swedish Research Council (VR; www.vr.se) and the Royal Physiographic Society in Lund (www.fysiografen.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attayde JL, 2001, LIMNOL OCEANOGR, V46, P1001, DOI 10.4319/lo.2001.46.5.1001; BLINDOW I, 1993, FRESHWATER BIOL, V30, P159, DOI 10.1111/j.1365-2427.1993.tb00796.x; Brett MT, 1997, SCIENCE, V275, P384, DOI 10.1126/science.275.5298.384; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brodersen J, 2008, OIKOS, V117, P40, DOI 10.1111/j.2007.0030-1299.16118.x; CARPENTER SR, 1991, COMPARATIVE ANALYSES OF ECOSYSTEMS, P67; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; CRYER M, 1986, LIMNOL OCEANOGR, V31, P1022, DOI 10.4319/lo.1986.31.5.1022; DURBIN J, 1971, BIOMETRIKA, V58, P1; Ferreira V, 2006, OECOLOGIA, V149, P718, DOI 10.1007/s00442-006-0478-0; Garibaldi LA, 2010, OIKOS, V119, P337, DOI 10.1111/j.1600-0706.2009.17862.x; GEORGE DG, 1985, NATURE, V316, P536, DOI 10.1038/316536a0; George DG, 2004, FRESHWATER BIOL, V49, P760, DOI 10.1111/j.1365-2427.2004.01223.x; Gerten D, 2000, LIMNOL OCEANOGR, V45, P1058, DOI 10.4319/lo.2000.45.5.1058; Gillet C, 2006, J FISH BIOL, V69, P518, DOI 10.1111/j.1095-8649.2006.01123.x; GLIWICZ ZM, 1981, HYDROBIOLOGIA, V80, P205, DOI 10.1007/BF00018359; Gliwicz ZM, 2002, FRESHWATER BIOL, V47, P2296; Gliwicz ZM, 1989, PLANKTON ECOLOGY SUC, P253; GOLDSPINK CR, 1979, J FISH BIOL, V15, P473, DOI 10.1111/j.1095-8649.1979.tb03632.x; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Hamback PA, 2007, OIKOS, V116, P1995, DOI 10.1111/j.2007.0030-1299.15800.x; HANSSON LA, 1992, ECOLOGY, V73, P241, DOI 10.2307/1938735; Hansson LA, 2004, FRESHWATER BIOL, V49, P1538, DOI 10.1111/j.1365-2427.2004.01291.x; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; HUNTER MD, 1992, ECOLOGY, V73, P724; JESPERSEN AM, 1987, ARCH HYDROBIOL, V109, P445; Lacroix G., 1991, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V48, P53; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; LAMPERT W, 1988, PROC INT ASSOC THE 2, V23, P713, DOI DOI 10.1080/03680770.1987.11899698; Lappalainen J, 2007, J FISH BIOL, V70, P441, DOI 10.1111/j.1095-8649.2007.01315.x; LAUDE U, 2002, VERTEILUNG ERNAHRUNG; LUECKE C, 1990, LIMNOL OCEANOGR, V35, P1718, DOI 10.4319/lo.1990.35.8.1718; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Mehner T, 1999, ENVIRON BIOL FISH, V56, P169, DOI 10.1023/A:1007532720226; MILLS EL, 1983, T AM FISH SOC, V112, P154, DOI 10.1577/1548-8659(1983)112<154:IODPOP>2.0.CO;2; Moss B, 2004, FRESHWATER BIOL, V49, P1633, DOI 10.1111/j.1365-2427.2004.01304.x; MullerNavarra DC, 1997, GLOB CHANGE BIOL, V3, P429, DOI 10.1046/j.1365-2486.1997.00080.x; Noges P, 2005, BOREAL ENVIRON RES, V10, P45; Osenberg Craig W., 1996, P134; Perrow M. R., 1999, Hydrobiologia, P85; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Previtali MA, 2009, ECOLOGY, V90, P1996, DOI 10.1890/08-0405.1; PTOVIN C, 2001, DESIGN ANAL ECOLOGIC, P63; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; SARNELLE O, 1992, ECOLOGY, V73, P551, DOI 10.2307/1940761; Scheffer M, 1997, OIKOS, V80, P519, DOI 10.2307/3546625; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Skov C, 2008, ECOL FRESHW FISH, V17, P406, DOI 10.1111/j.1600-0633.2008.00291.x; Sosa-Cordero E, 1998, J EXP MAR BIOL ECOL, V229, P1, DOI 10.1016/S0022-0981(98)00037-9; Straile D, 2000, GLOBAL CHANGE BIOL, V6, P663, DOI 10.1046/j.1365-2486.2000.00350.x; Straile D, 2000, OECOLOGIA, V122, P44, DOI 10.1007/PL00008834; THRELKELD ST, 1979, ECOLOGY, V60, P165, DOI 10.2307/1936478; Tveraa T, 2003, OECOLOGIA, V137, P370, DOI 10.1007/s00442-003-1373-6; URABE J, 1991, FRESHWATER BIOL, V25, P1, DOI 10.1111/j.1365-2427.1991.tb00467.x; Vakkilainen K, 2004, FRESHWATER BIOL, V49, P1619, DOI 10.1111/j.1365-2427.2004.01300.x; VANNI MJ, 1986, ECOLOGY, V67, P337, DOI 10.2307/1938577; Wagner A, 2004, ARCH HYDROBIOL, V160, P1, DOI 10.1127/0003-9136/2004/0160-0001; Wahlstrom E, 1999, CAN J FISH AQUAT SCI, V56, P1865, DOI 10.1139/cjfas-56-10-1865; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; WU L, 1994, J GREAT LAKES RES, V20, P537, DOI 10.1016/S0380-1330(94)71170-9	67	30	30	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16534	10.1371/journal.pone.0016534	http://dx.doi.org/10.1371/journal.pone.0016534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304980	Green Submitted, Green Published, gold			2022-12-25	WOS:000286834300080
J	Garbacki, N; Di Valentin, E; Huynh-Thu, VA; Geurts, P; Irrthum, A; Crahay, C; Arnould, T; Deroanne, C; Piette, J; Cataldo, D; Colige, A				Garbacki, Nancy; Di Valentin, Emmanuel; Huynh-Thu, Van Anh; Geurts, Pierre; Irrthum, Alexandre; Crahay, Celine; Arnould, Thierry; Deroanne, Christophe; Piette, Jacques; Cataldo, Didier; Colige, Alain			MicroRNAs Profiling in Murine Models of Acute and Chronic Asthma: A Relationship with mRNAs Targets	PLOS ONE			English	Article							LUNG-CANCER; MATRIX METALLOPROTEINASES; LYMPHOCYTIC-LEUKEMIA; AIRWAY INFLAMMATION; EXPRESSION PROFILES; CARDIAC DEVELOPMENT; CELL-PROLIFERATION; ANDROGEN RECEPTOR; GENE-EXPRESSION; SMOOTH-MUSCLE	Background: miRNAs are now recognized as key regulator elements in gene expression. Although they have been associated with a number of human diseases, their implication in acute and chronic asthma and their association with lung remodelling have never been thoroughly investigated. Methodology/Principal Findings: In order to establish a miRNAs expression profile in lung tissue, mice were sensitized and challenged with ovalbumin mimicking acute, intermediate and chronic human asthma. Levels of lung miRNAs were profiled by microarray and in silico analyses were performed to identify potential mRNA targets and to point out signalling pathways and biological processes regulated by miRNA-dependent mechanisms. Fifty-eight, 66 and 75 miRNAs were found to be significantly modulated at short-, intermediate- and long-term challenge, respectively. Inverse correlation with the expression of potential mRNA targets identified mmu-miR-146b, -223, -29b, -29c, -483, -574-5p, -672 and -690 as the best candidates for an active implication in asthma pathogenesis. A functional validation assay was performed by cotransfecting in human lung fibroblasts (WI26) synthetic miRNAs and engineered expression constructs containing the coding sequence of luciferase upstream of the 3'UTR of various potential mRNA targets. The bioinformatics analysis identified miRNA-linked regulation of several signalling pathways, as matrix metalloproteinases, inflammatory response and TGF-beta signalling, and biological processes, including apoptosis and inflammation. Conclusions/Significance: This study highlights that specific miRNAs are likely to be involved in asthma disease and could represent a valuable resource both for biological makers identification and for unveiling mechanisms underlying the pathogenesis of asthma.	[Garbacki, Nancy; Deroanne, Christophe; Colige, Alain] Univ Liege, GIGA Res, Lab Connect Tissues Biol, Liege, Belgium; [Di Valentin, Emmanuel; Piette, Jacques] Univ Liege, GIGA Res, Lab Virol & Immunol, Liege, Belgium; [Crahay, Celine; Cataldo, Didier] Univ Liege, GIGA Res, Lab Biol Tumours & Dev, Liege, Belgium; [Arnould, Thierry] Univ Namur, Lab Biochem & Cell Biol, Namur, Belgium	University of Liege; University of Liege; University of Liege; University of Namur	Garbacki, N (corresponding author), Univ Liege, GIGA Res, Lab Connect Tissues Biol, Liege, Belgium.	acolige@ulg.ac.be	Cataldo, Didier/GPG-3453-2022	Di Valentin, Emmanuel/0000-0002-5287-7950; Cataldo, Didier/0000-0002-3079-7941	Walloon Region Government [DGO6]; Fonds National de la Recherche Scientifique (FNRS, Brussels, Belgium); Fondation Leon Fredericq (University of Liege); CHU (Liege, Belgium); Action de Recherches Concertees; Communaute Francaise de Belgique; European Union; Interuniversity Attraction Poles Programme- Belgian Science Policy (Brussels, Belgium); IAP6/18 program (Brussels, Belgium)	Walloon Region Government; Fonds National de la Recherche Scientifique (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fondation Leon Fredericq (University of Liege)(University of Liege); CHU (Liege, Belgium); Action de Recherches Concertees; Communaute Francaise de Belgique(Australian Research Council); European Union(European Commission); Interuniversity Attraction Poles Programme- Belgian Science Policy (Brussels, Belgium)(Belgian Federal Science Policy Office); IAP6/18 program (Brussels, Belgium)	This work was supported by grants of the Walloon Region Government (DGO6), the Fonds National de la Recherche Scientifique (FNRS, Brussels, Belgium), the Fondation Leon Fredericq (University of Liege), the CHU (Liege, Belgium), Action de Recherches Concertees, Communaute Francaise de Belgique and European Union (FP6 and FP-7), the Interuniversity Attraction Poles Programme- Belgian Science Policy (Brussels, Belgium). Emmanuel Di Valentin is a postdoctoral fellow supported by the IAP6/18 program (Brussels, Belgium). The integrity of RNA extracts was analyzed with the help of Benoit Hennuy (GenoTranscriptomics Platform, GIGA, University of Liege). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; AKIRA S, 1992, IMMUNOL REV, V127, P25, DOI 10.1111/j.1600-065X.1992.tb01407.x; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Asirvatham AJ, 2009, CYTOKINE, V45, P58, DOI 10.1016/j.cyto.2008.11.010; Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BARNES PJ, 2002, ASTHMA COPD BASIC ME, P780; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Cataluccia D, 2008, ANN NY ACAD SCI, V1123, P20, DOI 10.1196/annals.1420.004; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chiba Y, 2009, AM J RESP CRIT CARE, V180, P713, DOI 10.1164/rccm.200903-0325OC; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Di Valentin E, 2009, AM J PHYSIOL-LUNG C, V296, pL185, DOI 10.1152/ajplung.90367.2008; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fabry Ben, 2007, Drug Discov Today Dis Models, V4, P131, DOI 10.1016/j.ddmod.2007.12.003; Foell J, 2003, J CLIN INVEST, V111, P1505, DOI 10.1172/JCI200317662; FOLKS JL, 1984, HDB STATISTICS, V4, P113, DOI DOI 10.1016/S0169-7161(84)04008-6; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gosens R, 2004, EUR J PHARMACOL, V494, P73, DOI 10.1016/j.ejphar.2004.04.035; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gueders MM, 2008, BIOCHEM PHARMACOL, V75, P514, DOI 10.1016/j.bcp.2007.09.012; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; Henderson N, 2007, AM J PHYSIOL-LUNG C, V292, pL1030, DOI 10.1152/ajplung.00317.2006; Hennessy Erica, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000781; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izuhara Kenji, 2006, Allergol Int, V55, P361, DOI 10.2332/allergolint.55.361; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; KUHN C, 1989, AM REV RESPIR DIS, V140, P1693, DOI 10.1164/ajrccm/140.6.1693; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malumbres R, 2009, BLOOD, V113, P3754, DOI 10.1182/blood-2008-10-184077; Mattes J, 2009, P NATL ACAD SCI USA, V106, P18704, DOI 10.1073/pnas.0905063106; MEEKER TC, 1990, BLOOD, V76, P285; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Muro AF, 2008, AM J RESP CRIT CARE, V177, P638, DOI 10.1164/rccm.200708-1291OC; Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002; Nal B, 2002, GENOMICS, V79, P77, DOI 10.1006/geno.2001.6682; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Nishioku T, 2002, J BIOL CHEM, V277, P4816, DOI 10.1074/jbc.M108382200; Noma T, 2002, J ASTHMA, V39, P591, DOI 10.1081/JAS-120014923; Noverstern N, 2008, AM J RESP CELL MOL, V38, P324, DOI 10.1165/rcmb.2007-0151OC; Ohta K, 2001, INT ARCH ALLERGY IMM, V124, P259, DOI 10.1159/000053727; OPAZO SA, 2004, AM J PHYSIOL-CELL PH, V286, pC433; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Park SG, 2008, INT ARCH ALLERGY IMM, V146, P44, DOI 10.1159/000112502; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pascual RM, 2005, J ALLERGY CLIN IMMUN, V116, P477, DOI 10.1016/j.jaci.2005.07.011; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; Pennings JLA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002596; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Polte T, 2006, J CLIN INVEST, V116, P1025, DOI 10.1172/JCI23792; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Poy MN, 2007, DIABETES OBES METAB, V9, P67, DOI 10.1111/j.1463-1326.2007.00775.x; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Recchia AG, 2009, INT J BIOCHEM CELL B, V41, P603, DOI 10.1016/j.biocel.2008.07.004; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rolph MS, 2006, PHARMACOL THERAPEUT, V109, P284, DOI 10.1016/j.pharmthera.2005.08.009; Saotome A, 2003, RESP MED, V97, P688, DOI 10.1053/rmed.2003.1502; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Shin SM, 2007, J LEUKOCYTE BIOL, V81, P1455, DOI 10.1189/jlb.1006619; Southam DS, 2008, AM J RESP CRIT CARE, V178, P1115, DOI 10.1164/rccm.200801-084OC; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Thomas PS, 2001, IMMUNOL CELL BIOL, V79, P132, DOI 10.1046/j.1440-1711.2001.00980.x; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Turner CE, 1998, INT J BIOCHEM CELL B, V30, P955, DOI 10.1016/S1357-2725(98)00062-4; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Van Hove CL, 2009, INT ARCH ALLERGY IMM, V149, P195, DOI 10.1159/000199715; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang J, 2009, CARDIOLOGY, V113, P81, DOI 10.1159/000172616; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang Y, 2008, CLIN GENET, V74, P307, DOI 10.1111/j.1399-0004.2008.01075.x; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Williams AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005889; Wolgemuth DJ, 2008, CELL CYCLE, V7, P3509, DOI 10.4161/cc.7.22.6978; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011; Yamashita N, 2005, CELL IMMUNOL, V235, P85, DOI 10.1016/j.cellimm.2005.07.006; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang RB, 2002, J BIOL CHEM, V277, P46364, DOI 10.1074/jbc.M207410200; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	126	117	128	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2011	6	1							e16509	10.1371/journal.pone.0016509	http://dx.doi.org/10.1371/journal.pone.0016509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JX	21305051	Green Submitted, gold, Green Published			2022-12-25	WOS:000286664100040
J	Lindgren, AG; Natsuhara, K; Tian, E; Vincent, JJ; Li, XM; Jiao, J; Wu, H; Banerjee, U; Clark, AT				Lindgren, Anne G.; Natsuhara, Kyle; Tian, E.; Vincent, John J.; Li, Xinmin; Jiao, Jing; Wu, Hong; Banerjee, Utpal; Clark, Amander T.			Loss of Pten Causes Tumor Initiation Following Differentiation of Murine Pluripotent Stem Cells Due to Failed Repression of Nanog	PLOS ONE			English	Article							IN-VITRO; TERATOMA FORMATION; GERM-CELLS; CULTURE ADAPTATION; MOUSE; SURVIVAL; TRANSPLANTATION; PROGRESSION; AKT; EXPRESSION	Pluripotent stem cells (PSCs) hold significant promise in regenerative medicine due to their unlimited capacity for self-renewal and potential to differentiate into every cell type in the body. One major barrier to the use of PSCs is their potential risk for tumor initiation following differentiation and transplantation in vivo. In the current study we sought to evaluate the role of the tumor suppressor Pten in murine PSC neoplastic progression. Using eight functional assays that have previously been used to indicate PSC adaptation or transformation, Pten null embryonic stem cells (ESCs) failed to rate as significant in five of them. Instead, our data demonstrate that the loss of Pten causes the emergence of a small number of aggressive, teratoma-initiating embryonic carcinoma cells (ECCs) during differentiation in vitro, while the remaining 90-95% of differentiated cells are non-tumorigenic. Furthermore, our data show that the mechanism by which Pten null ECCs emerge in vitro and cause tumors in vivo is through increased survival and self-renewal, due to failed repression of the transcription factor Nanog.	[Lindgren, Anne G.; Natsuhara, Kyle; Tian, E.; Vincent, John J.; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Vincent, John J.; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Li, Xinmin; Wu, Hong; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Jiao, Jing; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Lindgren, Anne G.; Vincent, John J.; Wu, Hong; Banerjee, Utpal; Clark, Amander T.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lindgren, AG (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	clarka@ucla.edu	Jiao, Jing/F-5354-2015	Natsuhara, Kyle/0000-0001-7682-1751	NIH/NICHD [R01, 1R01HD058047-01]; NIH/NIGMS [P01 P01GM081621]; Fuller Foundation; University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; California Institute for Regenerative Medicine [TG2-01169]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fuller Foundation; University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the following: NIH/NICHD R01, 1R01HD058047-01, NIH/NIGMS P01 P01GM081621, Fuller Foundation, University of California Los Angeles Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (http://www.stemcell.ucla.edu/), and California Institute for Regenerative Medicine Training grants TG2-01169 (http://www.cirm.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Blum B, 2009, NAT BIOTECHNOL, V27, P281, DOI 10.1038/nbt.1527; Chan EM, 2008, CLONING STEM CELLS, V10, P107, DOI 10.1089/clo.2007.0064; Conway AE, 2009, STEM CELLS, V27, P18, DOI 10.1634/stemcells.2008-0529; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Fong SP, 2007, J NEUROSCI RES, V85, P1851, DOI 10.1002/jnr.21319; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Harrison NJ, 2009, STEM CELLS, V27, P1057, DOI 10.1002/stem.41; Haston KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005654; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Herszfeld D, 2006, NAT BIOTECHNOL, V24, P351, DOI 10.1038/nbt1197; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Ishii T, 2007, STEM CELLS, V25, P3252, DOI 10.1634/stemcells.2007-0199; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lee MH, 2007, STEM CELLS, V25, P1654, DOI 10.1634/stemcells.2006-0753; Mandal S, 2010, STEM CELLS; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Rajpert-de Meyts E, 2003, APMIS, V111, P267, DOI 10.1034/j.1600-0463.2003.11101301.x; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; STEVENS LC, 1970, DEV BIOL, V21, P364, DOI 10.1016/0012-1606(70)90130-2; Storm MP, 2009, STEM CELLS, V27, P764, DOI 10.1002/stem.3; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; West JA, 2006, NAT PROTOC, V1, P2026, DOI 10.1038/nprot.2006.303; Yang S, 2010, CELL PROLIFERAT, V43, P195, DOI 10.1111/j.1365-2184.2010.00669.x; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Young JC, 2010, BIOL REPROD, V82, P390, DOI 10.1095/biolreprod.109.078493	38	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16478	10.1371/journal.pone.0016478	http://dx.doi.org/10.1371/journal.pone.0016478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304588	gold, Green Published, Green Submitted			2022-12-25	WOS:000286663900055
J	Chen, X; Zhang, H; Aravindakshan, JP; Gotlieb, WH; Sairam, MR				Chen, X.; Zhang, H.; Aravindakshan, J. P.; Gotlieb, W. H.; Sairam, M. R.			Anti-proliferative and pro-apoptotic actions of a novel human and mouse ovarian tumor-associated gene OTAG-12: downregulation, alternative splicing and drug sensitization	ONCOGENE			English	Article						ovarian cancer; tumor suppressor; splicing; G2 arrest; apoptosis; drug sensitivity	CARCINOMA CELL-LINE; CANCER CELLS; INDUCE APOPTOSIS; INHIBITS GROWTH; FSH RECEPTOR; FORKO MICE; CIDE-B; EXPRESSION; MODEL; SUPPRESSOR	In studying the age dependence and chronology of ovarian tumors in follicle stimulating hormone receptor knockout mice, we identified a novel ovarian tumor associated gene-12 (OTAG-12), which is progressively downregulated and maps to Chr. 8B3.3. OTAG-12 protein overexpression in mouse ovarian and mammary tumor cells suggested powerful anti-proliferative effects. In human epithelial ovarian cancers (OCs) and OC cell lines, OTAG-12 mRNA expression is downregulated in comparison with normal ovaries. Cloning and identification revealed that human OTAG-12 mapping to gene-rich Chr. 19p13.12 is expressed in three spliced forms: hOTAG-12a, hOTAG-12b and hOTAG-12c, of which b is predominant in the normal ovary. Functionally active hOTAG-12b is a simple protein with no disulfide bonds and a nuclear localization signal is present in all variants. Transfection of OTAG-12 variants in OC and tumorigenic HEK293 cells confirmed nuclear localization. hOTAG-12b overexpression in OC and HEK293 cells effectively suppressed cell growth, anchorage-dependent and independent colony formation followed by apoptosis, whereas hOTAG-12a and hOTAG-12c had no such effects. Deletion mutants identified the critical importance of carboxyl terminus for hOTAG-12b function. Doxycycline-inducible growth inhibition of HEK293 cells by hOTAG-12a was associated with effects on G2 cell cycle arrest and apoptosis induction. hOTAG-12b expression rendered tumorigenic cells more sensitive to four apoptotic stimuli including etoposide-a topoisomerase-II inhibitor. Doxycycline-induced hOTAG-12b expression blocked xenograft tumor growth in nude mice, whereas hOTAG-12a was ineffective. Although p53-pathway-dependent apoptotic agents could upregulate endogenous hOTAG-12b and p53 in UCI-101/107 OC cells, hOTAG-12b could also induce apoptosis in p53-null and platinum-resistant SKOV3 OC cells and Doxycycline-induced hOTAG-12b did not alter p53. Further study showed that hOTAG-12b increases mRNAs of pro-apoptotic genes such as BAD, GADD45 alpha and CIEDB, while inhibiting anti-apoptotic NAIP and Akt1 expression, suggesting that hOTAG-12b-induced apoptosis might be p53-independent. These results indicate that hOTAG-12b is a putative ovarian tumor suppressor gene warranting further studies. Oncogene (2011) 30, 2874-2887; doi:10.1038/onc.2011.11; published online 21 February 2011	[Chen, X.; Zhang, H.; Aravindakshan, J. P.; Sairam, M. R.] Clin Res Inst Montreal, Mol Endocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Gotlieb, W. H.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Sairam, M. R.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Sairam, M. R.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Sairam, M. R.] McGill Univ, Dept Physiol, Montreal, PQ, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; McGill University; McGill University	Sairam, MR (corresponding author), Clin Res Inst Montreal, Mol Endocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	sairamm@ircm.qc.ca			NCIC; CIHR	NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CIHR(Canadian Institutes of Health Research (CIHR))	We are grateful to Dr P Carpenter (UC Irvine) for providing ovarian cancer cell lines UCI101 and UCI107, Dr Roby KF (Univ Kansas) for ID8 cells, Drs Jolicoeur for HC11-26 cells and Seidah at IRCM for the modified HEK293 cell lines. We appreciate the useful suggestions provided by Drs Zhongjun Dong and Hua Lin during this investigation. We also acknowledge the help of Drs Marie-Claude Beauchamp and Amber Yasmeen in this study. This investigation was supported in part by the NCIC and the CIHR.	Al-Romaih K, 2008, NEOPLASIA, V10, P471, DOI 10.1593/neo.08174; Allen S, 2001, CLIN DIAGN LAB IMMUN, V8, P460, DOI 10.1128/CDLI.8.2.460-464.2001; Aravindakshan J, 2006, BIOCHEM BIOPH RES CO, V351, P507, DOI 10.1016/j.bbrc.2006.10.069; Aravindakshan J, 2010, MOL CELL ENDOCRINOL, V329, P37, DOI 10.1016/j.mce.2010.05.015; Aravindakshan J, 2006, NEOPLASIA, V8, P984, DOI 10.1593/neo.06529; Barnes BJ, 2003, CANCER RES, V63, P6424; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bignone PA, 2007, ONCOGENE, V26, P683, DOI 10.1038/sj.onc.1209827; Boisvert-Adamo K, 2008, ONCOGENE, V27, P3301, DOI 10.1038/sj.onc.1211003; Bruening W, 1999, CANCER RES, V59, P4973; Chen F, 2001, ONCOGENE, V20, P3585, DOI 10.1038/sj.onc.1204442; Chen XL, 2007, NEOPLASIA, V9, P521, DOI 10.1593/neo.07238; Chen XL, 2006, CARCINOGENESIS, V27, P903, DOI 10.1093/carcin/bgi305; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Corney DC, 2008, ADV EXP MED BIOL, V622, P99, DOI 10.1007/978-0-387-68969-2_9; Dai Y, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-392; Danilovich N, 2001, ENDOCRINOLOGY, V142, P3673, DOI 10.1210/en.142.8.3673; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; FUCHTNER C, 1993, GYNECOL ONCOL, V48, P203, DOI 10.1006/gyno.1993.1034; GAMBOA G, 1995, GYNECOL ONCOL, V58, P336, DOI 10.1006/gyno.1995.1239; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Jarboe EA, 2008, HISTOPATHOLOGY, V53, P127, DOI 10.1111/j.1365-2559.2007.02938.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Konstantinopoulos PA, 2008, NAT CLIN PRACT ONCOL, V5, P577, DOI 10.1038/ncponc1178; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Lugovskoy AA, 1999, CELL, V99, P747, DOI 10.1016/S0092-8674(00)81672-4; Luo RZ, 2003, ONCOGENE, V22, P2897, DOI 10.1038/sj.onc.1206380; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Nowak-Markwitz E, 2004, EUR J GYNAECOL ONCOL, V25, P465; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Schwartz MF, 2003, CELL CYCLE, V2, P384, DOI 10.4161/cc.2.4.457; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; Wagner MW, 2008, J BIOL CHEM, V283, P21382, DOI 10.1074/jbc.M709953200; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Wu ZZ, 2005, J LIPID RES, V46, P1396, DOI 10.1194/jlr.M500071-JLR200; Yan XJ, 2006, GYNECOL ONCOL, V102, P348, DOI 10.1016/j.ygyno.2005.12.033; Yin BWT, 2002, INT J CANCER, V98, P737, DOI 10.1002/ijc.10250; Zhu QS, 2008, CANCER RES, V68, P2895, DOI 10.1158/0008-5472.CAN-07-6268	46	7	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	25					2874	2887		10.1038/onc.2011.11	http://dx.doi.org/10.1038/onc.2011.11			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21339736				2022-12-25	WOS:000291977800007
J	Dettman, EJ; Simko, SJ; Ayanga, B; Carofino, BL; Margolin, JF; Morse, HC; Justice, MJ				Dettman, E. J.; Simko, S. J.; Ayanga, B.; Carofino, B. L.; Margolin, J. F.; Morse, H. C., III; Justice, M. J.			Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors	ONCOGENE			English	Article						leukemia; Prdm14; leukemia-initiating cell; pluripotency; common lymphoid progenitor; acute lymphoblastic leukemia	BREAST-CANCER; STEM-CELLS; RETROVIRAL INSERTIONS; MEIOTIC RECOMBINATION; BONE-MARROW; IN-VITRO; C-KIT; GENE; MICE; EXPRESSION	Understanding the heterogeneous genetic mechanisms of tumor initiation in lymphoid leukemias (LL) will lead to improvements in prognostic classification and treatment regimens. In previous studies of mouse leukemias, we showed that retroviral insertion at the ecotropic viral insertion site 32 locus leads to increased expression of Prdm14, a pluripotency gene implicated in the self-renewal capacity of embryonic stem cells and the early stages of breast cancer. Here, we show that PRDM14 is also overexpressed in similar to 25% of human lymphoid neoplasms, with increased frequencies in T-cell acute LL and hyperdiploid precursor B-cell acute LL. To test if Prdm14 overexpression could initiate leukemia, mice were transduced with bone marrow cells transfected with a Prdm14 expression vector. LLs developed in 96% of female mice and 42% of male mice. Before the onset of leukemia, differentiation of transduced cells was biased up to 1000-fold toward cells with features of common lymphoid progenitors (CLPs), and lymphoid differentiation showed a relative block at the pro-B stage. Microarray gene expression analysis of expanded CLP-like cells before the onset of leukemia demonstrated upregulation of genes involved in pluripotency, tumor initiation, early B-lineage commitment, Wnt/Ras signaling and the epithelial-to-mesenchymal transition. Among the dysregulated genes were imprinted genes and non-coding RNAs including Dlk1 and Meg3, which are also key pluripotency mediators. Heightened expression of the estrogen-dependent oncogene, Myb, in tumors suggests a basis for the increased frequency of cancer in female mice. These data provide the first direct evidence for the association of Prdm14 with cancer initiation in an in vivo mouse model and in human lymphoid malignancies, while suggesting mechanisms for Prdm14's mode of action. Oncogene (2011) 30, 2859-2873; doi:10.1038/onc.2011.12; published online 21 February 2011	[Dettman, E. J.; Ayanga, B.; Carofino, B. L.; Justice, M. J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Simko, S. J.; Margolin, J. F.] Baylor Coll Med, Sect Hematol & Oncol, Dept Pediat, Houston, TX 77030 USA; [Morse, H. C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD USA; [Justice, M. J.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine	Justice, MJ (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, MS227,1 Baylor Plaza R804, Houston, TX 77030 USA.	mjustice@bcm.edu	liang, yan/H-3894-2011	Morse, Herbert/0000-0002-9331-3705; Carofino, Brandi/0000-0003-0717-6917; Dettman, E.J./0000-0002-0059-836X; Simko, Stephen/0000-0002-4790-4117	NIH [R01 CA63229, R01 CA15530]; Baylor College of Medicine; NIH National Research Service [3 T32 CA115303-04]; NIH, National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [R01CA115503, R01CA063229, T32CA115303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001024, ZIAAI000858] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine; NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work by MJJ was supported by NIH R01 CA63229, R01 CA15530 and a Baylor College of Medicine Interim funding award. SJS was supported by an NIH National Research Service Award Institutional Training Grant 3 T32 CA115303-04, 'Pediatric Oncology Research Training Program.' HCM was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. We thank John Belmont and Molly Bray at the Laboratory for Translational Genomics at BCM for microarray data production; Jill Crowe for excellent technical assistance; and Frank Probst for the critical reading of the paper.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; BESMER P, 1993, DEVELOPMENT, P125; Bhojwani D, 2006, BLOOD, V108, P711, DOI 10.1182/blood-2006-02-002824; Boles MK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000759; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Davi F, 1996, BLOOD, V88, P609, DOI 10.1182/blood.V88.2.609.bloodjournal882609; Davidsson J, 2010, LEUKEMIA, V24, P924, DOI 10.1038/leu.2010.39; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dettman EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003823; DOWNING JR, 2006, HEMATOL-AM SOC HEMAT, V508, P118; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Ford AM, 2001, BLOOD, V98, P558, DOI 10.1182/blood.V98.3.558; Fredrickson T N, 1995, Curr Top Microbiol Immunol, V194, P109; Fumasoni I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-187; Greig KT, 2010, BLOOD, V115, P2796, DOI 10.1182/blood-2009-08-239210; GUERIN M, 1990, ONCOGENE, V5, P131; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Hao XP, 2006, LEUKEMIA RES, V30, P397, DOI 10.1016/j.leukres.2005.08.021; HAWLEY RG, 1992, J EXP MED, V176, P1149, DOI 10.1084/jem.176.4.1149; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang GL, 2000, HISTOL HISTOPATHOL, V15, P109, DOI 10.14670/HH-15.109; JONKERS S, 1996, BIOCHIM BIOPHYS ACTA, V1287, P29; Jordan CT, 2006, CANCER CELL, V10, P253, DOI 10.1016/j.ccr.2006.09.010; Khoury H, 2010, BLOOD, V115, P2260, DOI 10.1182/blood-2009-03-212746; Kim KC, 2003, CANCER BIOL THER, V2, P491, DOI 10.4161/cbt.2.5.629; Kim KC, 2003, CANCER RES, V63, P7619; Kinameri E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003859; Ko CD, 2003, CLIN EXP METASTAS, V20, P593, DOI 10.1023/A:1027323210736; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kurimoto K, 2008, CELL CYCLE, V7, P3514, DOI 10.4161/cc.7.22.6979; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Moelans CB, 2010, MODERN PATHOL, V23, P1029, DOI 10.1038/modpathol.2010.84; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Mullighan CG, 2005, CANCER J, V11, P268, DOI 10.1097/00130404-200507000-00003; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Palmu S, 2002, ANTICANCER RES, V22, P411; PARVANOV ED, 2010, SCIENCE, P327; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Pizzo PA, 2006, PRINCIPLES PRACTICE; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sorich MJ, 2008, PLOS MED, V5, P646, DOI 10.1371/journal.pmed.0050083; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Tsuda H, 2005, CANCER SCI, V96, P333, DOI 10.1111/j.1349-7006.2005.00060.x; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Weiser KC, 2007, MAMM GENOME, V18, P709, DOI 10.1007/s00335-007-9060-2; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Yan XQ, 1996, BLOOD, V88, P402, DOI 10.1182/blood.V88.2.402.bloodjournal882402	69	45	46	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN	2011	30	25					2859	2873		10.1038/onc.2011.12	http://dx.doi.org/10.1038/onc.2011.12			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	781ZV	21339739	Green Accepted			2022-12-25	WOS:000291977800006
J	Dowil, RT; Lu, XL; Saracco, SA; Vierstra, RD; Downes, BP				Dowil, Rebecca T.; Lu, Xiaolong; Saracco, Scott A.; Vierstra, Richard D.; Downes, Brian P.			Arabidopsis Membrane-anchored Ubiquitin-fold (MUB) Proteins Localize a Specific Subset of Ubiquitin-conjugating (E2) Enzymes to the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; NONCOVALENT INTERACTION; 26S PROTEASOME; BINDING; COMPLEX; SYSTEM; FAMILY; UBC9; CONSERVATION; VARIANT	The covalent attachment of ubiquitin (Ub) to various intracellular proteins plays important roles in altering the function, localization, processing, and degradation of the modified target. A minimal ubiquitylation pathway uses a three-enzyme cascade (E1, E2, and E3) to activate Ub and select target proteins for modification. Although diverse E3 families provide much of the target specificity, several factors have emerged recently that coordinate the subcellular localization of the ubiquitylation machinery. Here, we show that the family of membrane-anchored ubiquitin-fold (MUB) proteins recruits and docks specific E2s to the plasma membrane. Protein interaction screens with Arabidopsis MUBs revealed that interacting E2s are limited to a well defined subgroup that is phylogenetically related to human UbcH5 and yeast Ubc4/5 families. MUBs appear to interact noncovalently with an E2 surface opposite the active site that forms a covalent linkage with Ub. Bimolecular fluorescence complementation demonstrated that MUBs bind simultaneously to the plasma membrane via a prenyl tail and to the E2 in planta. These findings suggest that MUBs contribute subcellular specificity to ubiquitylation by docking the conjugation machinery to the plasma membrane.	[Dowil, Rebecca T.; Lu, Xiaolong; Downes, Brian P.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Saracco, Scott A.] Monsanto Co, St Louis, MO 63017 USA	Saint Louis University; University of Wisconsin System; University of Wisconsin Madison; Monsanto	Downes, BP (corresponding author), St Louis Univ, Dept Biol, 3507 Laclede Ave, St Louis, MO 63103 USA.	bdownes1@slu.edu	Lu, Xiaolong/Q-5252-2016	Lu, Xiaolong/0000-0003-1730-4644	Saint Louis University; Beaumont faculty development grant; National Science Foundation [MCB-0115870]	Saint Louis University; Beaumont faculty development grant; National Science Foundation(National Science Foundation (NSF))	This work was supported by Saint Louis University and a Beaumont faculty development grant (to B.P.D.).; Supported by National Science Foundation Arabidopsis 2010 Program Grant MCB-0115870.	Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brzovic PS, 2006, CELL CYCLE, V5, P2867, DOI 10.4161/cc.5.24.3592; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; David Y, 2010, J BIOL CHEM, V285, P8595, DOI 10.1074/jbc.M109.089003; de la Cruz NB, 2007, PROTEIN SCI, V16, P1479, DOI 10.1110/ps.072834007; Dinkins RD, 2003, PLANT SCI, V165, P33, DOI 10.1016/S0168-9452(03)00123-7; Downes B, 2005, BIOCHEM SOC T, V33, P393, DOI 10.1042/BST0330393; Downes BP, 2006, J BIOL CHEM, V281, P27145, DOI 10.1074/jbc.M602283200; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fu HY, 2010, TRENDS PLANT SCI, V15, P375, DOI 10.1016/j.tplants.2010.03.004; Fuchs BC, 2007, AM J PHYSIOL-CELL PH, V293, pC55, DOI 10.1152/ajpcell.00330.2006; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; GIROD PA, 1993, J BIOL CHEM, V268, P955; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; James P, 1996, GENETICS, V144, P1425; Khan BR, 2010, PLANT PHYSIOL, V154, P1602, DOI 10.1104/pp.110.162479; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Koller A, 1999, J CELL BIOL, V146, P99, DOI 10.1083/jcb.146.1.99; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kostova Z, 2009, J CELL SCI, V122, P1374, DOI 10.1242/jcs.044255; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Kragt A, 2005, J BIOL CHEM, V280, P7867, DOI 10.1074/jbc.M413553200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau OS, 2009, BIOCHEM J, V418, P683, DOI 10.1042/BJ20081943; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Liu LJ, 2010, PLANT J, V61, P893, DOI 10.1111/j.1365-313X.2009.04109.x; Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Platta HW, 2007, TRENDS CELL BIOL, V17, P474, DOI 10.1016/j.tcb.2007.06.009; Rambaut A, 1996, SEQUENCE ALIGNMENT S; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rossignol P, 2007, J CELL SCI, V120, P3678, DOI 10.1242/jcs.004119; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen R, 2008, PLANT CELL, V20, P213, DOI 10.1105/tpc.107.051862; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Zolman BK, 2005, PLANT CELL, V17, P3422, DOI 10.1105/tpc.105.035691	58	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2011	286	17					14913	14921		10.1074/jbc.M110.158808	http://dx.doi.org/10.1074/jbc.M110.158808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	753OI	21345795	hybrid, Green Published			2022-12-25	WOS:000289788300021
J	Rivera, CR; Kollman, JM; Polka, JK; Agard, DA; Mullins, RD				Rivera, Christopher R.; Kollman, Justin M.; Polka, Jessica K.; Agard, David A.; Mullins, R. Dyche			Architecture and Assembly of a Divergent Member of the ParM Family of Bacterial Actin-like Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; DNA SEGREGATION; PLASMID SEGREGATION; DYNAMIC INSTABILITY; KINETIC EVIDENCE; FILAMENTS; CELL; POLYMERIZATION; HOMOLOG; ENDS	Eubacteria and archaea contain a variety of actin-like proteins (ALPs) that form filaments with surprisingly diverse architectures, assembly dynamics, and cellular functions. Although there is much data supporting differences between ALP families, there is little data regarding conservation of structure and function within these families. We asked whether the filament architecture and biochemical properties of the best-understood prokaryotic actin, ParM from plasmid R1, are conserved in a divergent member of the ParM family from plasmid pB171. Previous work demonstrated that R1 ParM assembles into filaments that are structurally distinct from actin and the other characterized ALPs. They also display three biophysical properties thought to be essential for DNA segregation: 1) rapid spontaneous nucleation, 2) symmetrical elongation, and 3) dynamic instability. We used microscopic and biophysical techniques to compare and contrast the architecture and assembly of these related proteins. Despite being only 41% identical, R1 and pB171 ParMs polymerize into nearly identical filaments with similar assembly dynamics. Conservation of the core assembly properties argues for their importance in ParM-mediated DNA segregation and suggests that divergent DNA-segregating ALPs with different assembly properties operate via different mechanisms.	[Rivera, Christopher R.; Polka, Jessica K.; Mullins, R. Dyche] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Mullins, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	dyche@mullinslab.ucsf.edu	Kollman, Justin/F-3012-2012	Polka, Jessica/0000-0001-6610-9293	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031627] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Becker E, 2006, EMBO J, V25, P5919, DOI 10.1038/sj.emboj.7601443; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flyvbjerg H, 1996, P NATL ACAD SCI USA, V93, P5975, DOI 10.1073/pnas.93.12.5975; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Hara F, 2007, J BACTERIOL, V189, P2039, DOI 10.1128/JB.01454-06; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Needleman DJ, 2008, CURR BIOL, V18, pR212, DOI 10.1016/j.cub.2008.01.003; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Pradel N, 2006, P NATL ACAD SCI USA, V103, P17485, DOI 10.1073/pnas.0603760103; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teubner A, 1998, BIOCHEMISTRY-US, V37, P7532, DOI 10.1021/bi972176s; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200	43	19	19	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14282	14290		10.1074/jbc.M110.203828	http://dx.doi.org/10.1074/jbc.M110.203828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21339292	Green Published, hybrid			2022-12-25	WOS:000289556200051
J	Dolai, S; Pal, S; Yadav, RK; Adak, S				Dolai, Subhankar; Pal, Swati; Yadav, Rajesh K.; Adak, Subrata			Endoplasmic Reticulum Stress-induced Apoptosis in Leishmania through Ca2+-dependent and Caspase-independent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; UNFOLDED PROTEIN RESPONSE; ENDONUCLEASE-G; ASCORBATE-PEROXIDASE; OXIDATIVE STRESS; CYTOCHROME-C; TUNICAMYCIN; ER; MITOCHONDRIA; DONOVANI	Numerous reports have shown that mitochondrial dysfunctions play a major role in apoptosis of Leishmania parasites, but the endoplasmic reticulum (ER) stress-induced apoptosis in Leishmania remains largely unknown. In this study, we investigate ER stress-induced apoptotic pathways in Leishmania major using tunicamycin as an ER stress inducer. ER stress activates the expression of ER-localized chaperone protein BIP/GRP78 (binding protein/identical to the 78-kDa glucose-regulated protein) with concomitant generation of intracellular reactive oxygen species. Upon exposure to ER stress, the elevation of cytosolic Ca2+ level is observed due to release of Ca2+ from internal stores. Increase in cytosolic Ca2+ causes mitochondrial membrane potential depolarization and ATP loss as ablation of Ca2+ by blocking voltage-gated cation channels with verapamil preserves mitochondrial membrane potential and cellular ATP content. Furthermore, ER stress-induced reactive oxygen species (ROS)-dependent release of cytochrome c and endonuclease G from mitochondria to cytosol and subsequent translocation of endonuclease G to nucleus are observed. Inhibition of caspase-like proteases with the caspase inhibitor benzyloxycarbonyl-VAD-fluoromethyl ketone or metacaspase inhibitor antipain does not prevent nuclear DNA fragmentation and phosphatidylserine exposure. Conversely, significant protection in tunicamycin-induced DNA degradation and phosphatidylserine exposure was achieved by either pretreatment of antioxidants (N-acetyl-L-cysteine, GSH, and L-cysteine), chemical chaperone (4-phenylbutyric acid), or addition of Ca2+ chelator (1,2-bis(2-aminophenoxy)ethane-N,N,N,N-tetraacetic acidacetoxymethyl ester). Taken together, these data strongly demonstrate that ER stress-induced apoptosis in L. major is dependent on ROS and Ca2+-induced mitochondrial toxicity but independent of caspase-like proteases.	[Dolai, Subhankar; Pal, Swati; Yadav, Rajesh K.; Adak, Subrata] Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adak, S (corresponding author), Indian Inst Chem Biol, Div Struct Biol & Bioinformat, 4 Raja SC Mullick Rd, Kolkata 700032, India.	adaks@iicb.res.in		Pal, Swati/0000-0001-6179-4316; YADAV, RAJESH/0000-0002-4239-0428	Council of Scientific and Industrial Research [NWP 0038]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research Project NWP 0038 and Council of Scientific and Industrial Research fellowships (to S. D., R. K. Y., and S. P.).	Adak S, 2005, BIOCHEM J, V390, P465, DOI 10.1042/BJ20050311; Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Atlante A, 2000, J BIOL CHEM, V275, P37159, DOI 10.1074/jbc.M002361200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BoseDasgupta S, 2008, CELL DEATH DIFFER, V15, P1629, DOI 10.1038/cdd.2008.85; Boya P, 2002, CELL DEATH DIFFER, V9, P465, DOI 10.1038/sj.cdd.4401006; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chae HJ, 2004, MOL CELL, V15, P355, DOI 10.1016/j.molcel.2004.06.038; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; DAGGER F, 1984, BIOL CELL, V50, P173, DOI 10.1111/j.1768-322X.1984.tb00264.x; Das M, 2001, J CELL SCI, V114, P2461; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; DOTAI S, 2009, EUKARYOT CELL, V8, P1721; Dricu A, 1997, CANCER RES, V57, P543; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Gannavaram S, 2008, J CELL SCI, V121, P99, DOI 10.1242/jcs.014050; Gavilan MP, 2006, NEUROBIOL AGING, V27, P973, DOI 10.1016/j.neurobiolaging.2005.05.010; Goldshmidt H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000731; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Ishihara Y, 2006, J BIOL CHEM, V281, P6726, DOI 10.1074/jbc.M510382200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; KINK JA, 1987, P NATL ACAD SCI USA, V84, P1253, DOI 10.1073/pnas.84.5.1253; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; NOLAN TJ, 1985, MOL BIOCHEM PARASIT, V16, P127, DOI 10.1016/0166-6851(85)90081-7; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Strauss G, 2008, CELL DEATH DIFFER, V15, P332, DOI 10.1038/sj.cdd.4402272; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	52	90	99	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13638	13646		10.1074/jbc.M110.201889	http://dx.doi.org/10.1074/jbc.M110.201889			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330370	hybrid, Green Published			2022-12-25	WOS:000289282200082
J	Jia, LX; Linder, ME; Blumer, KJ				Jia, Lixia; Linder, Maurine E.; Blumer, Kendall J.			G(i/o) Signaling and the Palmitoyltransferase DHHC2 Regulate Palmitate Cycling and Shuttling of RGS7 Family-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE ACCELERATING PROTEIN; MEMBRANE ANCHOR; PLASMA-MEMBRANE; PALMITOYLATION; R7BP; COMPLEXES; R9AP; LOCALIZATION; IDENTIFICATION; STABILITY	R7BP (RGS7 family-binding protein) has been proposed to function in neurons as a palmitoylation-regulated protein that shuttles heterodimeric, G(i/o) alpha-specific GTPase-activating protein (GAP) complexes composed of G beta 5 and RGS7 (R7) isoforms between the plasma membrane and nucleus. To test this hypothesis we studied R7BP palmitoylation and localization in neuronal cells. We report that R7 BP undergoes dynamic, signal-regulated palmitate turnover; the palmitoyltransferase DHHC2 mediates de novo and turnover palmitoylation of R7BP; DHHC2 silencing redistributes R7BP from the plasma membrane to the nucleus; and G(i/o) signaling inhibits R7BP depalmitoylation whereas G(i/o) inactivation induces nuclear accumulation of R7BP. In concert with previous evidence, our findings suggest that agonist-induced changes in pahnitoylation state facilitate GAP action by (i) promoting Gi alpha depalmitoylation to create optimal GAP substrates, and (ii) inhibiting R7BP depalmitoylation to stabilize membrane association of R7-G beta 5 GAP complexes. Regulated palmitate turnover may also enable R7BP-bound GAPs to shuttle between sites of low and high G(i/o) activity or the plasma membrane and nucleus, potentially providing spatio-temporal control of signaling by G(i/o)-coupled receptors.	[Jia, Lixia; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Linder, Maurine E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	Washington University (WUSTL); Cornell University	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	kblumer@wustl.edu	Blumer, Kendall J/C-5268-2012; Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	National Institutes of Health [GM044592, HL075632, GM051466]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051466, R01GM044592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grants GM044592 and HL075632 (to K. J. B.), and GM051466 (to M. E. L.) from the National Institutes of Health.	Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Anderson GR, 2010, NEUROPSYCHOPHARMACOL, V35, P1040, DOI 10.1038/npp.2009.212; Anderson GR, 2009, CELL BIOCHEM BIOPHYS, V54, P33, DOI 10.1007/s12013-009-9052-9; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Chen CA, 2000, J BIOL CHEM, V275, P23516, DOI 10.1074/jbc.M003439200; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Chisari M, 2007, J BIOL CHEM, V282, P24092, DOI 10.1074/jbc.M704246200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Duncan JA, 2002, J BIOL CHEM, V277, P31740, DOI 10.1074/jbc.M202505200; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; He JCJ, 2006, CAN J PHYSIOL PHARM, V84, P687, DOI 10.1139/Y06-025; He YH, 2009, J LIPID RES, V50, P398, DOI 10.1194/jlr.M800360-JLR200; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Hooks SB, 2008, BIOCHEM PHARMACOL, V75, P76, DOI 10.1016/j.bcp.2007.07.045; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jayaraman M, 2009, TRENDS PHARMACOL SCI, V30, P17, DOI 10.1016/j.tips.2008.10.002; Jeffrey BG, 2010, VISUAL NEUROSCI, V27, P9, DOI 10.1017/S0952523809990319; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; Kim JH, 2009, LUNG CANCER, V64, pS30, DOI 10.1016/S0169-5002(09)70180-1; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Panicker LM, 2010, J NEUROCHEM, V113, P1101, DOI 10.1111/j.1471-4159.2010.06616.x; Planey SL, 2009, MOL BIOL CELL, V20, P1454, DOI 10.1091/mbc.E08-08-0849; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Zachariou V, 2003, P NATL ACAD SCI USA, V100, P13656, DOI 10.1073/pnas.2232594100; Zeidman R, 2009, MOL MEMBR BIOL, V26, P32, DOI 10.1080/09687680802629329; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163	49	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13695	13703		10.1074/jbc.M110.193763	http://dx.doi.org/10.1074/jbc.M110.193763			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21343290	Green Published, hybrid			2022-12-25	WOS:000289282200087
J	Chui, KKH; Wenger, JB; Cohen, SA; Naumova, EN				Chui, Kenneth K. H.; Wenger, Julia B.; Cohen, Steven A.; Naumova, Elena N.			Visual Analytics for Epidemiologists: Understanding the Interactions Between Age, Time, and Disease with Multi-Panel Graphs	PLOS ONE			English	Article							SEASONALITY; SURVEILLANCE; MORTALITY; INFLUENZA; POPULATION; PNEUMONIA; PATTERNS; PERIOD	Background: Visual analytics, a technique aiding data analysis and decision making, is a novel tool that allows for a better understanding of the context of complex systems. Public health professionals can greatly benefit from this technique since context is integral in disease monitoring and biosurveillance. We propose a graphical tool that can reveal the distribution of an outcome by time and age simultaneously. Methodology/Principal Findings: We introduce and demonstrate multi-panel (MP) graphs applied in four different settings: U.S. national influenza-associated and salmonellosis-associated hospitalizations among the older adult population (>= 65 years old), 1991-2004; confirmed salmonellosis cases reported to the Massachusetts Department of Public Health for the general population, 2004-2005; and asthma-associated hospital visits for children aged 0-18 at Milwaukee Children's Hospital of Wisconsin, 1997-2006. We illustrate trends and anomalies that otherwise would be obscured by traditional visualization techniques such as case pyramids and time-series plots. Conclusion/Significance: MP graphs can weave together two vital dynamics-temporality and demographics-that play important roles in the distribution and spread of diseases, making these graphs a powerful tool for public health and disease biosurveillance efforts.	[Chui, Kenneth K. H.; Cohen, Steven A.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Wenger, Julia B.] Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA; [Naumova, Elena N.] Tufts Univ, Sch Engn, Dept Civil & Environm Engn, Medford, MA 02155 USA	Massachusetts Department of Public Health; Tufts University; Harvard University; Massachusetts General Hospital; Tufts University	Chui, KKH (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	kenneth.chui@tufts.edu	Naumova, Elena N/C-5954-2011; Chui, Kenneth/AFT-2074-2022; Naumova, Elena/AAP-3395-2020	Chui, Kenneth/0000-0002-8063-8631; Naumova, Elena/0000-0002-9562-4734	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [U19 AI062627, N01 AI-50032]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062627, N01AI050032] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grants U19 AI062627 and N01 AI-50032. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekruse SF, 1996, J FOOD PROTECT, V59, P287, DOI 10.4315/0362-028X-59.3.287; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Amin OM, 2002, AM J TROP MED HYG, V66, P799, DOI 10.4269/ajtmh.2002.66.799; Barwick R S, 2000, MMWR CDC Surveill Summ, V49, P1; Bean Nancy H., 1996, Morbidity and Mortality Weekly Report, V45, P1; Bisset K, 2009, CYBER ENV SUPPORT PA; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Castronovo DA, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-61; CHOI K, 1981, AM J EPIDEMIOL, V113, P215, DOI 10.1093/oxfordjournals.aje.a113090; Chui KKH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-447; Cleveland W., 1993, VISUALIZING DATA; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Cohen SA, 2010, EPIDEMIOL INFECT, V138, P1135, DOI 10.1017/S0950268809991506; COHEN SA, 2009, INTELLIGENCE SECURIT, P47; DOSHI M, 2007, ADV DIS SURVEILLANCE, V2, P49; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Guo D, 2007, INT J GEOGR INF SCI, V21, P859, DOI 10.1080/13658810701349037; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS11, DOI 10.1097/01.inf.0000108188.37237.48; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Kumasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010207; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Maciejewski R, 2010, IEEE T VIS COMPUT GR, V16, P205, DOI 10.1109/TVCG.2009.100; Naumova EN, 2007, EPIDEMIOL INFECT, V135, P281, DOI 10.1017/S0950268806006698; Naumova EN, 2007, STAT IND TECHNOL, P437, DOI 10.1007/978-0-8176-4542-7_28; Naumova Elena N., 2005, Journal of Water and Health, V3, P185; Naumova EN, 2006, J PUBLIC HEALTH POL, V27, P2, DOI 10.1057/palgrave.jphp.3200061; Naumova EN, 2000, PUBLIC HEALTH REP, V115, P436, DOI 10.1093/phr/115.5.436; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Patz JA, 2000, ANNU REV PUBL HEALTH, V21, P271, DOI 10.1146/annurev.publhealth.21.1.271; Petridou ET, 2007, SCAND J PUBLIC HEALT, V35, P278, DOI 10.1080/14034940600996662; Rivera F, 2002, NEPHROL DIAL TRANSPL, V17, P1594, DOI 10.1093/ndt/17.9.1594; Simental L, 2008, APPL ENVIRON MICROB, V74, P5918, DOI 10.1128/AEM.01139-08; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TAYLOR JO, 1991, AM J EPIDEMIOL, V134, P489, DOI 10.1093/oxfordjournals.aje.a116121; THACKER SB, 1988, EPIDEMIOL REV, V10, P164, DOI 10.1093/oxfordjournals.epirev.a036021; Thomas JD, 2005, ILLUMINATING PATH RE, P3; Tufte ER, 2001, VISUAL DISPLAY QUANT; Vugia D., 2004, Morbidity and Mortality Weekly Report, V53, P340; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Wharton M, 1990, MMWR Recomm Rep, V39, P1; Wilkinson L., 1999, GRAMMAR GRAPHICS	41	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e14683	10.1371/journal.pone.0014683	http://dx.doi.org/10.1371/journal.pone.0014683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	721QH	21347221	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200002
J	Whalen, CC; Zalwango, S; Chiunda, A; Malone, L; Eisenach, K; Joloba, M; Boom, WH; Mugerwa, R				Whalen, Christopher C.; Zalwango, Sarah; Chiunda, Allan; Malone, LaShaunda; Eisenach, Kathleen; Joloba, Moses; Boom, W. Henry; Mugerwa, Roy			Secondary Attack Rate of Tuberculosis in Urban Households in Kampala, Uganda	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; SKIN-TEST; CONTACTS; EPIDEMIOLOGY; INFECTION; RISK; DISEASES; CHILDREN; ERROR	Background: Tuberculosis is an ancient disease that continues to threaten individual and public health today, especially in sub-Saharan Africa. Current surveillance systems describe general risk of tuberculosis in a population but do not characterize the risk to an individual following exposure to an infectious case. Methods: In a study of household contacts of infectious tuberculosis cases (n = 1918) and a community survey of tuberculosis infection (N = 1179) in Kampala, Uganda, we estimated the secondary attack rate for tuberculosis disease and tuberculosis infection. The ratio of these rates is the likelihood of progressive primary disease after recent household infection. Results: The secondary attack rate for tuberculosis disease was 3.0% (95% confidence interval: 2.2, 3.8). The overall secondary attack rate for tuberculosis infection was 47.4 (95% confidence interval: 44.3, 50.6) and did not vary widely with age, HIV status or BCG vaccination. The risk for progressive primary disease was highest among the young or HIV infected and was reduced by BCG vaccination. Conclusions: Early case detection and treatment may limit household transmission of M. tuberculosis. Household members at high risk for disease should be protected through vaccination or treatment of latent tuberculosis infection.	[Whalen, Christopher C.; Chiunda, Allan] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Zalwango, Sarah; Joloba, Moses] Makerere Univ, TB Res Unit, Kampala, Uganda; [Malone, LaShaunda; Boom, W. Henry] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Malone, LaShaunda; Boom, W. Henry] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Eisenach, Kathleen] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Mugerwa, Roy] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda	University System of Georgia; University of Georgia; Makerere University; Case Western Reserve University; University Hospitals of Cleveland; University of Arkansas System; University of Arkansas Medical Sciences; Makerere University	Whalen, CC (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	ccwhalen@uga.edu		Joloba, Moses/0000-0002-0334-9983	Tuberculosis Research Unit, United States National Institutes of Allergy and Infectious Diseases (NIAID); United States National Institutes of Health and Human Services [NO1-AI-95383, HHSN266200700022C/NO1-AI-7002]; Fogarty International Center [TW-00011]; Center for AIDS Research at the NIAID [AI 36219]; National Institutes of Health; FOGARTY INTERNATIONAL CENTER [D43TW000011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095383, P30AI036219] Funding Source: NIH RePORTER	Tuberculosis Research Unit, United States National Institutes of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States National Institutes of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research at the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in whole or in part by the Tuberculosis Research Unit, established with federal funds from the United States National Institutes of Allergy and Infectious Diseases (NIAID) and the United States National Institutes of Health and Human Services, under contract nos. NO1-AI-95383 and HHSN266200700022C/NO1-AI-7002, the AIDS International Training and Research Program of the Fogarty International Center (TW-00011), and the Center for AIDS Research (AI 36219) at the NIAID, the National Institutes of Health. The sponsor of the project reviewed and approved the study design and made periodic reviews of progress, but the sponsor did not participate in data collection, data analysis, the decision to publish, or preparation of the manuscript.	Chaves F, 1996, J CLIN MICROBIOL, V34, P1118, DOI 10.1128/JCM.34.5.1118-1123.1996; CHECKOWAY H, 1988, INT J EPIDEMIOL, V17, P666, DOI 10.1093/ije/17.3.666; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; EGSMOSE T, 1961, B WLD HLTH ORG, V25, P831; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FINE PEM, 1988, INT J EPIDEMIOL, V17, P635, DOI 10.1093/ije/17.3.635; Frost WH, 1933, AM J PUBLIC HEALTH N, V23, P426, DOI 10.2105/AJPH.23.5.426; Frost WH, 1938, AM J PUBLIC HEALTH N, V28, P7, DOI 10.2105/AJPH.28.1.7; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Halloran M. E., 2001, EPIDEMIOL METHODS ST, P56; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Joloba ML, 2000, E AFR MED J, V77, P111; KEMPER JT, 1980, AM J EPIDEMIOL, V112, P457, DOI 10.1093/oxfordjournals.aje.a113013; LESKE MC, 1981, AM J EPIDEMIOL, V113, P606, DOI 10.1093/oxfordjournals.aje.a113138; Lienhardt C, 2003, AM J RESP CRIT CARE, V168, P448, DOI 10.1164/rccm.200212-1483OC; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sutherland I, 1971, Bull Int Union Tuberc, V45, P80; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; WALTER SD, 1983, AM J EPIDEMIOL, V117, P598, DOI 10.1093/oxfordjournals.aje.a113582; WALTER SD, 1980, AM J EPIDEMIOL, V112, P409, DOI 10.1093/oxfordjournals.aje.a113007; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55	28	46	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16137	10.1371/journal.pone.0016137	http://dx.doi.org/10.1371/journal.pone.0016137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21339819	gold, Green Published, Green Submitted			2022-12-25	WOS:000287367600010
J	Plaisant, M; Giorgetti-Peraldi, S; Gabrielson, M; Loubat, A; Dani, C; Peraldi, P				Plaisant, Magali; Giorgetti-Peraldi, Sophie; Gabrielson, Marike; Loubat, Agnes; Dani, Christian; Peraldi, Pascal			Inhibition of Hedgehog Signaling Decreases Proliferation and Clonogenicity of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							SONIC HEDGEHOG; IN-VITRO; SELF-RENEWAL; DIFFERENTIATION; ACTIVATION; MECHANISMS; GROWTH; EXPRESSION; GLI2; SUPPRESSION	Human mesenchymal stem cells (hMSC) have the ability to differentiate into osteoblasts, adipocytes and chondrocytes. We have previously shown that hMSC were endowed with a basal level of Hedgehog signaling that decreased after differentiation of these cells. Since hMSC differentiation is associated with growth-arrest we investigated the function of Hh signaling on cell proliferation. Here, we show that inhibition of Hh signaling, using the classical inhibitor cyclopamine, or a siRNA directed against Gli-2, leads to a decrease in hMSC proliferation. This phenomenon is not linked to apoptosis but to a block of the cells in the G0/G1 phases of the cell cycle. At the molecular level, it is associated with an increase in the active form of pRB, and a decrease in cyclin A expression and MAP kinase phosphorylation. Inhibition of Hh signaling is also associated with a decrease in the ability of the cells to form clones. By contrast, inhibition of Hh signaling during hMSC proliferation does not affect their ability to differentiate. This study demonstrates that hMSC are endowed with a basal Hedgehog signaling activity that is necessary for efficient proliferation and clonogenicity of hMSC. This observation unravels an unexpected new function for Hedgehog signaling in the regulation of human mesenchymal stem cells and highlights the critical function of this morphogen in hMSC biology.	[Plaisant, Magali; Gabrielson, Marike; Dani, Christian; Peraldi, Pascal] CNRS, UMR6543, Inst Biol Dev & Canc, Fac Med, F-06034 Nice, France; [Plaisant, Magali; Giorgetti-Peraldi, Sophie; Gabrielson, Marike; Loubat, Agnes; Dani, Christian; Peraldi, Pascal] Univ Nice Sophia Antipolis, IFR50, Fac Med, Nice, France; [Giorgetti-Peraldi, Sophie] INSERM, U895, Team Cellular & Mol Physiopathol Obes & Diabet, Nice, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Plaisant, M (corresponding author), CNRS, UMR6543, Inst Biol Dev & Canc, Fac Med, F-06034 Nice, France.		DANI, Christian/G-3639-2014; Peraldi, Pascal/O-4592-2016	DANI, Christian/0000-0003-3228-0230; Peraldi, Pascal/0000-0003-0205-9252; Giorgetti-Peraldi, Sophie/0000-0002-2751-2618; Gabrielson, Marike/0000-0002-3171-1556	Agence National de la Recherche HYP-INSRES-HH [ANR09-GENO-036]; CNRS; Agence Nationale de la Recherche	Agence National de la Recherche HYP-INSRES-HH(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants from the "Agence National de la Recherche HYP-INSRES-HH grant ANR09-GENO-036" and the CNRS. MP is supported by the "Agence Nationale de la Recherche." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2008, P NATL ACAD SCI USA, V105, P4838, DOI 10.1073/pnas.0712216105; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Cai C, 2008, STEM CELLS, V26, P1097, DOI 10.1634/stemcells.2007-0684; Chen XJ, 2007, CANCER SCI, V98, P68, DOI 10.1111/j.1349-7006.2006.00353.x; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Elabd C, 2007, BIOCHEM BIOPH RES CO, V361, P342, DOI 10.1016/j.bbrc.2007.06.180; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Li N, 2008, STEM CELLS, V26, P1253, DOI 10.1634/stemcells.2007-0691; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Michaud EJ, 2006, CANCER RES, V66, P6463, DOI 10.1158/0008-5472.CAN-06-0462; Mill P, 2003, GENE DEV, V17, P282, DOI 10.1101/gad.1038103; Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zaragosi LE, 2006, STEM CELLS, V24, P2412, DOI 10.1634/stemcells.2006-0006; Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013	40	39	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16798	10.1371/journal.pone.0016798	http://dx.doi.org/10.1371/journal.pone.0016798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304817	gold, Green Published, Green Submitted			2022-12-25	WOS:000287036600025
J	Bernini, F; Ebranati, E; De Maddalena, C; Shkjezi, R; Milazzo, L; Lo Presti, A; Ciccozzi, M; Galli, M; Zehender, G				Bernini, Flavia; Ebranati, Erika; De Maddalena, Chiara; Shkjezi, Renata; Milazzo, Laura; Lo Presti, Alessandra; Ciccozzi, Massimo; Galli, Massimo; Zehender, Gianguglielmo			Within-Host Dynamics of the Hepatitis C Virus Quasispecies Population in HIV-1/HCV Coinfected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD MONONUCLEAR-CELLS; AMINO-ACID SITES; HYPERVARIABLE REGION; NEUTRALIZING ANTIBODIES; SCAVENGER RECEPTOR; SEQUENCE VARIATION; EVOLUTIONARY DYNAMICS; POSITIVE SELECTION	HIV/HCV coinfected individuals under highly active antiretroviral therapy (HAART) represent an interesting model for the investigation of the role played by the immune system in driving the evolution of the HCV quasispecies. We prospectively studied the intra-host evolution of the HCV heterogeneity in 8 coinfected subjects, selected from a cohort of 32 patients initiating HAART: 5 immunological responders (group A) and 3 immunological non-responders (group B), and in two HCV singly infected controls not assuming drugs (group C). For all these subjects at least two serial samples obtained at the first observation (before HAART) and more than 1 year later, underwent clonal sequence analysis of partial E1/E2 sequences, encompassing the whole HVR1. Evolutionary rates, dated phylogenies and population dynamics were co-estimated by using a Bayesian Markov Chain Monte Carlo approach, and site specific selection pressures were estimated by maximum likelihood-based methods. The intra-host evolutionary rates of HCV quasispecies was 10 times higher in subjects treated with HAART than in controls without immunodeficiency (1.9 and 2.3x10(-3) sub/site/month in group A and B and 0.29x10(-3) sub/site/month in group C individuals). The within-host Bayesian Skyline plot analysis showed an exponential growth of the quasispecies populations in immunological responders, coinciding with a peak in CD4 cell counts. On the contrary, quasispecies population remained constant in group B and in group C controls. A significant positive selection pressure was detected in a half of the patients under HAART and in none of the group C controls. Several sites under significant positive selection were described, mainly included in the HVR1. Our data indicate that different forces, in addition to the selection pressure, drive an exceptionally fast evolution of HCV during HAART immune restoration. We hypothesize that an important role is played by the enlargement of the viral replicative space.	[Bernini, Flavia; Ebranati, Erika; De Maddalena, Chiara; Shkjezi, Renata; Milazzo, Laura; Galli, Massimo; Zehender, Gianguglielmo] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy; [Lo Presti, Alessandra; Ciccozzi, Massimo] Inst Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy	University of Milan; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Bernini, F (corresponding author), Univ Milan, Dept Clin Sci L Sacco, Milan, Italy.	gianguglielmo.zehender@unimi.it	Ciccozzi, Massimo/AAC-3271-2022; Lo Presti, Alessandra/K-1451-2016; CICCOZZI, MASSIMO/C-6484-2016; GALLI, MASSIMO/L-7282-2017	Ciccozzi, Massimo/0000-0003-3866-9239; Lo Presti, Alessandra/0000-0001-7611-5021; CICCOZZI, MASSIMO/0000-0003-3866-9239; GALLI, MASSIMO/0000-0001-8887-6215				ABE K, 1992, J GEN VIROL, V73, P2725, DOI 10.1099/0022-1317-73-10-2725; Allain JP, 2000, J VIROL, V74, P2541, DOI 10.1128/JVI.74.6.2541-2549.2000; Babik JM, 2003, J VIROL, V77, P1940, DOI 10.1128/JVI.77.3.1940-1950.2003; Bartosch B, 2005, J VIROL, V79, P8217, DOI 10.1128/JVI.79.13.8217-8229.2005; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Blackard JT, 2004, J INFECT DIS, V189, P1472, DOI 10.1086/382959; Booth JCL, 1998, HEPATOLOGY, V27, P223, DOI 10.1002/hep.510270134; Brown RJP, 2005, J GEN VIROL, V86, P1931, DOI 10.1099/vir.0.80957-0; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Christie JML, 1999, HEPATOLOGY, V30, P1037, DOI 10.1002/hep.510300403; Chung RT, 2002, AIDS, V16, P1915, DOI 10.1097/00002030-200209270-00008; Cuevas JM, 2009, INFECT GENET EVOL, V9, P860, DOI 10.1016/j.meegid.2009.05.007; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubuisson J, 2007, WORLD J GASTROENTERO, V13, P2406, DOI 10.3748/wjg.v13.i17.2406; Duffy M, 2002, VIROLOGY, V301, P354, DOI 10.1006/viro.2002.1597; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Felsenstein J, 2006, MOL BIOL EVOL, V23, P691, DOI 10.1093/molbev/msj079; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; KATO N, 1992, BIOCHEM BIOPH RES CO, V189, P119, DOI 10.1016/0006-291X(92)91533-V; Kingman JFC, 2000, GENETICS, V156, P1461; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; KUMAR S, 1994, COMPUT APPL BIOSCI, V10, P189; Laskus T, 1998, J INFECT DIS, V178, P1189, DOI 10.1086/515682; Laskus T, 2007, HEPATOLOGY, V46, P359, DOI 10.1002/hep.21715; Marine-Barjoan E, 2004, AIDS, V18, P2163, DOI 10.1097/00002030-200411050-00008; McAllister J, 1998, J VIROL, V72, P4893, DOI 10.1128/JVI.72.6.4893-4905.1998; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2000, GENETICS, V155, P1429; Qurishi N, 2003, LANCET, V362, P1708, DOI 10.1016/S0140-6736(03)14844-1; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salemi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008153; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Sheridan I, 2004, J VIROL, V78, P3447, DOI 10.1128/JVI.78.7.3447-3454.2004; Shuhart MC, 2006, J INFECT DIS, V193, P1211, DOI 10.1086/502974; Smith DB, 1999, J VIRAL HEPATITIS, V6, P41, DOI 10.1046/j.1365-2893.1999.00010.x; Solmone M, 2006, ANTIVIR THER, V11, P87; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toyoda H, 1997, J HEPATOL, V26, P975, DOI 10.1016/S0168-8278(97)80105-5; Valdez H, 2001, CLIN INFECT DIS, V32, P1487, DOI 10.1086/320164; Vento S, 1998, AIDS, V12, P116; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Zehender G, 2005, J VIROL, V79, P9145, DOI 10.1128/JVI.79.14.9145-9156.2005; Zehender G, 1997, J INFECT DIS, V176, P1209, DOI 10.1086/514114; Zeisel MB, 2007, WORLD J GASTROENTERO, V13, P4824, DOI 10.3748/wjg.v13.i36.4824	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16551	10.1371/journal.pone.0016551	http://dx.doi.org/10.1371/journal.pone.0016551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304985	Green Published, gold			2022-12-25	WOS:000286834300084
J	Borth, N; Litsche, K; Franke, C; Sachse, K; Saluz, HP; Hanel, F				Borth, Nicole; Litsche, Katrin; Franke, Claudia; Sachse, Konrad; Saluz, Hans Peter; Haenel, Frank			Functional Interaction between Type III-Secreted Protein IncA of Chlamydophila psittaci and Human G3BP1	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; INCLUSION MEMBRANE; STRESS GRANULES; BINDING-PROTEIN; HOST-CELLS; C-MYC; APOPTOSIS; CYCLE; DEGRADATION; REQUIRES	Chlamydophila (Cp.) psittaci, the causative agent of psittacosis in birds and humans, is the most important zoonotic pathogen of the family Chlamydiaceae. These obligate intracellular bacteria are distinguished by a unique biphasic developmental cycle, which includes proliferation in a membrane-bound compartment termed inclusion. All Chlamydiaceae spp. possess a coding capacity for core components of a Type III secretion apparatus, which mediates specific delivery of anti-host effector proteins either into the chlamydial inclusion membrane or into the cytoplasm of target eukaryotic cells. Here we describe the interaction between Type III-secreted protein IncA of Cp. psittaci and host protein G3BP1 in a yeast two-hybrid system. In GST-pull down and co-immunoprecipitation experiments both in vitro and in vivo interaction between full-length IncA and G3BP1 were shown. Using fluorescence microscopy, the localization of G3BP1 near the inclusion membrane of Cp. psittaci-infected Hep-2 cells was demonstrated. Notably, infection of Hep-2 cells with Cp. psittaci and overexpression of IncA in HEK293 cells led to a decrease in c-Myc protein concentration. This effect could be ascribed to the interaction between IncA and G3BP1 since overexpression of an IncA mutant construct disabled to interact with G3BP1 failed to reduce c-Myc concentration. We hypothesize that lowering the host cell c-Myc protein concentration may be part of a strategy employed by Cp. psittaci to avoid apoptosis and scale down host cell proliferation.	[Borth, Nicole; Litsche, Katrin; Franke, Claudia; Saluz, Hans Peter; Haenel, Frank] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoell Inst, Dept Cell & Mol Biol, Jena, Germany; [Saluz, Hans Peter] Univ Jena, Jena, Germany; [Sachse, Konrad] Inst Mol Pathogenesis, Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Borth, N (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoell Inst, Dept Cell & Mol Biol, Jena, Germany.	frank.haenel@hki-jena.de	Sachse, Konrad/GWC-4999-2022	Sachse, Konrad/0000-0003-1230-1786	German Federal Ministry of Education and Research (BMBF) [01 KI 0724]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Federal Ministry of Education and Research (BMBF), grant 01 KI 0724 to H. P. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsara ZR, 2006, INFECT IMMUN, V74, P5602, DOI 10.1128/IAI.00266-06; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Beeckman DSA, 2008, VET RES, V39, DOI 10.1051/vetres:2008002; BETTS HJ, 2008, CURR OPIN MICROBIOL, V11, P1; Bohme L, 2009, MICROBES INFECT, V11, P1063, DOI 10.1016/j.micinf.2009.08.014; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Greene W, 2003, J INFECTION, V47, P45, DOI 10.1016/S0163-4453(03)00039-2; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Heinzen RA, 1996, INFECT IMMUN, V64, P796, DOI 10.1128/IAI.64.3.796-809.1996; HERMEKING H, 1994, SCIENCE, V265, P2091, DOI 10.1126/science.8091232; HOROSCHAK KD, 1978, INFECT IMMUN, V19, P281, DOI 10.1128/IAI.19.1.281-286.1978; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pantchev A., 2009, COMP IMMUNO IN PRESS; Parker F, 1996, MOL CELL BIOL, V16, P2561; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Schneider S, 1999, NAT BIOTECHNOL, V17, P170, DOI 10.1038/6172; Scidmore MA, 2001, MOL MICROBIOL, V39, P1638, DOI 10.1046/j.1365-2958.2001.02355.x; Sears RC, 2004, CELL CYCLE, V3, P1133, DOI 10.4161/cc.3.9.1145; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Szeredi L, 2005, VET RES COMMUN, V29, P37, DOI 10.1007/s11259-005-0835-1; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WOLF K, 2009, CELL MICROB IN PRESS; Wollmann Y, 2007, J CELL BIOCHEM, V102, P171, DOI 10.1002/jcb.21292; Ying Songmin, 2007, Curr Immunol Rev, V3, P31, DOI 10.2174/157339507779802179; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	42	13	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16692	10.1371/journal.pone.0016692	http://dx.doi.org/10.1371/journal.pone.0016692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304914	Green Published, gold, Green Submitted			2022-12-25	WOS:000286834300122
J	Loukovitis, D; Sarropoulou, E; Tsigenopoulos, CS; Batargias, C; Magoulas, A; Apostolidis, AP; Chatziplis, D; Kotoulas, G				Loukovitis, Dimitrios; Sarropoulou, Elena; Tsigenopoulos, Costas S.; Batargias, Costas; Magoulas, Antonios; Apostolidis, Apostolos P.; Chatziplis, Dimitrios; Kotoulas, Georgios			Quantitative Trait Loci Involved in Sex Determination and Body Growth in the Gilthead Sea Bream (Sparus aurata L.) through Targeted Genome Scan	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; OVARIAN AROMATASE; BINARY TRAITS; DIFFERENTIATION; FISH; QTL; EXPRESSION; REGRESSION; SEABREAM; BASS	Among vertebrates, teleost fish exhibit a considerably wide range of sex determination patterns that may be influenced by extrinsic parameters. However even for model fish species like the zebrafish Danio rerio the precise mechanisms involved in primary sex determination have not been studied extensively. The zebrafish, a gonochoristic species, is lacking discernible sex chromosomes and the sex of juvenile fish is difficult to determine. Sequential protandrous hermaphrodite species provide distinct determination of the gender and allow studying the sex determination process by looking at the mechanism of sex reversal. This is the first attempt to understand the genetic basis of phenotypic variation for sex determination and body weight in a sequential protandrous hermaphrodite species, the gilthead sea bream (Sparus aurata). This work demonstrates a fast and efficient strategy for Quantitative Trait Loci (QTL) detection in the gilthead sea bream, a non-model but target hermaphrodite fish species. Therefore a comparative mapping approach was performed to query syntenies against two other Perciformes, the European sea bass (Dicentrarchus labrax), a gonochoristic species and the Asian sea bass (Lates calcarifer) a protandrous hermaphrodite. In this manner two significant QTLs, one QTL affecting both body weight and sex and one QTL affecting sex, were detected on the same linkage group. The co-segregation of the two QTLs provides a genomic base to the observed genetic correlation between these two traits in sea bream as well as in other teleosts. The identification of QTLs linked to sex reversal and growth, will contribute significantly to a better understanding of the complex nature of sex determination in S. aurata where most individuals reverse to the female sex at the age of two years through development and maturation of the ovarian portion of the gonad and regression of the testicular area. [Genomic sequences reported in this manuscript have been submitted to GenBank under accession numbers HQ021443-HQ021749.]	[Loukovitis, Dimitrios; Chatziplis, Dimitrios] Alexander Technol Inst Thessaloniki, Sch Agr Technol, Dept Anim Prod, Sindos, Greece; [Sarropoulou, Elena; Tsigenopoulos, Costas S.; Magoulas, Antonios; Kotoulas, Georgios] Hellen Ctr Marine Res, Inst Marine Biol & Genet, Iraklion, Crete, Greece; [Batargias, Costas] Inst Educ Technol, Sch Agr Technol, Dept Fisheries & Aquaculture, Mesolongion, Greece; [Loukovitis, Dimitrios; Apostolidis, Apostolos P.] Aristotle Univ Thessaloniki, Fac Agr, Dept Anim Prod, Lab Ichthyol & Fisheries, GR-54006 Thessaloniki, Greece	Hellenic Centre for Marine Research; Western Greece University of Applied Sciences (TEI of Western Greece); Aristotle University of Thessaloniki	Loukovitis, D (corresponding author), Alexander Technol Inst Thessaloniki, Sch Agr Technol, Dept Anim Prod, Sindos, Greece.	sarris@her.hcmr.gr	Tsigenopoulos, Costas/R-9467-2019; Apostolidis, Apostolos P/P-6122-2014; Batargias, Costas/AAJ-9614-2020; Kotoulas, Georgios/AAM-7938-2020	Tsigenopoulos, Costas/0000-0003-0615-7941; Batargias, Costas/0000-0002-8846-8518; LOUKOVITIS, DIMITRIOS/0000-0002-4845-5747; Apostolidis, Apostolos/0000-0001-7941-1790; Kotoulas, Georgios/0000-0002-4667-8533	EU; Hellenic Centre for Marine Research; Alexander Technological Institute of Thessaloniki; AQUAGENOME	EU(European Commission); Hellenic Centre for Marine Research; Alexander Technological Institute of Thessaloniki; AQUAGENOME	The authors would like to acknowledge the EU FP5 BRIDGEMAP project, Hellenic Centre for Marine Research and Alexander Technological Institute of Thessaloniki as well as AQUAGENOME for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, OFFICIAL J EUROPEAN, VL358, P1; Batargias C, 1998, THESIS U CRETE; BECAK W, 1983, DIFFERENTIATION, V23, pS3; Brown R.C., 2003, THESIS U STIRLING; Brown RC, 2005, AQUACULTURE, V247, P219, DOI 10.1016/j.aquaculture.2005.02.002; BrusleSicard S, 1997, J FISH BIOL, V50, P1094, DOI 10.1006/jfbi.1996.0382; CATAUDELLA S, 1980, GENETICA, V54, P155, DOI 10.1007/BF00055985; Chatziplis D, 2007, AQUACULTURE, V272, pS172, DOI 10.1016/j.aquaculture.2007.08.022; CHURCHILL GA, 1994, GENETICS, V138, P963; de Koning DJ, 2001, J ANIM SCI, V79, P616; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Duchesne P, 2002, MOL ECOL NOTES, V2, P191, DOI 10.1046/j.1471-8286.2002.00164.x; Franch R, 2006, GENETICS, V174, P851, DOI 10.1534/genetics.106.059014; Fuller RC, 1998, P ROY SOC B-BIOL SCI, V265, P2365, DOI 10.1098/rspb.1998.0585; GREEN P, 1990, CRIMAP VERSION 2 4; Guiguen Y, 1999, MOL REPROD DEV, V54, P154, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;154::AID-MRD7&gt;3.0.CO;2-5; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Kadarmideen HN, 2001, J ANIM BREED GENET, V118, P297, DOI 10.1046/j.1439-0388.2001.00301.x; Kadarmideen HN, 2000, GENET RES, V76, P305, DOI 10.1017/S001667230000481X; KADMON D, 1985, PROSTATE, V6, P343, DOI 10.1002/pros.2990060403; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Knott SA, 1996, THEOR APPL GENET, V93, P71, DOI 10.1007/BF00225729; Kolbehdari D, 2005, GENET SEL EVOL, V37, P601, DOI 10.1051/gse:2005021; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Kwon JY, 2001, MOL REPROD DEV, V59, P359, DOI 10.1002/mrd.1042; Lee BY, 2004, HEREDITY, V92, P543, DOI 10.1038/sj.hdy.6800453; Lee BY, 2003, ANIM GENET, V34, P379, DOI 10.1046/j.1365-2052.2003.01035.x; Liarte S, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-20; Martyniuk CJ, 2003, J FISH BIOL, V63, P746, DOI 10.1046/j.1095-8649.2003.00188.x; Massault C, 2010, ANIM GENET, V41, P337, DOI 10.1111/j.1365-2052.2009.02010.x; MASSAULT C, 2010, ANIMAL GENETICS, DOI DOI 10.1111/J.1365-2052.2010.02110; Massault C, 2008, AQUACULTURE, V285, P23, DOI 10.1016/j.aquaculture.2008.06.040; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Meiri I, 2002, J EXP ZOOL, V292, P555, DOI 10.1002/jez.10072; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moghadam HK, 2007, MOL GENET GENOMICS, V277, P647, DOI 10.1007/s00438-007-0215-3; MOORE R, 1979, AUST J MAR FRESH RES, V30, P803, DOI 10.1071/MF9790803; Oldfield RG, 2005, FISH FISH, V6, P93, DOI 10.1111/j.1467-2979.2005.00184.x; Penman DJ, 2008, REV FISH SCI, V16, P16, DOI 10.1080/10641260802324610; Sarropoulou E, 2008, MAR BIOTECHNOL, V10, P227, DOI 10.1007/s10126-007-9066-5; Sarropoulou E, 2005, PHYSIOL GENOMICS, V23, P182, DOI 10.1152/physiolgenomics.00139.2005; Sarropoulou E, 2005, AQUACULTURE, V243, P69, DOI 10.1016/j.aquaculture.2004.10.012; Sarropoulou E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-44; Seaton G, 2006, P 8 WORLD C GEN APPL; Senger F, 2006, GENOMICS, V87, P793, DOI 10.1016/j.ygeno.2005.11.019; Simpson ER, 2001, ENDOCRINOLOGY, V142, P4589, DOI 10.1210/endo.142.11.8547; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Tong SK, 2010, DEV BIOL, V344, P849, DOI 10.1016/j.ydbio.2010.05.515; Vandeputte M, 2007, GENETICS, V176, P1049, DOI 10.1534/genetics.107.072140; Wang CM, 2008, ANIM GENET, V39, P34, DOI 10.1111/j.1365-2052.2007.01672.x; Wang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-274; Wong TT, 2006, BIOL REPROD, V74, P857, DOI 10.1095/biolreprod.105.045351; ZOHAR Y, 1978, ANN BIOL ANIM BIOCH, V18, P877, DOI 10.1051/rnd:19780519; ZOHAR Y, 1995, BROODSTOCK MANAGEMEN, P94; J FISH BIOL, V68, P1; 1998, ANIMAL BEHAV, V55, P251	56	59	61	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16599	10.1371/journal.pone.0016599	http://dx.doi.org/10.1371/journal.pone.0016599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304996	Green Published, Green Submitted, gold			2022-12-25	WOS:000286834300096
J	Ohya, S; Niwa, S; Yanagi, A; Fukuyo, Y; Yamamura, H; Imaizumi, Y				Ohya, Susumu; Niwa, Satomi; Yanagi, Ayano; Fukuyo, Yuka; Yamamura, Hisao; Imaizumi, Yuji			Involvement of Dominant-negative Spliced Variants of the Intermediate Conductance Ca2+-activated K+ Channel, K(Ca)3.1, in Immune Function of Lymphoid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; AMINO-ACIDS; EXPRESSION; TRAFFICKING; SK3; TARGETS; GENE; TRANSCRIPTION; LYMPHOCYTES; RECEPTOR	The intermediate conductance Ca2+-activated K+ channel (IKCa channel) encoded by K(Ca)3.1 is responsible for the control of proliferation and differentiation in various types of cells. We identified novel spliced variants of K(Ca)3.1 (human (h) K(Ca)3.1b) from the human thymus, which were lacking the N-terminal domains of the original hK(Ca)3.1a as a result of alternative splicing events. hK(Ca)3.1b was significantly expressed in human lymphoid tissues. Western blot analysis showed that hK(Ca)3.1a proteins were mainly expressed in the plasma membrane fraction, whereas hK(Ca)3.1b was in the cytoplasmic fraction. We also identified a similar N terminus lacking K(Ca)3.1 variants from mice and rat lymphoid tissues (mK(Ca)3.1b and rK(Ca)3.1b). In the HEK293 heterologous expression system, the cellular distribution of cyan fluorescent protein-tagged hK(Ca)3.1a and/or YFP-tagged hK(Ca)3.1b isoforms showed that hK(Ca)3.1b suppressed the localization of hK(Ca)3.1a to the plasma membrane. In the Xenopus oocyte translation system, co-expression of hK(Ca)3.1b with hK(Ca)3.1a suppressed IKCa channel activity of hK(Ca)3.1a in a dominant-negative manner. In addition, this study indicated that up-regulation of mK(Ca)3.1b in mouse thymocytes differentiated CD4(+) CD8(+) phenotype thymocytes into CD4(-) CD8(-) ones and suppressed concanavalin-A-stimulated thymocyte growth by down-regulation of mIL-2 transcripts. Anti-proliferative effects and down-regulation of mIL-2 transcripts were also observed in mK(Ca)3.1b-overexpressing mouse thymocytes. These suggest that the N-terminal domain of K(Ca)3.1 is critical for channel trafficking to the plasma membrane and that the fine-tuning of IKCa channel activity modulated through alternative splicing events may be related to the control in physiological and pathophysiological conditions in T-lymphocytes.	[Imaizumi, Yuji] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Nagoya City University	Imaizumi, Y (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	yimaizum@phar.nagoya-cu.ac.jp	Imaizumi, Yuji/AAF-6585-2020; Ohya, Susumu/AAB-3618-2020	Ohya, Susumu/0000-0002-5765-0667	Ministry of Education, Culture, Sports, Science and Technology, Japan [21590098]; Salt Science Research Foundation [10C6]; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology [20056027]; Grants-in-Aid for Scientific Research [21590098, 23390020, 23790092, 23136512] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Scientific Research (C) 21590098 from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S. O.), the Salt Science Research Foundation Grant 10C6 (to S. O.), Takeda Science Foundation (to S. O.), a grant-in-aid for scientific research (B) from the Ministry of Education, Culture, Sports, Science and Technology (to Y. I.), and Grant-in-aid for Scientific Research on Priority Areas 20056027 from the Ministry of Education, Culture, Sports, Science and Technology (to Y. I.).	Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Brenner R, 1996, J NEUROSCI, V16, P1827; Brown MR, 2008, J PHYSIOL-LONDON, V586, P5161, DOI 10.1113/jphysiol.2008.160861; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chandy KG, 2004, TRENDS PHARMACOL SCI, V25, P280, DOI 10.1016/j.tips.2004.03.010; Cheong A, 2005, MOL CELL, V20, P45, DOI 10.1016/j.molcel.2005.08.030; Decimo I, 2006, BIOSCIENCE REP, V26, P399, DOI 10.1007/s10540-006-9029-5; Di L, 2010, P NATL ACAD SCI USA, V107, P1541, DOI 10.1073/pnas.0910133107; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Elliott JL, 2003, EMBO REP, V4, P189, DOI 10.1038/sj.embor.embor722; Fanger CM, 2001, J BIOL CHEM, V276, P12249, DOI 10.1074/jbc.M011342200; Fanger CM, 2000, J IMMUNOL, V164, P1153, DOI 10.4049/jimmunol.164.3.1153; Gao YJ, 2008, J BIOL CHEM, V283, P9049, DOI 10.1074/jbc.M708022200; Gao YJ, 2010, J BIOL CHEM, V285, P17938, DOI 10.1074/jbc.M109.086553; Ghanshani S, 1998, GENOMICS, V51, P160, DOI 10.1006/geno.1998.5333; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Ghatta S, 2006, PHARMACOL THERAPEUT, V110, P103, DOI 10.1016/j.pharmthera.2005.10.007; Ghiani CA, 1999, J NEUROSCI, V19, P5380; Gillett A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007773; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOPKINS WF, 1994, J NEUROSCI, V14, P1385, DOI 10.1523/JNEUROSCI.14-03-01385.1994; Hu XZ, 2010, MOL IMMUNOL, V47, P1692, DOI 10.1016/j.molimm.2010.03.005; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jensen BS, 2001, CURR DRUG TARGETS, V2, P401, DOI 10.2174/1389450013348173; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kolski-Andreaco A, 2004, J BIOL CHEM, V279, P6893, DOI 10.1074/jbc.M311725200; Levitan ES, 2000, TRENDS CARDIOVAS MED, V10, P317, DOI 10.1016/S1050-1738(01)00078-0; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; MAHAUTSMITH MP, 1991, J PHYSIOL-LONDON, V439, P513, DOI 10.1113/jphysiol.1991.sp018679; Miller MJ, 2001, J BIOL CHEM, V276, P27753, DOI 10.1074/jbc.C100221200; Monaghan AS, 2004, J BIOL CHEM, V279, P1003, DOI 10.1074/jbc.M308070200; Mourich DV, 2009, CURR OPIN MOL THER, V11, P124; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Ohya S, 1997, FEBS LETT, V401, P252, DOI 10.1016/S0014-5793(96)01485-8; PAULY JL, 1986, J IMMUNOL, V136, P246; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Roncarati R, 2005, MOL CELL NEUROSCI, V28, P314, DOI 10.1016/j.mcn.2004.09.015; Snyders DJ, 1999, CARDIOVASC RES, V42, P377, DOI 10.1016/S0008-6363(99)00071-1; Srivastava S, 2006, MOL BIOL CELL, V17, P146, DOI 10.1091/mbc.e05-08-0763; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tomita H, 2003, MOL PSYCHIATR, V8, P524, DOI 10.1038/sj.mp.4001271; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135; Wulff H, 2003, CURR OPIN DRUG DI DE, V6, P640; Wulff H, 2007, CURR OPIN DRUG DISC, V10, P438	52	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2011	286	19					16940	16952		10.1074/jbc.M110.184192	http://dx.doi.org/10.1074/jbc.M110.184192			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	760CZ	21345794	hybrid, Green Published			2022-12-25	WOS:000290301900043
J	Du, Y; Garden, DP; Wang, LX; Zhorov, BS; Dong, K				Du, Yuzhe; Garden, Daniel P.; Wang, Lingxin; Zhorov, Boris S.; Dong, Ke			Identification of New Batrachotoxin-sensing Residues in Segment IIIS6 of the Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED NA+ CHANNELS; LOCAL-ANESTHETICS; GATING PROPERTIES; MEMBRANE-PROTEIN; CALCIUM-CHANNEL; POINT MUTATIONS; HOMOLOGY MODEL; NUCLEIC-ACIDS; CA2+ CHANNEL; DRUG-BINDING	Ion permeation through voltage-gated sodium channels is modulated by various drugs and toxins. The atomistic mechanisms of action of many toxins are poorly understood. A steroidal alkaloid batrachotoxin (BTX) causes persistent channel activation by inhibiting inactivation and shifting the voltage dependence of activation to more negative potentials. Traditionally, BTX is considered to bind at the channel-lipid interface and allosterically modulate the ion permeation. However, amino acid residues critical for BTX action are found in the inner helices of all four repeats, suggesting that BTX binds in the pore. In the octapeptide segment IEGSFFTL in IIIS6 of a cockroach sodium channel BgNa(v), besides Ser_3i15 and Leu_3i19, which correspond to known BTX-sensing residues of mammalian sodium channels, we found that Gly_3i14 and Phe_3i16 are critical for BTX action. Using these data along with published data as distance constraints, we docked BTX in the Kv1.2-based homology model of the open BgNav channel. We arrived at a model in which BTX adopts a horseshoe conformation with the horseshoe plane normal to the pore axis. The BTX ammonium group is engaged in cation-pi interactions with Phe_3i16 and BTX moieties interact with known BTX-sensing residues in all four repeats. Oxygen atoms at the horseshoe inner surface constitute a transient binding site for permeating cations, whereas the bulky BTX molecule would resist the pore closure, thus causing persistent channel activation. Our study reinforces the concept that steroidal sodium channel agonists bind in the inner pore of sodium channels and elaborates the atomistic mechanism of BTX action.	[Garden, Daniel P.; Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Du, Yuzhe; Wang, Lingxin; Dong, Ke] Michigan State Univ, Dept Entomol Genet & Neurosci Program, E Lansing, MI 48824 USA	McMaster University; Michigan State University	Zhorov, BS (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8N 3Z5, Canada.	zhorov@mcmaster.ca	Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019; Wang, Lingxin/ABC-7603-2020	Zhorov, Boris/0000-0002-3630-7114; 	National Institutes of Health [GM057440]; Canadian Institutes of Health Research [MOP-53229]; Natural Sciences and Engineering Council of Canada; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057440 (to K. D.). This work was also supported by Canadian Institutes of Health Research Grant MOP-53229 (to B. S. Z.) and the Natural Sciences and Engineering Council of Canada.	BEHRENS MI, 1989, J GEN PHYSIOL, V93, P23, DOI 10.1085/jgp.93.1.23; BROWN GB, 1988, INT REV NEUROBIOL, V29, P77, DOI 10.1016/S0074-7742(08)60084-7; Bruhova I, 2008, MOL PHARMACOL, V74, P1033, DOI 10.1124/mol.108.049759; Bruhova I, 2010, J GEN PHYSIOL, V135, P261, DOI 10.1085/jgp.200910288; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CATTERALL WA, 1977, J BIOL CHEM, V252, P8669; Cheng RCK, 2009, J BIOL CHEM, V284, P28332, DOI 10.1074/jbc.M109.027326; CORREA AM, 1991, J GEN PHYSIOL, V97, P605, DOI 10.1085/jgp.97.3.605; DALY JW, 1965, J AM CHEM SOC, V87, P124, DOI 10.1021/ja01079a026; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du Y, 2009, BIOCHEM J, V419, P377, DOI 10.1042/BJ20082082; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GARBER SS, 1987, J GEN PHYSIOL, V89, P459, DOI 10.1085/jgp.89.3.459; Garden DP, 2010, J COMPUT AID MOL DES, V24, P91, DOI 10.1007/s10822-009-9317-9; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HUANG LYM, 1979, J GEN PHYSIOL, V73, P839, DOI 10.1085/jgp.73.6.839; HUANG LYM, 1984, BIOPHYS J, V45, P313, DOI 10.1016/S0006-3495(84)84157-0; KHODOROV BI, 1992, CELL MOL NEUROBIOL, V12, P59, DOI 10.1007/BF00711639; KHODOROV BI, 1979, NEUROSCIENCE, V4, P1315, DOI 10.1016/0306-4522(79)90159-3; Li HL, 2002, MOL PHARMACOL, V61, P905, DOI 10.1124/mol.61.4.905; LI ZQ, 1987, P NATL ACAD SCI USA, V84, P6611, DOI 10.1073/pnas.84.19.6611; Linford NJ, 1998, P NATL ACAD SCI USA, V95, P13947, DOI 10.1073/pnas.95.23.13947; Lipkind GM, 2005, MOL PHARMACOL, V68, P1611, DOI 10.1124/mol.105.014803; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; MOZHAEVA G N, 1983, Neirofiziologiya, V15, P571; Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; QUANDT FN, 1982, P NATL ACAD SCI-BIOL, V79, P6732, DOI 10.1073/pnas.79.21.6732; REVENKO S V, 1977, Neirofiziologiya, V9, P313; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; Tikhonov DB, 2005, FEBS LETT, V579, P4207, DOI 10.1016/j.febslet.2005.07.017; Tikhonov DB, 2005, BIOPHYS J, V88, P184, DOI 10.1529/biophysj.104.048173; Tikhonov DB, 2007, BIOPHYS J, V93, P1557, DOI 10.1529/biophysj.106.100248; Tikhonov DB, 2006, FEBS LETT, V580, P6027, DOI 10.1016/j.febslet.2006.10.035; Totrov M, 1997, PROTEINS, P215; Vedantham V, 2000, BIOPHYS J, V78, P2943, DOI 10.1016/S0006-3495(00)76834-2; Wang SY, 2007, CHANNELS, V1, pE1, DOI 10.4161/chan.4437; Wang SY, 2007, PFLUG ARCH EUR J PHY, V454, P277, DOI 10.1007/s00424-006-0202-2; Wang SY, 2006, MOL PHARMACOL, V69, P788, DOI 10.1124/mol.105.018200; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Wang SY, 1999, BIOPHYS J, V76, P3141, DOI 10.1016/S0006-3495(99)77465-5; Wang SY, 1998, P NATL ACAD SCI USA, V95, P2653, DOI 10.1073/pnas.95.5.2653; Wang SY, 2001, MOL PHARMACOL, V59, P1100, DOI 10.1124/mol.59.5.1100; Wang SY, 2000, BIOPHYS J, V79, P1379, DOI 10.1016/S0006-3495(00)76390-9; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; WARNICK JE, 1975, J PHARMACOL EXP THER, V193, P232; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Zhen XG, 2005, J GEN PHYSIOL, V126, P193, DOI 10.1085/jgp.200509292; Zhorov BS, 2004, J NEUROCHEM, V88, P782, DOI 10.1111/j.1471-4159.2004.02261.x; ZHOROV BS, 1981, J STRUCT CHEM+, V22, P4, DOI 10.1007/BF00745970; Zhorov BS, 2001, ARCH BIOCHEM BIOPHYS, V393, P22, DOI 10.1006/abbi.2001.2484; ZHOROV BS, 1982, J STRUCT CHEM+, V23, P649, DOI 10.1007/BF00746185; Zlotkin E, 1999, ANNU REV ENTOMOL, V44, P429, DOI 10.1146/annurev.ento.44.1.429	60	45	46	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13151	13160		10.1074/jbc.M110.208496	http://dx.doi.org/10.1074/jbc.M110.208496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21303907	Green Published, hybrid			2022-12-25	WOS:000289282200036
J	Karki, P; Li, XJ; Schrama, D; Fliegel, L				Karki, Pratap; Li, Xiuju; Schrama, David; Fliegel, Larry			B-Raf Associates with and Activates the NHE1 Isoform of the Na+/H+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACIDS SER(770); MELANOMA-CELLS; FUNCTIONAL-ANALYSIS; PROTEIN-KINASE; PH; PHOSPHORYLATION; INHIBITORS; COMPLEXES; GROWTH; BRAF	The serine/threonine kinase B-Raf is the second most frequently occurring human oncogene after Ras. Mutations of B-Raf occur with the highest incidences in melanoma, and the most common mutant, V600E, renders B-Raf constitutively active. The sodium proton exchanger isoform 1 (NHE1) is a ubiquitously expressed plasma membrane protein responsible for regulating intracellular pH, cell volume, cell migration, and proliferation. A screen of protein kinases that bind to NHE1 revealed that B-Raf bound to the cytosolic regulatory tail of NHE1 Immunoprecipitation of NHE1 from He La and HEK cells confirmed the association of B-Raf with NHE1 in vivo. The expressed and purified C-terminal 182 amino acids of the NHE1 protein were also shown to associate with B-Raf protein in vitro. Because treatment with the kinase inhibitor sorafenib decreased NHE1 activity in HeLa and HEK cells, we examined the role of B-Raf in regulating NHE1 in malignant melanoma cells. Melanoma cells with the B-Raf(v600E) mutation demonstrated increased resting intracellular pH that was dependent on elevated NHE1 activity. NHE1 activity after an acute acid load was also elevated in these cell lines. Moreover, inhibition of B-Raf activity by either sorafenib, PLX4720, or siRNA reduction of B-Raf levels abolished ERK phosphorylation and decreased NHE1 activity. These results demonstrate that B-Raf associates with and stimulates NHE1 activity and that B-Raf(v600E) also increases NHE1 activity that raises intracellular pH.	[Karki, Pratap; Li, Xiuju; Fliegel, Larry] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Schrama, David] Med Univ Graz, Div Dermatol, A-8036 Graz, Austria	University of Alberta; Medical University of Graz	Fliegel, L (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	Ifliegel@ualberta.ca		Schrama, David/0000-0002-6931-8194	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Alberta Heritage Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research)	This work was supported in part by a grant from the Canadian Institutes of Health Research (to L. F.).; Supported in part by the Heart and Stroke Foundation of Canada.; Supported by Alberta Heritage Foundation for Medical Research Scientist award.	ANWER MS, 1994, HEPATOLOGY, V20, P1309, DOI 10.1016/0270-9139(94)90773-0; Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Cui Y, 2008, ONCOGENE, V27, P3122, DOI 10.1038/sj.onc.1210972; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FLAHERTY K, 2009, J CLIN ONCOL, V27, pS15; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Haworth RS, 2006, BIOCHEM J, V399, P493, DOI 10.1042/BJ20051628; Kang MG, 1998, BIOL CELL, V90, P477, DOI 10.1016/S0248-4900(99)80006-9; Karki P, 2010, BBA-BIOMEMBRANES, V1798, P1565, DOI 10.1016/j.bbamem.2010.05.005; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Li XJ, 2003, BIOCHEMISTRY-US, V42, P7448, DOI 10.1021/bi027143d; Li XJ, 2006, BIOCHEMISTRY-US, V45, P2414, DOI 10.1021/bi051132d; Lundquist JJ, 2006, BRAIN CELL BIOL, V35, P267, DOI 10.1007/s11068-008-9018-7; Malo ME, 2007, J BIOL CHEM, V282, P6292, DOI 10.1074/jbc.M611073200; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; MICHALAK M, 1990, J BIOL CHEM, V265, P5869; Misik AJ, 2005, BIOCHEMISTRY-US, V44, P5842, DOI 10.1021/bi047659s; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Paradiso A, 2004, BREAST CANCER RES, V6, pR616, DOI 10.1186/bcr922; Pratilas CA, 2007, REV RECENT CLIN TRIA, V2, P121, DOI 10.2174/157488707780599393; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Reshkin SJ, 2000, J BIOL CHEM, V275, P5361, DOI 10.1074/jbc.275.8.5361; Reshkin SJ, 2000, FASEB J, V14, P2185, DOI 10.1096/fj.00-0029com; Schrama David, 2008, J Carcinog, V7, P1, DOI 10.1186/1477-3163-7-1; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Silva NLCL, 1997, PFLUG ARCH EUR J PHY, V433, P792, DOI 10.1007/s004240050347; SILVA NLCL, 1995, BIOCHEMISTRY-US, V34, P10412, DOI 10.1021/bi00033a013; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2004, BIOCHEM J, V379, P31, DOI 10.1042/BJ20030884; Smalley KSM, 2009, FUTURE ONCOL, V5, P775, DOI [10.2217/fon.09.56, 10.2217/FON.09.56]; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2007, CELL PHYSIOL BIOCHEM, V20, P679, DOI 10.1159/000107550; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wang HY, 1997, J BIOL CHEM, V272, P26545, DOI 10.1074/jbc.272.42.26545; Wang XN, 2006, J CELL PHYSIOL, V209, P253, DOI 10.1002/jcp.20731; Wu XC, 2008, J CELL BIOCHEM, V105, P167, DOI 10.1002/jcb.21809; Zhao YH, 2008, BIOCHEM BIOPH RES CO, V370, P509, DOI 10.1016/j.bbrc.2008.03.148	51	33	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13096	13105		10.1074/jbc.M110.165134	http://dx.doi.org/10.1074/jbc.M110.165134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21345796	Green Published, hybrid			2022-12-25	WOS:000289282200030
J	Ma, HT; Poon, RYC				Ma, Hoi Tang; Poon, Randy Y. C.			Orderly Inactivation of the Key Checkpoint Protein Mitotic Arrest Deficient 2 (MAD2) during Mitotic Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; ANAPHASE-PROMOTING COMPLEX; CYCLIN-DEPENDENT KINASES; CDC20; CELLS; MITOSIS; BUBR1; APC/C; CDK1; PROTEOLYSIS	Anaphase is promoted by the ubiquitin ligase anaphase-promoting complex/cyclosome (APC/C) only when all the chromosomes have achieved bipolar attachment to the mitotic spindles. Unattached kinetochores or the absence of tension between the paired kinetochores activates a surveillance mechanism termed the spindle-assembly checkpoint. A fundamental principle of the checkpoint is the activation of mitotic arrest deficient 2 (MAD2). MAD2 then forms a diffusible complex called mitotic checkpoint complex (designated as MAD2((MCC))) before it is recruited to APC/C (designated as MAD2((APC/C))). Large gaps in our knowledge remain on how MAD2 is inactivated after the checkpoint is satisfied. In this study, we have investigated the regulation of MAD2-containing complexes during mitotic progression. Using selective immunoprecipitation of checkpoint components and gel filtration chromatography, we found that MAD2((MCC)) and MAD2((APC/C)) were regulated very differently during mitotic exit. Temporally, MAD2((MCC)) was broken down ahead of MAD2((APC/C)). The inactivation of the two complexes also displayed different requirements of proteolysis; although APC/C and proteasome activities were dispensable for MAD2((MCC)) inactivation, they are required for MAD2((APC/C)) inactivation. In fact, the degradation of CDC20 is inextricably linked to the breakdown of MAD2((APC/C)). These data extended our understanding of the checkpoint complexes during checkpoint silencing.	[Ma, Hoi Tang; Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	rycpoon@ust.hk		MA, Hoi Tang/0000-0001-5876-0107; Poon, Randy/0000-0001-5571-6231	Research Grants Council [662007, 662208]	Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by the Research Grants Council Grants 662007 and 662208 (to R. Y. C. P.).	Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Ausubel FM., 2006, ENZYMATIC MANIPULATI; Bellanger S, 2007, ONCOGENE, V26, P7175, DOI 10.1038/sj.onc.1210539; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chang DC, 2003, J BIOL CHEM, V278, P37865, DOI 10.1074/jbc.M306376200; CHOW JP, 2011, MOL CELL BI IN PRESS; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Eytan E, 2008, P NATL ACAD SCI USA, V105, P9181, DOI 10.1073/pnas.0804069105; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Li KKW, 2002, LIVER, V22, P259, DOI 10.1046/j.0106-9543.2002.01629.x; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pinsky BA, 2009, CURR BIOL, V19, P1182, DOI 10.1016/j.cub.2009.06.043; POON RYC, 1995, MOL BIOL CELL, V6, P1197, DOI 10.1091/mbc.6.9.1197; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Teichner A, 2011, P NATL ACAD SCI USA, V108, P3187, DOI 10.1073/pnas.1100023108; Vanoosthuyse V, 2009, CURR BIOL, V19, P1176, DOI 10.1016/j.cub.2009.05.060; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Visconti R, 2010, CELL CYCLE, V9, P564, DOI 10.4161/cc.9.3.10581; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Xia GH, 2004, EMBO J, V23, P3133, DOI 10.1038/sj.emboj.7600322; Yam CH, 2001, P NATL ACAD SCI USA, V98, P497, DOI 10.1073/pnas.240461397	36	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13052	13059		10.1074/jbc.M110.201897	http://dx.doi.org/10.1074/jbc.M110.201897			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21335556	Green Published, hybrid			2022-12-25	WOS:000289282200025
J	Shen, S; Bryant, KD; Brown, SM; Randell, SH; Asokan, A				Shen, Shen; Bryant, Kelli D.; Brown, Sarah M.; Randell, Scott H.; Asokan, Aravind			Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIDASE FUSION PROTEIN; GOLGI VESICLE MEMBRANES; MUTANT DEFICIENT; GENE-THERAPY; IN-VIVO; BINDING; ACID; TRANSDUCTION; VECTORS; LECTIN	Sialylated glycans serve as cell surface attachment factors for a broad range of pathogens. We report an atypical example, where desialylation increases cell surface binding and infectivity of adeno-associated virus (AAV) serotype 9, a human parvovirus isolate. Enzymatic removal of sialic acid, but not heparan sulfate or chondroitin sulfate, increased AAV9 transduction regardless of cell type. Viral binding and transduction assays on mutant Chinese hamster ovary (CHO) cell lines defective in various stages of glycan chain synthesis revealed a potential role for core glycan residues under sialic acid in AAV9 transduction. Treatment with chemical inhibitors of glycosylation and competitive inhibition studies with different lectins suggest that N-linked glycans with terminal galactosyl residues facilitate cell surface binding and transduction by AAV9. In corollary, resialylation of galactosylated glycans on the sialic acid-deficient CHO Lec2 cell line with different sialyltransferases partially blocked AAV9 transduction. Quantitative analysis of AAV9 binding to parental, sialidase-treated or sialic acid-deficient mutant CHO cells revealed a 3-15-fold increase in relative binding potential of AAV9 particles upon desialylation. Finally, pretreatment of well differentiated human airway epithelial cultures and intranasal instillation of recombinant sialidase in murine airways enhanced transduction efficiency of AAV9 by > 1 order of magnitude. Taken together, the studies described herein provide a molecular basis for low infectivity of AAV9 in vitro and a biochemical strategy to enhance gene transfer by AAV9 vectors in general.	[Shen, Shen; Bryant, Kelli D.; Brown, Sarah M.; Asokan, Aravind] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Shen, Shen; Asokan, Aravind] Univ N Carolina, Mol & Cellular Biophys Program, Chapel Hill, NC 27599 USA; [Shen, Shen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Randell, Scott H.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Asokan, Aravind] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Asokan, A (corresponding author), Univ N Carolina, Gene Therapy Ctr, CB 7352,4101 Thurston Bldg, Chapel Hill, NC 27599 USA.	aravind@med.unc.edu	Core, Vector/CAF-4832-2022		National Institutes of Health [R01HL089221-A1, R01HL089221-A1S2]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL089221-A1 and -A1S2 (to A. A.). This work was also supported by a grant from the American Heart Association (to A. A.).	Akache B, 2007, MOL THER, V15, P330, DOI 10.1038/sj.mt.6300053; Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Bai XM, 2001, GLYCOBIOLOGY, V11, P621, DOI 10.1093/glycob/11.8.621; Baker AH, 2007, MOL THER, V15, P1410, DOI 10.1038/sj.mt.6300206; Bowles D.E., 2006, PARVOVIRUSES, P15; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Dechecchi MC, 2001, J VIROL, V75, P8772, DOI 10.1128/JVI.75.18.8772-8780.2001; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; ELBEIN AD, 1981, P NATL ACAD SCI-BIOL, V78, P7393, DOI 10.1073/pnas.78.12.7393; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2005, CURR GENE THER, V5, P285, DOI 10.2174/1566523054065057; Govindasamy L, 2006, J VIROL, V80, P11556, DOI 10.1128/JVI.01536-06; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Guglielmi KM, 2006, CURR TOP MICROBIOL, V309, P1; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Kaludov N, 2001, J VIROL, V75, P6884, DOI 10.1128/JVI.75.15.6884-6893.2001; Kornegay JN, 2010, MOL THER, V18, P1501, DOI 10.1038/mt.2010.94; KUAN SF, 1989, J BIOL CHEM, V264, P19271; Malakhov MP, 2006, ANTIMICROB AGENTS CH, V50, P1470, DOI 10.1128/AAC.50.4.1470-1479.2006; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Mitchell AM, 2010, CURR GENE THER, V10, P319; Mountney A, 2010, P NATL ACAD SCI USA, V107, P11561, DOI 10.1073/pnas.1006683107; Mueller C, 2008, GENE THER, V15, P858, DOI 10.1038/gt.2008.68; Nam HJ, 2006, J BIOL CHEM, V281, P25670, DOI 10.1074/jbc.M604421200; Nemerow GR, 2009, VIROLOGY, V384, P380, DOI 10.1016/j.virol.2008.10.016; Neu U, 2009, VIROLOGY, V384, P389, DOI 10.1016/j.virol.2008.12.021; Ng R, 2010, J VIROL, V84, P12945, DOI 10.1128/JVI.01235-10; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; OHYAMA Y, 1985, J BIOL CHEM, V260, P6882; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Pacak CA, 2006, CIRC RES, V99, pE3, DOI 10.1161/01.RES.0000237661.18885.f6; Schmidt M, 2008, J VIROL, V82, P8911, DOI 10.1128/JVI.00672-08; Schmidt M, 2006, J VIROL, V80, P5516, DOI 10.1128/JVI.02393-05; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; STANLEY P, 1985, MOL CELL BIOL, V5, P1204, DOI 10.1128/MCB.5.6.1204; STULTS NL, 1989, J BIOL CHEM, V264, P19956; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Triana-Baltzer GB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007788; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4; Walters RW, 2001, J BIOL CHEM, V276, P20610, DOI 10.1074/jbc.M101559200; WANG WC, 1988, J BIOL CHEM, V263, P4576; Wu AM, 2007, GLYCOCONJUGATE J, V24, P591, DOI 10.1007/s10719-007-9063-y; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; YAMAMOTO K, 1981, BIOCHEMISTRY-US, V20, P5894, DOI 10.1021/bi00523a037; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76	48	163	170	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2011	286	15					13532	13540		10.1074/jbc.M110.210922	http://dx.doi.org/10.1074/jbc.M110.210922			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	746XH	21330365	Green Published, hybrid			2022-12-25	WOS:000289282200073
J	Das, S; Oliver, DB				Das, Sanchaita; Oliver, Donald B.			Mapping of the SecA.SecY and SecA.SecG Interfaces by Site-directed in Vivo Photocross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SECA; PROTEIN-CONDUCTING CHANNEL; PREPROTEIN TRANSLOCASE; MEMBRANE TOPOLOGY; CROSS-LINKING; DIMERIC SECA; AMINO-ACID; SECYEG; BINDING; ATPASE	The two major components of the Eubacteria Sec-dependent protein translocation system are the heterotrimeric channel-forming component SecYEG and its binding partner, the SecA ATPase nanomotor. Once bound to SecYEG, the preprotein substrate, and ATP, SecA undergoes ATP-hydrolytic cycles that drive the stepwise translocation of proteins. Although a previous site-directed in vivo photocross-linking study (Mori, H., and Ito, K. (2006) Proc. Natl. Acad. Sci. U. S. A. 103, 16159-16164) elucidated residues of SecY needed for interaction with SecA, no reciprocal study for SecA protein has been reported to date. In the present study we mapped residues of SecA that interact with SecY or SecG utilizing this approach. Our results show that distinct domains of SecA on two halves of the molecule interact with two corresponding SecY partners as well as with the central cytoplasmic domain of SecG. Our data support the in vivo relevance of the Thermotoga maritima SecA.SecYEG crystal structure that visualized SecYEG interaction for only one-half of SecA as well as previous studies indicating that SecA normally binds two molecules of SecYEG.	[Das, Sanchaita; Oliver, Donald B.] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA	Wesleyan University	Oliver, DB (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, 52 Lawn Ave, Middletown, CT 06457 USA.	doliver@wesleyan.edu						AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; Auclair SM, 2010, BIOCHEMISTRY-US, V49, P782, DOI 10.1021/bi901446r; BOST S, 1995, EMBO J, V14, P4412, DOI 10.1002/j.1460-2075.1995.tb00120.x; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; Chiba K, 2002, J BACTERIOL, V184, P2243, DOI 10.1128/JB.184.8.2243-2250.2002; Cooper DB, 2008, J MOL BIOL, V382, P74, DOI 10.1016/j.jmb.2008.06.049; DOUVILLE K, 1995, J BIOL CHEM, V270, P20106, DOI 10.1074/jbc.270.34.20106; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Eichler J, 1998, J BACTERIOL, V180, P5776, DOI 10.1128/JB.180.21.5776-5779.1998; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Farrelli IS, 2005, NAT METHODS, V2, P377, DOI 10.1038/nmeth0505-377; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; HANADA M, 1994, J BIOL CHEM, V269, P23625; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Jilaveanu LB, 2007, J BIOL CHEM, V282, P4661, DOI 10.1074/jbc.M610828200; Karamanou S, 2008, MOL MICROBIOL, V70, P311, DOI 10.1111/j.1365-2958.2008.06402.x; KAUER JC, 1986, J BIOL CHEM, V261, P695; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Manting EH, 1999, J BIOL CHEM, V274, P23868, DOI 10.1074/jbc.274.34.23868; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; Matsumoto G, 1998, P NATL ACAD SCI USA, V95, P13567, DOI 10.1073/pnas.95.23.13567; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mori H, 1998, J BIOCHEM, V124, P122, DOI 10.1093/oxfordjournals.jbchem.a022070; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; Mori H, 2006, P NATL ACAD SCI USA, V103, P16159, DOI 10.1073/pnas.0606390103; Mori H, 2006, J BIOL CHEM, V281, P36249, DOI 10.1074/jbc.M606906200; Nagamori S, 2002, J BIOCHEM, V132, P629, DOI 10.1093/oxfordjournals.jbchem.a003266; NISHIYAMA K, 1994, EMBO J, V13, P3272, DOI 10.1002/j.1460-2075.1994.tb06628.x; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; Ramamurthy V, 1998, J BACTERIOL, V180, P6419; Robson A, 2007, J MOL BIOL, V374, P965, DOI 10.1016/j.jmb.2007.09.086; Rusch SL, 2007, BBA-BIOMEMBRANES, V1768, P5, DOI 10.1016/j.bbamem.2006.08.013; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Snyders S, 1997, J BIOL CHEM, V272, P11302; Sugai R, 2007, J BIOL CHEM, V282, P29540, DOI 10.1074/jbc.M704716200; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; Taura T, 1997, BIOCHIMIE, V79, P517, DOI 10.1016/S0300-9084(97)82744-7; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Does C, 1998, BIOCHEMISTRY-US, V37, P201, DOI 10.1021/bi972105t; van der Slius EO, 2006, J BACTERIOL, V188, P1188, DOI 10.1128/JB.188.3.1188-1190.2006; van der Slurs EO, 2006, J MOL BIOL, V361, P839, DOI 10.1016/j.jmb.2006.07.017; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; vanderDoes C, 1996, MOL MICROBIOL, V22, P619, DOI 10.1046/j.1365-2958.1996.d01-1712.x; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Vrontou E, 2004, J BIOL CHEM, V279, P22490, DOI 10.1074/jbc.M401008200; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Zimmer J, 2009, J MOL BIOL, V394, P606, DOI 10.1016/j.jmb.2009.10.024	56	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.182931	http://dx.doi.org/10.1074/jbc.M110.182931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21317284	Green Published, hybrid			2022-12-25	WOS:000289077500051
J	Schmidt, J; Liebscher, K; Merten, N; Grundmann, M; Mielenz, M; Sauerwein, H; Christiansen, E; Due-Hansen, ME; Ulven, T; Ullrich, S; Gomeza, J; Drewke, C; Kostenis, E				Schmidt, Johannes; Liebscher, Kathrin; Merten, Nicole; Grundmann, Manuel; Mielenz, Manfred; Sauerwein, Helga; Christiansen, Elisabeth; Due-Hansen, Maria E.; Ulven, Trond; Ullrich, Susanne; Gomeza, Jesus; Drewke, Christel; Kostenis, Evi			Conjugated Linoleic Acids Mediate Insulin Release through Islet G Protein-coupled Receptor FFA1/GPR40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN FATTY-ACIDS; PANCREATIC BETA-CELLS; WHITE ADIPOSE-TISSUE; GLUCOSE-TOLERANCE; DIETARY SUPPLEMENTATION; ENDOTHELIAL-CELLS; GPR40; SECRETION; OBESITY; MICE	Among dietary components, conjugated linoleic acids (CLAs) have attracted considerable attention as weight loss supplements in the Western world because they reduce fat stores and increase muscle mass. However, a number of adverse effects are also ascribed to the intake of CLAs such as aggravation of insulin resistance and the risk of developing diabetes. However, the mechanisms accounting for the effects of CLAs on glucose homeostasis are incompletely understood. Herein we provide evidence that CLAs specifically activate the cell surface receptor FFA1, an emerging therapeutic target to treat type 2 diabetes. Using different recombinant cellular systems engineered to stably express FFA1 and a set of diverse functional assays including the novel, label-free non-invasive dynamic mass redistribution technology (Corning (R) Epic (R) biosensor), both CLA isomers cis-9, trans-11-CLA and trans-10, cis-12-CLA were found to activate FFA1 in vitro at concentrations sufficient to also account for FFA1 activation in vivo. Each CLA isomer markedly increased glucose-stimulated insulin secretion in insulin-producing INS-1E cells that endogenously express FFA1 and in primary pancreatic beta-cells of wild type but not FFA1(-/-) knock-out mice. Our findings establish a clear mechanistic link between CLAs and insulin production and identify the cell surface receptor FFA1 as a molecular target for CLAs, explaining their acute stimulatory effects on insulin secretion in vivo. CLAs are also revealed as insulinotropic components in widely used nutraceuticals, a finding with significant implication for development of FFA1 modulators to treat type 2 diabetes.	[Schmidt, Johannes; Merten, Nicole; Grundmann, Manuel; Gomeza, Jesus; Drewke, Christel; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Liebscher, Kathrin; Ullrich, Susanne] Univ Tubingen, Dept Internal Med 4, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, D-72076 Tubingen, Germany; [Mielenz, Manfred; Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, D-53115 Bonn, Germany; [Christiansen, Elisabeth; Due-Hansen, Maria E.; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark	University of Bonn; Eberhard Karls University of Tubingen; University of Bonn; University of Southern Denmark	Drewke, C (corresponding author), Univ Bonn, Inst Pharmaceut Biol, Nussallee 6, D-53115 Bonn, Germany.	cdrewke@uni-bonn.de; kostenis@uni-bonn.de	Mielenz, Manfred/ABB-2293-2021; Ulven, Trond/H-5500-2015; Due-Hansen, Maria E./K-1823-2019; Sauerwein, Helga/R-8242-2019; Rexen Ulven, Elisabeth/S-2026-2017	Ulven, Trond/0000-0002-8135-1755; Rexen Ulven, Elisabeth/0000-0003-1243-7587; Due-Hansen, Maria Elisabeth/0000-0001-8032-2189; Grundmann, Manuel/0000-0002-4473-7851	German Federal Ministry of Education and Research (BMBF); Danish Council for Independent Research Technology and Production [09-070364]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Danish Council for Independent Research Technology and Production(Det Frie Forskningsrad (DFF))	This work was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V.) (to K. L. and S. U.) and the Danish Council for Independent Research Technology and Production (Grant no. 09-070364) (to E. C., M. E. D.-H., and T. U.).	Ahren B, 2009, EUR J CLIN NUTR, V63, P778, DOI 10.1038/ejcn.2008.45; Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; Alquier T, 2009, DIABETES, V58, P1035, DOI 10.2337/db09-0215; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Benito P, 2001, LIPIDS, V36, P229, DOI 10.1007/s11745-001-0712-x; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Doyle L, 2005, EUR J CLIN NUTR, V59, P432, DOI 10.1038/sj.ejcn.1602093; Eder K, 2010, MOL NUTR FOOD RES, V54, P17, DOI 10.1002/mnfr.200900042; Fernstrom JD, 2008, PHARMACOL THERAPEUT, V117, P105, DOI 10.1016/j.pharmthera.2007.09.001; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Herbel BK, 1998, AM J CLIN NUTR, V67, P332, DOI 10.1093/ajcn/67.2.332; Humphries PS, 2009, BIOORG MED CHEM LETT, V19, P2400, DOI 10.1016/j.bmcl.2009.03.082; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kenakin T, 2010, NAT BIOTECHNOL, V28, P928, DOI 10.1038/nbt0910-928; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Lai KL, 2005, LIPIDS, V40, P1107, DOI 10.1007/s11745-005-1474-1; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Miller A, 2002, ANTICANCER RES, V22, P3879; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Moon HS, 2009, J NUTR BIOCHEM, V20, P187, DOI 10.1016/j.jnutbio.2008.02.001; Nagao K, 2005, J BIOSCI BIOENG, V100, P152, DOI 10.1263/jbb.100.152; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Padwal RS, 2007, LANCET, V369, P71, DOI 10.1016/S0140-6736(07)60033-6; Pariza MW, 2004, AM J CLIN NUTR, V79, p1132S, DOI 10.1093/ajcn/79.6.1132S; Poirier H, 2005, DIABETOLOGIA, V48, P1059, DOI 10.1007/s00125-005-1765-8; Poirier H, 2005, BIOCHIMIE, V87, P73, DOI 10.1016/j.biochi.2004.11.006; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Ryder JW, 2001, DIABETES, V50, P1149, DOI 10.2337/diabetes.50.5.1149; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schroder R, 2009, J BIOL CHEM, V284, P1324, DOI 10.1074/jbc.M806867200; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Taylor CG, 2004, AM J CLIN NUTR, V79, p1164S, DOI 10.1093/ajcn/79.6.1164S; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Winzell MS, 2007, PHARMACOL THERAPEUT, V116, P437, DOI 10.1016/j.pharmthera.2007.08.002; Winzell MS, 2006, AM J PHYSIOL-ENDOC M, V290, pE347, DOI 10.1152/ajpendo.00163.2005; Zhang XD, 2010, BIOMED PHARMACOTHER, V64, P647, DOI 10.1016/j.biopha.2010.06.008	45	42	42	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.C110.200477	http://dx.doi.org/10.1074/jbc.C110.200477			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21339298	Green Published, hybrid			2022-12-25	WOS:000289077500002
J	Chai, CC; Jiang, JF				Chai, Caichun; Jiang, Jifa			Competitive Exclusion and Coexistence of Pathogens in a Homosexually-Transmitted Disease Model	PLOS ONE			English	Article							DYNAMICS; CLASSIFICATION; COEVOLUTION	A sexually-transmitted disease model for two strains of pathogen in a one-sex, heterogeneously-mixing population has been studied completely by Jiang and Chai in (J Math Biol 56:373-390, 2008). In this paper, we give a analysis for a SIS STD with two competing strains, where populations are divided into three differential groups based on their susceptibility to two distinct pathogenic strains. We investigate the existence and stability of the boundary equilibria that characterizes competitive exclusion of the two competing strains; we also investigate the existence and stability of the positive coexistence equilibrium, which characterizes the possibility of coexistence of the two strains. We obtain sufficient and necessary conditions for the existence and global stability about these equilibria under some assumptions. We verify that there is a strong connection between the stability of the boundary equilibria and the existence of the coexistence equilibrium, that is, there exists a unique coexistence equilibrium if and only if the boundary equilibria both exist and have the same stability, the coexistence equilibrium is globally stable or unstable if and only if the two boundary equilibria are both unstable or both stable.	[Chai, Caichun] Anhui Univ Finance & Econ, Caichun Chai Coll Stat & Appl Math, Bengbu, Anhui, Peoples R China; [Chai, Caichun] Anhui Univ Finance & Econ, Inst Appl Math, Bengbu, Anhui, Peoples R China; [Jiang, Jifa] Shanghai Normal Univ, Jifa Jiang Math & Sci Coll, Shanghai, Peoples R China	Anhui University of Finance & Economics; Anhui University of Finance & Economics; Shanghai Normal University	Chai, CC (corresponding author), Anhui Univ Finance & Econ, Caichun Chai Coll Stat & Appl Math, Bengbu, Anhui, Peoples R China.	ccspring@ustc.edu			Youth Foundation of Anhui University of Finance and Economics [ACKYQ1065ZC]; Chinese NSF [10671143, 10531030]	Youth Foundation of Anhui University of Finance and Economics(Anhui University); Chinese NSF(National Natural Science Foundation of China (NSFC))	Supported by the Youth Foundation of Anhui University of Finance and Economics No. ACKYQ1065ZC, Chinese NSF grants 10671143 and 10531030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; BECK K, 1984, J MATH BIOL, V19, P63, DOI 10.1007/BF00275931; BERMAN A, 1989, NONNEGATIVE MARTICES; BREMERMANN HJ, 1989, J MATH BIOL, V27, P179, DOI 10.1007/BF00276102; BUTLER GJ, 1983, J MATH BIOL, V17, P133, DOI 10.1007/BF00305755; Castillo-Chavez C, 1999, SIAM J APPL MATH, V59, P1790, DOI 10.1137/S0036139997325862; Castillo-Chavez C, 1988, MATH ECOLOGY, P303; Castillo-Chavez C., 1995, DIFF EQUAT+, P289; CastilloChavez C, 1997, J MATH BIOL, V35, P503, DOI 10.1007/s002850050063; CastilloChavez C, 1996, SIAM J APPL MATH, V56, P494, DOI 10.1137/S003613999325419X; [柴彩春 CHAI Cai-chun], 2009, [中国科学技术大学学报, Journal of University of Science and Technology of China], V39, P570; DIETZ K, 1979, J MATH BIOL, V8, P291, DOI 10.1007/BF00276314; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; EWALD W, 1994, EVOLUTION INFECT DIS; Hethcote H.W., 1984, LECT NOTES BIOMATH, V56; Jiang J, 2008, J MATH BIOL, V56, P373, DOI 10.1007/s00285-007-0119-1; Levin S.A., 1983, COEVOLUTION, P21; Levin S.A., 1983, LECT NOTES BIOMATH, V52, P328, DOI DOI 10.1007/978-3-642-87893-0_41; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Li J, 2003, J MATH BIOL, V47, P547, DOI 10.1007/s00285-003-0235-5; May R. M., 1973, STABILITY COMPLEXITY; MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042; MAY RM, 1983, PHILOS T R SOC LON B, V219, P282; MAYNARD JS, 1978, EVOLUTION SEX; Qiu ZP, 2010, APPL MATH COMPUT, V216, P1553, DOI 10.1016/j.amc.2010.03.006; SMITH HL, 1986, SIAM J APPL MATH, V46, P856, DOI 10.1137/0146052; SMITH HL, 1986, NONLINEAR ANAL-THEOR, V10, P1037, DOI 10.1016/0362-546X(86)90087-8	28	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e16467	10.1371/journal.pone.0016467	http://dx.doi.org/10.1371/journal.pone.0016467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21347222	Green Published, Green Submitted, gold			2022-12-25	WOS:000287369200004
J	Fonseca-Silva, F; Inacio, JDF; Canto-Cavalheiro, MM; Almeida-Amaral, EE				Fonseca-Silva, Fernanda; Inacio, Job D. F.; Canto-Cavalheiro, Marilene M.; Almeida-Amaral, Elmo Eduardo			Reactive Oxygen Species Production and Mitochondrial Dysfunction Contribute to Quercetin Induced Death in Leishmania amazonensis	PLOS ONE			English	Article							NONSELECTIVE CATION CHANNELS; TRYPANOSOMA-CRUZI; IN-VIVO; DONOVANI PROMASTIGOTES; APOPTOSIS; FLAVONOIDS; DRUGS; CELLS; PARASITE; ANALOGS	Background: Leishmaniasis, a parasitic disease caused by protozoa of the genus Leishmania, affects more than 12 million people worldwide. Quercetin has generated considerable interest as a pharmaceutical compound with a wide range of therapeutic activities. One such activity is exhibited against the bloodstream parasite Trypanosoma brucei and amastigotes of Leishmania donovani. However, the mechanism of protozoan action of quercetin has not been studied. Methodology/Principal Findings: In the present study, we report here the mechanism for the antileishmanial activity of quercetin against Leishmania amazonensis promastigotes. Quercetin inhibited L. amazonensis promastigote growth in a dose- and time-dependent manner beginning at 48 hours of treatment and with maximum growth inhibition observed at 96 hours. The IC(50) for quercetin at 48 hours was 31.4 mu M. Quercetin increased ROS generation in a dose-dependent manner after 48 hours of treatment. The antioxidant GSH and NAC each significantly reduced quercetin-induced cell death. In addition, quercetin caused mitochondrial dysfunction due to collapse of mitochondrial membrane potential. Conclusions/Significance: The effects of several drugs that interfere directly with mitochondrial physiology in parasites such as Leishmania have been described. The unique mitochondrial features of Leishmania make this organelle an ideal drug target while minimizing toxicity. Quercetin has been described as a pro-oxidant, generating ROS which are responsible for cell death in some cancer cells. Mitochondrial membrane potential loss can be brought about by ROS added directly in vitro or induced by chemical agents. Taken together, our results demonstrate that quercetin eventually exerts its antileishmanial effect on L. amazonensis promastigotes due to the generation of ROS and disrupted parasite mitochondrial function.	[Fonseca-Silva, Fernanda; Inacio, Job D. F.; Canto-Cavalheiro, Marilene M.; Almeida-Amaral, Elmo Eduardo] Fundacao Oswaldo Cruz FIOCRUZ, Lab Bioquim Tripanosomatideos, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Fonseca-Silva, F (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Lab Bioquim Tripanosomatideos, Inst Oswaldo Cruz IOC, Rio De Janeiro, Brazil.	elmo@ioc.fiocruz.br	Almeida-Amaral, Elmo Eduardo/AAD-2834-2019; Inacio, Job Domingos/AAK-5961-2021		Fundacao Carlos Chagas Filho de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Oswaldo Cruz (FIOCRUZ)	Fundacao Carlos Chagas Filho de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ)	This work was supported by grants from Fundacao Carlos Chagas Filho de Amparo A Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fundacao Oswaldo Cruz (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1985, MOL BIOCHEM PARASIT, V16, P289, DOI 10.1016/0166-6851(85)90071-4; Banki K, 1999, J IMMUNOL, V162, P1466; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Castro-Pinto DB, 2007, J ENZYM INHIB MED CH, V22, P71, DOI 10.1080/14756360600920180; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; De Marchi U, 2009, BBA-BIOENERGETICS, V1787, P1425, DOI 10.1016/j.bbabio.2009.06.002; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dvorakova K, 2001, BLOOD, V97, P3544, DOI 10.1182/blood.V97.11.3544; Rodrigues JCF, 2008, CURR PHARM DESIGN, V14, P925, DOI 10.2174/138161208784041033; Guida MC, 2007, EXP PARASITOL, V117, P188, DOI 10.1016/j.exppara.2007.04.015; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halliwell B, 2008, ARCH BIOCHEM BIOPHYS, V476, P107, DOI 10.1016/j.abb.2008.01.028; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kayser O, 2003, PARASITOL RES, V90, pS55, DOI 10.1007/s00436-002-0768-3; Lapidot TM, 2002, J AGR FOOD CHEM, V50, P7220, DOI 10.1021/jf020615a; Leite MS, 2009, EXP PARASITOL, V121, P137, DOI 10.1016/j.exppara.2008.10.018; Luque-Ortega JR, 2001, ANTIMICROB AGENTS CH, V45, P1121, DOI 10.1128/AAC.45.4.1121-1125.2001; Mamani-Matsuda M, 2004, ANTIMICROB AGENTS CH, V48, P924, DOI 10.1128/AAC.48.3.924-929.2004; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Menna-Barreto RFS, 2007, PARASITOL RES, V101, P895, DOI 10.1007/s00436-007-0556-1; Menna-Barreto RFS, 2009, FREE RADICAL BIO MED, V47, P644, DOI 10.1016/j.freeradbiomed.2009.06.004; Mittra B, 2000, MOL MED, V6, P527, DOI 10.1007/BF03401792; Miura YH, 1998, BIOL PHARM BULL, V21, P93, DOI 10.1248/bpb.21.93; Mukherjee P, 2009, INT J ANTIMICROB AG, V34, P596, DOI 10.1016/j.ijantimicag.2009.08.007; Mukherjee SB, 2002, J BIOL CHEM, V277, P24717, DOI 10.1074/jbc.M201961200; Muzitano MF, 2006, PHYTOCHEMISTRY, V67, P2071, DOI 10.1016/j.phytochem.2006.06.027; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; ROY A, 2008, MOL PHARM; Santa-Rita RM, 2005, J ANTIMICROB CHEMOTH, V55, P780, DOI 10.1093/jac/dki087; Satoh T, 1997, J NEUROSCI RES, V50, P413, DOI 10.1002/(SICI)1097-4547(19971101)50:3<413::AID-JNR7>3.0.CO;2-L; Sen N, 2007, CELL DEATH DIFFER, V14, P358, DOI 10.1038/sj.cdd.4402002; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sen N, 2008, CURR PHARM DESIGN, V14, P839, DOI 10.2174/138161208784041024; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Tasdemir D, 2006, ANTIMICROB AGENTS CH, V50, P1352, DOI 10.1128/AAC.50.4.1352-1364.2006; ZILBERSTEIN D, 1988, BIOCHEM J, V256, P13, DOI 10.1042/bj2560013	39	120	121	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2011	6	2							e14666	10.1371/journal.pone.0014666	http://dx.doi.org/10.1371/journal.pone.0014666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717WH	21346801	Green Published, Green Submitted, gold			2022-12-25	WOS:000287077600002
J	Dancause, KN; Vilar, MG; Steffy, R; Lum, JK				Dancause, Kelsey Needham; Vilar, Miguel G.; Steffy, Rlene; Lum, J. Koji			Characterizing Genetic Diversity of Contemporary Pacific Chickens Using Mitochondrial DNA Analyses	PLOS ONE			English	Article							ORIGINS; MTDNA; DISPERSAL; VANUATU; ISLAND	Background: Mitochondrial DNA (mtDNA) hypervariable region (HVR) sequences of prehistoric Polynesian chicken samples reflect dispersal of two haplogroups-D and E-by the settlers of the Pacific. The distribution of these chicken haplogroups has been used as an indicator of human movement. Recent analyses suggested similarities between prehistoric Pacific and South American chicken samples, perhaps reflecting prehistoric Polynesian introduction of the chicken into South America. These analyses have been heavily debated. The current distribution of the D and E lineages among contemporary chicken populations in the Western Pacific is unclear, but might ultimately help to inform debates about the movements of humans that carried them. Objectives: We sought to characterize contemporary mtDNA diversity among chickens in two of the earliest settled archipelagoes of Remote Oceania, the Marianas and Vanuatu. Methods: We generated HVR sequences for 43 chickens from four islands in Vanuatu, and for 5 chickens from Guam in the Marianas. Results: Forty samples from Vanuatu and three from Guam were assigned to haplogroup D, supporting this as a Pacific chicken haplogroup that persists in the Western Pacific. Two haplogroup E lineages were observed in Guam and two in Vanuatu. Of the E lineages in Vanuatu, one was identical to prehistoric Vanuatu and Polynesian samples and the other differed by one polymorphism. Contrary to our expectations, we observed few globally distributed domesticate lineages not associated with Pacific chicken dispersal. This might suggest less European introgression of chickens into Vanuatu than expected. If so, the E lineages might represent lineages maintained from ancient Pacific chicken introductions. The Vanuatu sample might thus provide an opportunity to distinguish between maintained ancestral Pacific chicken lineages and replacement by global domesticates through genomic analyses, which could resolve questions of contemporary haplogroup E chicken relationships and inform interpretations of debated sequences from archaeological samples.	[Dancause, Kelsey Needham] McGill Univ, Douglas Hosp Res Ctr, Montreal, PQ, Canada; [Vilar, Miguel G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Steffy, Rlene] Univ Guam, Micronesian Area Res Ctr, Hagatna, GU USA; [Lum, J. Koji] Binghamton Univ, Dept Anthropol, Binghamton, NY USA	McGill University; University of Pennsylvania; University of Guam; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Dancause, KN (corresponding author), McGill Univ, Douglas Hosp Res Ctr, Montreal, PQ, Canada.	kelseydancause@gmail.com		Dancause, Kelsey/0000-0002-8677-9953				ALLEN JS, 1996, ARCHAEOL NZ, V39, P291; Fu Yan, 2001, Acta Genetica Sinica, V28, P411; Fumihito A, 1996, P NATL ACAD SCI USA, V93, P6792, DOI 10.1073/pnas.93.13.6792; Gongora J, 2008, P NATL ACAD SCI USA, V105, P10308, DOI 10.1073/pnas.0801991105; Gongora J, 2008, P NATL ACAD SCI USA, V105, pE100, DOI 10.1073/pnas.0809681105; Hunt TL, 2006, SCIENCE, V311, P1603, DOI 10.1126/science.1121879; KIRCH PV, 2000, ROAD WINDS ARCHAEOLO; Komiyama T, 2004, MOL PHYLOGENET EVOL, V33, P16, DOI 10.1016/j.ympev.2004.04.019; Komiyama T, 2003, GENE, V317, P195, DOI 10.1016/S0378-1119(03)00703-0; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; LIU ZG, 2004, GENETIC VARIABILITY; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; MACCLANCY J, 2002, KILL BIRD 2 STONES S; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; Miyake T, 1997, GALLUS GALLUS MITOCH; Nishibori M, 2005, ANIM GENET, V36, P367, DOI 10.1111/j.1365-2052.2005.01318.x; Oka T, 2007, ANIM GENET, V38, P287, DOI 10.1111/j.1365-2052.2007.01604.x; Oliver D, 1989, OCEANIA NATIVE CULTU; PIRANY N, 2009, DIRECT SUBMISSION GE; Qu LJ, 2004, HIGH POLYMORPHISM RA; REINMAN FRED R, 1977, ARCHAEOLOGICAL SURVE; Rogers R., 1995, DESTINYS LANDFALL HI; Silva P, 2009, ANIM GENET, V40, P1, DOI 10.1111/j.1365-2052.2008.01783.x; Storey AA, 2007, P NATL ACAD SCI USA, V104, P10335, DOI 10.1073/pnas.0703993104; Storey AA, 2010, J ARCHAEOL SCI, V37, P2459, DOI 10.1016/j.jas.2010.05.006; Storey AA, 2008, P NATL ACAD SCI USA, V105, pE99, DOI 10.1073/pnas.0807625105	27	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16843	10.1371/journal.pone.0016843	http://dx.doi.org/10.1371/journal.pone.0016843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326866	gold, Green Accepted, Green Published			2022-12-25	WOS:000287037000026
J	Lalor, MK; Floyd, S; Gorak-Stolinska, P; Weir, RE; Blitz, R; Branson, K; Fine, PE; Dockrell, HM				Lalor, Maeve K.; Floyd, Sian; Gorak-Stolinska, Patricia; Weir, Rosemary E.; Blitz, Rose; Branson, Keith; Fine, Paul E.; Dockrell, Hazel M.			BCG Vaccination: A Role for Vitamin D?	PLOS ONE			English	Article							D DEFICIENCY; PULMONARY TUBERCULOSIS; CHILDHOOD SURVIVAL; GUINEA-BISSAU; IMMUNITY; HEALTH; MYCOBACTERIA; IMMUNIZATION; CATHELICIDIN; METAANALYSIS	Background: BCG vaccination is administered in infancy in most countries with the aim of providing protection against tuberculosis. There is increasing interest in the role of vitamin D in immunity to tuberculosis. This study objective was to determine if there was an association between circulating 25(OH) D concentrations and BCG vaccination status and cytokine responses following BCG vaccination in infants. Methods: Blood samples were collected from UK infants who were vaccinated with BCG at 3 (n = 47) and 12 (n = 37) months post BCG vaccination. These two time-points are denoted as time-point 1 and time-point 2. Two blood samples were also collected from age-matched unvaccinated infants (n = 32 and 28 respectively), as a control group. Plasma vitamin D concentrations (25(OH) D) were measured by radio-immunoassay. The cytokine IFN gamma was measured in supernatants from diluted whole blood stimulated with M. tuberculosis (M.tb) PPD for 6 days. Results: 58% of infants had some level of hypovitaminosis (25(OH) D <30ng/ml) at time-point 1, and this increased to 97% 9 months later. BCG vaccinated infants were almost 6 times (CI: 1.8-18.6) more likely to have sufficient vitamin D concentrations than unvaccinated infants at time-point 1, and the association remained strong after controlling for season of blood collection, ethnic group and sex. Among vaccinees, there was also a strong inverse association between IFN gamma response to M.tb PPD and vitamin D concentration, with infants with higher vitamin D concentrations having lower IFN gamma responses. Conclusions: Vitamin D may play an immuno-regulatory role following BCG vaccination. The increased vitamin D concentrations in BCG vaccinated infants could have important implications: vitamin D may play a role in immunity induced by BCG vaccination and may contribute to non-specific effects observed following BCG vaccination.	[Lalor, Maeve K.; Gorak-Stolinska, Patricia; Weir, Rosemary E.; Blitz, Rose; Dockrell, Hazel M.] Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London WC1E 7HT, England; [Floyd, Sian; Branson, Keith; Fine, Paul E.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Publ Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Lalor, MK (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	maeve_lalor@yahoo.com		Dockrell, Hazel/0000-0003-1869-9107	Wellcome Trust [063558/Z/01/B]; Bill & Melinda Gates Foundation [37772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082575] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Wellcome Trust (grant number 063558/Z/01/B) and by grant 37772 from the Bill & Melinda Gates Foundation through the Grand Challenges in Global Health Initiative. http://www.grandchallenges.org/Pages/Default.aspx and wellcometrust.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby P, 2006, PEDIATR INFECT DIS J, V25, P721, DOI 10.1097/01.inf.0000227829.64686.ae; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Breiman RF, 2004, LANCET, V364, P2204, DOI 10.1016/S0140-6736(04)17593-4; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Elliott AM, 1999, LANCET, V354, P1000, DOI 10.1016/S0140-6736(99)03290-0; Enioutina EY, 2009, J IMMUNOL, V182, P4296, DOI 10.4049/jimmunol.0804344; Fine PEM, 2007, TROP MED INT HEALTH, V12, P1, DOI 10.1111/j.1365-3156.2006.01794.x; Friis H, 2008, J NUTR, V138, P2474, DOI 10.3945/jn.108.094979; Gibney KB, 2008, CLIN INFECT DIS, V46, P443, DOI 10.1086/525268; Griffin MD, 2003, ANNU REV NUTR, V23, P117, DOI 10.1146/annurev.nutr.23.011702.073114; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2007, AM J RESP CRIT CARE, V176, P208, DOI 10.1164/rccm.200701-007OC; Martineau AR, 2007, J STEROID BIOCHEM, V103, P793, DOI 10.1016/j.jsbmb.2006.12.052; Martineau AR, 2007, J IMMUNOL, V178, P7190, DOI 10.4049/jimmunol.178.11.7190; MATSUOKA LY, 1995, J LAB CLIN MED, V126, P452; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392; Rousseau MC, 2008, PEDIAT ALLERG IMM-UK, V19, P438, DOI 10.1111/j.1399-3038.2007.00669.x; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van Etten E, 2008, NUTR REV, V66, pS125, DOI 10.1111/j.1753-4887.2008.00096.x; Velilla PA, 2006, CLIN IMMUNOL, V121, P251, DOI 10.1016/j.clim.2006.08.010; Vidal M, 2002, MOL CELL BIOL, V22, P2777, DOI 10.1128/MCB.22.8.2777-2787.2002; VONESSEN MR, NAT IMMUNOL, V11, P344; Wagner CL, 2008, BREASTFEED MED, V3, P239, DOI 10.1089/bfm.2008.9984; Weir RE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-9; Wejse C, 2007, AM J CLIN NUTR, V86, P1376, DOI 10.1093/ajcn/86.5.1376; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; *WHO, 2007, IMM SURV ASS MON REP; Williams B, 2008, PEDIATR INFECT DIS J, V27, P941, DOI 10.1097/INF.0b013e31817525df	40	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16709	10.1371/journal.pone.0016709	http://dx.doi.org/10.1371/journal.pone.0016709			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304967	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000286834300126
J	Reetz, K; Kleinman, A; Klein, C; Lencer, R; Zuehlke, C; Brockmann, K; Rolfs, A; Binkofski, F				Reetz, Kathrin; Kleinman, Alexandra; Klein, Christine; Lencer, Rebekka; Zuehlke, Christine; Brockmann, Kathrin; Rolfs, Arndt; Binkofski, Ferdinand			CAG Repeats Determine Brain Atrophy in Spinocerebellar Ataxia 17: A VBM Study	PLOS ONE			English	Article							HUNTINGTONS-DISEASE-LIKE; TATA-BINDING PROTEIN; TRINUCLEOTIDE REPEAT; SCA17; PHENOTYPE; POLYGLUTAMINE; DEMENTIA; SPECTRUM; MUTATION; FEATURES	Background: Abnormal repeat length has been associated with an earlier age of onset and more severe disease progression in the rare neurodegenerative disorder spinocerebellar ataxia 17 (SCA17). Methodology/Principal Findings: To determine whether specific structural brain degeneration and rate of disease progression in SCA17 might be associated with the CAG repeat size, observer-independent voxel-based morphometry was applied to high-resolution magnetic resonance images of 16 patients with SCA17 and 16 age-matched healthy controls. The main finding contrasting SCA17 patients with healthy controls demonstrated atrophy in the cerebellum bilaterally. Multiple regression analyses with available genetic data and also post-hoc correlations revealed an inverse relationship again with cerebellar atrophy. Moreover, we found an inverse relationship between the CAG repeat length and rate of disease progression. Conclusions: Our results highlight the fundamental role of the cerebellum in this neurodegenerative disease and support the genotype-phenotype relationship in SCA17 patients. Genetic factors may determine individual susceptibility to neurodegeneration and rate of disease progression.	[Reetz, Kathrin; Kleinman, Alexandra] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Reetz, Kathrin; Kleinman, Alexandra] Forschungszentrum Julich, Inst Neurosci & Med, D-52425 Julich, Germany; [Reetz, Kathrin; Kleinman, Alexandra] Julich Aachen Res Alliance JARA Translat Brain Me, Aachen, Germany; [Klein, Christine] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Klein, Christine] Med Univ Lubeck, Schilling Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Lencer, Rebekka] Med Univ Lubeck, Dept Psychiat & Psychotherapy, D-23538 Lubeck, Germany; [Zuehlke, Christine] Med Univ Lubeck, Inst Human Genet, D-23538 Lubeck, Germany; [Brockmann, Kathrin; Rolfs, Arndt] Univ Rostock, Fac Med, Albrecht Kossel Inst Neuroregenerat, Rostock, Germany; [Binkofski, Ferdinand] Rhein Westfal TH Aachen, Div Cognit Neurol, Aachen, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich; University of Lubeck; University of Lubeck; University of Lubeck; University of Lubeck; University of Rostock; RWTH Aachen University	Reetz, K (corresponding author), Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany.	fbinkofski@ukaachen.de	Binkofski, Ferdinand/S-6997-2017; Lencer, Rebekka/A-4994-2009; Reetz, Kathrin/H-9510-2012; Klein, Christine/AGK-8003-2022	Binkofski, Ferdinand/0000-0002-6750-943X; Lencer, Rebekka/0000-0003-4032-7297; Reetz, Kathrin/0000-0002-9730-9228; Klein, Christine/0000-0003-2102-3431	DFG Translational Brain Research in Psychiatry and Neurology [DFG ZUK32/1]	DFG Translational Brain Research in Psychiatry and Neurology	KR was funded by the DFG Translational Brain Research in Psychiatry and Neurology (DFG ZUK32/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bauer P, 2004, J MED GENET, V41, P230, DOI 10.1136/jmg.2003.015602; Bech S, 2010, PARKINSONISM RELAT D, V16, P12, DOI 10.1016/j.parkreldis.2009.06.006; Bruni AC, 2004, ARCH NEUROL-CHICAGO, V61, P1314, DOI 10.1001/archneur.61.8.1314; Craig K, 2005, J NEUROL SCI, V239, P105, DOI 10.1016/j.jns.2005.08.009; De Michele G, 2003, NEUROL SCI, V24, P166, DOI 10.1007/s10072-003-0112-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HELSINKI WMA, 2000, JAMA-J AM MED ASSOC, V284, P3043; Klockgether T, 1998, BRAIN, V121, P1687, DOI 10.1093/brain/121.9.1687; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Lasek K, 2006, BRAIN, V129, P2341, DOI 10.1093/brain/awl148; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maltecca F, 2003, NEUROLOGY, V61, P1441, DOI 10.1212/01.WNL.0000094123.09098.A0; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Netravathi M, 2009, J NEUROL SCI, V277, P83, DOI 10.1016/j.jns.2008.10.016; Onodera O, 1998, ANN NEUROL, V43, P288, DOI 10.1002/ana.410430305; Reetz K, 2010, CEREBELLUM, V9, P210, DOI 10.1007/s12311-009-0150-4; Rolfs A, 2003, ANN NEUROL, V54, P367, DOI 10.1002/ana.10676; Schulz JB, 2010, NEUROIMAGE, V49, P158, DOI 10.1016/j.neuroimage.2009.07.027; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; Stevanin G, 2008, CEREBELLUM, V7, P170, DOI 10.1007/s12311-008-0016-1; Toyoshima Y, 2004, ANN NEUROL, V55, P281, DOI 10.1002/ana.10824; ZUHLKE C, 2007, CEREBELLUM, P1	23	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e15125	10.1371/journal.pone.0015125	http://dx.doi.org/10.1371/journal.pone.0015125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21311576	Green Published, gold			2022-12-25	WOS:000286520600008
J	Seux, M; Peuget, S; Montero, MP; Siret, C; Rigot, V; Clerc, P; Gigoux, V; Pellegrino, E; Pouyet, L; N'Guessan, P; Garcia, S; Dufresne, M; Iovanna, JL; Carrier, A; Andre, F; Dusetti, NJ				Seux, M.; Peuget, S.; Montero, M. P.; Siret, C.; Rigot, V.; Clerc, P.; Gigoux, V.; Pellegrino, E.; Pouyet, L.; N'Guessan, P.; Garcia, S.; Dufresne, M.; Iovanna, J. L.; Carrier, A.; Andre, F.; Dusetti, N. J.			TP53INP1 decreases pancreatic cancer cell migration by regulating SPARC expression	ONCOGENE			English	Article						TP53INP1; SPARC; migration; pancreatic cancer; PanIN	GROWTH-FACTOR-BETA; PROTEIN P53-INDUCED NUCLEAR-PROTEIN-1; CA2+-BINDING EF-HAND; GENE-EXPRESSION; NULL MICE; MATRICELLULAR PROTEIN; EXTRACELLULAR-MATRIX; MICROARRAY ANALYSIS; TUMOR-SUPPRESSOR; ENHANCED GROWTH	Tumor protein 53 induced nuclear protein 1 (TP53INP1) is a p53 target gene that induces cell growth arrest and apoptosis by modulating p53 transcriptional activity. TP53INP1 interacts physically with p53 and is a major player in the p53-driven oxidative stress response. Previously, we demonstrated that TP53INP1 is down-regulated in an early stage of pancreatic cancerogenesis and when restored is able to suppress pancreatic tumor development. TP53INP1 downregulation in pancreas is associated with an oncogenic microRNA miR-155. In the present work, we studied the effects of TP53INP1 on cell migration. We found that TP53INP1 inactivation correlates with increased cell migration both in vivo and in vitro. The impact of TP53INP1 expression on cell migration was studied in different cellular contexts: mouse embryonic fibroblast and different pancreatic cancer cell lines. Its expression decreases cell migration by the transcriptional downregulation of secreted protein acidic and rich in cysteine (SPARC). SPARC is a matrix cellular protein, which governs diverse cellular functions and has a pivotal role in regulating cell-matrix interactions, cellular proliferation and migration. SPARC was also showed to be upregulated in normal pancreas and in pancreatic intraepithelial neoplasia lesions in a pancreatic adenocarcinoma mouse model only in the TP53INP1-deficient animals. This novel TP53INP1 activity on the regulation of SPARC expression could explain in part its tumor suppressor function in pancreatic adenocarcinoma by modulating cellular spreading during the metastatic process. Oncogene (2011) 30, 3049-3061; doi: 10.1038/onc.2011.25; published online 21 February 2011	[Seux, M.; Peuget, S.; Pouyet, L.; N'Guessan, P.; Garcia, S.; Iovanna, J. L.; Carrier, A.; Dusetti, N. J.] INSERM, Stress Cellulaire U624, F-13288 Marseille, France; [Seux, M.; Peuget, S.; Pouyet, L.; N'Guessan, P.; Garcia, S.; Iovanna, J. L.; Carrier, A.; Dusetti, N. J.] Aix Marseille Univ, Marseille, France; [Montero, M. P.; Siret, C.; Rigot, V.; Pellegrino, E.; Andre, F.] Aix Marseille Univ, INSERM, CRO2, U911, Marseille, France; [Clerc, P.; Gigoux, V.; Dufresne, M.] Univ Toulouse, INSERM, IFR150, I2MR,U858, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse	Dusetti, NJ (corresponding author), INSERM, U624, Parc Sci Luminy,Case 915, F-13288 Marseille, France.	nelson.dusetti@inserm.fr	Gigoux, Véronique/AAE-6090-2020; Dusetti, Nelson/O-7919-2017; Dufresne, Marlène/M-6332-2014; Iovanna, Juan/M-9805-2017; Peuget, Sylvain/AAB-4730-2022	Gigoux, Véronique/0000-0003-1408-5335; Dusetti, Nelson/0000-0002-6161-8483; Iovanna, Juan/0000-0003-1822-2237; Montero, Marie-Pierre/0000-0003-4280-0674; Peuget, Sylvain/0000-0002-3315-1935	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique; Institut National du Cancer; La Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Club Franicais du Pancreas; Ministeere de la Recherche et de la Technologie	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer(Institut National du Cancer (INCA) France); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Agence Nationale de la Recherche(French National Research Agency (ANR)); Club Franicais du Pancreas; Ministeere de la Recherche et de la Technologie	This work was supported in part by Institut National de la Sante et de la Recherche Medicale (INSERM) and Centre National de la Recherche Scientifique and grants from the Institut National du Cancer, La Ligue Nationale Contre le Cancer, Association pour la Recherche sur le Cancer and the Agence Nationale de la Recherche. M Seux was supported by Association pour la Recherche sur le Cancer and S Peuget by the Club Franicais du Pancreas and Ministeere de la Recherche et de la Technologie. Authors acknowledge Tony George JACOB and Antoine Baud for critically reading the manuscript and helpful comments respectively.	Arnold S, 2008, EXP BIOL MED, V233, P860, DOI 10.3181/0801-RM-12; Basu A, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-15; Baumgart M, 2005, CELL ONCOL, V27, P3; BELLAHCENE A, 1995, AM J PATHOL, V146, P95; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Bradshaw AD, 2002, J HISTOCHEM CYTOCHEM, V50, P1; Bradshaw AD, 2001, J CLIN INVEST, V107, P1049, DOI 10.1172/JCI12939; Brekken RA, 2003, J CLIN INVEST, V111, P487, DOI 10.1172/JCI200316804; Brune K, 2008, CANCER EPIDEM BIOMAR, V17, P3536, DOI 10.1158/1055-9965.EPI-08-0630; Chen G, 2010, BRIT J CANCER, V102, P188, DOI 10.1038/sj.bjc.6605440; FORD R, 1993, EXP CELL RES, V206, P261, DOI 10.1006/excr.1993.1146; Framson PE, 2004, J CELL BIOCHEM, V92, P679, DOI 10.1002/jcb.20091; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Guweidhi A, 2005, ANN SURG, V242, P224, DOI 10.1097/01.sla.0000171866.45848.68; Hershko T, 2005, CELL DEATH DIFFER, V12, P377, DOI 10.1038/sj.cdd.4401575; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hunzelmann N, 1998, J INVEST DERMATOL, V110, P122, DOI 10.1046/j.1523-1747.1998.00094.x; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Ito Y, 2006, ANTICANCER RES, V26, P4391; Jiang PH, 2006, WORLD J GASTROENTERO, V12, P691, DOI 10.3748/wjg.v12.i5.691; Loging WT, 2000, GENOME RES, V10, P1393, DOI 10.1101/gr.138000; Lomberk G, 2008, CURR OPIN GASTROEN, V24, P597, DOI 10.1097/MOG.0b013e32830b111d; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Massi D, 1999, HUM PATHOL, V30, P339, DOI 10.1016/S0046-8177(99)90014-X; MURPHYULLRICH JE, 1995, J CELL BIOCHEM, V57, P341, DOI 10.1002/jcb.240570218; Ogawa Kumiko, 2005, Medical Molecular Morphology, V38, P23, DOI 10.1007/s00795-004-0265-0; Porte H, 1998, CLIN CANCER RES, V4, P1375; PORTE H, 1995, INT J CANCER, V64, P70, DOI 10.1002/ijc.2910640114; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; REED MJ, 1994, J CELL PHYSIOL, V158, P169, DOI 10.1002/jcp.1041580121; REED MJ, 1993, J HISTOCHEM CYTOCHEM, V41, P1467, DOI 10.1177/41.10.8245406; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Rempel SA, 2001, J NEURO-ONCOL, V53, P149, DOI 10.1023/A:1012201300188; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; Roger L, 2006, BIOL CELL, V98, P141, DOI 10.1042/BC20050058; Ryu B, 2001, CANCER RES, V61, P1833; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; SAGE EH, 1995, J CELL BIOCHEM, V57, P127, DOI 10.1002/jcb.240570113; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Schiemann BJ, 2003, MOL BIOL CELL, V14, P3977, DOI 10.1091/mbc.E03-01-0001; Seno T, 2009, INT J ONCOL, V34, P707, DOI 10.3892/ijo_00000197; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Suzuki S, 2004, CARCINOGENESIS, V25, P439, DOI 10.1093/carcin/bgh030; Tomasin R, 2001, J BIOL CHEM, V276, P44185, DOI 10.1074/jbc.M105647200; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Tomasini R, 2002, EUR J CELL BIOL, V81, P294, DOI 10.1078/0171-9335-00248; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200	54	55	60	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL	2011	30	27					3049	3061		10.1038/onc.2011.25	http://dx.doi.org/10.1038/onc.2011.25			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	789IW	21339733				2022-12-25	WOS:000292510100005
J	Vinnedge, LMP; McClaine, R; Wagh, PK; Wikenheiser-Brokamp, KA; Waltz, SE; Wells, SI				Vinnedge, L. M. Privette; McClaine, R.; Wagh, P. K.; Wikenheiser-Brokamp, K. A.; Waltz, S. E.; Wells, S. I.			The human DEK oncogene stimulates beta-catenin signaling, invasion and mammosphere formation in breast cancer	ONCOGENE			English	Article						DEK; breast cancer; metastasis; beta-catenin; cancer stem cells	PROTOONCOGENE PROTEIN DEK; HUMAN-PAPILLOMAVIRUS E7; STEM-CELLS; EXPRESSION SIGNATURE; IDENTIFICATION; CHROMATIN; BINDING; DNA; CARCINOGENESIS; RETINOBLASTOMA	Breast cancer is a major cause of cancer-related deaths in American women; therefore, the identification of novel breast cancer-related molecules for the discovery of new markers and drug targets remains essential. The human DEK gene, which encodes a chromatin-binding protein and DNA topology regulator, is upregulated in many types of cancer. DEK has been implicated as an oncogene in breast cancer based on mRNA expression studies, but its functional significance in breast cancer growth and progression has not yet been tested directly. We demonstrate that DEK is highly expressed in breast cancer cells compared with normal tissue, and functionally important for cellular growth, invasion and mammosphere formation. DEK overexpression in non-tumorigenic MCF10A cells resulted in increased growth and motility, with a concomitant downregulation of E-cadherin. Conversely, DEK knockdown in MCF7 and MDA-MB-468 breast cancer cells resulted in decreased growth and motility with upregulation of E-cadherin. The use of DEK-proficient and -deficient breast cancer cells in orthotopic xenografts provided further in vivo evidence that DEK contributes to tumor growth. Activation of the beta-catenin signaling pathway is important for normal and cancer stem cell character, growth and metastasis. We show that DEK expression stimulated, and DEK knockdown repressed beta-catenin nuclear translocation and activity. Importantly, the expression of constitutively active beta-catenin rescued breast cancer invasion defects of DEK knockdown cells. Together, our data indicate that DEK expression stimulates the growth, stem cell character and motility of breast cancer cells, and that DEK-dependent cellular invasion occurs at least in part via beta-catenin activation. Oncogene (2011) 30, 2741-2752; doi: 10.1038/onc.2011.2; published online 14 February 2011	[Vinnedge, L. M. Privette; Wells, S. I.] Cincinnati Childrens Hosp Med Ctr, Div Hematol Oncol, Dept Hematol, Cincinnati, OH 45229 USA; [Vinnedge, L. M. Privette; Wells, S. I.] Cincinnati Childrens Hosp Med Ctr, Div Hematol Oncol, Dept Oncol, Cincinnati, OH 45229 USA; [McClaine, R.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45267 USA; [Wagh, P. K.; Waltz, S. E.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH USA; [Wikenheiser-Brokamp, K. A.] Cincinnati Childrens Hosp Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Wells, SI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Hematol Oncol, Dept Hematol, TCHRF Room S7-206,MLC 7013,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Susanne.Wells@cchmc.org	Vinnedge, Lisa Privette/H-5869-2019	Vinnedge, Lisa Privette/0000-0003-2087-4920	NIH [AR-47363]; National Cancer Institute [F32CA139931, T32HL091805]; Public Health Service [CA116316, CA100002, HL079193]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	We thank Yi Zheng for critical evaluation of this manuscript. We also thank James Lessard, Aaron Zorn, Jose Cancelas, James Mulloy and James Wells for reagents and discussion, Gerard Grosveld for Dek knockout mice, Gina Kavanaugh for the immortalized Dek wild-type and knockout mouse embryonic fibroblasts and the Viral Vector Core at CCHMC. We would like to acknowledge the assistance of the Research Flow Cytometry Core in the Division of Rheumatology at Cincinnati Children's Hospital Medical Center, supported in part by NIH AR-47363. This research was supported by Kirschstein National Research Service Awards (NRSA) F32CA139931 and T32HL091805 from the National Cancer Institute (L.M.P.V.), and Public Health Service grants CA116316 (S.I.W.), CA100002 (S.E.W.), and HL079193 (K. W-B.)	Abba MC, 2007, MOL CANCER RES, V5, P881, DOI 10.1158/1541-7786.MCR-07-0055; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alexiadis V, 2000, GENE DEV, V14, P1308; Allan AL, 2006, AM J PATHOL, V169, P233, DOI 10.2353/ajpath.2006.051152; American Cancer Society [ACS], 2009, BREAST CANC FACTS FI; ANDREASSEN PR, 1994, J CELL BIOL, V127, P789, DOI 10.1083/jcb.127.3.789; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Bowles E, 2007, GENE CHROMOSOME CANC, V46, P118, DOI 10.1002/gcc.20383; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P1571, DOI 10.1093/nar/gkg247; Carro MS, 2006, CELL CYCLE, V5, P1202, DOI 10.4161/cc.5.11.2801; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Evans AJ, 2004, AM J PATHOL, V164, P285, DOI 10.1016/S0002-9440(10)63118-5; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Johung K, 2007, J VIROL, V81, P2102, DOI 10.1128/JVI.02348-06; Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07; Kappes F, 2001, J BIOL CHEM, V276, P26317, DOI 10.1074/jbc.M100162200; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Kondoh N, 1999, CANCER RES, V59, P4990; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lu ZL, 2005, WORLD J GASTROENTERO, V11, P3850; McGarvey T, 2000, J CELL BIOL, V150, P309, DOI 10.1083/jcb.150.2.309; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Prahalad P, 2004, AM J PHYSIOL-CELL PH, V286, pC693, DOI 10.1152/ajpcell.00124.2003; Privette LM, 2007, CANCER RES, V67, P6064, DOI 10.1158/0008-5472.CAN-06-4109; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ribeiro-Silva A, 2003, ARCH PATHOL LAB MED, V127, P336; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Sammons M, 2006, J BIOL CHEM, V281, P26802, DOI 10.1074/jbc.M600915200; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shibata T, 2010, ONCOGENE, V29, P4671, DOI 10.1038/onc.2010.217; SOULE HD, 1990, CANCER RES, V50, P6075; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tubiana M, 1999, ACTA ONCOL, V38, P295; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Waldmann T, 2003, NUCLEIC ACIDS RES, V31, P7003, DOI 10.1093/nar/gkg864; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Wise-Draper TM, 2006, MOL CELL BIOL, V26, P7506, DOI 10.1128/MCB.00430-06; Wise-Draper TM, 2009, CANCER RES, V69, P1792, DOI 10.1158/0008-5472.CAN-08-2304; Wise-Draper TM, 2009, AM J PATHOL, V174, P71, DOI 10.2353/ajpath.2009.080330; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	52	71	73	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUN	2011	30	24					2741	2752		10.1038/onc.2011.2	http://dx.doi.org/10.1038/onc.2011.2			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	778DB	21317931	Green Accepted			2022-12-25	WOS:000291678500005
J	Frase, H; Smith, CA; Toth, M; Champion, MM; Mobashery, S; Vakulenko, SB				Frase, Hilary; Smith, Clyde A.; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar; Vakulenko, Sergei B.			Identification of Products of Inhibition of GES-2 beta-Lactamase by Tazobactam by X-ray Crystallography and Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-ENAMINE INTERMEDIATE; CLASS-A CARBAPENEMASE; CRYSTAL-STRUCTURE; SHV-1; RESOLUTION; INACTIVATION; MECHANISM; RESISTANT; INSIGHTS; POPULATIONS	The GES-2 beta-lactamase is a class A carbapenemase, the emergence of which in clinically important bacterial pathogens is a disconcerting development as the enzyme confers resistance to carbapenem antibiotics. Tazobactam is a clinically used inhibitor of class A beta-lactamases, which inhibits the GES-2 enzyme effectively, restoring susceptibility to beta-lactam antibiotics. We have investigated the details of the mechanism of inhibition of the GES-2 enzyme by tazobactam. By the use of UV spectrometry, mass spectroscopy, and x-ray crystallography, we have documented and identified the involvement of a total of seven distinct GES-2 center dot tazobactam complexes and one product of the hydrolysis of tazobactam that contribute to the inhibition profile. The x-ray structures for the GES-2 enzyme are for both the native (1.45 angstrom) and the inhibited complex with tazobactam (1.65 angstrom). This is the first such structure of a carbapenemase in complex with a clinically important beta-lactam inhibitor, shedding light on the structural implications for the inhibition process.	[Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA; [Frase, Hilary; Toth, Marta; Champion, Matthew M.; Mobashery, Shahriar; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of Notre Dame	Smith, CA (corresponding author), Stanford Univ, Stanford Synchrotron Radiat Lab, Menlo Pk, CA 94025 USA.	csmith@slac.stanford.edu; svakulen@nd.edu		Champion, Matthew M./0000-0001-5927-5277	National Science Foundation [CHE-0741793]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089726] Funding Source: NIH RePORTER; Division Of Chemistry [0741793] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation Grant CHE-0741793.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; [Anonymous], 1988, MECH BASED ENZYME IN; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baughman Robert P, 2009, J Intensive Care Med, V24, P230, DOI 10.1177/0885066609335660; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonomo RA, 2001, BBA-PROTEIN STRUCT M, V1547, P196, DOI 10.1016/S0167-4838(01)00175-3; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; CARTWRIGHT SJ, 1979, NATURE, V278, P360, DOI 10.1038/278360a0; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher JF, 2010, J MED CHEM, V53, P4813, DOI 10.1021/jm100086u; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Girlich D, 2010, ANTIMICROB AGENTS CH, V54, P328, DOI 10.1128/AAC.00961-09; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Ibuka A, 1999, J MOL BIOL, V285, P2079, DOI 10.1006/jmbi.1998.2432; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kalp M, 2009, BIOCHEMISTRY-US, V48, P9912, DOI 10.1021/bi9012098; Kalp M, 2009, J AM CHEM SOC, V131, P2338, DOI 10.1021/ja808311s; Kattan JN, 2008, CLIN MICROBIOL INFEC, V14, P1102, DOI 10.1111/j.1469-0691.2008.02101.x; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuzin AP, 2001, BIOCHEMISTRY-US, V40, P1861, DOI 10.1021/bi0022745; MariotteBoyer S, 1996, FEMS MICROBIOL LETT, V143, P29, DOI 10.1016/0378-1097(96)00288-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Moubareck C, 2009, ANTIMICROB AGENTS CH, V53, P3579, DOI 10.1128/AAC.00072-09; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; OSTERCAMP DL, 1970, J ORG CHEM, V35, P1632, DOI 10.1021/jo00830a080; Padayatti PS, 2006, J AM CHEM SOC, V128, P13235, DOI 10.1021/ja063715w; Padayatti PS, 2004, BIOCHEMISTRY-US, V43, P843, DOI 10.1021/bi035985m; Pagan-Rodriguez D, 2004, J BIOL CHEM, V279, P19494, DOI 10.1074/jbc.M311669200; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Perez F, 2007, CURR OPIN PHARMACOL, V7, P459, DOI 10.1016/j.coph.2007.08.003; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; RIZWI I, 1989, BIOCHEM J, V258, P205, DOI 10.1042/bj2580205; Shahid M, 2009, CRIT REV MICROBIOL, V35, P81, DOI 10.1080/10408410902733979; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; Sougakoff W, 2002, ACTA CRYSTALLOGR D, V58, P267, DOI 10.1107/S0907444901019606; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2004, BIOCHEMISTRY-US, V43, P14111, DOI 10.1021/bi0487903; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; Testero S. A., 2010, BURGERS MED CHEM DRU, P259; Toth M, 2010, J AM CHEM SOC, V132, P816, DOI 10.1021/ja908850p; Totir MA, 2006, BIOCHEMISTRY-US, V45, P11895, DOI 10.1021/bi060990m; Tranier S, 2000, J BIOL CHEM, V275, P28075; Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Yang Y, 2000, J BIOL CHEM, V275, P26674	61	18	18	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14396	14409		10.1074/jbc.M110.208744	http://dx.doi.org/10.1074/jbc.M110.208744			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21345789	Green Published, hybrid			2022-12-25	WOS:000289556200061
J	Schilling, S; Kohlmann, S; Bauscher, C; Sedlmeier, R; Koch, B; Eichentopf, R; Becker, A; Cynis, H; Hoffmann, T; Berg, S; Freyse, EJ; von Horsten, S; Rossner, S; Graubner, S; Demuth, HU				Schilling, Stephan; Kohlmann, Stephanie; Baeuscher, Christoph; Sedlmeier, Reinhard; Koch, Birgit; Eichentopf, Rico; Becker, Andreas; Cynis, Holger; Hoffmann, Torsten; Berg, Sabine; Freyse, Ernst-Joachim; von Hoersten, Stephan; Rossner, Steffen; Graubner, Sigrid; Demuth, Hans-Ulrich			Glutaminyl Cyclase Knock-out Mice Exhibit Slight Hypothyroidism but No Hypogonadism IMPLICATIONS FOR ENZYME FUNCTION AND DRUG DEVELOPMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROGLUTAMIC ACID; A-BETA; AMYLOID PEPTIDES; HORMONE GENE; IN-VITRO; PGLU; INHIBITION; EXPRESSION; RECEPTOR; BRAIN	Glutaminyl cyclases (QCs) catalyze the formation of pyroglutamate (pGlu) residues at the N terminus of peptides and proteins. Hypothalamic pGlu hormones, such as thyrotropin-releasing hormone and gonadotropin-releasing hormone are essential for regulation of metabolism and fertility in the hypothalamic pituitary thyroid and gonadal axes, respectively. Here, we analyzed the consequences of constitutive genetic QC ablation on endocrine functions and on the behavior of adult mice. Adult homozygous QC knock-out mice are fertile and behave indistinguishably from wild type mice in tests of motor function, cognition, general activity, and ingestion behavior. The QC knock-out results in a dramatic drop of enzyme activity in the brain, especially in hypothalamus and in plasma. Other peripheral organs like liver and spleen still contain QC activity, which is most likely caused by its homolog isoQC. The serum gonadotropin-releasing hormone, TSH, and testosterone concentrations were not changed by QC depletion. The serum thyroxine was decreased by 24% in homozygous QC knock-out animals, suggesting a mild hypothyroidism. QC knock-out mice were indistinguishable from wild type with regard to blood glucose and glucose tolerance, thus differing from reports of thyrotropin-releasing hormone knock-out mice significantly. The results suggest a significant formation of the hypothalamic pGlu hormones by alternative mechanisms, like spontaneous cyclization or conversion by isoQC. The different effects of QC depletion on the hypothalamic pituitary thyroid and gonadal axes might indicate slightly different modes of substrate conversion of both enzymes. The absence of significant abnormalities in QC knock-out mice suggests the presence of a therapeutic window for suppression of QC activity in current drug development.	[Eichentopf, Rico; Cynis, Holger; Hoffmann, Torsten; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Germany; [Kohlmann, Stephanie; Baeuscher, Christoph; Sedlmeier, Reinhard; Becker, Andreas; Graubner, Sigrid; Demuth, Hans-Ulrich] Ingenium GmbH, D-82152 Martinsried, Germany; [Berg, Sabine; Freyse, Ernst-Joachim] Inst Diabet Endocrinol & Metab Dis, D-17495 Karlsburg, Germany; [von Hoersten, Stephan] Univ Erlangen Nurnberg, Franz Penzoldt Ctr, D-91054 Erlangen, Germany; [Rossner, Steffen] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Vivoryon Therapeutics; University of Erlangen Nuremberg; Leipzig University		stephan.schilling@probiodrug.de; sigrid.graubner@ingenium-ag.com	von Hörsten, Stephan/G-9005-2015; Rossner, Steffen/A-5184-2017	von Hörsten, Stephan/0000-0001-6409-0664; Cynis, Holger/0000-0001-6655-7539	Bundesministerium fuer Bildung und Forschung [0313185]	Bundesministerium fuer Bildung und Forschung	This work was supported by Bundesministerium fuer Bildung und Forschung Grant 0313185 (to H.-U. D.). S. S., B. K., R. E., H. C., and T. H. are employees of Probiodrug AG and hold stock option of the company. Ingenium Pharmaceuticals GmbH is a daughter company of Probiodrug AG, and therefore S. K., C. B., R. S., A. B., and S. G., as employees of Ingenium Pharmaceuticals, hold stock options of Probiodrug AG. H.-U. D. serves as Chief Scientific Officer of Probiodrug AG and Managing Director/Chief Executive Officer of Ingenium and holds shares and stock options of the Probiodrug group.	ABRAHAM GN, 1981, MOL CELL BIOCHEM, V38, P181, DOI 10.1007/BF00235695; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; BLOMBACK B, 1967, BIOCHIM BIOPHYS ACTA, V11, P398; BOCKERS TM, 1995, J NEUROENDOCRINOL, V7, P445, DOI 10.1111/j.1365-2826.1995.tb00780.x; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; FISCHER WH, 1987, P NATL ACAD SCI USA, V84, P3628, DOI 10.1073/pnas.84.11.3628; Garavelli JS, 2000, NUCLEIC ACIDS RES, V28, P209, DOI 10.1093/nar/28.1.209; GARCIAPARDO A, 1983, J BIOL CHEM, V258, P2670; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; GOREN HJ, 1977, MOL PHARMACOL, V13, P606; Hartlage-Rubsamen M, 2009, INT J DEV NEUROSCI, V27, P825, DOI 10.1016/j.ijdevneu.2009.08.007; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; KARTEN MJ, 1986, ENDOCR REV, V7, P44, DOI 10.1210/edrv-7-1-44; Keire DA, 2003, REGUL PEPTIDES, V113, P115, DOI 10.1016/S0167-0115(03)00005-3; Kinkead B, 2005, J PHARMACOL EXP THER, V315, P256, DOI 10.1124/jpet.105.087437; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Morty RE, 2006, BIOCHEM J, V394, P635, DOI 10.1042/BJ20051593; Nillni EA, 1999, ENDOCRINE, V10, P185, DOI 10.1007/BF02738618; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; OKADA Y, 1973, BIOCHEM BIOPH RES CO, V53, P1180, DOI 10.1016/0006-291X(73)90589-5; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Rehfeld JF, 2006, J MOL MED-JMM, V84, P544, DOI 10.1007/s00109-006-0055-3; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schilling S, 2008, J NEUROCHEM, V106, P1225, DOI 10.1111/j.1471-4159.2008.05471.x; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; Seifert F, 2009, BIOCHEMISTRY-US, V48, P11831, DOI 10.1021/bi9018835; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Tomidokoro Y, 2005, J BIOL CHEM, V280, P36883, DOI 10.1074/jbc.M504038200; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Wetsel WC, 2002, PROG BRAIN RES, V141, P221; Yamada M, 2003, THYROID, V13, P1111, DOI 10.1089/10507250360731505; Yamada M, 1997, P NATL ACAD SCI USA, V94, P10862, DOI 10.1073/pnas.94.20.10862	41	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14199	14208		10.1074/jbc.M111.229385	http://dx.doi.org/10.1074/jbc.M111.229385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21330373	hybrid, Green Published			2022-12-25	WOS:000289556200043
J	Abdel-Sater, F; Jean, C; Merhi, A; Vissers, S; Andre, B				Abdel-Sater, Fadi; Jean, Cathy; Merhi, Ahmad; Vissers, Stephan; Andre, Bruno			Amino Acid Signaling in Yeast: Activation of Ssy5 Protease Is Associated with Its Phosphorylation-induced Ubiquitylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASEIN KINASE-I; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; ENDOPROTEOLYTIC ACTIVATION; AGP1 GENE; SENSOR; PATHWAY; STP1; PROTEOLYSIS; UBIQUITIN	The yeast Ssy5 protein is a serine-type endoprotease autoprocessed into a catalytic domain and a large inhibitory prodomain. When external amino acids are detected by the plasma membrane Ssy1 sensor, Ssy5 is activated and catalyzes endoproteolytic processing of the Stp1 and Stp2 transcription factors. These Stp proteins then migrate into the nucleus and activate transcription of several amino acid permease genes. Previous studies showed that Ssy5 activation involves the SCFGrr1 ubiquitin ligase complex, but the molecular mechanisms of this activation remain unclear. We here report that the prodomain of Ssy5 is phosphorylated in a casein kinase I-dependent manner in response to amino acid detection. We describe a mutant form of Ssy5 whose prodomain is not phosphorylated and show that it is nonfunctional. Amino acid detection also induces ubiquitylation of the Ssy5 prodomain. This prodomain ubiquitylation requires its prior phosphorylation and the SCFGrr1 complex. When this ubiquitylation is defective, Ssy5 accumulates as a phosphorylated form but remains inactive. A constitutive Ssy5 form in which the prodomain fails to inhibit the catalytic domain does not need to be phosphorylated or ubiquitylated to be active. Finally, we provide evidence that ubiquitylation of the inhibitory prodomain rather than its subsequent degradation is the key step in the Ssy5 activation mechanism. We propose that the Ssy5 protease is activated by phosphorylation-induced ubiquitylation, the effect of which is relief from inhibition by its prodomain.	[Abdel-Sater, Fadi; Jean, Cathy; Merhi, Ahmad; Vissers, Stephan; Andre, Bruno] Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, Inst Biol & Med Mol, B-6041 Gosselies, Belgium	Universite Libre de Bruxelles	Andre, B (corresponding author), Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, Inst Biol & Med Mol, 11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be	André, Bruno/D-1725-2010	Merhi, Ahmad/0000-0001-7046-2508; abdel-sater, fadi/0000-0003-3590-140X	Fonds de la Recherche Scientifique Medicale [3.4.592.08.FF]; Region Wallonne de Belgique [716760]; Communaute Francaise de Belgique	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Region Wallonne de Belgique; Communaute Francaise de Belgique(Australian Research Council)	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4.592.08.FF, CIBLES Grant 716760 of the Region Wallonne de Belgique, and an Actions de Recherche Concertees grant of the Communaute Francaise de Belgique.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; Bernard F, 2001, MOL MICROBIOL, V41, P489, DOI 10.1046/j.1365-2958.2001.02538.x; Bernard F, 2001, FEBS LETT, V496, P81, DOI 10.1016/S0014-5793(01)02412-7; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; de Boer M, 1998, MOL MICROBIOL, V30, P603, DOI 10.1046/j.1365-2958.1998.01094.x; Didion T, 1998, MOL MICROBIOL, V27, P643, DOI 10.1046/j.1365-2958.1998.00714.x; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Emter R, 2002, FEBS LETT, V521, P57, DOI 10.1016/S0014-5793(02)02818-1; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Iraqui I, 1999, MOL CELL BIOL, V19, P989; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Jorgensen MU, 1997, CURR GENET, V31, P241, DOI 10.1007/s002940050201; Jorgensen MU, 1998, YEAST, V14, P103, DOI 10.1002/(SICI)1097-0061(19980130)14:2<103::AID-YEA203>3.0.CO;2-C; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Liu ZC, 2008, MOL CELL BIOL, V28, P551, DOI 10.1128/MCB.00929-07; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; Sohn J, 2009, STRUCTURE, V17, P1411, DOI 10.1016/j.str.2009.07.017; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263	32	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.200592	http://dx.doi.org/10.1074/jbc.M110.200592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21310956	Green Published, hybrid			2022-12-25	WOS:000289077500014
J	Su, X; Ao, LH; Shi, Y; Johnson, TR; Fullerton, DA; Meng, XZ				Su, Xin; Ao, Lihua; Shi, Yi; Johnson, Thomas R.; Fullerton, David A.; Meng, Xianzhong			Oxidized Low Density Lipoprotein Induces Bone Morphogenetic Protein-2 in Coronary Artery Endothelial Cells via Toll-like Receptors 2 and 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALVE INTERSTITIAL-CELLS; BMP-2 GENE-EXPRESSION; CALCIFICATION IN-VIVO; SMOOTH-MUSCLE-CELLS; VASCULAR CALCIFICATION; ATHEROSCLEROTIC PLAQUES; LECTIN-LIKE; MACROPHAGES; MICE; LDL	Vascular calcification is a common complication in atherosclerosis. Bone morphogenetic protein-2 (BMP-2) plays an important role in atherosclerotic vascular calcification. The aim of this study was to determine the effect of oxidized low density lipoprotein (oxLDL) on BMP-2 protein expression in human coronary artery endothelial cells (CAECs), the roles of Toll-like receptor (TLR) 2 and TLR4 in oxLDL-induced BMP-2 expression, and the signaling pathways involved. Human CAECs were stimulated with oxLDL. The roles of TLR2 and TLR4 in oxLDL-induced BMP-2 expression were determined by pretreatment with neutralizing antibody, siRNA, and overexpression. Stimulation with oxLDL increased cellular BMP-2 protein levels in a dose-dependent manner (40-160 mu g/ml). Pretreatment with neutralizing antibodies against TLR2 and TLR4 or silencing of these two receptors reduced oxLDL-induced BMP-2expression. Overexpression of TLR2 and TLR4 enhanced the cellular BMP-2 response to oxLDL. Furthermore, oxLDL was co-localized with TLR2 and TLR4. BMP-2 expression was associated with activation of nuclear factor-kappa B (NF-kappa B), p38 mitogen-activated protein kinase (MAPK), and extracellular signal-regulated kinase (ERK) 1/2. Inhibition of NF-kappa B and ERK1/2 reduced BMP-2 expression whereas inhibition of p38 MAPK had no effect. In conclusion, oxLDL induces BMP-2 expression through TLR2 and TLR4 in human CAECs. The NF-kappa B and ERK1/2 pathways are involved in the signaling mechanism. These findings underscore an important role for TLR2 and TLR4 in mediating the BMP-2 response to oxLDL in human CAECs and indicate that these two immunoreceptors contribute to the mechanisms underlying atherosclerotic vascular calcification.	[Su, Xin; Ao, Lihua; Johnson, Thomas R.; Fullerton, David A.; Meng, Xianzhong] Univ Colorado Denver, Dept Surg, Aurora, CO 80045 USA; [Su, Xin; Shi, Yi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210002, Peoples R China	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Nanjing University	Meng, XZ (corresponding author), 12700 E 19th Ave,Box C-320, Aurora, CO 80045 USA.	xianzhong.meng@ucdenver.edu	Su, Xin/X-2589-2018	su, Xin/0000-0002-3910-9156	National Institutes of Health [HL079051]; American Heart Association [0850148Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL079051. This work was also supported by American Heart Association Grant 0850148Z.	Ao LH, 2009, AM J PHYSIOL-HEART C, V297, pH21, DOI 10.1152/ajpheart.00292.2009; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Chen MJ, 2002, PHARMACOL THERAPEUT, V95, P89, DOI 10.1016/S0163-7258(02)00236-X; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; Cola C, 2004, BIOCHEM BIOPH RES CO, V320, P424, DOI 10.1016/j.bbrc.2004.05.181; Csiszar A, 2005, CIRCULATION, V111, P2364, DOI 10.1161/01.CIR.0000164201.40634.1D; de Castellarnau C, 2007, CLIN CHIM ACTA, V376, P233, DOI 10.1016/j.cca.2006.07.024; de Graaf R, 2006, MICROBES INFECT, V8, P1859, DOI 10.1016/j.micinf.2006.02.024; Dhore CR, 2001, ARTERIOSCL THROM VAS, V21, P1998, DOI 10.1161/hq1201.100229; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; FITZGERALD PJ, 1992, CIRCULATION, V86, P64, DOI 10.1161/01.CIR.86.1.64; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Katsargyris A, 2011, CEREBROVASC DIS, V31, P29, DOI 10.1159/000320259; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31; Miller YI, 2003, J BIOL CHEM, V278, P1561, DOI 10.1074/jbc.M209634200; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Nakagawa Y, 2010, ARTERIOSCL THROM VAS, V30, P1908, DOI 10.1161/ATVBAHA.110.206185; Nowicki M, 2010, J NEUROSCI RES, V88, P403, DOI 10.1002/jnr.22205; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Su X, 2008, BBA-MOL CELL RES, V1783, P1623, DOI 10.1016/j.bbamcr.2008.04.009; Su X, 2010, CYTOKINE, V51, P60, DOI 10.1016/j.cyto.2010.04.014; Willette RN, 1999, J VASC RES, V36, P120, DOI 10.1159/000025634; Xu XH, 2001, CIRCULATION, V104, P3103, DOI 10.1161/hc5001.100631; Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024; Yang XP, 2009, J AM COLL CARDIOL, V53, P491, DOI 10.1016/j.jacc.2008.09.052; Zou N, 2008, AM J PHYSIOL-HEART C, V294, pH2805, DOI 10.1152/ajpheart.00299.2008	37	67	73	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.214619	http://dx.doi.org/10.1074/jbc.M110.214619			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21325271	Green Published, hybrid			2022-12-25	WOS:000289077500036
J	Rosenthal, GG; Fitzsimmons, JN; Woods, KU; Gerlach, G; Fisher, HS				Rosenthal, Gil G.; Fitzsimmons, Jessica N.; Woods, Kristina U.; Gerlach, Gabriele; Fisher, Heidi S.			Tactical Release of a Sexually-Selected Pheromone in a Swordtail Fish	PLOS ONE			English	Article							OLFACTORY CUES; SIGNALS; RECOGNITION; PREFERENCE; DOMINANCE; EVOLUTION; AUDIENCE; FEMALES; URINE	Background: Chemical communication plays a critical role in sexual selection and speciation in fishes; however, it is generally assumed that most fish pheromones are passively released since most fishes lack specialized scent glands or scent-marking behavior. Swordtails (genus Xiphophorus) are widely used in studies of female mate choice, and female response to male chemical cues is important to sexual selection, reproductive isolation, and hybridization. However, it is unclear whether females are attending to passively produced cues, or to pheromones produced in the context of communication. Methodology/Principal Findings: We used fluorescein dye injections to visualize pulsed urine release in male sheepshead swordtails, Xiphophorus birchmanni. Simultaneous-choice assays of mating preference showed that females attend to species-and sex-specific chemical cues emitted in male urine. Males urinated more frequently in the presence and proximity of an audience (conspecific females). In the wild, males preferentially courted upstream of females, facilitating transmission of pheromone cues. Conclusions/Significance: Males in a teleost fish have evolved sophisticated temporal and spatial control of pheromone release, comparable to that found in terrestrial animals. Pheromones are released specifically in a communicative context, and the timing and positioning of release favors efficient signal transmission.	[Rosenthal, Gil G.; Fisher, Heidi S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Rosenthal, Gil G.] Ctr Invest Cient Huastecas Aguazarca, Calnali, Hidalgo, Mexico; [Fitzsimmons, Jessica N.; Woods, Kristina U.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Gerlach, Gabriele] Marine Biol Lab, Woods Hole, MA 02543 USA	Texas A&M University System; Texas A&M University College Station; Boston University; Marine Biological Laboratory - Woods Hole	Rosenthal, GG (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	grosenthal@bio.tamu.edu	Fitzsimmons, Jessica/G-1343-2011; Gerlach, Gabriele/K-5919-2012; Rosenthal, Gil/E-6924-2015	Rosenthal, Gil/0000-0003-0342-9024; Fisher, Heidi S./0000-0001-5622-4335	National Science Foundation [IOB-0447665]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (www.nsf.gov), IOB-0447665. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Appelt CW, 2007, ANIM BEHAV, V74, P1329, DOI 10.1016/j.anbehav.2007.02.032; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; Barata EN, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-54; Barata EN, 2008, J CHEM ECOL, V34, P438, DOI 10.1007/s10886-008-9458-7; Barata EN, 2008, ANIM BEHAV, V75, P379, DOI 10.1016/j.anbehav.2007.05.018; BASOLO AL, 1990, SCIENCE, V250, P808, DOI 10.1126/science.250.4982.808; Bergman DA, 2005, ANIM BEHAV, V70, P485, DOI 10.1016/j.anbehav.2004.11.021; Bradbury JW, 2000, ANIM BEHAV, V59, P259, DOI 10.1006/anbe.1999.1330; Breithaupt T, 2000, BEHAV ECOL SOCIOBIOL, V49, P67, DOI 10.1007/s002650000271; CULUMBER ZW, MOL ECOLOGY; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; DECAPRONA MDC, 1990, ANIM BEHAV, V39, P290; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fisher HS, 2007, BIOL LETTERS, V3, P5, DOI 10.1098/rsbl.2006.0556; Fisher HS, 2006, ANIM BEHAV, V72, P721, DOI 10.1016/j.anbehav.2006.02.009; Fisher HS, 2006, BEHAV ECOL, V17, P979, DOI 10.1093/beheco/arl038; Fisher HS, 2006, P ROY SOC B-BIOL SCI, V273, P1187, DOI 10.1098/rspb.2005.3406; Fisher HS, 2009, ANIM BEHAV, V78, P265, DOI 10.1016/j.anbehav.2009.02.029; GYGER M, 1986, ANIM BEHAV, V34, P1570, DOI 10.1016/S0003-3472(86)80229-9; Hankison SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P140; Holldobler B., 1990, pi; Jobling M., 1995, ENVIRON BIOL FISH; Marler P., 1991, P187; McLennan DA, 1997, ANIM BEHAV, V54, P1077, DOI 10.1006/anbe.1997.0504; McLennan DA, 1999, EVOLUTION, V53, P880, DOI 10.1111/j.1558-5646.1999.tb05382.x; McLennan DA, 2008, ANIM BEHAV, V75, P1731, DOI 10.1016/j.anbehav.2007.10.030; Miller GL, 2007, J CHEM ECOL, V33, P541, DOI 10.1007/s10886-006-9243-4; Morris MR, 1996, ANIM BEHAV, V52, P1193, DOI 10.1006/anbe.1996.0267; RAUCHENBERGER M, 1990, AM MUS NOVIT, P1; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Rosenthal GG, 2003, COPEIA, P299, DOI 10.1643/0045-8511(2003)003[0299:DOSSCI]2.0.CO;2; ROSENTHAL GG, 2006, BEHAV PHYSL FISH, P39; Rosenthal GG, 2006, ZEBRAFISH, V3, P85, DOI 10.1089/zeb.2006.3.85; Ryan MJ, 2001, MG BEH ECOL, P133; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; Stacey N. E., 2005, BEHAV INTERACTIONS F; Wong BBM, 2005, BEHAV ECOL, V16, P818, DOI 10.1093/beheco/ari058; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	39	33	34	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16994	10.1371/journal.pone.0016994	http://dx.doi.org/10.1371/journal.pone.0016994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21339807	Green Published, gold, Green Submitted			2022-12-25	WOS:000287361700063
J	Birbrair, A; Wang, ZM; Messi, ML; Enikolopov, GN; Delbono, O				Birbrair, Alexander; Wang, Zhong-Min; Messi, Maria Laura; Enikolopov, Grigori N.; Delbono, Osvaldo			Nestin-GFP Transgene Reveals Neural Precursor Cells in Adult Skeletal Muscle	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM-CELLS; PROGENITOR CELLS; SATELLITE CELLS; BETA-TUBULIN; SPINAL-CORD; DIFFERENTIATION; NEUROGENESIS; MULTIPOTENT; EXPRESSION	Background: Therapy for neural lesions or degenerative diseases relies mainly on finding transplantable active precursor cells. Identifying them in peripheral tissues accessible for biopsy, outside the central nervous system, would circumvent the serious immunological and ethical concerns impeding cell therapy. Methodology/Principal Findings: In this study, we isolated neural progenitor cells in cultured adult skeletal muscle from transgenic mice in which nestin regulatory elements control GFP expression. These cells also expressed the early neural marker Tuj1 and light and heavy neurofilament but not S100 beta, indicating that they express typical neural but not Schwann cell markers. GFP+/Tuj1+ cells were also negative for the endothelial and pericyte markers CD31 and alpha-smooth muscle actin, respectively. We established their a) functional response to glutamate in patch-clamp recordings; b) interstitial mesenchymal origin; c) replicative capacity; and d) the environment necessary for their survival after fluorescence-activated cell sorting. Conclusions/Significance: We propose that the decline in nestin-GFP expression in muscle progenitor cells and its persistence in neural precursor cells in muscle cultures provide an invaluable tool for isolating a population of predifferentiated neural cells with therapeutic potential.	[Birbrair, Alexander; Wang, Zhong-Min; Messi, Maria Laura; Delbono, Osvaldo] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Gerontol, Winston Salem, NC 27106 USA; [Birbrair, Alexander; Delbono, Osvaldo] Wake Forest Univ, Bowman Gray Sch Med, Neurosci Program, Winston Salem, NC 27103 USA; [Enikolopov, Grigori N.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Cold Spring Harbor Laboratory	Birbrair, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Gerontol, Winston Salem, NC 27106 USA.	odelbono@wfubmc.edu	Birbrair, Alexander/H-2497-2012; Enikolopov, Grigori/P-5731-2019	Birbrair, Alexander/0000-0003-1015-2561; Enikolopov, Grigori/0000-0001-8178-8917	National Institutes of Health/National Institute on Aging [AG13934, AG033385, AG15820]; Muscular Dystrophy Association (MDA) [33149]; Wake Forest University Claude D. Pepper Older Americans Independence Center [P30-AG21332]; National Institutes of Mental Health; Ira Hazan Fund	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); Wake Forest University Claude D. Pepper Older Americans Independence Center; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ira Hazan Fund	The present study was supported by grants to Osvaldo Delbono from the National Institutes of Health/National Institute on Aging (AG13934, AG033385, and AG15820), the Muscular Dystrophy Association (MDA #33149), and the Wake Forest University Claude D. Pepper Older Americans Independence Center (P30-AG21332) and by the National Institutes of Mental Health and Ira Hazan Fund to Grigori N. Enikolopov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2008, CLIN PHARMACOL THER, V83, P386, DOI 10.1038/sj.clpt.6100384; Aguiari P, 2008, P NATL ACAD SCI USA, V105, P1226, DOI 10.1073/pnas.0711402105; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Arsic N, 2008, EXP CELL RES, V314, P1266, DOI 10.1016/j.yexcr.2008.01.009; Bachstetter AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010496; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Mazzer PYCN, 2008, J NEUROSCI METH, V173, P249, DOI 10.1016/j.jneumeth.2008.06.019; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Carlson BM, 2001, J GERONTOL A-BIOL, V56, pB224, DOI 10.1093/gerona/56.5.B224; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gingras M, 2007, J CELL PHYSIOL, V210, P498, DOI 10.1002/jcp.20889; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin ZG, 2009, J BIOL CHEM, V284, P8160, DOI 10.1074/jbc.M805632200; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; JOSHI HC, 1989, J CELL BIOL, V109, P663, DOI 10.1083/jcb.109.2.663; Katsetos CD, 2000, ARCH PATHOL LAB MED, V124, P535; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; LEE MK, 1990, P NATL ACAD SCI USA, V87, P7195, DOI 10.1073/pnas.87.18.7195; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lepski G, 2010, EXP CELL RES, V316, P216, DOI 10.1016/j.yexcr.2009.08.006; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Li WW, 1998, J NEUROSCI, V18, P8853; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LUNN JS, 2010, PLEOTROPHIC EFFECTS; Luo KX, 2003, J BONE JOINT SURG AM, V85A, P39, DOI 10.2106/00004623-200300003-00008; Martinez-Cerdeno V, 2006, CEREB CORTEX, V16, pI152, DOI 10.1093/cercor/bhk017; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Pedersen BK, 2009, J PHYSIOL-LONDON, V587, P5559, DOI 10.1113/jphysiol.2009.179515; Pekcec A, 2006, NEUROREPORT, V17, P571, DOI 10.1097/00001756-200604240-00003; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Rao MS, 1999, ANAT RECORD, V257, P137; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Salgado Antonio J, 2006, Curr Stem Cell Res Ther, V1, P345; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022; Schultz SS, 2006, WOUND REPAIR REGEN, V14, P224, DOI 10.1111/j.1743-6109.2006.00114.x; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Silva AT, 2008, BRAIN RES, V1218, P47, DOI 10.1016/j.brainres.2008.04.051; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100; THAYER MJ, 1989, CELL, V58, P241, DOI 10.1016/0092-8674(89)90838-6; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; Wei LC, 2002, DEV BRAIN RES, V139, P9, DOI 10.1016/S0165-3806(02)00509-6; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zavan B, 2007, EUR J HISTOCHEM, V51, P1; Zipori Dov, 2006, Curr Stem Cell Res Ther, V1, P95, DOI 10.2174/157488806775269133	66	66	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16816	10.1371/journal.pone.0016816	http://dx.doi.org/10.1371/journal.pone.0016816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304812	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000287036600028
J	Li, HY; Daculsi, R; Grellier, M; Bareille, R; Bourget, C; Remy, M; Amedee, J				Li, Haiyan; Daculsi, Richard; Grellier, Maritie; Bareille, Reine; Bourget, Chantal; Remy, Murielle; Amedee, Joelle			The Role of Vascular Actors in Two Dimensional Dialogue of Human Bone Marrow Stromal Cell and Endothelial Cell for Inducing Self-Assembled Network	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FACTOR-INDUCED ANGIOGENESIS; IN-VITRO; VE-CADHERIN; UROKINASE RECEPTOR; FIBRIN MATRICES; CAPILLARY-LIKE; HUMAN OSTEOPROGENITORS; INVITRO ANGIOGENESIS; TUBE FORMATION	Angiogenesis is very important for vascularized tissue engineering. In this study, we found that a two-dimensional co-culture of human bone marrow stromal cell (HBMSC) and human umbical vein endothelial cell (HUVEC) is able to stimulate the migration of co-cultured HUVEC and induce self-assembled network formation. During this process, expression of vascular endothelial growth factor (VEGF(165)) was upregulated in co-cultured HBMSC. Meanwhile, VEGF(165)-receptor2 (KDR) and urokinase-type plasminogen activator (uPA) were upregulated in co-cultured HUVEC. Functional studies show that neutralization of VEGF(165) blocked the migration and the rearrangement of the cells and downregulated the expression of uPA and its receptor. Blocking of vascular endothelial-cadherin (VE-cad) did not affect the migration of co-cultured HUVEC but suppressed the self-assembled network formation. In conclusion, co-cultures upregulated the expression of VEGF(165) in co-cultured HBMSC; VEGF(165) then activated uPA in co-cultured HUVEC, which might be responsible for initiating the migration and the self-assembled network formation with the participation of VE-cad. All of these results indicated that only the direct contact of HBMSC and HUVEC and their respective dialogue are sufficient to stimulate secretion of soluble factors and to activate molecules that are critical for self-assembled network formation which show a great application potential for vascularization in tissue engineering.	[Li, Haiyan; Daculsi, Richard; Bareille, Reine; Bourget, Chantal; Remy, Murielle; Amedee, Joelle] INSERM, U577, Bordeaux, France; [Li, Haiyan; Daculsi, Richard; Bareille, Reine; Bourget, Chantal; Remy, Murielle; Amedee, Joelle] Univ Bordeaux 2, F-33076 Bordeaux, France; [Grellier, Maritie] Univ Porto, IPATIMUP Inst Patol Imunol Mol, P-4100 Oporto, Portugal	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Universidade do Porto	Li, HY (corresponding author), INSERM, U577, Bordeaux, France.	haiyan.li@inserm.fr	AMEDEE, Joelle VILAMITJANA/F-3369-2013	Li, Haiyan/0000-0002-7423-2715	L'Agence Nationale de la Recherche [ANR 06-PNANO-022-06, ANR 07-ITOV-TECSAN 011-01]	L'Agence Nationale de la Recherche(French National Research Agency (ANR))	The work was funded by L'Agence Nationale de la Recherche, grant numbers ANR 06-PNANO-022-06 and ANR 07-ITOV-TECSAN 011-01. http://www.agence-nationale-recherche.fr/Accueil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Bach TL, 1998, EXP CELL RES, V238, P324, DOI 10.1006/excr.1997.3844; BISCHOFF J, 1995, TRENDS CELL BIOL, V5, P69, DOI 10.1016/S0962-8924(00)88949-7; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398; BORDENAVE L, 1993, J BIOMED MATER RES, V27, P1367, DOI 10.1002/jbm.820271104; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Caveda L, 1996, J CLIN INVEST, V98, P886, DOI 10.1172/JCI118870; COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3; Corada M, 2001, BLOOD, V97, P1679, DOI 10.1182/blood.V97.6.1679; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; DENNIS PA, 1990, J CELL PHYSIOL, V144, P84, DOI 10.1002/jcp.1041440112; Deroanne CF, 1997, CANCER RES, V57, P5590; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Finkenzeller G, 2006, TISSUE ENG, V12, P2889, DOI 10.1089/ten.2006.12.2889; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOURNIER N, 1992, CELL BIOL INT REP, V16, P1251, DOI 10.1016/S0309-1651(06)80042-1; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018; Grellier M, 2009, TRENDS BIOTECHNOL, V27, P562, DOI 10.1016/j.tibtech.2009.07.001; Grellier M, 2009, J CELL BIOCHEM, V106, P390, DOI 10.1002/jcb.22018; Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025; Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342; Hudon V, 2003, BRIT J DERMATOL, V148, P1094, DOI 10.1046/j.1365-2133.2003.05298.x; Hurley JR, 2010, AM J PHYSIOL-CELL PH, V299, pC444, DOI 10.1152/ajpcell.00572.2009; JAFFE EA, 1980, TRANSPL P, V12, P49; KANZAWA S, 1993, ANN PLAS SURG, V30, P244, DOI 10.1097/00000637-199303000-00008; Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6; Kyriakidou K, 2008, J BIOACT COMPAT POL, V23, P227, DOI 10.1177/0883911508091905; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Li HY, 2010, AM J PHYSIOL-CELL PH, V299, pC422, DOI 10.1152/ajpcell.00562.2009; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Mandriota SJ, 1997, J CELL SCI, V110, P2293; Martin T A, 1999, Angiogenesis, V3, P69, DOI 10.1023/A:1009004212357; Martin TA, 2001, EUR J CLIN INVEST, V31, P931, DOI 10.1046/j.1365-2362.2001.00914.x; MONTESANO R, 1993, J CELL SCI, V105, P1013; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; NEHLS V, 1995, HISTOCHEM CELL BIOL, V104, P459, DOI 10.1007/BF01464336; Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685; Prager GW, 2004, CIRC RES, V94, P1562, DOI 10.1161/01.RES.0000131498.36194.6b; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Silvestri I, 2002, INT J CANCER, V102, P562, DOI 10.1002/ijc.10744; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; STOPPELLI MP, 1986, CELL, V45, P675, DOI 10.1016/0092-8674(86)90782-8; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Terman BI, 1996, CANCER METAST REV, V15, P159, DOI 10.1007/BF00437468; Tille JC, 2002, EXP CELL RES, V280, P179, DOI 10.1006/excr.2002.5635; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje; Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2; Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001; Wright TJ, 2002, EXP CELL RES, V280, P159, DOI 10.1006/excr.2002.5636; Yu HY, 2009, BIOMATERIALS, V30, P508, DOI 10.1016/j.biomaterials.2008.09.047	61	42	46	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2011	6	2							e16767	10.1371/journal.pone.0016767	http://dx.doi.org/10.1371/journal.pone.0016767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IJ	21304816	Green Submitted, gold, Green Published			2022-12-25	WOS:000287036600023
J	Li, Q; Ke, F; Zhang, WW; Shen, XY; Xu, QN; Wang, H; Yu, XZ; Leng, QB; Wang, HL				Li, Qun; Ke, Fang; Zhang, Weiwei; Shen, Xiaoyan; Xu, Qiannan; Wang, Hong; Yu, Xue-Zhong; Leng, Qibin; Wang, Honglin			Plasmin Plays an Essential Role in Amplification of Psoriasiform Skin Inflammation in Mice	PLOS ONE			English	Article							ANNEXIN-II; EXPRESSION; ACTIVATOR; MACROPHAGES; CYTOKINE; IL-23	Background: Although increased levels of plasminogen activators have been found in psoriatic lesions, the role of plasmin converted from plasminogen by plasminogen activators in pathogenesis of psoriasis has not been investigated. Methodology/Principal Findings: Here we examined the contribution of plasmin to amplification of inflammation in patients with psoriasis. We found that plasminogen was diminished, but that the amount and activity of its converted product plasmin were markedly increased in psoriasis. Moreover, annexin II, a receptor for plasmin was dramatically increased in both dermis and epidermis in psoriasis. Plasmin at sites of inflammation was pro-inflammatory, eliciting production of inflammatory factors, including CC chemokine ligand 20 (CCL20) and interleukin-23 (IL-23), that was mediated by the nuclear factor-kappaB (NF-kappa B) signaling pathway and that had an essential role in the recruitment and activation of pathogenic C-C chemokine receptor type 6 (CCR6)(+) T cells. Moreover, intradermal injection of plasmin or plasmin together with recombinant monocyte/macrophage chemotactic protein-1 (MCP-1) resulted in induction of psoriasiform skin inflammation around the injection sites with several aspects of human psoriasis in mice. Conclusions/Significance: Plasmin converted from plasminogen by plasminogen activators plays an essential role in amplification of psoriasiform skin inflammation in mice, and targeting plasmin receptor - annexin II - may harbor therapeutic potential for the treatment of human psoriasis.	[Li, Qun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Vasc Biol Lab,Dept Hypertens,Shanghai Ruijin Hosp, Shanghai 200030, Peoples R China; [Li, Qun] Shanghai Jiao Tong Univ, Sch Med, Inst Hlth Sci, Shanghai 200030, Peoples R China; [Li, Qun] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ke, Fang; Zhang, Weiwei; Xu, Qiannan; Wang, Hong; Wang, Honglin] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Inst Immunol, Shanghai 200030, Peoples R China; [Shen, Xiaoyan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Dermatol, Shanghai 200030, Peoples R China; [Yu, Xue-Zhong] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Leng, Qibin] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; H Lee Moffitt Cancer Center & Research Institute; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Li, Q (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Vasc Biol Lab,Dept Hypertens,Shanghai Ruijin Hosp, Shanghai 200030, Peoples R China.	honglin_wang@shsmu.edu.cn	WANG, Honglin/AAJ-2708-2020	WANG, Honglin/0000-0001-6302-6927; Yu, Xue-Zhong/0000-0002-1751-2884	National Natural Science Foundation of China [30972787]; Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [09140902600]; Shanghai Municipal Education Commission [J50208, J50207]; Shanghai Pujiang Program [10PJ407300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This research is supported by a grant from the National Natural Science Foundation of China (No: 30972787), by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, by the Science and Technology Commission of Shanghai Municipality (No.: 09140902600), and by the Leading Academic Discipline Project of the Shanghai Municipal Education Commission (No: J50208 and No: J50207). Supported by Shanghai Pujiang Program (No: 10PJ407300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATACSORGO Z, 1995, J INVEST DERMATOL, V105, pS89, DOI 10.1111/1523-1747.ep12316121; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Clark RA, 2006, J CLIN INVEST, V116, P2084, DOI 10.1172/JCI29441; FRAKI JE, 1982, SCIENCE, V215, P685, DOI 10.1126/science.7036342; GISSLER HM, 1993, BRIT J DERMATOL, V128, P612, DOI 10.1111/j.1365-2133.1993.tb00254.x; Gong Y, 2001, J BIOL CHEM, V276, P19078, DOI 10.1074/jbc.M101387200; Hajjar KA, 1997, ANN NY ACAD SCI, V811, P337, DOI 10.1111/j.1749-6632.1997.tb52013.x; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Herren T, 2001, BLOOD, V97, P1070, DOI 10.1182/blood.V97.4.1070; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; JENSEN PJ, 1988, J INVEST DERMATOL, V90, P777, DOI 10.1111/1523-1747.ep12461494; JENSEN PJ, 1990, J INVEST DERMATOL, V95, pS13, DOI 10.1111/1523-1747.ep12505666; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Karimi-Busheri F, 2002, J CELL BIOCHEM, V86, P737, DOI 10.1002/jcb.10256; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; Longstaff C, 1999, BLOOD, V93, P3839, DOI 10.1182/blood.V93.11.3839.411k08_3839_3846; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; SPIERS EM, 1994, J INVEST DERMATOL, V102, P333, DOI 10.1111/1523-1747.ep12371792; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Wang HL, 2009, J IMMUNOL, V183, P4755, DOI 10.4049/jimmunol.0900521; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zibert JR, 2010, J INVEST DERMATOL, V130, P150, DOI 10.1038/jid.2009.206	33	21	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2011	6	2							e16483	10.1371/journal.pone.0016483	http://dx.doi.org/10.1371/journal.pone.0016483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IF	21311769	Green Published, gold, Green Submitted			2022-12-25	WOS:000287036200016
J	Ghumra, A; Khunrae, P; Ataide, R; Raza, A; Rogerson, SJ; Higgins, MK; Rowe, JA				Ghumra, Ashfaq; Khunrae, Pongsak; Ataide, Ricardo; Raza, Ahmed; Rogerson, Stephen J.; Higgins, Matthew K.; Rowe, J. Alexandra			Immunisation with Recombinant PfEMP1 Domains Elicits Functional Rosette-Inhibiting and Phagocytosis-Inducing Antibodies to Plasmodium falciparum	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; SEVERE MALARIA; IN-VITRO; PARASITIZED ERYTHROCYTES; CODON OPTIMIZATION; ESCHERICHIA-COLI; CEREBRAL MALARIA; STRUCTURAL BASIS	Background: Rosetting is a Plasmodium falciparum virulence factor implicated in the pathogenesis of life-threatening malaria. Rosetting occurs when parasite-derived P. falciparum Erythrocyte Membrane Protein One (PfEMP1) on the surface of infected erythrocytes binds to human receptors on uninfected erythrocytes. PfEMP1 is a possible target for a vaccine to induce antibodies to inhibit rosetting and prevent severe malaria. Methodology/Findings: We examined the vaccine potential of the six extracellular domains of a rosette-mediating PfEMP1 variant (ITvar9/R29var1 from the R29 parasite strain) by immunizing rabbits with recombinant proteins expressed in E. coli. Antibodies raised to each domain were tested for surface fluorescence with live infected erythrocytes, rosette inhibition and phagocytosis-induction. Antibodies to all PfEMP1 domains recognized the surface of live infected erythrocytes down to low concentrations (0.02-1.56 mu g/ml of total IgG). Antibodies to all PfEMP1 domains except for the second Duffy-Binding-Like region inhibited rosetting (50% inhibitory concentration 0.04-4 mu g/ml) and were able to opsonize and induce phagocytosis of infected erythrocytes at low concentrations (1.56-6.25 mu g/ml). Antibodies to the N-terminal region (NTS-DBL1 alpha) were the most effective in all assays. All antibodies were specific for the R29 parasite strain, and showed no functional activity against five other rosetting strains. Conclusions/Significance: These results are encouraging for vaccine development as they show that potent antibodies can be generated to recombinant PfEMP1 domains that will inhibit rosetting and induce phagocytosis of infected erythrocytes. However, further work is needed on rosetting mechanisms and cross-reactivity in field isolates to define a set of PfEMP1 variants that could induce functional antibodies against a broad range of P. falciparum rosetting parasites.	[Ghumra, Ashfaq; Raza, Ahmed; Rowe, J. Alexandra] Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Khunrae, Pongsak; Higgins, Matthew K.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ataide, Ricardo; Rogerson, Stephen J.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Ataide, Ricardo] Univ Porto, Grad Program Areas Basic & Appl Biol, P-4100 Oporto, Portugal	University of Edinburgh; University of Cambridge; University of Melbourne; Universidade do Porto	Ghumra, A (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland.	Alex.Rowe@ed.ac.uk	Ataide, Ricardo/B-7307-2017	Ataide, Ricardo/0000-0002-1014-0432; Rogerson, Stephen/0000-0003-4287-1982; Rowe, Alexandra/0000-0002-7702-1892; Higgins, Matthew/0000-0002-2870-1955	Wellcome Trust [084226]; Royal Society; Royal Thai Government; National Health and Medical Research Council of Australia; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/32985/2006]	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Royal Thai Government; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	JAR, AG and AR are supported by the Wellcome Trust (http://www.wellcome.ac.uk/) via a Senior Research Fellowship in Basic Biomedical Science to JAR, grant no 084226. MKH is a Royal Society University Research Fellow (http://royalsociety.org/) and this work was supported by grants from the Royal Society and the Wellcome Trust. PK was funded by a scholarship from the Royal Thai Government. SJR is supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) and RA is supported by Fundacao para a Ciencia e Tecnologia, Portugal (http://alfa.fct.mctes.pt/), reference SFRH/BD/32985/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Baca AM, 2000, INT J PARASITOL, V30, P113, DOI 10.1016/S0020-7519(00)00019-9; Barfod L, 2006, INFECT IMMUN, V74, P4357, DOI 10.1128/IAI.01617-05; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; CELADA A, 1983, J PARASITOL, V69, P49, DOI 10.2307/3281273; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Chen Q, 1998, J EXP MED, V187, P15, DOI 10.1084/jem.187.1.15; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Corrigan RA, 2010, PARASITE IMMUNOL, V32, P512, DOI 10.1111/j.1365-3024.2010.01225.x; COX MJ, 1994, T ROY SOC TROP MED H, V88, P191, DOI 10.1016/0035-9203(94)90292-5; Deans AM, 2006, EXP PARASITOL, V112, P269, DOI 10.1016/j.exppara.2005.11.007; Dondorp AM, 2008, J INFECT DIS, V197, P79, DOI 10.1086/523762; Doumbo OK, 2009, AM J TROP MED HYG, V81, P987, DOI 10.4269/ajtmh.2009.09-0406; Ghumra A, 2008, J IMMUNOL, V181, P1988, DOI 10.4049/jimmunol.181.3.1988; HANDUNNETTI SM, 1992, AM J TROP MED HYG, V46, P371, DOI 10.4269/ajtmh.1992.46.371; Higgins MK, 2008, ACTA CRYSTALLOGR F, V64, P221, DOI 10.1107/S1744309108004211; Howell DPG, 2008, MOL MICROBIOL, V67, P78, DOI 10.1111/j.1365-2958.2007.06019.x; Joergensen LM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-100; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KAUL DK, 1991, BLOOD, V78, P812; Khunrae P, 2010, J MOL BIOL, V397, P826, DOI 10.1016/j.jmb.2010.01.040; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Kyriacou HM, 2007, ANTIMICROB AGENTS CH, V51, P1321, DOI 10.1128/AAC.01216-06; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; Mayor A, 2009, INFECT IMMUN, V77, P3857, DOI 10.1128/IAI.00049-09; Mota MM, 1998, INFECT IMMUN, V66, P4080; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; Oguariri RM, 2003, PARASITOL RES, V90, P467, DOI 10.1007/s00436-003-0884-8; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; Robinson BA, 2003, MOL MICROBIOL, V47, P1265, DOI 10.1046/j.1365-2958.2003.03378.x; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; Rowe JA, 1998, MOL BIOCHEM PARASIT, V92, P177, DOI 10.1016/S0166-6851(97)00237-5; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Russell C, 2005, MOL BIOCHEM PARASIT, V144, P109, DOI 10.1016/j.molbiopara.2005.06.009; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Singh AP, 2002, MOL BIOCHEM PARASIT, V121, P21, DOI 10.1016/S0166-6851(02)00017-8; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Smith JD, 2000, MOL BIOCHEM PARASIT, V110, P293, DOI 10.1016/S0166-6851(00)00279-6; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Srivastava A, 2010, P NATL ACAD SCI USA, V107, P4884, DOI 10.1073/pnas.1000951107; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; Trang DTX, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-7; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Warimwe GM, 2009, P NATL ACAD SCI USA, V106, P21801, DOI 10.1073/pnas.0907590106; Yadava A, 2003, INFECT IMMUN, V71, P4961, DOI 10.1128/IAI.71.9.4961-4969.2003; Zhou ZY, 2004, PROTEIN EXPRES PURIF, V34, P87, DOI 10.1016/j.pep.2003.11.006	64	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16414	10.1371/journal.pone.0016414	http://dx.doi.org/10.1371/journal.pone.0016414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21305024	gold, Green Published			2022-12-25	WOS:000286834300062
J	Oiki, S; Iwamoto, M; Sumikama, T				Oiki, Shigetoshi; Iwamoto, Masayuki; Sumikama, Takashi			Cycle Flux Algebra for Ion and Water Flux through the KcsA Channel Single-File Pore Links Microscopic Trajectories and Macroscopic Observables	PLOS ONE			English	Article							STREAMING POTENTIAL MEASUREMENTS; POTASSIUM CHANNELS; K+ CHANNEL; SELECTIVITY FILTER; CONDUCTION; PERMEATION; GRAMICIDIN; MECHANISM; TRANSPORT; DYNAMICS	In narrow pore ion channels, ions and water molecules diffuse in a single-file manner and cannot pass each other. Under such constraints, ion and water fluxes are coupled, leading to experimentally observable phenomena such as the streaming potential. Analysis of this coupled flux would provide unprecedented insights into the mechanismof permeation. In this study, ion and water permeation through the KcsA potassium channel was the focus, for which an eight-state discrete-state Markov model has been proposed based on the crystal structure, exhibiting four ion-binding sites. Random transitions on the model lead to the generation of the net flux. Here we introduced the concept of cycle flux to derive exact solutions of experimental observables from the permeation model. There are multiple cyclic paths on the model, and random transitions complete the cycles. The rate of cycle completion is called the cycle flux. The net flux is generated by a combination of cyclic paths with their own cycle flux. T.L. Hill developed a graphical method of exact solutions for the cycle flux. This method was extended to calculate one-way cycle fluxes of the KcsA channel. By assigning the stoichiometric numbers for ion and water transfer to each cycle, we established a method to calculate the water-ion coupling ratio (CRw-i) through cycle flux algebra. These calculations predicted that CRw-i would increase at low potassium concentrations. One envisions an intuitive picture of permeation as random transitions among cyclic paths, and the relative contributions of the cycle fluxes afford experimental observables.	[Oiki, Shigetoshi; Iwamoto, Masayuki; Sumikama, Takashi] Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 910, Japan	University of Fukui	Oiki, S (corresponding author), Univ Fukui, Fac Med Sci, Dept Mol Physiol & Biophys, Fukui 910, Japan.	oiki-fki@umin.ac.jp	Sumikama, Takashi/I-6527-2019	Sumikama, Takashi/0000-0003-3696-5720; Oiki, Shigetoshi/0000-0002-8438-6750; Iwamoto, Masayuki/0000-0001-9505-2652				ALCAYAGA C, 1989, BIOPHYS J, V55, P367, DOI 10.1016/S0006-3495(89)82814-0; ANDERSEN OS, 1989, METHOD ENZYMOL, V171, P62; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Domene C, 2008, J AM CHEM SOC, V130, P3389, DOI 10.1021/ja075164v; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Finkelstein A., 1987, WATER MOVEMENT LIPID; Furini S, 2009, P NATL ACAD SCI USA, V106, P16074, DOI 10.1073/pnas.0903226106; Heckmann K, 1972, Biomembranes, V3, P127; HILL TL, 1988, P NATL ACAD SCI USA, V85, P2879, DOI 10.1073/pnas.85.9.2879; HILL TL, 1975, P NATL ACAD SCI USA, V72, P1291, DOI 10.1073/pnas.72.4.1291; Hill TL, 2004, FREE ENERGY TRANSDUC; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HLADKY SB, 1984, CURR TOP MEMBR TRANS, V21, P327; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; Ismailov II, 1997, P NATL ACAD SCI USA, V94, P7651, DOI 10.1073/pnas.94.14.7651; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Katchalsky A., 1965, NONEQUILIBRIUM THERM; Khalili-Araghi F, 2006, BIOPHYS J, V91, pL2, DOI 10.1529/biophysj.106.091926; LEVITT DG, 1978, BIOCHIM BIOPHYS ACTA, V512, P436, DOI 10.1016/0005-2736(78)90266-3; MILLER C, 1982, BIOPHYS J, V38, P227, DOI 10.1016/S0006-3495(82)84552-9; Miller C, 1999, J GEN PHYSIOL, V113, P783, DOI 10.1085/jgp.113.6.783; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Oiki S, 2010, J GEN PHYSIOL, V136, P363, DOI 10.1085/jgp.201010504; ROSENBERG PA, 1978, J GEN PHYSIOL, V72, P327, DOI 10.1085/jgp.72.3.327; SCHULZ SG, 1980, BASIC PRINCIPLES MEM; Skiena S, 1990, IMPLEMENTING DISCRET; Sumikama T, 2006, J PHYS CHEM B, V110, P20671, DOI 10.1021/jp062547r; Swope WC, 2004, J PHYS CHEM B, V108, P6582, DOI 10.1021/jp037422q; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16578	10.1371/journal.pone.0016578	http://dx.doi.org/10.1371/journal.pone.0016578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21304994	gold, Green Published, Green Submitted			2022-12-25	WOS:000286834300090
J	Chaparro-Garcia, A; Wilkinson, RC; Gimenez-Ibanez, S; Findlay, K; Coffey, MD; Zipfel, C; Rathjen, JP; Kamoun, S; Schornack, S				Chaparro-Garcia, Angela; Wilkinson, Rachael C.; Gimenez-Ibanez, Selena; Findlay, Kim; Coffey, Michael D.; Zipfel, Cyril; Rathjen, John P.; Kamoun, Sophien; Schornack, Sebastian			The Receptor-Like Kinase SERK3/BAK1 Is Required for Basal Resistance against the Late Blight Pathogen Phytophthora infestans in Nicotiana benthamiana	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; INF1-INDUCED CELL-DEATH; INNATE IMMUNITY; EFFECTOR AVR3A; PLANT IMMUNITY; ELICITOR PROTEIN; GENE; ARABIDOPSIS; ACTIVATION; TOMATO	Background: The filamentous oomycete plant pathogen Phytophthora infestans causes late blight, an economically important disease, on members of the nightshade family (Solanaceae), such as the crop plants potato and tomato. The related plant Nicotiana benthamiana is a model system to study plant-pathogen interactions, and the susceptibility of N. benthamiana to Phytophthora species varies from susceptible to resistant. Little is known about the extent to which plant basal immunity, mediated by membrane receptors that recognise conserved pathogen-associated molecular patterns (PAMPs), contributes to P. infestans resistance. Principal Findings: We found that different species of Phytophthora have varying degrees of virulence on N. benthamiana ranging from avirulence (incompatible interaction) to moderate virulence through to full aggressiveness. The leucine-rich repeat receptor-like kinase (LRR-RLK) BAK1/SERK3 is a major modulator of PAMP-triggered immunity (PTI) in Arabidopsis thaliana and N. benthamiana. We cloned two NbSerk3 homologs, NbSerk3A and NbSerk3B, from N. benthamiana based on sequence similarity to the A. thaliana gene. N. benthamiana plants silenced for NbSerk3 showed markedly enhanced susceptibility to P. infestans infection but were not altered in resistance to Phytophthora mirabilis, a sister species of P. infestans that specializes on a different host plant. Furthermore, silencing of NbSerk3 reduced the cell death response triggered by the INF1, a secreted P. infestans protein with features of PAMPs. Conclusions/Significance: We demonstrated that N. benthamiana NbSERK3 significantly contributes to resistance to P. infestans and regulates the immune responses triggered by the P. infestans PAMP protein INF1. In the future, the identification of novel surface receptors that associate with NbSERK3A and/or NbSERK3B should lead to the identification of new receptors that mediate recognition of oomycete PAMPs, such as INF1.	[Chaparro-Garcia, Angela; Wilkinson, Rachael C.; Gimenez-Ibanez, Selena; Zipfel, Cyril; Rathjen, John P.; Kamoun, Sophien; Schornack, Sebastian] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England; [Coffey, Michael D.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California Riverside	Chaparro-Garcia, A (corresponding author), John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England.	sophien.kamoun@tsl.ac.uk; sebastian.schornack@tsl.ac.uk	ZIPFEL, CYRIL B/D-7103-2011; Schornack, Sebastian/AAE-4897-2020; Kamoun, Sophien/B-3529-2009; Schornack, Sebastian/A-3650-2011; ZIPFEL, CYRIL/ABD-5076-2021; rathjen, john p/C-9327-2009; Gimenez-Ibanez, Selena/B-1172-2017	ZIPFEL, CYRIL B/0000-0003-4935-8583; Schornack, Sebastian/0000-0002-7836-5881; Kamoun, Sophien/0000-0002-0290-0315; Schornack, Sebastian/0000-0002-7836-5881; ZIPFEL, CYRIL/0000-0003-4935-8583; rathjen, john p/0000-0003-4073-8088; Gimenez-Ibanez, Selena/0000-0002-5453-8565; Findlay, Kim/0000-0002-1556-0532; Wilkinson, Rachael/0000-0002-0749-108X	Gatsby Charitable Foundation; BBSRC; Nuffield Foundation; German Research Foundation (DFG);  [SCHO1347/1-1]	Gatsby Charitable Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nuffield Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); 	This work was supported by the Gatsby Charitable Foundation, BBSRC, Nuffield Foundation and the German Research Foundation (DFG). SS was supported by a personal research fellowship (SCHO1347/1-1). JPR is an Australian Research Council Future Fellow (FT0992129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; BAR M, 2010, PLANT J; Becktell MC, 2006, PLANT DIS, V90, P24, DOI 10.1094/PD-90-0024; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Bos JIB, 2009, MOL PLANT MICROBE IN, V22, P269, DOI 10.1094/MPMI-22-3-0269; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Flier WG, 2002, MYCOL RES, V106, P848, DOI 10.1017/S0953756202006123; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gimenez-Ibanez S, 2009, PLANT SIGNAL BEHAV, V4, P539, DOI 10.4161/psb.4.6.8697; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kamoun S, 1998, PLANT CELL, V10, P1413, DOI 10.1105/tpc.10.9.1413; Kamoun S, 2001, CURR OPIN PLANT BIOL, V4, P295, DOI 10.1016/S1369-5266(00)00176-X; KAMOUN S, 1993, MOL PLANT MICROBE IN, V6, P573, DOI 10.1094/MPMI-6-573; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P1028, DOI 10.1094/MPMI.1997.10.8.1028; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Kanzaki H, 2008, PLANTA, V228, P977, DOI 10.1007/s00425-008-0797-y; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Oh SK, 2009, PLANT CELL, V21, P2928, DOI 10.1105/tpc.109.068247; Peart JR, 2002, PLANT J, V29, P569, DOI 10.1046/j.1365-313X.2002.029005569.x; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; SCHORNACK S, 2010, P NATL ACAD SCI US; Schornack S, 2009, MOL PLANT PATHOL, V10, P795, DOI 10.1111/j.1364-3703.2009.00593.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shibata Y, 2010, MOL PLANT MICROBE IN, V23, P1130, DOI 10.1094/MPMI-23-9-1130; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Torres GA, 2010, PLANT DIS, V94, P1163, DOI 10.1094/PDIS-94-9-1163A; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; Wei CF, 2007, PLANT J, V51, P32, DOI 10.1111/j.1365-313X.2007.03126.x; WELLS B, 1985, MICRON MICROSC ACTA, V16, P49, DOI 10.1016/0739-6260(85)90031-0; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003	48	123	130	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2011	6	1							e16608	10.1371/journal.pone.0016608	http://dx.doi.org/10.1371/journal.pone.0016608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JV	21304602	Green Published, gold, Green Submitted			2022-12-25	WOS:000286663900080
J	Lee, J; Romero, R; Xu, Y; Kim, JS; Topping, V; Yoo, W; Kusanovic, JP; Chaiworapongsa, T; Hassan, SS; Yoon, BH; Kim, CJ				Lee, JoonHo; Romero, Roberto; Xu, Yi; Kim, Jung-Sun; Topping, Vanessa; Yoo, Wonsuk; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Yoon, Bo Hyun; Kim, Chong Jai			A Signature of Maternal Anti-Fetal Rejection in Spontaneous Preterm Birth: Chronic Chorioamnionitis, Anti-Human Leukocyte Antigen Antibodies, and C4d	PLOS ONE			English	Article							NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; CLINICAL-SIGNIFICANCE; ALLOGRAFT-REJECTION; RECURRENT ABORTION; MEDIATED REJECTION; HUMORAL IMMUNITY; UNKNOWN ETIOLOGY; HLA ANTIBODIES; PREGNANCY; MECHANISMS	Background: Chronic chorioamnionitis is found in more than one-third of spontaneous preterm births. Chronic chorioamnionitis and villitis of unknown etiology represent maternal anti-fetal cellular rejection. Antibody-mediated rejection is another type of transplantation rejection. We investigated whether there was evidence for antibody-mediated rejection against the fetus in spontaneous preterm birth. Methods and Findings: This cross-sectional study included women with (1) normal pregnancy and term delivery (n = 140) and (2) spontaneous preterm delivery (n = 140). We analyzed maternal and fetal sera for panel-reactive anti-HLA class I and class II antibodies, and determined C4d deposition on umbilical vein endothelium by immunohistochemistry. Maternal anti-HLA class I seropositivity in spontaneous preterm births was higher than in normal term births (48.6% vs. 32.1%, p = 0.005). Chronic chorioamnionitis was associated with a higher maternal anti-HLA class I seropositivity (p<0.01), significant in preterm and term birth. Villitis of unknown etiology was associated with increased maternal and fetal anti-HLA class I and II seropositivity (p<0.05, for each). Fetal anti-HLA seropositivity was closely related to maternal anti-HLA seropositivity in both groups (p<0.01, for each). C4d deposition on umbilical vein endothelium was more frequent in preterm labor than term labor (77.1% vs. 11.4%, p<0.001). Logistic regression analysis revealed that chronic chorioamnionitis (OR = 6.10, 95% CI 1.29-28.83), maternal anti-HLA class I seropositivity (OR = 5.90, 95% CI 1.60-21.83), and C4d deposition on umbilical vein endothelium (OR = 36.19, 95% CI 11.42-114.66) were associated with preterm labor and delivery. Conclusions: A major subset of spontaneous preterm births has a signature of maternal anti-fetal cellular and antibody-mediated rejections with links to fetal graft-versus-host disease and alloimmune reactions.	[Lee, JoonHo; Romero, Roberto; Xu, Yi; Topping, Vanessa; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Lee, JoonHo; Romero, Roberto; Xu, Yi; Topping, Vanessa; Pedro Kusanovic, Juan; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Detroit, MI USA; [Romero, Roberto; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Kim, Jung-Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Yoo, Wonsuk] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Pedro Kusanovic, Juan] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Santiago, Chile; [Pedro Kusanovic, Juan] Pontificia Univ Catolica Chile, Sch Med, Dept Obstet & Gynecol, Santiago, Chile; [Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Chong Jai] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Sungkyunkwan University (SKKU); Samsung Medical Center; Wayne State University; Universidad de Chile; Pontificia Universidad Catolica de Chile; Seoul National University (SNU); Wayne State University	Lee, J (corresponding author), NICHHD, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA.	prbchiefstaff@med.wayne.edu; cjkim@med.wayne.edu	Kusanovic, Juan Pedro/R-8616-2019; Yoon, Bo Hyun/H-6344-2011; Kusanovic, Juan Pedro/AAM-5782-2020; YOO, WONSUK/HHN-9044-2022; Romero, Roberto/A-5268-2019	Kusanovic, Juan Pedro/0000-0003-0640-2070; Lee, John Tayu/0000-0002-1551-4923; Millett, Christopher/0000-0002-0793-9884; YOO, WONSUK/0000-0003-2414-2399; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADENIYIJONES SCA, 1987, J IMMUNOL, V138, P1408; Agrawal Suraksha, 2002, BMC Pregnancy Childbirth, V2, P6, DOI 10.1186/1471-2393-2-6; AKSEL S, 1992, JAMA-J AM MED ASSOC, V268, P2930, DOI 10.1001/jama.268.20.2930; Althaus J, 2005, AM J OBSTET GYNECOL, V193, P1100, DOI 10.1016/j.ajog.2005.06.043; Ball B, 2000, TRANSPLANT P, V32, P353, DOI 10.1016/S0041-1345(99)00976-8; Bartel G, 2007, TRANSPLANTATION, V83, P727, DOI 10.1097/01.tp.0000256337.18347.aa; Bartel G, 2011, HUM IMMUNOL, V72, P187, DOI 10.1016/j.humimm.2010.11.005; Betkowski AS, 2002, J HEART LUNG TRANSPL, V21, P644, DOI 10.1016/S1053-2498(01)00422-3; COHEN F, 1964, BLOOD, V23, P621, DOI 10.1182/blood.V23.5.621.621; Collins AB, 1999, J AM SOC NEPHROL, V10, P2208; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; DUNN MJ, 1992, LANCET, V339, P1566, DOI 10.1016/0140-6736(92)91832-S; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gu DS, 2010, HUM IMMUNOL, V71, P586, DOI 10.1016/j.humimm.2010.02.010; Guleria I, 2007, J IMMUNOL, V178, P3345, DOI 10.4049/jimmunol.178.6.3345; Howell WM, 2010, J CLIN PATHOL, V63, P387, DOI 10.1136/jcp.2009.072371; Ionescu DN, 2005, TRANSPL IMMUNOL, V15, P63, DOI 10.1016/j.trim.2005.05.001; Jacques SM, 1998, HUM PATHOL, V29, P1457, DOI 10.1016/S0046-8177(98)90016-8; KILPATRICK DC, 1987, LANCET, V2, P1460; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim IK, 2008, TRANSPLANTATION, V86, P889, DOI 10.1097/TP.0b013e318186ac4a; Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834; Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001; Makrigiannakis A, 2008, AM J REPROD IMMUNOL, V60, P482, DOI 10.1111/j.1600-0897.2008.00655.x; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Moncharmont P, 2004, ACTA HAEMATOL-BASEL, V111, P215, DOI 10.1159/000077569; Nielsen HS, 2007, J REPROD IMMUNOL, V75, P63, DOI 10.1016/j.jri.2007.03.003; Nielsen HS, 2010, J REPROD IMMUNOL, V87, P67, DOI 10.1016/j.jri.2010.05.006; Pandey Manoj Kumar, 2004, Archives of Gynecology and Obstetrics, V269, P161, DOI 10.1007/s00404-003-0560-3; Piper KP, 2007, BIOL REPROD, V76, P96, DOI 10.1095/biolreprod.106.055426; Porter TF, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000112.pub2; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Raju TNK, 2006, CLIN PERINATOL, V33, P751, DOI 10.1016/j.clp.2006.09.009; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; REDLINE RW, 1993, AM J PATHOL, V143, P473; REDMAN CWG, 1983, AM J REPROD IMMUNOL, V4, P179, DOI 10.1111/j.1600-0897.1983.tb00274.x; REGAN L, 1991, HUM REPROD, V6, P294, DOI 10.1093/oxfordjournals.humrep.a137325; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Rowshani AT, 2008, CLIN TRANSPLANT, V22, P689, DOI 10.1111/j.1399-0012.2008.00872.x; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Saito S, 2003, TRANSFUSION, V43, P908, DOI 10.1046/j.1537-2995.2003.00429.x; SARGENT IL, 1988, LANCET, V2, P1099; Schild RL, 1999, ULTRASOUND OBST GYN, V14, P64, DOI 10.1046/j.1469-0705.1999.14010064.x; SEBRING ES, 1990, TRANSFUSION, V30, P344, DOI 10.1046/j.1537-2995.1990.30490273444.x; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Sumitran-Holgersson S, 2002, TRANSPLANTATION, V74, P268, DOI 10.1097/00007890-200207270-00019; Sumitran-Holgersson S, 2008, CURR OPIN IMMUNOL, V20, P607, DOI 10.1016/j.coi.2008.07.005; Taglauer ES, 2010, INT J DEV BIOL, V54, P421, DOI 10.1387/ijdb.082800et; Takemoto SK, 2004, AM J TRANSPLANT, V4, P1033, DOI 10.1111/j.1600-6143.2004.00500.x; Thude H, 2006, TRANSFUSION MED, V16, P143, DOI 10.1111/j.1365-3148.2006.00634.x; Tilburgs T, 2010, J REPROD IMMUNOL, V85, P58, DOI 10.1016/j.jri.2010.01.005; van Halteren AGS, 2009, BLOOD, V114, P2263, DOI 10.1182/blood-2009-01-200410; von Rango U, 2008, IMMUNOL LETT, V115, P21, DOI 10.1016/j.imlet.2007.09.014; Wasowska BA, 2010, IMMUNOL RES, V47, P25, DOI 10.1007/s12026-009-8136-3; Wilczynski JR, 2006, HUM IMMUNOL, V67, P492, DOI 10.1016/j.humimm.2006.04.007; Zeevi A, 2006, IMMUNOL RES, V36, P255, DOI 10.1385/IR:36:1:255	58	175	177	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16806	10.1371/journal.pone.0016806	http://dx.doi.org/10.1371/journal.pone.0016806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21326865	gold, Green Published, Green Submitted			2022-12-25	WOS:000287037000022
J	Schmeier, S; Schaefer, U; MacPherson, CR; Bajic, VB				Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.			dPORE-miRNA: Polymorphic Regulation of MicroRNA Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; DATABASE; CANCER; IDENTIFICATION; DISEASES; UPDATE; ROLES; SITES; SNP	Background: MicroRNAs (miRNAs) are short non-coding RNA molecules that act as post-transcriptional regulators and affect the regulation of protein-coding genes. Mostly transcribed by PolII, miRNA genes are regulated at the transcriptional level similarly to protein-coding genes. In this study we focus on human miRNAs. These miRNAs are involved in a variety of pathways and can affect many diseases. Our interest is on possible deregulation of the transcription initiation of the miRNA encoding genes, which is facilitated by variations in the genomic sequence of transcriptional control regions (promoters). Methodology: Our aim is to provide an online resource to facilitate the investigation of the potential effects of single nucleotide polymorphisms (SNPs) on miRNA gene regulation. We analyzed SNPs overlapped with predicted transcription factor binding sites (TFBSs) in promoters of miRNA genes. We also accounted for the creation of novel TFBSs due to polymorphisms not present in the reference genome. The resulting changes in the original TFBSs and potential creation of new TFBSs were incorporated into the Dragon Database of Polymorphic Regulation of miRNA genes (dPORE-miRNA). Conclusions: The dPORE-miRNA database enables researchers to explore potential effects of SNPs on the regulation of miRNAs. dPORE-miRNA can be interrogated with regards to: a/miRNAs (their targets, or involvement in diseases, or biological pathways), b/SNPs, or c/transcription factors. dPORE-miRNA can be accessed at http://cbrc.kaust.edu.sa/dpore and http://apps.sanbi.ac.za/dpore/. Its use is free for academic and non-profit users.	[Schmeier, Sebastian; Schaefer, Ulf; MacPherson, Cameron R.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia	King Abdullah University of Science & Technology	Schmeier, S (corresponding author), King Abdullah Univ Sci & Technol KAUST, Computat Biosci Res Ctr CBRC, Jeddah, Saudi Arabia.	vladimir.bajic@kaust.edu.sa	Schmeier, Sebastian/D-4731-2011; Bajic, Vladimir/D-2810-2009	Schmeier, Sebastian/0000-0002-3947-8226; MacPherson, Cameron/0000-0002-8945-9736; Bajic, Vladimir/0000-0001-5435-4750; Jankovic, Boris/0000-0003-1868-6007				Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Bandiera S, 2010, CLIN GENET, V77, P306, DOI 10.1111/j.1399-0004.2010.01370.x; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bracht J, 2004, RNA, V10, P1586, DOI 10.1261/rna.7122604; Brookes AJ, 1999, GENE, V234, P177, DOI 10.1016/S0378-1119(99)00219-X; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Canella D, 2010, GENOME RES, V20, P710, DOI 10.1101/gr.101337.109; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du LQ, 2010, CANCER METAST REV, V29, P109, DOI 10.1007/s10555-010-9204-9; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Heckmann JM, 2010, GENES IMMUN, V11, P1, DOI 10.1038/gene.2009.61; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kim BC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S2; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li GQ, 2010, BLOOD, V115, P1416, DOI 10.1182/blood-2009-07-234963; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schmeier S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-595; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	50	27	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16657	10.1371/journal.pone.0016657	http://dx.doi.org/10.1371/journal.pone.0016657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21750739	gold, Green Submitted, Green Published			2022-12-25	WOS:000287037000016
